cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
PRAD	cis	1	rs10000348	chr4:111379036	ENPEP	chr4:111397229-111484491:+	0.13	3.55	0.000431	Blood pressure	
PRAD	cis	1	rs1000113	chr5:150240076	C5orf62	chr5:150157867-150176297:+	0.3	3.82	0.000152	Crohn's disease	
PRAD	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.65	9.78	1.08E-20	Crohn's disease	
PRAD	cis	1	rs10002085	chr4:147491160	ZNF827	chr4:146681892-146859607:-	-0.17	-3.77	0.000181	Heart rate	
PRAD	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.47	7.84	3.01E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs10003641	chr4:71340427	AMTN	chr4:71384298-71398459:+	0.42	8.03	8.18E-15	Alcoholism (heaviness of drinking)	
PRAD	cis	1	rs10005733	chr4:292001	ZNF718	chr4:53272-156488:+	0.43	8.19	2.44E-15	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs10005989	chr4:56405206	TMEM165	chr4:56262090-56292342:+	0.18	3.98	8.07E-5	Personality dimensions	
PRAD	cis	1	rs10006789	chr4:1330333	CRIPAK	chr4:1385340-1389782:+	0.37	6.86	2.2E-11	Systolic blood pressure	
PRAD	cis	1	rs10007119	chr4:3473066	LRPAP1	chr4:3514290-3534224:-	0.17	4.16	3.73E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs10009541	chr4:17682218	MED28	chr4:17616273-17629791:+	-0.15	-3.85	0.000133	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10010958	chr4:147511918	ZNF827	chr4:146681892-146859607:-	-0.17	-3.81	0.00016	Heart rate	
PRAD	cis	1	rs10011259	chr4:54285952	FIP1L1	chr4:54243820-54326102:+	-0.18	-3.95	9.16E-5	DNA methylation (variation)	
PRAD	cis	1	rs10011730	chr4:75168571	RASSF6	chr4:74438862-74486340:-	0.36	4.15	4.01E-5	Immune reponse to smallpox (secreted IL-1beta)	
PRAD	cis	1	rs10011835	chr4:71340722	AMTN	chr4:71384298-71398459:+	0.42	8.03	8.18E-15	Alcoholism (heaviness of drinking)	
PRAD	cis	1	rs10011865	chr4:17645710	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10012335	chr4:17628630	MED28	chr4:17616273-17629791:+	0.23	5.68	2.32E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs1001446	chr19:32900957	DPY19L3	chr19:32896677-32975236:+	0.11	3.65	0.00029	Bipolar disorder	
PRAD	cis	1	rs10014502	chr4:147514051	ZNF827	chr4:146681892-146859607:-	-0.16	-3.61	0.00034	Heart rate	
PRAD	cis	1	rs10017903	chr4:54267009	FIP1L1	chr4:54243820-54326102:+	-0.18	-3.88	0.000119	DNA methylation (variation)	
PRAD	cis	1	rs10018049	chr4:39117401	KLHL5	chr4:39046659-39123828:+	-0.13	-3.78	0.000175	Uric acid levels	
PRAD	cis	1	rs10019681	chr4:89832532	FAM13A	chr4:89647106-90032549:-	0.18	3.45	0.000613	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs10019856	chr4:17615742	MED28	chr4:17616273-17629791:+	0.21	5.29	1.91E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10021364	chr4:310691	ZNF718	chr4:53272-156488:+	-0.35	-5.68	2.37E-8	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs10023335	chr4:77358987	CCDC158	chr4:77234193-77328458:-	0.21	4.16	3.78E-5	Creatinine levels	
PRAD	cis	1	rs10023335	chr4:77358987	FAM47E	chr4:77135193-77204923:+	0.23	4.16	3.72E-5	Creatinine levels	
PRAD	cis	1	rs10023907	chr4:88772535	SPP1	chr4:88896802-88904562:+	-0.2	-3.65	0.000291	Bone mineral density;Bone mineral density (paediatric, total body less head)	
PRAD	cis	1	rs10026531	chr4:154727070	RNF175	chr4:154631313-154681387:-	-0.18	-4.33	1.8E-5	Electrocardiographic conduction measures	
PRAD	cis	1	rs10026676	chr4:56478752	SRD5A3	chr4:56212409-56237866:+	-0.28	-4.1	4.91E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs1002675	chr3:38445226	XYLB	chr3:38388251-38456467:+	0.22	5.08	5.46E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs1002676	chr3:38444932	XYLB	chr3:38388251-38456467:+	-0.23	-5.06	6.08E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs10026775	chr4:39116775	KLHL5	chr4:39046659-39123828:+	-0.13	-3.78	0.000175	Uric acid levels	
PRAD	cis	1	rs10027325	chr4:282608	ZNF718	chr4:53272-156488:+	0.34	6.04	3.11E-9	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs10027755	chr4:17615954	MED28	chr4:17616273-17629791:+	0.19	4.85	1.68E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10027813	chr4:39121438	KLHL5	chr4:39046659-39123828:+	-0.13	-3.81	0.00016	Uric acid levels	
PRAD	cis	1	rs10028351	chr4:71295971	AMTN	chr4:71384298-71398459:+	0.41	8	9.57E-15	Alcoholism (heaviness of drinking)	
PRAD	cis	1	rs10028589	chr4:89841060	FAM13A	chr4:89647106-90032549:-	0.18	3.54	0.000435	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs10028679	chr4:89841170	FAM13A	chr4:89647106-90032549:-	0.19	3.61	0.000342	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs10030019	chr4:106998448	TBCK	chr4:106967233-107237861:-	0.17	3.66	0.000282	Airflow obstruction	
PRAD	cis	1	rs10030904	chr4:39115223	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	cis	1	rs10032147	chr4:147481344	ZNF827	chr4:146681892-146859607:-	0.17	3.79	0.000173	Heart rate	
PRAD	cis	1	rs10032326	chr4:17630717	MED28	chr4:17616273-17629791:+	0.23	5.65	2.77E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10033071	chr4:111375852	ENPEP	chr4:111397229-111484491:+	0.13	3.54	0.000448	Blood pressure	
PRAD	cis	1	rs10033329	chr4:147490123	ZNF827	chr4:146681892-146859607:-	-0.15	-3.47	0.000567	Heart rate	
PRAD	cis	1	rs10034433	chr4:56421176	TMEM165	chr4:56262090-56292342:+	0.18	4.03	6.43E-5	Personality dimensions	
PRAD	cis	1	rs1003623	chr11:108152582	ATM	chr11:108093559-108239826:+	-0.15	-4.53	7.62E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs10037055	chr5:176691279	MXD3	chr5:176732501-176739292:-	0.09	3.66	0.000283	Migraine without aura	
PRAD	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.47	-12.34	1.73E-30	Eye color traits	
PRAD	cis	1	rs10038095	chr5:74637711	POLK	chr5:74807657-74895644:+	-0.11	-3.47	0.000572	LDL cholesterol	
PRAD	cis	1	rs1004040	chr22:23585132	GNAZ	chr22:23412669-23467221:+	-0.1	-3.45	0.000622	Height	
PRAD	cis	1	rs10041072	chr5:150259642	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs10043959	chr5:107390144	FBXL17	chr5:107194740-107717799:-	0.21	4.35	1.68E-5	Educational attainment	
PRAD	cis	1	rs10045497	chr5:74636484	POLK	chr5:74807657-74895644:+	-0.11	-3.45	0.000604	LDL cholesterol	
PRAD	cis	1	rs10048683	chr2:26320519	GPR113	chr2:26531041-26569685:-	-0.24	-3.6	0.000347	Gut microbiome composition (summer)	
PRAD	cis	1	rs10050159	chr4:106765915	INTS12	chr4:106603787-106629881:-	-0.61	-7.01	8.59E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs10050311	chr4:87754419	C4orf36	chr4:87797359-87813575:-	-0.26	-3.55	0.00042	Insulin-related traits	
PRAD	cis	1	rs10050333	chr4:106765813	INTS12	chr4:106603787-106629881:-	-0.61	-7.01	8.59E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs10051240	chr5:115569931	COMMD10	chr5:115420727-115628978:+	0.29	3.66	0.000285	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.94	15.78	2.5E-45	Type 2 diabetes	
PRAD	cis	1	rs10051787	chr5:122732236	CEP120	chr5:122680580-122759252:-	-0.23	-5.07	5.8E-7	Waist circumference	
PRAD	cis	1	rs10051804	chr5:150226424	C5orf62	chr5:150157867-150176297:+	0.29	3.78	0.000177	Crohn's disease	
PRAD	cis	1	rs10051804	chr5:150226424	LOC134466	chr5:150310000-150326146:-	0.57	8.63	9.23E-17	Crohn's disease	
PRAD	cis	1	rs10051924	chr5:150226639	C5orf62	chr5:150157867-150176297:+	0.29	3.78	0.000177	Crohn's disease	
PRAD	cis	1	rs10051924	chr5:150226639	LOC134466	chr5:150310000-150326146:-	0.57	8.63	9.23E-17	Crohn's disease	
PRAD	cis	1	rs1005224	chr14:76173860	TTLL5	chr14:76127621-76421421:+	0.17	3.47	0.000573	Large artery stroke	
PRAD	cis	1	rs10052606	chr5:150272217	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs10053750	chr5:150270051	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs10056340	chr5:110190052	TMEM232	chr5:109624934-110062381:-	0.24	3.82	0.000152	Asthma and hay fever	
PRAD	cis	1	rs10057988	chr5:150272062	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs10058821	chr5:150226385	C5orf62	chr5:150157867-150176297:+	0.29	3.78	0.000177	Crohn's disease	
PRAD	cis	1	rs10058821	chr5:150226385	LOC134466	chr5:150310000-150326146:-	0.57	8.63	9.23E-17	Crohn's disease	
PRAD	cis	1	rs10058943	chr5:150226586	C5orf62	chr5:150157867-150176297:+	0.29	3.78	0.000177	Crohn's disease	
PRAD	cis	1	rs10058943	chr5:150226586	LOC134466	chr5:150310000-150326146:-	0.57	8.63	9.23E-17	Crohn's disease	
PRAD	cis	1	rs10061105	chr5:150255185	LOC134466	chr5:150310000-150326146:-	0.58	9.01	5.3E-18	Crohn's disease	
PRAD	cis	1	rs10062350	chr5:115453497	COMMD10	chr5:115420727-115628978:+	0.28	3.48	0.000557	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs1006396	chr22:30017000	SEC14L2	chr22:30792933-30824976:+	-0.28	-4.02	6.88E-5	Lipid traits	
PRAD	cis	1	rs1006441	chr11:77932126	GAB2	chr11:77926343-78128766:-	-0.19	-5.79	1.3E-8	Testicular germ cell tumor	
PRAD	cis	1	rs1006441	chr11:77932126	NARS2	chr11:78147017-78285909:-	-0.18	-3.51	0.000482	Testicular germ cell tumor	
PRAD	cis	1	rs10065172	chr5:150227998	C5orf62	chr5:150157867-150176297:+	0.29	3.78	0.000177	Crohn's disease	
PRAD	cis	1	rs10065172	chr5:150227998	LOC134466	chr5:150310000-150326146:-	0.57	8.63	9.23E-17	Crohn's disease	
PRAD	cis	1	rs1006581	chr7:150511923	TMEM176A	chr7:150497854-150502208:+	-0.15	-4.41	1.29E-5	Forced expiratory volume in 1 second (environmental interaction)	
PRAD	cis	1	rs10066259	chr5:115451892	COMMD10	chr5:115420727-115628978:+	0.27	3.47	0.000575	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs1006722	chr4:17618713	MED28	chr4:17616273-17629791:+	-0.2	-5.06	5.94E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10069077	chr5:110170026	TMEM232	chr5:109624934-110062381:-	-0.36	-4.11	4.72E-5	Mortality in heart failure	
PRAD	cis	1	rs10069964	chr5:101947692	PPIP5K2	chr5:102455958-102538907:+	-0.24	-3.65	0.000292	Crohn's disease	
PRAD	cis	1	rs1007000	chr9:113662681	PTGR1	chr9:114312003-114362135:-	-0.26	-4.01	7.2E-5	Corneal structure	
PRAD	cis	1	rs1007123	chr20:31345840	MAPRE1	chr20:31407699-31438210:+	0.19	4.46	1.04E-5	Ulcerative colitis	
PRAD	cis	1	rs1007124	chr20:31345752	MAPRE1	chr20:31407699-31438210:+	0.2	4.63	4.78E-6	Ulcerative colitis	
PRAD	cis	1	rs10073425	chr5:110163206	TMEM232	chr5:109624934-110062381:-	0.27	4.21	3.09E-5	Asthma and hay fever	
PRAD	cis	1	rs10076701	chr5:131596419	PDLIM4	chr5:131593351-131609145:+	-0.37	-11.74	4.47E-28	Blood metabolite levels	
PRAD	cis	1	rs10076701	chr5:131596419	SLC22A4	chr5:131630145-131679897:+	-0.19	-3.96	8.74E-5	Blood metabolite levels	
PRAD	cis	1	rs1007763	chr5:153639893	GALNT10	chr5:153570295-153799809:+	0.14	4.13	4.36E-5	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs10078968	chr5:150244273	LOC134466	chr5:150310000-150326146:-	0.54	8.65	8.5E-17	Crohn's disease	
PRAD	cis	1	rs10078	chr5:438102	C5orf55	chr5:441645-443258:-	0.36	7.46	4.17E-13	Fat distribution (HIV)	
PRAD	cis	1	rs10079394	chr5:115600919	COMMD10	chr5:115420727-115628978:+	0.27	3.56	0.000411	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs10080429	chr6:109738106	SMPD2	chr6:109761931-109765121:+	0.25	5.34	1.48E-7	Height	
PRAD	cis	1	rs10080513	chr6:88181103	C6orf165	chr6:88117721-88205858:+	-0.51	-4.33	1.86E-5	Obesity-related traits	
PRAD	cis	1	rs10082278	chr1:202495120	PPP1R12B	chr1:202317836-202557697:+	0.09	3.76	0.000189	Sex ratio	
PRAD	cis	1	rs1008374	chr4:17683219	MED28	chr4:17616273-17629791:+	0.19	4.67	3.99E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs1008375	chr4:17682834	MED28	chr4:17616273-17629791:+	0.22	5.57	4.4E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10086541	chr8:96033950	C8orf38	chr8:95908040-96088396:+	-0.35	-6.46	2.6E-10	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs1008953	chr20:43980726	SYS1	chr20:43991701-44004724:+	0.37	6.21	1.16E-9	Psoriasis	
PRAD	cis	1	rs1009051	chr3:49521549	AMIGO3	chr3:49754268-49757238:-	-0.42	-8.65	8.1E-17	Menarche (age at onset)	
PRAD	cis	1	rs1009051	chr3:49521549	CCDC36	chr3:49235861-49295537:+	0.24	4.42	1.21E-5	Menarche (age at onset)	
PRAD	cis	1	rs1009051	chr3:49521549	GMPPB	chr3:49758932-49761384:-	-0.47	-11.64	1.11E-27	Menarche (age at onset)	
PRAD	cis	1	rs1009051	chr3:49521549	NCKIPSD	chr3:48711280-48723334:-	0.28	5.68	2.37E-8	Menarche (age at onset)	
PRAD	cis	1	rs1009051	chr3:49521549	WDR6	chr3:49044637-49053386:+	-0.21	-4.18	3.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs1009168	chr12:62510495	MON2	chr12:62860597-62991362:+	-0.14	-3.63	0.000311	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs10092003	chr8:96036422	C8orf38	chr8:95908040-96088396:+	-0.38	-6.75	4.49E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs1009242	chr9:131916832	CRAT	chr9:131857075-131873070:-	0.22	4.04	6.21E-5	Blood metabolite ratios	
PRAD	cis	1	rs1009358	chr2:65276452	CEP68	chr2:65283495-65314141:+	0.12	4.37	1.56E-5	Triglycerides	
PRAD	cis	1	rs10093594	chr8:96033236	C8orf38	chr8:95908040-96088396:+	0.35	6.21	1.18E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10093594	chr8:96033236	TP53INP1	chr8:95938201-95961615:-	-0.24	-3.76	0.000192	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10095630	chr8:92071264	LRRC69	chr8:92114847-92231464:+	-0.33	-5.39	1.14E-7	Migraine - clinic-based	
PRAD	cis	1	rs10095849	chr8:39408586	TACC1	chr8:38585704-38710545:+	-0.15	-3.49	0.000522	Visceral adipose tissue/subcutaneous adipose tissue ratio	
PRAD	cis	1	rs10096455	chr8:96041250	C8orf38	chr8:95908040-96088396:+	-0.39	-6.76	4.09E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10097401	chr8:55460815	RP1	chr8:55528627-55682531:+	0.24	3.59	0.00036	Intracranial aneurysm	
PRAD	cis	1	rs10097930	chr8:96025735	C8orf38	chr8:95908040-96088396:+	-0.33	-5.9	6.89E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10097930	chr8:96025735	TP53INP1	chr8:95938201-95961615:-	0.24	3.77	0.000182	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10098197	chr8:96042890	C8orf38	chr8:95908040-96088396:+	-0.39	-6.76	4.09E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10098453	chr8:96029756	C8orf38	chr8:95908040-96088396:+	0.36	6.25	9.4E-10	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10098453	chr8:96029756	TP53INP1	chr8:95938201-95961615:-	-0.23	-3.58	0.000374	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10100089	chr8:96025093	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10100089	chr8:96025093	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10100842	chr8:96025903	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10100842	chr8:96025903	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10102164	chr8:55421614	RP1	chr8:55528627-55682531:+	0.23	3.57	0.0004	Intracranial aneurysm	
PRAD	cis	1	rs10103841	chr8:96025904	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10103841	chr8:96025904	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10104997	chr8:55440068	RP1	chr8:55528627-55682531:+	0.23	3.64	0.000301	Intracranial aneurysm	
PRAD	cis	1	rs10106491	chr8:96038959	C8orf38	chr8:95908040-96088396:+	-0.39	-6.8	3.09E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10109812	chr8:41524899	ANK1	chr8:41510745-41754280:-	-0.2	-3.58	0.00038	Type 2 diabetes	
PRAD	cis	1	rs10110267	chr8:92073814	LRRC69	chr8:92114847-92231464:+	-0.34	-5.61	3.44E-8	Migraine - clinic-based	
PRAD	cis	1	rs10110635	chr8:96025069	C8orf38	chr8:95908040-96088396:+	-0.33	-5.85	9.29E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10110635	chr8:96025069	TP53INP1	chr8:95938201-95961615:-	0.24	3.86	0.000127	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10111300	chr8:96025631	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10111300	chr8:96025631	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10112230	chr8:96038072	C8orf38	chr8:95908040-96088396:+	-0.39	-6.8	3.09E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10113545	chr8:96029707	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10113545	chr8:96029707	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.38	-6.89	1.75E-11	Rheumatoid arthritis	
PRAD	cis	1	rs10117059	chr9:123653477	TRAF1	chr9:123664672-123691479:-	0.18	4.99	8.49E-7	Rheumatoid arthritis	
PRAD	cis	1	rs1012376	chr14:65294790	CHURC1	chr14:65381140-65411309:+	0.48	6.37	4.41E-10	Daytime sleep phenotypes	
PRAD	cis	1	rs10124260	chr9:115559341	C9orf80	chr9:115448793-115480387:-	0.31	4.06	5.66E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10127539	chr1:110620117	ALX3	chr1:110602998-110613322:-	-0.22	-4.14	4.1E-5	Blood metabolite levels	
PRAD	cis	1	rs10128711	chr11:18632984	SPTY2D1	chr11:18627949-18656020:-	-0.3	-10.9	8.06E-25	Cholesterol, total	
PRAD	cis	1	rs10130255	chr14:60944435	C14orf39	chr14:60902675-60952764:-	0.44	5.9	6.95E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs10130267	chr14:60944527	C14orf39	chr14:60902675-60952764:-	0.49	6.02	3.5E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1013338	chr22:38974154	CBY1	chr22:39052658-39069853:+	0.13	3.61	0.00034	Resting heart rate	
PRAD	cis	1	rs1013338	chr22:38974154	LOC646851	chr22:38974125-39052634:-	0.19	4.69	3.56E-6	Resting heart rate	
PRAD	cis	1	rs10133880	chr14:61410039	MNAT1	chr14:61201470-61435396:+	-0.38	-4.46	1.01E-5	Immune reponse to smallpox (secreted IFN-alpha)	
PRAD	cis	1	rs10133880	chr14:61410039	PPM1A	chr14:60712470-60765803:+	-0.3	-3.6	0.000357	Immune reponse to smallpox (secreted IFN-alpha)	
PRAD	cis	1	rs10135248	chr14:104122310	BAG5	chr14:104022889-104029151:-	0.18	3.78	0.000176	Body mass index	
PRAD	cis	1	rs10135248	chr14:104122310	C14orf153	chr14:104029299-104057227:+	0.17	5.02	7.49E-7	Body mass index	
PRAD	cis	1	rs10135248	chr14:104122310	CKB	chr14:103985996-103989170:-	0.22	5.19	3.16E-7	Body mass index	
PRAD	cis	1	rs10135248	chr14:104122310	KLC1	chr14:104029299-104167887:+	-0.19	-3.96	8.62E-5	Body mass index	
PRAD	cis	1	rs10135248	chr14:104122310	MARK3	chr14:103851701-103970164:+	0.26	5.37	1.22E-7	Body mass index	
PRAD	cis	1	rs10135	chr22:39082174	CBY1	chr22:39052658-39069853:+	-0.13	-3.81	0.00016	Resting heart rate	
PRAD	cis	1	rs10135	chr22:39082174	LOC646851	chr22:38974125-39052634:-	-0.18	-4.49	8.98E-6	Resting heart rate	
PRAD	cis	1	rs10136642	chr14:60946098	C14orf39	chr14:60902675-60952764:-	0.44	5.82	1.06E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs10136948	chr14:75511075	EIF2B2	chr14:75469612-75476292:+	0.25	5.09	5.32E-7	Height	
PRAD	cis	1	rs10136948	chr14:75511075	MLH3	chr14:75480467-75518235:-	0.32	6.56	1.4E-10	Height	
PRAD	cis	1	rs10137323	chr14:76685733	ESRRB	chr14:76837690-76968178:+	-0.27	-3.46	0.00058	Blood pressure	
PRAD	cis	1	rs10138183	chr14:75615227	EIF2B2	chr14:75469612-75476292:+	0.25	4.97	9.21E-7	Height	
PRAD	cis	1	rs10138183	chr14:75615227	MLH3	chr14:75480467-75518235:-	0.33	6.55	1.5E-10	Height	
PRAD	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.43	-11.55	2.36E-27	Common traits (Other)	
PRAD	cis	1	rs10140851	chr14:75512612	EIF2B2	chr14:75469612-75476292:+	0.26	5.14	4.0E-7	Height	
PRAD	cis	1	rs10140851	chr14:75512612	MLH3	chr14:75480467-75518235:-	0.33	6.63	9.46E-11	Height	
PRAD	cis	1	rs1014098	chr1:119458215	WARS2	chr1:119573841-119683295:-	-0.36	-5.16	3.65E-7	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs1014244	chr10:118466150	C10orf82	chr10:118423208-118429775:-	-0.15	-3.6	0.000348	Age at smoking initiation in chronic obstructive pulmonary disease	
PRAD	cis	1	rs10142455	chr14:60980963	C14orf39	chr14:60902675-60952764:-	0.46	5.79	1.27E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1014246	chr10:118466042	C10orf82	chr10:118423208-118429775:-	-0.15	-3.6	0.000348	Age at smoking initiation in chronic obstructive pulmonary disease	
PRAD	cis	1	rs10142626	chr14:75555636	EIF2B2	chr14:75469612-75476292:+	0.24	4.86	1.63E-6	Height	
PRAD	cis	1	rs10142626	chr14:75555636	MLH3	chr14:75480467-75518235:-	0.33	6.63	9.49E-11	Height	
PRAD	cis	1	rs10142865	chr14:75555624	EIF2B2	chr14:75469612-75476292:+	0.24	4.83	1.81E-6	Height	
PRAD	cis	1	rs10142865	chr14:75555624	MLH3	chr14:75480467-75518235:-	0.33	6.67	7.08E-11	Height	
PRAD	cis	1	rs10143118	chr14:61066043	C14orf39	chr14:60902675-60952764:-	0.49	5.91	6.47E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs10143132	chr14:75525850	EIF2B2	chr14:75469612-75476292:+	0.26	5.14	3.98E-7	Height	
PRAD	cis	1	rs10143132	chr14:75525850	MLH3	chr14:75480467-75518235:-	0.33	6.63	9.47E-11	Height	
PRAD	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.43	-11.64	1.09E-27	Common traits (Other)	
PRAD	cis	1	rs10144805	chr14:60927652	C14orf39	chr14:60902675-60952764:-	0.45	5.97	4.56E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs10146482	chr14:75574087	EIF2B2	chr14:75469612-75476292:+	0.24	4.81	2.04E-6	Height	
PRAD	cis	1	rs10146482	chr14:75574087	MLH3	chr14:75480467-75518235:-	0.32	6.58	1.29E-10	Height	
PRAD	cis	1	rs10148202	chr14:61055940	C14orf39	chr14:60902675-60952764:-	-0.55	-6.41	3.63E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1014939	chr7:37941925	EPDR1	chr7:37960163-37991539:+	-0.22	-3.59	0.000364	Bone mineral density	
PRAD	cis	1	rs10149880	chr14:75633008	EIF2B2	chr14:75469612-75476292:+	-0.25	-4.94	1.08E-6	Height	
PRAD	cis	1	rs10149880	chr14:75633008	MLH3	chr14:75480467-75518235:-	-0.31	-6.21	1.19E-9	Height	
PRAD	cis	1	rs10149915	chr14:60943110	C14orf39	chr14:60902675-60952764:-	0.44	5.9	6.95E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.43	-11.59	1.75E-27	Common traits (Other)	
PRAD	cis	1	rs10151958	chr14:60977275	C14orf39	chr14:60902675-60952764:-	0.43	5.73	1.8E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs10152119	chr15:84570381	NMB	chr15:85198362-85201802:-	-0.17	-3.98	7.98E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs10152139	chr15:84570262	NMB	chr15:85198362-85201802:-	-0.16	-3.83	0.000148	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs10152868	chr15:79230969	CTSH	chr15:79214092-79237420:-	-0.46	-6.55	1.49E-10	Bipolar disorder	
PRAD	cis	1	rs10153800	chr2:242179134	FARP2	chr2:242295711-242434255:+	0.27	4.59	5.64E-6	Chronic lymphocytic leukemia	
PRAD	cis	1	rs10153800	chr2:242179134	SEPT2	chr2:242254723-242293439:+	-0.25	-5.62	3.36E-8	Chronic lymphocytic leukemia	
PRAD	cis	1	rs10155014	chr3:49432321	AMIGO3	chr3:49754268-49757238:-	-0.41	-8.5	2.57E-16	Menarche (age at onset)	
PRAD	cis	1	rs10155014	chr3:49432321	CCDC36	chr3:49235861-49295537:+	0.25	4.5	8.75E-6	Menarche (age at onset)	
PRAD	cis	1	rs10155014	chr3:49432321	GMPPB	chr3:49758932-49761384:-	-0.46	-11.27	2.94E-26	Menarche (age at onset)	
PRAD	cis	1	rs10155014	chr3:49432321	NCKIPSD	chr3:48711280-48723334:-	0.28	5.74	1.69E-8	Menarche (age at onset)	
PRAD	cis	1	rs10155014	chr3:49432321	P4HTM	chr3:49027341-49044579:+	0.15	3.54	0.00044	Menarche (age at onset)	
PRAD	cis	1	rs10155014	chr3:49432321	WDR6	chr3:49044637-49053386:+	-0.2	-3.99	7.54E-5	Menarche (age at onset)	
PRAD	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.92	-28.22	3.26E-103	Homocysteine levels	
PRAD	cis	1	rs10157597	chr1:45990278	MMACHC	chr1:45965856-45976737:+	-0.24	-5.12	4.48E-7	Homocysteine levels	
PRAD	cis	1	rs10157597	chr1:45990278	MUTYH	chr1:45794915-45806142:-	0.19	5.27	2.05E-7	Homocysteine levels	
PRAD	cis	1	rs10158100	chr1:202394199	PPP1R12B	chr1:202317836-202557697:+	0.09	3.64	0.000308	Sex ratio	
PRAD	cis	1	rs10158107	chr1:202394315	PPP1R12B	chr1:202317836-202557697:+	0.09	3.68	0.000255	Sex ratio	
PRAD	cis	1	rs10158481	chr1:25497792	RHCE	chr1:25688741-25756683:-	0.21	3.55	0.000432	Urate levels in obese individuals	
PRAD	cis	1	rs10158816	chr1:249167042	OR2T10	chr1:248756132-248757069:-	0.37	5.47	7.44E-8	Myopia (pathological)	
PRAD	cis	1	rs10159280	chr1:202394287	PPP1R12B	chr1:202317836-202557697:+	0.09	3.64	0.000307	Sex ratio	
PRAD	cis	1	rs10162686	chr15:96015083	LOC145820	chr15:95976322-96051074:+	0.23	4.36	1.63E-5	Motion sickness	
PRAD	cis	1	rs10164319	chr19:18569833	SSBP4	chr19:18530221-18545371:+	-0.17	-5.64	2.93E-8	Breast cancer	
PRAD	cis	1	rs10164323	chr19:18569492	ELL	chr19:18553475-18632937:-	-0.16	-3.86	0.000132	Breast cancer	
PRAD	cis	1	rs10164323	chr19:18569492	SSBP4	chr19:18530221-18545371:+	-0.18	-5.96	5.05E-9	Breast cancer	
PRAD	cis	1	rs10165099	chr2:3402591	TTC15	chr2:3383446-3488857:+	0.19	5.23	2.54E-7	Obesity-related traits	
PRAD	cis	1	rs10165485	chr2:54481636	C2orf73	chr2:54558071-54588714:+	0.29	3.93	9.72E-5	Telomere length	
PRAD	cis	1	rs1016669	chr3:41894440	ULK4	chr3:41288091-42003660:-	0.88	14.28	1.11E-38	Diastolic blood pressure	
PRAD	cis	1	rs10168946	chr2:102697206	MFSD9	chr2:103333666-103353337:-	0.17	4.08	5.23E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs10169714	chr2:73808773	ALMS1P	chr2:73872046-73912692:+	0.5	8.84	1.99E-17	Metabolite levels	
PRAD	cis	1	rs10169714	chr2:73808773	NAT8	chr2:73867850-73869537:-	0.26	4.09	5.15E-5	Metabolite levels	
PRAD	cis	1	rs10170359	chr2:26272219	GPR113	chr2:26531041-26569685:-	-0.25	-3.61	0.000339	Gut microbiome composition (summer)	
PRAD	cis	1	rs1017302	chr12:9367402	LOC642846	chr12:9436253-9466684:+	0.28	5.96	5.0E-9	Non-alcoholic fatty liver disease histology (AST)	
PRAD	cis	1	rs10173081	chr2:102957348	IL1R1	chr2:102686836-102796333:+	-0.33	-5.2	2.99E-7	Asthma	
PRAD	cis	1	rs10173181	chr2:17780733	GEN1	chr2:17935162-17966632:+	0.35	4.31	1.98E-5	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs10175180	chr2:73673123	ALMS1P	chr2:73872046-73912692:+	0.49	8.41	4.86E-16	Metabolite levels	
PRAD	cis	1	rs10175180	chr2:73673123	NAT8	chr2:73867850-73869537:-	0.26	3.98	7.99E-5	Metabolite levels	
PRAD	cis	1	rs10177970	chr2:37512968	CEBPZ	chr2:37428778-37458740:-	0.17	3.88	0.000118	Chronic lymphocytic leukemia	
PRAD	cis	1	rs10178409	chr2:73855507	ALMS1P	chr2:73872046-73912692:+	0.51	8.76	3.46E-17	Urinary metabolites	
PRAD	cis	1	rs10178409	chr2:73855507	NAT8	chr2:73867850-73869537:-	0.24	3.73	0.000212	Urinary metabolites	
PRAD	cis	1	rs10178975	chr2:37514564	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.91	0.000106	Chronic lymphocytic leukemia	
PRAD	cis	1	rs10178982	chr2:202227640	ALS2CR12	chr2:202153148-202222101:-	-0.29	-5.03	7.02E-7	Basal cell carcinoma	
PRAD	cis	1	rs1017908	chr11:77948095	GAB2	chr11:77926343-78128766:-	-0.19	-5.6	3.57E-8	Testicular germ cell tumor	
PRAD	cis	1	rs1017908	chr11:77948095	NARS2	chr11:78147017-78285909:-	-0.19	-3.59	0.000366	Testicular germ cell tumor	
PRAD	cis	1	rs10179134	chr2:73637519	ALMS1P	chr2:73872046-73912692:+	0.5	8.71	5.18E-17	Metabolite levels	
PRAD	cis	1	rs10179134	chr2:73637519	NAT8	chr2:73867850-73869537:-	0.25	3.79	0.000173	Metabolite levels	
PRAD	cis	1	rs10179458	chr2:102934974	IL1R1	chr2:102686836-102796333:+	-0.33	-5.23	2.55E-7	Asthma	
PRAD	cis	1	rs10181425	chr2:102697545	MFSD9	chr2:103333666-103353337:-	0.17	4.08	5.23E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs10181737	chr2:102706672	MFSD9	chr2:103333666-103353337:-	0.16	3.72	0.000226	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.47	10.71	4.19E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs10182857	chr2:26344411	GPR113	chr2:26531041-26569685:-	-0.25	-3.76	0.000189	Gut microbiome composition (summer)	
PRAD	cis	1	rs10184268	chr2:73627044	ALMS1P	chr2:73872046-73912692:+	0.5	8.57	1.46E-16	Metabolite levels	
PRAD	cis	1	rs10184268	chr2:73627044	NAT8	chr2:73867850-73869537:-	0.26	4.04	6.27E-5	Metabolite levels	
PRAD	cis	1	rs1018531	chr14:60970844	C14orf39	chr14:60902675-60952764:-	0.42	5.6	3.67E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs10186501	chr2:73697844	ALMS1P	chr2:73872046-73912692:+	0.48	8.33	8.85E-16	Metabolite levels	
PRAD	cis	1	rs10186501	chr2:73697844	NAT8	chr2:73867850-73869537:-	0.26	4.01	6.96E-5	Metabolite levels	
PRAD	cis	1	rs10187192	chr2:73713500	ALMS1P	chr2:73872046-73912692:+	0.51	8.55	1.77E-16	Metabolite levels	
PRAD	cis	1	rs10187192	chr2:73713500	NAT8	chr2:73867850-73869537:-	0.26	3.86	0.00013	Metabolite levels	
PRAD	cis	1	rs10187264	chr2:53727267	SPTBN1	chr2:54683454-54898582:+	-0.22	-3.57	0.000387	Bulimia nervosa	
PRAD	cis	1	rs10187416	chr2:73713741	ALMS1P	chr2:73872046-73912692:+	0.49	8.45	3.81E-16	Metabolite levels	
PRAD	cis	1	rs10187416	chr2:73713741	NAT8	chr2:73867850-73869537:-	0.25	3.93	9.85E-5	Metabolite levels	
PRAD	cis	1	rs10189154	chr2:102937544	IL1R1	chr2:102686836-102796333:+	-0.33	-5.23	2.55E-7	Asthma	
PRAD	cis	1	rs10189526	chr2:102937883	IL1R1	chr2:102686836-102796333:+	-0.33	-5.23	2.55E-7	Asthma	
PRAD	cis	1	rs10189574	chr2:73698518	ALMS1P	chr2:73872046-73912692:+	0.49	8.25	1.66E-15	Metabolite levels	
PRAD	cis	1	rs10189574	chr2:73698518	NAT8	chr2:73867850-73869537:-	0.27	4.17	3.66E-5	Metabolite levels	
PRAD	cis	1	rs10189996	chr2:240908800	NDUFA10	chr2:240900158-240964798:-	0.28	6.24	9.58E-10	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs10190219	chr2:73658331	ALMS1P	chr2:73872046-73912692:+	0.49	8.37	6.7E-16	Metabolite levels	
PRAD	cis	1	rs10190219	chr2:73658331	NAT8	chr2:73867850-73869537:-	0.25	3.76	0.000194	Metabolite levels	
PRAD	cis	1	rs1019217	chr11:22842622	SVIP	chr11:22843600-22851382:-	0.27	6.67	7.05E-11	Dialysis-related mortality	
PRAD	cis	1	rs10193373	chr2:281886	SH3YL1	chr2:218138-264810:-	-0.79	-18.59	3.26E-58	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs10193610	chr2:240940618	NDUFA10	chr2:240900158-240964798:-	0.28	6.28	7.52E-10	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs10193972	chr2:73717656	ALMS1P	chr2:73872046-73912692:+	0.49	8.45	3.71E-16	Metabolite levels	
PRAD	cis	1	rs10193972	chr2:73717656	NAT8	chr2:73867850-73869537:-	0.26	3.98	7.89E-5	Metabolite levels	
PRAD	cis	1	rs10199359	chr2:102707179	MFSD9	chr2:103333666-103353337:-	0.17	4.1	4.78E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs10202478	chr2:26276049	GPR113	chr2:26531041-26569685:-	-0.25	-3.61	0.000339	Gut microbiome composition (summer)	
PRAD	cis	1	rs10206231	chr2:202229225	ALS2CR12	chr2:202153148-202222101:-	-0.29	-5	8.1E-7	Basal cell carcinoma	
PRAD	cis	1	rs10206993	chr2:240900919	NDUFA10	chr2:240900158-240964798:-	0.26	6	4.02E-9	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs10207220	chr2:73785046	ALMS1P	chr2:73872046-73912692:+	0.49	8.53	1.97E-16	Metabolite levels	
PRAD	cis	1	rs10207220	chr2:73785046	NAT8	chr2:73867850-73869537:-	0.25	3.93	9.84E-5	Metabolite levels	
PRAD	cis	1	rs10208155	chr2:61115039	AHSA2	chr2:61404553-61414058:+	-0.17	-5.74	1.67E-8	Inflammatory skin disease	
PRAD	cis	1	rs10208155	chr2:61115039	C2orf74	chr2:61372243-61391964:+	0.33	5.5	6.09E-8	Inflammatory skin disease	
PRAD	cis	1	rs10209620	chr2:61173941	AHSA2	chr2:61404553-61414058:+	-0.17	-6.13	1.83E-9	Inflammatory skin disease	
PRAD	cis	1	rs10209620	chr2:61173941	C2orf74	chr2:61372243-61391964:+	0.33	5.6	3.56E-8	Inflammatory skin disease	
PRAD	cis	1	rs10209928	chr2:108863898	SULT1C2	chr2:108905095-108926370:+	0.34	5.21	2.77E-7	Blood pressure	
PRAD	cis	1	rs10210095	chr2:164500518	FIGN	chr2:164464118-164592513:-	-0.25	-3.84	0.000142	Folate pathway vitamin levels	
PRAD	cis	1	rs10212259	chr3:123811210	KALRN	chr3:123752542-124440035:+	0.33	3.53	0.00045	PR interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10212536	chr3:41827026	ULK4	chr3:41288091-42003660:-	0.81	13.08	1.43E-33	Diastolic blood pressure	
PRAD	cis	1	rs10212913	chr4:147499058	ZNF827	chr4:146681892-146859607:-	-0.16	-3.62	0.000324	Heart rate	
PRAD	cis	1	rs10212914	chr4:147499085	ZNF827	chr4:146681892-146859607:-	-0.16	-3.62	0.000324	Heart rate	
PRAD	cis	1	rs10212917	chr4:147499315	ZNF827	chr4:146681892-146859607:-	-0.16	-3.62	0.000324	Heart rate	
PRAD	cis	1	rs10212994	chr4:147501225	ZNF827	chr4:146681892-146859607:-	-0.17	-3.77	0.000181	Heart rate	
PRAD	cis	1	rs10212996	chr4:147501301	ZNF827	chr4:146681892-146859607:-	-0.16	-3.62	0.000324	Heart rate	
PRAD	cis	1	rs10213045	chr4:147500975	ZNF827	chr4:146681892-146859607:-	-0.17	-3.77	0.000181	Heart rate	
PRAD	cis	1	rs10213084	chr4:147499338	ZNF827	chr4:146681892-146859607:-	-0.16	-3.62	0.000324	Heart rate	
PRAD	cis	1	rs10213649	chr4:147499554	ZNF827	chr4:146681892-146859607:-	-0.16	-3.62	0.000324	Heart rate	
PRAD	cis	1	rs10214634	chr6:26564582	BTN2A3	chr6:26422317-26431927:+	0.26	6.5	2.05E-10	Educational attainment	
PRAD	cis	1	rs10214634	chr6:26564582	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.45	0.00062	Educational attainment	
PRAD	cis	1	rs10214634	chr6:26564582	ZNF184	chr6:27418522-27440897:-	-0.18	-3.64	0.000305	Educational attainment	
PRAD	cis	1	rs10215948	chr7:65747786	TPST1	chr7:65670259-65825437:+	-0.18	-4.5	8.48E-6	Aortic root size	
PRAD	cis	1	rs10216533	chr8:143763690	LY6K	chr8:143781529-143785582:+	0.21	3.66	0.000276	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs10216533	chr8:143763690	LYNX1	chr8:143845758-143859640:-	-0.31	-8.02	8.51E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs10216533	chr8:143763690	PSCA	chr8:143761875-143764142:+	0.53	10.13	6.03E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.89	10.42	5.34E-23	Coronary heart disease	
PRAD	cis	1	rs10220831	chr15:69992114	C15orf50	chr15:70127573-70135305:+	0.19	3.43	0.00065	Chronic lymphocytic leukemia	
PRAD	cis	1	rs1022413	chr19:15741984	CYP4F8	chr19:15726029-15740445:+	0.31	3.63	0.000318	Inflammatory biomarkers	
PRAD	cis	1	rs10224602	chr7:37950049	EPDR1	chr7:37960163-37991539:+	-0.23	-3.76	0.00019	Bone mineral density	
PRAD	cis	1	rs10226308	chr7:37938422	EPDR1	chr7:37960163-37991539:+	-0.22	-3.53	0.000465	Bone mineral density	
PRAD	cis	1	rs1022687	chr20:47648854	CSE1L	chr20:47662838-47713484:+	-0.19	-4.59	5.72E-6	Anger	
PRAD	cis	1	rs10228845	chr7:21583617	DNAH11	chr7:21582833-21941455:+	-0.18	-4.38	1.49E-5	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
PRAD	cis	1	rs10229224	chr7:21583921	DNAH11	chr7:21582833-21941455:+	-0.18	-4.39	1.42E-5	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
PRAD	cis	1	rs10234018	chr7:66146284	CRCP	chr7:65579805-65619551:+	0.23	4.51	8.24E-6	Aortic root size	
PRAD	cis	1	rs10234018	chr7:66146284	LOC493754	chr7:65993446-66057363:-	0.24	5.61	3.42E-8	Aortic root size	
PRAD	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.64	11.65	9.9E-28	Paget's disease	
PRAD	cis	1	rs10234309	chr7:135311167	SLC13A4	chr7:135365993-135412933:-	-0.74	-12.25	3.96E-30	Paget's disease	
PRAD	cis	1	rs10235774	chr7:37979141	EPDR1	chr7:37960163-37991539:+	-0.25	-4.03	6.49E-5	Bone mineral density	
PRAD	cis	1	rs10237860	chr7:37974800	EPDR1	chr7:37960163-37991539:+	-0.25	-4.1	4.85E-5	Bone mineral density	
PRAD	cis	1	rs10238070	chr7:23909791	C7orf46	chr7:23719749-23742268:+	0.22	5.74	1.73E-8	Schizophrenia	
PRAD	cis	1	rs10238520	chr7:3341615	CARD11	chr7:2945769-3083579:-	-0.08	-3.54	0.000433	Motion sickness	
PRAD	cis	1	rs1024037	chr3:47318449	C3orf75	chr3:47537131-47555199:-	0.16	4.85	1.68E-6	Colorectal cancer	
PRAD	cis	1	rs1024037	chr3:47318449	NBEAL2	chr3:47021173-47051193:+	0.16	4.85	1.66E-6	Colorectal cancer	
PRAD	cis	1	rs10240470	chr7:1949971	MAD1L1	chr7:1855428-2272583:-	-0.17	-3.95	8.84E-5	Bipolar disorder	
PRAD	cis	1	rs1024223	chr14:60926119	C14orf39	chr14:60902675-60952764:-	0.45	5.98	4.36E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs10244498	chr7:66116056	TPST1	chr7:65670259-65825437:+	0.18	4.27	2.41E-5	Aortic root size	
PRAD	cis	1	rs10245161	chr7:23907692	C7orf46	chr7:23719749-23742268:+	0.22	5.71	2.0E-8	Schizophrenia	
PRAD	cis	1	rs10247443	chr7:50620586	DDC	chr7:50526136-50633154:-	0.24	3.92	0.000102	Malaria	
PRAD	cis	1	rs10247443	chr7:50620586	FIGNL1	chr7:50511834-50518088:-	-0.22	-5.8	1.24E-8	Malaria	
PRAD	cis	1	rs10247526	chr7:65780696	CCT6P1	chr7:65216092-65228661:+	-0.33	-5.52	5.68E-8	Diabetic kidney disease	
PRAD	cis	1	rs10247526	chr7:65780696	CRCP	chr7:65579805-65619551:+	0.35	4.28	2.31E-5	Diabetic kidney disease	
PRAD	cis	1	rs10250513	chr7:50621488	DDC	chr7:50526136-50633154:-	0.23	3.9	0.000111	Malaria	
PRAD	cis	1	rs10250513	chr7:50621488	FIGNL1	chr7:50511834-50518088:-	-0.22	-5.79	1.31E-8	Malaria	
PRAD	cis	1	rs10252765	chr7:66228732	LOC493754	chr7:65993446-66057363:-	-0.21	-4.76	2.56E-6	Aortic root size	
PRAD	cis	1	rs10252765	chr7:66228732	TPST1	chr7:65670259-65825437:+	0.15	3.68	0.000258	Aortic root size	
PRAD	cis	1	rs10256195	chr7:37938610	EPDR1	chr7:37960163-37991539:+	-0.22	-3.53	0.000465	Bone mineral density	
PRAD	cis	1	rs1025646	chr3:41754422	ULK4	chr3:41288091-42003660:-	0.75	11.7	6.33E-28	Diastolic blood pressure	
PRAD	cis	1	rs10256972	chr7:1039003	ZFAND2A	chr7:1192544-1199855:-	0.34	7.67	9.66E-14	Longevity;Endometriosis	
PRAD	cis	1	rs10257427	chr7:65743208	TPST1	chr7:65670259-65825437:+	-0.18	-4.5	8.48E-6	Aortic root size	
PRAD	cis	1	rs10257777	chr7:23910981	C7orf46	chr7:23719749-23742268:+	0.22	5.52	5.65E-8	Schizophrenia	
PRAD	cis	1	rs10262624	chr7:23915676	C7orf46	chr7:23719749-23742268:+	0.22	5.74	1.72E-8	Schizophrenia	
PRAD	cis	1	rs10264106	chr7:37947818	EPDR1	chr7:37960163-37991539:+	0.24	3.91	0.000106	Bone mineral density	
PRAD	cis	1	rs10274773	chr7:66133578	CRCP	chr7:65579805-65619551:+	0.2	3.72	0.000225	Aortic root size	
PRAD	cis	1	rs10274773	chr7:66133578	LOC493754	chr7:65993446-66057363:-	0.22	5.04	6.68E-7	Aortic root size	
PRAD	cis	1	rs10274773	chr7:66133578	TPST1	chr7:65670259-65825437:+	-0.15	-3.64	0.000302	Aortic root size	
PRAD	cis	1	rs10276139	chr7:37939840	EPDR1	chr7:37960163-37991539:+	-0.21	-3.48	0.00055	Bone mineral density	
PRAD	cis	1	rs10280174	chr7:37974045	EPDR1	chr7:37960163-37991539:+	-0.25	-4.07	5.63E-5	Bone mineral density	
PRAD	cis	1	rs1028444	chr20:22267058	PAX1	chr20:21686297-21696620:+	-0.15	-3.96	8.58E-5	Glucose homeostasis traits	
PRAD	cis	1	rs1028449	chr14:35512995	PPP2R3C	chr14:35554679-35591679:-	0.31	4.71	3.32E-6	Atopic dermatitis	
PRAD	cis	1	rs1029406	chr11:2309580	C11orf21	chr11:2317507-2323143:-	-0.32	-5.6	3.63E-8	Obesity-related traits	
PRAD	cis	1	rs1029407	chr11:2309582	C11orf21	chr11:2317507-2323143:-	-0.32	-5.6	3.63E-8	Obesity-related traits	
PRAD	cis	1	rs1029408	chr11:2309855	C11orf21	chr11:2317507-2323143:-	-0.33	-5.76	1.5E-8	Obesity-related traits	
PRAD	cis	1	rs1029408	chr11:2309855	TSPAN32	chr11:2323243-2339430:+	-0.21	-3.59	0.000371	Obesity-related traits	
PRAD	cis	1	rs1029740	chr7:22873586	TOMM7	chr7:22852254-22862421:-	-0.3	-9.84	6.79E-21	Fibrinogen	
PRAD	cis	1	rs1030094	chr19:32910431	DPY19L3	chr19:32896677-32975236:+	0.1	3.46	0.000589	Bipolar disorder	
PRAD	cis	1	rs1030420	chr8:67360725	C8orf46	chr8:67405491-67430757:+	0.3	4.93	1.12E-6	Blood metabolite levels	
PRAD	cis	1	rs1030730	chr2:26284143	GPR113	chr2:26531041-26569685:-	-0.27	-3.75	0.000198	Gut microbiome composition (summer)	
PRAD	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.5	-8.51	2.39E-16	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1031925	chr3:51379274	TEX264	chr3:51705222-51738338:+	0.15	3.77	0.000182	Melanoma	
PRAD	cis	1	rs1032957	chr12:85528713	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.26	2.52E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1032957	chr12:85528713	SLC6A15	chr12:85253269-85306606:-	-0.31	-4.72	3.18E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1032957	chr12:85528713	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.55	4.83E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1033299	chr2:17774153	GEN1	chr2:17935162-17966632:+	0.41	5.23	2.51E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs1033301	chr2:17773998	GEN1	chr2:17935162-17966632:+	0.41	5.23	2.51E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs1033733	chr14:60932438	C14orf39	chr14:60902675-60952764:-	0.46	5.88	7.88E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1034219	chr1:93022678	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs1035142	chr2:202153078	ALS2CR12	chr2:202153148-202222101:-	-0.27	-4.78	2.39E-6	Melanoma;Esophageal squamous cell carcinoma	
PRAD	cis	1	rs1035142	chr2:202153078	PPIL3	chr2:201735680-201753999:-	0.19	3.52	0.000473	Melanoma;Esophageal squamous cell carcinoma	
PRAD	cis	1	rs1035986	chr20:22277099	PAX1	chr20:21686297-21696620:+	0.15	4.03	6.45E-5	Glucose homeostasis traits	
PRAD	cis	1	rs1035987	chr20:22277868	PAX1	chr20:21686297-21696620:+	0.15	3.99	7.53E-5	Glucose homeostasis traits	
PRAD	cis	1	rs1036036	chr4:39112724	KLHL5	chr4:39046659-39123828:+	-0.13	-3.71	0.000233	Uric acid levels	
PRAD	cis	1	rs1036037	chr4:39112892	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	cis	1	rs1036038	chr4:39113003	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	cis	1	rs1036476	chr15:48914775	DUT	chr15:48623621-48635568:+	-0.23	-3.45	0.000614	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs1037036	chr17:18764077	FAM18B	chr17:18684582-18710026:+	-0.22	-4.42	1.21E-5	Educational attainment (years of education)	
PRAD	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.5	-8.56	1.61E-16	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1039664	chr7:65449716	CCT6P1	chr7:65216092-65228661:+	0.28	4.99	8.4E-7	Diabetic kidney disease	
PRAD	cis	1	rs1039664	chr7:65449716	CRCP	chr7:65579805-65619551:+	-0.31	-4.02	6.75E-5	Diabetic kidney disease	
PRAD	cis	1	rs1039664	chr7:65449716	ZNF117	chr7:64434830-64467121:-	-0.28	-3.43	0.000661	Diabetic kidney disease	
PRAD	cis	1	rs1039665	chr2:228717392	CCL20	chr2:228678558-228682280:+	0.29	5.2	2.91E-7	Blood pressure	
PRAD	cis	1	rs10401485	chr19:7222234	ZNF358	chr19:7581004-7585911:+	-0.1	-3.96	8.69E-5	Triglycerides	
PRAD	cis	1	rs10401507	chr19:52156867	KLK5	chr19:51446561-51456344:-	-0.29	-3.69	0.000249	Plasma plasminogen levels	
PRAD	cis	1	rs10401507	chr19:52156867	SIGLEC5	chr19:52114782-52133727:-	0.19	3.64	0.000306	Plasma plasminogen levels	
PRAD	cis	1	rs10402468	chr19:17384003	ANKLE1	chr19:17392454-17398454:+	0.32	6.03	3.4E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10402468	chr19:17384003	MRPL34	chr19:17416477-17417652:+	-0.22	-4.27	2.34E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10402468	chr19:17384003	OCEL1	chr19:17337055-17340027:+	0.22	5.07	5.81E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10403249	chr19:18604942	ELL	chr19:18553475-18632937:-	-0.16	-3.89	0.000113	Breast cancer	
PRAD	cis	1	rs10403249	chr19:18604942	SSBP4	chr19:18530221-18545371:+	-0.18	-6.08	2.54E-9	Breast cancer	
PRAD	cis	1	rs10403370	chr19:32992855	DPY19L3	chr19:32896677-32975236:+	0.11	3.47	0.000574	Bipolar disorder	
PRAD	cis	1	rs10403540	chr19:39204846	LGALS7	chr19:39261608-39264157:-	-0.17	-3.75	0.000198	Heart rate	
PRAD	cis	1	rs1040393	chr1:166861596	MAEL	chr1:166958519-166991447:+	0.3	4.49	8.97E-6	Schizophrenia	
PRAD	cis	1	rs10403962	chr19:46160638	SYMPK	chr19:46318701-46366548:-	-0.18	-4.09	5.02E-5	Type 2 diabetes	
PRAD	cis	1	rs10404142	chr19:46160698	SYMPK	chr19:46318701-46366548:-	-0.18	-4.09	5.06E-5	Type 2 diabetes	
PRAD	cis	1	rs10404486	chr19:53284135	ZNF600	chr19:53268750-53290034:-	0.56	10.05	1.13E-21	Phospholipid levels (plasma)	
PRAD	cis	1	rs10405348	chr19:12062853	ZNF763	chr19:12035900-12091196:+	-0.37	-4.02	6.72E-5	Multiple sclerosis	
PRAD	cis	1	rs10405382	chr19:32896716	DPY19L3	chr19:32896677-32975236:+	0.11	3.51	0.000496	Bipolar disorder	
PRAD	cis	1	rs10405457	chr19:44296582	LYPD5	chr19:44300080-44324808:-	-0.24	-5.23	2.54E-7	Breast cancer	
PRAD	cis	1	rs10405457	chr19:44296582	ZNF155	chr19:44488355-44502477:+	-0.25	-4.89	1.41E-6	Breast cancer	
PRAD	cis	1	rs10405457	chr19:44296582	ZNF404	chr19:44376516-44384288:-	-0.19	-4.14	4.07E-5	Breast cancer	
PRAD	cis	1	rs10405636	chr19:18538742	ELL	chr19:18553475-18632937:-	-0.16	-3.83	0.000144	Breast cancer	
PRAD	cis	1	rs10405636	chr19:18538742	SSBP4	chr19:18530221-18545371:+	-0.17	-5.75	1.6E-8	Breast cancer	
PRAD	cis	1	rs10406778	chr19:39170473	LGALS7	chr19:39261608-39264157:-	-0.15	-3.47	0.000562	Heart rate	
PRAD	cis	1	rs10406920	chr19:17389648	ANKLE1	chr19:17392454-17398454:+	0.32	6.19	1.34E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10406920	chr19:17389648	MRPL34	chr19:17416477-17417652:+	-0.2	-4.02	6.86E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10406920	chr19:17389648	OCEL1	chr19:17337055-17340027:+	0.22	5.14	4.06E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs1040726	chr20:3264267	ITPA	chr20:3190056-3204504:+	-0.3	-7.72	7.22E-14	IFN-related cytopenia	
PRAD	cis	1	rs1040727	chr20:3264292	ITPA	chr20:3190056-3204504:+	-0.32	-7.91	1.83E-14	IFN-related cytopenia	
PRAD	cis	1	rs10409483	chr19:18590223	ELL	chr19:18553475-18632937:-	-0.16	-3.9	0.000109	Breast cancer	
PRAD	cis	1	rs10409483	chr19:18590223	SSBP4	chr19:18530221-18545371:+	-0.18	-5.96	4.91E-9	Breast cancer	
PRAD	cis	1	rs10409505	chr19:18590251	ELL	chr19:18553475-18632937:-	-0.16	-3.9	0.000109	Breast cancer	
PRAD	cis	1	rs10409505	chr19:18590251	SSBP4	chr19:18530221-18545371:+	-0.18	-5.96	4.91E-9	Breast cancer	
PRAD	cis	1	rs10409882	chr19:46160935	SYMPK	chr19:46318701-46366548:-	-0.18	-4.09	5.16E-5	Type 2 diabetes	
PRAD	cis	1	rs10410204	chr19:7224350	ZNF358	chr19:7581004-7585911:+	-0.09	-3.73	0.000215	Triglycerides	
PRAD	cis	1	rs10410651	chr19:45160896	PVR	chr19:45147098-45169426:+	0.19	3.89	0.000115	Multiple sclerosis	
PRAD	cis	1	rs10410770	chr19:32902404	DPY19L3	chr19:32896677-32975236:+	0.12	3.81	0.000155	Bipolar disorder	
PRAD	cis	1	rs10411009	chr19:18606266	ELL	chr19:18553475-18632937:-	-0.17	-3.91	0.000108	Breast cancer	
PRAD	cis	1	rs10411009	chr19:18606266	SSBP4	chr19:18530221-18545371:+	-0.18	-6.05	2.99E-9	Breast cancer	
PRAD	cis	1	rs10412219	chr19:33413246	SLC7A9	chr19:33321421-33360683:-	-0.33	-7.33	1.04E-12	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
PRAD	cis	1	rs10412972	chr19:52154905	KLK5	chr19:51446561-51456344:-	-0.26	-3.59	0.00036	Plasma plasminogen levels	
PRAD	cis	1	rs10413237	chr19:18548249	ELL	chr19:18553475-18632937:-	-0.15	-3.55	0.000418	Breast cancer	
PRAD	cis	1	rs10413237	chr19:18548249	SSBP4	chr19:18530221-18545371:+	-0.17	-5.77	1.41E-8	Breast cancer	
PRAD	cis	1	rs10413462	chr19:12054636	ZNF763	chr19:12035900-12091196:+	-0.39	-4.01	6.96E-5	Multiple sclerosis	
PRAD	cis	1	rs10413735	chr19:41921071	ATP5SL	chr19:41937224-41945810:-	0.16	3.61	0.000337	Height	
PRAD	cis	1	rs10416218	chr19:33599127	GPATCH1	chr19:33571786-33621318:+	0.53	9.56	6.45E-20	Bone properties (heel)	
PRAD	cis	1	rs10416265	chr19:33605300	GPATCH1	chr19:33571786-33621318:+	0.52	9.69	2.25E-20	Bone properties (heel)	
PRAD	cis	1	rs10416654	chr19:17385176	ANKLE1	chr19:17392454-17398454:+	0.34	6.61	1.07E-10	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10416654	chr19:17385176	MRPL34	chr19:17416477-17417652:+	-0.19	-3.84	0.000141	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10416654	chr19:17385176	OCEL1	chr19:17337055-17340027:+	0.21	4.99	8.37E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10417311	chr19:41902038	ATP5SL	chr19:41937224-41945810:-	0.16	3.65	0.000289	Height	
PRAD	cis	1	rs1041748	chr22:24700854	POM121L9P	chr22:24647589-24661490:+	-0.24	-4.95	1.02E-6	Gut microbiome composition (summer)	
PRAD	cis	1	rs10418154	chr19:17386006	ANKLE1	chr19:17392454-17398454:+	0.34	6.62	9.53E-11	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10418154	chr19:17386006	MRPL34	chr19:17416477-17417652:+	-0.19	-3.82	0.00015	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10418154	chr19:17386006	OCEL1	chr19:17337055-17340027:+	0.21	5.02	7.36E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10418362	chr19:17386107	ANKLE1	chr19:17392454-17398454:+	0.34	6.66	7.59E-11	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10418362	chr19:17386107	MRPL34	chr19:17416477-17417652:+	-0.19	-3.87	0.000123	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10418362	chr19:17386107	OCEL1	chr19:17337055-17340027:+	0.21	5	8.05E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10418728	chr19:39247302	CAPN12	chr19:39220832-39235114:-	0.12	3.53	0.000464	Heart rate	
PRAD	cis	1	rs10418728	chr19:39247302	LGALS7	chr19:39261608-39264157:-	-0.2	-4.41	1.27E-5	Heart rate	
PRAD	cis	1	rs10419418	chr19:9994286	PIN1	chr19:9945999-9960358:+	0.12	3.83	0.000148	Menarche (age at onset)	
PRAD	cis	1	rs10421259	chr19:46158860	SYMPK	chr19:46318701-46366548:-	-0.18	-4.09	5.16E-5	Type 2 diabetes	
PRAD	cis	1	rs10421560	chr19:39186613	LGALS7	chr19:39261608-39264157:-	-0.17	-3.83	0.000147	Heart rate	
PRAD	cis	1	rs10421887	chr19:44294849	LYPD5	chr19:44300080-44324808:-	0.24	5.1	4.81E-7	Breast cancer	
PRAD	cis	1	rs10421887	chr19:44294849	ZNF155	chr19:44488355-44502477:+	0.24	4.71	3.28E-6	Breast cancer	
PRAD	cis	1	rs10421887	chr19:44294849	ZNF223	chr19:44556164-44572142:+	0.16	3.52	0.000477	Breast cancer	
PRAD	cis	1	rs10421887	chr19:44294849	ZNF404	chr19:44376516-44384288:-	0.2	4.33	1.79E-5	Breast cancer	
PRAD	cis	1	rs10422783	chr19:41906436	ATP5SL	chr19:41937224-41945810:-	0.16	3.66	0.000285	Height	
PRAD	cis	1	rs10422956	chr19:41901261	ATP5SL	chr19:41937224-41945810:-	0.16	3.65	0.000289	Height	
PRAD	cis	1	rs10423531	chr19:33600140	GPATCH1	chr19:33571786-33621318:+	0.53	9.61	4.52E-20	Bone properties (heel)	
PRAD	cis	1	rs10424665	chr19:32895631	DPY19L3	chr19:32896677-32975236:+	0.11	3.64	0.000303	Bipolar disorder	
PRAD	cis	1	rs10425939	chr19:17397244	ANKLE1	chr19:17392454-17398454:+	0.31	5.65	2.85E-8	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10425939	chr19:17397244	MRPL34	chr19:17416477-17417652:+	-0.25	-4.83	1.85E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10425939	chr19:17397244	OCEL1	chr19:17337055-17340027:+	0.24	5.46	7.82E-8	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs10425982	chr19:18586519	ELL	chr19:18553475-18632937:-	-0.16	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs10425982	chr19:18586519	SSBP4	chr19:18530221-18545371:+	-0.18	-5.94	5.42E-9	Breast cancer	
PRAD	cis	1	rs10426297	chr19:37798373	ZNF607	chr19:38187276-38210691:-	-0.21	-3.86	0.000131	Coronary artery calcification	
PRAD	cis	1	rs10426297	chr19:37798373	ZNF781	chr19:38158650-38183216:-	0.22	3.85	0.000133	Coronary artery calcification	
PRAD	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.33	-5.81	1.15E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs10427083	chr19:18550276	ELL	chr19:18553475-18632937:-	-0.17	-3.84	0.000139	Breast cancer	
PRAD	cis	1	rs10427083	chr19:18550276	SSBP4	chr19:18530221-18545371:+	-0.18	-5.84	9.65E-9	Breast cancer	
PRAD	cis	1	rs1043099	chr22:30681257	GATSL3	chr22:30681108-30695540:-	-0.21	-3.79	0.00017	Rheumatoid arthritis	
PRAD	cis	1	rs10431060	chr11:108288228	ATM	chr11:108093559-108239826:+	-0.18	-5.58	4.09E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.39	8.46	3.39E-16	Multiple sclerosis	
PRAD	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.53	-13.18	5.51E-34	Multiple sclerosis	
PRAD	cis	1	rs10431505	chr12:58178589	XRCC6BP1	chr12:58335445-58351051:+	-0.24	-4.81	2.08E-6	Multiple sclerosis	
PRAD	cis	1	rs1043441	chr22:39130964	CBY1	chr22:39052658-39069853:+	0.13	3.84	0.000142	Resting heart rate	
PRAD	cis	1	rs1043441	chr22:39130964	LOC646851	chr22:38974125-39052634:-	0.18	4.18	3.54E-5	Resting heart rate	
PRAD	cis	1	rs1043515	chr17:36922196	PSMB3	chr17:36909002-36920477:+	0.12	5.25	2.35E-7	Height	
PRAD	cis	1	rs1043674	chr14:75549370	EIF2B2	chr14:75469612-75476292:+	0.24	4.86	1.62E-6	Height	
PRAD	cis	1	rs1043674	chr14:75549370	MLH3	chr14:75480467-75518235:-	0.33	6.63	9.51E-11	Height	
PRAD	cis	1	rs10439607	chr20:30258541	COX4I2	chr20:30225691-30232800:+	0.17	4.4	1.32E-5	Subcortical brain region volumes	
PRAD	cis	1	rs10439608	chr20:30258814	COX4I2	chr20:30225691-30232800:+	0.14	3.68	0.000264	Subcortical brain region volumes	
PRAD	cis	1	rs10440301	chr4:17663199	MED28	chr4:17616273-17629791:+	0.18	4.5	8.6E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10442696	chr1:207438128	CD55	chr1:207494817-207534309:+	0.47	8.8	2.61E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs10442	chr19:18545341	ELL	chr19:18553475-18632937:-	-0.16	-3.81	0.000155	Breast cancer	
PRAD	cis	1	rs10442	chr19:18545341	SSBP4	chr19:18530221-18545371:+	-0.17	-5.81	1.18E-8	Breast cancer	
PRAD	cis	1	rs10443172	chr1:85485768	MCOLN2	chr1:85391267-85462796:-	0.34	5.92	6.13E-9	Serum sulfate level	
PRAD	cis	1	rs10445014	chr16:58160974	C16orf80	chr16:58147497-58163296:-	0.38	4.1	4.9E-5	Telomere length	
PRAD	cis	1	rs10445300	chr17:2114587	SRR	chr17:2207248-2228553:+	-0.75	-13.97	2.34E-37	Esophageal cancer (squamous cell)	
PRAD	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.93	-28.71	1.91E-105	Homocysteine levels	
PRAD	cis	1	rs1044717	chr1:45976587	MMACHC	chr1:45965856-45976737:+	-0.24	-5.2	2.93E-7	Homocysteine levels	
PRAD	cis	1	rs1044717	chr1:45976587	MUTYH	chr1:45794915-45806142:-	0.19	5.19	3.14E-7	Homocysteine levels	
PRAD	cis	1	rs10454142	chr2:48646399	FOXN2	chr2:48541795-48606434:+	-0.14	-3.92	0.0001	Sex hormone-binding globulin levels	
PRAD	cis	1	rs10454142	chr2:48646399	GTF2A1L	chr2:48844948-48960284:+	-0.41	-6.43	3.12E-10	Sex hormone-binding globulin levels	
PRAD	cis	1	rs10454142	chr2:48646399	KLRAQ1	chr2:48667908-48742524:+	0.26	5.26	2.17E-7	Sex hormone-binding globulin levels	
PRAD	cis	1	rs10454142	chr2:48646399	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.33	-6.02	3.48E-9	Sex hormone-binding globulin levels	
PRAD	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.48	-10.94	5.48E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs1045531	chr8:143763547	LY6K	chr8:143781529-143785582:+	0.21	3.66	0.000276	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs1045531	chr8:143763547	LYNX1	chr8:143845758-143859640:-	-0.31	-8.02	8.51E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs1045531	chr8:143763547	PSCA	chr8:143761875-143764142:+	0.53	10.13	6.03E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.52	-11.24	3.87E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.52	-11.63	1.19E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.48	-10.94	5.48E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs1045547	chr8:143763757	LY6K	chr8:143781529-143785582:+	0.21	3.66	0.000276	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs1045547	chr8:143763757	LYNX1	chr8:143845758-143859640:-	-0.31	-8.02	8.51E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs1045547	chr8:143763757	PSCA	chr8:143761875-143764142:+	0.53	10.13	6.03E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs1045574	chr8:143763958	LY6K	chr8:143781529-143785582:+	0.22	3.91	0.000104	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs1045574	chr8:143763958	LYNX1	chr8:143845758-143859640:-	-0.32	-8.22	2.01E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs1045574	chr8:143763958	PSCA	chr8:143761875-143764142:+	0.53	9.95	2.61E-21	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs10455768	chr6:159364322	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs10455769	chr6:159374007	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs10455770	chr6:159374304	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs10455772	chr6:159396403	RSPH3	chr6:159398268-159421198:-	0.29	4.58	6.04E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs10455830	chr6:159361236	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs10455832	chr6:159364354	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs10455835	chr6:159392353	RSPH3	chr6:159398268-159421198:-	0.29	4.58	6.04E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs10455836	chr6:159394754	RSPH3	chr6:159398268-159421198:-	0.3	4.71	3.2E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs1045605	chr8:143764101	LY6K	chr8:143781529-143785582:+	0.2	3.62	0.00033	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs1045605	chr8:143764101	LYNX1	chr8:143845758-143859640:-	-0.32	-8.17	2.85E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs1045605	chr8:143764101	PSCA	chr8:143761875-143764142:+	0.53	10.12	6.54E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs10456078	chr6:35118075	UHRF1BP1	chr6:34759794-34853117:+	-0.12	-4.19	3.31E-5	Airway responsiveness in chronic obstructive pulmonary disease	
PRAD	cis	1	rs10456303	chr6:24317399	GPLD1	chr6:24428405-24489850:-	0.18	3.46	0.000596	Uric acid levels	
PRAD	cis	1	rs10456362	chr6:28221816	ZNF187	chr6:28234788-28245978:+	0.32	5.63	3.14E-8	Depression	
PRAD	cis	1	rs10456362	chr6:28221816	ZNF323	chr6:28292517-28324048:-	-0.42	-5.52	5.65E-8	Depression	
PRAD	cis	1	rs10456362	chr6:28221816	ZNF389	chr6:28129551-28137375:+	0.52	7.08	5.31E-12	Depression	
PRAD	cis	1	rs10456362	chr6:28221816	ZSCAN23	chr6:28393287-28411279:-	-0.18	-4.59	5.64E-6	Depression	
PRAD	cis	1	rs10456420	chr6:33754301	IP6K3	chr6:33689443-33714762:-	0.19	3.77	0.000188	Obesity (extreme)	
PRAD	cis	1	rs10456622	chr6:49396453	CENPQ	chr6:49431096-49460820:+	-0.38	-8.02	8.56E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.18	5.09	5.11E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs10456906	chr6:116621035	FAM26F	chr6:116782556-116784933:+	0.13	4.05	5.91E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs10456907	chr6:116621036	FAM26F	chr6:116782556-116784933:+	0.13	4.05	5.91E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs10459917	chr17:2009752	SRR	chr17:2207248-2228553:+	-0.28	-4.39	1.41E-5	Body mass index	
PRAD	cis	1	rs1046073	chr20:25281333	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.17	3.67E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1046073	chr20:25281333	FAM182B	chr20:25744102-25848786:-	0.37	6.77	3.78E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1046073	chr20:25281333	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.9	15.14	1.92E-42	Type 2 diabetes	
PRAD	cis	1	rs10463240	chr5:150256853	LOC134466	chr5:150310000-150326146:-	0.59	9.07	3.15E-18	Crohn's disease	
PRAD	cis	1	rs10463307	chr5:150254620	LOC134466	chr5:150310000-150326146:-	0.58	8.83	2.1E-17	Crohn's disease	
PRAD	cis	1	rs10463310	chr5:150260905	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs10465591	chr1:202308344	PPP1R12B	chr1:202317836-202557697:+	0.09	3.62	0.000329	Sex ratio	
PRAD	cis	1	rs10465756	chr1:93029698	EVI5	chr1:92974255-93257961:-	-0.31	-6.37	4.39E-10	Cholesterol, total	
PRAD	cis	1	rs1046701	chr14:59939804	C14orf149	chr14:59939406-59951126:-	0.34	4.01	7.12E-5	Schizophrenia	
PRAD	cis	1	rs1046701	chr14:59939804	JKAMP	chr14:59951161-59972080:+	-0.34	-4.09	5.0E-5	Schizophrenia	
PRAD	cis	1	rs10467146	chr12:40766904	LRRK2	chr12:40618813-40763084:+	0.09	3.45	0.000613	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs10468513	chr17:53062903	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.91	0.000107	Breast cancer	
PRAD	cis	1	rs1046875	chr17:80685426	FN3K	chr17:80693452-80709073:+	0.27	5.94	5.68E-9	Glycated hemoglobin levels	
PRAD	cis	1	rs1046875	chr17:80685426	FN3KRP	chr17:80674582-80685889:+	0.59	11.31	2.09E-26	Glycated hemoglobin levels	
PRAD	cis	1	rs1046896	chr17:80685533	FN3K	chr17:80693452-80709073:+	0.28	6.18	1.37E-9	Glycated hemoglobin levels	
PRAD	cis	1	rs1046896	chr17:80685533	FN3KRP	chr17:80674582-80685889:+	0.6	11.48	4.53E-27	Glycated hemoglobin levels	
PRAD	cis	1	rs1046917	chr17:80685655	FN3K	chr17:80693452-80709073:+	0.27	5.94	5.49E-9	Glycated hemoglobin levels	
PRAD	cis	1	rs1046917	chr17:80685655	FN3KRP	chr17:80674582-80685889:+	0.59	11.29	2.6E-26	Glycated hemoglobin levels	
PRAD	cis	1	rs10470527	chr3:184751266	VPS8	chr3:184529931-184770402:+	-0.33	-4.15	4.0E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs10470686	chr3:48449956	ATRIP	chr3:48488141-48507708:+	0.27	6.31	6.29E-10	Longevity	
PRAD	cis	1	rs10470686	chr3:48449956	CDC25A	chr3:48198668-48229801:-	0.22	4.03	6.56E-5	Longevity	
PRAD	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.18	-5.1	4.96E-7	Longevity	
PRAD	cis	1	rs1047171	chr20:25428786	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.28	2.26E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1047171	chr20:25428786	FAM182B	chr20:25744102-25848786:-	0.38	7.09	4.94E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1047171	chr20:25428786	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.59E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1047206	chr11:64089216	C11orf20	chr11:64067863-64072238:+	-0.42	-5.88	7.68E-9	Mean platelet volume	
PRAD	cis	1	rs1047418	chr14:75605792	EIF2B2	chr14:75469612-75476292:+	0.25	4.97	9.32E-7	Height	
PRAD	cis	1	rs1047418	chr14:75605792	MLH3	chr14:75480467-75518235:-	0.32	6.6	1.09E-10	Height	
PRAD	cis	1	rs10475598	chr5:173648438	CPEB4	chr5:173315331-173387312:+	0.13	3.64	0.000307	Information processing speed	
PRAD	cis	1	rs10476102	chr5:173648583	CPEB4	chr5:173315331-173387312:+	0.14	3.91	0.000107	Information processing speed	
PRAD	cis	1	rs10478026	chr5:110196467	TMEM232	chr5:109624934-110062381:-	0.26	4.05	5.89E-5	Asthma and hay fever	
PRAD	cis	1	rs10479179	chr5:137564115	REEP2	chr5:137774776-137782657:+	-0.1	-3.95	9.11E-5	Resting heart rate	
PRAD	cis	1	rs10483863	chr14:75322327	RPS6KL1	chr14:75372347-75389958:-	-0.25	-4.58	5.91E-6	Caffeine consumption	
PRAD	cis	1	rs10484442	chr6:26555879	BTN2A3	chr6:26422317-26431927:+	0.26	6.62	1.0E-10	Educational attainment	
PRAD	cis	1	rs10484442	chr6:26555879	ZNF184	chr6:27418522-27440897:-	-0.17	-3.45	0.000611	Educational attainment	
PRAD	cis	1	rs10485508	chr20:33605098	MMP24	chr20:33814539-33864804:+	-0.31	-4.69	3.55E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs10486607	chr7:29184489	CPVL	chr7:29035249-29234892:-	-0.19	-5.01	7.65E-7	Diabetes related insulin traits	
PRAD	cis	1	rs1048886	chr6:71289189	FAM135A	chr6:71123107-71270875:+	-0.35	-6.39	4.1E-10	Type 2 diabetes	
PRAD	cis	1	rs10490626	chr2:118835841	INSIG2	chr2:118846050-118867596:+	0.37	4.29	2.19E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs10490958	chr10:17233450	TRDMT1	chr10:17184983-17243681:-	0.26	5.29	1.92E-7	Homocysteine levels	
PRAD	cis	1	rs10492090	chr12:5391393	CD9	chr12:6308873-6347427:+	-0.23	-3.52	0.000467	Neuropathic pain in type 2 diabetes	
PRAD	cis	1	rs10492090	chr12:5391393	VWF	chr12:6058040-6233836:-	-0.25	-4.38	1.46E-5	Neuropathic pain in type 2 diabetes	
PRAD	cis	1	rs10492096	chr12:6580582	TAPBPL	chr12:6561177-6575601:+	-0.26	-4.04	6.24E-5	Hip geometry	
PRAD	cis	1	rs10492681	chr13:40807483	COG6	chr13:40229764-40365802:+	0.2	4.15	3.97E-5	Select biomarker traits	
PRAD	cis	1	rs10493485	chr1:72071129	NEGR1	chr1:71868626-72748405:-	-0.1	-3.61	0.000334	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs10494217	chr1:119469188	WARS2	chr1:119573841-119683295:-	0.36	4.91	1.25E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs10494260	chr1:149943784	MTMR11	chr1:149900544-149908791:-	0.17	4.04	6.33E-5	Height	
PRAD	cis	1	rs10494304	chr1:156285764	BGLAP	chr1:156182784-156213112:+	-0.22	-5.9	6.89E-9	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10494304	chr1:156285764	CCT3	chr1:156278752-156308195:-	0.15	3.6	0.00035	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10494833	chr1:202467427	PPP1R12B	chr1:202317836-202557697:+	0.09	3.78	0.000175	Sex ratio	
PRAD	cis	1	rs10494874	chr1:205754688	PM20D1	chr1:205797154-205819245:-	-0.32	-5.42	9.41E-8	Prostate-specific antigen levels	
PRAD	cis	1	rs10494889	chr1:207460308	CD55	chr1:207494817-207534309:+	0.43	8.24	1.79E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs10494890	chr1:207424386	CD55	chr1:207494817-207534309:+	-0.47	-8.82	2.25E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs1049564	chr14:20940606	PNP	chr14:20937542-20945246:+	-0.31	-6.02	3.43E-9	Interferon alpha levels in systemic lupus erythematosus	
PRAD	cis	1	rs10496191	chr2:73673798	ALMS1P	chr2:73872046-73912692:+	0.49	8.42	4.44E-16	Metabolite levels	
PRAD	cis	1	rs10496191	chr2:73673798	NAT8	chr2:73867850-73869537:-	0.26	4.01	7.11E-5	Metabolite levels	
PRAD	cis	1	rs10496193	chr2:73773503	ALMS1P	chr2:73872046-73912692:+	0.51	8.77	3.28E-17	Metabolite levels	
PRAD	cis	1	rs10496193	chr2:73773503	NAT8	chr2:73867850-73869537:-	0.28	4.32	1.88E-5	Metabolite levels	
PRAD	cis	1	rs10498633	chr14:92926952	C14orf184	chr14:92038788-92041383:-	0.25	3.72	0.000221	Alzheimer's disease in APOE e4- carriers;Alzheimer's disease (late onset)	
PRAD	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.52	11.65	9.85E-28	Response to antipsychotic treatment	
PRAD	cis	1	rs10500303	chr19:50512033	SIGLEC16	chr19:50472912-50479075:+	0.52	4.89	1.38E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs10501426	chr11:78057122	GAB2	chr11:77926343-78128766:-	-0.17	-5.86	8.82E-9	Testicular germ cell tumor	
PRAD	cis	1	rs10501426	chr11:78057122	NARS2	chr11:78147017-78285909:-	-0.25	-5.56	4.46E-8	Testicular germ cell tumor	
PRAD	cis	1	rs10504857	chr8:89582625	MMP16	chr8:89049462-89339717:-	-0.16	-3.88	0.000118	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs10506912	chr12:85512367	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.24	2.72E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10506912	chr12:85512367	SLC6A15	chr12:85253269-85306606:-	-0.31	-4.82	1.97E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10506912	chr12:85512367	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.72	1.86E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10508206	chr10:1075777	IDI2	chr10:1064847-1071799:-	-0.25	-4.9	1.32E-6	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs10508206	chr10:1075777	WDR37	chr10:1102344-1178237:+	0.27	4.74	2.87E-6	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs10508517	chr10:16997891	TRDMT1	chr10:17184983-17243681:-	0.35	3.51	0.000495	Quantitative traits	
PRAD	cis	1	rs10508895	chr10:45967768	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs10508896	chr10:46030643	MARCH8	chr10:45952817-46090354:-	0.22	4.95	1.03E-6	Red blood cell traits	
PRAD	cis	1	rs10509741	chr10:101917366	CWF19L1	chr10:101992055-102027437:-	-0.34	-4.33	1.79E-5	Schizophrenia	
PRAD	cis	1	rs10509744	chr10:102271579	SEC31B	chr10:102246403-102289636:-	-0.31	-9.3	5.13E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10509767	chr10:74045917	ASCC1	chr10:73856278-73976892:-	-0.19	-3.85	0.000137	Heschl's gyrus morphology	
PRAD	cis	1	rs10509767	chr10:74045917	DNAJB12	chr10:74092588-74114907:-	-0.19	-3.75	0.000196	Heschl's gyrus morphology	
PRAD	cis	1	rs10510761	chr3:52965255	RFT1	chr3:53122503-53164470:-	-0.38	-4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs10510761	chr3:52965255	TMEM110	chr3:52867139-52931547:-	-0.41	-5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs10513788	chr3:182121573	LAMP3	chr3:182840004-182880667:-	0.16	3.43	0.000661	Cognitive function	
PRAD	cis	1	rs1051424	chr17:58024324	RNFT1	chr17:58029724-58042117:-	-0.21	-3.81	0.000157	Obesity-related traits	
PRAD	cis	1	rs10514847	chr13:44626749	CCDC122	chr13:44410491-44453826:-	-0.49	-4.18	3.5E-5	Uric acid levels	
PRAD	cis	1	rs10514847	chr13:44626749	KIAA1704	chr13:45563687-45607742:+	-0.33	-3.69	0.000252	Uric acid levels	
PRAD	cis	1	rs10516525	chr4:106668025	INTS12	chr4:106603787-106629881:-	-0.79	-7.86	2.61E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs10516526	chr4:106688904	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs10516527	chr4:106734346	INTS12	chr4:106603787-106629881:-	-0.81	-7.98	1.09E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs10517073	chr4:25417371	ZCCHC4	chr4:25314396-25372003:+	-0.2	-4.17	3.62E-5	Rheumatoid arthritis	
PRAD	cis	1	rs10517825	chr4:165893486	C4orf39	chr4:165878100-165880273:+	-0.16	-3.75	0.000202	Ovarian cancer in BRCA1 mutation carriers	
PRAD	cis	1	rs10518693	chr15:40700022	DISP2	chr15:40650434-40663256:+	0.34	6.04	3.19E-9	Blood metabolite levels;Blood metabolite ratios	
PRAD	cis	1	rs10519203	chr15:78814046	CHRNA3	chr15:78885397-78913322:-	0.26	4.54	7.08E-6	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs10519203	chr15:78814046	CHRNA5	chr15:78857906-78886458:+	0.21	4.42	1.25E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs1051921	chr7:73007943	MLXIPL	chr7:73007524-73038870:-	0.23	3.53	0.000457	Triglycerides	
PRAD	cis	1	rs1051931	chr6:46672943	TDRD6	chr6:46655866-46670149:+	0.26	4.75	2.75E-6	Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-0.88	-14.6	4.25E-40	Diastolic blood pressure	
PRAD	cis	1	rs1052974	chr7:37946540	EPDR1	chr7:37960163-37991539:+	-0.23	-3.79	0.000167	Bone mineral density	
PRAD	cis	1	rs1053639	chr10:74035041	ASCC1	chr10:73856278-73976892:-	0.19	3.89	0.000113	Heschl's gyrus morphology	
PRAD	cis	1	rs1053639	chr10:74035041	DNAJB12	chr10:74092588-74114907:-	0.19	3.88	0.000121	Heschl's gyrus morphology	
PRAD	cis	1	rs10540	chr11:494662	ANO9	chr11:417930-442011:-	0.24	3.9	0.000112	Body mass index	
PRAD	cis	1	rs10540	chr11:494662	LRRC56	chr11:537522-554915:+	0.28	4.21	3.1E-5	Body mass index	
PRAD	cis	1	rs10540	chr11:494662	RNH1	chr11:494512-507273:-	-0.2	-3.71	0.000233	Body mass index	
PRAD	cis	1	rs1054399	chr10:102312565	SEC31B	chr10:102246403-102289636:-	-0.28	-8.31	1.05E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs1056610	chr22:39080078	CBY1	chr22:39052658-39069853:+	-0.14	-4.05	6.11E-5	Resting heart rate	
PRAD	cis	1	rs1056610	chr22:39080078	LOC646851	chr22:38974125-39052634:-	-0.19	-4.73	3.03E-6	Resting heart rate	
PRAD	cis	1	rs1056667	chr6:26510564	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.21E-10	Educational attainment	
PRAD	cis	1	rs1056667	chr6:26510564	ZNF184	chr6:27418522-27440897:-	-0.18	-3.72	0.000225	Educational attainment	
PRAD	cis	1	rs1056964	chr22:51017476	CPT1B	chr22:51007291-51017096:-	-0.22	-4.8	2.11E-6	Narcolepsy	
PRAD	cis	1	rs1056964	chr22:51017476	LOC100144603	chr22:51021455-51022353:+	-0.3	-3.51	0.000486	Narcolepsy	
PRAD	cis	1	rs1057305	chr1:175126223	KIAA0040	chr1:175126123-175162229:-	0.15	3.45	0.000606	Alcohol dependence	
PRAD	cis	1	rs1058600	chr5:115166713	ATG12	chr5:115165818-115177520:-	0.25	4.25	2.56E-5	IgG glycosylation	
PRAD	cis	1	rs1058600	chr5:115166713	CDO1	chr5:115140432-115152405:-	0.24	3.83	0.000145	IgG glycosylation	
PRAD	cis	1	rs1060330	chr3:52288945	LOC440957	chr3:52570621-52574586:+	-0.13	-4.18	3.5E-5	Electroencephalogram traits	
PRAD	cis	1	rs1060330	chr3:52288945	NEK4	chr3:52744803-52804951:-	-0.18	-5.02	7.44E-7	Electroencephalogram traits	
PRAD	cis	1	rs1060330	chr3:52288945	NT5DC2	chr3:52558386-52569093:-	-0.18	-4.25	2.63E-5	Electroencephalogram traits	
PRAD	cis	1	rs1060822	chr17:26092631	LGALS9	chr17:25958174-25976585:+	-0.09	-4.09	5.01E-5	Fractional exhaled nitric oxide (childhood)	
PRAD	cis	1	rs1061377	chr4:39124750	KLHL5	chr4:39046659-39123828:+	-0.13	-3.75	0.000201	Uric acid levels	
PRAD	cis	1	rs1062687	chr22:39134715	CBY1	chr22:39052658-39069853:+	0.13	3.83	0.000147	Resting heart rate	
PRAD	cis	1	rs1062687	chr22:39134715	LOC646851	chr22:38974125-39052634:-	0.17	4.12	4.39E-5	Resting heart rate	
PRAD	cis	1	rs1062794	chr20:30381758	COX4I2	chr20:30225691-30232800:+	0.14	3.68	0.000259	Subcortical brain region volumes	
PRAD	cis	1	rs1065201	chr22:39069510	CBY1	chr22:39052658-39069853:+	0.18	5.07	5.86E-7	Resting heart rate	
PRAD	cis	1	rs1065201	chr22:39069510	LOC646851	chr22:38974125-39052634:-	0.2	4.65	4.27E-6	Resting heart rate	
PRAD	cis	1	rs1072328	chr14:60876439	C14orf39	chr14:60902675-60952764:-	-0.46	-5.81	1.18E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs10732856	chr11:116907113	PCSK7	chr11:117075789-117102811:-	-0.25	-3.57	0.000401	Protein quantitative trait loci	
PRAD	cis	1	rs10733594	chr9:115552630	C9orf80	chr9:115448793-115480387:-	0.31	4.1	4.77E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10733886	chr10:74039074	ASCC1	chr10:73856278-73976892:-	0.2	3.91	0.000107	Heschl's gyrus morphology	
PRAD	cis	1	rs10733886	chr10:74039074	DNAJB12	chr10:74092588-74114907:-	0.2	4.06	5.75E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs10734259	chr11:18314865	GTF2H1	chr11:18343816-18388590:+	0.74	15.62	1.33E-44	Pancreatic cancer	
PRAD	cis	1	rs1073457	chr12:85485057	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1073457	chr12:85485057	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1073457	chr12:85485057	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1073458	chr12:85485396	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1073458	chr12:85485396	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1073458	chr12:85485396	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10734765	chr12:9369385	LOC642846	chr12:9436253-9466684:+	0.29	6.11	2.04E-9	Non-alcoholic fatty liver disease histology (AST)	
PRAD	cis	1	rs1073632	chr16:68248607	C16orf86	chr16:67700717-67702659:+	-0.3	-3.58	0.000379	Crohn's disease	
PRAD	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.86	24.03	7.89E-84	Homocysteine levels	
PRAD	cis	1	rs10736426	chr1:45984353	MMACHC	chr1:45965856-45976737:+	0.19	3.99	7.58E-5	Homocysteine levels	
PRAD	cis	1	rs10736426	chr1:45984353	MUTYH	chr1:45794915-45806142:-	-0.19	-5.25	2.33E-7	Homocysteine levels	
PRAD	cis	1	rs10739370	chr9:115556941	C9orf80	chr9:115448793-115480387:-	0.31	4.1	4.77E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10739373	chr9:115593239	C9orf80	chr9:115448793-115480387:-	0.31	4.09	5.14E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.29	-6.62	9.66E-11	Hematology traits	
PRAD	cis	1	rs10739388	chr9:115977175	PRPF4	chr9:116037974-116055054:+	0.22	4.53	7.63E-6	Hematology traits	
PRAD	cis	1	rs10740397	chr10:74039762	ASCC1	chr10:73856278-73976892:-	0.2	3.96	8.81E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs10740397	chr10:74039762	DNAJB12	chr10:74092588-74114907:-	0.21	4.16	3.84E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs10740398	chr10:74046191	ASCC1	chr10:73856278-73976892:-	0.2	3.96	8.72E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs10740398	chr10:74046191	DNAJB12	chr10:74092588-74114907:-	0.2	4	7.37E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs10741210	chr10:131984312	GLRX3	chr10:131934663-131982784:+	-0.21	-4.94	1.09E-6	Alcohol dependence	
PRAD	cis	1	rs10741741	chr11:18342081	GTF2H1	chr11:18343816-18388590:+	-0.61	-13	3.21E-33	Pancreatic cancer	
PRAD	cis	1	rs10741742	chr11:18342160	GTF2H1	chr11:18343816-18388590:+	0.66	14.02	1.5E-37	Pancreatic cancer	
PRAD	cis	1	rs1074263	chr5:42750751	CCDC152	chr5:42756920-42802539:+	0.16	4.42	1.25E-5	Height	
PRAD	cis	1	rs1074263	chr5:42750751	SEPP1	chr5:42799983-42825998:-	0.15	4.34	1.72E-5	Height	
PRAD	cis	1	rs10742862	chr11:48649316	FOLH1	chr11:49168188-49230222:-	-0.17	-4	7.21E-5	HDL cholesterol	
PRAD	cis	1	rs1074286	chr8:130737601	GSDMC	chr8:130760443-130799134:-	0.2	3.93	9.93E-5	Infant length;Height	
PRAD	cis	1	rs1074407	chr22:38156183	GALR3	chr22:38219389-38221502:+	-0.35	-6.76	4.12E-11	Optic cup area;Vertical cup-disc ratio	
PRAD	cis	1	rs1074407	chr22:38156183	LGALS2	chr22:37966254-37976024:-	-0.13	-3.58	0.000378	Optic cup area;Vertical cup-disc ratio	
PRAD	cis	1	rs1074407	chr22:38156183	TRIOBP	chr22:38082344-38172562:+	0.23	6.3	6.97E-10	Optic cup area;Vertical cup-disc ratio	
PRAD	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.38	7.9	1.95E-14	Multiple sclerosis	
PRAD	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.55	-13.44	4.6E-35	Multiple sclerosis	
PRAD	cis	1	rs10747783	chr12:58176614	XRCC6BP1	chr12:58335445-58351051:+	-0.25	-4.84	1.73E-6	Multiple sclerosis	
PRAD	cis	1	rs10749860	chr1:46328210	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	9.04E-30	Body mass index	
PRAD	cis	1	rs10749860	chr1:46328210	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000145	Body mass index	
PRAD	cis	1	rs10749860	chr1:46328210	MUTYH	chr1:45794915-45806142:-	0.21	5.97	4.63E-9	Body mass index	
PRAD	cis	1	rs10750100	chr11:116917244	PCSK7	chr11:117075789-117102811:-	-0.29	-4.09	5.05E-5	Protein quantitative trait loci	
PRAD	cis	1	rs10750101	chr11:116979689	PCSK7	chr11:117075789-117102811:-	-0.36	-4.54	7.31E-6	Protein quantitative trait loci	
PRAD	cis	1	rs10752615	chr1:156248609	BGLAP	chr1:156182784-156213112:+	0.21	5.47	7.47E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10752615	chr1:156248609	CCT3	chr1:156278752-156308195:-	-0.15	-3.43	0.000658	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs1075265	chr2:54354927	ACYP2	chr2:54342410-54532433:+	-0.29	-6.49	2.16E-10	Chronotype;Morning vs. evening chronotype	
PRAD	cis	1	rs10753918	chr1:202503061	PPP1R12B	chr1:202317836-202557697:+	0.09	3.77	0.000187	Sex ratio	
PRAD	cis	1	rs10754323	chr1:89119492	CCBL2	chr1:89401456-89458643:-	0.45	9	5.77E-18	Height	
PRAD	cis	1	rs10755146	chr3:190985158	UTS2D	chr3:190984945-191048325:-	-0.24	-4.97	9.24E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10759473	chr9:113654070	PTGR1	chr9:114312003-114362135:-	0.23	3.71	0.000235	Corneal structure	
PRAD	cis	1	rs10759584	chr9:115554736	C9orf80	chr9:115448793-115480387:-	0.27	4.32	1.92E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.3	-6.88	1.87E-11	Hematology traits	
PRAD	cis	1	rs10759636	chr9:116018777	PRPF4	chr9:116037974-116055054:+	0.23	4.59	5.64E-6	Hematology traits	
PRAD	cis	1	rs10760021	chr9:100697648	C9orf156	chr9:100666772-100684852:-	-0.2	-3.92	0.000104	Quantitative traits	
PRAD	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.36	-6.66	7.83E-11	Rheumatoid arthritis	
PRAD	cis	1	rs10760118	chr9:123641616	TRAF1	chr9:123664672-123691479:-	0.17	4.92	1.18E-6	Rheumatoid arthritis	
PRAD	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.39	-7.08	5.36E-12	Rheumatoid arthritis	
PRAD	cis	1	rs10760121	chr9:123647915	TRAF1	chr9:123664672-123691479:-	0.17	4.8	2.18E-6	Rheumatoid arthritis	
PRAD	cis	1	rs10760206	chr9:100984855	TBC1D2	chr9:100961281-101018003:-	0.24	4.48	9.2E-6	Post-traumatic stress disorder	
PRAD	cis	1	rs10760442	chr9:129383900	LMX1B	chr9:129376748-129463311:+	0.23	3.66	0.000286	Eyebrow thickness	
PRAD	cis	1	rs10760589	chr9:131906293	CRAT	chr9:131857075-131873070:-	0.22	4.2	3.14E-5	Blood metabolite ratios	
PRAD	cis	1	rs1076160	chr9:135776034	C9orf98	chr9:135600965-135754198:-	-0.21	-3.9	0.000108	Psoriasis	
PRAD	cis	1	rs10761723	chr10:64955581	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.57	0.000392	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10761723	chr10:64955581	NRBF2	chr10:64893007-64914785:+	-0.29	-6.48	2.34E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10761727	chr10:64995493	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.57	0.000399	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10761727	chr10:64995493	NRBF2	chr10:64893007-64914785:+	-0.29	-6.48	2.31E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10761742	chr10:65085048	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.72	0.000226	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10761742	chr10:65085048	NRBF2	chr10:64893007-64914785:+	-0.3	-6.64	8.7E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10762504	chr10:74039335	ASCC1	chr10:73856278-73976892:-	0.2	3.9	0.000111	Heschl's gyrus morphology	
PRAD	cis	1	rs10762504	chr10:74039335	DNAJB12	chr10:74092588-74114907:-	0.2	4.02	6.76E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs10762505	chr10:74046212	ASCC1	chr10:73856278-73976892:-	-0.2	-3.98	8.12E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs10762505	chr10:74046212	DNAJB12	chr10:74092588-74114907:-	-0.2	-4.05	5.94E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs1076394	chr3:47322781	C3orf75	chr3:47537131-47555199:-	0.16	4.82	1.93E-6	Colorectal cancer	
PRAD	cis	1	rs1076394	chr3:47322781	NBEAL2	chr3:47021173-47051193:+	0.16	5.14	4.05E-7	Colorectal cancer	
PRAD	cis	1	rs10765688	chr11:94309859	MRE11A	chr11:94150469-94227040:-	-0.14	-4.13	4.35E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
PRAD	cis	1	rs10766368	chr11:17014882	NUCB2	chr11:17281887-17371521:+	0.26	4.1	4.81E-5	Glaucoma (primary angle closure)	
PRAD	cis	1	rs10766814	chr11:3260222	MRGPRE	chr11:3249042-3253616:-	-0.17	-3.86	0.000129	Multiple sclerosis	
PRAD	cis	1	rs10766969	chr11:22849952	SVIP	chr11:22843600-22851382:-	-0.28	-6.83	2.63E-11	Dialysis-related mortality	
PRAD	cis	1	rs10767971	chr11:32895664	CCDC73	chr11:32623627-32816187:-	0.21	4.06	5.69E-5	Parkinson's disease (age of onset)	
PRAD	cis	1	rs10767972	chr11:32896419	CCDC73	chr11:32623627-32816187:-	0.21	4.16	3.83E-5	Parkinson's disease (age of onset)	
PRAD	cis	1	rs10769054	chr11:5566489	UBQLNL	chr11:5535624-5537956:-	-0.17	-3.62	0.00033	QRS duration in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10769371	chr11:48531184	FOLH1	chr11:49168188-49230222:-	-0.16	-3.67	0.000271	HDL cholesterol	
PRAD	cis	1	rs10769390	chr11:48618222	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000344	HDL cholesterol	
PRAD	cis	1	rs10771431	chr12:9380859	DDX12	chr12:9570288-9600768:-	0.12	3.51	0.000499	Breast size	
PRAD	cis	1	rs10771431	chr12:9380859	LOC642846	chr12:9436253-9466684:+	0.32	8.53	2.06E-16	Breast size	
PRAD	cis	1	rs10774351	chr12:5767119	ANO2	chr12:5671817-6055398:-	0.34	6.6	1.14E-10	Plasma clusterin levels	
PRAD	cis	1	rs10774352	chr12:5767155	ANO2	chr12:5671817-6055398:-	0.34	6.6	1.14E-10	Plasma clusterin levels	
PRAD	cis	1	rs10774353	chr12:5767174	ANO2	chr12:5671817-6055398:-	-0.34	-6.57	1.36E-10	Plasma clusterin levels	
PRAD	cis	1	rs1077514	chr1:23766233	ASAP3	chr1:23755056-23811057:-	-0.35	-5.52	5.62E-8	Cholesterol, total	
PRAD	cis	1	rs1077514	chr1:23766233	TCEA3	chr1:23707555-23751261:-	-0.26	-4.43	1.16E-5	Cholesterol, total	
PRAD	cis	1	rs1077514	chr1:23766233	ZNF436	chr1:23685942-23696357:-	0.23	3.53	0.00045	Cholesterol, total	
PRAD	cis	1	rs10775302	chr16:67792439	C16orf86	chr16:67700717-67702659:+	-0.32	-4.07	5.47E-5	Crohn's disease	
PRAD	cis	1	rs10778305	chr12:104311974	C12orf73	chr12:104343981-104359473:-	0.18	4.43	1.16E-5	Coronary heart disease	
PRAD	cis	1	rs1077889	chr20:25267893	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.18	3.46E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1077889	chr20:25267893	FAM182B	chr20:25744102-25848786:-	0.37	6.73	4.88E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1077889	chr20:25267893	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.81E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10779148	chr12:85489786	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.29	2.19E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10779148	chr12:85489786	SLC6A15	chr12:85253269-85306606:-	-0.32	-4.85	1.66E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10779148	chr12:85489786	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.75	1.6E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10782922	chr1:92974595	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs10783594	chr12:54067135	TARBP2	chr12:53894705-53900213:+	-0.14	-3.8	0.000167	Height	
PRAD	cis	1	rs10783832	chr12:57961494	BAZ2A	chr12:56989380-57030163:-	-0.09	-3.67	0.000273	Rheumatoid arthritis	
PRAD	cis	1	rs10783832	chr12:57961494	FAM119B	chr12:58166383-58176323:+	0.22	4.84	1.78E-6	Rheumatoid arthritis	
PRAD	cis	1	rs10783832	chr12:57961494	PIP4K2C	chr12:57984942-57997210:+	-0.12	-3.71	0.000234	Rheumatoid arthritis	
PRAD	cis	1	rs10783832	chr12:57961494	TSFM	chr12:58176536-58191367:+	-0.26	-6.28	7.76E-10	Rheumatoid arthritis	
PRAD	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.39	8.35	7.99E-16	Multiple sclerosis	
PRAD	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.54	-13.23	3.51E-34	Multiple sclerosis	
PRAD	cis	1	rs10783847	chr12:58196447	XRCC6BP1	chr12:58335445-58351051:+	-0.24	-4.84	1.75E-6	Multiple sclerosis	
PRAD	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.39	8.36	7.14E-16	Multiple sclerosis	
PRAD	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.54	-13.22	3.72E-34	Multiple sclerosis	
PRAD	cis	1	rs10783848	chr12:58196528	XRCC6BP1	chr12:58335445-58351051:+	-0.24	-4.83	1.84E-6	Multiple sclerosis	
PRAD	cis	1	rs10784281	chr12:62502979	MON2	chr12:62860597-62991362:+	-0.14	-3.56	0.000413	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs10784980	chr12:73021661	TMEM19	chr12:72079878-72097837:+	0.28	3.94	9.36E-5	Diastolic blood pressure	
PRAD	cis	1	rs10786596	chr10:102282126	SEC31B	chr10:102246403-102289636:-	-0.3	-9.09	2.69E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10786597	chr10:102291287	SEC31B	chr10:102246403-102289636:-	-0.3	-8.98	6.57E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10786598	chr10:102291579	SEC31B	chr10:102246403-102289636:-	-0.3	-8.98	6.57E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs1078679	chr6:26568741	BTN2A3	chr6:26422317-26431927:+	0.26	6.44	3.0E-10	Educational attainment	
PRAD	cis	1	rs1078679	chr6:26568741	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.44	0.00064	Educational attainment	
PRAD	cis	1	rs1078679	chr6:26568741	ZNF184	chr6:27418522-27440897:-	-0.18	-3.74	0.000206	Educational attainment	
PRAD	cis	1	rs10788271	chr10:124036619	BTBD16	chr10:124030821-124097676:+	0.23	3.85	0.000137	Gut microbiome composition (summer)	
PRAD	cis	1	rs10788795	chr1:150758047	CTSK	chr1:150768687-150780812:-	0.2	4.82	1.9E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs10789475	chr1:46304177	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.96	5.62E-29	Body mass index	
PRAD	cis	1	rs10789475	chr1:46304177	MMACHC	chr1:45965856-45976737:+	-0.17	-3.79	0.000167	Body mass index	
PRAD	cis	1	rs10789475	chr1:46304177	MUTYH	chr1:45794915-45806142:-	0.2	5.84	9.6E-9	Body mass index	
PRAD	cis	1	rs10789481	chr1:46383583	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.18	7.22E-30	Body mass index	
PRAD	cis	1	rs10789481	chr1:46383583	MMACHC	chr1:45965856-45976737:+	-0.17	-3.68	0.000257	Body mass index	
PRAD	cis	1	rs10789481	chr1:46383583	MUTYH	chr1:45794915-45806142:-	0.21	6.11	2.04E-9	Body mass index	
PRAD	cis	1	rs10789487	chr1:46420221	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.96	5.78E-29	Body mass index	
PRAD	cis	1	rs10789487	chr1:46420221	MMACHC	chr1:45965856-45976737:+	-0.17	-3.86	0.000129	Body mass index	
PRAD	cis	1	rs10789487	chr1:46420221	MUTYH	chr1:45794915-45806142:-	0.2	5.83	1.02E-8	Body mass index	
PRAD	cis	1	rs1078968	chr3:53123486	ITIH4	chr3:52847007-52866554:-	0.15	4.56	6.6E-6	Height	
PRAD	cis	1	rs10789823	chr11:111172403	C11orf92	chr11:111164171-111175770:-	0.17	3.51	0.000499	Colorectal cancer	
PRAD	cis	1	rs10789823	chr11:111172403	C11orf93	chr11:111169976-111179353:+	0.17	3.7	0.000237	Colorectal cancer	
PRAD	cis	1	rs10790518	chr11:122520706	LOC399959	chr11:121959811-122238467:-	0.08	4.08	5.27E-5	HDL cholesterol;Cholesterol, total	
PRAD	cis	1	rs10791830	chr11:65661291	CTSW	chr11:65647284-65651212:+	-0.78	-19.85	4.09E-64	Crohn's disease	
PRAD	cis	1	rs10791830	chr11:65661291	KCNK7	chr11:65360327-65363467:-	-0.19	-3.89	0.000113	Crohn's disease	
PRAD	cis	1	rs10791830	chr11:65661291	SNX32	chr11:65601410-65621170:+	0.52	7.52	2.86E-13	Crohn's disease	
PRAD	cis	1	rs1079284	chr6:3372545	SLC22A23	chr6:3269207-3456793:-	-0.2	-4.13	4.38E-5	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	
PRAD	cis	1	rs1079285	chr6:3372487	SLC22A23	chr6:3269207-3456793:-	-0.18	-3.85	0.000134	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	
PRAD	cis	1	rs10793273	chr11:77742595	INTS4	chr11:77589768-77705717:-	-0.2	-3.64	0.000301	Pelvic organ prolapse	
PRAD	cis	1	rs10793295	chr11:77996521	GAB2	chr11:77926343-78128766:-	0.18	6.19	1.34E-9	Testicular germ cell tumor	
PRAD	cis	1	rs10793295	chr11:77996521	NARS2	chr11:78147017-78285909:-	0.23	4.95	1.05E-6	Testicular germ cell tumor	
PRAD	cis	1	rs10793297	chr11:78009660	GAB2	chr11:77926343-78128766:-	-0.21	-6.58	1.27E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10793297	chr11:78009660	NARS2	chr11:78147017-78285909:-	-0.2	-3.82	0.000153	Testicular germ cell tumor	
PRAD	cis	1	rs10793300	chr11:78019582	GAB2	chr11:77926343-78128766:-	-0.21	-6.3	6.69E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10793300	chr11:78019582	NARS2	chr11:78147017-78285909:-	-0.19	-3.75	0.000202	Testicular germ cell tumor	
PRAD	cis	1	rs10793302	chr11:78040961	GAB2	chr11:77926343-78128766:-	-0.2	-6.4	3.78E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10793302	chr11:78040961	NARS2	chr11:78147017-78285909:-	-0.21	-4.38	1.44E-5	Testicular germ cell tumor	
PRAD	cis	1	rs10793303	chr11:78060750	GAB2	chr11:77926343-78128766:-	-0.2	-6.32	5.91E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10793304	chr11:78064907	GAB2	chr11:77926343-78128766:-	-0.19	-6.31	6.51E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10793304	chr11:78064907	NARS2	chr11:78147017-78285909:-	-0.26	-5.66	2.58E-8	Testicular germ cell tumor	
PRAD	cis	1	rs10793308	chr11:78086005	GAB2	chr11:77926343-78128766:-	-0.17	-5.78	1.36E-8	Testicular germ cell tumor	
PRAD	cis	1	rs10793308	chr11:78086005	NARS2	chr11:78147017-78285909:-	-0.2	-4.23	2.78E-5	Testicular germ cell tumor	
PRAD	cis	1	rs10793309	chr11:78093799	GAB2	chr11:77926343-78128766:-	-0.17	-5.87	8.13E-9	Testicular germ cell tumor	
PRAD	cis	1	rs10793309	chr11:78093799	NARS2	chr11:78147017-78285909:-	-0.21	-4.5	8.43E-6	Testicular germ cell tumor	
PRAD	cis	1	rs10793311	chr11:78104399	GAB2	chr11:77926343-78128766:-	-0.2	-6.34	5.31E-10	Testicular germ cell tumor	
PRAD	cis	1	rs1079389	chr10:1161980	IDI2	chr10:1064847-1071799:-	0.33	4.29	2.18E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs1079390	chr10:1161653	IDI2	chr10:1064847-1071799:-	0.33	4.29	2.18E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs10794720	chr10:1156165	IDI2	chr10:1064847-1071799:-	-0.36	-5.11	4.71E-7	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs10795452	chr10:17192712	TRDMT1	chr10:17184983-17243681:-	0.18	3.57	0.000392	Homocysteine levels	
PRAD	cis	1	rs10797432	chr1:2501338	MMEL1	chr1:2522081-2564481:-	-0.4	-7.93	1.57E-14	Ulcerative colitis	
PRAD	cis	1	rs10797895	chr1:183589625	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs10797896	chr1:183589800	NCF2	chr1:183524698-183560046:-	0.25	3.68	0.000261	Systemic lupus erythematosus	
PRAD	cis	1	rs10798304	chr1:171258642	FMO4	chr1:171283486-171311222:+	-0.22	-4.49	8.9E-6	Sudden cardiac arrest	
PRAD	cis	1	rs10800501	chr1:170128903	C1orf156	chr1:169761675-169764031:-	-0.16	-3.5	0.000509	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
PRAD	cis	1	rs10800830	chr1:202323296	PPP1R12B	chr1:202317836-202557697:+	0.09	3.61	0.00034	Sex ratio	
PRAD	cis	1	rs10800831	chr1:202323506	PPP1R12B	chr1:202317836-202557697:+	0.09	3.63	0.000317	Sex ratio	
PRAD	cis	1	rs10800833	chr1:202330653	PPP1R12B	chr1:202317836-202557697:+	0.09	3.71	0.000233	Sex ratio	
PRAD	cis	1	rs10800839	chr1:202518950	PPP1R12B	chr1:202317836-202557697:+	0.09	3.83	0.000147	Sex ratio	
PRAD	cis	1	rs10804111	chr2:202145612	ALS2CR12	chr2:202153148-202222101:-	-0.28	-4.88	1.44E-6	Melanoma;Esophageal squamous cell carcinoma	
PRAD	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.52	11.88	1.2E-28	Height	
PRAD	cis	1	rs10804632	chr3:134294501	CEP63	chr3:134204575-134293852:+	0.22	3.82	0.00015	Height	
PRAD	cis	1	rs10805357	chr4:17652352	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10805358	chr4:17652450	MED28	chr4:17616273-17629791:+	0.19	4.83	1.88E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10805359	chr4:17684886	MED28	chr4:17616273-17629791:+	0.17	4.3	2.05E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10806701	chr6:159385223	RSPH3	chr6:159398268-159421198:-	0.33	4.95	1.04E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs1080698	chr10:102295114	SEC31B	chr10:102246403-102289636:-	-0.3	-8.82	2.32E-17	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10807701	chr7:65724686	CCT6P1	chr7:65216092-65228661:+	-0.33	-5.52	5.68E-8	Diabetic kidney disease	
PRAD	cis	1	rs10807701	chr7:65724686	CRCP	chr7:65579805-65619551:+	0.35	4.28	2.31E-5	Diabetic kidney disease	
PRAD	cis	1	rs10807702	chr7:65767843	CCT6P1	chr7:65216092-65228661:+	0.32	5.52	5.57E-8	Diabetic kidney disease	
PRAD	cis	1	rs10807702	chr7:65767843	CRCP	chr7:65579805-65619551:+	-0.35	-4.36	1.61E-5	Diabetic kidney disease	
PRAD	cis	1	rs10808739	chr8:65640260	BHLHE22	chr8:65492814-65496185:+	-0.29	-5.35	1.37E-7	HIV-1 susceptibility	
PRAD	cis	1	rs10817108	chr9:113658671	PTGR1	chr9:114312003-114362135:-	-0.26	-4.07	5.46E-5	Corneal structure	
PRAD	cis	1	rs10817109	chr9:113672313	PTGR1	chr9:114312003-114362135:-	-0.25	-3.87	0.000125	Corneal structure	
PRAD	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.38	-6.93	1.41E-11	Rheumatoid arthritis	
PRAD	cis	1	rs10818480	chr9:123643170	TRAF1	chr9:123664672-123691479:-	0.18	5.09	5.32E-7	Rheumatoid arthritis	
PRAD	cis	1	rs10819087	chr9:128695180	PBX3	chr9:128509617-128729653:+	0.21	4.35	1.65E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10819464	chr9:131876277	CRAT	chr9:131857075-131873070:-	0.21	3.97	8.23E-5	Blood metabolite ratios	
PRAD	cis	1	rs10819466	chr9:131881492	CRAT	chr9:131857075-131873070:-	0.22	4.18	3.52E-5	Blood metabolite ratios	
PRAD	cis	1	rs10819469	chr9:131882067	CRAT	chr9:131857075-131873070:-	0.23	4.28	2.25E-5	Blood metabolite ratios	
PRAD	cis	1	rs10819471	chr9:131896325	CRAT	chr9:131857075-131873070:-	0.2	3.72	0.00022	Blood metabolite ratios	
PRAD	cis	1	rs10822145	chr10:64934548	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.66	0.000281	Triglycerides	
PRAD	cis	1	rs10822145	chr10:64934548	NRBF2	chr10:64893007-64914785:+	-0.28	-6.26	8.71E-10	Triglycerides	
PRAD	cis	1	rs10822149	chr10:64987412	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.57	0.000399	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10822149	chr10:64987412	NRBF2	chr10:64893007-64914785:+	-0.29	-6.48	2.31E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10822161	chr10:65118203	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.63	0.000318	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10822161	chr10:65118203	NRBF2	chr10:64893007-64914785:+	-0.28	-6.2	1.22E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10822163	chr10:65124098	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.61	0.000338	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10822163	chr10:65124098	NRBF2	chr10:64893007-64914785:+	-0.28	-6.12	1.94E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10823911	chr10:74040034	ASCC1	chr10:73856278-73976892:-	0.2	4	7.31E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs10823911	chr10:74040034	DNAJB12	chr10:74092588-74114907:-	0.2	4.09	5.03E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs10832921	chr11:18380835	GTF2H1	chr11:18343816-18388590:+	0.66	13.94	3.36E-37	Pancreatic cancer	
PRAD	cis	1	rs10832956	chr11:18645668	SPTY2D1	chr11:18627949-18656020:-	-0.29	-10.73	3.42E-24	Cholesterol, total	
PRAD	cis	1	rs10832962	chr11:18656271	SPTY2D1	chr11:18627949-18656020:-	-0.29	-10.65	6.97E-24	Cholesterol, total	
PRAD	cis	1	rs10833824	chr11:22847485	SVIP	chr11:22843600-22851382:-	-0.28	-6.71	5.55E-11	Dialysis-related mortality	
PRAD	cis	1	rs10833825	chr11:22850753	SVIP	chr11:22843600-22851382:-	-0.29	-6.97	1.06E-11	Dialysis-related mortality	
PRAD	cis	1	rs10838290	chr11:5560150	UBQLNL	chr11:5535624-5537956:-	-0.17	-3.5	0.000503	QRS duration in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10838291	chr11:5560226	UBQLNL	chr11:5535624-5537956:-	-0.18	-3.69	0.000252	QRS duration in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10838738	chr11:47663049	C1QTNF4	chr11:47611216-47615961:-	-0.15	-3.78	0.00018	Subjective well-being	
PRAD	cis	1	rs10838747	chr11:47716324	C1QTNF4	chr11:47611216-47615961:-	-0.14	-3.64	0.000298	Subjective well-being	
PRAD	cis	1	rs10838748	chr11:47716381	C1QTNF4	chr11:47611216-47615961:-	-0.14	-3.58	0.000382	Subjective well-being	
PRAD	cis	1	rs10838912	chr11:48496477	FOLH1	chr11:49168188-49230222:-	-0.15	-3.45	0.000611	HDL cholesterol	
PRAD	cis	1	rs10838917	chr11:48503127	FOLH1	chr11:49168188-49230222:-	-0.15	-3.44	0.000627	HDL cholesterol	
PRAD	cis	1	rs10838931	chr11:48540973	FOLH1	chr11:49168188-49230222:-	-0.15	-3.46	0.000584	HDL cholesterol	
PRAD	cis	1	rs10838943	chr11:48557442	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000333	HDL cholesterol	
PRAD	cis	1	rs10838944	chr11:48559571	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000333	HDL cholesterol	
PRAD	cis	1	rs10838954	chr11:48579323	FOLH1	chr11:49168188-49230222:-	-0.15	-3.58	0.000385	HDL cholesterol	
PRAD	cis	1	rs10838966	chr11:48589723	FOLH1	chr11:49168188-49230222:-	-0.16	-3.68	0.000261	HDL cholesterol	
PRAD	cis	1	rs10838971	chr11:48606624	FOLH1	chr11:49168188-49230222:-	-0.15	-3.48	0.000547	HDL cholesterol	
PRAD	cis	1	rs10838975	chr11:48617615	FOLH1	chr11:49168188-49230222:-	-0.15	-3.48	0.000547	HDL cholesterol	
PRAD	cis	1	rs10839171	chr11:48923034	FOLH1	chr11:49168188-49230222:-	0.17	3.93	9.74E-5	HDL cholesterol	
PRAD	cis	1	rs10845106	chr12:10472338	KLRD1	chr12:10457050-10469849:+	-0.16	-3.72	0.000224	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs10849311	chr12:5766698	ANO2	chr12:5671817-6055398:-	0.34	6.67	7.4E-11	Plasma clusterin levels	
PRAD	cis	1	rs10849462	chr12:6575992	TAPBPL	chr12:6561177-6575601:+	-0.29	-4.35	1.65E-5	Hip geometry	
PRAD	cis	1	rs10849605	chr12:1064438	RAD52	chr12:1021255-1099219:-	-0.23	-5.38	1.18E-7	Lung cancer	
PRAD	cis	1	rs10849689	chr12:110493222	C12orf24	chr12:110906229-110928191:+	-0.25	-4.34	1.76E-5	Schizophrenia	
PRAD	cis	1	rs10851521	chr15:52942111	ARPP19	chr15:52839432-52861364:-	0.15	4.12	4.5E-5	Schizophrenia	
PRAD	cis	1	rs1085243	chr1:46544768	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.26	3.54E-30	Body mass index	
PRAD	cis	1	rs1085243	chr1:46544768	MMACHC	chr1:45965856-45976737:+	-0.17	-3.9	0.00011	Body mass index	
PRAD	cis	1	rs1085243	chr1:46544768	MUTYH	chr1:45794915-45806142:-	0.2	5.79	1.32E-8	Body mass index	
PRAD	cis	1	rs1085244	chr1:46563680	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.9	1.02E-28	Body mass index	
PRAD	cis	1	rs1085244	chr1:46563680	MMACHC	chr1:45965856-45976737:+	-0.16	-3.7	0.000243	Body mass index	
PRAD	cis	1	rs1085244	chr1:46563680	MUTYH	chr1:45794915-45806142:-	0.2	5.91	6.68E-9	Body mass index	
PRAD	cis	1	rs10853057	chr17:62998023	AMZ2P1	chr17:62962668-62971703:-	0.52	8.02	8.28E-15	White matter microstructure (global fractional anisotropy)	
PRAD	cis	1	rs10853751	chr19:41903220	ATP5SL	chr19:41937224-41945810:-	0.16	3.65	0.000289	Height	
PRAD	cis	1	rs10857712	chr10:135225666	LOC619207	chr10:135267432-135337062:+	-0.26	-5.64	2.92E-8	Systemic lupus erythematosus	
PRAD	cis	1	rs10857712	chr10:135225666	MTG1	chr10:135207621-135234173:+	0.19	4.39	1.42E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs10857811	chr1:110617688	ALX3	chr1:110602998-110613322:-	0.24	4.44	1.12E-5	Blood metabolite levels	
PRAD	cis	1	rs10862955	chr12:85486611	LRRIQ1	chr12:85430099-85638880:+	-0.26	-4.45	1.06E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10862955	chr12:85486611	SLC6A15	chr12:85253269-85306606:-	-0.31	-4.7	3.38E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10862955	chr12:85486611	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.67	2.54E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10862956	chr12:85490035	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.29	2.19E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10862956	chr12:85490035	SLC6A15	chr12:85253269-85306606:-	-0.32	-4.85	1.66E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10862956	chr12:85490035	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.75	1.6E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10862958	chr12:85536557	LRRIQ1	chr12:85430099-85638880:+	-0.26	-4.38	1.49E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10862958	chr12:85536557	SLC6A15	chr12:85253269-85306606:-	-0.3	-4.53	7.63E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10862958	chr12:85536557	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.64	2.94E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs10864167	chr1:207421572	CD55	chr1:207494817-207534309:+	0.23	4.16	3.74E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs10864175	chr1:207433349	CD55	chr1:207494817-207534309:+	0.22	4.01	7.15E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs10864178	chr1:207445678	CD55	chr1:207494817-207534309:+	0.22	3.99	7.64E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs10864180	chr1:207445761	CD55	chr1:207494817-207534309:+	0.24	4.34	1.77E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs10864181	chr1:207448051	CD55	chr1:207494817-207534309:+	0.25	4.4	1.36E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs10864231	chr1:207506329	CD55	chr1:207494817-207534309:+	0.25	4.41	1.26E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs10864459	chr1:10563609	APITD1	chr1:10490159-10512208:+	0.24	5.12	4.55E-7	Prostate cancer	
PRAD	cis	1	rs10864460	chr1:10563671	APITD1	chr1:10490159-10512208:+	-0.23	-4.81	1.99E-6	Prostate cancer	
PRAD	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-0.88	-14.47	1.62E-39	Diastolic blood pressure	
PRAD	cis	1	rs10865956	chr3:49581559	AMIGO3	chr3:49754268-49757238:-	-0.44	-8.91	1.12E-17	Menarche (age at onset)	
PRAD	cis	1	rs10865956	chr3:49581559	CCDC36	chr3:49235861-49295537:+	0.23	4.14	4.2E-5	Menarche (age at onset)	
PRAD	cis	1	rs10865956	chr3:49581559	GMPPB	chr3:49758932-49761384:-	-0.48	-11.67	8.0E-28	Menarche (age at onset)	
PRAD	cis	1	rs10865956	chr3:49581559	NCKIPSD	chr3:48711280-48723334:-	0.32	6.34	5.39E-10	Menarche (age at onset)	
PRAD	cis	1	rs10865956	chr3:49581559	P4HTM	chr3:49027341-49044579:+	0.16	3.69	0.000247	Menarche (age at onset)	
PRAD	cis	1	rs10865956	chr3:49581559	WDR6	chr3:49044637-49053386:+	-0.2	-3.87	0.000125	Menarche (age at onset)	
PRAD	cis	1	rs10865970	chr3:51357501	HEMK1	chr3:50606583-50622419:+	0.21	3.92	0.000102	Melanoma	
PRAD	cis	1	rs10869767	chr9:79019811	RFK	chr9:79000433-79009444:-	0.2	3.69	0.000251	Dialysis-related mortality	
PRAD	cis	1	rs10869773	chr9:79035347	RFK	chr9:79000433-79009444:-	0.19	3.57	0.000397	Dialysis-related mortality	
PRAD	cis	1	rs10871290	chr16:74472696	RFWD3	chr16:74655298-74700779:-	0.19	4.55	6.71E-6	Breast cancer	
PRAD	cis	1	rs10872032	chr6:109676776	SMPD2	chr6:109761931-109765121:+	0.23	5	7.99E-7	Height	
PRAD	cis	1	rs10873275	chr14:75531460	EIF2B2	chr14:75469612-75476292:+	0.25	5.02	7.4E-7	Height	
PRAD	cis	1	rs10873275	chr14:75531460	MLH3	chr14:75480467-75518235:-	0.33	6.68	6.72E-11	Height	
PRAD	cis	1	rs10874122	chr1:75235866	CRYZ	chr1:75171175-75199092:-	-0.35	-6.47	2.46E-10	Resistin levels	
PRAD	cis	1	rs10874656	chr1:92947024	EVI5	chr1:92974255-93257961:-	-0.3	-6.02	3.57E-9	Cholesterol, total	
PRAD	cis	1	rs10875583	chr5:153613716	GALNT10	chr5:153570295-153799809:+	0.15	4.44	1.11E-5	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs10876480	chr12:54066271	TARBP2	chr12:53894705-53900213:+	-0.15	-3.91	0.000107	Height	
PRAD	cis	1	rs10876481	chr12:54066743	TARBP2	chr12:53894705-53900213:+	-0.15	-3.91	0.000107	Height	
PRAD	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.37	7.77	4.83E-14	Multiple sclerosis	
PRAD	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.55	-13.45	4.08E-35	Multiple sclerosis	
PRAD	cis	1	rs10877012	chr12:58162085	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-5.06	5.98E-7	Multiple sclerosis	
PRAD	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.37	7.96	1.27E-14	Multiple sclerosis	
PRAD	cis	1	rs10877013	chr12:58165085	TSFM	chr12:58176536-58191367:+	-0.52	-12.86	1.22E-32	Multiple sclerosis	
PRAD	cis	1	rs10877013	chr12:58165085	XRCC6BP1	chr12:58335445-58351051:+	-0.23	-4.56	6.39E-6	Multiple sclerosis	
PRAD	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.38	8.25	1.59E-15	Multiple sclerosis	
PRAD	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.53	-13.07	1.66E-33	Multiple sclerosis	
PRAD	cis	1	rs10877014	chr12:58167661	XRCC6BP1	chr12:58335445-58351051:+	-0.24	-4.85	1.69E-6	Multiple sclerosis	
PRAD	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.37	7.72	7.28E-14	Multiple sclerosis	
PRAD	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.55	-13.44	4.51E-35	Multiple sclerosis	
PRAD	cis	1	rs10877015	chr12:58167788	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-5.02	7.2E-7	Multiple sclerosis	
PRAD	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.38	-7.85	2.93E-14	Multiple sclerosis	
PRAD	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.57	13.79	1.47E-36	Multiple sclerosis	
PRAD	cis	1	rs10877019	chr12:58172929	XRCC6BP1	chr12:58335445-58351051:+	0.26	5.02	7.32E-7	Multiple sclerosis	
PRAD	cis	1	rs10877792	chr12:62503621	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs10878340	chr12:40695095	LRRK2	chr12:40618813-40763084:+	-0.11	-4.75	2.69E-6	Daytime sleep phenotypes	
PRAD	cis	1	rs10879435	chr12:72895948	TMEM19	chr12:72079878-72097837:+	0.31	3.64	0.000302	Diastolic blood pressure	
PRAD	cis	1	rs10879467	chr12:73011367	TMEM19	chr12:72079878-72097837:+	0.24	3.44	0.000641	Diastolic blood pressure	
PRAD	cis	1	rs10879469	chr12:73016740	TMEM19	chr12:72079878-72097837:+	0.24	3.46	0.000582	Diastolic blood pressure	
PRAD	cis	1	rs10879470	chr12:73019828	TMEM19	chr12:72079878-72097837:+	0.25	3.47	0.000568	Diastolic blood pressure	
PRAD	cis	1	rs10880230	chr12:42450253	GXYLT1	chr12:42475650-42538673:-	-0.15	-4.02	6.74E-5	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
PRAD	cis	1	rs10880569	chr12:44201636	TMEM117	chr12:44229962-44783540:+	-0.39	-6.38	4.15E-10	Inflammatory bowel disease	
PRAD	cis	1	rs10880570	chr12:44202465	TMEM117	chr12:44229962-44783540:+	0.4	6.59	1.15E-10	Inflammatory bowel disease	
PRAD	cis	1	rs10881926	chr10:93344254	PPP1R3C	chr10:93388201-93392858:-	-0.17	-4.04	6.37E-5	Smoking behavior	
PRAD	cis	1	rs10882644	chr10:97388579	ENTPD1	chr10:97471536-97637022:+	0.13	3.89	0.000113	Blood metabolite levels	
PRAD	cis	1	rs10882644	chr10:97388579	TCTN3	chr10:97423154-97453900:-	0.22	4.18	3.51E-5	Blood metabolite levels	
PRAD	cis	1	rs10883492	chr10:102206089	SEC31B	chr10:102246403-102289636:-	-0.3	-8.89	1.32E-17	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883493	chr10:102208188	SEC31B	chr10:102246403-102289636:-	-0.31	-9.28	6.33E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883496	chr10:102221931	SEC31B	chr10:102246403-102289636:-	-0.32	-9.62	3.98E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883497	chr10:102228519	SEC31B	chr10:102246403-102289636:-	-0.32	-9.54	7.52E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883499	chr10:102232188	SEC31B	chr10:102246403-102289636:-	-0.32	-9.77	1.24E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883500	chr10:102238324	SEC31B	chr10:102246403-102289636:-	-0.32	-9.75	1.46E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883501	chr10:102238326	SEC31B	chr10:102246403-102289636:-	-0.32	-9.75	1.46E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883502	chr10:102238343	SEC31B	chr10:102246403-102289636:-	-0.32	-9.75	1.46E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883503	chr10:102275504	SEC31B	chr10:102246403-102289636:-	-0.31	-9.1	2.52E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883504	chr10:102280687	SEC31B	chr10:102246403-102289636:-	-0.31	-9.07	3.18E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883505	chr10:102280772	SEC31B	chr10:102246403-102289636:-	-0.3	-8.98	6.57E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883506	chr10:102289743	SEC31B	chr10:102246403-102289636:-	-0.3	-8.98	6.57E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883507	chr10:102291275	SEC31B	chr10:102246403-102289636:-	-0.3	-8.98	6.57E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883508	chr10:102294413	SEC31B	chr10:102246403-102289636:-	-0.29	-8.57	1.45E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883509	chr10:102296461	SEC31B	chr10:102246403-102289636:-	-0.28	-8.47	3.24E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883510	chr10:102297018	SEC31B	chr10:102246403-102289636:-	-0.31	-8.95	8.23E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883511	chr10:102299407	SEC31B	chr10:102246403-102289636:-	-0.28	-8.54	1.92E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883512	chr10:102308516	SEC31B	chr10:102246403-102289636:-	-0.28	-8.39	5.63E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10883513	chr10:102316964	SEC31B	chr10:102246403-102289636:-	-0.3	-8.61	1.1E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs10887766	chr10:89755075	PTEN	chr10:89623195-89728531:+	0.19	3.43	0.00065	Type 2 diabetes	
PRAD	cis	1	rs10888396	chr1:150777514	CTSK	chr1:150768687-150780812:-	0.2	4.76	2.58E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs1088984	chr11:2377581	C11orf21	chr11:2317507-2323143:-	-0.23	-4.7	3.47E-6	Bacteremia	
PRAD	cis	1	rs1088985	chr11:2377852	C11orf21	chr11:2317507-2323143:-	-0.23	-4.68	3.83E-6	Bacteremia	
PRAD	cis	1	rs1088986	chr11:2377862	C11orf21	chr11:2317507-2323143:-	-0.24	-5.12	4.49E-7	Bacteremia	
PRAD	cis	1	rs1088986	chr11:2377862	TSPAN32	chr11:2323243-2339430:+	-0.17	-3.67	0.00027	Bacteremia	
PRAD	cis	1	rs1088987	chr11:2379196	C11orf21	chr11:2317507-2323143:-	-0.24	-5.05	6.37E-7	Bacteremia	
PRAD	cis	1	rs1088987	chr11:2379196	TSPAN32	chr11:2323243-2339430:+	-0.17	-3.52	0.000475	Bacteremia	
PRAD	cis	1	rs1088988	chr11:2380470	C11orf21	chr11:2317507-2323143:-	-0.22	-4.48	9.47E-6	Bacteremia	
PRAD	cis	1	rs1088990	chr11:2381771	C11orf21	chr11:2317507-2323143:-	-0.22	-4.46	1.04E-5	Bacteremia	
PRAD	cis	1	rs1088993	chr11:2382631	C11orf21	chr11:2317507-2323143:-	-0.2	-4.19	3.34E-5	Bacteremia	
PRAD	cis	1	rs10890352	chr1:46283628	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.26	3.43E-30	Body mass index	
PRAD	cis	1	rs10890352	chr1:46283628	MMACHC	chr1:45965856-45976737:+	-0.17	-3.81	0.00016	Body mass index	
PRAD	cis	1	rs10890352	chr1:46283628	MUTYH	chr1:45794915-45806142:-	0.21	6	3.93E-9	Body mass index	
PRAD	cis	1	rs10890354	chr1:46305347	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.18	7.74E-30	Body mass index	
PRAD	cis	1	rs10890354	chr1:46305347	MMACHC	chr1:45965856-45976737:+	-0.17	-3.8	0.000162	Body mass index	
PRAD	cis	1	rs10890354	chr1:46305347	MUTYH	chr1:45794915-45806142:-	0.21	6.03	3.32E-9	Body mass index	
PRAD	cis	1	rs10890361	chr1:46346234	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.26	3.48E-26	Body mass index	
PRAD	cis	1	rs10890361	chr1:46346234	MMACHC	chr1:45965856-45976737:+	-0.16	-3.52	0.000476	Body mass index	
PRAD	cis	1	rs10890361	chr1:46346234	MUTYH	chr1:45794915-45806142:-	0.19	5.19	3.13E-7	Body mass index	
PRAD	cis	1	rs10890363	chr1:46356148	CCDC163P	chr1:45960581-45965646:-	0.53	12.16	8.94E-30	Body mass index	
PRAD	cis	1	rs10890363	chr1:46356148	MMACHC	chr1:45965856-45976737:+	0.17	3.83	0.000146	Body mass index	
PRAD	cis	1	rs10890363	chr1:46356148	MUTYH	chr1:45794915-45806142:-	-0.21	-5.96	4.88E-9	Body mass index	
PRAD	cis	1	rs10890383	chr1:46588503	CCDC163P	chr1:45960581-45965646:-	-0.53	-11.66	9.1E-28	Body mass index	
PRAD	cis	1	rs10890383	chr1:46588503	MUTYH	chr1:45794915-45806142:-	0.21	5.79	1.29E-8	Body mass index	
PRAD	cis	1	rs10891692	chr11:114393652	FAM55A	chr11:114392438-114430580:-	-0.18	-3.58	0.000381	Ulcerative colitis	
PRAD	cis	1	rs10894804	chr11:134247842	GLB1L2	chr11:134201768-134248235:+	-0.19	-4.56	6.44E-6	Verbal declarative memory	
PRAD	cis	1	rs10896043	chr11:65543827	CTSW	chr11:65647284-65651212:+	0.27	5.37	1.22E-7	Systemic lupus erythematosus	
PRAD	cis	1	rs10896043	chr11:65543827	SNX32	chr11:65601410-65621170:+	-0.29	-4.17	3.63E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs10897009	chr11:59923194	PATL1	chr11:59404194-59436511:-	-0.11	-3.69	0.000254	Alzheimer's disease (late onset)	
PRAD	cis	1	rs10899451	chr11:77991222	GAB2	chr11:77926343-78128766:-	-0.21	-6.57	1.31E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899451	chr11:77991222	NARS2	chr11:78147017-78285909:-	-0.2	-3.83	0.000147	Testicular germ cell tumor	
PRAD	cis	1	rs10899452	chr11:77995143	GAB2	chr11:77926343-78128766:-	-0.2	-6.2	1.22E-9	Testicular germ cell tumor	
PRAD	cis	1	rs10899452	chr11:77995143	KCTD21	chr11:77882301-77899664:-	-0.23	-3.53	0.000458	Testicular germ cell tumor	
PRAD	cis	1	rs10899452	chr11:77995143	NARS2	chr11:78147017-78285909:-	-0.21	-4.03	6.51E-5	Testicular germ cell tumor	
PRAD	cis	1	rs10899453	chr11:77997482	GAB2	chr11:77926343-78128766:-	-0.2	-6.31	6.64E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899453	chr11:77997482	NARS2	chr11:78147017-78285909:-	-0.23	-4.78	2.34E-6	Testicular germ cell tumor	
PRAD	cis	1	rs10899454	chr11:77997513	GAB2	chr11:77926343-78128766:-	-0.19	-6.15	1.65E-9	Testicular germ cell tumor	
PRAD	cis	1	rs10899454	chr11:77997513	NARS2	chr11:78147017-78285909:-	-0.23	-4.74	2.83E-6	Testicular germ cell tumor	
PRAD	cis	1	rs10899455	chr11:77999163	GAB2	chr11:77926343-78128766:-	-0.19	-6.15	1.64E-9	Testicular germ cell tumor	
PRAD	cis	1	rs10899455	chr11:77999163	NARS2	chr11:78147017-78285909:-	-0.24	-4.88	1.48E-6	Testicular germ cell tumor	
PRAD	cis	1	rs10899456	chr11:78000155	GAB2	chr11:77926343-78128766:-	-0.19	-6.07	2.61E-9	Testicular germ cell tumor	
PRAD	cis	1	rs10899456	chr11:78000155	NARS2	chr11:78147017-78285909:-	-0.23	-4.79	2.25E-6	Testicular germ cell tumor	
PRAD	cis	1	rs10899457	chr11:78001163	GAB2	chr11:77926343-78128766:-	-0.21	-6.31	6.46E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899457	chr11:78001163	NARS2	chr11:78147017-78285909:-	-0.19	-3.73	0.000211	Testicular germ cell tumor	
PRAD	cis	1	rs10899458	chr11:78007451	GAB2	chr11:77926343-78128766:-	-0.21	-6.31	6.46E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899458	chr11:78007451	NARS2	chr11:78147017-78285909:-	-0.19	-3.73	0.000211	Testicular germ cell tumor	
PRAD	cis	1	rs10899460	chr11:78010080	GAB2	chr11:77926343-78128766:-	-0.21	-6.58	1.27E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899460	chr11:78010080	NARS2	chr11:78147017-78285909:-	-0.2	-3.82	0.000153	Testicular germ cell tumor	
PRAD	cis	1	rs10899465	chr11:78013588	GAB2	chr11:77926343-78128766:-	-0.21	-6.3	6.69E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899465	chr11:78013588	NARS2	chr11:78147017-78285909:-	-0.19	-3.75	0.000202	Testicular germ cell tumor	
PRAD	cis	1	rs10899467	chr11:78014057	GAB2	chr11:77926343-78128766:-	-0.21	-6.38	4.22E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899467	chr11:78014057	NARS2	chr11:78147017-78285909:-	-0.22	-4.31	2.03E-5	Testicular germ cell tumor	
PRAD	cis	1	rs10899468	chr11:78016650	GAB2	chr11:77926343-78128766:-	-0.21	-6.3	6.69E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899468	chr11:78016650	NARS2	chr11:78147017-78285909:-	-0.19	-3.75	0.000202	Testicular germ cell tumor	
PRAD	cis	1	rs10899469	chr11:78018313	GAB2	chr11:77926343-78128766:-	-0.21	-6.57	1.31E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899469	chr11:78018313	NARS2	chr11:78147017-78285909:-	-0.2	-3.83	0.000147	Testicular germ cell tumor	
PRAD	cis	1	rs10899470	chr11:78020052	GAB2	chr11:77926343-78128766:-	-0.21	-6.3	6.69E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899470	chr11:78020052	NARS2	chr11:78147017-78285909:-	-0.19	-3.75	0.000202	Testicular germ cell tumor	
PRAD	cis	1	rs10899474	chr11:78043636	GAB2	chr11:77926343-78128766:-	-0.21	-6.62	1.0E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899474	chr11:78043636	NARS2	chr11:78147017-78285909:-	-0.19	-3.88	0.00012	Testicular germ cell tumor	
PRAD	cis	1	rs10899475	chr11:78051610	GAB2	chr11:77926343-78128766:-	-0.19	-6.28	7.61E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899475	chr11:78051610	NARS2	chr11:78147017-78285909:-	-0.26	-5.65	2.85E-8	Testicular germ cell tumor	
PRAD	cis	1	rs10899476	chr11:78051794	GAB2	chr11:77926343-78128766:-	-0.21	-6.66	7.82E-11	Testicular germ cell tumor	
PRAD	cis	1	rs10899476	chr11:78051794	NARS2	chr11:78147017-78285909:-	-0.18	-3.53	0.00045	Testicular germ cell tumor	
PRAD	cis	1	rs10899477	chr11:78052104	GAB2	chr11:77926343-78128766:-	-0.21	-6.67	7.0E-11	Testicular germ cell tumor	
PRAD	cis	1	rs10899477	chr11:78052104	NARS2	chr11:78147017-78285909:-	-0.18	-3.5	0.000506	Testicular germ cell tumor	
PRAD	cis	1	rs10899478	chr11:78052238	GAB2	chr11:77926343-78128766:-	-0.19	-6.34	5.54E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899478	chr11:78052238	NARS2	chr11:78147017-78285909:-	-0.26	-5.7	2.15E-8	Testicular germ cell tumor	
PRAD	cis	1	rs10899479	chr11:78052539	GAB2	chr11:77926343-78128766:-	-0.21	-6.68	6.63E-11	Testicular germ cell tumor	
PRAD	cis	1	rs10899479	chr11:78052539	NARS2	chr11:78147017-78285909:-	-0.18	-3.59	0.000369	Testicular germ cell tumor	
PRAD	cis	1	rs10899481	chr11:78058721	GAB2	chr11:77926343-78128766:-	0.17	5.76	1.53E-8	Testicular germ cell tumor	
PRAD	cis	1	rs10899481	chr11:78058721	NARS2	chr11:78147017-78285909:-	0.26	5.88	7.98E-9	Testicular germ cell tumor	
PRAD	cis	1	rs10899483	chr11:78061057	GAB2	chr11:77926343-78128766:-	-0.17	-5.82	1.09E-8	Testicular germ cell tumor	
PRAD	cis	1	rs10899483	chr11:78061057	NARS2	chr11:78147017-78285909:-	-0.25	-5.44	8.52E-8	Testicular germ cell tumor	
PRAD	cis	1	rs10899485	chr11:78072383	GAB2	chr11:77926343-78128766:-	0.18	6.2	1.27E-9	Testicular germ cell tumor	
PRAD	cis	1	rs10899485	chr11:78072383	NARS2	chr11:78147017-78285909:-	0.22	4.98	8.87E-7	Testicular germ cell tumor	
PRAD	cis	1	rs10899486	chr11:78072398	GAB2	chr11:77926343-78128766:-	-0.21	-6.52	1.83E-10	Testicular germ cell tumor	
PRAD	cis	1	rs10899486	chr11:78072398	NARS2	chr11:78147017-78285909:-	-0.18	-3.52	0.000479	Testicular germ cell tumor	
PRAD	cis	1	rs10899489	chr11:78095373	GAB2	chr11:77926343-78128766:-	-0.16	-5.39	1.12E-7	Testicular germ cell tumor	
PRAD	cis	1	rs10899489	chr11:78095373	NARS2	chr11:78147017-78285909:-	-0.21	-4.34	1.77E-5	Testicular germ cell tumor	
PRAD	cis	1	rs10899491	chr11:78106305	GAB2	chr11:77926343-78128766:-	-0.21	-6.66	7.47E-11	Testicular germ cell tumor	
PRAD	cis	1	rs10899491	chr11:78106305	NARS2	chr11:78147017-78285909:-	-0.18	-3.49	0.000524	Testicular germ cell tumor	
PRAD	cis	1	rs10899492	chr11:78109810	GAB2	chr11:77926343-78128766:-	-0.17	-5.78	1.37E-8	Testicular germ cell tumor	
PRAD	cis	1	rs10899492	chr11:78109810	NARS2	chr11:78147017-78285909:-	-0.19	-4.08	5.24E-5	Testicular germ cell tumor	
PRAD	cis	1	rs10899495	chr11:78123293	GAB2	chr11:77926343-78128766:-	-0.21	-6.62	9.83E-11	Testicular germ cell tumor	
PRAD	cis	1	rs10901216	chr9:133471891	NCS1	chr9:132934857-132999583:+	0.13	3.97	8.15E-5	Bone mineral density	
PRAD	cis	1	rs10901216	chr9:133471891	USP20	chr9:132597696-132644107:+	0.14	3.47	0.000561	Bone mineral density	
PRAD	cis	1	rs10901513	chr10:127699936	UROS	chr10:127477148-127511837:-	-0.17	-4.01	6.99E-5	Visceral fat	
PRAD	cis	1	rs10901514	chr10:127700066	UROS	chr10:127477148-127511837:-	-0.17	-4.01	6.99E-5	Visceral fat	
PRAD	cis	1	rs10901520	chr10:127718837	UROS	chr10:127477148-127511837:-	-0.17	-4.03	6.61E-5	Visceral fat	
PRAD	cis	1	rs10902728	chr1:26598281	CCDC21	chr1:26560693-26605299:+	0.21	5.35	1.35E-7	Obesity-related traits	
PRAD	cis	1	rs10906982	chr15:84568158	FAM103A1	chr15:83654995-83659423:+	-0.17	-3.51	0.000497	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs10906982	chr15:84568158	NMB	chr15:85198362-85201802:-	-0.17	-4.03	6.4E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs10906983	chr15:84569183	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs10908353	chr1:37954950	MEAF6	chr1:37958176-37980364:-	-0.34	-4.97	9.49E-7	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs10908353	chr1:37954950	SNIP1	chr1:38002145-38019903:-	-0.28	-4.78	2.37E-6	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs10908387	chr1:35677039	C1orf216	chr1:36179477-36184790:-	-0.28	-3.61	0.000345	Endometrial cancer	
PRAD	cis	1	rs10908494	chr1:156263097	BGLAP	chr1:156182784-156213112:+	0.22	5.8	1.23E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908494	chr1:156263097	CCT3	chr1:156278752-156308195:-	-0.16	-3.72	0.000223	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908495	chr1:156263940	BGLAP	chr1:156182784-156213112:+	0.22	5.8	1.21E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908495	chr1:156263940	CCT3	chr1:156278752-156308195:-	-0.16	-3.81	0.000157	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908496	chr1:156264000	BGLAP	chr1:156182784-156213112:+	0.22	5.59	3.8E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908496	chr1:156264000	CCT3	chr1:156278752-156308195:-	-0.15	-3.45	0.000616	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908498	chr1:156278175	BGLAP	chr1:156182784-156213112:+	0.22	5.8	1.21E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908498	chr1:156278175	CCT3	chr1:156278752-156308195:-	-0.16	-3.81	0.000157	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908499	chr1:156279176	BGLAP	chr1:156182784-156213112:+	0.22	5.8	1.21E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908499	chr1:156279176	CCT3	chr1:156278752-156308195:-	-0.16	-3.81	0.000157	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908500	chr1:156280671	BGLAP	chr1:156182784-156213112:+	0.22	5.8	1.21E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908500	chr1:156280671	CCT3	chr1:156278752-156308195:-	-0.16	-3.81	0.000157	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908502	chr1:156300082	BGLAP	chr1:156182784-156213112:+	0.22	5.81	1.13E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10908502	chr1:156300082	CCT3	chr1:156278752-156308195:-	-0.16	-3.82	0.000154	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs10910092	chr1:2501516	MMEL1	chr1:2522081-2564481:-	-0.4	-7.91	1.92E-14	Ulcerative colitis	
PRAD	cis	1	rs10911383	chr1:183603962	NCF2	chr1:183524698-183560046:-	0.24	3.7	0.000245	Systemic lupus erythematosus	
PRAD	cis	1	rs10911385	chr1:183606183	NCF2	chr1:183524698-183560046:-	0.27	3.78	0.00018	Systemic lupus erythematosus	
PRAD	cis	1	rs10911389	chr1:183616805	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs10911390	chr1:183616884	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs10911391	chr1:183617094	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs10911392	chr1:183617311	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs10911395	chr1:183634257	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs10911397	chr1:183646757	NCF2	chr1:183524698-183560046:-	0.23	3.48	0.000557	Systemic lupus erythematosus	
PRAD	cis	1	rs10912749	chr1:171277506	FMO4	chr1:171283486-171311222:+	0.22	4.44	1.13E-5	Sudden cardiac arrest	
PRAD	cis	1	rs10916814	chr1:20892931	CDA	chr1:20915444-20945398:+	0.16	4.1	4.85E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10916814	chr1:20892931	FAM43B	chr1:20878932-20881512:+	-0.15	-3.68	0.000257	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10916820	chr1:20903792	CDA	chr1:20915444-20945398:+	-0.15	-3.77	0.000185	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10916820	chr1:20903792	FAM43B	chr1:20878932-20881512:+	0.16	3.85	0.000132	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10920392	chr1:202321123	PPP1R12B	chr1:202317836-202557697:+	0.09	3.55	0.000427	Sex ratio	
PRAD	cis	1	rs10920409	chr1:202443663	PPP1R12B	chr1:202317836-202557697:+	0.09	3.79	0.000173	Sex ratio	
PRAD	cis	1	rs10920410	chr1:202445856	PPP1R12B	chr1:202317836-202557697:+	-0.08	-3.45	0.000601	Sex ratio	
PRAD	cis	1	rs10920412	chr1:202454413	PPP1R12B	chr1:202317836-202557697:+	0.09	3.65	0.000289	Sex ratio	
PRAD	cis	1	rs10920414	chr1:202476924	PPP1R12B	chr1:202317836-202557697:+	0.09	3.81	0.000156	Sex ratio	
PRAD	cis	1	rs10920421	chr1:202517196	PPP1R12B	chr1:202317836-202557697:+	0.09	3.83	0.000147	Sex ratio	
PRAD	cis	1	rs10927875	chr1:16299312	CLCNKA	chr1:16345370-16360544:+	0.41	7.66	1.09E-13	Dilated cardiomyopathy	
PRAD	cis	1	rs10929965	chr2:160906931	LY75	chr2:160625141-160761262:-	-0.12	-4	7.26E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs10929965	chr2:160906931	PLA2R1	chr2:160798012-160919121:-	-0.24	-5.4	1.07E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs10929966	chr2:160908341	LY75	chr2:160625141-160761262:-	0.12	4.11	4.73E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs10929966	chr2:160908341	PLA2R1	chr2:160798012-160919121:-	0.24	5.4	1.09E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs10930973	chr2:182470425	CERKL	chr2:182401402-182545381:-	-0.16	-3.8	0.000161	Response to iloperidone treatment (QT prolongation)	
PRAD	cis	1	rs10931041	chr2:183685562	FRZB	chr2:183698737-183731498:-	0.13	3.57	0.0004	Waist-to-hip circumference ratio (interaction)	
PRAD	cis	1	rs10933518	chr2:241838091	C2orf54	chr2:241825466-241835573:-	0.52	9.78	1.14E-20	Urinary metabolites	
PRAD	cis	1	rs10934850	chr3:127886957	RUVBL1	chr3:127783627-127872757:-	0.24	4.37	1.56E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.52	-12.06	2.32E-29	Height	
PRAD	cis	1	rs10935120	chr3:134233092	CEP63	chr3:134204575-134293852:+	-0.2	-3.56	0.000415	Height	
PRAD	cis	1	rs10937463	chr3:190985247	UTS2D	chr3:190984945-191048325:-	0.24	4.98	8.88E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10937464	chr3:190985274	UTS2D	chr3:190984945-191048325:-	-0.24	-4.99	8.35E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10937465	chr3:190985279	UTS2D	chr3:190984945-191048325:-	-0.24	-4.99	8.35E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs10938353	chr4:44582487	GUF1	chr4:44680433-44702696:+	-0.22	-3.73	0.000213	Body mass index	
PRAD	cis	1	rs10939738	chr4:17604295	MED28	chr4:17616273-17629791:+	0.22	5.48	6.98E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10939740	chr4:17617490	MED28	chr4:17616273-17629791:+	0.21	5.3	1.75E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10939742	chr4:17659936	MED28	chr4:17616273-17629791:+	0.19	4.73	3.0E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10939743	chr4:17662731	MED28	chr4:17616273-17629791:+	0.2	4.97	9.21E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10939744	chr4:17664473	MED28	chr4:17616273-17629791:+	0.19	4.73	2.95E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10939746	chr4:17684951	MED28	chr4:17616273-17629791:+	-0.17	-4.24	2.72E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10939747	chr4:17691166	MED28	chr4:17616273-17629791:+	0.19	4.87	1.51E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10939748	chr4:17691230	MED28	chr4:17616273-17629791:+	0.19	4.87	1.51E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10939749	chr4:17692319	MED28	chr4:17616273-17629791:+	0.17	4.42	1.23E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10939750	chr4:17692422	MED28	chr4:17616273-17629791:+	0.17	4.39	1.41E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10939756	chr4:17693867	MED28	chr4:17616273-17629791:+	0.18	4.44	1.13E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.49	-11.05	2.17E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.52	-11.51	3.6E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.49	-11.28	2.82E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.48	-10.92	7.02E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs10945581	chr6:159376252	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs10945682	chr6:161069941	LPA	chr6:160952516-161087407:-	0.2	4.34	1.72E-5	Lipoprotein (a) levels	
PRAD	cis	1	rs10945683	chr6:161069952	LPA	chr6:160952516-161087407:-	0.15	3.51	0.000488	Lipoprotein (a) levels	
PRAD	cis	1	rs10946198	chr6:167404432	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.28E-8	Crohn's disease	
PRAD	cis	1	rs10946199	chr6:167404492	RNASET2	chr6:167343008-167412795:-	-0.23	-5.6	3.69E-8	Crohn's disease	
PRAD	cis	1	rs1094677	chr3:195129744	C3orf21	chr3:194789015-194991895:-	-0.31	-6.38	4.31E-10	Body mass index	
PRAD	cis	1	rs10946834	chr6:26533664	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs10946834	chr6:26533664	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs10946835	chr6:26533757	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs10946835	chr6:26533757	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs10950032	chr7:65738591	CCT6P1	chr7:65216092-65228661:+	-0.33	-5.52	5.68E-8	Diabetic kidney disease	
PRAD	cis	1	rs10950032	chr7:65738591	CRCP	chr7:65579805-65619551:+	0.35	4.28	2.31E-5	Diabetic kidney disease	
PRAD	cis	1	rs10950973	chr7:23917277	C7orf46	chr7:23719749-23742268:+	0.22	5.58	4.01E-8	Schizophrenia	
PRAD	cis	1	rs10950974	chr7:23917280	C7orf46	chr7:23719749-23742268:+	0.22	5.58	4.01E-8	Schizophrenia	
PRAD	cis	1	rs10950975	chr7:23917480	C7orf46	chr7:23719749-23742268:+	0.22	5.62	3.27E-8	Schizophrenia	
PRAD	cis	1	rs10955931	chr8:120556054	NOV	chr8:120428552-120436678:+	0.18	3.45	0.000613	Smoking cessation	
PRAD	cis	1	rs10955934	chr8:120676929	DSCC1	chr8:120846182-120868170:-	-0.28	-4.24	2.71E-5	Height	
PRAD	cis	1	rs10955943	chr8:120944143	DSCC1	chr8:120846182-120868170:-	-0.32	-7.51	2.91E-13	Interstitial lung disease	
PRAD	cis	1	rs10957322	chr8:65670364	BHLHE22	chr8:65492814-65496185:+	0.32	5.85	9.13E-9	HIV-1 susceptibility	
PRAD	cis	1	rs10957323	chr8:65680494	BHLHE22	chr8:65492814-65496185:+	0.28	5.33	1.57E-7	HIV-1 susceptibility	
PRAD	cis	1	rs10957375	chr8:67355484	C8orf46	chr8:67405491-67430757:+	-0.29	-4.73	2.93E-6	Blood metabolite levels	
PRAD	cis	1	rs10962071	chr9:1565678	DMRT3	chr9:976964-991732:+	0.38	4.14	4.05E-5	Superior frontal gyrus grey matter volume	
PRAD	cis	1	rs10962085	chr9:1567202	DMRT3	chr9:976964-991732:+	0.36	3.84	0.00014	Superior frontal gyrus grey matter volume	
PRAD	cis	1	rs10966	chr20:25282944	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.27	2.37E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10966	chr20:25282944	FAM182B	chr20:25744102-25848786:-	0.39	7.15	3.42E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10966	chr20:25282944	PYGB	chr20:25228706-25278647:+	-0.32	-7.03	7.13E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs10980620	chr9:113655288	PTGR1	chr9:114312003-114362135:-	-0.26	-4.07	5.42E-5	Corneal structure	
PRAD	cis	1	rs10980623	chr9:113660537	PTGR1	chr9:114312003-114362135:-	-0.26	-4.07	5.46E-5	Corneal structure	
PRAD	cis	1	rs10980624	chr9:113661528	PTGR1	chr9:114312003-114362135:-	-0.26	-4.07	5.46E-5	Corneal structure	
PRAD	cis	1	rs10980628	chr9:113671403	PTGR1	chr9:114312003-114362135:-	-0.25	-3.86	0.000131	Corneal structure	
PRAD	cis	1	rs10982256	chr9:117260834	DFNB31	chr9:117164361-117267730:-	0.22	4.51	8.19E-6	Bipolar disorder	
PRAD	cis	1	rs10982288	chr9:117314379	C9orf91	chr9:117373706-117408696:+	0.16	3.54	0.000433	Bone mineral density (spine) and age at menarche	
PRAD	cis	1	rs10984361	chr9:100681490	C9orf156	chr9:100666772-100684852:-	-0.19	-3.75	0.000202	Quantitative traits	
PRAD	cis	1	rs10984506	chr9:100716140	C9orf156	chr9:100666772-100684852:-	-0.19	-3.62	0.000327	Quantitative traits	
PRAD	cis	1	rs10985090	chr9:123677980	GSN	chr9:123963761-124095120:+	-0.14	-3.6	0.000348	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs10985500	chr9:100984191	TBC1D2	chr9:100961281-101018003:-	0.24	4.47	9.8E-6	Post-traumatic stress disorder	
PRAD	cis	1	rs10988125	chr9:131572903	C9orf114	chr9:131584346-131592085:-	0.24	5.93	5.71E-9	Blood metabolite levels	
PRAD	cis	1	rs10988125	chr9:131572903	ENDOG	chr9:131580779-131584954:+	0.34	9.61	4.42E-20	Blood metabolite levels	
PRAD	cis	1	rs10988214	chr9:131883752	CRAT	chr9:131857075-131873070:-	0.22	4.12	4.55E-5	Blood metabolite ratios	
PRAD	cis	1	rs10988223	chr9:131903021	CRAT	chr9:131857075-131873070:-	0.24	4.4	1.32E-5	Blood metabolite ratios	
PRAD	cis	1	rs10988224	chr9:131903334	CRAT	chr9:131857075-131873070:-	0.23	4.21	3.02E-5	Blood metabolite ratios	
PRAD	cis	1	rs10988232	chr9:131915348	CRAT	chr9:131857075-131873070:-	0.22	4.04	6.21E-5	Blood metabolite ratios	
PRAD	cis	1	rs10992221	chr9:94832043	NFIL3	chr9:94171329-94186144:-	0.22	3.66	0.000286	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs1099860	chr13:30883168	KATNAL1	chr13:30776768-30881584:-	0.18	3.72	0.000222	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs10999925	chr10:73396567	CHST3	chr10:73724120-73773321:+	-0.13	-4.32	1.92E-5	Selective IgA deficiency	
PRAD	cis	1	rs10999925	chr10:73396567	DDIT4	chr10:74033677-74035797:+	-0.23	-3.5	0.000502	Selective IgA deficiency	
PRAD	cis	1	rs1100046	chr7:102549295	PRKRIP1	chr7:102004341-102067129:+	0.13	3.63	0.000318	Morning vs. evening chronotype	
PRAD	cis	1	rs11006923	chr10:28504944	MPP7	chr10:28339923-28591995:-	-0.33	-3.89	0.000114	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs11020836	chr11:94308892	MRE11A	chr11:94150469-94227040:-	-0.12	-3.59	0.000362	Attention deficit hyperactivity disorder symptoms (interaction)	
PRAD	cis	1	rs11020840	chr11:94313514	MRE11A	chr11:94150469-94227040:-	-0.14	-4.13	4.35E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
PRAD	cis	1	rs11020847	chr11:94323912	MRE11A	chr11:94150469-94227040:-	0.16	4.5	8.77E-6	Attention deficit hyperactivity disorder symptoms (interaction)	
PRAD	cis	1	rs11024101	chr11:17005544	NUCB2	chr11:17281887-17371521:+	0.27	4.14	4.05E-5	Glaucoma (primary angle closure)	
PRAD	cis	1	rs11024102	chr11:17008605	NUCB2	chr11:17281887-17371521:+	0.26	4	7.38E-5	Glaucoma (primary angle closure)	
PRAD	cis	1	rs11024739	chr11:18645843	SPTY2D1	chr11:18627949-18656020:-	0.29	10.68	5.32E-24	Cholesterol, total	
PRAD	cis	1	rs11026091	chr11:3259809	MRGPRE	chr11:3249042-3253616:-	-0.16	-3.71	0.000231	Multiple sclerosis	
PRAD	cis	1	rs11026412	chr11:22114093	ANO5	chr11:22214722-22304913:+	0.22	5.34	1.44E-7	Parkinson's disease	
PRAD	cis	1	rs11026416	chr11:22125058	ANO5	chr11:22214722-22304913:+	0.24	5.77	1.44E-8	Parkinson's disease	
PRAD	cis	1	rs11026804	chr11:22841582	SVIP	chr11:22843600-22851382:-	0.28	6.64	8.85E-11	Dialysis-related mortality	
PRAD	cis	1	rs11037472	chr11:43575766	HSD17B12	chr11:43702143-43878160:+	-0.36	-3.89	0.000114	Birth length	
PRAD	cis	1	rs11037473	chr11:43576067	HSD17B12	chr11:43702143-43878160:+	0.33	3.73	0.000218	Birth length	
PRAD	cis	1	rs11037993	chr11:5557197	UBQLNL	chr11:5535624-5537956:-	-0.17	-3.45	0.000609	QRS duration in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs11038897	chr11:46470827	HARBI1	chr11:46624857-46638777:-	0.25	3.58	0.000378	Schizophrenia	
PRAD	cis	1	rs11038914	chr11:46561301	HARBI1	chr11:46624857-46638777:-	-0.25	-3.54	0.000436	Schizophrenia	
PRAD	cis	1	rs11039015	chr11:46897865	ARHGAP1	chr11:46698634-46722120:-	0.29	4.26	2.44E-5	Schizophrenia	
PRAD	cis	1	rs11039255	chr11:47495746	C1QTNF4	chr11:47611216-47615961:-	-0.17	-4.24	2.72E-5	Subjective well-being	
PRAD	cis	1	rs11039777	chr11:48517049	FOLH1	chr11:49168188-49230222:-	-0.16	-3.66	0.000279	HDL cholesterol	
PRAD	cis	1	rs11039779	chr11:48517895	FOLH1	chr11:49168188-49230222:-	-0.16	-3.66	0.000279	HDL cholesterol	
PRAD	cis	1	rs11039817	chr11:48561480	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000333	HDL cholesterol	
PRAD	cis	1	rs11039819	chr11:48562181	FOLH1	chr11:49168188-49230222:-	-0.16	-3.7	0.000244	HDL cholesterol	
PRAD	cis	1	rs11039820	chr11:48562252	FOLH1	chr11:49168188-49230222:-	-0.15	-3.46	0.000588	HDL cholesterol	
PRAD	cis	1	rs11039821	chr11:48562875	FOLH1	chr11:49168188-49230222:-	-0.16	-3.65	0.000288	HDL cholesterol	
PRAD	cis	1	rs11039851	chr11:48600839	FOLH1	chr11:49168188-49230222:-	-0.16	-3.65	0.00029	HDL cholesterol	
PRAD	cis	1	rs11039854	chr11:48607688	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000344	HDL cholesterol	
PRAD	cis	1	rs11039857	chr11:48610853	FOLH1	chr11:49168188-49230222:-	-0.15	-3.48	0.000547	HDL cholesterol	
PRAD	cis	1	rs11039859	chr11:48611988	FOLH1	chr11:49168188-49230222:-	-0.15	-3.48	0.000547	HDL cholesterol	
PRAD	cis	1	rs11039862	chr11:48618306	FOLH1	chr11:49168188-49230222:-	-0.16	-3.59	0.000362	HDL cholesterol	
PRAD	cis	1	rs11039868	chr11:48622146	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000344	HDL cholesterol	
PRAD	cis	1	rs11039871	chr11:48626620	FOLH1	chr11:49168188-49230222:-	0.15	3.49	0.000533	HDL cholesterol	
PRAD	cis	1	rs11039890	chr11:48653468	FOLH1	chr11:49168188-49230222:-	-0.17	-3.97	8.42E-5	HDL cholesterol	
PRAD	cis	1	rs11040871	chr11:6376679	PRKCDBP	chr11:6340176-6341740:-	0.26	6.04	3.2E-9	Diisocyanate-induced asthma	
PRAD	cis	1	rs11040899	chr11:6520015	RRP8	chr11:6621154-6624811:-	0.14	3.49	0.000524	DNA methylation (variation)	
PRAD	cis	1	rs11043143	chr11:2234093	ASCL2	chr11:2289729-2292182:-	-0.44	-7.92	1.69E-14	Prostate cancer (early onset);Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs11045891	chr12:21392572	SLCO1A2	chr12:21417535-21548371:-	0.23	3.44	0.000644	Blood metabolite levels	
PRAD	cis	1	rs11045892	chr12:21392794	SLCO1A2	chr12:21417535-21548371:-	0.23	3.51	0.000485	Blood metabolite levels	
PRAD	cis	1	rs11045897	chr12:21394544	SLCO1A2	chr12:21417535-21548371:-	0.23	3.44	0.000644	Blood metabolite levels	
PRAD	cis	1	rs1104918	chr15:88723712	NTRK3	chr15:88419988-88799661:-	0.19	4.07	5.45E-5	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
PRAD	cis	1	rs11057399	chr12:124425078	ZNF664	chr12:124457670-124499967:+	-0.15	-3.82	0.000149	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs11057860	chr12:125333980	FAM101A	chr12:124773710-124800568:+	-0.38	-3.48	0.000539	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	
PRAD	cis	1	rs11057861	chr12:125334318	FAM101A	chr12:124773710-124800568:+	-0.38	-3.48	0.000539	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	
PRAD	cis	1	rs11057864	chr12:125335950	FAM101A	chr12:124773710-124800568:+	0.39	3.74	0.000205	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	
PRAD	cis	1	rs11059384	chr12:123170301	GPR109B	chr12:123199304-123201439:-	0.36	6.18	1.37E-9	Adiponectin levels	
PRAD	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.67	10.17	4.29E-22	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs11063799	chr12:5766512	ANO2	chr12:5671817-6055398:-	0.34	6.67	7.4E-11	Plasma clusterin levels	
PRAD	cis	1	rs11064210	chr12:6576721	TAPBPL	chr12:6561177-6575601:+	-0.3	-4.63	4.84E-6	Hip geometry	
PRAD	cis	1	rs11064218	chr12:6586261	TAPBPL	chr12:6561177-6575601:+	-0.28	-4.35	1.67E-5	Hip geometry	
PRAD	cis	1	rs11064768	chr12:119818509	CCDC60	chr12:119772517-119978851:+	0.34	3.51	0.000496	Schizophrenia	
PRAD	cis	1	rs11064881	chr12:120146925	PRKAB1	chr12:120105757-120119428:+	-1.11	-11.53	2.88E-27	Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs1106565	chr10:102211613	SEC31B	chr10:102246403-102289636:-	-0.32	-9.55	7.18E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11067231	chr12:109993603	KCTD10	chr12:109886460-109915155:-	-0.33	-9.95	2.68E-21	HDL cholesterol	
PRAD	cis	1	rs11067231	chr12:109993603	MMAB	chr12:109991523-110011358:-	-0.18	-5.42	9.75E-8	HDL cholesterol	
PRAD	cis	1	rs11067231	chr12:109993603	MYO1H	chr12:109826524-109886176:+	-0.24	-5.34	1.46E-7	HDL cholesterol	
PRAD	cis	1	rs11067231	chr12:109993603	UBE3B	chr12:109915439-109974506:+	-0.14	-3.54	0.000438	HDL cholesterol	
PRAD	cis	1	rs11068224	chr12:117324967	FBXW8	chr12:117348761-117470180:+	-0.54	-6.03	3.41E-9	Subcortical brain region volumes	
PRAD	cis	1	rs11070798	chr15:50883263	SPPL2A	chr15:50999739-51057910:-	0.27	5.55	4.88E-8	QT interval	
PRAD	cis	1	rs11070800	chr15:50907347	SPPL2A	chr15:50999739-51057910:-	0.26	5.38	1.2E-7	QT interval	
PRAD	cis	1	rs11070805	chr15:50964192	SPPL2A	chr15:50999739-51057910:-	0.27	5.46	7.86E-8	QT interval	
PRAD	cis	1	rs11070807	chr15:50974505	SPPL2A	chr15:50999739-51057910:-	0.28	5.59	3.89E-8	QT interval	
PRAD	cis	1	rs11070907	chr15:52924231	ARPP19	chr15:52839432-52861364:-	0.16	4.22	2.95E-5	Schizophrenia	
PRAD	cis	1	rs11070909	chr15:52931601	ARPP19	chr15:52839432-52861364:-	0.15	4.01	7.17E-5	Schizophrenia	
PRAD	cis	1	rs11072113	chr15:70018281	C15orf50	chr15:70127573-70135305:+	0.21	3.57	0.000389	Chronic lymphocytic leukemia	
PRAD	cis	1	rs11072603	chr15:76881138	SCAPER	chr15:76640529-77197744:-	-0.13	-3.85	0.000132	Blood metabolite levels	
PRAD	cis	1	rs11072804	chr15:79078486	CHRNA3	chr15:78885397-78913322:-	-0.2	-3.62	0.000329	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11072805	chr15:79078518	CHRNA3	chr15:78885397-78913322:-	-0.2	-3.64	0.000302	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs1107328	chr9:131917534	CRAT	chr9:131857075-131873070:-	-0.22	-4	7.42E-5	Blood metabolite ratios	
PRAD	cis	1	rs11073619	chr15:85188839	WDR73	chr15:85186012-85197524:-	0.3	4.04	6.13E-5	Positive affect	
PRAD	cis	1	rs11073619	chr15:85188839	ZNF592	chr15:85291818-85349661:+	-0.25	-3.46	0.00059	Positive affect	
PRAD	cis	1	rs11076105	chr16:55614197	CAPNS2	chr16:55600584-55601592:+	0.18	5.06	6.02E-7	Thyroid hormone levels	
PRAD	cis	1	rs11076105	chr16:55614197	LPCAT2	chr16:55542913-55620581:+	-0.14	-5.06	6.1E-7	Thyroid hormone levels	
PRAD	cis	1	rs11076106	chr16:55614447	CAPNS2	chr16:55600584-55601592:+	0.18	5.14	3.94E-7	Thyroid hormone levels	
PRAD	cis	1	rs11076106	chr16:55614447	LPCAT2	chr16:55542913-55620581:+	-0.15	-5.16	3.67E-7	Thyroid hormone levels	
PRAD	cis	1	rs1107767	chr16:68020063	C16orf86	chr16:67700717-67702659:+	-0.31	-4.08	5.32E-5	Crohn's disease	
PRAD	cis	1	rs11079034	chr17:40288890	DHX58	chr17:40253422-40264751:-	-0.34	-7.42	5.39E-13	Fibrinogen levels	
PRAD	cis	1	rs11079034	chr17:40288890	HSPB9	chr17:40274756-40275371:+	0.28	4.94	1.1E-6	Fibrinogen levels	
PRAD	cis	1	rs11079508	chr17:61750066	CD79B	chr17:62006098-62009704:-	0.12	3.51	0.000496	Body mass index	
PRAD	cis	1	rs11079508	chr17:61750066	DDX42	chr17:61851567-61896676:+	-0.25	-5.18	3.28E-7	Body mass index	
PRAD	cis	1	rs11079508	chr17:61750066	FTSJ3	chr17:61896795-61905031:-	0.34	6.81	3.06E-11	Body mass index	
PRAD	cis	1	rs11079508	chr17:61750066	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.56E-6	Body mass index	
PRAD	cis	1	rs11079509	chr17:61762148	DDX42	chr17:61851567-61896676:+	-0.28	-5.36	1.32E-7	Body mass index	
PRAD	cis	1	rs11079509	chr17:61762148	FTSJ3	chr17:61896795-61905031:-	0.35	6.45	2.84E-10	Body mass index	
PRAD	cis	1	rs11079509	chr17:61762148	TCAM1P	chr17:61934376-61941738:+	-0.22	-3.75	0.000196	Body mass index	
PRAD	cis	1	rs11079511	chr17:61858537	DDX42	chr17:61851567-61896676:+	-0.28	-5.75	1.63E-8	Body mass index	
PRAD	cis	1	rs11079511	chr17:61858537	FTSJ3	chr17:61896795-61905031:-	0.35	6.78	3.6E-11	Body mass index	
PRAD	cis	1	rs11079511	chr17:61858537	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.22	2.95E-5	Body mass index	
PRAD	cis	1	rs11079706	chr17:65835470	LOC651250	chr17:66097696-66157623:+	-0.24	-4.24	2.67E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs11079707	chr17:65835617	LOC651250	chr17:66097696-66157623:+	0.23	4.05	5.93E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs11080114	chr17:28407287	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.07	5.6E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs11083475	chr19:39188112	LGALS7	chr19:39261608-39264157:-	-0.17	-3.94	9.2E-5	Heart rate	
PRAD	cis	1	rs11084084	chr19:52030156	ZNF175	chr19:52074531-52092990:+	-0.32	-5.09	5.19E-7	Carotid intima media thickness	
PRAD	cis	1	rs11084085	chr19:52030384	ZNF175	chr19:52074531-52092990:+	-0.34	-4.62	5.04E-6	Carotid intima media thickness	
PRAD	cis	1	rs11084085	chr19:52030384	ZNF766	chr19:52772824-52795977:+	-0.37	-3.64	0.000307	Carotid intima media thickness	
PRAD	cis	1	rs1108431	chr16:31054607	HSD3B7	chr16:30996519-31000473:+	0.45	9.41	2.25E-19	Response to metformin (IC50)	
PRAD	cis	1	rs1108431	chr16:31054607	MYST1	chr16:31128985-31142713:+	0.19	5.68	2.31E-8	Response to metformin (IC50)	
PRAD	cis	1	rs1108431	chr16:31054607	PRSS36	chr16:31150251-31161415:-	0.18	4.58	5.91E-6	Response to metformin (IC50)	
PRAD	cis	1	rs1108431	chr16:31054607	PRSS53	chr16:31094747-31106276:-	-0.19	-3.76	0.00019	Response to metformin (IC50)	
PRAD	cis	1	rs1108431	chr16:31054607	STX1B	chr16:31000577-31021829:-	0.21	5.21	2.79E-7	Response to metformin (IC50)	
PRAD	cis	1	rs11084785	chr19:35282054	ZNF181	chr19:35225151-35233774:+	-0.32	-7.09	5.09E-12	Urate levels (BMI interaction)	
PRAD	cis	1	rs11084786	chr19:35282181	ZNF181	chr19:35225151-35233774:+	-0.33	-7.19	2.56E-12	Urate levels (BMI interaction)	
PRAD	cis	1	rs11086102	chr19:18398628	KIAA1683	chr19:18367906-18385319:-	-0.22	-5	8.08E-7	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs11087520	chr20:25436827	ENTPD6	chr20:25176339-25207360:+	-0.17	-4.37	1.52E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs11087520	chr20:25436827	FAM182B	chr20:25744102-25848786:-	0.38	7.05	6.61E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs11087520	chr20:25436827	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.78E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs11087521	chr20:25440648	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.2	3.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs11087521	chr20:25440648	FAM182B	chr20:25744102-25848786:-	0.39	7.14	3.51E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs11087521	chr20:25440648	PYGB	chr20:25228706-25278647:+	-0.32	-6.97	1.07E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs11088226	chr21:33925531	TCP10L	chr21:33947152-33957845:-	-0.31	-4.94	1.11E-6	Gastritis	
PRAD	cis	1	rs1109227	chr3:48479207	ATRIP	chr3:48488141-48507708:+	0.27	6.48	2.38E-10	Longevity	
PRAD	cis	1	rs1109227	chr3:48479207	CDC25A	chr3:48198668-48229801:-	0.22	4	7.39E-5	Longevity	
PRAD	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.19	-5.12	4.36E-7	Longevity	
PRAD	cis	1	rs1109501	chr4:71329490	AMTN	chr4:71384298-71398459:+	0.41	7.85	2.84E-14	Alcoholism (heaviness of drinking)	
PRAD	cis	1	rs11096982	chr4:39134867	KLHL5	chr4:39046659-39123828:+	-0.13	-3.74	0.000204	Uric acid levels	
PRAD	cis	1	rs11097431	chr4:95506842	BMPR1B	chr4:95679128-96079592:+	0.24	4.4	1.32E-5	Response to simvastatin treatment (PCSK9 protein level change)	
PRAD	cis	1	rs11097901	chr4:106729933	INTS12	chr4:106603787-106629881:-	-0.81	-8.12	4.26E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11097912	chr4:107000462	TBCK	chr4:106967233-107237861:-	0.17	3.66	0.000282	Airflow obstruction	
PRAD	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.66	10.11	7.14E-22	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs11100712	chr4:142160229	ZNF330	chr4:142142049-142155848:+	-0.27	-4.94	1.11E-6	Conduct disorder	
PRAD	cis	1	rs11100713	chr4:142163347	ZNF330	chr4:142142049-142155848:+	-0.29	-5.26	2.14E-7	Conduct disorder	
PRAD	cis	1	rs11100	chr20:25281184	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.17	3.67E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs11100	chr20:25281184	FAM182B	chr20:25744102-25848786:-	0.37	6.77	3.78E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs11100	chr20:25281184	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs11105306	chr12:89897388	POC1B	chr12:89813501-89919777:-	-0.19	-4.09	5.04E-5	NT-proBNP levels in acute coronary syndrome	
PRAD	cis	1	rs11116702	chr12:85483398	LRRIQ1	chr12:85430099-85638880:+	-0.21	-3.6	0.000357	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116702	chr12:85483398	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.04	6.63E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116702	chr12:85483398	TSPAN19	chr12:85408095-85430055:-	-0.3	-5.37	1.25E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116708	chr12:85495873	LRRIQ1	chr12:85430099-85638880:+	-0.26	-4.41	1.27E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116708	chr12:85495873	SLC6A15	chr12:85253269-85306606:-	-0.31	-4.68	3.69E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116708	chr12:85495873	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.65	2.83E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116712	chr12:85499480	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.23	2.82E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116712	chr12:85499480	SLC6A15	chr12:85253269-85306606:-	-0.31	-4.79	2.23E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116712	chr12:85499480	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.69	2.27E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116715	chr12:85507438	LRRIQ1	chr12:85430099-85638880:+	-0.23	-3.92	0.0001	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116715	chr12:85507438	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.96	1.01E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116715	chr12:85507438	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.47	7.48E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116719	chr12:85522932	LRRIQ1	chr12:85430099-85638880:+	-0.23	-3.91	0.000104	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116719	chr12:85522932	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.94	1.09E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116719	chr12:85522932	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.48	6.99E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116720	chr12:85523025	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.32	1.9E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116720	chr12:85523025	SLC6A15	chr12:85253269-85306606:-	-0.31	-4.67	4.0E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116720	chr12:85523025	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.62	3.29E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116721	chr12:85523681	LRRIQ1	chr12:85430099-85638880:+	-0.23	-3.91	0.000104	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116721	chr12:85523681	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.94	1.09E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116721	chr12:85523681	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.48	6.99E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116723	chr12:85529415	LRRIQ1	chr12:85430099-85638880:+	-0.24	-3.94	9.29E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116723	chr12:85529415	SLC6A15	chr12:85253269-85306606:-	-0.32	-4.8	2.09E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116723	chr12:85529415	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.5	6.19E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116726	chr12:85535406	LRRIQ1	chr12:85430099-85638880:+	-0.24	-3.98	8.02E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116726	chr12:85535406	SLC6A15	chr12:85253269-85306606:-	-0.32	-4.83	1.81E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11116726	chr12:85535406	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.54	5.14E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11120733	chr1:207506649	CD55	chr1:207494817-207534309:+	0.25	4.36	1.6E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs1112137	chr1:247215375	ZNF670	chr1:247200087-247242069:-	-0.33	-7.33	1.01E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.86	-17.03	5.1E-51	Renal function-related traits (BUN)	
PRAD	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.81	-14.02	1.45E-37	Renal function-related traits (BUN)	
PRAD	cis	1	rs11123906	chr2:102701713	MFSD9	chr2:103333666-103353337:-	0.16	3.82	0.000153	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs1112444	chr6:160835192	SLC22A2	chr6:160592093-160679959:-	-0.2	-3.66	0.000285	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs11124575	chr2:37500435	CEBPZ	chr2:37428778-37458740:-	-0.19	-4.11	4.61E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs111248783	chr4:106770998	INTS12	chr4:106603787-106629881:-	-0.72	-7.05	6.48E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs111252524	chr2:203199188	NOP58	chr2:203130515-203168382:+	0.28	4.41	1.26E-5	Urate levels	
PRAD	cis	1	rs11125529	chr2:54475866	C2orf73	chr2:54558071-54588714:+	-0.3	-3.97	8.18E-5	Telomere length	
PRAD	cis	1	rs11126364	chr2:26314515	GPR113	chr2:26531041-26569685:-	-0.24	-3.52	0.000476	Gut microbiome composition (summer)	
PRAD	cis	1	rs11126375	chr2:26344787	GPR113	chr2:26531041-26569685:-	-0.25	-3.76	0.000189	Gut microbiome composition (summer)	
PRAD	cis	1	rs11127188	chr2:28972852	PPP1CB	chr2:28974612-29025805:+	0.27	5.82	1.1E-8	Body mass index	
PRAD	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.39	-8.25	1.56E-15	Body mass index	
PRAD	cis	1	rs111295372	chr2:86283357	LOC90784	chr2:86247339-86250991:-	-0.56	-4.81	2.08E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs11130127	chr3:47398793	C3orf75	chr3:47537131-47555199:-	0.16	4.89	1.39E-6	Colorectal cancer	
PRAD	cis	1	rs11130127	chr3:47398793	NBEAL2	chr3:47021173-47051193:+	0.15	4.81	2.02E-6	Colorectal cancer	
PRAD	cis	1	rs11130170	chr3:48449897	ATRIP	chr3:48488141-48507708:+	0.27	6.41	3.63E-10	Longevity	
PRAD	cis	1	rs11130170	chr3:48449897	CDC25A	chr3:48198668-48229801:-	0.21	3.98	8.08E-5	Longevity	
PRAD	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.18	-5.07	5.6E-7	Longevity	
PRAD	cis	1	rs11130171	chr3:48462461	ATRIP	chr3:48488141-48507708:+	0.27	6.64	8.79E-11	Longevity	
PRAD	cis	1	rs11130171	chr3:48462461	CDC25A	chr3:48198668-48229801:-	0.22	4.1	4.96E-5	Longevity	
PRAD	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.17	-4.81	2.04E-6	Longevity	
PRAD	cis	1	rs11130189	chr3:49347357	AMIGO3	chr3:49754268-49757238:-	-0.44	-8.69	6.13E-17	Menarche (age at onset)	
PRAD	cis	1	rs11130189	chr3:49347357	CCDC36	chr3:49235861-49295537:+	0.24	4.24	2.64E-5	Menarche (age at onset)	
PRAD	cis	1	rs11130189	chr3:49347357	GMPPB	chr3:49758932-49761384:-	-0.5	-11.86	1.46E-28	Menarche (age at onset)	
PRAD	cis	1	rs11130189	chr3:49347357	NCKIPSD	chr3:48711280-48723334:-	0.3	5.77	1.44E-8	Menarche (age at onset)	
PRAD	cis	1	rs11130189	chr3:49347357	P4HTM	chr3:49027341-49044579:+	0.16	3.5	0.000507	Menarche (age at onset)	
PRAD	cis	1	rs11130189	chr3:49347357	WDR6	chr3:49044637-49053386:+	-0.21	-4.15	3.88E-5	Menarche (age at onset)	
PRAD	cis	1	rs11130190	chr3:49402137	AMIGO3	chr3:49754268-49757238:-	-0.43	-8.79	2.93E-17	Menarche (age at onset)	
PRAD	cis	1	rs11130190	chr3:49402137	CCDC36	chr3:49235861-49295537:+	0.23	4.18	3.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs11130190	chr3:49402137	GMPPB	chr3:49758932-49761384:-	-0.48	-11.64	1.05E-27	Menarche (age at onset)	
PRAD	cis	1	rs11130190	chr3:49402137	NCKIPSD	chr3:48711280-48723334:-	0.31	6.09	2.34E-9	Menarche (age at onset)	
PRAD	cis	1	rs11130190	chr3:49402137	P4HTM	chr3:49027341-49044579:+	0.16	3.67	0.000275	Menarche (age at onset)	
PRAD	cis	1	rs11130190	chr3:49402137	WDR6	chr3:49044637-49053386:+	-0.19	-3.83	0.000146	Menarche (age at onset)	
PRAD	cis	1	rs11130213	chr3:49712297	GMPPB	chr3:49758932-49761384:-	-0.21	-4.52	7.79E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs11130213	chr3:49712297	MST1	chr3:49721381-49726196:-	0.1	3.47	0.000579	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs11130213	chr3:49712297	RBM6	chr3:49977592-50137484:+	0.11	3.44	0.000639	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs11130214	chr3:49735746	AMIGO3	chr3:49754268-49757238:-	0.22	4.37	1.53E-5	Resting heart rate	
PRAD	cis	1	rs11130214	chr3:49735746	CACNA2D2	chr3:50400233-50540892:-	0.21	4.46	1.02E-5	Resting heart rate	
PRAD	cis	1	rs11130214	chr3:49735746	GMPPB	chr3:49758932-49761384:-	0.22	5.07	5.62E-7	Resting heart rate	
PRAD	cis	1	rs11130214	chr3:49735746	RBM6	chr3:49977592-50137484:+	0.16	5.28	1.96E-7	Resting heart rate	
PRAD	cis	1	rs11130214	chr3:49735746	WDR6	chr3:49044637-49053386:+	0.2	4.23	2.81E-5	Resting heart rate	
PRAD	cis	1	rs11130216	chr3:49736172	AMIGO3	chr3:49754268-49757238:-	-0.22	-4.31	1.99E-5	Resting heart rate	
PRAD	cis	1	rs11130216	chr3:49736172	CACNA2D2	chr3:50400233-50540892:-	-0.22	-4.55	6.93E-6	Resting heart rate	
PRAD	cis	1	rs11130216	chr3:49736172	GMPPB	chr3:49758932-49761384:-	-0.23	-5.11	4.59E-7	Resting heart rate	
PRAD	cis	1	rs11130216	chr3:49736172	RBM6	chr3:49977592-50137484:+	-0.15	-5.13	4.17E-7	Resting heart rate	
PRAD	cis	1	rs11130216	chr3:49736172	WDR6	chr3:49044637-49053386:+	-0.21	-4.34	1.78E-5	Resting heart rate	
PRAD	cis	1	rs11130338	chr3:53120924	ITIH4	chr3:52847007-52866554:-	0.15	4.56	6.59E-6	Height	
PRAD	cis	1	rs111315781	chr2:201738724	CFLAR	chr2:201980816-202029001:+	-0.2	-4.52	7.93E-6	Triptolide cytotoxicity	
PRAD	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-1.04	-16.39	4.65E-48	Triptolide cytotoxicity	
PRAD	cis	1	rs11132254	chr4:185611592	CCDC111	chr4:185570767-185616112:+	0.16	3.68	0.000256	Kawasaki disease	
PRAD	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.46	-13.19	5.04E-34	Kawasaki disease	
PRAD	cis	1	rs11133399	chr4:56413831	TMEM165	chr4:56262090-56292342:+	0.17	3.5	0.000509	Personality dimensions	
PRAD	cis	1	rs111344533	chr16:4654144	NMRAL1	chr16:4511696-4526307:-	-0.3	-5.03	6.99E-7	Obesity-related traits	
PRAD	cis	1	rs11135910	chr8:25892142	EBF2	chr8:25701573-25902392:-	-0.51	-8.18	2.75E-15	Prostate cancer	
PRAD	cis	1	rs111392237	chr11:96122783	CCDC82	chr11:96085930-96123083:-	-0.24	-3.7	0.000246	Parkinson's disease	
PRAD	cis	1	rs111392584	chr3:10075991	C3orf10	chr3:10157333-10168873:+	-0.22	-4.17	3.66E-5	Alzheimer's disease	
PRAD	cis	1	rs111392584	chr3:10075991	LOC401052	chr3:10048102-10052779:-	-0.3	-5.26	2.22E-7	Alzheimer's disease	
PRAD	cis	1	rs1114380	chr2:73804708	ALMS1P	chr2:73872046-73912692:+	0.5	8.73	4.33E-17	Metabolite levels	
PRAD	cis	1	rs1114380	chr2:73804708	NAT8	chr2:73867850-73869537:-	0.26	4.05	5.89E-5	Metabolite levels	
PRAD	cis	1	rs11144880	chr9:79025675	RFK	chr9:79000433-79009444:-	0.2	3.79	0.000168	Dialysis-related mortality	
PRAD	cis	1	rs11148252	chr13:53009048	CKAP2	chr13:53029495-53050763:+	-0.47	-9.87	5.09E-21	Lewy body disease	
PRAD	cis	1	rs11148252	chr13:53009048	NEK3	chr13:52706780-52733996:-	0.29	5.52	5.69E-8	Lewy body disease	
PRAD	cis	1	rs11149710	chr16:74472546	RFWD3	chr16:74655298-74700779:-	0.21	4.95	1.04E-6	Breast cancer	
PRAD	cis	1	rs11150589	chr16:30482494	LOC595101	chr16:30278914-30346695:-	0.29	5.51	6.02E-8	Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs111542497	chr2:203195092	NOP58	chr2:203130515-203168382:+	0.22	3.92	0.000103	Urate levels	
PRAD	cis	1	rs111558493	chr8:13073005	LONRF1	chr8:12579406-12612992:-	0.28	3.71	0.000234	Emphysema imaging phenotypes	
PRAD	cis	1	rs11156875	chr14:35619816	BRMS1L	chr14:36295597-36341168:+	0.18	3.46	0.000582	Atopic dermatitis	
PRAD	cis	1	rs11156875	chr14:35619816	PPP2R3C	chr14:35554679-35591679:-	0.37	6	3.84E-9	Atopic dermatitis	
PRAD	cis	1	rs11157696	chr14:50105746	PPIL5	chr14:50065415-50081389:+	0.21	3.63	0.000312	Carotid intima media thickness	
PRAD	cis	1	rs11157696	chr14:50105746	RPL36AL	chr14:50085407-50087349:-	-0.44	-12.74	3.85E-32	Carotid intima media thickness	
PRAD	cis	1	rs11158293	chr14:61109020	C14orf39	chr14:60902675-60952764:-	0.58	6.59	1.18E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs11158293	chr14:61109020	SIX6	chr14:60975938-60978523:+	0.31	3.5	0.000507	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs11158559	chr14:65240949	CHURC1	chr14:65381140-65411309:+	0.18	3.44	0.000625	Obesity-related traits	
PRAD	cis	1	rs11158559	chr14:65240949	MTHFD1	chr14:64854759-64926727:+	-0.17	-3.71	0.000228	Obesity-related traits	
PRAD	cis	1	rs11159067	chr14:74637444	COQ6	chr14:74416643-74429811:+	0.2	3.66	0.00028	Common traits (Other)	
PRAD	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.44	11.71	5.81E-28	Common traits (Other)	
PRAD	cis	1	rs11159117	chr14:75584867	EIF2B2	chr14:75469612-75476292:+	0.25	4.96	9.71E-7	Height	
PRAD	cis	1	rs11159117	chr14:75584867	MLH3	chr14:75480467-75518235:-	0.32	6.52	1.87E-10	Height	
PRAD	cis	1	rs11159183	chr14:76662902	C14orf118	chr14:76618259-76669133:+	0.14	3.61	0.00034	Blood pressure	
PRAD	cis	1	rs11159183	chr14:76662902	ESRRB	chr14:76837690-76968178:+	0.26	3.66	0.000276	Blood pressure	
PRAD	cis	1	rs111596617	chr6:26191678	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.72	0.000223	Renal underexcretion gout;Gout	
PRAD	cis	1	rs111596617	chr6:26191678	HIST1H3E	chr6:26224427-26226589:+	0.36	5.75	1.57E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs11159833	chr14:88476004	GPR65	chr14:88471496-88478414:+	0.15	3.46	0.000582	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs11159856	chr14:88883929	SPATA7	chr14:88852012-88904802:+	-0.21	-3.95	8.9E-5	Coronary artery calcification	
PRAD	cis	1	rs11161510	chr1:76210289	ACADM	chr1:76190043-76229353:+	-0.2	-4.29	2.19E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs11161511	chr1:76210477	ACADM	chr1:76190043-76229353:+	-0.17	-3.75	0.000197	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs11161515	chr1:76212559	ACADM	chr1:76190043-76229353:+	0.19	4	7.3E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs11161521	chr1:76216330	ACADM	chr1:76190043-76229353:+	0.19	4	7.3E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs11161820	chr1:86900760	CLCA2	chr1:86889769-86922238:+	0.3	5.32	1.62E-7	Crohn's disease-related phenotypes	
PRAD	cis	1	rs11163924	chr1:76132070	ACADM	chr1:76190043-76229353:+	-0.18	-4.03	6.54E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs111641740	chr20:33707177	MMP24	chr20:33814539-33864804:+	-0.25	-3.96	8.51E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11164654	chr1:92968312	EVI5	chr1:92974255-93257961:-	-0.31	-6.32	6.15E-10	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs111648355	chr2:48165909	GTF2A1L	chr2:48844948-48960284:+	-0.42	-4.23	2.78E-5	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs111648355	chr2:48165909	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.34	-3.94	9.52E-5	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs111649495	chr5:118356415	DTWD2	chr5:118172571-118324240:-	-0.23	-3.9	0.000112	Response to amphetamines	
PRAD	cis	1	rs11167254	chr20:33654584	MMP24	chr20:33814539-33864804:+	-0.22	-3.7	0.000243	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11167260	chr20:33775200	MMP24	chr20:33814539-33864804:+	-0.26	-3.66	0.000281	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11167515	chr5:150239471	C5orf62	chr5:150157867-150176297:+	0.31	3.81	0.000155	Crohn's disease	
PRAD	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.66	9.67	2.63E-20	Crohn's disease	
PRAD	cis	1	rs11167518	chr5:150258920	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs11167519	chr5:150265407	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs11167520	chr5:150265639	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs11167521	chr5:150271785	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs11167526	chr5:150332481	LOC134466	chr5:150310000-150326146:-	0.63	8.09	5.15E-15	Crohn's disease	
PRAD	cis	1	rs11167666	chr5:153641317	GALNT10	chr5:153570295-153799809:+	0.14	4.13	4.36E-5	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs11167667	chr5:153653945	GALNT10	chr5:153570295-153799809:+	-0.12	-3.59	0.000363	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs1116853	chr14:60917476	C14orf39	chr14:60902675-60952764:-	0.48	5.98	4.31E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1116854	chr14:60917496	C14orf39	chr14:60902675-60952764:-	-0.45	-5.97	4.56E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs11168936	chr12:49645240	TUBA1C	chr12:49621709-49667113:+	0.28	5.69	2.26E-8	Cancer (pleiotropy)	
PRAD	cis	1	rs111696803	chr9:100696636	C9orf156	chr9:100666772-100684852:-	-0.19	-3.68	0.000264	Quantitative traits	
PRAD	cis	1	rs11171803	chr12:56718422	MIP	chr12:56843885-56848429:-	0.77	5.69	2.28E-8	Psoriasis vulgaris	
PRAD	cis	1	rs11171806	chr12:56733531	MIP	chr12:56843885-56848429:-	-0.76	-5.67	2.46E-8	Psoriasis vulgaris	
PRAD	cis	1	rs11172086	chr12:57449206	TAC3	chr12:57403786-57410325:-	0.35	3.92	0.000101	Asthma	
PRAD	cis	1	rs11172254	chr12:57968738	BAZ2A	chr12:56989380-57030163:-	0.09	3.79	0.000172	Rheumatoid arthritis	
PRAD	cis	1	rs11172254	chr12:57968738	FAM119B	chr12:58166383-58176323:+	-0.21	-4.73	2.93E-6	Rheumatoid arthritis	
PRAD	cis	1	rs11172254	chr12:57968738	OS9	chr12:58087886-58115338:+	0.13	3.74	0.000208	Rheumatoid arthritis	
PRAD	cis	1	rs11172254	chr12:57968738	PIP4K2C	chr12:57984942-57997210:+	0.13	4.17	3.62E-5	Rheumatoid arthritis	
PRAD	cis	1	rs11172254	chr12:57968738	TSFM	chr12:58176536-58191367:+	0.25	6.07	2.63E-9	Rheumatoid arthritis	
PRAD	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.38	7.83	3.22E-14	Multiple sclerosis	
PRAD	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.56	-13.6	9.74E-36	Multiple sclerosis	
PRAD	cis	1	rs11172333	chr12:58170335	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-5.01	7.91E-7	Multiple sclerosis	
PRAD	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.38	7.85	2.93E-14	Multiple sclerosis	
PRAD	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.57	-13.79	1.47E-36	Multiple sclerosis	
PRAD	cis	1	rs11172335	chr12:58175201	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-5.02	7.32E-7	Multiple sclerosis	
PRAD	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.38	7.81	3.89E-14	Multiple sclerosis	
PRAD	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.57	-13.78	1.56E-36	Multiple sclerosis	
PRAD	cis	1	rs11172342	chr12:58187758	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-5.03	6.89E-7	Multiple sclerosis	
PRAD	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.38	7.81	3.89E-14	Multiple sclerosis	
PRAD	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.57	-13.78	1.56E-36	Multiple sclerosis	
PRAD	cis	1	rs11172343	chr12:58188157	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-5.03	6.89E-7	Multiple sclerosis	
PRAD	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.39	8.36	7.14E-16	Multiple sclerosis	
PRAD	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.54	-13.22	3.72E-34	Multiple sclerosis	
PRAD	cis	1	rs11172344	chr12:58193448	XRCC6BP1	chr12:58335445-58351051:+	-0.24	-4.83	1.84E-6	Multiple sclerosis	
PRAD	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.37	7.78	4.63E-14	Multiple sclerosis	
PRAD	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.56	-13.55	1.56E-35	Multiple sclerosis	
PRAD	cis	1	rs11172349	chr12:58212528	XRCC6BP1	chr12:58335445-58351051:+	-0.25	-4.88	1.49E-6	Multiple sclerosis	
PRAD	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.38	7.9	1.93E-14	Multiple sclerosis	
PRAD	cis	1	rs11172351	chr12:58213485	TSFM	chr12:58176536-58191367:+	-0.57	-13.63	6.96E-36	Multiple sclerosis	
PRAD	cis	1	rs11172351	chr12:58213485	XRCC6BP1	chr12:58335445-58351051:+	-0.25	-4.93	1.14E-6	Multiple sclerosis	
PRAD	cis	1	rs11172582	chr12:58772812	TSFM	chr12:58176536-58191367:+	-0.18	-3.59	0.00037	Obesity-related traits	
PRAD	cis	1	rs1117367	chr15:76872330	SCAPER	chr15:76640529-77197744:-	-0.13	-3.83	0.000148	Blood metabolite levels	
PRAD	cis	1	rs11174325	chr12:62503773	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs1117640	chr21:43625274	CBS	chr21:44473301-44496472:-	0.25	3.71	0.000234	Eating disorder in bipolar disorder	
PRAD	cis	1	rs11180559	chr12:75920285	GLIPR1L2	chr12:75784889-75825591:+	0.45	5.29	1.9E-7	Daytime sleep phenotypes	
PRAD	cis	1	rs11181308	chr12:42445259	GXYLT1	chr12:42475650-42538673:-	-0.15	-3.98	7.92E-5	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
PRAD	cis	1	rs11181328	chr12:42504679	GXYLT1	chr12:42475650-42538673:-	-0.15	-3.95	8.86E-5	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
PRAD	cis	1	rs11185804	chr10:91379093	FLJ37201	chr10:91451057-91457685:-	0.25	3.68	0.000263	Metabolic traits	
PRAD	cis	1	rs111873045	chr4:106639712	INTS12	chr4:106603787-106629881:-	-0.77	-7.7	8.23E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs111873081	chr16:24955577	SLC5A11	chr16:24857316-24922943:+	-0.45	-3.51	0.000498	Blood metabolite levels	
PRAD	cis	1	rs11188394	chr10:97365458	ENTPD1	chr10:97471536-97637022:+	0.13	3.88	0.000118	Blood metabolite levels	
PRAD	cis	1	rs11188394	chr10:97365458	TCTN3	chr10:97423154-97453900:-	0.21	3.99	7.57E-5	Blood metabolite levels	
PRAD	cis	1	rs11188396	chr10:97367510	ENTPD1	chr10:97471536-97637022:+	0.13	3.82	0.000151	Blood metabolite levels	
PRAD	cis	1	rs11188396	chr10:97367510	TCTN3	chr10:97423154-97453900:-	0.21	4.01	7.09E-5	Blood metabolite levels	
PRAD	cis	1	rs11188398	chr10:97369093	ENTPD1	chr10:97471536-97637022:+	0.13	3.81	0.000155	Blood metabolite levels	
PRAD	cis	1	rs11188398	chr10:97369093	TCTN3	chr10:97423154-97453900:-	0.21	4.03	6.57E-5	Blood metabolite levels	
PRAD	cis	1	rs11188400	chr10:97371327	ENTPD1	chr10:97471536-97637022:+	0.13	3.77	0.000181	Blood metabolite levels	
PRAD	cis	1	rs11188400	chr10:97371327	TCTN3	chr10:97423154-97453900:-	0.21	4.07	5.62E-5	Blood metabolite levels	
PRAD	cis	1	rs11188406	chr10:97390195	ENTPD1	chr10:97471536-97637022:+	0.13	3.89	0.000113	Blood metabolite levels	
PRAD	cis	1	rs11188406	chr10:97390195	TCTN3	chr10:97423154-97453900:-	0.22	4.2	3.13E-5	Blood metabolite levels	
PRAD	cis	1	rs11188407	chr10:97390533	ENTPD1	chr10:97471536-97637022:+	0.13	3.89	0.000113	Blood metabolite levels	
PRAD	cis	1	rs11188407	chr10:97390533	TCTN3	chr10:97423154-97453900:-	0.22	4.2	3.13E-5	Blood metabolite levels	
PRAD	cis	1	rs11188411	chr10:97397344	ENTPD1	chr10:97471536-97637022:+	0.13	4.02	6.77E-5	Blood metabolite levels	
PRAD	cis	1	rs11188411	chr10:97397344	TCTN3	chr10:97423154-97453900:-	0.24	4.79	2.25E-6	Blood metabolite levels	
PRAD	cis	1	rs11188417	chr10:97411680	ENTPD1	chr10:97471536-97637022:+	-0.13	-3.97	8.15E-5	Blood metabolite levels	
PRAD	cis	1	rs11188417	chr10:97411680	TCTN3	chr10:97423154-97453900:-	-0.23	-4.54	7.22E-6	Blood metabolite levels	
PRAD	cis	1	rs111885088	chr12:56657216	COQ10A	chr12:56660642-56664748:+	-0.34	-3.44	0.000627	Psoriasis vulgaris	
PRAD	cis	1	rs111885088	chr12:56657216	MIP	chr12:56843885-56848429:-	0.69	5.24	2.44E-7	Psoriasis vulgaris	
PRAD	cis	1	rs111899361	chr7:1112348	GPR146	chr7:1084243-1098897:+	0.28	3.73	0.000215	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs111899361	chr7:1112348	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.1E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs111902838	chr19:50496614	SIGLEC16	chr19:50472912-50479075:+	0.52	4.91	1.23E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs111902838	chr19:50496614	TSKS	chr19:50243012-50266515:-	0.34	3.52	0.000476	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs11190540	chr10:102202629	SEC31B	chr10:102246403-102289636:-	-0.3	-9.1	2.55E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190541	chr10:102203071	SEC31B	chr10:102246403-102289636:-	-0.31	-9.31	4.74E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190551	chr10:102204734	SEC31B	chr10:102246403-102289636:-	-0.3	-8.89	1.32E-17	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190552	chr10:102206607	SEC31B	chr10:102246403-102289636:-	-0.31	-9.15	1.67E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190555	chr10:102209160	SEC31B	chr10:102246403-102289636:-	-0.31	-9.28	6.33E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190556	chr10:102209223	SEC31B	chr10:102246403-102289636:-	-0.31	-9.28	6.33E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190557	chr10:102209369	SEC31B	chr10:102246403-102289636:-	-0.31	-9.28	6.33E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190558	chr10:102209397	SEC31B	chr10:102246403-102289636:-	-0.31	-9.28	6.33E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190569	chr10:102227409	SEC31B	chr10:102246403-102289636:-	-0.3	-9.17	1.45E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190570	chr10:102227702	SEC31B	chr10:102246403-102289636:-	-0.32	-9.62	3.98E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190572	chr10:102232879	SEC31B	chr10:102246403-102289636:-	-0.32	-9.77	1.24E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190578	chr10:102238953	SEC31B	chr10:102246403-102289636:-	-0.33	-9.81	8.35E-21	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190587	chr10:102266638	SEC31B	chr10:102246403-102289636:-	-0.32	-9.44	1.72E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190589	chr10:102275471	SEC31B	chr10:102246403-102289636:-	-0.3	-9.22	9.68E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190592	chr10:102291059	SEC31B	chr10:102246403-102289636:-	-0.3	-9	5.71E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190595	chr10:102291761	SEC31B	chr10:102246403-102289636:-	-0.3	-8.98	6.57E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190596	chr10:102293238	SEC31B	chr10:102246403-102289636:-	-0.31	-9	5.58E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190597	chr10:102293676	SEC31B	chr10:102246403-102289636:-	-0.29	-8.7	5.63E-17	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190599	chr10:102295420	SEC31B	chr10:102246403-102289636:-	-0.28	-8.5	2.56E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190601	chr10:102296730	SEC31B	chr10:102246403-102289636:-	-0.28	-8.4	5.49E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190602	chr10:102297256	SEC31B	chr10:102246403-102289636:-	-0.28	-8.52	2.26E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190604	chr10:102302457	SEC31B	chr10:102246403-102289636:-	-0.29	-8.59	1.27E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190607	chr10:102303614	SEC31B	chr10:102246403-102289636:-	-0.28	-8.45	3.61E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11190613	chr10:102313997	SEC31B	chr10:102246403-102289636:-	0.27	8.3	1.12E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11191416	chr10:104604916	SFXN2	chr10:104474298-104498946:+	0.31	3.49	0.00053	Hypertension;Systolic blood pressure;Diastolic blood pressure	
PRAD	cis	1	rs11191419	chr10:104612335	AS3MT	chr10:104613967-104661653:+	-0.48	-11.15	8.61E-26	Schizophrenia	
PRAD	cis	1	rs11191419	chr10:104612335	C10orf32	chr10:104613967-104624718:+	-0.36	-7.42	5.42E-13	Schizophrenia	
PRAD	cis	1	rs11191419	chr10:104612335	NT5C2	chr10:104845940-104953056:-	-0.2	-3.89	0.000116	Schizophrenia	
PRAD	cis	1	rs11191419	chr10:104612335	TMEM180	chr10:104221170-104238858:+	-0.28	-4.45	1.09E-5	Schizophrenia	
PRAD	cis	1	rs11191425	chr10:104625970	SFXN2	chr10:104474298-104498946:+	-0.31	-3.53	0.000459	Hypertension;Systolic blood pressure;Diastolic blood pressure	
PRAD	cis	1	rs111957218	chr19:10839089	LOC147727	chr19:10762539-10764548:-	0.27	3.53	0.000459	LDL cholesterol	
PRAD	cis	1	rs11196085	chr10:114505037	VTI1A	chr10:114206756-114578501:+	-0.2	-3.53	0.000463	QRS duration	
PRAD	cis	1	rs11201297	chr10:81793749	LOC219347	chr10:81805991-81838949:-	0.73	9.45	1.63E-19	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs11201298	chr10:81793751	LOC219347	chr10:81805991-81838949:-	0.72	9.36	3.27E-19	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs11201312	chr10:81795778	LOC219347	chr10:81805991-81838949:-	0.85	10.23	2.62E-22	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs11201660	chr10:81854531	LOC219347	chr10:81805991-81838949:-	-0.72	-9.1	2.65E-18	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs112017572	chr19:12089903	ZNF763	chr19:12035900-12091196:+	-0.38	-3.88	0.000121	Multiple sclerosis	
PRAD	cis	1	rs11201799	chr10:81881954	LOC219347	chr10:81805991-81838949:-	-0.65	-8.35	7.87E-16	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs11202627	chr10:89769340	ATAD1	chr10:89512875-89577917:-	-0.24	-3.72	0.000222	Type 2 diabetes	
PRAD	cis	1	rs11202627	chr10:89769340	PTEN	chr10:89623195-89728531:+	-0.25	-4.39	1.43E-5	Type 2 diabetes	
PRAD	cis	1	rs11202627	chr10:89769340	RNLS	chr10:89892057-90343082:-	-0.35	-4.94	1.08E-6	Type 2 diabetes	
PRAD	cis	1	rs11203031	chr10:90964395	IFIT5	chr10:91174325-91180758:+	-0.27	-3.52	0.000475	Heart failure	
PRAD	cis	1	rs11204700	chr1:150660702	CTSK	chr1:150768687-150780812:-	0.18	4.36	1.57E-5	Congenital left-sided heart lesions	
PRAD	cis	1	rs11204971	chr1:152259078	FLG	chr1:152274651-152297679:-	0.35	4.95	1.02E-6	Atopic dermatitis	
PRAD	cis	1	rs112062277	chr11:94314273	MRE11A	chr11:94150469-94227040:-	-0.14	-4.15	3.91E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
PRAD	cis	1	rs11209800	chr1:72066623	NEGR1	chr1:71868626-72748405:-	-0.09	-3.54	0.00044	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11209801	chr1:72067202	NEGR1	chr1:71868626-72748405:-	-0.1	-3.69	0.000251	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs1121089	chr4:17676476	MED28	chr4:17616273-17629791:+	0.18	4.42	1.24E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs1121090	chr4:17676437	MED28	chr4:17616273-17629791:+	0.18	4.42	1.24E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs1121091	chr4:17676386	MED28	chr4:17616273-17629791:+	0.18	4.42	1.24E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.92	-28.22	3.26E-103	Homocysteine levels	
PRAD	cis	1	rs11211132	chr1:45990516	MMACHC	chr1:45965856-45976737:+	-0.24	-5.12	4.48E-7	Homocysteine levels	
PRAD	cis	1	rs11211132	chr1:45990516	MUTYH	chr1:45794915-45806142:-	0.19	5.27	2.05E-7	Homocysteine levels	
PRAD	cis	1	rs11211199	chr1:46287869	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	8.94E-30	Body mass index	
PRAD	cis	1	rs11211199	chr1:46287869	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000146	Body mass index	
PRAD	cis	1	rs11211199	chr1:46287869	MUTYH	chr1:45794915-45806142:-	0.21	5.96	4.88E-9	Body mass index	
PRAD	cis	1	rs11211208	chr1:46334256	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.14	1.1E-29	Body mass index	
PRAD	cis	1	rs11211208	chr1:46334256	MMACHC	chr1:45965856-45976737:+	-0.17	-3.92	0.000104	Body mass index	
PRAD	cis	1	rs11211208	chr1:46334256	MUTYH	chr1:45794915-45806142:-	0.2	5.73	1.79E-8	Body mass index	
PRAD	cis	1	rs11211230	chr1:46406767	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.13	1.15E-29	Body mass index	
PRAD	cis	1	rs11211230	chr1:46406767	MMACHC	chr1:45965856-45976737:+	-0.17	-3.82	0.000153	Body mass index	
PRAD	cis	1	rs11211230	chr1:46406767	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.23E-9	Body mass index	
PRAD	cis	1	rs11211234	chr1:46438787	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.26	3.55E-30	Body mass index	
PRAD	cis	1	rs11211234	chr1:46438787	MMACHC	chr1:45965856-45976737:+	-0.17	-3.78	0.000176	Body mass index	
PRAD	cis	1	rs11211234	chr1:46438787	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.5E-9	Body mass index	
PRAD	cis	1	rs11211241	chr1:46452683	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.26	3.46E-30	Body mass index	
PRAD	cis	1	rs11211241	chr1:46452683	MMACHC	chr1:45965856-45976737:+	-0.17	-3.77	0.000181	Body mass index	
PRAD	cis	1	rs11211241	chr1:46452683	MUTYH	chr1:45794915-45806142:-	0.2	5.88	7.83E-9	Body mass index	
PRAD	cis	1	rs11212579	chr11:108150664	ATM	chr11:108093559-108239826:+	-0.15	-4.55	6.91E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs11212610	chr11:108274593	ATM	chr11:108093559-108239826:+	-0.18	-5.71	1.97E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs11212615	chr11:108281267	ATM	chr11:108093559-108239826:+	-0.18	-5.65	2.86E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs11212617	chr11:108283161	ATM	chr11:108093559-108239826:+	-0.17	-5.4	1.03E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs11212619	chr11:108289167	ATM	chr11:108093559-108239826:+	-0.18	-5.58	4.09E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs112143304	chr17:61822401	DDX42	chr17:61851567-61896676:+	-0.28	-5.47	7.32E-8	Body mass index	
PRAD	cis	1	rs112143304	chr17:61822401	FTSJ3	chr17:61896795-61905031:-	0.36	6.65	8.09E-11	Body mass index	
PRAD	cis	1	rs112143304	chr17:61822401	TCAM1P	chr17:61934376-61941738:+	-0.22	-3.72	0.000221	Body mass index	
PRAD	cis	1	rs11215037	chr11:114403674	FAM55A	chr11:114392438-114430580:-	-0.19	-3.77	0.000185	Ulcerative colitis	
PRAD	cis	1	rs112162741	chr12:53274499	KRT8	chr12:53290971-53343626:-	-0.24	-4.45	1.06E-5	Prostate cancer	
PRAD	cis	1	rs11216316	chr11:117081500	PCSK7	chr11:117075789-117102811:-	0.4	5.2	2.96E-7	Protein quantitative trait loci	
PRAD	cis	1	rs112245786	chr1:150074642	RPRD2	chr1:150336990-150449039:+	0.13	3.46	0.000585	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs112256404	chr19:49505313	BAX	chr19:49458117-49465054:+	0.25	3.55	0.000431	Follicule stimulating hormone	
PRAD	cis	1	rs11227284	chr11:65503224	CTSW	chr11:65647284-65651212:+	-0.29	-5.63	3.16E-8	Systemic lupus erythematosus	
PRAD	cis	1	rs11227284	chr11:65503224	SNX32	chr11:65601410-65621170:+	0.29	3.97	8.29E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs11227288	chr11:65516588	CTSW	chr11:65647284-65651212:+	-0.27	-5.29	1.9E-7	Systemic lupus erythematosus	
PRAD	cis	1	rs11227288	chr11:65516588	SNX32	chr11:65601410-65621170:+	0.3	4.27	2.38E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs11230147	chr11:59877394	PATL1	chr11:59404194-59436511:-	-0.11	-3.44	0.000623	Alzheimer's disease (late onset)	
PRAD	cis	1	rs11230155	chr11:59904959	PATL1	chr11:59404194-59436511:-	-0.11	-3.44	0.000637	Alzheimer's disease (late onset)	
PRAD	cis	1	rs11230160	chr11:59919165	MS4A4A	chr11:60048139-60076444:+	0.13	3.65	0.000289	Alzheimer's disease (late onset)	
PRAD	cis	1	rs11230160	chr11:59919165	PATL1	chr11:59404194-59436511:-	0.11	3.67	0.000269	Alzheimer's disease (late onset)	
PRAD	cis	1	rs112306637	chr2:203198918	NOP58	chr2:203130515-203168382:+	0.28	4.41	1.26E-5	Urate levels	
PRAD	cis	1	rs1123072	chr16:67898797	C16orf86	chr16:67700717-67702659:+	-0.31	-4.2	3.16E-5	Crohn's disease	
PRAD	cis	1	rs11231050	chr11:62131660	ASRGL1	chr11:62104774-62160885:+	0.36	4.52	7.82E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs11237438	chr11:77998488	GAB2	chr11:77926343-78128766:-	-0.19	-6.15	1.65E-9	Testicular germ cell tumor	
PRAD	cis	1	rs11237438	chr11:77998488	NARS2	chr11:78147017-78285909:-	-0.23	-4.74	2.83E-6	Testicular germ cell tumor	
PRAD	cis	1	rs11237456	chr11:78040780	GAB2	chr11:77926343-78128766:-	-0.18	-6.07	2.63E-9	Testicular germ cell tumor	
PRAD	cis	1	rs11237456	chr11:78040780	NARS2	chr11:78147017-78285909:-	-0.26	-5.8	1.19E-8	Testicular germ cell tumor	
PRAD	cis	1	rs11237460	chr11:78056274	GAB2	chr11:77926343-78128766:-	-0.18	-6.04	3.23E-9	Testicular germ cell tumor	
PRAD	cis	1	rs11237460	chr11:78056274	NARS2	chr11:78147017-78285909:-	-0.23	-5.14	3.95E-7	Testicular germ cell tumor	
PRAD	cis	1	rs11237462	chr11:78058812	GAB2	chr11:77926343-78128766:-	-0.2	-6.32	5.91E-10	Testicular germ cell tumor	
PRAD	cis	1	rs11237468	chr11:78072833	GAB2	chr11:77926343-78128766:-	-0.17	-5.79	1.29E-8	Testicular germ cell tumor	
PRAD	cis	1	rs11237468	chr11:78072833	NARS2	chr11:78147017-78285909:-	-0.25	-5.58	4.14E-8	Testicular germ cell tumor	
PRAD	cis	1	rs11237469	chr11:78072875	GAB2	chr11:77926343-78128766:-	-0.2	-6.29	7.29E-10	Testicular germ cell tumor	
PRAD	cis	1	rs11237469	chr11:78072875	NARS2	chr11:78147017-78285909:-	-0.17	-3.47	0.000577	Testicular germ cell tumor	
PRAD	cis	1	rs11237471	chr11:78082604	GAB2	chr11:77926343-78128766:-	-0.18	-6.1	2.27E-9	Testicular germ cell tumor	
PRAD	cis	1	rs11237471	chr11:78082604	NARS2	chr11:78147017-78285909:-	-0.21	-4.51	8.25E-6	Testicular germ cell tumor	
PRAD	cis	1	rs11237480	chr11:78110385	GAB2	chr11:77926343-78128766:-	-0.17	-5.73	1.77E-8	Testicular germ cell tumor	
PRAD	cis	1	rs11237480	chr11:78110385	NARS2	chr11:78147017-78285909:-	-0.19	-4.18	3.47E-5	Testicular germ cell tumor	
PRAD	cis	1	rs11239345	chr10:45557783	C10orf25	chr10:45489381-45496336:-	0.67	5.62	3.29E-8	Lung function (FEV1/FVC)	
PRAD	cis	1	rs11239346	chr10:45557795	C10orf25	chr10:45489381-45496336:-	0.67	5.62	3.29E-8	Lung function (FEV1/FVC)	
PRAD	cis	1	rs11242	chr3:53125922	ITIH4	chr3:52847007-52866554:-	-0.16	-4.7	3.5E-6	Height	
PRAD	cis	1	rs112434347	chr3:127840447	RUVBL1	chr3:127783627-127872757:-	0.24	4.35	1.64E-5	Post bronchodilator FEV1	
PRAD	cis	1	rs11247124	chr15:100265725	LYSMD4	chr15:100255906-100273626:-	0.14	3.72	0.000219	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs1124769	chr15:51352249	SPPL2A	chr15:50999739-51057910:-	0.26	4.39	1.42E-5	Cognitive performance	
PRAD	cis	1	rs11247726	chr1:28260180	RPA2	chr1:28218049-28241236:-	-0.27	-4.98	9.11E-7	Corneal astigmatism	
PRAD	cis	1	rs11247915	chr1:26650550	SH3BGRL3	chr1:26606213-26608012:+	0.1	3.5	0.00051	Obesity-related traits	
PRAD	cis	1	rs11247915	chr1:26650550	ZNF593	chr1:26496388-26497362:+	0.1	3.65	0.000293	Obesity-related traits	
PRAD	cis	1	rs11248009	chr4:220149	ZNF718	chr4:53272-156488:+	0.33	5.29	1.92E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11248013	chr4:311425	ZNF718	chr4:53272-156488:+	0.37	5.72	1.93E-8	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11248850	chr16:163598	NPRL3	chr16:134273-188672:-	0.19	5.05	6.3E-7	Red blood cell traits	
PRAD	cis	1	rs11249502	chr4:71341161	AMTN	chr4:71384298-71398459:+	0.42	8.03	8.18E-15	Alcoholism (heaviness of drinking)	
PRAD	cis	1	rs11250228	chr10:1074887	IDI2	chr10:1064847-1071799:-	-0.24	-4.64	4.57E-6	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs11250228	chr10:1074887	WDR37	chr10:1102344-1178237:+	0.28	4.94	1.08E-6	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs11250249	chr10:1116999	IDI2	chr10:1064847-1071799:-	0.42	5.08	5.33E-7	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs11250252	chr10:1124939	IDI2	chr10:1064847-1071799:-	0.37	4.84	1.74E-6	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs11250264	chr10:1151723	IDI2	chr10:1064847-1071799:-	0.4	5.2	2.95E-7	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs112509186	chr3:10156533	C3orf10	chr3:10157333-10168873:+	-0.23	-4.42	1.23E-5	Alzheimer's disease	
PRAD	cis	1	rs112509186	chr3:10156533	LOC401052	chr3:10048102-10052779:-	-0.3	-5.37	1.26E-7	Alzheimer's disease	
PRAD	cis	1	rs1125203	chr3:41760895	ULK4	chr3:41288091-42003660:-	0.82	13.24	3.2E-34	Diastolic blood pressure	
PRAD	cis	1	rs112521467	chr1:150073298	RPRD2	chr1:150336990-150449039:+	0.13	3.46	0.000585	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs112526325	chr16:67761917	C16orf86	chr16:67700717-67702659:+	-0.32	-4.11	4.59E-5	Crohn's disease	
PRAD	cis	1	rs112528936	chr4:106633029	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs112529587	chr8:96060035	C8orf38	chr8:95908040-96088396:+	-0.39	-6.52	1.78E-10	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs112529587	chr8:96060035	TP53INP1	chr8:95938201-95961615:-	0.25	3.7	0.000237	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs112537273	chr8:38248306	DDHD2	chr8:38089009-38120286:+	0.3	5	8.29E-7	Schizophrenia	
PRAD	cis	1	rs11259928	chr15:84568095	FAM103A1	chr15:83654995-83659423:+	-0.17	-3.53	0.000463	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11259928	chr15:84568095	NMB	chr15:85198362-85201802:-	-0.17	-4	7.35E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11259929	chr15:84577202	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11259930	chr15:84577350	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11259931	chr15:84580022	FAM103A1	chr15:83654995-83659423:+	0.2	4.35	1.7E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11259932	chr15:84580057	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11259933	chr15:84580156	FAM103A1	chr15:83654995-83659423:+	-0.17	-3.49	0.000537	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11259933	chr15:84580156	NMB	chr15:85198362-85201802:-	-0.16	-3.89	0.000116	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11259934	chr15:84580171	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11259935	chr15:84580427	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11259936	chr15:84580582	NMB	chr15:85198362-85201802:-	0.17	4.07	5.59E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11259937	chr15:84587833	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11264119	chr1:35676580	C1orf216	chr1:36179477-36184790:-	-0.28	-3.57	0.00039	Endometrial cancer	
PRAD	cis	1	rs11264120	chr1:35676595	C1orf216	chr1:36179477-36184790:-	-0.28	-3.57	0.00039	Endometrial cancer	
PRAD	cis	1	rs11264203	chr1:36239234	C1orf216	chr1:36179477-36184790:-	-0.33	-4.52	7.68E-6	Schizophrenia	
PRAD	cis	1	rs11264211	chr1:36270607	C1orf216	chr1:36179477-36184790:-	-0.34	-4.93	1.13E-6	Schizophrenia	
PRAD	cis	1	rs11264213	chr1:36283954	C1orf216	chr1:36179477-36184790:-	-0.34	-4.77	2.47E-6	Schizophrenia	
PRAD	cis	1	rs11264462	chr1:156241728	BGLAP	chr1:156182784-156213112:+	0.21	5.24	2.45E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs11264462	chr1:156241728	CCT3	chr1:156278752-156308195:-	-0.15	-3.46	0.000598	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs11264464	chr1:156250887	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs11264464	chr1:156250887	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs11264467	chr1:156273061	BGLAP	chr1:156182784-156213112:+	-0.19	-4.98	9.03E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs11264468	chr1:156274585	BGLAP	chr1:156182784-156213112:+	0.21	5.49	6.46E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs11264468	chr1:156274585	CCT3	chr1:156278752-156308195:-	-0.15	-3.56	0.000403	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs112654776	chr4:106765058	INTS12	chr4:106603787-106629881:-	-0.76	-7.82	3.47E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs1127030	chr3:128338953	RPN1	chr3:128338813-128399918:-	-0.15	-3.43	0.000652	Monocyte count	
PRAD	cis	1	rs1127354	chr20:3193842	C20orf27	chr20:3734156-3748452:-	-0.25	-3.47	0.000559	Response to hepatitis C treatment	
PRAD	cis	1	rs112751982	chr6:26191958	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.72	0.000223	Renal underexcretion gout;Gout	
PRAD	cis	1	rs112751982	chr6:26191958	HIST1H3E	chr6:26224427-26226589:+	0.36	5.75	1.57E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs112753638	chr2:203199219	NOP58	chr2:203130515-203168382:+	0.28	4.41	1.26E-5	Urate levels	
PRAD	cis	1	rs112777695	chr20:33693177	MMP24	chr20:33814539-33864804:+	-0.29	-4.44	1.12E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs1127931	chr1:54317485	TMEM59	chr1:54497351-54519111:-	0.31	3.43	0.000662	Nonalcoholic fatty liver disease	
PRAD	cis	1	rs112814713	chr1:150074759	RPRD2	chr1:150336990-150449039:+	0.13	3.46	0.000585	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs112847840	chr3:10101652	C3orf10	chr3:10157333-10168873:+	-0.22	-4.15	4.02E-5	Alzheimer's disease	
PRAD	cis	1	rs112847840	chr3:10101652	LOC401052	chr3:10048102-10052779:-	-0.29	-5.18	3.38E-7	Alzheimer's disease	
PRAD	cis	1	rs11292	chr10:102313607	SEC31B	chr10:102246403-102289636:-	-0.27	-7.94	1.51E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs1129448	chr22:38170026	GALR3	chr22:38219389-38221502:+	-0.35	-6.74	4.77E-11	Optic cup area;Vertical cup-disc ratio	
PRAD	cis	1	rs1129448	chr22:38170026	LGALS2	chr22:37966254-37976024:-	-0.13	-3.54	0.000445	Optic cup area;Vertical cup-disc ratio	
PRAD	cis	1	rs1129448	chr22:38170026	TRIOBP	chr22:38082344-38172562:+	0.22	5.99	4.24E-9	Optic cup area;Vertical cup-disc ratio	
PRAD	cis	1	rs112953061	chr7:106718508	PRKAR2B	chr7:106685178-106802255:+	-0.3	-3.61	0.000344	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs1130650	chr14:20940626	PNP	chr14:20937542-20945246:+	-0.32	-6.11	2.12E-9	Interferon alpha levels in systemic lupus erythematosus	
PRAD	cis	1	rs113066613	chr7:1094128	GPR146	chr7:1084243-1098897:+	0.29	3.85	0.000135	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs113066613	chr7:1094128	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.06E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs113075795	chr14:65968955	LOC645431	chr14:65877313-65879335:-	-0.43	-4.37	1.5E-5	Ischemic stroke	
PRAD	cis	1	rs1131095	chr3:49714225	GMPPB	chr3:49758932-49761384:-	-0.21	-4.52	7.79E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs1131095	chr3:49714225	MST1	chr3:49721381-49726196:-	0.1	3.47	0.000579	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs1131095	chr3:49714225	RBM6	chr3:49977592-50137484:+	0.11	3.44	0.000639	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs113134232	chr17:61715461	DDX42	chr17:61851567-61896676:+	-0.23	-4.48	9.49E-6	Body mass index	
PRAD	cis	1	rs113134232	chr17:61715461	FTSJ3	chr17:61896795-61905031:-	0.38	7.1	4.74E-12	Body mass index	
PRAD	cis	1	rs113134232	chr17:61715461	TCAM1P	chr17:61934376-61941738:+	-0.22	-3.71	0.000228	Body mass index	
PRAD	cis	1	rs113134644	chr3:10086286	C3orf10	chr3:10157333-10168873:+	-0.2	-3.82	0.000153	Alzheimer's disease	
PRAD	cis	1	rs113134644	chr3:10086286	LOC401052	chr3:10048102-10052779:-	-0.28	-5.12	4.5E-7	Alzheimer's disease	
PRAD	cis	1	rs113146460	chr7:1105164	GPR146	chr7:1084243-1098897:+	0.27	3.64	0.000298	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs113146460	chr7:1105164	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.32	1.63E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs113153120	chr3:10156398	C3orf10	chr3:10157333-10168873:+	-0.23	-4.43	1.2E-5	Alzheimer's disease	
PRAD	cis	1	rs113153120	chr3:10156398	LOC401052	chr3:10048102-10052779:-	-0.3	-5.35	1.35E-7	Alzheimer's disease	
PRAD	cis	1	rs113179672	chr12:117327241	FBXW8	chr12:117348761-117470180:+	-0.53	-5.78	1.36E-8	Subcortical brain region volumes	
PRAD	cis	1	rs113205216	chr12:117326943	FBXW8	chr12:117348761-117470180:+	-0.56	-6.05	3.01E-9	Subcortical brain region volumes	
PRAD	cis	1	rs1133090	chr16:68021468	C16orf86	chr16:67700717-67702659:+	-0.32	-4.19	3.29E-5	Crohn's disease	
PRAD	cis	1	rs113315674	chr9:100720053	C9orf156	chr9:100666772-100684852:-	-0.19	-3.73	0.000215	Quantitative traits	
PRAD	cis	1	rs113333037	chr17:2200106	SRR	chr17:2207248-2228553:+	-0.77	-14.44	2.23E-39	Esophageal cancer (squamous cell)	
PRAD	cis	1	rs1133483	chr4:100023923	ADH5	chr4:99992132-100009931:-	-0.16	-4.02	6.88E-5	HDL cholesterol	
PRAD	cis	1	rs113366623	chr16:23898931	PRKCB	chr16:23847300-24231930:+	0.16	5.78	1.39E-8	Rheumatoid arthritis	
PRAD	cis	1	rs113491584	chr2:203196447	NOP58	chr2:203130515-203168382:+	0.28	4.41	1.26E-5	Urate levels	
PRAD	cis	1	rs113522867	chr3:10154503	C3orf10	chr3:10157333-10168873:+	-0.23	-4.48	9.35E-6	Alzheimer's disease	
PRAD	cis	1	rs113522867	chr3:10154503	LOC401052	chr3:10048102-10052779:-	-0.3	-5.46	7.81E-8	Alzheimer's disease	
PRAD	cis	1	rs113575110	chr7:1084394	GPR146	chr7:1084243-1098897:+	0.27	3.62	0.000326	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs113575110	chr7:1084394	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.25	2.27E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs113638727	chr15:40706101	C15orf23	chr15:40674922-40686488:+	0.97	14.11	6.24E-38	Heschl's gyrus morphology	
PRAD	cis	1	rs113638727	chr15:40706101	C15orf57	chr15:40823540-40857252:-	0.3	3.53	0.000457	Heschl's gyrus morphology	
PRAD	cis	1	rs113767110	chr4:106599814	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs113770724	chr6:159370137	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs113771705	chr3:10075983	C3orf10	chr3:10157333-10168873:+	-0.22	-4.17	3.66E-5	Alzheimer's disease	
PRAD	cis	1	rs113771705	chr3:10075983	LOC401052	chr3:10048102-10052779:-	-0.3	-5.26	2.22E-7	Alzheimer's disease	
PRAD	cis	1	rs113807377	chr2:242052354	PASK	chr2:242045515-242088878:-	0.31	3.72	0.000223	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs113812453	chr20:3963193	MAVS	chr20:3827449-3856761:+	-0.27	-3.7	0.000238	Response to antidepressants in depression	
PRAD	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.53	12.05	2.63E-29	Height	
PRAD	cis	1	rs113835537	chr11:66339639	ACTN3	chr11:66313866-66330797:+	0.37	4.55	6.75E-6	Airway imaging phenotypes	
PRAD	cis	1	rs113835537	chr11:66339639	DPP3	chr11:66247880-66277130:+	-0.32	-4.94	1.07E-6	Airway imaging phenotypes	
PRAD	cis	1	rs113858334	chr7:1073476	GPR146	chr7:1084243-1098897:+	0.27	3.57	0.000387	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs113858334	chr7:1073476	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.15	3.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs113877751	chr2:203194721	NOP58	chr2:203130515-203168382:+	0.28	4.41	1.26E-5	Urate levels	
PRAD	cis	1	rs113902152	chr5:78977241	DMGDH	chr5:78293430-78365449:-	0.29	3.48	0.000548	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs1139178	chr16:69781468	CLEC18C	chr16:69984626-70220796:+	-0.22	-3.57	0.00039	IgE levels	
PRAD	cis	1	rs113995589	chr3:53132372	ITIH4	chr3:52847007-52866554:-	-0.21	-3.79	0.000173	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs113995589	chr3:53132372	RFT1	chr3:53122503-53164470:-	0.44	5.1	4.94E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs113995589	chr3:53132372	TMEM110	chr3:52867139-52931547:-	0.35	4.59	5.67E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs1140047	chr11:18327684	GTF2H1	chr11:18343816-18388590:+	0.75	15.69	6.69E-45	Pancreatic cancer	
PRAD	cis	1	rs114007205	chr20:33647503	MMP24	chr20:33814539-33864804:+	-0.32	-4.79	2.26E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs114031213	chr2:207619463	MDH1B	chr2:207598943-207630050:-	0.44	3.61	0.000345	Episodic memory	
PRAD	cis	1	rs114072976	chr1:150024300	RPRD2	chr1:150336990-150449039:+	0.13	3.54	0.00044	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs114085878	chr12:62505234	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs1141313	chr2:27460968	C2orf28	chr2:27434899-27440044:+	0.26	7.17	2.97E-12	Blood metabolite levels	
PRAD	cis	1	rs1141313	chr2:27460968	KHK	chr2:27309611-27323619:+	0.21	4.51	8.06E-6	Blood metabolite levels	
PRAD	cis	1	rs114132090	chr10:103590342	KCNIP2	chr10:103585732-103603677:-	0.28	3.83	0.000146	Coronary artery calcification	
PRAD	cis	1	rs1141321	chr6:49412433	CENPQ	chr6:49431096-49460820:+	-0.39	-7.95	1.35E-14	Folate pathway vitamin levels	
PRAD	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.16	4.33	1.82E-5	Folate pathway vitamin levels	
PRAD	cis	1	rs114142124	chr11:78047537	GAB2	chr11:77926343-78128766:-	-0.2	-6.33	5.64E-10	Testicular germ cell tumor	
PRAD	cis	1	rs114142124	chr11:78047537	NARS2	chr11:78147017-78285909:-	-0.18	-3.49	0.00052	Testicular germ cell tumor	
PRAD	cis	1	rs114154984	chr12:120863171	GATC	chr12:120884284-120897761:+	0.31	3.46	0.000595	Insulin resistance/response	
PRAD	cis	1	rs114155121	chr2:203718682	CYP20A1	chr2:204103164-204170562:+	0.33	3.58	0.000376	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs114171212	chr4:106616191	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs114200987	chr14:35586916	PPP2R3C	chr14:35554679-35591679:-	0.38	6.01	3.62E-9	Atopic dermatitis	
PRAD	cis	1	rs114244137	chr5:150264753	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs114256679	chr4:106636598	INTS12	chr4:106603787-106629881:-	-0.77	-7.7	8.23E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs114304428	chr1:152254010	FLG	chr1:152274651-152297679:-	0.35	4.95	1.02E-6	Atopic dermatitis	
PRAD	cis	1	rs114395475	chr2:203769112	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs1144894	chr7:65542894	TPST1	chr7:65670259-65825437:+	-0.19	-4.47	9.72E-6	Aortic root size	
PRAD	cis	1	rs1144895	chr7:65541307	TPST1	chr7:65670259-65825437:+	-0.19	-4.52	7.89E-6	Aortic root size	
PRAD	cis	1	rs114490726	chr4:17680898	MED28	chr4:17616273-17629791:+	0.17	4.13	4.35E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs114491252	chr1:183605243	NCF2	chr1:183524698-183560046:-	0.27	3.78	0.00018	Systemic lupus erythematosus	
PRAD	cis	1	rs114508153	chr1:183632551	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs114520702	chr2:203697092	CYP20A1	chr2:204103164-204170562:+	0.33	3.5	0.000507	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs114558609	chr2:118736370	INSIG2	chr2:118846050-118867596:+	0.34	4.25	2.57E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs114562844	chr3:52991584	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs114562844	chr3:52991584	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs114604770	chr8:89587010	MMP16	chr8:89049462-89339717:-	0.15	3.55	0.000431	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs1147610	chr10:105941167	C10orf79	chr10:105889647-105992120:-	0.26	4.75	2.65E-6	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs1148000	chr12:75936301	GLIPR1L2	chr12:75784889-75825591:+	-0.35	-5.69	2.26E-8	Polycystic ovary syndrome	
PRAD	cis	1	rs1148003	chr12:75978996	GLIPR1L2	chr12:75784889-75825591:+	-0.31	-4.71	3.24E-6	Polycystic ovary syndrome	
PRAD	cis	1	rs1148004	chr12:75978677	GLIPR1L2	chr12:75784889-75825591:+	-0.32	-4.83	1.89E-6	Polycystic ovary syndrome	
PRAD	cis	1	rs1148005	chr12:75978513	GLIPR1L2	chr12:75784889-75825591:+	-0.29	-4.53	7.32E-6	Polycystic ovary syndrome	
PRAD	cis	1	rs1148006	chr12:75978358	GLIPR1L2	chr12:75784889-75825591:+	-0.28	-4.37	1.53E-5	Polycystic ovary syndrome	
PRAD	cis	1	rs11485508	chr1:152253167	FLG	chr1:152274651-152297679:-	-0.32	-5.29	1.91E-7	Atopic dermatitis	
PRAD	cis	1	rs114878198	chr5:78939907	DMGDH	chr5:78293430-78365449:-	0.29	3.5	0.000512	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs114899426	chr2:203771652	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs11494720	chr12:21396865	SLCO1A2	chr12:21417535-21548371:-	0.23	3.44	0.000644	Blood metabolite levels	
PRAD	cis	1	rs114948279	chr20:33733641	MMP24	chr20:33814539-33864804:+	-0.31	-4.66	4.2E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	0.88	14.34	6.1E-39	Diastolic blood pressure	
PRAD	cis	1	rs114976176	chr2:264621	SH3YL1	chr2:218138-264810:-	-0.77	-18.08	7.16E-56	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs115011681	chr1:183619683	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs115170232	chr2:203281513	NOP58	chr2:203130515-203168382:+	0.27	4.38	1.47E-5	Urate levels	
PRAD	cis	1	rs115188238	chr3:184736757	VPS8	chr3:184529931-184770402:+	-0.33	-4.15	3.87E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs115224187	chr11:48757499	FOLH1	chr11:49168188-49230222:-	0.18	4.05	5.9E-5	HDL cholesterol	
PRAD	cis	1	rs1152591	chr14:64680848	MTHFD1	chr14:64854759-64926727:+	-0.16	-3.87	0.000125	Atrial fibrillation	
PRAD	cis	1	rs115277680	chr1:183614362	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs11532322	chr12:123731423	ABCB9	chr12:123413540-123459752:-	-0.3	-5.58	4.14E-8	Schizophrenia	
PRAD	cis	1	rs11532322	chr12:123731423	OGFOD2	chr12:123459354-123464588:+	-0.11	-3.46	0.000591	Schizophrenia	
PRAD	cis	1	rs11532387	chr12:85486964	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11532387	chr12:85486964	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11532387	chr12:85486964	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs115329674	chr3:182067083	LAMP3	chr3:182840004-182880667:-	0.17	3.57	0.000389	Cognitive function	
PRAD	cis	1	rs11538349	chr7:65421871	CCT6P1	chr7:65216092-65228661:+	0.3	5.43	8.97E-8	Diabetic kidney disease	
PRAD	cis	1	rs11538349	chr7:65421871	CRCP	chr7:65579805-65619551:+	-0.27	-3.49	0.000529	Diabetic kidney disease	
PRAD	cis	1	rs11538349	chr7:65421871	ZNF117	chr7:64434830-64467121:-	-0.28	-3.44	0.00064	Diabetic kidney disease	
PRAD	cis	1	rs11538549	chr1:27248283	PIGV	chr1:27114455-27124886:+	-0.38	-4.18	3.51E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs115391623	chr16:68276064	C16orf86	chr16:67700717-67702659:+	-0.3	-3.53	0.000455	Crohn's disease	
PRAD	cis	1	rs115391636	chr10:46012045	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs115395195	chr11:62100353	ASRGL1	chr11:62104774-62160885:+	0.4	4.67	4.03E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs115396314	chr2:203721314	CYP20A1	chr2:204103164-204170562:+	0.33	3.58	0.000376	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs11542436	chr17:61778689	DDX42	chr17:61851567-61896676:+	-0.24	-4.93	1.12E-6	Body mass index	
PRAD	cis	1	rs11542436	chr17:61778689	FTSJ3	chr17:61896795-61905031:-	0.31	6.06	2.86E-9	Body mass index	
PRAD	cis	1	rs11542436	chr17:61778689	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.67	3.99E-6	Body mass index	
PRAD	cis	1	rs11553746	chr2:272203	SH3YL1	chr2:218138-264810:-	-0.78	-18.41	2.25E-57	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs11555809	chr1:27216669	PIGV	chr1:27114455-27124886:+	-0.33	-3.78	0.000177	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs11557072	chr15:40713374	C15orf23	chr15:40674922-40686488:+	1	14.18	2.87E-38	Heschl's gyrus morphology	
PRAD	cis	1	rs11558800	chr19:49507542	BAX	chr19:49458117-49465054:+	0.24	3.51	0.000486	Follicule stimulating hormone	
PRAD	cis	1	rs115650067	chr3:184668515	VPS8	chr3:184529931-184770402:+	-0.35	-4.35	1.69E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs115743514	chr22:51011933	CPT1B	chr22:51007291-51017096:-	-0.22	-4.79	2.19E-6	Narcolepsy	
PRAD	cis	1	rs115743514	chr22:51011933	LOC100144603	chr22:51021455-51022353:+	-0.3	-3.49	0.000536	Narcolepsy	
PRAD	cis	1	rs115756021	chr12:53275701	KRT8	chr12:53290971-53343626:-	-0.24	-4.45	1.06E-5	Prostate cancer	
PRAD	cis	1	rs115772301	chr1:27075684	PIGV	chr1:27114455-27124886:+	-0.35	-4.05	6.03E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs11577346	chr1:150066530	RPRD2	chr1:150336990-150449039:+	0.13	3.46	0.000597	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs11579634	chr1:46466391	CCDC163P	chr1:45960581-45965646:-	0.52	11.7	6.14E-28	Body mass index	
PRAD	cis	1	rs11579634	chr1:46466391	MUTYH	chr1:45794915-45806142:-	-0.2	-5.62	3.34E-8	Body mass index	
PRAD	cis	1	rs11580382	chr1:207418392	CD55	chr1:207494817-207534309:+	0.47	8.78	2.98E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs11580387	chr1:207418408	CD55	chr1:207494817-207534309:+	0.47	8.8	2.72E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs11582249	chr1:207441608	CD55	chr1:207494817-207534309:+	0.47	8.8	2.61E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs1158282	chr14:76172916	TTLL5	chr14:76127621-76421421:+	0.22	4.51	8.3E-6	Large artery stroke	
PRAD	cis	1	rs11584091	chr1:150101169	RPRD2	chr1:150336990-150449039:+	0.13	3.45	0.000619	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs11584095	chr1:8387779	RERE	chr1:8412466-8877699:-	-0.18	-3.51	0.00049	Breast cancer	
PRAD	cis	1	rs11584921	chr1:207441975	CD55	chr1:207494817-207534309:+	0.53	9.81	8.32E-21	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs11585955	chr1:150043544	FAM63A	chr1:150969302-150980854:-	-0.22	-3.94	9.57E-5	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs11585955	chr1:150043544	RPRD2	chr1:150336990-150449039:+	-0.13	-3.84	0.000138	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs11587460	chr1:25496945	RHCE	chr1:25688741-25756683:-	0.21	3.55	0.000425	Urate levels in obese individuals	
PRAD	cis	1	rs11587963	chr1:150106554	RPRD2	chr1:150336990-150449039:+	0.13	3.54	0.000444	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs11588062	chr1:46779764	C1orf190	chr1:46669006-46686927:+	0.14	4.75	2.71E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs11588062	chr1:46779764	FAAH	chr1:46859939-46879520:+	0.29	6.76	4.15E-11	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs11588062	chr1:46779764	NSUN4	chr1:46806390-46830690:+	0.32	5.42	9.62E-8	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs11588170	chr1:152286032	FLG	chr1:152274651-152297679:-	0.37	5.23	2.5E-7	Atopic dermatitis	
PRAD	cis	1	rs115889150	chr2:207597807	MDH1B	chr2:207598943-207630050:-	0.4	3.58	0.000382	Episodic memory	
PRAD	cis	1	rs11589562	chr1:46466721	CCDC163P	chr1:45960581-45965646:-	0.53	11.5	3.76E-27	Body mass index	
PRAD	cis	1	rs11589562	chr1:46466721	MMACHC	chr1:45965856-45976737:+	0.16	3.52	0.00048	Body mass index	
PRAD	cis	1	rs11589562	chr1:46466721	MUTYH	chr1:45794915-45806142:-	-0.2	-5.42	9.34E-8	Body mass index	
PRAD	cis	1	rs11589922	chr1:150133323	RPRD2	chr1:150336990-150449039:+	0.13	3.55	0.000429	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs11590365	chr1:152165489	FLG	chr1:152274651-152297679:-	0.34	4.97	9.45E-7	Atopic dermatitis	
PRAD	cis	1	rs115903765	chr11:67436893	ALDH3B2	chr11:67429634-67448685:-	0.52	5.64	2.93E-8	Serum metabolite levels	
PRAD	cis	1	rs11591200	chr1:150133563	FAM63A	chr1:150969302-150980854:-	-0.24	-3.89	0.000116	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs11591200	chr1:150133563	RPRD2	chr1:150336990-150449039:+	-0.15	-3.97	8.35E-5	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs11592213	chr10:97396103	ENTPD1	chr10:97471536-97637022:+	0.13	3.95	8.86E-5	Blood metabolite levels	
PRAD	cis	1	rs11592213	chr10:97396103	TCTN3	chr10:97423154-97453900:-	0.23	4.43	1.18E-5	Blood metabolite levels	
PRAD	cis	1	rs11592862	chr10:124039222	BTBD16	chr10:124030821-124097676:+	0.22	3.73	0.000217	Gut microbiome composition (summer)	
PRAD	cis	1	rs115953525	chr2:203744445	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs115965884	chr22:24594662	SUSD2	chr22:24577444-24585074:+	0.67	9	5.46E-18	Amyotrophic lateral sclerosis	
PRAD	cis	1	rs11600990	chr11:64082807	C11orf20	chr11:64067863-64072238:+	-0.43	-5.9	7.08E-9	Mean platelet volume	
PRAD	cis	1	rs11601161	chr11:78073280	GAB2	chr11:77926343-78128766:-	-0.2	-6.29	7.29E-10	Testicular germ cell tumor	
PRAD	cis	1	rs11601161	chr11:78073280	NARS2	chr11:78147017-78285909:-	-0.17	-3.47	0.000577	Testicular germ cell tumor	
PRAD	cis	1	rs11601196	chr11:78043431	GAB2	chr11:77926343-78128766:-	-0.21	-6.6	1.14E-10	Testicular germ cell tumor	
PRAD	cis	1	rs11601196	chr11:78043431	NARS2	chr11:78147017-78285909:-	-0.2	-3.98	7.94E-5	Testicular germ cell tumor	
PRAD	cis	1	rs11601205	chr11:34768479	APIP	chr11:34896714-34937939:-	0.26	5.31	1.69E-7	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs11601590	chr11:78073288	GAB2	chr11:77926343-78128766:-	-0.17	-5.79	1.29E-8	Testicular germ cell tumor	
PRAD	cis	1	rs11601590	chr11:78073288	NARS2	chr11:78147017-78285909:-	-0.25	-5.58	4.14E-8	Testicular germ cell tumor	
PRAD	cis	1	rs11601923	chr11:34764354	APIP	chr11:34896714-34937939:-	0.27	5.46	7.67E-8	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs11602266	chr11:57094509	TIMM10	chr11:57295936-57298232:-	-0.23	-3.67	0.000272	Low high density lipoprotein cholesterol levels	
PRAD	cis	1	rs11602622	chr11:78010830	GAB2	chr11:77926343-78128766:-	-0.2	-6.48	2.33E-10	Testicular germ cell tumor	
PRAD	cis	1	rs11602622	chr11:78010830	NARS2	chr11:78147017-78285909:-	-0.22	-4.39	1.39E-5	Testicular germ cell tumor	
PRAD	cis	1	rs11602909	chr11:34768003	APIP	chr11:34896714-34937939:-	0.29	5.76	1.53E-8	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs11603112	chr11:78073491	GAB2	chr11:77926343-78128766:-	-0.17	-5.77	1.46E-8	Testicular germ cell tumor	
PRAD	cis	1	rs11603112	chr11:78073491	NARS2	chr11:78147017-78285909:-	-0.25	-5.55	4.83E-8	Testicular germ cell tumor	
PRAD	cis	1	rs116034011	chr4:106735622	INTS12	chr4:106603787-106629881:-	-0.81	-7.98	1.09E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11603691	chr11:57107617	TIMM10	chr11:57295936-57298232:-	-0.24	-3.79	0.00017	Low high density lipoprotein cholesterol levels	
PRAD	cis	1	rs11604069	chr11:34764251	APIP	chr11:34896714-34937939:-	0.25	5.03	7.15E-7	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs11604149	chr11:6519642	RRP8	chr11:6621154-6624811:-	-0.14	-3.49	0.000524	DNA methylation (variation)	
PRAD	cis	1	rs11605924	chr11:45873091	DKFZp779M0652	chr11:45792983-45793908:+	-0.19	-4.25	2.54E-5	Fasting glucose-related traits (interaction with BMI);Fasting glucose-related traits	
PRAD	cis	1	rs11606049	chr11:112033129	IL18	chr11:112013976-112034840:-	-0.21	-6.79	3.42E-11	Interleukin-18 levels	
PRAD	cis	1	rs11607300	chr11:34759319	APIP	chr11:34896714-34937939:-	0.25	5.01	7.65E-7	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs11609088	chr12:85456887	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11609088	chr12:85456887	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11609088	chr12:85456887	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs116101630	chr11:506826	LRRC56	chr11:537522-554915:+	0.26	4.04	6.34E-5	Body mass index	
PRAD	cis	1	rs116101630	chr11:506826	RNH1	chr11:494512-507273:-	-0.19	-3.65	0.000295	Body mass index	
PRAD	cis	1	rs11611246	chr12:939480	RAD52	chr12:1021255-1099219:-	-0.18	-3.44	0.000641	Body mass index	
PRAD	cis	1	rs11611670	chr12:9385535	LOC642846	chr12:9436253-9466684:+	0.33	8.59	1.24E-16	Breast size	
PRAD	cis	1	rs11612309	chr12:85473497	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11612309	chr12:85473497	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11612309	chr12:85473497	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs11613879	chr12:48477577	TMEM106C	chr12:48357330-48362660:+	0.35	3.62	0.000331	Prostate cancer	
PRAD	cis	1	rs116139393	chr7:6771660	PMS2CL	chr7:6749757-6793492:+	-0.42	-6.03	3.32E-9	Alzheimer's disease (APOE e4 interaction)	
PRAD	cis	1	rs11621378	chr14:81814426	STON2	chr14:81727000-81893748:-	-0.2	-3.69	0.000249	Night sleep phenotypes	
PRAD	cis	1	rs11622962	chr14:65299145	CHURC1	chr14:65381140-65411309:+	0.52	6.68	6.63E-11	Daytime sleep phenotypes	
PRAD	cis	1	rs11623413	chr14:75588824	EIF2B2	chr14:75469612-75476292:+	-0.23	-4.59	5.75E-6	Height	
PRAD	cis	1	rs11623413	chr14:75588824	MLH3	chr14:75480467-75518235:-	-0.32	-6.44	2.87E-10	Height	
PRAD	cis	1	rs11626933	chr14:90754311	C14orf102	chr14:90744398-90798279:-	0.2	3.56	0.000404	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.43	11.42	7.84E-27	Common traits (Other)	
PRAD	cis	1	rs11630417	chr15:68012609	IQCH	chr15:67547188-67794139:+	0.3	6.06	2.87E-9	Motion sickness	
PRAD	cis	1	rs11631955	chr15:79085915	CHRNA3	chr15:78885397-78913322:-	-0.23	-4.25	2.53E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11631963	chr15:83318202	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.12	3.87	0.000122	Schizophrenia	
PRAD	cis	1	rs11631963	chr15:83318202	LOC80154	chr15:82944795-82975797:+;chr15	-0.2	-4.14	4.12E-5	Schizophrenia	
PRAD	cis	1	rs11632465	chr15:85282045	LOC388152	chr15:84867600-84898920:-	-0.33	-5.48	6.78E-8	Schizophrenia	
PRAD	cis	1	rs11632465	chr15:85282045	NMB	chr15:85198362-85201802:-	-0.53	-12.65	9.17E-32	Schizophrenia	
PRAD	cis	1	rs11632465	chr15:85282045	WDR73	chr15:85186012-85197524:-	-0.27	-5.69	2.21E-8	Schizophrenia	
PRAD	cis	1	rs11633301	chr15:84585038	FAM103A1	chr15:83654995-83659423:+	0.18	3.76	0.000193	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11633301	chr15:84585038	NMB	chr15:85198362-85201802:-	0.17	3.95	8.84E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11633958	chr15:78862064	CHRNA3	chr15:78885397-78913322:-	-0.28	-4.76	2.57E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11633958	chr15:78862064	CHRNA5	chr15:78857906-78886458:+	-0.21	-4.21	3.02E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11634746	chr15:50941496	SPPL2A	chr15:50999739-51057910:-	0.27	5.59	3.95E-8	QT interval	
PRAD	cis	1	rs11636344	chr15:48715237	DUT	chr15:48623621-48635568:+	0.22	3.79	0.000169	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs11636964	chr15:50899616	SPPL2A	chr15:50999739-51057910:-	0.26	5.38	1.2E-7	QT interval	
PRAD	cis	1	rs11637027	chr15:67937755	IQCH	chr15:67547188-67794139:+	0.32	6.46	2.69E-10	Motion sickness	
PRAD	cis	1	rs11637142	chr15:85295927	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.48	0.000553	Schizophrenia	
PRAD	cis	1	rs11637142	chr15:85295927	LOC388152	chr15:84867600-84898920:-	-0.32	-5.29	1.84E-7	Schizophrenia	
PRAD	cis	1	rs11637142	chr15:85295927	NMB	chr15:85198362-85201802:-	-0.52	-12.26	3.58E-30	Schizophrenia	
PRAD	cis	1	rs11637142	chr15:85295927	WDR73	chr15:85186012-85197524:-	-0.26	-5.56	4.45E-8	Schizophrenia	
PRAD	cis	1	rs11637228	chr15:50899972	SPPL2A	chr15:50999739-51057910:-	0.26	5.38	1.2E-7	QT interval	
PRAD	cis	1	rs11637433	chr15:83321336	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.11	3.66	0.000277	Schizophrenia	
PRAD	cis	1	rs11637433	chr15:83321336	LOC80154	chr15:82944795-82975797:+;chr15	-0.2	-4.04	6.14E-5	Schizophrenia	
PRAD	cis	1	rs11637866	chr15:84587958	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs116382857	chr2:203751932	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs11638290	chr15:85227636	LOC388152	chr15:84867600-84898920:-	-0.32	-5.44	8.69E-8	Schizophrenia	
PRAD	cis	1	rs11638290	chr15:85227636	NMB	chr15:85198362-85201802:-	-0.52	-12.25	3.97E-30	Schizophrenia	
PRAD	cis	1	rs11638290	chr15:85227636	WDR73	chr15:85186012-85197524:-	-0.27	-5.75	1.57E-8	Schizophrenia	
PRAD	cis	1	rs11638297	chr15:84782417	GOLGA6L5	chr15:85047738-85060078:-	-0.19	-4.73	3.01E-6	Schizophrenia	
PRAD	cis	1	rs11638297	chr15:84782417	LOC388152	chr15:84867600-84898920:-	-0.37	-6.34	5.36E-10	Schizophrenia	
PRAD	cis	1	rs11638297	chr15:84782417	NMB	chr15:85198362-85201802:-	-0.38	-8.55	1.69E-16	Schizophrenia	
PRAD	cis	1	rs11638297	chr15:84782417	WDR73	chr15:85186012-85197524:-	-0.21	-4.52	7.75E-6	Schizophrenia	
PRAD	cis	1	rs11638394	chr15:84778928	GOLGA6L5	chr15:85047738-85060078:-	-0.18	-4.71	3.28E-6	Schizophrenia	
PRAD	cis	1	rs11638394	chr15:84778928	LOC388152	chr15:84867600-84898920:-	-0.36	-6.26	8.86E-10	Schizophrenia	
PRAD	cis	1	rs11638394	chr15:84778928	NMB	chr15:85198362-85201802:-	-0.37	-8.31	1.03E-15	Schizophrenia	
PRAD	cis	1	rs11638394	chr15:84778928	WDR73	chr15:85186012-85197524:-	-0.22	-4.59	5.7E-6	Schizophrenia	
PRAD	cis	1	rs11638815	chr15:83352282	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.14	3.93	9.68E-5	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	
PRAD	cis	1	rs11640439	chr16:57303194	AMFR	chr16:56395365-56459444:-	0.32	3.44	0.000636	Sleep duration	
PRAD	cis	1	rs11641365	chr16:88773893	CTU2	chr16:88772891-88781784:+	0.15	3.58	0.000377	Autism spectrum disorder-related traits	
PRAD	cis	1	rs11641365	chr16:88773893	RNF166	chr16:88762910-88772800:-	0.15	3.81	0.000156	Autism spectrum disorder-related traits	
PRAD	cis	1	rs11641566	chr16:58835180	GOT2	chr16:58741035-58768246:-	-0.21	-4.48	9.41E-6	Blood metabolite ratios	
PRAD	cis	1	rs11641836	chr16:58832047	GOT2	chr16:58741035-58768246:-	-0.19	-4.15	3.87E-5	Blood metabolite ratios	
PRAD	cis	1	rs116439150	chr2:203388537	NOP58	chr2:203130515-203168382:+	0.28	4.49	9.12E-6	Urate levels	
PRAD	cis	1	rs11644601	chr16:15172118	RRN3	chr16:15153881-15188158:-	-0.16	-3.61	0.000335	Metabolite levels (lipid measures)	
PRAD	cis	1	rs11644891	chr16:58833825	GOT2	chr16:58741035-58768246:-	-0.21	-4.57	6.36E-6	Blood metabolite ratios	
PRAD	cis	1	rs11645002	chr16:20617841	ACSM1	chr16:20634559-20709066:-	0.52	6.38	4.25E-10	Urinary metabolites	
PRAD	cis	1	rs11648514	chr16:58832080	GOT2	chr16:58741035-58768246:-	-0.21	-4.54	7.17E-6	Blood metabolite ratios	
PRAD	cis	1	rs11650372	chr17:45721795	C17orf57	chr17:45401142-45518675:+	0.39	8.92	1.02E-17	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs11650372	chr17:45721795	TBKBP1	chr17:45772630-45789427:+	-0.16	-4.38	1.46E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.76	-18.34	4.56E-57	Eye color traits	
PRAD	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.77	18.78	4.0E-59	Eye color traits	
PRAD	cis	1	rs11653708	chr17:76709170	USP36	chr17:76791735-76836969:-	-0.18	-3.5	0.000514	Ulcerative colitis	
PRAD	cis	1	rs11654335	chr17:61797579	DDX42	chr17:61851567-61896676:+	-0.27	-5.45	8.07E-8	Body mass index	
PRAD	cis	1	rs11654335	chr17:61797579	FTSJ3	chr17:61896795-61905031:-	0.34	6.72	5.36E-11	Body mass index	
PRAD	cis	1	rs11654335	chr17:61797579	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.42	1.23E-5	Body mass index	
PRAD	cis	1	rs11654527	chr17:76703516	USP36	chr17:76791735-76836969:-	-0.18	-3.51	0.000499	Ulcerative colitis	
PRAD	cis	1	rs11654553	chr17:17462149	RAI1	chr17:17584787-17714763:+	0.26	3.87	0.000124	Obsessive-compulsive symptoms	
PRAD	cis	1	rs11654777	chr17:17462630	RAI1	chr17:17584787-17714763:+	0.26	3.94	9.23E-5	Obsessive-compulsive symptoms	
PRAD	cis	1	rs11654964	chr17:32989538	CCT6B	chr17:33254940-33288506:-	0.22	3.45	0.000605	Lobular breast cancer (menopausal hormone therapy interaction)	
PRAD	cis	1	rs116551361	chr6:24483512	GPLD1	chr6:24428405-24489850:-	0.41	8.18	2.74E-15	Hematological and biochemical traits	
PRAD	cis	1	rs116551361	chr6:24483512	MRS2	chr6:24403153-24425809:+	0.26	4.14	4.2E-5	Hematological and biochemical traits	
PRAD	cis	1	rs116564386	chr10:103583355	KCNIP2	chr10:103585732-103603677:-	0.33	4.44	1.1E-5	Coronary artery calcification	
PRAD	cis	1	rs1165668	chr12:104317996	C12orf73	chr12:104343981-104359473:-	0.18	4.46	1.01E-5	Coronary heart disease	
PRAD	cis	1	rs1165669	chr12:104318172	C12orf73	chr12:104343981-104359473:-	-0.18	-4.48	9.56E-6	Coronary heart disease	
PRAD	cis	1	rs1165669	chr12:104318172	NT5DC3	chr12:104164231-104234975:-	-0.18	-3.51	0.000485	Coronary heart disease	
PRAD	cis	1	rs1165670	chr12:104318406	C12orf73	chr12:104343981-104359473:-	0.18	4.46	1.01E-5	Coronary heart disease	
PRAD	cis	1	rs11657081	chr17:61792339	CD79B	chr17:62006098-62009704:-	0.12	3.46	0.00058	Body mass index	
PRAD	cis	1	rs11657081	chr17:61792339	DDX42	chr17:61851567-61896676:+	-0.26	-5.42	9.67E-8	Body mass index	
PRAD	cis	1	rs11657081	chr17:61792339	FTSJ3	chr17:61896795-61905031:-	0.33	6.66	7.56E-11	Body mass index	
PRAD	cis	1	rs11657081	chr17:61792339	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.12	4.48E-5	Body mass index	
PRAD	cis	1	rs11657120	chr17:61857218	DDX42	chr17:61851567-61896676:+	-0.27	-5.57	4.36E-8	Body mass index	
PRAD	cis	1	rs11657120	chr17:61857218	FTSJ3	chr17:61896795-61905031:-	0.34	6.77	3.95E-11	Body mass index	
PRAD	cis	1	rs11657120	chr17:61857218	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.5	8.45E-6	Body mass index	
PRAD	cis	1	rs11657306	chr17:61704822	DDX42	chr17:61851567-61896676:+	-0.25	-5.25	2.37E-7	Body mass index	
PRAD	cis	1	rs11657306	chr17:61704822	FTSJ3	chr17:61896795-61905031:-	0.33	6.69	6.35E-11	Body mass index	
PRAD	cis	1	rs11657306	chr17:61704822	TCAM1P	chr17:61934376-61941738:+	-0.22	-3.91	0.000105	Body mass index	
PRAD	cis	1	rs11657371	chr17:46843873	SNF8	chr17:47007461-47022154:-	-0.14	-4.16	3.79E-5	Schizophrenia or bipolar disorder	
PRAD	cis	1	rs11658168	chr17:7406134	CHRNB1	chr17:7348406-7360931:+	0.34	7.14	3.6E-12	Height	
PRAD	cis	1	rs11658175	chr17:61923838	DDX42	chr17:61851567-61896676:+	-0.28	-5.78	1.35E-8	Body mass index	
PRAD	cis	1	rs11658175	chr17:61923838	FTSJ3	chr17:61896795-61905031:-	0.34	6.65	8.03E-11	Body mass index	
PRAD	cis	1	rs11658175	chr17:61923838	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.48	9.38E-6	Body mass index	
PRAD	cis	1	rs11658311	chr17:17470526	RAI1	chr17:17584787-17714763:+	0.23	3.6	0.000349	Obsessive-compulsive symptoms	
PRAD	cis	1	rs11658329	chr17:61763031	DDX42	chr17:61851567-61896676:+	0.27	5.78	1.34E-8	Body mass index	
PRAD	cis	1	rs11658329	chr17:61763031	FTSJ3	chr17:61896795-61905031:-	-0.31	-6.27	8.01E-10	Body mass index	
PRAD	cis	1	rs11658329	chr17:61763031	TCAM1P	chr17:61934376-61941738:+	0.2	3.71	0.000232	Body mass index	
PRAD	cis	1	rs11658555	chr17:18817486	FAM18B	chr17:18684582-18710026:+	0.26	5.26	2.2E-7	Pancreatic cancer	
PRAD	cis	1	rs11658740	chr17:61751069	DDX42	chr17:61851567-61896676:+	-0.25	-5.09	5.3E-7	Body mass index	
PRAD	cis	1	rs11658740	chr17:61751069	FTSJ3	chr17:61896795-61905031:-	0.34	6.81	2.95E-11	Body mass index	
PRAD	cis	1	rs11658740	chr17:61751069	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	5.04E-6	Body mass index	
PRAD	cis	1	rs116616340	chr3:53132371	ITIH4	chr3:52847007-52866554:-	-0.21	-3.79	0.000173	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs116616340	chr3:53132371	RFT1	chr3:53122503-53164470:-	0.44	5.1	4.94E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs116616340	chr3:53132371	TMEM110	chr3:52867139-52931547:-	0.35	4.59	5.67E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11662586	chr18:77716171	HSBP1L1	chr18:77724582-77730820:+	-0.3	-5.6	3.66E-8	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
PRAD	cis	1	rs11663505	chr18:74491325	ZNF236	chr18:74536116-74682680:+	0.15	4.18	3.46E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
PRAD	cis	1	rs116635509	chr2:203324750	NOP58	chr2:203130515-203168382:+	0.28	4.53	7.63E-6	Urate levels	
PRAD	cis	1	rs116648076	chr2:99882347	MRPL30	chr2:99758185-99939196:+	0.23	3.74	0.000205	IgG glycosylation	
PRAD	cis	1	rs116648076	chr2:99882347	TSGA10	chr2:99613725-99771187:-	0.29	4.39	1.42E-5	IgG glycosylation	
PRAD	cis	1	rs11665924	chr19:44286982	LYPD5	chr19:44300080-44324808:-	-0.23	-4.97	9.51E-7	Breast cancer	
PRAD	cis	1	rs11665924	chr19:44286982	ZNF155	chr19:44488355-44502477:+	-0.24	-4.76	2.62E-6	Breast cancer	
PRAD	cis	1	rs11665924	chr19:44286982	ZNF404	chr19:44376516-44384288:-	-0.21	-4.44	1.12E-5	Breast cancer	
PRAD	cis	1	rs11666415	chr19:24228512	LOC100101266	chr19:24344995-24346249:-	0.32	4.57	6.34E-6	Response to taxane treatment (placlitaxel)	
PRAD	cis	1	rs11667192	chr19:9975970	ZNF266	chr19:9523272-9546234:-	-0.15	-3.55	0.000416	Sleep duration	
PRAD	cis	1	rs11668269	chr19:22513960	ZNF98	chr19:22573899-22605148:-	0.2	3.94	9.39E-5	Telomere length	
PRAD	cis	1	rs11669175	chr19:44289824	LYPD5	chr19:44300080-44324808:-	-0.24	-5.07	5.63E-7	Breast cancer	
PRAD	cis	1	rs11669175	chr19:44289824	ZNF155	chr19:44488355-44502477:+	-0.24	-4.64	4.59E-6	Breast cancer	
PRAD	cis	1	rs11669175	chr19:44289824	ZNF223	chr19:44556164-44572142:+	-0.15	-3.44	0.000634	Breast cancer	
PRAD	cis	1	rs11669175	chr19:44289824	ZNF404	chr19:44376516-44384288:-	-0.2	-4.27	2.34E-5	Breast cancer	
PRAD	cis	1	rs11669253	chr19:10836329	LOC147727	chr19:10762539-10764548:-	0.29	3.7	0.000242	LDL cholesterol	
PRAD	cis	1	rs11670668	chr19:41920454	ATP5SL	chr19:41937224-41945810:-	0.17	3.87	0.000123	Height	
PRAD	cis	1	rs11671653	chr19:10838486	LOC147727	chr19:10762539-10764548:-	-0.27	-3.46	0.000596	LDL cholesterol	
PRAD	cis	1	rs11673070	chr19:15746095	CYP4F8	chr19:15726029-15740445:+	0.31	3.63	0.000318	Inflammatory biomarkers	
PRAD	cis	1	rs1167411	chr7:65539264	TPST1	chr7:65670259-65825437:+	-0.19	-4.52	7.89E-6	Aortic root size	
PRAD	cis	1	rs11674298	chr2:197922571	ANKRD44	chr2:197831743-198175495:-	-0.14	-3.99	7.78E-5	Interferon alpha levels in systemic lupus erythematosus	
PRAD	cis	1	rs11674602	chr2:73723185	ALMS1P	chr2:73872046-73912692:+	0.47	8.05	6.87E-15	Metabolite levels	
PRAD	cis	1	rs11674602	chr2:73723185	NAT8	chr2:73867850-73869537:-	0.26	3.92	0.000102	Metabolite levels	
PRAD	cis	1	rs1167612	chr7:65567976	TPST1	chr7:65670259-65825437:+	-0.19	-4.62	5.08E-6	Aortic root size	
PRAD	cis	1	rs1167613	chr7:65487439	CCT6P1	chr7:65216092-65228661:+	0.28	4.97	9.54E-7	Diabetic kidney disease	
PRAD	cis	1	rs1167613	chr7:65487439	CRCP	chr7:65579805-65619551:+	-0.31	-4.04	6.36E-5	Diabetic kidney disease	
PRAD	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.38	-11.73	4.56E-28	Body mass index	
PRAD	cis	1	rs1167827	chr7:75163169	POM121C	chr7:75046066-75115568:-	-0.23	-6.06	2.75E-9	Body mass index	
PRAD	cis	1	rs1167827	chr7:75163169	SPDYE5	chr7:75124299-75133627:+	0.18	4	7.23E-5	Body mass index	
PRAD	cis	1	rs1167827	chr7:75163169	STAG3L1	chr7:74988447-75026250:+	-0.24	-5.13	4.17E-7	Body mass index	
PRAD	cis	1	rs11681299	chr2:88901732	RPIA	chr2:88991176-89050451:+	0.17	3.48	0.000546	Height	
PRAD	cis	1	rs11681497	chr2:242344333	SEPT2	chr2:242254723-242293439:+	0.52	7.96	1.34E-14	Chronic lymphocytic leukemia	
PRAD	cis	1	rs11681777	chr2:192121467	GLS	chr2:191745547-191829776:+	-0.14	-3.76	0.00019	Obesity-related traits	
PRAD	cis	1	rs11681777	chr2:192121467	STAT4	chr2:191894306-192038902:-	0.11	3.62	0.000325	Obesity-related traits	
PRAD	cis	1	rs116828138	chr12:62503431	MON2	chr12:62860597-62991362:+	-0.14	-3.56	0.000413	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs11684337	chr2:3395287	TTC15	chr2:3383446-3488857:+	-0.19	-5.23	2.59E-7	Obesity-related traits	
PRAD	cis	1	rs116849218	chr12:56683975	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs116849218	chr12:56683975	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs11685222	chr2:120748571	TMEM177	chr2:120436743-120481191:+	-0.42	-5.53	5.42E-8	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
PRAD	cis	1	rs116867513	chr19:22166026	ZNF257	chr19:22235266-22273901:+	0.41	5.31	1.73E-7	Body mass index (change over time)	
PRAD	cis	1	rs116876680	chr11:517473	ANO9	chr11:417930-442011:-	0.25	3.98	8.07E-5	Body mass index	
PRAD	cis	1	rs116876680	chr11:517473	LRRC56	chr11:537522-554915:+	0.28	4.24	2.72E-5	Body mass index	
PRAD	cis	1	rs116876680	chr11:517473	RNH1	chr11:494512-507273:-	-0.21	-3.8	0.000164	Body mass index	
PRAD	cis	1	rs11688129	chr2:28952581	PPP1CB	chr2:28974612-29025805:+	-0.28	-5.99	4.25E-9	Body mass index	
PRAD	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.41	8.39	5.83E-16	Body mass index	
PRAD	cis	1	rs116886316	chr16:68286291	C16orf86	chr16:67700717-67702659:+	-0.29	-3.43	0.000658	Crohn's disease	
PRAD	cis	1	rs11689392	chr2:73622026	ALMS1P	chr2:73872046-73912692:+	0.5	8.54	1.94E-16	Metabolite levels	
PRAD	cis	1	rs11689392	chr2:73622026	NAT8	chr2:73867850-73869537:-	0.26	4.04	6.32E-5	Metabolite levels	
PRAD	cis	1	rs11690423	chr2:28951537	PPP1CB	chr2:28974612-29025805:+	-0.29	-6.04	3.14E-9	Body mass index	
PRAD	cis	1	rs11690423	chr2:28951537	TRMT61B	chr2:29072690-29093175:-	0.4	8.19	2.45E-15	Body mass index	
PRAD	cis	1	rs11691372	chr2:192114678	STAT4	chr2:191894306-192038902:-	0.12	3.8	0.000166	Obesity-related traits	
PRAD	cis	1	rs11692425	chr2:3395383	TTC15	chr2:3383446-3488857:+	0.2	5.44	8.71E-8	Obesity-related traits	
PRAD	cis	1	rs11694842	chr2:25482970	DNAJC27	chr2:25166505-25194824:-	-0.14	-3.56	0.000407	Height	
PRAD	cis	1	rs11695244	chr2:242176706	FARP2	chr2:242295711-242434255:+	0.27	4.69	3.64E-6	Chronic lymphocytic leukemia	
PRAD	cis	1	rs11695244	chr2:242176706	SEPT2	chr2:242254723-242293439:+	-0.23	-5.02	7.28E-7	Chronic lymphocytic leukemia	
PRAD	cis	1	rs11696396	chr20:47753019	CSE1L	chr20:47662838-47713484:+	0.18	4.51	8.17E-6	Anger	
PRAD	cis	1	rs11696396	chr20:47753019	PREX1	chr20:47240793-47444420:-	-0.17	-3.55	0.000429	Anger	
PRAD	cis	1	rs11696501	chr20:44124523	WFDC3	chr20:44402847-44420547:-	0.41	5.96	4.88E-9	Brain structure	
PRAD	cis	1	rs11696845	chr20:43371320	KCNK15	chr20:43374488-43379666:+	0.27	4.84	1.73E-6	Obesity-related traits	
PRAD	cis	1	rs11696870	chr20:47725607	CSE1L	chr20:47662838-47713484:+	0.19	4.77	2.52E-6	Anger	
PRAD	cis	1	rs11696870	chr20:47725607	PREX1	chr20:47240793-47444420:-	-0.17	-3.53	0.00045	Anger	
PRAD	cis	1	rs116971206	chr16:68173156	C16orf86	chr16:67700717-67702659:+	-0.31	-4.07	5.41E-5	Crohn's disease	
PRAD	cis	1	rs116988148	chr16:68146952	C16orf86	chr16:67700717-67702659:+	-0.34	-4.44	1.13E-5	Crohn's disease	
PRAD	cis	1	rs116988415	chr14:65292145	CHURC1	chr14:65381140-65411309:+	0.48	6.32	5.96E-10	Daytime sleep phenotypes	
PRAD	cis	1	rs11699551	chr20:55087964	C20orf43	chr20:55043647-55093942:+	0.16	3.93	9.91E-5	Refractive astigmatism	
PRAD	cis	1	rs11699576	chr20:47349878	PREX1	chr20:47240793-47444420:-	0.39	6.47	2.39E-10	Tonometry	
PRAD	cis	1	rs11699883	chr20:55087041	C20orf43	chr20:55043647-55093942:+	0.17	3.99	7.68E-5	Refractive astigmatism	
PRAD	cis	1	rs11700	chr16:67232684	FHOD1	chr16:67263294-67281425:-	-0.49	-5.71	2.05E-8	HDL cholesterol	
PRAD	cis	1	rs11701091	chr21:33920244	TCP10L	chr21:33947152-33957845:-	-0.32	-5.14	4.01E-7	Gastritis	
PRAD	cis	1	rs11701627	chr21:33927794	TCP10L	chr21:33947152-33957845:-	-0.31	-5.08	5.59E-7	Gastritis	
PRAD	cis	1	rs117031571	chr15:84572654	NMB	chr15:85198362-85201802:-	-0.16	-3.89	0.000113	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11703914	chr22:24767602	GGT5	chr22:24615623-24641110:-	-0.11	-3.6	0.000347	Gut microbiome composition (summer)	
PRAD	cis	1	rs11703914	chr22:24767602	POM121L9P	chr22:24647589-24661490:+	-0.27	-5.38	1.19E-7	Gut microbiome composition (summer)	
PRAD	cis	1	rs11704021	chr22:39074716	CBY1	chr22:39052658-39069853:+	0.17	4.88	1.48E-6	Resting heart rate	
PRAD	cis	1	rs11704021	chr22:39074716	LOC646851	chr22:38974125-39052634:-	0.2	4.65	4.4E-6	Resting heart rate	
PRAD	cis	1	rs11705483	chr22:46630544	PKDREJ	chr22:46651561-46659219:-	-0.58	-6.88	1.91E-11	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs11706035	chr3:53011868	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11706035	chr3:53011868	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.5	11.1	1.35E-25	Height	
PRAD	cis	1	rs11706304	chr3:128050614	RUVBL1	chr3:127783627-127872757:-	0.21	3.79	0.000168	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11706455	chr3:127891991	RUVBL1	chr3:127783627-127872757:-	0.23	4.25	2.57E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11706826	chr3:128032991	RUVBL1	chr3:127783627-127872757:-	0.23	4.21	3.09E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11706852	chr3:128032887	RUVBL1	chr3:127783627-127872757:-	0.23	4.24	2.74E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11706908	chr3:128033048	RUVBL1	chr3:127783627-127872757:-	0.23	4.3	2.06E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11707462	chr3:127838630	RUVBL1	chr3:127783627-127872757:-	0.23	4.25	2.54E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11707575	chr3:53113762	ITIH4	chr3:52847007-52866554:-	-0.18	-3.45	0.000622	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11707575	chr3:53113762	RFT1	chr3:53122503-53164470:-	0.41	5.04	6.61E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11707575	chr3:53113762	TMEM110	chr3:52867139-52931547:-	0.27	3.76	0.000189	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11707780	chr3:53084326	RFT1	chr3:53122503-53164470:-	-0.39	-4.41	1.26E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11707780	chr3:53084326	TMEM110	chr3:52867139-52931547:-	-0.31	-3.98	8.09E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11707890	chr3:71503479	EIF4E3	chr3:71728442-71803924:-	0.18	3.74	0.000204	Educational attainment (years of education)	
PRAD	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.55	12.83	1.62E-32	Height	
PRAD	cis	1	rs11709066	chr3:127874912	RUVBL1	chr3:127783627-127872757:-	-0.22	-4.08	5.38E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11709377	chr3:127815670	RUVBL1	chr3:127783627-127872757:-	0.25	4.62	4.94E-6	Post bronchodilator FEV1	
PRAD	cis	1	rs11709525	chr3:49690496	GMPPB	chr3:49758932-49761384:-	-0.21	-4.46	1.04E-5	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs11709611	chr3:128067275	RUVBL1	chr3:127783627-127872757:-	0.22	3.96	8.54E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11709976	chr3:58325347	PXK	chr3:58318617-58410878:+	0.19	3.99	7.67E-5	Cholesterol, total	
PRAD	cis	1	rs11710136	chr3:190985993	UTS2D	chr3:190984945-191048325:-	-0.24	-4.96	9.96E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs11710292	chr3:53117798	RFT1	chr3:53122503-53164470:-	0.45	4.76	2.63E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11710292	chr3:53117798	TMEM110	chr3:52867139-52931547:-	0.37	4.42	1.22E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11710434	chr3:49346130	AMIGO3	chr3:49754268-49757238:-	-0.43	-8.76	3.51E-17	Menarche (age at onset)	
PRAD	cis	1	rs11710434	chr3:49346130	CCDC36	chr3:49235861-49295537:+	0.24	4.27	2.32E-5	Menarche (age at onset)	
PRAD	cis	1	rs11710434	chr3:49346130	GMPPB	chr3:49758932-49761384:-	-0.49	-11.74	4.23E-28	Menarche (age at onset)	
PRAD	cis	1	rs11710434	chr3:49346130	NCKIPSD	chr3:48711280-48723334:-	0.31	6.16	1.59E-9	Menarche (age at onset)	
PRAD	cis	1	rs11710434	chr3:49346130	P4HTM	chr3:49027341-49044579:+	0.16	3.62	0.000326	Menarche (age at onset)	
PRAD	cis	1	rs11710434	chr3:49346130	WDR6	chr3:49044637-49053386:+	-0.21	-4.15	4.0E-5	Menarche (age at onset)	
PRAD	cis	1	rs11710627	chr3:128047009	RUVBL1	chr3:127783627-127872757:-	0.22	4.08	5.33E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11710675	chr3:49751900	AMIGO3	chr3:49754268-49757238:-	-0.22	-4.49	9.02E-6	Resting heart rate	
PRAD	cis	1	rs11710675	chr3:49751900	CACNA2D2	chr3:50400233-50540892:-	-0.22	-4.5	8.52E-6	Resting heart rate	
PRAD	cis	1	rs11710675	chr3:49751900	GMPPB	chr3:49758932-49761384:-	-0.23	-5.18	3.26E-7	Resting heart rate	
PRAD	cis	1	rs11710675	chr3:49751900	RBM6	chr3:49977592-50137484:+	-0.15	-5.25	2.32E-7	Resting heart rate	
PRAD	cis	1	rs11710675	chr3:49751900	WDR6	chr3:49044637-49053386:+	-0.21	-4.29	2.21E-5	Resting heart rate	
PRAD	cis	1	rs11710704	chr3:128047236	RUVBL1	chr3:127783627-127872757:-	0.23	4.18	3.41E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11710707	chr3:52975916	GNL3	chr3:52719936-52728508:+	-0.24	-3.43	0.00065	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11710707	chr3:52975916	RFT1	chr3:53122503-53164470:-	0.42	4.53	7.41E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11710707	chr3:52975916	TMEM110	chr3:52867139-52931547:-	0.43	5.29	1.9E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11711710	chr3:127872506	RUVBL1	chr3:127783627-127872757:-	0.23	4.16	3.76E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11712111	chr3:156608940	LEKR1	chr3:156544076-156763918:+	0.29	5.73	1.77E-8	Multiple sclerosis (severity)	
PRAD	cis	1	rs11712561	chr3:48435272	ATRIP	chr3:48488141-48507708:+	0.27	6.27	8.4E-10	Longevity	
PRAD	cis	1	rs11712561	chr3:48435272	CDC25A	chr3:48198668-48229801:-	0.21	3.97	8.33E-5	Longevity	
PRAD	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.18	-4.89	1.38E-6	Longevity	
PRAD	cis	1	rs11712653	chr3:53070875	RFT1	chr3:53122503-53164470:-	-0.4	-4.54	7.24E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11712653	chr3:53070875	TMEM110	chr3:52867139-52931547:-	-0.38	-4.86	1.63E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11712798	chr3:127894294	RUVBL1	chr3:127783627-127872757:-	0.24	4.39	1.38E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs117128498	chr12:62503517	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs11713206	chr3:52999243	RFT1	chr3:53122503-53164470:-	0.43	4.58	6.03E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11713206	chr3:52999243	TMEM110	chr3:52867139-52931547:-	0.41	5.03	7.15E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11713290	chr3:52971579	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11713290	chr3:52971579	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11713859	chr3:53042080	RFT1	chr3:53122503-53164470:-	0.43	4.55	6.83E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11713859	chr3:53042080	TMEM110	chr3:52867139-52931547:-	0.41	4.97	9.5E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11714052	chr3:127814457	RUVBL1	chr3:127783627-127872757:-	0.23	4.24	2.75E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11714294	chr3:47339723	C3orf75	chr3:47537131-47555199:-	0.17	4.94	1.11E-6	Colorectal cancer	
PRAD	cis	1	rs11714294	chr3:47339723	NBEAL2	chr3:47021173-47051193:+	0.16	4.96	1.01E-6	Colorectal cancer	
PRAD	cis	1	rs11714337	chr3:71582521	EIF4E3	chr3:71728442-71803924:-	0.17	3.5	0.000509	Educational attainment (years of education)	
PRAD	cis	1	rs11714406	chr3:121372513	IQCB1	chr3:121488610-121553926:-	0.5	9.76	1.29E-20	Cognitive performance	
PRAD	cis	1	rs11714619	chr3:127850076	RUVBL1	chr3:127783627-127872757:-	0.23	4.15	3.95E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11714876	chr3:53101640	RFT1	chr3:53122503-53164470:-	-0.46	-4.98	9.15E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11714876	chr3:53101640	TMEM110	chr3:52867139-52931547:-	-0.38	-4.66	4.06E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11715394	chr3:127893564	RUVBL1	chr3:127783627-127872757:-	0.22	3.89	0.000114	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11716941	chr3:127875374	RUVBL1	chr3:127783627-127872757:-	-0.22	-4.12	4.52E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11717256	chr3:49868520	AMIGO3	chr3:49754268-49757238:-	-0.24	-4.69	3.58E-6	Resting heart rate	
PRAD	cis	1	rs11717256	chr3:49868520	CACNA2D2	chr3:50400233-50540892:-	-0.21	-4.41	1.28E-5	Resting heart rate	
PRAD	cis	1	rs11717256	chr3:49868520	GMPPB	chr3:49758932-49761384:-	-0.23	-5.13	4.33E-7	Resting heart rate	
PRAD	cis	1	rs11717256	chr3:49868520	RBM6	chr3:49977592-50137484:+	-0.16	-5.47	7.26E-8	Resting heart rate	
PRAD	cis	1	rs11717256	chr3:49868520	WDR6	chr3:49044637-49053386:+	-0.21	-4.35	1.67E-5	Resting heart rate	
PRAD	cis	1	rs11717423	chr3:58330177	PXK	chr3:58318617-58410878:+	0.19	3.61	0.000338	Cholesterol, total	
PRAD	cis	1	rs11717619	chr3:53003179	RFT1	chr3:53122503-53164470:-	0.35	4.05	5.94E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11717619	chr3:53003179	TMEM110	chr3:52867139-52931547:-	0.41	5.45	8.27E-8	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11718165	chr3:49696797	GMPPB	chr3:49758932-49761384:-	-0.21	-4.46	1.03E-5	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs11718502	chr3:42529082	VIPR1	chr3:42544104-42579065:+	0.24	3.79	0.00017	Magnesium levels	
PRAD	cis	1	rs11718538	chr3:52975987	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11718538	chr3:52975987	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11718752	chr3:53130745	ITIH4	chr3:52847007-52866554:-	-0.19	-3.56	0.000413	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11718752	chr3:53130745	RFT1	chr3:53122503-53164470:-	0.43	5.17	3.43E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11718752	chr3:53130745	TMEM110	chr3:52867139-52931547:-	0.29	3.9	0.000111	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11718834	chr3:52963668	RFT1	chr3:53122503-53164470:-	0.37	4.24	2.72E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11718834	chr3:52963668	TMEM110	chr3:52867139-52931547:-	0.41	5.34	1.47E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11719079	chr3:127824049	RUVBL1	chr3:127783627-127872757:-	0.26	4.67	3.91E-6	Post bronchodilator FEV1	
PRAD	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.5	9.71	1.91E-20	Cognitive performance	
PRAD	cis	1	rs11719546	chr3:127872602	RUVBL1	chr3:127783627-127872757:-	0.23	4.26	2.5E-5	Post bronchodilator FEV1	
PRAD	cis	1	rs11719762	chr3:49409002	AMIGO3	chr3:49754268-49757238:-	-0.41	-8.5	2.57E-16	Menarche (age at onset)	
PRAD	cis	1	rs11719762	chr3:49409002	CCDC36	chr3:49235861-49295537:+	0.25	4.5	8.75E-6	Menarche (age at onset)	
PRAD	cis	1	rs11719762	chr3:49409002	GMPPB	chr3:49758932-49761384:-	-0.46	-11.27	2.94E-26	Menarche (age at onset)	
PRAD	cis	1	rs11719762	chr3:49409002	NCKIPSD	chr3:48711280-48723334:-	0.28	5.74	1.69E-8	Menarche (age at onset)	
PRAD	cis	1	rs11719762	chr3:49409002	P4HTM	chr3:49027341-49044579:+	0.15	3.54	0.00044	Menarche (age at onset)	
PRAD	cis	1	rs11719762	chr3:49409002	WDR6	chr3:49044637-49053386:+	-0.2	-3.99	7.54E-5	Menarche (age at onset)	
PRAD	cis	1	rs11720191	chr3:53013839	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11720191	chr3:53013839	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs11720239	chr3:127817955	RUVBL1	chr3:127783627-127872757:-	0.25	4.62	4.94E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11720542	chr3:49357427	AMIGO3	chr3:49754268-49757238:-	-0.43	-8.76	3.51E-17	Menarche (age at onset)	
PRAD	cis	1	rs11720542	chr3:49357427	CCDC36	chr3:49235861-49295537:+	0.24	4.27	2.32E-5	Menarche (age at onset)	
PRAD	cis	1	rs11720542	chr3:49357427	GMPPB	chr3:49758932-49761384:-	-0.49	-11.74	4.23E-28	Menarche (age at onset)	
PRAD	cis	1	rs11720542	chr3:49357427	NCKIPSD	chr3:48711280-48723334:-	0.31	6.16	1.59E-9	Menarche (age at onset)	
PRAD	cis	1	rs11720542	chr3:49357427	P4HTM	chr3:49027341-49044579:+	0.16	3.62	0.000326	Menarche (age at onset)	
PRAD	cis	1	rs11720542	chr3:49357427	WDR6	chr3:49044637-49053386:+	-0.21	-4.15	4.0E-5	Menarche (age at onset)	
PRAD	cis	1	rs11721213	chr3:128067441	RUVBL1	chr3:127783627-127872757:-	-0.21	-3.88	0.00012	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11721318	chr3:121429485	IQCB1	chr3:121488610-121553926:-	0.48	9.33	4.12E-19	Cognitive performance	
PRAD	cis	1	rs11722037	chr4:17683811	MED28	chr4:17616273-17629791:+	0.17	4.32	1.94E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs11722197	chr4:281707	ZNF718	chr4:53272-156488:+	0.34	5.57	4.26E-8	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11722225	chr4:106766430	INTS12	chr4:106603787-106629881:-	-0.76	-7.82	3.47E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11722521	chr4:276765	ZNF718	chr4:53272-156488:+	0.34	5.57	4.35E-8	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11723120	chr4:103502551	BDH2	chr4:103998783-104021024:-	0.15	3.84	0.000141	Ulcerative colitis	
PRAD	cis	1	rs11723225	chr4:106746065	INTS12	chr4:106603787-106629881:-	-0.81	-7.98	1.15E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11723240	chr4:106736936	INTS12	chr4:106603787-106629881:-	-0.81	-7.98	1.15E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11723261	chr4:282499	ZNF718	chr4:53272-156488:+	0.34	5.57	4.26E-8	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11723615	chr4:276983	ZNF718	chr4:53272-156488:+	0.34	5.57	4.35E-8	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11723639	chr4:106741163	INTS12	chr4:106603787-106629881:-	-0.8	-7.79	4.41E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs117236853	chr20:33667783	MMP24	chr20:33814539-33864804:+	-0.32	-4.72	3.08E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11723803	chr4:292369	ZNF718	chr4:53272-156488:+	0.44	8.89	1.27E-17	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11724176	chr4:224901	ZNF718	chr4:53272-156488:+	0.32	5.16	3.63E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11724417	chr4:223352	ZNF718	chr4:53272-156488:+	0.32	5.16	3.63E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11724495	chr4:17621310	MED28	chr4:17616273-17629791:+	0.2	4.9	1.33E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs11724839	chr4:106638256	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11724884	chr4:106677384	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs117249133	chr20:33773630	MMP24	chr20:33814539-33864804:+	-0.27	-4	7.44E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11726094	chr4:106773387	INTS12	chr4:106603787-106629881:-	-0.72	-7.05	6.48E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs11726124	chr4:106766496	INTS12	chr4:106603787-106629881:-	0.77	7.93	1.62E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11726569	chr4:106606608	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11726829	chr4:224948	ZNF718	chr4:53272-156488:+	0.4	7.39	6.73E-13	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11727189	chr4:106619140	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11727312	chr4:17669185	MED28	chr4:17616273-17629791:+	0.2	4.92	1.2E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs11727348	chr4:106679848	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11727500	chr4:106745948	INTS12	chr4:106603787-106629881:-	-0.81	-7.98	1.15E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11727735	chr4:106631870	INTS12	chr4:106603787-106629881:-	-0.77	-7.7	8.23E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11727745	chr4:106716527	INTS12	chr4:106603787-106629881:-	-0.81	-8.08	5.61E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11727875	chr4:39135319	KLHL5	chr4:39046659-39123828:+	-0.13	-3.74	0.000204	Uric acid levels	
PRAD	cis	1	rs11728044	chr4:106604786	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11728716	chr4:106755996	INTS12	chr4:106603787-106629881:-	0.73	7.48	3.7E-13	Post bronchodilator FEV1	
PRAD	cis	1	rs11729365	chr4:272524	ZNF718	chr4:53272-156488:+	0.34	5.54	5.11E-8	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11729657	chr4:1737585	FAM53A	chr4:1641609-1685854:-	-0.42	-7.68	9.31E-14	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs117300105	chr16:68170298	C16orf86	chr16:67700717-67702659:+	-0.31	-4.07	5.41E-5	Crohn's disease	
PRAD	cis	1	rs11730202	chr4:210096	ZNF718	chr4:53272-156488:+	0.3	4.83	1.85E-6	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11730354	chr4:106773435	INTS12	chr4:106603787-106629881:-	-0.73	-7.23	1.99E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs11731386	chr4:106600338	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11731417	chr4:106746012	INTS12	chr4:106603787-106629881:-	-0.81	-7.98	1.15E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs117316403	chr20:33693175	MMP24	chr20:33814539-33864804:+	-0.28	-4.25	2.63E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11731714	chr4:106675946	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11731938	chr4:106725140	INTS12	chr4:106603787-106629881:-	-0.8	-7.89	2.18E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11732213	chr4:1704244	FAM53A	chr4:1641609-1685854:-	0.44	7.47	3.9E-13	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs11732298	chr4:106701679	INTS12	chr4:106603787-106629881:-	0.79	8.24	1.68E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11732629	chr4:106754347	INTS12	chr4:106603787-106629881:-	-0.76	-7.73	6.44E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11732650	chr4:106754231	INTS12	chr4:106603787-106629881:-	-0.77	-7.92	1.7E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11733093	chr4:106765063	INTS12	chr4:106603787-106629881:-	-0.75	-7.63	1.3E-13	Post bronchodilator FEV1	
PRAD	cis	1	rs11733124	chr4:106677541	INTS12	chr4:106603787-106629881:-	-0.79	-7.96	1.34E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11733150	chr4:106765351	INTS12	chr4:106603787-106629881:-	-0.76	-7.82	3.47E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11733223	chr4:106765525	INTS12	chr4:106603787-106629881:-	0.78	8.23	1.92E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11733225	chr4:106705363	INTS12	chr4:106603787-106629881:-	-0.8	-7.78	4.77E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11733284	chr4:48028097	CNGA1	chr4:47937996-48018610:-	0.26	4.6	5.53E-6	Renal underexcretion gout;Gout	
PRAD	cis	1	rs11733284	chr4:48028097	NIPAL1	chr4:48018791-48039078:+	0.21	6.77	3.76E-11	Renal underexcretion gout;Gout	
PRAD	cis	1	rs11733284	chr4:48028097	TXK	chr4:48068412-48136273:-	0.18	3.97	8.16E-5	Renal underexcretion gout;Gout	
PRAD	cis	1	rs11733287	chr4:106705339	INTS12	chr4:106603787-106629881:-	-0.81	-7.97	1.24E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11733654	chr4:106730710	INTS12	chr4:106603787-106629881:-	-0.81	-8.08	5.61E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11733864	chr4:56321530	TMEM165	chr4:56262090-56292342:+	-0.17	-3.65	0.000288	Personality dimensions	
PRAD	cis	1	rs117339389	chr11:505025	ANO9	chr11:417930-442011:-	0.24	3.83	0.000148	Body mass index	
PRAD	cis	1	rs117339389	chr11:505025	LRRC56	chr11:537522-554915:+	0.25	3.75	0.000196	Body mass index	
PRAD	cis	1	rs117339389	chr11:505025	RNH1	chr11:494512-507273:-	-0.2	-3.65	0.000297	Body mass index	
PRAD	cis	1	rs11734039	chr4:54264428	FIP1L1	chr4:54243820-54326102:+	-0.16	-3.47	0.000574	DNA methylation (variation)	
PRAD	cis	1	rs11734571	chr4:106703557	INTS12	chr4:106603787-106629881:-	-0.81	-7.97	1.24E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11734800	chr4:147502651	ZNF827	chr4:146681892-146859607:-	-0.17	-3.77	0.000181	Heart rate	
PRAD	cis	1	rs11735213	chr4:106527508	INTS12	chr4:106603787-106629881:-	-0.74	-7.36	8.13E-13	Post bronchodilator FEV1	
PRAD	cis	1	rs11735527	chr4:106679692	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs11735851	chr4:106697254	INTS12	chr4:106603787-106629881:-	-0.79	-7.88	2.34E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11736834	chr4:106708764	INTS12	chr4:106603787-106629881:-	-0.8	-7.78	4.77E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11736859	chr4:106708785	INTS12	chr4:106603787-106629881:-	-0.81	-7.97	1.24E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs11737138	chr4:17657986	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs11737268	chr4:224452	ZNF718	chr4:53272-156488:+	0.4	7.39	6.73E-13	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs11737481	chr4:159621250	ETFDH	chr4:159593277-159629839:+	-0.25	-4.48	9.25E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
PRAD	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.94	16.03	1.93E-46	Type 2 diabetes	
PRAD	cis	1	rs11739619	chr5:150264662	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs11739677	chr5:150294883	LOC134466	chr5:150310000-150326146:-	0.69	9.86	5.91E-21	Crohn's disease	
PRAD	cis	1	rs11740172	chr5:150300278	LOC134466	chr5:150310000-150326146:-	0.68	9.99	1.99E-21	Crohn's disease	
PRAD	cis	1	rs11741861	chr5:150277909	C5orf62	chr5:150157867-150176297:+	-0.31	-3.61	0.000341	Crohn's disease	
PRAD	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.72	-10.17	4.34E-22	Crohn's disease	
PRAD	cis	1	rs11743488	chr5:150279218	C5orf62	chr5:150157867-150176297:+	0.31	3.7	0.000239	Crohn's disease	
PRAD	cis	1	rs11743488	chr5:150279218	LOC134466	chr5:150310000-150326146:-	0.7	10.1	7.55E-22	Crohn's disease	
PRAD	cis	1	rs11746108	chr5:150264622	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs11746560	chr5:150185925	LOC134466	chr5:150310000-150326146:-	0.71	9.16	1.56E-18	Crohn's disease	
PRAD	cis	1	rs11746807	chr5:150300419	LOC134466	chr5:150310000-150326146:-	0.67	9.87	5.17E-21	Crohn's disease	
PRAD	cis	1	rs11747065	chr5:150295486	LOC134466	chr5:150310000-150326146:-	0.68	9.99	1.99E-21	Crohn's disease	
PRAD	cis	1	rs11747270	chr5:150258867	LOC134466	chr5:150310000-150326146:-	-0.57	-8.87	1.56E-17	Crohn's disease	
PRAD	cis	1	rs11748151	chr5:150226292	C5orf62	chr5:150157867-150176297:+	0.29	3.78	0.000177	Crohn's disease	
PRAD	cis	1	rs11748151	chr5:150226292	LOC134466	chr5:150310000-150326146:-	0.57	8.63	9.23E-17	Crohn's disease	
PRAD	cis	1	rs11748158	chr5:150226345	C5orf62	chr5:150157867-150176297:+	0.29	3.82	0.00015	Crohn's disease	
PRAD	cis	1	rs11748158	chr5:150226345	LOC134466	chr5:150310000-150326146:-	0.57	8.65	8.34E-17	Crohn's disease	
PRAD	cis	1	rs11748553	chr5:150184553	LOC134466	chr5:150310000-150326146:-	0.7	9.13	2.03E-18	Crohn's disease	
PRAD	cis	1	rs11749391	chr5:150229066	LOC134466	chr5:150310000-150326146:-	0.56	8.68	6.56E-17	Crohn's disease	
PRAD	cis	1	rs11749783	chr5:74626082	POLK	chr5:74807657-74895644:+	-0.11	-3.53	0.000463	LDL cholesterol	
PRAD	cis	1	rs11750992	chr6:42496457	PRPH2	chr6:42664334-42690358:-	0.18	3.43	0.000647	Obesity-related traits	
PRAD	cis	1	rs11752297	chr6:33735154	LEMD2	chr6:33738991-33756906:-	-0.22	-6.76	4.19E-11	Crohn's disease	
PRAD	cis	1	rs11753083	chr6:33761111	LEMD2	chr6:33738991-33756906:-	0.2	5.03	7.07E-7	Body mass index	
PRAD	cis	1	rs11754690	chr6:33744157	LEMD2	chr6:33738991-33756906:-	0.19	4.92	1.18E-6	Body mass index	
PRAD	cis	1	rs11754744	chr6:26202605	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.8	0.000163	Renal underexcretion gout;Gout	
PRAD	cis	1	rs11754744	chr6:26202605	HIST1H3E	chr6:26224427-26226589:+	0.34	5.47	7.15E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs11755210	chr6:26202768	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.8	0.000163	Renal underexcretion gout;Gout	
PRAD	cis	1	rs11755210	chr6:26202768	HIST1H3E	chr6:26224427-26226589:+	0.34	5.47	7.15E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs11755593	chr6:33740325	LEMD2	chr6:33738991-33756906:-	0.19	4.83	1.81E-6	Body mass index	
PRAD	cis	1	rs11756120	chr6:26529808	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs11756120	chr6:26529808	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs117573845	chr20:33651621	MMP24	chr20:33814539-33864804:+	-0.32	-4.78	2.38E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11758152	chr6:42496494	PRPH2	chr6:42664334-42690358:-	0.18	3.54	0.000443	Obesity-related traits	
PRAD	cis	1	rs11758351	chr6:26203910	HIST1H2AE	chr6:26217148-26217711:+	-0.24	-3.68	0.000263	Renal underexcretion gout;Gout	
PRAD	cis	1	rs11758351	chr6:26203910	HIST1H3E	chr6:26224427-26226589:+	0.34	5.61	3.43E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.49	-10.76	2.64E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs11758943	chr6:42501162	PRPH2	chr6:42664334-42690358:-	-0.18	-3.54	0.000439	Obesity-related traits	
PRAD	cis	1	rs11759396	chr6:33656654	ITPR3	chr6:33589161-33664346:+	-0.12	-4.1	4.78E-5	Height	
PRAD	cis	1	rs11759396	chr6:33656654	LEMD2	chr6:33738991-33756906:-	-0.12	-3.57	0.000389	Height	
PRAD	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.51	-11.48	4.56E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs11760485	chr7:4401550	SLC29A4	chr7:5322561-5343702:+	0.21	3.67	0.000274	Early childhood aggressive behavior	
PRAD	cis	1	rs117616040	chr20:33565528	MMP24	chr20:33814539-33864804:+	-0.33	-4.76	2.61E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11761941	chr7:1097183	GPR146	chr7:1084243-1098897:+	0.29	3.85	0.000135	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11761941	chr7:1097183	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.06E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11763020	chr7:1060288	GPR146	chr7:1084243-1098897:+	0.28	3.72	0.000226	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11763020	chr7:1060288	ZFAND2A	chr7:1192544-1199855:-	-0.32	-4.64	4.51E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11763147	chr7:65326821	CCT6P1	chr7:65216092-65228661:+	0.14	3.67	0.000272	Corneal structure	
PRAD	cis	1	rs11763147	chr7:65326821	CRCP	chr7:65579805-65619551:+	0.21	4.13	4.35E-5	Corneal structure	
PRAD	cis	1	rs11763147	chr7:65326821	LOC493754	chr7:65993446-66057363:-	0.21	4.87	1.54E-6	Corneal structure	
PRAD	cis	1	rs11763147	chr7:65326821	TPST1	chr7:65670259-65825437:+	-0.16	-4.01	7.12E-5	Corneal structure	
PRAD	cis	1	rs11763147	chr7:65326821	ZNF117	chr7:64434830-64467121:-	-0.23	-4.36	1.62E-5	Corneal structure	
PRAD	cis	1	rs11763743	chr7:37971866	EPDR1	chr7:37960163-37991539:+	-0.23	-3.82	0.000152	Bone mineral density	
PRAD	cis	1	rs11763793	chr7:1094342	GPR146	chr7:1084243-1098897:+	0.29	3.86	0.000128	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11763793	chr7:1094342	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.21	2.77E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs117638181	chr19:22163014	ZNF257	chr19:22235266-22273901:+	0.39	5.31	1.74E-7	Body mass index (change over time)	
PRAD	cis	1	rs11763835	chr7:1094513	GPR146	chr7:1084243-1098897:+	0.29	3.86	0.000128	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11763835	chr7:1094513	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.21	2.77E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11764748	chr7:1094508	GPR146	chr7:1084243-1098897:+	0.26	3.66	0.000284	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11764748	chr7:1094508	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.45	7.96E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11765693	chr7:75985373	SRCRB4D	chr7:76018647-76039012:-	0.23	4.57	6.15E-6	Multiple sclerosis	
PRAD	cis	1	rs11765693	chr7:75985373	UPK3B	chr7:76139745-76157197:+	-0.28	-5.03	6.84E-7	Multiple sclerosis	
PRAD	cis	1	rs11766369	chr7:37974019	EPDR1	chr7:37960163-37991539:+	-0.24	-4.02	6.88E-5	Bone mineral density	
PRAD	cis	1	rs11766526	chr7:1101433	GPR146	chr7:1084243-1098897:+	0.28	3.73	0.000215	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11766526	chr7:1101433	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.1E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11767124	chr7:23919080	C7orf46	chr7:23719749-23742268:+	0.23	5.73	1.83E-8	Schizophrenia	
PRAD	cis	1	rs11767527	chr7:1097394	GPR146	chr7:1084243-1098897:+	0.29	3.85	0.000135	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11767527	chr7:1097394	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.06E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11768309	chr7:97773812	BHLHA15	chr7:97840778-97842271:+	-0.14	-3.63	0.000312	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs117683816	chr12:56638267	COQ10A	chr12:56660642-56664748:+	-0.36	-3.53	0.000459	Psoriasis vulgaris	
PRAD	cis	1	rs117683816	chr12:56638267	MIP	chr12:56843885-56848429:-	0.69	5.1	5.05E-7	Psoriasis vulgaris	
PRAD	cis	1	rs11768761	chr7:1069807	GPR146	chr7:1084243-1098897:+	0.27	3.57	0.000387	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11768761	chr7:1069807	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.15	3.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11770909	chr7:1086716	GPR146	chr7:1084243-1098897:+	0.27	3.62	0.000326	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11770909	chr7:1086716	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.25	2.27E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs1177202	chr2:61074576	PUS10	chr2:61167550-61245365:-	0.18	3.66	0.000277	Psoriasis	
PRAD	cis	1	rs1177207	chr2:61075209	PUS10	chr2:61167550-61245365:-	0.17	3.51	0.000496	Psoriasis	
PRAD	cis	1	rs117735470	chr12:22592653	KIAA0528	chr12:22601526-22697452:-	0.29	3.73	0.000218	Coronary artery calcification	
PRAD	cis	1	rs11773829	chr7:66141074	CRCP	chr7:65579805-65619551:+	0.2	3.74	0.00021	Aortic root size	
PRAD	cis	1	rs11773829	chr7:66141074	LOC493754	chr7:65993446-66057363:-	0.22	5.13	4.22E-7	Aortic root size	
PRAD	cis	1	rs11773829	chr7:66141074	TPST1	chr7:65670259-65825437:+	-0.15	-3.74	0.000205	Aortic root size	
PRAD	cis	1	rs11774085	chr8:96020877	C8orf38	chr8:95908040-96088396:+	-0.36	-6.24	9.85E-10	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs11774085	chr8:96020877	TP53INP1	chr8:95938201-95961615:-	0.27	4.08	5.39E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs11776189	chr8:96036741	C8orf38	chr8:95908040-96088396:+	-0.38	-6.75	4.49E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs117802529	chr20:33786677	MMP24	chr20:33814539-33864804:+	-0.29	-4.43	1.15E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11780931	chr8:96043829	C8orf38	chr8:95908040-96088396:+	-0.43	-7.54	2.46E-13	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs11781040	chr8:96041746	C8orf38	chr8:95908040-96088396:+	-0.39	-6.76	4.09E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs11781619	chr8:96017323	C8orf38	chr8:95908040-96088396:+	-0.41	-6.81	2.91E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs11782652	chr8:82653644	CHMP4C	chr8:82644688-82671746:+	-0.86	-12.33	1.88E-30	Epithelial ovarian cancer;Ovarian cancer	
PRAD	cis	1	rs11784251	chr8:18260013	NAT2	chr8:18248755-18258723:+	0.2	3.83	0.000147	Blood metabolite levels	
PRAD	cis	1	rs11785712	chr8:120675220	DSCC1	chr8:120846182-120868170:-	-0.42	-5.45	8.31E-8	Height	
PRAD	cis	1	rs11786380	chr8:96028136	C8orf38	chr8:95908040-96088396:+	-0.34	-5.95	5.38E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs11786380	chr8:96028136	TP53INP1	chr8:95938201-95961615:-	0.24	3.76	0.000193	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs11786878	chr8:96033292	C8orf38	chr8:95908040-96088396:+	-0.36	-6.25	9.48E-10	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs11786878	chr8:96033292	TP53INP1	chr8:95938201-95961615:-	0.26	3.94	9.36E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs117883100	chr10:103813134	KCNIP2	chr10:103585732-103603677:-	0.27	3.78	0.000177	Coronary artery calcification	
PRAD	cis	1	rs11789898	chr9:136925663	BRD3	chr9:136895454-136933655:-	0.28	5.99	4.24E-9	Platelet count	
PRAD	cis	1	rs117905338	chr12:22518855	KIAA0528	chr12:22601526-22697452:-	0.27	3.55	0.00042	Coronary artery calcification	
PRAD	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.49	-11.53	3.07E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs11792861	chr9:111809295	C9orf4	chr9:111899581-111929571:-	0.3	6.23	1.03E-9	Menarche (age at onset)	
PRAD	cis	1	rs11792861	chr9:111809295	C9orf5	chr9:111777416-111882225:-	0.16	4.69	3.64E-6	Menarche (age at onset)	
PRAD	cis	1	rs11792861	chr9:111809295	CTNNAL1	chr9:111704851-111775764:-	-0.17	-3.45	0.000618	Menarche (age at onset)	
PRAD	cis	1	rs11792861	chr9:111809295	EPB41L4B	chr9:111934254-112083021:-	-0.23	-4.62	5.01E-6	Menarche (age at onset)	
PRAD	cis	1	rs117981067	chr11:57064112	TIMM10	chr11:57295936-57298232:-	-0.23	-3.46	0.000596	Low high density lipoprotein cholesterol levels	
PRAD	cis	1	rs11801695	chr1:205916175	PM20D1	chr1:205797154-205819245:-	-0.2	-3.69	0.000246	Cystic fibrosis-related diabetes	
PRAD	cis	1	rs11803516	chr1:183640687	NCF2	chr1:183524698-183560046:-	0.25	3.74	0.000205	Systemic lupus erythematosus	
PRAD	cis	1	rs118049526	chr11:62107508	ASRGL1	chr11:62104774-62160885:+	0.4	4.69	3.62E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs118059236	chr7:1073202	GPR146	chr7:1084243-1098897:+	0.27	3.57	0.000387	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs118059236	chr7:1073202	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.15	3.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs11807824	chr1:27270338	PIGV	chr1:27114455-27124886:+	-0.31	-3.85	0.000134	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs11808304	chr1:183604095	NCF2	chr1:183524698-183560046:-	0.24	3.7	0.000245	Systemic lupus erythematosus	
PRAD	cis	1	rs118091174	chr10:103831601	KCNIP2	chr10:103585732-103603677:-	0.29	3.78	0.000177	Coronary artery calcification	
PRAD	cis	1	rs11809957	chr1:6584420	TNFRSF25	chr1:6521221-6526255:-	-0.13	-3.45	0.000618	Body mass index	
PRAD	cis	1	rs11810993	chr1:46478793	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.11	1.41E-29	Body mass index	
PRAD	cis	1	rs11810993	chr1:46478793	MMACHC	chr1:45965856-45976737:+	-0.17	-3.73	0.000211	Body mass index	
PRAD	cis	1	rs11810993	chr1:46478793	MUTYH	chr1:45794915-45806142:-	0.21	6.13	1.87E-9	Body mass index	
PRAD	cis	1	rs11811007	chr1:6584657	TNFRSF25	chr1:6521221-6526255:-	-0.13	-3.45	0.000619	Body mass index	
PRAD	cis	1	rs118110670	chr10:81792242	LOC219347	chr10:81805991-81838949:-	0.79	9.41	2.28E-19	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs11811536	chr1:183604258	NCF2	chr1:183524698-183560046:-	0.27	3.78	0.00018	Systemic lupus erythematosus	
PRAD	cis	1	rs118130855	chr12:56677979	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs118130855	chr12:56677979	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs11813099	chr10:17183451	TRDMT1	chr10:17184983-17243681:-	-0.24	-4.78	2.3E-6	Homocysteine levels	
PRAD	cis	1	rs118143176	chr16:68184250	C16orf86	chr16:67700717-67702659:+	-0.31	-4.07	5.41E-5	Crohn's disease	
PRAD	cis	1	rs11816485	chr10:1147974	IDI2	chr10:1064847-1071799:-	0.39	5.06	5.92E-7	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs11816840	chr10:102309220	SEC31B	chr10:102246403-102289636:-	-0.28	-8.38	6.25E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs11818314	chr10:1148157	IDI2	chr10:1064847-1071799:-	0.39	5.06	5.92E-7	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs11819230	chr10:1128812	IDI2	chr10:1064847-1071799:-	0.34	4.62	4.86E-6	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs11819869	chr11:46560680	HARBI1	chr11:46624857-46638777:-	0.28	3.97	8.17E-5	Schizophrenia	
PRAD	cis	1	rs1182882	chr7:65562063	TPST1	chr7:65670259-65825437:+	-0.19	-4.62	4.85E-6	Aortic root size	
PRAD	cis	1	rs11831942	chr12:53272113	KRT8	chr12:53290971-53343626:-	-0.2	-3.86	0.00013	Prostate cancer	
PRAD	cis	1	rs1183245	chr7:65541185	TPST1	chr7:65670259-65825437:+	-0.19	-4.47	9.72E-6	Aortic root size	
PRAD	cis	1	rs11833002	chr12:124446616	ZNF664	chr12:124457670-124499967:+	-0.15	-3.9	0.000111	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs11835839	chr12:124431049	ZNF664	chr12:124457670-124499967:+	-0.14	-3.63	0.000311	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs11844747	chr14:65870128	LOC645431	chr14:65877313-65879335:-	0.39	3.98	8.09E-5	Ischemic stroke	
PRAD	cis	1	rs11845369	chr14:60944959	C14orf39	chr14:60902675-60952764:-	0.44	5.9	6.95E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs11845639	chr14:75570293	EIF2B2	chr14:75469612-75476292:+	0.24	4.83	1.88E-6	Height	
PRAD	cis	1	rs11845639	chr14:75570293	MLH3	chr14:75480467-75518235:-	0.33	6.66	7.44E-11	Height	
PRAD	cis	1	rs11849252	chr14:66069769	LOC645431	chr14:65877313-65879335:-	-0.4	-4.22	2.97E-5	Ischemic stroke	
PRAD	cis	1	rs11850847	chr14:65933798	LOC645431	chr14:65877313-65879335:-	-0.45	-4.37	1.52E-5	Ischemic stroke	
PRAD	cis	1	rs11851013	chr14:66016212	LOC645431	chr14:65877313-65879335:-	-0.45	-4.52	7.98E-6	Ischemic stroke	
PRAD	cis	1	rs11851772	chr14:66022047	LOC645431	chr14:65877313-65879335:-	-0.45	-4.52	7.98E-6	Ischemic stroke	
PRAD	cis	1	rs11853052	chr15:84576159	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs11853917	chr15:52922054	ARPP19	chr15:52839432-52861364:-	0.15	4.08	5.23E-5	Schizophrenia	
PRAD	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.53	-6.46	2.65E-10	Tumor biomarkers	
PRAD	cis	1	rs11856184	chr15:43919162	CATSPER2	chr15:43922774-43959900:-	-0.27	-4.61	5.15E-6	Tumor biomarkers	
PRAD	cis	1	rs11856184	chr15:43919162	CKMT1A	chr15:43985084-43991419:+	-0.51	-5.59	3.94E-8	Tumor biomarkers	
PRAD	cis	1	rs11857150	chr15:52922216	ARPP19	chr15:52839432-52861364:-	0.15	4.15	4.0E-5	Schizophrenia	
PRAD	cis	1	rs11858210	chr15:79078358	AGPHD1	chr15:78799906-78829714:+	-0.21	-3.64	0.000305	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11858210	chr15:79078358	CHRNA3	chr15:78885397-78913322:-	-0.21	-3.7	0.000245	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs11858714	chr15:40717447	C15orf23	chr15:40674922-40686488:+	0.99	14.12	5.48E-38	Heschl's gyrus morphology	
PRAD	cis	1	rs11858743	chr15:52936330	ARPP19	chr15:52839432-52861364:-	0.15	4.15	3.9E-5	Schizophrenia	
PRAD	cis	1	rs11862083	chr16:4649720	NMRAL1	chr16:4511696-4526307:-	-0.3	-5.14	4.13E-7	Obesity-related traits	
PRAD	cis	1	rs11862744	chr16:31057800	HSD3B7	chr16:30996519-31000473:+	0.49	10.7	4.5E-24	Response to metformin (IC50)	
PRAD	cis	1	rs11862744	chr16:31057800	MYST1	chr16:31128985-31142713:+	0.21	6.47	2.47E-10	Response to metformin (IC50)	
PRAD	cis	1	rs11862744	chr16:31057800	PRSS36	chr16:31150251-31161415:-	0.19	4.9	1.31E-6	Response to metformin (IC50)	
PRAD	cis	1	rs11862744	chr16:31057800	PRSS53	chr16:31094747-31106276:-	-0.19	-3.79	0.00017	Response to metformin (IC50)	
PRAD	cis	1	rs11862744	chr16:31057800	STX1B	chr16:31000577-31021829:-	0.23	5.8	1.24E-8	Response to metformin (IC50)	
PRAD	cis	1	rs11865098	chr16:67857436	C16orf86	chr16:67700717-67702659:+	-0.32	-4.11	4.59E-5	Crohn's disease	
PRAD	cis	1	rs11865131	chr16:163667	NPRL3	chr16:134273-188672:-	0.19	5.12	4.57E-7	Red blood cell traits	
PRAD	cis	1	rs11867104	chr16:78072333	CLEC3A	chr16:78056443-78065997:+	-0.49	-5.81	1.12E-8	Colorectal or endometrial cancer	
PRAD	cis	1	rs11867405	chr17:40570741	CNTNAP1	chr17:40834632-40852010:+	0.16	4.57	6.3E-6	Crohn's disease	
PRAD	cis	1	rs11867405	chr17:40570741	NAGLU	chr17:40687951-40696464:+	-0.18	-4.11	4.58E-5	Crohn's disease	
PRAD	cis	1	rs11868085	chr17:46847575	SNF8	chr17:47007461-47022154:-	-0.14	-4.26	2.5E-5	Schizophrenia or bipolar disorder	
PRAD	cis	1	rs11869819	chr17:65868669	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs11870068	chr17:65944515	LOC651250	chr17:66097696-66157623:+	-0.22	-3.94	9.24E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs11870797	chr17:61804622	DDX42	chr17:61851567-61896676:+	-0.27	-5.45	8.07E-8	Body mass index	
PRAD	cis	1	rs11870797	chr17:61804622	FTSJ3	chr17:61896795-61905031:-	0.34	6.72	5.36E-11	Body mass index	
PRAD	cis	1	rs11870797	chr17:61804622	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.42	1.23E-5	Body mass index	
PRAD	cis	1	rs11870935	chr17:45732605	C17orf57	chr17:45401142-45518675:+	-0.38	-9.06	3.48E-18	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs11870935	chr17:45732605	TBKBP1	chr17:45772630-45789427:+	0.13	3.77	0.000184	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs11871767	chr17:61698723	DDX42	chr17:61851567-61896676:+	-0.25	-5.14	4.05E-7	Body mass index	
PRAD	cis	1	rs11871767	chr17:61698723	FTSJ3	chr17:61896795-61905031:-	0.34	6.75	4.45E-11	Body mass index	
PRAD	cis	1	rs11871767	chr17:61698723	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.44	1.14E-5	Body mass index	
PRAD	cis	1	rs11871801	chr17:40570772	CNTNAP1	chr17:40834632-40852010:+	0.15	4.35	1.66E-5	Crohn's disease	
PRAD	cis	1	rs11871801	chr17:40570772	NAGLU	chr17:40687951-40696464:+	-0.18	-4.14	4.12E-5	Crohn's disease	
PRAD	cis	1	rs11875806	chr18:20777414	RIOK3	chr18:21032787-21063097:+	-0.28	-3.61	0.000342	Breast cancer	
PRAD	cis	1	rs11879853	chr19:23029434	ZNF492	chr19:22817126-22850472:+	0.3	3.92	0.000103	Bronchopulmonary dysplasia	
PRAD	cis	1	rs11880092	chr19:3159224	FZR1	chr19:3506295-3536755:+	-0.18	-3.51	0.000486	Heart failure	
PRAD	cis	1	rs11880198	chr19:3159769	FZR1	chr19:3506295-3536755:+	-0.19	-3.59	0.000362	Heart failure	
PRAD	cis	1	rs11880333	chr19:49144790	SEC1	chr19:49141296-49185501:+	-0.45	-4.88	1.43E-6	Elevated serum carcinoembryonic antigen levels	
PRAD	cis	1	rs11880539	chr19:41918949	ATP5SL	chr19:41937224-41945810:-	-0.17	-3.91	0.000105	Height	
PRAD	cis	1	rs11880825	chr19:3159712	FZR1	chr19:3506295-3536755:+	-0.19	-3.59	0.000362	Heart failure	
PRAD	cis	1	rs11881224	chr19:22220340	ZNF257	chr19:22235266-22273901:+	0.38	5.29	1.91E-7	Body mass index (change over time)	
PRAD	cis	1	rs11882084	chr19:3158713	FZR1	chr19:3506295-3536755:+	-0.19	-3.58	0.000381	Heart failure	
PRAD	cis	1	rs11882112	chr19:3158801	FZR1	chr19:3506295-3536755:+	-0.19	-3.58	0.000381	Heart failure	
PRAD	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.6	13.5	2.4E-35	Schizophrenia	
PRAD	cis	1	rs11882234	chr19:22145727	ZNF257	chr19:22235266-22273901:+	0.39	5.29	1.92E-7	Body mass index (change over time)	
PRAD	cis	1	rs11882498	chr19:23060012	ZNF492	chr19:22817126-22850472:+	-0.33	-4.23	2.86E-5	Bronchopulmonary dysplasia	
PRAD	cis	1	rs11883104	chr19:41923799	ATP5SL	chr19:41937224-41945810:-	0.16	3.61	0.000337	Height	
PRAD	cis	1	rs11886999	chr2:96841793	LOC729234	chr2:96676299-96688882:+	-0.17	-3.8	0.000166	Cardiac Troponin-T levels	
PRAD	cis	1	rs11888938	chr2:127758829	SFT2D3	chr2:128458597-128461405:+	0.2	3.47	0.000564	Systemic lupus erythematosus	
PRAD	cis	1	rs11888938	chr2:127758829	WDR33	chr2:128461808-128568745:-	0.24	4.53	7.58E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs11889798	chr2:228481419	COL4A4	chr2:227867435-228029275:-	0.2	3.68	0.000261	Immune reponse to smallpox (secreted TNF-alpha)	
PRAD	cis	1	rs11892031	chr2:234565283	UGT1A1	chr2:234668919-234681945:+	0.34	3.86	0.000129	Bladder cancer	
PRAD	cis	1	rs11892031	chr2:234565283	UGT1A3	chr2:234637773-234681945:+	0.32	3.5	0.000513	Bladder cancer	
PRAD	cis	1	rs11893118	chr2:241828308	C2orf54	chr2:241825466-241835573:-	0.56	10.68	5.58E-24	Urinary metabolites	
PRAD	cis	1	rs11893247	chr2:234565254	UGT1A10	chr2:234545123-234681949:+	0.29	3.75	0.000201	Bladder cancer	
PRAD	cis	1	rs11893247	chr2:234565254	UGT1A1	chr2:234668919-234681945:+	0.31	3.65	0.000291	Bladder cancer	
PRAD	cis	1	rs11893247	chr2:234565254	UGT1A3	chr2:234637773-234681945:+	0.34	3.75	0.000199	Bladder cancer	
PRAD	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.82	-9.37	2.93E-19	Plasma clusterin levels	
PRAD	cis	1	rs11893881	chr2:73824373	ALMS1P	chr2:73872046-73912692:+	0.5	8.68	6.52E-17	Metabolite levels	
PRAD	cis	1	rs11893881	chr2:73824373	NAT8	chr2:73867850-73869537:-	0.26	4.02	6.91E-5	Metabolite levels	
PRAD	cis	1	rs11896604	chr2:54479199	C2orf73	chr2:54558071-54588714:+	-0.26	-3.58	0.000375	Telomere length	
PRAD	cis	1	rs11898716	chr2:241828311	C2orf54	chr2:241825466-241835573:-	0.57	10.28	1.64E-22	Urinary metabolites	
PRAD	cis	1	rs11899740	chr2:73631212	ALMS1P	chr2:73872046-73912692:+	0.52	8.68	6.33E-17	Metabolite levels	
PRAD	cis	1	rs11899740	chr2:73631212	NAT8	chr2:73867850-73869537:-	0.25	3.74	0.000209	Metabolite levels	
PRAD	cis	1	rs11899836	chr2:203236039	NOP58	chr2:203130515-203168382:+	0.28	4.55	6.69E-6	Urate levels	
PRAD	cis	1	rs11899902	chr2:73631564	ALMS1P	chr2:73872046-73912692:+	0.5	8.49	2.69E-16	Metabolite levels	
PRAD	cis	1	rs11899902	chr2:73631564	NAT8	chr2:73867850-73869537:-	0.25	3.83	0.000146	Metabolite levels	
PRAD	cis	1	rs11901272	chr2:73720444	ALMS1P	chr2:73872046-73912692:+	0.49	8.5	2.6E-16	Metabolite levels	
PRAD	cis	1	rs11901272	chr2:73720444	NAT8	chr2:73867850-73869537:-	0.26	4.01	7.06E-5	Metabolite levels	
PRAD	cis	1	rs11903916	chr2:73815328	ALMS1P	chr2:73872046-73912692:+	0.47	8.11	4.59E-15	Metabolite levels	
PRAD	cis	1	rs11903916	chr2:73815328	NAT8	chr2:73867850-73869537:-	0.24	3.68	0.000258	Metabolite levels	
PRAD	cis	1	rs1190448	chr2:233419084	EIF4E2	chr2:233415357-233448349:+	0.19	3.72	0.000224	Height	
PRAD	cis	1	rs1190450	chr2:233418302	EIF4E2	chr2:233415357-233448349:+	0.19	3.77	0.000182	Height	
PRAD	cis	1	rs11905354	chr20:33677164	MMP24	chr20:33814539-33864804:+	-0.23	-3.89	0.000116	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs1190553	chr14:102915331	ANKRD9	chr14:102973198-102976128:-	-0.16	-4.05	6.02E-5	QT interval	
PRAD	cis	1	rs1190554	chr14:102918686	ANKRD9	chr14:102973198-102976128:-	0.15	3.7	0.000243	QT interval	
PRAD	cis	1	rs1190596	chr14:102595625	RAGE	chr14:102690838-102771531:-	0.24	4.59	5.76E-6	Behavioural disinhibition (generation interaction)	
PRAD	cis	1	rs11906148	chr20:33784021	MMP24	chr20:33814539-33864804:+	-0.29	-4.43	1.15E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11906274	chr20:3945536	MAVS	chr20:3827449-3856761:+	-0.25	-3.56	0.000406	Response to antidepressants in depression	
PRAD	cis	1	rs11906318	chr20:33729442	GDF5	chr20:33897002-34042568:-	0.24	3.86	0.000128	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11906318	chr20:33729442	MMP24	chr20:33814539-33864804:+	-0.25	-4.13	4.33E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11907010	chr20:33737661	MMP24	chr20:33814539-33864804:+	-0.31	-4.66	4.2E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11907011	chr20:33767770	MMP24	chr20:33814539-33864804:+	-0.27	-4.1	4.82E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11907438	chr20:33641220	MMP24	chr20:33814539-33864804:+	-0.23	-3.87	0.000125	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11907594	chr20:33673843	MMP24	chr20:33814539-33864804:+	-0.22	-3.7	0.000243	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11908100	chr20:33729479	GDF5	chr20:33897002-34042568:-	0.24	3.86	0.000128	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11908100	chr20:33729479	MMP24	chr20:33814539-33864804:+	-0.25	-4.13	4.33E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11908232	chr20:33729477	GDF5	chr20:33897002-34042568:-	0.24	3.86	0.000128	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11908232	chr20:33729477	MMP24	chr20:33814539-33864804:+	-0.25	-4.13	4.33E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11908424	chr20:61863955	BIRC7	chr20:61867276-61871853:+	0.35	4.32	1.88E-5	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs11908473	chr20:60957770	LAMA5	chr20:60884123-60942368:-	-0.15	-3.51	0.000494	Colorectal cancer	
PRAD	cis	1	rs11908683	chr20:33720920	GDF5	chr20:33897002-34042568:-	0.25	3.57	0.000389	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11908683	chr20:33720920	MMP24	chr20:33814539-33864804:+	-0.31	-4.65	4.24E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs11918807	chr3:15446277	EAF1	chr3:15469064-15484119:+	0.13	3.96	8.68E-5	Uric acid levels	
PRAD	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.69	6.89E-28	Height	
PRAD	cis	1	rs11920570	chr3:122090102	WDR5B	chr3:122130700-122134882:-	0.27	4.96	9.88E-7	Resting heart rate	
PRAD	cis	1	rs11920900	chr3:49823024	AMIGO3	chr3:49754268-49757238:-	-0.23	-4.35	1.68E-5	Resting heart rate	
PRAD	cis	1	rs11920900	chr3:49823024	CACNA2D2	chr3:50400233-50540892:-	-0.21	-4.25	2.56E-5	Resting heart rate	
PRAD	cis	1	rs11920900	chr3:49823024	GMPPB	chr3:49758932-49761384:-	-0.24	-5.26	2.23E-7	Resting heart rate	
PRAD	cis	1	rs11920900	chr3:49823024	RBM6	chr3:49977592-50137484:+	-0.16	-5.1	5.06E-7	Resting heart rate	
PRAD	cis	1	rs11920900	chr3:49823024	WDR6	chr3:49044637-49053386:+	-0.22	-4.46	1.03E-5	Resting heart rate	
PRAD	cis	1	rs11921456	chr3:128581001	ACAD9	chr3:128598333-128634910:+	0.27	3.57	0.00039	Dental caries	
PRAD	cis	1	rs11923562	chr3:41760331	ULK4	chr3:41288091-42003660:-	0.76	11.71	5.69E-28	Diastolic blood pressure	
PRAD	cis	1	rs11926979	chr3:24656936	RARB	chr3:25215823-25639420:+	-0.24	-3.78	0.000179	Cognitive function	
PRAD	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.69	6.89E-28	Height	
PRAD	cis	1	rs11927309	chr3:38935115	XIRP1	chr3:39224707-39234077:-	0.25	3.71	0.000235	Social communication problems	
PRAD	cis	1	rs11928090	chr3:49604904	AMIGO3	chr3:49754268-49757238:-	-0.43	-8.8	2.63E-17	Menarche (age at onset)	
PRAD	cis	1	rs11928090	chr3:49604904	CCDC36	chr3:49235861-49295537:+	0.24	4.31	1.96E-5	Menarche (age at onset)	
PRAD	cis	1	rs11928090	chr3:49604904	GMPPB	chr3:49758932-49761384:-	-0.48	-11.88	1.2E-28	Menarche (age at onset)	
PRAD	cis	1	rs11928090	chr3:49604904	NCKIPSD	chr3:48711280-48723334:-	0.28	5.66	2.69E-8	Menarche (age at onset)	
PRAD	cis	1	rs11928090	chr3:49604904	WDR6	chr3:49044637-49053386:+	-0.22	-4.41	1.28E-5	Menarche (age at onset)	
PRAD	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.63	1.19E-27	Height	
PRAD	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	0.88	14.26	1.4E-38	Diastolic blood pressure	
PRAD	cis	1	rs11931061	chr4:56338793	TMEM165	chr4:56262090-56292342:+	-0.17	-3.64	0.000301	Personality dimensions	
PRAD	cis	1	rs11932207	chr4:71330534	AMTN	chr4:71384298-71398459:+	0.42	7.95	1.45E-14	Alcoholism (heaviness of drinking)	
PRAD	cis	1	rs11942153	chr4:106960172	TBCK	chr4:106967233-107237861:-	0.17	3.53	0.000453	Airflow obstruction	
PRAD	cis	1	rs11943720	chr4:5238185	TMEM128	chr4:4237269-4249959:-	0.41	4.14	4.09E-5	Alzheimer's disease (cognitive decline)	
PRAD	cis	1	rs11946892	chr4:5850377	CRMP1	chr4:5749811-5894785:-	0.23	3.99	7.59E-5	Dysphagia	
PRAD	cis	1	rs11947857	chr4:17691047	MED28	chr4:17616273-17629791:+	-0.21	-5.09	5.27E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs11950957	chr5:150253914	LOC134466	chr5:150310000-150326146:-	0.58	9.01	5.3E-18	Crohn's disease	
PRAD	cis	1	rs11951515	chr5:43382858	HMGCS1	chr5:43289494-43313595:-	0.24	4.68	3.82E-6	Metabolite levels  (X-11787)	
PRAD	cis	1	rs11951694	chr5:150254338	LOC134466	chr5:150310000-150326146:-	0.57	8.91	1.12E-17	Crohn's disease	
PRAD	cis	1	rs11955172	chr5:150254378	LOC134466	chr5:150310000-150326146:-	0.57	8.91	1.12E-17	Crohn's disease	
PRAD	cis	1	rs11957134	chr5:150230950	C5orf62	chr5:150157867-150176297:+	-0.3	-3.64	0.0003	Crohn's disease	
PRAD	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.67	-9.7	2.08E-20	Crohn's disease	
PRAD	cis	1	rs11958404	chr5:157410278	NIPAL4	chr5:156887027-156901729:+	0.2	3.66	0.000281	IgG glycosylation	
PRAD	cis	1	rs11961560	chr6:170130121	WDR27	chr6:169857307-170102159:-	-0.13	-3.45	0.00061	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs11962024	chr6:25610203	SCGN	chr6:25652429-25702006:+	0.42	7.21	2.2E-12	Uric acid levels	
PRAD	cis	1	rs11962469	chr6:24482421	GPLD1	chr6:24428405-24489850:-	0.41	8.18	2.74E-15	Hematological and biochemical traits	
PRAD	cis	1	rs11962469	chr6:24482421	MRS2	chr6:24403153-24425809:+	0.26	4.14	4.2E-5	Hematological and biochemical traits	
PRAD	cis	1	rs11965411	chr6:149608349	ULBP2	chr6:150263136-150270366:+	0.2	3.63	0.000315	Breast cancer	
PRAD	cis	1	rs11965538	chr6:28239915	ZKSCAN3	chr6:28317691-28334523:+	-0.18	-3.78	0.000175	Depression	
PRAD	cis	1	rs11965538	chr6:28239915	ZNF187	chr6:28234788-28245978:+	-0.32	-5.84	9.74E-9	Depression	
PRAD	cis	1	rs11965538	chr6:28239915	ZNF323	chr6:28292517-28324048:-	0.41	5.6	3.69E-8	Depression	
PRAD	cis	1	rs11965538	chr6:28239915	ZNF389	chr6:28129551-28137375:+	-0.53	-7.69	8.78E-14	Depression	
PRAD	cis	1	rs11965538	chr6:28239915	ZSCAN23	chr6:28393287-28411279:-	0.17	4.62	5.03E-6	Depression	
PRAD	cis	1	rs11970960	chr7:38883838	FAM183B	chr7:38724947-38726689:-	0.38	3.99	7.72E-5	Cognitive performance	
PRAD	cis	1	rs11971779	chr7:139040258	LUC7L2	chr7:139025105-139108198:+	0.22	4.79	2.19E-6	Diisocyanate-induced asthma	
PRAD	cis	1	rs11971949	chr7:65626014	TPST1	chr7:65670259-65825437:+	-0.18	-4.45	1.09E-5	Aortic root size	
PRAD	cis	1	rs11974219	chr7:65647410	TPST1	chr7:65670259-65825437:+	-0.18	-4.41	1.26E-5	Aortic root size	
PRAD	cis	1	rs11974264	chr7:65647582	TPST1	chr7:65670259-65825437:+	-0.18	-4.4	1.37E-5	Aortic root size	
PRAD	cis	1	rs11974409	chr7:72989390	MLXIPL	chr7:73007524-73038870:-	0.22	3.45	0.000614	Triglycerides	
PRAD	cis	1	rs11975942	chr7:143740580	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.24	8.35E-19	Obesity-related traits	
PRAD	cis	1	rs11975942	chr7:143740580	OR2A9P	chr7:143991573-143997832:+;chr7	-0.32	-5.4	1.06E-7	Obesity-related traits	
PRAD	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	1.08	21.37	2.65E-71	Educational attainment (years of education)	
PRAD	cis	1	rs11976037	chr7:143741024	ARHGEF35	chr7:143883677-143892736:-	-0.51	-9.38	2.74E-19	Obesity-related traits	
PRAD	cis	1	rs11976037	chr7:143741024	OR2A9P	chr7:143991573-143997832:+;chr7	-0.33	-5.54	4.98E-8	Obesity-related traits	
PRAD	cis	1	rs11976180	chr7:143741580	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.16	1.67E-18	Obesity-related traits	
PRAD	cis	1	rs11976180	chr7:143741580	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.54	0.000438	Obesity-related traits	
PRAD	cis	1	rs11976180	chr7:143741580	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.17	3.54E-7	Obesity-related traits	
PRAD	cis	1	rs11977016	chr7:38877033	FAM183B	chr7:38724947-38726689:-	0.38	3.6	0.000346	Cognitive performance	
PRAD	cis	1	rs11978816	chr7:38845707	FAM183B	chr7:38724947-38726689:-	0.39	3.64	0.000308	Cognitive performance	
PRAD	cis	1	rs11980534	chr7:38825980	FAM183B	chr7:38724947-38726689:-	0.36	3.52	0.000472	Cognitive performance	
PRAD	cis	1	rs11982889	chr7:38838948	FAM183B	chr7:38724947-38726689:-	0.34	3.55	0.000428	Cognitive performance	
PRAD	cis	1	rs11983997	chr7:72939244	MLXIPL	chr7:73007524-73038870:-	0.25	3.95	9.08E-5	Triglycerides	
PRAD	cis	1	rs1198433	chr1:23756695	ASAP3	chr1:23755056-23811057:-	0.37	5.67	2.51E-8	Cholesterol, total	
PRAD	cis	1	rs1198433	chr1:23756695	TCEA3	chr1:23707555-23751261:-	0.24	4.08	5.2E-5	Cholesterol, total	
PRAD	cis	1	rs1198440	chr1:23780861	ASAP3	chr1:23755056-23811057:-	0.37	5.77	1.47E-8	Cholesterol, total	
PRAD	cis	1	rs1198440	chr1:23780861	TCEA3	chr1:23707555-23751261:-	0.26	4.45	1.09E-5	Cholesterol, total	
PRAD	cis	1	rs1198440	chr1:23780861	ZNF436	chr1:23685942-23696357:-	-0.24	-3.57	0.000389	Cholesterol, total	
PRAD	cis	1	rs11984666	chr8:130730280	GSDMC	chr8:130760443-130799134:-	0.2	3.93	9.93E-5	Infant length;Height	
PRAD	cis	1	rs11987056	chr8:120542647	NOV	chr8:120428552-120436678:+	-0.18	-3.44	0.000624	Smoking cessation	
PRAD	cis	1	rs11992601	chr8:65696040	BHLHE22	chr8:65492814-65496185:+	0.28	5.42	9.35E-8	HIV-1 susceptibility	
PRAD	cis	1	rs11995536	chr8:120945268	DSCC1	chr8:120846182-120868170:-	-0.32	-7.26	1.6E-12	Interstitial lung disease	
PRAD	cis	1	rs11995572	chr8:89592083	MMP16	chr8:89049462-89339717:-	0.14	3.62	0.000323	Schizophrenia	
PRAD	cis	1	rs11996540	chr8:65668267	BHLHE22	chr8:65492814-65496185:+	0.28	5.38	1.15E-7	HIV-1 susceptibility	
PRAD	cis	1	rs12021522	chr1:183600257	NCF2	chr1:183524698-183560046:-	0.25	3.57	0.000396	Systemic lupus erythematosus	
PRAD	cis	1	rs12021587	chr1:46472759	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.17	8.4E-30	Body mass index	
PRAD	cis	1	rs12021587	chr1:46472759	MMACHC	chr1:45965856-45976737:+	-0.17	-3.78	0.000179	Body mass index	
PRAD	cis	1	rs12021587	chr1:46472759	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.51E-9	Body mass index	
PRAD	cis	1	rs12022194	chr1:156312331	BGLAP	chr1:156182784-156213112:+	0.22	5.51	6.05E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12022194	chr1:156312331	CCT3	chr1:156278752-156308195:-	-0.15	-3.57	0.000395	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12022452	chr1:40953300	DEM1	chr1:40974433-40982212:+	0.45	5.3	1.77E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs12022469	chr1:183601157	NCF2	chr1:183524698-183560046:-	0.25	3.73	0.000217	Systemic lupus erythematosus	
PRAD	cis	1	rs12023106	chr1:202365332	PPP1R12B	chr1:202317836-202557697:+	0.09	3.63	0.000318	Sex ratio	
PRAD	cis	1	rs12023438	chr1:156254358	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12023438	chr1:156254358	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12023704	chr1:156294149	BGLAP	chr1:156182784-156213112:+	0.21	5.36	1.3E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12023704	chr1:156294149	CCT3	chr1:156278752-156308195:-	-0.15	-3.61	0.000345	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12023865	chr1:183634210	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12024089	chr1:183608107	NCF2	chr1:183524698-183560046:-	0.27	3.78	0.00018	Systemic lupus erythematosus	
PRAD	cis	1	rs12024813	chr1:156224529	BGLAP	chr1:156182784-156213112:+	0.2	5.08	5.42E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12024880	chr1:155908910	RIT1	chr1:155867601-155881177:-	0.17	3.89	0.000117	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs12025732	chr1:183614855	NCF2	chr1:183524698-183560046:-	0.21	3.66	0.000286	Systemic lupus erythematosus	
PRAD	cis	1	rs12026500	chr1:149945558	MTMR11	chr1:149900544-149908791:-	0.17	4.1	4.93E-5	Height	
PRAD	cis	1	rs12027103	chr1:156244856	BGLAP	chr1:156182784-156213112:+	0.21	5.47	7.47E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12027103	chr1:156244856	CCT3	chr1:156278752-156308195:-	-0.15	-3.43	0.000658	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12027412	chr1:155908930	RIT1	chr1:155867601-155881177:-	0.17	3.88	0.00012	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs12027598	chr1:6600804	TNFRSF25	chr1:6521221-6526255:-	-0.14	-3.5	0.000502	Body mass index	
PRAD	cis	1	rs12027741	chr1:156248148	BGLAP	chr1:156182784-156213112:+	0.21	5.47	7.47E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12027741	chr1:156248148	CCT3	chr1:156278752-156308195:-	-0.15	-3.43	0.000658	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12028474	chr1:183643542	NCF2	chr1:183524698-183560046:-	0.25	3.74	0.000205	Systemic lupus erythematosus	
PRAD	cis	1	rs12029647	chr1:183593968	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs12029676	chr1:183594057	NCF2	chr1:183524698-183560046:-	0.28	3.92	0.000102	Systemic lupus erythematosus	
PRAD	cis	1	rs12029723	chr1:183594236	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs12029926	chr1:183640149	NCF2	chr1:183524698-183560046:-	-0.23	-3.51	0.000498	Systemic lupus erythematosus	
PRAD	cis	1	rs12029935	chr1:183588983	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.65	9.86	5.91E-21	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.65	9.86	5.91E-21	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs12031255	chr1:183591537	NCF2	chr1:183524698-183560046:-	0.26	3.82	0.000154	Systemic lupus erythematosus	
PRAD	cis	1	rs12031263	chr1:183591586	NCF2	chr1:183524698-183560046:-	0.25	3.66	0.00028	Systemic lupus erythematosus	
PRAD	cis	1	rs12031278	chr1:40976918	DEM1	chr1:40974433-40982212:+	0.44	5.32	1.59E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs1203156	chr6:88079694	C6orf164	chr6:88032306-88109459:+	-0.19	-3.96	8.79E-5	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs1203156	chr6:88079694	C6orf165	chr6:88117721-88205858:+	-0.52	-9.56	6.35E-20	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs1203156	chr6:88079694	SLC35A1	chr6:88146444-88222051:+	-0.2	-3.78	0.000174	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs12031720	chr1:202449706	PPP1R12B	chr1:202317836-202557697:+	0.09	3.67	0.000269	Sex ratio	
PRAD	cis	1	rs12032643	chr1:249168436	OR2T10	chr1:248756132-248757069:-	-0.32	-3.82	0.000152	Myopia (pathological)	
PRAD	cis	1	rs12033293	chr1:183640422	NCF2	chr1:183524698-183560046:-	0.25	3.74	0.000205	Systemic lupus erythematosus	
PRAD	cis	1	rs12033433	chr1:183594279	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs12034162	chr1:40964605	DEM1	chr1:40974433-40982212:+	0.44	5.3	1.75E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs12036501	chr1:202336996	PPP1R12B	chr1:202317836-202557697:+	0.09	3.68	0.000262	Sex ratio	
PRAD	cis	1	rs12036825	chr1:183594432	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs12036830	chr1:183601471	NCF2	chr1:183524698-183560046:-	0.25	3.73	0.000217	Systemic lupus erythematosus	
PRAD	cis	1	rs12037222	chr1:40064961	BMP8A	chr1:39957318-39995537:+	0.24	3.7	0.000237	C-reactive protein levels or triglyceride levels (pleiotropy)	
PRAD	cis	1	rs12037222	chr1:40064961	OXCT2	chr1:40235197-40237020:-	0.21	3.44	0.00064	C-reactive protein levels or triglyceride levels (pleiotropy)	
PRAD	cis	1	rs12037222	chr1:40064961	PABPC4	chr1:40026485-40042521:-	-0.28	-5.31	1.67E-7	C-reactive protein levels or triglyceride levels (pleiotropy)	
PRAD	cis	1	rs12037290	chr1:183637038	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12037876	chr1:202469970	PPP1R12B	chr1:202317836-202557697:+	0.09	3.73	0.000213	Sex ratio	
PRAD	cis	1	rs12038024	chr1:183603907	NCF2	chr1:183524698-183560046:-	0.24	3.7	0.000245	Systemic lupus erythematosus	
PRAD	cis	1	rs12038203	chr1:156248265	BGLAP	chr1:156182784-156213112:+	0.21	5.47	7.47E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12038203	chr1:156248265	CCT3	chr1:156278752-156308195:-	-0.15	-3.43	0.000658	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12038217	chr1:156248297	BGLAP	chr1:156182784-156213112:+	0.21	5.47	7.47E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12038217	chr1:156248297	CCT3	chr1:156278752-156308195:-	-0.15	-3.43	0.000658	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12038369	chr1:183608146	NCF2	chr1:183524698-183560046:-	0.27	3.78	0.00018	Systemic lupus erythematosus	
PRAD	cis	1	rs12038481	chr1:156284815	BGLAP	chr1:156182784-156213112:+	0.22	5.59	3.8E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12038481	chr1:156284815	CCT3	chr1:156278752-156308195:-	-0.15	-3.45	0.000616	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12038826	chr1:230922951	CAPN9	chr1:230883130-230937749:+	0.4	3.76	0.000193	Myopia (pathological)	
PRAD	cis	1	rs12039168	chr1:183638854	NCF2	chr1:183524698-183560046:-	0.25	3.74	0.000205	Systemic lupus erythematosus	
PRAD	cis	1	rs12039431	chr1:38082122	RSPO1	chr1:38076951-38100491:-	-0.18	-3.95	9.06E-5	Epithelial ovarian cancer	
PRAD	cis	1	rs12039982	chr1:183614998	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs12040169	chr1:183639963	NCF2	chr1:183524698-183560046:-	0.23	3.51	0.000498	Systemic lupus erythematosus	
PRAD	cis	1	rs12040868	chr1:156284803	BGLAP	chr1:156182784-156213112:+	0.21	5.36	1.3E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12040868	chr1:156284803	CCT3	chr1:156278752-156308195:-	-0.15	-3.61	0.000345	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12040874	chr1:183615776	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.65	9.71	1.88E-20	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs12041164	chr1:156279811	BGLAP	chr1:156182784-156213112:+	0.22	5.8	1.21E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12041164	chr1:156279811	CCT3	chr1:156278752-156308195:-	-0.16	-3.81	0.000157	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12041202	chr1:202457177	PPP1R12B	chr1:202317836-202557697:+	0.09	3.81	0.000156	Sex ratio	
PRAD	cis	1	rs12041485	chr1:183591526	NCF2	chr1:183524698-183560046:-	0.26	3.82	0.000154	Systemic lupus erythematosus	
PRAD	cis	1	rs12041570	chr1:183612890	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs12041999	chr1:183608393	NCF2	chr1:183524698-183560046:-	0.27	3.78	0.00018	Systemic lupus erythematosus	
PRAD	cis	1	rs12042642	chr1:183614246	NCF2	chr1:183524698-183560046:-	-0.27	-3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12042646	chr1:183614282	NCF2	chr1:183524698-183560046:-	-0.24	-3.51	0.000497	Systemic lupus erythematosus	
PRAD	cis	1	rs12042669	chr1:202453928	PPP1R12B	chr1:202317836-202557697:+	0.09	3.71	0.000234	Sex ratio	
PRAD	cis	1	rs12042704	chr1:183614433	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs12043259	chr1:204828041	NFASC	chr1:204797782-204991949:+	-0.27	-5.84	9.74E-9	Addiction	
PRAD	cis	1	rs12043560	chr1:183594102	NCF2	chr1:183524698-183560046:-	0.25	3.64	0.0003	Systemic lupus erythematosus	
PRAD	cis	1	rs12043858	chr1:25047459	CLIC4	chr1:25071760-25170815:+	-0.09	-3.59	0.000372	Height	
PRAD	cis	1	rs12044355	chr1:231844347	DISC1	chr1:231762561-232177016:+	0.2	3.97	8.24E-5	Alzheimer's disease	
PRAD	cis	1	rs12044718	chr1:183616403	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs12044922	chr1:183613088	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12045319	chr1:183608449	NCF2	chr1:183524698-183560046:-	0.27	3.81	0.000159	Systemic lupus erythematosus	
PRAD	cis	1	rs12045339	chr1:156294211	BGLAP	chr1:156182784-156213112:+	0.22	5.89	7.26E-9	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12045339	chr1:156294211	CCT3	chr1:156278752-156308195:-	-0.15	-3.52	0.000476	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12045516	chr1:183625631	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12045554	chr1:183625753	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs12045762	chr1:183617413	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12045807	chr1:150584834	CTSK	chr1:150768687-150780812:-	0.17	4.15	3.9E-5	Congenital left-sided heart lesions	
PRAD	cis	1	rs12046650	chr1:38082123	RSPO1	chr1:38076951-38100491:-	-0.18	-3.95	9.06E-5	Epithelial ovarian cancer	
PRAD	cis	1	rs12046884	chr1:6594561	TNFRSF25	chr1:6521221-6526255:-	-0.14	-3.83	0.000148	Body mass index	
PRAD	cis	1	rs12047836	chr1:183615880	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12047865	chr1:183615929	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12047897	chr1:28253307	RPA2	chr1:28218049-28241236:-	0.28	5.17	3.44E-7	Corneal astigmatism	
PRAD	cis	1	rs12047931	chr1:6587614	TNFRSF25	chr1:6521221-6526255:-	-0.14	-3.44	0.000632	Body mass index	
PRAD	cis	1	rs12048127	chr1:183610804	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12048186	chr1:183611003	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12048457	chr1:183625491	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs1204853	chr6:116577113	FAM26F	chr6:116782556-116784933:+	0.14	4.2	3.26E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs1204853	chr6:116577113	FRK	chr6:116262693-116381921:-	-0.13	-3.65	0.000295	Fast beta electroencephalogram	
PRAD	cis	1	rs12048678	chr1:40947768	DEM1	chr1:40974433-40982212:+	0.44	5.21	2.8E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs12049175	chr1:183625562	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs12049588	chr1:46472422	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.17	8.4E-30	Body mass index	
PRAD	cis	1	rs12049588	chr1:46472422	MMACHC	chr1:45965856-45976737:+	-0.17	-3.78	0.000179	Body mass index	
PRAD	cis	1	rs12049588	chr1:46472422	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.51E-9	Body mass index	
PRAD	cis	1	rs12050300	chr14:74386523	HEATR4	chr14:73945193-74025651:-	-0.42	-3.76	0.000191	Morning vs. evening chronotype	
PRAD	cis	1	rs12050300	chr14:74386523	LIN52	chr14:74551656-74667117:+	0.3	3.65	0.000286	Morning vs. evening chronotype	
PRAD	cis	1	rs12050434	chr14:74341438	ENTPD5	chr14:74424715-74486026:-	-0.23	-3.5	0.00051	Morning vs. evening chronotype	
PRAD	cis	1	rs12050434	chr14:74341438	HEATR4	chr14:73945193-74025651:-	-0.43	-4.05	6.06E-5	Morning vs. evening chronotype	
PRAD	cis	1	rs12051145	chr16:67239676	FHOD1	chr16:67263294-67281425:-	0.49	5.62	3.24E-8	HDL cholesterol	
PRAD	cis	1	rs12051247	chr16:67241282	FHOD1	chr16:67263294-67281425:-	0.51	5.94	5.61E-9	HDL cholesterol	
PRAD	cis	1	rs12051247	chr16:67241282	PLEKHG4	chr16:67311413-67323402:+	0.31	3.48	0.000554	HDL cholesterol	
PRAD	cis	1	rs12051249	chr16:67241427	FHOD1	chr16:67263294-67281425:-	0.59	7.45	4.55E-13	HDL cholesterol	
PRAD	cis	1	rs12051249	chr16:67241427	SLC9A5	chr16:67282855-67306093:+	0.36	5.19	3.21E-7	HDL cholesterol	
PRAD	cis	1	rs12052257	chr2:202241594	ALS2CR12	chr2:202153148-202222101:-	0.25	4.36	1.59E-5	Basal cell carcinoma	
PRAD	cis	1	rs12053514	chr2:219167965	CCDC108	chr2:219867576-219906245:-	0.13	3.66	0.000282	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs12053519	chr2:99875018	MRPL30	chr2:99758185-99939196:+	0.24	3.9	0.000111	IgG glycosylation	
PRAD	cis	1	rs12053519	chr2:99875018	TSGA10	chr2:99613725-99771187:-	0.27	4.24	2.72E-5	IgG glycosylation	
PRAD	cis	1	rs12054923	chr5:150249059	LOC134466	chr5:150310000-150326146:-	0.59	8.96	7.62E-18	Crohn's disease	
PRAD	cis	1	rs12055786	chr6:153431125	RGS17	chr6:153332041-153452389:-	-0.56	-13.61	8.88E-36	Prostate cancer	
PRAD	cis	1	rs12067907	chr1:183658255	NCF2	chr1:183524698-183560046:-	0.23	3.45	0.000614	Systemic lupus erythematosus	
PRAD	cis	1	rs12073359	chr1:150008790	FAM63A	chr1:150969302-150980854:-	0.22	3.86	0.000127	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs12073359	chr1:150008790	RPRD2	chr1:150336990-150449039:+	0.13	3.52	0.000475	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs12081206	chr1:16087731	FBLIM1	chr1:16083154-16114431:+	0.18	3.71	0.00023	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs12083902	chr1:36275112	C1orf216	chr1:36179477-36184790:-	-0.35	-4.96	9.96E-7	Schizophrenia	
PRAD	cis	1	rs1208932	chr1:23429122	C1orf213	chr1:23695464-23698278:+	0.18	4.66	4.1E-6	Height	
PRAD	cis	1	rs12091564	chr1:145395604	NOTCH2NL	chr1:145209111-145295525:+	-0.89	-10.42	5.34E-23	Coronary heart disease	
PRAD	cis	1	rs12091720	chr1:76186949	ACADM	chr1:76190043-76229353:+	0.18	3.84	0.000142	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs12091731	chr1:16087824	FBLIM1	chr1:16083154-16114431:+	-0.18	-3.85	0.000135	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs12095015	chr1:207456474	CD55	chr1:207494817-207534309:+	-0.23	-4.03	6.45E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs12101255	chr14:81451052	SEL1L	chr14:81939240-82000205:-	0.14	3.55	0.000424	Graves' disease	
PRAD	cis	1	rs12101597	chr15:65935195	IGDCC4	chr15:65673825-65715410:-	-0.14	-3.44	0.000636	Mean corpuscular hemoglobin	
PRAD	cis	1	rs12105996	chr20:33731010	GDF5	chr20:33897002-34042568:-	0.24	3.81	0.000158	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs12105996	chr20:33731010	MMP24	chr20:33814539-33864804:+	-0.24	-3.99	7.62E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs12106067	chr20:55086063	C20orf43	chr20:55043647-55093942:+	0.16	3.68	0.000264	Refractive astigmatism	
PRAD	cis	1	rs12107539	chr3:151042464	P2RY12	chr3:151055238-151102544:-	-0.16	-3.91	0.000106	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
PRAD	cis	1	rs12117903	chr1:156311165	BGLAP	chr1:156182784-156213112:+	0.22	5.81	1.13E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12117903	chr1:156311165	CCT3	chr1:156278752-156308195:-	-0.16	-3.82	0.000154	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12117947	chr1:156244058	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12117947	chr1:156244058	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12117951	chr1:156305286	BGLAP	chr1:156182784-156213112:+	0.22	5.51	6.05E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12117951	chr1:156305286	CCT3	chr1:156278752-156308195:-	-0.15	-3.57	0.000395	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12118238	chr1:156235221	BGLAP	chr1:156182784-156213112:+	0.21	5.23	2.57E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12118238	chr1:156235221	CCT3	chr1:156278752-156308195:-	-0.15	-3.52	0.000472	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.65	9.83	7.41E-21	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs12121805	chr1:156257876	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12121805	chr1:156257876	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12122100	chr1:146508934	PDIA3P	chr1:146649430-146651528:+	-0.15	-3.43	0.000661	HIV-1 control	
PRAD	cis	1	rs12122180	chr1:156244559	BGLAP	chr1:156182784-156213112:+	0.21	5.47	7.47E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12122180	chr1:156244559	CCT3	chr1:156278752-156308195:-	-0.15	-3.43	0.000658	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12122290	chr1:247215810	ZNF670	chr1:247200087-247242069:-	-0.33	-7.33	1.01E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs12123006	chr1:202435228	PPP1R12B	chr1:202317836-202557697:+	0.1	3.93	9.86E-5	Sex ratio	
PRAD	cis	1	rs12126607	chr1:76217097	ACADM	chr1:76190043-76229353:+	0.17	3.75	0.000197	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs12126971	chr1:113231286	ST7L	chr1:113066142-113162405:-	0.66	9.84	6.67E-21	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs12127402	chr1:76205643	ACADM	chr1:76190043-76229353:+	0.18	3.85	0.000132	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs12130075	chr1:247218491	ZNF670	chr1:247200087-247242069:-	-0.32	-7.16	3.09E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs12130219	chr1:152162106	FLG	chr1:152274651-152297679:-	0.39	7.02	7.7E-12	Inflammatory skin disease	
PRAD	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.65	9.71	1.88E-20	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs12130361	chr1:156260301	BGLAP	chr1:156182784-156213112:+	0.21	5.47	7.47E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12130361	chr1:156260301	CCT3	chr1:156278752-156308195:-	-0.15	-3.43	0.000658	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12131882	chr1:202188264	UBE2T	chr1:202300786-202311094:-	-0.12	-3.51	0.000492	Breast cancer	
PRAD	cis	1	rs12132534	chr1:147098986	ACP6	chr1:147119168-147142634:-	0.25	3.82	0.000153	Warfarin maintenance dose	
PRAD	cis	1	rs12132794	chr1:156281020	BGLAP	chr1:156182784-156213112:+	-0.22	-5.48	7.11E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12132919	chr1:156318141	BGLAP	chr1:156182784-156213112:+	0.21	5.32	1.61E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.66	10.11	7.14E-22	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs12133933	chr1:37958389	MEAF6	chr1:37958176-37980364:-	-0.35	-5.07	5.67E-7	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs12133933	chr1:37958389	SNIP1	chr1:38002145-38019903:-	-0.27	-4.62	4.96E-6	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs12133982	chr1:119464002	WARS2	chr1:119573841-119683295:-	0.36	4.92	1.2E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12134133	chr1:207457845	CD55	chr1:207494817-207534309:+	0.43	8.24	1.79E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs12134163	chr1:119466993	WARS2	chr1:119573841-119683295:-	0.36	4.91	1.25E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12134983	chr1:156290409	BGLAP	chr1:156182784-156213112:+	0.22	5.59	3.8E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12134983	chr1:156290409	CCT3	chr1:156278752-156308195:-	-0.15	-3.45	0.000616	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12135657	chr1:119470813	WARS2	chr1:119573841-119683295:-	0.36	4.91	1.25E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12138117	chr1:16305279	CLCNKA	chr1:16345370-16360544:+	-0.41	-7.74	6.07E-14	Dilated cardiomyopathy	
PRAD	cis	1	rs12138343	chr1:119495317	WARS2	chr1:119573841-119683295:-	0.36	4.9	1.29E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12139321	chr1:156230429	BGLAP	chr1:156182784-156213112:+	0.2	5.09	5.07E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12139321	chr1:156230429	CCT3	chr1:156278752-156308195:-	-0.16	-3.69	0.00025	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12139630	chr1:46350935	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.08	1.89E-29	Body mass index	
PRAD	cis	1	rs12139630	chr1:46350935	MMACHC	chr1:45965856-45976737:+	-0.17	-3.78	0.000176	Body mass index	
PRAD	cis	1	rs12139630	chr1:46350935	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.53E-9	Body mass index	
PRAD	cis	1	rs12139690	chr1:119491316	WARS2	chr1:119573841-119683295:-	0.36	4.95	1.06E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12141236	chr1:156302575	BGLAP	chr1:156182784-156213112:+	0.22	5.81	1.13E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12141236	chr1:156302575	CCT3	chr1:156278752-156308195:-	-0.16	-3.82	0.000154	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12141651	chr1:119492703	WARS2	chr1:119573841-119683295:-	0.36	4.88	1.47E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12141912	chr1:247863927	OR2W3	chr1:248031265-248060142:+	-0.33	-4.95	1.06E-6	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs12141912	chr1:247863927	TRIM58	chr1:248020501-248043436:+	-0.3	-4.41	1.26E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs12142808	chr1:156230546	BGLAP	chr1:156182784-156213112:+	0.2	5.09	5.07E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12142808	chr1:156230546	CCT3	chr1:156278752-156308195:-	-0.16	-3.69	0.00025	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12143789	chr1:119497154	WARS2	chr1:119573841-119683295:-	-0.34	-4.76	2.62E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12144263	chr1:46352446	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.13	1.15E-29	Body mass index	
PRAD	cis	1	rs12144263	chr1:46352446	MMACHC	chr1:45965856-45976737:+	-0.17	-3.82	0.000153	Body mass index	
PRAD	cis	1	rs12144263	chr1:46352446	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.23E-9	Body mass index	
PRAD	cis	1	rs12144610	chr1:119501103	WARS2	chr1:119573841-119683295:-	0.35	4.76	2.64E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12145310	chr1:20901064	CDA	chr1:20915444-20945398:+	-0.15	-3.78	0.000174	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs12145310	chr1:20901064	FAM43B	chr1:20878932-20881512:+	0.15	3.75	0.000203	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs12145351	chr1:20901181	CDA	chr1:20915444-20945398:+	-0.15	-3.78	0.000175	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs12145351	chr1:20901181	FAM43B	chr1:20878932-20881512:+	0.15	3.7	0.000245	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs12147690	chr14:60924009	C14orf39	chr14:60902675-60952764:-	0.45	5.97	4.56E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs12147952	chr14:76624884	C14orf118	chr14:76618259-76669133:+	-0.15	-3.5	0.000507	Blood pressure	
PRAD	cis	1	rs12147952	chr14:76624884	ESRRB	chr14:76837690-76968178:+	-0.27	-3.51	0.000483	Blood pressure	
PRAD	cis	1	rs12148786	chr15:76800362	SCAPER	chr15:76640529-77197744:-	-0.12	-3.54	0.000446	Blood metabolite levels	
PRAD	cis	1	rs12149608	chr16:68586504	CDH1	chr16:68771195-68869444:+	-0.25	-3.59	0.000366	Ulcerative colitis	
PRAD	cis	1	rs12149703	chr16:159210	NPRL3	chr16:134273-188672:-	0.19	4.89	1.4E-6	Red blood cell traits	
PRAD	cis	1	rs12149862	chr16:69497203	PDF	chr16:69362524-69364498:-	0.21	3.87	0.000124	Blood pressure (smoking interaction)	
PRAD	cis	1	rs12152512	chr3:10143770	C3orf10	chr3:10157333-10168873:+	-0.19	-3.83	0.000147	Alzheimer's disease	
PRAD	cis	1	rs12152512	chr3:10143770	LOC401052	chr3:10048102-10052779:-	-0.3	-5.57	4.34E-8	Alzheimer's disease	
PRAD	cis	1	rs12152515	chr3:10143976	C3orf10	chr3:10157333-10168873:+	-0.19	-3.78	0.000178	Alzheimer's disease	
PRAD	cis	1	rs12152515	chr3:10143976	LOC401052	chr3:10048102-10052779:-	-0.3	-5.53	5.28E-8	Alzheimer's disease	
PRAD	cis	1	rs12153877	chr6:33765465	IP6K3	chr6:33689443-33714762:-	0.19	3.74	0.000209	Obesity (extreme)	
PRAD	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.49	-11.05	2.17E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs12155623	chr8:49812201	EFCAB1	chr8:49623351-49647870:-	0.18	3.75	0.000198	Sudden cardiac arrest	
PRAD	cis	1	rs12171333	chr4:129879711	C4orf33	chr4:130014829-130033842:+	0.44	6.98	1.03E-11	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs12172	chr2:97500852	CNNM4	chr2:97426639-97477626:+	0.24	3.55	0.000424	Erectile dysfunction and prostate cancer treatment	
PRAD	cis	1	rs12178257	chr6:149607060	ULBP2	chr6:150263136-150270366:+	0.2	3.63	0.000315	Breast cancer	
PRAD	cis	1	rs12185102	chr15:75352201	PPCDC	chr15:75315927-75343066:+	0.14	3.68	0.000256	Blood trace element (Zn levels)	
PRAD	cis	1	rs12185102	chr15:75352201	SCAMP5	chr15:75287901-75313836:+	0.43	7.43	5.2E-13	Blood trace element (Zn levels)	
PRAD	cis	1	rs12188164	chr5:428236	C5orf55	chr5:441645-443258:-	0.18	3.8	0.000162	Cystic fibrosis severity	
PRAD	cis	1	rs12188164	chr5:428236	LOC25845	chr5:470626-473080:-	0.29	4.93	1.14E-6	Cystic fibrosis severity	
PRAD	cis	1	rs12188678	chr5:428231	C5orf55	chr5:441645-443258:-	0.18	3.8	0.000162	Cystic fibrosis severity	
PRAD	cis	1	rs12188678	chr5:428231	LOC25845	chr5:470626-473080:-	0.29	4.93	1.14E-6	Cystic fibrosis severity	
PRAD	cis	1	rs12189725	chr6:33703394	IP6K3	chr6:33689443-33714762:-	0.19	3.9	0.000108	Obesity (extreme)	
PRAD	cis	1	rs12190146	chr6:159414155	RSPH3	chr6:159398268-159421198:-	0.29	4.57	6.35E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.49	-10.48	3.2E-23	Response to antipsychotic treatment	
PRAD	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.5	-11.41	8.93E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12190954	chr6:33746618	IP6K3	chr6:33689443-33714762:-	0.19	3.71	0.000233	Obesity (extreme)	
PRAD	cis	1	rs12192279	chr6:110055313	PPIL6	chr6:109711419-109761990:-	0.33	3.49	0.000533	Hematological parameters	
PRAD	cis	1	rs12192947	chr6:24318570	GPLD1	chr6:24428405-24489850:-	0.18	3.46	0.000596	Uric acid levels	
PRAD	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.51	-11.5	3.96E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12193658	chr6:33705528	IP6K3	chr6:33689443-33714762:-	0.2	4.01	7.09E-5	Obesity (extreme)	
PRAD	cis	1	rs12195409	chr6:33757482	IP6K3	chr6:33689443-33714762:-	0.19	3.77	0.000188	Obesity (extreme)	
PRAD	cis	1	rs12195680	chr6:116647428	FAM26F	chr6:116782556-116784933:+	0.13	4.01	7.15E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.51	-11.4	9.73E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.52	-11.4	9.15E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12196937	chr6:49382808	CENPQ	chr6:49431096-49460820:+	-0.39	-8.21	2.1E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.18	5.03	7.09E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs12197114	chr6:109735498	SMPD2	chr6:109761931-109765121:+	0.3	6.39	4.07E-10	Height	
PRAD	cis	1	rs12199015	chr6:132058947	ENPP3	chr6:131949582-132068549:+	-0.43	-3.73	0.000214	Response to fenofibrate (adiponectin levels)	
PRAD	cis	1	rs12199132	chr6:33708250	IP6K3	chr6:33689443-33714762:-	0.19	3.93	9.58E-5	Obesity (extreme)	
PRAD	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.51	-11.63	1.24E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.5	-11.48	4.5E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.51	-11.55	2.39E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.51	-11.48	4.56E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.49	-11.03	2.69E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.47	-10.4	6.06E-23	Response to antipsychotic treatment	
PRAD	cis	1	rs12201741	chr6:86602619	SYNCRIP	chr6:86317503-86353043:-	0.14	3.5	0.000511	Response to antipsychotic treatment	
PRAD	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.49	-11.05	2.17E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs12202075	chr6:49427655	CENPQ	chr6:49431096-49460820:+	-0.41	-8.73	4.39E-17	Folate pathway vitamin levels	
PRAD	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.19	5.23	2.55E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs12202783	chr6:159388629	RSPH3	chr6:159398268-159421198:-	0.29	4.58	6.04E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12203483	chr6:159386228	RSPH3	chr6:159398268-159421198:-	0.29	4.58	6.04E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.51	-11.41	8.48E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12203516	chr6:116638619	FAM26F	chr6:116782556-116784933:+	0.13	4.11	4.76E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.51	-11.41	8.48E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.51	-11.98	5.02E-29	Response to antipsychotic treatment	
PRAD	cis	1	rs12204234	chr6:116647587	FAM26F	chr6:116782556-116784933:+	0.13	4.04	6.29E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.48	-10.84	1.33E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs12204992	chr6:33741724	IP6K3	chr6:33689443-33714762:-	0.19	3.77	0.000188	Obesity (extreme)	
PRAD	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.51	-11.64	1.1E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.52	-11.58	1.95E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12206452	chr6:24318680	GPLD1	chr6:24428405-24489850:-	0.18	3.46	0.000596	Uric acid levels	
PRAD	cis	1	rs12206779	chr6:132055593	ENPP3	chr6:131949582-132068549:+	0.44	3.78	0.000176	Response to fenofibrate (adiponectin levels)	
PRAD	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.5	-11.48	4.5E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.47	-10.77	2.6E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs12207795	chr6:159366261	RSPH3	chr6:159398268-159421198:-	0.28	4.4	1.37E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12207932	chr6:24318912	GPLD1	chr6:24428405-24489850:-	0.18	3.46	0.000596	Uric acid levels	
PRAD	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.5	-11.39	1.08E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs12208892	chr6:159371192	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12208901	chr6:159371238	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.51	-11.6	1.55E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12210218	chr6:159377219	RSPH3	chr6:159398268-159421198:-	0.28	4.52	7.78E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12211490	chr6:33725528	IP6K3	chr6:33689443-33714762:-	0.19	3.78	0.000175	Obesity (extreme)	
PRAD	cis	1	rs12211554	chr6:33725788	IP6K3	chr6:33689443-33714762:-	0.19	3.78	0.000175	Obesity (extreme)	
PRAD	cis	1	rs12211565	chr6:33725852	IP6K3	chr6:33689443-33714762:-	0.19	3.78	0.000175	Obesity (extreme)	
PRAD	cis	1	rs12212556	chr6:116613907	FAM26F	chr6:116782556-116784933:+	0.13	4.08	5.28E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs12212609	chr6:116614045	FAM26F	chr6:116782556-116784933:+	0.13	4.05	5.91E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.51	-11.62	1.25E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12213122	chr6:24317873	GPLD1	chr6:24428405-24489850:-	0.19	3.56	0.000404	Uric acid levels	
PRAD	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.5	-11.39	1.08E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs12213434	chr6:159369128	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12213442	chr6:116636907	FAM26F	chr6:116782556-116784933:+	0.13	3.98	8.05E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.48	-10.88	1.01E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs12214813	chr6:159362013	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12214878	chr6:159362118	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12214926	chr6:116643292	FAM26F	chr6:116782556-116784933:+	0.13	4.1	4.83E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.53	-11.87	1.34E-28	Response to antipsychotic treatment	
PRAD	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.48	-10.95	5.18E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs12215936	chr6:159371324	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.5	-11.37	1.23E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.5	-11.26	3.45E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs12216499	chr6:159368524	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12219158	chr10:102302923	SEC31B	chr10:102246403-102289636:-	-0.29	-8.54	1.91E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs12219789	chr10:102213778	SEC31B	chr10:102246403-102289636:-	-0.32	-9.55	7.18E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-0.7	-8.72	4.78E-17	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs12227986	chr12:85467544	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12227986	chr12:85467544	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12227986	chr12:85467544	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12229825	chr12:58766330	TSFM	chr12:58176536-58191367:+	-0.18	-3.56	0.000406	Obesity-related traits	
PRAD	cis	1	rs12229923	chr12:85453272	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12229923	chr12:85453272	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12229923	chr12:85453272	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12231122	chr12:85465237	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12231122	chr12:85465237	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12231122	chr12:85465237	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12231824	chr12:58754222	TSFM	chr12:58176536-58191367:+	-0.17	-3.45	0.000613	Obesity-related traits	
PRAD	cis	1	rs12236346	chr9:113657701	PTGR1	chr9:114312003-114362135:-	-0.24	-3.75	0.000201	Corneal structure	
PRAD	cis	1	rs12237653	chr9:2551654	FLJ35024	chr9:2422702-2622373:-	0.38	5.06	5.97E-7	Gambling	
PRAD	cis	1	rs12243096	chr10:101812302	CWF19L1	chr10:101992055-102027437:-	0.27	5.51	6.01E-8	Bone mineral density	
PRAD	cis	1	rs12250141	chr10:1160106	IDI2	chr10:1064847-1071799:-	0.38	4.54	7.31E-6	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs12261336	chr10:81685557	LOC219347	chr10:81805991-81838949:-	0.39	3.62	0.000326	Rheumatoid arthritis	
PRAD	cis	1	rs12261337	chr10:81685558	LOC219347	chr10:81805991-81838949:-	0.38	3.59	0.000366	Rheumatoid arthritis	
PRAD	cis	1	rs12270208	chr11:7706976	CYB5R2	chr11:7686327-7694994:-	0.19	4.2	3.23E-5	Waist circumference	
PRAD	cis	1	rs12270434	chr11:78103300	GAB2	chr11:77926343-78128766:-	-0.17	-5.76	1.56E-8	Testicular germ cell tumor	
PRAD	cis	1	rs12270434	chr11:78103300	NARS2	chr11:78147017-78285909:-	-0.2	-4.28	2.3E-5	Testicular germ cell tumor	
PRAD	cis	1	rs12271537	chr11:7707101	CYB5R2	chr11:7686327-7694994:-	0.19	4.19	3.35E-5	Waist circumference	
PRAD	cis	1	rs12273360	chr11:46889719	ARHGAP1	chr11:46698634-46722120:-	-0.26	-3.84	0.000138	Schizophrenia	
PRAD	cis	1	rs12274672	chr11:7706857	CYB5R2	chr11:7686327-7694994:-	0.19	4.22	2.99E-5	Waist circumference	
PRAD	cis	1	rs12277648	chr11:78054336	GAB2	chr11:77926343-78128766:-	-0.18	-6.14	1.77E-9	Testicular germ cell tumor	
PRAD	cis	1	rs12277648	chr11:78054336	NARS2	chr11:78147017-78285909:-	-0.26	-5.67	2.48E-8	Testicular germ cell tumor	
PRAD	cis	1	rs12279819	chr11:62137245	ASRGL1	chr11:62104774-62160885:+	0.39	4.78	2.32E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs12286683	chr11:18348662	GTF2H1	chr11:18343816-18388590:+	0.75	15.75	3.6E-45	Pancreatic cancer	
PRAD	cis	1	rs12287212	chr11:14449861	COPB1	chr11:14479049-14521441:-	0.12	3.97	8.15E-5	Vitamin D levels	
PRAD	cis	1	rs12287832	chr11:65553492	CTSW	chr11:65647284-65651212:+	-0.3	-5.67	2.44E-8	Systemic lupus erythematosus	
PRAD	cis	1	rs12287832	chr11:65553492	SNX32	chr11:65601410-65621170:+	0.29	3.95	9.09E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12292425	chr11:46644143	HARBI1	chr11:46624857-46638777:-	0.27	3.65	0.000287	Schizophrenia	
PRAD	cis	1	rs12294369	chr11:5567068	UBQLNL	chr11:5535624-5537956:-	0.17	3.62	0.00033	QRS duration in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs12295163	chr11:7706968	CYB5R2	chr11:7686327-7694994:-	0.19	4.2	3.23E-5	Waist circumference	
PRAD	cis	1	rs12299125	chr12:123862447	ABCB9	chr12:123413540-123459752:-	0.28	4.79	2.24E-6	Educational attainment;Height;Head circumference (infant)	
PRAD	cis	1	rs12299125	chr12:123862447	CDK2AP1	chr12:123745542-123756687:-	-0.2	-4.29	2.13E-5	Educational attainment;Height;Head circumference (infant)	
PRAD	cis	1	rs12301299	chr12:991710	RAD52	chr12:1021255-1099219:-	-0.39	-6.31	6.52E-10	Colorectal cancer	
PRAD	cis	1	rs12301673	chr12:124455818	ZNF664	chr12:124457670-124499967:+	-0.16	-4.07	5.4E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12303914	chr12:10471050	KLRD1	chr12:10457050-10469849:+	-0.16	-3.74	0.000203	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs12304878	chr12:51353851	TFCP2	chr12:51488608-51566917:-	-0.21	-3.46	0.00059	Type 2 diabetes	
PRAD	cis	1	rs12304921	chr12:51357542	TFCP2	chr12:51488608-51566917:-	0.22	3.58	0.000384	Type 2 diabetes	
PRAD	cis	1	rs12306808	chr12:51354803	TFCP2	chr12:51488608-51566917:-	-0.21	-3.5	0.000515	Type 2 diabetes	
PRAD	cis	1	rs12309274	chr12:975948	RAD52	chr12:1021255-1099219:-	-0.42	-6.91	1.6E-11	Colorectal cancer	
PRAD	cis	1	rs12312603	chr12:988269	RAD52	chr12:1021255-1099219:-	-0.42	-6.87	1.99E-11	Colorectal cancer	
PRAD	cis	1	rs12315928	chr12:51355931	TFCP2	chr12:51488608-51566917:-	-0.21	-3.5	0.000515	Type 2 diabetes	
PRAD	cis	1	rs12317171	chr12:51337669	TFCP2	chr12:51488608-51566917:-	0.2	3.5	0.000517	Type 2 diabetes	
PRAD	cis	1	rs12318464	chr12:51357346	TFCP2	chr12:51488608-51566917:-	-0.21	-3.5	0.000515	Type 2 diabetes	
PRAD	cis	1	rs12323989	chr15:68206030	PIAS1	chr15:68346572-68480402:+	-0.14	-4.62	5.04E-6	Cognitive performance	
PRAD	cis	1	rs12324912	chr15:75361006	PPCDC	chr15:75315927-75343066:+	0.14	3.62	0.00033	Blood trace element (Zn levels)	
PRAD	cis	1	rs12324912	chr15:75361006	SCAMP5	chr15:75287901-75313836:+	0.41	7.16	3.15E-12	Blood trace element (Zn levels)	
PRAD	cis	1	rs12325866	chr17:61755974	CD79B	chr17:62006098-62009704:-	0.12	3.51	0.000496	Body mass index	
PRAD	cis	1	rs12325866	chr17:61755974	DDX42	chr17:61851567-61896676:+	-0.25	-5.18	3.28E-7	Body mass index	
PRAD	cis	1	rs12325866	chr17:61755974	FTSJ3	chr17:61896795-61905031:-	0.34	6.81	3.06E-11	Body mass index	
PRAD	cis	1	rs12325866	chr17:61755974	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.56E-6	Body mass index	
PRAD	cis	1	rs12329875	chr21:30137796	N6AMT1	chr21:30244513-30257693:-	-0.3	-4	7.4E-5	Cognitive test performance	
PRAD	cis	1	rs12332658	chr5:115545606	COMMD10	chr5:115420727-115628978:+	0.27	3.54	0.000438	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs12354411	chr10:102294537	SEC31B	chr10:102246403-102289636:-	-0.28	-8.5	2.56E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs12355721	chr10:102244911	SEC31B	chr10:102246403-102289636:-	-0.33	-9.85	6.42E-21	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs12355784	chr10:65121565	JMJD1C	chr10:64926990-65225722:-	-0.11	-3.9	0.00011	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs12355784	chr10:65121565	NRBF2	chr10:64893007-64914785:+	-0.29	-6.35	5.11E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs12358187	chr10:102284449	SEC31B	chr10:102246403-102289636:-	-0.3	-8.98	6.57E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs12358475	chr10:11848792	ECHDC3	chr10:11784356-11806064:+	-0.3	-4.05	5.99E-5	Breast cancer (survival)	
PRAD	cis	1	rs12359272	chr10:97365163	ENTPD1	chr10:97471536-97637022:+	0.14	4.07	5.5E-5	Blood metabolite levels	
PRAD	cis	1	rs12359272	chr10:97365163	TCTN3	chr10:97423154-97453900:-	0.22	4.21	3.1E-5	Blood metabolite levels	
PRAD	cis	1	rs12361812	chr11:48563104	FOLH1	chr11:49168188-49230222:-	-0.16	-3.64	0.000299	HDL cholesterol	
PRAD	cis	1	rs12363232	chr11:47623890	C1QTNF4	chr11:47611216-47615961:-	-0.16	-3.97	8.37E-5	Subjective well-being	
PRAD	cis	1	rs12365220	chr11:48555957	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000333	HDL cholesterol	
PRAD	cis	1	rs12370842	chr12:21393586	SLCO1A2	chr12:21417535-21548371:-	0.23	3.51	0.000485	Blood metabolite levels	
PRAD	cis	1	rs12372593	chr12:21393829	SLCO1A2	chr12:21417535-21548371:-	0.23	3.51	0.000485	Blood metabolite levels	
PRAD	cis	1	rs12372597	chr12:42412850	GXYLT1	chr12:42475650-42538673:-	-0.14	-3.77	0.000185	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
PRAD	cis	1	rs12372623	chr12:42531666	GXYLT1	chr12:42475650-42538673:-	-0.14	-3.88	0.00012	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
PRAD	cis	1	rs12374115	chr3:10134766	C3orf10	chr3:10157333-10168873:+	0.21	4.3	2.11E-5	Alzheimer's disease	
PRAD	cis	1	rs12374115	chr3:10134766	LOC401052	chr3:10048102-10052779:-	0.29	5.44	8.48E-8	Alzheimer's disease	
PRAD	cis	1	rs12374256	chr4:106617361	INTS12	chr4:106603787-106629881:-	-0.78	-7.93	1.61E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs12377604	chr9:100697287	C9orf156	chr9:100666772-100684852:-	-0.19	-3.68	0.000264	Quantitative traits	
PRAD	cis	1	rs12377624	chr9:129373110	LMX1B	chr9:129376748-129463311:+	0.23	3.69	0.000248	Eyebrow thickness	
PRAD	cis	1	rs12401795	chr1:6594773	TNFRSF25	chr1:6521221-6526255:-	-0.14	-3.86	0.000131	Body mass index	
PRAD	cis	1	rs12405278	chr1:152282267	FLG	chr1:152274651-152297679:-	0.37	5.23	2.5E-7	Atopic dermatitis	
PRAD	cis	1	rs12405451	chr1:46384326	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.17	8.32E-30	Body mass index	
PRAD	cis	1	rs12405451	chr1:46384326	MMACHC	chr1:45965856-45976737:+	-0.17	-3.77	0.000181	Body mass index	
PRAD	cis	1	rs12405451	chr1:46384326	MUTYH	chr1:45794915-45806142:-	0.21	5.94	5.4E-9	Body mass index	
PRAD	cis	1	rs12405771	chr1:202464280	PPP1R12B	chr1:202317836-202557697:+	0.09	3.71	0.000234	Sex ratio	
PRAD	cis	1	rs12409773	chr1:46358831	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.15	9.52E-30	Body mass index	
PRAD	cis	1	rs12409773	chr1:46358831	MMACHC	chr1:45965856-45976737:+	-0.17	-3.77	0.000184	Body mass index	
PRAD	cis	1	rs12409773	chr1:46358831	MUTYH	chr1:45794915-45806142:-	0.21	5.93	5.95E-9	Body mass index	
PRAD	cis	1	rs12410060	chr1:75245848	CRYZ	chr1:75171175-75199092:-	-0.35	-6.49	2.21E-10	Resistin levels	
PRAD	cis	1	rs12410071	chr1:46358886	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.15	9.52E-30	Body mass index	
PRAD	cis	1	rs12410071	chr1:46358886	MMACHC	chr1:45965856-45976737:+	-0.17	-3.77	0.000184	Body mass index	
PRAD	cis	1	rs12410071	chr1:46358886	MUTYH	chr1:45794915-45806142:-	0.21	5.93	5.95E-9	Body mass index	
PRAD	cis	1	rs12411269	chr1:46271052	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.26	3.52E-30	Body mass index	
PRAD	cis	1	rs12411269	chr1:46271052	MMACHC	chr1:45965856-45976737:+	-0.17	-3.81	0.00016	Body mass index	
PRAD	cis	1	rs12411269	chr1:46271052	MUTYH	chr1:45794915-45806142:-	0.21	5.99	4.24E-9	Body mass index	
PRAD	cis	1	rs12413671	chr10:5355552	TUBAL3	chr10:5435062-5446793:-	-0.26	-3.74	0.000204	Intelligence	
PRAD	cis	1	rs12414891	chr10:81690385	PLAC9	chr10:81892258-81904784:+	-0.24	-3.47	0.000563	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs12414891	chr10:81690385	SFTPA1	chr10:81370712-81375201:+	-0.51	-4.4	1.37E-5	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs12416300	chr10:5355462	TUBAL3	chr10:5435062-5446793:-	-0.26	-3.57	0.000388	Intelligence	
PRAD	cis	1	rs12416687	chr10:104629011	AS3MT	chr10:104613967-104661653:+	-0.46	-9.67	2.68E-20	Arsenic metabolism	
PRAD	cis	1	rs12416687	chr10:104629011	C10orf32	chr10:104613967-104624718:+	-0.44	-8.6	1.19E-16	Arsenic metabolism	
PRAD	cis	1	rs12416687	chr10:104629011	NT5C2	chr10:104845940-104953056:-	-0.29	-5.17	3.45E-7	Arsenic metabolism	
PRAD	cis	1	rs12417570	chr11:462684	LRRC56	chr11:537522-554915:+	0.31	4.5	8.56E-6	Body mass index	
PRAD	cis	1	rs12417570	chr11:462684	RNH1	chr11:494512-507273:-	-0.21	-3.7	0.00024	Body mass index	
PRAD	cis	1	rs12418639	chr11:473300	ANO9	chr11:417930-442011:-	-0.22	-3.73	0.000212	Body mass index	
PRAD	cis	1	rs12418639	chr11:473300	LRRC56	chr11:537522-554915:+	-0.28	-4.41	1.27E-5	Body mass index	
PRAD	cis	1	rs12418639	chr11:473300	RNH1	chr11:494512-507273:-	0.19	3.58	0.00038	Body mass index	
PRAD	cis	1	rs12419576	chr11:48581644	FOLH1	chr11:49168188-49230222:-	-0.16	-3.62	0.000326	HDL cholesterol	
PRAD	cis	1	rs12419692	chr11:47624714	C1QTNF4	chr11:47611216-47615961:-	0.16	4.21	3.04E-5	Subjective well-being	
PRAD	cis	1	rs12419716	chr11:503385	ANO9	chr11:417930-442011:-	0.25	3.96	8.67E-5	Body mass index	
PRAD	cis	1	rs12419716	chr11:503385	LRRC56	chr11:537522-554915:+	0.27	4.05	5.97E-5	Body mass index	
PRAD	cis	1	rs12419716	chr11:503385	RNH1	chr11:494512-507273:-	-0.2	-3.68	0.000258	Body mass index	
PRAD	cis	1	rs12419766	chr11:503710	ANO9	chr11:417930-442011:-	0.25	3.96	8.67E-5	Body mass index	
PRAD	cis	1	rs12419766	chr11:503710	LRRC56	chr11:537522-554915:+	0.27	4.05	5.97E-5	Body mass index	
PRAD	cis	1	rs12419766	chr11:503710	RNH1	chr11:494512-507273:-	-0.2	-3.68	0.000258	Body mass index	
PRAD	cis	1	rs12421159	chr11:48624841	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000344	HDL cholesterol	
PRAD	cis	1	rs12421457	chr11:505780	ANO9	chr11:417930-442011:-	0.25	3.96	8.67E-5	Body mass index	
PRAD	cis	1	rs12421457	chr11:505780	LRRC56	chr11:537522-554915:+	0.27	4.05	5.97E-5	Body mass index	
PRAD	cis	1	rs12421457	chr11:505780	RNH1	chr11:494512-507273:-	-0.2	-3.68	0.000258	Body mass index	
PRAD	cis	1	rs12421879	chr11:48689978	FOLH1	chr11:49168188-49230222:-	-0.18	-4.03	6.56E-5	HDL cholesterol	
PRAD	cis	1	rs12422267	chr12:132601596	DDX51	chr12:132621142-132628880:-	0.56	7.02	7.56E-12	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs12422267	chr12:132601596	EP400NL	chr12:132568828-132600084:+;chr12	-0.62	-8.14	3.51E-15	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs1242229	chr11:117062370	PCSK7	chr11:117075789-117102811:-	-0.34	-4.3	2.12E-5	Protein quantitative trait loci	
PRAD	cis	1	rs12422771	chr12:6580273	TAPBPL	chr12:6561177-6575601:+	-0.26	-4.04	6.24E-5	Hip geometry	
PRAD	cis	1	rs12423325	chr12:62507054	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs12425896	chr12:62506902	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs12428	chr20:25433821	ENTPD6	chr20:25176339-25207360:+	0.15	3.88	0.000119	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs12428	chr20:25433821	FAM182B	chr20:25744102-25848786:-	-0.38	-7.12	4.07E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs12428	chr20:25433821	PYGB	chr20:25228706-25278647:+	0.3	6.67	7.42E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs12431420	chr14:66001076	LOC645431	chr14:65877313-65879335:-	-0.4	-4.21	3.07E-5	Ischemic stroke	
PRAD	cis	1	rs12433464	chr14:88824015	SPATA7	chr14:88852012-88904802:+	-0.2	-3.98	7.89E-5	Coronary artery calcification	
PRAD	cis	1	rs12433827	chr14:66055610	LOC645431	chr14:65877313-65879335:-	-0.41	-3.89	0.000115	Ischemic stroke	
PRAD	cis	1	rs12434585	chr14:65938368	LOC645431	chr14:65877313-65879335:-	-0.44	-4.46	1.05E-5	Ischemic stroke	
PRAD	cis	1	rs12435391	chr14:75601737	EIF2B2	chr14:75469612-75476292:+	0.25	5.03	6.91E-7	Height	
PRAD	cis	1	rs12435391	chr14:75601737	MLH3	chr14:75480467-75518235:-	0.33	6.58	1.29E-10	Height	
PRAD	cis	1	rs12435835	chr14:65499909	CHURC1	chr14:65381140-65411309:+	0.19	4.17	3.69E-5	Red blood cell traits	
PRAD	cis	1	rs12437310	chr14:76642757	ESRRB	chr14:76837690-76968178:+	0.26	3.58	0.000375	Blood pressure	
PRAD	cis	1	rs12438305	chr15:50912454	SPPL2A	chr15:50999739-51057910:-	0.27	5.57	4.31E-8	QT interval	
PRAD	cis	1	rs12439239	chr15:31651718	CHRFAM7A	chr15:30653443-30685864:-	-0.31	-3.45	0.000621	Survival in colorectal cancer (non-distant metastatic)	
PRAD	cis	1	rs12439744	chr15:50899211	SPPL2A	chr15:50999739-51057910:-	0.26	5.38	1.2E-7	QT interval	
PRAD	cis	1	rs12440862	chr15:79217900	CTSH	chr15:79214092-79237420:-	0.44	6.06	2.79E-9	Bipolar disorder	
PRAD	cis	1	rs12441433	chr15:76816015	SCAPER	chr15:76640529-77197744:-	-0.12	-3.69	0.00025	Blood metabolite levels	
PRAD	cis	1	rs12441725	chr15:79218773	CTSH	chr15:79214092-79237420:-	0.44	6.04	3.22E-9	Bipolar disorder	
PRAD	cis	1	rs12442787	chr15:50918107	SPPL2A	chr15:50999739-51057910:-	0.26	5.38	1.2E-7	QT interval	
PRAD	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.52	-6.37	4.63E-10	Tumor biomarkers	
PRAD	cis	1	rs12443102	chr15:43932103	CKMT1A	chr15:43985084-43991419:+	-0.54	-6.05	2.98E-9	Tumor biomarkers	
PRAD	cis	1	rs12443137	chr15:76840832	SCAPER	chr15:76640529-77197744:-	-0.13	-3.76	0.000193	Blood metabolite levels	
PRAD	cis	1	rs12443295	chr15:63313666	RPS27L	chr15:63445540-63449741:-	0.14	3.49	0.000538	Orofacial clefts	
PRAD	cis	1	rs12445650	chr16:31044897	HSD3B7	chr16:30996519-31000473:+	0.49	10.68	5.71E-24	Response to metformin (IC50)	
PRAD	cis	1	rs12445650	chr16:31044897	MYST1	chr16:31128985-31142713:+	0.21	6.42	3.27E-10	Response to metformin (IC50)	
PRAD	cis	1	rs12445650	chr16:31044897	PRSS36	chr16:31150251-31161415:-	0.19	4.93	1.13E-6	Response to metformin (IC50)	
PRAD	cis	1	rs12445650	chr16:31044897	PRSS53	chr16:31094747-31106276:-	-0.19	-3.76	0.000191	Response to metformin (IC50)	
PRAD	cis	1	rs12445650	chr16:31044897	STX1B	chr16:31000577-31021829:-	0.22	5.75	1.6E-8	Response to metformin (IC50)	
PRAD	cis	1	rs12446632	chr16:19935389	C16orf88	chr16:19717676-19729492:-	0.24	4.03	6.51E-5	Body mass index;Menarche (age at onset);Childhood body mass index;Obesity	
PRAD	cis	1	rs12451511	chr17:65874861	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs12451707	chr17:65871598	LOC651250	chr17:66097696-66157623:+	-0.24	-4.29	2.19E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs12451721	chr17:65939075	KPNA2	chr17:66031848-66042969:+	-0.13	-3.5	0.000512	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs12451721	chr17:65939075	LOC651250	chr17:66097696-66157623:+	-0.23	-4.1	4.85E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs12452511	chr17:65832576	LOC651250	chr17:66097696-66157623:+	-0.22	-3.91	0.000108	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs1245507	chr10:73799349	CHST3	chr10:73724120-73773321:+	0.09	3.54	0.000439	Smoking behavior	
PRAD	cis	1	rs1245513	chr10:73802257	CHST3	chr10:73724120-73773321:+	0.09	3.58	0.000378	Smoking behavior	
PRAD	cis	1	rs12460161	chr19:44293986	LYPD5	chr19:44300080-44324808:-	-0.25	-5.39	1.11E-7	Breast cancer	
PRAD	cis	1	rs12460161	chr19:44293986	ZNF155	chr19:44488355-44502477:+	-0.24	-4.73	2.94E-6	Breast cancer	
PRAD	cis	1	rs12460161	chr19:44293986	ZNF404	chr19:44376516-44384288:-	-0.2	-4.26	2.51E-5	Breast cancer	
PRAD	cis	1	rs12460678	chr19:52018951	ZNF175	chr19:52074531-52092990:+	-0.31	-4.13	4.27E-5	Carotid intima media thickness	
PRAD	cis	1	rs12461762	chr19:52026450	ZNF175	chr19:52074531-52092990:+	-0.32	-4.37	1.5E-5	Carotid intima media thickness	
PRAD	cis	1	rs12461773	chr19:52026219	ZNF175	chr19:52074531-52092990:+	-0.32	-4.37	1.5E-5	Carotid intima media thickness	
PRAD	cis	1	rs12462270	chr19:39201488	LGALS7	chr19:39261608-39264157:-	-0.16	-3.65	0.000296	Heart rate	
PRAD	cis	1	rs12462756	chr19:50098423	FLT3LG	chr19:49977486-49990893:+	0.09	3.52	0.00048	Fibrinogen levels	
PRAD	cis	1	rs12464151	chr2:179690909	PRKRA	chr2:179296142-179315958:-	-0.2	-3.6	0.000355	QT interval	
PRAD	cis	1	rs12467409	chr2:203394348	NOP58	chr2:203130515-203168382:+	0.28	4.49	9.12E-6	Urate levels	
PRAD	cis	1	rs12468226	chr2:203337001	NOP58	chr2:203130515-203168382:+	0.28	4.49	9.12E-6	Urate levels	
PRAD	cis	1	rs12469163	chr2:26283587	GPR113	chr2:26531041-26569685:-	-0.23	-3.49	0.000522	Gut microbiome composition (summer)	
PRAD	cis	1	rs12469367	chr2:179691670	PRKRA	chr2:179296142-179315958:-	-0.19	-3.49	0.000537	QT interval	
PRAD	cis	1	rs12470450	chr2:232113888	ARMC9	chr2:232063342-232238606:+	0.19	3.63	0.000312	Food antigen IgG levels	
PRAD	cis	1	rs12470837	chr2:132582511	C2orf27A	chr2:132480064-132524977:+	0.29	3.98	8.03E-5	Cerebrospinal fluid clusterin levels in APOEe4+ carriers;Cerebrospinal fluid clusterin levels	
PRAD	cis	1	rs12471809	chr2:26307140	GPR113	chr2:26531041-26569685:-	-0.24	-3.5	0.000505	Gut microbiome composition (summer)	
PRAD	cis	1	rs12472278	chr2:108873433	SULT1C2	chr2:108905095-108926370:+	-0.35	-5.39	1.11E-7	Blood pressure	
PRAD	cis	1	rs12472408	chr2:203278696	NOP58	chr2:203130515-203168382:+	0.27	4.38	1.47E-5	Urate levels	
PRAD	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.79	-9.05	3.68E-18	Plasma clusterin levels	
PRAD	cis	1	rs12476268	chr2:69722616	LOC100133985	chr2:70351169-70352448:-	-0.28	-3.87	0.000123	Parkinson's disease (age of onset)	
PRAD	cis	1	rs12477202	chr2:108867112	SULT1C2	chr2:108905095-108926370:+	0.36	5.4	1.07E-7	Blood pressure	
PRAD	cis	1	rs12477716	chr2:112668644	MERTK	chr2:112656191-112786945:+	0.23	3.96	8.75E-5	Multiple sclerosis	
PRAD	cis	1	rs12478744	chr2:23947589	C2orf84	chr2:24397531-24414566:+	-0.28	-5.36	1.34E-7	Obesity-related traits	
PRAD	cis	1	rs12478744	chr2:23947589	LOC375190	chr2:24299728-24397519:+	0.25	7.12	3.98E-12	Obesity-related traits	
PRAD	cis	1	rs12478819	chr2:207645078	MDH1B	chr2:207598943-207630050:-	0.44	3.61	0.000345	Episodic memory	
PRAD	cis	1	rs12479491	chr20:30265450	COX4I2	chr20:30225691-30232800:+	0.14	3.69	0.000249	Subcortical brain region volumes	
PRAD	cis	1	rs12482477	chr21:43517233	C21orf128	chr21:43522244-43528644:-	0.36	5.13	4.17E-7	IgG glycosylation	
PRAD	cis	1	rs12483517	chr21:42691920	FAM3B	chr21:42676177-42729654:+	-0.19	-3.99	7.82E-5	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
PRAD	cis	1	rs12487542	chr3:48426076	ATRIP	chr3:48488141-48507708:+	0.27	6.28	7.73E-10	Longevity	
PRAD	cis	1	rs12487542	chr3:48426076	CDC25A	chr3:48198668-48229801:-	0.22	4.12	4.39E-5	Longevity	
PRAD	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.18	-5.01	7.64E-7	Longevity	
PRAD	cis	1	rs12489891	chr3:46310518	CCR5	chr3:46411633-46417690:+	-0.1	-3.94	9.26E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.54	12.25	3.96E-30	Height	
PRAD	cis	1	rs1249910	chr3:112391174	CCDC80	chr3:112323411-112359977:-	0.09	3.47	0.000561	Diabetic kidney disease	
PRAD	cis	1	rs12499266	chr4:39119753	KLHL5	chr4:39046659-39123828:+	0.13	3.81	0.000159	Uric acid levels	
PRAD	cis	1	rs12500118	chr4:155344634	DCHS2	chr4:155155527-155412930:-	0.14	3.93	9.71E-5	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs12500426	chr4:95514609	BMPR1B	chr4:95679128-96079592:+	0.26	5.74	1.75E-8	Prostate cancer	
PRAD	cis	1	rs12504643	chr4:159634916	ETFDH	chr4:159593277-159629839:+	-0.26	-4.58	6.09E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
PRAD	cis	1	rs12505475	chr4:159635244	ETFDH	chr4:159593277-159629839:+	-0.25	-4.45	1.09E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
PRAD	cis	1	rs12505835	chr4:297525	ZNF718	chr4:53272-156488:+	0.35	5.52	5.56E-8	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs12507142	chr4:17656103	MED28	chr4:17616273-17629791:+	0.22	5.54	4.95E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs12509366	chr4:107003343	TBCK	chr4:106967233-107237861:-	0.2	4.2	3.18E-5	Airflow obstruction	
PRAD	cis	1	rs12509640	chr4:106996677	TBCK	chr4:106967233-107237861:-	-0.2	-4.19	3.32E-5	Airflow obstruction	
PRAD	cis	1	rs12510966	chr4:106983604	TBCK	chr4:106967233-107237861:-	0.2	4.23	2.85E-5	Airflow obstruction	
PRAD	cis	1	rs12512283	chr4:165908927	C4orf39	chr4:165878100-165880273:+	0.17	3.81	0.000157	Ovarian cancer in BRCA1 mutation carriers	
PRAD	cis	1	rs12512683	chr4:106999471	TBCK	chr4:106967233-107237861:-	0.17	3.66	0.000282	Airflow obstruction	
PRAD	cis	1	rs1251355	chr10:32290146	ARHGAP12	chr10:32095225-32217770:-	-0.27	-8	1.01E-14	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs1251363	chr10:32328526	ARHGAP12	chr10:32095225-32217770:-	0.27	7.97	1.21E-14	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs12517431	chr5:156392248	TIMD4	chr5:156346293-156390266:-	-0.21	-3.98	7.93E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs12517604	chr5:130748500	P4HA2	chr5:131528306-131563556:-	-0.21	-3.82	0.000153	Life satisfaction	
PRAD	cis	1	rs12519401	chr5:153609014	GALNT10	chr5:153570295-153799809:+	0.14	4.18	3.41E-5	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs12519989	chr5:115562642	COMMD10	chr5:115420727-115628978:+	0.29	3.73	0.000212	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs12521320	chr5:130755920	P4HA2	chr5:131528306-131563556:-	-0.22	-3.92	0.000104	Life satisfaction	
PRAD	cis	1	rs12521554	chr5:153603003	GALNT10	chr5:153570295-153799809:+	0.15	4.43	1.19E-5	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs1252318	chr10:100573445	CUTC	chr10:101491958-101515893:+	-0.18	-3.51	0.000482	Obesity-related traits	
PRAD	cis	1	rs12523347	chr5:115572395	COMMD10	chr5:115420727-115628978:+	0.29	3.66	0.000285	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs12523389	chr5:153647324	GALNT10	chr5:153570295-153799809:+	0.14	4.14	4.2E-5	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs12523441	chr5:153654667	GALNT10	chr5:153570295-153799809:+	0.12	3.67	0.000269	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs12524423	chr6:159375364	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs12524768	chr6:33760478	LEMD2	chr6:33738991-33756906:-	0.16	4.21	3.05E-5	Body mass index	
PRAD	cis	1	rs12524835	chr6:33730843	LEMD2	chr6:33738991-33756906:-	0.2	4.97	9.51E-7	Body mass index	
PRAD	cis	1	rs12526680	chr6:26550954	BTN2A3	chr6:26422317-26431927:+	0.26	6.62	1.01E-10	Educational attainment	
PRAD	cis	1	rs12526787	chr6:71187813	FAM135A	chr6:71123107-71270875:+	-0.42	-6.67	7.03E-11	Type 2 diabetes	
PRAD	cis	1	rs12527396	chr6:159389017	RSPH3	chr6:159398268-159421198:-	0.26	3.83	0.000145	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs1253099	chr14:59946830	C14orf149	chr14:59939406-59951126:-	-0.34	-4.23	2.87E-5	Schizophrenia	
PRAD	cis	1	rs1253102	chr14:59947861	C14orf149	chr14:59939406-59951126:-	-0.34	-4.23	2.87E-5	Schizophrenia	
PRAD	cis	1	rs12532998	chr7:65967459	TPST1	chr7:65670259-65825437:+	0.18	4.45	1.09E-5	Aortic root size	
PRAD	cis	1	rs12533997	chr7:65965377	TPST1	chr7:65670259-65825437:+	0.18	4.49	8.78E-6	Aortic root size	
PRAD	cis	1	rs12537549	chr7:3361023	CARD11	chr7:2945769-3083579:-	0.07	3.5	0.000506	Motion sickness	
PRAD	cis	1	rs12539530	chr7:107976561	NRCAM	chr7:107788084-108096826:-	0.23	3.81	0.000157	Femoral neck bone geometry and menarche (age at onset)	
PRAD	cis	1	rs12540874	chr7:50664922	FIGNL1	chr7:50511834-50518088:-	0.22	5.8	1.24E-8	Systemic sclerosis	
PRAD	cis	1	rs1254254	chr14:60831146	C14orf39	chr14:60902675-60952764:-	-0.46	-5.8	1.23E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254255	chr14:60831342	C14orf39	chr14:60902675-60952764:-	-0.48	-6.01	3.71E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254265	chr14:60840478	C14orf39	chr14:60902675-60952764:-	-0.46	-5.78	1.34E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254270	chr14:60843134	C14orf39	chr14:60902675-60952764:-	-0.49	-6.04	3.12E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254286	chr14:60858300	C14orf39	chr14:60902675-60952764:-	-0.46	-5.79	1.29E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254287	chr14:60861774	C14orf39	chr14:60902675-60952764:-	-0.44	-5.81	1.14E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254291	chr14:60863570	C14orf39	chr14:60902675-60952764:-	-0.46	-5.88	7.88E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254292	chr14:60863636	C14orf39	chr14:60902675-60952764:-	-0.44	-5.81	1.14E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254296	chr14:60870389	C14orf39	chr14:60902675-60952764:-	-0.46	-5.54	5.06E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254298	chr14:60883842	C14orf39	chr14:60902675-60952764:-	-0.49	-5.9	7.05E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254302	chr14:60885343	C14orf39	chr14:60902675-60952764:-	-0.49	-6.05	2.92E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254303	chr14:60886301	C14orf39	chr14:60902675-60952764:-	-0.49	-6.05	2.92E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254318	chr14:60902549	C14orf39	chr14:60902675-60952764:-	-0.46	-5.79	1.29E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254322	chr14:60906976	C14orf39	chr14:60902675-60952764:-	-0.48	-6	3.84E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254323	chr14:60908378	C14orf39	chr14:60902675-60952764:-	-0.45	-5.95	5.13E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254324	chr14:60908551	C14orf39	chr14:60902675-60952764:-	-0.45	-5.95	5.13E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1254332	chr14:60916587	C14orf39	chr14:60902675-60952764:-	-0.45	-5.97	4.56E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs12547941	chr8:29980332	MBOAT4	chr8:29989188-30002200:-	0.32	4.51	8.06E-6	Migraine	
PRAD	cis	1	rs12561806	chr1:46396776	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.17	8.32E-30	Body mass index	
PRAD	cis	1	rs12561806	chr1:46396776	MMACHC	chr1:45965856-45976737:+	-0.17	-3.77	0.000181	Body mass index	
PRAD	cis	1	rs12561806	chr1:46396776	MUTYH	chr1:45794915-45806142:-	0.21	5.94	5.4E-9	Body mass index	
PRAD	cis	1	rs1256210	chr3:122375981	DIRC2	chr3:122513901-122599983:+	0.35	3.49	0.00052	Acoustic startle blink response	
PRAD	cis	1	rs12563631	chr1:156258953	BGLAP	chr1:156182784-156213112:+	0.22	5.81	1.17E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12563631	chr1:156258953	CCT3	chr1:156278752-156308195:-	-0.15	-3.69	0.000248	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs12564541	chr1:46380237	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.13	1.15E-29	Body mass index	
PRAD	cis	1	rs12564541	chr1:46380237	MMACHC	chr1:45965856-45976737:+	-0.17	-3.82	0.000153	Body mass index	
PRAD	cis	1	rs12564541	chr1:46380237	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.23E-9	Body mass index	
PRAD	cis	1	rs12564885	chr1:72063310	NEGR1	chr1:71868626-72748405:-	-0.1	-3.63	0.000311	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs12567136	chr1:11883731	CLCN6	chr1:11866207-11907674:+	-0.25	-4.89	1.38E-6	QRS complex (12-leadsum)	
PRAD	cis	1	rs12567136	chr1:11883731	TARDBP	chr1:11072679-11085548:+	-0.2	-3.59	0.000368	QRS complex (12-leadsum)	
PRAD	cis	1	rs12567463	chr1:152180128	FLG	chr1:152274651-152297679:-	0.33	5.11	4.62E-7	Atopic dermatitis	
PRAD	cis	1	rs12569017	chr1:111287581	RAP1A	chr1:112085055-112256100:+	0.26	3.66	0.000281	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs12571119	chr10:72763174	PRF1	chr10:72357105-72362531:-	0.22	3.6	0.000353	Multiple myeloma (IgH translocation)	
PRAD	cis	1	rs12573978	chr11:46578400	HARBI1	chr11:46624857-46638777:-	0.26	3.46	0.000598	Schizophrenia	
PRAD	cis	1	rs12574668	chr11:46422686	HARBI1	chr11:46624857-46638777:-	0.31	4.23	2.83E-5	Schizophrenia	
PRAD	cis	1	rs12575085	chr11:30428262	KCNA4	chr11:30031766-30038488:-	0.28	4.48	9.21E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs12575519	chr11:46391602	HARBI1	chr11:46624857-46638777:-	0.29	3.97	8.46E-5	Schizophrenia	
PRAD	cis	1	rs12575609	chr11:46807378	ARHGAP1	chr11:46698634-46722120:-	-0.21	-3.43	0.000651	HDL cholesterol	
PRAD	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.58	-11.68	7.39E-28	Forced vital capacity	
PRAD	cis	1	rs12578042	chr11:46515004	HARBI1	chr11:46624857-46638777:-	-0.27	-3.85	0.000132	Schizophrenia	
PRAD	cis	1	rs12579846	chr12:62509328	MON2	chr12:62860597-62991362:+	0.14	3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs12580035	chr12:1911860	CACNA2D4	chr12:1901124-2027870:-	-0.29	-4.89	1.4E-6	Urate levels in lean individuals	
PRAD	cis	1	rs12583	chr3:49571462	AMIGO3	chr3:49754268-49757238:-	0.44	8.83	2.04E-17	Menarche (age at onset)	
PRAD	cis	1	rs12583	chr3:49571462	CCDC36	chr3:49235861-49295537:+	-0.22	-3.89	0.000113	Menarche (age at onset)	
PRAD	cis	1	rs12583	chr3:49571462	GMPPB	chr3:49758932-49761384:-	0.47	11.21	5.07E-26	Menarche (age at onset)	
PRAD	cis	1	rs12583	chr3:49571462	NCKIPSD	chr3:48711280-48723334:-	-0.33	-6.57	1.34E-10	Menarche (age at onset)	
PRAD	cis	1	rs12583	chr3:49571462	P4HTM	chr3:49027341-49044579:+	-0.16	-3.56	0.000413	Menarche (age at onset)	
PRAD	cis	1	rs12583	chr3:49571462	WDR6	chr3:49044637-49053386:+	0.18	3.53	0.000452	Menarche (age at onset)	
PRAD	cis	1	rs12587386	chr14:88827764	SPATA7	chr14:88852012-88904802:+	-0.2	-4	7.32E-5	Coronary artery calcification	
PRAD	cis	1	rs12587609	chr14:60928850	C14orf39	chr14:60902675-60952764:-	0.45	5.97	4.56E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs12588240	chr14:75612083	EIF2B2	chr14:75469612-75476292:+	0.25	4.97	9.26E-7	Height	
PRAD	cis	1	rs12588240	chr14:75612083	MLH3	chr14:75480467-75518235:-	0.33	6.57	1.32E-10	Height	
PRAD	cis	1	rs12588538	chr14:103360000	RCOR1	chr14:103059233-103196912:+	-0.2	-3.6	0.000347	Body mass index	
PRAD	cis	1	rs12589376	chr14:75561152	EIF2B2	chr14:75469612-75476292:+	0.24	4.85	1.67E-6	Height	
PRAD	cis	1	rs12589376	chr14:75561152	MLH3	chr14:75480467-75518235:-	0.33	6.65	8.16E-11	Height	
PRAD	cis	1	rs12589467	chr14:88823583	SPATA7	chr14:88852012-88904802:+	-0.2	-3.86	0.000128	Coronary artery calcification	
PRAD	cis	1	rs12589480	chr14:88881270	SPATA7	chr14:88852012-88904802:+	-0.21	-4.1	4.82E-5	Coronary artery calcification	
PRAD	cis	1	rs12589815	chr14:75544101	EIF2B2	chr14:75469612-75476292:+	0.25	4.95	1.06E-6	Height	
PRAD	cis	1	rs12589815	chr14:75544101	MLH3	chr14:75480467-75518235:-	0.33	6.81	3.03E-11	Height	
PRAD	cis	1	rs12589876	chr14:75544189	EIF2B2	chr14:75469612-75476292:+	0.25	5.01	7.86E-7	Height	
PRAD	cis	1	rs12589876	chr14:75544189	MLH3	chr14:75480467-75518235:-	0.33	6.8	3.17E-11	Height	
PRAD	cis	1	rs12590238	chr14:103350197	RCOR1	chr14:103059233-103196912:+	-0.18	-3.58	0.000375	Body mass index	
PRAD	cis	1	rs12590452	chr14:75548756	EIF2B2	chr14:75469612-75476292:+	0.24	4.83	1.81E-6	Height	
PRAD	cis	1	rs12590452	chr14:75548756	MLH3	chr14:75480467-75518235:-	0.33	6.67	7.11E-11	Height	
PRAD	cis	1	rs12591751	chr15:50972497	SPPL2A	chr15:50999739-51057910:-	0.26	5.3	1.78E-7	QT interval	
PRAD	cis	1	rs1259180	chr15:83244680	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.11	-3.61	0.000337	Schizophrenia	
PRAD	cis	1	rs1259180	chr15:83244680	LOC80154	chr15:82944795-82975797:+;chr15	0.19	3.83	0.000144	Schizophrenia	
PRAD	cis	1	rs12593295	chr15:68208777	PIAS1	chr15:68346572-68480402:+	0.14	4.56	6.58E-6	Cognitive performance	
PRAD	cis	1	rs12594212	chr15:76802014	SCAPER	chr15:76640529-77197744:-	-0.13	-3.8	0.000165	Blood metabolite levels	
PRAD	cis	1	rs12594541	chr15:76834368	SCAPER	chr15:76640529-77197744:-	-0.13	-3.76	0.000194	Blood metabolite levels	
PRAD	cis	1	rs1259882	chr12:32097629	FAM60A	chr12:31433527-31479159:-	0.13	3.58	0.000375	Corneal astigmatism	
PRAD	cis	1	rs12598978	chr16:30482540	LOC595101	chr16:30278914-30346695:-	0.29	5.41	1.02E-7	Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs12599931	chr16:58826531	GOT2	chr16:58741035-58768246:-	-0.19	-4.12	4.45E-5	Blood metabolite ratios	
PRAD	cis	1	rs12600855	chr17:28279591	EFCAB5	chr17:28256874-28435469:+	0.24	4.08	5.31E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs12600941	chr17:65918807	KPNA2	chr17:66031848-66042969:+	-0.13	-3.61	0.000336	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs12600941	chr17:65918807	LOC651250	chr17:66097696-66157623:+	-0.24	-4.15	3.91E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs12600993	chr17:28291222	EFCAB5	chr17:28256874-28435469:+	0.25	4.25	2.58E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs12602655	chr17:65909442	KPNA2	chr17:66031848-66042969:+	-0.13	-3.58	0.000376	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs12602655	chr17:65909442	LOC651250	chr17:66097696-66157623:+	-0.24	-4.13	4.3E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs12602912	chr17:65870073	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs12603327	chr17:40290552	DHX58	chr17:40253422-40264751:-	-0.35	-7.54	2.5E-13	Fibrinogen levels	
PRAD	cis	1	rs12603327	chr17:40290552	HSPB9	chr17:40274756-40275371:+	0.27	4.85	1.69E-6	Fibrinogen levels	
PRAD	cis	1	rs12603330	chr17:40290589	DHX58	chr17:40253422-40264751:-	-0.35	-7.55	2.24E-13	Fibrinogen levels	
PRAD	cis	1	rs12603330	chr17:40290589	HSPB9	chr17:40274756-40275371:+	0.27	4.85	1.71E-6	Fibrinogen levels	
PRAD	cis	1	rs12605316	chr18:77693600	HSBP1L1	chr18:77724582-77730820:+	-0.28	-5.62	3.22E-8	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
PRAD	cis	1	rs12605822	chr18:9296524	VAPA	chr18:9913955-9960017:+	-0.27	-3.9	0.000112	Emphysema imaging phenotypes	
PRAD	cis	1	rs12608504	chr19:18389135	KIAA1683	chr19:18367906-18385319:-	-0.21	-4.96	9.96E-7	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12609594	chr19:9972417	OR7D2	chr19:9296270-9299493:+	-0.22	-3.65	0.000292	Sleep duration	
PRAD	cis	1	rs12610373	chr19:18398284	KIAA1683	chr19:18367906-18385319:-	-0.22	-5.12	4.46E-7	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12611088	chr19:44072802	ETHE1	chr19:44010872-44031396:-	0.18	4.11	4.62E-5	Plasma amyloid beta peptide concentrations (ABx-42)	
PRAD	cis	1	rs12611088	chr19:44072802	XRCC1	chr19:44047464-44079730:-	-0.26	-5.05	6.24E-7	Plasma amyloid beta peptide concentrations (ABx-42)	
PRAD	cis	1	rs12611334	chr19:40229409	LOC400696	chr19:40170014-40177013:+	-0.2	-3.66	0.00028	Schizophrenia	
PRAD	cis	1	rs12615749	chr2:54475885	C2orf73	chr2:54558071-54588714:+	0.3	3.93	9.87E-5	Telomere length	
PRAD	cis	1	rs12615793	chr2:54475914	C2orf73	chr2:54558071-54588714:+	-0.27	-3.56	0.000415	Telomere length	
PRAD	cis	1	rs12616140	chr2:108867728	SULT1C2	chr2:108905095-108926370:+	0.34	5.21	2.77E-7	Blood pressure	
PRAD	cis	1	rs12617955	chr2:191558492	OSGEPL1	chr2:190611386-190627953:-	0.2	3.71	0.000229	Primary biliary cirrhosis	
PRAD	cis	1	rs12619985	chr2:46641627	ATP6V1E2	chr2:46738988-46769696:-	-0.18	-3.44	0.000637	HDL cholesterol	
PRAD	cis	1	rs12620810	chr2:86391481	LOC90784	chr2:86247339-86250991:-	-0.51	-4.47	9.9E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs12621280	chr2:232132984	ARMC9	chr2:232063342-232238606:+	0.19	3.53	0.000449	Food antigen IgG levels	
PRAD	cis	1	rs12621567	chr2:232118813	ARMC9	chr2:232063342-232238606:+	0.22	4.2	3.23E-5	Food antigen IgG levels	
PRAD	cis	1	rs1262174	chr14:60887194	C14orf39	chr14:60902675-60952764:-	0.33	4.7	3.43E-6	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs12623832	chr2:192125644	GLS	chr2:191745547-191829776:+	-0.14	-3.74	0.00021	Obesity-related traits	
PRAD	cis	1	rs12623832	chr2:192125644	STAT4	chr2:191894306-192038902:-	0.11	3.63	0.00031	Obesity-related traits	
PRAD	cis	1	rs12624	chr6:49660418	CRISP1	chr6:49801979-49834218:-	0.27	5.53	5.43E-8	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs12624	chr6:49660418	CRISP2	chr6:49660072-49681299:-	0.39	7.39	6.63E-13	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs12624	chr6:49660418	CRISP3	chr6:49695092-49712056:-	0.47	10.29	1.52E-22	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs12624	chr6:49660418	RHAG	chr6:49572893-49604587:-	0.48	9.12	2.19E-18	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs12627540	chr21:41214958	IGSF5	chr21:41117334-41174021:+	0.17	3.44	0.000636	Systolic blood pressure (alcohol consumption interaction)	
PRAD	cis	1	rs12627787	chr22:51012381	CPT1B	chr22:51007291-51017096:-	-0.22	-4.79	2.19E-6	Narcolepsy	
PRAD	cis	1	rs12627787	chr22:51012381	LOC100144603	chr22:51021455-51022353:+	-0.3	-3.49	0.000536	Narcolepsy	
PRAD	cis	1	rs12635377	chr3:119260454	ARHGAP31	chr3:119013220-119138322:+	-0.11	-3.45	0.00061	Systemic lupus erythematosus	
PRAD	cis	1	rs12636651	chr3:46282391	CCR5	chr3:46411633-46417690:+	-0.1	-3.75	0.000203	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs12636651	chr3:46282391	FYCO1	chr3:45959396-46037307:-	-0.12	-3.57	0.0004	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.69	6.89E-28	Height	
PRAD	cis	1	rs12638253	chr3:156626091	LEKR1	chr3:156544076-156763918:+	-0.29	-5.76	1.55E-8	Multiple sclerosis (severity)	
PRAD	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.82	12.89	9.51E-33	Diastolic blood pressure	
PRAD	cis	1	rs12642900	chr4:107010329	TBCK	chr4:106967233-107237861:-	0.17	3.74	0.000204	Airflow obstruction	
PRAD	cis	1	rs12643926	chr4:56310621	TMEM165	chr4:56262090-56292342:+	-0.16	-3.59	0.000362	Personality dimensions	
PRAD	cis	1	rs12644950	chr4:155537321	DCHS2	chr4:155155527-155412930:-	0.14	3.45	0.000601	Fibrinogen	
PRAD	cis	1	rs12645134	chr4:154713430	RNF175	chr4:154631313-154681387:-	-0.18	-4.41	1.26E-5	Electrocardiographic conduction measures	
PRAD	cis	1	rs12646124	chr4:154718084	RNF175	chr4:154631313-154681387:-	-0.19	-4.62	4.92E-6	Electrocardiographic conduction measures	
PRAD	cis	1	rs12646758	chr4:154731625	RNF175	chr4:154631313-154681387:-	-0.19	-4.56	6.44E-6	Electrocardiographic conduction measures	
PRAD	cis	1	rs12648232	chr4:17612537	MED28	chr4:17616273-17629791:+	-0.22	-5.3	1.75E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs12649528	chr4:48376806	OCIAD1	chr4:48833015-48863831:+	0.21	4.13	4.38E-5	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs12651051	chr4:154722114	RNF175	chr4:154631313-154681387:-	-0.18	-4.33	1.83E-5	Electrocardiographic conduction measures	
PRAD	cis	1	rs12652003	chr5:150231945	C5orf62	chr5:150157867-150176297:+	0.3	3.72	0.00022	Crohn's disease	
PRAD	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.67	9.81	8.61E-21	Crohn's disease	
PRAD	cis	1	rs12654264	chr5:74648603	POLK	chr5:74807657-74895644:+	0.11	3.68	0.000257	LDL cholesterol	
PRAD	cis	1	rs12654593	chr5:130756867	P4HA2	chr5:131528306-131563556:-	-0.21	-3.77	0.000182	Life satisfaction	
PRAD	cis	1	rs12656538	chr5:150251380	C5orf62	chr5:150157867-150176297:+	0.33	3.96	8.78E-5	Crohn's disease	
PRAD	cis	1	rs12656538	chr5:150251380	LOC134466	chr5:150310000-150326146:-	0.7	9.93	3.16E-21	Crohn's disease	
PRAD	cis	1	rs12656600	chr5:150311872	LOC134466	chr5:150310000-150326146:-	0.68	9.99	1.99E-21	Crohn's disease	
PRAD	cis	1	rs12657266	chr5:156396003	TIMD4	chr5:156346293-156390266:-	-0.2	-4.02	6.91E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs12657392	chr5:78963323	DMGDH	chr5:78293430-78365449:-	0.29	3.48	0.000548	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs12659118	chr5:150324622	LOC134466	chr5:150310000-150326146:-	0.69	9.5	1.09E-19	Crohn's disease	
PRAD	cis	1	rs12659961	chr5:110187004	TMEM232	chr5:109624934-110062381:-	0.26	4.07	5.59E-5	Asthma and hay fever	
PRAD	cis	1	rs12660955	chr6:33760320	IP6K3	chr6:33689443-33714762:-	0.19	3.7	0.000241	Obesity (extreme)	
PRAD	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.52	-11.51	3.6E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12662447	chr6:33714673	IP6K3	chr6:33689443-33714762:-	0.2	3.98	7.97E-5	Obesity (extreme)	
PRAD	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.48	-10.84	1.33E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.48	10.9	7.92E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs12664322	chr6:87803671	C6orf165	chr6:88117721-88205858:+	0.26	4.75	2.65E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
PRAD	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.49	11.04	2.45E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.52	-11.58	1.95E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs12671584	chr7:23915422	C7orf46	chr7:23719749-23742268:+	0.22	5.79	1.32E-8	Schizophrenia	
PRAD	cis	1	rs12671624	chr7:23915413	C7orf46	chr7:23719749-23742268:+	0.22	5.74	1.72E-8	Schizophrenia	
PRAD	cis	1	rs1267657	chr15:83215251	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.13	-4.15	3.95E-5	Schizophrenia	
PRAD	cis	1	rs1267657	chr15:83215251	LOC80154	chr15:82944795-82975797:+;chr15	0.18	3.55	0.000425	Schizophrenia	
PRAD	cis	1	rs1267817	chr7:66110040	CCT6P1	chr7:65216092-65228661:+	0.32	5.26	2.25E-7	Gout	
PRAD	cis	1	rs1267817	chr7:66110040	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.4E-5	Gout	
PRAD	cis	1	rs1267818	chr7:66107024	CCT6P1	chr7:65216092-65228661:+	0.32	5.26	2.25E-7	Gout	
PRAD	cis	1	rs1267818	chr7:66107024	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.4E-5	Gout	
PRAD	cis	1	rs1267820	chr7:66050295	CCT6P1	chr7:65216092-65228661:+	0.31	5.14	3.95E-7	Diabetic kidney disease	
PRAD	cis	1	rs1267820	chr7:66050295	CRCP	chr7:65579805-65619551:+	-0.36	-4.31	2.0E-5	Diabetic kidney disease	
PRAD	cis	1	rs12681963	chr8:29982518	MBOAT4	chr8:29989188-30002200:-	-0.42	-5.51	5.78E-8	Migraine	
PRAD	cis	1	rs12683919	chr9:97324322	FAM22F	chr9:97080478-97090926:-	0.43	3.77	0.000182	Height	
PRAD	cis	1	rs12684576	chr9:97323940	FAM22F	chr9:97080478-97090926:-	0.44	3.87	0.000122	Height	
PRAD	cis	1	rs12684837	chr9:97328333	FAM22F	chr9:97080478-97090926:-	0.43	3.82	0.000149	Height	
PRAD	cis	1	rs1268621	chr14:60921571	C14orf39	chr14:60902675-60952764:-	-0.45	-5.97	4.56E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs12691307	chr16:29939877	LOC595101	chr16:30278914-30346695:-	-0.28	-4.92	1.19E-6	Schizophrenia	
PRAD	cis	1	rs12691307	chr16:29939877	MAPK3	chr16:30125427-30134630:-	-0.25	-5.75	1.6E-8	Schizophrenia	
PRAD	cis	1	rs12691307	chr16:29939877	TBX6	chr16:30097117-30103208:-	0.21	4.86	1.62E-6	Schizophrenia	
PRAD	cis	1	rs12698509	chr7:65418876	CCT6P1	chr7:65216092-65228661:+	0.31	5.58	4.11E-8	Diabetic kidney disease	
PRAD	cis	1	rs12698509	chr7:65418876	CRCP	chr7:65579805-65619551:+	-0.29	-3.76	0.00019	Diabetic kidney disease	
PRAD	cis	1	rs12698509	chr7:65418876	ZNF117	chr7:64434830-64467121:-	-0.29	-3.59	0.000362	Diabetic kidney disease	
PRAD	cis	1	rs12698523	chr7:65968113	TPST1	chr7:65670259-65825437:+	0.18	4.45	1.09E-5	Aortic root size	
PRAD	cis	1	rs1269984	chr14:60898138	C14orf39	chr14:60902675-60952764:-	-0.49	-6.05	2.92E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs12700743	chr7:26567398	HOXA4	chr7:27168127-27170399:-	-0.22	-3.69	0.000251	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs12700744	chr7:26567494	HOXA4	chr7:27168127-27170399:-	-0.22	-3.69	0.000251	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs12700745	chr7:26570535	HOXA4	chr7:27168127-27170399:-	-0.21	-3.5	0.000517	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs12700789	chr7:3358276	CARD11	chr7:2945769-3083579:-	0.08	3.67	0.000272	Motion sickness	
PRAD	cis	1	rs12709013	chr16:58829790	GOT2	chr16:58741035-58768246:-	0.18	4.07	5.57E-5	Blood metabolite ratios	
PRAD	cis	1	rs12709812	chr19:37794850	SIPA1L3	chr19:38397868-38699006:+	-0.17	-3.58	0.000375	Coronary artery calcification	
PRAD	cis	1	rs12709812	chr19:37794850	ZNF781	chr19:38158650-38183216:-	-0.24	-4.12	4.47E-5	Coronary artery calcification	
PRAD	cis	1	rs12710454	chr21:40656919	HMGN1	chr21:40714247-40721270:-	-0.25	-4.93	1.12E-6	Cognitive function	
PRAD	cis	1	rs12710454	chr21:40656919	PSMG1	chr21:40547390-40555440:-	-0.34	-6.96	1.18E-11	Cognitive function	
PRAD	cis	1	rs12712126	chr2:102696472	MFSD9	chr2:103333666-103353337:-	0.18	4.12	4.45E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs12712530	chr2:37505561	CEBPZ	chr2:37428778-37458740:-	-0.17	-3.88	0.00012	Chronic lymphocytic leukemia	
PRAD	cis	1	rs12712612	chr2:38907605	GALM	chr2:38893052-38961908:+	0.44	5.18	3.37E-7	5-HTT brain serotonin transporter levels	
PRAD	cis	1	rs12714408	chr2:590637	SH3YL1	chr2:218138-264810:-	0.18	3.58	0.000376	Heschl's gyrus morphology	
PRAD	cis	1	rs12725198	chr1:16080171	SLC25A34	chr1:16062809-16067885:+	0.26	5.33	1.52E-7	Cardiac Troponin-T levels	
PRAD	cis	1	rs12725694	chr1:16080501	SLC25A34	chr1:16062809-16067885:+	-0.27	-5.58	4.02E-8	Cardiac Troponin-T levels	
PRAD	cis	1	rs12725833	chr1:16080618	SLC25A34	chr1:16062809-16067885:+	-0.27	-5.54	5.03E-8	Cardiac Troponin-T levels	
PRAD	cis	1	rs12726081	chr1:27037575	PIGV	chr1:27114455-27124886:+	-0.35	-3.98	8.09E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12726287	chr1:27039228	PIGV	chr1:27114455-27124886:+	-0.35	-3.98	8.09E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs1272688	chr14:60920718	C14orf39	chr14:60902675-60952764:-	-0.44	-5.79	1.27E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs12729444	chr1:27037154	PIGV	chr1:27114455-27124886:+	-0.35	-3.98	8.09E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12730386	chr1:27037989	PIGV	chr1:27114455-27124886:+	-0.35	-3.98	8.09E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs1273153	chr14:59946459	C14orf149	chr14:59939406-59951126:-	0.31	3.96	8.72E-5	Schizophrenia	
PRAD	cis	1	rs12731749	chr1:27085562	PIGV	chr1:27114455-27124886:+	-0.36	-4.06	5.84E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12733173	chr1:152173972	FLG	chr1:152274651-152297679:-	0.39	7.02	7.7E-12	Inflammatory skin disease	
PRAD	cis	1	rs12737946	chr1:27079894	PIGV	chr1:27114455-27124886:+	-0.36	-4.06	5.84E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12738345	chr1:27019744	PIGV	chr1:27114455-27124886:+	-0.35	-3.93	9.74E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12739698	chr1:27230033	PIGV	chr1:27114455-27124886:+	-0.38	-4.17	3.65E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12740374	chr1:109817590	PSRC1	chr1:109822179-109825808:-	0.24	4.53	7.63E-6	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs12741472	chr1:27221609	PIGV	chr1:27114455-27124886:+	-0.34	-3.94	9.24E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12742115	chr1:27079931	PIGV	chr1:27114455-27124886:+	-0.36	-4.06	5.84E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12742376	chr1:27285195	PIGV	chr1:27114455-27124886:+	-0.34	-3.96	8.76E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12743862	chr1:27028221	PIGV	chr1:27114455-27124886:+	-0.29	-3.43	0.00066	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12744221	chr1:145645606	NUDT17	chr1:145586494-145590461:-	0.32	6.34	5.52E-10	Epilepsy (remission after treatment)	
PRAD	cis	1	rs12744221	chr1:145645606	PIAS3	chr1:145575290-145586546:+	-0.2	-4.16	3.78E-5	Epilepsy (remission after treatment)	
PRAD	cis	1	rs1274493	chr12:56682371	MIP	chr12:56843885-56848429:-	-0.35	-3.5	0.000514	Psoriasis vulgaris	
PRAD	cis	1	rs12746810	chr1:27013133	PIGV	chr1:27114455-27124886:+	-0.31	-3.51	0.0005	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12748152	chr1:27138393	PIGV	chr1:27114455-27124886:+	-0.35	-3.93	9.6E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12752711	chr1:27250258	PIGV	chr1:27114455-27124886:+	-0.34	-3.95	8.87E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12753981	chr1:27001893	PIGV	chr1:27114455-27124886:+	-0.31	-3.56	0.000413	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12754089	chr1:37965304	MEAF6	chr1:37958176-37980364:-	-0.34	-4.97	9.29E-7	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs12754089	chr1:37965304	SNIP1	chr1:38002145-38019903:-	-0.27	-4.68	3.83E-6	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs12754423	chr1:37965549	MEAF6	chr1:37958176-37980364:-	-0.34	-4.97	9.61E-7	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs12754423	chr1:37965549	SNIP1	chr1:38002145-38019903:-	-0.27	-4.67	3.88E-6	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs12754468	chr1:27014748	PIGV	chr1:27114455-27124886:+	-0.31	-3.58	0.000379	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs1275468	chr12:75935157	GLIPR1L2	chr12:75784889-75825591:+	-0.36	-5.65	2.76E-8	Polycystic ovary syndrome	
PRAD	cis	1	rs1275469	chr12:75935230	GLIPR1L2	chr12:75784889-75825591:+	-0.36	-5.81	1.15E-8	Polycystic ovary syndrome	
PRAD	cis	1	rs1275501	chr2:27419282	C2orf28	chr2:27434899-27440044:+	-0.26	-7.15	3.24E-12	Blood metabolite levels	
PRAD	cis	1	rs1275501	chr2:27419282	KHK	chr2:27309611-27323619:+	-0.21	-4.56	6.53E-6	Blood metabolite levels	
PRAD	cis	1	rs1275522	chr2:27426878	C2orf28	chr2:27434899-27440044:+	-0.27	-7.23	2.03E-12	Blood metabolite levels	
PRAD	cis	1	rs1275522	chr2:27426878	KHK	chr2:27309611-27323619:+	-0.21	-4.57	6.22E-6	Blood metabolite levels	
PRAD	cis	1	rs1275528	chr2:27430781	C2orf28	chr2:27434899-27440044:+	-0.26	-7.1	4.79E-12	Blood metabolite levels	
PRAD	cis	1	rs1275528	chr2:27430781	KHK	chr2:27309611-27323619:+	-0.21	-4.52	7.7E-6	Blood metabolite levels	
PRAD	cis	1	rs1275530	chr2:27432547	C2orf28	chr2:27434899-27440044:+	-0.26	-6.98	1.02E-11	Blood metabolite levels	
PRAD	cis	1	rs1275530	chr2:27432547	KHK	chr2:27309611-27323619:+	-0.21	-4.37	1.52E-5	Blood metabolite levels	
PRAD	cis	1	rs1275537	chr2:27441302	C2orf28	chr2:27434899-27440044:+	0.26	7.14	3.56E-12	Blood metabolite levels	
PRAD	cis	1	rs1275537	chr2:27441302	KHK	chr2:27309611-27323619:+	0.21	4.66	4.12E-6	Blood metabolite levels	
PRAD	cis	1	rs1275538	chr2:27441397	C2orf28	chr2:27434899-27440044:+	0.26	7.26	1.6E-12	Blood metabolite levels	
PRAD	cis	1	rs1275538	chr2:27441397	KHK	chr2:27309611-27323619:+	0.21	4.48	9.27E-6	Blood metabolite levels	
PRAD	cis	1	rs12756074	chr1:27047893	PIGV	chr1:27114455-27124886:+	-0.35	-3.98	8.09E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12759356	chr1:37957194	MEAF6	chr1:37958176-37980364:-	-0.35	-5.07	5.67E-7	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs12759356	chr1:37957194	SNIP1	chr1:38002145-38019903:-	-0.27	-4.62	4.96E-6	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs12760175	chr1:46447840	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.03	3.14E-29	Body mass index	
PRAD	cis	1	rs12760175	chr1:46447840	MMACHC	chr1:45965856-45976737:+	-0.16	-3.46	0.000581	Body mass index	
PRAD	cis	1	rs12760175	chr1:46447840	MUTYH	chr1:45794915-45806142:-	0.2	5.7	2.09E-8	Body mass index	
PRAD	cis	1	rs12760759	chr1:27158344	PIGV	chr1:27114455-27124886:+	0.35	3.98	7.87E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs12762495	chr10:46013615	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs12762955	chr10:1078782	IDI2	chr10:1064847-1071799:-	-0.23	-4.62	4.94E-6	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs12762955	chr10:1078782	WDR37	chr10:1102344-1178237:+	0.27	4.79	2.2E-6	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs12763205	chr10:45986495	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs12764485	chr10:46002587	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs12764693	chr10:46023327	MARCH8	chr10:45952817-46090354:-	0.25	5.53	5.23E-8	Red blood cell traits	
PRAD	cis	1	rs12766550	chr10:46011355	MARCH8	chr10:45952817-46090354:-	0.25	5.03	6.83E-7	Red blood cell traits	
PRAD	cis	1	rs12767171	chr10:1084491	IDI2	chr10:1064847-1071799:-	-0.23	-4.57	6.24E-6	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs12767171	chr10:1084491	WDR37	chr10:1102344-1178237:+	0.25	4.46	1.02E-5	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs12768131	chr10:45986448	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs12768613	chr10:81916566	PLAC9	chr10:81892258-81904784:+	-0.18	-3.46	0.000579	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs12768834	chr10:74043874	ASCC1	chr10:73856278-73976892:-	0.2	4.02	6.76E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs12768834	chr10:74043874	DNAJB12	chr10:74092588-74114907:-	0.2	4.11	4.63E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs12769244	chr10:45959385	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs12771275	chr10:45959652	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs12771477	chr10:17209464	TRDMT1	chr10:17184983-17243681:-	-0.27	-5.39	1.13E-7	Homocysteine levels	
PRAD	cis	1	rs12772275	chr10:17204542	TRDMT1	chr10:17184983-17243681:-	-0.24	-4.88	1.45E-6	Homocysteine levels	
PRAD	cis	1	rs12772485	chr10:46011421	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs12773075	chr10:63831501	ARID5B	chr10:63661443-63856703:+	-0.16	-3.61	0.000337	Corneal structure	
PRAD	cis	1	rs12773263	chr10:45984346	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs12773463	chr10:46003631	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs12773642	chr10:17196055	TRDMT1	chr10:17184983-17243681:-	-0.26	-5.08	5.49E-7	Homocysteine levels	
PRAD	cis	1	rs12774134	chr10:4963327	AKR1C2	chr10:4964715-5060207:-	0.67	9.4	2.36E-19	Height	
PRAD	cis	1	rs12776291	chr10:46038507	MARCH8	chr10:45952817-46090354:-	0.25	5.52	5.59E-8	Red blood cell traits	
PRAD	cis	1	rs12777800	chr10:1070361	IDI2	chr10:1064847-1071799:-	-0.26	-4.81	2.03E-6	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs12777800	chr10:1070361	WDR37	chr10:1102344-1178237:+	0.33	5.52	5.53E-8	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs12778514	chr10:63832279	ARID5B	chr10:63661443-63856703:+	0.16	3.55	0.00043	Corneal structure	
PRAD	cis	1	rs12778980	chr10:45994211	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs12779198	chr10:46013547	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs12779281	chr10:45977447	MARCH8	chr10:45952817-46090354:-	0.25	5.53	5.23E-8	Red blood cell traits	
PRAD	cis	1	rs12779976	chr10:46042932	MARCH8	chr10:45952817-46090354:-	-0.25	-5.54	5.02E-8	Red blood cell traits	
PRAD	cis	1	rs12780845	chr10:17223244	TRDMT1	chr10:17184983-17243681:-	-0.21	-4.31	1.97E-5	Homocysteine levels	
PRAD	cis	1	rs12781186	chr10:46013438	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs12782687	chr10:17223368	TRDMT1	chr10:17184983-17243681:-	-0.24	-4.94	1.09E-6	Homocysteine levels	
PRAD	cis	1	rs12783490	chr10:17223716	TRDMT1	chr10:17184983-17243681:-	-0.27	-5.35	1.37E-7	Homocysteine levels	
PRAD	cis	1	rs12783621	chr10:1083304	IDI2	chr10:1064847-1071799:-	-0.22	-4.27	2.36E-5	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs12783621	chr10:1083304	WDR37	chr10:1102344-1178237:+	0.25	4.33	1.84E-5	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs12785488	chr11:64107521	C11orf20	chr11:64067863-64072238:+	-0.43	-5.94	5.56E-9	Mean platelet volume	
PRAD	cis	1	rs12786555	chr11:506229	ANO9	chr11:417930-442011:-	0.25	3.96	8.67E-5	Body mass index	
PRAD	cis	1	rs12786555	chr11:506229	LRRC56	chr11:537522-554915:+	0.27	4.05	5.97E-5	Body mass index	
PRAD	cis	1	rs12786555	chr11:506229	RNH1	chr11:494512-507273:-	-0.2	-3.68	0.000258	Body mass index	
PRAD	cis	1	rs12788729	chr11:502371	ANO9	chr11:417930-442011:-	0.26	4.15	3.97E-5	Body mass index	
PRAD	cis	1	rs12788729	chr11:502371	LRRC56	chr11:537522-554915:+	0.27	4.11	4.71E-5	Body mass index	
PRAD	cis	1	rs12788729	chr11:502371	RNH1	chr11:494512-507273:-	-0.2	-3.74	0.000204	Body mass index	
PRAD	cis	1	rs12792532	chr11:34765782	APIP	chr11:34896714-34937939:-	0.25	5	8.17E-7	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs12794284	chr11:477623	ANO9	chr11:417930-442011:-	0.25	4	7.42E-5	Body mass index	
PRAD	cis	1	rs12794284	chr11:477623	LRRC56	chr11:537522-554915:+	0.29	4.43	1.17E-5	Body mass index	
PRAD	cis	1	rs12794284	chr11:477623	RNH1	chr11:494512-507273:-	-0.22	-3.95	8.99E-5	Body mass index	
PRAD	cis	1	rs12794698	chr11:45871861	DKFZp779M0652	chr11:45792983-45793908:+	-0.19	-4.25	2.54E-5	Fasting glucose-related traits (interaction with BMI);Fasting glucose-related traits	
PRAD	cis	1	rs12796693	chr11:30429583	KCNA4	chr11:30031766-30038488:-	0.28	4.44	1.1E-5	Morning vs. evening chronotype	
PRAD	cis	1	rs12796784	chr11:4620328	OR52I1	chr11:4615269-4616242:+	0.49	4.45	1.05E-5	Response to serotonin reuptake inhibitors in major depressive disorder	
PRAD	cis	1	rs12799017	chr11:61738545	BEST1	chr11:61717356-61731939:+	0.16	3.62	0.000326	Phospholipid levels (plasma)	
PRAD	cis	1	rs12799529	chr11:30408552	KCNA4	chr11:30031766-30038488:-	0.28	4.42	1.22E-5	Morning vs. evening chronotype	
PRAD	cis	1	rs12800378	chr11:87865942	RAB38	chr11:87846431-87908599:-	0.19	5.48	7.13E-8	Frontotemporal dementia	
PRAD	cis	1	rs1280044	chr6:76522602	MYO6	chr6:76458909-76629254:+	-0.25	-4.99	8.44E-7	Prostate cancer	
PRAD	cis	1	rs1280047	chr6:76527791	IMPG1	chr6:76631062-76782335:-	0.19	3.45	0.000612	Prostate cancer	
PRAD	cis	1	rs1280047	chr6:76527791	MYO6	chr6:76458909-76629254:+	0.23	4.49	9.17E-6	Prostate cancer	
PRAD	cis	1	rs1280048	chr6:76529583	IMPG1	chr6:76631062-76782335:-	0.19	3.43	0.000657	Prostate cancer	
PRAD	cis	1	rs1280048	chr6:76529583	MYO6	chr6:76458909-76629254:+	0.24	4.71	3.19E-6	Prostate cancer	
PRAD	cis	1	rs12801148	chr11:511707	ANO9	chr11:417930-442011:-	0.24	3.91	0.000107	Body mass index	
PRAD	cis	1	rs12801148	chr11:511707	LRRC56	chr11:537522-554915:+	0.28	4.14	4.14E-5	Body mass index	
PRAD	cis	1	rs12801148	chr11:511707	RNH1	chr11:494512-507273:-	-0.21	-3.77	0.000185	Body mass index	
PRAD	cis	1	rs12801271	chr11:508720	ANO9	chr11:417930-442011:-	0.24	3.91	0.000107	Body mass index	
PRAD	cis	1	rs12801271	chr11:508720	LRRC56	chr11:537522-554915:+	0.28	4.14	4.14E-5	Body mass index	
PRAD	cis	1	rs12801271	chr11:508720	RNH1	chr11:494512-507273:-	-0.21	-3.77	0.000185	Body mass index	
PRAD	cis	1	rs12806328	chr11:48647971	FOLH1	chr11:49168188-49230222:-	-0.17	-3.88	0.000121	HDL cholesterol	
PRAD	cis	1	rs12806671	chr11:123956887	SLC37A2	chr11:124933013-124960411:+	0.26	3.81	0.000157	Obesity-related traits	
PRAD	cis	1	rs12811039	chr12:85540593	LRRIQ1	chr12:85430099-85638880:+	-0.24	-3.98	8.08E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12811039	chr12:85540593	SLC6A15	chr12:85253269-85306606:-	-0.32	-4.82	1.97E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12811039	chr12:85540593	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.55	4.87E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12814669	chr12:85464044	LRRIQ1	chr12:85430099-85638880:+	-0.24	-3.99	7.66E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12814669	chr12:85464044	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.9	1.3E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12814669	chr12:85464044	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.41	1.01E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs12815795	chr12:21391818	SLCO1A2	chr12:21417535-21548371:-	0.23	3.51	0.000485	Blood metabolite levels	
PRAD	cis	1	rs12828040	chr12:7326541	PEX5	chr12:7341759-7371167:+	0.47	9.43	1.81E-19	IgG glycosylation	
PRAD	cis	1	rs12828421	chr12:7335217	PEX5	chr12:7341759-7371167:+	-0.46	-9.43	1.84E-19	IgG glycosylation	
PRAD	cis	1	rs12829595	chr12:62507518	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs12829704	chr12:21388621	SLCO1A2	chr12:21417535-21548371:-	0.25	3.68	0.000265	Blood metabolite levels	
PRAD	cis	1	rs1284464	chr12:57964617	BAZ2A	chr12:56989380-57030163:-	-0.09	-3.51	0.000483	Rheumatoid arthritis	
PRAD	cis	1	rs1284464	chr12:57964617	FAM119B	chr12:58166383-58176323:+	0.21	4.81	2.07E-6	Rheumatoid arthritis	
PRAD	cis	1	rs1284464	chr12:57964617	PIP4K2C	chr12:57984942-57997210:+	-0.12	-3.79	0.000168	Rheumatoid arthritis	
PRAD	cis	1	rs1284464	chr12:57964617	TSFM	chr12:58176536-58191367:+	-0.26	-6.37	4.43E-10	Rheumatoid arthritis	
PRAD	cis	1	rs12870594	chr13:31462909	C13orf33	chr13:31480312-31499708:+	0.24	3.69	0.000246	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs12876002	chr13:31467467	C13orf33	chr13:31480312-31499708:+	0.25	3.8	0.000161	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs12879542	chr14:75507525	EIF2B2	chr14:75469612-75476292:+	0.25	5.02	7.38E-7	Height	
PRAD	cis	1	rs12879542	chr14:75507525	MLH3	chr14:75480467-75518235:-	0.32	6.51	1.96E-10	Height	
PRAD	cis	1	rs12881735	chr14:92932828	C14orf184	chr14:92038788-92041383:-	0.27	3.91	0.000106	Alzheimer's disease in APOE e4- carriers;Alzheimer's disease (late onset)	
PRAD	cis	1	rs12889309	chr14:75593902	EIF2B2	chr14:75469612-75476292:+	0.25	4.96	1.0E-6	Height	
PRAD	cis	1	rs12889309	chr14:75593902	MLH3	chr14:75480467-75518235:-	0.33	6.63	9.26E-11	Height	
PRAD	cis	1	rs12889472	chr14:75543979	ACYP1	chr14:75519930-75530736:-	-0.13	-3.46	0.000597	Height	
PRAD	cis	1	rs12889472	chr14:75543979	EIF2B2	chr14:75469612-75476292:+	0.25	4.93	1.14E-6	Height	
PRAD	cis	1	rs12889472	chr14:75543979	MLH3	chr14:75480467-75518235:-	0.33	6.71	5.5E-11	Height	
PRAD	cis	1	rs12895784	chr14:60980116	C14orf39	chr14:60902675-60952764:-	0.46	5.79	1.27E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs12897094	chr14:75579416	ACYP1	chr14:75519930-75530736:-	-0.13	-3.56	0.000414	Height	
PRAD	cis	1	rs12897094	chr14:75579416	EIF2B2	chr14:75469612-75476292:+	0.24	4.77	2.42E-6	Height	
PRAD	cis	1	rs12897094	chr14:75579416	MLH3	chr14:75480467-75518235:-	0.33	6.66	7.49E-11	Height	
PRAD	cis	1	rs12898259	chr15:75369780	SCAMP5	chr15:75287901-75313836:+	0.39	6.96	1.14E-11	Blood trace element (Zn levels)	
PRAD	cis	1	rs12898430	chr15:76874923	SCAPER	chr15:76640529-77197744:-	-0.13	-3.86	0.000127	Blood metabolite levels	
PRAD	cis	1	rs12899981	chr15:85302373	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.48	0.000546	Schizophrenia	
PRAD	cis	1	rs12899981	chr15:85302373	LOC388152	chr15:84867600-84898920:-	-0.32	-5.25	2.35E-7	Schizophrenia	
PRAD	cis	1	rs12899981	chr15:85302373	NMB	chr15:85198362-85201802:-	-0.53	-12.48	4.37E-31	Schizophrenia	
PRAD	cis	1	rs12899981	chr15:85302373	WDR73	chr15:85186012-85197524:-	-0.27	-5.65	2.86E-8	Schizophrenia	
PRAD	cis	1	rs12900413	chr15:90321039	MESP1	chr15:90293100-90294540:-	0.18	5.15	3.75E-7	Coronary artery aneurysm in Kawasaki disease	
PRAD	cis	1	rs12901243	chr15:75374233	SCAMP5	chr15:75287901-75313836:+	0.39	6.96	1.14E-11	Blood trace element (Zn levels)	
PRAD	cis	1	rs12902672	chr15:84716986	GOLGA6L5	chr15:85047738-85060078:-	-0.19	-4.72	3.13E-6	Schizophrenia	
PRAD	cis	1	rs12902672	chr15:84716986	LOC388152	chr15:84867600-84898920:-	-0.36	-6.26	8.71E-10	Schizophrenia	
PRAD	cis	1	rs12902672	chr15:84716986	NMB	chr15:85198362-85201802:-	-0.37	-8.33	9.2E-16	Schizophrenia	
PRAD	cis	1	rs12902672	chr15:84716986	WDR73	chr15:85186012-85197524:-	-0.21	-4.53	7.36E-6	Schizophrenia	
PRAD	cis	1	rs12902679	chr15:52881317	ARPP19	chr15:52839432-52861364:-	-0.16	-4.1	4.84E-5	Schizophrenia	
PRAD	cis	1	rs12903134	chr15:85337699	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.47	0.000569	Schizophrenia	
PRAD	cis	1	rs12903134	chr15:85337699	LOC388152	chr15:84867600-84898920:-	-0.32	-5.24	2.39E-7	Schizophrenia	
PRAD	cis	1	rs12903134	chr15:85337699	NMB	chr15:85198362-85201802:-	-0.53	-12.47	4.92E-31	Schizophrenia	
PRAD	cis	1	rs12903134	chr15:85337699	WDR73	chr15:85186012-85197524:-	-0.27	-5.67	2.45E-8	Schizophrenia	
PRAD	cis	1	rs12903201	chr15:75370776	SCAMP5	chr15:75287901-75313836:+	0.39	6.96	1.14E-11	Blood trace element (Zn levels)	
PRAD	cis	1	rs12903402	chr15:100300806	C15orf51	chr15:100330361-100347132:-	-0.24	-3.5	0.000511	Major depressive disorder	
PRAD	cis	1	rs12903750	chr15:100300341	C15orf51	chr15:100330361-100347132:-	-0.27	-4.1	4.9E-5	Major depressive disorder	
PRAD	cis	1	rs12903765	chr15:100300362	C15orf51	chr15:100330361-100347132:-	-0.24	-3.5	0.000511	Major depressive disorder	
PRAD	cis	1	rs12903820	chr15:84723820	GOLGA6L5	chr15:85047738-85060078:-	-0.18	-4.69	3.67E-6	Schizophrenia	
PRAD	cis	1	rs12903820	chr15:84723820	LOC388152	chr15:84867600-84898920:-	-0.36	-6.27	8.25E-10	Schizophrenia	
PRAD	cis	1	rs12903820	chr15:84723820	NMB	chr15:85198362-85201802:-	-0.37	-8.34	8.43E-16	Schizophrenia	
PRAD	cis	1	rs12903820	chr15:84723820	WDR73	chr15:85186012-85197524:-	-0.22	-4.57	6.13E-6	Schizophrenia	
PRAD	cis	1	rs12904259	chr15:100300606	C15orf51	chr15:100330361-100347132:-	-0.24	-3.5	0.000511	Major depressive disorder	
PRAD	cis	1	rs12905057	chr15:85210765	LOC388152	chr15:84867600-84898920:-	-0.33	-5.46	7.56E-8	Schizophrenia	
PRAD	cis	1	rs12905057	chr15:85210765	NMB	chr15:85198362-85201802:-	-0.52	-12.13	1.21E-29	Schizophrenia	
PRAD	cis	1	rs12905057	chr15:85210765	WDR73	chr15:85186012-85197524:-	-0.27	-5.67	2.52E-8	Schizophrenia	
PRAD	cis	1	rs12907687	chr15:100305120	C15orf51	chr15:100330361-100347132:-	-0.28	-4.02	6.76E-5	Major depressive disorder	
PRAD	cis	1	rs12908161	chr15:85207825	LOC388152	chr15:84867600-84898920:-	-0.31	-5.25	2.33E-7	Schizophrenia	
PRAD	cis	1	rs12908161	chr15:85207825	NMB	chr15:85198362-85201802:-	-0.53	-12.53	2.85E-31	Schizophrenia	
PRAD	cis	1	rs12908161	chr15:85207825	WDR73	chr15:85186012-85197524:-	-0.26	-5.45	8.04E-8	Schizophrenia	
PRAD	cis	1	rs12908539	chr15:100300268	C15orf51	chr15:100330361-100347132:-	-0.25	-3.8	0.000164	Major depressive disorder	
PRAD	cis	1	rs12908549	chr15:85322351	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.44	0.000625	Schizophrenia	
PRAD	cis	1	rs12908549	chr15:85322351	LOC388152	chr15:84867600-84898920:-	-0.32	-5.26	2.15E-7	Schizophrenia	
PRAD	cis	1	rs12908549	chr15:85322351	NMB	chr15:85198362-85201802:-	-0.53	-12.5	3.63E-31	Schizophrenia	
PRAD	cis	1	rs12908549	chr15:85322351	WDR73	chr15:85186012-85197524:-	-0.27	-5.72	1.88E-8	Schizophrenia	
PRAD	cis	1	rs12909095	chr15:43558142	STRC	chr15:43891762-43924561:-	0.24	4.9	1.3E-6	Lung cancer	
PRAD	cis	1	rs12909095	chr15:43558142	TGM7	chr15:43568479-43594453:-	0.24	3.78	0.000175	Lung cancer	
PRAD	cis	1	rs12909280	chr15:85429356	NMB	chr15:85198362-85201802:-	-0.32	-6.68	6.95E-11	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs12909280	chr15:85429356	WDR73	chr15:85186012-85197524:-	-0.22	-4.39	1.39E-5	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs12910012	chr15:85298662	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.48	0.000546	Schizophrenia	
PRAD	cis	1	rs12910012	chr15:85298662	LOC388152	chr15:84867600-84898920:-	-0.32	-5.25	2.35E-7	Schizophrenia	
PRAD	cis	1	rs12910012	chr15:85298662	NMB	chr15:85198362-85201802:-	-0.53	-12.48	4.37E-31	Schizophrenia	
PRAD	cis	1	rs12910012	chr15:85298662	WDR73	chr15:85186012-85197524:-	-0.27	-5.65	2.86E-8	Schizophrenia	
PRAD	cis	1	rs12910644	chr15:75358388	PPCDC	chr15:75315927-75343066:+	0.14	3.69	0.000253	Blood trace element (Zn levels)	
PRAD	cis	1	rs12910644	chr15:75358388	SCAMP5	chr15:75287901-75313836:+	0.42	7.38	7.17E-13	Blood trace element (Zn levels)	
PRAD	cis	1	rs12910759	chr15:100305314	C15orf51	chr15:100330361-100347132:-	-0.28	-4.02	6.76E-5	Major depressive disorder	
PRAD	cis	1	rs12910992	chr15:90372465	AP3S2	chr15:90373832-90456222:-	-0.79	-16.52	1.1E-48	Type 2 diabetes	
PRAD	cis	1	rs12911132	chr15:43560436	STRC	chr15:43891762-43924561:-	0.25	4.99	8.31E-7	Lung cancer	
PRAD	cis	1	rs12911132	chr15:43560436	TGM7	chr15:43568479-43594453:-	0.25	3.94	9.2E-5	Lung cancer	
PRAD	cis	1	rs12911736	chr15:85240008	LOC388152	chr15:84867600-84898920:-	-0.32	-5.4	1.03E-7	Schizophrenia	
PRAD	cis	1	rs12911736	chr15:85240008	NMB	chr15:85198362-85201802:-	-0.51	-12.07	2.04E-29	Schizophrenia	
PRAD	cis	1	rs12911736	chr15:85240008	WDR73	chr15:85186012-85197524:-	-0.27	-5.68	2.35E-8	Schizophrenia	
PRAD	cis	1	rs12912388	chr15:85344550	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.46	0.0006	Schizophrenia	
PRAD	cis	1	rs12912388	chr15:85344550	LOC388152	chr15:84867600-84898920:-	-0.31	-5.22	2.74E-7	Schizophrenia	
PRAD	cis	1	rs12912388	chr15:85344550	NMB	chr15:85198362-85201802:-	-0.53	-12.5	3.77E-31	Schizophrenia	
PRAD	cis	1	rs12912388	chr15:85344550	WDR73	chr15:85186012-85197524:-	-0.27	-5.58	4.17E-8	Schizophrenia	
PRAD	cis	1	rs12914047	chr15:52970993	ARPP19	chr15:52839432-52861364:-	0.17	4.64	4.58E-6	Schizophrenia	
PRAD	cis	1	rs12914502	chr15:52911335	ARPP19	chr15:52839432-52861364:-	0.14	3.7	0.000242	Schizophrenia	
PRAD	cis	1	rs12914773	chr15:68019958	IQCH	chr15:67547188-67794139:+	0.3	6.11	2.05E-9	Motion sickness	
PRAD	cis	1	rs12914857	chr15:84581166	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs12915234	chr15:84758301	GOLGA6L5	chr15:85047738-85060078:-	-0.19	-4.74	2.79E-6	Schizophrenia	
PRAD	cis	1	rs12915234	chr15:84758301	LOC388152	chr15:84867600-84898920:-	-0.36	-6.25	9.07E-10	Schizophrenia	
PRAD	cis	1	rs12915234	chr15:84758301	NMB	chr15:85198362-85201802:-	-0.37	-8.3	1.1E-15	Schizophrenia	
PRAD	cis	1	rs12915234	chr15:84758301	WDR73	chr15:85186012-85197524:-	-0.22	-4.6	5.48E-6	Schizophrenia	
PRAD	cis	1	rs12915981	chr15:52901433	ARPP19	chr15:52839432-52861364:-	0.13	3.47	0.000566	Schizophrenia	
PRAD	cis	1	rs12916348	chr15:84765527	GOLGA6L5	chr15:85047738-85060078:-	-0.19	-4.74	2.79E-6	Schizophrenia	
PRAD	cis	1	rs12916348	chr15:84765527	LOC388152	chr15:84867600-84898920:-	-0.36	-6.25	9.07E-10	Schizophrenia	
PRAD	cis	1	rs12916348	chr15:84765527	NMB	chr15:85198362-85201802:-	-0.37	-8.3	1.1E-15	Schizophrenia	
PRAD	cis	1	rs12916348	chr15:84765527	WDR73	chr15:85186012-85197524:-	-0.22	-4.6	5.48E-6	Schizophrenia	
PRAD	cis	1	rs12917342	chr15:100297845	C15orf51	chr15:100330361-100347132:-	-0.25	-3.88	0.000121	Major depressive disorder	
PRAD	cis	1	rs12917429	chr15:85425097	NMB	chr15:85198362-85201802:-	0.36	7.07	5.52E-12	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs12917429	chr15:85425097	WDR73	chr15:85186012-85197524:-	0.25	4.69	3.51E-6	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs12925274	chr16:77320515	VAT1L	chr16:77822483-78014001:+	-0.27	-3.62	0.000324	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	
PRAD	cis	1	rs12926993	chr16:58823122	GOT2	chr16:58741035-58768246:-	-0.2	-4.5	8.71E-6	Blood metabolite ratios	
PRAD	cis	1	rs12937756	chr17:40576813	CNTNAP1	chr17:40834632-40852010:+	0.16	4.65	4.26E-6	Crohn's disease	
PRAD	cis	1	rs12937756	chr17:40576813	NAGLU	chr17:40687951-40696464:+	-0.18	-4.17	3.6E-5	Crohn's disease	
PRAD	cis	1	rs12938856	chr17:40570649	CNTNAP1	chr17:40834632-40852010:+	0.15	4.38	1.47E-5	Crohn's disease	
PRAD	cis	1	rs12938856	chr17:40570649	NAGLU	chr17:40687951-40696464:+	-0.17	-3.82	0.000149	Crohn's disease	
PRAD	cis	1	rs1293988	chr1:186266293	IVNS1ABP	chr1:185265524-185286461:-	0.16	3.65	0.000294	Clozapine-induced cytotoxicity	
PRAD	cis	1	rs12940106	chr17:53067683	TOM1L1	chr17:52978052-53039328:+	-0.17	-4.31	1.97E-5	Breast cancer	
PRAD	cis	1	rs12943498	chr17:40593901	CNTNAP1	chr17:40834632-40852010:+	0.16	4.73	2.98E-6	Crohn's disease	
PRAD	cis	1	rs12943498	chr17:40593901	NAGLU	chr17:40687951-40696464:+	-0.18	-4.06	5.71E-5	Crohn's disease	
PRAD	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.74	17.47	4.96E-53	Eye color traits	
PRAD	cis	1	rs12948909	chr17:40570602	CNTNAP1	chr17:40834632-40852010:+	0.13	3.89	0.000113	Crohn's disease	
PRAD	cis	1	rs12948909	chr17:40570602	NAGLU	chr17:40687951-40696464:+	-0.17	-3.9	0.00011	Crohn's disease	
PRAD	cis	1	rs12951549	chr17:40593502	CNTNAP1	chr17:40834632-40852010:+	0.16	4.73	2.98E-6	Crohn's disease	
PRAD	cis	1	rs12951549	chr17:40593502	NAGLU	chr17:40687951-40696464:+	-0.18	-4.06	5.71E-5	Crohn's disease	
PRAD	cis	1	rs12951640	chr17:40594298	CNTNAP1	chr17:40834632-40852010:+	0.16	4.73	2.98E-6	Crohn's disease	
PRAD	cis	1	rs12951640	chr17:40594298	NAGLU	chr17:40687951-40696464:+	-0.18	-4.06	5.71E-5	Crohn's disease	
PRAD	cis	1	rs12955930	chr18:73030682	ZADH2	chr18:72909279-72921281:-	-0.45	-4.36	1.6E-5	Colorectal or endometrial cancer	
PRAD	cis	1	rs1296028	chr8:11698747	AMAC1L2	chr8:11188495-11189695:+	0.24	3.83	0.000144	Parkinson's disease	
PRAD	cis	1	rs1296028	chr8:11698747	CTSB	chr8:11700036-11725646:-	0.19	5.75	1.57E-8	Parkinson's disease	
PRAD	cis	1	rs1296028	chr8:11698747	FDFT1	chr8:11653082-11696817:+	0.24	4.13	4.38E-5	Parkinson's disease	
PRAD	cis	1	rs12971120	chr18:72174023	CNDP2	chr18:72163597-72188356:+	0.48	7.45	4.37E-13	Refractive error	
PRAD	cis	1	rs12973620	chr19:58249643	ZNF586	chr19:58281025-58311962:+	-0.35	-5.18	3.37E-7	Allergic rhinitis	
PRAD	cis	1	rs12980225	chr19:23026745	ZNF492	chr19:22817126-22850472:+	-0.3	-3.88	0.000119	Bronchopulmonary dysplasia	
PRAD	cis	1	rs12980403	chr19:18398139	KIAA1683	chr19:18367906-18385319:-	-0.22	-5.12	4.46E-7	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs12983770	chr19:23023614	ZNF492	chr19:22817126-22850472:+	-0.3	-3.94	9.31E-5	Bronchopulmonary dysplasia	
PRAD	cis	1	rs12992014	chr2:179691285	PRKRA	chr2:179296142-179315958:-	-0.19	-3.5	0.000517	QT interval	
PRAD	cis	1	rs12992807	chr2:127761971	SFT2D3	chr2:128458597-128461405:+	0.21	3.5	0.00051	Systemic lupus erythematosus	
PRAD	cis	1	rs12992807	chr2:127761971	WDR33	chr2:128461808-128568745:-	0.23	4.17	3.63E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs12993006	chr2:127758448	WDR33	chr2:128461808-128568745:-	0.24	4.59	5.66E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs1299548	chr7:7302293	ZNF12	chr7:6728064-6746566:-	-0.16	-4.43	1.18E-5	Visceral adipose tissue adjusted for BMI	
PRAD	cis	1	rs12995491	chr2:88527414	THNSL2	chr2:88469835-88486145:+	-0.28	-4.85	1.7E-6	Response to metformin (IC50)	
PRAD	cis	1	rs12997796	chr2:86974318	LOC285074	chr2:87257799-87303536:-	-0.25	-3.72	0.000223	Schizophrenia	
PRAD	cis	1	rs13000081	chr2:127762453	SFT2D3	chr2:128458597-128461405:+	0.21	3.5	0.00051	Systemic lupus erythematosus	
PRAD	cis	1	rs13000081	chr2:127762453	WDR33	chr2:128461808-128568745:-	0.23	4.17	3.63E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs13002735	chr2:232268884	B3GNT7	chr2:232260335-232265873:+	-0.22	-4.05	5.87E-5	Resting heart rate	
PRAD	cis	1	rs13003464	chr2:61186829	AHSA2	chr2:61404553-61414058:+	-0.15	-6.31	6.51E-10	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs13003464	chr2:61186829	C2orf74	chr2:61372243-61391964:+	0.46	9.46	1.51E-19	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs13006376	chr2:38914251	GALM	chr2:38893052-38961908:+	0.48	5.34	1.45E-7	5-HTT brain serotonin transporter levels	
PRAD	cis	1	rs13006483	chr2:187522750	FAM171B	chr2:187558789-187630684:+	0.15	3.44	0.000629	Urinary albumin-to-creatinine ratio;Urinary albumin-to-creatinine ratio in non-diabetics	
PRAD	cis	1	rs13006833	chr2:191205499	HIBCH	chr2:191069361-191184559:-	0.61	14.44	2.28E-39	Urinary metabolites	
PRAD	cis	1	rs13008738	chr2:61078921	AHSA2	chr2:61404553-61414058:+	-0.16	-5.49	6.7E-8	Inflammatory skin disease	
PRAD	cis	1	rs13008738	chr2:61078921	C2orf74	chr2:61372243-61391964:+	0.38	6.2	1.25E-9	Inflammatory skin disease	
PRAD	cis	1	rs13010022	chr2:38909706	GALM	chr2:38893052-38961908:+	0.49	5.6	3.72E-8	5-HTT brain serotonin transporter levels	
PRAD	cis	1	rs13012704	chr2:38918793	GALM	chr2:38893052-38961908:+	0.39	4.81	2.01E-6	5-HTT brain serotonin transporter levels	
PRAD	cis	1	rs13014235	chr2:202215492	ALS2CR12	chr2:202153148-202222101:-	-0.28	-4.83	1.88E-6	Basal cell carcinoma	
PRAD	cis	1	rs13016963	chr2:202162811	ALS2CR12	chr2:202153148-202222101:-	-0.24	-4.27	2.35E-5	Melanoma;Esophageal squamous cell carcinoma	
PRAD	cis	1	rs13018014	chr2:127759607	WDR33	chr2:128461808-128568745:-	0.24	4.61	5.16E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs13019004	chr2:192110219	STAT4	chr2:191894306-192038902:-	-0.12	-3.72	0.000226	Obesity-related traits	
PRAD	cis	1	rs13019711	chr2:127764826	SFT2D3	chr2:128458597-128461405:+	0.22	3.7	0.000239	Systemic lupus erythematosus	
PRAD	cis	1	rs13019711	chr2:127764826	WDR33	chr2:128461808-128568745:-	0.21	3.9	0.000111	Systemic lupus erythematosus	
PRAD	cis	1	rs13024600	chr2:127754526	WDR33	chr2:128461808-128568745:-	-0.23	-4.29	2.13E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs13028032	chr2:127759210	SFT2D3	chr2:128458597-128461405:+	0.2	3.47	0.000564	Systemic lupus erythematosus	
PRAD	cis	1	rs13028032	chr2:127759210	WDR33	chr2:128461808-128568745:-	0.24	4.53	7.58E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs13030858	chr2:26315451	GPR113	chr2:26531041-26569685:-	-0.24	-3.52	0.000476	Gut microbiome composition (summer)	
PRAD	cis	1	rs13033143	chr2:61161095	AHSA2	chr2:61404553-61414058:+	-0.18	-6.45	2.84E-10	Inflammatory skin disease	
PRAD	cis	1	rs13033143	chr2:61161095	C2orf74	chr2:61372243-61391964:+	0.33	5.6	3.62E-8	Inflammatory skin disease	
PRAD	cis	1	rs13037594	chr20:55040168	C20orf43	chr20:55043647-55093942:+	0.17	4.11	4.76E-5	Refractive astigmatism	
PRAD	cis	1	rs13037759	chr20:43370692	KCNK15	chr20:43374488-43379666:+	0.26	4.73	3.02E-6	Obesity-related traits	
PRAD	cis	1	rs13038016	chr20:43370497	KCNK15	chr20:43374488-43379666:+	0.26	4.73	3.02E-6	Obesity-related traits	
PRAD	cis	1	rs13038485	chr20:43767759	SLPI	chr20:43880879-43883206:-	0.24	3.87	0.000126	Parental longevity (mother's age at death)	
PRAD	cis	1	rs13038834	chr20:25441433	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.2	3.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs13038834	chr20:25441433	FAM182B	chr20:25744102-25848786:-	0.39	7.14	3.51E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs13038834	chr20:25441433	PYGB	chr20:25228706-25278647:+	-0.32	-6.97	1.07E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1304164	chr2:198877234	PLCL1	chr2:198669426-199014606:+	0.15	4.02	6.91E-5	Ulcerative colitis	
PRAD	cis	1	rs1304165	chr2:198877300	PLCL1	chr2:198669426-199014606:+	0.16	4.14	4.15E-5	Ulcerative colitis	
PRAD	cis	1	rs13041953	chr20:55081353	C20orf43	chr20:55043647-55093942:+	0.17	4.02	6.67E-5	Refractive astigmatism	
PRAD	cis	1	rs13042991	chr20:43767178	SLPI	chr20:43880879-43883206:-	0.23	3.63	0.00031	Parental longevity (mother's age at death)	
PRAD	cis	1	rs13043313	chr20:60958269	LAMA5	chr20:60884123-60942368:-	-0.16	-3.68	0.00026	Colorectal cancer	
PRAD	cis	1	rs13043526	chr20:55088798	C20orf43	chr20:55043647-55093942:+	0.17	4.08	5.23E-5	Refractive astigmatism	
PRAD	cis	1	rs13053175	chr22:37613309	BAIAP2L2	chr22:38480897-38506676:-	0.17	3.48	0.000546	Longevity	
PRAD	cis	1	rs13056719	chr22:24724099	POM121L9P	chr22:24647589-24661490:+	-0.27	-5.41	1.03E-7	Gut microbiome composition (summer)	
PRAD	cis	1	rs13058084	chr22:30679682	GATSL3	chr22:30681108-30695540:-	-0.28	-4.48	9.25E-6	Coronary artery calcification	
PRAD	cis	1	rs13058084	chr22:30679682	SEC14L2	chr22:30792933-30824976:+	-0.38	-4.58	6.02E-6	Coronary artery calcification	
PRAD	cis	1	rs13058399	chr22:30694428	GATSL3	chr22:30681108-30695540:-	-0.25	-4.18	3.41E-5	Coronary artery calcification	
PRAD	cis	1	rs13058399	chr22:30694428	SEC14L2	chr22:30792933-30824976:+	-0.35	-4.5	8.54E-6	Coronary artery calcification	
PRAD	cis	1	rs13058817	chr3:53024139	RFT1	chr3:53122503-53164470:-	0.43	4.55	6.83E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13058817	chr3:53024139	TMEM110	chr3:52867139-52931547:-	0.41	5.03	6.86E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13058903	chr3:38513365	XYLB	chr3:38388251-38456467:+	-0.24	-5.34	1.48E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.56	2.28E-27	Height	
PRAD	cis	1	rs13059843	chr3:195028183	C3orf21	chr3:194789015-194991895:-	0.35	7.27	1.51E-12	Body mass index	
PRAD	cis	1	rs13059975	chr3:127849684	RUVBL1	chr3:127783627-127872757:-	0.23	4.18	3.46E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs13060453	chr3:127810738	RUVBL1	chr3:127783627-127872757:-	0.25	4.5	8.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs13062252	chr3:127828631	RUVBL1	chr3:127783627-127872757:-	0.25	4.5	8.61E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs13062518	chr3:195038287	C3orf21	chr3:194789015-194991895:-	0.35	7.22	2.13E-12	Body mass index	
PRAD	cis	1	rs13067650	chr3:127889542	RUVBL1	chr3:127783627-127872757:-	0.24	4.28	2.25E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs13069006	chr3:52973305	GNL3	chr3:52719936-52728508:+	-0.24	-3.43	0.00065	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13069006	chr3:52973305	RFT1	chr3:53122503-53164470:-	0.42	4.53	7.41E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13069006	chr3:52973305	TMEM110	chr3:52867139-52931547:-	0.43	5.29	1.9E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13069054	chr3:127855982	RUVBL1	chr3:127783627-127872757:-	0.23	4.24	2.74E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs13069467	chr3:46201875	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs13069724	chr3:48478039	ATRIP	chr3:48488141-48507708:+	0.26	6.31	6.61E-10	Longevity	
PRAD	cis	1	rs13069724	chr3:48478039	CDC25A	chr3:48198668-48229801:-	0.2	3.68	0.000262	Longevity	
PRAD	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.18	-5.01	7.67E-7	Longevity	
PRAD	cis	1	rs13069750	chr3:46224850	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs13071337	chr3:48438189	ATRIP	chr3:48488141-48507708:+	0.27	6.28	7.73E-10	Longevity	
PRAD	cis	1	rs13071337	chr3:48438189	CDC25A	chr3:48198668-48229801:-	0.22	4.12	4.39E-5	Longevity	
PRAD	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.18	-5.01	7.64E-7	Longevity	
PRAD	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.84	1.68E-28	Height	
PRAD	cis	1	rs13071740	chr3:127881568	RUVBL1	chr3:127783627-127872757:-	0.22	4.11	4.72E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs13072395	chr3:52980573	RFT1	chr3:53122503-53164470:-	0.44	4.62	4.89E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13072395	chr3:52980573	TMEM110	chr3:52867139-52931547:-	0.42	5.05	6.38E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13072457	chr3:53102389	RFT1	chr3:53122503-53164470:-	0.45	4.75	2.75E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13072457	chr3:53102389	TMEM110	chr3:52867139-52931547:-	0.39	4.67	3.92E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13072809	chr3:38468171	XYLB	chr3:38388251-38456467:+	0.22	5.04	6.49E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs13072818	chr3:53074263	RFT1	chr3:53122503-53164470:-	0.43	4.72	3.18E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13072818	chr3:53074263	TMEM110	chr3:52867139-52931547:-	0.4	5.06	6.11E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13072826	chr3:195064755	C3orf21	chr3:194789015-194991895:-	0.34	7.06	6.15E-12	Body mass index	
PRAD	cis	1	rs13074025	chr3:38455704	XYLB	chr3:38388251-38456467:+	0.23	5.06	5.97E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs13074160	chr3:38455650	XYLB	chr3:38388251-38456467:+	0.23	5.06	5.97E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs13074524	chr3:52974184	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13074524	chr3:52974184	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13075694	chr3:15450400	EAF1	chr3:15469064-15484119:+	0.13	3.96	8.68E-5	Uric acid levels	
PRAD	cis	1	rs13075773	chr3:15450569	EAF1	chr3:15469064-15484119:+	0.13	3.96	8.68E-5	Uric acid levels	
PRAD	cis	1	rs13075836	chr3:46186638	CCR9	chr3:45928019-45944667:+	0.36	3.76	0.000191	Celiac disease	
PRAD	cis	1	rs13076033	chr3:52898427	RFT1	chr3:53122503-53164470:-	0.39	4.3	2.12E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13076033	chr3:52898427	TMEM110	chr3:52867139-52931547:-	0.36	4.55	6.85E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13076076	chr3:48479039	ATRIP	chr3:48488141-48507708:+	0.27	6.64	8.79E-11	Longevity	
PRAD	cis	1	rs13076076	chr3:48479039	CDC25A	chr3:48198668-48229801:-	0.22	4.1	4.96E-5	Longevity	
PRAD	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.17	-4.81	2.04E-6	Longevity	
PRAD	cis	1	rs13077359	chr3:190983412	UTS2D	chr3:190984945-191048325:-	-0.22	-4.49	9.0E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs13077790	chr3:127882658	RUVBL1	chr3:127783627-127872757:-	0.22	4.11	4.72E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs13077913	chr3:127882604	RUVBL1	chr3:127783627-127872757:-	0.22	4.11	4.72E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs13078971	chr3:53103645	RFT1	chr3:53122503-53164470:-	0.45	4.75	2.76E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13078971	chr3:53103645	TMEM110	chr3:52867139-52931547:-	0.37	4.46	1.05E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13079757	chr3:38491444	XYLB	chr3:38388251-38456467:+	0.23	5.13	4.24E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs13080979	chr3:46233690	CCR9	chr3:45928019-45944667:+	0.34	3.64	0.0003	Celiac disease	
PRAD	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.62	1.29E-27	Height	
PRAD	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.64	1.11E-27	Height	
PRAD	cis	1	rs13082038	chr3:127828456	RUVBL1	chr3:127783627-127872757:-	0.25	4.6	5.48E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs13083794	chr3:121464928	IQCB1	chr3:121488610-121553926:-	0.48	9.33	4.12E-19	Cognitive performance	
PRAD	cis	1	rs13083881	chr3:46184620	CCR9	chr3:45928019-45944667:+	0.35	3.74	0.00021	Celiac disease	
PRAD	cis	1	rs13083914	chr3:46184680	CCR9	chr3:45928019-45944667:+	0.33	3.76	0.00019	Celiac disease	
PRAD	cis	1	rs13084057	chr3:46184725	CCR9	chr3:45928019-45944667:+	-0.33	-3.79	0.000171	Celiac disease	
PRAD	cis	1	rs13084175	chr3:46184639	CCR9	chr3:45928019-45944667:+	0.33	3.76	0.00019	Celiac disease	
PRAD	cis	1	rs13085791	chr3:49721798	GMPPB	chr3:49758932-49761384:-	-0.21	-4.6	5.51E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs13085791	chr3:49721798	UBA7	chr3:49842639-49851391:-	0.14	3.46	0.000584	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs13086611	chr3:49385417	GMPPB	chr3:49758932-49761384:-	-0.17	-3.8	0.000162	Educational attainment	
PRAD	cis	1	rs13086611	chr3:49385417	UBA7	chr3:49842639-49851391:-	0.14	3.53	0.00045	Educational attainment	
PRAD	cis	1	rs13087578	chr3:121369207	IQCB1	chr3:121488610-121553926:-	0.52	10	1.78E-21	Cognitive performance	
PRAD	cis	1	rs13087719	chr3:41951576	ULK4	chr3:41288091-42003660:-	-0.89	-14.74	1.04E-40	Diastolic blood pressure	
PRAD	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.77	3.32E-28	Height	
PRAD	cis	1	rs13088281	chr3:53147576	RFT1	chr3:53122503-53164470:-	-0.35	-3.76	0.000194	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13088281	chr3:53147576	TMEM110	chr3:52867139-52931547:-	-0.31	-3.84	0.00014	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13088309	chr3:49368317	AMIGO3	chr3:49754268-49757238:-	-0.44	-8.84	1.92E-17	Menarche (age at onset)	
PRAD	cis	1	rs13088309	chr3:49368317	CCDC36	chr3:49235861-49295537:+	0.24	4.23	2.76E-5	Menarche (age at onset)	
PRAD	cis	1	rs13088309	chr3:49368317	GMPPB	chr3:49758932-49761384:-	-0.49	-11.77	3.46E-28	Menarche (age at onset)	
PRAD	cis	1	rs13088309	chr3:49368317	NCKIPSD	chr3:48711280-48723334:-	0.32	6.25	9.11E-10	Menarche (age at onset)	
PRAD	cis	1	rs13088309	chr3:49368317	P4HTM	chr3:49027341-49044579:+	0.16	3.62	0.000331	Menarche (age at onset)	
PRAD	cis	1	rs13088309	chr3:49368317	WDR6	chr3:49044637-49053386:+	-0.21	-4.09	4.99E-5	Menarche (age at onset)	
PRAD	cis	1	rs13089394	chr3:38446309	XYLB	chr3:38388251-38456467:+	0.22	5.03	7.06E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.69	6.89E-28	Height	
PRAD	cis	1	rs13090388	chr3:49391082	GMPPB	chr3:49758932-49761384:-	-0.18	-3.86	0.000127	Educational attainment (years of education)	
PRAD	cis	1	rs13090388	chr3:49391082	MST1	chr3:49721381-49726196:-	0.1	3.61	0.000336	Educational attainment (years of education)	
PRAD	cis	1	rs13090388	chr3:49391082	RBM6	chr3:49977592-50137484:+	0.11	3.43	0.000663	Educational attainment (years of education)	
PRAD	cis	1	rs13090388	chr3:49391082	UBA7	chr3:49842639-49851391:-	0.14	3.58	0.000376	Educational attainment (years of education)	
PRAD	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.79	2.67E-28	Height	
PRAD	cis	1	rs13091785	chr3:48494098	ATRIP	chr3:48488141-48507708:+	0.27	6.43	3.17E-10	Longevity	
PRAD	cis	1	rs13091785	chr3:48494098	CDC25A	chr3:48198668-48229801:-	0.21	3.94	9.38E-5	Longevity	
PRAD	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.19	-5.14	4.1E-7	Longevity	
PRAD	cis	1	rs13091844	chr3:53010271	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13091844	chr3:53010271	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13091924	chr3:195051136	C3orf21	chr3:194789015-194991895:-	0.34	7.12	4.14E-12	Body mass index	
PRAD	cis	1	rs13092352	chr3:52969697	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13092352	chr3:52969697	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs13094203	chr3:112993367	KIAA1407	chr3:113682986-113775460:-	-0.2	-3.51	0.0005	Dental caries	
PRAD	cis	1	rs13094414	chr3:38930568	XIRP1	chr3:39224707-39234077:-	0.25	3.77	0.000187	Social communication problems	
PRAD	cis	1	rs13095660	chr3:127848156	RUVBL1	chr3:127783627-127872757:-	0.23	4.15	3.95E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs13096325	chr3:46186838	CCR9	chr3:45928019-45944667:+	0.36	3.76	0.000191	Celiac disease	
PRAD	cis	1	rs13096474	chr3:49443081	AMIGO3	chr3:49754268-49757238:-	0.41	8.54	1.83E-16	Menarche (age at onset)	
PRAD	cis	1	rs13096474	chr3:49443081	CCDC36	chr3:49235861-49295537:+	-0.24	-4.34	1.78E-5	Menarche (age at onset)	
PRAD	cis	1	rs13096474	chr3:49443081	GMPPB	chr3:49758932-49761384:-	0.45	11.18	6.95E-26	Menarche (age at onset)	
PRAD	cis	1	rs13096474	chr3:49443081	NCKIPSD	chr3:48711280-48723334:-	-0.28	-5.68	2.43E-8	Menarche (age at onset)	
PRAD	cis	1	rs13096474	chr3:49443081	P4HTM	chr3:49027341-49044579:+	-0.15	-3.48	0.000549	Menarche (age at onset)	
PRAD	cis	1	rs13096474	chr3:49443081	WDR6	chr3:49044637-49053386:+	0.2	4.02	6.84E-5	Menarche (age at onset)	
PRAD	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.56	2.28E-27	Height	
PRAD	cis	1	rs13096715	chr3:195074488	C3orf21	chr3:194789015-194991895:-	0.35	7.25	1.72E-12	Body mass index	
PRAD	cis	1	rs13097340	chr3:46187118	CCR9	chr3:45928019-45944667:+	0.36	3.76	0.000191	Celiac disease	
PRAD	cis	1	rs13097666	chr3:46234467	CCR9	chr3:45928019-45944667:+	0.34	3.64	0.0003	Celiac disease	
PRAD	cis	1	rs13098911	chr3:46235201	CCR9	chr3:45928019-45944667:+	0.34	3.64	0.0003	Celiac disease	
PRAD	cis	1	rs13099	chr14:75599155	EIF2B2	chr14:75469612-75476292:+	-0.26	-5.3	1.77E-7	Height	
PRAD	cis	1	rs13099	chr14:75599155	MLH3	chr14:75480467-75518235:-	-0.33	-6.75	4.39E-11	Height	
PRAD	cis	1	rs13102385	chr4:56345255	TMEM165	chr4:56262090-56292342:+	-0.16	-3.57	0.000395	Personality dimensions	
PRAD	cis	1	rs13106338	chr4:17676871	MED28	chr4:17616273-17629791:+	-0.15	-3.83	0.000146	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs13109200	chr4:39126016	KLHL5	chr4:39046659-39123828:+	-0.13	-3.75	0.000201	Uric acid levels	
PRAD	cis	1	rs13113553	chr4:147494348	ZNF827	chr4:146681892-146859607:-	-0.17	-3.77	0.000181	Heart rate	
PRAD	cis	1	rs13115724	chr4:147510680	ZNF827	chr4:146681892-146859607:-	-0.16	-3.63	0.000319	Heart rate	
PRAD	cis	1	rs13119927	chr4:17691640	MED28	chr4:17616273-17629791:+	-0.17	-4.06	5.83E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs13120847	chr4:48030036	CNGA1	chr4:47937996-48018610:-	0.26	4.63	4.84E-6	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13120847	chr4:48030036	NIPAL1	chr4:48018791-48039078:+	0.21	6.8	3.12E-11	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13120847	chr4:48030036	TXK	chr4:48068412-48136273:-	0.18	3.98	7.95E-5	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13121235	chr4:56311947	TMEM165	chr4:56262090-56292342:+	-0.16	-3.55	0.000419	Personality dimensions	
PRAD	cis	1	rs13122002	chr4:147503754	ZNF827	chr4:146681892-146859607:-	-0.17	-3.77	0.000181	Heart rate	
PRAD	cis	1	rs13122400	chr4:39713743	RFC1	chr4:39289076-39367995:-	0.15	3.47	0.000568	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs13122400	chr4:39713743	RPL9	chr4:39455747-39460568:-	-0.4	-7.84	3.09E-14	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs13125949	chr4:48026560	CNGA1	chr4:47937996-48018610:-	0.25	4.52	7.99E-6	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13125949	chr4:48026560	NIPAL1	chr4:48018791-48039078:+	0.21	6.73	4.87E-11	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13125949	chr4:48026560	TXK	chr4:48068412-48136273:-	0.17	3.79	0.000174	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.5	-8.47	3.07E-16	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1313243	chr14:60876398	C14orf39	chr14:60902675-60952764:-	-0.49	-6.03	3.33E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1313249	chr14:60881997	C14orf39	chr14:60902675-60952764:-	-0.46	-5.89	7.19E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs13138954	chr4:122955347	BBS12	chr4:123653857-123666097:+	-0.16	-3.45	0.000606	Emphysema imaging phenotypes	
PRAD	cis	1	rs13140968	chr4:48025095	CNGA1	chr4:47937996-48018610:-	0.25	4.51	8.24E-6	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13140968	chr4:48025095	NIPAL1	chr4:48018791-48039078:+	0.21	6.8	3.17E-11	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13140968	chr4:48025095	TXK	chr4:48068412-48136273:-	0.17	3.72	0.000222	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13142905	chr4:48025298	CNGA1	chr4:47937996-48018610:-	0.25	4.52	7.99E-6	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13142905	chr4:48025298	NIPAL1	chr4:48018791-48039078:+	0.21	6.73	4.87E-11	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13142905	chr4:48025298	TXK	chr4:48068412-48136273:-	0.17	3.79	0.000174	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13144374	chr4:39130479	KLHL5	chr4:39046659-39123828:+	-0.13	-3.75	0.000201	Uric acid levels	
PRAD	cis	1	rs13145705	chr4:85720367	C4orf12	chr4:85887971-85928168:+	0.15	3.7	0.000241	Oropharynx cancer	
PRAD	cis	1	rs13146880	chr4:48031499	CNGA1	chr4:47937996-48018610:-	0.26	4.74	2.86E-6	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13146880	chr4:48031499	NIPAL1	chr4:48018791-48039078:+	0.21	6.83	2.59E-11	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13146880	chr4:48031499	TXK	chr4:48068412-48136273:-	0.17	3.86	0.000127	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13148900	chr4:71361114	AMTN	chr4:71384298-71398459:+	-0.43	-8.27	1.38E-15	Alcoholism (heaviness of drinking)	
PRAD	cis	1	rs13151390	chr4:68422349	CENPC1	chr4:68337989-68411256:-	0.17	3.59	0.000372	Parkinson's disease	
PRAD	cis	1	rs13155558	chr5:153651962	GALNT10	chr5:153570295-153799809:+	0.12	3.63	0.000316	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs1316829	chr1:25051225	CLIC4	chr1:25071760-25170815:+	-0.09	-3.61	0.000341	Height	
PRAD	cis	1	rs13168670	chr5:140146899	WDR55	chr5:140044384-140050551:+	-0.24	-5.55	4.84E-8	Schizophrenia	
PRAD	cis	1	rs13168670	chr5:140146899	ZMAT2	chr5:140080032-140086239:+	-0.18	-4.06	5.76E-5	Schizophrenia	
PRAD	cis	1	rs13169185	chr5:153601658	GALNT10	chr5:153570295-153799809:+	0.15	4.43	1.19E-5	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs1317140	chr3:49878652	AMIGO3	chr3:49754268-49757238:-	-0.24	-4.66	4.17E-6	Resting heart rate	
PRAD	cis	1	rs1317140	chr3:49878652	CACNA2D2	chr3:50400233-50540892:-	-0.22	-4.3	2.05E-5	Resting heart rate	
PRAD	cis	1	rs1317140	chr3:49878652	GMPPB	chr3:49758932-49761384:-	-0.23	-5.12	4.44E-7	Resting heart rate	
PRAD	cis	1	rs1317140	chr3:49878652	RBM6	chr3:49977592-50137484:+	-0.17	-5.47	7.3E-8	Resting heart rate	
PRAD	cis	1	rs1317140	chr3:49878652	WDR6	chr3:49044637-49053386:+	-0.22	-4.28	2.31E-5	Resting heart rate	
PRAD	cis	1	rs1317149	chr11:47486885	C1QTNF4	chr11:47611216-47615961:-	-0.16	-3.95	8.95E-5	Subjective well-being	
PRAD	cis	1	rs13174348	chr5:115138748	ATG12	chr5:115165818-115177520:-	0.26	4.41	1.26E-5	IgG glycosylation	
PRAD	cis	1	rs13174348	chr5:115138748	CDO1	chr5:115140432-115152405:-	0.25	4.05	6.04E-5	IgG glycosylation	
PRAD	cis	1	rs13176880	chr5:37081882	NIPBL	chr5:36876861-37065920:+	0.11	4.51	8.11E-6	Height	
PRAD	cis	1	rs13177431	chr5:153608112	GALNT10	chr5:153570295-153799809:+	0.15	4.5	8.67E-6	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs13178541	chr5:135164618	LOC153328	chr5:135170365-135224324:+	-0.23	-4.3	2.03E-5	IgG glycosylation	
PRAD	cis	1	rs131801	chr22:50966634	SCO2	chr22:50961999-50964034:-	-0.2	-6.1	2.25E-9	Mean corpuscular hemoglobin	
PRAD	cis	1	rs13180925	chr5:153665250	GALNT10	chr5:153570295-153799809:+	0.13	3.99	7.75E-5	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs1318241	chr11:77930792	GAB2	chr11:77926343-78128766:-	-0.19	-5.8	1.25E-8	Testicular germ cell tumor	
PRAD	cis	1	rs1318241	chr11:77930792	NARS2	chr11:78147017-78285909:-	-0.18	-3.49	0.00053	Testicular germ cell tumor	
PRAD	cis	1	rs13182	chr4:39122913	KLHL5	chr4:39046659-39123828:+	-0.13	-3.73	0.000212	Uric acid levels	
PRAD	cis	1	rs13184089	chr5:148932568	HTR4	chr5:147830595-148045296:-	0.18	3.48	0.000553	Esophageal cancer	
PRAD	cis	1	rs13193303	chr6:88269357	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs13193911	chr6:88311406	C6orf165	chr6:88117721-88205858:+	0.37	3.57	0.000397	Obesity-related traits	
PRAD	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.51	-11.49	4.19E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs13195182	chr6:52886703	GCM1	chr6:52991762-53013624:-	0.32	3.48	0.000551	Staphylococcus aureus nasal carriage (intermittent)	
PRAD	cis	1	rs13195401	chr6:26463574	BTN3A2	chr6:26365398-26378546:+	-0.87	-12.81	1.88E-32	Schizophrenia	
PRAD	cis	1	rs13195402	chr6:26463575	BTN3A2	chr6:26365398-26378546:+	-0.87	-12.81	1.88E-32	Schizophrenia	
PRAD	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.52	-11.68	7.74E-28	Response to antipsychotic treatment	
PRAD	cis	1	rs13197090	chr6:88253920	C6orf165	chr6:88117721-88205858:+	-0.34	-3.45	0.000606	Obesity-related traits	
PRAD	cis	1	rs13198094	chr6:88351699	C6orf165	chr6:88117721-88205858:+	0.42	3.9	0.00011	Obesity-related traits	
PRAD	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.49	-11.48	4.54E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs1319987	chr6:118782236	C6orf204	chr6:118786239-119031238:-	-0.14	-3.45	0.000621	Renal cell carcinoma	
PRAD	cis	1	rs1319988	chr6:118782379	C6orf204	chr6:118786239-119031238:-	-0.14	-3.45	0.000621	Renal cell carcinoma	
PRAD	cis	1	rs13200063	chr6:33730171	IP6K3	chr6:33689443-33714762:-	0.19	3.78	0.000175	Obesity (extreme)	
PRAD	cis	1	rs13200462	chr6:28218199	ZKSCAN3	chr6:28317691-28334523:+	-0.18	-3.65	0.000288	Depression	
PRAD	cis	1	rs13200462	chr6:28218199	ZNF187	chr6:28234788-28245978:+	-0.3	-5.5	6.23E-8	Depression	
PRAD	cis	1	rs13200462	chr6:28218199	ZNF323	chr6:28292517-28324048:-	0.38	5.1	4.96E-7	Depression	
PRAD	cis	1	rs13200462	chr6:28218199	ZNF389	chr6:28129551-28137375:+	-0.53	-7.63	1.31E-13	Depression	
PRAD	cis	1	rs13200462	chr6:28218199	ZSCAN23	chr6:28393287-28411279:-	0.17	4.69	3.5E-6	Depression	
PRAD	cis	1	rs13201083	chr6:89918597	GABRR1	chr6:89887223-89927496:-	0.36	4.71	3.32E-6	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs13203790	chr6:88310327	C6orf165	chr6:88117721-88205858:+	0.37	3.57	0.000397	Obesity-related traits	
PRAD	cis	1	rs13206536	chr6:88323444	C6orf165	chr6:88117721-88205858:+	0.42	3.9	0.00011	Obesity-related traits	
PRAD	cis	1	rs13206957	chr6:88353696	C6orf165	chr6:88117721-88205858:+	0.45	4.06	5.85E-5	Obesity-related traits	
PRAD	cis	1	rs13208890	chr6:111821823	KIAA1919	chr6:111580482-111590259:+	0.33	3.54	0.000441	Psoriasis	
PRAD	cis	1	rs13208933	chr6:88269280	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs1320893	chr7:143752112	ARHGEF35	chr7:143883677-143892736:-	-0.48	-9.19	1.24E-18	Obesity-related traits	
PRAD	cis	1	rs1320893	chr7:143752112	OR2A1	chr7:144015236-144016148:+;chr7	-0.24	-4.02	6.81E-5	Obesity-related traits	
PRAD	cis	1	rs1320893	chr7:143752112	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.41	1.02E-7	Obesity-related traits	
PRAD	cis	1	rs1320894	chr7:143751802	ARHGEF35	chr7:143883677-143892736:-	-0.51	-9.66	3.01E-20	Obesity-related traits	
PRAD	cis	1	rs1320894	chr7:143751802	OR2A1	chr7:144015236-144016148:+;chr7	-0.25	-4.07	5.51E-5	Obesity-related traits	
PRAD	cis	1	rs1320894	chr7:143751802	OR2A9P	chr7:143991573-143997832:+;chr7	-0.33	-5.66	2.66E-8	Obesity-related traits	
PRAD	cis	1	rs1320996	chr6:56100431	COL21A1	chr6:55921389-56258892:-	0.25	7.36	8.34E-13	Pulse pressure	
PRAD	cis	1	rs1321196	chr6:161081842	LPA	chr6:160952516-161087407:-	-0.16	-3.55	0.00042	Lipoprotein (a) levels	
PRAD	cis	1	rs1321252	chr6:25616232	SCGN	chr6:25652429-25702006:+	0.42	7.13	3.88E-12	Uric acid levels	
PRAD	cis	1	rs13213522	chr6:111705341	KIAA1919	chr6:111580482-111590259:+	0.36	3.79	0.00017	Psoriasis	
PRAD	cis	1	rs13214667	chr6:116637440	FAM26F	chr6:116782556-116784933:+	0.13	4	7.47E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs1321479	chr6:26501897	BTN2A3	chr6:26422317-26431927:+	-0.26	-6.69	6.19E-11	Educational attainment	
PRAD	cis	1	rs1321479	chr6:26501897	HIST1H2AG	chr6:27100817-27101313:+	-0.17	-3.44	0.000627	Educational attainment	
PRAD	cis	1	rs1321479	chr6:26501897	ZNF184	chr6:27418522-27440897:-	0.2	4.11	4.74E-5	Educational attainment	
PRAD	cis	1	rs1321480	chr6:26532742	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs1321480	chr6:26532742	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs1321481	chr6:26538210	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs1321481	chr6:26538210	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs13215017	chr6:89918264	GABRR1	chr6:89887223-89927496:-	0.36	4.72	3.15E-6	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs13215566	chr6:89918638	GABRR1	chr6:89887223-89927496:-	0.3	4.09	5.1E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.48	-10.58	1.36E-23	Response to antipsychotic treatment	
PRAD	cis	1	rs13217384	chr6:86720000	SYNCRIP	chr6:86317503-86353043:-	0.14	3.47	0.000579	Response to antipsychotic treatment	
PRAD	cis	1	rs13220495	chr6:26441640	BTN3A2	chr6:26365398-26378546:+	-0.87	-12.96	4.47E-33	Schizophrenia	
PRAD	cis	1	rs13220510	chr6:56779141	BEND6	chr6:56819773-56892138:+	-0.63	-11.1	1.34E-25	Menarche (age at onset)	
PRAD	cis	1	rs13220979	chr7:65363204	CCT6P1	chr7:65216092-65228661:+	0.28	5.03	7.0E-7	Diabetic kidney disease	
PRAD	cis	1	rs13226728	chr7:143746578	ARHGEF35	chr7:143883677-143892736:-	-0.49	-9.27	6.61E-19	Obesity-related traits	
PRAD	cis	1	rs13226728	chr7:143746578	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.57	0.0004	Obesity-related traits	
PRAD	cis	1	rs13226728	chr7:143746578	OR2A9P	chr7:143991573-143997832:+;chr7	-0.32	-5.57	4.4E-8	Obesity-related traits	
PRAD	cis	1	rs13230698	chr7:3361125	CARD11	chr7:2945769-3083579:-	0.07	3.5	0.000506	Motion sickness	
PRAD	cis	1	rs13235972	chr7:65883605	CCT6P1	chr7:65216092-65228661:+	0.31	5.22	2.7E-7	Diabetic kidney disease	
PRAD	cis	1	rs13235972	chr7:65883605	CRCP	chr7:65579805-65619551:+	-0.36	-4.49	9.17E-6	Diabetic kidney disease	
PRAD	cis	1	rs13237037	chr7:65997882	CCT6P1	chr7:65216092-65228661:+	0.31	5.22	2.71E-7	Diabetic kidney disease	
PRAD	cis	1	rs13237037	chr7:65997882	CRCP	chr7:65579805-65619551:+	-0.36	-4.48	9.34E-6	Diabetic kidney disease	
PRAD	cis	1	rs13238274	chr7:29180335	CPVL	chr7:29035249-29234892:-	-0.17	-4.7	3.41E-6	Diabetes related insulin traits	
PRAD	cis	1	rs13239306	chr7:66136017	CRCP	chr7:65579805-65619551:+	0.19	3.55	0.000421	Aortic root size	
PRAD	cis	1	rs13239306	chr7:66136017	LOC493754	chr7:65993446-66057363:-	0.21	4.78	2.35E-6	Aortic root size	
PRAD	cis	1	rs13239306	chr7:66136017	TPST1	chr7:65670259-65825437:+	-0.15	-3.63	0.000311	Aortic root size	
PRAD	cis	1	rs13240156	chr7:78338731	MAGI2	chr7:77646375-79082890:-	-0.21	-4.65	4.28E-6	Schizophrenia	
PRAD	cis	1	rs13243677	chr7:143746572	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.42	1.98E-19	Obesity-related traits	
PRAD	cis	1	rs13243677	chr7:143746572	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.69	0.000253	Obesity-related traits	
PRAD	cis	1	rs13243677	chr7:143746572	OR2A9P	chr7:143991573-143997832:+;chr7	-0.33	-5.59	3.89E-8	Obesity-related traits	
PRAD	cis	1	rs13244265	chr7:23917903	C7orf46	chr7:23719749-23742268:+	0.22	5.64	2.95E-8	Schizophrenia	
PRAD	cis	1	rs13245225	chr7:29181626	CPVL	chr7:29035249-29234892:-	-0.18	-4.9	1.33E-6	Diabetes related insulin traits	
PRAD	cis	1	rs13247184	chr7:65358928	CCT6P1	chr7:65216092-65228661:+	0.34	5.86	8.9E-9	Diabetic kidney disease	
PRAD	cis	1	rs1325195	chr1:179071756	ABL2	chr1:179068463-179198819:-	-0.2	-4.74	2.8E-6	IgE grass sensitization	
PRAD	cis	1	rs1325195	chr1:179071756	FAM20B	chr1:178995074-179045701:+	0.15	3.47	0.000562	IgE grass sensitization	
PRAD	cis	1	rs1325195	chr1:179071756	TOR3A	chr1:179051112-179065127:+	-0.19	-3.68	0.000263	IgE grass sensitization	
PRAD	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	1.04	30.17	5.26E-112	Bone mineral density	
PRAD	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	1.03	30.28	1.7E-112	Bone mineral density	
PRAD	cis	1	rs13256903	chr8:89596159	MMP16	chr8:89049462-89339717:-	0.17	4	7.42E-5	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs13258638	chr8:143683582	ARC	chr8:143692410-143695833:-	-0.18	-3.48	0.000539	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs13265280	chr8:65702121	BHLHE22	chr8:65492814-65496185:+	0.28	5.34	1.48E-7	HIV-1 susceptibility	
PRAD	cis	1	rs13267565	chr8:89596182	MMP16	chr8:89049462-89339717:-	0.15	3.61	0.000345	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs13268482	chr8:89596484	MMP16	chr8:89049462-89339717:-	0.15	3.65	0.000295	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs1326892	chr9:113656865	PTGR1	chr9:114312003-114362135:-	-0.26	-4.07	5.46E-5	Corneal structure	
PRAD	cis	1	rs13271746	chr8:65677873	BHLHE22	chr8:65492814-65496185:+	0.31	5.83	1.06E-8	HIV-1 susceptibility	
PRAD	cis	1	rs13272719	chr8:65663801	BHLHE22	chr8:65492814-65496185:+	0.28	5.38	1.15E-7	HIV-1 susceptibility	
PRAD	cis	1	rs1329650	chr10:93348120	PPP1R3C	chr10:93388201-93392858:-	0.17	4.03	6.48E-5	Smoking behavior	
PRAD	cis	1	rs13310597	chr7:65598540	CCT6P1	chr7:65216092-65228661:+	0.33	5.76	1.51E-8	Diabetic kidney disease	
PRAD	cis	1	rs13310597	chr7:65598540	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000132	Diabetic kidney disease	
PRAD	cis	1	rs1331215	chr20:3376565	ITPA	chr20:3190056-3204504:+	-0.3	-7.61	1.52E-13	IFN-related cytopenia	
PRAD	cis	1	rs1331455	chr9:2557493	FLJ35024	chr9:2422702-2622373:-	0.44	5.5	6.39E-8	Gambling	
PRAD	cis	1	rs13314659	chr3:48449149	ATRIP	chr3:48488141-48507708:+	-0.27	-6.31	6.29E-10	Longevity	
PRAD	cis	1	rs13314659	chr3:48449149	CDC25A	chr3:48198668-48229801:-	-0.22	-4.03	6.56E-5	Longevity	
PRAD	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.18	5.1	4.96E-7	Longevity	
PRAD	cis	1	rs13316065	chr3:49884913	AMIGO3	chr3:49754268-49757238:-	-0.24	-4.38	1.47E-5	Resting heart rate	
PRAD	cis	1	rs13316065	chr3:49884913	CACNA2D2	chr3:50400233-50540892:-	-0.21	-3.98	8.12E-5	Resting heart rate	
PRAD	cis	1	rs13316065	chr3:49884913	GMPPB	chr3:49758932-49761384:-	-0.24	-5.05	6.31E-7	Resting heart rate	
PRAD	cis	1	rs13316065	chr3:49884913	RBM6	chr3:49977592-50137484:+	-0.16	-5.04	6.51E-7	Resting heart rate	
PRAD	cis	1	rs13316065	chr3:49884913	WDR6	chr3:49044637-49053386:+	-0.22	-4.11	4.75E-5	Resting heart rate	
PRAD	cis	1	rs13316695	chr3:49684917	GMPPB	chr3:49758932-49761384:-	-0.21	-4.6	5.51E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs13316695	chr3:49684917	UBA7	chr3:49842639-49851391:-	0.14	3.46	0.000584	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs13319597	chr3:10126312	C3orf10	chr3:10157333-10168873:+	0.21	4.12	4.53E-5	Alzheimer's disease	
PRAD	cis	1	rs13319597	chr3:10126312	LOC401052	chr3:10048102-10052779:-	0.3	5.5	6.34E-8	Alzheimer's disease	
PRAD	cis	1	rs13321783	chr3:119615375	NR1I2	chr3:119499331-119537331:+	0.23	4.17	3.62E-5	HDL cholesterol	
PRAD	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.52	11.68	7.66E-28	Height	
PRAD	cis	1	rs13322305	chr3:134310791	CEP63	chr3:134204575-134293852:+	0.2	3.56	0.000415	Height	
PRAD	cis	1	rs13322887	chr3:49555583	AMIGO3	chr3:49754268-49757238:-	0.44	8.88	1.43E-17	Menarche (age at onset)	
PRAD	cis	1	rs13322887	chr3:49555583	CCDC36	chr3:49235861-49295537:+	-0.23	-4.12	4.57E-5	Menarche (age at onset)	
PRAD	cis	1	rs13322887	chr3:49555583	GMPPB	chr3:49758932-49761384:-	0.49	11.91	9.35E-29	Menarche (age at onset)	
PRAD	cis	1	rs13322887	chr3:49555583	NCKIPSD	chr3:48711280-48723334:-	-0.31	-6.2	1.21E-9	Menarche (age at onset)	
PRAD	cis	1	rs13322887	chr3:49555583	P4HTM	chr3:49027341-49044579:+	-0.16	-3.63	0.000313	Menarche (age at onset)	
PRAD	cis	1	rs13322887	chr3:49555583	WDR6	chr3:49044637-49053386:+	0.2	3.98	7.96E-5	Menarche (age at onset)	
PRAD	cis	1	rs13323323	chr3:44333324	ZNF501	chr3:44771124-44778575:+	0.21	3.75	0.000201	IgG glycosylation	
PRAD	cis	1	rs13323323	chr3:44333324	ZNF502	chr3:44754135-44765321:+	0.3	5.45	8.26E-8	IgG glycosylation	
PRAD	cis	1	rs13323787	chr3:128602135	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.000438	Dental caries	
PRAD	cis	1	rs13324487	chr3:184679915	VPS8	chr3:184529931-184770402:+	-0.33	-4.28	2.24E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs13324903	chr3:195086647	C3orf21	chr3:194789015-194991895:-	-0.32	-6.67	7.0E-11	Body mass index	
PRAD	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.81	11.95	6.26E-29	Diastolic blood pressure	
PRAD	cis	1	rs13328032	chr4:89809873	FAM13A	chr4:89647106-90032549:-	0.18	3.44	0.000642	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs13333317	chr16:67872251	C16orf86	chr16:67700717-67702659:+	-0.32	-4.11	4.59E-5	Crohn's disease	
PRAD	cis	1	rs13335998	chr16:4651921	NMRAL1	chr16:4511696-4526307:-	-0.32	-5.46	7.86E-8	Obesity-related traits	
PRAD	cis	1	rs13338688	chr16:67248831	FHOD1	chr16:67263294-67281425:-	0.61	6.7	6.15E-11	HDL cholesterol	
PRAD	cis	1	rs13338688	chr16:67248831	SLC9A5	chr16:67282855-67306093:+	0.3	3.8	0.000164	HDL cholesterol	
PRAD	cis	1	rs13339140	chr16:67213923	FHOD1	chr16:67263294-67281425:-	0.52	5.72	1.94E-8	HDL cholesterol	
PRAD	cis	1	rs13339140	chr16:67213923	SLC9A5	chr16:67282855-67306093:+	0.28	3.57	0.000398	HDL cholesterol	
PRAD	cis	1	rs13339239	chr16:67809401	C16orf86	chr16:67700717-67702659:+	-0.32	-4.11	4.59E-5	Crohn's disease	
PRAD	cis	1	rs13342397	chr17:17460926	RAI1	chr17:17584787-17714763:+	0.23	3.6	0.000358	Obsessive-compulsive symptoms	
PRAD	cis	1	rs13345720	chr19:12917686	C19orf56	chr19:12778881-12780465:-	0.22	3.74	0.00021	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	
PRAD	cis	1	rs13356202	chr5:137564588	REEP2	chr5:137774776-137782657:+	-0.11	-4.1	4.87E-5	Resting heart rate	
PRAD	cis	1	rs13361189	chr5:150223387	C5orf62	chr5:150157867-150176297:+	0.27	3.59	0.000372	Crohn's disease	
PRAD	cis	1	rs13361189	chr5:150223387	LOC134466	chr5:150310000-150326146:-	0.52	8.04	7.26E-15	Crohn's disease	
PRAD	cis	1	rs1336499	chr10:100570928	CUTC	chr10:101491958-101515893:+	-0.2	-3.54	0.000437	Obesity-related traits	
PRAD	cis	1	rs1336980	chr9:129377855	LMX1B	chr9:129376748-129463311:+	0.23	3.71	0.000236	Eyebrow thickness	
PRAD	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.48	-10.89	8.97E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.51	-11.64	1.1E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs13380863	chr17:61780793	DDX42	chr17:61851567-61896676:+	-0.27	-5.38	1.17E-7	Body mass index	
PRAD	cis	1	rs13380863	chr17:61780793	FTSJ3	chr17:61896795-61905031:-	0.33	6.41	3.61E-10	Body mass index	
PRAD	cis	1	rs13380863	chr17:61780793	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.07	5.6E-5	Body mass index	
PRAD	cis	1	rs13382466	chr2:102703333	MFSD9	chr2:103333666-103353337:-	-0.17	-3.98	8.11E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs13383762	chr2:38907001	GALM	chr2:38893052-38961908:+	0.43	5.12	4.47E-7	5-HTT brain serotonin transporter levels	
PRAD	cis	1	rs13383871	chr2:73631779	ALMS1P	chr2:73872046-73912692:+	0.5	8.55	1.7E-16	Metabolite levels	
PRAD	cis	1	rs13383871	chr2:73631779	NAT8	chr2:73867850-73869537:-	0.24	3.61	0.000345	Metabolite levels	
PRAD	cis	1	rs13384777	chr2:102709117	MFSD9	chr2:103333666-103353337:-	0.16	3.8	0.000167	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs13384952	chr2:73723959	ALMS1P	chr2:73872046-73912692:+	-0.36	-5.17	3.52E-7	Metabolite levels	
PRAD	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.26	-4.47	9.65E-6	Prostate cancer	
PRAD	cis	1	rs13386161	chr2:53753793	SPTBN1	chr2:54683454-54898582:+	0.21	3.55	0.000418	Bulimia nervosa	
PRAD	cis	1	rs13387221	chr2:44135314	LRPPRC	chr2:44113363-44223144:-	-0.18	-4.08	5.35E-5	Intelligence (childhood)	
PRAD	cis	1	rs13389798	chr2:203213093	NOP58	chr2:203130515-203168382:+	0.26	4.17	3.61E-5	Urate levels	
PRAD	cis	1	rs13393692	chr2:233442016	EIF4E2	chr2:233415357-233448349:+	-0.18	-3.56	0.000412	Height	
PRAD	cis	1	rs13393800	chr2:233442091	EIF4E2	chr2:233415357-233448349:+	-0.18	-3.51	0.000492	Height	
PRAD	cis	1	rs1339582	chr10:59937183	IPMK	chr10:59955618-60027694:-	0.09	3.47	0.000565	Inflammatory bowel disease	
PRAD	cis	1	rs1339583	chr10:59937003	IPMK	chr10:59955618-60027694:-	0.09	3.47	0.000565	Inflammatory bowel disease	
PRAD	cis	1	rs1339584	chr10:59936857	IPMK	chr10:59955618-60027694:-	0.09	3.47	0.000565	Inflammatory bowel disease	
PRAD	cis	1	rs1339585	chr10:59936841	IPMK	chr10:59955618-60027694:-	0.09	3.47	0.000565	Inflammatory bowel disease	
PRAD	cis	1	rs13396983	chr2:111900598	ACOXL	chr2:111490150-111875799:+	0.2	3.54	0.000436	Chronic lymphocytic leukemia	
PRAD	cis	1	rs13396983	chr2:111900598	BCL2L11	chr2:111878491-111926022:+	-0.15	-3.58	0.000386	Chronic lymphocytic leukemia	
PRAD	cis	1	rs13398075	chr2:202376269	CFLAR	chr2:201980816-202029001:+	0.2	4.04	6.13E-5	Rheumatoid arthritis	
PRAD	cis	1	rs13398075	chr2:202376269	NIF3L1	chr2:201754050-201768655:+	0.27	3.69	0.000252	Rheumatoid arthritis	
PRAD	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.75	9.47	1.38E-19	Rheumatoid arthritis	
PRAD	cis	1	rs13398545	chr2:102700938	MFSD9	chr2:103333666-103353337:-	0.16	3.82	0.000153	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs13398956	chr2:73720258	ALMS1P	chr2:73872046-73912692:+	0.48	8.38	6.08E-16	Metabolite levels	
PRAD	cis	1	rs13398956	chr2:73720258	NAT8	chr2:73867850-73869537:-	0.25	3.89	0.000113	Metabolite levels	
PRAD	cis	1	rs13405728	chr2:48978159	GTF2A1L	chr2:48844948-48960284:+	-0.46	-4.78	2.36E-6	Polycystic ovary syndrome	
PRAD	cis	1	rs13405728	chr2:48978159	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.36	-4.31	1.95E-5	Polycystic ovary syndrome	
PRAD	cis	1	rs13408294	chr2:202171573	CFLAR	chr2:201980816-202029001:+	-0.16	-3.73	0.000212	Rheumatoid arthritis	
PRAD	cis	1	rs13408294	chr2:202171573	NIF3L1	chr2:201754050-201768655:+	-0.29	-4.55	6.71E-6	Rheumatoid arthritis	
PRAD	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.7	-10.17	4.15E-22	Rheumatoid arthritis	
PRAD	cis	1	rs13408569	chr2:102955056	IL1R1	chr2:102686836-102796333:+	-0.33	-5.16	3.66E-7	Asthma	
PRAD	cis	1	rs13408661	chr2:102955082	IL1R1	chr2:102686836-102796333:+	-0.33	-5.16	3.66E-7	Asthma	
PRAD	cis	1	rs13409250	chr2:37463642	CEBPZ	chr2:37428778-37458740:-	-0.21	-4.65	4.29E-6	Chronic lymphocytic leukemia	
PRAD	cis	1	rs13413635	chr2:178680431	PDE11A	chr2:178487979-178973066:-	-0.34	-6.72	5.19E-11	Heart rate	
PRAD	cis	1	rs13415839	chr2:232126534	ARMC9	chr2:232063342-232238606:+	0.18	3.49	0.000532	Food antigen IgG levels	
PRAD	cis	1	rs1341759	chr6:26195502	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.72	0.000223	Renal underexcretion gout;Gout	
PRAD	cis	1	rs1341759	chr6:26195502	HIST1H3E	chr6:26224427-26226589:+	0.36	5.75	1.57E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs13421462	chr2:73719875	ALMS1P	chr2:73872046-73912692:+	0.48	8.3	1.14E-15	Metabolite levels	
PRAD	cis	1	rs13421462	chr2:73719875	NAT8	chr2:73867850-73869537:-	0.25	3.75	0.000199	Metabolite levels	
PRAD	cis	1	rs13424612	chr2:240900121	NDUFA10	chr2:240900158-240964798:-	0.27	6.03	3.24E-9	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs13426118	chr2:203255485	NOP58	chr2:203130515-203168382:+	0.23	4.14	4.06E-5	Urate levels	
PRAD	cis	1	rs13428235	chr2:73633430	ALMS1P	chr2:73872046-73912692:+	0.5	8.5	2.46E-16	Metabolite levels	
PRAD	cis	1	rs13428235	chr2:73633430	NAT8	chr2:73867850-73869537:-	0.26	3.92	0.000102	Metabolite levels	
PRAD	cis	1	rs13431267	chr2:73782200	ALMS1P	chr2:73872046-73912692:+	0.49	8.46	3.3E-16	Metabolite levels	
PRAD	cis	1	rs13431267	chr2:73782200	NAT8	chr2:73867850-73869537:-	0.25	3.93	9.8E-5	Metabolite levels	
PRAD	cis	1	rs13431828	chr2:102954653	IL1R1	chr2:102686836-102796333:+	-0.33	-5.16	3.66E-7	Asthma	
PRAD	cis	1	rs13432605	chr2:73810981	ALMS1P	chr2:73872046-73912692:+	0.5	8.72	5.0E-17	Metabolite levels	
PRAD	cis	1	rs13432605	chr2:73810981	NAT8	chr2:73867850-73869537:-	0.26	4.02	6.65E-5	Metabolite levels	
PRAD	cis	1	rs13432955	chr2:102708892	MFSD9	chr2:103333666-103353337:-	-0.16	-3.79	0.000169	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs13433809	chr3:32935126	CCR4	chr3:32993066-32996403:+	-0.11	-3.65	0.000294	Pulmonary function	
PRAD	cis	1	rs13434201	chr3:128609255	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.000438	Dental caries	
PRAD	cis	1	rs13437938	chr7:16889007	AGR2	chr7:16832266-16844738:-	-0.21	-3.83	0.000145	Type 2 diabetes (dietary heme iron intake interaction)	
PRAD	cis	1	rs1345824	chr5:42724062	CCDC152	chr5:42756920-42802539:+	0.14	3.94	9.56E-5	Height	
PRAD	cis	1	rs1345824	chr5:42724062	SEPP1	chr5:42799983-42825998:-	0.13	3.71	0.000234	Height	
PRAD	cis	1	rs1346516	chr5:122728261	CEP120	chr5:122680580-122759252:-	-0.23	-5.07	5.64E-7	Waist circumference	
PRAD	cis	1	rs1346649	chr2:198166117	PLCL1	chr2:198669426-199014606:+	-0.11	-3.43	0.000659	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs1346719	chr3:53077372	ITIH4	chr3:52847007-52866554:-	-0.19	-3.71	0.000231	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs1346719	chr3:53077372	RFT1	chr3:53122503-53164470:-	0.39	4.77	2.44E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs1346719	chr3:53077372	TMEM110	chr3:52867139-52931547:-	0.28	3.79	0.000172	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs1346833	chr11:4605490	OR52I1	chr11:4615269-4616242:+	-0.34	-3.8	0.000165	Response to serotonin reuptake inhibitors in major depressive disorder	
PRAD	cis	1	rs134869	chr22:42652074	C22orf32	chr22:42475699-42480287:+	0.15	4.7	3.43E-6	Cognitive function	
PRAD	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.32	-9.68	2.44E-20	Cognitive function	
PRAD	cis	1	rs134869	chr22:42652074	NAGA	chr22:42454339-42466846:-	0.25	4.9	1.32E-6	Cognitive function	
PRAD	cis	1	rs134873	chr22:42657566	C22orf32	chr22:42475699-42480287:+	0.14	4.53	7.65E-6	Cognitive function	
PRAD	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.32	-9.78	1.06E-20	Cognitive function	
PRAD	cis	1	rs134873	chr22:42657566	NAGA	chr22:42454339-42466846:-	0.25	4.74	2.9E-6	Cognitive function	
PRAD	cis	1	rs134882	chr22:42670965	C22orf32	chr22:42475699-42480287:+	0.12	3.83	0.000146	Cognitive function	
PRAD	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.32	-9.7	2.12E-20	Cognitive function	
PRAD	cis	1	rs134882	chr22:42670965	NAGA	chr22:42454339-42466846:-	0.21	4.06	5.68E-5	Cognitive function	
PRAD	cis	1	rs134900	chr22:42683343	C22orf32	chr22:42475699-42480287:+	0.14	4.44	1.1E-5	Cognitive function	
PRAD	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.32	-9.86	5.86E-21	Cognitive function	
PRAD	cis	1	rs134900	chr22:42683343	NAGA	chr22:42454339-42466846:-	0.24	4.64	4.44E-6	Cognitive function	
PRAD	cis	1	rs134902	chr22:42683997	C22orf32	chr22:42475699-42480287:+	0.14	4.41	1.26E-5	Cognitive function	
PRAD	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.32	-9.89	4.36E-21	Cognitive function	
PRAD	cis	1	rs134902	chr22:42683997	NAGA	chr22:42454339-42466846:-	0.23	4.55	6.79E-6	Cognitive function	
PRAD	cis	1	rs1351452	chr11:116943354	PCSK7	chr11:117075789-117102811:-	0.25	3.53	0.000464	Protein quantitative trait loci	
PRAD	cis	1	rs1354181	chr16:55607809	CAPNS2	chr16:55600584-55601592:+	0.18	5.13	4.32E-7	Thyroid hormone levels	
PRAD	cis	1	rs1354181	chr16:55607809	LPCAT2	chr16:55542913-55620581:+	-0.14	-4.86	1.57E-6	Thyroid hormone levels	
PRAD	cis	1	rs1354774	chr19:51393118	KLK2	chr19:51376689-51383822:+	-0.31	-8.09	5.28E-15	Prostate-specific antigen levels	
PRAD	cis	1	rs1355221	chr11:34758609	APIP	chr11:34896714-34937939:-	0.21	4.3	2.05E-5	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs1355222	chr11:34758716	APIP	chr11:34896714-34937939:-	0.29	5.78	1.38E-8	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs1355223	chr11:34764479	APIP	chr11:34896714-34937939:-	0.25	5	8.17E-7	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs1355412	chr8:29985683	MBOAT4	chr8:29989188-30002200:-	0.4	5.53	5.19E-8	Migraine	
PRAD	cis	1	rs1357481	chr4:8496221	C4orf23	chr4:8440604-8495258:+	-0.29	-4.65	4.41E-6	Response to antineoplastic agents	
PRAD	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.52	11.87	1.35E-28	Height	
PRAD	cis	1	rs1357762	chr3:134264859	CEP63	chr3:134204575-134293852:+	0.21	3.64	0.000303	Height	
PRAD	cis	1	rs1358023	chr3:133484393	TF	chr3:133419211-133497635:+	-0.17	-3.61	0.000334	Iron status biomarkers	
PRAD	cis	1	rs1359781	chr6:33762104	LEMD2	chr6:33738991-33756906:-	-0.22	-6.83	2.67E-11	Crohn's disease	
PRAD	cis	1	rs1360172	chr9:131907980	CRAT	chr9:131857075-131873070:-	0.21	3.98	8.12E-5	Blood metabolite ratios	
PRAD	cis	1	rs1361353	chr10:59938091	IPMK	chr10:59955618-60027694:-	0.09	3.47	0.000565	Inflammatory bowel disease	
PRAD	cis	1	rs1361720	chr9:115535579	C9orf80	chr9:115448793-115480387:-	0.25	3.91	0.000107	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs1363055	chr7:65943275	TPST1	chr7:65670259-65825437:+	0.18	4.4	1.32E-5	Aortic root size	
PRAD	cis	1	rs1365505	chr15:50477138	SLC27A2	chr15:50474393-50528588:+	-0.19	-3.61	0.000338	Blood metabolite ratios	
PRAD	cis	1	rs1365506	chr15:50477139	LOC100129387	chr15:50646371-50650501:+	0.21	3.82	0.000154	Subjective well-being	
PRAD	cis	1	rs1368882	chr1:55107019	ACOT11	chr1:55007930-55100417:+	-0.19	-4.56	6.64E-6	Non-substance related behavioral disinhibition	
PRAD	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.89	-19.26	2.38E-61	Type 2 diabetes	
PRAD	cis	1	rs1371135	chr15:90391270	C15orf38	chr15:90443832-90456222:-	0.2	3.76	0.00019	Type 2 diabetes	
PRAD	cis	1	rs137115	chr22:43011403	NFAM1	chr22:42776415-42828401:-	-0.19	-3.62	0.00033	Parental extreme longevity (95 years and older)	
PRAD	cis	1	rs1371553	chr2:26262948	GPR113	chr2:26531041-26569685:-	-0.23	-3.44	0.000642	Gut microbiome composition (summer)	
PRAD	cis	1	rs1372520	chr4:90757505	SNCA	chr4:90645251-90759447:-	0.43	7.81	3.7E-14	Neuroticism	
PRAD	cis	1	rs1374469	chr4:1724799	FAM53A	chr4:1641609-1685854:-	-0.47	-8.54	1.92E-16	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs1374531	chr4:106523932	INTS12	chr4:106603787-106629881:-	-0.73	-7.23	2.02E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs1378756	chr2:138553305	HNMT	chr2:138721590-138773933:+	0.37	3.75	0.000201	Daytime sleep phenotypes	
PRAD	cis	1	rs138209	chr22:50539413	MLC1	chr22:50497820-50524358:-	-0.33	-6.48	2.26E-10	Gestational age at birth in labor-initiated deliveries (child effect)	
PRAD	cis	1	rs1382339	chr5:115558163	COMMD10	chr5:115420727-115628978:+	0.29	3.76	0.000192	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs1382340	chr5:115558161	COMMD10	chr5:115420727-115628978:+	0.29	3.76	0.000192	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs138244	chr22:50565367	MLC1	chr22:50497820-50524358:-	-0.33	-6.71	5.64E-11	Gestational age at birth in labor-initiated deliveries (child effect)	
PRAD	cis	1	rs138249	chr22:50569790	MLC1	chr22:50497820-50524358:-	-0.34	-6.77	3.83E-11	Gestational age at birth in labor-initiated deliveries (child effect)	
PRAD	cis	1	rs138250	chr22:50570361	MLC1	chr22:50497820-50524358:-	-0.34	-6.77	3.83E-11	Gestational age at birth in labor-initiated deliveries (child effect)	
PRAD	cis	1	rs138252	chr22:50570873	MLC1	chr22:50497820-50524358:-	-0.34	-6.77	3.83E-11	Gestational age at birth in labor-initiated deliveries (child effect)	
PRAD	cis	1	rs1382573	chr1:150132324	RPRD2	chr1:150336990-150449039:+	0.14	3.58	0.000376	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs1383251	chr3:51366840	HEMK1	chr3:50606583-50622419:+	0.21	3.98	7.95E-5	Melanoma	
PRAD	cis	1	rs1385263	chr4:85704974	C4orf12	chr4:85887971-85928168:+	0.15	3.71	0.000232	Oropharynx cancer	
PRAD	cis	1	rs138544659	chr15:78900701	CHRNA3	chr15:78885397-78913322:-	-0.31	-5.41	1.0E-7	Post bronchodilator FEV1;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs138544659	chr15:78900701	CHRNA5	chr15:78857906-78886458:+	-0.21	-4.29	2.16E-5	Post bronchodilator FEV1;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs1385600	chr11:77936166	GAB2	chr11:77926343-78128766:-	0.17	5.91	6.54E-9	Testicular germ cell tumor	
PRAD	cis	1	rs1385600	chr11:77936166	NARS2	chr11:78147017-78285909:-	0.22	4.7	3.39E-6	Testicular germ cell tumor	
PRAD	cis	1	rs1385601	chr11:77936064	GAB2	chr11:77926343-78128766:-	-0.18	-5.89	7.31E-9	Testicular germ cell tumor	
PRAD	cis	1	rs1385601	chr11:77936064	NARS2	chr11:78147017-78285909:-	-0.24	-5.11	4.63E-7	Testicular germ cell tumor	
PRAD	cis	1	rs138573550	chr3:127840025	RUVBL1	chr3:127783627-127872757:-	0.25	4.6	5.48E-6	Post bronchodilator FEV1	
PRAD	cis	1	rs138702	chr22:39132601	CBY1	chr22:39052658-39069853:+	-0.13	-3.88	0.000118	Resting heart rate	
PRAD	cis	1	rs138702	chr22:39132601	LOC646851	chr22:38974125-39052634:-	-0.2	-4.74	2.89E-6	Resting heart rate	
PRAD	cis	1	rs138704	chr22:39133410	CBY1	chr22:39052658-39069853:+	0.13	3.65	0.000294	Resting heart rate	
PRAD	cis	1	rs138704	chr22:39133410	LOC646851	chr22:38974125-39052634:-	0.17	4.23	2.84E-5	Resting heart rate	
PRAD	cis	1	rs138705	chr22:39133803	CBY1	chr22:39052658-39069853:+	0.13	3.56	0.000412	Resting heart rate	
PRAD	cis	1	rs138705	chr22:39133803	LOC646851	chr22:38974125-39052634:-	0.17	3.9	0.000112	Resting heart rate	
PRAD	cis	1	rs138706	chr22:39137834	CBY1	chr22:39052658-39069853:+	0.13	3.81	0.000156	Resting heart rate	
PRAD	cis	1	rs138706	chr22:39137834	LOC646851	chr22:38974125-39052634:-	0.19	4.56	6.42E-6	Resting heart rate	
PRAD	cis	1	rs138709	chr22:39139216	CBY1	chr22:39052658-39069853:+	0.13	3.75	0.000199	Resting heart rate	
PRAD	cis	1	rs138709	chr22:39139216	LOC646851	chr22:38974125-39052634:-	0.17	4.1	4.82E-5	Resting heart rate	
PRAD	cis	1	rs138712	chr22:39141600	CBY1	chr22:39052658-39069853:+	0.14	4.13	4.29E-5	Resting heart rate	
PRAD	cis	1	rs138712	chr22:39141600	LOC646851	chr22:38974125-39052634:-	0.19	4.56	6.57E-6	Resting heart rate	
PRAD	cis	1	rs138713	chr22:39142615	CBY1	chr22:39052658-39069853:+	0.14	3.96	8.83E-5	Resting heart rate	
PRAD	cis	1	rs138713	chr22:39142615	LOC646851	chr22:38974125-39052634:-	0.17	3.96	8.66E-5	Resting heart rate	
PRAD	cis	1	rs138716	chr22:39146527	CBY1	chr22:39052658-39069853:+	0.13	3.56	0.000412	Resting heart rate	
PRAD	cis	1	rs138716	chr22:39146527	LOC646851	chr22:38974125-39052634:-	0.16	3.74	0.000204	Resting heart rate	
PRAD	cis	1	rs1387977	chr12:73021340	TMEM19	chr12:72079878-72097837:+	0.28	3.81	0.000159	Diastolic blood pressure	
PRAD	cis	1	rs1388527	chr11:6948441	ZNF215	chr11:6947654-7005861:+	-0.33	-6.11	2.1E-9	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs1389798	chr12:85502803	LRRIQ1	chr12:85430099-85638880:+	0.24	4.23	2.81E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1389798	chr12:85502803	SLC6A15	chr12:85253269-85306606:-	0.31	4.79	2.28E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1389798	chr12:85502803	TSPAN19	chr12:85408095-85430055:-	0.32	5.73	1.82E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1392104	chr7:65759107	CCT6P1	chr7:65216092-65228661:+	-0.33	-5.52	5.68E-8	Diabetic kidney disease	
PRAD	cis	1	rs1392104	chr7:65759107	CRCP	chr7:65579805-65619551:+	0.35	4.28	2.31E-5	Diabetic kidney disease	
PRAD	cis	1	rs1393258	chr16:55608032	CAPNS2	chr16:55600584-55601592:+	0.19	5.54	5.1E-8	Thyroid hormone levels	
PRAD	cis	1	rs1393258	chr16:55608032	LPCAT2	chr16:55542913-55620581:+	-0.14	-5.01	7.62E-7	Thyroid hormone levels	
PRAD	cis	1	rs1395297	chr15:50878509	SPPL2A	chr15:50999739-51057910:-	-0.29	-5.92	6.05E-9	QT interval	
PRAD	cis	1	rs1395	chr2:27424636	C2orf28	chr2:27434899-27440044:+	-0.25	-6.66	7.89E-11	Blood metabolite levels	
PRAD	cis	1	rs1395	chr2:27424636	KHK	chr2:27309611-27323619:+	-0.21	-4.6	5.49E-6	Blood metabolite levels	
PRAD	cis	1	rs1396879	chr11:34766653	APIP	chr11:34896714-34937939:-	0.25	4.99	8.34E-7	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs1396883	chr11:34757447	APIP	chr11:34896714-34937939:-	0.28	5.61	3.5E-8	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs1399196	chr11:78071876	GAB2	chr11:77926343-78128766:-	-0.17	-6.01	3.69E-9	Testicular germ cell tumor	
PRAD	cis	1	rs1399196	chr11:78071876	NARS2	chr11:78147017-78285909:-	-0.23	-5.1	5.02E-7	Testicular germ cell tumor	
PRAD	cis	1	rs1400321	chr2:112670046	MERTK	chr2:112656191-112786945:+	0.2	3.5	0.000503	Multiple sclerosis	
PRAD	cis	1	rs1401419	chr11:45879739	DKFZp779M0652	chr11:45792983-45793908:+	-0.2	-4.39	1.4E-5	Fasting glucose-related traits (interaction with BMI);Fasting glucose-related traits	
PRAD	cis	1	rs140296914	chr12:62505769	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs1403284	chr2:73726662	ALMS1P	chr2:73872046-73912692:+	-0.49	-8.2	2.3E-15	Metabolite levels	
PRAD	cis	1	rs1403284	chr2:73726662	NAT8	chr2:73867850-73869537:-	-0.23	-3.43	0.000649	Metabolite levels	
PRAD	cis	1	rs140330585	chr15:78866445	CHRNA3	chr15:78885397-78913322:-	-0.28	-4.91	1.28E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs140330585	chr15:78866445	CHRNA5	chr15:78857906-78886458:+	-0.22	-4.49	9.1E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs1404147	chr7:65264524	CCT6P1	chr7:65216092-65228661:+	0.35	6.51	1.95E-10	Diabetic kidney disease	
PRAD	cis	1	rs14047	chr20:3914215	MAVS	chr20:3827449-3856761:+	-0.27	-3.66	0.000281	Response to antidepressants in depression	
PRAD	cis	1	rs1404868	chr12:85422590	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.21	3.05E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1404868	chr12:85422590	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.9	1.35E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1404868	chr12:85422590	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.5	6.12E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1406384	chr11:62083530	ASRGL1	chr11:62104774-62160885:+	0.34	4.3	2.08E-5	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs1406384	chr11:62083530	FADS3	chr11:61640999-61659422:-	0.2	3.47	0.000573	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs1406947	chr20:33969530	CEP250	chr20:34042996-34099802:+	-0.24	-5.41	1.01E-7	Height	
PRAD	cis	1	rs1406947	chr20:33969530	CPNE1	chr20:34213968-34262539:-	0.18	3.53	0.000452	Height	
PRAD	cis	1	rs1406947	chr20:33969530	GDF5	chr20:33897002-34042568:-	-0.21	-5.17	3.52E-7	Height	
PRAD	cis	1	rs1406947	chr20:33969530	UQCC	chr20:33890383-33999833:-	0.36	6.82	2.76E-11	Height	
PRAD	cis	1	rs1407644	chr6:111802098	KIAA1919	chr6:111580482-111590259:+	-0.34	-3.74	0.000207	Psoriasis	
PRAD	cis	1	rs1408916	chr1:92992627	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs1409682	chr9:113665419	PTGR1	chr9:114312003-114362135:-	-0.23	-3.58	0.000381	Corneal structure	
PRAD	cis	1	rs1409684	chr9:113665254	PTGR1	chr9:114312003-114362135:-	-0.23	-3.58	0.000381	Corneal structure	
PRAD	cis	1	rs1412444	chr10:91002927	LIPA	chr10:90973328-91174382:-	0.19	4.04	6.18E-5	Fibrinogen levels	
PRAD	cis	1	rs1412445	chr10:91002804	LIPA	chr10:90973328-91174382:-	0.2	4.14	4.1E-5	Fibrinogen levels	
PRAD	cis	1	rs1413299	chr9:101761241	COL15A1	chr9:101706138-101833068:+	-0.1	-4.07	5.45E-5	Epithelial ovarian cancer	
PRAD	cis	1	rs141518190	chr15:78900647	CHRNA3	chr15:78885397-78913322:-	-0.31	-5.41	1.0E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs141518190	chr15:78900647	CHRNA5	chr15:78857906-78886458:+	-0.21	-4.29	2.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.51	-11.41	8.48E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs1417823	chr10:102227886	SEC31B	chr10:102246403-102289636:-	0.3	9.2	1.18E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs1418409	chr9:115573707	C9orf80	chr9:115448793-115480387:-	0.31	4.1	4.77E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs1418410	chr9:115465282	C9orf80	chr9:115448793-115480387:-	-0.28	-4.25	2.59E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs1419183	chr6:28242794	ZKSCAN3	chr6:28317691-28334523:+	-0.18	-3.75	0.0002	Depression	
PRAD	cis	1	rs1419183	chr6:28242794	ZNF187	chr6:28234788-28245978:+	-0.32	-5.84	9.92E-9	Depression	
PRAD	cis	1	rs1419183	chr6:28242794	ZNF323	chr6:28292517-28324048:-	0.41	5.61	3.54E-8	Depression	
PRAD	cis	1	rs1419183	chr6:28242794	ZNF389	chr6:28129551-28137375:+	-0.53	-7.7	8.19E-14	Depression	
PRAD	cis	1	rs1419183	chr6:28242794	ZSCAN23	chr6:28393287-28411279:-	0.17	4.62	4.89E-6	Depression	
PRAD	cis	1	rs142039564	chr1:119056258	WARS2	chr1:119573841-119683295:-	-0.2	-3.64	0.000298	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	
PRAD	cis	1	rs1421371	chr6:46670822	TDRD6	chr6:46655866-46670149:+	0.25	4.57	6.12E-6	Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs1422783	chr5:153652994	GALNT10	chr5:153570295-153799809:+	0.12	3.63	0.000316	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs1422786	chr5:153658017	GALNT10	chr5:153570295-153799809:+	0.13	3.94	9.32E-5	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.88	15.59	1.74E-44	Type 2 diabetes	
PRAD	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.91	16.14	6.25E-47	Type 2 diabetes	
PRAD	cis	1	rs1423653	chr5:42751448	CCDC152	chr5:42756920-42802539:+	0.16	4.42	1.25E-5	Height	
PRAD	cis	1	rs1423653	chr5:42751448	SEPP1	chr5:42799983-42825998:-	0.15	4.34	1.72E-5	Height	
PRAD	cis	1	rs1428551	chr5:150259832	LOC134466	chr5:150310000-150326146:-	0.62	9.38	2.7E-19	Crohn's disease	
PRAD	cis	1	rs1428552	chr5:150259831	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs1428554	chr5:150257616	LOC134466	chr5:150310000-150326146:-	0.59	9.17	1.44E-18	Crohn's disease	
PRAD	cis	1	rs1428555	chr5:150257391	LOC134466	chr5:150310000-150326146:-	-0.55	-8.43	4.22E-16	Crohn's disease	
PRAD	cis	1	rs1429414	chr2:198162430	PLCL1	chr2:198669426-199014606:+	-0.12	-3.95	9.05E-5	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs1429904	chr1:207461884	CD55	chr1:207494817-207534309:+	0.43	8.16	3.13E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs1429906	chr1:207420327	CD55	chr1:207494817-207534309:+	0.24	4.42	1.25E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs1430920	chr18:40280407	SYT4	chr18:40847859-40857615:-	0.22	3.46	0.000597	Cognitive performance	
PRAD	cis	1	rs1435127	chr4:142159511	ZNF330	chr4:142142049-142155848:+	-0.27	-4.88	1.47E-6	Conduct disorder	
PRAD	cis	1	rs1435134	chr4:142153343	ZNF330	chr4:142142049-142155848:+	-0.28	-5.02	7.51E-7	Conduct disorder	
PRAD	cis	1	rs1437872	chr2:197921055	ANKRD44	chr2:197831743-198175495:-	-0.14	-3.99	7.78E-5	Interferon alpha levels in systemic lupus erythematosus	
PRAD	cis	1	rs1440087	chr2:198871476	PLCL1	chr2:198669426-199014606:+	0.16	3.93	9.86E-5	Ulcerative colitis	
PRAD	cis	1	rs1440088	chr2:198871417	PLCL1	chr2:198669426-199014606:+	0.17	4.3	2.1E-5	Ulcerative colitis	
PRAD	cis	1	rs1440090	chr2:198879297	PLCL1	chr2:198669426-199014606:+	0.15	4.09	5.18E-5	Ulcerative colitis	
PRAD	cis	1	rs1440091	chr2:198879457	PLCL1	chr2:198669426-199014606:+	0.14	3.7	0.000239	Ulcerative colitis	
PRAD	cis	1	rs1442744	chr6:153441733	RGS17	chr6:153332041-153452389:-	-0.55	-13.5	2.52E-35	Prostate cancer	
PRAD	cis	1	rs1444221	chr12:40769062	LRRK2	chr12:40618813-40763084:+	0.1	3.84	0.000139	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs1451374	chr7:50622653	DDC	chr7:50526136-50633154:-	0.24	4.05	6.1E-5	Malaria	
PRAD	cis	1	rs1451374	chr7:50622653	FIGNL1	chr7:50511834-50518088:-	-0.22	-5.76	1.51E-8	Malaria	
PRAD	cis	1	rs1451375	chr7:50622712	DDC	chr7:50526136-50633154:-	-0.24	-3.91	0.000104	Malaria	
PRAD	cis	1	rs1451375	chr7:50622712	FIGNL1	chr7:50511834-50518088:-	0.22	5.81	1.16E-8	Malaria	
PRAD	cis	1	rs1451707	chr6:56801877	BEND6	chr6:56819773-56892138:+	-0.63	-11.05	2.25E-25	Menarche (age at onset)	
PRAD	cis	1	rs1451707	chr6:56801877	KIAA1586	chr6:56911384-56920021:+	-0.22	-3.47	0.000566	Menarche (age at onset)	
PRAD	cis	1	rs1451708	chr6:56802201	BEND6	chr6:56819773-56892138:+	-0.63	-11.05	2.25E-25	Menarche (age at onset)	
PRAD	cis	1	rs1451708	chr6:56802201	KIAA1586	chr6:56911384-56920021:+	-0.22	-3.47	0.000566	Menarche (age at onset)	
PRAD	cis	1	rs1452408	chr15:90891117	CRTC3	chr15:91073198-91188576:+	-0.17	-3.75	0.000202	Rheumatoid arthritis	
PRAD	cis	1	rs1452408	chr15:90891117	ZNF774	chr15:90895477-90904714:+	-0.24	-4.94	1.08E-6	Rheumatoid arthritis	
PRAD	cis	1	rs1454749	chr2:192105635	STAT4	chr2:191894306-192038902:-	-0.13	-3.98	8.09E-5	Obesity-related traits	
PRAD	cis	1	rs1455244	chr18:11494199	FAM38B	chr18:10670860-10701979:-;chr18	0.1	3.45	0.00061	Schizophrenia	
PRAD	cis	1	rs1456391	chr4:154720485	RNF175	chr4:154631313-154681387:-	-0.18	-4.38	1.49E-5	Electrocardiographic conduction measures	
PRAD	cis	1	rs145861664	chr12:62505458	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs1459242	chr3:48413537	ATRIP	chr3:48488141-48507708:+	-0.27	-6.45	2.73E-10	Longevity	
PRAD	cis	1	rs1459242	chr3:48413537	CDC25A	chr3:48198668-48229801:-	-0.22	-4.13	4.33E-5	Longevity	
PRAD	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.18	4.87	1.55E-6	Longevity	
PRAD	cis	1	rs146009840	chr15:78906177	CHRNA3	chr15:78885397-78913322:-	-0.3	-5.21	2.8E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs146009840	chr15:78906177	CHRNA5	chr15:78857906-78886458:+	-0.21	-4.3	2.05E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs1460561	chr6:56797574	BEND6	chr6:56819773-56892138:+	-0.61	-10.58	1.3E-23	Menarche (age at onset)	
PRAD	cis	1	rs1464569	chr3:49460350	AMIGO3	chr3:49754268-49757238:-	-0.42	-8.69	5.96E-17	Menarche (age at onset)	
PRAD	cis	1	rs1464569	chr3:49460350	CCDC36	chr3:49235861-49295537:+	0.24	4.38	1.49E-5	Menarche (age at onset)	
PRAD	cis	1	rs1464569	chr3:49460350	GMPPB	chr3:49758932-49761384:-	-0.48	-11.69	7.05E-28	Menarche (age at onset)	
PRAD	cis	1	rs1464569	chr3:49460350	NCKIPSD	chr3:48711280-48723334:-	0.28	5.67	2.45E-8	Menarche (age at onset)	
PRAD	cis	1	rs1464569	chr3:49460350	WDR6	chr3:49044637-49053386:+	-0.21	-4.23	2.78E-5	Menarche (age at onset)	
PRAD	cis	1	rs1465880	chr2:240932326	NDUFA10	chr2:240900158-240964798:-	0.27	6.09	2.39E-9	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs1466211	chr2:108856412	SULT1C2	chr2:108905095-108926370:+	0.35	5.2	2.92E-7	Blood pressure	
PRAD	cis	1	rs1466212	chr2:108856532	SULT1C2	chr2:108905095-108926370:+	0.35	5.2	2.92E-7	Blood pressure	
PRAD	cis	1	rs1466213	chr2:108856607	SULT1C2	chr2:108905095-108926370:+	0.33	5.02	7.24E-7	Blood pressure	
PRAD	cis	1	rs1466389	chr17:2096384	SRR	chr17:2207248-2228553:+	-0.67	-12.61	1.33E-31	Esophageal cancer (squamous cell)	
PRAD	cis	1	rs1466661	chr4:155347496	DCHS2	chr4:155155527-155412930:-	0.15	3.99	7.63E-5	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs1466662	chr4:155347393	DCHS2	chr4:155155527-155412930:-	0.14	3.79	0.000173	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs1466788	chr1:110618730	ALX3	chr1:110602998-110613322:-	-0.22	-4.23	2.83E-5	Blood metabolite levels	
PRAD	cis	1	rs1467472	chr20:43371551	KCNK15	chr20:43374488-43379666:+	0.26	4.72	3.08E-6	Obesity-related traits	
PRAD	cis	1	rs1468333	chr5:137552970	REEP2	chr5:137774776-137782657:+	-0.1	-4.07	5.61E-5	Resting heart rate	
PRAD	cis	1	rs1469712	chr19:19528821	GATAD2A	chr19:19496642-19619740:+	0.14	3.55	0.000421	Schizophrenia	
PRAD	cis	1	rs1471399	chr4:88774073	SPP1	chr4:88896802-88904562:+	-0.2	-3.65	0.000288	Bone mineral density;Bone mineral density (paediatric, total body less head)	
PRAD	cis	1	rs1471401	chr4:88774340	SPP1	chr4:88896802-88904562:+	-0.2	-3.65	0.000288	Bone mineral density;Bone mineral density (paediatric, total body less head)	
PRAD	cis	1	rs1471403	chr4:88775243	SPP1	chr4:88896802-88904562:+	0.2	3.61	0.000345	Bone mineral density;Bone mineral density (paediatric, total body less head)	
PRAD	cis	1	rs147144681	chr15:78900908	CHRNA3	chr15:78885397-78913322:-	-0.3	-5.23	2.62E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs147144681	chr15:78900908	CHRNA5	chr15:78857906-78886458:+	-0.22	-4.47	9.83E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs1471552	chr15:84570734	NMB	chr15:85198362-85201802:-	-0.17	-3.98	7.98E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1471553	chr15:84571038	NMB	chr15:85198362-85201802:-	-0.17	-3.98	7.98E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1472001	chr11:46484685	HARBI1	chr11:46624857-46638777:-	0.26	3.44	0.000642	Schizophrenia	
PRAD	cis	1	rs1473248	chr19:41923314	ATP5SL	chr19:41937224-41945810:-	-0.16	-3.61	0.000337	Height	
PRAD	cis	1	rs1474698	chr6:56064197	COL21A1	chr6:55921389-56258892:-	-0.25	-7.53	2.58E-13	Pulse pressure	
PRAD	cis	1	rs147499554	chr15:78900650	CHRNA3	chr15:78885397-78913322:-	-0.31	-5.41	1.0E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs147499554	chr15:78900650	CHRNA5	chr15:78857906-78886458:+	-0.21	-4.29	2.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs1474999	chr14:60905920	C14orf39	chr14:60902675-60952764:-	-0.45	-5.97	4.56E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1475695	chr9:100691168	C9orf156	chr9:100666772-100684852:-	-0.19	-3.68	0.000264	Quantitative traits	
PRAD	cis	1	rs1475696	chr9:100691397	C9orf156	chr9:100666772-100684852:-	-0.19	-3.68	0.000264	Quantitative traits	
PRAD	cis	1	rs1475911	chr21:43513480	C21orf128	chr21:43522244-43528644:-	0.35	5.01	7.74E-7	IgG glycosylation	
PRAD	cis	1	rs1480354	chr3:51364458	HEMK1	chr3:50606583-50622419:+	0.21	3.92	0.000102	Melanoma	
PRAD	cis	1	rs1480823	chr15:84585746	NMB	chr15:85198362-85201802:-	-0.17	-4.05	6.05E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1480827	chr15:84577792	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1481824	chr4:54241402	FIP1L1	chr4:54243820-54326102:+	-0.17	-3.8	0.000162	DNA methylation (variation)	
PRAD	cis	1	rs1484994	chr20:30305975	COX4I2	chr20:30225691-30232800:+	0.14	3.69	0.000249	Subcortical brain region volumes	
PRAD	cis	1	rs1485483	chr11:77930138	GAB2	chr11:77926343-78128766:-	-0.2	-5.77	1.41E-8	Testicular germ cell tumor	
PRAD	cis	1	rs148734725	chr3:49406708	GMPPB	chr3:49758932-49761384:-	-0.18	-3.88	0.000117	Educational attainment (college completion)	
PRAD	cis	1	rs148734725	chr3:49406708	MST1	chr3:49721381-49726196:-	0.09	3.58	0.000385	Educational attainment (college completion)	
PRAD	cis	1	rs148734725	chr3:49406708	RBM6	chr3:49977592-50137484:+	0.11	3.44	0.000641	Educational attainment (college completion)	
PRAD	cis	1	rs148734725	chr3:49406708	UBA7	chr3:49842639-49851391:-	0.14	3.53	0.000459	Educational attainment (college completion)	
PRAD	cis	1	rs149613931	chr10:103550281	KCNIP2	chr10:103585732-103603677:-	0.33	4.44	1.1E-5	Educational attainment (years of education)	
PRAD	cis	1	rs1497266	chr3:139283462	NMNAT3	chr3:139279041-139396840:-	0.25	4.17	3.63E-5	Gut microbiota (functional units)	
PRAD	cis	1	rs1497406	chr1:16505320	C1orf89	chr1:16558183-16563659:-	-0.21	-4.25	2.61E-5	Gamma gluatamyl transferase levels;Liver enzyme levels (gamma-glutamyl transferase)	
PRAD	cis	1	rs1498312	chr1:76177849	ACADM	chr1:76190043-76229353:+	0.18	3.86	0.000132	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs1498315	chr1:76159225	ACADM	chr1:76190043-76229353:+	0.18	3.9	0.000111	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs1498316	chr1:76159198	ACADM	chr1:76190043-76229353:+	0.19	4.11	4.62E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs1498316	chr1:76159198	RABGGTB	chr1:76251886-76260764:+	0.17	3.58	0.000379	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.51	11.72	5.37E-28	Height	
PRAD	cis	1	rs1498718	chr3:134205920	CEP63	chr3:134204575-134293852:+	0.2	3.49	0.000526	Height	
PRAD	cis	1	rs1499613	chr7:65730860	CCT6P1	chr7:65216092-65228661:+	-0.33	-5.52	5.68E-8	Diabetic kidney disease	
PRAD	cis	1	rs1499613	chr7:65730860	CRCP	chr7:65579805-65619551:+	0.35	4.28	2.31E-5	Diabetic kidney disease	
PRAD	cis	1	rs1499614	chr7:65730798	CCT6P1	chr7:65216092-65228661:+	0.33	5.58	4.13E-8	Diabetic kidney disease	
PRAD	cis	1	rs1499614	chr7:65730798	CRCP	chr7:65579805-65619551:+	-0.34	-4.23	2.83E-5	Diabetic kidney disease	
PRAD	cis	1	rs1501908	chr5:156398169	TIMD4	chr5:156346293-156390266:-	0.2	4	7.25E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs1502006	chr16:55610366	CAPNS2	chr16:55600584-55601592:+	0.18	5.09	5.28E-7	Thyroid hormone levels	
PRAD	cis	1	rs1502006	chr16:55610366	LPCAT2	chr16:55542913-55620581:+	-0.14	-4.81	2.0E-6	Thyroid hormone levels	
PRAD	cis	1	rs1502007	chr16:55613522	CAPNS2	chr16:55600584-55601592:+	-0.17	-4.76	2.54E-6	Thyroid hormone levels	
PRAD	cis	1	rs1502007	chr16:55613522	LPCAT2	chr16:55542913-55620581:+	0.12	4.12	4.47E-5	Thyroid hormone levels	
PRAD	cis	1	rs150380	chr5:36880871	NIPBL	chr5:36876861-37065920:+	0.11	4.38	1.46E-5	Height	
PRAD	cis	1	rs1507216	chr12:85538620	LRRIQ1	chr12:85430099-85638880:+	-0.23	-3.88	0.00012	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1507216	chr12:85538620	SLC6A15	chr12:85253269-85306606:-	-0.32	-4.77	2.49E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1507216	chr12:85538620	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.46	7.92E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1507758	chr1:207507481	CD55	chr1:207494817-207534309:+	0.24	4.13	4.36E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs1507760	chr1:207509365	CD55	chr1:207494817-207534309:+	-0.24	-4.29	2.19E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs1507761	chr1:207509799	CD55	chr1:207494817-207534309:+	-0.25	-4.33	1.79E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs1509460	chr5:42433819	GHR	chr5:42424026-42721925:+	-0.21	-4.95	1.04E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs1509461	chr5:42407860	GHR	chr5:42424026-42721925:+	0.2	4.53	7.38E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs1510228	chr6:160807403	SLC22A2	chr6:160592093-160679959:-	-0.22	-3.58	0.000382	Response to hepatitis C treatment	
PRAD	cis	1	rs1511218	chr2:160906390	LY75	chr2:160625141-160761262:-	0.12	3.98	8.09E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs1511218	chr2:160906390	PLA2R1	chr2:160798012-160919121:-	0.23	5.33	1.57E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs151317012	chr4:106806194	INTS12	chr4:106603787-106629881:-	-0.77	-7.18	2.67E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs1516629	chr2:112658779	MERTK	chr2:112656191-112786945:+	-0.23	-3.91	0.000105	Multiple sclerosis	
PRAD	cis	1	rs1519466	chr9:111860797	C9orf5	chr9:111777416-111882225:-	-0.25	-5.08	5.41E-7	Information processing speed	
PRAD	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.36	-11.51	3.49E-27	Ankylosing spondylitis	
PRAD	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.55	10.76	2.7E-24	Ankylosing spondylitis	
PRAD	cis	1	rs1520884	chr11:18309700	GTF2H1	chr11:18343816-18388590:+	-0.74	-15.56	2.45E-44	Pancreatic cancer	
PRAD	cis	1	rs1522110	chr4:56380283	TMEM165	chr4:56262090-56292342:+	-0.16	-3.49	0.000529	Personality dimensions	
PRAD	cis	1	rs1525738	chr7:16889926	AGR2	chr7:16832266-16844738:-	-0.18	-3.58	0.000383	Type 2 diabetes (dietary heme iron intake interaction)	
PRAD	cis	1	rs1525739	chr7:16889812	AGR2	chr7:16832266-16844738:-	0.19	3.63	0.000311	Type 2 diabetes (dietary heme iron intake interaction)	
PRAD	cis	1	rs1525892	chr3:133484712	TF	chr3:133419211-133497635:+	-0.17	-3.59	0.000371	Iron status biomarkers	
PRAD	cis	1	rs1526080	chr15:84589920	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1526081	chr15:84590066	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1529957	chr19:37739801	ZNF607	chr19:38187276-38210691:-	-0.22	-4.03	6.62E-5	Coronary artery calcification	
PRAD	cis	1	rs1529957	chr19:37739801	ZNF781	chr19:38158650-38183216:-	0.23	4.01	7.1E-5	Coronary artery calcification	
PRAD	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.37	2.99E-19	Obesity-related traits	
PRAD	cis	1	rs1533266	chr7:143766714	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.72	0.000224	Obesity-related traits	
PRAD	cis	1	rs1533266	chr7:143766714	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.36	1.3E-7	Obesity-related traits	
PRAD	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.37	2.99E-19	Obesity-related traits	
PRAD	cis	1	rs1533267	chr7:143766440	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.72	0.000224	Obesity-related traits	
PRAD	cis	1	rs1533267	chr7:143766440	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.36	1.3E-7	Obesity-related traits	
PRAD	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.37	2.99E-19	Obesity-related traits	
PRAD	cis	1	rs1533268	chr7:143766358	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.72	0.000224	Obesity-related traits	
PRAD	cis	1	rs1533268	chr7:143766358	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.36	1.3E-7	Obesity-related traits	
PRAD	cis	1	rs1533642	chr9:111903349	C9orf5	chr9:111777416-111882225:-	0.23	4.55	6.82E-6	Information processing speed	
PRAD	cis	1	rs1533665	chr15:78530940	CIB2	chr15:78396991-78423878:-	-0.17	-3.43	0.000651	Personality dimensions	
PRAD	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.4	9.37E-27	Height	
PRAD	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.55	12.68	6.73E-32	Height	
PRAD	cis	1	rs1534471	chr2:73647508	ALMS1P	chr2:73872046-73912692:+	0.5	8.75	3.73E-17	Metabolite levels	
PRAD	cis	1	rs1534471	chr2:73647508	NAT8	chr2:73867850-73869537:-	0.25	3.85	0.000133	Metabolite levels	
PRAD	cis	1	rs1535277	chr6:26567802	BTN2A3	chr6:26422317-26431927:+	0.26	6.44	3.0E-10	Educational attainment	
PRAD	cis	1	rs1535277	chr6:26567802	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.44	0.00064	Educational attainment	
PRAD	cis	1	rs1535277	chr6:26567802	ZNF184	chr6:27418522-27440897:-	-0.18	-3.74	0.000206	Educational attainment	
PRAD	cis	1	rs1538767	chr3:195007852	C3orf21	chr3:194789015-194991895:-	0.42	8.96	7.49E-18	Body mass index	
PRAD	cis	1	rs1539338	chr9:115586187	C9orf80	chr9:115448793-115480387:-	0.31	4.09	5.14E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs1540651	chr7:65650121	TPST1	chr7:65670259-65825437:+	-0.18	-4.4	1.37E-5	Aortic root size	
PRAD	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.51	-9.5	1.04E-19	Obesity-related traits	
PRAD	cis	1	rs1540894	chr7:143767676	OR2A1	chr7:144015236-144016148:+;chr7	-0.24	-3.83	0.000145	Obesity-related traits	
PRAD	cis	1	rs1540894	chr7:143767676	OR2A9P	chr7:143991573-143997832:+;chr7	-0.32	-5.35	1.36E-7	Obesity-related traits	
PRAD	cis	1	rs1540909	chr6:35488853	TULP1	chr6:35465653-35480647:-	-0.34	-4.96	9.63E-7	Hepatitis C induced liver fibrosis	
PRAD	cis	1	rs1540927	chr20:33931344	CEP250	chr20:34042996-34099802:+	-0.24	-5.35	1.4E-7	Height	
PRAD	cis	1	rs1540927	chr20:33931344	CPNE1	chr20:34213968-34262539:-	0.2	3.95	9.03E-5	Height	
PRAD	cis	1	rs1540927	chr20:33931344	FAM83C	chr20:33873287-33880225:-	0.16	3.65	0.000286	Height	
PRAD	cis	1	rs1540927	chr20:33931344	GDF5	chr20:33897002-34042568:-	-0.2	-5.01	7.75E-7	Height	
PRAD	cis	1	rs1540927	chr20:33931344	MMP24	chr20:33814539-33864804:+	0.14	3.63	0.000315	Height	
PRAD	cis	1	rs1540927	chr20:33931344	UQCC	chr20:33890383-33999833:-	0.39	7.44	4.9E-13	Height	
PRAD	cis	1	rs1541424	chr7:26557421	HOXA4	chr7:27168127-27170399:-	-0.21	-3.53	0.000449	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs1543185	chr9:97321172	FAM22F	chr9:97080478-97090926:-	0.45	3.89	0.000116	Height	
PRAD	cis	1	rs1544549	chr7:66090663	TPST1	chr7:65670259-65825437:+	-0.18	-4.4	1.33E-5	Aortic root size	
PRAD	cis	1	rs1546059	chr7:65654709	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs1546059	chr7:65654709	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs1546753	chr3:119557075	NR1I2	chr3:119499331-119537331:+	0.22	4.05	5.91E-5	HDL cholesterol	
PRAD	cis	1	rs1547958	chr7:150640285	ABCB8	chr7:150725510-150744867:+	0.17	3.66	0.000278	QT interval	
PRAD	cis	1	rs1548226	chr20:43983777	SYS1	chr20:43991701-44004724:+	0.35	6.36	4.73E-10	Psoriasis	
PRAD	cis	1	rs1549829	chr3:150879527	P2RY12	chr3:151055238-151102544:-	0.29	5.24	2.43E-7	Heschl's gyrus morphology	
PRAD	cis	1	rs1552244	chr3:10135577	C3orf10	chr3:10157333-10168873:+	-0.19	-3.75	0.000198	Alzheimer's disease	
PRAD	cis	1	rs1552244	chr3:10135577	LOC401052	chr3:10048102-10052779:-	-0.28	-5.22	2.68E-7	Alzheimer's disease	
PRAD	cis	1	rs1552994	chr1:152171461	FLG	chr1:152274651-152297679:-	0.39	7.02	7.7E-12	Inflammatory skin disease	
PRAD	cis	1	rs1553174	chr7:65731194	CCT6P1	chr7:65216092-65228661:+	-0.33	-5.52	5.68E-8	Diabetic kidney disease	
PRAD	cis	1	rs1553174	chr7:65731194	CRCP	chr7:65579805-65619551:+	0.35	4.28	2.31E-5	Diabetic kidney disease	
PRAD	cis	1	rs1553609	chr7:66197139	CRCP	chr7:65579805-65619551:+	-0.21	-3.95	9.01E-5	Aortic root size	
PRAD	cis	1	rs1553609	chr7:66197139	LOC493754	chr7:65993446-66057363:-	-0.24	-5.4	1.07E-7	Aortic root size	
PRAD	cis	1	rs1553609	chr7:66197139	TPST1	chr7:65670259-65825437:+	0.15	3.52	0.000474	Aortic root size	
PRAD	cis	1	rs1553610	chr7:66197233	CRCP	chr7:65579805-65619551:+	-0.21	-3.97	8.46E-5	Aortic root size	
PRAD	cis	1	rs1553610	chr7:66197233	LOC493754	chr7:65993446-66057363:-	-0.24	-5.5	6.25E-8	Aortic root size	
PRAD	cis	1	rs1553610	chr7:66197233	TPST1	chr7:65670259-65825437:+	0.15	3.57	0.000396	Aortic root size	
PRAD	cis	1	rs1554120	chr3:150935371	P2RY12	chr3:151055238-151102544:-	0.3	5.04	6.79E-7	Heschl's gyrus morphology	
PRAD	cis	1	rs1555299	chr20:43370106	KCNK15	chr20:43374488-43379666:+	0.26	4.71	3.21E-6	Obesity-related traits	
PRAD	cis	1	rs1555337	chr20:61863641	BIRC7	chr20:61867276-61871853:+	-0.35	-4.12	4.52E-5	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.75	-14.19	2.81E-38	Esophageal cancer (squamous cell)	
PRAD	cis	1	rs1556562	chr1:93034023	EVI5	chr1:92974255-93257961:-	0.28	5.74	1.72E-8	Cholesterol, total	
PRAD	cis	1	rs1557503	chr22:51013072	CPT1B	chr22:51007291-51017096:-	-0.22	-4.82	1.91E-6	Narcolepsy	
PRAD	cis	1	rs1558377	chr4:17650758	MED28	chr4:17616273-17629791:+	0.2	5.11	4.7E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs1558378	chr4:17650351	MED28	chr4:17616273-17629791:+	0.2	5.11	4.7E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.9	15.83	1.45E-45	Type 2 diabetes	
PRAD	cis	1	rs1559777	chr15:58080617	CGNL1	chr15:57668705-57842920:+	-0.17	-3.44	0.000643	Myopia (pathological)	
PRAD	cis	1	rs1560277	chr2:198187903	PLCL1	chr2:198669426-199014606:+	0.11	3.53	0.000452	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs1560396	chr4:39113712	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	cis	1	rs1560397	chr4:39113885	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	cis	1	rs1560706	chr19:10838004	LOC147727	chr19:10762539-10764548:-	0.27	3.52	0.000468	LDL cholesterol	
PRAD	cis	1	rs1560734	chr19:10841049	LOC147727	chr19:10762539-10764548:-	-0.28	-3.68	0.00026	LDL cholesterol	
PRAD	cis	1	rs1560868	chr2:26281459	GPR113	chr2:26531041-26569685:-	0.26	3.73	0.000212	Gut microbiome composition (summer)	
PRAD	cis	1	rs1561288	chr2:25369002	POMC	chr2:25383722-25391559:-	0.23	4.74	2.8E-6	Body mass index	
PRAD	cis	1	rs1561289	chr2:25369040	POMC	chr2:25383722-25391559:-	-0.23	-4.9	1.34E-6	Body mass index	
PRAD	cis	1	rs1561609	chr2:164499515	FIGN	chr2:164464118-164592513:-	-0.25	-3.84	0.000142	Folate pathway vitamin levels	
PRAD	cis	1	rs1562915	chr2:161573679	RBMS1	chr2:161128663-161350318:-	-0.11	-3.63	0.000311	Educational attainment	
PRAD	cis	1	rs1563736	chr3:48436794	ATRIP	chr3:48488141-48507708:+	0.27	6.28	7.73E-10	Longevity	
PRAD	cis	1	rs1563736	chr3:48436794	CDC25A	chr3:48198668-48229801:-	0.22	4.12	4.39E-5	Longevity	
PRAD	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.18	-5.01	7.64E-7	Longevity	
PRAD	cis	1	rs15637	chr17:61772050	DDX42	chr17:61851567-61896676:+	-0.27	-5.59	3.84E-8	Body mass index	
PRAD	cis	1	rs15637	chr17:61772050	FTSJ3	chr17:61896795-61905031:-	0.32	6.42	3.36E-10	Body mass index	
PRAD	cis	1	rs15637	chr17:61772050	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.2	3.25E-5	Body mass index	
PRAD	cis	1	rs156407	chr7:23315639	GPNMB	chr7:23286316-23314728:+	-0.17	-4.67	3.97E-6	Parkinson's disease	
PRAD	cis	1	rs156421	chr7:23312487	GPNMB	chr7:23286316-23314728:+	-0.15	-4.18	3.41E-5	Parkinson's disease	
PRAD	cis	1	rs156425	chr7:23309119	GPNMB	chr7:23286316-23314728:+	0.15	4.3	2.04E-5	Parkinson's disease	
PRAD	cis	1	rs1564472	chr15:84569793	NMB	chr15:85198362-85201802:-	-0.16	-3.77	0.000186	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1564473	chr15:84569942	NMB	chr15:85198362-85201802:-	-0.17	-3.89	0.000113	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1564474	chr15:84570033	NMB	chr15:85198362-85201802:-	-0.17	-3.98	7.98E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1564475	chr15:84572229	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.82	12.89	9.51E-33	Diastolic blood pressure	
PRAD	cis	1	rs1565531	chr7:65663113	TPST1	chr7:65670259-65825437:+	-0.18	-4.41	1.26E-5	Aortic root size	
PRAD	cis	1	rs15676	chr9:131572027	C9orf114	chr9:131584346-131592085:-	-0.21	-5	8.05E-7	Blood metabolite levels	
PRAD	cis	1	rs15676	chr9:131572027	ENDOG	chr9:131580779-131584954:+	-0.33	-9.17	1.5E-18	Blood metabolite levels	
PRAD	cis	1	rs1567890	chr11:78101700	GAB2	chr11:77926343-78128766:-	-0.21	-6.66	7.47E-11	Testicular germ cell tumor	
PRAD	cis	1	rs1567890	chr11:78101700	NARS2	chr11:78147017-78285909:-	-0.18	-3.49	0.000524	Testicular germ cell tumor	
PRAD	cis	1	rs1569483	chr6:25614595	SCGN	chr6:25652429-25702006:+	0.42	7.13	3.88E-12	Uric acid levels	
PRAD	cis	1	rs1569716	chr22:38998519	CBY1	chr22:39052658-39069853:+	0.15	4.24	2.69E-5	Resting heart rate	
PRAD	cis	1	rs1569716	chr22:38998519	LOC646851	chr22:38974125-39052634:-	0.21	4.99	8.37E-7	Resting heart rate	
PRAD	cis	1	rs1570004	chr20:33958253	CEP250	chr20:34042996-34099802:+	-0.24	-5.35	1.4E-7	Height	
PRAD	cis	1	rs1570004	chr20:33958253	CPNE1	chr20:34213968-34262539:-	0.2	3.95	9.03E-5	Height	
PRAD	cis	1	rs1570004	chr20:33958253	FAM83C	chr20:33873287-33880225:-	0.16	3.65	0.000286	Height	
PRAD	cis	1	rs1570004	chr20:33958253	GDF5	chr20:33897002-34042568:-	-0.2	-5.01	7.75E-7	Height	
PRAD	cis	1	rs1570004	chr20:33958253	MMP24	chr20:33814539-33864804:+	0.14	3.63	0.000315	Height	
PRAD	cis	1	rs1570004	chr20:33958253	UQCC	chr20:33890383-33999833:-	0.39	7.44	4.9E-13	Height	
PRAD	cis	1	rs1570063	chr6:49637027	RHAG	chr6:49572893-49604587:-	0.29	4.6	5.34E-6	Prothrombin fragments F1+2 levels in ischemic stroke	
PRAD	cis	1	rs1570836	chr1:92972457	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs1570837	chr1:93006816	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs1571229	chr9:131913711	CRAT	chr9:131857075-131873070:-	0.22	4.2	3.14E-5	Blood metabolite ratios	
PRAD	cis	1	rs1571466	chr1:23449183	C1orf213	chr1:23695464-23698278:+	-0.18	-4.68	3.78E-6	Height	
PRAD	cis	1	rs1572275	chr1:207478980	CD55	chr1:207494817-207534309:+	-0.21	-3.72	0.000222	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs1573897	chr1:247215054	ZNF670	chr1:247200087-247242069:-	-0.33	-7.3	1.25E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.5	-11.14	9.65E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.51	-11.41	8.48E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs1583090	chr1:207435783	CD55	chr1:207494817-207534309:+	0.51	9.55	7.4E-20	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs158622	chr5:36887895	NIPBL	chr5:36876861-37065920:+	-0.1	-3.95	8.99E-5	Height	
PRAD	cis	1	rs158623	chr5:36883019	NIPBL	chr5:36876861-37065920:+	0.11	4.33	1.81E-5	Height	
PRAD	cis	1	rs158624	chr5:36865669	NIPBL	chr5:36876861-37065920:+	0.11	4.27	2.35E-5	Height	
PRAD	cis	1	rs158791	chr5:36948362	NIPBL	chr5:36876861-37065920:+	-0.1	-4.15	3.9E-5	Height	
PRAD	cis	1	rs158796	chr5:36878780	NIPBL	chr5:36876861-37065920:+	0.11	4.32	1.91E-5	Height	
PRAD	cis	1	rs1593071	chr5:42786309	CCDC152	chr5:42756920-42802539:+	0.16	4.49	8.85E-6	Height	
PRAD	cis	1	rs1593071	chr5:42786309	SEPP1	chr5:42799983-42825998:-	0.15	4.37	1.54E-5	Height	
PRAD	cis	1	rs1595825	chr2:198875464	PLCL1	chr2:198669426-199014606:+	0.15	4.02	6.91E-5	Ulcerative colitis	
PRAD	cis	1	rs159751	chr5:36999998	NIPBL	chr5:36876861-37065920:+	0.11	4.53	7.65E-6	Height	
PRAD	cis	1	rs159753	chr5:37007629	NIPBL	chr5:36876861-37065920:+	0.11	4.56	6.43E-6	Height	
PRAD	cis	1	rs159755	chr5:36995205	NIPBL	chr5:36876861-37065920:+	0.11	4.53	7.6E-6	Height	
PRAD	cis	1	rs1598859	chr4:103506444	BDH2	chr4:103998783-104021024:-	0.15	3.79	0.000168	Ulcerative colitis	
PRAD	cis	1	rs159913	chr5:37053983	NIPBL	chr5:36876861-37065920:+	0.11	4.45	1.06E-5	Height	
PRAD	cis	1	rs1599280	chr6:56792576	BEND6	chr6:56819773-56892138:+	-0.61	-10.98	4.06E-25	Menarche (age at onset)	
PRAD	cis	1	rs1599281	chr6:56789311	BEND6	chr6:56819773-56892138:+	0.59	10.67	6.2E-24	Menarche (age at onset)	
PRAD	cis	1	rs1599281	chr6:56789311	KIAA1586	chr6:56911384-56920021:+	0.21	3.47	0.000575	Menarche (age at onset)	
PRAD	cis	1	rs1599476	chr8:120351800	NOV	chr8:120428552-120436678:+	-0.24	-3.67	0.000273	Hypertension	
PRAD	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.38	7.85	2.93E-14	Multiple sclerosis	
PRAD	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.57	-13.79	1.47E-36	Multiple sclerosis	
PRAD	cis	1	rs1599932	chr12:58177943	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-5.02	7.32E-7	Multiple sclerosis	
PRAD	cis	1	rs160208	chr3:12159294	SYN2	chr3:12045862-12233530:+	-0.36	-4.41	1.29E-5	Fasting insulin-related traits (interaction with BMI)	
PRAD	cis	1	rs160214	chr3:12168910	SYN2	chr3:12045862-12233530:+	-0.37	-4.66	4.07E-6	Fasting insulin-related traits (interaction with BMI)	
PRAD	cis	1	rs1605364	chr11:48684843	FOLH1	chr11:49168188-49230222:-	-0.18	-4.11	4.59E-5	HDL cholesterol	
PRAD	cis	1	rs160633	chr7:65528228	CCT6P1	chr7:65216092-65228661:+	0.35	5.95	5.39E-9	Diabetic kidney disease	
PRAD	cis	1	rs160633	chr7:65528228	CRCP	chr7:65579805-65619551:+	-0.29	-3.54	0.000448	Diabetic kidney disease	
PRAD	cis	1	rs160634	chr7:65528664	CCT6P1	chr7:65216092-65228661:+	-0.27	-4.88	1.44E-6	Diabetic kidney disease	
PRAD	cis	1	rs160637	chr7:65584318	CCT6P1	chr7:65216092-65228661:+	0.33	5.76	1.51E-8	Diabetic kidney disease	
PRAD	cis	1	rs160637	chr7:65584318	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000132	Diabetic kidney disease	
PRAD	cis	1	rs160639	chr7:65579987	CCT6P1	chr7:65216092-65228661:+	0.32	5.47	7.5E-8	Diabetic kidney disease	
PRAD	cis	1	rs160639	chr7:65579987	CRCP	chr7:65579805-65619551:+	-0.31	-3.86	0.000132	Diabetic kidney disease	
PRAD	cis	1	rs160642	chr7:65558373	CCT6P1	chr7:65216092-65228661:+	0.34	5.83	1.03E-8	Diabetic kidney disease	
PRAD	cis	1	rs160642	chr7:65558373	CRCP	chr7:65579805-65619551:+	-0.28	-3.48	0.000553	Diabetic kidney disease	
PRAD	cis	1	rs160643	chr7:65558222	CCT6P1	chr7:65216092-65228661:+	0.3	5.37	1.25E-7	Diabetic kidney disease	
PRAD	cis	1	rs160644	chr7:65558186	CCT6P1	chr7:65216092-65228661:+	0.34	5.94	5.58E-9	Diabetic kidney disease	
PRAD	cis	1	rs160644	chr7:65558186	CRCP	chr7:65579805-65619551:+	-0.28	-3.51	0.000494	Diabetic kidney disease	
PRAD	cis	1	rs160646	chr7:65556280	CCT6P1	chr7:65216092-65228661:+	0.34	5.94	5.58E-9	Diabetic kidney disease	
PRAD	cis	1	rs160646	chr7:65556280	CRCP	chr7:65579805-65619551:+	-0.28	-3.51	0.000494	Diabetic kidney disease	
PRAD	cis	1	rs160648	chr7:65543384	CCT6P1	chr7:65216092-65228661:+	0.35	6.05	3.0E-9	Diabetic kidney disease	
PRAD	cis	1	rs160652	chr7:65538431	CCT6P1	chr7:65216092-65228661:+	0.35	5.92	6.09E-9	Diabetic kidney disease	
PRAD	cis	1	rs160655	chr7:65533214	CCT6P1	chr7:65216092-65228661:+	0.35	6.05	3.0E-9	Diabetic kidney disease	
PRAD	cis	1	rs1606803	chr2:88933316	RPIA	chr2:88991176-89050451:+	0.18	3.67	0.000266	Height	
PRAD	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	0.86	14.28	1.09E-38	Diastolic blood pressure	
PRAD	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.38	-6.83	2.65E-11	Rheumatoid arthritis	
PRAD	cis	1	rs1609810	chr9:123642351	TRAF1	chr9:123664672-123691479:-	0.18	5.05	6.29E-7	Rheumatoid arthritis	
PRAD	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.84	-13.69	3.95E-36	Diastolic blood pressure	
PRAD	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	0.87	14.31	8.03E-39	Diastolic blood pressure	
PRAD	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-0.89	-15.01	6.71E-42	Diastolic blood pressure	
PRAD	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	0.87	14.31	8.03E-39	Diastolic blood pressure	
PRAD	cis	1	rs1618893	chr7:66096119	CCT6P1	chr7:65216092-65228661:+	0.26	4.41	1.3E-5	Diabetic kidney disease	
PRAD	cis	1	rs1618893	chr7:66096119	CRCP	chr7:65579805-65619551:+	-0.3	-3.71	0.000228	Diabetic kidney disease	
PRAD	cis	1	rs1623294	chr10:59939025	IPMK	chr10:59955618-60027694:-	0.09	3.47	0.000565	Inflammatory bowel disease	
PRAD	cis	1	rs1628874	chr3:41955714	ULK4	chr3:41288091-42003660:-	-0.89	-14.78	6.88E-41	Diastolic blood pressure	
PRAD	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-0.88	-14.6	4.25E-40	Diastolic blood pressure	
PRAD	cis	1	rs1633360	chr12:58108052	FAM119B	chr12:58166383-58176323:+	-0.24	-5.04	6.66E-7	Rheumatoid arthritis	
PRAD	cis	1	rs1633360	chr12:58108052	OS9	chr12:58087886-58115338:+	0.14	3.71	0.000231	Rheumatoid arthritis	
PRAD	cis	1	rs1633360	chr12:58108052	TSFM	chr12:58176536-58191367:+	0.38	9.01	5.38E-18	Rheumatoid arthritis	
PRAD	cis	1	rs1634409	chr17:18836177	FAM18B	chr17:18684582-18710026:+	-0.25	-5.15	3.89E-7	Educational attainment (years of education)	
PRAD	cis	1	rs1634411	chr17:18833810	FAM18B	chr17:18684582-18710026:+	-0.25	-5.15	3.89E-7	Educational attainment (years of education)	
PRAD	cis	1	rs1635	chr6:28227604	ZSCAN12	chr6:28346770-28367544:-	0.31	3.69	0.00025	Schizophrenia	
PRAD	cis	1	rs1638676	chr3:47327651	C3orf75	chr3:47537131-47555199:-	-0.17	-5.23	2.59E-7	Colorectal cancer	
PRAD	cis	1	rs1638676	chr3:47327651	NBEAL2	chr3:47021173-47051193:+	-0.13	-4.12	4.39E-5	Colorectal cancer	
PRAD	cis	1	rs1638731	chr7:66144679	CCT6P1	chr7:65216092-65228661:+	0.32	5.48	7.08E-8	Gout	
PRAD	cis	1	rs1638731	chr7:66144679	CRCP	chr7:65579805-65619551:+	-0.34	-4.22	2.97E-5	Gout	
PRAD	cis	1	rs1638734	chr7:66097539	CCT6P1	chr7:65216092-65228661:+	0.31	5.24	2.45E-7	Diabetic kidney disease	
PRAD	cis	1	rs1638734	chr7:66097539	CRCP	chr7:65579805-65619551:+	-0.32	-3.93	9.68E-5	Diabetic kidney disease	
PRAD	cis	1	rs164106	chr17:74290566	FAM100B	chr17:74261286-74267379:+	-0.18	-5.05	6.22E-7	White matter hyperintensities in ischemic stroke	
PRAD	cis	1	rs1648348	chr15:50474766	SLC27A2	chr15:50474393-50528588:+	-0.19	-3.64	0.000302	Blood metabolite ratios	
PRAD	cis	1	rs1652333	chr1:207470460	CD55	chr1:207494817-207534309:+	-0.22	-3.78	0.000175	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs1659685	chr2:27420690	C2orf28	chr2:27434899-27440044:+	-0.26	-7.15	3.24E-12	Blood metabolite levels	
PRAD	cis	1	rs1659685	chr2:27420690	KHK	chr2:27309611-27323619:+	-0.21	-4.56	6.53E-6	Blood metabolite levels	
PRAD	cis	1	rs1659695	chr2:27406944	C2orf28	chr2:27434899-27440044:+	-0.26	-7.12	4.19E-12	Blood metabolite levels	
PRAD	cis	1	rs1659695	chr2:27406944	KHK	chr2:27309611-27323619:+	-0.22	-4.7	3.5E-6	Blood metabolite levels	
PRAD	cis	1	rs1665050	chr15:59293605	SLTM	chr15:59171245-59225852:-	-0.15	-3.43	0.000658	Atopic dermatitis	
PRAD	cis	1	rs1665362	chr4:1726367	FAM53A	chr4:1641609-1685854:-	-0.44	-8.33	8.83E-16	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs1665364	chr4:1727206	FAM53A	chr4:1641609-1685854:-	0.43	8.19	2.43E-15	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs1665366	chr4:1728381	FAM53A	chr4:1641609-1685854:-	0.46	8.45	3.8E-16	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs1665982	chr3:47905079	CDC25A	chr3:48198668-48229801:-	-0.34	-5.76	1.56E-8	Educational attainment (years of education)	
PRAD	cis	1	rs1665982	chr3:47905079	SPINK8	chr3:48348336-48369831:-	-0.26	-4.81	2.06E-6	Educational attainment (years of education)	
PRAD	cis	1	rs166663	chr7:23316742	GPNMB	chr7:23286316-23314728:+	-0.17	-4.7	3.47E-6	Parkinson's disease	
PRAD	cis	1	rs1668357	chr7:38004406	EPDR1	chr7:37960163-37991539:+	0.35	4.28	2.25E-5	Myopia (pathological)	
PRAD	cis	1	rs166925	chr19:41926098	ATP5SL	chr19:41937224-41945810:-	0.16	3.55	0.000421	Height	
PRAD	cis	1	rs1678542	chr12:57968715	FAM119B	chr12:58166383-58176323:+	-0.22	-5.14	4.02E-7	Rheumatoid arthritis	
PRAD	cis	1	rs1678542	chr12:57968715	PIP4K2C	chr12:57984942-57997210:+	0.12	3.7	0.000239	Rheumatoid arthritis	
PRAD	cis	1	rs1678542	chr12:57968715	TSFM	chr12:58176536-58191367:+	0.27	6.5	2.06E-10	Rheumatoid arthritis	
PRAD	cis	1	rs1678982	chr15:48901420	DUT	chr15:48623621-48635568:+	0.27	4.56	6.67E-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs1679381	chr12:75946124	GLIPR1L2	chr12:75784889-75825591:+	-0.34	-5.43	9.02E-8	Polycystic ovary syndrome	
PRAD	cis	1	rs1679709	chr6:28228342	ZKSCAN3	chr6:28317691-28334523:+	0.18	3.7	0.000238	Depression	
PRAD	cis	1	rs1679709	chr6:28228342	ZNF187	chr6:28234788-28245978:+	0.32	5.79	1.26E-8	Depression	
PRAD	cis	1	rs1679709	chr6:28228342	ZNF323	chr6:28292517-28324048:-	-0.41	-5.61	3.45E-8	Depression	
PRAD	cis	1	rs1679709	chr6:28228342	ZNF389	chr6:28129551-28137375:+	0.52	7.56	2.18E-13	Depression	
PRAD	cis	1	rs1679709	chr6:28228342	ZSCAN23	chr6:28393287-28411279:-	-0.17	-4.58	6.09E-6	Depression	
PRAD	cis	1	rs1679732	chr6:28221264	ZKSCAN3	chr6:28317691-28334523:+	0.18	3.7	0.000238	Depression	
PRAD	cis	1	rs1679732	chr6:28221264	ZNF187	chr6:28234788-28245978:+	0.32	5.79	1.26E-8	Depression	
PRAD	cis	1	rs1679732	chr6:28221264	ZNF323	chr6:28292517-28324048:-	-0.41	-5.61	3.45E-8	Depression	
PRAD	cis	1	rs1679732	chr6:28221264	ZNF389	chr6:28129551-28137375:+	0.52	7.56	2.18E-13	Depression	
PRAD	cis	1	rs1679732	chr6:28221264	ZSCAN23	chr6:28393287-28411279:-	-0.17	-4.58	6.09E-6	Depression	
PRAD	cis	1	rs1680784	chr3:128644458	ACAD9	chr3:128598333-128634910:+	-0.2	-3.71	0.000231	IgG glycosylation	
PRAD	cis	1	rs1680790	chr3:128625853	ACAD9	chr3:128598333-128634910:+	-0.2	-3.73	0.000213	IgG glycosylation	
PRAD	cis	1	rs16824599	chr2:203222966	NOP58	chr2:203130515-203168382:+	0.29	4.42	1.23E-5	Urate levels	
PRAD	cis	1	rs16826864	chr3:156580033	LEKR1	chr3:156544076-156763918:+	-0.43	-5.62	3.27E-8	Bone mineral density	
PRAD	cis	1	rs16828976	chr1:183608481	NCF2	chr1:183524698-183560046:-	0.27	3.81	0.000159	Systemic lupus erythematosus	
PRAD	cis	1	rs16828981	chr1:183608658	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000221	Systemic lupus erythematosus	
PRAD	cis	1	rs16828985	chr1:183609830	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs16829945	chr1:25040315	CLIC4	chr1:25071760-25170815:+	-0.09	-3.54	0.000446	Height	
PRAD	cis	1	rs16831514	chr1:160146494	ATP1A4	chr1:160121352-160156766:+	0.81	7.91	1.88E-14	Gout	
PRAD	cis	1	rs16832834	chr2:191554447	OSGEPL1	chr2:190611386-190627953:-	0.21	3.85	0.000133	Primary biliary cirrhosis	
PRAD	cis	1	rs16832836	chr2:191558030	OSGEPL1	chr2:190611386-190627953:-	0.2	3.71	0.000229	Primary biliary cirrhosis	
PRAD	cis	1	rs16833062	chr3:182076647	LAMP3	chr3:182840004-182880667:-	0.17	3.6	0.00035	Cognitive function	
PRAD	cis	1	rs16837131	chr2:202173812	CFLAR	chr2:201980816-202029001:+	0.2	4.52	7.77E-6	Rheumatoid arthritis	
PRAD	cis	1	rs16837131	chr2:202173812	NIF3L1	chr2:201754050-201768655:+	0.35	5.32	1.61E-7	Rheumatoid arthritis	
PRAD	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.76	10.79	2.1E-24	Rheumatoid arthritis	
PRAD	cis	1	rs1683776	chr3:128622760	ACAD9	chr3:128598333-128634910:+	-0.2	-3.65	0.000292	IgG glycosylation	
PRAD	cis	1	rs1683778	chr3:128644595	ACAD9	chr3:128598333-128634910:+	-0.2	-3.77	0.000185	IgG glycosylation	
PRAD	cis	1	rs1683782	chr3:128640277	ACAD9	chr3:128598333-128634910:+	-0.2	-3.78	0.000176	IgG glycosylation	
PRAD	cis	1	rs1683811	chr3:128612113	ACAD9	chr3:128598333-128634910:+	-0.2	-3.63	0.000309	IgG glycosylation	
PRAD	cis	1	rs16839077	chr2:203208693	NOP58	chr2:203130515-203168382:+	0.28	4.4	1.34E-5	Urate levels	
PRAD	cis	1	rs16839090	chr2:203213061	NOP58	chr2:203130515-203168382:+	0.28	4.3	2.11E-5	Urate levels	
PRAD	cis	1	rs16839149	chr2:203292344	NOP58	chr2:203130515-203168382:+	0.28	4.47	1.0E-5	Urate levels	
PRAD	cis	1	rs16839793	chr3:132622657	NPHP3	chr3:132363641-132441276:-	-0.13	-3.71	0.000235	Number of pregnancies	
PRAD	cis	1	rs16840074	chr1:150683156	CTSK	chr1:150768687-150780812:-	-0.22	-4.6	5.42E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs16843245	chr2:242032709	PASK	chr2:242045515-242088878:-	-0.34	-3.73	0.000217	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs16843267	chr2:242039589	PASK	chr2:242045515-242088878:-	0.3	3.53	0.000451	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs16844002	chr3:128053487	RUVBL1	chr3:127783627-127872757:-	0.23	4.2	3.19E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs16844715	chr2:160915106	LY75	chr2:160625141-160761262:-	-0.13	-4.59	5.66E-6	Idiopathic membranous nephropathy	
PRAD	cis	1	rs16844715	chr2:160915106	PLA2R1	chr2:160798012-160919121:-	-0.22	-5.15	3.76E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs16847251	chr1:200800081	DDX59	chr1:200610119-200639126:-	0.26	3.49	0.000538	Epilepsy	
PRAD	cis	1	rs1684942	chr3:47900703	CCDC72	chr3:48481686-48485537:+	0.12	3.85	0.000134	Educational attainment (years of education)	
PRAD	cis	1	rs1684942	chr3:47900703	CDC25A	chr3:48198668-48229801:-	0.28	5.23	2.62E-7	Educational attainment (years of education)	
PRAD	cis	1	rs1684942	chr3:47900703	SPINK8	chr3:48348336-48369831:-	0.2	3.94	9.36E-5	Educational attainment (years of education)	
PRAD	cis	1	rs16851607	chr3:128570263	ACAD9	chr3:128598333-128634910:+	-0.28	-3.59	0.000368	Dental caries	
PRAD	cis	1	rs16861243	chr1:183589382	NCF2	chr1:183524698-183560046:-	-0.25	-3.76	0.000192	Systemic lupus erythematosus	
PRAD	cis	1	rs16861254	chr1:183592275	NCF2	chr1:183524698-183560046:-	0.25	3.66	0.00028	Systemic lupus erythematosus	
PRAD	cis	1	rs16861256	chr1:183592594	NCF2	chr1:183524698-183560046:-	-0.24	-3.58	0.000377	Systemic lupus erythematosus	
PRAD	cis	1	rs16861259	chr1:183593328	NCF2	chr1:183524698-183560046:-	-0.23	-3.53	0.000451	Systemic lupus erythematosus	
PRAD	cis	1	rs16861298	chr1:183598181	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs16861394	chr1:183617693	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs16861400	chr1:183619781	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs16861402	chr1:183620178	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs16861414	chr1:183620393	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs16865791	chr2:178668000	PDE11A	chr2:178487979-178973066:-	-0.32	-3.91	0.000107	Height	
PRAD	cis	1	rs168662	chr5:36925735	NIPBL	chr5:36876861-37065920:+	0.1	4.23	2.83E-5	Height	
PRAD	cis	1	rs16867454	chr2:182462485	CERKL	chr2:182401402-182545381:-	-0.16	-3.92	0.000102	Response to iloperidone treatment (QT prolongation)	
PRAD	cis	1	rs16876336	chr5:78323482	BHMT2	chr5:78365583-78385273:+	0.09	3.74	0.000209	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.5	-11.83	1.83E-28	Response to antipsychotic treatment	
PRAD	cis	1	rs1687715	chr10:17003999	TRDMT1	chr10:17184983-17243681:-	-0.34	-3.43	0.000662	Quantitative traits	
PRAD	cis	1	rs16879765	chr7:37989095	EPDR1	chr7:37960163-37991539:+	0.28	3.68	0.000265	Dupuytren's disease	
PRAD	cis	1	rs16879964	chr7:38834868	FAM183B	chr7:38724947-38726689:-	0.35	3.55	0.000425	Cognitive performance	
PRAD	cis	1	rs16879966	chr7:38843256	FAM183B	chr7:38724947-38726689:-	-0.32	-3.47	0.000569	Cognitive performance	
PRAD	cis	1	rs16884476	chr8:89584486	MMP16	chr8:89049462-89339717:-	0.17	3.96	8.77E-5	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs16887244	chr8:38031345	DDHD2	chr8:38089009-38120286:+	0.39	6.6	1.1E-10	Schizophrenia	
PRAD	cis	1	rs16889317	chr6:159414843	RSPH3	chr6:159398268-159421198:-	0.29	4.57	6.35E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs16889320	chr6:159414899	RSPH3	chr6:159398268-159421198:-	0.29	4.57	6.35E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs16889325	chr6:159417132	RSPH3	chr6:159398268-159421198:-	0.29	4.57	6.35E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs16889440	chr6:24544967	GPLD1	chr6:24428405-24489850:-	-0.28	-5.31	1.67E-7	Radiation response	
PRAD	cis	1	rs16891378	chr6:26188864	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.81	0.000157	Renal underexcretion gout;Gout	
PRAD	cis	1	rs16891378	chr6:26188864	HIST1H3E	chr6:26224427-26226589:+	0.36	5.64	2.89E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs16891397	chr6:26200256	HIST1H2AE	chr6:26217148-26217711:+	-0.27	-3.98	8.05E-5	Renal underexcretion gout;Gout	
PRAD	cis	1	rs16891397	chr6:26200256	HIST1H3E	chr6:26224427-26226589:+	0.34	5.46	7.89E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs16891401	chr6:26202337	HIST1H2AE	chr6:26217148-26217711:+	-0.25	-3.78	0.00018	Renal underexcretion gout;Gout	
PRAD	cis	1	rs16891401	chr6:26202337	HIST1H3E	chr6:26224427-26226589:+	0.34	5.48	7.05E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs16891405	chr6:26204506	HIST1H1D	chr6:26234441-26235216:-	0.26	3.44	0.000644	Renal underexcretion gout;Gout	
PRAD	cis	1	rs16891405	chr6:26204506	HIST1H3E	chr6:26224427-26226589:+	0.37	6	3.94E-9	Renal underexcretion gout;Gout	
PRAD	cis	1	rs16892900	chr8:120644433	DSCC1	chr8:120846182-120868170:-	0.24	3.67	0.000275	Height	
PRAD	cis	1	rs16892938	chr8:120684434	DSCC1	chr8:120846182-120868170:-	-0.31	-4.54	7.01E-6	Height	
PRAD	cis	1	rs16894959	chr6:34825662	UHRF1BP1	chr6:34759794-34853117:+	0.16	4.21	3.06E-5	Pubertal anthropometrics	
PRAD	cis	1	rs16895812	chr6:42495278	PRPH2	chr6:42664334-42690358:-	-0.18	-3.54	0.000435	Obesity-related traits	
PRAD	cis	1	rs16895815	chr6:42495928	PRPH2	chr6:42664334-42690358:-	-0.18	-3.52	0.000482	Obesity-related traits	
PRAD	cis	1	rs16897870	chr8:101025631	SPAG1	chr8:101170263-101254130:+	0.17	3.45	0.000608	Basal cell carcinoma	
PRAD	cis	1	rs16898097	chr8:124195034	FAM83A	chr8:124191287-124222317:+	-0.33	-3.48	0.000547	Urinary uromodulin levels	
PRAD	cis	1	rs16911377	chr10:59724110	LOC728640	chr10:60474775-60477291:+	0.29	3.54	0.00044	Blood pressure	
PRAD	cis	1	rs16917224	chr8:96030110	C8orf38	chr8:95908040-96088396:+	-0.34	-6.07	2.59E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs16917224	chr8:96030110	TP53INP1	chr8:95938201-95961615:-	0.23	3.64	0.000306	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs16917233	chr8:96044967	C8orf38	chr8:95908040-96088396:+	0.37	6.5	2.08E-10	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs16928809	chr11:2936952	SLC22A18	chr11:2920951-2946475:+	-0.56	-8.64	8.84E-17	Bilirubin levels	
PRAD	cis	1	rs16933407	chr12:5424226	VWF	chr12:6058040-6233836:-	-0.22	-3.49	0.000531	Neuropathic pain in type 2 diabetes	
PRAD	cis	1	rs16935432	chr11:18470487	LDHC	chr11:18433853-18472792:+	-0.31	-3.82	0.000151	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs16938506	chr11:46454313	HARBI1	chr11:46624857-46638777:-	0.26	3.64	0.000308	Schizophrenia	
PRAD	cis	1	rs16944254	chr15:90898527	CRTC3	chr15:91073198-91188576:+	-0.16	-3.49	0.000531	Rheumatoid arthritis	
PRAD	cis	1	rs16944254	chr15:90898527	ZNF774	chr15:90895477-90904714:+	-0.22	-4.47	9.94E-6	Rheumatoid arthritis	
PRAD	cis	1	rs16945894	chr16:48180110	PHKB	chr16:47495210-47735433:+	-0.26	-4.15	3.97E-5	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs16947005	chr17:61702989	CD79B	chr17:62006098-62009704:-	-0.12	-3.59	0.000372	Body mass index	
PRAD	cis	1	rs16947005	chr17:61702989	DDX42	chr17:61851567-61896676:+	0.26	5.33	1.53E-7	Body mass index	
PRAD	cis	1	rs16947005	chr17:61702989	FTSJ3	chr17:61896795-61905031:-	-0.34	-6.81	3.09E-11	Body mass index	
PRAD	cis	1	rs16947005	chr17:61702989	TCAM1P	chr17:61934376-61941738:+	0.26	4.74	2.88E-6	Body mass index	
PRAD	cis	1	rs16947014	chr17:61719032	CD79B	chr17:62006098-62009704:-	0.12	3.5	0.000512	Body mass index	
PRAD	cis	1	rs16947014	chr17:61719032	DDX42	chr17:61851567-61896676:+	-0.22	-4.54	7.32E-6	Body mass index	
PRAD	cis	1	rs16947014	chr17:61719032	FTSJ3	chr17:61896795-61905031:-	0.36	7.21	2.19E-12	Body mass index	
PRAD	cis	1	rs16947014	chr17:61719032	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.55	6.75E-6	Body mass index	
PRAD	cis	1	rs16947042	chr17:61766457	DDX42	chr17:61851567-61896676:+	-0.27	-5.62	3.25E-8	Body mass index	
PRAD	cis	1	rs16947042	chr17:61766457	FTSJ3	chr17:61896795-61905031:-	0.32	6.38	4.38E-10	Body mass index	
PRAD	cis	1	rs16947042	chr17:61766457	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.25	2.55E-5	Body mass index	
PRAD	cis	1	rs16948098	chr15:44219607	ADAL	chr15:43622872-43646094:+	-0.62	-5.56	4.44E-8	Serum albumin level	
PRAD	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.69	-13.08	1.4E-33	Esophageal cancer (squamous cell)	
PRAD	cis	1	rs16955471	chr17:53058807	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs16957524	chr16:67798005	C16orf86	chr16:67700717-67702659:+	-0.27	-4.22	2.96E-5	Crohn's disease	
PRAD	cis	1	rs16959799	chr16:58229628	C16orf80	chr16:58147497-58163296:-	0.36	4.35	1.66E-5	Telomere length	
PRAD	cis	1	rs16960886	chr15:48699486	DUT	chr15:48623621-48635568:+	-0.22	-3.53	0.000453	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs169618	chr15:92657119	LOC100144604	chr15:93111048-93115493:-	-0.16	-3.74	0.000204	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs16967057	chr19:32914078	DPY19L3	chr19:32896677-32975236:+	-0.11	-3.56	0.000412	Bipolar disorder	
PRAD	cis	1	rs16967141	chr19:32971223	DPY19L3	chr19:32896677-32975236:+	0.11	3.57	0.00039	Bipolar disorder	
PRAD	cis	1	rs16970287	chr15:79228257	CTSH	chr15:79214092-79237420:-	0.43	6.1	2.28E-9	Bipolar disorder	
PRAD	cis	1	rs16976887	chr18:11986656	IMPA2	chr18:11981057-12030876:+	0.34	4.61	5.09E-6	Stroke	
PRAD	cis	1	rs1697845	chr5:75922504	F2RL2	chr5:75911308-75919240:-	-0.19	-4.54	7.14E-6	Hearing impairment	
PRAD	cis	1	rs16979973	chr20:55056589	C20orf43	chr20:55043647-55093942:+	0.16	3.98	7.96E-5	Refractive astigmatism	
PRAD	cis	1	rs16981031	chr19:49497453	BAX	chr19:49458117-49465054:+	0.25	3.8	0.000167	Follicule stimulating hormone	
PRAD	cis	1	rs1698395	chr10:59938724	IPMK	chr10:59955618-60027694:-	0.09	3.47	0.000565	Inflammatory bowel disease	
PRAD	cis	1	rs1698396	chr10:59937308	IPMK	chr10:59955618-60027694:-	0.09	3.47	0.000565	Inflammatory bowel disease	
PRAD	cis	1	rs16987832	chr22:29978749	SEC14L2	chr22:30792933-30824976:+	-0.28	-3.94	9.56E-5	Lipid traits	
PRAD	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.47	-8.02	8.76E-15	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1699389	chr4:130004079	C4orf33	chr4:130014829-130033842:+	-0.45	-7.71	7.77E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1699391	chr4:130005096	C4orf33	chr4:130014829-130033842:+	-0.45	-7.82	3.39E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.5	-8.47	3.07E-16	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.46	-7.71	7.42E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.46	-7.87	2.52E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs16996444	chr19:9997238	PIN1	chr19:9945999-9960358:+	0.13	3.91	0.000105	Menarche (age at onset)	
PRAD	cis	1	rs17001074	chr19:11104121	ECSIT	chr19:11616744-11639987:-	-0.28	-3.89	0.000114	LDL cholesterol	
PRAD	cis	1	rs17001074	chr19:11104121	SMARCA4	chr19:11071598-11172959:+	-0.32	-3.67	0.000268	LDL cholesterol	
PRAD	cis	1	rs17001074	chr19:11104121	ZNF627	chr19:11708235-11729974:+	-0.31	-4	7.31E-5	LDL cholesterol	
PRAD	cis	1	rs17001074	chr19:11104121	ZNF700	chr19:12035900-12061577:+	-0.3	-3.8	0.000164	LDL cholesterol	
PRAD	cis	1	rs1700490	chr5:176402401	FGFR4	chr5:176513921-176525124:+	0.18	3.76	0.000191	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs17007017	chr4:142142729	ZNF330	chr4:142142049-142155848:+	-0.27	-4.91	1.28E-6	Conduct disorder	
PRAD	cis	1	rs17007038	chr4:142161731	ZNF330	chr4:142142049-142155848:+	-0.25	-4.57	6.12E-6	Conduct disorder	
PRAD	cis	1	rs17012522	chr12:85445435	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.04	6.22E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs17012522	chr12:85445435	SLC6A15	chr12:85253269-85306606:-	-0.34	-5.02	7.43E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs17012522	chr12:85445435	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.55	4.86E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs17012533	chr12:85466723	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs17012533	chr12:85466723	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs17012533	chr12:85466723	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs17012589	chr12:85516904	LRRIQ1	chr12:85430099-85638880:+	-0.23	-3.92	0.0001	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs17012589	chr12:85516904	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.96	1.01E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs17012589	chr12:85516904	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.47	7.48E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs17017302	chr3:2655205	CRBN	chr3:3191698-3221390:-	-0.2	-3.67	0.00027	Blood pressure	
PRAD	cis	1	rs1701750	chr7:65467145	CCT6P1	chr7:65216092-65228661:+	0.28	4.99	8.4E-7	Diabetic kidney disease	
PRAD	cis	1	rs1701750	chr7:65467145	CRCP	chr7:65579805-65619551:+	-0.31	-4.02	6.75E-5	Diabetic kidney disease	
PRAD	cis	1	rs1701758	chr7:65470201	CCT6P1	chr7:65216092-65228661:+	0.28	4.99	8.4E-7	Diabetic kidney disease	
PRAD	cis	1	rs1701758	chr7:65470201	CRCP	chr7:65579805-65619551:+	-0.31	-4.02	6.75E-5	Diabetic kidney disease	
PRAD	cis	1	rs17027011	chr2:86406556	LOC90784	chr2:86247339-86250991:-	-0.37	-3.58	0.000384	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs17030434	chr4:154703596	RNF175	chr4:154631313-154681387:-	-0.18	-4.42	1.24E-5	Electrocardiographic conduction measures	
PRAD	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.65	9.84	6.83E-21	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs17030651	chr1:113239382	ST7L	chr1:113066142-113162405:-	0.66	9.88	4.72E-21	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs17032268	chr3:10067972	C3orf10	chr3:10157333-10168873:+	-0.2	-3.83	0.000145	Alzheimer's disease	
PRAD	cis	1	rs17032268	chr3:10067972	LOC401052	chr3:10048102-10052779:-	-0.29	-5.35	1.4E-7	Alzheimer's disease	
PRAD	cis	1	rs17032276	chr3:10076975	C3orf10	chr3:10157333-10168873:+	-0.22	-4.17	3.66E-5	Alzheimer's disease	
PRAD	cis	1	rs17032276	chr3:10076975	LOC401052	chr3:10048102-10052779:-	-0.3	-5.26	2.22E-7	Alzheimer's disease	
PRAD	cis	1	rs17032277	chr3:10077023	C3orf10	chr3:10157333-10168873:+	-0.22	-4.17	3.66E-5	Alzheimer's disease	
PRAD	cis	1	rs17032277	chr3:10077023	LOC401052	chr3:10048102-10052779:-	-0.3	-5.26	2.22E-7	Alzheimer's disease	
PRAD	cis	1	rs17032278	chr3:10077955	C3orf10	chr3:10157333-10168873:+	-0.22	-4.17	3.66E-5	Alzheimer's disease	
PRAD	cis	1	rs17032278	chr3:10077955	LOC401052	chr3:10048102-10052779:-	-0.3	-5.26	2.22E-7	Alzheimer's disease	
PRAD	cis	1	rs17032283	chr3:10081545	C3orf10	chr3:10157333-10168873:+	-0.23	-4.48	9.38E-6	Alzheimer's disease	
PRAD	cis	1	rs17032283	chr3:10081545	LOC401052	chr3:10048102-10052779:-	-0.3	-5.37	1.23E-7	Alzheimer's disease	
PRAD	cis	1	rs17032295	chr3:10086680	C3orf10	chr3:10157333-10168873:+	-0.21	-4.06	5.71E-5	Alzheimer's disease	
PRAD	cis	1	rs17032295	chr3:10086680	LOC401052	chr3:10048102-10052779:-	-0.29	-5.3	1.81E-7	Alzheimer's disease	
PRAD	cis	1	rs17032299	chr3:10087638	C3orf10	chr3:10157333-10168873:+	-0.23	-4.45	1.08E-5	Alzheimer's disease	
PRAD	cis	1	rs17032299	chr3:10087638	LOC401052	chr3:10048102-10052779:-	-0.3	-5.35	1.36E-7	Alzheimer's disease	
PRAD	cis	1	rs17032396	chr3:10153559	C3orf10	chr3:10157333-10168873:+	0.23	4.5	8.43E-6	Alzheimer's disease	
PRAD	cis	1	rs17032396	chr3:10153559	LOC401052	chr3:10048102-10052779:-	0.31	5.65	2.75E-8	Alzheimer's disease	
PRAD	cis	1	rs17032414	chr3:10158302	C3orf10	chr3:10157333-10168873:+	-0.21	-4.25	2.62E-5	Alzheimer's disease	
PRAD	cis	1	rs17032414	chr3:10158302	LOC401052	chr3:10048102-10052779:-	-0.27	-5.01	7.69E-7	Alzheimer's disease	
PRAD	cis	1	rs17032850	chr4:103507703	BDH2	chr4:103998783-104021024:-	0.15	3.78	0.00018	Ulcerative colitis	
PRAD	cis	1	rs17035960	chr4:106531846	INTS12	chr4:106603787-106629881:-	-0.84	-8.05	6.91E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs17036105	chr4:106603272	INTS12	chr4:106603787-106629881:-	-0.79	-7.88	2.34E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs17036120	chr4:106621508	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs17036123	chr4:106622190	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs17036125	chr4:106623674	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs17036129	chr4:106624529	INTS12	chr4:106603787-106629881:-	-0.79	-7.88	2.34E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs17036139	chr4:106632657	INTS12	chr4:106603787-106629881:-	-0.76	-7.8	3.95E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs17036177	chr4:106672511	INTS12	chr4:106603787-106629881:-	-0.79	-7.86	2.61E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs17036189	chr4:106687959	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs17036225	chr4:106710092	INTS12	chr4:106603787-106629881:-	-0.74	-7.54	2.42E-13	Post bronchodilator FEV1	
PRAD	cis	1	rs17036230	chr4:106715148	INTS12	chr4:106603787-106629881:-	-0.79	-7.91	1.83E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs17036258	chr4:106737382	INTS12	chr4:106603787-106629881:-	-0.8	-7.79	4.41E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs17036308	chr4:106749593	INTS12	chr4:106603787-106629881:-	-0.81	-7.98	1.15E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs17036310	chr4:106752340	INTS12	chr4:106603787-106629881:-	-0.8	-8.08	5.7E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs17036821	chr3:12533148	TSEN2	chr3:12525931-12581122:+	-0.37	-4.03	6.4E-5	Prostate cancer (gene x gene interaction)	
PRAD	cis	1	rs17037427	chr1:11873416	CLCN6	chr1:11866207-11907674:+	0.21	4.25	2.56E-5	QRS complex (12-leadsum)	
PRAD	cis	1	rs17037429	chr1:11873787	CLCN6	chr1:11866207-11907674:+	-0.23	-4.52	7.74E-6	QRS complex (12-leadsum)	
PRAD	cis	1	rs17037452	chr1:11895675	CLCN6	chr1:11866207-11907674:+	0.22	4.32	1.89E-5	QRS complex (12-leadsum)	
PRAD	cis	1	rs17040322	chr2:26351274	GPR113	chr2:26531041-26569685:-	-0.25	-3.76	0.000189	Gut microbiome composition (summer)	
PRAD	cis	1	rs17045711	chr2:54476678	C2orf73	chr2:54558071-54588714:+	0.29	3.96	8.67E-5	Telomere length	
PRAD	cis	1	rs17052727	chr3:53070914	RFT1	chr3:53122503-53164470:-	0.43	4.84	1.78E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs17052727	chr3:53070914	TMEM110	chr3:52867139-52931547:-	0.39	5.04	6.67E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	0.82	13.24	3.15E-34	Diastolic blood pressure	
PRAD	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.83	13.69	4.05E-36	Diastolic blood pressure	
PRAD	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.82	12.96	4.74E-33	Diastolic blood pressure	
PRAD	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.82	12.89	9.51E-33	Diastolic blood pressure	
PRAD	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.82	12.9	8.05E-33	Diastolic blood pressure	
PRAD	cis	1	rs17064124	chr3:41890803	ULK4	chr3:41288091-42003660:-	0.88	14.28	1.11E-38	Diastolic blood pressure	
PRAD	cis	1	rs17070580	chr6:109738714	SMPD2	chr6:109761931-109765121:+	-0.21	-4.57	6.38E-6	Height	
PRAD	cis	1	rs17072683	chr6:111731210	KIAA1919	chr6:111580482-111590259:+	0.38	3.99	7.65E-5	Psoriasis	
PRAD	cis	1	rs1707304	chr1:46598269	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.44	6.36E-31	Body mass index	
PRAD	cis	1	rs1707304	chr1:46598269	MMACHC	chr1:45965856-45976737:+	-0.17	-3.78	0.000177	Body mass index	
PRAD	cis	1	rs1707304	chr1:46598269	MUTYH	chr1:45794915-45806142:-	0.2	5.68	2.39E-8	Body mass index	
PRAD	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.28	2.82E-30	Body mass index	
PRAD	cis	1	rs1707321	chr1:46505309	MMACHC	chr1:45965856-45976737:+	-0.17	-3.85	0.000136	Body mass index	
PRAD	cis	1	rs1707321	chr1:46505309	MUTYH	chr1:45794915-45806142:-	0.19	5.57	4.18E-8	Body mass index	
PRAD	cis	1	rs1707335	chr1:46571921	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.9	1.02E-28	Body mass index	
PRAD	cis	1	rs1707335	chr1:46571921	MMACHC	chr1:45965856-45976737:+	-0.16	-3.7	0.000243	Body mass index	
PRAD	cis	1	rs1707335	chr1:46571921	MUTYH	chr1:45794915-45806142:-	0.2	5.91	6.68E-9	Body mass index	
PRAD	cis	1	rs1707336	chr1:46493460	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.06	2.2E-29	Body mass index	
PRAD	cis	1	rs1707336	chr1:46493460	MMACHC	chr1:45965856-45976737:+	-0.17	-3.72	0.000221	Body mass index	
PRAD	cis	1	rs1707336	chr1:46493460	MUTYH	chr1:45794915-45806142:-	0.21	6.09	2.33E-9	Body mass index	
PRAD	cis	1	rs1707340	chr1:46514942	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.41	8.79E-31	Body mass index	
PRAD	cis	1	rs1707340	chr1:46514942	MMACHC	chr1:45965856-45976737:+	-0.18	-3.96	8.66E-5	Body mass index	
PRAD	cis	1	rs1707340	chr1:46514942	MUTYH	chr1:45794915-45806142:-	0.2	5.68	2.38E-8	Body mass index	
PRAD	cis	1	rs17079773	chr13:24598384	PARP4	chr13:24995075-25086948:-	0.19	3.57	0.000399	Inattentive symptoms	
PRAD	cis	1	rs17082782	chr4:54306440	FIP1L1	chr4:54243820-54326102:+	-0.18	-4	7.32E-5	DNA methylation (variation)	
PRAD	cis	1	rs17083581	chr6:153429447	RGS17	chr6:153332041-153452389:-	-0.56	-13.61	8.88E-36	Prostate cancer	
PRAD	cis	1	rs17085889	chr4:56402115	TMEM165	chr4:56262090-56292342:+	0.18	3.98	8.07E-5	Personality dimensions	
PRAD	cis	1	rs17086954	chr6:156337304	TFB1M	chr6:155578791-155635626:-	0.21	3.43	0.000649	Early childhood aggressive behavior	
PRAD	cis	1	rs17090837	chr6:111751853	KIAA1919	chr6:111580482-111590259:+	0.38	4.01	7.0E-5	Psoriasis	
PRAD	cis	1	rs17092215	chr20:33595913	MMP24	chr20:33814539-33864804:+	-0.22	-3.63	0.000309	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs17093141	chr14:74326903	LIN52	chr14:74551656-74667117:+	0.26	4.28	2.31E-5	Morning vs. evening chronotype	
PRAD	cis	1	rs17093474	chr14:74342413	LIN52	chr14:74551656-74667117:+	0.26	4.39	1.41E-5	Morning vs. evening chronotype	
PRAD	cis	1	rs17094021	chr14:74394295	LIN52	chr14:74551656-74667117:+	0.31	4.87	1.5E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.41	10.89	8.96E-25	Common traits (Other)	
PRAD	cis	1	rs17111346	chr14:81452172	SEL1L	chr14:81939240-82000205:-	0.14	3.59	0.000365	Graves' disease	
PRAD	cis	1	rs17111376	chr5:150226899	C5orf62	chr5:150157867-150176297:+	0.29	3.78	0.000177	Crohn's disease	
PRAD	cis	1	rs17111376	chr5:150226899	LOC134466	chr5:150310000-150326146:-	0.57	8.63	9.23E-17	Crohn's disease	
PRAD	cis	1	rs17113137	chr10:102241998	SEC31B	chr10:102246403-102289636:-	-0.33	-9.74	1.48E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs17114359	chr21:43510437	C21orf128	chr21:43522244-43528644:-	0.35	4.92	1.19E-6	IgG glycosylation	
PRAD	cis	1	rs17115100	chr10:104591393	SFXN2	chr10:104474298-104498946:+	-0.34	-3.88	0.000121	Hypertension;Systolic blood pressure;Diastolic blood pressure	
PRAD	cis	1	rs17115231	chr12:75933675	GLIPR1L2	chr12:75784889-75825591:+	-0.36	-5.92	6.17E-9	Polycystic ovary syndrome	
PRAD	cis	1	rs1711739	chr9:115464474	C9orf80	chr9:115448793-115480387:-	-0.26	-4.11	4.64E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs17118403	chr12:56630067	COQ10A	chr12:56660642-56664748:+	-0.36	-3.47	0.000562	Psoriasis vulgaris	
PRAD	cis	1	rs17118403	chr12:56630067	MIP	chr12:56843885-56848429:-	0.73	5.31	1.71E-7	Psoriasis vulgaris	
PRAD	cis	1	rs17118409	chr12:56630764	COQ10A	chr12:56660642-56664748:+	-0.36	-3.47	0.000562	Psoriasis vulgaris	
PRAD	cis	1	rs17118409	chr12:56630764	MIP	chr12:56843885-56848429:-	0.73	5.31	1.71E-7	Psoriasis vulgaris	
PRAD	cis	1	rs17118439	chr12:56667604	COQ10A	chr12:56660642-56664748:+	0.39	3.97	8.22E-5	Psoriasis vulgaris	
PRAD	cis	1	rs17118439	chr12:56667604	MIP	chr12:56843885-56848429:-	-0.68	-5.23	2.54E-7	Psoriasis vulgaris	
PRAD	cis	1	rs17121651	chr14:50097172	PPIL5	chr14:50065415-50081389:+	-0.24	-4.42	1.25E-5	Carotid intima media thickness	
PRAD	cis	1	rs17121651	chr14:50097172	RPL36AL	chr14:50085407-50087349:-	0.39	11.38	1.15E-26	Carotid intima media thickness	
PRAD	cis	1	rs17122021	chr11:118145686	MPZL2	chr11:118124135-118135009:-	0.11	3.59	0.000359	Pain	
PRAD	cis	1	rs17122021	chr11:118145686	MPZL3	chr11:118100337-118123011:-	0.15	4.86	1.62E-6	Pain	
PRAD	cis	1	rs17122021	chr11:118145686	NLRX1	chr11:119039437-119054723:+	0.16	3.6	0.000349	Pain	
PRAD	cis	1	rs17122021	chr11:118145686	SCN2B	chr11:118033519-118047337:-	-0.12	-4.01	7.18E-5	Pain	
PRAD	cis	1	rs17124700	chr14:88905629	SPATA7	chr14:88852012-88904802:+	-0.22	-4.29	2.15E-5	Coronary artery calcification	
PRAD	cis	1	rs17130635	chr1:68725890	DEPDC1	chr1:68939837-68962799:-	-0.31	-3.46	0.000593	Diastolic blood pressure	
PRAD	cis	1	rs17132442	chr5:110192122	TMEM232	chr5:109624934-110062381:-	-0.23	-3.65	0.000294	Asthma and hay fever	
PRAD	cis	1	rs1713422	chr14:20940834	PNP	chr14:20937542-20945246:+	-0.32	-6.13	1.9E-9	Interferon alpha levels in systemic lupus erythematosus	
PRAD	cis	1	rs17138884	chr5:115425628	COMMD10	chr5:115420727-115628978:+	0.28	3.66	0.000285	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs17139192	chr5:115561710	COMMD10	chr5:115420727-115628978:+	0.29	3.73	0.000212	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs17139193	chr5:115562073	COMMD10	chr5:115420727-115628978:+	0.29	3.73	0.000212	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs17140062	chr10:17202840	TRDMT1	chr10:17184983-17243681:-	-0.25	-5.08	5.33E-7	Homocysteine levels	
PRAD	cis	1	rs17145713	chr7:72904810	MLXIPL	chr7:73007524-73038870:-	0.25	3.81	0.00016	Triglycerides	
PRAD	cis	1	rs17149161	chr7:75978229	SRCRB4D	chr7:76018647-76039012:-	0.23	4.58	5.97E-6	Multiple sclerosis	
PRAD	cis	1	rs17149161	chr7:75978229	UPK3B	chr7:76139745-76157197:+	-0.28	-5.02	7.23E-7	Multiple sclerosis	
PRAD	cis	1	rs1715235	chr7:65488394	CCT6P1	chr7:65216092-65228661:+	0.3	5.24	2.43E-7	Diabetic kidney disease	
PRAD	cis	1	rs1715235	chr7:65488394	CRCP	chr7:65579805-65619551:+	-0.31	-4.03	6.49E-5	Diabetic kidney disease	
PRAD	cis	1	rs17155886	chr10:1145182	IDI2	chr10:1064847-1071799:-	0.35	4.7	3.35E-6	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs17157832	chr10:45961761	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs17157836	chr10:45963586	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs17157839	chr10:45963777	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs17157852	chr10:45967801	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs17157880	chr10:46014488	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs17157884	chr10:46015942	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs17157887	chr10:46020348	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs17157898	chr10:46037209	MARCH8	chr10:45952817-46090354:-	0.25	5.52	5.59E-8	Red blood cell traits	
PRAD	cis	1	rs17157919	chr10:46044092	MARCH8	chr10:45952817-46090354:-	-0.25	-5.51	5.85E-8	Red blood cell traits	
PRAD	cis	1	rs17157928	chr10:46048229	MARCH8	chr10:45952817-46090354:-	0.25	5.51	6.06E-8	Red blood cell traits	
PRAD	cis	1	rs17161692	chr7:98953863	CYP3A5	chr7:99245818-99332821:-	-0.3	-6.16	1.53E-9	Blood metabolite levels	
PRAD	cis	1	rs17162339	chr1:27252823	PIGV	chr1:27114455-27124886:+	0.33	4.16	3.84E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs17162387	chr1:27293356	PIGV	chr1:27114455-27124886:+	-0.31	-3.8	0.000164	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs17164747	chr4:260587	ZNF718	chr4:53272-156488:+	0.33	5.31	1.73E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-0.89	-15.01	6.71E-42	Diastolic blood pressure	
PRAD	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.84	-13.69	3.95E-36	Diastolic blood pressure	
PRAD	cis	1	rs17166496	chr5:132628884	RAD50	chr5:131891711-131979593:+	-0.12	-3.61	0.000341	Type 1 diabetes	
PRAD	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-0.89	-15.01	6.71E-42	Diastolic blood pressure	
PRAD	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-0.88	-14.47	1.62E-39	Diastolic blood pressure	
PRAD	cis	1	rs1716660	chr3:41929960	ULK4	chr3:41288091-42003660:-	-0.87	-14.57	5.94E-40	Diastolic blood pressure	
PRAD	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-0.89	-14.93	1.53E-41	Diastolic blood pressure	
PRAD	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-0.88	-14.6	4.25E-40	Diastolic blood pressure	
PRAD	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	0.87	14.31	8.03E-39	Diastolic blood pressure	
PRAD	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	0.86	14.28	1.09E-38	Diastolic blood pressure	
PRAD	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	0.88	14.38	4.04E-39	Diastolic blood pressure	
PRAD	cis	1	rs1716683	chr3:41923074	ULK4	chr3:41288091-42003660:-	-0.88	-14.47	1.62E-39	Diastolic blood pressure	
PRAD	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	0.89	14.7	1.66E-40	Diastolic blood pressure	
PRAD	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-0.88	-14.6	4.25E-40	Diastolic blood pressure	
PRAD	cis	1	rs1716690	chr3:41922102	ULK4	chr3:41288091-42003660:-	-0.88	-14.47	1.62E-39	Diastolic blood pressure	
PRAD	cis	1	rs1716692	chr3:41983786	ULK4	chr3:41288091-42003660:-	-0.89	-15.08	3.38E-42	Diastolic blood pressure	
PRAD	cis	1	rs1716693	chr3:41985600	ULK4	chr3:41288091-42003660:-	-0.9	-14.8	5.73E-41	Diastolic blood pressure	
PRAD	cis	1	rs1716696	chr3:41935811	ULK4	chr3:41288091-42003660:-	-0.87	-14.57	5.94E-40	Diastolic blood pressure	
PRAD	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.84	-13.59	1.06E-35	Diastolic blood pressure	
PRAD	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.84	-13.71	3.21E-36	Diastolic blood pressure	
PRAD	cis	1	rs1716997	chr3:41924333	ULK4	chr3:41288091-42003660:-	-0.87	-14.45	1.98E-39	Diastolic blood pressure	
PRAD	cis	1	rs1716999	chr3:41930041	ULK4	chr3:41288091-42003660:-	-0.87	-14.57	5.94E-40	Diastolic blood pressure	
PRAD	cis	1	rs1717000	chr3:41930219	ULK4	chr3:41288091-42003660:-	-0.87	-14.57	5.94E-40	Diastolic blood pressure	
PRAD	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-0.88	-14.6	4.25E-40	Diastolic blood pressure	
PRAD	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	0.87	14.29	9.78E-39	Diastolic blood pressure	
PRAD	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-0.87	-14.57	5.94E-40	Diastolic blood pressure	
PRAD	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-0.89	-15.08	3.38E-42	Diastolic blood pressure	
PRAD	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	0.88	14.47	1.62E-39	Diastolic blood pressure	
PRAD	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	0.87	14.31	8.03E-39	Diastolic blood pressure	
PRAD	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	0.88	14.62	3.54E-40	Diastolic blood pressure	
PRAD	cis	1	rs1717021	chr3:41983860	ULK4	chr3:41288091-42003660:-	-0.9	-15.1	2.74E-42	Diastolic blood pressure	
PRAD	cis	1	rs1717024	chr3:41984888	ULK4	chr3:41288091-42003660:-	-0.86	-14.45	1.97E-39	Diastolic blood pressure	
PRAD	cis	1	rs1717027	chr3:41987920	ULK4	chr3:41288091-42003660:-	-0.9	-15.07	3.69E-42	Diastolic blood pressure	
PRAD	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	0.87	14.31	8.03E-39	Diastolic blood pressure	
PRAD	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	0.86	14.28	1.09E-38	Diastolic blood pressure	
PRAD	cis	1	rs17171466	chr7:38835926	FAM183B	chr7:38724947-38726689:-	0.34	3.51	0.000497	Cognitive performance	
PRAD	cis	1	rs17171767	chr5:137493528	REEP2	chr5:137774776-137782657:+	0.1	4.01	6.94E-5	Resting heart rate	
PRAD	cis	1	rs17171770	chr5:137514815	REEP2	chr5:137774776-137782657:+	-0.1	-3.92	0.000101	Resting heart rate	
PRAD	cis	1	rs17171772	chr5:137514853	REEP2	chr5:137774776-137782657:+	-0.11	-4.26	2.45E-5	Resting heart rate	
PRAD	cis	1	rs17174870	chr2:112665201	MERTK	chr2:112656191-112786945:+	-0.24	-4.03	6.4E-5	Multiple sclerosis	
PRAD	cis	1	rs17185907	chr1:119465793	WARS2	chr1:119573841-119683295:-	0.37	5.05	6.19E-7	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs17185933	chr1:119474772	WARS2	chr1:119573841-119683295:-	0.35	4.83	1.87E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs17192831	chr20:22281954	PAX1	chr20:21686297-21696620:+	0.15	3.92	9.99E-5	Glucose homeostasis traits	
PRAD	cis	1	rs17197037	chr14:21725654	RPGRIP1	chr14:21756136-21819458:+	-0.21	-4.48	9.39E-6	Bipolar disorder	
PRAD	cis	1	rs1719890	chr3:119577868	NR1I2	chr3:119499331-119537331:+	0.22	3.97	8.38E-5	HDL cholesterol	
PRAD	cis	1	rs1719894	chr3:119590322	NR1I2	chr3:119499331-119537331:+	0.22	3.97	8.38E-5	HDL cholesterol	
PRAD	cis	1	rs1721359	chr2:228751874	CCL20	chr2:228678558-228682280:+	0.25	4.51	8.17E-6	Blood pressure	
PRAD	cis	1	rs17214441	chr2:207683777	MDH1B	chr2:207598943-207630050:-	0.47	3.77	0.000187	Episodic memory	
PRAD	cis	1	rs17214621	chr20:3925924	MAVS	chr20:3827449-3856761:+	-0.27	-3.75	0.000196	Response to antidepressants in depression	
PRAD	cis	1	rs17214949	chr20:3940952	MAVS	chr20:3827449-3856761:+	-0.27	-3.7	0.000238	Response to antidepressants in depression	
PRAD	cis	1	rs17215053	chr8:120659553	DSCC1	chr8:120846182-120868170:-	-0.4	-5.21	2.77E-7	Height	
PRAD	cis	1	rs17215054	chr20:3944779	MAVS	chr20:3827449-3856761:+	-0.27	-3.7	0.000238	Response to antidepressants in depression	
PRAD	cis	1	rs17215340	chr20:3970173	MAVS	chr20:3827449-3856761:+	0.28	3.99	7.81E-5	Response to antidepressants in depression	
PRAD	cis	1	rs17215529	chr20:3975402	MAVS	chr20:3827449-3856761:+	-0.26	-3.83	0.000145	Response to antidepressants in depression	
PRAD	cis	1	rs17223420	chr12:983720	RAD52	chr12:1021255-1099219:-	-0.41	-6.73	4.8E-11	Colorectal cancer	
PRAD	cis	1	rs1723267	chr7:65473314	CCT6P1	chr7:65216092-65228661:+	0.3	5.27	2.13E-7	Diabetic kidney disease	
PRAD	cis	1	rs1723267	chr7:65473314	CRCP	chr7:65579805-65619551:+	-0.31	-4.02	6.89E-5	Diabetic kidney disease	
PRAD	cis	1	rs1723269	chr7:65472786	CCT6P1	chr7:65216092-65228661:+	0.34	5.82	1.11E-8	Diabetic kidney disease	
PRAD	cis	1	rs1723269	chr7:65472786	CRCP	chr7:65579805-65619551:+	-0.32	-4.04	6.35E-5	Diabetic kidney disease	
PRAD	cis	1	rs1723270	chr7:65469830	CCT6P1	chr7:65216092-65228661:+	0.33	5.68	2.38E-8	Diabetic kidney disease	
PRAD	cis	1	rs1723270	chr7:65469830	CRCP	chr7:65579805-65619551:+	-0.31	-3.96	8.72E-5	Diabetic kidney disease	
PRAD	cis	1	rs17236800	chr7:37944375	EPDR1	chr7:37960163-37991539:+	-0.21	-3.58	0.000386	Bone mineral density	
PRAD	cis	1	rs17236975	chr7:37946958	EPDR1	chr7:37960163-37991539:+	-0.23	-3.79	0.000167	Bone mineral density	
PRAD	cis	1	rs17239287	chr19:52022033	ZNF175	chr19:52074531-52092990:+	-0.32	-4.37	1.5E-5	Carotid intima media thickness	
PRAD	cis	1	rs17244834	chr5:74642848	POLK	chr5:74807657-74895644:+	-0.11	-3.47	0.000572	LDL cholesterol	
PRAD	cis	1	rs17246035	chr14:65874130	LOC645431	chr14:65877313-65879335:-	-0.39	-4	7.25E-5	Ischemic stroke	
PRAD	cis	1	rs17246042	chr14:65874330	LOC645431	chr14:65877313-65879335:-	-0.41	-4.16	3.74E-5	Ischemic stroke	
PRAD	cis	1	rs17246259	chr14:66075327	LOC645431	chr14:65877313-65879335:-	-0.4	-4.16	3.78E-5	Ischemic stroke	
PRAD	cis	1	rs17282391	chr3:46179481	CCR9	chr3:45928019-45944667:+	-0.35	-3.74	0.00021	Celiac disease	
PRAD	cis	1	rs17282797	chr3:46232765	CCR9	chr3:45928019-45944667:+	0.34	3.64	0.0003	Celiac disease	
PRAD	cis	1	rs17286349	chr20:3914302	MAVS	chr20:3827449-3856761:+	-0.26	-3.5	0.000515	Response to antidepressants in depression	
PRAD	cis	1	rs17286768	chr20:3924569	MAVS	chr20:3827449-3856761:+	-0.27	-3.75	0.000196	Response to antidepressants in depression	
PRAD	cis	1	rs17287486	chr20:3946267	MAVS	chr20:3827449-3856761:+	-0.27	-3.7	0.000238	Response to antidepressants in depression	
PRAD	cis	1	rs17290219	chr3:150881774	P2RY12	chr3:151055238-151102544:-	0.32	5.43	9.28E-8	Heschl's gyrus morphology	
PRAD	cis	1	rs17293608	chr10:1056252	IDI2	chr10:1064847-1071799:-	-0.31	-5.73	1.82E-8	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs17293608	chr10:1056252	WDR37	chr10:1102344-1178237:+	0.32	5.33	1.52E-7	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs17301482	chr4:155349776	DCHS2	chr4:155155527-155412930:-	0.14	3.86	0.000131	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs17304569	chr19:24240905	LOC100101266	chr19:24344995-24346249:-	0.33	4.74	2.78E-6	Response to taxane treatment (placlitaxel)	
PRAD	cis	1	rs17305573	chr20:33180152	NECAB3	chr20:32244894-32262264:-	-0.32	-4.37	1.51E-5	Melanoma	
PRAD	cis	1	rs17310467	chr20:33545616	MMP24	chr20:33814539-33864804:+	-0.31	-4.56	6.44E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs17311679	chr19:50521331	SIGLEC16	chr19:50472912-50479075:+	-0.52	-5.08	5.39E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs17317888	chr20:33594959	MMP24	chr20:33814539-33864804:+	-0.31	-4.69	3.55E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs17319967	chr20:33693650	MMP24	chr20:33814539-33864804:+	-0.28	-4.42	1.22E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs1732170	chr3:119583676	NR1I2	chr3:119499331-119537331:+	0.22	3.97	8.38E-5	HDL cholesterol	
PRAD	cis	1	rs17332243	chr20:43756071	SLPI	chr20:43880879-43883206:-	0.24	3.78	0.000175	Parental longevity (mother's age at death)	
PRAD	cis	1	rs173334	chr6:88080223	C6orf164	chr6:88032306-88109459:+	-0.19	-4.06	5.8E-5	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs173334	chr6:88080223	C6orf165	chr6:88117721-88205858:+	-0.55	-10.19	3.64E-22	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs173334	chr6:88080223	SLC35A1	chr6:88146444-88222051:+	-0.24	-4.44	1.14E-5	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs17336353	chr4:95516516	BMPR1B	chr4:95679128-96079592:+	0.25	4.35	1.7E-5	Response to simvastatin treatment (PCSK9 protein level change)	
PRAD	cis	1	rs17340509	chr1:27274700	PIGV	chr1:27114455-27124886:+	-0.34	-3.95	9.07E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs17341301	chr2:160902420	LY75	chr2:160625141-160761262:-	0.13	4.3	2.06E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs17341301	chr2:160902420	PLA2R1	chr2:160798012-160919121:-	0.23	5.25	2.25E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs17347505	chr7:23915283	C7orf46	chr7:23719749-23742268:+	0.22	5.79	1.32E-8	Schizophrenia	
PRAD	cis	1	rs17347692	chr7:23918367	C7orf46	chr7:23719749-23742268:+	0.22	5.71	2.04E-8	Schizophrenia	
PRAD	cis	1	rs17347733	chr7:23918510	C7orf46	chr7:23719749-23742268:+	0.22	5.71	1.97E-8	Schizophrenia	
PRAD	cis	1	rs17350440	chr4:142161479	ZNF330	chr4:142142049-142155848:+	-0.28	-5.05	6.24E-7	Conduct disorder	
PRAD	cis	1	rs17356923	chr1:27282676	PIGV	chr1:27114455-27124886:+	-0.34	-3.95	9.07E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs17360053	chr1:22499530	HSPC157	chr1:22351707-22357713:+	-0.19	-3.74	0.000206	Obesity-related traits	
PRAD	cis	1	rs17360994	chr1:27278573	PIGV	chr1:27114455-27124886:+	-0.34	-3.97	8.19E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs17361668	chr11:102720344	MMP12	chr11:102733465-102745712:-	-0.26	-3.57	0.000396	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs17371021	chr4:154664295	TLR2	chr4:154605441-154627240:+	0.13	3.75	0.000202	Response to statins (LDL cholesterol change)	
PRAD	cis	1	rs17373494	chr4:155349158	DCHS2	chr4:155155527-155412930:-	0.15	3.99	7.63E-5	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs1737944	chr17:18840433	FAM18B	chr17:18684582-18710026:+	-0.28	-5.73	1.82E-8	Educational attainment (years of education)	
PRAD	cis	1	rs1737947	chr17:18831432	FAM18B	chr17:18684582-18710026:+	0.25	4.96	9.84E-7	Pancreatic cancer	
PRAD	cis	1	rs17382723	chr2:242053546	MTERFD2	chr2:242034545-242041747:-	-0.23	-3.67	0.000266	Height	
PRAD	cis	1	rs17401737	chr20:33552642	MMP24	chr20:33814539-33864804:+	-0.32	-4.71	3.26E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs17412623	chr8:20221586	ATP6V1B2	chr8:20054704-20079205:+	0.36	4.04	6.36E-5	Preeclampsia	
PRAD	cis	1	rs17423416	chr20:43758144	SLPI	chr20:43880879-43883206:-	0.24	3.78	0.000175	Parental longevity (mother's age at death)	
PRAD	cis	1	rs17423617	chr20:43768050	SLPI	chr20:43880879-43883206:-	0.24	3.87	0.000126	Parental longevity (mother's age at death)	
PRAD	cis	1	rs17425839	chr7:106763278	PRKAR2B	chr7:106685178-106802255:+	0.29	3.52	0.00047	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs17431357	chr12:120880434	GATC	chr12:120884284-120897761:+	0.35	3.97	8.48E-5	Insulin resistance/response	
PRAD	cis	1	rs17431446	chr12:120884291	GATC	chr12:120884284-120897761:+	0.31	3.48	0.000547	Insulin resistance/response	
PRAD	cis	1	rs17431934	chr9:100695776	C9orf156	chr9:100666772-100684852:-	-0.19	-3.68	0.000264	Quantitative traits	
PRAD	cis	1	rs17432497	chr2:63027337	C2orf86	chr2:63348537-63815851:-	0.26	4.47	9.88E-6	Prostate cancer	
PRAD	cis	1	rs17432497	chr2:63027337	EHBP1	chr2:62901013-63273619:+	0.22	3.49	0.00052	Prostate cancer	
PRAD	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.87	24.59	1.82E-86	Carotid intima media thickness	
PRAD	cis	1	rs17433780	chr1:89474818	RBMXL1	chr1:89445140-89458643:-	0.17	3.99	7.59E-5	Carotid intima media thickness	
PRAD	cis	1	rs17435590	chr7:97784061	BHLHA15	chr7:97840778-97842271:+	-0.14	-3.67	0.00027	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs17435847	chr7:97792820	BHLHA15	chr7:97840778-97842271:+	-0.14	-3.71	0.000236	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs17450788	chr19:22224755	ZNF257	chr19:22235266-22273901:+	0.37	5.02	7.4E-7	Body mass index (change over time)	
PRAD	cis	1	rs17450853	chr6:56788004	BEND6	chr6:56819773-56892138:+	-0.59	-10.96	4.75E-25	Menarche (age at onset)	
PRAD	cis	1	rs17451208	chr10:46051905	MARCH8	chr10:45952817-46090354:-	0.25	5.42	9.35E-8	Red blood cell traits	
PRAD	cis	1	rs174551	chr11:61573684	FADS1	chr11:61567103-61584529:-	-0.28	-4.51	8.25E-6	LDL cholesterol	
PRAD	cis	1	rs17459044	chr9:131853624	CRAT	chr9:131857075-131873070:-	0.24	4.38	1.49E-5	Pelvic organ prolapse (moderate/severe)	
PRAD	cis	1	rs17471869	chr10:70749869	STOX1	chr10:70587294-70655209:+	-0.24	-4.33	1.83E-5	Schizophrenia	
PRAD	cis	1	rs17494056	chr2:160052731	WDSUB1	chr2:160092305-160143236:-	0.34	5.6	3.62E-8	Resting heart rate	
PRAD	cis	1	rs17496332	chr1:107546375	PRMT6	chr1:107599267-107601907:+	0.21	3.96	8.71E-5	Sex hormone-binding globulin levels	
PRAD	cis	1	rs17505772	chr13:31456002	C13orf33	chr13:31480312-31499708:+	0.24	3.71	0.000235	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs17507481	chr4:17620066	MED28	chr4:17616273-17629791:+	0.2	5.01	7.6E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs17508864	chr4:39130645	KLHL5	chr4:39046659-39123828:+	-0.14	-4.02	6.68E-5	Uric acid levels	
PRAD	cis	1	rs17510189	chr2:118687645	INSIG2	chr2:118846050-118867596:+	0.43	5.11	4.7E-7	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs17510363	chr2:118690792	INSIG2	chr2:118846050-118867596:+	0.43	5.11	4.71E-7	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs17510733	chr6:111710918	KIAA1919	chr6:111580482-111590259:+	0.36	3.79	0.00017	Psoriasis	
PRAD	cis	1	rs17510761	chr6:111708583	KIAA1919	chr6:111580482-111590259:+	0.36	3.79	0.00017	Psoriasis	
PRAD	cis	1	rs17510763	chr2:118694943	INSIG2	chr2:118846050-118867596:+	0.37	4.56	6.66E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs17510959	chr2:118697676	INSIG2	chr2:118846050-118867596:+	0.35	4.29	2.18E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs17511227	chr2:118703719	INSIG2	chr2:118846050-118867596:+	0.37	4.56	6.48E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs17511331	chr2:118706990	INSIG2	chr2:118846050-118867596:+	0.37	4.56	6.48E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs17511561	chr2:118712113	INSIG2	chr2:118846050-118867596:+	0.37	4.56	6.48E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs17511672	chr6:107776430	QRSL1	chr6:107077441-107116290:+	0.3	3.5	0.000503	Airway responsiveness in chronic obstructive pulmonary disease	
PRAD	cis	1	rs17511672	chr6:107776430	SNX3	chr6:108532718-108582464:-	0.27	3.76	0.000191	Airway responsiveness in chronic obstructive pulmonary disease	
PRAD	cis	1	rs17512204	chr2:118732831	INSIG2	chr2:118846050-118867596:+	0.37	4.5	8.59E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs1752435	chr14:59946094	C14orf149	chr14:59939406-59951126:-	-0.34	-4.23	2.87E-5	Schizophrenia	
PRAD	cis	1	rs17528859	chr11:59867379	PATL1	chr11:59404194-59436511:-	-0.11	-3.44	0.000623	Alzheimer's disease (late onset)	
PRAD	cis	1	rs17534004	chr13:31469665	C13orf33	chr13:31480312-31499708:+	0.28	4.46	1.02E-5	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs17534109	chr13:31470937	C13orf33	chr13:31480312-31499708:+	-0.25	-4.09	5.1E-5	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs17534137	chr13:31471920	C13orf33	chr13:31480312-31499708:+	0.26	4.24	2.65E-5	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs17538840	chr2:61077817	AHSA2	chr2:61404553-61414058:+	0.15	5.25	2.33E-7	Inflammatory skin disease	
PRAD	cis	1	rs17538840	chr2:61077817	C2orf74	chr2:61372243-61391964:+	-0.36	-5.89	7.45E-9	Inflammatory skin disease	
PRAD	cis	1	rs175425	chr14:75626131	EIF2B2	chr14:75469612-75476292:+	-0.26	-5.37	1.25E-7	Height	
PRAD	cis	1	rs175425	chr14:75626131	MLH3	chr14:75480467-75518235:-	-0.33	-6.8	3.25E-11	Height	
PRAD	cis	1	rs175426	chr14:75624134	EIF2B2	chr14:75469612-75476292:+	-0.25	-5.17	3.44E-7	Height	
PRAD	cis	1	rs175426	chr14:75624134	MLH3	chr14:75480467-75518235:-	-0.33	-6.89	1.86E-11	Height	
PRAD	cis	1	rs175436	chr14:75608683	EIF2B2	chr14:75469612-75476292:+	-0.25	-5.19	3.21E-7	Height	
PRAD	cis	1	rs175436	chr14:75608683	MLH3	chr14:75480467-75518235:-	-0.34	-6.99	9.52E-12	Height	
PRAD	cis	1	rs175442	chr14:75603564	EIF2B2	chr14:75469612-75476292:+	-0.26	-5.3	1.76E-7	Height	
PRAD	cis	1	rs175442	chr14:75603564	MLH3	chr14:75480467-75518235:-	-0.33	-6.77	3.79E-11	Height	
PRAD	cis	1	rs175443	chr14:75601963	EIF2B2	chr14:75469612-75476292:+	-0.25	-5.06	5.95E-7	Height	
PRAD	cis	1	rs175443	chr14:75601963	MLH3	chr14:75480467-75518235:-	-0.33	-6.94	1.3E-11	Height	
PRAD	cis	1	rs175449	chr14:75590846	EIF2B2	chr14:75469612-75476292:+	-0.26	-5.3	1.76E-7	Height	
PRAD	cis	1	rs175449	chr14:75590846	MLH3	chr14:75480467-75518235:-	-0.33	-6.77	3.79E-11	Height	
PRAD	cis	1	rs175492	chr14:75545220	EIF2B2	chr14:75469612-75476292:+	0.26	5.28	1.95E-7	Height	
PRAD	cis	1	rs175492	chr14:75545220	MLH3	chr14:75480467-75518235:-	0.34	7.01	8.14E-12	Height	
PRAD	cis	1	rs17549954	chr17:61707032	DDX42	chr17:61851567-61896676:+	-0.25	-4.97	9.46E-7	Body mass index	
PRAD	cis	1	rs17549954	chr17:61707032	FTSJ3	chr17:61896795-61905031:-	0.35	6.76	4.02E-11	Body mass index	
PRAD	cis	1	rs17549954	chr17:61707032	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.15	3.89E-5	Body mass index	
PRAD	cis	1	rs175512	chr14:75523382	EIF2B2	chr14:75469612-75476292:+	-0.26	-5.22	2.66E-7	Height	
PRAD	cis	1	rs175512	chr14:75523382	MLH3	chr14:75480467-75518235:-	-0.34	-6.83	2.62E-11	Height	
PRAD	cis	1	rs17554465	chr10:11849626	ECHDC3	chr10:11784356-11806064:+	0.29	3.98	8.13E-5	Breast cancer (survival)	
PRAD	cis	1	rs17566701	chr7:66193183	CRCP	chr7:65579805-65619551:+	-0.23	-4.29	2.15E-5	Aortic root size	
PRAD	cis	1	rs17566701	chr7:66193183	LOC493754	chr7:65993446-66057363:-	-0.25	-5.63	3.04E-8	Aortic root size	
PRAD	cis	1	rs17569034	chr2:118675337	INSIG2	chr2:118846050-118867596:+	0.43	5.07	5.6E-7	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs17569222	chr2:118677813	INSIG2	chr2:118846050-118867596:+	0.43	5.08	5.47E-7	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs17569710	chr2:118690820	INSIG2	chr2:118846050-118867596:+	-0.34	-4.1	4.87E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs1757044	chr1:23515631	C1orf213	chr1:23695464-23698278:+	-0.18	-4.52	7.76E-6	Height	
PRAD	cis	1	rs1757048	chr1:23510601	C1orf213	chr1:23695464-23698278:+	-0.18	-4.43	1.16E-5	Height	
PRAD	cis	1	rs17576507	chr2:38910131	GALM	chr2:38893052-38961908:+	0.43	5.1	5.01E-7	5-HTT brain serotonin transporter levels	
PRAD	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.48	-8.27	1.4E-15	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.48	8.28	1.25E-15	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.5	-8.47	3.07E-16	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.5	-8.47	3.07E-16	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.47	-8.01	8.98E-15	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.5	-8.54	1.9E-16	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs17583641	chr2:118712802	INSIG2	chr2:118846050-118867596:+	0.37	4.52	7.99E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs17584578	chr2:86307624	LOC90784	chr2:86247339-86250991:-	0.6	5.46	7.56E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.58	-12.32	1.98E-30	Forced vital capacity	
PRAD	cis	1	rs17596719	chr6:26097194	HIST1H1T	chr6:26107641-26108364:-	-0.29	-3.62	0.000321	HIV-1 viral setpoint	
PRAD	cis	1	rs17598927	chr6:26184640	HIST1H3E	chr6:26224427-26226589:+	-0.32	-4.95	1.05E-6	Renal underexcretion gout;Gout	
PRAD	cis	1	rs17599764	chr13:31469580	C13orf33	chr13:31480312-31499708:+	0.25	3.84	0.000142	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs17600551	chr15:85319258	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.46	0.000598	Schizophrenia	
PRAD	cis	1	rs17600551	chr15:85319258	LOC388152	chr15:84867600-84898920:-	-0.31	-5.27	2.05E-7	Schizophrenia	
PRAD	cis	1	rs17600551	chr15:85319258	NMB	chr15:85198362-85201802:-	-0.52	-12.31	2.13E-30	Schizophrenia	
PRAD	cis	1	rs17600551	chr15:85319258	WDR73	chr15:85186012-85197524:-	-0.27	-5.67	2.55E-8	Schizophrenia	
PRAD	cis	1	rs17601029	chr15:85347709	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.44	0.000627	Schizophrenia	
PRAD	cis	1	rs17601029	chr15:85347709	LOC388152	chr15:84867600-84898920:-	-0.32	-5.23	2.58E-7	Schizophrenia	
PRAD	cis	1	rs17601029	chr15:85347709	NMB	chr15:85198362-85201802:-	-0.54	-12.42	7.74E-31	Schizophrenia	
PRAD	cis	1	rs17601029	chr15:85347709	WDR73	chr15:85186012-85197524:-	-0.26	-5.44	8.4E-8	Schizophrenia	
PRAD	cis	1	rs17605685	chr19:50486741	SIGLEC16	chr19:50472912-50479075:+	0.54	5.13	4.24E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs17605685	chr19:50486741	TSKS	chr19:50243012-50266515:-	0.35	3.61	0.000333	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.5	-10.18	4.11E-22	Temperament	
PRAD	cis	1	rs17614559	chr15:52878719	ARPP19	chr15:52839432-52861364:-	0.14	3.57	0.000397	Schizophrenia	
PRAD	cis	1	rs17632	chr20:47713063	CSE1L	chr20:47662838-47713484:+	0.2	4.87	1.53E-6	Anger	
PRAD	cis	1	rs17641971	chr8:49884817	C8orf22	chr8:49984903-49988641:+	-0.2	-4.1	4.8E-5	Blood metabolite levels	
PRAD	cis	1	rs17645523	chr15:50882645	SPPL2A	chr15:50999739-51057910:-	0.27	5.6	3.7E-8	QT interval	
PRAD	cis	1	rs17645649	chr15:50900370	SPPL2A	chr15:50999739-51057910:-	0.27	5.62	3.36E-8	QT interval	
PRAD	cis	1	rs17645826	chr15:50950141	SPPL2A	chr15:50999739-51057910:-	0.27	5.54	5.16E-8	QT interval	
PRAD	cis	1	rs17661933	chr19:50534520	SIGLEC16	chr19:50472912-50479075:+	-0.4	-4.1	4.88E-5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs17661933	chr19:50534520	TSKS	chr19:50243012-50266515:-	-0.31	-3.51	0.00049	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs17662328	chr3:71564943	EIF4E3	chr3:71728442-71803924:-	0.17	3.53	0.000461	Educational attainment (years of education)	
PRAD	cis	1	rs17668478	chr3:143794370	C3orf58	chr3:143690640-143711209:+	-0.17	-3.44	0.000639	Economic and political preferences (feminism/equality)	
PRAD	cis	1	rs17671250	chr15:40673124	C15orf23	chr15:40674922-40686488:+	-0.66	-10	1.76E-21	Heschl's gyrus morphology	
PRAD	cis	1	rs17677510	chr7:29182574	CPVL	chr7:29035249-29234892:-	-0.18	-4.9	1.33E-6	Diabetes related insulin traits	
PRAD	cis	1	rs1768208	chr3:39523003	RPSA	chr3:39448204-39454030:+	0.15	4.33	1.83E-5	Corticobasal degeneration;Progressive supranuclear palsy	
PRAD	cis	1	rs17685143	chr6:56774788	BEND6	chr6:56819773-56892138:+	-0.62	-11.05	2.08E-25	Menarche (age at onset)	
PRAD	cis	1	rs17685143	chr6:56774788	KIAA1586	chr6:56911384-56920021:+	-0.22	-3.45	0.000616	Menarche (age at onset)	
PRAD	cis	1	rs1768803	chr1:46546208	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.25	3.85E-30	Body mass index	
PRAD	cis	1	rs1768803	chr1:46546208	MMACHC	chr1:45965856-45976737:+	-0.17	-3.9	0.000112	Body mass index	
PRAD	cis	1	rs1768803	chr1:46546208	MUTYH	chr1:45794915-45806142:-	0.2	5.78	1.39E-8	Body mass index	
PRAD	cis	1	rs1768816	chr1:46528599	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.3	2.45E-30	Body mass index	
PRAD	cis	1	rs1768816	chr1:46528599	MMACHC	chr1:45965856-45976737:+	-0.17	-3.93	9.7E-5	Body mass index	
PRAD	cis	1	rs1768816	chr1:46528599	MUTYH	chr1:45794915-45806142:-	0.2	5.77	1.47E-8	Body mass index	
PRAD	cis	1	rs17689987	chr12:53275746	KRT8	chr12:53290971-53343626:-	-0.24	-4.45	1.06E-5	Prostate cancer	
PRAD	cis	1	rs1769003	chr10:59937590	IPMK	chr10:59955618-60027694:-	0.09	3.47	0.000565	Inflammatory bowel disease	
PRAD	cis	1	rs1769005	chr10:59935940	IPMK	chr10:59955618-60027694:-	0.09	3.47	0.000565	Inflammatory bowel disease	
PRAD	cis	1	rs1769006	chr10:59935547	IPMK	chr10:59955618-60027694:-	0.09	3.47	0.000565	Inflammatory bowel disease	
PRAD	cis	1	rs17691170	chr3:121357626	IQCB1	chr3:121488610-121553926:-	0.5	9.92	3.34E-21	Cognitive performance	
PRAD	cis	1	rs17692896	chr19:33089431	CCDC123	chr19:33369906-33462869:-	-0.44	-4.09	5.04E-5	Major depressive disorder	
PRAD	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.54	12.38	1.12E-30	Height	
PRAD	cis	1	rs17697908	chr10:103562936	KCNIP2	chr10:103585732-103603677:-	0.33	4.44	1.1E-5	Coronary artery calcification	
PRAD	cis	1	rs17698817	chr14:88822976	SPATA7	chr14:88852012-88904802:+	-0.18	-3.56	0.000415	Coronary artery calcification	
PRAD	cis	1	rs17698831	chr10:103656466	KCNIP2	chr10:103585732-103603677:-	0.29	4	7.24E-5	Coronary artery calcification	
PRAD	cis	1	rs17699425	chr10:103720813	KCNIP2	chr10:103585732-103603677:-	0.27	3.8	0.000164	Coronary artery calcification	
PRAD	cis	1	rs17713396	chr2:227201	SH3YL1	chr2:218138-264810:-	-0.79	-18.84	2.1E-59	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs17713729	chr2:249092	SH3YL1	chr2:218138-264810:-	-0.78	-18.63	2.11E-58	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs17714252	chr2:285471	SH3YL1	chr2:218138-264810:-	-0.75	-17.86	7.82E-55	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs1771628	chr10:31368479	ZNF438	chr10:31133567-31320866:-	-0.19	-3.63	0.000314	Response to antipsychotic treatment	
PRAD	cis	1	rs17716789	chr16:77769679	NUDT7	chr16:77756411-77776153:+	0.24	3.52	0.000466	Obesity-related traits	
PRAD	cis	1	rs17727568	chr5:150244688	C5orf62	chr5:150157867-150176297:+	0.32	3.76	0.000194	Crohn's disease	
PRAD	cis	1	rs17727568	chr5:150244688	LOC134466	chr5:150310000-150326146:-	0.73	10.22	2.78E-22	Crohn's disease	
PRAD	cis	1	rs17733640	chr3:38446742	XYLB	chr3:38388251-38456467:+	0.22	5.06	6.02E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs17736589	chr17:76737118	USP36	chr17:76791735-76836969:-	-0.19	-3.74	0.000209	Ulcerative colitis	
PRAD	cis	1	rs177377	chr14:73753519	HEATR4	chr14:73945193-74025651:-	-0.23	-4.26	2.51E-5	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs17739794	chr8:812946	DLGAP2	chr8:1449569-1656640:+	-0.17	-3.87	0.000125	Clozapine-induced cytotoxicity	
PRAD	cis	1	rs17745344	chr17:53048319	TOM1L1	chr17:52978052-53039328:+	-0.17	-4.28	2.26E-5	Breast cancer	
PRAD	cis	1	rs17746014	chr10:102315354	SEC31B	chr10:102246403-102289636:-	-0.27	-8.09	5.21E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs1775148	chr1:205757824	PM20D1	chr1:205797154-205819245:-	-0.38	-7.39	6.64E-13	Prostate cancer	
PRAD	cis	1	rs1775148	chr1:205757824	RAB7L1	chr1:205737115-205744610:-	0.35	8.04	7.51E-15	Prostate cancer	
PRAD	cis	1	rs1775151	chr1:205745684	RAB7L1	chr1:205737115-205744610:-	0.29	5.78	1.34E-8	Parkinson's disease	
PRAD	cis	1	rs17752459	chr6:56798755	BEND6	chr6:56819773-56892138:+	-0.61	-11.02	2.77E-25	Menarche (age at onset)	
PRAD	cis	1	rs17752459	chr6:56798755	KIAA1586	chr6:56911384-56920021:+	-0.21	-3.43	0.000655	Menarche (age at onset)	
PRAD	cis	1	rs1775715	chr10:32309005	ARHGAP12	chr10:32095225-32217770:-	0.26	7.77	4.85E-14	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.73	13.53	1.83E-35	Esophageal cancer (squamous cell)	
PRAD	cis	1	rs17761864	chr17:2171637	SRR	chr17:2207248-2228553:+	-0.71	-13.54	1.63E-35	Esophageal cancer (squamous cell)	
PRAD	cis	1	rs17772064	chr14:88822871	SPATA7	chr14:88852012-88904802:+	-0.2	-3.84	0.00014	Coronary artery calcification	
PRAD	cis	1	rs17772222	chr14:88826482	SPATA7	chr14:88852012-88904802:+	0.21	3.96	8.73E-5	Coronary artery calcification	
PRAD	cis	1	rs17772288	chr14:88827366	SPATA7	chr14:88852012-88904802:+	-0.21	-4.04	6.18E-5	Coronary artery calcification	
PRAD	cis	1	rs17779494	chr15:43579223	STRC	chr15:43891762-43924561:-	-0.26	-5.31	1.73E-7	Lung cancer	
PRAD	cis	1	rs17779494	chr15:43579223	TGM7	chr15:43568479-43594453:-	-0.26	-4.15	4.01E-5	Lung cancer	
PRAD	cis	1	rs17780080	chr17:30343146	C17orf79	chr17:30178885-30186326:-	-0.28	-4.56	6.42E-6	Height	
PRAD	cis	1	rs17780086	chr17:30343282	C17orf79	chr17:30178885-30186326:-	-0.28	-4.56	6.42E-6	Height	
PRAD	cis	1	rs1778508	chr6:28229881	ZKSCAN3	chr6:28317691-28334523:+	0.16	3.46	0.000589	Depression	
PRAD	cis	1	rs1778508	chr6:28229881	ZNF187	chr6:28234788-28245978:+	0.31	5.6	3.72E-8	Depression	
PRAD	cis	1	rs1778508	chr6:28229881	ZNF323	chr6:28292517-28324048:-	-0.4	-5.38	1.15E-7	Depression	
PRAD	cis	1	rs1778508	chr6:28229881	ZNF389	chr6:28129551-28137375:+	0.52	7.52	2.71E-13	Depression	
PRAD	cis	1	rs1778508	chr6:28229881	ZSCAN23	chr6:28393287-28411279:-	-0.18	-4.89	1.39E-6	Depression	
PRAD	cis	1	rs1778511	chr6:28229411	ZKSCAN3	chr6:28317691-28334523:+	0.18	3.71	0.000229	Depression	
PRAD	cis	1	rs1778511	chr6:28229411	ZNF187	chr6:28234788-28245978:+	0.32	5.88	7.86E-9	Depression	
PRAD	cis	1	rs1778511	chr6:28229411	ZNF323	chr6:28292517-28324048:-	-0.41	-5.6	3.58E-8	Depression	
PRAD	cis	1	rs1778511	chr6:28229411	ZNF389	chr6:28129551-28137375:+	0.53	7.62	1.42E-13	Depression	
PRAD	cis	1	rs1778511	chr6:28229411	ZSCAN23	chr6:28393287-28411279:-	-0.17	-4.66	4.15E-6	Depression	
PRAD	cis	1	rs17789174	chr16:85103885	ZDHHC7	chr16:85008067-85045141:-	-0.31	-5.37	1.24E-7	Dysphagia	
PRAD	cis	1	rs17800886	chr5:150309539	LOC134466	chr5:150310000-150326146:-	0.64	9.57	6.33E-20	Crohn's disease	
PRAD	cis	1	rs17800987	chr5:150323428	LOC134466	chr5:150310000-150326146:-	0.68	10.28	1.74E-22	Crohn's disease	
PRAD	cis	1	rs17818028	chr17:53062755	TOM1L1	chr17:52978052-53039328:+	0.17	4.34	1.72E-5	Breast cancer	
PRAD	cis	1	rs17818399	chr2:46826026	ATP6V1E2	chr2:46738988-46769696:-	-0.2	-3.76	0.000193	Height	
PRAD	cis	1	rs17818399	chr2:46826026	CRIPT	chr2:46844325-46852880:+	0.35	6.91	1.62E-11	Height	
PRAD	cis	1	rs1782468	chr1:207470415	CD55	chr1:207494817-207534309:+	0.43	8.23	1.92E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs17826580	chr14:65915262	LOC645431	chr14:65877313-65879335:-	-0.44	-4.48	9.29E-6	Ischemic stroke	
PRAD	cis	1	rs17826724	chr14:66068320	LOC645431	chr14:65877313-65879335:-	-0.34	-3.64	0.000302	Ischemic stroke	
PRAD	cis	1	rs17826736	chr14:66082202	LOC645431	chr14:65877313-65879335:-	-0.36	-3.83	0.000143	Ischemic stroke	
PRAD	cis	1	rs17826790	chr14:66103427	LOC645431	chr14:65877313-65879335:-	-0.39	-4.02	6.85E-5	Ischemic stroke	
PRAD	cis	1	rs17826796	chr14:66104187	LOC645431	chr14:65877313-65879335:-	-0.35	-3.7	0.000238	Ischemic stroke	
PRAD	cis	1	rs17826820	chr14:66113837	LOC645431	chr14:65877313-65879335:-	-0.41	-4.14	4.09E-5	Ischemic stroke	
PRAD	cis	1	rs17831161	chr2:160909360	LY75	chr2:160625141-160761262:-	0.12	4.15	3.94E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs17831161	chr2:160909360	PLA2R1	chr2:160798012-160919121:-	0.23	5.34	1.46E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs17831191	chr2:160911332	LY75	chr2:160625141-160761262:-	0.12	4.15	3.94E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs17831191	chr2:160911332	PLA2R1	chr2:160798012-160919121:-	0.23	5.34	1.46E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs17831251	chr2:160914156	LY75	chr2:160625141-160761262:-	0.12	4.17	3.67E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs17831251	chr2:160914156	PLA2R1	chr2:160798012-160919121:-	0.23	5.22	2.65E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs17834627	chr17:2198892	SRR	chr17:2207248-2228553:+	-0.77	-14.44	2.23E-39	Esophageal cancer (squamous cell)	
PRAD	cis	1	rs17835605	chr2:112661106	MERTK	chr2:112656191-112786945:+	-0.23	-3.89	0.000117	Multiple sclerosis	
PRAD	cis	1	rs17839567	chr16:31057945	HSD3B7	chr16:30996519-31000473:+	0.49	10.63	8.83E-24	Response to metformin (IC50)	
PRAD	cis	1	rs17839567	chr16:31057945	MYST1	chr16:31128985-31142713:+	0.21	6.52	1.86E-10	Response to metformin (IC50)	
PRAD	cis	1	rs17839567	chr16:31057945	PRSS36	chr16:31150251-31161415:-	0.19	4.92	1.17E-6	Response to metformin (IC50)	
PRAD	cis	1	rs17839567	chr16:31057945	PRSS53	chr16:31094747-31106276:-	-0.19	-3.74	0.00021	Response to metformin (IC50)	
PRAD	cis	1	rs17839567	chr16:31057945	STX1B	chr16:31000577-31021829:-	0.23	5.84	9.94E-9	Response to metformin (IC50)	
PRAD	cis	1	rs17848459	chr22:51012311	CPT1B	chr22:51007291-51017096:-	-0.22	-4.79	2.19E-6	Narcolepsy	
PRAD	cis	1	rs17848459	chr22:51012311	LOC100144603	chr22:51021455-51022353:+	-0.3	-3.49	0.000536	Narcolepsy	
PRAD	cis	1	rs17878846	chr10:104630412	SFXN2	chr10:104474298-104498946:+	-0.37	-4.01	7.03E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
PRAD	cis	1	rs17884887	chr10:81703433	LOC219347	chr10:81805991-81838949:-	0.39	3.44	0.000626	Rheumatoid arthritis	
PRAD	cis	1	rs1794693	chr6:167405670	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.28E-8	Crohn's disease	
PRAD	cis	1	rs1795379	chr12:75941042	GLIPR1L2	chr12:75784889-75825591:+	-0.37	-5.8	1.19E-8	Polycystic ovary syndrome	
PRAD	cis	1	rs1796220	chr7:66062100	CCT6P1	chr7:65216092-65228661:+	0.34	5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs1796220	chr7:66062100	CRCP	chr7:65579805-65619551:+	-0.31	-3.88	0.00012	Diabetic kidney disease	
PRAD	cis	1	rs1796228	chr7:66033084	CCT6P1	chr7:65216092-65228661:+	0.31	5.22	2.71E-7	Diabetic kidney disease	
PRAD	cis	1	rs1796228	chr7:66033084	CRCP	chr7:65579805-65619551:+	-0.36	-4.48	9.34E-6	Diabetic kidney disease	
PRAD	cis	1	rs1797313	chr15:50485464	SLC27A2	chr15:50474393-50528588:+	-0.19	-3.64	0.000308	Blood metabolite ratios	
PRAD	cis	1	rs1798219	chr12:123180061	GPR109B	chr12:123199304-123201439:-	0.36	6.37	4.49E-10	Adiponectin levels	
PRAD	cis	1	rs1799867	chr11:46747979	ARHGAP1	chr11:46698634-46722120:-	-0.22	-3.5	0.000518	HDL cholesterol	
PRAD	cis	1	rs1800615	chr1:15832281	AGMAT	chr1:15899152-15911605:-	0.2	3.82	0.000152	Glomerular filtration rate (creatinine)	
PRAD	cis	1	rs1800615	chr1:15832281	CASP9	chr1:15817324-15851384:-	0.48	9.06	3.52E-18	Glomerular filtration rate (creatinine)	
PRAD	cis	1	rs1800662	chr10:102289078	SEC31B	chr10:102246403-102289636:-	-0.3	-8.98	6.57E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs1801	chr4:103501054	BDH2	chr4:103998783-104021024:-	-0.16	-3.89	0.000116	Ulcerative colitis	
PRAD	cis	1	rs1802236	chr12:56679751	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs1802236	chr12:56679751	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs1805074	chr5:78324352	BHMT2	chr5:78365583-78385273:+	0.1	3.81	0.000158	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs180515	chr17:58024275	DHX40P1	chr17:58053385-58096336:-	0.23	4.45	1.1E-5	Multiple sclerosis	
PRAD	cis	1	rs1805165	chr2:88874891	RPIA	chr2:88991176-89050451:+	-0.17	-3.51	0.000485	Height	
PRAD	cis	1	rs1806606	chr1:202442385	PPP1R12B	chr1:202317836-202557697:+	0.09	3.68	0.000257	Sex ratio	
PRAD	cis	1	rs1809986	chr11:48987539	FOLH1	chr11:49168188-49230222:-	-0.17	-3.88	0.000119	HDL cholesterol	
PRAD	cis	1	rs1810049	chr15:84576052	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1813217	chr11:59872498	PATL1	chr11:59404194-59436511:-	-0.11	-3.44	0.000623	Alzheimer's disease (late onset)	
PRAD	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.52	11.95	6.06E-29	Height	
PRAD	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.53	12.32	2.04E-30	Height	
PRAD	cis	1	rs1815787	chr11:116921397	PCSK7	chr11:117075789-117102811:-	-0.29	-4.08	5.28E-5	Subjective well-being	
PRAD	cis	1	rs1816256	chr5:150272853	LOC134466	chr5:150310000-150326146:-	0.62	9.36	3.35E-19	Crohn's disease	
PRAD	cis	1	rs1816752	chr13:24980949	C1QTNF9	chr13:24553839-24896665:+	-0.19	-3.76	0.000195	Obesity-related traits	
PRAD	cis	1	rs1816752	chr13:24980949	LOC374491	chr13:25141011-25171810:+	-0.21	-3.61	0.000338	Obesity-related traits	
PRAD	cis	1	rs1816752	chr13:24980949	PARP4	chr13:24995075-25086948:-	0.21	5.44	8.73E-8	Obesity-related traits	
PRAD	cis	1	rs1816854	chr12:44205018	TMEM117	chr12:44229962-44783540:+	-0.41	-6.69	6.17E-11	Inflammatory bowel disease	
PRAD	cis	1	rs1818462	chr1:202459114	PPP1R12B	chr1:202317836-202557697:+	0.09	3.71	0.000234	Sex ratio	
PRAD	cis	1	rs1818950	chr15:84722521	GOLGA6L5	chr15:85047738-85060078:-	-0.18	-4.65	4.27E-6	Schizophrenia	
PRAD	cis	1	rs1818950	chr15:84722521	LOC388152	chr15:84867600-84898920:-	-0.36	-6.29	7.38E-10	Schizophrenia	
PRAD	cis	1	rs1818950	chr15:84722521	NMB	chr15:85198362-85201802:-	-0.37	-8.27	1.39E-15	Schizophrenia	
PRAD	cis	1	rs1818950	chr15:84722521	WDR73	chr15:85186012-85197524:-	-0.21	-4.43	1.19E-5	Schizophrenia	
PRAD	cis	1	rs1819333	chr6:167373547	RNASET2	chr6:167343008-167412795:-	-0.25	-5.99	4.21E-9	Crohn's disease	
PRAD	cis	1	rs1820682	chr5:150262142	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs1823061	chr19:37800626	ZNF607	chr19:38187276-38210691:-	-0.21	-3.96	8.74E-5	Coronary artery calcification	
PRAD	cis	1	rs1823061	chr19:37800626	ZNF781	chr19:38158650-38183216:-	0.23	3.92	0.0001	Coronary artery calcification	
PRAD	cis	1	rs1823874	chr15:100357435	C15orf51	chr15:100330361-100347132:-	-0.39	-9.06	3.63E-18	IgG glycosylation	
PRAD	cis	1	rs1823913	chr2:192118047	GLS	chr2:191745547-191829776:+	0.13	3.47	0.000574	Obesity-related traits	
PRAD	cis	1	rs1830074	chr7:6718674	C7orf28B	chr7:6838572-6865861:-	-0.23	-3.67	0.000268	Body mass index	
PRAD	cis	1	rs1830074	chr7:6718674	PMS2CL	chr7:6749757-6793492:+	-0.3	-5.33	1.55E-7	Body mass index	
PRAD	cis	1	rs1832371	chr20:22271089	PAX1	chr20:21686297-21696620:+	-0.15	-3.89	0.000113	Glucose homeostasis traits	
PRAD	cis	1	rs1832719	chr1:202447026	PPP1R12B	chr1:202317836-202557697:+	0.09	3.67	0.000269	Sex ratio	
PRAD	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.9	15.88	9.21E-46	Type 2 diabetes	
PRAD	cis	1	rs1834481	chr11:112023827	IL18	chr11:112013976-112034840:-	0.2	6.58	1.29E-10	Interleukin-18 levels	
PRAD	cis	1	rs1835307	chr1:207426565	CD55	chr1:207494817-207534309:+	0.22	4.05	6.02E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs183618	chr17:53235974	COX11	chr17:53029259-53046064:-	0.23	4.62	4.9E-6	Menarche (age at onset)	
PRAD	cis	1	rs183618	chr17:53235974	STXBP4	chr17:53046126-53241449:+	0.14	3.51	0.000497	Menarche (age at onset)	
PRAD	cis	1	rs183618	chr17:53235974	TOM1L1	chr17:52978052-53039328:+	0.14	3.88	0.000118	Menarche (age at onset)	
PRAD	cis	1	rs1838671	chr12:85419056	LRRIQ1	chr12:85430099-85638880:+	-0.24	-3.96	8.6E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1838671	chr12:85419056	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.88	1.46E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1838671	chr12:85419056	TSPAN19	chr12:85408095-85430055:-	-0.3	-5.28	1.95E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1839622	chr12:7334534	PEX5	chr12:7341759-7371167:+	0.47	9.66	2.97E-20	IgG glycosylation	
PRAD	cis	1	rs1839972	chr15:90891354	CRTC3	chr15:91073198-91188576:+	-0.16	-3.65	0.000295	Rheumatoid arthritis	
PRAD	cis	1	rs1839972	chr15:90891354	ZNF774	chr15:90895477-90904714:+	-0.24	-4.85	1.72E-6	Rheumatoid arthritis	
PRAD	cis	1	rs1840377	chr2:192122718	GLS	chr2:191745547-191829776:+	-0.14	-3.76	0.00019	Obesity-related traits	
PRAD	cis	1	rs1840377	chr2:192122718	STAT4	chr2:191894306-192038902:-	0.11	3.62	0.000325	Obesity-related traits	
PRAD	cis	1	rs1841777	chr3:38484819	XYLB	chr3:38388251-38456467:+	0.23	5.13	4.24E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs184182	chr5:37005105	NIPBL	chr5:36876861-37065920:+	0.11	4.57	6.38E-6	Height	
PRAD	cis	1	rs1848048	chr11:18468996	LDHC	chr11:18433853-18472792:+	-0.31	-3.82	0.000151	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs1848093	chr15:84755527	GOLGA6L5	chr15:85047738-85060078:-	-0.19	-4.74	2.79E-6	Schizophrenia	
PRAD	cis	1	rs1848093	chr15:84755527	LOC388152	chr15:84867600-84898920:-	-0.36	-6.25	9.07E-10	Schizophrenia	
PRAD	cis	1	rs1848093	chr15:84755527	NMB	chr15:85198362-85201802:-	-0.37	-8.3	1.1E-15	Schizophrenia	
PRAD	cis	1	rs1848093	chr15:84755527	WDR73	chr15:85186012-85197524:-	-0.22	-4.6	5.48E-6	Schizophrenia	
PRAD	cis	1	rs1849004	chr19:22142455	ZNF257	chr19:22235266-22273901:+	0.39	5.29	1.92E-7	Body mass index (change over time)	
PRAD	cis	1	rs1852264	chr15:84589940	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1854774	chr4:129988405	C4orf33	chr4:130014829-130033842:+	-0.46	-7.84	3.01E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs185538822	chr4:106803682	INTS12	chr4:106603787-106629881:-	-0.76	-6.94	1.32E-11	Post bronchodilator FEV1	
PRAD	cis	1	rs1855647	chr1:72061816	NEGR1	chr1:71868626-72748405:-	0.1	3.67	0.00027	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs1856355	chr1:247862003	OR2W3	chr1:248031265-248060142:+	-0.33	-4.97	9.49E-7	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs1856355	chr1:247862003	TRIM58	chr1:248020501-248043436:+	-0.3	-4.45	1.06E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs185694	chr13:30885223	KATNAL1	chr13:30776768-30881584:-	-0.19	-4.04	6.21E-5	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.51	-11.48	4.56E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.49	-11.05	2.17E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs1858001	chr1:207488004	CD55	chr1:207494817-207534309:+	-0.25	-4.41	1.31E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs1858482	chr1:152306921	FLG	chr1:152274651-152297679:-	-0.32	-5.02	7.33E-7	Atopic dermatitis	
PRAD	cis	1	rs185968827	chr6:56708510	BEND6	chr6:56819773-56892138:+	-0.32	-5.3	1.79E-7	Alzheimer disease and age of onset	
PRAD	cis	1	rs1859925	chr2:242022038	MTERFD2	chr2:242034545-242041747:-	0.36	4.04	6.33E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs1859925	chr2:242022038	PASK	chr2:242045515-242088878:-	0.3	3.86	0.000131	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs1859926	chr2:242022111	MTERFD2	chr2:242034545-242041747:-	0.36	4.04	6.33E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs1859926	chr2:242022111	PASK	chr2:242045515-242088878:-	0.3	3.86	0.000131	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs1860596	chr4:17660082	MED28	chr4:17616273-17629791:+	0.23	5.7	2.06E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs1860597	chr4:17657650	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs1861444	chr2:37464511	CEBPZ	chr2:37428778-37458740:-	0.2	4.44	1.1E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs1862228	chr5:78314051	BHMT2	chr5:78365583-78385273:+	0.09	3.68	0.000264	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.9	15.88	9.21E-46	Type 2 diabetes	
PRAD	cis	1	rs1862630	chr5:42754243	CCDC152	chr5:42756920-42802539:+	0.16	4.42	1.25E-5	Height	
PRAD	cis	1	rs1862630	chr5:42754243	SEPP1	chr5:42799983-42825998:-	0.15	4.35	1.7E-5	Height	
PRAD	cis	1	rs1863512	chr15:52959687	ARPP19	chr15:52839432-52861364:-	0.17	4.63	4.81E-6	Schizophrenia	
PRAD	cis	1	rs186378	chr7:65582058	CCT6P1	chr7:65216092-65228661:+	0.33	5.76	1.51E-8	Diabetic kidney disease	
PRAD	cis	1	rs186378	chr7:65582058	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000132	Diabetic kidney disease	
PRAD	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.51	11.77	3.36E-28	Height	
PRAD	cis	1	rs1863913	chr3:134200205	CEP63	chr3:134204575-134293852:+	0.2	3.56	0.000406	Height	
PRAD	cis	1	rs1863998	chr5:150271753	LOC134466	chr5:150310000-150326146:-	0.57	8.83	2.13E-17	Crohn's disease	
PRAD	cis	1	rs1864367	chr3:53111704	ITIH4	chr3:52847007-52866554:-	0.16	4.74	2.84E-6	Height	
PRAD	cis	1	rs1864399	chr10:43610455	CSGALNACT2	chr10:43633934-43680747:+	-0.14	-3.71	0.00023	Hirschsprung disease	
PRAD	cis	1	rs1864410	chr10:43575625	RET	chr10:43572517-43625795:+	0.23	3.56	0.000405	Hirschsprung disease	
PRAD	cis	1	rs186593	chr11:108262439	ATM	chr11:108093559-108239826:+	-0.17	-5.34	1.47E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs186595	chr11:108251211	ATM	chr11:108093559-108239826:+	-0.18	-5.69	2.29E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs1866071	chr12:104310638	C12orf73	chr12:104343981-104359473:-	0.19	4.67	4.01E-6	Coronary heart disease	
PRAD	cis	1	rs1866071	chr12:104310638	NT5DC3	chr12:104164231-104234975:-	0.2	3.8	0.000165	Coronary heart disease	
PRAD	cis	1	rs1867146	chr15:75354971	PPCDC	chr15:75315927-75343066:+	0.14	3.72	0.000222	Blood trace element (Zn levels)	
PRAD	cis	1	rs1867146	chr15:75354971	SCAMP5	chr15:75287901-75313836:+	0.42	7.4	6.47E-13	Blood trace element (Zn levels)	
PRAD	cis	1	rs1867982	chr10:73527047	DNAJB12	chr10:74092588-74114907:-	0.26	3.53	0.000454	Pulmonary function decline;Age at smoking initiation in chronic obstructive pulmonary disease	
PRAD	cis	1	rs1869596	chr1:110624104	ALX3	chr1:110602998-110613322:-	-0.25	-4.61	5.31E-6	Blood metabolite levels	
PRAD	cis	1	rs1871045	chr19:45326768	PVRL2	chr19:45349393-45392485:+	0.17	4.69	3.62E-6	Waist-to-hip circumference ratio (interaction)	
PRAD	cis	1	rs1872329	chr2:54471823	C2orf73	chr2:54558071-54588714:+	0.31	4.18	3.49E-5	Telomere length	
PRAD	cis	1	rs1873147	chr15:63312632	RPS27L	chr15:63445540-63449741:-	0.14	3.49	0.000538	Orofacial clefts	
PRAD	cis	1	rs1873149	chr15:63312428	RPS27L	chr15:63445540-63449741:-	-0.14	-3.54	0.000433	Orofacial clefts	
PRAD	cis	1	rs1873494	chr7:65649899	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs1873494	chr7:65649899	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs187455071	chr4:106805884	INTS12	chr4:106603787-106629881:-	-0.78	-7.21	2.31E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.53	12.11	1.45E-29	Height	
PRAD	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.38	7.81	3.89E-14	Multiple sclerosis	
PRAD	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.57	-13.78	1.56E-36	Multiple sclerosis	
PRAD	cis	1	rs1875124	chr12:58196802	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-5.03	6.89E-7	Multiple sclerosis	
PRAD	cis	1	rs1877316	chr17:61766880	DDX42	chr17:61851567-61896676:+	-0.28	-5.67	2.48E-8	Body mass index	
PRAD	cis	1	rs1877316	chr17:61766880	FTSJ3	chr17:61896795-61905031:-	0.33	6.52	1.77E-10	Body mass index	
PRAD	cis	1	rs1877316	chr17:61766880	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.4	1.36E-5	Body mass index	
PRAD	cis	1	rs1880023	chr4:8480831	C4orf23	chr4:8440604-8495258:+	0.3	4.78	2.3E-6	Response to antineoplastic agents	
PRAD	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.56	2.28E-27	Height	
PRAD	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.56	2.28E-27	Height	
PRAD	cis	1	rs1880730	chr15:84584184	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs1881123	chr7:1084706	GPR146	chr7:1084243-1098897:+	0.27	3.62	0.000326	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs1881123	chr7:1084706	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.25	2.27E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs1881245	chr2:73649928	ALMS1P	chr2:73872046-73912692:+	0.49	8.49	2.77E-16	Metabolite levels	
PRAD	cis	1	rs1881245	chr2:73649928	NAT8	chr2:73867850-73869537:-	0.25	3.86	0.000128	Metabolite levels	
PRAD	cis	1	rs1881534	chr11:62085083	ASRGL1	chr11:62104774-62160885:+	-0.39	-4.75	2.72E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs1882099	chr4:1352685	CRIPAK	chr4:1385340-1389782:+	0.33	5.93	5.77E-9	Systolic blood pressure	
PRAD	cis	1	rs1882655	chr7:66147057	CCT6P1	chr7:65216092-65228661:+	-0.32	-5.48	7.08E-8	Gout	
PRAD	cis	1	rs1882655	chr7:66147057	CRCP	chr7:65579805-65619551:+	0.34	4.22	2.97E-5	Gout	
PRAD	cis	1	rs1883467	chr1:25494504	RHCE	chr1:25688741-25756683:-	0.22	3.65	0.000296	Urate levels in obese individuals	
PRAD	cis	1	rs1884418	chr20:55070076	C20orf43	chr20:55043647-55093942:+	0.16	3.88	0.00012	Refractive astigmatism	
PRAD	cis	1	rs1884946	chr6:26545308	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.6E-10	Educational attainment	
PRAD	cis	1	rs1884946	chr6:26545308	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000367	Educational attainment	
PRAD	cis	1	rs1884948	chr6:26567988	BTN2A3	chr6:26422317-26431927:+	0.26	6.44	3.0E-10	Educational attainment	
PRAD	cis	1	rs1884948	chr6:26567988	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.44	0.00064	Educational attainment	
PRAD	cis	1	rs1884948	chr6:26567988	ZNF184	chr6:27418522-27440897:-	-0.18	-3.74	0.000206	Educational attainment	
PRAD	cis	1	rs1884949	chr6:26568067	BTN2A3	chr6:26422317-26431927:+	0.26	6.44	3.0E-10	Educational attainment	
PRAD	cis	1	rs1884949	chr6:26568067	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.44	0.00064	Educational attainment	
PRAD	cis	1	rs1884949	chr6:26568067	ZNF184	chr6:27418522-27440897:-	-0.18	-3.74	0.000206	Educational attainment	
PRAD	cis	1	rs188541	chr5:37061261	NIPBL	chr5:36876861-37065920:+	0.11	4.52	7.73E-6	Height	
PRAD	cis	1	rs1885708	chr14:102960164	ANKRD9	chr14:102973198-102976128:-	0.17	4.23	2.86E-5	QT interval	
PRAD	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.76	-14.26	1.41E-38	Esophageal cancer (squamous cell)	
PRAD	cis	1	rs1886242	chr6:35117656	UHRF1BP1	chr6:34759794-34853117:+	0.13	4.38	1.46E-5	Airway responsiveness in chronic obstructive pulmonary disease	
PRAD	cis	1	rs1886328	chr6:17635023	NUP153	chr6:17615269-17706818:-	0.1	3.64	0.000304	Obesity-related traits	
PRAD	cis	1	rs1886682	chr1:92977275	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs1886683	chr1:92976023	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs1888997	chr20:25298988	ENTPD6	chr20:25176339-25207360:+	0.18	4.74	2.85E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1888997	chr20:25298988	FAM182B	chr20:25744102-25848786:-	-0.35	-6.5	2.05E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1888997	chr20:25298988	PYGB	chr20:25228706-25278647:+	0.35	7.67	1.03E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1888998	chr20:25291826	ENTPD6	chr20:25176339-25207360:+	0.16	4.32	1.88E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1888998	chr20:25291826	FAM182B	chr20:25744102-25848786:-	-0.37	-6.81	3.08E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1888998	chr20:25291826	PYGB	chr20:25228706-25278647:+	0.33	7.21	2.22E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1888999	chr20:25291848	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.33	1.79E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1888999	chr20:25291848	FAM182B	chr20:25744102-25848786:-	0.37	6.75	4.4E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1888999	chr20:25291848	PYGB	chr20:25228706-25278647:+	-0.33	-7.2	2.36E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1890875	chr1:202531366	PPP1R12B	chr1:202317836-202557697:+	0.09	3.72	0.000227	Sex ratio	
PRAD	cis	1	rs1891403	chr9:115527183	C9orf80	chr9:115448793-115480387:-	0.24	3.87	0.000124	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs1891969	chr1:114185855	PHTF1	chr1:114239824-114302098:-	0.26	4.8	2.14E-6	Bacteremia	
PRAD	cis	1	rs1893033	chr11:119089055	CBL	chr11:119076990-119178858:+	-0.31	-4.82	1.96E-6	Platelet count	
PRAD	cis	1	rs1893447	chr11:77973182	GAB2	chr11:77926343-78128766:-	-0.17	-5.7	2.09E-8	Testicular germ cell tumor	
PRAD	cis	1	rs1893447	chr11:77973182	NARS2	chr11:78147017-78285909:-	-0.25	-5.46	7.81E-8	Testicular germ cell tumor	
PRAD	cis	1	rs1893448	chr11:77969180	GAB2	chr11:77926343-78128766:-	-0.18	-5.96	4.99E-9	Testicular germ cell tumor	
PRAD	cis	1	rs1893448	chr11:77969180	NARS2	chr11:78147017-78285909:-	-0.25	-5.32	1.57E-7	Testicular germ cell tumor	
PRAD	cis	1	rs1894720	chr22:27067224	CRYBA4	chr22:27017928-27026635:+	-0.27	-5.13	4.31E-7	Electroencephalogram traits	
PRAD	cis	1	rs1895320	chr5:159849586	SLU7	chr5:159828649-159846168:-	-0.45	-7.45	4.5E-13	Insulin-related traits	
PRAD	cis	1	rs1895457	chr5:42765332	CCDC152	chr5:42756920-42802539:+	0.16	4.42	1.24E-5	Height	
PRAD	cis	1	rs1895457	chr5:42765332	SEPP1	chr5:42799983-42825998:-	0.15	4.35	1.68E-5	Height	
PRAD	cis	1	rs1896707	chr5:150245129	LOC134466	chr5:150310000-150326146:-	0.54	8.65	8.5E-17	Crohn's disease	
PRAD	cis	1	rs1896708	chr5:150245076	LOC134466	chr5:150310000-150326146:-	0.57	8.8	2.71E-17	Crohn's disease	
PRAD	cis	1	rs1896709	chr5:150245032	LOC134466	chr5:150310000-150326146:-	0.54	8.65	8.5E-17	Crohn's disease	
PRAD	cis	1	rs1897136	chr4:39132862	KLHL5	chr4:39046659-39123828:+	-0.14	-3.97	8.19E-5	Uric acid levels	
PRAD	cis	1	rs1897137	chr4:39133007	KLHL5	chr4:39046659-39123828:+	-0.14	-3.97	8.19E-5	Uric acid levels	
PRAD	cis	1	rs1900120	chr14:76626516	ESRRB	chr14:76837690-76968178:+	0.25	3.54	0.000447	Blood pressure	
PRAD	cis	1	rs1900122	chr14:76629517	ESRRB	chr14:76837690-76968178:+	0.25	3.54	0.000447	Blood pressure	
PRAD	cis	1	rs1900125	chr14:76657470	C14orf118	chr14:76618259-76669133:+	-0.15	-3.72	0.000222	Blood pressure	
PRAD	cis	1	rs1903330	chr6:56776985	BEND6	chr6:56819773-56892138:+	0.6	10.7	4.78E-24	Menarche (age at onset)	
PRAD	cis	1	rs1903330	chr6:56776985	KIAA1586	chr6:56911384-56920021:+	0.22	3.53	0.000452	Menarche (age at onset)	
PRAD	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.93	15.94	4.93E-46	Type 2 diabetes	
PRAD	cis	1	rs1911155	chr15:84787635	GOLGA6L5	chr15:85047738-85060078:-	-0.18	-4.66	4.11E-6	Schizophrenia	
PRAD	cis	1	rs1911155	chr15:84787635	LOC388152	chr15:84867600-84898920:-	-0.36	-6.18	1.43E-9	Schizophrenia	
PRAD	cis	1	rs1911155	chr15:84787635	NMB	chr15:85198362-85201802:-	-0.37	-8.19	2.42E-15	Schizophrenia	
PRAD	cis	1	rs1911155	chr15:84787635	WDR73	chr15:85186012-85197524:-	-0.21	-4.48	9.43E-6	Schizophrenia	
PRAD	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.49	-11.44	6.46E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.48	-10.82	1.59E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs1912453	chr1:162821291	HSD17B7	chr1:162760496-162782607:+	0.19	3.54	0.000437	Colorectal cancer	
PRAD	cis	1	rs1916326	chr4:8500023	C4orf23	chr4:8440604-8495258:+	0.31	5	7.94E-7	Response to antineoplastic agents	
PRAD	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.33	1.86E-26	Height	
PRAD	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.37	2.99E-19	Obesity-related traits	
PRAD	cis	1	rs1919948	chr7:143762843	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.72	0.000224	Obesity-related traits	
PRAD	cis	1	rs1919948	chr7:143762843	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.36	1.3E-7	Obesity-related traits	
PRAD	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.51	-9.48	1.27E-19	Obesity-related traits	
PRAD	cis	1	rs1919949	chr7:143767723	OR2A1	chr7:144015236-144016148:+;chr7	-0.24	-3.84	0.000138	Obesity-related traits	
PRAD	cis	1	rs1919949	chr7:143767723	OR2A9P	chr7:143991573-143997832:+;chr7	-0.32	-5.42	9.33E-8	Obesity-related traits	
PRAD	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.51	-9.45	1.6E-19	Obesity-related traits	
PRAD	cis	1	rs1919950	chr7:143767898	OR2A1	chr7:144015236-144016148:+;chr7	-0.24	-3.83	0.000147	Obesity-related traits	
PRAD	cis	1	rs1919950	chr7:143767898	OR2A9P	chr7:143991573-143997832:+;chr7	-0.32	-5.44	8.67E-8	Obesity-related traits	
PRAD	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.51	-9.46	1.51E-19	Obesity-related traits	
PRAD	cis	1	rs1919951	chr7:143768891	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.59	0.000362	Obesity-related traits	
PRAD	cis	1	rs1919951	chr7:143768891	OR2A9P	chr7:143991573-143997832:+;chr7	-0.32	-5.47	7.46E-8	Obesity-related traits	
PRAD	cis	1	rs1923834	chr13:28360487	POLR1D	chr13:28194895-28241547:+	-0.25	-3.45	0.000616	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	
PRAD	cis	1	rs1924525	chr1:68926381	DEPDC1	chr1:68939837-68962799:-	0.49	8.12	4.27E-15	IgG glycosylation	
PRAD	cis	1	rs1925148	chr6:56095672	COL21A1	chr6:55921389-56258892:-	0.25	7.37	7.76E-13	Pulse pressure	
PRAD	cis	1	rs1925152	chr6:56102709	COL21A1	chr6:55921389-56258892:-	0.25	7.49	3.48E-13	Pulse pressure	
PRAD	cis	1	rs1928020	chr13:36695968	SOHLH2	chr13:36742347-36871992:-	0.27	4.33	1.8E-5	Optic cup area	
PRAD	cis	1	rs1930961	chr22:25875265	CRYBB2	chr22:25615612-25627836:+	0.92	15.27	4.95E-43	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs1933182	chr1:109999838	SYPL2	chr1:110009100-110024763:+	-0.36	-7.68	9.2E-14	Chronic kidney disease	
PRAD	cis	1	rs1933488	chr6:153441079	RGS17	chr6:153332041-153452389:-	-0.55	-13.21	4.36E-34	Prostate cancer	
PRAD	cis	1	rs1935	chr10:64927823	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.58	0.000377	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1935	chr10:64927823	NRBF2	chr10:64893007-64914785:+	-0.29	-6.4	3.7E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs1936365	chr6:28268452	ZKSCAN3	chr6:28317691-28334523:+	0.17	3.51	0.000497	Depression	
PRAD	cis	1	rs1936365	chr6:28268452	ZNF187	chr6:28234788-28245978:+	0.3	5.54	5.03E-8	Depression	
PRAD	cis	1	rs1936365	chr6:28268452	ZNF323	chr6:28292517-28324048:-	-0.46	-6.35	5.04E-10	Depression	
PRAD	cis	1	rs1936365	chr6:28268452	ZNF389	chr6:28129551-28137375:+	0.49	7.15	3.39E-12	Depression	
PRAD	cis	1	rs1936365	chr6:28268452	ZSCAN23	chr6:28393287-28411279:-	-0.17	-4.67	4.02E-6	Depression	
PRAD	cis	1	rs193693	chr16:56962169	SLC12A3	chr16:56899119-56949760:+	0.26	3.61	0.000335	Metabolic syndrome	
PRAD	cis	1	rs1937332	chr10:90826779	IFIT2	chr10:91061706-91069032:+	0.15	3.58	0.000382	Obesity-related traits	
PRAD	cis	1	rs1937334	chr10:90826252	IFIT2	chr10:91061706-91069032:+	-0.14	-3.47	0.000579	Obesity-related traits	
PRAD	cis	1	rs1942352	chr11:77970563	GAB2	chr11:77926343-78128766:-	-0.2	-6.25	9.33E-10	Testicular germ cell tumor	
PRAD	cis	1	rs1942352	chr11:77970563	NARS2	chr11:78147017-78285909:-	-0.23	-4.81	1.99E-6	Testicular germ cell tumor	
PRAD	cis	1	rs1945390	chr11:122520253	LOC399959	chr11:121959811-122238467:-	-0.09	-4.43	1.19E-5	HDL cholesterol;Cholesterol, total	
PRAD	cis	1	rs1946812	chr2:178674935	PDE11A	chr2:178487979-178973066:-	-0.34	-4.35	1.68E-5	Height	
PRAD	cis	1	rs1947861	chr6:49482687	CENPQ	chr6:49431096-49460820:+	-0.22	-4.37	1.53E-5	Brain structure	
PRAD	cis	1	rs1949510	chr2:17778129	GEN1	chr2:17935162-17966632:+	0.41	5.22	2.74E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs1949733	chr4:8503359	C4orf23	chr4:8440604-8495258:+	0.29	4.66	4.13E-6	Response to antineoplastic agents	
PRAD	cis	1	rs1950319	chr14:61048844	C14orf39	chr14:60902675-60952764:-	0.49	6.03	3.35E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1950904	chr14:60964954	C14orf39	chr14:60902675-60952764:-	0.46	5.89	7.45E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1951114	chr14:60922005	C14orf39	chr14:60902675-60952764:-	-0.45	-5.97	4.56E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1951115	chr14:60922006	C14orf39	chr14:60902675-60952764:-	-0.45	-5.97	4.56E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1952012	chr14:50098896	PPIL5	chr14:50065415-50081389:+	-0.24	-4.35	1.68E-5	Carotid intima media thickness	
PRAD	cis	1	rs1952012	chr14:50098896	RPL36AL	chr14:50085407-50087349:-	0.39	11.35	1.52E-26	Carotid intima media thickness	
PRAD	cis	1	rs1953099	chr1:111290542	AHCYL1	chr1:110527308-110566363:+	-0.25	-3.53	0.000462	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs1953099	chr1:111290542	RAP1A	chr1:112085055-112256100:+	-0.31	-4.46	1.02E-5	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.39	-6.94	1.31E-11	Rheumatoid arthritis	
PRAD	cis	1	rs1953126	chr9:123640500	TRAF1	chr9:123664672-123691479:-	0.18	5.05	6.2E-7	Rheumatoid arthritis	
PRAD	cis	1	rs1953417	chr14:65878909	LOC645431	chr14:65877313-65879335:-	-0.41	-4.16	3.81E-5	Ischemic stroke	
PRAD	cis	1	rs1953600	chr10:81911725	ANXA11	chr10:81914880-81965433:-	-0.17	-3.62	0.000329	Sarcoidosis	
PRAD	cis	1	rs1955599	chr14:88825132	SPATA7	chr14:88852012-88904802:+	-0.2	-3.96	8.6E-5	Coronary artery calcification	
PRAD	cis	1	rs1955600	chr14:88825384	SPATA7	chr14:88852012-88904802:+	-0.2	-3.96	8.6E-5	Coronary artery calcification	
PRAD	cis	1	rs1955686	chr14:61093560	C14orf39	chr14:60902675-60952764:-	0.57	6.54	1.63E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1955686	chr14:61093560	SIX6	chr14:60975938-60978523:+	0.3	3.43	0.000646	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1955699	chr14:61045989	C14orf39	chr14:60902675-60952764:-	0.51	6.38	4.26E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1956549	chr14:60928201	C14orf39	chr14:60902675-60952764:-	0.45	5.97	4.56E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1956554	chr14:60963775	C14orf39	chr14:60902675-60952764:-	-0.46	-5.89	7.37E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1956555	chr14:60968804	C14orf39	chr14:60902675-60952764:-	0.42	5.59	3.88E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1956557	chr14:60972569	C14orf39	chr14:60902675-60952764:-	0.46	5.79	1.27E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1956875	chr14:60846212	C14orf39	chr14:60902675-60952764:-	-0.46	-5.89	7.47E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs1957977	chr14:50090603	PPIL5	chr14:50065415-50081389:+	-0.22	-4	7.27E-5	Carotid intima media thickness	
PRAD	cis	1	rs1957977	chr14:50090603	RPL36AL	chr14:50085407-50087349:-	0.45	13.22	3.88E-34	Carotid intima media thickness	
PRAD	cis	1	rs1961649	chr12:99904540	ACTR6	chr12:100594574-100635625:+	0.25	3.66	0.000281	Metabolite levels (HVA/5-HIAA ratio)	
PRAD	cis	1	rs1961649	chr12:99904540	GOLGA2B	chr12:100550195-100567335:-	0.2	3.61	0.00034	Metabolite levels (HVA/5-HIAA ratio)	
PRAD	cis	1	rs1962636	chr16:22064395	RRN3P1	chr16:21807951-21831731:-	-0.16	-4.31	1.98E-5	Schizophrenia	
PRAD	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.52	-11.85	1.6E-28	Response to antipsychotic treatment	
PRAD	cis	1	rs1964692	chr7:65454183	CCT6P1	chr7:65216092-65228661:+	0.3	5.27	2.13E-7	Diabetic kidney disease	
PRAD	cis	1	rs1964692	chr7:65454183	CRCP	chr7:65579805-65619551:+	-0.31	-4.02	6.89E-5	Diabetic kidney disease	
PRAD	cis	1	rs1965335	chr9:115504483	C9orf80	chr9:115448793-115480387:-	-0.25	-3.54	0.000447	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs1966423	chr2:202216661	ALS2CR12	chr2:202153148-202222101:-	-0.26	-4.52	7.81E-6	Basal cell carcinoma	
PRAD	cis	1	rs1966839	chr7:50627101	DDC	chr7:50526136-50633154:-	0.24	3.94	9.27E-5	Malaria	
PRAD	cis	1	rs1966839	chr7:50627101	FIGNL1	chr7:50511834-50518088:-	-0.23	-6.21	1.18E-9	Malaria	
PRAD	cis	1	rs1968225	chr7:65874773	TPST1	chr7:65670259-65825437:+	0.18	4.46	1.03E-5	Aortic root size	
PRAD	cis	1	rs1971762	chr12:54058238	TARBP2	chr12:53894705-53900213:+	-0.14	-3.9	0.000112	Height	
PRAD	cis	1	rs1971898	chr15:90890836	CRTC3	chr15:91073198-91188576:+	-0.16	-3.67	0.000268	Rheumatoid arthritis	
PRAD	cis	1	rs1971898	chr15:90890836	ZNF774	chr15:90895477-90904714:+	-0.23	-4.64	4.48E-6	Rheumatoid arthritis	
PRAD	cis	1	rs1974624	chr4:17650281	MED28	chr4:17616273-17629791:+	0.22	5.53	5.19E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs1975174	chr19:22515251	ZNF98	chr19:22573899-22605148:-	0.21	4.09	5.07E-5	Telomere length	
PRAD	cis	1	rs1976053	chr17:65833002	LOC651250	chr17:66097696-66157623:+	-0.24	-4.51	8.32E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs1976054	chr17:65833224	LOC651250	chr17:66097696-66157623:+	-0.24	-4.37	1.5E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs1976270	chr12:85436909	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1976270	chr12:85436909	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1976270	chr12:85436909	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs1977447	chr9:131868196	CRAT	chr9:131857075-131873070:-	-0.23	-3.96	8.73E-5	Blood metabolite ratios	
PRAD	cis	1	rs1979755	chr2:42708405	COX7A2L	chr2:42577647-42596150:-	-0.19	-3.93	9.81E-5	Body mass index	
PRAD	cis	1	rs1979755	chr2:42708405	HAAO	chr2:42994230-43019751:-	-0.1	-3.97	8.35E-5	Body mass index	
PRAD	cis	1	rs1979823	chr7:65704613	CCT6P1	chr7:65216092-65228661:+	-0.31	-5.23	2.57E-7	Diabetic kidney disease	
PRAD	cis	1	rs1979823	chr7:65704613	CRCP	chr7:65579805-65619551:+	0.36	4.5	8.46E-6	Diabetic kidney disease	
PRAD	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.96	-18.85	1.99E-59	Schizophrenia	
PRAD	cis	1	rs1980045	chr2:111904541	ACOXL	chr2:111490150-111875799:+	0.19	3.49	0.00052	Chronic lymphocytic leukemia	
PRAD	cis	1	rs1980045	chr2:111904541	BCL2L11	chr2:111878491-111926022:+	-0.17	-3.98	8.02E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs1981798	chr7:65954903	TPST1	chr7:65670259-65825437:+	0.18	4.37	1.55E-5	Aortic root size	
PRAD	cis	1	rs1981898	chr14:76175565	TTLL5	chr14:76127621-76421421:+	0.23	4.55	6.69E-6	Large artery stroke	
PRAD	cis	1	rs1982009	chr4:39124873	KLHL5	chr4:39046659-39123828:+	-0.14	-4.02	6.68E-5	Uric acid levels	
PRAD	cis	1	rs1982861	chr3:49577665	AMIGO3	chr3:49754268-49757238:-	-0.44	-8.88	1.42E-17	Menarche (age at onset)	
PRAD	cis	1	rs1982861	chr3:49577665	CCDC36	chr3:49235861-49295537:+	0.23	4.12	4.52E-5	Menarche (age at onset)	
PRAD	cis	1	rs1982861	chr3:49577665	GMPPB	chr3:49758932-49761384:-	-0.48	-11.65	9.5E-28	Menarche (age at onset)	
PRAD	cis	1	rs1982861	chr3:49577665	NCKIPSD	chr3:48711280-48723334:-	0.32	6.32	6.16E-10	Menarche (age at onset)	
PRAD	cis	1	rs1982861	chr3:49577665	P4HTM	chr3:49027341-49044579:+	0.16	3.66	0.000281	Menarche (age at onset)	
PRAD	cis	1	rs1982861	chr3:49577665	WDR6	chr3:49044637-49053386:+	-0.2	-3.87	0.000125	Menarche (age at onset)	
PRAD	cis	1	rs1983891	chr6:41536427	FOXP4	chr6:41514164-41570121:+	0.23	4.35	1.65E-5	Prostate cancer	
PRAD	cis	1	rs1985359	chr19:40226728	LOC400696	chr19:40170014-40177013:+	0.19	3.55	0.000422	Schizophrenia	
PRAD	cis	1	rs1985875	chr12:62508024	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs1986074	chr15:50857452	SPPL2A	chr15:50999739-51057910:-	0.29	5.92	6.06E-9	QT interval	
PRAD	cis	1	rs1986112	chr15:63540572	RPS27L	chr15:63445540-63449741:-	-0.15	-3.63	0.000309	Schizophrenia	
PRAD	cis	1	rs1986557	chr4:283118	ZNF718	chr4:53272-156488:+	0.34	6.04	3.11E-9	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs198806	chr6:26133616	BTN3A2	chr6:26365398-26378546:+	0.19	4.47	9.81E-6	Schizophrenia	
PRAD	cis	1	rs198806	chr6:26133616	HIST1H1T	chr6:26107641-26108364:-	-0.22	-3.88	0.00012	Schizophrenia	
PRAD	cis	1	rs198811	chr6:26128446	BTN3A2	chr6:26365398-26378546:+	-0.19	-4.63	4.82E-6	Schizophrenia	
PRAD	cis	1	rs198811	chr6:26128446	HIST1H1T	chr6:26107641-26108364:-	0.21	3.77	0.000181	Schizophrenia	
PRAD	cis	1	rs198956	chr19:51390353	KLK2	chr19:51376689-51383822:+	-0.29	-7.41	5.86E-13	Prostate-specific antigen levels	
PRAD	cis	1	rs198957	chr19:51389560	KLK2	chr19:51376689-51383822:+	-0.29	-7.41	5.78E-13	Prostate-specific antigen levels	
PRAD	cis	1	rs198958	chr19:51388878	KLK2	chr19:51376689-51383822:+	-0.29	-7.48	3.6E-13	Prostate-specific antigen levels	
PRAD	cis	1	rs1990674	chr17:53061075	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs199347	chr7:23293746	GPNMB	chr7:23286316-23314728:+	-0.2	-5.44	8.62E-8	Parkinson's disease	
PRAD	cis	1	rs199348	chr7:23293098	GPNMB	chr7:23286316-23314728:+	-0.23	-6.4	3.68E-10	Parkinson's disease	
PRAD	cis	1	rs199351	chr7:23300049	GPNMB	chr7:23286316-23314728:+	-0.19	-5.34	1.49E-7	Parkinson's disease	
PRAD	cis	1	rs199357	chr7:23288309	GPNMB	chr7:23286316-23314728:+	0.22	6.41	3.65E-10	Parkinson's disease	
PRAD	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.81	12.17	8.22E-30	Diastolic blood pressure	
PRAD	cis	1	rs1995156	chr11:5566112	UBQLNL	chr11:5535624-5537956:-	-0.18	-3.78	0.000176	QRS duration in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.48	-10.82	1.59E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs1996608	chr9:111857391	C9orf5	chr9:111777416-111882225:-	0.24	4.87	1.51E-6	Information processing speed	
PRAD	cis	1	rs1997243	chr7:1083777	GPR146	chr7:1084243-1098897:+	0.27	3.62	0.000326	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs1997243	chr7:1083777	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.25	2.27E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs1998035	chr14:66126230	LOC645431	chr14:65877313-65879335:-	-0.42	-4.19	3.33E-5	Ischemic stroke	
PRAD	cis	1	rs1998422	chr14:102980993	ANKRD9	chr14:102973198-102976128:-	0.18	4.19	3.32E-5	QT interval	
PRAD	cis	1	rs1998615	chr6:87808289	C6orf162	chr6:88032306-88052043:+	0.18	3.46	0.000593	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
PRAD	cis	1	rs1998615	chr6:87808289	C6orf165	chr6:88117721-88205858:+	0.27	4.83	1.84E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
PRAD	cis	1	rs1998616	chr6:87808430	C6orf165	chr6:88117721-88205858:+	0.26	4.7	3.42E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
PRAD	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.5	-11.37	1.28E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs2000614	chr11:116915742	PCSK7	chr11:117075789-117102811:-	-0.29	-4.09	5.05E-5	Protein quantitative trait loci	
PRAD	cis	1	rs2000615	chr11:116915819	PCSK7	chr11:117075789-117102811:-	-0.25	-3.5	0.000502	Protein quantitative trait loci	
PRAD	cis	1	rs2000616	chr11:116916529	PCSK7	chr11:117075789-117102811:-	-0.29	-4.09	5.05E-5	Protein quantitative trait loci	
PRAD	cis	1	rs2001444	chr2:112659538	MERTK	chr2:112656191-112786945:+	-0.23	-3.91	0.000105	Multiple sclerosis	
PRAD	cis	1	rs2001703	chr3:128383097	RPN1	chr3:128338813-128399918:-	-0.15	-3.47	0.000579	Monocyte count	
PRAD	cis	1	rs2003284	chr10:102202338	SEC31B	chr10:102246403-102289636:-	-0.31	-9.29	5.91E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2003301	chr7:66147656	CRCP	chr7:65579805-65619551:+	0.2	3.73	0.000219	Aortic root size	
PRAD	cis	1	rs2003301	chr7:66147656	LOC493754	chr7:65993446-66057363:-	0.22	5.03	6.84E-7	Aortic root size	
PRAD	cis	1	rs2003301	chr7:66147656	TPST1	chr7:65670259-65825437:+	-0.15	-3.7	0.000246	Aortic root size	
PRAD	cis	1	rs2004711	chr5:150225068	C5orf62	chr5:150157867-150176297:+	0.3	3.83	0.000145	Crohn's disease	
PRAD	cis	1	rs2004711	chr5:150225068	LOC134466	chr5:150310000-150326146:-	0.56	8.53	2.05E-16	Crohn's disease	
PRAD	cis	1	rs200505	chr13:30900868	KATNAL1	chr13:30776768-30881584:-	0.19	4.04	6.28E-5	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs2005199	chr19:52033206	ZNF175	chr19:52074531-52092990:+	-0.33	-4.37	1.53E-5	Carotid intima media thickness	
PRAD	cis	1	rs2005199	chr19:52033206	ZNF766	chr19:52772824-52795977:+	-0.36	-3.52	0.000467	Carotid intima media thickness	
PRAD	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.58	-11.71	5.51E-28	Forced vital capacity	
PRAD	cis	1	rs2007981	chr19:18567555	SSBP4	chr19:18530221-18545371:+	-0.17	-5.64	2.93E-8	Breast cancer	
PRAD	cis	1	rs2010648	chr14:35604892	PPP2R3C	chr14:35554679-35591679:-	0.39	6.17	1.47E-9	Atopic dermatitis	
PRAD	cis	1	rs2011064	chr15:50957625	SPPL2A	chr15:50999739-51057910:-	0.26	5.38	1.17E-7	QT interval	
PRAD	cis	1	rs2011331	chr1:152286002	FLG	chr1:152274651-152297679:-	0.34	5.47	7.3E-8	Atopic dermatitis	
PRAD	cis	1	rs2013288	chr17:61785904	DDX42	chr17:61851567-61896676:+	-0.26	-5.35	1.41E-7	Body mass index	
PRAD	cis	1	rs2013288	chr17:61785904	FTSJ3	chr17:61896795-61905031:-	0.34	6.73	4.88E-11	Body mass index	
PRAD	cis	1	rs2013288	chr17:61785904	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.2	3.24E-5	Body mass index	
PRAD	cis	1	rs2013815	chr6:167373812	RNASET2	chr6:167343008-167412795:-	0.24	5.92	6.28E-9	Crohn's disease	
PRAD	cis	1	rs2014252	chr2:27462405	C2orf28	chr2:27434899-27440044:+	0.27	7.25	1.69E-12	Blood metabolite levels	
PRAD	cis	1	rs2014252	chr2:27462405	KHK	chr2:27309611-27323619:+	0.21	4.55	6.85E-6	Blood metabolite levels	
PRAD	cis	1	rs2014279	chr3:150487945	SIAH2	chr3:150458911-150481263:-	0.41	4.25	2.6E-5	Breast cancer	
PRAD	cis	1	rs2015336	chr17:18073610	LOC220594	chr17:18414577-18445234:-	-0.27	-3.75	0.000197	Obesity-related traits	
PRAD	cis	1	rs2015336	chr17:18073610	MYO15A	chr17:18012020-18083115:+	0.23	4.3	2.11E-5	Obesity-related traits	
PRAD	cis	1	rs2015454	chr2:111872148	ACOXL	chr2:111490150-111875799:+	0.21	3.6	0.000349	Chronic lymphocytic leukemia	
PRAD	cis	1	rs2015454	chr2:111872148	BCL2L11	chr2:111878491-111926022:+	-0.17	-3.73	0.000216	Chronic lymphocytic leukemia	
PRAD	cis	1	rs2016072	chr2:118742157	INSIG2	chr2:118846050-118867596:+	0.37	4.52	7.88E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs2016366	chr1:2513678	MMEL1	chr1:2522081-2564481:-	-0.42	-8.25	1.65E-15	Ulcerative colitis	
PRAD	cis	1	rs2017760	chr1:207455421	CD55	chr1:207494817-207534309:+	0.22	3.85	0.000135	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2017962	chr19:22208751	ZNF208	chr19:22115760-22193745:-	0.28	5.55	4.72E-8	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2017962	chr19:22208751	ZNF257	chr19:22235266-22273901:+	0.47	7.69	8.46E-14	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2018002	chr20:31351623	MAPRE1	chr20:31407699-31438210:+	0.17	4.08	5.32E-5	Ulcerative colitis	
PRAD	cis	1	rs2018519	chr19:35559787	LOC643719	chr19:35067639-35068596:-	0.18	3.48	0.000546	Serum albumin level	
PRAD	cis	1	rs2019097	chr2:202193463	CFLAR	chr2:201980816-202029001:+	-0.16	-3.81	0.000155	Rheumatoid arthritis	
PRAD	cis	1	rs2019097	chr2:202193463	NIF3L1	chr2:201754050-201768655:+	-0.3	-4.62	5.0E-6	Rheumatoid arthritis	
PRAD	cis	1	rs2019097	chr2:202193463	PPIL3	chr2:201735680-201753999:-	-0.71	-10.36	8.37E-23	Rheumatoid arthritis	
PRAD	cis	1	rs201983168	chr1:150314981	C1orf54	chr1:150244773-150253325:+	-0.16	-4.18	3.43E-5	Eye morphology	
PRAD	cis	1	rs201983168	chr1:150314981	MRPS21	chr1:150266269-150280818:+	0.17	3.54	0.000434	Eye morphology	
PRAD	cis	1	rs2020010	chr1:202510881	PPP1R12B	chr1:202317836-202557697:+	0.09	3.83	0.000145	Sex ratio	
PRAD	cis	1	rs202082	chr13:30881026	KATNAL1	chr13:30776768-30881584:-	0.19	3.81	0.00016	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs202083	chr13:30881316	KATNAL1	chr13:30776768-30881584:-	0.19	3.81	0.00016	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs202098	chr13:30896774	KATNAL1	chr13:30776768-30881584:-	0.19	4.13	4.29E-5	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs202099	chr13:30896874	KATNAL1	chr13:30776768-30881584:-	0.19	4.13	4.29E-5	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs202101	chr13:30897337	KATNAL1	chr13:30776768-30881584:-	0.19	4.01	6.99E-5	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs2023669	chr16:23905013	PRKCB	chr16:23847300-24231930:+	0.16	6.06	2.86E-9	Rheumatoid arthritis	
PRAD	cis	1	rs2023786	chr7:23915153	C7orf46	chr7:23719749-23742268:+	0.22	5.7	2.16E-8	Schizophrenia	
PRAD	cis	1	rs2023787	chr7:23915140	C7orf46	chr7:23719749-23742268:+	0.22	5.74	1.72E-8	Schizophrenia	
PRAD	cis	1	rs2024959	chr20:47695391	CSE1L	chr20:47662838-47713484:+	0.2	4.87	1.53E-6	Anger	
PRAD	cis	1	rs2027003	chr20:25350498	ENTPD6	chr20:25176339-25207360:+	0.16	4.33	1.79E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2027003	chr20:25350498	FAM182B	chr20:25744102-25848786:-	-0.37	-6.75	4.4E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2027003	chr20:25350498	PYGB	chr20:25228706-25278647:+	0.33	7.2	2.36E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2027004	chr20:25350618	ENTPD6	chr20:25176339-25207360:+	0.16	4.33	1.79E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2027004	chr20:25350618	FAM182B	chr20:25744102-25848786:-	-0.37	-6.75	4.4E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2027004	chr20:25350618	PYGB	chr20:25228706-25278647:+	0.33	7.2	2.36E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2028062	chr11:61745953	BEST1	chr11:61717356-61731939:+	-0.15	-3.52	0.000467	Phospholipid levels (plasma)	
PRAD	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.88	-18.79	3.83E-59	Type 2 diabetes	
PRAD	cis	1	rs2028299	chr15:90374257	C15orf38	chr15:90443832-90456222:-	0.2	3.87	0.000126	Type 2 diabetes	
PRAD	cis	1	rs2028299	chr15:90374257	GABARAPL3	chr15:90889765-90892679:-	0.22	3.44	0.000626	Type 2 diabetes	
PRAD	cis	1	rs2028669	chr1:202517364	PPP1R12B	chr1:202317836-202557697:+	0.09	3.75	0.000202	Sex ratio	
PRAD	cis	1	rs2030838	chr15:84583810	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2030839	chr15:84583959	NMB	chr15:85198362-85201802:-	-0.18	-4.22	2.89E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2030840	chr15:84584134	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2030973	chr1:202307863	PPP1R12B	chr1:202317836-202557697:+	0.09	3.53	0.000462	Sex ratio	
PRAD	cis	1	rs2031061	chr19:15721961	CYP4F8	chr19:15726029-15740445:+	0.39	4.2	3.16E-5	Inflammatory biomarkers	
PRAD	cis	1	rs2031062	chr19:15717573	CYP4F8	chr19:15726029-15740445:+	0.41	4.29	2.19E-5	Inflammatory biomarkers	
PRAD	cis	1	rs2031365	chr6:87805592	C6orf165	chr6:88117721-88205858:+	0.26	4.76	2.54E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
PRAD	cis	1	rs2031366	chr6:87805890	C6orf165	chr6:88117721-88205858:+	0.26	4.76	2.54E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
PRAD	cis	1	rs2031367	chr6:87807180	C6orf165	chr6:88117721-88205858:+	0.27	4.84	1.77E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
PRAD	cis	1	rs2031494	chr1:92965969	EVI5	chr1:92974255-93257961:-	-0.31	-6.32	6.15E-10	Cholesterol, total	
PRAD	cis	1	rs2032843	chr17:46847524	SNF8	chr17:47007461-47022154:-	-0.14	-4.16	3.79E-5	Schizophrenia or bipolar disorder	
PRAD	cis	1	rs2032844	chr17:46847364	SNF8	chr17:47007461-47022154:-	-0.14	-4.26	2.5E-5	Schizophrenia or bipolar disorder	
PRAD	cis	1	rs2034899	chr5:78316188	BHMT2	chr5:78365583-78385273:+	0.1	3.73	0.000214	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs2034900	chr5:78315964	BHMT2	chr5:78365583-78385273:+	-0.09	-3.61	0.000341	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs2036264	chr7:65799904	TPST1	chr7:65670259-65825437:+	-0.18	-4.47	9.75E-6	Aortic root size	
PRAD	cis	1	rs2037965	chr3:128025044	RUVBL1	chr3:127783627-127872757:-	-0.22	-3.95	8.9E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2038227	chr16:539140	AXIN1	chr16:337440-402464:-	-0.13	-3.43	0.000657	Venous thromboembolism (SNP x SNP interaction)	
PRAD	cis	1	rs2038227	chr16:539140	DECR2	chr16:451858-462486:+	-0.21	-4.8	2.17E-6	Venous thromboembolism (SNP x SNP interaction)	
PRAD	cis	1	rs2038227	chr16:539140	WFIKKN1	chr16:679239-684116:+	-0.25	-4.95	1.05E-6	Venous thromboembolism (SNP x SNP interaction)	
PRAD	cis	1	rs2041837	chr2:37468564	CEBPZ	chr2:37428778-37458740:-	-0.2	-4.48	9.23E-6	Chronic lymphocytic leukemia	
PRAD	cis	1	rs2041840	chr2:37467264	CEBPZ	chr2:37428778-37458740:-	-0.2	-4.42	1.24E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs2042133	chr7:65931922	TPST1	chr7:65670259-65825437:+	0.18	4.44	1.11E-5	Aortic root size	
PRAD	cis	1	rs2045241	chr11:114428783	FAM55A	chr11:114392438-114430580:-	-0.19	-3.87	0.000124	Ulcerative colitis	
PRAD	cis	1	rs2045554	chr3:48494542	ATRIP	chr3:48488141-48507708:+	-0.28	-6.78	3.53E-11	Longevity	
PRAD	cis	1	rs2045554	chr3:48494542	CDC25A	chr3:48198668-48229801:-	-0.19	-3.62	0.000322	Longevity	
PRAD	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.18	5	8.24E-7	Longevity	
PRAD	cis	1	rs2046120	chr15:84567762	FAM103A1	chr15:83654995-83659423:+	-0.17	-3.51	0.000497	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2046120	chr15:84567762	NMB	chr15:85198362-85201802:-	-0.17	-4.03	6.4E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2046323	chr17:65849927	LOC651250	chr17:66097696-66157623:+	-0.24	-4.24	2.67E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs2046768	chr11:46396479	HARBI1	chr11:46624857-46638777:-	0.29	3.99	7.52E-5	Schizophrenia	
PRAD	cis	1	rs2048123	chr12:85513015	LRRIQ1	chr12:85430099-85638880:+	-0.23	-3.92	0.0001	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs2048123	chr12:85513015	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.96	1.01E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs2048123	chr12:85513015	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.47	7.48E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs2050265	chr1:11879699	CLCN6	chr1:11866207-11907674:+	0.23	4.56	6.59E-6	QRS complex (12-leadsum)	
PRAD	cis	1	rs2052187	chr17:65834737	LOC651250	chr17:66097696-66157623:+	-0.25	-4.59	5.79E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs2053367	chr2:26293413	GPR113	chr2:26531041-26569685:-	-0.24	-3.5	0.000505	Gut microbiome composition (summer)	
PRAD	cis	1	rs2055619	chr5:176415964	FGFR4	chr5:176513921-176525124:+	0.17	3.62	0.000322	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs2055682	chr7:66260289	CRCP	chr7:65579805-65619551:+	-0.23	-4.29	2.13E-5	Aortic root size	
PRAD	cis	1	rs2055682	chr7:66260289	LOC493754	chr7:65993446-66057363:-	-0.25	-5.79	1.28E-8	Aortic root size	
PRAD	cis	1	rs2055712	chr15:84581605	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2056486	chr2:73717567	ALMS1P	chr2:73872046-73912692:+	0.49	8.45	3.71E-16	Metabolite levels	
PRAD	cis	1	rs2056486	chr2:73717567	NAT8	chr2:73867850-73869537:-	0.26	3.98	7.89E-5	Metabolite levels	
PRAD	cis	1	rs2056544	chr15:76826003	SCAPER	chr15:76640529-77197744:-	-0.13	-3.84	0.00014	Blood metabolite levels	
PRAD	cis	1	rs2056566	chr2:228713241	CCL20	chr2:228678558-228682280:+	0.28	5	8.19E-7	Blood pressure	
PRAD	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.51	11.53	3.07E-27	Height	
PRAD	cis	1	rs2056603	chr3:134312749	CEP63	chr3:134204575-134293852:+	0.2	3.54	0.000448	Height	
PRAD	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.51	11.62	1.26E-27	Height	
PRAD	cis	1	rs2056604	chr3:134312648	CEP63	chr3:134204575-134293852:+	0.2	3.57	0.000388	Height	
PRAD	cis	1	rs2056938	chr20:44022672	SYS1	chr20:43991701-44004724:+	0.34	6.19	1.34E-9	Psoriasis	
PRAD	cis	1	rs2057831	chr5:137535133	REEP2	chr5:137774776-137782657:+	-0.11	-4.21	3.08E-5	Resting heart rate	
PRAD	cis	1	rs2058059	chr7:72311817	TYW1B	chr7:72023729-72298813:-	-0.41	-5.72	1.9E-8	Subcutaneous adipose tissue	
PRAD	cis	1	rs2058337	chr4:17678649	MED28	chr4:17616273-17629791:+	0.18	4.53	7.59E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2058338	chr4:17678600	MED28	chr4:17616273-17629791:+	-0.16	-3.93	9.81E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2058339	chr4:17678456	MED28	chr4:17616273-17629791:+	0.19	4.67	3.99E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2058805	chr12:109998591	KCTD10	chr12:109886460-109915155:-	-0.33	-10.08	9.25E-22	HDL cholesterol	
PRAD	cis	1	rs2058805	chr12:109998591	MMAB	chr12:109991523-110011358:-	-0.18	-5.39	1.1E-7	HDL cholesterol	
PRAD	cis	1	rs2058805	chr12:109998591	MYO1H	chr12:109826524-109886176:+	-0.24	-5.4	1.08E-7	HDL cholesterol	
PRAD	cis	1	rs2058805	chr12:109998591	UBE3B	chr12:109915439-109974506:+	-0.14	-3.5	0.000506	HDL cholesterol	
PRAD	cis	1	rs2061164	chr11:18329006	GTF2H1	chr11:18343816-18388590:+	0.75	15.67	7.96E-45	Pancreatic cancer	
PRAD	cis	1	rs2061973	chr6:49487125	CENPQ	chr6:49431096-49460820:+	0.21	4.22	2.93E-5	Brain structure	
PRAD	cis	1	rs2061999	chr15:84582740	NMB	chr15:85198362-85201802:-	-0.17	-3.97	8.25E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2062078	chr8:130734461	GSDMC	chr8:130760443-130799134:-	-0.2	-3.94	9.21E-5	Infant length;Height	
PRAD	cis	1	rs2062340	chr2:54480245	C2orf73	chr2:54558071-54588714:+	0.3	3.91	0.000105	Telomere length	
PRAD	cis	1	rs2064088	chr22:39053382	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs2064088	chr22:39053382	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs2066558	chr13:50610595	EBPL	chr13:50234811-50265623:-	-0.18	-3.63	0.000317	Height	
PRAD	cis	1	rs2066575	chr13:50656582	EBPL	chr13:50234811-50265623:-	-0.19	-3.79	0.00017	Height	
PRAD	cis	1	rs2066587	chr13:50685954	EBPL	chr13:50234811-50265623:-	-0.21	-4.17	3.56E-5	Height	
PRAD	cis	1	rs2066854	chr4:155535181	DCHS2	chr4:155155527-155412930:-	0.14	3.47	0.000577	Fibrinogen	
PRAD	cis	1	rs2067615	chr12:107149422	RFX4	chr12:106977033-107156580:+	-0.2	-3.91	0.000106	Heart rate	
PRAD	cis	1	rs2067987	chr2:242027926	MTERFD2	chr2:242034545-242041747:-	0.37	4.09	5.16E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs2067987	chr2:242027926	PASK	chr2:242045515-242088878:-	0.31	3.93	9.63E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.37	-7.56	2.1E-13	Multiple sclerosis	
PRAD	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.54	12.81	2.01E-32	Multiple sclerosis	
PRAD	cis	1	rs2069502	chr12:58144665	XRCC6BP1	chr12:58335445-58351051:+	0.22	4.26	2.44E-5	Multiple sclerosis	
PRAD	cis	1	rs2069940	chr20:33759272	MMP24	chr20:33814539-33864804:+	-0.29	-4.53	7.62E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs2070180	chr3:121351338	IQCB1	chr3:121488610-121553926:-	-0.49	-9.55	6.89E-20	Cognitive performance	
PRAD	cis	1	rs2070488	chr3:38442490	XYLB	chr3:38388251-38456467:+	-0.23	-5.11	4.8E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs2070850	chr11:46741495	ARHGAP1	chr11:46698634-46722120:-	-0.22	-3.53	0.000452	HDL cholesterol	
PRAD	cis	1	rs2070970	chr11:59861983	PATL1	chr11:59404194-59436511:-	-0.11	-3.45	0.000621	Alzheimer's disease (late onset)	
PRAD	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.36	7.48	3.57E-13	Multiple sclerosis	
PRAD	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.55	-13.13	8.81E-34	Multiple sclerosis	
PRAD	cis	1	rs2072052	chr12:58146719	XRCC6BP1	chr12:58335445-58351051:+	-0.23	-4.45	1.08E-5	Multiple sclerosis	
PRAD	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.44	11.64	1.11E-27	Common traits (Other)	
PRAD	cis	1	rs2072435	chr7:75959188	SRCRB4D	chr7:76018647-76039012:-	0.22	4.35	1.69E-5	Multiple sclerosis	
PRAD	cis	1	rs2072435	chr7:75959188	UPK3B	chr7:76139745-76157197:+	-0.28	-5.05	6.35E-7	Multiple sclerosis	
PRAD	cis	1	rs2072478	chr2:102636526	IL1R2	chr2:102608306-102644880:+	-0.24	-3.54	0.000441	Hormone measurements	
PRAD	cis	1	rs2072499	chr1:156169610	SEMA4A	chr1:156119810-156147534:+	0.21	3.55	0.000429	Testicular germ cell tumor	
PRAD	cis	1	rs2072794	chr22:39150543	CBY1	chr22:39052658-39069853:+	0.14	3.91	0.000106	Resting heart rate	
PRAD	cis	1	rs2072794	chr22:39150543	LOC646851	chr22:38974125-39052634:-	0.17	3.94	9.3E-5	Resting heart rate	
PRAD	cis	1	rs2072795	chr22:39064209	CBY1	chr22:39052658-39069853:+	-0.16	-4.6	5.39E-6	Resting heart rate	
PRAD	cis	1	rs2072795	chr22:39064209	LOC646851	chr22:38974125-39052634:-	-0.18	-4.3	2.05E-5	Resting heart rate	
PRAD	cis	1	rs2072796	chr22:39064230	CBY1	chr22:39052658-39069853:+	0.16	4.68	3.84E-6	Resting heart rate	
PRAD	cis	1	rs2072796	chr22:39064230	LOC646851	chr22:38974125-39052634:-	0.18	4.29	2.13E-5	Resting heart rate	
PRAD	cis	1	rs2072798	chr22:39148483	CBY1	chr22:39052658-39069853:+	0.14	4.08	5.29E-5	Resting heart rate	
PRAD	cis	1	rs2072798	chr22:39148483	LOC646851	chr22:38974125-39052634:-	0.18	4.27	2.35E-5	Resting heart rate	
PRAD	cis	1	rs2073294	chr14:66082493	LOC645431	chr14:65877313-65879335:-	-0.39	-3.97	8.47E-5	Ischemic stroke	
PRAD	cis	1	rs2073604	chr22:51008925	CPT1B	chr22:51007291-51017096:-	-0.23	-4.76	2.59E-6	Narcolepsy	
PRAD	cis	1	rs2073604	chr22:51008925	LOC100144603	chr22:51021455-51022353:+	-0.34	-3.81	0.000155	Narcolepsy	
PRAD	cis	1	rs2074018	chr11:2309634	C11orf21	chr11:2317507-2323143:-	0.32	5.6	3.63E-8	Obesity-related traits	
PRAD	cis	1	rs2074038	chr11:44087989	ACCS	chr11:44087475-44105569:+	0.81	13.42	5.54E-35	IgA nephropathy	
PRAD	cis	1	rs2074771	chr2:242350944	SEPT2	chr2:242254723-242293439:+	0.57	8.6	1.23E-16	Chronic lymphocytic leukemia	
PRAD	cis	1	rs2074823	chr2:242051503	PASK	chr2:242045515-242088878:-	0.31	3.72	0.000223	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs2075060	chr17:36925750	PSMB3	chr17:36909002-36920477:+	-0.11	-4.51	8.07E-6	Height	
PRAD	cis	1	rs2075292	chr11:116732512	PCSK7	chr11:117075789-117102811:-	-0.27	-3.53	0.000453	Protein quantitative trait loci	
PRAD	cis	1	rs2075555	chr17:48274291	SGCA	chr17:48243366-48253292:+	0.13	3.75	0.000199	Breast cancer	
PRAD	cis	1	rs2075678	chr20:47701339	CSE1L	chr20:47662838-47713484:+	0.21	4.96	1.0E-6	Anger	
PRAD	cis	1	rs2076028	chr22:39150450	CBY1	chr22:39052658-39069853:+	0.14	3.89	0.000115	Resting heart rate	
PRAD	cis	1	rs2076028	chr22:39150450	LOC646851	chr22:38974125-39052634:-	0.17	4.08	5.22E-5	Resting heart rate	
PRAD	cis	1	rs2076146	chr20:39798418	ZHX3	chr20:39807089-39946242:-	-0.27	-5.91	6.58E-9	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs2076148	chr20:39788855	ZHX3	chr20:39807089-39946242:-	-0.27	-5.95	5.16E-9	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs2077393	chr6:25607365	SCGN	chr6:25652429-25702006:+	0.43	7.31	1.19E-12	Uric acid levels	
PRAD	cis	1	rs2077593	chr7:65892530	TPST1	chr7:65670259-65825437:+	0.18	4.41	1.3E-5	Aortic root size	
PRAD	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.92	-28.22	3.26E-103	Homocysteine levels	
PRAD	cis	1	rs2077808	chr1:45988115	MMACHC	chr1:45965856-45976737:+	-0.24	-5.12	4.48E-7	Homocysteine levels	
PRAD	cis	1	rs2077808	chr1:45988115	MUTYH	chr1:45794915-45806142:-	0.19	5.27	2.05E-7	Homocysteine levels	
PRAD	cis	1	rs2078089	chr19:22209753	ZNF208	chr19:22115760-22193745:-	0.29	5.6	3.66E-8	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2078089	chr19:22209753	ZNF257	chr19:22235266-22273901:+	0.47	7.74	6.05E-14	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs207954	chr15:92657373	LOC100144604	chr15:93111048-93115493:-	-0.18	-4.29	2.13E-5	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs207955	chr15:92657283	LOC100144604	chr15:93111048-93115493:-	-0.18	-4.17	3.66E-5	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs207958	chr15:92656157	LOC100144604	chr15:93111048-93115493:-	-0.16	-3.73	0.000219	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs2080303	chr2:202165206	ALS2CR12	chr2:202153148-202222101:-	-0.32	-5.1	4.86E-7	Basal cell carcinoma	
PRAD	cis	1	rs2080303	chr2:202165206	PPIL3	chr2:201735680-201753999:-	-0.23	-3.85	0.000133	Basal cell carcinoma	
PRAD	cis	1	rs2081015	chr5:153606932	GALNT10	chr5:153570295-153799809:+	0.14	4.15	4.03E-5	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs2081302	chr2:23945355	C2orf84	chr2:24397531-24414566:+	-0.27	-5.09	5.28E-7	Obesity-related traits	
PRAD	cis	1	rs2081302	chr2:23945355	LOC375190	chr2:24299728-24397519:+	0.22	5.79	1.28E-8	Obesity-related traits	
PRAD	cis	1	rs2083729	chr15:45935159	DUOX1	chr15:45422192-45457774:+	-0.1	-3.46	0.000596	Obesity-related traits	
PRAD	cis	1	rs2083729	chr15:45935159	DUOX2	chr15:45384853-45406359:-	-0.15	-3.67	0.00027	Obesity-related traits	
PRAD	cis	1	rs2083729	chr15:45935159	SPATA5L1	chr15:45694519-45713614:+	0.22	3.43	0.000658	Obesity-related traits	
PRAD	cis	1	rs2083731	chr15:75368538	NEIL1	chr15:75639331-75647586:+	0.11	3.43	0.000656	Blood trace element (Zn levels)	
PRAD	cis	1	rs2083731	chr15:75368538	SCAMP5	chr15:75287901-75313836:+	0.39	6.88	1.93E-11	Blood trace element (Zn levels)	
PRAD	cis	1	rs2084220	chr11:18656932	SPTY2D1	chr11:18627949-18656020:-	-0.29	-10.75	3.03E-24	Cholesterol, total	
PRAD	cis	1	rs2084761	chr19:52156057	KLK5	chr19:51446561-51456344:-	-0.27	-3.45	0.000603	Plasma plasminogen levels	
PRAD	cis	1	rs2084761	chr19:52156057	SIGLEC12	chr19:51994613-52005043:-	-0.29	-3.47	0.000563	Plasma plasminogen levels	
PRAD	cis	1	rs2087647	chr7:65593188	TPST1	chr7:65670259-65825437:+	-0.18	-4.48	9.58E-6	Aortic root size	
PRAD	cis	1	rs2089162	chr15:78739763	CHRNA3	chr15:78885397-78913322:-	-0.21	-3.44	0.00064	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2089162	chr15:78739763	CHRNA5	chr15:78857906-78886458:+	-0.2	-3.94	9.48E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2090117	chr4:54300591	FIP1L1	chr4:54243820-54326102:+	0.18	4.01	7.1E-5	DNA methylation (variation)	
PRAD	cis	1	rs2092931	chr6:161077342	LPA	chr6:160952516-161087407:-	-0.15	-3.51	0.000487	Lipoprotein (a) levels	
PRAD	cis	1	rs2092990	chr20:3346338	ITPA	chr20:3190056-3204504:+	-0.3	-7.57	1.95E-13	IFN-related cytopenia	
PRAD	cis	1	rs2093212	chr14:60843322	C14orf39	chr14:60902675-60952764:-	-0.48	-6.01	3.71E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs2093395	chr6:41155026	LOC221442	chr6:41068773-41108567:+	-0.17	-4.56	6.49E-6	Alzheimer's disease (late onset)	
PRAD	cis	1	rs2093395	chr6:41155026	TREM2	chr6:41126246-41130922:-	-0.18	-3.86	0.000127	Alzheimer's disease (late onset)	
PRAD	cis	1	rs2093396	chr6:41155000	LOC221442	chr6:41068773-41108567:+	0.17	4.55	6.71E-6	Alzheimer's disease (late onset)	
PRAD	cis	1	rs2093396	chr6:41155000	TREM2	chr6:41126246-41130922:-	0.18	3.85	0.000133	Alzheimer's disease (late onset)	
PRAD	cis	1	rs2093761	chr1:207786542	CD55	chr1:207494817-207534309:+	-0.22	-3.72	0.000225	Alzheimer's disease (late onset)	
PRAD	cis	1	rs2098297	chr14:75619118	EIF2B2	chr14:75469612-75476292:+	-0.23	-4.67	4.0E-6	Height	
PRAD	cis	1	rs2098297	chr14:75619118	MLH3	chr14:75480467-75518235:-	-0.32	-6.56	1.4E-10	Height	
PRAD	cis	1	rs2099880	chr15:45935074	DUOX1	chr15:45422192-45457774:+	-0.1	-3.46	0.000596	Obesity-related traits	
PRAD	cis	1	rs2099880	chr15:45935074	DUOX2	chr15:45384853-45406359:-	-0.15	-3.67	0.00027	Obesity-related traits	
PRAD	cis	1	rs2099880	chr15:45935074	SPATA5L1	chr15:45694519-45713614:+	0.22	3.43	0.000658	Obesity-related traits	
PRAD	cis	1	rs2104506	chr6:41533579	FOXP4	chr6:41514164-41570121:+	-0.21	-4.07	5.6E-5	Prostate cancer	
PRAD	cis	1	rs2106346	chr9:135784169	C9orf98	chr9:135600965-135754198:-	0.2	3.74	0.000204	Psoriasis	
PRAD	cis	1	rs2106747	chr7:23911499	C7orf46	chr7:23719749-23742268:+	0.22	5.67	2.57E-8	Schizophrenia	
PRAD	cis	1	rs2106748	chr7:23911313	C7orf46	chr7:23719749-23742268:+	0.22	5.69	2.25E-8	Schizophrenia	
PRAD	cis	1	rs2109522	chr4:17658645	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.94	15.89	8.06E-46	Type 2 diabetes	
PRAD	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.98	17.14	1.66E-51	Type 2 diabetes	
PRAD	cis	1	rs2113422	chr2:23939007	C2orf84	chr2:24397531-24414566:+	-0.27	-5.26	2.24E-7	Obesity-related traits	
PRAD	cis	1	rs2113422	chr2:23939007	LOC375190	chr2:24299728-24397519:+	0.24	6.8	3.23E-11	Obesity-related traits	
PRAD	cis	1	rs2113423	chr2:23942287	C2orf84	chr2:24397531-24414566:+	-0.27	-5.26	2.24E-7	Obesity-related traits	
PRAD	cis	1	rs2113423	chr2:23942287	LOC375190	chr2:24299728-24397519:+	0.24	6.8	3.23E-11	Obesity-related traits	
PRAD	cis	1	rs2114646	chr2:170624221	BBS5	chr2:170336006-170363164:+	-0.24	-3.72	0.000223	Obesity-related traits	
PRAD	cis	1	rs2114646	chr2:170624221	KLHL23	chr2:170551001-170606438:+	-0.16	-4.92	1.2E-6	Obesity-related traits	
PRAD	cis	1	rs2115069	chr5:150252365	C5orf62	chr5:150157867-150176297:+	0.29	3.71	0.000235	Crohn's disease	
PRAD	cis	1	rs2115069	chr5:150252365	LOC134466	chr5:150310000-150326146:-	0.6	8.92	1.01E-17	Crohn's disease	
PRAD	cis	1	rs2115671	chr15:50956432	SPPL2A	chr15:50999739-51057910:-	0.23	4.88	1.48E-6	QT interval	
PRAD	cis	1	rs211718	chr1:76106675	ACADM	chr1:76190043-76229353:+	0.18	3.9	0.000112	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs2117217	chr8:120664291	DSCC1	chr8:120846182-120868170:-	-0.4	-5.21	2.77E-7	Height	
PRAD	cis	1	rs211723	chr1:76103030	ACADM	chr1:76190043-76229353:+	-0.18	-3.8	0.000167	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs2118404	chr2:25377329	POMC	chr2:25383722-25391559:-	0.23	4.88	1.43E-6	Body mass index	
PRAD	cis	1	rs2119289	chr2:164497946	FIGN	chr2:164464118-164592513:-	-0.22	-3.72	0.000226	Folate pathway vitamin levels	
PRAD	cis	1	rs2119992	chr6:153449670	RGS17	chr6:153332041-153452389:-	-0.56	-13.68	4.18E-36	Prostate cancer	
PRAD	cis	1	rs2120019	chr15:75334184	PPCDC	chr15:75315927-75343066:+	0.16	4.09	5.17E-5	Blood trace element (Zn levels)	
PRAD	cis	1	rs2120019	chr15:75334184	SCAMP5	chr15:75287901-75313836:+	0.41	7.39	6.84E-13	Blood trace element (Zn levels)	
PRAD	cis	1	rs2120107	chr15:76869789	ETFA	chr15:76508629-76603810:-	0.17	3.47	0.000564	Blood metabolite levels	
PRAD	cis	1	rs2120107	chr15:76869789	SCAPER	chr15:76640529-77197744:-	-0.13	-3.78	0.000178	Blood metabolite levels	
PRAD	cis	1	rs2121070	chr14:76650764	ESRRB	chr14:76837690-76968178:+	0.25	3.52	0.000472	Blood pressure	
PRAD	cis	1	rs2121071	chr14:76665477	C14orf118	chr14:76618259-76669133:+	0.14	3.53	0.000451	Blood pressure	
PRAD	cis	1	rs2121071	chr14:76665477	ESRRB	chr14:76837690-76968178:+	0.27	3.7	0.000241	Blood pressure	
PRAD	cis	1	rs2121077	chr14:76676355	ESRRB	chr14:76837690-76968178:+	-0.26	-3.43	0.000645	Blood pressure	
PRAD	cis	1	rs2123694	chr2:108857505	SULT1C2	chr2:108905095-108926370:+	0.35	5.23	2.59E-7	Blood pressure	
PRAD	cis	1	rs2126129	chr2:212548	SH3YL1	chr2:218138-264810:-	-0.78	-18.67	1.35E-58	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2127905	chr11:117026374	PCSK7	chr11:117075789-117102811:-	-0.35	-4.58	5.94E-6	Protein quantitative trait loci	
PRAD	cis	1	rs2128792	chr17:65857177	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.8	12.54	2.62E-31	Diastolic blood pressure	
PRAD	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.82	12.91	7.47E-33	Diastolic blood pressure	
PRAD	cis	1	rs2130165	chr15:63314519	RPS27L	chr15:63445540-63449741:-	0.15	3.7	0.000241	Orofacial clefts	
PRAD	cis	1	rs2130392	chr4:185639169	CCDC111	chr4:185570767-185616112:+	0.15	3.59	0.000372	Kawasaki disease	
PRAD	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.49	-14.39	3.58E-39	Kawasaki disease	
PRAD	cis	1	rs2131877	chr3:194858374	C3orf21	chr3:194789015-194991895:-	-0.27	-4.28	2.32E-5	Non-small cell lung cancer	
PRAD	cis	1	rs2132238	chr3:184724335	VPS8	chr3:184529931-184770402:+	-0.33	-4.17	3.68E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs2133134	chr1:76179587	ACADM	chr1:76190043-76229353:+	0.19	4.05	6.01E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs2134688	chr1:150816886	CTSK	chr1:150768687-150780812:-	0.21	4.95	1.05E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs2135481	chr2:228706657	CCL20	chr2:228678558-228682280:+	0.27	4.79	2.22E-6	Blood pressure	
PRAD	cis	1	rs2135880	chr15:84589613	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs213742	chr1:41621127	RLF	chr1:40627041-40706592:+	0.12	3.52	0.000471	Height	
PRAD	cis	1	rs2137435	chr1:202499321	PPP1R12B	chr1:202317836-202557697:+	0.09	3.69	0.000254	Sex ratio	
PRAD	cis	1	rs213754	chr1:41598848	RLF	chr1:40627041-40706592:+	0.13	3.57	0.000396	Height	
PRAD	cis	1	rs2139424	chr11:20684040	NELL1	chr11:20691117-21597227:+	0.25	4.09	5.01E-5	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs2140195	chr2:73702344	ALMS1P	chr2:73872046-73912692:+	0.49	8.44	3.89E-16	Metabolite levels	
PRAD	cis	1	rs2140195	chr2:73702344	NAT8	chr2:73867850-73869537:-	0.26	4.01	6.95E-5	Metabolite levels	
PRAD	cis	1	rs2140270	chr3:49439440	AMIGO3	chr3:49754268-49757238:-	0.43	8.79	2.93E-17	Menarche (age at onset)	
PRAD	cis	1	rs2140270	chr3:49439440	CCDC36	chr3:49235861-49295537:+	-0.23	-4.18	3.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs2140270	chr3:49439440	GMPPB	chr3:49758932-49761384:-	0.48	11.64	1.05E-27	Menarche (age at onset)	
PRAD	cis	1	rs2140270	chr3:49439440	NCKIPSD	chr3:48711280-48723334:-	-0.31	-6.09	2.34E-9	Menarche (age at onset)	
PRAD	cis	1	rs2140270	chr3:49439440	P4HTM	chr3:49027341-49044579:+	-0.16	-3.67	0.000275	Menarche (age at onset)	
PRAD	cis	1	rs2140270	chr3:49439440	WDR6	chr3:49044637-49053386:+	0.19	3.83	0.000146	Menarche (age at onset)	
PRAD	cis	1	rs2140337	chr4:8502112	C4orf23	chr4:8440604-8495258:+	-0.31	-5	7.94E-7	Response to antineoplastic agents	
PRAD	cis	1	rs2141924	chr7:66186246	CCT6P1	chr7:65216092-65228661:+	0.32	5.48	7.06E-8	Gout	
PRAD	cis	1	rs2141924	chr7:66186246	CRCP	chr7:65579805-65619551:+	-0.33	-4.04	6.24E-5	Gout	
PRAD	cis	1	rs2143346	chr6:26198449	HIST1H2AE	chr6:26217148-26217711:+	0.26	3.85	0.000133	Renal underexcretion gout;Gout	
PRAD	cis	1	rs2143346	chr6:26198449	HIST1H3E	chr6:26224427-26226589:+	-0.35	-5.51	5.94E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs2143347	chr6:26198494	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.87	0.000125	Renal underexcretion gout;Gout	
PRAD	cis	1	rs2143347	chr6:26198494	HIST1H3E	chr6:26224427-26226589:+	0.34	5.46	7.62E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs2143950	chr14:35572357	BRMS1L	chr14:36295597-36341168:+	0.18	3.58	0.000377	Atopic dermatitis	
PRAD	cis	1	rs2143950	chr14:35572357	PPP2R3C	chr14:35554679-35591679:-	0.36	5.71	2.01E-8	Atopic dermatitis	
PRAD	cis	1	rs2144114	chr14:61064210	C14orf39	chr14:60902675-60952764:-	0.55	6.26	8.56E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs2144726	chr6:161076247	LPA	chr6:160952516-161087407:-	-0.15	-3.49	0.000533	Lipoprotein (a) levels	
PRAD	cis	1	rs2147712	chr14:50091684	PPIL5	chr14:50065415-50081389:+	-0.23	-4.01	7.02E-5	Carotid intima media thickness	
PRAD	cis	1	rs2147712	chr14:50091684	RPL36AL	chr14:50085407-50087349:-	0.45	13.21	4.39E-34	Carotid intima media thickness	
PRAD	cis	1	rs2149085	chr6:167371110	RNASET2	chr6:167343008-167412795:-	0.24	5.89	7.54E-9	Crohn's disease	
PRAD	cis	1	rs2149090	chr6:167372764	RNASET2	chr6:167343008-167412795:-	0.24	5.88	7.85E-9	Crohn's disease	
PRAD	cis	1	rs2149091	chr6:167372786	RNASET2	chr6:167343008-167412795:-	0.24	5.88	7.85E-9	Crohn's disease	
PRAD	cis	1	rs2149423	chr13:36772381	SOHLH2	chr13:36742347-36871992:-	0.21	3.72	0.000221	Glucose homeostasis traits	
PRAD	cis	1	rs2152375	chr14:65915778	LOC645431	chr14:65877313-65879335:-	-0.45	-4.37	1.52E-5	Ischemic stroke	
PRAD	cis	1	rs2152916	chr10:97392265	ENTPD1	chr10:97471536-97637022:+	0.13	3.91	0.000107	Blood metabolite levels	
PRAD	cis	1	rs2152916	chr10:97392265	TCTN3	chr10:97423154-97453900:-	0.22	4.22	2.91E-5	Blood metabolite levels	
PRAD	cis	1	rs2153657	chr6:24321397	GPLD1	chr6:24428405-24489850:-	-0.2	-3.88	0.000121	Uric acid levels	
PRAD	cis	1	rs2153837	chr9:115463001	C9orf80	chr9:115448793-115480387:-	-0.34	-4.94	1.1E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2153904	chr1:205642790	RAB7L1	chr1:205737115-205744610:-	-0.2	-3.91	0.000106	Prostate-specific antigen levels	
PRAD	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.47	-12.2	6.07E-30	Eye color traits	
PRAD	cis	1	rs2155098	chr11:94322052	MRE11A	chr11:94150469-94227040:-	-0.14	-3.98	7.89E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
PRAD	cis	1	rs2155583	chr11:116915217	PCSK7	chr11:117075789-117102811:-	-0.26	-3.57	0.000399	Protein quantitative trait loci	
PRAD	cis	1	rs2158100	chr17:18811479	FAM18B	chr17:18684582-18710026:+	0.26	5.26	2.2E-7	Pancreatic cancer	
PRAD	cis	1	rs2158428	chr5:130751481	P4HA2	chr5:131528306-131563556:-	-0.22	-3.93	9.72E-5	Life satisfaction	
PRAD	cis	1	rs2159400	chr3:47375890	C3orf75	chr3:47537131-47555199:-	0.16	4.85	1.67E-6	Colorectal cancer	
PRAD	cis	1	rs2159400	chr3:47375890	NBEAL2	chr3:47021173-47051193:+	0.15	4.86	1.59E-6	Colorectal cancer	
PRAD	cis	1	rs2159583	chr4:17658838	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2159584	chr4:17620568	MED28	chr4:17616273-17629791:+	0.23	5.68	2.3E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2160392	chr2:37527393	CEBPZ	chr2:37428778-37458740:-	-0.18	-4.06	5.69E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs2160393	chr2:37516950	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.98	8.1E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs2160395	chr2:37479862	CEBPZ	chr2:37428778-37458740:-	-0.19	-4.17	3.56E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs2160869	chr3:10079255	C3orf10	chr3:10157333-10168873:+	-0.2	-3.86	0.000128	Alzheimer's disease	
PRAD	cis	1	rs2160869	chr3:10079255	LOC401052	chr3:10048102-10052779:-	-0.29	-5.3	1.8E-7	Alzheimer's disease	
PRAD	cis	1	rs2160908	chr22:37586792	C1QTNF6	chr22:37576206-37594341:-	-0.28	-6.83	2.62E-11	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2163167	chr3:53131772	ITIH4	chr3:52847007-52866554:-	0.16	4.71	3.31E-6	Height	
PRAD	cis	1	rs2163272	chr4:39114410	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	cis	1	rs2163273	chr4:39114455	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	cis	1	rs216345	chr9:33799370	NUDT2	chr9:34329504-34343695:+	-0.28	-5.71	2.04E-8	Bipolar disorder	
PRAD	cis	1	rs2165237	chr2:198875003	PLCL1	chr2:198669426-199014606:+	0.15	4.02	6.91E-5	Ulcerative colitis	
PRAD	cis	1	rs2165525	chr11:59906792	PATL1	chr11:59404194-59436511:-	-0.11	-3.44	0.000642	Alzheimer's disease (late onset)	
PRAD	cis	1	rs2166580	chr4:1743169	FAM53A	chr4:1641609-1685854:-	-0.44	-7.92	1.72E-14	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.49	-11.52	3.15E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs2167269	chr7:37941929	EPDR1	chr7:37960163-37991539:+	-0.22	-3.59	0.000364	Bone mineral density	
PRAD	cis	1	rs2168154	chr3:190987963	UTS2D	chr3:190984945-191048325:-	-0.25	-5.13	4.17E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2168344	chr21:43621496	CBS	chr21:44473301-44496472:-	0.23	3.46	0.000596	Eating disorder in bipolar disorder	
PRAD	cis	1	rs2169748	chr2:28957753	PPP1CB	chr2:28974612-29025805:+	-0.26	-5.35	1.39E-7	Body mass index	
PRAD	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.41	8.22	2.0E-15	Body mass index	
PRAD	cis	1	rs2169751	chr2:28966758	PPP1CB	chr2:28974612-29025805:+	0.28	5.83	1.03E-8	Body mass index	
PRAD	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.41	-8.45	3.68E-16	Body mass index	
PRAD	cis	1	rs2170935	chr4:85718948	C4orf12	chr4:85887971-85928168:+	0.16	3.95	8.89E-5	Oropharynx cancer	
PRAD	cis	1	rs2171667	chr11:46467092	HARBI1	chr11:46624857-46638777:-	0.26	3.51	0.000489	Schizophrenia	
PRAD	cis	1	rs2172252	chr3:49678307	GMPPB	chr3:49758932-49761384:-	-0.21	-4.47	9.95E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs217263	chr5:137480666	REEP2	chr5:137774776-137782657:+	-0.1	-3.69	0.000254	Resting heart rate	
PRAD	cis	1	rs217274	chr5:137490974	REEP2	chr5:137774776-137782657:+	-0.09	-3.67	0.000273	Resting heart rate	
PRAD	cis	1	rs2174304	chr4:147507463	ZNF827	chr4:146681892-146859607:-	-0.16	-3.53	0.000451	Heart rate	
PRAD	cis	1	rs2174608	chr15:50871993	SPPL2A	chr15:50999739-51057910:-	0.28	5.83	1.02E-8	QT interval	
PRAD	cis	1	rs2175366	chr19:22128279	ZNF208	chr19:22115760-22193745:-	0.29	5.68	2.35E-8	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2175366	chr19:22128279	ZNF257	chr19:22235266-22273901:+	0.48	7.9	2.0E-14	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2175416	chr2:160904021	LY75	chr2:160625141-160761262:-	0.12	3.98	8.09E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs2175416	chr2:160904021	PLA2R1	chr2:160798012-160919121:-	0.23	5.33	1.57E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs2177129	chr4:56365414	TMEM165	chr4:56262090-56292342:+	-0.17	-3.81	0.000155	Personality dimensions	
PRAD	cis	1	rs2177268	chr3:49439725	AMIGO3	chr3:49754268-49757238:-	0.43	8.79	2.93E-17	Menarche (age at onset)	
PRAD	cis	1	rs2177268	chr3:49439725	CCDC36	chr3:49235861-49295537:+	-0.23	-4.18	3.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs2177268	chr3:49439725	GMPPB	chr3:49758932-49761384:-	0.48	11.64	1.05E-27	Menarche (age at onset)	
PRAD	cis	1	rs2177268	chr3:49439725	NCKIPSD	chr3:48711280-48723334:-	-0.31	-6.09	2.34E-9	Menarche (age at onset)	
PRAD	cis	1	rs2177268	chr3:49439725	P4HTM	chr3:49027341-49044579:+	-0.16	-3.67	0.000275	Menarche (age at onset)	
PRAD	cis	1	rs2177268	chr3:49439725	WDR6	chr3:49044637-49053386:+	0.19	3.83	0.000146	Menarche (age at onset)	
PRAD	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.69	6.89E-28	Height	
PRAD	cis	1	rs2177703	chr7:65391717	CCT6P1	chr7:65216092-65228661:+	0.3	5.31	1.65E-7	Diabetic kidney disease	
PRAD	cis	1	rs2177703	chr7:65391717	CRCP	chr7:65579805-65619551:+	-0.27	-3.54	0.000439	Diabetic kidney disease	
PRAD	cis	1	rs2177703	chr7:65391717	ZNF117	chr7:64434830-64467121:-	-0.27	-3.43	0.000659	Diabetic kidney disease	
PRAD	cis	1	rs2179142	chr22:39037954	CBY1	chr22:39052658-39069853:+	0.15	4.13	4.38E-5	Resting heart rate	
PRAD	cis	1	rs2179142	chr22:39037954	LOC646851	chr22:38974125-39052634:-	0.21	4.88	1.47E-6	Resting heart rate	
PRAD	cis	1	rs2179699	chr6:159386594	RSPH3	chr6:159398268-159421198:-	0.29	4.58	6.04E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs2181043	chr10:17217803	TRDMT1	chr10:17184983-17243681:-	-0.24	-4.84	1.73E-6	Homocysteine levels	
PRAD	cis	1	rs2181205	chr10:81704156	LOC219347	chr10:81805991-81838949:-	0.38	3.44	0.000641	Rheumatoid arthritis	
PRAD	cis	1	rs2182578	chr9:113664990	PTGR1	chr9:114312003-114362135:-	-0.25	-3.85	0.000135	Corneal structure	
PRAD	cis	1	rs2184000	chr20:25395878	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2184000	chr20:25395878	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2184000	chr20:25395878	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2184476	chr1:207504669	CD55	chr1:207494817-207534309:+	0.25	4.42	1.24E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2184602	chr14:65915672	LOC645431	chr14:65877313-65879335:-	-0.44	-4.48	9.29E-6	Ischemic stroke	
PRAD	cis	1	rs2184877	chr1:40996932	DEM1	chr1:40974433-40982212:+	0.42	5.32	1.63E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2185769	chr9:115462594	C9orf80	chr9:115448793-115480387:-	-0.32	-4.82	1.97E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2192008	chr2:191545147	TMEM194B	chr2:191371620-191399468:-	0.19	3.48	0.000554	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs2192750	chr2:102699100	MFSD9	chr2:103333666-103353337:-	0.16	3.6	0.00035	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs2195510	chr2:198161195	PLCL1	chr2:198669426-199014606:+	-0.11	-3.49	0.000525	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs2198042	chr4:129885499	C4orf33	chr4:130014829-130033842:+	0.43	6.96	1.16E-11	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs2198463	chr2:108875093	SULT1C2	chr2:108905095-108926370:+	0.36	5.47	7.29E-8	Blood pressure	
PRAD	cis	1	rs2200578	chr2:99876244	MRPL30	chr2:99758185-99939196:+	0.22	3.51	0.0005	IgG glycosylation	
PRAD	cis	1	rs2200578	chr2:99876244	TSGA10	chr2:99613725-99771187:-	0.31	4.59	5.63E-6	IgG glycosylation	
PRAD	cis	1	rs2201867	chr11:5558273	UBQLNL	chr11:5535624-5537956:-	-0.17	-3.54	0.00044	QRS duration in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2205802	chr22:39046327	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs2205802	chr22:39046327	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs2208331	chr6:26507319	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.21E-10	Educational attainment	
PRAD	cis	1	rs2208331	chr6:26507319	ZNF184	chr6:27418522-27440897:-	-0.18	-3.72	0.000225	Educational attainment	
PRAD	cis	1	rs2210913	chr1:157668993	FCRL3	chr1:157646278-157670775:-	0.18	4.9	1.31E-6	Type 1 diabetes autoantibodies	
PRAD	cis	1	rs2212361	chr11:94312323	MRE11A	chr11:94150469-94227040:-	-0.14	-4.05	5.89E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
PRAD	cis	1	rs2215450	chr4:17675394	MED28	chr4:17616273-17629791:+	0.2	5.04	6.75E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2216464	chr6:46662577	TDRD6	chr6:46655866-46670149:+	0.29	5.08	5.34E-7	Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs2217266	chr5:150272621	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs2217332	chr16:56969148	SLC12A3	chr16:56899119-56949760:+	0.27	3.75	0.000198	Metabolic syndrome	
PRAD	cis	1	rs2217678	chr12:73015662	TMEM19	chr12:72079878-72097837:+	0.24	3.46	0.000582	Diastolic blood pressure	
PRAD	cis	1	rs2219078	chr2:108875198	SULT1C2	chr2:108905095-108926370:+	0.33	4.92	1.18E-6	Blood pressure	
PRAD	cis	1	rs2219800	chr15:68208760	IQCH	chr15:67547188-67794139:+	-0.19	-3.62	0.000332	Cognitive performance	
PRAD	cis	1	rs2219800	chr15:68208760	PIAS1	chr15:68346572-68480402:+	-0.14	-4.46	1.0E-5	Cognitive performance	
PRAD	cis	1	rs2220626	chr7:65546062	TPST1	chr7:65670259-65825437:+	-0.19	-4.66	4.2E-6	Aortic root size	
PRAD	cis	1	rs2221559	chr11:48707973	FOLH1	chr11:49168188-49230222:-	0.18	4.06	5.8E-5	HDL cholesterol	
PRAD	cis	1	rs2221720	chr11:34754921	APIP	chr11:34896714-34937939:-	-0.24	-4.9	1.29E-6	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs2224380	chr6:26553943	BTN2A3	chr6:26422317-26431927:+	0.26	6.58	1.29E-10	Educational attainment	
PRAD	cis	1	rs2224380	chr6:26553943	ZNF184	chr6:27418522-27440897:-	-0.17	-3.51	0.000488	Educational attainment	
PRAD	cis	1	rs2224410	chr14:60970531	C14orf39	chr14:60902675-60952764:-	0.42	5.51	5.78E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs2224410	chr14:60970531	DHRS7	chr14:60611502-60636561:-	0.21	3.54	0.000433	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs222451	chr6:52909609	GCM1	chr6:52991762-53013624:-	-0.35	-3.71	0.000231	Staphylococcus aureus nasal carriage (intermittent)	
PRAD	cis	1	rs222453	chr6:52896853	GCM1	chr6:52991762-53013624:-	-0.32	-3.48	0.000551	Staphylococcus aureus nasal carriage (intermittent)	
PRAD	cis	1	rs222458	chr6:52890625	GCM1	chr6:52991762-53013624:-	-0.32	-3.48	0.000551	Staphylococcus aureus nasal carriage (intermittent)	
PRAD	cis	1	rs2224949	chr14:50096560	PPIL5	chr14:50065415-50081389:+	0.24	4.41	1.31E-5	Carotid intima media thickness	
PRAD	cis	1	rs2224949	chr14:50096560	RPL36AL	chr14:50085407-50087349:-	-0.39	-11.32	1.88E-26	Carotid intima media thickness	
PRAD	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.33	-5.82	1.12E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs2229205	chr20:62729431	RGS19	chr20:62704537-62711324:-	0.18	3.44	0.000632	LDL peak particle diameter (total fat intake interaction)	
PRAD	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.44	9.28	6.16E-19	Homocysteine levels	
PRAD	cis	1	rs2229642	chr6:33659472	ITPR3	chr6:33589161-33664346:+	-0.11	-3.88	0.00012	Height	
PRAD	cis	1	rs2230278	chr11:126277216	ST3GAL4	chr11:126225579-126310752:+	-0.24	-4.02	6.65E-5	Coronary heart disease	
PRAD	cis	1	rs2231239	chr1:183602075	NCF2	chr1:183524698-183560046:-	0.25	3.73	0.000217	Systemic lupus erythematosus	
PRAD	cis	1	rs2231240	chr1:183599638	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs2231241	chr1:183596703	NCF2	chr1:183524698-183560046:-	0.28	3.97	8.23E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs2231626	chr20:44002665	SYS1	chr20:43991701-44004724:+	0.35	6.34	5.31E-10	Psoriasis	
PRAD	cis	1	rs2232470	chr6:116575083	FAM26F	chr6:116782556-116784933:+	-0.14	-4.16	3.76E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs2235230	chr22:39124467	CBY1	chr22:39052658-39069853:+	-0.15	-4.27	2.42E-5	Resting heart rate	
PRAD	cis	1	rs2235230	chr22:39124467	LOC646851	chr22:38974125-39052634:-	-0.18	-4.06	5.76E-5	Resting heart rate	
PRAD	cis	1	rs2236087	chr20:3255905	ITPA	chr20:3190056-3204504:+	-0.32	-7.87	2.51E-14	IFN-related cytopenia	
PRAD	cis	1	rs2236089	chr20:3257194	ITPA	chr20:3190056-3204504:+	-0.3	-7.62	1.44E-13	IFN-related cytopenia	
PRAD	cis	1	rs2236092	chr20:3258188	ITPA	chr20:3190056-3204504:+	-0.3	-7.56	2.19E-13	IFN-related cytopenia	
PRAD	cis	1	rs2236098	chr20:3267133	ITPA	chr20:3190056-3204504:+	-0.3	-7.63	1.34E-13	IFN-related cytopenia	
PRAD	cis	1	rs2236104	chr20:3277602	ITPA	chr20:3190056-3204504:+	-0.31	-7.88	2.25E-14	IFN-related cytopenia	
PRAD	cis	1	rs2236106	chr20:3278410	ITPA	chr20:3190056-3204504:+	-0.3	-7.75	5.89E-14	IFN-related cytopenia	
PRAD	cis	1	rs2236107	chr20:3285821	ITPA	chr20:3190056-3204504:+	-0.33	-8.09	5.03E-15	IFN-related cytopenia	
PRAD	cis	1	rs2236108	chr20:3286331	ITPA	chr20:3190056-3204504:+	-0.3	-7.75	5.89E-14	IFN-related cytopenia	
PRAD	cis	1	rs2236117	chr20:3302021	ITPA	chr20:3190056-3204504:+	-0.3	-7.75	5.89E-14	IFN-related cytopenia	
PRAD	cis	1	rs2236118	chr20:3302058	ITPA	chr20:3190056-3204504:+	-0.3	-7.77	5.01E-14	IFN-related cytopenia	
PRAD	cis	1	rs2236122	chr20:3305240	ITPA	chr20:3190056-3204504:+	-0.31	-7.9	2.01E-14	IFN-related cytopenia	
PRAD	cis	1	rs2236123	chr20:3305305	ITPA	chr20:3190056-3204504:+	0.31	7.97	1.25E-14	IFN-related cytopenia	
PRAD	cis	1	rs2236352	chr14:24610733	FAM158A	chr14:24608175-24610797:-	-0.62	-20.45	5.79E-67	IgG glycosylation	
PRAD	cis	1	rs2236352	chr14:24610733	RNF31	chr14:24616096-24635772:+	0.21	4.27	2.32E-5	IgG glycosylation	
PRAD	cis	1	rs2236402	chr14:90734378	C14orf102	chr14:90744398-90798279:-	0.2	3.49	0.000528	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs2236786	chr4:1719294	FAM53A	chr4:1641609-1685854:-	0.45	7.45	4.49E-13	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.41	10.9	8.3E-25	Common traits (Other)	
PRAD	cis	1	rs2239815	chr22:29192670	ZNRF3	chr22:29279890-29453475:+	0.14	3.47	0.000573	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
PRAD	cis	1	rs2240539	chr2:242035544	PASK	chr2:242045515-242088878:-	0.3	3.53	0.000451	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs2240541	chr2:242065624	PASK	chr2:242045515-242088878:-	0.27	3.63	0.000312	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs2240705	chr10:118467334	C10orf82	chr10:118423208-118429775:-	-0.15	-3.59	0.000366	Age at smoking initiation in chronic obstructive pulmonary disease	
PRAD	cis	1	rs2240706	chr10:118466297	C10orf82	chr10:118423208-118429775:-	-0.15	-3.57	0.00039	Age at smoking initiation in chronic obstructive pulmonary disease	
PRAD	cis	1	rs2241106	chr1:156218910	BGLAP	chr1:156182784-156213112:+	0.21	5.29	1.89E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2241107	chr1:156182710	SEMA4A	chr1:156119810-156147534:+	-0.23	-3.96	8.54E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2241108	chr1:156181007	SEMA4A	chr1:156119810-156147534:+	0.22	3.78	0.00018	Testicular germ cell tumor	
PRAD	cis	1	rs2241435	chr2:86360916	LOC90784	chr2:86247339-86250991:-	-0.48	-4.59	5.83E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs2241706	chr19:41912807	ATP5SL	chr19:41937224-41945810:-	0.16	3.71	0.00023	Height	
PRAD	cis	1	rs2241710	chr19:41912092	ATP5SL	chr19:41937224-41945810:-	0.16	3.73	0.000219	Height	
PRAD	cis	1	rs2241711	chr19:41911980	ATP5SL	chr19:41937224-41945810:-	0.16	3.73	0.000219	Height	
PRAD	cis	1	rs2242150	chr3:48505964	ATRIP	chr3:48488141-48507708:+	-0.27	-6.41	3.54E-10	Longevity	
PRAD	cis	1	rs2242150	chr3:48505964	CDC25A	chr3:48198668-48229801:-	-0.21	-4.01	7.13E-5	Longevity	
PRAD	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.17	4.78	2.37E-6	Longevity	
PRAD	cis	1	rs2242482	chr13:50655879	EBPL	chr13:50234811-50265623:-	-0.18	-3.66	0.00028	Height	
PRAD	cis	1	rs224329	chr20:34019579	CEP250	chr20:34042996-34099802:+	0.23	5.22	2.67E-7	Height	
PRAD	cis	1	rs224329	chr20:34019579	CPNE1	chr20:34213968-34262539:-	-0.19	-3.91	0.000106	Height	
PRAD	cis	1	rs224329	chr20:34019579	GDF5	chr20:33897002-34042568:-	0.19	4.57	6.25E-6	Height	
PRAD	cis	1	rs224329	chr20:34019579	MMP24	chr20:33814539-33864804:+	-0.15	-3.84	0.000142	Height	
PRAD	cis	1	rs224329	chr20:34019579	UQCC	chr20:33890383-33999833:-	-0.38	-7.22	2.11E-12	Height	
PRAD	cis	1	rs224333	chr20:34023962	CEP250	chr20:34042996-34099802:+	0.27	5.92	6.25E-9	Height	
PRAD	cis	1	rs224333	chr20:34023962	CPNE1	chr20:34213968-34262539:-	-0.2	-3.96	8.48E-5	Height	
PRAD	cis	1	rs224333	chr20:34023962	GDF5	chr20:33897002-34042568:-	0.19	4.47	9.64E-6	Height	
PRAD	cis	1	rs224333	chr20:34023962	MMP24	chr20:33814539-33864804:+	-0.15	-3.75	0.000197	Height	
PRAD	cis	1	rs224333	chr20:34023962	UQCC	chr20:33890383-33999833:-	-0.36	-6.72	5.33E-11	Height	
PRAD	cis	1	rs2243480	chr7:65599196	CCT6P1	chr7:65216092-65228661:+	0.34	5.75	1.6E-8	Diabetic kidney disease	
PRAD	cis	1	rs2243480	chr7:65599196	CRCP	chr7:65579805-65619551:+	-0.3	-3.63	0.000319	Diabetic kidney disease	
PRAD	cis	1	rs2244508	chr11:77948515	GAB2	chr11:77926343-78128766:-	-0.18	-5.6	3.64E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2244508	chr11:77948515	NARS2	chr11:78147017-78285909:-	-0.2	-4.14	4.09E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2245717	chr20:43995880	SYS1	chr20:43991701-44004724:+	0.35	6.31	6.48E-10	Psoriasis	
PRAD	cis	1	rs2246531	chr6:160838648	SLC22A2	chr6:160592093-160679959:-	-0.21	-3.44	0.000644	Response to hepatitis C treatment	
PRAD	cis	1	rs2246565	chr10:42897648	LOC84856	chr10:42970939-42990784:+	-0.3	-4.49	8.82E-6	Helix rolling	
PRAD	cis	1	rs2246833	chr10:91005854	LIPA	chr10:90973328-91174382:-	0.22	4.61	5.17E-6	Fibrinogen levels	
PRAD	cis	1	rs2246920	chr11:62104937	ASRGL1	chr11:62104774-62160885:+	-0.35	-4.5	8.68E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs2246942	chr10:91004886	LIPA	chr10:90973328-91174382:-	0.23	4.7	3.43E-6	Fibrinogen levels	
PRAD	cis	1	rs2247037	chr20:44031295	SYS1	chr20:43991701-44004724:+	0.37	6.7	6.15E-11	Psoriasis	
PRAD	cis	1	rs2247753	chr22:30022936	SEC14L2	chr22:30792933-30824976:+	-0.25	-3.67	0.000275	Lipid traits	
PRAD	cis	1	rs2248061	chr2:208495059	FAM119A	chr2:208446079-208490065:-	0.24	4.36	1.59E-5	Opioid sensitivity	
PRAD	cis	1	rs2248062	chr2:208495051	FAM119A	chr2:208446079-208490065:-	0.24	4.36	1.59E-5	Opioid sensitivity	
PRAD	cis	1	rs2248393	chr20:33926103	CEP250	chr20:34042996-34099802:+	0.24	5.33	1.56E-7	Height	
PRAD	cis	1	rs2248393	chr20:33926103	CPNE1	chr20:34213968-34262539:-	-0.2	-3.96	8.83E-5	Height	
PRAD	cis	1	rs2248393	chr20:33926103	FAM83C	chr20:33873287-33880225:-	-0.17	-3.8	0.000165	Height	
PRAD	cis	1	rs2248393	chr20:33926103	GDF5	chr20:33897002-34042568:-	0.2	4.85	1.67E-6	Height	
PRAD	cis	1	rs2248393	chr20:33926103	MMP24	chr20:33814539-33864804:+	-0.15	-3.7	0.000243	Height	
PRAD	cis	1	rs2248393	chr20:33926103	UQCC	chr20:33890383-33999833:-	-0.39	-7.32	1.06E-12	Height	
PRAD	cis	1	rs2248407	chr11:77937800	GAB2	chr11:77926343-78128766:-	-0.18	-5.94	5.46E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2248407	chr11:77937800	NARS2	chr11:78147017-78285909:-	-0.26	-5.39	1.12E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2248637	chr20:43997240	SYS1	chr20:43991701-44004724:+	-0.35	-6.31	6.48E-10	Psoriasis	
PRAD	cis	1	rs2248814	chr17:26100321	LGALS9	chr17:25958174-25976585:+	-0.09	-3.77	0.000185	Fractional exhaled nitric oxide (childhood)	
PRAD	cis	1	rs2249296	chr1:86910264	CLCA2	chr1:86889769-86922238:+	-0.29	-5.17	3.54E-7	Crohn's disease-related phenotypes	
PRAD	cis	1	rs2249296	chr1:86910264	CLCA4	chr1:87012759-87046430:+	-0.16	-3.47	0.000566	Crohn's disease-related phenotypes	
PRAD	cis	1	rs2249811	chr1:202531741	PPP1R12B	chr1:202317836-202557697:+	-0.09	-3.91	0.000106	Sex ratio	
PRAD	cis	1	rs2250644	chr10:91008879	LIPA	chr10:90973328-91174382:-	0.21	4.36	1.6E-5	Fibrinogen levels	
PRAD	cis	1	rs2250886	chr11:6529642	FXC1	chr11:6502677-6505910:+	-0.17	-3.68	0.000264	DNA methylation (variation)	
PRAD	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.43	-9.29	5.76E-19	Homocysteine levels	
PRAD	cis	1	rs2251900	chr4:154654145	TLR2	chr4:154605441-154627240:+	-0.12	-3.44	0.000631	Response to statins (LDL cholesterol change)	
PRAD	cis	1	rs2252259	chr20:47662823	CSE1L	chr20:47662838-47713484:+	-0.19	-4.59	5.7E-6	Anger	
PRAD	cis	1	rs2252313	chr1:86908149	CLCA2	chr1:86889769-86922238:+	0.25	4.41	1.29E-5	Crohn's disease-related phenotypes	
PRAD	cis	1	rs2252502	chr7:158738634	WDR60	chr7:158649269-158738882:+	0.2	4.4	1.33E-5	Height	
PRAD	cis	1	rs2252790	chr6:116663323	FAM26F	chr6:116782556-116784933:+	-0.13	-3.89	0.000113	Fast beta electroencephalogram	
PRAD	cis	1	rs2253105	chr20:44011301	SYS1	chr20:43991701-44004724:+	0.35	6.31	6.48E-10	Psoriasis	
PRAD	cis	1	rs2253209	chr3:53115160	ITIH4	chr3:52847007-52866554:-	0.15	4.56	6.64E-6	Height	
PRAD	cis	1	rs2253656	chr3:53119099	ITIH4	chr3:52847007-52866554:-	0.15	4.56	6.62E-6	Height	
PRAD	cis	1	rs2253685	chr3:53119703	ITIH4	chr3:52847007-52866554:-	0.15	4.56	6.62E-6	Height	
PRAD	cis	1	rs2253796	chr3:53120098	ITIH4	chr3:52847007-52866554:-	0.15	4.56	6.62E-6	Height	
PRAD	cis	1	rs2253809	chr1:156172125	SEMA4A	chr1:156119810-156147534:+	0.21	3.68	0.00026	Testicular germ cell tumor	
PRAD	cis	1	rs2254230	chr9:131905177	CRAT	chr9:131857075-131873070:-	-0.23	-4.04	6.13E-5	Blood metabolite ratios	
PRAD	cis	1	rs2255070	chr6:26501777	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.21E-10	Educational attainment	
PRAD	cis	1	rs2255070	chr6:26501777	ZNF184	chr6:27418522-27440897:-	-0.18	-3.72	0.000225	Educational attainment	
PRAD	cis	1	rs2256051	chr11:77920457	GAB2	chr11:77926343-78128766:-	-0.19	-6.01	3.66E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2256051	chr11:77920457	NARS2	chr11:78147017-78285909:-	-0.25	-5.13	4.31E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2256187	chr11:77919768	GAB2	chr11:77926343-78128766:-	-0.2	-5.84	9.57E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2256187	chr11:77919768	NARS2	chr11:78147017-78285909:-	-0.19	-3.56	0.000404	Testicular germ cell tumor	
PRAD	cis	1	rs2256464	chr11:77917305	GAB2	chr11:77926343-78128766:-	-0.18	-5.73	1.81E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2256464	chr11:77917305	NARS2	chr11:78147017-78285909:-	-0.24	-5.06	6.05E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2256686	chr20:44017331	SYS1	chr20:43991701-44004724:+	0.34	6.19	1.34E-9	Psoriasis	
PRAD	cis	1	rs2256920	chr11:6508124	RRP8	chr11:6621154-6624811:-	-0.14	-3.51	0.000488	DNA methylation (variation)	
PRAD	cis	1	rs2257420	chr20:25275890	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.27	2.32E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257420	chr20:25275890	FAM182B	chr20:25744102-25848786:-	0.37	6.72	5.42E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257420	chr20:25275890	PYGB	chr20:25228706-25278647:+	-0.33	-7.21	2.2E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257432	chr20:25271086	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.16	3.8E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257432	chr20:25271086	FAM182B	chr20:25744102-25848786:-	0.37	6.73	5.07E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257432	chr20:25271086	PYGB	chr20:25228706-25278647:+	-0.33	-7.08	5.15E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257496	chr20:25279315	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.17	3.67E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257496	chr20:25279315	FAM182B	chr20:25744102-25848786:-	0.37	6.77	3.78E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257496	chr20:25279315	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257790	chr7:65600450	CCT6P1	chr7:65216092-65228661:+	0.32	5.48	6.79E-8	Diabetic kidney disease	
PRAD	cis	1	rs2257790	chr7:65600450	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000135	Diabetic kidney disease	
PRAD	cis	1	rs2257808	chr20:25266450	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.16	3.81E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257808	chr20:25266450	FAM182B	chr20:25744102-25848786:-	0.37	6.74	4.76E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257808	chr20:25266450	PYGB	chr20:25228706-25278647:+	-0.33	-7.09	5.03E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257809	chr20:25266476	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.16	3.81E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257809	chr20:25266476	FAM182B	chr20:25744102-25848786:-	0.37	6.74	4.76E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257809	chr20:25266476	PYGB	chr20:25228706-25278647:+	-0.33	-7.09	5.03E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257982	chr20:25269630	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.16	3.81E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257982	chr20:25269630	FAM182B	chr20:25744102-25848786:-	0.37	6.74	4.76E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257982	chr20:25269630	PYGB	chr20:25228706-25278647:+	-0.33	-7.09	5.03E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257985	chr20:25269743	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.16	3.81E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257985	chr20:25269743	FAM182B	chr20:25744102-25848786:-	0.37	6.74	4.76E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257985	chr20:25269743	PYGB	chr20:25228706-25278647:+	-0.33	-7.09	5.03E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257988	chr20:25270003	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.16	3.81E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257988	chr20:25270003	FAM182B	chr20:25744102-25848786:-	0.37	6.74	4.76E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257988	chr20:25270003	PYGB	chr20:25228706-25278647:+	-0.33	-7.09	5.03E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257991	chr20:25270339	ENTPD6	chr20:25176339-25207360:+	0.16	4.25	2.54E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257991	chr20:25270339	FAM182B	chr20:25744102-25848786:-	-0.37	-6.79	3.5E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2257991	chr20:25270339	PYGB	chr20:25228706-25278647:+	0.33	7.14	3.64E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258066	chr20:25271326	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.16	3.8E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258066	chr20:25271326	FAM182B	chr20:25744102-25848786:-	0.37	6.73	5.07E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258066	chr20:25271326	PYGB	chr20:25228706-25278647:+	-0.33	-7.08	5.15E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258135	chr20:25272323	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.16	3.8E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258135	chr20:25272323	FAM182B	chr20:25744102-25848786:-	0.37	6.73	5.07E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258135	chr20:25272323	PYGB	chr20:25228706-25278647:+	-0.33	-7.08	5.15E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258201	chr20:25272490	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.15	4.01E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258201	chr20:25272490	FAM182B	chr20:25744102-25848786:-	0.37	6.79	3.37E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258201	chr20:25272490	PYGB	chr20:25228706-25278647:+	-0.33	-7.1	4.79E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258563	chr20:25273435	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.15	3.95E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258563	chr20:25273435	FAM182B	chr20:25744102-25848786:-	0.37	6.79	3.38E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258563	chr20:25273435	PYGB	chr20:25228706-25278647:+	-0.33	-7.1	4.79E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258617	chr20:25274318	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.15	3.95E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258617	chr20:25274318	FAM182B	chr20:25744102-25848786:-	0.37	6.79	3.38E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258617	chr20:25274318	PYGB	chr20:25228706-25278647:+	-0.33	-7.1	4.79E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258719	chr20:25275843	ENTPD6	chr20:25176339-25207360:+	-0.15	-4.08	5.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258719	chr20:25275843	FAM182B	chr20:25744102-25848786:-	0.37	6.82	2.88E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258719	chr20:25275843	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.27E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258769	chr20:25276680	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.17	3.67E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258769	chr20:25276680	FAM182B	chr20:25744102-25848786:-	0.37	6.77	3.78E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258769	chr20:25276680	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258879	chr20:25279213	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.17	3.67E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258879	chr20:25279213	FAM182B	chr20:25744102-25848786:-	0.37	6.77	3.78E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258879	chr20:25279213	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258884	chr20:25279539	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.17	3.67E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258884	chr20:25279539	FAM182B	chr20:25744102-25848786:-	0.37	6.77	3.78E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2258884	chr20:25279539	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259837	chr20:25280205	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.17	3.67E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259837	chr20:25280205	FAM182B	chr20:25744102-25848786:-	0.37	6.77	3.78E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259837	chr20:25280205	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259873	chr20:25280781	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.17	3.67E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259873	chr20:25280781	FAM182B	chr20:25744102-25848786:-	0.37	6.77	3.78E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259873	chr20:25280781	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259926	chr20:25281733	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.17	3.67E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259926	chr20:25281733	FAM182B	chr20:25744102-25848786:-	0.37	6.77	3.78E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259926	chr20:25281733	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259928	chr20:25281834	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.17	3.67E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259928	chr20:25281834	FAM182B	chr20:25744102-25848786:-	0.37	6.77	3.78E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259928	chr20:25281834	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259956	chr20:25282433	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.17	3.67E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259956	chr20:25282433	FAM182B	chr20:25744102-25848786:-	0.37	6.77	3.78E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2259956	chr20:25282433	PYGB	chr20:25228706-25278647:+	-0.32	-7.08	5.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2262623	chr3:99164806	C3orf26	chr3:99536681-99897446:+	0.15	3.43	0.000661	RR interval (heart rate)	
PRAD	cis	1	rs2262909	chr19:22135270	ZNF208	chr19:22115760-22193745:-	0.28	5.68	2.38E-8	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2262909	chr19:22135270	ZNF257	chr19:22235266-22273901:+	0.49	8.13	3.81E-15	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2263759	chr20:44011502	SYS1	chr20:43991701-44004724:+	0.35	6.31	6.33E-10	Psoriasis	
PRAD	cis	1	rs2263764	chr20:44025815	SYS1	chr20:43991701-44004724:+	0.34	6.19	1.34E-9	Psoriasis	
PRAD	cis	1	rs2263768	chr20:44031241	SYS1	chr20:43991701-44004724:+	0.37	6.7	6.15E-11	Psoriasis	
PRAD	cis	1	rs2267393	chr22:39101619	CBY1	chr22:39052658-39069853:+	0.14	4.12	4.4E-5	Resting heart rate	
PRAD	cis	1	rs2267393	chr22:39101619	LOC646851	chr22:38974125-39052634:-	0.19	4.63	4.82E-6	Resting heart rate	
PRAD	cis	1	rs2267394	chr22:39101633	CBY1	chr22:39052658-39069853:+	0.14	4.12	4.4E-5	Resting heart rate	
PRAD	cis	1	rs2267394	chr22:39101633	LOC646851	chr22:38974125-39052634:-	0.19	4.63	4.82E-6	Resting heart rate	
PRAD	cis	1	rs2267395	chr22:39113903	CBY1	chr22:39052658-39069853:+	0.13	3.91	0.000104	Resting heart rate	
PRAD	cis	1	rs2267395	chr22:39113903	LOC646851	chr22:38974125-39052634:-	0.19	4.76	2.63E-6	Resting heart rate	
PRAD	cis	1	rs2268241	chr21:34781050	TMEM50B	chr21:34804793-34852281:-	-0.32	-3.97	8.19E-5	Obesity-related traits	
PRAD	cis	1	rs2268617	chr14:75608728	EIF2B2	chr14:75469612-75476292:+	0.25	5.09	5.25E-7	Height	
PRAD	cis	1	rs2268617	chr14:75608728	MLH3	chr14:75480467-75518235:-	0.33	6.68	6.89E-11	Height	
PRAD	cis	1	rs2268753	chr3:38500189	XYLB	chr3:38388251-38456467:+	0.23	5.13	4.24E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs2268757	chr3:38505853	XYLB	chr3:38388251-38456467:+	0.23	5.15	3.88E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs2268758	chr3:38514049	XYLB	chr3:38388251-38456467:+	0.23	5.13	4.16E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs2268957	chr14:66113233	LOC645431	chr14:65877313-65879335:-	0.41	4.14	4.09E-5	Ischemic stroke	
PRAD	cis	1	rs2268958	chr14:66128238	LOC645431	chr14:65877313-65879335:-	-0.42	-4.05	5.94E-5	Ischemic stroke	
PRAD	cis	1	rs2268960	chr14:66145500	LOC645431	chr14:65877313-65879335:-	-0.41	-4.28	2.26E-5	Ischemic stroke	
PRAD	cis	1	rs2269381	chr22:51020069	CPT1B	chr22:51007291-51017096:-	-0.25	-4.82	1.94E-6	Narcolepsy	
PRAD	cis	1	rs2269381	chr22:51020069	LOC100144603	chr22:51021455-51022353:+	-0.43	-4.4	1.32E-5	Narcolepsy	
PRAD	cis	1	rs2269382	chr22:51018911	CPT1B	chr22:51007291-51017096:-	-0.25	-4.82	1.94E-6	Narcolepsy	
PRAD	cis	1	rs2269382	chr22:51018911	LOC100144603	chr22:51021455-51022353:+	-0.43	-4.4	1.32E-5	Narcolepsy	
PRAD	cis	1	rs2269384	chr22:51011115	CPT1B	chr22:51007291-51017096:-	-0.22	-4.79	2.19E-6	Narcolepsy	
PRAD	cis	1	rs2269384	chr22:51011115	LOC100144603	chr22:51021455-51022353:+	-0.3	-3.49	0.000536	Narcolepsy	
PRAD	cis	1	rs2269385	chr22:51010939	CPT1B	chr22:51007291-51017096:-	-0.22	-4.79	2.19E-6	Narcolepsy	
PRAD	cis	1	rs2269385	chr22:51010939	LOC100144603	chr22:51021455-51022353:+	-0.3	-3.49	0.000536	Narcolepsy	
PRAD	cis	1	rs2269558	chr16:682250	PIGQ	chr16:617032-634108:+	-0.13	-3.9	0.00011	Height	
PRAD	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.49	9.95	2.68E-21	Height	
PRAD	cis	1	rs2270044	chr2:242056924	PASK	chr2:242045515-242088878:-	0.35	4.28	2.3E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs2270291	chr1:156244992	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2270291	chr1:156244992	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2270676	chr11:74168411	P4HA3	chr11:73958550-74022699:-	-0.24	-3.53	0.000459	Corneal astigmatism	
PRAD	cis	1	rs227077	chr11:108253252	ATM	chr11:108093559-108239826:+	-0.18	-5.53	5.28E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs227087	chr11:108244114	ATM	chr11:108093559-108239826:+	-0.18	-5.68	2.39E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs227088	chr11:108243755	ATM	chr11:108093559-108239826:+	-0.19	-5.82	1.11E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs227092	chr11:108236783	ATM	chr11:108093559-108239826:+	-0.19	-5.82	1.11E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs227093	chr11:108233939	ATM	chr11:108093559-108239826:+	-0.19	-6.05	3.02E-9	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs227094	chr11:108233800	ATM	chr11:108093559-108239826:+	-0.18	-5.62	3.2E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs2271554	chr4:54252222	FIP1L1	chr4:54243820-54326102:+	-0.18	-3.93	9.9E-5	DNA methylation (variation)	
PRAD	cis	1	rs2272006	chr3:41997059	ULK4	chr3:41288091-42003660:-	-0.9	-15.09	2.91E-42	Diastolic blood pressure	
PRAD	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.9	-15.09	2.91E-42	Diastolic blood pressure	
PRAD	cis	1	rs2272123	chr3:10140115	C3orf10	chr3:10157333-10168873:+	-0.21	-4.06	5.85E-5	Alzheimer's disease	
PRAD	cis	1	rs2272123	chr3:10140115	LOC401052	chr3:10048102-10052779:-	-0.3	-5.48	6.8E-8	Alzheimer's disease	
PRAD	cis	1	rs2272125	chr3:10138069	C3orf10	chr3:10157333-10168873:+	-0.18	-3.6	0.000356	Alzheimer's disease	
PRAD	cis	1	rs2272125	chr3:10138069	LOC401052	chr3:10048102-10052779:-	-0.28	-5.22	2.65E-7	Alzheimer's disease	
PRAD	cis	1	rs2272390	chr2:202195311	CFLAR	chr2:201980816-202029001:+	-0.19	-3.85	0.000133	Rheumatoid arthritis	
PRAD	cis	1	rs2272390	chr2:202195311	NIF3L1	chr2:201754050-201768655:+	-0.36	-4.73	2.94E-6	Rheumatoid arthritis	
PRAD	cis	1	rs2272390	chr2:202195311	PPIL3	chr2:201735680-201753999:-	-0.76	-9.18	1.33E-18	Rheumatoid arthritis	
PRAD	cis	1	rs2273653	chr20:47770756	CSE1L	chr20:47662838-47713484:+	0.2	4.74	2.82E-6	Anger	
PRAD	cis	1	rs2273669	chr6:109285189	SESN1	chr6:109307647-109415277:-	0.32	4.51	8.23E-6	Prostate cancer	
PRAD	cis	1	rs2273694	chr10:102256496	SEC31B	chr10:102246403-102289636:-	-0.31	-9.22	1.02E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2273695	chr10:102259568	SEC31B	chr10:102246403-102289636:-	-0.29	-9.04	4.2E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2273832	chr1:156233143	BGLAP	chr1:156182784-156213112:+	0.2	5.07	5.75E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2273832	chr1:156233143	CCT3	chr1:156278752-156308195:-	-0.15	-3.55	0.000417	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2273833	chr1:156233189	BGLAP	chr1:156182784-156213112:+	0.2	5.2	2.93E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2273833	chr1:156233189	CCT3	chr1:156278752-156308195:-	-0.15	-3.51	0.000486	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2273905	chr14:102974999	ANKRD9	chr14:102973198-102976128:-	0.18	4.21	3.04E-5	QT interval	
PRAD	cis	1	rs2274459	chr6:33762242	IP6K3	chr6:33689443-33714762:-	0.19	3.7	0.000241	Obesity (extreme)	
PRAD	cis	1	rs2275122	chr1:111726288	DENND2D	chr1:111729801-111747031:-	-0.26	-3.74	0.000206	Liver enzyme levels (gamma-glutamyl transferase)	
PRAD	cis	1	rs2275241	chr9:129370576	LMX1B	chr9:129376748-129463311:+	0.23	3.69	0.000254	Eyebrow thickness	
PRAD	cis	1	rs2275426	chr1:46487552	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.11	1.38E-29	Body mass index	
PRAD	cis	1	rs2275426	chr1:46487552	MMACHC	chr1:45965856-45976737:+	-0.17	-3.73	0.000218	Body mass index	
PRAD	cis	1	rs2275426	chr1:46487552	MUTYH	chr1:45794915-45806142:-	0.21	6.11	2.14E-9	Body mass index	
PRAD	cis	1	rs2276014	chr11:64081445	C11orf20	chr11:64067863-64072238:+	-0.42	-5.89	7.41E-9	Mean platelet volume	
PRAD	cis	1	rs2276498	chr20:52610496	BCAS1	chr20:52560079-52687304:-	-0.2	-3.59	0.000362	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs2276499	chr20:52610443	BCAS1	chr20:52560079-52687304:-	0.2	3.94	9.52E-5	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs2276540	chr3:38512507	XYLB	chr3:38388251-38456467:+	0.23	5.1	4.98E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs2276547	chr2:28975107	PPP1CB	chr2:28974612-29025805:+	0.28	5.79	1.32E-8	Body mass index	
PRAD	cis	1	rs2276547	chr2:28975107	TRMT61B	chr2:29072690-29093175:-	-0.4	-8.09	5.27E-15	Body mass index	
PRAD	cis	1	rs2276654	chr2:97492479	CNNM4	chr2:97426639-97477626:+	0.23	3.49	0.000536	Erectile dysfunction and prostate cancer treatment	
PRAD	cis	1	rs2276834	chr3:52325759	LOC440957	chr3:52570621-52574586:+	-0.14	-4.22	2.92E-5	Electroencephalogram traits	
PRAD	cis	1	rs2276834	chr3:52325759	NEK4	chr3:52744803-52804951:-	-0.18	-5.11	4.76E-7	Electroencephalogram traits	
PRAD	cis	1	rs2276834	chr3:52325759	NT5DC2	chr3:52558386-52569093:-	-0.18	-4.09	5.09E-5	Electroencephalogram traits	
PRAD	cis	1	rs2277717	chr18:44702718	KATNAL2	chr18:44497557-44628613:+	0.24	4.23	2.81E-5	Educational attainment	
PRAD	cis	1	rs2277862	chr20:34152782	CEP250	chr20:34042996-34099802:+	0.32	5.6	3.67E-8	Cholesterol, total	
PRAD	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.72	-12.6	1.46E-31	Cholesterol, total	
PRAD	cis	1	rs2277869	chr12:1016910	RAD52	chr12:1021255-1099219:-	-0.39	-6.37	4.53E-10	Colorectal cancer	
PRAD	cis	1	rs2277870	chr1:156246792	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2277870	chr1:156246792	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2277871	chr1:156246742	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2277871	chr1:156246742	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2278086	chr2:86281905	LOC90784	chr2:86247339-86250991:-	-0.56	-4.81	2.08E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs2278161	chr18:72176083	CNDP2	chr18:72163597-72188356:+	0.46	7.16	3.16E-12	Refractive error	
PRAD	cis	1	rs2278162	chr18:72175814	CNDP2	chr18:72163597-72188356:+	0.46	7.16	3.16E-12	Refractive error	
PRAD	cis	1	rs2278238	chr19:18576484	ELL	chr19:18553475-18632937:-	-0.16	-3.85	0.000132	Breast cancer	
PRAD	cis	1	rs2278238	chr19:18576484	SSBP4	chr19:18530221-18545371:+	-0.18	-5.95	5.33E-9	Breast cancer	
PRAD	cis	1	rs2278843	chr10:102056508	CWF19L1	chr10:101992055-102027437:-	-0.2	-3.96	8.7E-5	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	
PRAD	cis	1	rs2279077	chr3:48474249	ATRIP	chr3:48488141-48507708:+	0.27	6.48	2.38E-10	Longevity	
PRAD	cis	1	rs2279077	chr3:48474249	CDC25A	chr3:48198668-48229801:-	0.22	4	7.39E-5	Longevity	
PRAD	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.19	-5.12	4.36E-7	Longevity	
PRAD	cis	1	rs2279144	chr19:39201781	LGALS7	chr19:39261608-39264157:-	-0.16	-3.65	0.000296	Heart rate	
PRAD	cis	1	rs2279256	chr10:1132852	IDI2	chr10:1064847-1071799:-	0.34	4.45	1.09E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs2279433	chr10:45954807	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs2279465	chr11:46399538	HARBI1	chr11:46624857-46638777:-	0.3	3.97	8.45E-5	Schizophrenia	
PRAD	cis	1	rs2280017	chr16:15151361	RRN3	chr16:15153881-15188158:-	0.19	4.57	6.22E-6	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid);Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
PRAD	cis	1	rs2280018	chr16:15150833	RRN3	chr16:15153881-15188158:-	-0.19	-4.6	5.35E-6	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid);Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
PRAD	cis	1	rs2281019	chr22:39064378	CBY1	chr22:39052658-39069853:+	0.17	4.7	3.42E-6	Resting heart rate	
PRAD	cis	1	rs2281019	chr22:39064378	LOC646851	chr22:38974125-39052634:-	0.18	4.3	2.1E-5	Resting heart rate	
PRAD	cis	1	rs2281020	chr22:39064406	CBY1	chr22:39052658-39069853:+	0.17	4.7	3.42E-6	Resting heart rate	
PRAD	cis	1	rs2281020	chr22:39064406	LOC646851	chr22:38974125-39052634:-	0.18	4.3	2.1E-5	Resting heart rate	
PRAD	cis	1	rs2281021	chr22:39064667	CBY1	chr22:39052658-39069853:+	0.17	4.7	3.42E-6	Resting heart rate	
PRAD	cis	1	rs2281021	chr22:39064667	LOC646851	chr22:38974125-39052634:-	0.18	4.3	2.1E-5	Resting heart rate	
PRAD	cis	1	rs2281223	chr20:48484241	SPATA2	chr20:48519931-48532080:-	-0.2	-4.21	3.06E-5	Gut microbiota (beta diversity)	
PRAD	cis	1	rs2281494	chr20:3235494	ITPA	chr20:3190056-3204504:+	-0.3	-7.5	3.31E-13	IFN-related cytopenia	
PRAD	cis	1	rs2281497	chr20:3258874	ITPA	chr20:3190056-3204504:+	-0.29	-7.37	7.49E-13	IFN-related cytopenia	
PRAD	cis	1	rs2281500	chr20:3262824	ITPA	chr20:3190056-3204504:+	-0.29	-7.35	9.12E-13	IFN-related cytopenia	
PRAD	cis	1	rs2281503	chr20:3263636	ITPA	chr20:3190056-3204504:+	-0.3	-7.58	1.85E-13	IFN-related cytopenia	
PRAD	cis	1	rs2281808	chr20:1610551	SIRPB1	chr20:1545030-1600689:-	0.15	3.85	0.000137	Type 1 diabetes	
PRAD	cis	1	rs2282300	chr11:30435585	KCNA4	chr11:30031766-30038488:-	0.25	3.88	0.000117	Morning vs. evening chronotype	
PRAD	cis	1	rs2282679	chr4:72608383	DCK	chr4:71859265-71896627:+	-0.14	-3.58	0.000381	Vitamin D levels;Vitamin D insufficiency	
PRAD	cis	1	rs2283603	chr19:15731128	CYP4F8	chr19:15726029-15740445:+	0.32	3.78	0.000176	Inflammatory biomarkers	
PRAD	cis	1	rs2284073	chr22:39105948	CBY1	chr22:39052658-39069853:+	0.13	3.82	0.000149	Resting heart rate	
PRAD	cis	1	rs2284073	chr22:39105948	LOC646851	chr22:38974125-39052634:-	0.18	4.5	8.6E-6	Resting heart rate	
PRAD	cis	1	rs228590	chr11:108096141	ATM	chr11:108093559-108239826:+	-0.17	-5.28	1.93E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs228591	chr11:108097333	ATM	chr11:108093559-108239826:+	-0.17	-5.41	9.99E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs2285946	chr7:21583329	DNAH11	chr7:21582833-21941455:+	-0.18	-4.38	1.49E-5	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
PRAD	cis	1	rs2285947	chr7:21584088	DNAH11	chr7:21582833-21941455:+	0.18	4.27	2.34E-5	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
PRAD	cis	1	rs2285949	chr7:21584243	DNAH11	chr7:21582833-21941455:+	-0.18	-4.44	1.12E-5	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
PRAD	cis	1	rs228594	chr11:108104525	ATM	chr11:108093559-108239826:+	-0.13	-4.02	6.65E-5	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs2285950	chr7:21584432	DNAH11	chr7:21582833-21941455:+	0.18	4.35	1.68E-5	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
PRAD	cis	1	rs228598	chr11:108107497	ATM	chr11:108093559-108239826:+	-0.16	-4.75	2.71E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs2286498	chr7:22857504	TOMM7	chr7:22852254-22862421:-	0.3	10.1	7.83E-22	Fibrinogen	
PRAD	cis	1	rs2286499	chr7:22857477	TOMM7	chr7:22852254-22862421:-	-0.3	-10.02	1.51E-21	Fibrinogen	
PRAD	cis	1	rs2286501	chr7:22856785	TOMM7	chr7:22852254-22862421:-	-0.31	-10.2	3.42E-22	Fibrinogen	
PRAD	cis	1	rs2286503	chr7:22856606	TOMM7	chr7:22852254-22862421:-	-0.3	-10.18	4.08E-22	Fibrinogen	
PRAD	cis	1	rs2286614	chr11:64068310	C11orf20	chr11:64067863-64072238:+	-0.43	-5.87	8.31E-9	Mean platelet volume	
PRAD	cis	1	rs2286672	chr17:4712617	ALOX15	chr17:4534221-4545589:-	0.23	3.64	0.000301	Systemic lupus erythematosus	
PRAD	cis	1	rs2286684	chr7:66129830	CRCP	chr7:65579805-65619551:+	0.2	3.72	0.000225	Aortic root size	
PRAD	cis	1	rs2286684	chr7:66129830	LOC493754	chr7:65993446-66057363:-	0.22	5.04	6.68E-7	Aortic root size	
PRAD	cis	1	rs2286684	chr7:66129830	TPST1	chr7:65670259-65825437:+	-0.15	-3.64	0.000302	Aortic root size	
PRAD	cis	1	rs2286771	chr4:17643848	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2286809	chr11:22851455	SVIP	chr11:22843600-22851382:-	0.28	6.78	3.51E-11	Dialysis-related mortality	
PRAD	cis	1	rs2287679	chr19:33600764	GPATCH1	chr19:33571786-33621318:+	0.53	9.61	4.52E-20	Bone properties (heel)	
PRAD	cis	1	rs2287680	chr19:33608566	GPATCH1	chr19:33571786-33621318:+	-0.54	-9.87	5.35E-21	Bone properties (heel)	
PRAD	cis	1	rs2287754	chr19:49496494	BAX	chr19:49458117-49465054:+	0.24	3.58	0.000385	Follicule stimulating hormone	
PRAD	cis	1	rs2287838	chr19:9959014	OR7D2	chr19:9296270-9299493:+	0.22	3.51	0.000483	Sleep duration	
PRAD	cis	1	rs2288073	chr2:24413298	C2orf84	chr2:24397531-24414566:+	-0.39	-6.78	3.56E-11	Venous thromboembolism (SNP x SNP interaction)	
PRAD	cis	1	rs2288073	chr2:24413298	LOC375190	chr2:24299728-24397519:+	0.28	6.97	1.05E-11	Venous thromboembolism (SNP x SNP interaction)	
PRAD	cis	1	rs2288271	chr15:52886466	ARPP19	chr15:52839432-52861364:-	0.14	3.59	0.000366	Schizophrenia	
PRAD	cis	1	rs2288920	chr19:50091798	FLT3LG	chr19:49977486-49990893:+	0.09	3.57	0.000393	Fibrinogen levels	
PRAD	cis	1	rs2289022	chr2:26350136	GPR113	chr2:26531041-26569685:-	-0.25	-3.76	0.000189	Gut microbiome composition (summer)	
PRAD	cis	1	rs2289329	chr15:40705159	DISP2	chr15:40650434-40663256:+	0.34	6.05	2.91E-9	Blood metabolite levels;Blood metabolite ratios	
PRAD	cis	1	rs2289695	chr15:79217631	CTSH	chr15:79214092-79237420:-	0.44	6.06	2.79E-9	Bipolar disorder	
PRAD	cis	1	rs2289697	chr15:79221907	CTSH	chr15:79214092-79237420:-	0.41	5.84	9.49E-9	Bipolar disorder	
PRAD	cis	1	rs2289698	chr15:79223445	CTSH	chr15:79214092-79237420:-	0.43	6.04	3.09E-9	Bipolar disorder	
PRAD	cis	1	rs2289836	chr14:76640125	C14orf118	chr14:76618259-76669133:+	-0.14	-3.44	0.000626	Blood pressure	
PRAD	cis	1	rs2289836	chr14:76640125	ESRRB	chr14:76837690-76968178:+	-0.28	-3.69	0.000251	Blood pressure	
PRAD	cis	1	rs2290143	chr13:21280363	IFT88	chr13:21141208-21265574:+	-0.27	-4.33	1.85E-5	Dental caries	
PRAD	cis	1	rs2290659	chr19:52031153	ZNF175	chr19:52074531-52092990:+	-0.32	-4.38	1.46E-5	Carotid intima media thickness	
PRAD	cis	1	rs2290659	chr19:52031153	ZNF766	chr19:52772824-52795977:+	-0.35	-3.43	0.000661	Carotid intima media thickness	
PRAD	cis	1	rs2290661	chr19:52031316	ZNF175	chr19:52074531-52092990:+	-0.32	-4.38	1.47E-5	Carotid intima media thickness	
PRAD	cis	1	rs2290661	chr19:52031316	ZNF766	chr19:52772824-52795977:+	-0.35	-3.44	0.000641	Carotid intima media thickness	
PRAD	cis	1	rs2290822	chr3:48473204	ATRIP	chr3:48488141-48507708:+	0.27	6.64	8.79E-11	Longevity	
PRAD	cis	1	rs2290822	chr3:48473204	CDC25A	chr3:48198668-48229801:-	0.22	4.1	4.96E-5	Longevity	
PRAD	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.17	-4.81	2.04E-6	Longevity	
PRAD	cis	1	rs2290883	chr11:46890197	ARHGAP1	chr11:46698634-46722120:-	0.22	3.56	0.000413	HDL cholesterol	
PRAD	cis	1	rs2290911	chr2:224919	SH3YL1	chr2:218138-264810:-	-0.79	-19.03	2.7E-60	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2291361	chr12:56717805	MIP	chr12:56843885-56848429:-	0.77	5.69	2.28E-8	Psoriasis vulgaris	
PRAD	cis	1	rs2291542	chr3:49751585	AMIGO3	chr3:49754268-49757238:-	-0.23	-4.59	5.63E-6	Resting heart rate	
PRAD	cis	1	rs2291542	chr3:49751585	CACNA2D2	chr3:50400233-50540892:-	-0.22	-4.58	6.02E-6	Resting heart rate	
PRAD	cis	1	rs2291542	chr3:49751585	GMPPB	chr3:49758932-49761384:-	-0.22	-5.1	4.96E-7	Resting heart rate	
PRAD	cis	1	rs2291542	chr3:49751585	RBM6	chr3:49977592-50137484:+	-0.16	-5.4	1.09E-7	Resting heart rate	
PRAD	cis	1	rs2291542	chr3:49751585	WDR6	chr3:49044637-49053386:+	-0.2	-4.2	3.2E-5	Resting heart rate	
PRAD	cis	1	rs2291738	chr12:56815281	TIMELESS	chr12:56810157-56843200:-	-0.15	-3.55	0.000425	Axial length	
PRAD	cis	1	rs2292174	chr15:50924956	SPPL2A	chr15:50999739-51057910:-	0.28	5.68	2.31E-8	QT interval	
PRAD	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.76	15.59	1.84E-44	Cognitive function	
PRAD	cis	1	rs2292255	chr5:176334195	FGFR4	chr5:176513921-176525124:+	0.17	3.63	0.00032	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs2292256	chr5:176333126	FGFR4	chr5:176513921-176525124:+	0.18	3.67	0.00027	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs2292489	chr1:202536848	PPP1R12B	chr1:202317836-202557697:+	0.09	3.75	0.000198	Sex ratio	
PRAD	cis	1	rs2292572	chr11:78052864	GAB2	chr11:77926343-78128766:-	-0.18	-5.97	4.75E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2292572	chr11:78052864	NARS2	chr11:78147017-78285909:-	-0.25	-5.56	4.47E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2292573	chr11:78053139	GAB2	chr11:77926343-78128766:-	-0.18	-6.19	1.33E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2292573	chr11:78053139	NARS2	chr11:78147017-78285909:-	-0.26	-5.66	2.69E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2293551	chr1:202408594	PPP1R12B	chr1:202317836-202557697:+	0.09	3.83	0.000147	Sex ratio	
PRAD	cis	1	rs2293552	chr1:202408751	PPP1R12B	chr1:202317836-202557697:+	0.09	3.74	0.00021	Sex ratio	
PRAD	cis	1	rs2294008	chr8:143761931	LY6K	chr8:143781529-143785582:+	0.23	4.02	6.65E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2294008	chr8:143761931	LYNX1	chr8:143845758-143859640:-	-0.31	-7.93	1.65E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2294008	chr8:143761931	PSCA	chr8:143761875-143764142:+	0.55	10.34	1.01E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2294010	chr8:143762430	LY6K	chr8:143781529-143785582:+	0.21	3.8	0.000166	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2294010	chr8:143762430	LYNX1	chr8:143845758-143859640:-	-0.31	-7.84	3.03E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2294010	chr8:143762430	PSCA	chr8:143761875-143764142:+	0.54	10.35	9.32E-23	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2294296	chr22:39053049	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs2294296	chr22:39053049	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs2294873	chr1:37961613	MEAF6	chr1:37958176-37980364:-	-0.35	-5.07	5.67E-7	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs2294873	chr1:37961613	SNIP1	chr1:38002145-38019903:-	-0.26	-4.54	7.06E-6	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs2295028	chr20:47582958	CSE1L	chr20:47662838-47713484:+	-0.18	-4.38	1.44E-5	Anger	
PRAD	cis	1	rs2295135	chr14:88894210	SPATA7	chr14:88852012-88904802:+	-0.22	-4.12	4.47E-5	Coronary artery calcification	
PRAD	cis	1	rs229528	chr22:37581677	C1QTNF6	chr22:37576206-37594341:-	-0.18	-4.34	1.77E-5	Type 1 diabetes	
PRAD	cis	1	rs229531	chr22:37585736	C1QTNF6	chr22:37576206-37594341:-	-0.17	-4.09	5.03E-5	Type 1 diabetes	
PRAD	cis	1	rs229533	chr22:37587111	C1QTNF6	chr22:37576206-37594341:-	-0.17	-4.16	3.71E-5	Type 1 diabetes	
PRAD	cis	1	rs229536	chr22:37589869	C1QTNF6	chr22:37576206-37594341:-	-0.17	-4.03	6.5E-5	Type 1 diabetes	
PRAD	cis	1	rs229540	chr22:37591290	C1QTNF6	chr22:37576206-37594341:-	-0.16	-3.88	0.00012	Type 1 diabetes	
PRAD	cis	1	rs229541	chr22:37591318	C1QTNF6	chr22:37576206-37594341:-	0.18	4.18	3.44E-5	Type 1 diabetes	
PRAD	cis	1	rs229542	chr22:37592106	C1QTNF6	chr22:37576206-37594341:-	-0.17	-3.99	7.72E-5	Type 1 diabetes	
PRAD	cis	1	rs2295599	chr6:10961454	MAK	chr6:10762957-10838760:-	0.31	4.71	3.3E-6	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	
PRAD	cis	1	rs2295700	chr20:33591627	MMP24	chr20:33814539-33864804:+	-0.32	-4.76	2.57E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs2295714	chr20:47739814	CSE1L	chr20:47662838-47713484:+	0.17	4.1	4.8E-5	Anger	
PRAD	cis	1	rs2295714	chr20:47739814	PREX1	chr20:47240793-47444420:-	-0.18	-3.79	0.000172	Anger	
PRAD	cis	1	rs2295770	chr10:102239829	SEC31B	chr10:102246403-102289636:-	-0.32	-9.8	9.66E-21	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2295772	chr10:102265183	SEC31B	chr10:102246403-102289636:-	-0.31	-9.29	5.59E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2295773	chr10:102265815	SEC31B	chr10:102246403-102289636:-	-0.31	-9.29	5.59E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2295774	chr10:102265847	SEC31B	chr10:102246403-102289636:-	-0.32	-9.44	1.72E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2295776	chr10:102295629	SEC31B	chr10:102246403-102289636:-	-0.28	-8.5	2.56E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2295779	chr10:102296061	SEC31B	chr10:102246403-102289636:-	-0.28	-8.41	4.77E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2295780	chr10:102305965	SEC31B	chr10:102246403-102289636:-	-0.3	-8.77	3.2E-17	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2295888	chr20:33722863	GDF5	chr20:33897002-34042568:-	0.24	3.89	0.000116	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs2295888	chr20:33722863	MMP24	chr20:33814539-33864804:+	-0.24	-4.02	6.65E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs2296375	chr1:156309372	BGLAP	chr1:156182784-156213112:+	0.21	5.19	3.18E-7	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs2296691	chr10:97370989	ENTPD1	chr10:97471536-97637022:+	0.13	3.81	0.000155	Blood metabolite levels	
PRAD	cis	1	rs2296691	chr10:97370989	TCTN3	chr10:97423154-97453900:-	0.21	4.03	6.57E-5	Blood metabolite levels	
PRAD	cis	1	rs2296736	chr6:33656250	ITPR3	chr6:33589161-33664346:+	-0.12	-4.23	2.84E-5	Height	
PRAD	cis	1	rs2296736	chr6:33656250	LEMD2	chr6:33738991-33756906:-	-0.11	-3.51	0.000496	Height	
PRAD	cis	1	rs2296738	chr6:33656850	ITPR3	chr6:33589161-33664346:+	-0.13	-4.38	1.46E-5	Height	
PRAD	cis	1	rs2296738	chr6:33656850	LEMD2	chr6:33738991-33756906:-	-0.11	-3.49	0.000527	Height	
PRAD	cis	1	rs2296741	chr6:33659557	ITPR3	chr6:33589161-33664346:+	-0.12	-3.91	0.000105	Height	
PRAD	cis	1	rs2296741	chr6:33659557	LEMD2	chr6:33738991-33756906:-	-0.12	-3.55	0.000428	Height	
PRAD	cis	1	rs2296742	chr6:33659793	ITPR3	chr6:33589161-33664346:+	-0.12	-3.92	9.97E-5	Height	
PRAD	cis	1	rs2296747	chr6:33744882	LEMD2	chr6:33738991-33756906:-	-0.22	-7.18	2.67E-12	Crohn's disease	
PRAD	cis	1	rs2296748	chr6:33745071	LEMD2	chr6:33738991-33756906:-	-0.22	-6.97	1.08E-11	Crohn's disease	
PRAD	cis	1	rs2296749	chr6:33763127	IP6K3	chr6:33689443-33714762:-	0.19	3.74	0.000209	Obesity (extreme)	
PRAD	cis	1	rs2297112	chr9:131900180	CRAT	chr9:131857075-131873070:-	0.22	4.15	3.96E-5	Blood metabolite ratios	
PRAD	cis	1	rs2297496	chr20:25295787	ENTPD6	chr20:25176339-25207360:+	0.16	4.17	3.65E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2297496	chr20:25295787	FAM182B	chr20:25744102-25848786:-	-0.37	-6.77	3.87E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2297496	chr20:25295787	PYGB	chr20:25228706-25278647:+	0.32	7.08	5.34E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2297497	chr20:25297909	ENTPD6	chr20:25176339-25207360:+	0.15	3.93	9.84E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2297497	chr20:25297909	FAM182B	chr20:25744102-25848786:-	-0.37	-6.74	4.68E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2297497	chr20:25297909	PYGB	chr20:25228706-25278647:+	0.32	6.91	1.55E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2298074	chr10:102247526	SEC31B	chr10:102246403-102289636:-	-0.33	-9.79	1.01E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2298075	chr10:102247408	SEC31B	chr10:102246403-102289636:-	-0.33	-9.81	8.44E-21	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2298632	chr1:23710475	C1orf213	chr1:23695464-23698278:+	0.18	4.55	6.69E-6	QT interval	
PRAD	cis	1	rs2300027	chr7:107975461	NRCAM	chr7:107788084-108096826:-	0.22	3.68	0.00026	Femoral neck bone geometry and menarche (age at onset)	
PRAD	cis	1	rs2300601	chr14:75639571	EIF2B2	chr14:75469612-75476292:+	0.28	5.77	1.42E-8	Height	
PRAD	cis	1	rs2300601	chr14:75639571	MLH3	chr14:75480467-75518235:-	0.35	7.04	6.69E-12	Height	
PRAD	cis	1	rs2300867	chr14:66129154	LOC645431	chr14:65877313-65879335:-	-0.46	-4.6	5.42E-6	Ischemic stroke	
PRAD	cis	1	rs2300871	chr14:66147694	LOC645431	chr14:65877313-65879335:-	0.35	3.65	0.000295	Ischemic stroke	
PRAD	cis	1	rs2300872	chr14:66147761	LOC645431	chr14:65877313-65879335:-	-0.4	-3.92	0.000102	Ischemic stroke	
PRAD	cis	1	rs2301889	chr7:98931105	CYP3A5	chr7:99245818-99332821:-	0.3	6.27	8.02E-10	Blood metabolite levels	
PRAD	cis	1	rs2302045	chr2:242021216	PASK	chr2:242045515-242088878:-	0.31	3.66	0.000276	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs2302048	chr2:242062117	PASK	chr2:242045515-242088878:-	0.34	4.25	2.53E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs2302051	chr2:242062410	PASK	chr2:242045515-242088878:-	0.33	3.9	0.000109	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs2302052	chr2:242063448	PASK	chr2:242045515-242088878:-	0.33	3.9	0.000109	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs2302138	chr14:74363305	LIN52	chr14:74551656-74667117:+	0.27	4.49	9.05E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs2302139	chr14:74362935	LIN52	chr14:74551656-74667117:+	0.25	4.15	3.89E-5	Morning vs. evening chronotype	
PRAD	cis	1	rs2302278	chr3:47361082	C3orf75	chr3:47537131-47555199:-	0.18	5.41	9.8E-8	Colorectal cancer	
PRAD	cis	1	rs2302278	chr3:47361082	NBEAL2	chr3:47021173-47051193:+	0.14	4.45	1.09E-5	Colorectal cancer	
PRAD	cis	1	rs2302327	chr17:4711798	ALOX15	chr17:4534221-4545589:-	-0.24	-3.61	0.00034	Systemic lupus erythematosus	
PRAD	cis	1	rs2302772	chr19:32902050	DPY19L3	chr19:32896677-32975236:+	0.11	3.43	0.000648	Bipolar disorder	
PRAD	cis	1	rs2302773	chr19:32927311	DPY19L3	chr19:32896677-32975236:+	0.11	3.57	0.00039	Bipolar disorder	
PRAD	cis	1	rs2303040	chr19:39138608	LGALS7	chr19:39261608-39264157:-	-0.15	-3.43	0.00066	Heart rate	
PRAD	cis	1	rs2303049	chr19:49494812	BAX	chr19:49458117-49465054:+	0.24	3.49	0.000534	Follicule stimulating hormone	
PRAD	cis	1	rs2303100	chr19:9968434	OR7D2	chr19:9296270-9299493:+	0.21	3.46	0.000588	Sleep duration	
PRAD	cis	1	rs2303129	chr5:78324482	BHMT2	chr5:78365583-78385273:+	0.1	3.81	0.000158	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs2303339	chr2:86346180	LOC90784	chr2:86247339-86250991:-	0.51	4.53	7.54E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs2303340	chr2:86333193	LOC90784	chr2:86247339-86250991:-	-0.51	-4.64	4.53E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs2303695	chr19:18562624	ELL	chr19:18553475-18632937:-	-0.15	-3.46	0.000583	Breast cancer	
PRAD	cis	1	rs2303695	chr19:18562624	SSBP4	chr19:18530221-18545371:+	-0.17	-5.67	2.43E-8	Breast cancer	
PRAD	cis	1	rs2303697	chr19:18546678	ELL	chr19:18553475-18632937:-	-0.17	-3.87	0.000125	Breast cancer	
PRAD	cis	1	rs2303697	chr19:18546678	SSBP4	chr19:18530221-18545371:+	-0.18	-5.85	9.1E-9	Breast cancer	
PRAD	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.34	-5.41	1.01E-7	Multiple sclerosis	
PRAD	cis	1	rs2303759	chr19:49869051	SLC6A16	chr19:49792894-49828474:-	0.2	4.01	7.2E-5	Multiple sclerosis	
PRAD	cis	1	rs2304641	chr1:85513398	MCOLN2	chr1:85391267-85462796:-	-0.44	-6.93	1.38E-11	Serum sulfate level	
PRAD	cis	1	rs2305188	chr4:1739592	FAM53A	chr4:1641609-1685854:-	-0.42	-7.73	6.8E-14	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs2305815	chr1:150956947	CTSK	chr1:150768687-150780812:-	-0.23	-4.75	2.76E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs2306693	chr12:56680531	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs2306693	chr12:56680531	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs2306694	chr12:56680636	COQ10A	chr12:56660642-56664748:+	0.35	3.44	0.000642	Psoriasis vulgaris	
PRAD	cis	1	rs2306694	chr12:56680636	MIP	chr12:56843885-56848429:-	-0.71	-5.33	1.56E-7	Psoriasis vulgaris	
PRAD	cis	1	rs2306937	chr1:113246506	ST7L	chr1:113066142-113162405:-	0.63	9.32	4.51E-19	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.66	10.1	8.07E-22	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs2307021	chr3:49765483	AMIGO3	chr3:49754268-49757238:-	-0.22	-4.26	2.5E-5	Resting heart rate	
PRAD	cis	1	rs2307021	chr3:49765483	CACNA2D2	chr3:50400233-50540892:-	-0.22	-4.46	1.03E-5	Resting heart rate	
PRAD	cis	1	rs2307021	chr3:49765483	GMPPB	chr3:49758932-49761384:-	-0.23	-5.13	4.2E-7	Resting heart rate	
PRAD	cis	1	rs2307021	chr3:49765483	RBM6	chr3:49977592-50137484:+	-0.16	-5.22	2.75E-7	Resting heart rate	
PRAD	cis	1	rs2307021	chr3:49765483	WDR6	chr3:49044637-49053386:+	-0.23	-4.53	7.32E-6	Resting heart rate	
PRAD	cis	1	rs2307393	chr6:88362943	C6orf165	chr6:88117721-88205858:+	0.46	4.2	3.15E-5	Obesity-related traits	
PRAD	cis	1	rs230812	chr5:42797761	CCDC152	chr5:42756920-42802539:+	-0.16	-4.48	9.2E-6	Height	
PRAD	cis	1	rs230812	chr5:42797761	SEPP1	chr5:42799983-42825998:-	-0.15	-4.36	1.57E-5	Height	
PRAD	cis	1	rs230813	chr5:42799033	CCDC152	chr5:42756920-42802539:+	-0.16	-4.43	1.17E-5	Height	
PRAD	cis	1	rs230813	chr5:42799033	SEPP1	chr5:42799983-42825998:-	-0.15	-4.33	1.85E-5	Height	
PRAD	cis	1	rs230814	chr5:42799271	CCDC152	chr5:42756920-42802539:+	-0.16	-4.43	1.17E-5	Height	
PRAD	cis	1	rs230814	chr5:42799271	SEPP1	chr5:42799983-42825998:-	-0.15	-4.33	1.85E-5	Height	
PRAD	cis	1	rs2310997	chr3:48678011	CCDC36	chr3:49235861-49295537:+	-0.34	-4.22	2.89E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs2310997	chr3:48678011	NCKIPSD	chr3:48711280-48723334:-	-0.3	-4.11	4.76E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs2310997	chr3:48678011	WDR6	chr3:49044637-49053386:+	0.28	3.83	0.000145	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs2312462	chr3:49601255	AMIGO3	chr3:49754268-49757238:-	-0.44	-8.97	7.07E-18	Menarche (age at onset)	
PRAD	cis	1	rs2312462	chr3:49601255	CCDC36	chr3:49235861-49295537:+	0.23	4.04	6.3E-5	Menarche (age at onset)	
PRAD	cis	1	rs2312462	chr3:49601255	GMPPB	chr3:49758932-49761384:-	-0.48	-11.65	9.74E-28	Menarche (age at onset)	
PRAD	cis	1	rs2312462	chr3:49601255	NCKIPSD	chr3:48711280-48723334:-	0.32	6.31	6.4E-10	Menarche (age at onset)	
PRAD	cis	1	rs2312462	chr3:49601255	P4HTM	chr3:49027341-49044579:+	0.16	3.66	0.000283	Menarche (age at onset)	
PRAD	cis	1	rs2312462	chr3:49601255	WDR6	chr3:49044637-49053386:+	-0.2	-3.94	9.49E-5	Menarche (age at onset)	
PRAD	cis	1	rs231499	chr17:41973507	G6PC3	chr17:42148118-42153711:+	0.19	3.68	0.000259	Cognitive function	
PRAD	cis	1	rs231513	chr17:41965200	G6PC3	chr17:42148118-42153711:+	-0.2	-3.69	0.000253	Cognitive function	
PRAD	cis	1	rs231518	chr17:41961451	G6PC3	chr17:42148118-42153711:+	0.2	3.7	0.000242	Cognitive function	
PRAD	cis	1	rs231519	chr17:41961051	G6PC3	chr17:42148118-42153711:+	0.21	4.21	3.02E-5	Cognitive function	
PRAD	cis	1	rs231526	chr17:41951277	G6PC3	chr17:42148118-42153711:+	-0.22	-3.98	8.09E-5	Cognitive function	
PRAD	cis	1	rs2315281	chr19:19480099	GATAD2A	chr19:19496642-19619740:+	-0.14	-3.43	0.000659	Schizophrenia	
PRAD	cis	1	rs2315504	chr17:39046881	TMEM99	chr17:38975374-38992526:+	-0.32	-7.21	2.25E-12	Height	
PRAD	cis	1	rs2315556	chr4:17670861	MED28	chr4:17616273-17629791:+	0.19	4.66	4.03E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2315560	chr4:17677305	MED28	chr4:17616273-17629791:+	0.18	4.42	1.24E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2315561	chr4:17679695	MED28	chr4:17616273-17629791:+	0.17	4.13	4.35E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2319398	chr3:119612942	NR1I2	chr3:119499331-119537331:+	-0.22	-3.98	7.93E-5	HDL cholesterol	
PRAD	cis	1	rs2319399	chr3:119636207	NR1I2	chr3:119499331-119537331:+	-0.23	-4.09	5.14E-5	HDL cholesterol	
PRAD	cis	1	rs2319458	chr22:50236306	CRELD2	chr22:50312283-50321186:+	0.18	3.69	0.000249	Schizophrenia	
PRAD	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.52	-11.6	1.58E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs2325918	chr1:159221267	FCER1A	chr1:159259506-159278013:+	-0.14	-3.8	0.000164	Inflammatory biomarkers	
PRAD	cis	1	rs2326289	chr20:3952300	MAVS	chr20:3827449-3856761:+	-0.27	-3.7	0.000238	Response to antidepressants in depression	
PRAD	cis	1	rs2329340	chr7:50620229	DDC	chr7:50526136-50633154:-	0.24	3.9	0.000111	Malaria	
PRAD	cis	1	rs2329340	chr7:50620229	FIGNL1	chr7:50511834-50518088:-	-0.22	-5.82	1.07E-8	Malaria	
PRAD	cis	1	rs2329341	chr7:50620275	DDC	chr7:50526136-50633154:-	0.24	3.9	0.000111	Malaria	
PRAD	cis	1	rs2329341	chr7:50620275	FIGNL1	chr7:50511834-50518088:-	-0.22	-5.82	1.07E-8	Malaria	
PRAD	cis	1	rs2329342	chr7:50624971	DDC	chr7:50526136-50633154:-	-0.23	-3.88	0.000118	Malaria	
PRAD	cis	1	rs2329342	chr7:50624971	FIGNL1	chr7:50511834-50518088:-	0.23	6.24	9.93E-10	Malaria	
PRAD	cis	1	rs2333194	chr14:73767214	HEATR4	chr14:73945193-74025651:-	-0.23	-4.28	2.26E-5	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs2336030	chr1:11736600	FBXO2	chr1:11708450-11714739:-	-0.16	-3.65	0.000295	Visceral adipose tissue adjusted for BMI	
PRAD	cis	1	rs2336540	chr3:52974589	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs2336540	chr3:52974589	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs2336541	chr3:52974630	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs2336541	chr3:52974630	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs2336723	chr3:53106047	ITIH4	chr3:52847007-52866554:-	0.13	3.98	8.1E-5	Height	
PRAD	cis	1	rs2338555	chr1:152309380	FLG	chr1:152274651-152297679:-	0.32	5.08	5.4E-7	Atopic dermatitis	
PRAD	cis	1	rs2338556	chr1:152309427	FLG	chr1:152274651-152297679:-	0.32	5.08	5.4E-7	Atopic dermatitis	
PRAD	cis	1	rs2340536	chr8:96010435	C8orf38	chr8:95908040-96088396:+	-0.42	-7.09	4.89E-12	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs2340952	chr8:39823239	ADAM9	chr8:38854505-38962777:+	0.15	3.75	0.000198	Blood metabolite levels	
PRAD	cis	1	rs2344180	chr5:150267357	LOC134466	chr5:150310000-150326146:-	0.57	8.83	2.13E-17	Crohn's disease	
PRAD	cis	1	rs2344181	chr5:150262574	LOC134466	chr5:150310000-150326146:-	0.57	8.83	2.13E-17	Crohn's disease	
PRAD	cis	1	rs2345001	chr5:150266518	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs2346676	chr16:67223803	FHOD1	chr16:67263294-67281425:-	0.58	7.31	1.12E-12	HDL cholesterol	
PRAD	cis	1	rs2346676	chr16:67223803	SLC9A5	chr16:67282855-67306093:+	0.34	4.77	2.43E-6	HDL cholesterol	
PRAD	cis	1	rs2349075	chr2:202223566	ALS2CR12	chr2:202153148-202222101:-	-0.28	-4.73	2.97E-6	Basal cell carcinoma	
PRAD	cis	1	rs2350809	chr2:203328933	NOP58	chr2:203130515-203168382:+	0.3	4.78	2.36E-6	Urate levels	
PRAD	cis	1	rs2350900	chr14:60938681	C14orf39	chr14:60902675-60952764:-	0.45	5.79	1.31E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs2350900	chr14:60938681	DHRS7	chr14:60611502-60636561:-	0.22	3.72	0.000223	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs2351175	chr14:61066730	C14orf39	chr14:60902675-60952764:-	0.57	6.47	2.44E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs2351176	chr14:61073731	C14orf39	chr14:60902675-60952764:-	0.55	6.28	7.68E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.89	-18.86	1.73E-59	Type 2 diabetes	
PRAD	cis	1	rs2351706	chr15:90384115	C15orf38	chr15:90443832-90456222:-	0.2	3.8	0.000161	Type 2 diabetes	
PRAD	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.89	-18.86	1.73E-59	Type 2 diabetes	
PRAD	cis	1	rs2351707	chr15:90384045	C15orf38	chr15:90443832-90456222:-	0.2	3.8	0.000161	Type 2 diabetes	
PRAD	cis	1	rs2353605	chr4:219538	ZNF718	chr4:53272-156488:+	0.36	6.18	1.39E-9	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.9	-26.7	2.93E-96	Homocysteine levels	
PRAD	cis	1	rs2356559	chr1:45981512	MMACHC	chr1:45965856-45976737:+	-0.22	-4.68	3.78E-6	Homocysteine levels	
PRAD	cis	1	rs2356559	chr1:45981512	MUTYH	chr1:45794915-45806142:-	0.19	5.15	3.85E-7	Homocysteine levels	
PRAD	cis	1	rs2356559	chr1:45981512	PRDX1	chr1:45976708-45987609:-	-0.13	-3.44	0.000639	Homocysteine levels	
PRAD	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.85	-23.7	2.88E-82	Homocysteine levels	
PRAD	cis	1	rs2356561	chr1:45980862	MMACHC	chr1:45965856-45976737:+	-0.19	-4	7.33E-5	Homocysteine levels	
PRAD	cis	1	rs2356561	chr1:45980862	MUTYH	chr1:45794915-45806142:-	0.19	5.17	3.4E-7	Homocysteine levels	
PRAD	cis	1	rs2356801	chr11:108281999	ATM	chr11:108093559-108239826:+	-0.18	-5.65	2.75E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.43	-11.52	3.12E-27	Common traits (Other)	
PRAD	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.43	-11.53	2.85E-27	Common traits (Other)	
PRAD	cis	1	rs2359155	chr19:21671869	ZNF493	chr19:21579921-21610294:+	-0.16	-4.08	5.24E-5	Pain	
PRAD	cis	1	rs2359811	chr19:22152876	ZNF257	chr19:22235266-22273901:+	0.41	5.31	1.66E-7	Body mass index (change over time)	
PRAD	cis	1	rs2359820	chr19:22208114	ZNF257	chr19:22235266-22273901:+	0.36	4.95	1.02E-6	Body mass index (change over time)	
PRAD	cis	1	rs2359821	chr19:22208314	ZNF208	chr19:22115760-22193745:-	0.28	5.55	4.72E-8	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2359821	chr19:22208314	ZNF257	chr19:22235266-22273901:+	0.47	7.69	8.46E-14	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2360977	chr14:76654481	C14orf118	chr14:76618259-76669133:+	0.14	3.61	0.00034	Blood pressure	
PRAD	cis	1	rs2360977	chr14:76654481	ESRRB	chr14:76837690-76968178:+	0.26	3.66	0.000276	Blood pressure	
PRAD	cis	1	rs236104	chr20:5958960	CRLS1	chr20:5986739-6020694:+	-0.26	-4.87	1.53E-6	HIV-1 viral setpoint	
PRAD	cis	1	rs236104	chr20:5958960	MCM8	chr20:5931298-5975829:+	-0.39	-8.68	6.44E-17	HIV-1 viral setpoint	
PRAD	cis	1	rs236121	chr20:5972594	CRLS1	chr20:5986739-6020694:+	-0.26	-4.91	1.24E-6	HIV-1 viral setpoint	
PRAD	cis	1	rs236121	chr20:5972594	MCM8	chr20:5931298-5975829:+	-0.39	-8.54	1.81E-16	HIV-1 viral setpoint	
PRAD	cis	1	rs2361453	chr1:202336314	PPP1R12B	chr1:202317836-202557697:+	0.09	3.71	0.000233	Sex ratio	
PRAD	cis	1	rs2362450	chr3:48461313	ATRIP	chr3:48488141-48507708:+	0.28	6.75	4.26E-11	Longevity	
PRAD	cis	1	rs2362450	chr3:48461313	CDC25A	chr3:48198668-48229801:-	0.2	3.81	0.000155	Longevity	
PRAD	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.18	-5.14	4.11E-7	Longevity	
PRAD	cis	1	rs2362452	chr3:48418214	ATRIP	chr3:48488141-48507708:+	-0.28	-6.85	2.31E-11	Longevity	
PRAD	cis	1	rs2362452	chr3:48418214	CDC25A	chr3:48198668-48229801:-	-0.19	-3.66	0.000279	Longevity	
PRAD	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.17	4.76	2.63E-6	Longevity	
PRAD	cis	1	rs2363286	chr7:1091625	GPR146	chr7:1084243-1098897:+	0.32	4.43	1.17E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs2363286	chr7:1091625	INTS1	chr7:1509913-1544018:-	0.2	3.74	0.00021	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs2363286	chr7:1091625	ZFAND2A	chr7:1192544-1199855:-	-0.31	-4.76	2.6E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.84	-9.62	4.01E-20	Plasma clusterin levels	
PRAD	cis	1	rs236373	chr6:36792057	PPIL1	chr6:36822606-36842800:-	0.27	4.53	7.43E-6	Heart rate	
PRAD	cis	1	rs2364143	chr5:78316227	BHMT2	chr5:78365583-78385273:+	0.1	3.73	0.000214	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs2365468	chr17:65841318	LOC651250	chr17:66097696-66157623:+	-0.25	-4.57	6.19E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs2365764	chr17:65857714	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs236918	chr11:117091609	PCSK7	chr11:117075789-117102811:-	0.4	5.15	3.78E-7	Protein quantitative trait loci	
PRAD	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.51	11.53	3.05E-27	Height	
PRAD	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.54	12.38	1.12E-30	Height	
PRAD	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.52	11.72	5.21E-28	Height	
PRAD	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.49	-9.18	1.4E-18	Obesity-related traits	
PRAD	cis	1	rs2371244	chr7:143757611	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.59	0.000359	Obesity-related traits	
PRAD	cis	1	rs2371244	chr7:143757611	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.32	1.57E-7	Obesity-related traits	
PRAD	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.49	-9.21	1.04E-18	Obesity-related traits	
PRAD	cis	1	rs2371247	chr7:143764179	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.59	0.00036	Obesity-related traits	
PRAD	cis	1	rs2371247	chr7:143764179	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.34	1.48E-7	Obesity-related traits	
PRAD	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.37	2.99E-19	Obesity-related traits	
PRAD	cis	1	rs2371248	chr7:143764189	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.72	0.000224	Obesity-related traits	
PRAD	cis	1	rs2371248	chr7:143764189	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.36	1.3E-7	Obesity-related traits	
PRAD	cis	1	rs2371454	chr12:56647243	COQ10A	chr12:56660642-56664748:+	0.36	3.52	0.000468	Psoriasis vulgaris	
PRAD	cis	1	rs2371454	chr12:56647243	MIP	chr12:56843885-56848429:-	-0.69	-5.1	5.05E-7	Psoriasis vulgaris	
PRAD	cis	1	rs2371623	chr3:41761083	ULK4	chr3:41288091-42003660:-	0.81	12.99	3.56E-33	Diastolic blood pressure	
PRAD	cis	1	rs2371627	chr3:41839219	ULK4	chr3:41288091-42003660:-	0.83	13.46	3.57E-35	Diastolic blood pressure	
PRAD	cis	1	rs2373000	chr2:37592628	CEBPZ	chr2:37428778-37458740:-	-0.15	-3.43	0.000657	Schizophrenia	
PRAD	cis	1	rs2373009	chr11:77945815	GAB2	chr11:77926343-78128766:-	-0.19	-5.7	2.1E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2373009	chr11:77945815	NARS2	chr11:78147017-78285909:-	-0.19	-3.66	0.000285	Testicular germ cell tumor	
PRAD	cis	1	rs2373115	chr11:78091150	GAB2	chr11:77926343-78128766:-	-0.18	-6.22	1.13E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2373115	chr11:78091150	NARS2	chr11:78147017-78285909:-	-0.22	-4.71	3.23E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.72	5.46E-28	Height	
PRAD	cis	1	rs2381284	chr4:39119596	KLHL5	chr4:39046659-39123828:+	-0.13	-3.89	0.000113	Uric acid levels	
PRAD	cis	1	rs2381285	chr4:39114395	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	cis	1	rs2384321	chr2:26290054	GPR113	chr2:26531041-26569685:-	-0.27	-3.75	0.000198	Gut microbiome composition (summer)	
PRAD	cis	1	rs2384322	chr2:26291146	GPR113	chr2:26531041-26569685:-	-0.27	-3.76	0.00019	Gut microbiome composition (summer)	
PRAD	cis	1	rs2384323	chr2:26306473	GPR113	chr2:26531041-26569685:-	-0.23	-3.51	0.000499	Gut microbiome composition (summer)	
PRAD	cis	1	rs2387299	chr10:1163427	IDI2	chr10:1064847-1071799:-	0.33	4.26	2.44E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs2387880	chr20:25377787	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2387880	chr20:25377787	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2387880	chr20:25377787	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2387881	chr20:25378172	ENTPD6	chr20:25176339-25207360:+	0.17	4.48	9.59E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2387881	chr20:25378172	FAM182B	chr20:25744102-25848786:-	-0.35	-6.52	1.77E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2387881	chr20:25378172	PYGB	chr20:25228706-25278647:+	0.33	7.35	9.06E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2387884	chr20:25379069	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2387884	chr20:25379069	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2387884	chr20:25379069	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2390847	chr7:23911701	C7orf46	chr7:23719749-23742268:+	0.22	5.69	2.25E-8	Schizophrenia	
PRAD	cis	1	rs2391159	chr1:92971951	EVI5	chr1:92974255-93257961:-	-0.32	-6.41	3.54E-10	Cholesterol, total	
PRAD	cis	1	rs2391160	chr1:92992797	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs2391282	chr7:26558154	LOC441204	chr7:26438339-26538594:+	-0.28	-5.29	1.83E-7	Smoking behavior	
PRAD	cis	1	rs2391282	chr7:26558154	NFE2L3	chr7:26191847-26226754:+	-0.15	-3.75	0.000203	Smoking behavior	
PRAD	cis	1	rs2391283	chr7:26570259	HOXA4	chr7:27168127-27170399:-	-0.21	-3.56	0.000404	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2393593	chr6:26285683	BTN3A2	chr6:26365398-26378546:+	0.2	4.53	7.59E-6	Educational attainment	
PRAD	cis	1	rs2393593	chr6:26285683	HIST1H3E	chr6:26224427-26226589:+	0.2	4.17	3.67E-5	Educational attainment	
PRAD	cis	1	rs2393670	chr6:26535541	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs2393670	chr6:26535541	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs2393969	chr10:65140440	NRBF2	chr10:64893007-64914785:+	-0.25	-5.43	9.22E-8	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2395400	chr6:33770076	LEMD2	chr6:33738991-33756906:-	0.19	5.06	6.11E-7	Body mass index	
PRAD	cis	1	rs2395449	chr6:33728755	LEMD2	chr6:33738991-33756906:-	-0.23	-7.06	5.9E-12	Crohn's disease	
PRAD	cis	1	rs2396499	chr2:228724368	CCL20	chr2:228678558-228682280:+	-0.26	-4.55	6.94E-6	Blood pressure	
PRAD	cis	1	rs239935	chr6:167411788	RNASET2	chr6:167343008-167412795:-	-0.23	-5.42	9.78E-8	Crohn's disease	
PRAD	cis	1	rs2401172	chr15:84576957	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2401173	chr15:84576970	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2401174	chr15:84576992	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2401175	chr15:84578217	NMB	chr15:85198362-85201802:-	0.17	3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2401176	chr15:84578364	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2401179	chr15:84578948	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2401180	chr15:84579186	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs2403205	chr14:104143385	BAG5	chr14:104022889-104029151:-	0.18	3.75	0.000201	Body mass index	
PRAD	cis	1	rs2403205	chr14:104143385	C14orf153	chr14:104029299-104057227:+	0.14	4.18	3.51E-5	Body mass index	
PRAD	cis	1	rs2403205	chr14:104143385	CKB	chr14:103985996-103989170:-	0.22	4.89	1.41E-6	Body mass index	
PRAD	cis	1	rs2403205	chr14:104143385	KLC1	chr14:104029299-104167887:+	-0.17	-3.52	0.000471	Body mass index	
PRAD	cis	1	rs2403205	chr14:104143385	MARK3	chr14:103851701-103970164:+	0.24	5	7.95E-7	Body mass index	
PRAD	cis	1	rs2404602	chr15:77030792	ETFA	chr15:76508629-76603810:-	0.17	3.52	0.000478	Blood metabolite levels	
PRAD	cis	1	rs2404602	chr15:77030792	SCAPER	chr15:76640529-77197744:-	-0.13	-3.9	0.000111	Blood metabolite levels	
PRAD	cis	1	rs2404740	chr15:76852143	SCAPER	chr15:76640529-77197744:-	-0.12	-3.58	0.000385	Blood metabolite levels	
PRAD	cis	1	rs2404741	chr15:76851735	SCAPER	chr15:76640529-77197744:-	-0.12	-3.58	0.000385	Blood metabolite levels	
PRAD	cis	1	rs2409488	chr21:34688914	IFNAR1	chr21:34696734-34732126:+	-0.18	-3.45	0.000614	Narcolepsy	
PRAD	cis	1	rs2412488	chr4:54330867	FIP1L1	chr4:54243820-54326102:+	-0.2	-4.32	1.89E-5	DNA methylation (variation)	
PRAD	cis	1	rs2413544	chr22:39059404	CBY1	chr22:39052658-39069853:+	0.17	4.88	1.48E-6	Resting heart rate	
PRAD	cis	1	rs2413544	chr22:39059404	LOC646851	chr22:38974125-39052634:-	0.19	4.41	1.3E-5	Resting heart rate	
PRAD	cis	1	rs2413545	chr22:39092524	CBY1	chr22:39052658-39069853:+	0.16	4.37	1.55E-5	Resting heart rate	
PRAD	cis	1	rs2413545	chr22:39092524	LOC646851	chr22:38974125-39052634:-	0.17	3.89	0.000114	Resting heart rate	
PRAD	cis	1	rs2413546	chr22:39107001	CBY1	chr22:39052658-39069853:+	0.17	4.73	2.94E-6	Resting heart rate	
PRAD	cis	1	rs2413546	chr22:39107001	LOC646851	chr22:38974125-39052634:-	0.19	4.43	1.15E-5	Resting heart rate	
PRAD	cis	1	rs2413547	chr22:39107338	CBY1	chr22:39052658-39069853:+	0.17	4.73	2.94E-6	Resting heart rate	
PRAD	cis	1	rs2413547	chr22:39107338	LOC646851	chr22:38974125-39052634:-	0.19	4.43	1.15E-5	Resting heart rate	
PRAD	cis	1	rs2413748	chr22:43530982	MCAT	chr22:43528212-43539403:-	-0.19	-3.72	0.000222	Prostate cancer	
PRAD	cis	1	rs2414060	chr15:50873262	SPPL2A	chr15:50999739-51057910:-	0.28	5.83	1.02E-8	QT interval	
PRAD	cis	1	rs2414098	chr15:51537806	AP4E1	chr15:51200946-51298097:+	0.14	3.72	0.000224	Endometrial endometrioid carcinoma;Endometrial cancer	
PRAD	cis	1	rs2414166	chr15:52901977	ARPP19	chr15:52839432-52861364:-	0.15	3.98	8.1E-5	Schizophrenia	
PRAD	cis	1	rs2414885	chr15:66034624	IGDCC4	chr15:65673825-65715410:-	-0.14	-3.44	0.000644	Mean corpuscular hemoglobin	
PRAD	cis	1	rs2415159	chr15:75430715	MPI	chr15:75182410-75190565:+	0.16	3.64	0.000302	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs2415253	chr15:75375699	SCAMP5	chr15:75287901-75313836:+	0.39	7.01	8.26E-12	Blood trace element (Zn levels)	
PRAD	cis	1	rs2415255	chr15:75332412	PPCDC	chr15:75315927-75343066:+	0.16	4.11	4.65E-5	Blood trace element (Zn levels)	
PRAD	cis	1	rs2415255	chr15:75332412	SCAMP5	chr15:75287901-75313836:+	0.41	7.37	7.86E-13	Blood trace element (Zn levels)	
PRAD	cis	1	rs2417577	chr9:100701446	C9orf156	chr9:100666772-100684852:-	-0.19	-3.68	0.000256	Quantitative traits	
PRAD	cis	1	rs2420168	chr7:65630631	TPST1	chr7:65670259-65825437:+	-0.18	-4.47	1.0E-5	Aortic root size	
PRAD	cis	1	rs2420170	chr7:65656053	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs2420170	chr7:65656053	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs2420171	chr7:65637760	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs2420171	chr7:65637760	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs2420591	chr7:65912381	TPST1	chr7:65670259-65825437:+	0.18	4.4	1.32E-5	Aortic root size	
PRAD	cis	1	rs2420820	chr7:66091907	TPST1	chr7:65670259-65825437:+	-0.18	-4.41	1.31E-5	Aortic root size	
PRAD	cis	1	rs2420824	chr7:66131116	CRCP	chr7:65579805-65619551:+	0.22	4.07	5.62E-5	Aortic root size	
PRAD	cis	1	rs2420824	chr7:66131116	LOC493754	chr7:65993446-66057363:-	0.23	5.29	1.87E-7	Aortic root size	
PRAD	cis	1	rs2421017	chr10:124148167	BTBD16	chr10:124030821-124097676:+	0.19	3.65	0.000293	Height	
PRAD	cis	1	rs2421332	chr2:61876965	AHSA2	chr2:61404553-61414058:+	0.11	3.72	0.000219	Homeostasis model assessment of beta-cell function (interaction)	
PRAD	cis	1	rs2421332	chr2:61876965	C2orf74	chr2:61372243-61391964:+	-0.34	-5.74	1.73E-8	Homeostasis model assessment of beta-cell function (interaction)	
PRAD	cis	1	rs2421555	chr2:73816955	ALMS1P	chr2:73872046-73912692:+	0.49	8.51	2.32E-16	Metabolite levels	
PRAD	cis	1	rs2421555	chr2:73816955	NAT8	chr2:73867850-73869537:-	0.25	3.87	0.000126	Metabolite levels	
PRAD	cis	1	rs242271	chr6:88082029	C6orf162	chr6:88032306-88052043:+	-0.21	-3.81	0.000156	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs242271	chr6:88082029	C6orf164	chr6:88032306-88109459:+	-0.22	-4.63	4.81E-6	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs242271	chr6:88082029	C6orf165	chr6:88117721-88205858:+	-0.54	-9.91	3.9E-21	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs242271	chr6:88082029	SLC35A1	chr6:88146444-88222051:+	-0.25	-4.68	3.79E-6	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs2424700	chr20:25266513	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.16	3.81E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424700	chr20:25266513	FAM182B	chr20:25744102-25848786:-	0.37	6.74	4.76E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424700	chr20:25266513	PYGB	chr20:25228706-25278647:+	-0.33	-7.09	5.03E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424704	chr20:25273929	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.22	2.97E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424704	chr20:25273929	FAM182B	chr20:25744102-25848786:-	0.38	7.05	6.58E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424704	chr20:25273929	PYGB	chr20:25228706-25278647:+	-0.33	-7.21	2.25E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424710	chr20:25283886	ENTPD6	chr20:25176339-25207360:+	-0.18	-4.74	2.88E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424710	chr20:25283886	FAM182B	chr20:25744102-25848786:-	0.36	6.54	1.62E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424710	chr20:25283886	PYGB	chr20:25228706-25278647:+	-0.35	-7.7	8.07E-14	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424712	chr20:25416942	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.28	2.26E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424712	chr20:25416942	FAM182B	chr20:25744102-25848786:-	0.38	7.09	4.94E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424712	chr20:25416942	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.59E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424713	chr20:25418482	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.33	1.81E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424713	chr20:25418482	FAM182B	chr20:25744102-25848786:-	0.37	6.79	3.43E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424713	chr20:25418482	PYGB	chr20:25228706-25278647:+	-0.33	-7.24	1.9E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424716	chr20:25423538	ENTPD6	chr20:25176339-25207360:+	-0.18	-4.68	3.71E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424716	chr20:25423538	FAM182B	chr20:25744102-25848786:-	0.36	6.65	8.08E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424716	chr20:25423538	PYGB	chr20:25228706-25278647:+	-0.34	-7.42	5.72E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2424900	chr20:31344342	MAPRE1	chr20:31407699-31438210:+	0.19	4.46	1.03E-5	Ulcerative colitis	
PRAD	cis	1	rs2424901	chr20:31344512	MAPRE1	chr20:31407699-31438210:+	0.19	4.46	1.03E-5	Ulcerative colitis	
PRAD	cis	1	rs2425037	chr20:33856429	MMP24	chr20:33814539-33864804:+	0.21	3.43	0.000659	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs2425040	chr20:33858878	MMP24	chr20:33814539-33864804:+	-0.23	-3.75	0.000198	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs2425041	chr20:33859013	MMP24	chr20:33814539-33864804:+	-0.23	-3.62	0.000332	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs2425065	chr20:33926268	CEP250	chr20:34042996-34099802:+	0.24	5.38	1.2E-7	Height	
PRAD	cis	1	rs2425065	chr20:33926268	CPNE1	chr20:34213968-34262539:-	-0.2	-3.97	8.15E-5	Height	
PRAD	cis	1	rs2425065	chr20:33926268	FAM83C	chr20:33873287-33880225:-	-0.17	-3.7	0.000237	Height	
PRAD	cis	1	rs2425065	chr20:33926268	GDF5	chr20:33897002-34042568:-	0.2	4.91	1.29E-6	Height	
PRAD	cis	1	rs2425065	chr20:33926268	MMP24	chr20:33814539-33864804:+	-0.14	-3.62	0.000328	Height	
PRAD	cis	1	rs2425065	chr20:33926268	UQCC	chr20:33890383-33999833:-	-0.38	-7.13	3.76E-12	Height	
PRAD	cis	1	rs2425066	chr20:33927006	CEP250	chr20:34042996-34099802:+	0.24	5.31	1.73E-7	Height	
PRAD	cis	1	rs2425066	chr20:33927006	CPNE1	chr20:34213968-34262539:-	-0.2	-4	7.26E-5	Height	
PRAD	cis	1	rs2425066	chr20:33927006	FAM83C	chr20:33873287-33880225:-	-0.16	-3.55	0.000421	Height	
PRAD	cis	1	rs2425066	chr20:33927006	GDF5	chr20:33897002-34042568:-	0.21	5.04	6.68E-7	Height	
PRAD	cis	1	rs2425066	chr20:33927006	MMP24	chr20:33814539-33864804:+	-0.14	-3.5	0.000505	Height	
PRAD	cis	1	rs2425066	chr20:33927006	UQCC	chr20:33890383-33999833:-	-0.39	-7.43	5.23E-13	Height	
PRAD	cis	1	rs2425697	chr20:44025175	SYS1	chr20:43991701-44004724:+	0.34	6.19	1.34E-9	Psoriasis	
PRAD	cis	1	rs2426106	chr20:47639464	CSE1L	chr20:47662838-47713484:+	-0.19	-4.6	5.49E-6	Anger	
PRAD	cis	1	rs2426109	chr20:47662627	CSE1L	chr20:47662838-47713484:+	-0.19	-4.6	5.47E-6	Anger	
PRAD	cis	1	rs2426109	chr20:47662627	PREX1	chr20:47240793-47444420:-	0.17	3.43	0.000658	Anger	
PRAD	cis	1	rs2426112	chr20:47690139	CSE1L	chr20:47662838-47713484:+	-0.2	-4.92	1.21E-6	Anger	
PRAD	cis	1	rs2426113	chr20:47690189	CSE1L	chr20:47662838-47713484:+	-0.2	-4.92	1.21E-6	Anger	
PRAD	cis	1	rs2426116	chr20:47693047	CSE1L	chr20:47662838-47713484:+	-0.2	-4.92	1.21E-6	Anger	
PRAD	cis	1	rs2429024	chr10:70740573	KIAA1279	chr10:70748493-70776734:+	-0.14	-3.46	0.000597	Schizophrenia	
PRAD	cis	1	rs2429024	chr10:70740573	STOX1	chr10:70587294-70655209:+	-0.21	-3.85	0.000133	Schizophrenia	
PRAD	cis	1	rs2429030	chr10:70751673	STOX1	chr10:70587294-70655209:+	-0.24	-4.35	1.71E-5	Schizophrenia	
PRAD	cis	1	rs2429031	chr10:70755877	STOX1	chr10:70587294-70655209:+	-0.22	-3.97	8.32E-5	Schizophrenia	
PRAD	cis	1	rs2430494	chr2:37463620	CEBPZ	chr2:37428778-37458740:-	-0.2	-4.49	9.1E-6	Chronic lymphocytic leukemia	
PRAD	cis	1	rs2431349	chr5:75921330	F2RL2	chr5:75911308-75919240:-	-0.2	-4.46	1.04E-5	Hearing impairment	
PRAD	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.92	15.47	5.97E-44	Type 2 diabetes	
PRAD	cis	1	rs2432871	chr6:143733908	ADAT2	chr6:143743970-143771841:-	0.13	3.74	0.000206	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
PRAD	cis	1	rs2432872	chr6:143734156	ADAT2	chr6:143743970-143771841:-	0.12	3.7	0.000241	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
PRAD	cis	1	rs2433420	chr11:86414361	CCDC83	chr11:85566144-85631051:+	-0.21	-3.94	9.22E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	
PRAD	cis	1	rs2433420	chr11:86414361	SYTL2	chr11:85405267-85522178:-	-0.19	-3.62	0.000322	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	
PRAD	cis	1	rs2435362	chr10:43578779	RET	chr10:43572517-43625795:+	0.23	3.57	0.000396	Hirschsprung disease	
PRAD	cis	1	rs2436094	chr8:133106065	KCNQ3	chr8:133141257-133493004:-	0.34	4.56	6.42E-6	Common traits (Other)	
PRAD	cis	1	rs244286	chr17:53232594	COX11	chr17:53029259-53046064:-	-0.22	-4.47	9.81E-6	Menarche (age at onset)	
PRAD	cis	1	rs244286	chr17:53232594	STXBP4	chr17:53046126-53241449:+	-0.14	-3.51	0.000489	Menarche (age at onset)	
PRAD	cis	1	rs244286	chr17:53232594	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.69	0.000249	Menarche (age at onset)	
PRAD	cis	1	rs244288	chr17:53231841	COX11	chr17:53029259-53046064:-	-0.22	-4.42	1.24E-5	Menarche (age at onset)	
PRAD	cis	1	rs244288	chr17:53231841	STXBP4	chr17:53046126-53241449:+	-0.14	-3.5	0.000506	Menarche (age at onset)	
PRAD	cis	1	rs244288	chr17:53231841	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.64	0.000301	Menarche (age at onset)	
PRAD	cis	1	rs244289	chr17:53231788	COX11	chr17:53029259-53046064:-	-0.23	-4.47	9.9E-6	Menarche (age at onset)	
PRAD	cis	1	rs244289	chr17:53231788	STXBP4	chr17:53046126-53241449:+	-0.14	-3.51	0.000487	Menarche (age at onset)	
PRAD	cis	1	rs244289	chr17:53231788	TOM1L1	chr17:52978052-53039328:+	-0.12	-3.52	0.000467	Menarche (age at onset)	
PRAD	cis	1	rs244291	chr17:53231137	COX11	chr17:53029259-53046064:-	-0.2	-4.03	6.49E-5	Menarche (age at onset)	
PRAD	cis	1	rs244292	chr17:53230734	COX11	chr17:53029259-53046064:-	-0.23	-4.47	9.9E-6	Menarche (age at onset)	
PRAD	cis	1	rs244292	chr17:53230734	STXBP4	chr17:53046126-53241449:+	-0.14	-3.51	0.000487	Menarche (age at onset)	
PRAD	cis	1	rs244292	chr17:53230734	TOM1L1	chr17:52978052-53039328:+	-0.12	-3.52	0.000467	Menarche (age at onset)	
PRAD	cis	1	rs244293	chr17:53230722	COX11	chr17:53029259-53046064:-	-0.2	-4.02	6.75E-5	Menarche (age at onset)	
PRAD	cis	1	rs244295	chr17:53242899	COX11	chr17:53029259-53046064:-	-0.22	-4.31	2.03E-5	Menarche (age at onset)	
PRAD	cis	1	rs244295	chr17:53242899	STXBP4	chr17:53046126-53241449:+	-0.14	-3.61	0.000338	Menarche (age at onset)	
PRAD	cis	1	rs244295	chr17:53242899	TOM1L1	chr17:52978052-53039328:+	-0.12	-3.47	0.00056	Menarche (age at onset)	
PRAD	cis	1	rs244296	chr17:53242878	COX11	chr17:53029259-53046064:-	-0.23	-4.53	7.66E-6	Menarche (age at onset)	
PRAD	cis	1	rs244296	chr17:53242878	STXBP4	chr17:53046126-53241449:+	-0.15	-3.69	0.000254	Menarche (age at onset)	
PRAD	cis	1	rs244299	chr17:53240266	COX11	chr17:53029259-53046064:-	0.2	4.11	4.59E-5	Menarche (age at onset)	
PRAD	cis	1	rs244316	chr17:53215223	COX11	chr17:53029259-53046064:-	-0.24	-4.75	2.7E-6	Menarche (age at onset)	
PRAD	cis	1	rs2447151	chr8:120384770	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000236	Hypertension	
PRAD	cis	1	rs2447153	chr8:120383871	NOV	chr8:120428552-120436678:+	-0.24	-3.72	0.000226	Hypertension	
PRAD	cis	1	rs2447155	chr8:120380303	NOV	chr8:120428552-120436678:+	-0.24	-3.72	0.000226	Hypertension	
PRAD	cis	1	rs2447159	chr8:120375189	NOV	chr8:120428552-120436678:+	-0.24	-3.64	0.000304	Hypertension	
PRAD	cis	1	rs2447160	chr8:120374473	NOV	chr8:120428552-120436678:+	-0.24	-3.67	0.000266	Hypertension	
PRAD	cis	1	rs2447163	chr8:120373249	NOV	chr8:120428552-120436678:+	-0.24	-3.67	0.000266	Hypertension	
PRAD	cis	1	rs2447164	chr8:120371887	NOV	chr8:120428552-120436678:+	-0.23	-3.58	0.000373	Hypertension	
PRAD	cis	1	rs2447165	chr8:120371318	NOV	chr8:120428552-120436678:+	-0.24	-3.7	0.000243	Hypertension	
PRAD	cis	1	rs2447167	chr8:120366068	NOV	chr8:120428552-120436678:+	-0.24	-3.7	0.000243	Hypertension	
PRAD	cis	1	rs2447168	chr8:120365613	NOV	chr8:120428552-120436678:+	-0.25	-3.71	0.000231	Hypertension	
PRAD	cis	1	rs2447169	chr8:120365063	NOV	chr8:120428552-120436678:+	0.24	3.69	0.000249	Hypertension	
PRAD	cis	1	rs2447171	chr8:120360953	NOV	chr8:120428552-120436678:+	-0.24	-3.66	0.000276	Hypertension	
PRAD	cis	1	rs2447172	chr8:120360863	NOV	chr8:120428552-120436678:+	-0.24	-3.66	0.000276	Hypertension	
PRAD	cis	1	rs2447174	chr8:120358571	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000236	Hypertension	
PRAD	cis	1	rs2447176	chr8:120356892	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000236	Hypertension	
PRAD	cis	1	rs2447178	chr8:120356188	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000229	Hypertension	
PRAD	cis	1	rs2447179	chr8:120355775	NOV	chr8:120428552-120436678:+	-0.25	-3.78	0.000177	Hypertension	
PRAD	cis	1	rs2447181	chr8:120354288	NOV	chr8:120428552-120436678:+	-0.24	-3.67	0.000273	Hypertension	
PRAD	cis	1	rs2447183	chr8:120352978	NOV	chr8:120428552-120436678:+	-0.24	-3.68	0.000258	Hypertension	
PRAD	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.52	6.64	8.81E-11	Tumor biomarkers	
PRAD	cis	1	rs2447196	chr15:43893818	CATSPER2	chr15:43922774-43959900:-	0.23	4.22	2.9E-5	Tumor biomarkers	
PRAD	cis	1	rs2447196	chr15:43893818	CKMT1A	chr15:43985084-43991419:+	0.46	5.3	1.75E-7	Tumor biomarkers	
PRAD	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.53	-6.72	5.31E-11	Tumor biomarkers	
PRAD	cis	1	rs2447208	chr15:43933895	CATSPER2	chr15:43922774-43959900:-	-0.28	-5.09	5.26E-7	Tumor biomarkers	
PRAD	cis	1	rs2447208	chr15:43933895	CKMT1A	chr15:43985084-43991419:+	-0.49	-5.6	3.56E-8	Tumor biomarkers	
PRAD	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.54	-6.66	7.57E-11	Tumor biomarkers	
PRAD	cis	1	rs2447211	chr15:43936351	CATSPER2	chr15:43922774-43959900:-	-0.26	-4.56	6.39E-6	Tumor biomarkers	
PRAD	cis	1	rs2447211	chr15:43936351	CKMT1A	chr15:43985084-43991419:+	-0.52	-5.8	1.2E-8	Tumor biomarkers	
PRAD	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.43	9.13	2.1E-18	Homocysteine levels	
PRAD	cis	1	rs2448707	chr6:49446951	CENPQ	chr6:49431096-49460820:+	0.39	8.21	2.11E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs2448707	chr6:49446951	MUT	chr6:49398994-49431031:-	-0.18	-4.99	8.46E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs244899	chr5:167911040	FBLL1	chr5:167956582-167957638:+	0.55	10.47	3.37E-23	Response to platinum-based chemotherapy (carboplatin)	
PRAD	cis	1	rs2450122	chr11:77930345	GAB2	chr11:77926343-78128766:-	-0.19	-5.91	6.41E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2450123	chr11:77952771	GAB2	chr11:77926343-78128766:-	-0.2	-6.15	1.67E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2450123	chr11:77952771	NARS2	chr11:78147017-78285909:-	-0.19	-3.75	0.000199	Testicular germ cell tumor	
PRAD	cis	1	rs2450128	chr11:77940075	GAB2	chr11:77926343-78128766:-	-0.18	-5.82	1.1E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2450128	chr11:77940075	NARS2	chr11:78147017-78285909:-	-0.25	-5.32	1.57E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2450129	chr11:77940385	GAB2	chr11:77926343-78128766:-	-0.19	-5.79	1.25E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2450129	chr11:77940385	NARS2	chr11:78147017-78285909:-	-0.23	-4.61	5.13E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2450131	chr11:77944568	GAB2	chr11:77926343-78128766:-	-0.19	-5.82	1.08E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2450131	chr11:77944568	NARS2	chr11:78147017-78285909:-	-0.19	-3.65	0.000295	Testicular germ cell tumor	
PRAD	cis	1	rs2454722	chr12:123171218	GPR109B	chr12:123199304-123201439:-	0.34	6	4.05E-9	Adiponectin levels	
PRAD	cis	1	rs2455219	chr5:75922581	F2RL2	chr5:75911308-75919240:-	-0.2	-4.55	6.88E-6	Hearing impairment	
PRAD	cis	1	rs2456173	chr5:176514595	RGS14	chr5:176784844-176799598:+	-0.2	-3.81	0.000156	Height	
PRAD	cis	1	rs2457552	chr6:160804637	SLC22A2	chr6:160592093-160679959:-	-0.22	-3.58	0.000382	Response to hepatitis C treatment	
PRAD	cis	1	rs2457555	chr6:160800312	SLC22A2	chr6:160592093-160679959:-	-0.22	-3.58	0.000382	Response to hepatitis C treatment	
PRAD	cis	1	rs2457570	chr6:160829518	SLC22A2	chr6:160592093-160679959:-	-0.22	-3.52	0.000478	Response to hepatitis C treatment	
PRAD	cis	1	rs2458344	chr11:106306154	GUCY1A2	chr11:106557910-106889171:-	-0.17	-3.51	0.000493	Colorectal or endometrial cancer	
PRAD	cis	1	rs2458413	chr8:105359432	TM7SF4	chr8:105352054-105368916:+	0.21	3.91	0.000106	Paget's disease	
PRAD	cis	1	rs2458414	chr8:105355840	TM7SF4	chr8:105352054-105368916:+	0.21	3.99	7.56E-5	Paget's disease	
PRAD	cis	1	rs2459629	chr5:42790874	CCDC152	chr5:42756920-42802539:+	-0.16	-4.43	1.17E-5	Height	
PRAD	cis	1	rs2459629	chr5:42790874	SEPP1	chr5:42799983-42825998:-	-0.15	-4.33	1.82E-5	Height	
PRAD	cis	1	rs2460422	chr7:65601505	CCT6P1	chr7:65216092-65228661:+	0.33	5.78	1.37E-8	Diabetic kidney disease	
PRAD	cis	1	rs2460422	chr7:65601505	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000135	Diabetic kidney disease	
PRAD	cis	1	rs2462569	chr7:65474846	CCT6P1	chr7:65216092-65228661:+	-0.3	-5.45	8.12E-8	Diabetic kidney disease	
PRAD	cis	1	rs2462569	chr7:65474846	CRCP	chr7:65579805-65619551:+	0.27	3.47	0.000567	Diabetic kidney disease	
PRAD	cis	1	rs2463820	chr11:62112290	ASRGL1	chr11:62104774-62160885:+	-0.39	-4.81	2.01E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs2463821	chr11:62111662	ASRGL1	chr11:62104774-62160885:+	-0.39	-4.78	2.32E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs2463822	chr11:62103420	ASRGL1	chr11:62104774-62160885:+	-0.39	-4.79	2.24E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs2463825	chr11:62094493	ASRGL1	chr11:62104774-62160885:+	-0.35	-4.49	8.81E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.36	-11.49	4.24E-27	Ankylosing spondylitis	
PRAD	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.55	10.78	2.32E-24	Ankylosing spondylitis	
PRAD	cis	1	rs2465120	chr7:65620974	CCT6P1	chr7:65216092-65228661:+	0.34	5.85	9.2E-9	Diabetic kidney disease	
PRAD	cis	1	rs2465120	chr7:65620974	CRCP	chr7:65579805-65619551:+	-0.32	-3.94	9.21E-5	Diabetic kidney disease	
PRAD	cis	1	rs2468186	chr8:120200702	COLEC10	chr8:120079424-120119195:+	0.18	3.62	0.000323	Osteoprotegerin levels	
PRAD	cis	1	rs2469996	chr8:120353011	NOV	chr8:120428552-120436678:+	-0.24	-3.76	0.00019	Hypertension	
PRAD	cis	1	rs2469997	chr8:120353267	NOV	chr8:120428552-120436678:+	0.26	3.96	8.71E-5	Hypertension	
PRAD	cis	1	rs2469998	chr8:120354022	NOV	chr8:120428552-120436678:+	-0.24	-3.67	0.000273	Hypertension	
PRAD	cis	1	rs2469999	chr8:120354695	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000236	Hypertension	
PRAD	cis	1	rs2470003	chr8:120357482	NOV	chr8:120428552-120436678:+	-0.23	-3.59	0.000362	Hypertension	
PRAD	cis	1	rs2470006	chr8:120358591	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000236	Hypertension	
PRAD	cis	1	rs2470008	chr8:120359366	NOV	chr8:120428552-120436678:+	-0.23	-3.59	0.000362	Hypertension	
PRAD	cis	1	rs2470009	chr8:120359377	NOV	chr8:120428552-120436678:+	-0.23	-3.59	0.000362	Hypertension	
PRAD	cis	1	rs2470012	chr8:120360488	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000236	Hypertension	
PRAD	cis	1	rs2470014	chr8:120360820	NOV	chr8:120428552-120436678:+	-0.25	-3.78	0.000177	Hypertension	
PRAD	cis	1	rs2470016	chr8:120361220	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000236	Hypertension	
PRAD	cis	1	rs2470017	chr8:120361534	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000236	Hypertension	
PRAD	cis	1	rs2470021	chr8:120362644	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000236	Hypertension	
PRAD	cis	1	rs2470024	chr8:120363181	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000236	Hypertension	
PRAD	cis	1	rs2470025	chr8:120364727	NOV	chr8:120428552-120436678:+	-0.25	-3.8	0.000162	Hypertension	
PRAD	cis	1	rs2470026	chr8:120365112	NOV	chr8:120428552-120436678:+	0.23	3.57	0.000394	Hypertension	
PRAD	cis	1	rs2470028	chr8:120365878	NOV	chr8:120428552-120436678:+	-0.24	-3.64	0.000298	Hypertension	
PRAD	cis	1	rs2470033	chr8:120375066	NOV	chr8:120428552-120436678:+	-0.24	-3.69	0.000255	Hypertension	
PRAD	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.55	6.81	3.06E-11	Tumor biomarkers	
PRAD	cis	1	rs2470134	chr15:43849886	CKMT1A	chr15:43985084-43991419:+	0.52	5.89	7.46E-9	Tumor biomarkers	
PRAD	cis	1	rs2471851	chr11:113301069	TTC12	chr11:113185251-113244016:+	0.25	3.45	0.000606	Select biomarker traits	
PRAD	cis	1	rs2471884	chr11:117010320	PCSK7	chr11:117075789-117102811:-	-0.39	-5.15	3.76E-7	Protein quantitative trait loci	
PRAD	cis	1	rs2472476	chr9:107531956	LOC286367	chr9:107536633-107540044:+	0.16	3.72	0.000225	Obesity-related traits	
PRAD	cis	1	rs2472476	chr9:107531956	NIPSNAP3A	chr9:107509969-107535189:+	0.26	5.31	1.67E-7	Obesity-related traits	
PRAD	cis	1	rs2472478	chr9:107531361	LOC286367	chr9:107536633-107540044:+	0.17	3.89	0.000113	Obesity-related traits	
PRAD	cis	1	rs2472478	chr9:107531361	NIPSNAP3A	chr9:107509969-107535189:+	0.26	5.29	1.88E-7	Obesity-related traits	
PRAD	cis	1	rs2473851	chr1:23489869	C1orf213	chr1:23695464-23698278:+	-0.18	-4.57	6.35E-6	Height	
PRAD	cis	1	rs2474777	chr20:25272633	FAM182B	chr20:25744102-25848786:-	0.32	5.83	1.01E-8	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2474777	chr20:25272633	PYGB	chr20:25228706-25278647:+	-0.28	-6.08	2.55E-9	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs247606	chr16:56961204	SLC12A3	chr16:56899119-56949760:+	0.27	3.63	0.000313	Metabolic syndrome	
PRAD	cis	1	rs2477083	chr1:68921521	DEPDC1	chr1:68939837-68962799:-	0.47	7.91	1.82E-14	IgG glycosylation	
PRAD	cis	1	rs2482427	chr9:107532425	NIPSNAP3A	chr9:107509969-107535189:+	0.26	5.38	1.18E-7	Obesity-related traits	
PRAD	cis	1	rs2482911	chr20:25395528	ENTPD6	chr20:25176339-25207360:+	0.18	4.75	2.67E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482911	chr20:25395528	FAM182B	chr20:25744102-25848786:-	-0.35	-6.44	2.89E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482911	chr20:25395528	PYGB	chr20:25228706-25278647:+	0.35	7.66	1.08E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482919	chr20:25299756	ENTPD6	chr20:25176339-25207360:+	0.16	4.32	1.88E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482919	chr20:25299756	FAM182B	chr20:25744102-25848786:-	-0.37	-6.81	3.08E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482919	chr20:25299756	PYGB	chr20:25228706-25278647:+	0.33	7.21	2.22E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482927	chr20:25327151	ENTPD6	chr20:25176339-25207360:+	0.16	4.32	1.88E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482927	chr20:25327151	FAM182B	chr20:25744102-25848786:-	-0.37	-6.81	3.08E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482927	chr20:25327151	PYGB	chr20:25228706-25278647:+	0.33	7.21	2.22E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482928	chr20:25331530	ENTPD6	chr20:25176339-25207360:+	0.18	4.74	2.85E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482928	chr20:25331530	FAM182B	chr20:25744102-25848786:-	-0.35	-6.5	2.05E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482928	chr20:25331530	PYGB	chr20:25228706-25278647:+	0.35	7.67	1.03E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482930	chr20:25334115	ENTPD6	chr20:25176339-25207360:+	0.18	4.74	2.85E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482930	chr20:25334115	FAM182B	chr20:25744102-25848786:-	-0.35	-6.5	2.05E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482930	chr20:25334115	PYGB	chr20:25228706-25278647:+	0.35	7.67	1.03E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482931	chr20:25334445	ENTPD6	chr20:25176339-25207360:+	0.16	4.32	1.88E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482931	chr20:25334445	FAM182B	chr20:25744102-25848786:-	-0.37	-6.81	3.08E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482931	chr20:25334445	PYGB	chr20:25228706-25278647:+	0.33	7.21	2.22E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482937	chr20:25340786	ENTPD6	chr20:25176339-25207360:+	0.18	4.74	2.85E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482937	chr20:25340786	FAM182B	chr20:25744102-25848786:-	-0.35	-6.5	2.05E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482937	chr20:25340786	PYGB	chr20:25228706-25278647:+	0.35	7.67	1.03E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482940	chr20:25349830	ENTPD6	chr20:25176339-25207360:+	0.16	4.33	1.79E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482940	chr20:25349830	FAM182B	chr20:25744102-25848786:-	-0.37	-6.75	4.4E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482940	chr20:25349830	PYGB	chr20:25228706-25278647:+	0.33	7.2	2.36E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482941	chr20:25361216	ENTPD6	chr20:25176339-25207360:+	0.16	4.33	1.79E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482941	chr20:25361216	FAM182B	chr20:25744102-25848786:-	-0.37	-6.75	4.4E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482941	chr20:25361216	PYGB	chr20:25228706-25278647:+	0.33	7.2	2.36E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482943	chr20:25380593	ENTPD6	chr20:25176339-25207360:+	0.17	4.53	7.35E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482943	chr20:25380593	FAM182B	chr20:25744102-25848786:-	-0.37	-6.67	7.13E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2482943	chr20:25380593	PYGB	chr20:25228706-25278647:+	0.34	7.4	6.53E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2486447	chr1:46545724	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.89	1.11E-28	Body mass index	
PRAD	cis	1	rs2486447	chr1:46545724	MMACHC	chr1:45965856-45976737:+	-0.16	-3.69	0.000247	Body mass index	
PRAD	cis	1	rs2486447	chr1:46545724	MUTYH	chr1:45794915-45806142:-	0.2	5.9	7.07E-9	Body mass index	
PRAD	cis	1	rs248652	chr5:130654837	P4HA2	chr5:131528306-131563556:-	-0.22	-3.96	8.63E-5	Life satisfaction	
PRAD	cis	1	rs2487701	chr10:70746267	STOX1	chr10:70587294-70655209:+	-0.21	-3.8	0.000161	Schizophrenia	
PRAD	cis	1	rs2487702	chr10:70750148	STOX1	chr10:70587294-70655209:+	-0.24	-4.39	1.4E-5	Schizophrenia	
PRAD	cis	1	rs2487706	chr10:70764444	STOX1	chr10:70587294-70655209:+	-0.23	-4.21	3.06E-5	Schizophrenia	
PRAD	cis	1	rs2487707	chr10:70765092	STOX1	chr10:70587294-70655209:+	-0.23	-4.21	3.05E-5	Schizophrenia	
PRAD	cis	1	rs2487708	chr10:70767402	STOX1	chr10:70587294-70655209:+	-0.23	-4.29	2.18E-5	Schizophrenia	
PRAD	cis	1	rs2487715	chr9:107532394	NIPSNAP3A	chr9:107509969-107535189:+	0.29	5.89	7.31E-9	Obesity-related traits	
PRAD	cis	1	rs2489034	chr10:102319192	SEC31B	chr10:102246403-102289636:-	-0.26	-7.99	1.03E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489035	chr10:102319395	SEC31B	chr10:102246403-102289636:-	-0.26	-7.97	1.25E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489036	chr10:102319581	SEC31B	chr10:102246403-102289636:-	-0.26	-7.98	1.16E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489037	chr10:102319918	SEC31B	chr10:102246403-102289636:-	0.3	8.6	1.17E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489039	chr10:102328036	SEC31B	chr10:102246403-102289636:-	-0.27	-8.23	1.81E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489040	chr10:102331298	SEC31B	chr10:102246403-102289636:-	-0.29	-8.6	1.23E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489043	chr10:102334327	SEC31B	chr10:102246403-102289636:-	-0.27	-8.32	9.52E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489045	chr10:102344754	SEC31B	chr10:102246403-102289636:-	-0.3	-8.47	3.18E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489046	chr10:102346282	SEC31B	chr10:102246403-102289636:-	-0.25	-7.85	2.92E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489047	chr10:102347028	SEC31B	chr10:102246403-102289636:-	-0.26	-7.93	1.66E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489048	chr10:102348497	SEC31B	chr10:102246403-102289636:-	-0.29	-8.27	1.4E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489049	chr10:102350732	SEC31B	chr10:102246403-102289636:-	-0.26	-7.87	2.4E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489050	chr10:102350898	SEC31B	chr10:102246403-102289636:-	-0.29	-8.26	1.5E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489051	chr10:102351785	SEC31B	chr10:102246403-102289636:-	0.27	7.94	1.54E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489053	chr10:102353341	SEC31B	chr10:102246403-102289636:-	-0.26	-7.76	5.46E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2489715	chr10:42917476	LOC84856	chr10:42970939-42990784:+	-0.32	-4.68	3.7E-6	Helix rolling	
PRAD	cis	1	rs2490261	chr1:207477469	CD55	chr1:207494817-207534309:+	0.47	9.13	2.08E-18	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2491023	chr10:70754071	KIAA1279	chr10:70748493-70776734:+	-0.14	-3.46	0.000589	Schizophrenia	
PRAD	cis	1	rs2491023	chr10:70754071	STOX1	chr10:70587294-70655209:+	-0.22	-4.01	7.0E-5	Schizophrenia	
PRAD	cis	1	rs2492859	chr6:34645266	C6orf106	chr6:34555066-34664625:-	0.25	3.53	0.000457	Pubertal anthropometrics	
PRAD	cis	1	rs2492859	chr6:34645266	UHRF1BP1	chr6:34759794-34853117:+	0.19	5.05	6.39E-7	Pubertal anthropometrics	
PRAD	cis	1	rs2495732	chr10:102357780	SEC31B	chr10:102246403-102289636:-	-0.28	-7.87	2.49E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495734	chr10:102338686	SEC31B	chr10:102246403-102289636:-	-0.28	-8.3	1.13E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495736	chr10:102338410	SEC31B	chr10:102246403-102289636:-	-0.29	-8.36	7.01E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495737	chr10:102338344	SEC31B	chr10:102246403-102289636:-	-0.28	-8.31	1.05E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495739	chr10:102335507	SEC31B	chr10:102246403-102289636:-	-0.29	-8.6	1.23E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495741	chr10:102331795	SEC31B	chr10:102246403-102289636:-	-0.27	-8.32	9.52E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495742	chr10:102331364	SEC31B	chr10:102246403-102289636:-	-0.29	-8.54	1.86E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495743	chr10:102329739	SEC31B	chr10:102246403-102289636:-	-0.29	-8.37	6.5E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495745	chr10:102329075	SEC31B	chr10:102246403-102289636:-	-0.26	-8.09	5.09E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495747	chr10:102328247	SEC31B	chr10:102246403-102289636:-	-0.26	-8.09	5.09E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495750	chr10:102327708	SEC31B	chr10:102246403-102289636:-	-0.27	-8.2	2.26E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495751	chr10:102327260	SEC31B	chr10:102246403-102289636:-	-0.27	-8.23	1.81E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495752	chr10:102326115	SEC31B	chr10:102246403-102289636:-	-0.27	-8.02	8.31E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495753	chr10:102325640	SEC31B	chr10:102246403-102289636:-	-0.29	-8.32	9.84E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495754	chr10:102324812	SEC31B	chr10:102246403-102289636:-	-0.27	-8.02	8.31E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495755	chr10:102324649	SEC31B	chr10:102246403-102289636:-	-0.3	-8.49	2.8E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495758	chr10:102321900	SEC31B	chr10:102246403-102289636:-	-0.3	-8.49	2.8E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495759	chr10:102320363	SEC31B	chr10:102246403-102289636:-	-0.29	-7.96	1.27E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2495760	chr10:102318771	SEC31B	chr10:102246403-102289636:-	-0.3	-8.5	2.63E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs2496588	chr6:143733124	ADAT2	chr6:143743970-143771841:-	0.13	3.68	0.000265	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
PRAD	cis	1	rs2498471	chr6:49484433	CENPQ	chr6:49431096-49460820:+	0.22	4.35	1.68E-5	Brain structure	
PRAD	cis	1	rs2498703	chr6:116660670	FAM26F	chr6:116782556-116784933:+	-0.13	-3.97	8.4E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs2498710	chr6:116670636	FAM26F	chr6:116782556-116784933:+	-0.13	-3.89	0.000113	Fast beta electroencephalogram	
PRAD	cis	1	rs2500404	chr20:25359758	ENTPD6	chr20:25176339-25207360:+	0.16	4.33	1.79E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500404	chr20:25359758	FAM182B	chr20:25744102-25848786:-	-0.37	-6.75	4.4E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500404	chr20:25359758	PYGB	chr20:25228706-25278647:+	0.33	7.2	2.36E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500405	chr20:25360826	ENTPD6	chr20:25176339-25207360:+	0.16	4.33	1.79E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500405	chr20:25360826	FAM182B	chr20:25744102-25848786:-	-0.37	-6.75	4.4E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500405	chr20:25360826	PYGB	chr20:25228706-25278647:+	0.33	7.2	2.36E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500418	chr20:25382268	ENTPD6	chr20:25176339-25207360:+	0.17	4.43	1.18E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500418	chr20:25382268	FAM182B	chr20:25744102-25848786:-	-0.36	-6.59	1.16E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500418	chr20:25382268	PYGB	chr20:25228706-25278647:+	0.33	7.26	1.61E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500424	chr20:25391969	ENTPD6	chr20:25176339-25207360:+	0.16	4.31	1.98E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500424	chr20:25391969	FAM182B	chr20:25744102-25848786:-	-0.37	-6.69	6.53E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500424	chr20:25391969	PYGB	chr20:25228706-25278647:+	0.33	7.17	3.02E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500432	chr20:25290512	ENTPD6	chr20:25176339-25207360:+	-0.18	-4.73	2.96E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500432	chr20:25290512	FAM182B	chr20:25744102-25848786:-	0.35	6.49	2.24E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500432	chr20:25290512	PYGB	chr20:25228706-25278647:+	-0.34	-7.64	1.25E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500436	chr20:25406366	ENTPD6	chr20:25176339-25207360:+	0.18	4.75	2.67E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500436	chr20:25406366	FAM182B	chr20:25744102-25848786:-	-0.36	-6.48	2.35E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500436	chr20:25406366	PYGB	chr20:25228706-25278647:+	0.35	7.69	8.68E-14	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500443	chr20:25331442	ENTPD6	chr20:25176339-25207360:+	0.18	4.74	2.85E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500443	chr20:25331442	FAM182B	chr20:25744102-25848786:-	-0.35	-6.5	2.05E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500443	chr20:25331442	PYGB	chr20:25228706-25278647:+	0.35	7.67	1.03E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500446	chr20:25339664	ENTPD6	chr20:25176339-25207360:+	0.18	4.74	2.85E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500446	chr20:25339664	FAM182B	chr20:25744102-25848786:-	-0.35	-6.5	2.05E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500446	chr20:25339664	PYGB	chr20:25228706-25278647:+	0.35	7.67	1.03E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500448	chr20:25404027	ENTPD6	chr20:25176339-25207360:+	0.16	4.33	1.8E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500448	chr20:25404027	FAM182B	chr20:25744102-25848786:-	-0.37	-6.78	3.55E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2500448	chr20:25404027	PYGB	chr20:25228706-25278647:+	0.33	7.23	1.95E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2501050	chr6:116663206	FAM26F	chr6:116782556-116784933:+	-0.13	-3.89	0.000113	Fast beta electroencephalogram	
PRAD	cis	1	rs2501962	chr6:49453636	CENPQ	chr6:49431096-49460820:+	0.41	8.62	1.03E-16	Folate pathway vitamin levels	
PRAD	cis	1	rs2501962	chr6:49453636	MUT	chr6:49398994-49431031:-	-0.18	-5.15	3.84E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs2501963	chr6:49454281	CENPQ	chr6:49431096-49460820:+	0.4	8.4	5.38E-16	Folate pathway vitamin levels	
PRAD	cis	1	rs2501963	chr6:49454281	MUT	chr6:49398994-49431031:-	-0.18	-5.12	4.56E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs2502731	chr9:130976557	CIZ1	chr9:130928345-130966662:-	0.18	3.52	0.000475	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs2502731	chr9:130976557	LCN2	chr9:130911732-130915734:+	-0.18	-3.84	0.00014	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs2502757	chr9:136586954	SARDH	chr9:136528686-136605077:-	-0.38	-6.17	1.45E-9	Asthma	
PRAD	cis	1	rs2504917	chr6:160806044	SLC22A2	chr6:160592093-160679959:-	-0.22	-3.58	0.000382	Response to hepatitis C treatment	
PRAD	cis	1	rs2504931	chr6:160835529	SLC22A2	chr6:160592093-160679959:-	-0.22	-3.52	0.000478	Response to hepatitis C treatment	
PRAD	cis	1	rs2504938	chr6:160824754	SLC22A2	chr6:160592093-160679959:-	-0.22	-3.47	0.000576	Response to hepatitis C treatment	
PRAD	cis	1	rs2504939	chr6:160832150	SLC22A2	chr6:160592093-160679959:-	-0.22	-3.56	0.000409	Response to hepatitis C treatment	
PRAD	cis	1	rs2505841	chr10:42886786	LOC84856	chr10:42970939-42990784:+	-0.29	-4.4	1.32E-5	Helix rolling	
PRAD	cis	1	rs2505842	chr10:42887560	LOC84856	chr10:42970939-42990784:+	-0.34	-4.91	1.27E-6	Helix rolling	
PRAD	cis	1	rs2505859	chr10:42905911	LOC84856	chr10:42970939-42990784:+	-0.32	-4.65	4.3E-6	Helix rolling	
PRAD	cis	1	rs2505998	chr10:43570925	RET	chr10:43572517-43625795:+	0.24	3.67	0.000275	Hirschsprung disease	
PRAD	cis	1	rs2510032	chr11:77968631	GAB2	chr11:77926343-78128766:-	-0.2	-6.14	1.74E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2510032	chr11:77968631	NARS2	chr11:78147017-78285909:-	-0.19	-3.64	0.000305	Testicular germ cell tumor	
PRAD	cis	1	rs2510035	chr11:77953175	GAB2	chr11:77926343-78128766:-	-0.2	-6.05	2.94E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2510035	chr11:77953175	NARS2	chr11:78147017-78285909:-	-0.19	-3.56	0.000409	Testicular germ cell tumor	
PRAD	cis	1	rs2510036	chr11:77966788	GAB2	chr11:77926343-78128766:-	-0.2	-6.04	3.09E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2510036	chr11:77966788	NARS2	chr11:78147017-78285909:-	-0.2	-3.9	0.000109	Testicular germ cell tumor	
PRAD	cis	1	rs2510037	chr11:77966099	GAB2	chr11:77926343-78128766:-	-0.18	-6	3.92E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2510037	chr11:77966099	NARS2	chr11:78147017-78285909:-	-0.26	-5.57	4.19E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2510039	chr11:77944480	GAB2	chr11:77926343-78128766:-	-0.19	-5.78	1.37E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2510039	chr11:77944480	NARS2	chr11:78147017-78285909:-	-0.2	-3.72	0.000226	Testicular germ cell tumor	
PRAD	cis	1	rs2510040	chr11:77944548	GAB2	chr11:77926343-78128766:-	-0.19	-5.85	9.34E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2510040	chr11:77944548	NARS2	chr11:78147017-78285909:-	-0.23	-4.57	6.16E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2510041	chr11:77945284	GAB2	chr11:77926343-78128766:-	-0.17	-5.72	1.9E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2510041	chr11:77945284	NARS2	chr11:78147017-78285909:-	-0.23	-5.01	7.76E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2510043	chr11:77977481	GAB2	chr11:77926343-78128766:-	-0.18	-6.24	9.99E-10	Testicular germ cell tumor	
PRAD	cis	1	rs2510043	chr11:77977481	NARS2	chr11:78147017-78285909:-	-0.23	-5.03	7.1E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2510045	chr11:77920563	GAB2	chr11:77926343-78128766:-	-0.2	-5.93	6.04E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2510045	chr11:77920563	NARS2	chr11:78147017-78285909:-	-0.23	-4.36	1.58E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2510046	chr11:77988817	GAB2	chr11:77926343-78128766:-	-0.22	-6.6	1.12E-10	Testicular germ cell tumor	
PRAD	cis	1	rs2510046	chr11:77988817	NARS2	chr11:78147017-78285909:-	-0.2	-3.84	0.000139	Testicular germ cell tumor	
PRAD	cis	1	rs2510047	chr11:77988668	GAB2	chr11:77926343-78128766:-	0.19	6.12	1.97E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2510047	chr11:77988668	NARS2	chr11:78147017-78285909:-	0.26	5.6	3.69E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2510048	chr11:77987464	GAB2	chr11:77926343-78128766:-	-0.21	-6.57	1.31E-10	Testicular germ cell tumor	
PRAD	cis	1	rs2510048	chr11:77987464	NARS2	chr11:78147017-78285909:-	-0.2	-3.83	0.000147	Testicular germ cell tumor	
PRAD	cis	1	rs2510049	chr11:77985459	GAB2	chr11:77926343-78128766:-	-0.21	-6.3	6.69E-10	Testicular germ cell tumor	
PRAD	cis	1	rs2510049	chr11:77985459	NARS2	chr11:78147017-78285909:-	-0.19	-3.75	0.000202	Testicular germ cell tumor	
PRAD	cis	1	rs2510050	chr11:77982564	GAB2	chr11:77926343-78128766:-	-0.19	-5.88	7.92E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2510050	chr11:77982564	NARS2	chr11:78147017-78285909:-	-0.2	-3.97	8.46E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2510051	chr11:77981171	GAB2	chr11:77926343-78128766:-	-0.2	-6.24	9.7E-10	Testicular germ cell tumor	
PRAD	cis	1	rs2510051	chr11:77981171	NARS2	chr11:78147017-78285909:-	-0.24	-4.93	1.13E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2510054	chr11:77959659	GAB2	chr11:77926343-78128766:-	0.18	5.81	1.17E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2510054	chr11:77959659	NARS2	chr11:78147017-78285909:-	0.19	3.93	9.94E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2510055	chr11:77961912	GAB2	chr11:77926343-78128766:-	-0.2	-6.12	1.99E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2510055	chr11:77961912	NARS2	chr11:78147017-78285909:-	-0.19	-3.66	0.000277	Testicular germ cell tumor	
PRAD	cis	1	rs2511155	chr11:77969223	GAB2	chr11:77926343-78128766:-	-0.19	-6.02	3.58E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2511155	chr11:77969223	NARS2	chr11:78147017-78285909:-	-0.23	-4.62	5.0E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2511156	chr11:77971167	GAB2	chr11:77926343-78128766:-	-0.2	-6.02	3.54E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2511156	chr11:77971167	NARS2	chr11:78147017-78285909:-	-0.2	-3.99	7.76E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2511157	chr11:77972632	GAB2	chr11:77926343-78128766:-	-0.21	-6.33	5.73E-10	Testicular germ cell tumor	
PRAD	cis	1	rs2511157	chr11:77972632	NARS2	chr11:78147017-78285909:-	-0.21	-3.97	8.18E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2511158	chr11:77973980	GAB2	chr11:77926343-78128766:-	-0.2	-6.06	2.81E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2511158	chr11:77973980	NARS2	chr11:78147017-78285909:-	-0.2	-3.89	0.000114	Testicular germ cell tumor	
PRAD	cis	1	rs2511166	chr11:77964331	GAB2	chr11:77926343-78128766:-	-0.18	-5.94	5.63E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2511166	chr11:77964331	NARS2	chr11:78147017-78285909:-	-0.24	-5.14	4.11E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2511168	chr11:77965081	GAB2	chr11:77926343-78128766:-	-0.19	-5.86	8.84E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2511168	chr11:77965081	NARS2	chr11:78147017-78285909:-	-0.23	-4.71	3.34E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2511169	chr11:77965321	GAB2	chr11:77926343-78128766:-	-0.18	-5.91	6.55E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2511169	chr11:77965321	NARS2	chr11:78147017-78285909:-	-0.24	-5.27	2.08E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2511170	chr11:77980582	GAB2	chr11:77926343-78128766:-	-0.19	-5.99	4.13E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2511170	chr11:77980582	NARS2	chr11:78147017-78285909:-	-0.24	-5.04	6.62E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2511171	chr11:77930935	GAB2	chr11:77926343-78128766:-	-0.19	-5.8	1.25E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2511171	chr11:77930935	NARS2	chr11:78147017-78285909:-	-0.18	-3.49	0.00053	Testicular germ cell tumor	
PRAD	cis	1	rs2511175	chr11:77975081	GAB2	chr11:77926343-78128766:-	-0.21	-6.32	6.23E-10	Testicular germ cell tumor	
PRAD	cis	1	rs2511175	chr11:77975081	NARS2	chr11:78147017-78285909:-	-0.21	-4.13	4.21E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2511177	chr11:77922960	GAB2	chr11:77926343-78128766:-	-0.17	-5.62	3.21E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2511177	chr11:77922960	NARS2	chr11:78147017-78285909:-	-0.24	-5.06	6.17E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2511178	chr11:77923220	GAB2	chr11:77926343-78128766:-	-0.19	-5.88	7.69E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2511180	chr11:77937255	GAB2	chr11:77926343-78128766:-	-0.19	-5.89	7.18E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2511180	chr11:77937255	NARS2	chr11:78147017-78285909:-	-0.23	-4.56	6.65E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2511182	chr11:77982130	GAB2	chr11:77926343-78128766:-	-0.19	-5.82	1.07E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2511182	chr11:77982130	NARS2	chr11:78147017-78285909:-	-0.2	-3.86	0.000127	Testicular germ cell tumor	
PRAD	cis	1	rs2511185	chr11:77982496	GAB2	chr11:77926343-78128766:-	-0.18	-5.96	4.82E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2511185	chr11:77982496	NARS2	chr11:78147017-78285909:-	-0.25	-5.32	1.57E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2511186	chr11:77984306	GAB2	chr11:77926343-78128766:-	-0.2	-6.32	5.9E-10	Testicular germ cell tumor	
PRAD	cis	1	rs2511186	chr11:77984306	NARS2	chr11:78147017-78285909:-	-0.24	-4.78	2.37E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2511187	chr11:77985849	GAB2	chr11:77926343-78128766:-	-0.19	-5.82	1.07E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2511187	chr11:77985849	NARS2	chr11:78147017-78285909:-	-0.2	-3.86	0.000127	Testicular germ cell tumor	
PRAD	cis	1	rs2511190	chr11:77988310	GAB2	chr11:77926343-78128766:-	-0.2	-6.1	2.23E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2511190	chr11:77988310	NARS2	chr11:78147017-78285909:-	-0.2	-3.91	0.000106	Testicular germ cell tumor	
PRAD	cis	1	rs2512532	chr11:77968641	GAB2	chr11:77926343-78128766:-	-0.19	-5.92	6.08E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2512532	chr11:77968641	NARS2	chr11:78147017-78285909:-	-0.23	-4.64	4.55E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2512533	chr11:77968674	GAB2	chr11:77926343-78128766:-	-0.2	-6.12	1.99E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2512533	chr11:77968674	NARS2	chr11:78147017-78285909:-	-0.19	-3.66	0.000277	Testicular germ cell tumor	
PRAD	cis	1	rs2512535	chr11:77971468	GAB2	chr11:77926343-78128766:-	-0.19	-6.21	1.17E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2512535	chr11:77971468	NARS2	chr11:78147017-78285909:-	-0.26	-5.55	4.7E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2512537	chr11:77971947	GAB2	chr11:77926343-78128766:-	-0.2	-6.19	1.3E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2512537	chr11:77971947	NARS2	chr11:78147017-78285909:-	-0.21	-4.05	6.09E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2512538	chr11:77972461	GAB2	chr11:77926343-78128766:-	-0.2	-6.19	1.3E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2512538	chr11:77972461	NARS2	chr11:78147017-78285909:-	-0.21	-4.05	6.09E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2512541	chr11:77981747	GAB2	chr11:77926343-78128766:-	-0.19	-6.04	3.07E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2512541	chr11:77981747	NARS2	chr11:78147017-78285909:-	-0.23	-4.68	3.7E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2512542	chr11:77981780	GAB2	chr11:77926343-78128766:-	-0.18	-6.06	2.75E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2512542	chr11:77981780	NARS2	chr11:78147017-78285909:-	-0.23	-4.88	1.46E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2512544	chr11:77986371	GAB2	chr11:77926343-78128766:-	-0.19	-5.88	7.92E-9	Testicular germ cell tumor	
PRAD	cis	1	rs2512544	chr11:77986371	NARS2	chr11:78147017-78285909:-	-0.2	-3.97	8.46E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2512546	chr11:77957276	GAB2	chr11:77926343-78128766:-	-0.17	-5.83	1.02E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2512546	chr11:77957276	NARS2	chr11:78147017-78285909:-	-0.23	-4.98	8.85E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2512547	chr11:77960888	GAB2	chr11:77926343-78128766:-	-0.18	-5.8	1.2E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2512547	chr11:77960888	NARS2	chr11:78147017-78285909:-	-0.2	-4.05	5.89E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2512549	chr11:77940163	GAB2	chr11:77926343-78128766:-	0.17	5.67	2.44E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2512549	chr11:77940163	NARS2	chr11:78147017-78285909:-	0.25	5.37	1.24E-7	Testicular germ cell tumor	
PRAD	cis	1	rs2512550	chr11:77943848	GAB2	chr11:77926343-78128766:-	-0.17	-5.47	7.25E-8	Testicular germ cell tumor	
PRAD	cis	1	rs2512550	chr11:77943848	NARS2	chr11:78147017-78285909:-	-0.23	-4.91	1.26E-6	Testicular germ cell tumor	
PRAD	cis	1	rs2512985	chr11:86414443	CCDC83	chr11:85566144-85631051:+	-0.21	-3.98	7.85E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	
PRAD	cis	1	rs2512985	chr11:86414443	SYTL2	chr11:85405267-85522178:-	-0.19	-3.59	0.000365	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	
PRAD	cis	1	rs2512986	chr11:86414328	CCDC83	chr11:85566144-85631051:+	-0.21	-3.91	0.000106	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	
PRAD	cis	1	rs2512986	chr11:86414328	SYTL2	chr11:85405267-85522178:-	-0.2	-3.71	0.000232	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	
PRAD	cis	1	rs2512987	chr11:86414282	CCDC83	chr11:85566144-85631051:+	-0.21	-3.95	8.95E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	
PRAD	cis	1	rs2512987	chr11:86414282	SYTL2	chr11:85405267-85522178:-	-0.19	-3.56	0.000405	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	
PRAD	cis	1	rs2513052	chr11:62108248	ASRGL1	chr11:62104774-62160885:+	-0.35	-4.52	7.96E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs2513071	chr11:62098387	ASRGL1	chr11:62104774-62160885:+	-0.35	-4.49	8.81E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs2513074	chr11:62100880	ASRGL1	chr11:62104774-62160885:+	-0.35	-4.49	8.81E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs2513076	chr11:62103711	ASRGL1	chr11:62104774-62160885:+	-0.36	-4.56	6.63E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs2513610	chr11:106314798	GUCY1A2	chr11:106557910-106889171:-	-0.16	-3.43	0.000652	Colorectal or endometrial cancer	
PRAD	cis	1	rs2513744	chr11:62077785	ASRGL1	chr11:62104774-62160885:+	-0.37	-4.56	6.6E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs2513747	chr11:62098735	ASRGL1	chr11:62104774-62160885:+	-0.35	-4.49	8.81E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs2513749	chr11:62105391	ASRGL1	chr11:62104774-62160885:+	-0.35	-4.52	7.96E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs251778	chr12:5774124	ANO2	chr12:5671817-6055398:-	-0.36	-6.76	4.01E-11	Plasma clusterin levels	
PRAD	cis	1	rs251779	chr12:5773975	ANO2	chr12:5671817-6055398:-	-0.35	-6.8	3.15E-11	Plasma clusterin levels	
PRAD	cis	1	rs251780	chr12:5773312	ANO2	chr12:5671817-6055398:-	-0.36	-6.89	1.78E-11	Plasma clusterin levels	
PRAD	cis	1	rs251781	chr12:5772269	ANO2	chr12:5671817-6055398:-	-0.35	-6.8	3.15E-11	Plasma clusterin levels	
PRAD	cis	1	rs251784	chr12:5770190	ANO2	chr12:5671817-6055398:-	-0.35	-6.63	9.36E-11	Plasma clusterin levels	
PRAD	cis	1	rs251785	chr12:5769857	ANO2	chr12:5671817-6055398:-	-0.34	-6.64	8.87E-11	Plasma clusterin levels	
PRAD	cis	1	rs2518058	chr16:56966554	SLC12A3	chr16:56899119-56949760:+	0.28	3.87	0.000123	Metabolic syndrome	
PRAD	cis	1	rs2518806	chr22:18976603	PRODH	chr22:18900295-18924066:-	0.15	3.45	0.0006	Response to serotonin reuptake inhibitors in major depressive disorder	
PRAD	cis	1	rs2521263	chr11:2308762	C11orf21	chr11:2317507-2323143:-	-0.31	-5.47	7.25E-8	Obesity-related traits	
PRAD	cis	1	rs2524005	chr6:29899677	HCG4	chr6:29758809-29760850:-	-0.47	-7.94	1.45E-14	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs2524005	chr6:29899677	HLA-G	chr6:29794756-29977731:+	-0.3	-4.65	4.38E-6	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs2524005	chr6:29899677	KIAA1949	chr6:30644168-30655672:-	-0.12	-4.19	3.4E-5	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs2524005	chr6:29899677	RNF39	chr6:30038044-30043628:-	0.2	3.64	0.000304	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs2524005	chr6:29899677	TRIM31	chr6:30070674-30080867:-	-0.24	-3.73	0.000217	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs2524005	chr6:29899677	VARS2	chr6:30881982-30894233:+	-0.21	-3.68	0.00026	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.74	11.86	1.48E-28	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs2524276	chr6:31408265	ATP6V1G2	chr6:31512242-31514627:-	0.65	5.96	5.1E-9	Capecitabine sensitivity	
PRAD	cis	1	rs2524276	chr6:31408265	MICB	chr6:31462658-31478898:+	0.28	3.6	0.000355	Capecitabine sensitivity	
PRAD	cis	1	rs2524296	chr11:61601378	FADS1	chr11:61567103-61584529:-	-0.37	-3.88	0.000121	Gestational age at birth (child effect);Trans fatty acid levels	
PRAD	cis	1	rs2524300	chr17:39040877	TMEM99	chr17:38975374-38992526:+	0.32	7.19	2.52E-12	Height	
PRAD	cis	1	rs2524306	chr17:39035811	TMEM99	chr17:38975374-38992526:+	0.34	7.41	5.97E-13	Height	
PRAD	cis	1	rs2527199	chr7:158737113	WDR60	chr7:158649269-158738882:+	0.22	4.79	2.25E-6	Height	
PRAD	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.97	16.79	6.76E-50	Type 2 diabetes	
PRAD	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.96	16.15	5.69E-47	Type 2 diabetes	
PRAD	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.95	16.63	3.49E-49	Type 2 diabetes	
PRAD	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.96	16.79	6.78E-50	Type 2 diabetes	
PRAD	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.93	15.7	6.07E-45	Type 2 diabetes	
PRAD	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	1.01	16.96	1.07E-50	Type 2 diabetes	
PRAD	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.93	-15.97	3.58E-46	Type 2 diabetes	
PRAD	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.91	15.27	4.85E-43	Type 2 diabetes	
PRAD	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.92	15.49	5.24E-44	Type 2 diabetes	
PRAD	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.96	16.6	4.75E-49	Type 2 diabetes	
PRAD	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.96	16.53	1.06E-48	Type 2 diabetes	
PRAD	cis	1	rs2530664	chr22:30038152	SEC14L2	chr22:30792933-30824976:+	-0.28	-3.94	9.56E-5	Lipid traits	
PRAD	cis	1	rs2531848	chr22:30032484	SEC14L2	chr22:30792933-30824976:+	-0.28	-4.01	6.95E-5	Lipid traits	
PRAD	cis	1	rs2531849	chr22:30037900	SEC14L2	chr22:30792933-30824976:+	-0.28	-3.94	9.56E-5	Lipid traits	
PRAD	cis	1	rs2533288	chr7:66056711	CCT6P1	chr7:65216092-65228661:+	0.34	5.83	1.04E-8	Diabetic kidney disease	
PRAD	cis	1	rs2533288	chr7:66056711	CRCP	chr7:65579805-65619551:+	-0.31	-3.87	0.000123	Diabetic kidney disease	
PRAD	cis	1	rs2540173	chr1:156188214	SEMA4A	chr1:156119810-156147534:+	0.22	3.68	0.000259	Testicular germ cell tumor	
PRAD	cis	1	rs2540949	chr2:65284231	CEP68	chr2:65283495-65314141:+	-0.12	-4.3	2.09E-5	Triglycerides	
PRAD	cis	1	rs2540951	chr2:65276736	CEP68	chr2:65283495-65314141:+	-0.12	-4.3	2.05E-5	Triglycerides	
PRAD	cis	1	rs2540977	chr2:37462228	CEBPZ	chr2:37428778-37458740:-	-0.2	-4.43	1.15E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs2541161	chr9:131884802	CRAT	chr9:131857075-131873070:-	-0.22	-4.17	3.64E-5	Blood metabolite ratios	
PRAD	cis	1	rs2541164	chr9:131876908	CRAT	chr9:131857075-131873070:-	0.22	3.99	7.51E-5	Blood metabolite ratios	
PRAD	cis	1	rs2543383	chr14:76626703	ESRRB	chr14:76837690-76968178:+	0.25	3.51	0.000493	Blood pressure	
PRAD	cis	1	rs2543384	chr14:76627301	ESRRB	chr14:76837690-76968178:+	0.25	3.54	0.000447	Blood pressure	
PRAD	cis	1	rs2543387	chr14:76629046	ESRRB	chr14:76837690-76968178:+	0.25	3.54	0.000447	Blood pressure	
PRAD	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.96	16.6	4.78E-49	Type 2 diabetes	
PRAD	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.96	16.6	4.78E-49	Type 2 diabetes	
PRAD	cis	1	rs2549018	chr5:130698949	P4HA2	chr5:131528306-131563556:-	-0.23	-4.16	3.73E-5	Life satisfaction	
PRAD	cis	1	rs2551036	chr5:130648994	P4HA2	chr5:131528306-131563556:-	0.23	4.15	3.95E-5	Life satisfaction	
PRAD	cis	1	rs2551936	chr2:208497027	FAM119A	chr2:208446079-208490065:-	0.24	4.25	2.61E-5	Opioid sensitivity	
PRAD	cis	1	rs2551938	chr2:208496390	FAM119A	chr2:208446079-208490065:-	0.24	4.34	1.76E-5	Opioid sensitivity	
PRAD	cis	1	rs2551941	chr2:208492143	FAM119A	chr2:208446079-208490065:-	0.26	4.68	3.72E-6	Opioid sensitivity	
PRAD	cis	1	rs2555154	chr11:6524556	FXC1	chr11:6502677-6505910:+	-0.16	-3.51	0.000488	DNA methylation (variation)	
PRAD	cis	1	rs2555154	chr11:6524556	RRP8	chr11:6621154-6624811:-	-0.15	-3.83	0.000146	DNA methylation (variation)	
PRAD	cis	1	rs2562456	chr19:21666210	ZNF493	chr19:21579921-21610294:+	0.17	4.21	3.1E-5	Pain	
PRAD	cis	1	rs2562784	chr15:84286492	NMB	chr15:85198362-85201802:-	0.22	4.48	9.21E-6	Height	
PRAD	cis	1	rs2564921	chr3:53125585	ITIH4	chr3:52847007-52866554:-	-0.15	-4.45	1.06E-5	Height	
PRAD	cis	1	rs2564926	chr3:53094730	RFT1	chr3:53122503-53164470:-	-0.48	-5.21	2.82E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs2564926	chr3:53094730	TMEM110	chr3:52867139-52931547:-	-0.38	-4.7	3.44E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs2564940	chr3:53107569	ITIH4	chr3:52847007-52866554:-	0.15	4.32	1.89E-5	Height	
PRAD	cis	1	rs2564973	chr1:207480104	CD55	chr1:207494817-207534309:+	0.44	8.53	2.03E-16	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2564974	chr1:207483445	CD55	chr1:207494817-207534309:+	-0.22	-3.9	0.000109	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2564978	chr1:207494416	CD55	chr1:207494817-207534309:+	0.25	4.45	1.08E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2566254	chr11:4605026	OR52I1	chr11:4615269-4616242:+	-0.32	-3.61	0.000337	Response to serotonin reuptake inhibitors in major depressive disorder	
PRAD	cis	1	rs2566255	chr11:4605195	OR52I1	chr11:4615269-4616242:+	0.33	3.75	0.000201	Response to serotonin reuptake inhibitors in major depressive disorder	
PRAD	cis	1	rs2569754	chr19:41936734	ATP5SL	chr19:41937224-41945810:-	0.15	3.44	0.000638	Height	
PRAD	cis	1	rs2572910	chr8:143770135	LY6K	chr8:143781529-143785582:+	0.21	3.75	0.0002	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2572910	chr8:143770135	LYNX1	chr8:143845758-143859640:-	-0.32	-8.16	3.02E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2572910	chr8:143770135	PSCA	chr8:143761875-143764142:+	0.53	10.07	1.02E-21	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2573346	chr10:81918041	ANXA11	chr10:81914880-81965433:-	0.17	3.61	0.000336	Sarcoidosis	
PRAD	cis	1	rs257390	chr5:130740617	P4HA2	chr5:131528306-131563556:-	-0.22	-4.07	5.42E-5	Life satisfaction	
PRAD	cis	1	rs2574726	chr3:11627978	TSEN2	chr3:12525931-12581122:+	-0.37	-3.51	0.00049	Height	
PRAD	cis	1	rs2581782	chr3:53122257	ITIH4	chr3:52847007-52866554:-	0.15	4.6	5.55E-6	Height	
PRAD	cis	1	rs2581783	chr3:53122258	ITIH4	chr3:52847007-52866554:-	0.15	4.6	5.55E-6	Height	
PRAD	cis	1	rs2581786	chr3:53126143	ITIH4	chr3:52847007-52866554:-	0.15	4.56	6.6E-6	Height	
PRAD	cis	1	rs2581787	chr3:53127677	ITIH4	chr3:52847007-52866554:-	0.16	4.67	4.01E-6	Height	
PRAD	cis	1	rs2581800	chr3:53109352	ITIH4	chr3:52847007-52866554:-	0.15	4.38	1.44E-5	Height	
PRAD	cis	1	rs2583282	chr12:104313579	C12orf73	chr12:104343981-104359473:-	0.19	4.6	5.5E-6	Coronary heart disease	
PRAD	cis	1	rs2583282	chr12:104313579	NT5DC3	chr12:104164231-104234975:-	0.18	3.56	0.000403	Coronary heart disease	
PRAD	cis	1	rs2583471	chr11:59861814	PATL1	chr11:59404194-59436511:-	-0.11	-3.45	0.000621	Alzheimer's disease (late onset)	
PRAD	cis	1	rs2585179	chr8:143774193	LY6K	chr8:143781529-143785582:+	0.21	3.75	0.0002	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2585179	chr8:143774193	LYNX1	chr8:143845758-143859640:-	-0.32	-8.16	3.03E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2585179	chr8:143774193	PSCA	chr8:143761875-143764142:+	0.53	10.06	1.05E-21	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2591092	chr14:76630133	ESRRB	chr14:76837690-76968178:+	0.25	3.54	0.000447	Blood pressure	
PRAD	cis	1	rs2591094	chr14:76632335	ESRRB	chr14:76837690-76968178:+	0.25	3.54	0.000447	Blood pressure	
PRAD	cis	1	rs2595500	chr11:6963165	ZNF215	chr11:6947654-7005861:+	0.32	5.94	5.4E-9	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs2595501	chr11:6955340	ZNF215	chr11:6947654-7005861:+	-0.33	-6.02	3.62E-9	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs2602836	chr4:100014805	ADH5	chr4:99992132-100009931:-	0.16	3.83	0.000147	HDL cholesterol	
PRAD	cis	1	rs2604169	chr15:33388030	FMN1	chr15:33066347-33360085:-	-0.2	-5.56	4.57E-8	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs261360	chr20:5037774	C20orf30	chr20:5049130-5093733:-	-0.15	-3.66	0.000283	Hair morphology	
PRAD	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.5	-6.09	2.4E-9	Tumor biomarkers	
PRAD	cis	1	rs2614811	chr15:43913487	CATSPER2	chr15:43922774-43959900:-	-0.25	-4.39	1.42E-5	Tumor biomarkers	
PRAD	cis	1	rs2614811	chr15:43913487	CKMT1A	chr15:43985084-43991419:+	-0.48	-5.27	2.12E-7	Tumor biomarkers	
PRAD	cis	1	rs2617170	chr12:10560957	KLRC1	chr12:10594863-10606984:-	0.3	6.45	2.74E-10	Behcet's disease	
PRAD	cis	1	rs2617170	chr12:10560957	KLRC2	chr12:10579193-10588592:-	-0.2	-3.56	0.000411	Behcet's disease	
PRAD	cis	1	rs2619555	chr3:2650895	CRBN	chr3:3191698-3221390:-	0.2	3.5	0.000507	Blood pressure	
PRAD	cis	1	rs262147	chr7:158745142	WDR60	chr7:158649269-158738882:+	-0.45	-6.88	1.95E-11	Hippocampal volume	
PRAD	cis	1	rs2625667	chr3:41900951	ULK4	chr3:41288091-42003660:-	0.88	14.28	1.11E-38	Diastolic blood pressure	
PRAD	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	0.87	14.31	8.03E-39	Diastolic blood pressure	
PRAD	cis	1	rs2628313	chr17:53235352	COX11	chr17:53029259-53046064:-	-0.22	-4.44	1.13E-5	Menarche (age at onset)	
PRAD	cis	1	rs2628313	chr17:53235352	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.65	0.000288	Menarche (age at onset)	
PRAD	cis	1	rs2628314	chr17:53235182	COX11	chr17:53029259-53046064:-	-0.2	-3.95	9.01E-5	Menarche (age at onset)	
PRAD	cis	1	rs2629540	chr10:126426148	METTL10	chr10:126447406-126480439:-	0.39	6.58	1.29E-10	Cocaine dependence	
PRAD	cis	1	rs2630252	chr3:128624772	ACAD9	chr3:128598333-128634910:+	-0.2	-3.65	0.000292	IgG glycosylation	
PRAD	cis	1	rs2630	chr15:50849399	SPPL2A	chr15:50999739-51057910:-	0.31	6.33	5.63E-10	QT interval	
PRAD	cis	1	rs2630	chr15:50849399	TRPM7	chr15:50852491-50978994:-	0.11	3.63	0.000312	QT interval	
PRAD	cis	1	rs2631740	chr4:8484106	C4orf23	chr4:8440604-8495258:+	0.3	4.78	2.3E-6	Response to antineoplastic agents	
PRAD	cis	1	rs2631745	chr4:8490530	C4orf23	chr4:8440604-8495258:+	0.3	4.78	2.3E-6	Response to antineoplastic agents	
PRAD	cis	1	rs2631758	chr4:8495304	C4orf23	chr4:8440604-8495258:+	0.29	4.62	5.03E-6	Response to antineoplastic agents	
PRAD	cis	1	rs2632401	chr4:95147055	HPGDS	chr4:95219707-95264027:-	0.29	5.67	2.52E-8	Capecitabine sensitivity	
PRAD	cis	1	rs2635043	chr18:44679769	IER3IP1	chr18:44681415-44702745:-	0.17	3.5	0.000509	Educational attainment	
PRAD	cis	1	rs2635043	chr18:44679769	KATNAL2	chr18:44497557-44628613:+	0.24	4.23	2.87E-5	Educational attainment	
PRAD	cis	1	rs2635045	chr18:44668417	IER3IP1	chr18:44681415-44702745:-	0.17	3.53	0.000458	Educational attainment	
PRAD	cis	1	rs2635045	chr18:44668417	KATNAL2	chr18:44497557-44628613:+	0.23	4.17	3.7E-5	Educational attainment	
PRAD	cis	1	rs2635047	chr18:44736336	KATNAL2	chr18:44497557-44628613:+	0.21	3.74	0.000207	Educational attainment	
PRAD	cis	1	rs2635049	chr18:44687303	IER3IP1	chr18:44681415-44702745:-	-0.17	-3.45	0.000605	Educational attainment	
PRAD	cis	1	rs2635049	chr18:44687303	KATNAL2	chr18:44497557-44628613:+	-0.23	-4.2	3.19E-5	Educational attainment	
PRAD	cis	1	rs2638090	chr11:6955142	ZNF215	chr11:6947654-7005861:+	-0.33	-6.04	3.06E-9	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs2638092	chr11:6961746	ZNF215	chr11:6947654-7005861:+	-0.33	-6.09	2.32E-9	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs2645424	chr8:11684463	GATA4	chr8:11534468-11617509:+	0.16	3.45	0.000622	Non-alcoholic fatty liver disease histology (lobular);Non-alcoholic fatty liver disease histology (other)	
PRAD	cis	1	rs2645991	chr9:115519035	C9orf80	chr9:115448793-115480387:-	0.28	3.71	0.000234	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2645993	chr9:115536267	C9orf80	chr9:115448793-115480387:-	0.25	3.98	8.06E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2645994	chr9:115483322	C9orf80	chr9:115448793-115480387:-	-0.28	-3.59	0.000365	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2648337	chr3:12162280	SYN2	chr3:12045862-12233530:+	-0.38	-4.72	3.1E-6	Fasting insulin-related traits (interaction with BMI)	
PRAD	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.36	-11.41	8.47E-27	Ankylosing spondylitis	
PRAD	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.55	10.7	4.82E-24	Ankylosing spondylitis	
PRAD	cis	1	rs2651807	chr11:2378840	C11orf21	chr11:2317507-2323143:-	-0.24	-5.12	4.49E-7	Bacteremia	
PRAD	cis	1	rs2651807	chr11:2378840	TSPAN32	chr11:2323243-2339430:+	-0.17	-3.67	0.00027	Bacteremia	
PRAD	cis	1	rs2651829	chr11:2308304	C11orf21	chr11:2317507-2323143:-	0.29	5.2	2.94E-7	Obesity-related traits	
PRAD	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.46	-7.95	1.42E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs2657345	chr7:158744169	WDR60	chr7:158649269-158738882:+	0.2	4.41	1.25E-5	Height	
PRAD	cis	1	rs2657365	chr7:158722753	WDR60	chr7:158649269-158738882:+	0.22	4.85	1.7E-6	Height	
PRAD	cis	1	rs2658779	chr11:93163137	CCDC67	chr11:93063156-93171634:+	0.25	3.5	0.000507	Pulmonary function decline	
PRAD	cis	1	rs2659889	chr7:66217112	CRCP	chr7:65579805-65619551:+	-0.21	-3.88	0.000118	Aortic root size	
PRAD	cis	1	rs2659889	chr7:66217112	LOC493754	chr7:65993446-66057363:-	-0.24	-5.52	5.75E-8	Aortic root size	
PRAD	cis	1	rs2659889	chr7:66217112	TPST1	chr7:65670259-65825437:+	0.15	3.61	0.000339	Aortic root size	
PRAD	cis	1	rs2659903	chr7:66180931	CCT6P1	chr7:65216092-65228661:+	0.32	5.48	7.06E-8	Gout	
PRAD	cis	1	rs2659903	chr7:66180931	CRCP	chr7:65579805-65619551:+	-0.33	-4.04	6.24E-5	Gout	
PRAD	cis	1	rs2659906	chr7:66165310	CRCP	chr7:65579805-65619551:+	-0.21	-3.95	8.96E-5	Aortic root size	
PRAD	cis	1	rs2659906	chr7:66165310	LOC493754	chr7:65993446-66057363:-	-0.24	-5.38	1.17E-7	Aortic root size	
PRAD	cis	1	rs2659906	chr7:66165310	TPST1	chr7:65670259-65825437:+	0.15	3.66	0.000283	Aortic root size	
PRAD	cis	1	rs2659909	chr7:66160279	CRCP	chr7:65579805-65619551:+	-0.23	-4.3	2.08E-5	Aortic root size	
PRAD	cis	1	rs2659909	chr7:66160279	LOC493754	chr7:65993446-66057363:-	-0.25	-5.65	2.84E-8	Aortic root size	
PRAD	cis	1	rs2659911	chr7:66158420	CCT6P1	chr7:65216092-65228661:+	0.32	5.47	7.45E-8	Gout	
PRAD	cis	1	rs2659911	chr7:66158420	CRCP	chr7:65579805-65619551:+	-0.34	-4.19	3.32E-5	Gout	
PRAD	cis	1	rs2659912	chr7:66157999	CRCP	chr7:65579805-65619551:+	-0.2	-3.76	0.000192	Aortic root size	
PRAD	cis	1	rs2659912	chr7:66157999	LOC493754	chr7:65993446-66057363:-	-0.22	-5.1	4.82E-7	Aortic root size	
PRAD	cis	1	rs2659912	chr7:66157999	TPST1	chr7:65670259-65825437:+	0.15	3.63	0.000318	Aortic root size	
PRAD	cis	1	rs2659913	chr7:66157336	CCT6P1	chr7:65216092-65228661:+	0.32	5.47	7.45E-8	Gout	
PRAD	cis	1	rs2659913	chr7:66157336	CRCP	chr7:65579805-65619551:+	-0.34	-4.19	3.32E-5	Gout	
PRAD	cis	1	rs2659915	chr7:66153101	LOC493754	chr7:65993446-66057363:-	-0.19	-4.32	1.9E-5	Aortic root size	
PRAD	cis	1	rs2659915	chr7:66153101	TPST1	chr7:65670259-65825437:+	0.15	3.55	0.000431	Aortic root size	
PRAD	cis	1	rs2661357	chr1:207483938	CD55	chr1:207494817-207534309:+	0.45	8.55	1.69E-16	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2664871	chr4:95146281	HPGDS	chr4:95219707-95264027:-	0.3	5.77	1.44E-8	Capecitabine sensitivity	
PRAD	cis	1	rs2665826	chr17:61944924	DDX42	chr17:61851567-61896676:+	-0.27	-5.65	2.72E-8	Body mass index	
PRAD	cis	1	rs2665826	chr17:61944924	FTSJ3	chr17:61896795-61905031:-	0.33	6.62	9.95E-11	Body mass index	
PRAD	cis	1	rs2665826	chr17:61944924	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.5	8.51E-6	Body mass index	
PRAD	cis	1	rs2667011	chr2:160867059	LY75	chr2:160625141-160761262:-	-0.15	-4.03	6.53E-5	Bilirubin levels	
PRAD	cis	1	rs2670321	chr3:99167107	C3orf26	chr3:99536681-99897446:+	0.16	3.43	0.000665	RR interval (heart rate)	
PRAD	cis	1	rs2670322	chr3:99167401	C3orf26	chr3:99536681-99897446:+	0.16	3.43	0.000665	RR interval (heart rate)	
PRAD	cis	1	rs2670346	chr3:99163961	C3orf26	chr3:99536681-99897446:+	0.16	3.43	0.000665	RR interval (heart rate)	
PRAD	cis	1	rs267736	chr1:150945607	CTSK	chr1:150768687-150780812:-	-0.19	-4.48	9.38E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	0.86	14.28	1.09E-38	Diastolic blood pressure	
PRAD	cis	1	rs2684818	chr18:44712965	KATNAL2	chr18:44497557-44628613:+	0.2	3.48	0.000546	Educational attainment	
PRAD	cis	1	rs2684825	chr18:44666415	IER3IP1	chr18:44681415-44702745:-	0.19	3.78	0.000179	Educational attainment	
PRAD	cis	1	rs2684825	chr18:44666415	KATNAL2	chr18:44497557-44628613:+	0.23	4.02	6.76E-5	Educational attainment	
PRAD	cis	1	rs2684826	chr18:44679147	IER3IP1	chr18:44681415-44702745:-	0.17	3.45	0.000611	Educational attainment	
PRAD	cis	1	rs2684826	chr18:44679147	KATNAL2	chr18:44497557-44628613:+	0.23	4.09	5.16E-5	Educational attainment	
PRAD	cis	1	rs2684841	chr18:44724262	KATNAL2	chr18:44497557-44628613:+	0.21	3.71	0.000233	Educational attainment	
PRAD	cis	1	rs2687723	chr3:127865559	RUVBL1	chr3:127783627-127872757:-	0.22	4.02	6.7E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2687730	chr3:127915457	RUVBL1	chr3:127783627-127872757:-	0.24	4.32	1.88E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2688223	chr4:8471398	C4orf23	chr4:8440604-8495258:+	-0.31	-4.95	1.03E-6	Response to antineoplastic agents	
PRAD	cis	1	rs2688233	chr4:8491885	C4orf23	chr4:8440604-8495258:+	-0.29	-4.68	3.78E-6	Response to antineoplastic agents	
PRAD	cis	1	rs2688608	chr10:75658349	SEC24C	chr10:75504132-75531917:+	-0.17	-3.49	0.000528	Inflammatory bowel disease	
PRAD	cis	1	rs2695782	chr12:56722830	MIP	chr12:56843885-56848429:-	-0.35	-3.52	0.000465	Psoriasis vulgaris	
PRAD	cis	1	rs26965	chr5:112739017	REEP5	chr5:112212081-112258031:-	0.21	3.52	0.00048	F-cell distribution	
PRAD	cis	1	rs26965	chr5:112739017	YTHDC2	chr5:112849410-112930979:+	0.18	3.44	0.000641	F-cell distribution	
PRAD	cis	1	rs2700633	chr3:99160551	C3orf26	chr3:99536681-99897446:+	0.15	3.44	0.000641	RR interval (heart rate)	
PRAD	cis	1	rs2707828	chr7:66171377	CCT6P1	chr7:65216092-65228661:+	0.32	5.47	7.45E-8	Gout	
PRAD	cis	1	rs2707828	chr7:66171377	CRCP	chr7:65579805-65619551:+	-0.34	-4.19	3.32E-5	Gout	
PRAD	cis	1	rs2707830	chr7:66167645	CCT6P1	chr7:65216092-65228661:+	0.32	5.47	7.45E-8	Gout	
PRAD	cis	1	rs2707830	chr7:66167645	CRCP	chr7:65579805-65619551:+	-0.34	-4.19	3.32E-5	Gout	
PRAD	cis	1	rs2707831	chr7:66062511	CCT6P1	chr7:65216092-65228661:+	0.34	5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs2707831	chr7:66062511	CRCP	chr7:65579805-65619551:+	-0.31	-3.88	0.00012	Diabetic kidney disease	
PRAD	cis	1	rs2707832	chr7:66136549	CCT6P1	chr7:65216092-65228661:+	0.31	5.35	1.41E-7	Gout	
PRAD	cis	1	rs2707832	chr7:66136549	CRCP	chr7:65579805-65619551:+	-0.35	-4.35	1.71E-5	Gout	
PRAD	cis	1	rs2707836	chr7:66160435	CRCP	chr7:65579805-65619551:+	-0.21	-3.96	8.74E-5	Aortic root size	
PRAD	cis	1	rs2707836	chr7:66160435	LOC493754	chr7:65993446-66057363:-	-0.23	-5.38	1.21E-7	Aortic root size	
PRAD	cis	1	rs2707836	chr7:66160435	TPST1	chr7:65670259-65825437:+	0.15	3.66	0.00028	Aortic root size	
PRAD	cis	1	rs2707838	chr7:66159201	CCT6P1	chr7:65216092-65228661:+	0.32	5.47	7.45E-8	Gout	
PRAD	cis	1	rs2707838	chr7:66159201	CRCP	chr7:65579805-65619551:+	-0.34	-4.19	3.32E-5	Gout	
PRAD	cis	1	rs2707840	chr7:66158015	CCT6P1	chr7:65216092-65228661:+	0.32	5.45	8.1E-8	Gout	
PRAD	cis	1	rs2707840	chr7:66158015	CRCP	chr7:65579805-65619551:+	-0.34	-4.2	3.25E-5	Gout	
PRAD	cis	1	rs2707844	chr7:66059509	CCT6P1	chr7:65216092-65228661:+	0.34	5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs2707844	chr7:66059509	CRCP	chr7:65579805-65619551:+	-0.31	-3.88	0.00012	Diabetic kidney disease	
PRAD	cis	1	rs2707845	chr7:66198798	CRCP	chr7:65579805-65619551:+	-0.21	-3.98	8.04E-5	Aortic root size	
PRAD	cis	1	rs2707845	chr7:66198798	LOC493754	chr7:65993446-66057363:-	-0.24	-5.5	6.19E-8	Aortic root size	
PRAD	cis	1	rs2707845	chr7:66198798	TPST1	chr7:65670259-65825437:+	0.15	3.56	0.000404	Aortic root size	
PRAD	cis	1	rs2707850	chr7:66203870	CRCP	chr7:65579805-65619551:+	-0.21	-3.98	8.04E-5	Aortic root size	
PRAD	cis	1	rs2707850	chr7:66203870	LOC493754	chr7:65993446-66057363:-	-0.24	-5.5	6.19E-8	Aortic root size	
PRAD	cis	1	rs2707850	chr7:66203870	TPST1	chr7:65670259-65825437:+	0.15	3.56	0.000404	Aortic root size	
PRAD	cis	1	rs2707854	chr7:66212597	CRCP	chr7:65579805-65619551:+	-0.21	-3.98	8.04E-5	Aortic root size	
PRAD	cis	1	rs2707854	chr7:66212597	LOC493754	chr7:65993446-66057363:-	-0.24	-5.5	6.19E-8	Aortic root size	
PRAD	cis	1	rs2707854	chr7:66212597	TPST1	chr7:65670259-65825437:+	0.15	3.56	0.000404	Aortic root size	
PRAD	cis	1	rs2707856	chr7:66211010	CRCP	chr7:65579805-65619551:+	-0.21	-3.98	8.03E-5	Aortic root size	
PRAD	cis	1	rs2707856	chr7:66211010	LOC493754	chr7:65993446-66057363:-	-0.24	-5.5	6.36E-8	Aortic root size	
PRAD	cis	1	rs2707856	chr7:66211010	TPST1	chr7:65670259-65825437:+	0.15	3.57	0.000397	Aortic root size	
PRAD	cis	1	rs2709379	chr2:208496182	FAM119A	chr2:208446079-208490065:-	0.24	4.36	1.59E-5	Opioid sensitivity	
PRAD	cis	1	rs2709380	chr2:208496410	FAM119A	chr2:208446079-208490065:-	0.24	4.34	1.76E-5	Opioid sensitivity	
PRAD	cis	1	rs2709382	chr2:208496715	FAM119A	chr2:208446079-208490065:-	0.24	4.31	1.96E-5	Opioid sensitivity	
PRAD	cis	1	rs2709383	chr2:208496742	FAM119A	chr2:208446079-208490065:-	0.24	4.31	1.96E-5	Opioid sensitivity	
PRAD	cis	1	rs2709384	chr2:208496943	FAM119A	chr2:208446079-208490065:-	0.23	4.14	4.04E-5	Opioid sensitivity	
PRAD	cis	1	rs2709386	chr2:208497034	FAM119A	chr2:208446079-208490065:-	0.24	4.25	2.61E-5	Opioid sensitivity	
PRAD	cis	1	rs2709390	chr2:208506371	FAM119A	chr2:208446079-208490065:-	0.23	4.17	3.69E-5	Opioid sensitivity	
PRAD	cis	1	rs2709394	chr2:208491975	FAM119A	chr2:208446079-208490065:-	0.26	4.59	5.76E-6	Opioid sensitivity	
PRAD	cis	1	rs2709397	chr2:208492569	FAM119A	chr2:208446079-208490065:-	0.26	4.68	3.72E-6	Opioid sensitivity	
PRAD	cis	1	rs2709409	chr2:208511233	FAM119A	chr2:208446079-208490065:-	0.23	4.07	5.55E-5	Opioid sensitivity	
PRAD	cis	1	rs2710331	chr3:52837855	GNL3	chr3:52719936-52728508:+	-0.15	-3.74	0.000203	Bipolar disorder	
PRAD	cis	1	rs2710331	chr3:52837855	ITIH4	chr3:52847007-52866554:-	0.12	3.46	0.000582	Bipolar disorder	
PRAD	cis	1	rs2710331	chr3:52837855	NEK4	chr3:52744803-52804951:-	-0.16	-4.26	2.46E-5	Bipolar disorder	
PRAD	cis	1	rs2710646	chr2:63134879	C2orf86	chr2:63348537-63815851:-	0.26	4.55	6.73E-6	Prostate cancer	
PRAD	cis	1	rs2710646	chr2:63134879	EHBP1	chr2:62901013-63273619:+	0.23	3.72	0.000222	Prostate cancer	
PRAD	cis	1	rs2712381	chr3:128338600	RPN1	chr3:128338813-128399918:-	-0.15	-3.43	0.000652	Monocyte count	
PRAD	cis	1	rs2712417	chr3:128345179	RPN1	chr3:128338813-128399918:-	-0.15	-3.43	0.000652	Monocyte count	
PRAD	cis	1	rs2712419	chr3:128340896	RPN1	chr3:128338813-128399918:-	-0.15	-3.43	0.000652	Monocyte count	
PRAD	cis	1	rs2714470	chr2:37486527	CEBPZ	chr2:37428778-37458740:-	-0.19	-4.03	6.55E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs271621	chr19:18631332	ELL	chr19:18553475-18632937:-	-0.16	-3.74	0.000203	Breast cancer	
PRAD	cis	1	rs271621	chr19:18631332	SSBP4	chr19:18530221-18545371:+	-0.17	-5.65	2.74E-8	Breast cancer	
PRAD	cis	1	rs271623	chr19:18628947	ELL	chr19:18553475-18632937:-	-0.16	-3.76	0.000192	Breast cancer	
PRAD	cis	1	rs271623	chr19:18628947	SSBP4	chr19:18530221-18545371:+	-0.17	-5.67	2.56E-8	Breast cancer	
PRAD	cis	1	rs271624	chr19:18627953	ELL	chr19:18553475-18632937:-	-0.15	-3.44	0.000642	Breast cancer	
PRAD	cis	1	rs271624	chr19:18627953	SSBP4	chr19:18530221-18545371:+	-0.16	-5.24	2.48E-7	Breast cancer	
PRAD	cis	1	rs2717562	chr8:143776668	LY6K	chr8:143781529-143785582:+	0.21	3.8	0.000164	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2717562	chr8:143776668	LYNX1	chr8:143845758-143859640:-	-0.31	-7.99	1.08E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2717562	chr8:143776668	PSCA	chr8:143761875-143764142:+	0.53	10.09	8.2E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2723065	chr2:65279414	CEP68	chr2:65283495-65314141:+	-0.12	-4.36	1.6E-5	Triglycerides	
PRAD	cis	1	rs2723620	chr11:6523657	FXC1	chr11:6502677-6505910:+	-0.16	-3.43	0.00065	DNA methylation (variation)	
PRAD	cis	1	rs2723620	chr11:6523657	RRP8	chr11:6621154-6624811:-	-0.15	-3.75	0.000201	DNA methylation (variation)	
PRAD	cis	1	rs2730241	chr7:158723014	WDR60	chr7:158649269-158738882:+	0.17	3.68	0.000262	Height	
PRAD	cis	1	rs2730245	chr7:158724789	WDR60	chr7:158649269-158738882:+	0.21	4.67	3.93E-6	Height	
PRAD	cis	1	rs2734839	chr11:113286490	ANKK1	chr11:113258513-113271139:+	0.14	3.64	0.000299	Information processing speed	
PRAD	cis	1	rs2734839	chr11:113286490	TTC12	chr11:113185251-113244016:+	-0.33	-7.03	7.38E-12	Information processing speed	
PRAD	cis	1	rs2735403	chr16:78062190	CLEC3A	chr16:78056443-78065997:+	-0.47	-5.83	1.01E-8	Colorectal or endometrial cancer	
PRAD	cis	1	rs2736345	chr8:11352485	FAM66D	chr8:11973291-12424354:+	-0.22	-3.57	0.000401	Systemic lupus erythematosus	
PRAD	cis	1	rs2736371	chr8:11105529	AMAC1L2	chr8:11188495-11189695:+	0.22	3.83	0.000148	Retinal vascular caliber	
PRAD	cis	1	rs2736371	chr8:11105529	TDH	chr8:11197146-11225961:+	0.2	3.65	0.000286	Retinal vascular caliber	
PRAD	cis	1	rs2738413	chr14:64679960	MTHFD1	chr14:64854759-64926727:+	-0.16	-3.81	0.000156	Atrial fibrillation	
PRAD	cis	1	rs2739482	chr19:51394286	KLK2	chr19:51376689-51383822:+	-0.3	-8.01	8.92E-15	Prostate-specific antigen levels	
PRAD	cis	1	rs2740544	chr13:50617640	EBPL	chr13:50234811-50265623:-	-0.18	-3.67	0.000271	Height	
PRAD	cis	1	rs2741432	chr20:43989514	SYS1	chr20:43991701-44004724:+	0.35	6.26	8.58E-10	Psoriasis	
PRAD	cis	1	rs2741435	chr20:43988198	SYS1	chr20:43991701-44004724:+	0.35	6.26	8.57E-10	Psoriasis	
PRAD	cis	1	rs2741611	chr20:44020809	SYS1	chr20:43991701-44004724:+	0.34	6.19	1.34E-9	Psoriasis	
PRAD	cis	1	rs2741612	chr20:44019972	SYS1	chr20:43991701-44004724:+	0.34	6.19	1.34E-9	Psoriasis	
PRAD	cis	1	rs2741639	chr20:44008432	SYS1	chr20:43991701-44004724:+	0.35	6.31	6.48E-10	Psoriasis	
PRAD	cis	1	rs2741640	chr20:44008408	SYS1	chr20:43991701-44004724:+	0.35	6.31	6.48E-10	Psoriasis	
PRAD	cis	1	rs27421	chr5:130743771	P4HA2	chr5:131528306-131563556:-	-0.21	-3.8	0.000166	Life satisfaction	
PRAD	cis	1	rs2742234	chr10:43612609	CSGALNACT2	chr10:43633934-43680747:+	0.14	3.62	0.000326	Hirschsprung disease	
PRAD	cis	1	rs2743237	chr20:44026618	SYS1	chr20:43991701-44004724:+	0.35	6.49	2.17E-10	Psoriasis	
PRAD	cis	1	rs2743402	chr20:43985204	SYS1	chr20:43991701-44004724:+	0.34	6.07	2.69E-9	Psoriasis	
PRAD	cis	1	rs2743414	chr20:43991566	SYS1	chr20:43991701-44004724:+	0.35	6.3	6.92E-10	Psoriasis	
PRAD	cis	1	rs2743419	chr20:43992645	SYS1	chr20:43991701-44004724:+	0.35	6.3	6.93E-10	Psoriasis	
PRAD	cis	1	rs2743423	chr20:43993539	SYS1	chr20:43991701-44004724:+	0.35	6.3	6.93E-10	Psoriasis	
PRAD	cis	1	rs2743424	chr20:43993934	SYS1	chr20:43991701-44004724:+	0.35	6.3	6.92E-10	Psoriasis	
PRAD	cis	1	rs2743439	chr20:43999636	SYS1	chr20:43991701-44004724:+	0.35	6.31	6.48E-10	Psoriasis	
PRAD	cis	1	rs2744301	chr6:25323143	TDP2	chr6:24650206-24667115:-	0.41	3.82	0.000151	Schizophrenia	
PRAD	cis	1	rs2744947	chr6:34657809	C6orf106	chr6:34555066-34664625:-	0.25	3.53	0.000457	Pubertal anthropometrics	
PRAD	cis	1	rs2744947	chr6:34657809	UHRF1BP1	chr6:34759794-34853117:+	0.19	5.05	6.39E-7	Pubertal anthropometrics	
PRAD	cis	1	rs2744954	chr6:34621470	C6orf106	chr6:34555066-34664625:-	0.25	3.53	0.000457	Pubertal anthropometrics	
PRAD	cis	1	rs2744954	chr6:34621470	UHRF1BP1	chr6:34759794-34853117:+	0.19	5.05	6.39E-7	Pubertal anthropometrics	
PRAD	cis	1	rs2744955	chr6:34618958	C6orf106	chr6:34555066-34664625:-	0.25	3.53	0.000457	Pubertal anthropometrics	
PRAD	cis	1	rs2744955	chr6:34618958	UHRF1BP1	chr6:34759794-34853117:+	0.19	5.05	6.39E-7	Pubertal anthropometrics	
PRAD	cis	1	rs2744956	chr6:34618937	C6orf106	chr6:34555066-34664625:-	0.26	3.59	0.000365	Pubertal anthropometrics	
PRAD	cis	1	rs2744956	chr6:34618937	UHRF1BP1	chr6:34759794-34853117:+	0.19	4.89	1.42E-6	Pubertal anthropometrics	
PRAD	cis	1	rs2744972	chr6:34659054	C6orf106	chr6:34555066-34664625:-	0.26	3.68	0.000262	Pubertal anthropometrics	
PRAD	cis	1	rs2744972	chr6:34659054	UHRF1BP1	chr6:34759794-34853117:+	0.19	5.23	2.58E-7	Pubertal anthropometrics	
PRAD	cis	1	rs2746553	chr1:23493246	C1orf213	chr1:23695464-23698278:+	-0.18	-4.61	5.1E-6	Height	
PRAD	cis	1	rs2749418	chr1:41509674	RLF	chr1:40627041-40706592:+	0.14	3.96	8.69E-5	Height	
PRAD	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.35	-10.89	8.87E-25	Ankylosing spondylitis	
PRAD	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.55	10.89	8.96E-25	Ankylosing spondylitis	
PRAD	cis	1	rs2753462	chr14:60850703	C14orf39	chr14:60902675-60952764:-	-0.29	-5.21	2.78E-7	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2757042	chr6:167371234	RNASET2	chr6:167343008-167412795:-	0.24	5.84	9.53E-9	Crohn's disease	
PRAD	cis	1	rs2757047	chr6:167374489	RNASET2	chr6:167343008-167412795:-	0.24	5.92	6.08E-9	Crohn's disease	
PRAD	cis	1	rs2758322	chr6:160075188	MRPL18	chr6:160211022-160219460:+	-0.24	-5.39	1.1E-7	Age-related macular degeneration (GA)	
PRAD	cis	1	rs27663	chr5:130741438	P4HA2	chr5:131528306-131563556:-	-0.21	-3.87	0.000125	Life satisfaction	
PRAD	cis	1	rs2768630	chr9:131866388	CRAT	chr9:131857075-131873070:-	-0.23	-3.95	9.06E-5	Blood metabolite ratios	
PRAD	cis	1	rs2769347	chr6:167371737	RNASET2	chr6:167343008-167412795:-	0.24	5.84	9.77E-9	Crohn's disease	
PRAD	cis	1	rs2769352	chr6:167378619	RNASET2	chr6:167343008-167412795:-	0.24	5.66	2.61E-8	Crohn's disease	
PRAD	cis	1	rs2769354	chr6:167379771	RNASET2	chr6:167343008-167412795:-	0.24	5.8	1.25E-8	Crohn's disease	
PRAD	cis	1	rs27708	chr5:130743541	P4HA2	chr5:131528306-131563556:-	-0.21	-3.83	0.000145	Life satisfaction	
PRAD	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.36	11.41	8.51E-27	Ankylosing spondylitis	
PRAD	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.55	-10.83	1.52E-24	Ankylosing spondylitis	
PRAD	cis	1	rs2776819	chr1:23470116	C1orf213	chr1:23695464-23698278:+	-0.18	-4.46	1.01E-5	Height	
PRAD	cis	1	rs2776822	chr1:23492782	C1orf213	chr1:23695464-23698278:+	0.14	3.64	0.000307	Height	
PRAD	cis	1	rs2782828	chr1:207496999	CD55	chr1:207494817-207534309:+	0.25	4.29	2.14E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2782840	chr1:207484183	CD55	chr1:207494817-207534309:+	0.45	8.53	1.96E-16	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2782842	chr1:207483576	CD55	chr1:207494817-207534309:+	0.43	8.23	1.86E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2782846	chr1:207473840	CD55	chr1:207494817-207534309:+	0.44	8.51	2.36E-16	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2782848	chr1:207466752	CD55	chr1:207494817-207534309:+	0.43	8.18	2.67E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2782850	chr1:207465437	CD55	chr1:207494817-207534309:+	0.43	8.16	3.13E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2782851	chr1:207465062	CD55	chr1:207494817-207534309:+	0.43	8.16	3.13E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2782854	chr1:207462714	CD55	chr1:207494817-207534309:+	0.43	8.16	3.13E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2785213	chr10:100565640	CUTC	chr10:101491958-101515893:+	-0.2	-3.54	0.000437	Obesity-related traits	
PRAD	cis	1	rs2786023	chr1:234981565	ARID4B	chr1:235294499-235491532:-	-0.19	-3.65	0.000295	HIV-1 control	
PRAD	cis	1	rs2786023	chr1:234981565	GGPS1	chr1:235491753-235507842:+	-0.28	-4.37	1.54E-5	HIV-1 control	
PRAD	cis	1	rs2786023	chr1:234981565	RBM34	chr1:235294499-235324772:-	-0.21	-3.72	0.000224	HIV-1 control	
PRAD	cis	1	rs27873	chr5:130731151	P4HA2	chr5:131528306-131563556:-	-0.2	-3.82	0.000152	Life satisfaction	
PRAD	cis	1	rs2789679	chr10:81907884	ANXA11	chr10:81914880-81965433:-	0.17	3.65	0.000294	Sarcoidosis	
PRAD	cis	1	rs2791464	chr1:86911543	CLCA2	chr1:86889769-86922238:+	0.29	5.09	5.18E-7	Crohn's disease-related phenotypes	
PRAD	cis	1	rs2791603	chr3:195142939	C3orf21	chr3:194789015-194991895:-	-0.31	-6.48	2.31E-10	Body mass index	
PRAD	cis	1	rs2796025	chr9:115549684	C9orf80	chr9:115448793-115480387:-	0.36	4.45	1.06E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2796027	chr9:115529404	C9orf80	chr9:115448793-115480387:-	0.3	4	7.43E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2796028	chr9:115528755	C9orf80	chr9:115448793-115480387:-	0.26	3.55	0.000421	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2796035	chr9:115515597	C9orf80	chr9:115448793-115480387:-	0.28	3.71	0.000234	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2796037	chr9:115511826	C9orf80	chr9:115448793-115480387:-	-0.24	-3.93	9.58E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs2797529	chr1:111239130	AHCYL1	chr1:110527308-110566363:+	0.3	3.67	0.000271	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs2797529	chr1:111239130	DRAM2	chr1:111659955-111682838:-	0.41	4.07	5.5E-5	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs2797530	chr1:111242670	AHCYL1	chr1:110527308-110566363:+	0.33	4.04	6.22E-5	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs2797530	chr1:111242670	DRAM2	chr1:111659955-111682838:-	0.42	4.29	2.17E-5	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs2797530	chr1:111242670	RAP1A	chr1:112085055-112256100:+	0.3	3.7	0.00024	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs2799077	chr6:28234597	ZKSCAN3	chr6:28317691-28334523:+	-0.18	-3.76	0.000191	Depression	
PRAD	cis	1	rs2799077	chr6:28234597	ZNF187	chr6:28234788-28245978:+	-0.32	-5.87	8.39E-9	Depression	
PRAD	cis	1	rs2799077	chr6:28234597	ZNF323	chr6:28292517-28324048:-	0.41	5.6	3.71E-8	Depression	
PRAD	cis	1	rs2799077	chr6:28234597	ZNF389	chr6:28129551-28137375:+	-0.53	-7.64	1.25E-13	Depression	
PRAD	cis	1	rs2799077	chr6:28234597	ZSCAN23	chr6:28393287-28411279:-	0.17	4.64	4.54E-6	Depression	
PRAD	cis	1	rs2799079	chr6:28235176	ZKSCAN3	chr6:28317691-28334523:+	-0.17	-3.56	0.000415	Depression	
PRAD	cis	1	rs2799079	chr6:28235176	ZNF187	chr6:28234788-28245978:+	-0.3	-5.57	4.2E-8	Depression	
PRAD	cis	1	rs2799079	chr6:28235176	ZNF323	chr6:28292517-28324048:-	0.42	5.76	1.5E-8	Depression	
PRAD	cis	1	rs2799079	chr6:28235176	ZNF389	chr6:28129551-28137375:+	-0.51	-7.36	8.17E-13	Depression	
PRAD	cis	1	rs2799079	chr6:28235176	ZSCAN23	chr6:28393287-28411279:-	0.17	4.64	4.51E-6	Depression	
PRAD	cis	1	rs2801020	chr10:42957330	LOC84856	chr10:42970939-42990784:+	0.29	4.35	1.65E-5	Helix rolling	
PRAD	cis	1	rs2801405	chr10:100583915	CUTC	chr10:101491958-101515893:+	-0.21	-3.94	9.41E-5	Obesity-related traits	
PRAD	cis	1	rs2802217	chr1:207482970	CD55	chr1:207494817-207534309:+	0.25	4.34	1.73E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2802232	chr1:207468151	CD55	chr1:207494817-207534309:+	0.43	8.18	2.67E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2802233	chr1:207471224	CD55	chr1:207494817-207534309:+	-0.21	-3.64	0.000307	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2802234	chr1:207471589	CD55	chr1:207494817-207534309:+	0.22	3.86	0.000127	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2802235	chr1:207471799	CD55	chr1:207494817-207534309:+	0.46	8.99	5.88E-18	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2802236	chr1:207472189	CD55	chr1:207494817-207534309:+	-0.23	-3.96	8.61E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2802237	chr1:207474170	CD55	chr1:207494817-207534309:+	0.44	8.48	2.9E-16	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2802238	chr1:207476141	CD55	chr1:207494817-207534309:+	0.25	4.36	1.59E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2802727	chr1:243483326	SDCCAG8	chr1:243419320-243663392:+	0.27	3.7	0.000243	Obesity (early onset extreme)	
PRAD	cis	1	rs280603	chr4:129915063	C4orf33	chr4:130014829-130033842:+	-0.46	-7.74	6.1E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs280604	chr4:129921170	C4orf33	chr4:130014829-130033842:+	-0.45	-7.71	7.31E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs2806558	chr1:23503456	C1orf213	chr1:23695464-23698278:+	-0.18	-4.49	8.9E-6	Height	
PRAD	cis	1	rs2806561	chr1:23504795	C1orf213	chr1:23695464-23698278:+	0.18	4.43	1.16E-5	Height	
PRAD	cis	1	rs2806563	chr1:23506625	C1orf213	chr1:23695464-23698278:+	0.16	3.9	0.000109	Height	
PRAD	cis	1	rs2811381	chr3:127997912	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.14	4.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811387	chr3:128015178	RUVBL1	chr3:127783627-127872757:-	-0.21	-3.9	0.000112	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811390	chr3:128021481	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.3	2.04E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811391	chr3:128022368	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.3	2.04E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811392	chr3:128023976	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.22	2.94E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811393	chr3:128023999	RUVBL1	chr3:127783627-127872757:-	-0.22	-4.17	3.55E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811396	chr3:127987356	RUVBL1	chr3:127783627-127872757:-	-0.25	-4.63	4.77E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811397	chr3:128027237	RUVBL1	chr3:127783627-127872757:-	-0.22	-3.95	8.9E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811414	chr3:127991177	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.14	4.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811488	chr3:128336517	RPN1	chr3:128338813-128399918:-	-0.15	-3.43	0.000652	Monocyte count	
PRAD	cis	1	rs2811490	chr3:128351755	CCDC48	chr3:128720472-128759583:+	-0.17	-3.43	0.000645	Monocyte count	
PRAD	cis	1	rs2811511	chr3:127912988	RUVBL1	chr3:127783627-127872757:-	0.23	4.31	2.03E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811518	chr3:128013645	RUVBL1	chr3:127783627-127872757:-	-0.25	-4.62	4.96E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811519	chr3:128012876	RUVBL1	chr3:127783627-127872757:-	-0.25	-4.62	4.96E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811522	chr3:128011423	RUVBL1	chr3:127783627-127872757:-	-0.25	-4.72	3.09E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811523	chr3:128011397	RUVBL1	chr3:127783627-127872757:-	0.23	4.4	1.32E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811525	chr3:127999430	RUVBL1	chr3:127783627-127872757:-	-0.25	-4.67	3.87E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811526	chr3:127995718	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.38	1.47E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811527	chr3:127994604	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.26	2.5E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811528	chr3:127994436	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.14	4.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811530	chr3:127993166	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.14	4.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811533	chr3:127991729	RUVBL1	chr3:127783627-127872757:-	-0.25	-4.72	3.09E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811534	chr3:127991108	RUVBL1	chr3:127783627-127872757:-	-0.25	-4.63	4.67E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811536	chr3:127988919	RUVBL1	chr3:127783627-127872757:-	-0.22	-4.07	5.53E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811537	chr3:127987924	RUVBL1	chr3:127783627-127872757:-	0.23	4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811538	chr3:127986631	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811539	chr3:127986473	RUVBL1	chr3:127783627-127872757:-	0.23	4.36	1.57E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811540	chr3:127985569	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811541	chr3:127984794	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811542	chr3:127983800	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811543	chr3:127983796	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811544	chr3:127983495	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811545	chr3:127983148	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2811549	chr3:127938708	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.39	1.38E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2812533	chr10:71452285	ADAMTS14	chr10:72432559-72522193:+	0.19	3.57	0.000392	Type 2 diabetes	
PRAD	cis	1	rs2812533	chr10:71452285	TACR2	chr10:71163958-71176674:-	-0.24	-3.71	0.000231	Type 2 diabetes	
PRAD	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.49	-11.6	1.61E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs2814993	chr6:34618893	C6orf106	chr6:34555066-34664625:-	-0.25	-3.54	0.000441	Pubertal anthropometrics	
PRAD	cis	1	rs2814993	chr6:34618893	UHRF1BP1	chr6:34759794-34853117:+	-0.19	-5.08	5.55E-7	Pubertal anthropometrics	
PRAD	cis	1	rs2814994	chr6:34620153	C6orf106	chr6:34555066-34664625:-	0.27	3.91	0.000107	Pubertal anthropometrics	
PRAD	cis	1	rs2814994	chr6:34620153	UHRF1BP1	chr6:34759794-34853117:+	0.19	4.95	1.01E-6	Pubertal anthropometrics	
PRAD	cis	1	rs2814996	chr6:34621314	C6orf106	chr6:34555066-34664625:-	0.25	3.53	0.000457	Pubertal anthropometrics	
PRAD	cis	1	rs2814996	chr6:34621314	UHRF1BP1	chr6:34759794-34853117:+	0.19	5.05	6.39E-7	Pubertal anthropometrics	
PRAD	cis	1	rs2815005	chr6:34638847	C6orf106	chr6:34555066-34664625:-	0.26	3.63	0.000318	Pubertal anthropometrics	
PRAD	cis	1	rs2815005	chr6:34638847	UHRF1BP1	chr6:34759794-34853117:+	0.19	5	7.92E-7	Pubertal anthropometrics	
PRAD	cis	1	rs2815701	chr1:28244854	RPA2	chr1:28218049-28241236:-	0.26	4.9	1.34E-6	Corneal astigmatism	
PRAD	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.5	-11.84	1.68E-28	Response to antipsychotic treatment	
PRAD	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.49	-11.47	4.85E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs2832065	chr21:30135362	N6AMT1	chr21:30244513-30257693:-	-0.3	-3.94	9.38E-5	Cognitive test performance	
PRAD	cis	1	rs2832077	chr21:30141021	CCT8	chr21:30428650-30446010:-	-0.2	-3.55	0.000427	Cognitive test performance	
PRAD	cis	1	rs2832077	chr21:30141021	N6AMT1	chr21:30244513-30257693:-	-0.31	-4.07	5.61E-5	Cognitive test performance	
PRAD	cis	1	rs2833888	chr21:33927560	TCP10L	chr21:33947152-33957845:-	-0.31	-4.92	1.2E-6	Gastritis	
PRAD	cis	1	rs2833889	chr21:33927768	TCP10L	chr21:33947152-33957845:-	0.29	4.77	2.48E-6	Gastritis	
PRAD	cis	1	rs2833890	chr21:33927886	TCP10L	chr21:33947152-33957845:-	0.3	4.89	1.39E-6	Gastritis	
PRAD	cis	1	rs2834190	chr21:34693011	IFNAR1	chr21:34696734-34732126:+	0.18	3.51	0.000484	Narcolepsy	
PRAD	cis	1	rs2834288	chr21:35264397	ATP5O	chr21:35275758-35288158:-	-0.12	-3.95	9.16E-5	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.47	-12.2	6.07E-30	Eye color traits	
PRAD	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.47	-12.2	6.07E-30	Eye color traits	
PRAD	cis	1	rs28360661	chr21:40681972	HMGN1	chr21:40714247-40721270:-	-0.24	-4.74	2.87E-6	Cognitive function	
PRAD	cis	1	rs28360661	chr21:40681972	PSMG1	chr21:40547390-40555440:-	-0.34	-6.8	3.25E-11	Cognitive function	
PRAD	cis	1	rs28363725	chr8:96027108	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28363725	chr8:96027108	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28365850	chr14:35591316	PPP2R3C	chr14:35554679-35591679:-	0.39	6.09	2.4E-9	Atopic dermatitis	
PRAD	cis	1	rs28367503	chr16:67854534	C16orf86	chr16:67700717-67702659:+	-0.3	-4.75	2.69E-6	Crohn's disease	
PRAD	cis	1	rs28367503	chr16:67854534	FHOD1	chr16:67263294-67281425:-	0.29	3.47	0.000564	Crohn's disease	
PRAD	cis	1	rs2836974	chr21:40663181	HMGN1	chr21:40714247-40721270:-	0.25	5.11	4.73E-7	Cognitive function	
PRAD	cis	1	rs2836974	chr21:40663181	PSMG1	chr21:40547390-40555440:-	0.32	6.68	6.75E-11	Cognitive function	
PRAD	cis	1	rs28371412	chr4:68415525	CENPC1	chr4:68337989-68411256:-	0.16	3.55	0.000417	Parkinson's disease	
PRAD	cis	1	rs28371583	chr1:207494679	CD55	chr1:207494817-207534309:+	0.46	8.81	2.38E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs28371597	chr1:207496896	CD55	chr1:207494817-207534309:+	0.55	10.39	6.68E-23	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs28371614	chr1:207505274	CD55	chr1:207494817-207534309:+	0.49	9.48	1.27E-19	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs2837246	chr21:41215018	IGSF5	chr21:41117334-41174021:+	0.19	3.71	0.000234	Systolic blood pressure (alcohol consumption interaction)	
PRAD	cis	1	rs2837247	chr21:41219400	IGSF5	chr21:41117334-41174021:+	0.17	3.46	0.000587	Systolic blood pressure (alcohol consumption interaction)	
PRAD	cis	1	rs2837249	chr21:41220127	IGSF5	chr21:41117334-41174021:+	0.18	3.56	0.000414	Systolic blood pressure (alcohol consumption interaction)	
PRAD	cis	1	rs2837258	chr21:41224073	IGSF5	chr21:41117334-41174021:+	0.18	3.51	0.000488	Systolic blood pressure (alcohol consumption interaction)	
PRAD	cis	1	rs28372828	chr1:156253031	BGLAP	chr1:156182784-156213112:+	0.21	5.47	7.47E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs28372828	chr1:156253031	CCT3	chr1:156278752-156308195:-	-0.15	-3.43	0.000658	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs28374715	chr15:41563950	LOC729082	chr15:41576201-41601901:+	-0.22	-4.61	5.15E-6	Ulcerative colitis	
PRAD	cis	1	rs28374715	chr15:41563950	NDUFAF1	chr15:41679553-41694642:-	0.26	4.93	1.15E-6	Ulcerative colitis	
PRAD	cis	1	rs28378156	chr8:96027127	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28378156	chr8:96027127	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28379681	chr7:1070539	GPR146	chr7:1084243-1098897:+	0.27	3.57	0.000387	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs28379681	chr7:1070539	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.15	3.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs2838009	chr21:42694284	FAM3B	chr21:42676177-42729654:+	0.17	3.52	0.000474	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
PRAD	cis	1	rs28381487	chr6:88320798	C6orf165	chr6:88117721-88205858:+	0.42	3.9	0.00011	Obesity-related traits	
PRAD	cis	1	rs28385591	chr6:88333140	C6orf165	chr6:88117721-88205858:+	0.42	3.9	0.00011	Obesity-related traits	
PRAD	cis	1	rs28385632	chr6:88305378	C6orf165	chr6:88117721-88205858:+	0.37	3.57	0.000397	Obesity-related traits	
PRAD	cis	1	rs28391259	chr4:107014012	TBCK	chr4:106967233-107237861:-	0.19	3.99	7.82E-5	Airflow obstruction	
PRAD	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.22	-7.18	2.73E-12	Testicular germ cell tumor	
PRAD	cis	1	rs2839181	chr21:47685939	MCM3APAS	chr21:47649158-47671743:+	0.17	4.46	1.04E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2839181	chr21:47685939	MCM3AP	chr21:47655048-47705236:-	0.14	3.44	0.000628	Testicular germ cell tumor	
PRAD	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.24	-7.69	8.73E-14	Testicular germ cell tumor	
PRAD	cis	1	rs2839186	chr21:47690068	MCM3APAS	chr21:47649158-47671743:+	0.15	3.77	0.000182	Testicular germ cell tumor	
PRAD	cis	1	rs2839186	chr21:47690068	MCM3AP	chr21:47655048-47705236:-	0.17	3.95	9.17E-5	Testicular germ cell tumor	
PRAD	cis	1	rs2839434	chr21:43418905	C21orf121	chr21:43442113-43445060:+	0.29	4.88	1.48E-6	Hand grip strength	
PRAD	cis	1	rs2839465	chr21:43511232	C21orf128	chr21:43522244-43528644:-	0.35	5.13	4.16E-7	IgG glycosylation	
PRAD	cis	1	rs2839466	chr21:43512324	C21orf128	chr21:43522244-43528644:-	-0.32	-4.74	2.9E-6	IgG glycosylation	
PRAD	cis	1	rs2839467	chr21:43513200	C21orf128	chr21:43522244-43528644:-	-0.35	-4.96	9.81E-7	IgG glycosylation	
PRAD	cis	1	rs28396304	chr19:12081484	ZNF763	chr19:12035900-12091196:+	-0.38	-3.86	0.000127	Multiple sclerosis	
PRAD	cis	1	rs28399702	chr14:35625217	BRMS1L	chr14:36295597-36341168:+	0.18	3.47	0.000569	Atopic dermatitis	
PRAD	cis	1	rs28399702	chr14:35625217	PPP2R3C	chr14:35554679-35591679:-	0.39	6.36	4.88E-10	Atopic dermatitis	
PRAD	cis	1	rs28399710	chr7:1070631	GPR146	chr7:1084243-1098897:+	0.27	3.57	0.000387	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs28399710	chr7:1070631	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.15	3.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs2840382	chr1:111250018	AHCYL1	chr1:110527308-110566363:+	-0.29	-3.64	0.000304	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs2840382	chr1:111250018	DRAM2	chr1:111659955-111682838:-	-0.37	-3.88	0.000119	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs2840382	chr1:111250018	RAP1A	chr1:112085055-112256100:+	-0.28	-3.55	0.000426	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs28406132	chr8:96030377	C8orf38	chr8:95908040-96088396:+	-0.35	-6.12	1.94E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28406132	chr8:96030377	TP53INP1	chr8:95938201-95961615:-	0.23	3.6	0.000351	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.56	2.28E-27	Height	
PRAD	cis	1	rs28415874	chr4:147485988	ZNF827	chr4:146681892-146859607:-	-0.17	-3.74	0.00021	Heart rate	
PRAD	cis	1	rs28416696	chr2:54484326	C2orf73	chr2:54558071-54588714:+	0.29	3.97	8.34E-5	Telomere length	
PRAD	cis	1	rs2842992	chr6:160071159	MRPL18	chr6:160211022-160219460:+	-0.24	-5.35	1.38E-7	Age-related macular degeneration (GA)	
PRAD	cis	1	rs28436199	chr17:18751730	FAM18B	chr17:18684582-18710026:+	-0.24	-5.01	7.56E-7	Educational attainment (years of education)	
PRAD	cis	1	rs28440026	chr8:96026744	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28440026	chr8:96026744	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28444423	chr15:65982141	IGDCC4	chr15:65673825-65715410:-	-0.14	-3.44	0.000629	Mean corpuscular hemoglobin	
PRAD	cis	1	rs28444611	chr6:11040767	ELOVL2	chr6:10980995-11044624:-	0.79	13.53	1.94E-35	Blood metabolite ratios	
PRAD	cis	1	rs28444611	chr6:11040767	MAK	chr6:10762957-10838760:-	0.34	5.35	1.4E-7	Blood metabolite ratios	
PRAD	cis	1	rs28447319	chr9:33218922	NFX1	chr9:33290510-33371154:+	0.3	4.05	6.09E-5	Influenza A (H1N1) infection;Severe influenza A (H1N1) infection;Mild influenza (H1N1) infection	
PRAD	cis	1	rs2845573	chr11:61601908	FADS1	chr11:61567103-61584529:-	0.36	3.78	0.000178	Gestational age at birth (child effect);Trans fatty acid levels	
PRAD	cis	1	rs2845574	chr11:61601872	FADS1	chr11:61567103-61584529:-	-0.36	-3.78	0.000178	Gestational age at birth (child effect);Trans fatty acid levels	
PRAD	cis	1	rs28457747	chr7:37965963	EPDR1	chr7:37960163-37991539:+	-0.27	-4.4	1.33E-5	Bone mineral density	
PRAD	cis	1	rs28457828	chr8:55451142	RP1	chr8:55528627-55682531:+	0.26	4.01	7.06E-5	Intracranial aneurysm	
PRAD	cis	1	rs28461247	chr7:37944492	EPDR1	chr7:37960163-37991539:+	-0.23	-3.7	0.000239	Bone mineral density	
PRAD	cis	1	rs28463311	chr17:61919643	DDX42	chr17:61851567-61896676:+	-0.28	-5.67	2.55E-8	Body mass index	
PRAD	cis	1	rs28463311	chr17:61919643	FTSJ3	chr17:61896795-61905031:-	0.34	6.66	7.89E-11	Body mass index	
PRAD	cis	1	rs28463311	chr17:61919643	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.24	2.68E-5	Body mass index	
PRAD	cis	1	rs284648	chr19:41926790	ATP5SL	chr19:41937224-41945810:-	0.16	3.53	0.000464	Height	
PRAD	cis	1	rs284649	chr19:41926838	ATP5SL	chr19:41937224-41945810:-	0.16	3.53	0.000464	Height	
PRAD	cis	1	rs284650	chr19:41927129	ATP5SL	chr19:41937224-41945810:-	0.16	3.53	0.000464	Height	
PRAD	cis	1	rs284651	chr19:41928336	ATP5SL	chr19:41937224-41945810:-	0.16	3.62	0.000323	Height	
PRAD	cis	1	rs284652	chr19:41928652	ATP5SL	chr19:41937224-41945810:-	0.16	3.61	0.000339	Height	
PRAD	cis	1	rs28465556	chr4:39121189	KLHL5	chr4:39046659-39123828:+	-0.13	-3.79	0.000168	Uric acid levels	
PRAD	cis	1	rs284655	chr19:41928765	ATP5SL	chr19:41937224-41945810:-	0.16	3.67	0.000269	Height	
PRAD	cis	1	rs284656	chr19:41929251	ATP5SL	chr19:41937224-41945810:-	0.16	3.61	0.000339	Height	
PRAD	cis	1	rs28468623	chr7:98922812	CYP3A5	chr7:99245818-99332821:-	0.3	6.12	1.96E-9	Blood metabolite levels	
PRAD	cis	1	rs28469723	chr20:33700717	MMP24	chr20:33814539-33864804:+	-0.28	-4.31	2.0E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs28475846	chr18:11987669	IMPA2	chr18:11981057-12030876:+	-0.37	-4.39	1.39E-5	Stroke	
PRAD	cis	1	rs2847655	chr11:59865671	PATL1	chr11:59404194-59436511:-	-0.11	-3.55	0.000421	Alzheimer's disease (late onset)	
PRAD	cis	1	rs2847667	chr11:59859609	PATL1	chr11:59404194-59436511:-	-0.11	-3.53	0.000463	Alzheimer's disease (late onset)	
PRAD	cis	1	rs2847668	chr11:59862261	PATL1	chr11:59404194-59436511:-	-0.11	-3.45	0.000621	Alzheimer's disease (late onset)	
PRAD	cis	1	rs28477467	chr8:96032905	C8orf38	chr8:95908040-96088396:+	-0.34	-6.06	2.79E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28477467	chr8:96032905	TP53INP1	chr8:95938201-95961615:-	0.23	3.7	0.000239	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28477577	chr4:147495971	ZNF827	chr4:146681892-146859607:-	-0.16	-3.62	0.000324	Heart rate	
PRAD	cis	1	rs28480159	chr4:17685707	MED28	chr4:17616273-17629791:+	0.17	4.3	2.05E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs28485881	chr17:80690014	FN3K	chr17:80693452-80709073:+	-0.28	-6.17	1.51E-9	Glycated hemoglobin levels	
PRAD	cis	1	rs28485881	chr17:80690014	FN3KRP	chr17:80674582-80685889:+	-0.6	-11.4	9.51E-27	Glycated hemoglobin levels	
PRAD	cis	1	rs28488297	chr4:106767226	INTS12	chr4:106603787-106629881:-	-0.61	-7.01	8.59E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs28490940	chr16:68010262	C16orf86	chr16:67700717-67702659:+	-0.32	-4.18	3.51E-5	Crohn's disease	
PRAD	cis	1	rs28494067	chr15:50908272	SPPL2A	chr15:50999739-51057910:-	0.26	5.38	1.2E-7	QT interval	
PRAD	cis	1	rs28496357	chr8:96030511	C8orf38	chr8:95908040-96088396:+	-0.35	-6.21	1.14E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28496357	chr8:96030511	TP53INP1	chr8:95938201-95961615:-	0.23	3.66	0.000278	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28497813	chr4:17685503	MED28	chr4:17616273-17629791:+	0.17	4.3	2.05E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs28499558	chr18:11986282	IMPA2	chr18:11981057-12030876:+	-0.36	-4.44	1.11E-5	Stroke	
PRAD	cis	1	rs28501187	chr4:17643620	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs28503706	chr8:55441799	RP1	chr8:55528627-55682531:+	0.24	3.65	0.000293	Intracranial aneurysm	
PRAD	cis	1	rs28509217	chr18:11986326	IMPA2	chr18:11981057-12030876:+	-0.36	-4.44	1.11E-5	Stroke	
PRAD	cis	1	rs28512382	chr10:1092195	IDI2	chr10:1064847-1071799:-	-0.28	-5.18	3.37E-7	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs28512382	chr10:1092195	WDR37	chr10:1102344-1178237:+	0.33	5.51	5.81E-8	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs28514423	chr4:56429239	TMEM165	chr4:56262090-56292342:+	0.18	4.03	6.43E-5	Personality dimensions	
PRAD	cis	1	rs28522614	chr10:102323141	SEC31B	chr10:102246403-102289636:-	-0.26	-7.76	5.49E-14	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs28528096	chr7:1070912	GPR146	chr7:1084243-1098897:+	0.27	3.57	0.000387	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs28528096	chr7:1070912	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.15	3.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs28529050	chr4:89820790	FAM13A	chr4:89647106-90032549:-	0.19	3.65	0.000291	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs28539246	chr17:29226630	SUZ12P	chr17:29035714-29097067:+	-0.17	-5.2	2.98E-7	Height	
PRAD	cis	1	rs2854218	chr17:61942940	DDX42	chr17:61851567-61896676:+	-0.23	-4.58	6.05E-6	Body mass index	
PRAD	cis	1	rs2854218	chr17:61942940	FTSJ3	chr17:61896795-61905031:-	0.34	6.68	6.87E-11	Body mass index	
PRAD	cis	1	rs2854218	chr17:61942940	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.38	1.48E-5	Body mass index	
PRAD	cis	1	rs2854219	chr17:61942682	DDX42	chr17:61851567-61896676:+	-0.27	-5.47	7.29E-8	Body mass index	
PRAD	cis	1	rs2854219	chr17:61942682	FTSJ3	chr17:61896795-61905031:-	0.35	6.89	1.78E-11	Body mass index	
PRAD	cis	1	rs2854219	chr17:61942682	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.21	3.12E-5	Body mass index	
PRAD	cis	1	rs2854223	chr17:61939014	DDX42	chr17:61851567-61896676:+	-0.28	-5.86	8.96E-9	Body mass index	
PRAD	cis	1	rs2854223	chr17:61939014	FTSJ3	chr17:61896795-61905031:-	0.34	6.89	1.75E-11	Body mass index	
PRAD	cis	1	rs2854223	chr17:61939014	TCAM1P	chr17:61934376-61941738:+	-0.22	-4	7.25E-5	Body mass index	
PRAD	cis	1	rs28545485	chr4:17645376	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs28548763	chr4:147486866	ZNF827	chr4:146681892-146859607:-	-0.17	-3.71	0.000234	Heart rate	
PRAD	cis	1	rs28548932	chr18:11986277	IMPA2	chr18:11981057-12030876:+	-0.36	-4.44	1.11E-5	Stroke	
PRAD	cis	1	rs2855017	chr11:59866309	PATL1	chr11:59404194-59436511:-	-0.11	-3.48	0.000558	Alzheimer's disease (late onset)	
PRAD	cis	1	rs28552744	chr4:17620165	MED28	chr4:17616273-17629791:+	0.19	4.77	2.52E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs28557374	chr4:147503141	ZNF827	chr4:146681892-146859607:-	-0.16	-3.62	0.000324	Heart rate	
PRAD	cis	1	rs28558133	chr6:26531433	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs28558133	chr6:26531433	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs28558726	chr17:53058676	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.81	0.000159	Breast cancer	
PRAD	cis	1	rs28562777	chr19:32900819	DPY19L3	chr19:32896677-32975236:+	0.11	3.44	0.000639	Bipolar disorder	
PRAD	cis	1	rs28564902	chr4:56479491	SRD5A3	chr4:56212409-56237866:+	-0.28	-4.07	5.55E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs28567450	chr6:34747409	UHRF1BP1	chr6:34759794-34853117:+	0.17	4.61	5.15E-6	Pubertal anthropometrics	
PRAD	cis	1	rs2856	chr20:25433536	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.35	1.7E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2856	chr20:25433536	FAM182B	chr20:25744102-25848786:-	0.4	7.35	8.75E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs2856	chr20:25433536	PYGB	chr20:25228706-25278647:+	-0.33	-7.13	3.91E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs28572537	chr19:18552208	SSBP4	chr19:18530221-18545371:+	-0.17	-5.55	4.79E-8	Breast cancer	
PRAD	cis	1	rs2857891	chr11:6962957	ZNF215	chr11:6947654-7005861:+	-0.33	-6.09	2.32E-9	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs28582059	chr4:56408404	TMEM165	chr4:56262090-56292342:+	0.18	4.07	5.59E-5	Personality dimensions	
PRAD	cis	1	rs28583584	chr17:17483297	RAI1	chr17:17584787-17714763:+	0.27	3.51	0.000488	Obsessive-compulsive symptoms	
PRAD	cis	1	rs28591316	chr8:41524425	ANK1	chr8:41510745-41754280:-	-0.2	-3.53	0.000461	Type 2 diabetes	
PRAD	cis	1	rs28600710	chr8:55436793	RP1	chr8:55528627-55682531:+	0.23	3.66	0.000277	Intracranial aneurysm	
PRAD	cis	1	rs28602663	chr1:76235355	ACADM	chr1:76190043-76229353:+	0.18	3.93	9.95E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs28602970	chr8:41524505	ANK1	chr8:41510745-41754280:-	-0.2	-3.53	0.000461	Type 2 diabetes	
PRAD	cis	1	rs28607301	chr4:39138080	KLHL5	chr4:39046659-39123828:+	-0.13	-3.92	0.000101	Uric acid levels	
PRAD	cis	1	rs28615248	chr8:55451193	RP1	chr8:55528627-55682531:+	0.24	3.61	0.000343	Intracranial aneurysm	
PRAD	cis	1	rs28616734	chr8:96021443	C8orf38	chr8:95908040-96088396:+	-0.35	-6.32	6.21E-10	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28616734	chr8:96021443	TP53INP1	chr8:95938201-95961615:-	0.22	3.52	0.00047	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28617320	chr4:147480098	ZNF827	chr4:146681892-146859607:-	-0.16	-3.64	0.000298	Heart rate	
PRAD	cis	1	rs28626045	chr14:75589195	EIF2B2	chr14:75469612-75476292:+	0.25	4.98	9.03E-7	Height	
PRAD	cis	1	rs28626045	chr14:75589195	MLH3	chr14:75480467-75518235:-	0.32	6.58	1.25E-10	Height	
PRAD	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.58	12.01	3.5E-29	Forced vital capacity	
PRAD	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.59	12.14	1.06E-29	Forced vital capacity	
PRAD	cis	1	rs28629854	chr9:98262833	PTCH1	chr9:98205266-98279247:-	-0.14	-3.55	0.000429	Height	
PRAD	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.59	-12.19	7.14E-30	Forced vital capacity	
PRAD	cis	1	rs28636952	chr17:17462506	RAI1	chr17:17584787-17714763:+	0.23	3.6	0.000358	Obsessive-compulsive symptoms	
PRAD	cis	1	rs2864076	chr11:46460038	HARBI1	chr11:46624857-46638777:-	0.26	3.49	0.000527	Schizophrenia	
PRAD	cis	1	rs2864	chr5:137523430	REEP2	chr5:137774776-137782657:+	-0.1	-3.93	9.75E-5	Resting heart rate	
PRAD	cis	1	rs28651964	chr8:96026781	C8orf38	chr8:95908040-96088396:+	-0.34	-6.07	2.59E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28651964	chr8:96026781	TP53INP1	chr8:95938201-95961615:-	0.23	3.64	0.000306	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28655136	chr16:68001447	C16orf86	chr16:67700717-67702659:+	-0.32	-4.18	3.51E-5	Crohn's disease	
PRAD	cis	1	rs28655955	chr19:12064771	ZNF763	chr19:12035900-12091196:+	-0.4	-4.04	6.16E-5	Multiple sclerosis	
PRAD	cis	1	rs28661978	chr3:156579739	LEKR1	chr3:156544076-156763918:+	-0.43	-5.7	2.17E-8	Bone mineral density	
PRAD	cis	1	rs28662210	chr17:26093864	LGALS9	chr17:25958174-25976585:+	-0.09	-4.28	2.22E-5	Fractional exhaled nitric oxide (childhood)	
PRAD	cis	1	rs28664971	chr17:28437410	EFCAB5	chr17:28256874-28435469:+	0.26	4.34	1.75E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs28668389	chr3:58323942	PXK	chr3:58318617-58410878:+	0.19	3.99	7.67E-5	Cholesterol, total	
PRAD	cis	1	rs28668419	chr16:68010195	C16orf86	chr16:67700717-67702659:+	-0.32	-4.18	3.51E-5	Crohn's disease	
PRAD	cis	1	rs28672333	chr7:142826798	TMEM139	chr7:142982044-142985140:+	-0.22	-3.64	0.000301	Dermatomyositis	
PRAD	cis	1	rs28672356	chr19:32907843	DPY19L3	chr19:32896677-32975236:+	0.11	3.59	0.000359	Bipolar disorder	
PRAD	cis	1	rs28675843	chr3:128575353	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.00044	Dental caries	
PRAD	cis	1	rs2867898	chr20:37690952	FAM83D	chr20:37554955-37581701:+	-0.22	-5.12	4.58E-7	Dialysis-related mortality	
PRAD	cis	1	rs28679372	chr16:67882932	C16orf86	chr16:67700717-67702659:+	0.29	3.62	0.000328	Crohn's disease	
PRAD	cis	1	rs28680843	chr7:38869571	FAM183B	chr7:38724947-38726689:-	0.4	4.12	4.45E-5	Cognitive performance	
PRAD	cis	1	rs28683528	chr12:123845351	ABCB9	chr12:123413540-123459752:-	0.27	4.6	5.42E-6	Educational attainment;Height;Head circumference (infant)	
PRAD	cis	1	rs28683528	chr12:123845351	CDK2AP1	chr12:123745542-123756687:-	-0.22	-4.73	2.96E-6	Educational attainment;Height;Head circumference (infant)	
PRAD	cis	1	rs28684871	chr3:10072635	C3orf10	chr3:10157333-10168873:+	-0.19	-3.78	0.000179	Alzheimer's disease	
PRAD	cis	1	rs28684871	chr3:10072635	LOC401052	chr3:10048102-10052779:-	-0.28	-5.09	5.09E-7	Alzheimer's disease	
PRAD	cis	1	rs2869042	chr15:78691154	CRABP1	chr15:78632666-78640572:+	-0.21	-3.78	0.000175	Obesity-related traits	
PRAD	cis	1	rs28693609	chr4:17645233	MED28	chr4:17616273-17629791:+	0.2	4.96	9.63E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs28694035	chr3:128575365	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.00044	Dental caries	
PRAD	cis	1	rs2869548	chr15:78922638	CHRNA3	chr15:78885397-78913322:-	-0.34	-5.78	1.38E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2869548	chr15:78922638	CHRNA5	chr15:78857906-78886458:+	-0.21	-4.16	3.81E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2869716	chr20:47779340	CSE1L	chr20:47662838-47713484:+	0.19	4.52	7.86E-6	Anger	
PRAD	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.81	12.17	8.22E-30	Diastolic blood pressure	
PRAD	cis	1	rs28712702	chr8:96026980	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28712702	chr8:96026980	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs28716236	chr2:38899228	GALM	chr2:38893052-38961908:+	0.43	4.96	9.77E-7	5-HTT brain serotonin transporter levels	
PRAD	cis	1	rs28718130	chr15:50909489	SPPL2A	chr15:50999739-51057910:-	0.26	5.38	1.2E-7	QT interval	
PRAD	cis	1	rs28729153	chr19:32907578	DPY19L3	chr19:32896677-32975236:+	0.11	3.7	0.000243	Bipolar disorder	
PRAD	cis	1	rs2872958	chr4:17665032	MED28	chr4:17616273-17629791:+	0.19	4.68	3.68E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2872959	chr4:17677163	MED28	chr4:17616273-17629791:+	-0.15	-3.83	0.000146	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.82	12.9	8.05E-33	Diastolic blood pressure	
PRAD	cis	1	rs28739535	chr4:147486830	ZNF827	chr4:146681892-146859607:-	-0.17	-3.71	0.000234	Heart rate	
PRAD	cis	1	rs2874121	chr17:61731024	CD79B	chr17:62006098-62009704:-	0.12	3.63	0.000319	Body mass index	
PRAD	cis	1	rs2874121	chr17:61731024	DDX42	chr17:61851567-61896676:+	-0.23	-4.7	3.47E-6	Body mass index	
PRAD	cis	1	rs2874121	chr17:61731024	FTSJ3	chr17:61896795-61905031:-	0.36	7.25	1.77E-12	Body mass index	
PRAD	cis	1	rs2874121	chr17:61731024	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.54	7.07E-6	Body mass index	
PRAD	cis	1	rs2874490	chr3:156635513	LEKR1	chr3:156544076-156763918:+	-0.48	-6.68	6.61E-11	Bone mineral density	
PRAD	cis	1	rs2874491	chr3:156649111	LEKR1	chr3:156544076-156763918:+	-0.47	-6.43	3.1E-10	Bone mineral density	
PRAD	cis	1	rs28755797	chr3:41774446	ULK4	chr3:41288091-42003660:-	0.75	11.07	1.84E-25	Diastolic blood pressure	
PRAD	cis	1	rs2875781	chr1:159219794	FCER1A	chr1:159259506-159278013:+	-0.14	-3.8	0.000166	Inflammatory biomarkers	
PRAD	cis	1	rs2880791	chr5:150267376	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs28817917	chr15:50965846	SPPL2A	chr15:50999739-51057910:-	0.26	5.3	1.78E-7	QT interval	
PRAD	cis	1	rs28824259	chr3:48425675	ATRIP	chr3:48488141-48507708:+	0.27	6.28	7.73E-10	Longevity	
PRAD	cis	1	rs28824259	chr3:48425675	CDC25A	chr3:48198668-48229801:-	0.22	4.12	4.39E-5	Longevity	
PRAD	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.18	-5.01	7.64E-7	Longevity	
PRAD	cis	1	rs28829049	chr1:19349281	KIAA0090	chr1:19544585-19578046:-	-0.13	-3.69	0.000253	QRS duration in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs2884030	chr11:108281903	ATM	chr11:108093559-108239826:+	-0.17	-5.33	1.53E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs2885510	chr3:48418226	ATRIP	chr3:48488141-48507708:+	-0.27	-6.34	5.55E-10	Longevity	
PRAD	cis	1	rs2885510	chr3:48418226	CDC25A	chr3:48198668-48229801:-	-0.22	-4.13	4.33E-5	Longevity	
PRAD	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.18	4.99	8.62E-7	Longevity	
PRAD	cis	1	rs28856331	chr7:102543763	PRKRIP1	chr7:102004341-102067129:+	0.13	3.63	0.000318	Morning vs. evening chronotype	
PRAD	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.53	11.98	4.85E-29	Height	
PRAD	cis	1	rs2888674	chr7:150510915	TMEM176A	chr7:150497854-150502208:+	0.15	4.39	1.39E-5	Forced expiratory volume in 1 second (environmental interaction)	
PRAD	cis	1	rs28889328	chr3:184705379	VPS8	chr3:184529931-184770402:+	-0.29	-3.82	0.000152	Heschl's gyrus morphology	
PRAD	cis	1	rs2889363	chr2:198163699	PLCL1	chr2:198669426-199014606:+	-0.11	-3.47	0.00056	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs28897193	chr4:107005529	TBCK	chr4:106967233-107237861:-	0.17	3.66	0.000282	Airflow obstruction	
PRAD	cis	1	rs2889873	chr20:33646841	MMP24	chr20:33814539-33864804:+	-0.31	-4.76	2.61E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs2890659	chr4:39127021	KLHL5	chr4:39046659-39123828:+	-0.13	-3.8	0.000163	Uric acid levels	
PRAD	cis	1	rs2891490	chr2:26325927	GPR113	chr2:26531041-26569685:-	-0.23	-3.48	0.00055	Gut microbiome composition (summer)	
PRAD	cis	1	rs2893685	chr12:117001193	MAP1LC3B2	chr12:116997186-117014425:+	-0.38	-3.81	0.000156	Acute lymphoblastic leukemia (childhood)	
PRAD	cis	1	rs2896954	chr15:76851692	ETFA	chr15:76508629-76603810:-	0.17	3.44	0.000629	Blood metabolite levels	
PRAD	cis	1	rs2896954	chr15:76851692	SCAPER	chr15:76640529-77197744:-	-0.13	-3.69	0.000246	Blood metabolite levels	
PRAD	cis	1	rs2897770	chr13:50325070	EBPL	chr13:50234811-50265623:-	-0.27	-3.94	9.34E-5	Obesity-related traits	
PRAD	cis	1	rs2899462	chr15:50939254	SPPL2A	chr15:50999739-51057910:-	0.27	5.56	4.64E-8	QT interval	
PRAD	cis	1	rs2901438	chr2:73665656	ALMS1P	chr2:73872046-73912692:+	0.48	8.38	5.96E-16	Metabolite levels	
PRAD	cis	1	rs2901438	chr2:73665656	NAT8	chr2:73867850-73869537:-	0.26	4.01	6.99E-5	Metabolite levels	
PRAD	cis	1	rs2902858	chr11:46524013	HARBI1	chr11:46624857-46638777:-	0.26	3.51	0.000489	Schizophrenia	
PRAD	cis	1	rs2904804	chr10:5009759	AKR1C1	chr10:4934796-5020157:+	-0.31	-7.29	1.32E-12	Economic and political preferences (immigration/crime)	
PRAD	cis	1	rs2904804	chr10:5009759	AKR1C2	chr10:4964715-5060207:-	-0.32	-6.6	1.09E-10	Economic and political preferences (immigration/crime)	
PRAD	cis	1	rs2906124	chr5:137528835	REEP2	chr5:137774776-137782657:+	-0.11	-4.22	2.89E-5	Resting heart rate	
PRAD	cis	1	rs2906127	chr5:137539466	REEP2	chr5:137774776-137782657:+	-0.1	-3.88	0.00012	Resting heart rate	
PRAD	cis	1	rs2906128	chr5:137550054	REEP2	chr5:137774776-137782657:+	-0.1	-3.88	0.000118	Resting heart rate	
PRAD	cis	1	rs2907948	chr7:150638484	ABCB8	chr7:150725510-150744867:+	0.17	3.69	0.000249	QT interval	
PRAD	cis	1	rs2910851	chr5:42787232	CCDC152	chr5:42756920-42802539:+	0.16	4.49	8.85E-6	Height	
PRAD	cis	1	rs2910851	chr5:42787232	SEPP1	chr5:42799983-42825998:-	0.15	4.37	1.54E-5	Height	
PRAD	cis	1	rs2910855	chr5:42782335	CCDC152	chr5:42756920-42802539:+	0.16	4.48	9.34E-6	Height	
PRAD	cis	1	rs2910855	chr5:42782335	SEPP1	chr5:42799983-42825998:-	0.15	4.33	1.84E-5	Height	
PRAD	cis	1	rs2910856	chr5:42781376	CCDC152	chr5:42756920-42802539:+	0.16	4.51	8.37E-6	Height	
PRAD	cis	1	rs2910856	chr5:42781376	SEPP1	chr5:42799983-42825998:-	0.15	4.41	1.29E-5	Height	
PRAD	cis	1	rs2910862	chr5:42766404	CCDC152	chr5:42756920-42802539:+	0.16	4.42	1.24E-5	Height	
PRAD	cis	1	rs2910862	chr5:42766404	SEPP1	chr5:42799983-42825998:-	0.15	4.35	1.68E-5	Height	
PRAD	cis	1	rs2910864	chr5:42763707	CCDC152	chr5:42756920-42802539:+	0.16	4.42	1.24E-5	Height	
PRAD	cis	1	rs2910864	chr5:42763707	SEPP1	chr5:42799983-42825998:-	0.15	4.35	1.68E-5	Height	
PRAD	cis	1	rs2910869	chr5:42741846	CCDC152	chr5:42756920-42802539:+	0.15	4.23	2.84E-5	Height	
PRAD	cis	1	rs2910869	chr5:42741846	SEPP1	chr5:42799983-42825998:-	0.14	4.16	3.73E-5	Height	
PRAD	cis	1	rs2910872	chr5:42730292	CCDC152	chr5:42756920-42802539:+	0.15	4.16	3.78E-5	Height	
PRAD	cis	1	rs2910872	chr5:42730292	SEPP1	chr5:42799983-42825998:-	0.14	4	7.47E-5	Height	
PRAD	cis	1	rs2910875	chr5:42719826	CCDC152	chr5:42756920-42802539:+	0.15	4.07	5.49E-5	Height	
PRAD	cis	1	rs2910875	chr5:42719826	SEPP1	chr5:42799983-42825998:-	0.13	3.85	0.000134	Height	
PRAD	cis	1	rs2914937	chr1:207488768	CD55	chr1:207494817-207534309:+	0.24	4.21	3.04E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs2916068	chr19:19516433	GATAD2A	chr19:19496642-19619740:+	0.15	3.66	0.000283	Schizophrenia	
PRAD	cis	1	rs2920280	chr8:143761144	LY6K	chr8:143781529-143785582:+	0.26	4.47	9.96E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920280	chr8:143761144	LYNX1	chr8:143845758-143859640:-	-0.31	-7.51	2.92E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920280	chr8:143761144	PSCA	chr8:143761875-143764142:+	0.57	10.51	2.47E-23	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920282	chr8:143757763	LY6K	chr8:143781529-143785582:+	0.22	3.88	0.000121	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920282	chr8:143757763	LYNX1	chr8:143845758-143859640:-	-0.32	-7.85	2.86E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920282	chr8:143757763	PSCA	chr8:143761875-143764142:+	0.54	10.01	1.7E-21	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920283	chr8:143757037	LY6K	chr8:143781529-143785582:+	0.22	3.88	0.00012	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920283	chr8:143757037	LYNX1	chr8:143845758-143859640:-	-0.32	-7.85	2.84E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920283	chr8:143757037	PSCA	chr8:143761875-143764142:+	0.54	10.01	1.67E-21	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920292	chr8:143765699	LY6K	chr8:143781529-143785582:+	0.2	3.62	0.00033	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920292	chr8:143765699	LYNX1	chr8:143845758-143859640:-	-0.32	-8.17	2.85E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920292	chr8:143765699	PSCA	chr8:143761875-143764142:+	0.53	10.12	6.54E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920293	chr8:143765414	LY6K	chr8:143781529-143785582:+	0.21	3.72	0.000223	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920293	chr8:143765414	LYNX1	chr8:143845758-143859640:-	-0.31	-8.05	6.91E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920293	chr8:143765414	PSCA	chr8:143761875-143764142:+	0.53	10.12	6.79E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920294	chr8:143765326	LY6K	chr8:143781529-143785582:+	0.2	3.62	0.00033	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920294	chr8:143765326	LYNX1	chr8:143845758-143859640:-	-0.32	-8.17	2.85E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920294	chr8:143765326	PSCA	chr8:143761875-143764142:+	0.53	10.12	6.54E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920295	chr8:143764937	LY6K	chr8:143781529-143785582:+	0.2	3.61	0.000342	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920295	chr8:143764937	LYNX1	chr8:143845758-143859640:-	-0.32	-7.98	1.12E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920295	chr8:143764937	PSCA	chr8:143761875-143764142:+	0.54	10.25	2.11E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920296	chr8:143763109	LY6K	chr8:143781529-143785582:+	0.21	3.66	0.000276	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920296	chr8:143763109	LYNX1	chr8:143845758-143859640:-	-0.31	-8.02	8.51E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920296	chr8:143763109	PSCA	chr8:143761875-143764142:+	0.53	10.13	6.03E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920297	chr8:143763083	LY6K	chr8:143781529-143785582:+	0.21	3.66	0.000276	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920297	chr8:143763083	LYNX1	chr8:143845758-143859640:-	-0.31	-8.02	8.51E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920297	chr8:143763083	PSCA	chr8:143761875-143764142:+	0.53	10.13	6.03E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920298	chr8:143763043	LY6K	chr8:143781529-143785582:+	0.21	3.66	0.000276	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920298	chr8:143763043	LYNX1	chr8:143845758-143859640:-	-0.31	-8.02	8.51E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920298	chr8:143763043	PSCA	chr8:143761875-143764142:+	0.53	10.13	6.03E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.53	-6.46	2.65E-10	Tumor biomarkers	
PRAD	cis	1	rs2920781	chr15:43924682	CATSPER2	chr15:43922774-43959900:-	-0.27	-4.61	5.15E-6	Tumor biomarkers	
PRAD	cis	1	rs2920781	chr15:43924682	CKMT1A	chr15:43985084-43991419:+	-0.51	-5.59	3.94E-8	Tumor biomarkers	
PRAD	cis	1	rs292168	chr5:36807189	NIPBL	chr5:36876861-37065920:+	0.09	3.52	0.000477	Height	
PRAD	cis	1	rs292182	chr5:36954812	NIPBL	chr5:36876861-37065920:+	0.11	4.42	1.2E-5	Height	
PRAD	cis	1	rs292184	chr5:36963805	NIPBL	chr5:36876861-37065920:+	0.11	4.58	5.93E-6	Height	
PRAD	cis	1	rs292194	chr5:36941767	NIPBL	chr5:36876861-37065920:+	-0.1	-3.83	0.000143	Height	
PRAD	cis	1	rs2922809	chr8:6350464	MCPH1	chr8:6264121-6506025:+	0.39	3.99	7.66E-5	Cytomegalovirus antibody response	
PRAD	cis	1	rs2924584	chr4:99988208	ADH5	chr4:99992132-100009931:-	-0.18	-4.34	1.73E-5	HDL cholesterol	
PRAD	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.53	-6.46	2.65E-10	Tumor biomarkers	
PRAD	cis	1	rs2927072	chr15:43922398	CATSPER2	chr15:43922774-43959900:-	-0.27	-4.61	5.15E-6	Tumor biomarkers	
PRAD	cis	1	rs2927072	chr15:43922398	CKMT1A	chr15:43985084-43991419:+	-0.51	-5.59	3.94E-8	Tumor biomarkers	
PRAD	cis	1	rs2929859	chr3:128608341	ACAD9	chr3:128598333-128634910:+	-0.19	-3.49	0.000525	IgG glycosylation	
PRAD	cis	1	rs2932538	chr1:113216543	ST7L	chr1:113066142-113162405:-	-0.48	-7.09	5.05E-12	Systolic blood pressure;Hypertension;Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs2933343	chr3:128658492	ACAD9	chr3:128598333-128634910:+	-0.2	-3.67	0.000275	IgG glycosylation	
PRAD	cis	1	rs2935183	chr17:45607572	C17orf57	chr17:45401142-45518675:+	-0.4	-9.21	1.06E-18	Multiple sclerosis or amyotrophic lateral sclerosis	
PRAD	cis	1	rs2935183	chr17:45607572	TBKBP1	chr17:45772630-45789427:+	0.15	4.09	5.04E-5	Multiple sclerosis or amyotrophic lateral sclerosis	
PRAD	cis	1	rs2938670	chr15:78740688	CHRNA5	chr15:78857906-78886458:+	-0.18	-3.57	0.000395	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1 in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2940927	chr5:42422389	GHR	chr5:42424026-42721925:+	-0.21	-4.78	2.38E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs2940940	chr5:42397230	GHR	chr5:42424026-42721925:+	-0.2	-4.61	5.1E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs2947494	chr15:41375741	CHP	chr15:41523437-41574081:+	-0.17	-3.96	8.58E-5	Glomerular filtration rate (creatinine)	
PRAD	cis	1	rs2951308	chr7:143767149	ARHGEF35	chr7:143883677-143892736:-	0.5	9.39	2.53E-19	Obesity-related traits	
PRAD	cis	1	rs2951308	chr7:143767149	OR2A1	chr7:144015236-144016148:+;chr7	0.23	3.69	0.000249	Obesity-related traits	
PRAD	cis	1	rs2951308	chr7:143767149	OR2A9P	chr7:143991573-143997832:+;chr7	0.31	5.36	1.29E-7	Obesity-related traits	
PRAD	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.49	-9.21	1.04E-18	Obesity-related traits	
PRAD	cis	1	rs2951353	chr7:143761116	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.59	0.00036	Obesity-related traits	
PRAD	cis	1	rs2951353	chr7:143761116	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.34	1.48E-7	Obesity-related traits	
PRAD	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.37	2.99E-19	Obesity-related traits	
PRAD	cis	1	rs2951354	chr7:143761001	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.72	0.000224	Obesity-related traits	
PRAD	cis	1	rs2951354	chr7:143761001	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.36	1.3E-7	Obesity-related traits	
PRAD	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.39	2.55E-19	Obesity-related traits	
PRAD	cis	1	rs2951360	chr7:143757349	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.71	0.000236	Obesity-related traits	
PRAD	cis	1	rs2951360	chr7:143757349	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.29	1.92E-7	Obesity-related traits	
PRAD	cis	1	rs2951363	chr7:143754724	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.38	2.78E-19	Obesity-related traits	
PRAD	cis	1	rs2951363	chr7:143754724	OR2A1	chr7:144015236-144016148:+;chr7	-0.24	-3.85	0.000135	Obesity-related traits	
PRAD	cis	1	rs2951363	chr7:143754724	OR2A9P	chr7:143991573-143997832:+;chr7	-0.32	-5.58	3.98E-8	Obesity-related traits	
PRAD	cis	1	rs2951364	chr7:143754483	ARHGEF35	chr7:143883677-143892736:-	-0.51	-9.53	8.18E-20	Obesity-related traits	
PRAD	cis	1	rs2951364	chr7:143754483	OR2A1	chr7:144015236-144016148:+;chr7	-0.24	-3.97	8.21E-5	Obesity-related traits	
PRAD	cis	1	rs2951364	chr7:143754483	OR2A9P	chr7:143991573-143997832:+;chr7	-0.33	-5.61	3.53E-8	Obesity-related traits	
PRAD	cis	1	rs2951368	chr7:143752821	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.5	1.05E-19	Obesity-related traits	
PRAD	cis	1	rs2951368	chr7:143752821	OR2A1	chr7:144015236-144016148:+;chr7	-0.24	-3.95	9.16E-5	Obesity-related traits	
PRAD	cis	1	rs2951368	chr7:143752821	OR2A9P	chr7:143991573-143997832:+;chr7	-0.33	-5.64	3.02E-8	Obesity-related traits	
PRAD	cis	1	rs2951369	chr7:143752638	ARHGEF35	chr7:143883677-143892736:-	-0.51	-9.66	3.01E-20	Obesity-related traits	
PRAD	cis	1	rs2951369	chr7:143752638	OR2A1	chr7:144015236-144016148:+;chr7	-0.25	-4.07	5.51E-5	Obesity-related traits	
PRAD	cis	1	rs2951369	chr7:143752638	OR2A9P	chr7:143991573-143997832:+;chr7	-0.33	-5.66	2.66E-8	Obesity-related traits	
PRAD	cis	1	rs2951372	chr7:143749503	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.5	1.05E-19	Obesity-related traits	
PRAD	cis	1	rs2951372	chr7:143749503	OR2A1	chr7:144015236-144016148:+;chr7	-0.24	-3.95	9.16E-5	Obesity-related traits	
PRAD	cis	1	rs2951372	chr7:143749503	OR2A9P	chr7:143991573-143997832:+;chr7	-0.33	-5.64	3.02E-8	Obesity-related traits	
PRAD	cis	1	rs2951497	chr3:99166634	C3orf26	chr3:99536681-99897446:+	0.16	3.43	0.000665	RR interval (heart rate)	
PRAD	cis	1	rs2951498	chr3:99166060	C3orf26	chr3:99536681-99897446:+	0.16	3.43	0.000665	RR interval (heart rate)	
PRAD	cis	1	rs2952768	chr2:208494234	FAM119A	chr2:208446079-208490065:-	0.25	4.5	8.5E-6	Opioid sensitivity	
PRAD	cis	1	rs2952770	chr2:208496923	FAM119A	chr2:208446079-208490065:-	0.23	4.17	3.61E-5	Opioid sensitivity	
PRAD	cis	1	rs2953176	chr2:241520754	PASK	chr2:242045515-242088878:-	-0.25	-3.66	0.000281	Bipolar disorder	
PRAD	cis	1	rs295428	chr3:47359262	C3orf75	chr3:47537131-47555199:-	-0.17	-5.2	2.94E-7	Colorectal cancer	
PRAD	cis	1	rs295428	chr3:47359262	NBEAL2	chr3:47021173-47051193:+	-0.13	-4.24	2.7E-5	Colorectal cancer	
PRAD	cis	1	rs295442	chr3:47335881	C3orf75	chr3:47537131-47555199:-	-0.16	-4.69	3.6E-6	Colorectal cancer	
PRAD	cis	1	rs295442	chr3:47335881	NBEAL2	chr3:47021173-47051193:+	-0.15	-4.71	3.3E-6	Colorectal cancer	
PRAD	cis	1	rs295449	chr3:47375955	C3orf75	chr3:47537131-47555199:-	-0.17	-5.27	2.05E-7	Colorectal cancer	
PRAD	cis	1	rs295449	chr3:47375955	NBEAL2	chr3:47021173-47051193:+	-0.14	-4.25	2.53E-5	Colorectal cancer	
PRAD	cis	1	rs295458	chr3:47385585	C3orf75	chr3:47537131-47555199:-	-0.17	-5.28	1.97E-7	Colorectal cancer	
PRAD	cis	1	rs295458	chr3:47385585	NBEAL2	chr3:47021173-47051193:+	-0.14	-4.29	2.21E-5	Colorectal cancer	
PRAD	cis	1	rs295461	chr3:47368010	C3orf75	chr3:47537131-47555199:-	-0.17	-5.19	3.2E-7	Colorectal cancer	
PRAD	cis	1	rs295461	chr3:47368010	NBEAL2	chr3:47021173-47051193:+	-0.13	-4.18	3.51E-5	Colorectal cancer	
PRAD	cis	1	rs2955077	chr3:127958869	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.36	1.59E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955078	chr3:127959186	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.36	1.59E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955079	chr3:127959824	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.51	8.22E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955080	chr3:127959865	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.51	8.22E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955081	chr3:127960299	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.36	1.59E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955082	chr3:127960334	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.51	8.22E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955083	chr3:127961178	RUVBL1	chr3:127783627-127872757:-	-0.22	-3.99	7.51E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955085	chr3:127962757	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.36	1.59E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955086	chr3:127963191	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.51	8.05E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955088	chr3:127963710	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.36	1.59E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955089	chr3:127969330	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.36	1.59E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955090	chr3:127969371	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.36	1.59E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955091	chr3:127971361	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.3	2.12E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955095	chr3:127977665	RUVBL1	chr3:127783627-127872757:-	0.25	4.72	3.09E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955096	chr3:127977866	RUVBL1	chr3:127783627-127872757:-	0.23	4.14	4.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955097	chr3:127978505	RUVBL1	chr3:127783627-127872757:-	-0.22	-4.15	3.98E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955099	chr3:127979654	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955100	chr3:127993325	RUVBL1	chr3:127783627-127872757:-	-0.25	-4.72	3.09E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955101	chr3:128009612	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.38	1.47E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955126	chr3:127926254	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.31	2.03E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955129	chr3:127929207	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.38	1.48E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955130	chr3:127937814	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.39	1.38E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2955245	chr17:61979845	FTSJ3	chr17:61896795-61905031:-	-0.26	-4.93	1.14E-6	Height	
PRAD	cis	1	rs2955245	chr17:61979845	TCAM1P	chr17:61934376-61941738:+	0.22	3.84	0.000142	Height	
PRAD	cis	1	rs2957356	chr8:120373995	NOV	chr8:120428552-120436678:+	-0.24	-3.67	0.000266	Hypertension	
PRAD	cis	1	rs2957357	chr8:120378699	NOV	chr8:120428552-120436678:+	-0.24	-3.68	0.000256	Hypertension	
PRAD	cis	1	rs2961102	chr7:65424658	CCT6P1	chr7:65216092-65228661:+	0.36	6.28	7.56E-10	Diabetic kidney disease	
PRAD	cis	1	rs2961102	chr7:65424658	CRCP	chr7:65579805-65619551:+	-0.27	-3.45	0.000611	Diabetic kidney disease	
PRAD	cis	1	rs2961115	chr7:143753371	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.5	1.05E-19	Obesity-related traits	
PRAD	cis	1	rs2961115	chr7:143753371	OR2A1	chr7:144015236-144016148:+;chr7	-0.24	-3.95	9.16E-5	Obesity-related traits	
PRAD	cis	1	rs2961115	chr7:143753371	OR2A9P	chr7:143991573-143997832:+;chr7	-0.33	-5.64	3.02E-8	Obesity-related traits	
PRAD	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.31	4.96E-19	Obesity-related traits	
PRAD	cis	1	rs2961117	chr7:143755253	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.54	0.000434	Obesity-related traits	
PRAD	cis	1	rs2961117	chr7:143755253	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.3	1.78E-7	Obesity-related traits	
PRAD	cis	1	rs2961118	chr7:143755443	ARHGEF35	chr7:143883677-143892736:-	-0.49	-9.18	1.4E-18	Obesity-related traits	
PRAD	cis	1	rs2961118	chr7:143755443	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.59	0.000359	Obesity-related traits	
PRAD	cis	1	rs2961118	chr7:143755443	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.32	1.57E-7	Obesity-related traits	
PRAD	cis	1	rs2961119	chr7:143755852	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.33	4.04E-19	Obesity-related traits	
PRAD	cis	1	rs2961119	chr7:143755852	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.72	0.000224	Obesity-related traits	
PRAD	cis	1	rs2961119	chr7:143755852	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.35	1.38E-7	Obesity-related traits	
PRAD	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.39	2.55E-19	Obesity-related traits	
PRAD	cis	1	rs2961120	chr7:143756585	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.71	0.000236	Obesity-related traits	
PRAD	cis	1	rs2961120	chr7:143756585	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.29	1.92E-7	Obesity-related traits	
PRAD	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.37	2.99E-19	Obesity-related traits	
PRAD	cis	1	rs2961125	chr7:143761770	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.72	0.000224	Obesity-related traits	
PRAD	cis	1	rs2961125	chr7:143761770	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.36	1.3E-7	Obesity-related traits	
PRAD	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.37	2.99E-19	Obesity-related traits	
PRAD	cis	1	rs2961126	chr7:143762736	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.72	0.000224	Obesity-related traits	
PRAD	cis	1	rs2961126	chr7:143762736	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.36	1.3E-7	Obesity-related traits	
PRAD	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.37	2.99E-19	Obesity-related traits	
PRAD	cis	1	rs2961128	chr7:143763483	OR2A1	chr7:144015236-144016148:+;chr7	-0.23	-3.72	0.000224	Obesity-related traits	
PRAD	cis	1	rs2961128	chr7:143763483	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.36	1.3E-7	Obesity-related traits	
PRAD	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.49	-9.18	1.41E-18	Obesity-related traits	
PRAD	cis	1	rs2961132	chr7:143768128	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.6	0.000347	Obesity-related traits	
PRAD	cis	1	rs2961132	chr7:143768128	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.23	2.49E-7	Obesity-related traits	
PRAD	cis	1	rs2961134	chr7:143771062	ARHGEF35	chr7:143883677-143892736:-	-0.49	-9.06	3.65E-18	Obesity-related traits	
PRAD	cis	1	rs2961134	chr7:143771062	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.22	2.66E-7	Obesity-related traits	
PRAD	cis	1	rs2961144	chr7:143747870	ARHGEF35	chr7:143883677-143892736:-	0.51	9.66	2.89E-20	Obesity-related traits	
PRAD	cis	1	rs2961144	chr7:143747870	OR2A1	chr7:144015236-144016148:+;chr7	0.25	4.1	4.8E-5	Obesity-related traits	
PRAD	cis	1	rs2961144	chr7:143747870	OR2A9P	chr7:143991573-143997832:+;chr7	0.33	5.65	2.75E-8	Obesity-related traits	
PRAD	cis	1	rs2965188	chr19:19522557	GATAD2A	chr19:19496642-19619740:+	0.15	3.65	0.000288	Schizophrenia	
PRAD	cis	1	rs2967781	chr5:137557609	REEP2	chr5:137774776-137782657:+	-0.1	-3.88	0.000118	Resting heart rate	
PRAD	cis	1	rs2967782	chr5:137529682	REEP2	chr5:137774776-137782657:+	-0.11	-4.22	2.89E-5	Resting heart rate	
PRAD	cis	1	rs2967784	chr5:137539239	REEP2	chr5:137774776-137782657:+	-0.1	-3.88	0.00012	Resting heart rate	
PRAD	cis	1	rs2968854	chr7:150637834	ABCB8	chr7:150725510-150744867:+	0.18	4.02	6.71E-5	QT interval	
PRAD	cis	1	rs2968864	chr7:150622162	ABCB8	chr7:150725510-150744867:+	0.17	3.67	0.000268	QT interval	
PRAD	cis	1	rs296962	chr5:36990483	NIPBL	chr5:36876861-37065920:+	0.11	4.6	5.34E-6	Height	
PRAD	cis	1	rs2972396	chr5:42407985	GHR	chr5:42424026-42721925:+	-0.2	-4.63	4.65E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs2972767	chr5:42749057	CCDC152	chr5:42756920-42802539:+	0.16	4.42	1.25E-5	Height	
PRAD	cis	1	rs2972767	chr5:42749057	SEPP1	chr5:42799983-42825998:-	0.15	4.34	1.72E-5	Height	
PRAD	cis	1	rs2972770	chr5:42731772	CCDC152	chr5:42756920-42802539:+	0.15	4.16	3.79E-5	Height	
PRAD	cis	1	rs2972770	chr5:42731772	SEPP1	chr5:42799983-42825998:-	0.14	4.04	6.22E-5	Height	
PRAD	cis	1	rs2972994	chr5:42756500	CCDC152	chr5:42756920-42802539:+	0.16	4.42	1.24E-5	Height	
PRAD	cis	1	rs2972994	chr5:42756500	SEPP1	chr5:42799983-42825998:-	0.15	4.35	1.68E-5	Height	
PRAD	cis	1	rs2972998	chr5:42763512	CCDC152	chr5:42756920-42802539:+	0.16	4.42	1.24E-5	Height	
PRAD	cis	1	rs2972998	chr5:42763512	SEPP1	chr5:42799983-42825998:-	0.15	4.35	1.68E-5	Height	
PRAD	cis	1	rs2972999	chr5:42763797	CCDC152	chr5:42756920-42802539:+	0.16	4.42	1.24E-5	Height	
PRAD	cis	1	rs2972999	chr5:42763797	SEPP1	chr5:42799983-42825998:-	0.15	4.35	1.68E-5	Height	
PRAD	cis	1	rs2973006	chr5:42772154	CCDC152	chr5:42756920-42802539:+	0.16	4.54	7.17E-6	Height	
PRAD	cis	1	rs2973006	chr5:42772154	SEPP1	chr5:42799983-42825998:-	0.15	4.42	1.25E-5	Height	
PRAD	cis	1	rs2973011	chr5:42782492	CCDC152	chr5:42756920-42802539:+	-0.16	-4.38	1.46E-5	Height	
PRAD	cis	1	rs2973011	chr5:42782492	SEPP1	chr5:42799983-42825998:-	-0.15	-4.26	2.46E-5	Height	
PRAD	cis	1	rs2973015	chr5:42717992	CCDC152	chr5:42756920-42802539:+	0.15	4.21	3.09E-5	Height	
PRAD	cis	1	rs2973015	chr5:42717992	SEPP1	chr5:42799983-42825998:-	0.14	3.99	7.74E-5	Height	
PRAD	cis	1	rs2973018	chr5:42723790	CCDC152	chr5:42756920-42802539:+	0.15	4.08	5.31E-5	Height	
PRAD	cis	1	rs2973018	chr5:42723790	SEPP1	chr5:42799983-42825998:-	0.13	3.86	0.000129	Height	
PRAD	cis	1	rs2973023	chr5:42732883	CCDC152	chr5:42756920-42802539:+	0.15	4.16	3.79E-5	Height	
PRAD	cis	1	rs2973023	chr5:42732883	SEPP1	chr5:42799983-42825998:-	0.14	4.04	6.22E-5	Height	
PRAD	cis	1	rs2973029	chr5:42746566	CCDC152	chr5:42756920-42802539:+	0.15	4.23	2.76E-5	Height	
PRAD	cis	1	rs2973029	chr5:42746566	SEPP1	chr5:42799983-42825998:-	0.14	4.18	3.49E-5	Height	
PRAD	cis	1	rs2975734	chr8:10090097	MSRA	chr8:9911830-10286399:+	0.15	3.99	7.67E-5	Chronotype;Morning vs. evening chronotype	
PRAD	cis	1	rs2975754	chr2:241522634	PASK	chr2:242045515-242088878:-	-0.24	-3.57	0.000391	Bipolar disorder	
PRAD	cis	1	rs2976388	chr8:143760256	LY6K	chr8:143781529-143785582:+	0.27	4.69	3.58E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976388	chr8:143760256	LYNX1	chr8:143845758-143859640:-	-0.3	-7.51	2.91E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976388	chr8:143760256	PSCA	chr8:143761875-143764142:+	0.57	10.77	2.51E-24	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976392	chr8:143762932	LY6K	chr8:143781529-143785582:+	0.21	3.8	0.000166	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976392	chr8:143762932	LYNX1	chr8:143845758-143859640:-	-0.31	-7.84	3.03E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976392	chr8:143762932	PSCA	chr8:143761875-143764142:+	0.54	10.35	9.32E-23	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976394	chr8:143763622	LY6K	chr8:143781529-143785582:+	0.21	3.66	0.000276	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976394	chr8:143763622	LYNX1	chr8:143845758-143859640:-	-0.31	-8.02	8.51E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976394	chr8:143763622	PSCA	chr8:143761875-143764142:+	0.53	10.13	6.03E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976396	chr8:143764001	C8orf55	chr8:143808621-143818350:+	-0.16	-3.79	0.000168	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976396	chr8:143764001	LY6K	chr8:143781529-143785582:+	-0.19	-3.45	0.000602	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976396	chr8:143764001	LYNX1	chr8:143845758-143859640:-	0.31	7.81	3.7E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976396	chr8:143764001	PSCA	chr8:143761875-143764142:+	-0.53	-10.08	8.93E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976398	chr8:143764879	LY6K	chr8:143781529-143785582:+	0.2	3.49	0.000534	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976398	chr8:143764879	LYNX1	chr8:143845758-143859640:-	-0.32	-8.06	6.5E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2976398	chr8:143764879	PSCA	chr8:143761875-143764142:+	0.53	10.02	1.46E-21	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2977993	chr9:131608786	C9orf114	chr9:131584346-131592085:-	0.22	5.2	2.92E-7	Schizophrenia	
PRAD	cis	1	rs2977993	chr9:131608786	ENDOG	chr9:131580779-131584954:+	0.33	8.87	1.49E-17	Schizophrenia	
PRAD	cis	1	rs2978982	chr8:143763490	LY6K	chr8:143781529-143785582:+	0.21	3.8	0.000166	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2978982	chr8:143763490	LYNX1	chr8:143845758-143859640:-	-0.31	-7.84	3.03E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2978982	chr8:143763490	PSCA	chr8:143761875-143764142:+	0.54	10.35	9.32E-23	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PRAD	cis	1	rs2983236	chr6:161072331	LPA	chr6:160952516-161087407:-	-0.15	-3.52	0.000465	Lipoprotein (a) levels	
PRAD	cis	1	rs2985684	chr14:50101682	PPIL5	chr14:50065415-50081389:+	-0.23	-4.21	3.04E-5	Carotid intima media thickness	
PRAD	cis	1	rs2985684	chr14:50101682	RPL36AL	chr14:50085407-50087349:-	0.38	11.06	1.99E-25	Carotid intima media thickness	
PRAD	cis	1	rs2985687	chr14:50100386	PPIL5	chr14:50065415-50081389:+	-0.24	-4.35	1.68E-5	Carotid intima media thickness	
PRAD	cis	1	rs2985687	chr14:50100386	RPL36AL	chr14:50085407-50087349:-	0.39	11.35	1.52E-26	Carotid intima media thickness	
PRAD	cis	1	rs2985696	chr14:50094913	PPIL5	chr14:50065415-50081389:+	-0.23	-4.03	6.5E-5	Carotid intima media thickness	
PRAD	cis	1	rs2985696	chr14:50094913	RPL36AL	chr14:50085407-50087349:-	0.45	13.13	8.92E-34	Carotid intima media thickness	
PRAD	cis	1	rs2985697	chr14:50092902	PPIL5	chr14:50065415-50081389:+	-0.23	-4.11	4.72E-5	Carotid intima media thickness	
PRAD	cis	1	rs2985697	chr14:50092902	RPL36AL	chr14:50085407-50087349:-	0.45	13.14	8.06E-34	Carotid intima media thickness	
PRAD	cis	1	rs2993207	chr1:155873314	RIT1	chr1:155867601-155881177:-	0.19	4.45	1.07E-5	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.92	-28.22	3.26E-103	Homocysteine levels	
PRAD	cis	1	rs2993259	chr1:46001550	MMACHC	chr1:45965856-45976737:+	-0.24	-5.12	4.48E-7	Homocysteine levels	
PRAD	cis	1	rs2993259	chr1:46001550	MUTYH	chr1:45794915-45806142:-	0.19	5.27	2.05E-7	Homocysteine levels	
PRAD	cis	1	rs2994684	chr10:31366271	ZNF438	chr10:31133567-31320866:-	0.19	3.59	0.000367	Response to antipsychotic treatment	
PRAD	cis	1	rs2999061	chr3:127993623	RUVBL1	chr3:127783627-127872757:-	0.25	4.65	4.28E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999062	chr3:127993606	RUVBL1	chr3:127783627-127872757:-	-0.25	-4.72	3.09E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999065	chr3:127981438	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999066	chr3:127980286	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999067	chr3:127978531	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999068	chr3:127977978	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.29	2.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999069	chr3:127971609	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.22	2.88E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999070	chr3:127964651	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.43	1.19E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999071	chr3:127963615	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.51	8.22E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999072	chr3:127962876	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.36	1.59E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999073	chr3:127962329	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.51	8.22E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999076	chr3:127958692	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.56	6.68E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999077	chr3:127958414	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.35	1.66E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999079	chr3:127957232	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.51	8.22E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999084	chr3:127952488	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.51	8.22E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999085	chr3:127951559	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.51	8.22E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999086	chr3:127951248	RUVBL1	chr3:127783627-127872757:-	-0.24	-4.51	8.22E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999089	chr3:127935159	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.06	5.75E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs2999090	chr3:127931340	RUVBL1	chr3:127783627-127872757:-	0.25	4.42	1.25E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs300049	chr5:37084073	NIPBL	chr5:36876861-37065920:+	0.11	4.47	9.88E-6	Height	
PRAD	cis	1	rs300051	chr5:37088627	NIPBL	chr5:36876861-37065920:+	0.11	4.63	4.66E-6	Height	
PRAD	cis	1	rs300055	chr5:37072824	NIPBL	chr5:36876861-37065920:+	0.11	4.49	9.08E-6	Height	
PRAD	cis	1	rs300058	chr5:37053976	NIPBL	chr5:36876861-37065920:+	0.11	4.54	7.0E-6	Height	
PRAD	cis	1	rs300060	chr5:37019354	NIPBL	chr5:36876861-37065920:+	0.11	4.55	6.74E-6	Height	
PRAD	cis	1	rs300061	chr5:37022775	NIPBL	chr5:36876861-37065920:+	0.11	4.62	5.0E-6	Height	
PRAD	cis	1	rs300063	chr5:37023898	NIPBL	chr5:36876861-37065920:+	0.11	4.62	5.01E-6	Height	
PRAD	cis	1	rs300064	chr5:37025871	NIPBL	chr5:36876861-37065920:+	-0.09	-3.68	0.000256	Height	
PRAD	cis	1	rs300065	chr5:36997827	NIPBL	chr5:36876861-37065920:+	0.11	4.54	7.0E-6	Height	
PRAD	cis	1	rs3002702	chr20:25268920	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.16	3.81E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs3002702	chr20:25268920	FAM182B	chr20:25744102-25848786:-	0.37	6.74	4.76E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs3002702	chr20:25268920	PYGB	chr20:25228706-25278647:+	-0.33	-7.09	5.03E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs3007030	chr14:50086563	PPIL5	chr14:50065415-50081389:+	-0.22	-3.78	0.000179	Carotid intima media thickness	
PRAD	cis	1	rs3007030	chr14:50086563	RPL36AL	chr14:50085407-50087349:-	0.43	12.31	2.16E-30	Carotid intima media thickness	
PRAD	cis	1	rs3007031	chr14:50102269	PPIL5	chr14:50065415-50081389:+	-0.23	-4.21	3.04E-5	Carotid intima media thickness	
PRAD	cis	1	rs3007031	chr14:50102269	RPL36AL	chr14:50085407-50087349:-	0.38	11.06	1.99E-25	Carotid intima media thickness	
PRAD	cis	1	rs3008607	chr1:222785692	TAF1A	chr1:222731244-222763255:-	0.2	3.43	0.000652	LDL peak particle diameter (total fat intake interaction)	
PRAD	cis	1	rs301859	chr5:37045841	NIPBL	chr5:36876861-37065920:+	0.11	4.47	9.7E-6	Height	
PRAD	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.36	-11.42	8.3E-27	Ankylosing spondylitis	
PRAD	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.55	10.69	5.19E-24	Ankylosing spondylitis	
PRAD	cis	1	rs301901	chr5:37046626	NIPBL	chr5:36876861-37065920:+	0.11	4.46	1.01E-5	Height	
PRAD	cis	1	rs3021301	chr6:116670364	FAM26F	chr6:116782556-116784933:+	-0.13	-3.89	0.000113	Fast beta electroencephalogram	
PRAD	cis	1	rs302660	chr11:87885448	RAB38	chr11:87846431-87908599:-	0.19	5.67	2.56E-8	Frontotemporal dementia	
PRAD	cis	1	rs302662	chr11:87881236	RAB38	chr11:87846431-87908599:-	0.2	5.73	1.76E-8	Frontotemporal dementia	
PRAD	cis	1	rs302663	chr11:87880759	RAB38	chr11:87846431-87908599:-	0.2	5.73	1.76E-8	Frontotemporal dementia	
PRAD	cis	1	rs302668	chr11:87876911	RAB38	chr11:87846431-87908599:-	0.2	5.79	1.27E-8	Frontotemporal dementia	
PRAD	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.37	-11.74	4.29E-28	Ankylosing spondylitis	
PRAD	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.55	10.74	3.27E-24	Ankylosing spondylitis	
PRAD	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.37	-11.74	4.29E-28	Ankylosing spondylitis	
PRAD	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.55	10.74	3.27E-24	Ankylosing spondylitis	
PRAD	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.37	-11.74	4.29E-28	Ankylosing spondylitis	
PRAD	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.55	10.74	3.27E-24	Ankylosing spondylitis	
PRAD	cis	1	rs30736	chr5:130724240	P4HA2	chr5:131528306-131563556:-	-0.22	-4.08	5.3E-5	Life satisfaction	
PRAD	cis	1	rs307567	chr3:12166424	SYN2	chr3:12045862-12233530:+	-0.37	-4.6	5.45E-6	Fasting insulin-related traits (interaction with BMI)	
PRAD	cis	1	rs307571	chr3:12126112	SYN2	chr3:12045862-12233530:+	-0.37	-4.53	7.6E-6	Fasting insulin-related traits (interaction with BMI)	
PRAD	cis	1	rs307594	chr3:12106191	SYN2	chr3:12045862-12233530:+	0.37	4.67	3.99E-6	Fasting insulin-related traits (interaction with BMI)	
PRAD	cis	1	rs308969	chr3:12177083	SYN2	chr3:12045862-12233530:+	-0.72	-7.44	4.79E-13	Fasting insulin-related traits (interaction with BMI)	
PRAD	cis	1	rs308971	chr3:12116620	SYN2	chr3:12045862-12233530:+	-0.38	-4.78	2.37E-6	Fasting insulin-related traits (interaction with BMI)	
PRAD	cis	1	rs3091242	chr1:25674785	RHCE	chr1:25688741-25756683:-	0.57	12.82	1.71E-32	Erythrocyte sedimentation rate	
PRAD	cis	1	rs3091242	chr1:25674785	RHD	chr1:25598981-25656935:+	-0.59	-11.79	2.68E-28	Erythrocyte sedimentation rate	
PRAD	cis	1	rs3091244	chr1:159684665	AIM2	chr1:159032275-159046647:-	0.13	3.51	0.000499	C-reactive protein levels or triglyceride levels (pleiotropy)	
PRAD	cis	1	rs3091250	chr3:46306130	CCR5	chr3:46411633-46417690:+	-0.1	-4.03	6.54E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs3091312	chr3:46308472	CCR5	chr3:46411633-46417690:+	-0.1	-3.73	0.000211	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs3091497	chr20:47645427	CSE1L	chr20:47662838-47713484:+	-0.19	-4.64	4.46E-6	Anger	
PRAD	cis	1	rs3091529	chr20:47647068	CSE1L	chr20:47662838-47713484:+	-0.19	-4.59	5.72E-6	Anger	
PRAD	cis	1	rs3091866	chr20:47648353	CSE1L	chr20:47662838-47713484:+	-0.19	-4.6	5.49E-6	Anger	
PRAD	cis	1	rs3092039	chr20:47678770	CSE1L	chr20:47662838-47713484:+	-0.19	-4.6	5.51E-6	Anger	
PRAD	cis	1	rs3092374	chr20:47663944	CSE1L	chr20:47662838-47713484:+	-0.18	-4.3	2.06E-5	Anger	
PRAD	cis	1	rs3092374	chr20:47663944	PREX1	chr20:47240793-47444420:-	0.17	3.57	0.000394	Anger	
PRAD	cis	1	rs3092411	chr20:47690591	CSE1L	chr20:47662838-47713484:+	-0.2	-4.92	1.21E-6	Anger	
PRAD	cis	1	rs3092720	chr20:47640466	CSE1L	chr20:47662838-47713484:+	-0.19	-4.59	5.7E-6	Anger	
PRAD	cis	1	rs3092744	chr20:44025282	SYS1	chr20:43991701-44004724:+	0.34	6.23	1.04E-9	Psoriasis	
PRAD	cis	1	rs3093253	chr13:113774092	F10	chr13:113777113-113803841:+	0.18	3.68	0.000259	End-stage coagulation	
PRAD	cis	1	rs3093253	chr13:113774092	F7	chr13:113760105-113774994:+	-0.4	-5.04	6.66E-7	End-stage coagulation	
PRAD	cis	1	rs3097417	chr3:53088601	RFT1	chr3:53122503-53164470:-	-0.39	-4.24	2.69E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs3097417	chr3:53088601	TMEM110	chr3:52867139-52931547:-	-0.35	-4.32	1.94E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.98	16.85	3.63E-50	Type 2 diabetes	
PRAD	cis	1	rs3099555	chr4:1725651	FAM53A	chr4:1641609-1685854:-	-0.44	-8.33	8.83E-16	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs3099899	chr4:129917368	C4orf33	chr4:130014829-130033842:+	-0.45	-7.71	7.31E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.5	-6.1	2.17E-9	Tumor biomarkers	
PRAD	cis	1	rs3101443	chr15:43912372	CATSPER2	chr15:43922774-43959900:-	-0.25	-4.41	1.27E-5	Tumor biomarkers	
PRAD	cis	1	rs3101443	chr15:43912372	CKMT1A	chr15:43985084-43991419:+	-0.48	-5.25	2.33E-7	Tumor biomarkers	
PRAD	cis	1	rs3101852	chr15:50848370	SPPL2A	chr15:50999739-51057910:-	-0.29	-6.04	3.15E-9	QT interval	
PRAD	cis	1	rs3101853	chr15:50848382	SPPL2A	chr15:50999739-51057910:-	-0.28	-5.79	1.3E-8	QT interval	
PRAD	cis	1	rs3101855	chr15:50859874	SPPL2A	chr15:50999739-51057910:-	0.29	6.08	2.43E-9	QT interval	
PRAD	cis	1	rs3103067	chr4:8511223	C4orf23	chr4:8440604-8495258:+	-0.26	-4.16	3.72E-5	Response to antineoplastic agents	
PRAD	cis	1	rs3103071	chr4:8508579	C4orf23	chr4:8440604-8495258:+	0.31	5.07	5.6E-7	Response to antineoplastic agents	
PRAD	cis	1	rs3103072	chr4:8508431	C4orf23	chr4:8440604-8495258:+	0.31	5.02	7.2E-7	Response to antineoplastic agents	
PRAD	cis	1	rs3103099	chr4:8511567	C4orf23	chr4:8440604-8495258:+	0.29	4.58	5.99E-6	Response to antineoplastic agents	
PRAD	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.5	-8.47	3.07E-16	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs3105442	chr8:101840134	SNX31	chr8:101585114-101661893:-	0.2	3.45	0.000611	AIDS	
PRAD	cis	1	rs3105590	chr15:50864145	SPPL2A	chr15:50999739-51057910:-	0.31	6.27	7.97E-10	QT interval	
PRAD	cis	1	rs3105590	chr15:50864145	TRPM7	chr15:50852491-50978994:-	0.11	3.65	0.000291	QT interval	
PRAD	cis	1	rs3105591	chr15:50869042	SPPL2A	chr15:50999739-51057910:-	0.29	6.09	2.41E-9	QT interval	
PRAD	cis	1	rs3105593	chr15:50845018	SPPL2A	chr15:50999739-51057910:-	0.22	4.79	2.22E-6	QT interval	
PRAD	cis	1	rs3106134	chr4:95128091	HPGDS	chr4:95219707-95264027:-	-0.26	-5.07	5.71E-7	Capecitabine sensitivity	
PRAD	cis	1	rs3106136	chr4:95153349	HPGDS	chr4:95219707-95264027:-	-0.28	-5.34	1.44E-7	Capecitabine sensitivity	
PRAD	cis	1	rs3107669	chr3:119567101	NR1I2	chr3:119499331-119537331:+	0.22	4.07	5.45E-5	HDL cholesterol	
PRAD	cis	1	rs3108919	chr8:101841546	SNX31	chr8:101585114-101661893:-	-0.25	-4.48	9.23E-6	AIDS	
PRAD	cis	1	rs3109878	chr15:50836243	SPPL2A	chr15:50999739-51057910:-	0.22	4.74	2.79E-6	QT interval	
PRAD	cis	1	rs3109879	chr15:50837618	SPPL2A	chr15:50999739-51057910:-	0.27	5.58	4.07E-8	QT interval	
PRAD	cis	1	rs3109880	chr15:50837812	SPPL2A	chr15:50999739-51057910:-	0.27	5.61	3.54E-8	QT interval	
PRAD	cis	1	rs3109881	chr15:50839272	SPPL2A	chr15:50999739-51057910:-	0.28	5.74	1.67E-8	QT interval	
PRAD	cis	1	rs3109888	chr15:50860694	SPPL2A	chr15:50999739-51057910:-	0.29	6.03	3.28E-9	QT interval	
PRAD	cis	1	rs3109892	chr15:50877011	SPPL2A	chr15:50999739-51057910:-	0.28	5.78	1.37E-8	QT interval	
PRAD	cis	1	rs3109894	chr15:50878574	SPPL2A	chr15:50999739-51057910:-	0.24	5.01	7.63E-7	QT interval	
PRAD	cis	1	rs3109895	chr15:50880560	SPPL2A	chr15:50999739-51057910:-	0.27	5.55	4.88E-8	QT interval	
PRAD	cis	1	rs3110337	chr8:120378478	NOV	chr8:120428552-120436678:+	-0.24	-3.71	0.000236	Hypertension	
PRAD	cis	1	rs3110496	chr17:27917771	ABHD15	chr17:27888311-27894048:-	-0.36	-6.92	1.51E-11	Height	
PRAD	cis	1	rs3113489	chr4:129961179	C4orf33	chr4:130014829-130033842:+	-0.46	-7.74	5.98E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs3116089	chr8:101057587	SPAG1	chr8:101170263-101254130:+	-0.17	-3.52	0.000481	Basal cell carcinoma	
PRAD	cis	1	rs3118625	chr9:131873256	CRAT	chr9:131857075-131873070:-	-0.22	-3.94	9.21E-5	Blood metabolite ratios	
PRAD	cis	1	rs3118632	chr9:131901284	CRAT	chr9:131857075-131873070:-	-0.22	-4.18	3.45E-5	Blood metabolite ratios	
PRAD	cis	1	rs3120034	chr1:183167051	LAMC2	chr1:183155174-183214262:+	-0.11	-3.56	0.000416	Hypertriglyceridemia	
PRAD	cis	1	rs3120662	chr1:152302865	FLG	chr1:152274651-152297679:-	0.32	5.02	7.33E-7	Atopic dermatitis	
PRAD	cis	1	rs3124510	chr9:131899690	CRAT	chr9:131857075-131873070:-	-0.21	-3.89	0.000116	Blood metabolite ratios	
PRAD	cis	1	rs3124511	chr9:131901458	CRAT	chr9:131857075-131873070:-	-0.22	-3.99	7.81E-5	Blood metabolite ratios	
PRAD	cis	1	rs3124511	chr9:131901458	PHYHD1	chr9:131683174-131704320:+	0.17	3.44	0.000642	Blood metabolite ratios	
PRAD	cis	1	rs3124512	chr9:131903881	CRAT	chr9:131857075-131873070:-	-0.23	-4.06	5.66E-5	Blood metabolite ratios	
PRAD	cis	1	rs3124513	chr9:131904593	CRAT	chr9:131857075-131873070:-	-0.24	-4.41	1.3E-5	Blood metabolite ratios	
PRAD	cis	1	rs3124514	chr9:131904608	CRAT	chr9:131857075-131873070:-	-0.24	-4.41	1.3E-5	Blood metabolite ratios	
PRAD	cis	1	rs3126085	chr1:152300817	FLG	chr1:152274651-152297679:-	0.32	5.02	7.33E-7	Atopic dermatitis	
PRAD	cis	1	rs3126092	chr1:152307955	FLG	chr1:152274651-152297679:-	0.32	5.02	7.33E-7	Atopic dermatitis	
PRAD	cis	1	rs3126095	chr1:152309683	FLG	chr1:152274651-152297679:-	0.32	5.02	7.33E-7	Atopic dermatitis	
PRAD	cis	1	rs3126098	chr1:152311923	FLG	chr1:152274651-152297679:-	0.33	5.13	4.3E-7	Atopic dermatitis	
PRAD	cis	1	rs3131573	chr15:50869601	SPPL2A	chr15:50999739-51057910:-	0.28	5.84	9.85E-9	QT interval	
PRAD	cis	1	rs3131577	chr15:50863516	SPPL2A	chr15:50999739-51057910:-	0.29	6.02	3.49E-9	QT interval	
PRAD	cis	1	rs3131578	chr15:50861470	SPPL2A	chr15:50999739-51057910:-	-0.31	-6.28	7.8E-10	QT interval	
PRAD	cis	1	rs3131578	chr15:50861470	TRPM7	chr15:50852491-50978994:-	-0.11	-3.57	0.000398	QT interval	
PRAD	cis	1	rs3131580	chr15:50854926	SPPL2A	chr15:50999739-51057910:-	0.29	6.08	2.48E-9	QT interval	
PRAD	cis	1	rs3131582	chr15:50879670	SPPL2A	chr15:50999739-51057910:-	0.26	5.35	1.37E-7	QT interval	
PRAD	cis	1	rs3131584	chr15:50847401	SPPL2A	chr15:50999739-51057910:-	0.29	6.09	2.41E-9	QT interval	
PRAD	cis	1	rs3131585	chr15:50845796	SPPL2A	chr15:50999739-51057910:-	0.29	5.96	4.83E-9	QT interval	
PRAD	cis	1	rs3131586	chr15:50845236	SPPL2A	chr15:50999739-51057910:-	0.28	5.85	9.24E-9	QT interval	
PRAD	cis	1	rs3131587	chr15:50845101	SPPL2A	chr15:50999739-51057910:-	0.31	6.21	1.14E-9	QT interval	
PRAD	cis	1	rs3131587	chr15:50845101	TRPM7	chr15:50852491-50978994:-	0.11	3.58	0.000378	QT interval	
PRAD	cis	1	rs3131589	chr15:50841053	SPPL2A	chr15:50999739-51057910:-	0.27	5.63	3.07E-8	QT interval	
PRAD	cis	1	rs3131590	chr15:50840955	SPPL2A	chr15:50999739-51057910:-	0.3	6.16	1.58E-9	QT interval	
PRAD	cis	1	rs3131590	chr15:50840955	TRPM7	chr15:50852491-50978994:-	0.11	3.46	0.000591	QT interval	
PRAD	cis	1	rs3131596	chr15:50877575	SPPL2A	chr15:50999739-51057910:-	0.28	5.83	1.02E-8	QT interval	
PRAD	cis	1	rs313798	chr7:65493031	CCT6P1	chr7:65216092-65228661:+	0.33	5.65	2.82E-8	Diabetic kidney disease	
PRAD	cis	1	rs313798	chr7:65493031	CRCP	chr7:65579805-65619551:+	-0.32	-3.98	7.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs313799	chr7:65494330	CCT6P1	chr7:65216092-65228661:+	0.27	4.85	1.68E-6	Diabetic kidney disease	
PRAD	cis	1	rs313799	chr7:65494330	CRCP	chr7:65579805-65619551:+	-0.31	-4.05	5.94E-5	Diabetic kidney disease	
PRAD	cis	1	rs313802	chr7:65516373	CCT6P1	chr7:65216092-65228661:+	0.33	5.63	3.14E-8	Diabetic kidney disease	
PRAD	cis	1	rs313802	chr7:65516373	CRCP	chr7:65579805-65619551:+	-0.33	-4.06	5.81E-5	Diabetic kidney disease	
PRAD	cis	1	rs313803	chr7:65514731	CCT6P1	chr7:65216092-65228661:+	0.33	5.63	3.14E-8	Diabetic kidney disease	
PRAD	cis	1	rs313803	chr7:65514731	CRCP	chr7:65579805-65619551:+	-0.33	-4.06	5.81E-5	Diabetic kidney disease	
PRAD	cis	1	rs313807	chr7:65499481	CCT6P1	chr7:65216092-65228661:+	0.27	4.85	1.68E-6	Diabetic kidney disease	
PRAD	cis	1	rs313807	chr7:65499481	CRCP	chr7:65579805-65619551:+	-0.31	-4.05	5.94E-5	Diabetic kidney disease	
PRAD	cis	1	rs313809	chr7:65499983	CCT6P1	chr7:65216092-65228661:+	0.33	5.65	2.82E-8	Diabetic kidney disease	
PRAD	cis	1	rs313809	chr7:65499983	CRCP	chr7:65579805-65619551:+	-0.32	-3.98	7.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs313813	chr7:65503500	CCT6P1	chr7:65216092-65228661:+	0.29	5.03	7.11E-7	Diabetic kidney disease	
PRAD	cis	1	rs313813	chr7:65503500	CRCP	chr7:65579805-65619551:+	-0.34	-4.38	1.46E-5	Diabetic kidney disease	
PRAD	cis	1	rs3138144	chr12:56114769	RDH5	chr12:56114151-56118525:+	-0.2	-5.29	1.88E-7	Refractive error	
PRAD	cis	1	rs313814	chr7:65503293	CCT6P1	chr7:65216092-65228661:+	0.33	5.67	2.55E-8	Diabetic kidney disease	
PRAD	cis	1	rs313814	chr7:65503293	CRCP	chr7:65579805-65619551:+	-0.33	-4.09	5.05E-5	Diabetic kidney disease	
PRAD	cis	1	rs313820	chr7:65574466	CCT6P1	chr7:65216092-65228661:+	0.34	5.8	1.22E-8	Diabetic kidney disease	
PRAD	cis	1	rs313820	chr7:65574466	CRCP	chr7:65579805-65619551:+	-0.31	-3.92	0.0001	Diabetic kidney disease	
PRAD	cis	1	rs313824	chr7:65581207	CCT6P1	chr7:65216092-65228661:+	0.33	5.76	1.51E-8	Diabetic kidney disease	
PRAD	cis	1	rs313824	chr7:65581207	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000132	Diabetic kidney disease	
PRAD	cis	1	rs313831	chr7:65551226	CCT6P1	chr7:65216092-65228661:+	0.34	5.84	9.91E-9	Diabetic kidney disease	
PRAD	cis	1	rs313831	chr7:65551226	CRCP	chr7:65579805-65619551:+	-0.28	-3.46	0.000587	Diabetic kidney disease	
PRAD	cis	1	rs313832	chr7:65550891	CCT6P1	chr7:65216092-65228661:+	0.34	5.81	1.15E-8	Diabetic kidney disease	
PRAD	cis	1	rs313832	chr7:65550891	CRCP	chr7:65579805-65619551:+	-0.28	-3.45	0.00062	Diabetic kidney disease	
PRAD	cis	1	rs313839	chr19:47221557	FKRP	chr19:47249303-47261832:+	0.41	5.48	6.95E-8	Type 1 diabetes	
PRAD	cis	1	rs313839	chr19:47221557	PRKD2	chr19:47177574-47220384:-	0.23	3.84	0.000142	Type 1 diabetes	
PRAD	cis	1	rs316009	chr6:160675764	SLC22A2	chr6:160592093-160679959:-	0.39	4.48	9.37E-6	Blood metabolite ratios	
PRAD	cis	1	rs316010	chr6:160674557	SLC22A2	chr6:160592093-160679959:-	0.34	4	7.28E-5	Blood metabolite ratios	
PRAD	cis	1	rs316020	chr6:160669081	SLC22A2	chr6:160592093-160679959:-	-0.39	-4.73	3.04E-6	Blood metabolite ratios	
PRAD	cis	1	rs316304	chr7:65616894	CCT6P1	chr7:65216092-65228661:+	0.34	5.85	9.2E-9	Diabetic kidney disease	
PRAD	cis	1	rs316304	chr7:65616894	CRCP	chr7:65579805-65619551:+	-0.32	-3.94	9.21E-5	Diabetic kidney disease	
PRAD	cis	1	rs316307	chr7:65570171	CCT6P1	chr7:65216092-65228661:+	0.34	5.81	1.16E-8	Diabetic kidney disease	
PRAD	cis	1	rs316307	chr7:65570171	CRCP	chr7:65579805-65619551:+	-0.3	-3.78	0.000175	Diabetic kidney disease	
PRAD	cis	1	rs316312	chr7:65596491	CCT6P1	chr7:65216092-65228661:+	0.33	5.76	1.51E-8	Diabetic kidney disease	
PRAD	cis	1	rs316312	chr7:65596491	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000132	Diabetic kidney disease	
PRAD	cis	1	rs316313	chr7:65593548	CCT6P1	chr7:65216092-65228661:+	0.33	5.76	1.51E-8	Diabetic kidney disease	
PRAD	cis	1	rs316313	chr7:65593548	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000132	Diabetic kidney disease	
PRAD	cis	1	rs316315	chr7:65591205	CCT6P1	chr7:65216092-65228661:+	-0.26	-5.07	5.74E-7	Diabetic kidney disease	
PRAD	cis	1	rs316315	chr7:65591205	CRCP	chr7:65579805-65619551:+	0.27	3.92	0.000102	Diabetic kidney disease	
PRAD	cis	1	rs316317	chr7:65613637	CCT6P1	chr7:65216092-65228661:+	0.34	5.85	9.2E-9	Diabetic kidney disease	
PRAD	cis	1	rs316317	chr7:65613637	CRCP	chr7:65579805-65619551:+	-0.32	-3.94	9.21E-5	Diabetic kidney disease	
PRAD	cis	1	rs316318	chr7:65612904	CCT6P1	chr7:65216092-65228661:+	0.34	5.85	9.2E-9	Diabetic kidney disease	
PRAD	cis	1	rs316318	chr7:65612904	CRCP	chr7:65579805-65619551:+	-0.32	-3.94	9.21E-5	Diabetic kidney disease	
PRAD	cis	1	rs316321	chr7:65611613	CCT6P1	chr7:65216092-65228661:+	0.34	5.89	7.35E-9	Diabetic kidney disease	
PRAD	cis	1	rs316321	chr7:65611613	CRCP	chr7:65579805-65619551:+	-0.31	-3.91	0.000108	Diabetic kidney disease	
PRAD	cis	1	rs316322	chr7:65611233	CCT6P1	chr7:65216092-65228661:+	0.34	5.87	8.06E-9	Diabetic kidney disease	
PRAD	cis	1	rs316322	chr7:65611233	CRCP	chr7:65579805-65619551:+	-0.31	-3.9	0.000109	Diabetic kidney disease	
PRAD	cis	1	rs316325	chr7:65609518	CCT6P1	chr7:65216092-65228661:+	0.34	5.89	7.35E-9	Diabetic kidney disease	
PRAD	cis	1	rs316325	chr7:65609518	CRCP	chr7:65579805-65619551:+	-0.31	-3.91	0.000108	Diabetic kidney disease	
PRAD	cis	1	rs316326	chr7:65609453	CCT6P1	chr7:65216092-65228661:+	0.34	5.89	7.35E-9	Diabetic kidney disease	
PRAD	cis	1	rs316326	chr7:65609453	CRCP	chr7:65579805-65619551:+	-0.31	-3.91	0.000108	Diabetic kidney disease	
PRAD	cis	1	rs316327	chr7:65609201	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.89	7.35E-9	Diabetic kidney disease	
PRAD	cis	1	rs316327	chr7:65609201	CRCP	chr7:65579805-65619551:+	0.31	3.91	0.000108	Diabetic kidney disease	
PRAD	cis	1	rs316329	chr7:65608416	CCT6P1	chr7:65216092-65228661:+	0.35	6.08	2.45E-9	Diabetic kidney disease	
PRAD	cis	1	rs316329	chr7:65608416	CRCP	chr7:65579805-65619551:+	-0.29	-3.57	0.000394	Diabetic kidney disease	
PRAD	cis	1	rs316330	chr7:65605372	CCT6P1	chr7:65216092-65228661:+	0.34	5.88	7.78E-9	Diabetic kidney disease	
PRAD	cis	1	rs316330	chr7:65605372	CRCP	chr7:65579805-65619551:+	-0.31	-3.89	0.000115	Diabetic kidney disease	
PRAD	cis	1	rs316331	chr7:65604622	CCT6P1	chr7:65216092-65228661:+	-0.32	-5.43	9.22E-8	Diabetic kidney disease	
PRAD	cis	1	rs316331	chr7:65604622	CRCP	chr7:65579805-65619551:+	0.34	4.2	3.24E-5	Diabetic kidney disease	
PRAD	cis	1	rs316332	chr7:65604299	CCT6P1	chr7:65216092-65228661:+	0.32	5.53	5.46E-8	Diabetic kidney disease	
PRAD	cis	1	rs316332	chr7:65604299	CRCP	chr7:65579805-65619551:+	-0.3	-3.81	0.000157	Diabetic kidney disease	
PRAD	cis	1	rs316334	chr7:65602126	CCT6P1	chr7:65216092-65228661:+	0.33	5.78	1.37E-8	Diabetic kidney disease	
PRAD	cis	1	rs316334	chr7:65602126	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000135	Diabetic kidney disease	
PRAD	cis	1	rs317689	chr12:69727190	LYZ	chr12:69742134-69748013:+	-0.21	-4.94	1.09E-6	Response to diuretic therapy	
PRAD	cis	1	rs317689	chr12:69727190	YEATS4	chr12:69753532-69784575:+	-0.19	-3.76	0.000189	Response to diuretic therapy	
PRAD	cis	1	rs3180872	chr22:51017394	CPT1B	chr22:51007291-51017096:-	-0.22	-4.8	2.11E-6	Narcolepsy	
PRAD	cis	1	rs3180872	chr22:51017394	LOC100144603	chr22:51021455-51022353:+	-0.3	-3.51	0.000486	Narcolepsy	
PRAD	cis	1	rs3183928	chr9:100684719	C9orf156	chr9:100666772-100684852:-	-0.19	-3.79	0.000172	Quantitative traits	
PRAD	cis	1	rs319680	chr3:47898307	CCDC72	chr3:48481686-48485537:+	0.13	3.89	0.000113	Educational attainment (years of education)	
PRAD	cis	1	rs319680	chr3:47898307	CDC25A	chr3:48198668-48229801:-	0.34	5.94	5.45E-9	Educational attainment (years of education)	
PRAD	cis	1	rs319680	chr3:47898307	SPINK8	chr3:48348336-48369831:-	0.26	4.89	1.41E-6	Educational attainment (years of education)	
PRAD	cis	1	rs319690	chr3:47927484	CCDC72	chr3:48481686-48485537:+	0.12	3.78	0.000178	Blood pressure	
PRAD	cis	1	rs319690	chr3:47927484	CDC25A	chr3:48198668-48229801:-	0.29	5.42	9.42E-8	Blood pressure	
PRAD	cis	1	rs319690	chr3:47927484	SPINK8	chr3:48348336-48369831:-	0.21	4.19	3.39E-5	Blood pressure	
PRAD	cis	1	rs3197999	chr3:49721532	GMPPB	chr3:49758932-49761384:-	-0.2	-4.13	4.33E-5	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs3197999	chr3:49721532	MST1	chr3:49721381-49726196:-	0.1	3.52	0.000466	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.69	-13.5	2.45E-35	Dental caries	
PRAD	cis	1	rs3204270	chr17:79682051	TSPAN10	chr17:79609349-79615778:+	-0.58	-6.35	5.12E-10	Dental caries	
PRAD	cis	1	rs3206817	chr17:65892834	LOC651250	chr17:66097696-66157623:+	-0.22	-3.95	9.16E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.33	-5.71	2.02E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs3213861	chr19:41919944	ATP5SL	chr19:41937224-41945810:-	0.17	3.87	0.000123	Height	
PRAD	cis	1	rs3214041	chr3:48454468	ATRIP	chr3:48488141-48507708:+	0.27	6.4	3.77E-10	Longevity	
PRAD	cis	1	rs3214041	chr3:48454468	CDC25A	chr3:48198668-48229801:-	0.21	3.95	8.85E-5	Longevity	
PRAD	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.18	-5.08	5.45E-7	Longevity	
PRAD	cis	1	rs321622	chr4:48024380	CNGA1	chr4:47937996-48018610:-	0.25	4.54	7.12E-6	Renal underexcretion gout;Gout	
PRAD	cis	1	rs321622	chr4:48024380	NIPAL1	chr4:48018791-48039078:+	0.21	6.79	3.47E-11	Renal underexcretion gout;Gout	
PRAD	cis	1	rs321622	chr4:48024380	TXK	chr4:48068412-48136273:-	0.17	3.7	0.000241	Renal underexcretion gout;Gout	
PRAD	cis	1	rs3217810	chr12:4388271	CCND2	chr12:4382902-4414521:+	-0.44	-9.27	6.5E-19	Colorectal cancer	
PRAD	cis	1	rs3229	chr12:42475888	GXYLT1	chr12:42475650-42538673:-	-0.15	-4.01	7.15E-5	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
PRAD	cis	1	rs325101	chr12:125852658	BRI3BP	chr12:125478194-125510349:+	0.18	3.62	0.000323	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs3310	chr20:3237232	ITPA	chr20:3190056-3204504:+	-0.3	-7.56	2.19E-13	IFN-related cytopenia	
PRAD	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.97	16.6	5.05E-49	Type 2 diabetes	
PRAD	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.96	16.66	2.69E-49	Type 2 diabetes	
PRAD	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.98	16.98	8.95E-51	Type 2 diabetes	
PRAD	cis	1	rs334140	chr2:128235148	SFT2D3	chr2:128458597-128461405:+	0.28	3.68	0.00026	Educational attainment	
PRAD	cis	1	rs338388	chr15:68260214	PIAS1	chr15:68346572-68480402:+	-0.12	-3.77	0.000181	Survival in rectal cancer	
PRAD	cis	1	rs338389	chr15:68260008	PIAS1	chr15:68346572-68480402:+	-0.12	-3.77	0.000181	Survival in rectal cancer	
PRAD	cis	1	rs33917318	chr3:10067797	C3orf10	chr3:10157333-10168873:+	-0.2	-3.83	0.000145	Alzheimer's disease	
PRAD	cis	1	rs33917318	chr3:10067797	LOC401052	chr3:10048102-10052779:-	-0.29	-5.35	1.4E-7	Alzheimer's disease	
PRAD	cis	1	rs33955793	chr3:12544829	TSEN2	chr3:12525931-12581122:+	0.36	3.95	9.14E-5	Prostate cancer (gene x gene interaction)	
PRAD	cis	1	rs33988592	chr3:121415610	IQCB1	chr3:121488610-121553926:-	0.48	9.33	4.12E-19	Cognitive performance	
PRAD	cis	1	rs33993216	chr10:17204139	TRDMT1	chr10:17184983-17243681:-	-0.27	-5.41	9.98E-8	Homocysteine levels	
PRAD	cis	1	rs33998546	chr3:127831038	RUVBL1	chr3:127783627-127872757:-	0.23	4.25	2.54E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs33999310	chr3:52883332	RFT1	chr3:53122503-53164470:-	0.37	4.19	3.27E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs33999310	chr3:52883332	TMEM110	chr3:52867139-52931547:-	0.37	4.75	2.64E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34010330	chr19:18559657	ELL	chr19:18553475-18632937:-	-0.15	-3.51	0.000487	Breast cancer	
PRAD	cis	1	rs34010330	chr19:18559657	SSBP4	chr19:18530221-18545371:+	-0.17	-5.48	7.06E-8	Breast cancer	
PRAD	cis	1	rs34014631	chr10:103698705	KCNIP2	chr10:103585732-103603677:-	0.29	4.13	4.37E-5	Coronary artery calcification	
PRAD	cis	1	rs34026879	chr1:27068238	PIGV	chr1:27114455-27124886:+	-0.35	-4.05	6.03E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34055941	chr9:131895076	CRAT	chr9:131857075-131873070:-	0.23	4.3	2.1E-5	Blood metabolite ratios	
PRAD	cis	1	rs34072732	chr4:106604364	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs34081402	chr10:45994427	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs34084277	chr19:17387176	ANKLE1	chr19:17392454-17398454:+	0.34	6.75	4.44E-11	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs34084277	chr19:17387176	MRPL34	chr19:17416477-17417652:+	-0.19	-3.78	0.000178	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs34084277	chr19:17387176	OCEL1	chr19:17337055-17340027:+	0.21	5.08	5.43E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs34086988	chr3:121352745	IQCB1	chr3:121488610-121553926:-	0.51	9.99	1.94E-21	Cognitive performance	
PRAD	cis	1	rs34101673	chr3:46197286	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs34102169	chr1:46424864	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.96	5.57E-29	Body mass index	
PRAD	cis	1	rs34102169	chr1:46424864	MMACHC	chr1:45965856-45976737:+	-0.17	-3.86	0.000131	Body mass index	
PRAD	cis	1	rs34102169	chr1:46424864	MUTYH	chr1:45794915-45806142:-	0.2	5.84	9.94E-9	Body mass index	
PRAD	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.48	-10.89	8.97E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs34107692	chr6:88268344	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs34121720	chr3:53072167	RFT1	chr3:53122503-53164470:-	0.43	4.72	3.18E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34121720	chr3:53072167	TMEM110	chr3:52867139-52931547:-	0.4	5.06	6.11E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34134191	chr3:46221531	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs34136756	chr7:65381256	CCT6P1	chr7:65216092-65228661:+	0.31	5.59	3.91E-8	Diabetic kidney disease	
PRAD	cis	1	rs34136756	chr7:65381256	CRCP	chr7:65579805-65619551:+	-0.27	-3.53	0.00045	Diabetic kidney disease	
PRAD	cis	1	rs34138033	chr10:46046512	MARCH8	chr10:45952817-46090354:-	0.25	5.51	5.85E-8	Red blood cell traits	
PRAD	cis	1	rs34139049	chr6:33716784	IP6K3	chr6:33689443-33714762:-	0.2	3.9	0.000111	Obesity (extreme)	
PRAD	cis	1	rs34154420	chr6:88339411	C6orf165	chr6:88117721-88205858:+	0.42	3.9	0.00011	Obesity-related traits	
PRAD	cis	1	rs34156253	chr5:150226230	C5orf62	chr5:150157867-150176297:+	0.28	3.63	0.000315	Crohn's disease	
PRAD	cis	1	rs34156253	chr5:150226230	LOC134466	chr5:150310000-150326146:-	0.55	8.19	2.44E-15	Crohn's disease	
PRAD	cis	1	rs34171762	chr19:18559410	ELL	chr19:18553475-18632937:-	-0.16	-3.78	0.000174	Breast cancer	
PRAD	cis	1	rs34171762	chr19:18559410	SSBP4	chr19:18530221-18545371:+	-0.17	-5.79	1.27E-8	Breast cancer	
PRAD	cis	1	rs34174370	chr3:127849744	RUVBL1	chr3:127783627-127872757:-	0.22	4.03	6.46E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs34174778	chr20:33544277	MMP24	chr20:33814539-33864804:+	-0.3	-4.51	8.36E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs34175245	chr1:27001711	PIGV	chr1:27114455-27124886:+	-0.31	-3.56	0.000413	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34179822	chr3:10140017	C3orf10	chr3:10157333-10168873:+	-0.19	-3.77	0.000181	Alzheimer's disease	
PRAD	cis	1	rs34179822	chr3:10140017	LOC401052	chr3:10048102-10052779:-	-0.3	-5.54	5.09E-8	Alzheimer's disease	
PRAD	cis	1	rs34191675	chr3:46189448	CCR9	chr3:45928019-45944667:+	0.32	3.72	0.000226	Celiac disease	
PRAD	cis	1	rs34192067	chr7:65887657	CCT6P1	chr7:65216092-65228661:+	0.31	5.22	2.7E-7	Diabetic kidney disease	
PRAD	cis	1	rs34192067	chr7:65887657	CRCP	chr7:65579805-65619551:+	-0.36	-4.49	9.17E-6	Diabetic kidney disease	
PRAD	cis	1	rs34193460	chr7:65393110	CCT6P1	chr7:65216092-65228661:+	0.35	6.16	1.57E-9	Diabetic kidney disease	
PRAD	cis	1	rs34193460	chr7:65393110	CRCP	chr7:65579805-65619551:+	-0.28	-3.5	0.000502	Diabetic kidney disease	
PRAD	cis	1	rs34195613	chr10:46030374	MARCH8	chr10:45952817-46090354:-	0.25	5.53	5.23E-8	Red blood cell traits	
PRAD	cis	1	rs34198350	chr2:48169382	GTF2A1L	chr2:48844948-48960284:+	-0.39	-3.98	8.14E-5	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs34198350	chr2:48169382	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.34	-4.16	3.86E-5	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs34201939	chr1:27093711	PIGV	chr1:27114455-27124886:+	-0.3	-3.5	0.000514	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34216334	chr1:27063419	PIGV	chr1:27114455-27124886:+	-0.35	-4.05	6.03E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34217609	chr1:27008267	PIGV	chr1:27114455-27124886:+	-0.31	-3.53	0.000457	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34228187	chr3:127816433	RUVBL1	chr3:127783627-127872757:-	0.25	4.52	7.78E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs34237279	chr15:75361121	PPCDC	chr15:75315927-75343066:+	0.14	3.62	0.00033	Blood trace element (Zn levels)	
PRAD	cis	1	rs34237279	chr15:75361121	SCAMP5	chr15:75287901-75313836:+	0.41	7.16	3.15E-12	Blood trace element (Zn levels)	
PRAD	cis	1	rs34244302	chr3:53102236	RFT1	chr3:53122503-53164470:-	0.45	4.72	3.14E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34244302	chr3:53102236	TMEM110	chr3:52867139-52931547:-	0.39	4.64	4.56E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34245511	chr12:50573433	DIP2B	chr12:50898768-51142448:+	0.09	3.58	0.000382	Colorectal cancer	
PRAD	cis	1	rs34246550	chr8:89585399	MMP16	chr8:89049462-89339717:-	0.15	3.56	0.000414	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs34256197	chr19:18606472	ELL	chr19:18553475-18632937:-	-0.16	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs34256197	chr19:18606472	SSBP4	chr19:18530221-18545371:+	-0.18	-6.06	2.78E-9	Breast cancer	
PRAD	cis	1	rs34258593	chr3:38464565	XYLB	chr3:38388251-38456467:+	0.23	5.13	4.2E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.5	-11.26	3.45E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs34292685	chr11:64049021	C11orf20	chr11:64067863-64072238:+	-0.42	-5.84	9.72E-9	Mean platelet volume	
PRAD	cis	1	rs34309840	chr10:46039361	MARCH8	chr10:45952817-46090354:-	0.25	5.52	5.59E-8	Red blood cell traits	
PRAD	cis	1	rs34313230	chr20:43755858	SLPI	chr20:43880879-43883206:-	0.24	3.78	0.000175	Parental longevity (mother's age at death)	
PRAD	cis	1	rs34313969	chr3:52995166	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34313969	chr3:52995166	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34315739	chr11:74165954	P4HA3	chr11:73958550-74022699:-	-0.23	-3.44	0.000626	Corneal astigmatism	
PRAD	cis	1	rs34319345	chr16:58820592	GOT2	chr16:58741035-58768246:-	-0.2	-4.31	2.03E-5	Blood metabolite ratios	
PRAD	cis	1	rs34320230	chr7:97785500	BHLHA15	chr7:97840778-97842271:+	-0.14	-3.67	0.00027	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs34333482	chr6:116855952	FAM26F	chr6:116782556-116784933:+	0.16	5.29	1.84E-7	Pelvic organ prolapse (moderate/severe)	
PRAD	cis	1	rs34339105	chr6:33723457	IP6K3	chr6:33689443-33714762:-	0.19	3.78	0.000175	Obesity (extreme)	
PRAD	cis	1	rs34340501	chr3:46225216	CCR9	chr3:45928019-45944667:+	0.34	3.64	0.0003	Celiac disease	
PRAD	cis	1	rs34340609	chr3:53077276	RFT1	chr3:53122503-53164470:-	0.39	4.71	3.29E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34340609	chr3:53077276	TMEM110	chr3:52867139-52931547:-	0.31	4.37	1.54E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34344888	chr14:23387585	HAUS4	chr14:23415438-23426335:-	-0.32	-7.94	1.55E-14	Educational attainment (years of education)	
PRAD	cis	1	rs34348847	chr3:150501389	SIAH2	chr3:150458911-150481263:-	0.5	4.97	9.25E-7	Breast cancer	
PRAD	cis	1	rs34373625	chr10:4981201	AKR1C2	chr10:4964715-5060207:-	0.69	9.52	8.89E-20	Height	
PRAD	cis	1	rs34378541	chr3:46239649	CCR9	chr3:45928019-45944667:+	0.34	3.64	0.0003	Celiac disease	
PRAD	cis	1	rs34382476	chr6:111744754	KIAA1919	chr6:111580482-111590259:+	0.38	4.01	7.0E-5	Psoriasis	
PRAD	cis	1	rs34385811	chr6:88308237	C6orf165	chr6:88117721-88205858:+	0.37	3.57	0.000397	Obesity-related traits	
PRAD	cis	1	rs34395299	chr6:88268702	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs34400328	chr4:175298214	HPGD	chr4:175411328-175444044:-	-0.23	-3.45	0.000611	Response to acetaminophen (hepatotoxicity)	
PRAD	cis	1	rs34401473	chr3:46189772	CCR9	chr3:45928019-45944667:+	0.32	3.61	0.000336	Celiac disease	
PRAD	cis	1	rs34403909	chr3:127810445	RUVBL1	chr3:127783627-127872757:-	0.25	4.62	4.94E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs34406563	chr11:46398916	HARBI1	chr11:46624857-46638777:-	0.28	3.98	7.84E-5	Schizophrenia	
PRAD	cis	1	rs344081	chr3:156555984	LEKR1	chr3:156544076-156763918:+	-0.44	-6.35	4.96E-10	Bone mineral density	
PRAD	cis	1	rs344088	chr3:156561361	LEKR1	chr3:156544076-156763918:+	-0.43	-6.29	7.29E-10	Bone mineral density	
PRAD	cis	1	rs344090	chr3:156563140	LEKR1	chr3:156544076-156763918:+	-0.43	-6.29	7.29E-10	Bone mineral density	
PRAD	cis	1	rs34409160	chr2:28943865	PPP1CB	chr2:28974612-29025805:+	-0.27	-5.6	3.72E-8	Body mass index	
PRAD	cis	1	rs34409160	chr2:28943865	TRMT61B	chr2:29072690-29093175:-	0.39	7.86	2.59E-14	Body mass index	
PRAD	cis	1	rs34409248	chr3:46198071	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs34409786	chr3:127888175	RUVBL1	chr3:127783627-127872757:-	0.23	4.25	2.57E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs34415465	chr10:45985580	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs34421316	chr21:43513989	C21orf128	chr21:43522244-43528644:-	0.34	4.8	2.1E-6	IgG glycosylation	
PRAD	cis	1	rs34423353	chr6:88356960	C6orf165	chr6:88117721-88205858:+	0.46	4.2	3.15E-5	Obesity-related traits	
PRAD	cis	1	rs34427132	chr7:107984569	NRCAM	chr7:107788084-108096826:-	0.23	3.81	0.000157	Femoral neck bone geometry and menarche (age at onset)	
PRAD	cis	1	rs34428306	chr1:152184316	FLG	chr1:152274651-152297679:-	0.39	7.08	5.3E-12	Inflammatory skin disease	
PRAD	cis	1	rs34431049	chr15:52940538	ARPP19	chr15:52839432-52861364:-	0.15	4	7.31E-5	Schizophrenia	
PRAD	cis	1	rs34434809	chr10:17187634	TRDMT1	chr10:17184983-17243681:-	-0.28	-5.47	7.49E-8	Homocysteine levels	
PRAD	cis	1	rs34453673	chr5:434722	C5orf55	chr5:441645-443258:-	0.17	3.68	0.000262	Cystic fibrosis severity	
PRAD	cis	1	rs34453673	chr5:434722	LOC25845	chr5:470626-473080:-	0.28	4.84	1.76E-6	Cystic fibrosis severity	
PRAD	cis	1	rs34455158	chr6:88328233	C6orf165	chr6:88117721-88205858:+	0.42	3.9	0.00011	Obesity-related traits	
PRAD	cis	1	rs34460651	chr6:33731312	IP6K3	chr6:33689443-33714762:-	0.2	3.85	0.000134	Obesity (extreme)	
PRAD	cis	1	rs34473788	chr1:27271519	PIGV	chr1:27114455-27124886:+	-0.31	-3.85	0.000134	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs3448	chr3:49396751	AMIGO3	chr3:49754268-49757238:-	-0.43	-8.79	2.93E-17	Menarche (age at onset)	
PRAD	cis	1	rs3448	chr3:49396751	CCDC36	chr3:49235861-49295537:+	0.23	4.18	3.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs3448	chr3:49396751	GMPPB	chr3:49758932-49761384:-	-0.48	-11.64	1.05E-27	Menarche (age at onset)	
PRAD	cis	1	rs3448	chr3:49396751	NCKIPSD	chr3:48711280-48723334:-	0.31	6.09	2.34E-9	Menarche (age at onset)	
PRAD	cis	1	rs3448	chr3:49396751	P4HTM	chr3:49027341-49044579:+	0.16	3.67	0.000275	Menarche (age at onset)	
PRAD	cis	1	rs3448	chr3:49396751	WDR6	chr3:49044637-49053386:+	-0.19	-3.83	0.000146	Menarche (age at onset)	
PRAD	cis	1	rs34500464	chr10:17191996	TRDMT1	chr10:17184983-17243681:-	-0.24	-4.82	1.97E-6	Homocysteine levels	
PRAD	cis	1	rs34510678	chr5:139064835	SLC23A1	chr5:138702891-138719039:-	0.19	3.43	0.00065	Schizophrenia	
PRAD	cis	1	rs34514856	chr1:27287560	PIGV	chr1:27114455-27124886:+	-0.34	-3.95	9.07E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34522725	chr5:153606366	GALNT10	chr5:153570295-153799809:+	0.15	4.47	9.93E-6	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs34523728	chr3:46219833	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs34529418	chr7:65403209	CCT6P1	chr7:65216092-65228661:+	0.3	5.31	1.65E-7	Diabetic kidney disease	
PRAD	cis	1	rs34529418	chr7:65403209	CRCP	chr7:65579805-65619551:+	-0.27	-3.54	0.000439	Diabetic kidney disease	
PRAD	cis	1	rs34529418	chr7:65403209	ZNF117	chr7:64434830-64467121:-	-0.27	-3.43	0.000659	Diabetic kidney disease	
PRAD	cis	1	rs34530577	chr3:53103796	ITIH4	chr3:52847007-52866554:-	0.14	4.11	4.72E-5	Height	
PRAD	cis	1	rs34538248	chr13:31468796	C13orf33	chr13:31480312-31499708:+	0.24	3.77	0.000184	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs34544865	chr19:37801242	ZNF781	chr19:38158650-38183216:-	0.24	3.6	0.000348	Coronary artery calcification	
PRAD	cis	1	rs34552628	chr20:55070268	C20orf43	chr20:55043647-55093942:+	0.15	3.57	0.000401	Refractive astigmatism	
PRAD	cis	1	rs34558323	chr10:17184228	TRDMT1	chr10:17184983-17243681:-	-0.24	-4.78	2.35E-6	Homocysteine levels	
PRAD	cis	1	rs34560516	chr7:65404092	CCT6P1	chr7:65216092-65228661:+	0.35	6.14	1.71E-9	Diabetic kidney disease	
PRAD	cis	1	rs34560516	chr7:65404092	CRCP	chr7:65579805-65619551:+	-0.27	-3.49	0.000526	Diabetic kidney disease	
PRAD	cis	1	rs34562493	chr3:127817022	RUVBL1	chr3:127783627-127872757:-	0.25	4.5	8.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs34566829	chr10:45973598	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs34567015	chr3:46202212	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs34570071	chr15:85280212	LOC388152	chr15:84867600-84898920:-	-0.32	-5.32	1.63E-7	Schizophrenia	
PRAD	cis	1	rs34570071	chr15:85280212	NMB	chr15:85198362-85201802:-	-0.53	-12.53	2.69E-31	Schizophrenia	
PRAD	cis	1	rs34570071	chr15:85280212	WDR73	chr15:85186012-85197524:-	-0.28	-5.79	1.27E-8	Schizophrenia	
PRAD	cis	1	rs34570200	chr3:46220500	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs34576193	chr1:27054780	PIGV	chr1:27114455-27124886:+	-0.36	-4.01	7.18E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34577383	chr7:65385726	CCT6P1	chr7:65216092-65228661:+	0.3	5.31	1.65E-7	Diabetic kidney disease	
PRAD	cis	1	rs34577383	chr7:65385726	CRCP	chr7:65579805-65619551:+	-0.27	-3.54	0.000439	Diabetic kidney disease	
PRAD	cis	1	rs34577383	chr7:65385726	ZNF117	chr7:64434830-64467121:-	-0.27	-3.43	0.000659	Diabetic kidney disease	
PRAD	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.5	-11.42	8.05E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs34583567	chr15:67983281	IQCH	chr15:67547188-67794139:+	0.31	6.26	8.62E-10	Motion sickness	
PRAD	cis	1	rs34585496	chr1:27025940	PIGV	chr1:27114455-27124886:+	-0.35	-3.98	8.09E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34589365	chr11:67435976	ALDH3B2	chr11:67429634-67448685:-	0.49	5.25	2.26E-7	Serum metabolite levels	
PRAD	cis	1	rs34594435	chr7:72977249	MLXIPL	chr7:73007524-73038870:-	0.24	3.69	0.000249	Triglycerides	
PRAD	cis	1	rs34602589	chr20:43768734	SLPI	chr20:43880879-43883206:-	0.24	3.87	0.000126	Parental longevity (mother's age at death)	
PRAD	cis	1	rs34610643	chr17:40574388	CNTNAP1	chr17:40834632-40852010:+	0.16	4.65	4.26E-6	Crohn's disease	
PRAD	cis	1	rs34610643	chr17:40574388	NAGLU	chr17:40687951-40696464:+	-0.18	-4.17	3.6E-5	Crohn's disease	
PRAD	cis	1	rs34622539	chr20:43756548	SLPI	chr20:43880879-43883206:-	0.24	3.84	0.000141	Parental longevity (mother's age at death)	
PRAD	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.48	-10.82	1.59E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs34629498	chr19:23060720	ZNF492	chr19:22817126-22850472:+	-0.33	-4.23	2.86E-5	Bronchopulmonary dysplasia	
PRAD	cis	1	rs34636547	chr11:48590103	FOLH1	chr11:49168188-49230222:-	-0.16	-3.68	0.000261	HDL cholesterol	
PRAD	cis	1	rs34637256	chr7:65360131	CCT6P1	chr7:65216092-65228661:+	0.3	5.3	1.76E-7	Diabetic kidney disease	
PRAD	cis	1	rs34638860	chr20:43765839	SLPI	chr20:43880879-43883206:-	0.23	3.63	0.00031	Parental longevity (mother's age at death)	
PRAD	cis	1	rs34640283	chr20:3989576	MAVS	chr20:3827449-3856761:+	-0.26	-3.53	0.000451	Response to antidepressants in depression	
PRAD	cis	1	rs34645895	chr20:25368373	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs34645895	chr20:25368373	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs34645895	chr20:25368373	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs34661476	chr10:45971413	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs34667713	chr1:27292678	PIGV	chr1:27114455-27124886:+	-0.34	-3.96	8.76E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs346785	chr17:74283769	FAM100B	chr17:74261286-74267379:+	0.19	5.48	7.09E-8	White matter hyperintensities in ischemic stroke	
PRAD	cis	1	rs34681611	chr1:27089446	PIGV	chr1:27114455-27124886:+	-0.36	-4.06	5.84E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34684276	chr15:78813155	CHRNA3	chr15:78885397-78913322:-	-0.26	-4.42	1.24E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio;Nicotine dependence	
PRAD	cis	1	rs34684276	chr15:78813155	CHRNA5	chr15:78857906-78886458:+	-0.22	-4.36	1.57E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio;Nicotine dependence	
PRAD	cis	1	rs34693293	chr1:27068971	PIGV	chr1:27114455-27124886:+	-0.35	-4.05	6.03E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34693386	chr3:46195402	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs34700722	chr8:96021876	C8orf38	chr8:95908040-96088396:+	-0.35	-6.21	1.14E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs34700722	chr8:96021876	TP53INP1	chr8:95938201-95961615:-	0.23	3.66	0.000278	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs34702770	chr7:65344823	CCT6P1	chr7:65216092-65228661:+	0.3	5.3	1.76E-7	Diabetic kidney disease	
PRAD	cis	1	rs34703416	chr7:65300642	CCT6P1	chr7:65216092-65228661:+	0.31	5.42	9.41E-8	Diabetic kidney disease	
PRAD	cis	1	rs34709844	chr3:127818869	RUVBL1	chr3:127783627-127872757:-	0.24	4.35	1.64E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs34718682	chr9:71165704	PIP5K1B	chr9:71320616-71624090:+	0.31	3.49	0.000523	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs34728853	chr1:27000579	PIGV	chr1:27114455-27124886:+	-0.31	-3.58	0.000377	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34731408	chr10:45961020	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs34746918	chr19:18539744	SSBP4	chr19:18530221-18545371:+	-0.17	-5.64	2.99E-8	Breast cancer	
PRAD	cis	1	rs34751999	chr15:84758419	GOLGA6L5	chr15:85047738-85060078:-	-0.19	-4.74	2.79E-6	Schizophrenia	
PRAD	cis	1	rs34751999	chr15:84758419	LOC388152	chr15:84867600-84898920:-	-0.36	-6.25	9.07E-10	Schizophrenia	
PRAD	cis	1	rs34751999	chr15:84758419	NMB	chr15:85198362-85201802:-	-0.37	-8.3	1.1E-15	Schizophrenia	
PRAD	cis	1	rs34751999	chr15:84758419	WDR73	chr15:85186012-85197524:-	-0.22	-4.6	5.48E-6	Schizophrenia	
PRAD	cis	1	rs34762726	chr3:49689210	GMPPB	chr3:49758932-49761384:-	-0.21	-4.6	5.51E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs34762726	chr3:49689210	UBA7	chr3:49842639-49851391:-	0.14	3.46	0.000584	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs34771104	chr4:39129052	KLHL5	chr4:39046659-39123828:+	-0.14	-4.02	6.68E-5	Uric acid levels	
PRAD	cis	1	rs34771643	chr10:45970632	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs34777851	chr2:242047530	PASK	chr2:242045515-242088878:-	0.31	3.72	0.000223	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs34781030	chr8:65641102	BHLHE22	chr8:65492814-65496185:+	0.32	5.88	7.93E-9	HIV-1 susceptibility	
PRAD	cis	1	rs34782690	chr8:65706044	BHLHE22	chr8:65492814-65496185:+	0.28	5.42	9.35E-8	HIV-1 susceptibility	
PRAD	cis	1	rs34798402	chr12:85492094	LRRIQ1	chr12:85430099-85638880:+	-0.24	-3.97	8.18E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs34798402	chr12:85492094	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.99	8.55E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs34798402	chr12:85492094	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.5	6.15E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs34811768	chr20:43765800	SLPI	chr20:43880879-43883206:-	0.22	3.58	0.000378	Parental longevity (mother's age at death)	
PRAD	cis	1	rs34812189	chr6:56806727	BEND6	chr6:56819773-56892138:+	-0.63	-11.26	3.45E-26	Menarche (age at onset)	
PRAD	cis	1	rs34815098	chr7:65292254	CCT6P1	chr7:65216092-65228661:+	0.29	5.15	3.92E-7	Diabetic kidney disease	
PRAD	cis	1	rs34817706	chr3:127861058	RUVBL1	chr3:127783627-127872757:-	0.22	3.96	8.63E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs34826754	chr5:122749299	CEP120	chr5:122680580-122759252:-	-0.24	-5.39	1.11E-7	Waist circumference	
PRAD	cis	1	rs34847072	chr5:437862	C5orf55	chr5:441645-443258:-	0.17	3.76	0.000192	Cystic fibrosis severity	
PRAD	cis	1	rs34847072	chr5:437862	LOC25845	chr5:470626-473080:-	0.28	4.88	1.46E-6	Cystic fibrosis severity	
PRAD	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.66	10.11	7.14E-22	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs34849118	chr2:240919912	NDUFA10	chr2:240900158-240964798:-	0.28	6.44	2.87E-10	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.47	-10.73	3.72E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs34869648	chr6:33724059	IP6K3	chr6:33689443-33714762:-	0.19	3.78	0.000175	Obesity (extreme)	
PRAD	cis	1	rs34870159	chr3:46189490	CCR9	chr3:45928019-45944667:+	0.32	3.69	0.000251	Celiac disease	
PRAD	cis	1	rs34872586	chr17:65863466	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs34878139	chr12:124446253	ZNF664	chr12:124457670-124499967:+	-0.15	-3.9	0.000111	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs34879733	chr10:45997761	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs34884883	chr6:33768726	IP6K3	chr6:33689443-33714762:-	0.18	3.67	0.000267	Obesity (extreme)	
PRAD	cis	1	rs34885854	chr1:27086249	PIGV	chr1:27114455-27124886:+	-0.36	-4.06	5.84E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34886124	chr15:85431566	NMB	chr15:85198362-85201802:-	-0.35	-6.76	4.12E-11	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs34886124	chr15:85431566	WDR73	chr15:85186012-85197524:-	-0.23	-4.44	1.12E-5	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs34889675	chr1:37965851	MEAF6	chr1:37958176-37980364:-	-0.34	-4.97	9.61E-7	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs34889675	chr1:37965851	SNIP1	chr1:38002145-38019903:-	-0.27	-4.67	3.88E-6	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs34897497	chr10:46024677	MARCH8	chr10:45952817-46090354:-	0.25	5.53	5.23E-8	Red blood cell traits	
PRAD	cis	1	rs34897745	chr3:46198376	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs34900908	chr15:85257599	LOC388152	chr15:84867600-84898920:-	-0.32	-5.42	9.53E-8	Schizophrenia	
PRAD	cis	1	rs34900908	chr15:85257599	NMB	chr15:85198362-85201802:-	-0.52	-12.28	2.93E-30	Schizophrenia	
PRAD	cis	1	rs34900908	chr15:85257599	WDR73	chr15:85186012-85197524:-	-0.27	-5.62	3.27E-8	Schizophrenia	
PRAD	cis	1	rs34902959	chr2:160037557	WDSUB1	chr2:160092305-160143236:-	-0.33	-5.49	6.73E-8	Resting heart rate	
PRAD	cis	1	rs34913635	chr12:48672654	TMEM106C	chr12:48357330-48362660:+	0.36	3.59	0.00037	Prostate cancer	
PRAD	cis	1	rs34919068	chr20:43755830	SLPI	chr20:43880879-43883206:-	0.24	3.78	0.000175	Parental longevity (mother's age at death)	
PRAD	cis	1	rs34927605	chr5:137580418	REEP2	chr5:137774776-137782657:+	-0.1	-4.14	4.1E-5	Resting heart rate	
PRAD	cis	1	rs34933390	chr3:53006265	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34933390	chr3:53006265	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34933526	chr7:65383199	CCT6P1	chr7:65216092-65228661:+	0.31	5.59	3.91E-8	Diabetic kidney disease	
PRAD	cis	1	rs34933526	chr7:65383199	CRCP	chr7:65579805-65619551:+	-0.27	-3.53	0.00045	Diabetic kidney disease	
PRAD	cis	1	rs34937315	chr10:45970717	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs34943350	chr3:53012888	RFT1	chr3:53122503-53164470:-	0.43	4.58	6.03E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34943350	chr3:53012888	TMEM110	chr3:52867139-52931547:-	0.41	5.03	7.15E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34949904	chr22:24695298	POM121L9P	chr22:24647589-24661490:+	-0.25	-5.05	6.18E-7	Gut microbiome composition (summer)	
PRAD	cis	1	rs34953792	chr20:55086281	C20orf43	chr20:55043647-55093942:+	0.16	4.01	6.92E-5	Refractive astigmatism	
PRAD	cis	1	rs34955225	chr3:127825078	RUVBL1	chr3:127783627-127872757:-	0.24	4.36	1.59E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs34970380	chr7:65431493	CCT6P1	chr7:65216092-65228661:+	0.35	6.27	8.39E-10	Diabetic kidney disease	
PRAD	cis	1	rs34970380	chr7:65431493	CRCP	chr7:65579805-65619551:+	-0.27	-3.44	0.000638	Diabetic kidney disease	
PRAD	cis	1	rs34971845	chr10:72762281	PRF1	chr10:72357105-72362531:-	0.22	3.61	0.000339	Multiple myeloma (IgH translocation)	
PRAD	cis	1	rs34974928	chr7:65364006	CCT6P1	chr7:65216092-65228661:+	0.28	5.03	7.0E-7	Diabetic kidney disease	
PRAD	cis	1	rs34976021	chr1:27298564	PIGV	chr1:27114455-27124886:+	-0.33	-3.96	8.83E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs34979715	chr3:53048960	RFT1	chr3:53122503-53164470:-	0.43	4.64	4.6E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34979715	chr3:53048960	TMEM110	chr3:52867139-52931547:-	0.38	4.71	3.29E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs34983295	chr20:55079380	C20orf43	chr20:55043647-55093942:+	0.16	3.99	7.62E-5	Refractive astigmatism	
PRAD	cis	1	rs34996127	chr3:46198173	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs35000415	chr7:128585616	IRF5	chr7:128577769-128590086:+	0.38	5.26	2.15E-7	Systemic lupus erythematosus	
PRAD	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.47	7.83	3.32E-14	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs35021342	chr1:27086227	PIGV	chr1:27114455-27124886:+	-0.3	-3.5	0.000514	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs35034867	chr10:46039565	MARCH8	chr10:45952817-46090354:-	0.25	5.52	5.59E-8	Red blood cell traits	
PRAD	cis	1	rs35035279	chr11:123957179	SLC37A2	chr11:124933013-124960411:+	0.27	3.9	0.000112	Obesity-related traits	
PRAD	cis	1	rs35036712	chr10:46046710	MARCH8	chr10:45952817-46090354:-	0.25	5.51	5.85E-8	Red blood cell traits	
PRAD	cis	1	rs35041418	chr1:27048983	PIGV	chr1:27114455-27124886:+	-0.29	-3.43	0.00066	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs35046236	chr7:65408613	CCT6P1	chr7:65216092-65228661:+	0.31	5.59	3.91E-8	Diabetic kidney disease	
PRAD	cis	1	rs35046236	chr7:65408613	CRCP	chr7:65579805-65619551:+	-0.27	-3.53	0.00045	Diabetic kidney disease	
PRAD	cis	1	rs35056702	chr6:109736326	SMPD2	chr6:109761931-109765121:+	0.25	5.32	1.64E-7	Height	
PRAD	cis	1	rs35058610	chr7:65390925	CCT6P1	chr7:65216092-65228661:+	0.31	5.6	3.65E-8	Diabetic kidney disease	
PRAD	cis	1	rs35058610	chr7:65390925	CRCP	chr7:65579805-65619551:+	-0.27	-3.52	0.000468	Diabetic kidney disease	
PRAD	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.58	-12.32	2.02E-30	Forced vital capacity	
PRAD	cis	1	rs35062783	chr10:17202869	TRDMT1	chr10:17184983-17243681:-	-0.25	-5.08	5.33E-7	Homocysteine levels	
PRAD	cis	1	rs35068485	chr11:466032	ANO9	chr11:417930-442011:-	0.25	4.17	3.56E-5	Body mass index	
PRAD	cis	1	rs35068485	chr11:466032	LRRC56	chr11:537522-554915:+	0.29	4.45	1.1E-5	Body mass index	
PRAD	cis	1	rs35068485	chr11:466032	RNH1	chr11:494512-507273:-	-0.21	-3.84	0.000137	Body mass index	
PRAD	cis	1	rs35106985	chr10:102307542	SEC31B	chr10:102246403-102289636:-	-0.28	-8.39	5.63E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs35108146	chr1:27248440	PIGV	chr1:27114455-27124886:+	-0.34	-3.95	8.87E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs35116118	chr4:39128913	KLHL5	chr4:39046659-39123828:+	-0.13	-3.97	8.33E-5	Uric acid levels	
PRAD	cis	1	rs35124757	chr6:89918215	GABRR1	chr6:89887223-89927496:-	0.43	5.49	6.67E-8	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs35131026	chr10:46014759	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs351365	chr1:113046395	CTTNBP2NL	chr1:112938800-113006063:+	0.16	3.46	0.000594	Pancreatic cancer	
PRAD	cis	1	rs35145047	chr6:88359698	C6orf165	chr6:88117721-88205858:+	0.46	4.2	3.15E-5	Obesity-related traits	
PRAD	cis	1	rs35145572	chr3:127847418	RUVBL1	chr3:127783627-127872757:-	0.22	4.08	5.33E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs35149210	chr7:65929925	TPST1	chr7:65670259-65825437:+	0.18	4.4	1.32E-5	Aortic root size	
PRAD	cis	1	rs35151650	chr6:111757727	KIAA1919	chr6:111580482-111590259:+	0.38	4.01	7.0E-5	Psoriasis	
PRAD	cis	1	rs35160687	chr2:86472114	LOC90784	chr2:86247339-86250991:-	0.29	5.53	5.37E-8	Night sleep phenotypes	
PRAD	cis	1	rs35160687	chr2:86472114	MRPL35	chr2:86426556-86440476:+	0.35	6.57	1.35E-10	Night sleep phenotypes	
PRAD	cis	1	rs35160687	chr2:86472114	REEP1	chr2:86441122-86564777:-	0.47	10.33	1.12E-22	Night sleep phenotypes	
PRAD	cis	1	rs35162796	chr3:46204379	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs35163227	chr3:53127876	RFT1	chr3:53122503-53164470:-	0.46	4.77	2.48E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35163227	chr3:53127876	TMEM110	chr3:52867139-52931547:-	0.38	4.54	7.25E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35172875	chr10:46004160	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs35174175	chr3:53041509	RFT1	chr3:53122503-53164470:-	0.43	4.55	6.83E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35174175	chr3:53041509	TMEM110	chr3:52867139-52931547:-	0.41	4.97	9.5E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35174328	chr3:14479888	SH3BP5	chr3:15296357-15382901:-	-0.13	-3.62	0.000331	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs35178150	chr3:46194769	CCR9	chr3:45928019-45944667:+	0.37	3.85	0.000136	Celiac disease	
PRAD	cis	1	rs35187216	chr10:45986620	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs35190023	chr4:155345395	DCHS2	chr4:155155527-155412930:-	0.14	3.9	0.00011	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs35194171	chr2:61072183	PUS10	chr2:61167550-61245365:-	-0.18	-3.61	0.000336	Psoriasis	
PRAD	cis	1	rs35194524	chr12:62507200	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs35196908	chr8:65665988	BHLHE22	chr8:65492814-65496185:+	0.28	5.38	1.15E-7	HIV-1 susceptibility	
PRAD	cis	1	rs35198334	chr3:10104553	C3orf10	chr3:10157333-10168873:+	-0.21	-4.12	4.39E-5	Alzheimer's disease	
PRAD	cis	1	rs35198334	chr3:10104553	LOC401052	chr3:10048102-10052779:-	-0.29	-5.23	2.51E-7	Alzheimer's disease	
PRAD	cis	1	rs35202312	chr6:56788937	BEND6	chr6:56819773-56892138:+	-0.59	-10.88	9.24E-25	Menarche (age at onset)	
PRAD	cis	1	rs35208445	chr6:111756147	KIAA1919	chr6:111580482-111590259:+	0.38	4.01	7.0E-5	Psoriasis	
PRAD	cis	1	rs35212307	chr2:203765756	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs35216461	chr21:44614253	C21orf33	chr21:45553494-45565604:+	0.19	3.43	0.000648	Schizophrenia	
PRAD	cis	1	rs35220123	chr3:10083169	C3orf10	chr3:10157333-10168873:+	-0.22	-4.16	3.84E-5	Alzheimer's disease	
PRAD	cis	1	rs35220123	chr3:10083169	LOC401052	chr3:10048102-10052779:-	-0.29	-5.21	2.88E-7	Alzheimer's disease	
PRAD	cis	1	rs35227660	chr20:43756697	SLPI	chr20:43880879-43883206:-	0.23	3.75	0.0002	Parental longevity (mother's age at death)	
PRAD	cis	1	rs35231079	chr11:515224	ANO9	chr11:417930-442011:-	0.24	3.91	0.000107	Body mass index	
PRAD	cis	1	rs35231079	chr11:515224	LRRC56	chr11:537522-554915:+	0.28	4.14	4.14E-5	Body mass index	
PRAD	cis	1	rs35231079	chr11:515224	RNH1	chr11:494512-507273:-	-0.21	-3.77	0.000185	Body mass index	
PRAD	cis	1	rs35243555	chr17:65876477	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs35244261	chr11:108283808	ATM	chr11:108093559-108239826:+	0.15	4.51	8.32E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs35248830	chr6:111756750	KIAA1919	chr6:111580482-111590259:+	0.38	4.01	7.0E-5	Psoriasis	
PRAD	cis	1	rs35255804	chr11:492617	ANO9	chr11:417930-442011:-	0.24	3.89	0.000115	Body mass index	
PRAD	cis	1	rs35255804	chr11:492617	LRRC56	chr11:537522-554915:+	0.29	4.45	1.09E-5	Body mass index	
PRAD	cis	1	rs35255804	chr11:492617	RNH1	chr11:494512-507273:-	-0.2	-3.69	0.000254	Body mass index	
PRAD	cis	1	rs35256560	chr1:27054016	PIGV	chr1:27114455-27124886:+	-0.35	-4.05	6.03E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs35261210	chr17:40588316	CNTNAP1	chr17:40834632-40852010:+	0.16	4.58	5.97E-6	Crohn's disease	
PRAD	cis	1	rs35261210	chr17:40588316	NAGLU	chr17:40687951-40696464:+	-0.18	-4.05	5.88E-5	Crohn's disease	
PRAD	cis	1	rs35272895	chr17:40580669	CNTNAP1	chr17:40834632-40852010:+	0.16	4.62	5.02E-6	Crohn's disease	
PRAD	cis	1	rs35272895	chr17:40580669	NAGLU	chr17:40687951-40696464:+	-0.19	-4.36	1.57E-5	Crohn's disease	
PRAD	cis	1	rs35273426	chr8:41524688	ANK1	chr8:41510745-41754280:-	-0.2	-3.55	0.000423	Type 2 diabetes	
PRAD	cis	1	rs35274562	chr6:33716831	IP6K3	chr6:33689443-33714762:-	0.2	3.9	0.000111	Obesity (extreme)	
PRAD	cis	1	rs35283677	chr7:65359233	CCT6P1	chr7:65216092-65228661:+	0.34	5.86	8.9E-9	Diabetic kidney disease	
PRAD	cis	1	rs35288652	chr3:46209427	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs35290231	chr1:44103033	SLC2A1	chr1:43391046-43424847:-	-0.19	-3.53	0.000459	Hypertension risk in short sleep duration	
PRAD	cis	1	rs35294227	chr10:46006798	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs35297609	chr15:84772896	GOLGA6L5	chr15:85047738-85060078:-	-0.19	-4.74	2.79E-6	Schizophrenia	
PRAD	cis	1	rs35297609	chr15:84772896	LOC388152	chr15:84867600-84898920:-	-0.36	-6.25	9.07E-10	Schizophrenia	
PRAD	cis	1	rs35297609	chr15:84772896	NMB	chr15:85198362-85201802:-	-0.37	-8.3	1.1E-15	Schizophrenia	
PRAD	cis	1	rs35297609	chr15:84772896	WDR73	chr15:85186012-85197524:-	-0.22	-4.6	5.48E-6	Schizophrenia	
PRAD	cis	1	rs35303148	chr10:45989254	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs35303215	chr22:24801535	GGT5	chr22:24615623-24641110:-	-0.11	-3.46	0.0006	Gut microbiome composition (summer)	
PRAD	cis	1	rs35303215	chr22:24801535	POM121L9P	chr22:24647589-24661490:+	-0.28	-5.59	3.82E-8	Gut microbiome composition (summer)	
PRAD	cis	1	rs35312483	chr12:85504616	LRRIQ1	chr12:85430099-85638880:+	-0.23	-3.92	0.0001	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs35312483	chr12:85504616	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.96	1.01E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs35312483	chr12:85504616	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.47	7.48E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs35316992	chr15:85248133	LOC388152	chr15:84867600-84898920:-	-0.32	-5.42	9.53E-8	Schizophrenia	
PRAD	cis	1	rs35316992	chr15:85248133	NMB	chr15:85198362-85201802:-	-0.52	-12.28	2.93E-30	Schizophrenia	
PRAD	cis	1	rs35316992	chr15:85248133	WDR73	chr15:85186012-85197524:-	-0.27	-5.62	3.27E-8	Schizophrenia	
PRAD	cis	1	rs35326978	chr10:45997712	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs35328846	chr8:65660350	BHLHE22	chr8:65492814-65496185:+	0.32	5.91	6.44E-9	HIV-1 susceptibility	
PRAD	cis	1	rs35332070	chr19:23034266	ZNF492	chr19:22817126-22850472:+	-0.31	-4.12	4.39E-5	Bronchopulmonary dysplasia	
PRAD	cis	1	rs35341359	chr3:112994937	KIAA1407	chr3:113682986-113775460:-	-0.2	-3.56	0.000415	Dental caries	
PRAD	cis	1	rs35341640	chr17:18818228	FAM18B	chr17:18684582-18710026:+	0.26	5.09	5.18E-7	Pancreatic cancer	
PRAD	cis	1	rs353464	chr5:176403023	FGFR4	chr5:176513921-176525124:+	0.18	3.77	0.000183	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs353467	chr5:176445698	FGFR4	chr5:176513921-176525124:+	0.18	3.71	0.000236	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs353468	chr5:176445494	FGFR4	chr5:176513921-176525124:+	0.18	3.73	0.000219	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs353478	chr5:176370988	FGFR4	chr5:176513921-176525124:+	0.17	3.68	0.000264	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs353490	chr5:176433063	FGFR4	chr5:176513921-176525124:+	0.17	3.58	0.000382	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs35349326	chr10:45973624	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs353493	chr5:176432585	FGFR4	chr5:176513921-176525124:+	0.17	3.62	0.000322	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs35365094	chr11:34767790	APIP	chr11:34896714-34937939:-	0.25	4.97	9.44E-7	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs35370743	chr4:106604190	INTS12	chr4:106603787-106629881:-	-0.79	-7.88	2.34E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs35372377	chr15:52882281	ARPP19	chr15:52839432-52861364:-	0.14	3.7	0.000242	Schizophrenia	
PRAD	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.49	-11.51	3.41E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs35391607	chr7:65360829	CCT6P1	chr7:65216092-65228661:+	0.28	5.03	7.0E-7	Diabetic kidney disease	
PRAD	cis	1	rs35391654	chr10:72763685	PRF1	chr10:72357105-72362531:-	0.22	3.6	0.000353	Multiple myeloma (IgH translocation)	
PRAD	cis	1	rs35394192	chr10:46000761	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs35395156	chr15:67962763	IQCH	chr15:67547188-67794139:+	0.31	6.3	7.04E-10	Motion sickness	
PRAD	cis	1	rs35396113	chr7:65495461	CCT6P1	chr7:65216092-65228661:+	0.32	5.64	2.89E-8	Diabetic kidney disease	
PRAD	cis	1	rs35396113	chr7:65495461	CRCP	chr7:65579805-65619551:+	-0.31	-3.96	8.81E-5	Diabetic kidney disease	
PRAD	cis	1	rs35398388	chr19:37740358	SIPA1L3	chr19:38397868-38699006:+	0.17	3.53	0.000455	Coronary artery calcification	
PRAD	cis	1	rs35398388	chr19:37740358	ZNF607	chr19:38187276-38210691:-	-0.19	-3.5	0.000511	Coronary artery calcification	
PRAD	cis	1	rs35398388	chr19:37740358	ZNF781	chr19:38158650-38183216:-	0.24	4.14	4.16E-5	Coronary artery calcification	
PRAD	cis	1	rs354031	chr7:149285921	RARRES2	chr7:150035408-150038763:-	-0.07	-3.51	0.000491	Multiple sclerosis	
PRAD	cis	1	rs354033	chr7:149289464	RARRES2	chr7:150035408-150038763:-	0.07	3.5	0.000505	Multiple sclerosis	
PRAD	cis	1	rs354034	chr7:149290497	RARRES2	chr7:150035408-150038763:-	-0.07	-3.67	0.00027	Multiple sclerosis	
PRAD	cis	1	rs354042	chr7:149297104	RARRES2	chr7:150035408-150038763:-	-0.07	-3.54	0.000447	Multiple sclerosis	
PRAD	cis	1	rs354043	chr7:149297332	RARRES2	chr7:150035408-150038763:-	-0.08	-3.77	0.000182	Multiple sclerosis	
PRAD	cis	1	rs35407243	chr8:65650449	BHLHE22	chr8:65492814-65496185:+	0.3	5.74	1.7E-8	HIV-1 susceptibility	
PRAD	cis	1	rs35407375	chr1:27041218	PIGV	chr1:27114455-27124886:+	-0.35	-3.98	8.09E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.5	-11.26	3.45E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs35421223	chr3:127829879	RUVBL1	chr3:127783627-127872757:-	0.23	4.21	3.03E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs35421653	chr7:65363429	CCT6P1	chr7:65216092-65228661:+	0.34	5.86	8.9E-9	Diabetic kidney disease	
PRAD	cis	1	rs354225	chr2:54923766	SPTBN1	chr2:54683454-54898582:+	0.15	4.13	4.36E-5	Schizophrenia	
PRAD	cis	1	rs35424022	chr10:45976540	MARCH8	chr10:45952817-46090354:-	0.25	5.4	1.04E-7	Red blood cell traits	
PRAD	cis	1	rs35432774	chr7:65393019	CCT6P1	chr7:65216092-65228661:+	0.3	5.31	1.65E-7	Diabetic kidney disease	
PRAD	cis	1	rs35432774	chr7:65393019	CRCP	chr7:65579805-65619551:+	-0.27	-3.54	0.000439	Diabetic kidney disease	
PRAD	cis	1	rs35432774	chr7:65393019	ZNF117	chr7:64434830-64467121:-	-0.27	-3.43	0.000659	Diabetic kidney disease	
PRAD	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.76	18.34	4.56E-57	Eye color traits	
PRAD	cis	1	rs35437629	chr4:39133332	KLHL5	chr4:39046659-39123828:+	-0.13	-3.74	0.000204	Uric acid levels	
PRAD	cis	1	rs35437840	chr3:127825306	RUVBL1	chr3:127783627-127872757:-	0.25	4.6	5.48E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs35445446	chr6:33716745	IP6K3	chr6:33689443-33714762:-	0.2	3.96	8.78E-5	Obesity (extreme)	
PRAD	cis	1	rs35454259	chr6:27254475	BTN3A2	chr6:26365398-26378546:+	-0.48	-9.79	1.02E-20	Schizophrenia	
PRAD	cis	1	rs35454259	chr6:27254475	ZNF389	chr6:28129551-28137375:+	-0.35	-5.13	4.3E-7	Schizophrenia	
PRAD	cis	1	rs35464392	chr10:45972880	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs35464459	chr10:4964640	AKR1C2	chr10:4964715-5060207:-	0.74	10.1	7.55E-22	Height	
PRAD	cis	1	rs35468197	chr10:4978256	AKR1C2	chr10:4964715-5060207:-	0.69	9.48	1.31E-19	Height	
PRAD	cis	1	rs35468353	chr16:31056433	HSD3B7	chr16:30996519-31000473:+	0.49	10.7	4.5E-24	Response to metformin (IC50)	
PRAD	cis	1	rs35468353	chr16:31056433	MYST1	chr16:31128985-31142713:+	0.21	6.47	2.47E-10	Response to metformin (IC50)	
PRAD	cis	1	rs35468353	chr16:31056433	PRSS36	chr16:31150251-31161415:-	0.19	4.9	1.31E-6	Response to metformin (IC50)	
PRAD	cis	1	rs35468353	chr16:31056433	PRSS53	chr16:31094747-31106276:-	-0.19	-3.79	0.00017	Response to metformin (IC50)	
PRAD	cis	1	rs35468353	chr16:31056433	STX1B	chr16:31000577-31021829:-	0.23	5.8	1.24E-8	Response to metformin (IC50)	
PRAD	cis	1	rs35476574	chr8:143683784	ARC	chr8:143692410-143695833:-	-0.18	-3.46	0.000591	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs35477332	chr5:42420637	GHR	chr5:42424026-42721925:+	-0.21	-4.79	2.23E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs35504302	chr10:46010505	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs35504787	chr6:88270686	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs35507120	chr3:53053924	RFT1	chr3:53122503-53164470:-	0.43	4.51	8.2E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35507120	chr3:53053924	TMEM110	chr3:52867139-52931547:-	0.4	4.79	2.28E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35515217	chr3:127813811	RUVBL1	chr3:127783627-127872757:-	0.23	4.24	2.75E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs35522482	chr22:39063015	CBY1	chr22:39052658-39069853:+	0.17	4.7	3.42E-6	Resting heart rate	
PRAD	cis	1	rs35522482	chr22:39063015	LOC646851	chr22:38974125-39052634:-	0.18	4.3	2.1E-5	Resting heart rate	
PRAD	cis	1	rs35524990	chr15:85258203	LOC388152	chr15:84867600-84898920:-	-0.32	-5.42	9.53E-8	Schizophrenia	
PRAD	cis	1	rs35524990	chr15:85258203	NMB	chr15:85198362-85201802:-	-0.52	-12.28	2.93E-30	Schizophrenia	
PRAD	cis	1	rs35524990	chr15:85258203	WDR73	chr15:85186012-85197524:-	-0.27	-5.62	3.27E-8	Schizophrenia	
PRAD	cis	1	rs35526714	chr12:56634639	MIP	chr12:56843885-56848429:-	0.79	5.47	7.44E-8	Psoriasis vulgaris	
PRAD	cis	1	rs35527216	chr6:56791278	BEND6	chr6:56819773-56892138:+	-0.61	-10.98	4.0E-25	Menarche (age at onset)	
PRAD	cis	1	rs35527216	chr6:56791278	KIAA1586	chr6:56911384-56920021:+	-0.22	-3.5	0.000508	Menarche (age at onset)	
PRAD	cis	1	rs35531186	chr3:127841060	RUVBL1	chr3:127783627-127872757:-	0.24	4.35	1.64E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs35542501	chr7:65431215	CCT6P1	chr7:65216092-65228661:+	0.3	5.43	8.97E-8	Diabetic kidney disease	
PRAD	cis	1	rs35542501	chr7:65431215	CRCP	chr7:65579805-65619551:+	-0.27	-3.49	0.000529	Diabetic kidney disease	
PRAD	cis	1	rs35542501	chr7:65431215	ZNF117	chr7:64434830-64467121:-	-0.28	-3.44	0.00064	Diabetic kidney disease	
PRAD	cis	1	rs35542947	chr3:58323244	PXK	chr3:58318617-58410878:+	0.18	3.61	0.000337	Cholesterol, total	
PRAD	cis	1	rs35552264	chr20:33544973	MMP24	chr20:33814539-33864804:+	-0.31	-4.65	4.28E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs35560426	chr1:27069169	PIGV	chr1:27114455-27124886:+	-0.35	-4.05	6.03E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs35565791	chr22:39063011	CBY1	chr22:39052658-39069853:+	0.17	4.7	3.42E-6	Resting heart rate	
PRAD	cis	1	rs35565791	chr22:39063011	LOC646851	chr22:38974125-39052634:-	0.18	4.3	2.1E-5	Resting heart rate	
PRAD	cis	1	rs35566550	chr3:46210512	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs35576914	chr3:53092270	RFT1	chr3:53122503-53164470:-	0.45	4.73	2.94E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35576914	chr3:53092270	TMEM110	chr3:52867139-52931547:-	0.4	4.76	2.59E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35577967	chr15:75354621	PPCDC	chr15:75315927-75343066:+	0.14	3.72	0.000222	Blood trace element (Zn levels)	
PRAD	cis	1	rs35577967	chr15:75354621	SCAMP5	chr15:75287901-75313836:+	0.42	7.4	6.47E-13	Blood trace element (Zn levels)	
PRAD	cis	1	rs35593189	chr11:18468378	LDHC	chr11:18433853-18472792:+	-0.31	-3.82	0.000149	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs35610797	chr6:88274253	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs35617712	chr1:27051223	PIGV	chr1:27114455-27124886:+	-0.35	-4.02	6.65E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs35621601	chr3:58323174	PXK	chr3:58318617-58410878:+	0.18	3.61	0.000337	Cholesterol, total	
PRAD	cis	1	rs35623865	chr11:46631181	HARBI1	chr11:46624857-46638777:-	0.28	3.86	0.000132	Schizophrenia	
PRAD	cis	1	rs35624992	chr11:47615798	C1QTNF4	chr11:47611216-47615961:-	-0.15	-3.91	0.000105	Subjective well-being	
PRAD	cis	1	rs35630683	chr15:85349231	LOC388152	chr15:84867600-84898920:-	-0.31	-5.08	5.33E-7	Schizophrenia	
PRAD	cis	1	rs35630683	chr15:85349231	NMB	chr15:85198362-85201802:-	-0.54	-12.79	2.36E-32	Schizophrenia	
PRAD	cis	1	rs35630683	chr15:85349231	WDR73	chr15:85186012-85197524:-	-0.26	-5.42	9.59E-8	Schizophrenia	
PRAD	cis	1	rs35630951	chr10:17215649	TRDMT1	chr10:17184983-17243681:-	-0.26	-5.24	2.38E-7	Homocysteine levels	
PRAD	cis	1	rs35632234	chr10:45983379	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs35646598	chr6:33717416	IP6K3	chr6:33689443-33714762:-	0.21	4.26	2.51E-5	Obesity (extreme)	
PRAD	cis	1	rs35646895	chr13:31469604	C13orf33	chr13:31480312-31499708:+	0.25	3.84	0.000142	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs35648189	chr15:84740748	GOLGA6L5	chr15:85047738-85060078:-	-0.19	-4.72	3.12E-6	Schizophrenia	
PRAD	cis	1	rs35648189	chr15:84740748	LOC388152	chr15:84867600-84898920:-	-0.36	-6.26	8.45E-10	Schizophrenia	
PRAD	cis	1	rs35648189	chr15:84740748	NMB	chr15:85198362-85201802:-	-0.37	-8.33	9.05E-16	Schizophrenia	
PRAD	cis	1	rs35648189	chr15:84740748	WDR73	chr15:85186012-85197524:-	-0.22	-4.58	5.89E-6	Schizophrenia	
PRAD	cis	1	rs35648280	chr4:155347767	DCHS2	chr4:155155527-155412930:-	0.15	3.99	7.63E-5	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs35658069	chr15:84780146	GOLGA6L5	chr15:85047738-85060078:-	-0.18	-4.71	3.28E-6	Schizophrenia	
PRAD	cis	1	rs35658069	chr15:84780146	LOC388152	chr15:84867600-84898920:-	-0.36	-6.26	8.86E-10	Schizophrenia	
PRAD	cis	1	rs35658069	chr15:84780146	NMB	chr15:85198362-85201802:-	-0.37	-8.31	1.03E-15	Schizophrenia	
PRAD	cis	1	rs35658069	chr15:84780146	WDR73	chr15:85186012-85197524:-	-0.22	-4.59	5.7E-6	Schizophrenia	
PRAD	cis	1	rs35659126	chr7:72988069	MLXIPL	chr7:73007524-73038870:-	0.23	3.62	0.000328	Triglycerides	
PRAD	cis	1	rs35672725	chr8:89581838	MMP16	chr8:89049462-89339717:-	0.17	4.09	5.07E-5	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs35674337	chr3:38878881	XIRP1	chr3:39224707-39234077:-	0.23	3.53	0.00045	Social communication problems	
PRAD	cis	1	rs35682316	chr7:29181260	CPVL	chr7:29035249-29234892:-	-0.18	-4.9	1.33E-6	Diabetes related insulin traits	
PRAD	cis	1	rs35683065	chr12:123164062	GPR109B	chr12:123199304-123201439:-	0.35	6.11	2.14E-9	Adiponectin levels	
PRAD	cis	1	rs35685805	chr3:46202778	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs35688969	chr6:88353153	C6orf165	chr6:88117721-88205858:+	0.45	4.12	4.45E-5	Obesity-related traits	
PRAD	cis	1	rs35715471	chr8:89582284	MMP16	chr8:89049462-89339717:-	0.15	3.64	0.000299	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.69	6.89E-28	Height	
PRAD	cis	1	rs35720014	chr3:52982110	GNL3	chr3:52719936-52728508:+	-0.24	-3.43	0.00065	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35720014	chr3:52982110	RFT1	chr3:53122503-53164470:-	0.42	4.53	7.41E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35720014	chr3:52982110	TMEM110	chr3:52867139-52931547:-	0.43	5.29	1.9E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35721478	chr6:33725129	IP6K3	chr6:33689443-33714762:-	0.19	3.68	0.000265	Obesity (extreme)	
PRAD	cis	1	rs35724792	chr3:127809616	RUVBL1	chr3:127783627-127872757:-	0.25	4.5	8.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs35726233	chr15:85337800	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.47	0.000569	Schizophrenia	
PRAD	cis	1	rs35726233	chr15:85337800	LOC388152	chr15:84867600-84898920:-	-0.32	-5.24	2.39E-7	Schizophrenia	
PRAD	cis	1	rs35726233	chr15:85337800	NMB	chr15:85198362-85201802:-	-0.53	-12.47	4.92E-31	Schizophrenia	
PRAD	cis	1	rs35726233	chr15:85337800	WDR73	chr15:85186012-85197524:-	-0.27	-5.67	2.45E-8	Schizophrenia	
PRAD	cis	1	rs35735127	chr7:65300423	CCT6P1	chr7:65216092-65228661:+	0.29	5.15	3.92E-7	Diabetic kidney disease	
PRAD	cis	1	rs35736167	chr15:75332002	PPCDC	chr15:75315927-75343066:+	0.16	4.3	2.04E-5	Blood trace element (Zn levels)	
PRAD	cis	1	rs35736167	chr15:75332002	SCAMP5	chr15:75287901-75313836:+	0.42	7.55	2.26E-13	Blood trace element (Zn levels)	
PRAD	cis	1	rs35737577	chr3:53002557	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35737577	chr3:53002557	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35741213	chr3:10087661	C3orf10	chr3:10157333-10168873:+	-0.22	-4.15	4.02E-5	Alzheimer's disease	
PRAD	cis	1	rs35741213	chr3:10087661	LOC401052	chr3:10048102-10052779:-	-0.29	-5.18	3.38E-7	Alzheimer's disease	
PRAD	cis	1	rs35741374	chr2:61072567	PUS10	chr2:61167550-61245365:-	-0.17	-3.51	0.000495	Psoriasis	
PRAD	cis	1	rs35754688	chr3:46187706	CCR9	chr3:45928019-45944667:+	0.32	3.66	0.000285	Celiac disease	
PRAD	cis	1	rs35755354	chr7:37942857	EPDR1	chr7:37960163-37991539:+	-0.22	-3.59	0.000364	Bone mineral density	
PRAD	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.49	-11.51	3.41E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.52	-11.48	4.75E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs35768117	chr15:68204241	PIAS1	chr15:68346572-68480402:+	-0.14	-4.66	4.17E-6	Cognitive performance	
PRAD	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.5	-11.35	1.51E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs35808647	chr15:85377441	LOC388152	chr15:84867600-84898920:-	-0.32	-5.31	1.73E-7	Schizophrenia	
PRAD	cis	1	rs35808647	chr15:85377441	NMB	chr15:85198362-85201802:-	-0.53	-12.36	1.4E-30	Schizophrenia	
PRAD	cis	1	rs35808647	chr15:85377441	WDR73	chr15:85186012-85197524:-	-0.26	-5.4	1.08E-7	Schizophrenia	
PRAD	cis	1	rs35808787	chr4:106681179	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs35809595	chr10:63831928	ARID5B	chr10:63661443-63856703:+	-0.16	-3.61	0.000337	Corneal structure	
PRAD	cis	1	rs35811812	chr11:498442	ANO9	chr11:417930-442011:-	0.32	5.27	2.09E-7	Body mass index	
PRAD	cis	1	rs35811812	chr11:498442	LRRC56	chr11:537522-554915:+	0.26	3.97	8.29E-5	Body mass index	
PRAD	cis	1	rs35811812	chr11:498442	RNH1	chr11:494512-507273:-	-0.2	-3.68	0.000264	Body mass index	
PRAD	cis	1	rs35820085	chr7:65442758	CCT6P1	chr7:65216092-65228661:+	0.33	5.66	2.62E-8	Diabetic kidney disease	
PRAD	cis	1	rs35820085	chr7:65442758	CRCP	chr7:65579805-65619551:+	-0.32	-3.98	8.11E-5	Diabetic kidney disease	
PRAD	cis	1	rs35824277	chr10:46030477	MARCH8	chr10:45952817-46090354:-	0.25	5.53	5.23E-8	Red blood cell traits	
PRAD	cis	1	rs35825738	chr7:65318027	CCT6P1	chr7:65216092-65228661:+	0.28	5.03	7.11E-7	Diabetic kidney disease	
PRAD	cis	1	rs35835884	chr10:127708468	UROS	chr10:127477148-127511837:-	-0.17	-4.02	6.78E-5	Visceral fat	
PRAD	cis	1	rs35838363	chr17:17466572	RAI1	chr17:17584787-17714763:+	0.24	3.62	0.000323	Obsessive-compulsive symptoms	
PRAD	cis	1	rs35849389	chr3:53005235	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35849389	chr3:53005235	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs35853141	chr3:46198388	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs35856111	chr6:111773468	KIAA1919	chr6:111580482-111590259:+	0.38	4.02	6.88E-5	Psoriasis	
PRAD	cis	1	rs35858501	chr13:31472120	C13orf33	chr13:31480312-31499708:+	0.27	4.32	1.88E-5	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs35868630	chr8:143685933	ARC	chr8:143692410-143695833:-	-0.18	-3.51	0.000495	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs35874808	chr11:506442	ANO9	chr11:417930-442011:-	0.25	3.96	8.67E-5	Body mass index	
PRAD	cis	1	rs35874808	chr11:506442	LRRC56	chr11:537522-554915:+	0.27	4.05	5.97E-5	Body mass index	
PRAD	cis	1	rs35874808	chr11:506442	RNH1	chr11:494512-507273:-	-0.2	-3.68	0.000258	Body mass index	
PRAD	cis	1	rs35882692	chr20:43763968	SLPI	chr20:43880879-43883206:-	0.24	3.87	0.000125	Parental longevity (mother's age at death)	
PRAD	cis	1	rs35887108	chr3:143780632	C3orf58	chr3:143690640-143711209:+	-0.18	-3.67	0.000266	Economic and political preferences (feminism/equality)	
PRAD	cis	1	rs35898083	chr11:484469	ANO9	chr11:417930-442011:-	0.25	4.03	6.59E-5	Body mass index	
PRAD	cis	1	rs35898083	chr11:484469	LRRC56	chr11:537522-554915:+	0.3	4.51	8.37E-6	Body mass index	
PRAD	cis	1	rs35898083	chr11:484469	RNH1	chr11:494512-507273:-	-0.21	-3.92	0.000104	Body mass index	
PRAD	cis	1	rs35902429	chr10:46024335	MARCH8	chr10:45952817-46090354:-	0.25	5.53	5.23E-8	Red blood cell traits	
PRAD	cis	1	rs35917448	chr1:27017325	PIGV	chr1:27114455-27124886:+	-0.34	-3.81	0.000158	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs35918870	chr10:45998278	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs35919278	chr3:46213594	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs35946241	chr6:88356433	C6orf165	chr6:88117721-88205858:+	0.46	4.2	3.15E-5	Obesity-related traits	
PRAD	cis	1	rs35947214	chr3:127833231	RUVBL1	chr3:127783627-127872757:-	0.25	4.6	5.48E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs35953049	chr6:89916692	GABRR1	chr6:89887223-89927496:-	0.37	4.98	8.98E-7	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs35955426	chr13:31471381	C13orf33	chr13:31480312-31499708:+	0.26	4.1	4.94E-5	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs35955841	chr14:65319361	CHURC1	chr14:65381140-65411309:+	-0.3	-6.66	7.54E-11	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs35955841	chr14:65319361	FNTB	chr14:65381140-65529369:+	0.2	3.43	0.000658	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs35960805	chr15:85343980	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.46	0.0006	Schizophrenia	
PRAD	cis	1	rs35960805	chr15:85343980	LOC388152	chr15:84867600-84898920:-	-0.31	-5.22	2.74E-7	Schizophrenia	
PRAD	cis	1	rs35960805	chr15:85343980	NMB	chr15:85198362-85201802:-	-0.53	-12.5	3.77E-31	Schizophrenia	
PRAD	cis	1	rs35960805	chr15:85343980	WDR73	chr15:85186012-85197524:-	-0.27	-5.58	4.17E-8	Schizophrenia	
PRAD	cis	1	rs35960997	chr22:30692301	GATSL3	chr22:30681108-30695540:-	-0.27	-4.34	1.77E-5	Coronary artery calcification	
PRAD	cis	1	rs35960997	chr22:30692301	SEC14L2	chr22:30792933-30824976:+	-0.38	-4.59	5.6E-6	Coronary artery calcification	
PRAD	cis	1	rs35962879	chr1:27283456	PIGV	chr1:27114455-27124886:+	-0.31	-3.84	0.000138	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs35969145	chr1:27259392	PIGV	chr1:27114455-27124886:+	-0.34	-3.96	8.76E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs3596	chr12:95696420	NR2C1	chr12:95414060-95467404:-	0.15	3.46	0.000595	Endometriosis	
PRAD	cis	1	rs3596	chr12:95696420	VEZT	chr12:95611522-95696566:+	0.14	3.74	0.000204	Endometriosis	
PRAD	cis	1	rs35977534	chr5:176335231	FGFR4	chr5:176513921-176525124:+	0.18	3.67	0.00027	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs35988617	chr3:121432902	IQCB1	chr3:121488610-121553926:-	0.48	9.28	6.31E-19	Cognitive performance	
PRAD	cis	1	rs35989952	chr1:27005154	PIGV	chr1:27114455-27124886:+	-0.31	-3.58	0.000379	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs35993975	chr3:10067794	C3orf10	chr3:10157333-10168873:+	-0.2	-3.71	0.000228	Alzheimer's disease	
PRAD	cis	1	rs35993975	chr3:10067794	CIDECP	chr3:10055926-10067820:-	0.17	3.65	0.000288	Alzheimer's disease	
PRAD	cis	1	rs35993975	chr3:10067794	LOC401052	chr3:10048102-10052779:-	-0.32	-5.48	6.88E-8	Alzheimer's disease	
PRAD	cis	1	rs35996687	chr11:458595	LRRC56	chr11:537522-554915:+	0.31	4.51	8.31E-6	Body mass index	
PRAD	cis	1	rs35996687	chr11:458595	RNH1	chr11:494512-507273:-	-0.21	-3.71	0.000228	Body mass index	
PRAD	cis	1	rs36000835	chr10:4979788	AKR1C2	chr10:4964715-5060207:-	0.76	10.25	2.18E-22	Height	
PRAD	cis	1	rs36004835	chr15:67951542	IQCH	chr15:67547188-67794139:+	0.31	6.27	8.08E-10	Motion sickness	
PRAD	cis	1	rs36006749	chr3:38443312	XYLB	chr3:38388251-38456467:+	0.22	4.97	9.4E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs36010446	chr3:46226725	CCR9	chr3:45928019-45944667:+	0.34	3.64	0.0003	Celiac disease	
PRAD	cis	1	rs36020402	chr6:88355606	C6orf165	chr6:88117721-88205858:+	0.46	4.2	3.15E-5	Obesity-related traits	
PRAD	cis	1	rs36033484	chr7:65390558	CCT6P1	chr7:65216092-65228661:+	0.35	6.14	1.71E-9	Diabetic kidney disease	
PRAD	cis	1	rs36033484	chr7:65390558	CRCP	chr7:65579805-65619551:+	-0.27	-3.49	0.000526	Diabetic kidney disease	
PRAD	cis	1	rs36033486	chr15:85319692	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.44	0.000625	Schizophrenia	
PRAD	cis	1	rs36033486	chr15:85319692	LOC388152	chr15:84867600-84898920:-	-0.32	-5.26	2.15E-7	Schizophrenia	
PRAD	cis	1	rs36033486	chr15:85319692	NMB	chr15:85198362-85201802:-	-0.53	-12.5	3.63E-31	Schizophrenia	
PRAD	cis	1	rs36033486	chr15:85319692	WDR73	chr15:85186012-85197524:-	-0.27	-5.72	1.88E-8	Schizophrenia	
PRAD	cis	1	rs36035949	chr6:109736614	SMPD2	chr6:109761931-109765121:+	0.29	6.15	1.62E-9	Height	
PRAD	cis	1	rs36037390	chr3:58321954	PXK	chr3:58318617-58410878:+	0.19	3.62	0.000323	Cholesterol, total	
PRAD	cis	1	rs36053186	chr8:89583242	MMP16	chr8:89049462-89339717:-	0.15	3.63	0.000318	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs36053809	chr1:27083093	PIGV	chr1:27114455-27124886:+	-0.34	-3.85	0.000134	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs36054203	chr10:46037861	MARCH8	chr10:45952817-46090354:-	0.25	5.52	5.59E-8	Red blood cell traits	
PRAD	cis	1	rs360559	chr6:49659871	CRISP1	chr6:49801979-49834218:-	0.26	5.4	1.03E-7	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360559	chr6:49659871	CRISP2	chr6:49660072-49681299:-	0.39	7.4	6.16E-13	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360559	chr6:49659871	CRISP3	chr6:49695092-49712056:-	0.47	10.3	1.42E-22	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360559	chr6:49659871	RHAG	chr6:49572893-49604587:-	0.47	8.9	1.24E-17	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360560	chr6:49659634	CRISP1	chr6:49801979-49834218:-	0.26	5.4	1.03E-7	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360560	chr6:49659634	CRISP2	chr6:49660072-49681299:-	0.39	7.4	6.16E-13	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360560	chr6:49659634	CRISP3	chr6:49695092-49712056:-	0.47	10.3	1.42E-22	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360560	chr6:49659634	RHAG	chr6:49572893-49604587:-	0.47	8.9	1.24E-17	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360564	chr6:49658090	CRISP1	chr6:49801979-49834218:-	0.26	5.37	1.21E-7	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360564	chr6:49658090	CRISP2	chr6:49660072-49681299:-	0.39	7.34	9.19E-13	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360564	chr6:49658090	CRISP3	chr6:49695092-49712056:-	0.47	10.21	3.17E-22	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360564	chr6:49658090	RHAG	chr6:49572893-49604587:-	0.46	8.76	3.6E-17	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360565	chr6:49657805	CRISP1	chr6:49801979-49834218:-	0.26	5.37	1.21E-7	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360565	chr6:49657805	CRISP2	chr6:49660072-49681299:-	0.39	7.34	9.19E-13	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360565	chr6:49657805	CRISP3	chr6:49695092-49712056:-	0.47	10.21	3.17E-22	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs360565	chr6:49657805	RHAG	chr6:49572893-49604587:-	0.46	8.76	3.6E-17	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs36059338	chr3:127815927	RUVBL1	chr3:127783627-127872757:-	0.25	4.62	4.94E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs36068983	chr7:65408991	CCT6P1	chr7:65216092-65228661:+	0.31	5.59	3.91E-8	Diabetic kidney disease	
PRAD	cis	1	rs36068983	chr7:65408991	CRCP	chr7:65579805-65619551:+	-0.27	-3.53	0.00045	Diabetic kidney disease	
PRAD	cis	1	rs36070535	chr10:46022238	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs36070902	chr10:45983977	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs36090629	chr4:39138815	KLHL5	chr4:39046659-39123828:+	-0.13	-3.69	0.000247	Uric acid levels	
PRAD	cis	1	rs36090640	chr13:33691171	KL	chr13:33590201-33640281:+	0.24	3.78	0.000178	Intracranial aneurysm	
PRAD	cis	1	rs36090640	chr13:33691171	STARD13	chr13:33677273-34250932:-	0.29	4.87	1.49E-6	Intracranial aneurysm	
PRAD	cis	1	rs36090694	chr3:53010742	GNL3	chr3:52719936-52728508:+	-0.24	-3.45	0.000618	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs36090694	chr3:53010742	RFT1	chr3:53122503-53164470:-	0.42	4.49	9.14E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs36090694	chr3:53010742	TMEM110	chr3:52867139-52931547:-	0.42	5.26	2.14E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs36090981	chr6:88361055	C6orf165	chr6:88117721-88205858:+	0.46	4.2	3.15E-5	Obesity-related traits	
PRAD	cis	1	rs36096746	chr10:4975353	AKR1C2	chr10:4964715-5060207:-	0.64	8.97	7.08E-18	Height	
PRAD	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.48	-10.89	9.18E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs36122085	chr6:33765255	IP6K3	chr6:33689443-33714762:-	0.18	3.66	0.000286	Obesity (extreme)	
PRAD	cis	1	rs36123022	chr3:12552980	TSEN2	chr3:12525931-12581122:+	0.42	4.77	2.47E-6	Prostate cancer (gene x gene interaction)	
PRAD	cis	1	rs36216559	chr2:262335	SH3YL1	chr2:218138-264810:-	-0.79	-19.14	8.72E-61	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs364283	chr6:167383750	RNASET2	chr6:167343008-167412795:-	-0.24	-5.89	7.47E-9	Crohn's disease	
PRAD	cis	1	rs364451	chr6:167384756	RNASET2	chr6:167343008-167412795:-	-0.23	-5.63	3.15E-8	Crohn's disease	
PRAD	cis	1	rs365132	chr5:176378574	FGFR4	chr5:176513921-176525124:+	0.18	3.77	0.000183	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs365189	chr6:167384545	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs371025208	chr20:43928602	MATN4	chr20:43922087-43937169:-	-0.33	-4.79	2.24E-6	Parental longevity (mother's age at death)	
PRAD	cis	1	rs371674	chr21:42695445	FAM3B	chr21:42676177-42729654:+	-0.19	-4.08	5.31E-5	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
PRAD	cis	1	rs372644	chr15:68206578	PIAS1	chr15:68346572-68480402:+	-0.14	-4.62	5.04E-6	Cognitive performance	
PRAD	cis	1	rs3729639	chr16:67225501	FHOD1	chr16:67263294-67281425:-	0.55	6.88	1.93E-11	HDL cholesterol	
PRAD	cis	1	rs3729639	chr16:67225501	SLC9A5	chr16:67282855-67306093:+	0.29	4.06	5.69E-5	HDL cholesterol	
PRAD	cis	1	rs3730399	chr16:67229019	FHOD1	chr16:67263294-67281425:-	0.5	5.71	1.97E-8	HDL cholesterol	
PRAD	cis	1	rs3731696	chr2:203431804	NOP58	chr2:203130515-203168382:+	0.3	4.62	5.03E-6	Urate levels	
PRAD	cis	1	rs3731714	chr2:202060820	BZW1	chr2:201676612-201688559:+	-0.16	-3.5	0.000507	Trans fatty acid levels	
PRAD	cis	1	rs3731714	chr2:202060820	PPIL3	chr2:201735680-201753999:-	0.33	5.5	6.22E-8	Trans fatty acid levels	
PRAD	cis	1	rs3732276	chr2:242343404	SEPT2	chr2:242254723-242293439:+	0.58	8.64	9.07E-17	Chronic lymphocytic leukemia	
PRAD	cis	1	rs3732361	chr3:119542297	NR1I2	chr3:119499331-119537331:+	0.22	3.97	8.24E-5	HDL cholesterol	
PRAD	cis	1	rs3732408	chr3:121421179	IQCB1	chr3:121488610-121553926:-	0.48	9.33	4.12E-19	Cognitive performance	
PRAD	cis	1	rs3733274	chr4:39122577	KLHL5	chr4:39046659-39123828:+	-0.14	-4.02	6.68E-5	Uric acid levels	
PRAD	cis	1	rs3733276	chr4:39116911	KLHL5	chr4:39046659-39123828:+	-0.13	-3.78	0.000175	Uric acid levels	
PRAD	cis	1	rs3733277	chr4:39117103	KLHL5	chr4:39046659-39123828:+	-0.13	-3.78	0.000175	Uric acid levels	
PRAD	cis	1	rs3733278	chr4:39117235	KLHL5	chr4:39046659-39123828:+	-0.13	-3.78	0.000175	Uric acid levels	
PRAD	cis	1	rs3733279	chr4:39117245	KLHL5	chr4:39046659-39123828:+	-0.13	-3.78	0.000175	Uric acid levels	
PRAD	cis	1	rs3733484	chr4:142155518	ZNF330	chr4:142142049-142155848:+	-0.28	-5.02	7.51E-7	Conduct disorder	
PRAD	cis	1	rs3733579	chr4:17694943	MED28	chr4:17616273-17629791:+	0.17	4.43	1.19E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs3734266	chr6:34823187	UHRF1BP1	chr6:34759794-34853117:+	0.24	6.32	5.91E-10	Systemic lupus erythematosus	
PRAD	cis	1	rs3734530	chr6:26195408	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.72	0.000223	Renal underexcretion gout;Gout	
PRAD	cis	1	rs3734530	chr6:26195408	HIST1H3E	chr6:26224427-26226589:+	0.36	5.75	1.57E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs3735148	chr7:65971009	TPST1	chr7:65670259-65825437:+	0.18	4.53	7.48E-6	Aortic root size	
PRAD	cis	1	rs3736781	chr6:26505362	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.21E-10	Educational attainment	
PRAD	cis	1	rs3736781	chr6:26505362	ZNF184	chr6:27418522-27440897:-	-0.18	-3.72	0.000225	Educational attainment	
PRAD	cis	1	rs3736782	chr6:26505403	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.21E-10	Educational attainment	
PRAD	cis	1	rs3736782	chr6:26505403	ZNF184	chr6:27418522-27440897:-	-0.18	-3.72	0.000225	Educational attainment	
PRAD	cis	1	rs3738000	chr3:130947435	NEK11	chr3:130745694-131069308:+	-0.26	-4.52	7.98E-6	Carotid intima media thickness	
PRAD	cis	1	rs3738471	chr1:41006545	DEM1	chr1:40974433-40982212:+	0.45	5.49	6.58E-8	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs3738483	chr1:150801466	CTSK	chr1:150768687-150780812:-	0.2	4.71	3.21E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs3738848	chr2:73761881	ALMS1P	chr2:73872046-73912692:+	0.5	8.6	1.21E-16	Metabolite levels	
PRAD	cis	1	rs3738848	chr2:73761881	NAT8	chr2:73867850-73869537:-	0.28	4.36	1.62E-5	Metabolite levels	
PRAD	cis	1	rs3739821	chr9:130702477	DPM2	chr9:130697374-130700763:-	-0.14	-4.64	4.5E-6	Glaucoma (primary angle closure)	
PRAD	cis	1	rs3739821	chr9:130702477	PIP5KL1	chr9:130683809-130693076:-	-0.19	-4	7.26E-5	Glaucoma (primary angle closure)	
PRAD	cis	1	rs3739843	chr9:131882961	CRAT	chr9:131857075-131873070:-	0.22	4.12	4.55E-5	Blood metabolite ratios	
PRAD	cis	1	rs3739847	chr9:131911574	CRAT	chr9:131857075-131873070:-	-0.24	-4.39	1.39E-5	Blood metabolite ratios	
PRAD	cis	1	rs3740353	chr10:63832898	ARID5B	chr10:63661443-63856703:+	-0.16	-3.62	0.000323	Corneal structure	
PRAD	cis	1	rs3740354	chr10:63832863	ARID5B	chr10:63661443-63856703:+	-0.17	-3.69	0.000254	Corneal structure	
PRAD	cis	1	rs3740711	chr11:18379839	GTF2H1	chr11:18343816-18388590:+	0.66	13.94	3.36E-37	Pancreatic cancer	
PRAD	cis	1	rs3740974	chr11:46397323	HARBI1	chr11:46624857-46638777:-	0.3	3.96	8.73E-5	Schizophrenia	
PRAD	cis	1	rs3741578	chr12:57394635	TAC3	chr12:57403786-57410325:-	0.36	3.98	8.01E-5	Asthma	
PRAD	cis	1	rs3742320	chr13:33164418	N4BP2L2	chr13:33006930-33112936:-	0.15	3.5	0.000506	Body mass index	
PRAD	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.6	-20.54	2.26E-67	IgG glycosylation	
PRAD	cis	1	rs3742500	chr14:24611978	RNF31	chr14:24616096-24635772:+	0.21	4.33	1.86E-5	IgG glycosylation	
PRAD	cis	1	rs3742669	chr14:90767746	C14orf102	chr14:90744398-90798279:-	-0.24	-4.41	1.3E-5	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs3742773	chr14:75579643	EIF2B2	chr14:75469612-75476292:+	0.24	4.86	1.63E-6	Height	
PRAD	cis	1	rs3742773	chr14:75579643	MLH3	chr14:75480467-75518235:-	0.33	6.61	1.02E-10	Height	
PRAD	cis	1	rs3742778	chr14:75538217	EIF2B2	chr14:75469612-75476292:+	-0.26	-5.32	1.65E-7	Height	
PRAD	cis	1	rs3742778	chr14:75538217	MLH3	chr14:75480467-75518235:-	-0.34	-6.83	2.66E-11	Height	
PRAD	cis	1	rs3742780	chr14:75505008	EIF2B2	chr14:75469612-75476292:+	0.25	5.08	5.45E-7	Height	
PRAD	cis	1	rs3742780	chr14:75505008	MLH3	chr14:75480467-75518235:-	0.32	6.5	2.05E-10	Height	
PRAD	cis	1	rs3743161	chr15:85430838	NMB	chr15:85198362-85201802:-	-0.35	-7.09	4.99E-12	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs3743161	chr15:85430838	WDR73	chr15:85186012-85197524:-	-0.21	-4.06	5.81E-5	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs3743162	chr15:85430969	NMB	chr15:85198362-85201802:-	-0.34	-6.93	1.4E-11	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs3743162	chr15:85430969	WDR73	chr15:85186012-85197524:-	-0.22	-4.33	1.81E-5	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs3743266	chr15:60781513	ANXA2	chr15:60639351-60690185:-	0.14	4.73	3.04E-6	Menarche (age at onset)	
PRAD	cis	1	rs3745859	chr19:39196745	LGALS7	chr19:39261608-39264157:-	-0.16	-3.67	0.000266	Heart rate	
PRAD	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.62	13.54	1.74E-35	Schizophrenia	
PRAD	cis	1	rs3746016	chr19:32877259	DPY19L3	chr19:32896677-32975236:+	0.11	3.47	0.000578	Bipolar disorder	
PRAD	cis	1	rs3746666	chr20:3910861	MAVS	chr20:3827449-3856761:+	-0.26	-3.5	0.000515	Response to antidepressants in depression	
PRAD	cis	1	rs3746722	chr20:1610939	SIRPB1	chr20:1545030-1600689:-	0.16	4.07	5.51E-5	Type 1 diabetes	
PRAD	cis	1	rs3747113	chr22:24717518	POM121L9P	chr22:24647589-24661490:+	0.24	5.07	5.83E-7	Gut microbiome composition (summer)	
PRAD	cis	1	rs3747170	chr22:39067331	CBY1	chr22:39052658-39069853:+	0.17	4.7	3.42E-6	Resting heart rate	
PRAD	cis	1	rs3747170	chr22:39067331	LOC646851	chr22:38974125-39052634:-	0.18	4.3	2.1E-5	Resting heart rate	
PRAD	cis	1	rs3747172	chr22:39067524	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs3747172	chr22:39067524	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs3747174	chr22:39069181	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs3747174	chr22:39069181	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs3747865	chr10:73527676	DNAJB12	chr10:74092588-74114907:-	0.3	3.52	0.000481	Pulmonary function decline;Age at smoking initiation in chronic obstructive pulmonary disease	
PRAD	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.66	10.11	7.14E-22	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs3748682	chr1:38279987	FHL3	chr1:38462444-38471234:-	0.14	4.02	6.67E-5	Hypothyroidism	
PRAD	cis	1	rs3749237	chr3:49770032	AMIGO3	chr3:49754268-49757238:-	-0.21	-4.27	2.41E-5	Resting heart rate	
PRAD	cis	1	rs3749237	chr3:49770032	CACNA2D2	chr3:50400233-50540892:-	-0.22	-4.51	8.36E-6	Resting heart rate	
PRAD	cis	1	rs3749237	chr3:49770032	GMPPB	chr3:49758932-49761384:-	-0.22	-5.07	5.73E-7	Resting heart rate	
PRAD	cis	1	rs3749237	chr3:49770032	RBM6	chr3:49977592-50137484:+	-0.15	-5.19	3.13E-7	Resting heart rate	
PRAD	cis	1	rs3749237	chr3:49770032	WDR6	chr3:49044637-49053386:+	-0.21	-4.25	2.6E-5	Resting heart rate	
PRAD	cis	1	rs3749449	chr3:7188072	GRM7	chr3:6902802-7783218:+	-0.2	-3.44	0.000643	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	
PRAD	cis	1	rs3750626	chr10:102266316	SEC31B	chr10:102246403-102289636:-	-0.31	-9.27	6.5E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs3750627	chr10:102275642	SEC31B	chr10:102246403-102289636:-	-0.28	-8.49	2.71E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs3750629	chr10:102275727	SEC31B	chr10:102246403-102289636:-	-0.31	-9.43	1.84E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs3750630	chr10:102275780	SEC31B	chr10:102246403-102289636:-	-0.3	-9.22	9.68E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs3750633	chr10:102308214	SEC31B	chr10:102246403-102289636:-	-0.3	-8.63	9.56E-17	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs3750719	chr10:102248950	SEC31B	chr10:102246403-102289636:-	-0.33	-9.74	1.59E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs3750720	chr10:102248884	SEC31B	chr10:102246403-102289636:-	-0.32	-9.52	8.8E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs3751178	chr12:125664357	AACS	chr12:125549925-125627872:+	-0.17	-3.99	7.81E-5	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs3751614	chr15:52901638	ARPP19	chr15:52839432-52861364:-	0.15	3.98	7.95E-5	Schizophrenia	
PRAD	cis	1	rs3751972	chr17:26206414	C17orf108	chr17:26205341-26220409:-	0.24	5.74	1.65E-8	Fractional exhaled nitric oxide (childhood)	
PRAD	cis	1	rs3751972	chr17:26206414	NOS2	chr17:26083793-26220409:-	-0.38	-6	3.84E-9	Fractional exhaled nitric oxide (childhood)	
PRAD	cis	1	rs3752603	chr22:27064494	CRYBA4	chr22:27017928-27026635:+	-0.27	-5.15	3.81E-7	Electroencephalogram traits	
PRAD	cis	1	rs3752749	chr4:1737262	FAM53A	chr4:1641609-1685854:-	-0.44	-7.95	1.37E-14	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs3752950	chr10:17203356	TRDMT1	chr10:17184983-17243681:-	-0.26	-5.15	3.77E-7	Homocysteine levels	
PRAD	cis	1	rs3753908	chr1:202511295	PPP1R12B	chr1:202317836-202557697:+	0.09	3.8	0.000164	Sex ratio	
PRAD	cis	1	rs3754210	chr1:150954261	CTSK	chr1:150768687-150780812:-	-0.17	-4.37	1.51E-5	Congenital left-sided heart lesions	
PRAD	cis	1	rs3754439	chr1:110615094	ALX3	chr1:110602998-110613322:-	-0.24	-4.61	5.21E-6	Blood metabolite levels	
PRAD	cis	1	rs3754440	chr1:110613674	ALX3	chr1:110602998-110613322:-	-0.26	-4.91	1.25E-6	Blood metabolite levels	
PRAD	cis	1	rs3755934	chr4:1236083	KIAA1530	chr4:1341104-1381836:+	-0.28	-3.77	0.000186	Type 2 diabetes	
PRAD	cis	1	rs3756106	chr4:142151262	ZNF330	chr4:142142049-142155848:+	-0.27	-4.99	8.72E-7	Conduct disorder	
PRAD	cis	1	rs3756416	chr5:43383502	HMGCS1	chr5:43289494-43313595:-	0.24	4.64	4.44E-6	Metabolite levels  (X-11787)	
PRAD	cis	1	rs3757135	chr6:26200707	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.8	0.000163	Renal underexcretion gout;Gout	
PRAD	cis	1	rs3757135	chr6:26200707	HIST1H3E	chr6:26224427-26226589:+	0.34	5.47	7.15E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs3757241	chr6:46623698	TDRD6	chr6:46655866-46670149:+	0.28	4.89	1.37E-6	Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs3758253	chr9:100700654	C9orf156	chr9:100666772-100684852:-	-0.19	-3.68	0.000256	Quantitative traits	
PRAD	cis	1	rs3758254	chr9:100701001	C9orf156	chr9:100666772-100684852:-	-0.19	-3.68	0.000256	Quantitative traits	
PRAD	cis	1	rs3758557	chr10:103572925	KCNIP2	chr10:103585732-103603677:-	0.33	4.44	1.1E-5	Coronary artery calcification	
PRAD	cis	1	rs3758927	chr11:133829644	IGSF9B	chr11:133785186-133826880:-	-0.18	-3.6	0.000358	Schizophrenia	
PRAD	cis	1	rs3758977	chr11:61737244	BEST1	chr11:61717356-61731939:+	0.15	3.5	0.000505	Phospholipid levels (plasma)	
PRAD	cis	1	rs3760707	chr19:50084454	FLT3LG	chr19:49977486-49990893:+	0.1	3.92	0.000103	Fibrinogen levels	
PRAD	cis	1	rs3760707	chr19:50084454	IRF3	chr19:50162829-50169132:-	0.09	3.53	0.00046	Fibrinogen levels	
PRAD	cis	1	rs3760891	chr19:33599708	GPATCH1	chr19:33571786-33621318:+	0.53	9.61	4.52E-20	Bone properties (heel)	
PRAD	cis	1	rs3760982	chr19:44286513	LYPD5	chr19:44300080-44324808:-	-0.23	-5.01	7.63E-7	Breast cancer	
PRAD	cis	1	rs3760982	chr19:44286513	ZNF155	chr19:44488355-44502477:+	-0.24	-4.67	3.93E-6	Breast cancer	
PRAD	cis	1	rs3760982	chr19:44286513	ZNF404	chr19:44376516-44384288:-	-0.2	-4.33	1.83E-5	Breast cancer	
PRAD	cis	1	rs3760983	chr19:44286660	LYPD5	chr19:44300080-44324808:-	0.23	4.89	1.41E-6	Breast cancer	
PRAD	cis	1	rs3760983	chr19:44286660	ZNF155	chr19:44488355-44502477:+	0.25	4.78	2.33E-6	Breast cancer	
PRAD	cis	1	rs3760983	chr19:44286660	ZNF404	chr19:44376516-44384288:-	0.21	4.37	1.54E-5	Breast cancer	
PRAD	cis	1	rs3761117	chr20:25388070	ENTPD6	chr20:25176339-25207360:+	0.16	4.21	3.03E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs3761117	chr20:25388070	FAM182B	chr20:25744102-25848786:-	-0.38	-7	8.61E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs3761117	chr20:25388070	PYGB	chr20:25228706-25278647:+	0.32	6.91	1.54E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs3761218	chr20:3776175	CDC25B	chr20:3767578-3786759:+	-0.32	-9.31	4.97E-19	Bipolar disorder	
PRAD	cis	1	rs3761219	chr20:3776368	CDC25B	chr20:3767578-3786759:+	0.35	9.64	3.36E-20	Bipolar disorder	
PRAD	cis	1	rs3761430	chr22:31538002	PISD	chr22:32014477-32058201:-	0.38	4.44	1.14E-5	Age-related hearing impairment	
PRAD	cis	1	rs3761430	chr22:31538002	RNF185	chr22:31556138-31603004:+	0.32	4.39	1.41E-5	Age-related hearing impairment	
PRAD	cis	1	rs3761454	chr22:39066820	CBY1	chr22:39052658-39069853:+	0.17	4.7	3.42E-6	Resting heart rate	
PRAD	cis	1	rs3761454	chr22:39066820	LOC646851	chr22:38974125-39052634:-	0.18	4.3	2.1E-5	Resting heart rate	
PRAD	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.19	5.3	1.74E-7	Type 1 diabetes autoantibodies	
PRAD	cis	1	rs3763695	chr10:102269206	SEC31B	chr10:102246403-102289636:-	-0.3	-9.23	9.3E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs3764419	chr17:29164023	SUZ12P	chr17:29035714-29097067:+	-0.17	-5.17	3.42E-7	Height	
PRAD	cis	1	rs3764563	chr19:15724203	CYP4F8	chr19:15726029-15740445:+	0.41	4.78	2.39E-6	Inflammatory biomarkers	
PRAD	cis	1	rs3764617	chr19:49497123	BAX	chr19:49458117-49465054:+	0.26	3.81	0.000157	Follicule stimulating hormone	
PRAD	cis	1	rs3764619	chr19:49497277	BAX	chr19:49458117-49465054:+	0.25	3.8	0.000167	Follicule stimulating hormone	
PRAD	cis	1	rs3764621	chr19:49506330	BAX	chr19:49458117-49465054:+	0.25	3.53	0.000457	Follicule stimulating hormone	
PRAD	cis	1	rs3764622	chr19:49506390	BAX	chr19:49458117-49465054:+	0.24	3.51	0.000492	Follicule stimulating hormone	
PRAD	cis	1	rs3765044	chr12:85438499	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs3765044	chr12:85438499	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs3765044	chr12:85438499	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs3765158	chr4:54327584	FIP1L1	chr4:54243820-54326102:+	-0.2	-4.32	1.89E-5	DNA methylation (variation)	
PRAD	cis	1	rs376551	chr6:167384923	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs376574	chr6:167389956	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs3767395	chr1:202536140	PPP1R12B	chr1:202317836-202557697:+	0.09	3.83	0.000145	Sex ratio	
PRAD	cis	1	rs3767397	chr1:202534389	PPP1R12B	chr1:202317836-202557697:+	0.09	3.8	0.000164	Sex ratio	
PRAD	cis	1	rs3767404	chr1:202519900	PPP1R12B	chr1:202317836-202557697:+	-0.09	-3.75	0.0002	Sex ratio	
PRAD	cis	1	rs3767405	chr1:202516875	PPP1R12B	chr1:202317836-202557697:+	0.09	3.83	0.000147	Sex ratio	
PRAD	cis	1	rs3767406	chr1:202512246	PPP1R12B	chr1:202317836-202557697:+	-0.09	-3.7	0.000239	Sex ratio	
PRAD	cis	1	rs3767408	chr1:202498111	PPP1R12B	chr1:202317836-202557697:+	0.09	3.73	0.000212	Sex ratio	
PRAD	cis	1	rs3767411	chr1:202471315	PPP1R12B	chr1:202317836-202557697:+	0.09	3.81	0.000156	Sex ratio	
PRAD	cis	1	rs3767412	chr1:202462023	PPP1R12B	chr1:202317836-202557697:+	0.09	3.51	0.0005	Sex ratio	
PRAD	cis	1	rs3767425	chr1:202413840	PPP1R12B	chr1:202317836-202557697:+	0.09	3.79	0.000171	Sex ratio	
PRAD	cis	1	rs3767627	chr1:149938898	MTMR11	chr1:149900544-149908791:-	0.17	4.1	4.93E-5	Height	
PRAD	cis	1	rs3768707	chr2:215645135	BARD1	chr2:215593275-215674428:-	-0.28	-8.88	1.45E-17	Neuroblastoma	
PRAD	cis	1	rs3769143	chr2:27450724	C2orf28	chr2:27434899-27440044:+	-0.26	-7.01	8.42E-12	Blood metabolite levels	
PRAD	cis	1	rs3769143	chr2:27450724	KHK	chr2:27309611-27323619:+	-0.22	-4.56	6.54E-6	Blood metabolite levels	
PRAD	cis	1	rs3770047	chr2:178685534	PDE11A	chr2:178487979-178973066:-	-0.34	-4.36	1.61E-5	Height	
PRAD	cis	1	rs3770066	chr2:86392350	LOC90784	chr2:86247339-86250991:-	-0.53	-4.94	1.07E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs3770752	chr2:37576136	CEBPZ	chr2:37428778-37458740:-	0.24	5.05	6.23E-7	Schizophrenia	
PRAD	cis	1	rs3771175	chr2:102960210	IL1R1	chr2:102686836-102796333:+	0.34	5.3	1.82E-7	Asthma	
PRAD	cis	1	rs3771180	chr2:102953617	IL1R1	chr2:102686836-102796333:+	-0.33	-5.16	3.66E-7	Asthma	
PRAD	cis	1	rs3771317	chr2:191543962	OSGEPL1	chr2:190611386-190627953:-	0.21	3.85	0.000135	Primary biliary cirrhosis	
PRAD	cis	1	rs3771355	chr2:242054143	MTERFD2	chr2:242034545-242041747:-	0.34	3.78	0.000176	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs3771355	chr2:242054143	PASK	chr2:242045515-242088878:-	0.35	4.51	8.17E-6	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs3772128	chr3:121345094	IQCB1	chr3:121488610-121553926:-	0.5	9.85	6.26E-21	Cognitive performance	
PRAD	cis	1	rs3772130	chr3:121344140	IQCB1	chr3:121488610-121553926:-	0.51	9.96	2.4E-21	Cognitive performance	
PRAD	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.81	12.11	1.41E-29	Diastolic blood pressure	
PRAD	cis	1	rs3774808	chr3:48481647	ATRIP	chr3:48488141-48507708:+	0.27	6.48	2.38E-10	Longevity	
PRAD	cis	1	rs3774808	chr3:48481647	CDC25A	chr3:48198668-48229801:-	0.22	4	7.39E-5	Longevity	
PRAD	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.19	-5.12	4.36E-7	Longevity	
PRAD	cis	1	rs3774957	chr4:103509025	BDH2	chr4:103998783-104021024:-	0.15	3.78	0.00018	Ulcerative colitis	
PRAD	cis	1	rs3775594	chr4:142143252	ZNF330	chr4:142142049-142155848:+	-0.27	-4.95	1.03E-6	Conduct disorder	
PRAD	cis	1	rs3777113	chr5:137493897	REEP2	chr5:137774776-137782657:+	-0.1	-3.99	7.7E-5	Resting heart rate	
PRAD	cis	1	rs3778483	chr6:46627100	SLC25A27	chr6:46620679-46645925:+	-0.17	-7.03	7.43E-12	QRS complex (Sokolow-Lyon)	
PRAD	cis	1	rs3778909	chr7:66255646	CRCP	chr7:65579805-65619551:+	-0.21	-3.98	8.01E-5	Aortic root size	
PRAD	cis	1	rs3778909	chr7:66255646	LOC493754	chr7:65993446-66057363:-	-0.24	-5.4	1.04E-7	Aortic root size	
PRAD	cis	1	rs3778909	chr7:66255646	TPST1	chr7:65670259-65825437:+	0.15	3.65	0.000288	Aortic root size	
PRAD	cis	1	rs3781001	chr10:127706028	UROS	chr10:127477148-127511837:-	-0.17	-4.01	6.99E-5	Visceral fat	
PRAD	cis	1	rs3781421	chr10:126709703	CTBP2	chr10:126676419-126849624:-	0.24	3.67	0.000268	Height	
PRAD	cis	1	rs3781781	chr11:126280545	ST3GAL4	chr11:126225579-126310752:+	-0.23	-3.78	0.000174	Coronary heart disease	
PRAD	cis	1	rs3782089	chr11:65336819	PACS1	chr11:65837824-66012213:+	-0.39	-3.96	8.63E-5	Height	
PRAD	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.37	7.81	3.79E-14	Multiple sclerosis	
PRAD	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.54	-13.16	6.48E-34	Multiple sclerosis	
PRAD	cis	1	rs3782130	chr12:58161898	XRCC6BP1	chr12:58335445-58351051:+	-0.25	-5	7.91E-7	Multiple sclerosis	
PRAD	cis	1	rs3782894	chr12:110026024	KCTD10	chr12:109886460-109915155:-	-0.33	-10.09	8.1E-22	HDL cholesterol	
PRAD	cis	1	rs3782894	chr12:110026024	MMAB	chr12:109991523-110011358:-	-0.18	-5.6	3.58E-8	HDL cholesterol	
PRAD	cis	1	rs3782894	chr12:110026024	MYO1H	chr12:109826524-109886176:+	-0.25	-5.52	5.54E-8	HDL cholesterol	
PRAD	cis	1	rs3782894	chr12:110026024	UBE3B	chr12:109915439-109974506:+	-0.14	-3.58	0.000374	HDL cholesterol	
PRAD	cis	1	rs3783404	chr14:104118498	BAG5	chr14:104022889-104029151:-	0.18	3.66	0.000282	Body mass index	
PRAD	cis	1	rs3783404	chr14:104118498	C14orf153	chr14:104029299-104057227:+	0.14	4.19	3.34E-5	Body mass index	
PRAD	cis	1	rs3783404	chr14:104118498	CKB	chr14:103985996-103989170:-	0.22	5.17	3.4E-7	Body mass index	
PRAD	cis	1	rs3783404	chr14:104118498	KLC1	chr14:104029299-104167887:+	-0.18	-3.7	0.000238	Body mass index	
PRAD	cis	1	rs3783404	chr14:104118498	MARK3	chr14:103851701-103970164:+	0.23	4.9	1.35E-6	Body mass index	
PRAD	cis	1	rs3784537	chr15:79218994	CTSH	chr15:79214092-79237420:-	0.44	6.06	2.79E-9	Bipolar disorder	
PRAD	cis	1	rs3784538	chr15:79219180	CTSH	chr15:79214092-79237420:-	0.44	6.06	2.79E-9	Bipolar disorder	
PRAD	cis	1	rs3784540	chr15:79219332	CTSH	chr15:79214092-79237420:-	0.4	5.62	3.31E-8	Bipolar disorder	
PRAD	cis	1	rs3785162	chr16:55603226	CAPNS2	chr16:55600584-55601592:+	0.19	5.35	1.37E-7	Thyroid hormone levels	
PRAD	cis	1	rs3785162	chr16:55603226	LPCAT2	chr16:55542913-55620581:+	-0.14	-4.99	8.57E-7	Thyroid hormone levels	
PRAD	cis	1	rs3785396	chr16:23903156	PRKCB	chr16:23847300-24231930:+	0.16	6.2	1.21E-9	Rheumatoid arthritis	
PRAD	cis	1	rs3785397	chr16:23903132	PRKCB	chr16:23847300-24231930:+	0.16	6.06	2.86E-9	Rheumatoid arthritis	
PRAD	cis	1	rs3785398	chr16:23900568	PRKCB	chr16:23847300-24231930:+	0.16	5.74	1.69E-8	Rheumatoid arthritis	
PRAD	cis	1	rs3785574	chr17:61763185	FTSJ3	chr17:61896795-61905031:-	0.26	5.11	4.69E-7	Height	
PRAD	cis	1	rs3785574	chr17:61763185	PSMC5	chr17:61904810-61909386:+	0.11	3.51	0.000499	Height	
PRAD	cis	1	rs3785574	chr17:61763185	TCAM1P	chr17:61934376-61941738:+	-0.22	-3.89	0.000117	Height	
PRAD	cis	1	rs3786839	chr19:39182565	LGALS7	chr19:39261608-39264157:-	-0.17	-3.85	0.000135	Heart rate	
PRAD	cis	1	rs3786845	chr19:39195083	LGALS7	chr19:39261608-39264157:-	-0.16	-3.55	0.000432	Heart rate	
PRAD	cis	1	rs3786848	chr19:39207329	LGALS7	chr19:39261608-39264157:-	-0.16	-3.74	0.000206	Heart rate	
PRAD	cis	1	rs3786851	chr19:39215333	LGALS7	chr19:39261608-39264157:-	-0.16	-3.74	0.000206	Heart rate	
PRAD	cis	1	rs3786933	chr19:33602881	GPATCH1	chr19:33571786-33621318:+	0.53	9.61	4.52E-20	Bone properties (heel)	
PRAD	cis	1	rs3787395	chr20:55078573	C20orf43	chr20:55043647-55093942:+	-0.16	-3.96	8.6E-5	Refractive astigmatism	
PRAD	cis	1	rs3788544	chr22:39064966	CBY1	chr22:39052658-39069853:+	0.16	4.53	7.52E-6	Resting heart rate	
PRAD	cis	1	rs3788544	chr22:39064966	LOC646851	chr22:38974125-39052634:-	0.16	3.8	0.000164	Resting heart rate	
PRAD	cis	1	rs3788545	chr22:39065172	CBY1	chr22:39052658-39069853:+	0.17	4.71	3.32E-6	Resting heart rate	
PRAD	cis	1	rs3788545	chr22:39065172	LOC646851	chr22:38974125-39052634:-	0.18	4.3	2.05E-5	Resting heart rate	
PRAD	cis	1	rs3789967	chr12:124447339	ZNF664	chr12:124457670-124499967:+	-0.15	-4.02	6.81E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs3790012	chr13:36773489	SOHLH2	chr13:36742347-36871992:-	0.21	3.72	0.000221	Glucose homeostasis traits	
PRAD	cis	1	rs3790515	chr1:151786372	TDRKH	chr1:151742583-151763010:-	-0.64	-9.99	2.01E-21	Depressive symptoms (SSRI exposure interaction)	
PRAD	cis	1	rs3790844	chr1:200007432	NR5A2	chr1:199996770-200146548:+	-0.21	-3.58	0.000375	Pancreatic cancer	
PRAD	cis	1	rs3791220	chr2:227066	SH3YL1	chr2:218138-264810:-	-0.78	-19.03	2.92E-60	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs3791221	chr2:226933	SH3YL1	chr2:218138-264810:-	-0.78	-19.03	2.92E-60	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs3791223	chr2:222336	SH3YL1	chr2:218138-264810:-	-0.8	-19.39	5.48E-62	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs3791224	chr2:221981	SH3YL1	chr2:218138-264810:-	-0.77	-18.78	4.28E-59	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs3792527	chr3:38493212	XYLB	chr3:38388251-38456467:+	0.23	5.13	4.24E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs3792528	chr3:38493303	XYLB	chr3:38388251-38456467:+	0.22	4.94	1.06E-6	Electrocardiographic conduction measures	
PRAD	cis	1	rs379281	chr15:68210700	PIAS1	chr15:68346572-68480402:+	-0.14	-4.45	1.09E-5	Cognitive performance	
PRAD	cis	1	rs3793079	chr6:33767788	LEMD2	chr6:33738991-33756906:-	-0.23	-7.05	6.38E-12	Crohn's disease	
PRAD	cis	1	rs3793080	chr6:33767803	IP6K3	chr6:33689443-33714762:-	-0.17	-3.52	0.000481	Obesity (extreme)	
PRAD	cis	1	rs3793706	chr10:102269085	SEC31B	chr10:102246403-102289636:-	0.3	9.13	1.97E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs3793771	chr10:102222957	SEC31B	chr10:102246403-102289636:-	-0.32	-9.62	3.98E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs3793772	chr10:102222825	SEC31B	chr10:102246403-102289636:-	-0.31	-9.29	5.58E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs3795128	chr20:39774163	ZHX3	chr20:39807089-39946242:-	-0.26	-5.79	1.28E-8	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.66	-10.01	1.59E-21	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs3796093	chr2:242039198	PASK	chr2:242045515-242088878:-	0.31	3.67	0.000269	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs3796352	chr3:52913279	RFT1	chr3:53122503-53164470:-	0.43	4.53	7.46E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs3796352	chr3:52913279	TMEM110	chr3:52867139-52931547:-	0.4	4.79	2.27E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs3796509	chr4:39110186	KLHL5	chr4:39046659-39123828:+	-0.13	-3.87	0.000124	Uric acid levels	
PRAD	cis	1	rs3796511	chr4:39122206	KLHL5	chr4:39046659-39123828:+	-0.14	-4.02	6.68E-5	Uric acid levels	
PRAD	cis	1	rs3796689	chr4:185649866	CCDC111	chr4:185570767-185616112:+	0.15	3.46	0.000581	Kawasaki disease	
PRAD	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.48	-13.46	3.61E-35	Kawasaki disease	
PRAD	cis	1	rs3797537	chr5:78322650	BHMT2	chr5:78365583-78385273:+	0.09	3.74	0.000209	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs3797538	chr5:78322671	BHMT2	chr5:78365583-78385273:+	0.09	3.74	0.000209	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs3798153	chr5:137782204	BRD8	chr5:137384973-137514358:-	-0.17	-3.77	0.000184	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	
PRAD	cis	1	rs3798718	chr6:11036447	ELOVL2	chr6:10980995-11044624:-	0.74	14.11	5.79E-38	Blood metabolite ratios	
PRAD	cis	1	rs3798718	chr6:11036447	MAK	chr6:10762957-10838760:-	0.35	5.96	4.99E-9	Blood metabolite ratios	
PRAD	cis	1	rs3798718	chr6:11036447	SYCP2L	chr6:10747995-10974539:+	0.25	3.64	0.0003	Blood metabolite ratios	
PRAD	cis	1	rs3798721	chr6:11040183	ELOVL2	chr6:10980995-11044624:-	-0.74	-14.53	8.84E-40	Blood metabolite ratios	
PRAD	cis	1	rs3798721	chr6:11040183	MAK	chr6:10762957-10838760:-	-0.36	-6.39	3.92E-10	Blood metabolite ratios	
PRAD	cis	1	rs3798721	chr6:11040183	SYCP2L	chr6:10747995-10974539:+	-0.24	-3.5	0.000502	Blood metabolite ratios	
PRAD	cis	1	rs3798723	chr6:11041720	ELOVL2	chr6:10980995-11044624:-	0.75	14.51	1.12E-39	Blood metabolite ratios	
PRAD	cis	1	rs3798723	chr6:11041720	MAK	chr6:10762957-10838760:-	0.37	6.5	2.03E-10	Blood metabolite ratios	
PRAD	cis	1	rs3798723	chr6:11041720	SYCP2L	chr6:10747995-10974539:+	0.24	3.45	0.0006	Blood metabolite ratios	
PRAD	cis	1	rs3799277	chr6:46657057	TDRD6	chr6:46655866-46670149:+	0.29	5.08	5.34E-7	Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs3800316	chr6:27256102	BTN3A2	chr6:26365398-26378546:+	-0.3	-6.49	2.15E-10	Schizophrenia	
PRAD	cis	1	rs3800316	chr6:27256102	ZNF389	chr6:28129551-28137375:+	-0.3	-4.83	1.81E-6	Schizophrenia	
PRAD	cis	1	rs3800457	chr6:34663598	UHRF1BP1	chr6:34759794-34853117:+	-0.19	-5.17	3.5E-7	Pubertal anthropometrics	
PRAD	cis	1	rs3800812	chr7:66223461	CRCP	chr7:65579805-65619551:+	-0.21	-3.98	8.0E-5	Aortic root size	
PRAD	cis	1	rs3800812	chr7:66223461	LOC493754	chr7:65993446-66057363:-	-0.24	-5.5	6.24E-8	Aortic root size	
PRAD	cis	1	rs3800812	chr7:66223461	TPST1	chr7:65670259-65825437:+	0.15	3.56	0.000403	Aortic root size	
PRAD	cis	1	rs3802315	chr8:41528178	ANK1	chr8:41510745-41754280:-	-0.19	-3.46	0.000588	Type 2 diabetes	
PRAD	cis	1	rs3802316	chr8:41528228	ANK1	chr8:41510745-41754280:-	-0.2	-3.53	0.000457	Type 2 diabetes	
PRAD	cis	1	rs3802840	chr11:111171646	C11orf92	chr11:111164171-111175770:-	-0.17	-3.69	0.000246	Colorectal cancer	
PRAD	cis	1	rs3802840	chr11:111171646	C11orf93	chr11:111169976-111179353:+	-0.18	-4.04	6.24E-5	Colorectal cancer	
PRAD	cis	1	rs3802841	chr11:111171672	C11orf92	chr11:111164171-111175770:-	0.17	3.71	0.000233	Colorectal cancer	
PRAD	cis	1	rs3802841	chr11:111171672	C11orf93	chr11:111169976-111179353:+	0.18	4.03	6.48E-5	Colorectal cancer	
PRAD	cis	1	rs3802842	chr11:111171709	C11orf92	chr11:111164171-111175770:-	0.18	3.75	0.000199	Colorectal cancer	
PRAD	cis	1	rs3802842	chr11:111171709	C11orf93	chr11:111169976-111179353:+	0.18	3.99	7.6E-5	Colorectal cancer	
PRAD	cis	1	rs3802888	chr11:46515902	HARBI1	chr11:46624857-46638777:-	0.26	3.75	0.000196	Schizophrenia	
PRAD	cis	1	rs3802924	chr11:133827733	IGSF9B	chr11:133785186-133826880:-	0.19	3.69	0.000248	Schizophrenia	
PRAD	cis	1	rs3803538	chr15:90891771	CRTC3	chr15:91073198-91188576:+	-0.17	-3.76	0.000192	Rheumatoid arthritis	
PRAD	cis	1	rs3803538	chr15:90891771	ZNF774	chr15:90895477-90904714:+	-0.24	-4.82	1.95E-6	Rheumatoid arthritis	
PRAD	cis	1	rs3803539	chr15:90891982	ZNF774	chr15:90895477-90904714:+	-0.26	-4.99	8.51E-7	Rheumatoid arthritis	
PRAD	cis	1	rs3804105	chr6:25612683	SCGN	chr6:25652429-25702006:+	0.42	7.13	3.88E-12	Uric acid levels	
PRAD	cis	1	rs3804106	chr6:25608374	SCGN	chr6:25652429-25702006:+	0.43	7.33	1.01E-12	Uric acid levels	
PRAD	cis	1	rs3804108	chr6:25608215	SCGN	chr6:25652429-25702006:+	0.43	7.33	1.01E-12	Uric acid levels	
PRAD	cis	1	rs3804109	chr6:25608009	SCGN	chr6:25652429-25702006:+	0.43	7.33	1.01E-12	Uric acid levels	
PRAD	cis	1	rs3804118	chr6:25592651	HIST1H4B	chr6:26027125-26027480:-	0.23	3.93	9.82E-5	Uric acid levels	
PRAD	cis	1	rs3804118	chr6:25592651	SCGN	chr6:25652429-25702006:+	0.42	6.98	9.9E-12	Uric acid levels	
PRAD	cis	1	rs3805157	chr4:56364103	TMEM165	chr4:56262090-56292342:+	-0.17	-3.81	0.000155	Personality dimensions	
PRAD	cis	1	rs3805383	chr4:56475338	SRD5A3	chr4:56212409-56237866:+	-0.28	-4.02	6.68E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs3805389	chr4:56482750	SRD5A3	chr4:56212409-56237866:+	-0.28	-4.04	6.27E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs3806107	chr6:33767413	IP6K3	chr6:33689443-33714762:-	0.17	3.56	0.000405	Obesity (extreme)	
PRAD	cis	1	rs3806108	chr6:33767579	LEMD2	chr6:33738991-33756906:-	-0.23	-7.17	2.99E-12	Crohn's disease	
PRAD	cis	1	rs3806407	chr1:156251742	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs3806407	chr1:156251742	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs3806408	chr1:156252137	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs3806408	chr1:156252137	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs3806409	chr1:156252291	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs3806409	chr1:156252291	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs3806692	chr3:53080987	RFT1	chr3:53122503-53164470:-	0.41	4.49	9.15E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs3806692	chr3:53080987	TMEM110	chr3:52867139-52931547:-	0.35	4.42	1.22E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs3806988	chr6:49431569	CENPQ	chr6:49431096-49460820:+	-0.39	-8.16	3.18E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs3806988	chr6:49431569	MUT	chr6:49398994-49431031:-	0.18	5.05	6.4E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs3808894	chr9:100686129	C9orf156	chr9:100666772-100684852:-	-0.19	-3.65	0.000289	Quantitative traits	
PRAD	cis	1	rs3809868	chr17:45750596	C17orf57	chr17:45401142-45518675:+	-0.38	-8.87	1.53E-17	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs3809868	chr17:45750596	TBKBP1	chr17:45772630-45789427:+	0.14	3.96	8.54E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs3810037	chr18:40301641	SYT4	chr18:40847859-40857615:-	0.22	3.54	0.000432	Cognitive performance	
PRAD	cis	1	rs3810174	chr19:41904165	ATP5SL	chr19:41937224-41945810:-	0.16	3.73	0.000216	Height	
PRAD	cis	1	rs3810175	chr19:41904396	ATP5SL	chr19:41937224-41945810:-	-0.16	-3.5	0.000503	Height	
PRAD	cis	1	rs3810176	chr19:49496786	BAX	chr19:49458117-49465054:+	-0.26	-3.86	0.000127	Follicule stimulating hormone	
PRAD	cis	1	rs3810429	chr19:18543270	ELL	chr19:18553475-18632937:-	-0.16	-3.84	0.000143	Breast cancer	
PRAD	cis	1	rs3810429	chr19:18543270	SSBP4	chr19:18530221-18545371:+	-0.18	-5.84	9.59E-9	Breast cancer	
PRAD	cis	1	rs3811782	chr4:54243905	FIP1L1	chr4:54243820-54326102:+	-0.18	-3.92	0.000101	DNA methylation (variation)	
PRAD	cis	1	rs3813227	chr2:73651967	ALMS1P	chr2:73872046-73912692:+	-0.49	-8.35	7.57E-16	Metabolite levels	
PRAD	cis	1	rs3813227	chr2:73651967	NAT8	chr2:73867850-73869537:-	-0.27	-4.05	5.95E-5	Metabolite levels	
PRAD	cis	1	rs3814492	chr9:131873222	CRAT	chr9:131857075-131873070:-	0.23	4.24	2.72E-5	Blood metabolite ratios	
PRAD	cis	1	rs3814855	chr14:88933360	SPATA7	chr14:88852012-88904802:+	-0.23	-4.37	1.55E-5	Coronary artery calcification	
PRAD	cis	1	rs3815292	chr2:242032762	PASK	chr2:242045515-242088878:-	0.31	3.67	0.000269	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs3815304	chr2:242050761	PASK	chr2:242045515-242088878:-	0.33	3.71	0.000236	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs3815413	chr4:17654648	MED28	chr4:17616273-17629791:+	0.2	5.11	4.7E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs3815414	chr4:17606659	MED28	chr4:17616273-17629791:+	-0.21	-5.35	1.38E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs381551	chr6:13716723	RANBP9	chr6:13621731-13711796:-	-0.16	-3.61	0.000338	Breast cancer	
PRAD	cis	1	rs3816587	chr4:25417244	ZCCHC4	chr4:25314396-25372003:+	-0.22	-4.77	2.48E-6	Rheumatoid arthritis	
PRAD	cis	1	rs3817181	chr17:61776538	DDX42	chr17:61851567-61896676:+	-0.27	-5.38	1.17E-7	Body mass index	
PRAD	cis	1	rs3817181	chr17:61776538	FTSJ3	chr17:61896795-61905031:-	0.33	6.41	3.61E-10	Body mass index	
PRAD	cis	1	rs3817181	chr17:61776538	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.07	5.6E-5	Body mass index	
PRAD	cis	1	rs3818262	chr20:47741556	CSE1L	chr20:47662838-47713484:+	0.19	4.68	3.78E-6	Anger	
PRAD	cis	1	rs3818262	chr20:47741556	PREX1	chr20:47240793-47444420:-	-0.17	-3.53	0.000449	Anger	
PRAD	cis	1	rs3818361	chr1:207784968	CD55	chr1:207494817-207534309:+	-0.2	-3.45	0.000605	Alzheimer's disease (late onset)	
PRAD	cis	1	rs3818523	chr6:33660371	ITPR3	chr6:33589161-33664346:+	-0.11	-3.9	0.000111	Height	
PRAD	cis	1	rs3820541	chr1:150848681	CTSK	chr1:150768687-150780812:-	-0.23	-4.64	4.54E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs3820543	chr1:150812858	CTSK	chr1:150768687-150780812:-	-0.23	-4.64	4.5E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs3821008	chr2:178682329	PDE11A	chr2:178487979-178973066:-	-0.3	-3.85	0.000133	Height	
PRAD	cis	1	rs3822957	chr6:76607280	IMPG1	chr6:76631062-76782335:-	-0.21	-3.65	0.000294	Prostate cancer	
PRAD	cis	1	rs3822957	chr6:76607280	MYO6	chr6:76458909-76629254:+	-0.23	-4.38	1.49E-5	Prostate cancer	
PRAD	cis	1	rs3823114	chr6:49431720	CENPQ	chr6:49431096-49460820:+	-0.41	-8.62	1.03E-16	Folate pathway vitamin levels	
PRAD	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.18	5.15	3.84E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs3824496	chr9:100684645	C9orf156	chr9:100666772-100684852:-	-0.19	-3.65	0.000294	Quantitative traits	
PRAD	cis	1	rs3824754	chr10:104614350	SFXN2	chr10:104474298-104498946:+	-0.39	-4.2	3.14E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
PRAD	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.38	7.81	3.7E-14	Multiple sclerosis	
PRAD	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.57	-13.79	1.39E-36	Multiple sclerosis	
PRAD	cis	1	rs3825079	chr12:58203354	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-5.01	7.6E-7	Multiple sclerosis	
PRAD	cis	1	rs3825661	chr14:90767607	C14orf102	chr14:90744398-90798279:-	-0.23	-4.39	1.43E-5	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs3825931	chr15:79219372	CTSH	chr15:79214092-79237420:-	0.4	5.62	3.31E-8	Bipolar disorder	
PRAD	cis	1	rs3826258	chr16:23903552	PRKCB	chr16:23847300-24231930:+	0.15	5.73	1.84E-8	Rheumatoid arthritis	
PRAD	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.34	5.83	1.04E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs3826	chr3:10141065	C3orf10	chr3:10157333-10168873:+	-0.19	-3.77	0.000181	Alzheimer's disease	
PRAD	cis	1	rs3826	chr3:10141065	LOC401052	chr3:10048102-10052779:-	-0.3	-5.54	5.09E-8	Alzheimer's disease	
PRAD	cis	1	rs3827066	chr20:44586023	WFDC3	chr20:44402847-44420547:-	-0.52	-7.15	3.27E-12	Abdominal aortic aneurysm	
PRAD	cis	1	rs3827066	chr20:44586023	ZSWIM1	chr20:44509848-44513904:+	0.25	3.47	0.000559	Abdominal aortic aneurysm	
PRAD	cis	1	rs3827107	chr20:55070539	C20orf43	chr20:55043647-55093942:+	0.16	3.88	0.00012	Refractive astigmatism	
PRAD	cis	1	rs3827357	chr22:39079413	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs3827357	chr22:39079413	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs3827500	chr6:25607908	SCGN	chr6:25652429-25702006:+	0.43	7.33	1.01E-12	Uric acid levels	
PRAD	cis	1	rs3827959	chr20:21179145	PLK1S1	chr20:21106624-21227256:+	0.25	4.55	6.83E-6	Height	
PRAD	cis	1	rs3828165	chr2:220889	SH3YL1	chr2:218138-264810:-	-0.79	-18.65	1.68E-58	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs3829640	chr18:72174980	CNDP2	chr18:72163597-72188356:+	0.44	7	8.75E-12	Refractive error	
PRAD	cis	1	rs383144	chr15:68204581	PIAS1	chr15:68346572-68480402:+	0.13	4.34	1.75E-5	Cognitive performance	
PRAD	cis	1	rs383168	chr15:68204994	PIAS1	chr15:68346572-68480402:+	-0.14	-4.62	5.04E-6	Cognitive performance	
PRAD	cis	1	rs383402	chr7:65586653	CCT6P1	chr7:65216092-65228661:+	-0.37	-6.47	2.41E-10	Diabetic kidney disease	
PRAD	cis	1	rs383402	chr7:65586653	CRCP	chr7:65579805-65619551:+	0.33	4.28	2.29E-5	Diabetic kidney disease	
PRAD	cis	1	rs3843061	chr5:110160392	TMEM232	chr5:109624934-110062381:-	0.27	4.2	3.23E-5	Asthma and hay fever	
PRAD	cis	1	rs3843480	chr5:74624482	POLK	chr5:74807657-74895644:+	-0.11	-3.48	0.000554	LDL cholesterol	
PRAD	cis	1	rs3843481	chr5:74628375	POLK	chr5:74807657-74895644:+	-0.11	-3.54	0.000434	LDL cholesterol	
PRAD	cis	1	rs3843482	chr5:74639259	POLK	chr5:74807657-74895644:+	-0.11	-3.45	0.000604	LDL cholesterol	
PRAD	cis	1	rs3845624	chr1:159218266	FCER1A	chr1:159259506-159278013:+	-0.14	-3.8	0.000166	Inflammatory biomarkers	
PRAD	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.53	11.91	8.79E-29	Height	
PRAD	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.55	12.75	3.51E-32	Height	
PRAD	cis	1	rs3846177	chr3:10068572	C3orf10	chr3:10157333-10168873:+	-0.2	-3.83	0.000145	Alzheimer's disease	
PRAD	cis	1	rs3846177	chr3:10068572	LOC401052	chr3:10048102-10052779:-	-0.29	-5.35	1.4E-7	Alzheimer's disease	
PRAD	cis	1	rs3846357	chr4:17635887	MED28	chr4:17616273-17629791:+	0.19	4.63	4.65E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs3846926	chr6:56092186	COL21A1	chr6:55921389-56258892:-	0.25	7.4	6.27E-13	Pulse pressure	
PRAD	cis	1	rs3847669	chr12:75949158	GLIPR1L2	chr12:75784889-75825591:+	-0.39	-6.3	6.72E-10	Polycystic ovary syndrome	
PRAD	cis	1	rs3848129	chr15:50892064	SPPL2A	chr15:50999739-51057910:-	0.27	5.6	3.7E-8	QT interval	
PRAD	cis	1	rs3848130	chr15:50892111	SPPL2A	chr15:50999739-51057910:-	0.26	5.35	1.37E-7	QT interval	
PRAD	cis	1	rs3850304	chr14:59895019	JKAMP	chr14:59951161-59972080:+	0.38	4.35	1.71E-5	Schizophrenia	
PRAD	cis	1	rs385113	chr6:167403971	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs3853750	chr5:110154309	TMEM232	chr5:109624934-110062381:-	0.28	4.27	2.39E-5	Asthma and hay fever	
PRAD	cis	1	rs3856600	chr3:66525393	LRIG1	chr3:66429222-66550845:-	0.32	3.87	0.000127	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	
PRAD	cis	1	rs3856807	chr3:12527600	TSEN2	chr3:12525931-12581122:+	0.41	4.61	5.1E-6	Prostate cancer (gene x gene interaction)	
PRAD	cis	1	rs3857422	chr5:150268609	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs3857688	chr7:66127806	CRCP	chr7:65579805-65619551:+	0.2	3.72	0.000225	Aortic root size	
PRAD	cis	1	rs3857688	chr7:66127806	LOC493754	chr7:65993446-66057363:-	0.22	5.04	6.68E-7	Aortic root size	
PRAD	cis	1	rs3857688	chr7:66127806	TPST1	chr7:65670259-65825437:+	-0.15	-3.64	0.000302	Aortic root size	
PRAD	cis	1	rs3858534	chr12:75947084	GLIPR1L2	chr12:75784889-75825591:+	-0.38	-6.13	1.81E-9	Polycystic ovary syndrome	
PRAD	cis	1	rs385863	chr6:167386615	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs3860055	chr2:17775828	GEN1	chr2:17935162-17966632:+	0.41	5.23	2.51E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs3862188	chr1:247865773	OR2W3	chr1:248031265-248060142:+	-0.29	-4.2	3.17E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs3862188	chr1:247865773	TRIM58	chr1:248020501-248043436:+	-0.28	-4.12	4.53E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs3864639	chr7:76738591	CCDC146	chr7:76751934-76924519:+	0.17	3.79	0.000171	Obesity-related traits	
PRAD	cis	1	rs3865444	chr19:51727962	CD33	chr19:51728335-51747115:+	-0.11	-3.59	0.000363	Alzheimer's disease (late onset)	
PRAD	cis	1	rs386548	chr6:167385533	RNASET2	chr6:167343008-167412795:-	0.24	5.84	9.65E-9	Crohn's disease	
PRAD	cis	1	rs3866330	chr3:49582994	AMIGO3	chr3:49754268-49757238:-	-0.42	-8.6	1.19E-16	Menarche (age at onset)	
PRAD	cis	1	rs3866330	chr3:49582994	CCDC36	chr3:49235861-49295537:+	0.24	4.45	1.07E-5	Menarche (age at onset)	
PRAD	cis	1	rs3866330	chr3:49582994	GMPPB	chr3:49758932-49761384:-	-0.46	-11.28	2.83E-26	Menarche (age at onset)	
PRAD	cis	1	rs3866330	chr3:49582994	NCKIPSD	chr3:48711280-48723334:-	0.3	5.97	4.57E-9	Menarche (age at onset)	
PRAD	cis	1	rs3866330	chr3:49582994	P4HTM	chr3:49027341-49044579:+	0.16	3.56	0.000401	Menarche (age at onset)	
PRAD	cis	1	rs3866330	chr3:49582994	WDR6	chr3:49044637-49053386:+	-0.2	-4.02	6.64E-5	Menarche (age at onset)	
PRAD	cis	1	rs3870339	chr3:49536863	AMIGO3	chr3:49754268-49757238:-	-0.42	-8.65	8.1E-17	Menarche (age at onset)	
PRAD	cis	1	rs3870339	chr3:49536863	CCDC36	chr3:49235861-49295537:+	0.24	4.42	1.21E-5	Menarche (age at onset)	
PRAD	cis	1	rs3870339	chr3:49536863	GMPPB	chr3:49758932-49761384:-	-0.47	-11.64	1.11E-27	Menarche (age at onset)	
PRAD	cis	1	rs3870339	chr3:49536863	NCKIPSD	chr3:48711280-48723334:-	0.28	5.68	2.37E-8	Menarche (age at onset)	
PRAD	cis	1	rs3870339	chr3:49536863	WDR6	chr3:49044637-49053386:+	-0.21	-4.18	3.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs3870341	chr3:49584745	AMIGO3	chr3:49754268-49757238:-	-0.41	-8.44	3.84E-16	Menarche (age at onset)	
PRAD	cis	1	rs3870341	chr3:49584745	CCDC36	chr3:49235861-49295537:+	0.24	4.44	1.13E-5	Menarche (age at onset)	
PRAD	cis	1	rs3870341	chr3:49584745	GMPPB	chr3:49758932-49761384:-	-0.46	-11.14	1.0E-25	Menarche (age at onset)	
PRAD	cis	1	rs3870341	chr3:49584745	NCKIPSD	chr3:48711280-48723334:-	0.3	5.95	5.19E-9	Menarche (age at onset)	
PRAD	cis	1	rs3870341	chr3:49584745	P4HTM	chr3:49027341-49044579:+	0.16	3.67	0.000271	Menarche (age at onset)	
PRAD	cis	1	rs3870341	chr3:49584745	WDR6	chr3:49044637-49053386:+	-0.2	-3.93	9.74E-5	Menarche (age at onset)	
PRAD	cis	1	rs3870366	chr6:153439767	RGS17	chr6:153332041-153452389:-	-0.55	-13.21	4.36E-34	Prostate cancer	
PRAD	cis	1	rs387676	chr7:65598220	CCT6P1	chr7:65216092-65228661:+	0.33	5.76	1.51E-8	Diabetic kidney disease	
PRAD	cis	1	rs387676	chr7:65598220	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000132	Diabetic kidney disease	
PRAD	cis	1	rs388098	chr5:37068544	NIPBL	chr5:36876861-37065920:+	0.11	4.48	9.51E-6	Height	
PRAD	cis	1	rs3885839	chr7:65290403	CCT6P1	chr7:65216092-65228661:+	0.34	5.98	4.43E-9	Diabetic kidney disease	
PRAD	cis	1	rs388675	chr15:68205747	PIAS1	chr15:68346572-68480402:+	-0.14	-4.62	5.04E-6	Cognitive performance	
PRAD	cis	1	rs3886938	chr8:130737546	GSDMC	chr8:130760443-130799134:-	0.2	3.93	9.93E-5	Infant length;Height	
PRAD	cis	1	rs3889890	chr1:183621385	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs3890604	chr3:41760625	ULK4	chr3:41288091-42003660:-	0.82	13.24	3.2E-34	Diastolic blood pressure	
PRAD	cis	1	rs3892630	chr19:33181484	CCDC123	chr19:33369906-33462869:-	-0.27	-4.52	7.87E-6	Red blood cell traits	
PRAD	cis	1	rs3892630	chr19:33181484	NUDT19	chr19:33182867-33204701:+	0.22	3.78	0.000175	Red blood cell traits	
PRAD	cis	1	rs3892761	chr12:54070445	TARBP2	chr12:53894705-53900213:+	-0.15	-3.87	0.000125	Height	
PRAD	cis	1	rs3895942	chr3:10108745	C3orf10	chr3:10157333-10168873:+	-0.19	-3.82	0.000154	Alzheimer's disease	
PRAD	cis	1	rs3895942	chr3:10108745	LOC401052	chr3:10048102-10052779:-	-0.29	-5.27	2.1E-7	Alzheimer's disease	
PRAD	cis	1	rs389946	chr6:167407268	RNASET2	chr6:167343008-167412795:-	-0.24	-5.8	1.21E-8	Crohn's disease	
PRAD	cis	1	rs389956	chr6:167407254	RNASET2	chr6:167343008-167412795:-	-0.24	-5.8	1.21E-8	Crohn's disease	
PRAD	cis	1	rs3900064	chr5:150264414	C5orf62	chr5:150157867-150176297:+	-0.28	-3.57	0.000388	Crohn's disease	
PRAD	cis	1	rs3900064	chr5:150264414	LOC134466	chr5:150310000-150326146:-	-0.59	-8.9	1.26E-17	Crohn's disease	
PRAD	cis	1	rs3901668	chr1:202501761	PPP1R12B	chr1:202317836-202557697:+	0.09	3.79	0.000172	Sex ratio	
PRAD	cis	1	rs3905330	chr3:49550774	AMIGO3	chr3:49754268-49757238:-	-0.42	-8.57	1.47E-16	Menarche (age at onset)	
PRAD	cis	1	rs3905330	chr3:49550774	CCDC36	chr3:49235861-49295537:+	0.24	4.43	1.17E-5	Menarche (age at onset)	
PRAD	cis	1	rs3905330	chr3:49550774	GMPPB	chr3:49758932-49761384:-	-0.47	-11.51	3.68E-27	Menarche (age at onset)	
PRAD	cis	1	rs3905330	chr3:49550774	NCKIPSD	chr3:48711280-48723334:-	0.29	5.84	9.81E-9	Menarche (age at onset)	
PRAD	cis	1	rs3905330	chr3:49550774	P4HTM	chr3:49027341-49044579:+	0.15	3.5	0.000509	Menarche (age at onset)	
PRAD	cis	1	rs3905330	chr3:49550774	WDR6	chr3:49044637-49053386:+	-0.21	-4.14	4.13E-5	Menarche (age at onset)	
PRAD	cis	1	rs3905807	chr12:58776768	TSFM	chr12:58176536-58191367:+	-0.18	-3.71	0.000229	Obesity-related traits	
PRAD	cis	1	rs3906527	chr5:150266392	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs3906528	chr5:150266718	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs3910272	chr2:26287842	GPR113	chr2:26531041-26569685:-	-0.27	-3.75	0.000198	Gut microbiome composition (summer)	
PRAD	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.46	-7.62	1.42E-13	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs3915733	chr14:104147353	BAG5	chr14:104022889-104029151:-	0.18	3.7	0.000239	Body mass index	
PRAD	cis	1	rs3915733	chr14:104147353	C14orf153	chr14:104029299-104057227:+	0.14	4.15	3.95E-5	Body mass index	
PRAD	cis	1	rs3915733	chr14:104147353	CKB	chr14:103985996-103989170:-	0.22	4.88	1.49E-6	Body mass index	
PRAD	cis	1	rs3915733	chr14:104147353	KLC1	chr14:104029299-104167887:+	-0.17	-3.53	0.00045	Body mass index	
PRAD	cis	1	rs3915733	chr14:104147353	MARK3	chr14:103851701-103970164:+	0.24	5.02	7.22E-7	Body mass index	
PRAD	cis	1	rs392452	chr15:68207015	IQCH	chr15:67547188-67794139:+	-0.18	-3.51	0.000493	Cognitive performance	
PRAD	cis	1	rs392452	chr15:68207015	PIAS1	chr15:68346572-68480402:+	-0.14	-4.58	5.98E-6	Cognitive performance	
PRAD	cis	1	rs3931020	chr1:75235317	CRYZ	chr1:75171175-75199092:-	-0.34	-6.42	3.4E-10	Resistin levels	
PRAD	cis	1	rs3931460	chr14:60939101	C14orf39	chr14:60902675-60952764:-	0.49	6.21	1.17E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs393179	chr12:5772332	ANO2	chr12:5671817-6055398:-	-0.35	-6.8	3.15E-11	Plasma clusterin levels	
PRAD	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.51	11.72	5.37E-28	Height	
PRAD	cis	1	rs3932818	chr3:134206069	CEP63	chr3:134204575-134293852:+	0.2	3.49	0.000526	Height	
PRAD	cis	1	rs3933453	chr4:17636319	MED28	chr4:17616273-17629791:+	0.22	5.37	1.21E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.84	-13.61	8.45E-36	Diastolic blood pressure	
PRAD	cis	1	rs3934135	chr15:84583799	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.76	18.34	4.56E-57	Eye color traits	
PRAD	cis	1	rs393558	chr6:167397750	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs3935969	chr17:65881959	LOC651250	chr17:66097696-66157623:+	-0.24	-4.45	1.08E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs3936203	chr2:241834654	C2orf54	chr2:241825466-241835573:-	-0.57	-10.31	1.36E-22	Urinary metabolites	
PRAD	cis	1	rs393727	chr6:167398632	RNASET2	chr6:167343008-167412795:-	-0.26	-6.23	1.05E-9	Crohn's disease	
PRAD	cis	1	rs394522	chr6:167398071	RNASET2	chr6:167343008-167412795:-	-0.24	-5.78	1.34E-8	Crohn's disease	
PRAD	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.89	-18.86	1.73E-59	Type 2 diabetes	
PRAD	cis	1	rs3960018	chr15:90383307	C15orf38	chr15:90443832-90456222:-	0.2	3.8	0.000161	Type 2 diabetes	
PRAD	cis	1	rs396007	chr5:176518426	RGS14	chr5:176784844-176799598:+	-0.19	-3.58	0.000378	Height	
PRAD	cis	1	rs396508	chr16:20682354	ACSM1	chr16:20634559-20709066:-	-0.55	-10.9	7.84E-25	Schizophrenia	
PRAD	cis	1	rs396508	chr16:20682354	TMEM159	chr16:21169912-21191935:+	-0.24	-4.15	3.9E-5	Schizophrenia	
PRAD	cis	1	rs397119	chr20:25440187	ENTPD6	chr20:25176339-25207360:+	-0.17	-4.37	1.52E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs397119	chr20:25440187	FAM182B	chr20:25744102-25848786:-	0.38	7.05	6.61E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs397119	chr20:25440187	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.78E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs397713	chr6:167386714	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs3979179	chr1:16306846	CLCNKA	chr1:16345370-16360544:+	0.43	7.92	1.77E-14	Dilated cardiomyopathy	
PRAD	cis	1	rs398036	chr20:25439850	ENTPD6	chr20:25176339-25207360:+	-0.17	-4.37	1.52E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs398036	chr20:25439850	FAM182B	chr20:25744102-25848786:-	0.38	7.05	6.61E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs398036	chr20:25439850	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.78E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs3981131	chr7:65951677	TPST1	chr7:65670259-65825437:+	0.16	3.96	8.62E-5	Aortic root size	
PRAD	cis	1	rs3981351	chr10:115515120	CASP7	chr10:115438935-115490662:+	0.19	3.72	0.000222	Obesity-related traits	
PRAD	cis	1	rs398278	chr6:167388169	RNASET2	chr6:167343008-167412795:-	-0.24	-5.72	1.95E-8	Crohn's disease	
PRAD	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.35	-9.92	3.56E-21	Inflammatory skin disease	
PRAD	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.6	10.93	6.15E-25	Inflammatory skin disease	
PRAD	cis	1	rs3997734	chr6:35503475	TULP1	chr6:35465653-35480647:-	-0.32	-4.54	7.12E-6	Hepatitis C induced liver fibrosis	
PRAD	cis	1	rs3999544	chr6:26285867	BTN3A2	chr6:26365398-26378546:+	0.2	4.58	6.06E-6	Educational attainment	
PRAD	cis	1	rs3999544	chr6:26285867	HIST1H3E	chr6:26224427-26226589:+	0.2	4.15	3.87E-5	Educational attainment	
PRAD	cis	1	rs400063	chr6:167386592	RNASET2	chr6:167343008-167412795:-	-0.26	-6.37	4.63E-10	Crohn's disease	
PRAD	cis	1	rs400176	chr6:167406238	RNASET2	chr6:167343008-167412795:-	-0.24	-5.92	6.27E-9	Crohn's disease	
PRAD	cis	1	rs400736	chr1:8078309	PARK7	chr1:8021714-8045341:+	0.12	4.17	3.6E-5	Response to antidepressants and depression	
PRAD	cis	1	rs400837	chr6:167411008	RNASET2	chr6:167343008-167412795:-	-0.23	-5.65	2.83E-8	Crohn's disease	
PRAD	cis	1	rs401166	chr20:25446308	ENTPD6	chr20:25176339-25207360:+	-0.15	-3.83	0.000143	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs401166	chr20:25446308	FAM182B	chr20:25744102-25848786:-	0.39	7.18	2.71E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs401166	chr20:25446308	PYGB	chr20:25228706-25278647:+	-0.3	-6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs401897	chr20:55029758	C20orf43	chr20:55043647-55093942:+	0.16	3.82	0.000152	Refractive astigmatism	
PRAD	cis	1	rs402418	chr7:65509469	CCT6P1	chr7:65216092-65228661:+	0.33	5.63	3.14E-8	Diabetic kidney disease	
PRAD	cis	1	rs402418	chr7:65509469	CRCP	chr7:65579805-65619551:+	-0.33	-4.06	5.81E-5	Diabetic kidney disease	
PRAD	cis	1	rs402511	chr5:176434440	FGFR4	chr5:176513921-176525124:+	0.17	3.62	0.000322	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs402749	chr6:167386104	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs403029	chr10:8090001	FLJ45983	chr10:8092413-8095447:-	0.14	3.52	0.000479	Hodgkin's lymphoma	
PRAD	cis	1	rs4037	chr10:97365820	ENTPD1	chr10:97471536-97637022:+	0.13	3.76	0.000194	Blood metabolite levels	
PRAD	cis	1	rs4037	chr10:97365820	TCTN3	chr10:97423154-97453900:-	0.2	3.97	8.44E-5	Blood metabolite levels	
PRAD	cis	1	rs4038129	chr2:17774746	GEN1	chr2:17935162-17966632:+	0.41	5.23	2.51E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs4038130	chr2:17774912	GEN1	chr2:17935162-17966632:+	-0.41	-5.23	2.51E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs4038131	chr2:17775032	GEN1	chr2:17935162-17966632:+	0.38	4.93	1.12E-6	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs40396	chr5:130708044	P4HA2	chr5:131528306-131563556:-	-0.23	-4.16	3.74E-5	Life satisfaction	
PRAD	cis	1	rs404222	chr6:167402150	RNASET2	chr6:167343008-167412795:-	-0.24	-5.76	1.48E-8	Crohn's disease	
PRAD	cis	1	rs404394	chr20:25447896	ENTPD6	chr20:25176339-25207360:+	-0.15	-3.83	0.000143	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs404394	chr20:25447896	FAM182B	chr20:25744102-25848786:-	0.39	7.18	2.71E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs404394	chr20:25447896	PYGB	chr20:25228706-25278647:+	-0.3	-6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs405553	chr6:167395058	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs406095	chr6:167409087	RNASET2	chr6:167343008-167412795:-	-0.23	-5.65	2.83E-8	Crohn's disease	
PRAD	cis	1	rs4061660	chr17:2004377	SRR	chr17:2207248-2228553:+	0.3	4.52	7.9E-6	Body mass index	
PRAD	cis	1	rs4073846	chr1:46462881	CCDC163P	chr1:45960581-45965646:-	0.52	11.85	1.54E-28	Body mass index	
PRAD	cis	1	rs4073846	chr1:46462881	MUTYH	chr1:45794915-45806142:-	-0.2	-5.93	6.0E-9	Body mass index	
PRAD	cis	1	rs4074170	chr17:28381141	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.12	4.53E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.75	-17.99	2.02E-55	Eye color traits	
PRAD	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.76	-18.35	4.35E-57	Eye color traits	
PRAD	cis	1	rs407515	chr6:167407544	RNASET2	chr6:167343008-167412795:-	-0.23	-5.65	2.83E-8	Crohn's disease	
PRAD	cis	1	rs4075623	chr17:28386526	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.11	4.64E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs4076006	chr1:46438076	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.26	3.55E-30	Body mass index	
PRAD	cis	1	rs4076006	chr1:46438076	MMACHC	chr1:45965856-45976737:+	-0.17	-3.78	0.000176	Body mass index	
PRAD	cis	1	rs4076006	chr1:46438076	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.5E-9	Body mass index	
PRAD	cis	1	rs4077468	chr1:205914757	PM20D1	chr1:205797154-205819245:-	0.23	4.12	4.43E-5	Cystic fibrosis-related diabetes	
PRAD	cis	1	rs4077469	chr1:205914885	PM20D1	chr1:205797154-205819245:-	0.22	4.04	6.17E-5	Cystic fibrosis-related diabetes	
PRAD	cis	1	rs4078160	chr10:52565940	ASAH2B	chr10:52499696-52514567:+	-0.35	-5.8	1.21E-8	Urate levels in lean individuals	
PRAD	cis	1	rs4078178	chr3:23190494	UBE2E2	chr3:23244653-23632296:+	-0.32	-4.5	8.66E-6	Type 2 diabetes	
PRAD	cis	1	rs408040	chr6:167398903	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs408080	chr6:167392522	RNASET2	chr6:167343008-167412795:-	-0.24	-5.76	1.48E-8	Crohn's disease	
PRAD	cis	1	rs408087	chr6:167398952	RNASET2	chr6:167343008-167412795:-	-0.25	-6.2	1.24E-9	Crohn's disease	
PRAD	cis	1	rs4083914	chr6:153427706	RGS17	chr6:153332041-153452389:-	0.56	13.36	9.57E-35	Prostate cancer	
PRAD	cis	1	rs408918	chr6:167399282	RNASET2	chr6:167343008-167412795:-	-0.24	-5.82	1.06E-8	Crohn's disease	
PRAD	cis	1	rs409356	chr6:167405226	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.28E-8	Crohn's disease	
PRAD	cis	1	rs4099209	chr5:110162262	TMEM232	chr5:109624934-110062381:-	0.27	4.2	3.15E-5	Asthma and hay fever	
PRAD	cis	1	rs410128	chr7:65603173	CCT6P1	chr7:65216092-65228661:+	0.34	5.64	2.96E-8	Diabetic kidney disease	
PRAD	cis	1	rs4113953	chr12:40767990	LRRK2	chr12:40618813-40763084:+	0.1	3.86	0.000129	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs41265383	chr6:170068025	WDR27	chr6:169857307-170102159:-	-0.13	-3.5	0.000503	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs41266807	chr6:26199822	HIST1H2AE	chr6:26217148-26217711:+	-0.27	-4	7.47E-5	Renal underexcretion gout;Gout	
PRAD	cis	1	rs41266807	chr6:26199822	HIST1H3E	chr6:26224427-26226589:+	0.34	5.4	1.05E-7	Renal underexcretion gout;Gout	
PRAD	cis	1	rs41266839	chr6:26409890	BTN3A2	chr6:26365398-26378546:+	-0.87	-12.58	1.76E-31	Schizophrenia	
PRAD	cis	1	rs41275472	chr1:11876300	CLCN6	chr1:11866207-11907674:+	0.22	4.36	1.58E-5	QRS complex (12-leadsum)	
PRAD	cis	1	rs41279762	chr2:118705886	INSIG2	chr2:118846050-118867596:+	0.35	4.3	2.12E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs41280035	chr22:38054038	GALR3	chr22:38219389-38221502:+	0.27	4.84	1.79E-6	Fat distribution (HIV)	
PRAD	cis	1	rs41280035	chr22:38054038	LGALS1	chr22:38071613-38075807:+	-0.09	-5.14	4.1E-7	Fat distribution (HIV)	
PRAD	cis	1	rs41280035	chr22:38054038	LGALS2	chr22:37966254-37976024:-	0.18	4.6	5.43E-6	Fat distribution (HIV)	
PRAD	cis	1	rs4128206	chr11:78015952	GAB2	chr11:77926343-78128766:-	-0.18	-6.15	1.61E-9	Testicular germ cell tumor	
PRAD	cis	1	rs4128206	chr11:78015952	NARS2	chr11:78147017-78285909:-	-0.24	-5.21	2.76E-7	Testicular germ cell tumor	
PRAD	cis	1	rs41282998	chr20:61875513	BIRC7	chr20:61867276-61871853:+	0.37	4.12	4.46E-5	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs41291490	chr10:103590737	KCNIP2	chr10:103585732-103603677:-	0.31	4.27	2.35E-5	Coronary artery calcification	
PRAD	cis	1	rs41291969	chr12:48538615	TMEM106C	chr12:48357330-48362660:+	0.35	3.52	0.000476	Prostate cancer	
PRAD	cis	1	rs41294396	chr11:64078581	C11orf20	chr11:64067863-64072238:+	-0.42	-5.89	7.41E-9	Mean platelet volume	
PRAD	cis	1	rs4129956	chr4:302008	ZNF718	chr4:53272-156488:+	0.36	5.91	6.47E-9	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs41303629	chr1:27057621	PIGV	chr1:27114455-27124886:+	-0.36	-4.01	7.18E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs4130590	chr9:130107964	RPL12	chr9:130209955-130213684:-	-0.11	-3.72	0.000221	Bipolar disorder	
PRAD	cis	1	rs4130590	chr9:130107964	SLC2A8	chr9:130159465-130170161:+	0.15	4.12	4.46E-5	Bipolar disorder	
PRAD	cis	1	rs4130590	chr9:130107964	ZNF79	chr9:130186653-130207650:+	0.24	4.48	9.45E-6	Bipolar disorder	
PRAD	cis	1	rs413232	chr6:167400972	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs4134342	chr8:65700156	BHLHE22	chr8:65492814-65496185:+	0.28	5.42	9.35E-8	HIV-1 susceptibility	
PRAD	cis	1	rs41343448	chr8:20271413	ATP6V1B2	chr8:20054704-20079205:+	0.41	4.7	3.39E-6	Preeclampsia	
PRAD	cis	1	rs4134379	chr11:77992588	GAB2	chr11:77926343-78128766:-	-0.18	-6.04	3.07E-9	Testicular germ cell tumor	
PRAD	cis	1	rs4134379	chr11:77992588	NARS2	chr11:78147017-78285909:-	-0.23	-4.93	1.15E-6	Testicular germ cell tumor	
PRAD	cis	1	rs4134386	chr1:46395089	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.17	8.32E-30	Body mass index	
PRAD	cis	1	rs4134386	chr1:46395089	MMACHC	chr1:45965856-45976737:+	-0.17	-3.77	0.000181	Body mass index	
PRAD	cis	1	rs4134386	chr1:46395089	MUTYH	chr1:45794915-45806142:-	0.21	5.94	5.4E-9	Body mass index	
PRAD	cis	1	rs41363748	chr12:56696056	COQ10A	chr12:56660642-56664748:+	0.38	3.84	0.000138	Psoriasis vulgaris	
PRAD	cis	1	rs41363748	chr12:56696056	MIP	chr12:56843885-56848429:-	-0.72	-5.59	3.87E-8	Psoriasis vulgaris	
PRAD	cis	1	rs41392645	chr12:56696742	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs41392645	chr12:56696742	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs4140574	chr6:56099424	COL21A1	chr6:55921389-56258892:-	0.24	7.07	5.63E-12	Pulse pressure	
PRAD	cis	1	rs4140575	chr6:56099222	COL21A1	chr6:55921389-56258892:-	0.25	7.4	6.3E-13	Pulse pressure	
PRAD	cis	1	rs4141194	chr11:17011176	NUCB2	chr11:17281887-17371521:+	-0.26	-4.04	6.22E-5	Glaucoma (primary angle closure)	
PRAD	cis	1	rs4142248	chr19:44888276	ZNF285	chr19:44889809-44905777:-	-0.31	-3.76	0.00019	Myopia (pathological)	
PRAD	cis	1	rs41423244	chr12:56693520	COQ10A	chr12:56660642-56664748:+	0.36	3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs41423244	chr12:56693520	MIP	chr12:56843885-56848429:-	-0.72	-5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs414233	chr15:68211387	IQCH	chr15:67547188-67794139:+	-0.2	-3.68	0.000265	Cognitive performance	
PRAD	cis	1	rs414233	chr15:68211387	PIAS1	chr15:68346572-68480402:+	-0.14	-4.34	1.72E-5	Cognitive performance	
PRAD	cis	1	rs4144937	chr6:46628516	SLC25A27	chr6:46620679-46645925:+	-0.16	-6.48	2.38E-10	QRS complex (Sokolow-Lyon)	
PRAD	cis	1	rs4145008	chr7:65647511	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs4145008	chr7:65647511	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs4145130	chr6:95422618	MANEA	chr6:96025413-96057326:+	0.3	4.21	3.12E-5	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
PRAD	cis	1	rs414671	chr15:58692479	LIPC	chr15:58702775-58861072:+	0.24	3.5	0.000515	HDL cholesterol	
PRAD	cis	1	rs4147024	chr3:38456664	XYLB	chr3:38388251-38456467:+	0.22	5.03	7.01E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs4147025	chr3:38456531	XYLB	chr3:38388251-38456467:+	0.23	5.06	5.97E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs4147929	chr19:1063443	ABCA7	chr19:1040102-1065568:+	-0.23	-3.78	0.000175	Alzheimer's disease (late onset)	
PRAD	cis	1	rs4148191	chr2:44042904	ABCG5	chr2:44039612-44066004:-	-0.36	-3.52	0.000478	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs4149423	chr2:108916044	SULT1C2	chr2:108905095-108926370:+	0.48	6.95	1.25E-11	Lobe size	
PRAD	cis	1	rs4149468	chr7:65825690	CCT6P1	chr7:65216092-65228661:+	0.3	5.19	3.17E-7	Diabetic kidney disease	
PRAD	cis	1	rs4149468	chr7:65825690	CRCP	chr7:65579805-65619551:+	-0.35	-4.44	1.13E-5	Diabetic kidney disease	
PRAD	cis	1	rs4149547	chr2:240933308	NDUFA10	chr2:240900158-240964798:-	0.27	6.08	2.54E-9	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs4149551	chr2:240921463	NDUFA10	chr2:240900158-240964798:-	0.27	6.09	2.32E-9	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs4149556	chr2:240915307	NDUFA10	chr2:240900158-240964798:-	0.28	6.39	3.99E-10	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs4150550	chr11:18350898	GTF2H1	chr11:18343816-18388590:+	0.67	14.14	4.46E-38	Pancreatic cancer	
PRAD	cis	1	rs4150562	chr11:18354995	GTF2H1	chr11:18343816-18388590:+	0.65	13.8	1.37E-36	Pancreatic cancer	
PRAD	cis	1	rs4150564	chr11:18355308	GTF2H1	chr11:18343816-18388590:+	0.75	15.75	3.6E-45	Pancreatic cancer	
PRAD	cis	1	rs4150566	chr11:18355599	GTF2H1	chr11:18343816-18388590:+	0.71	15.2	9.68E-43	Pancreatic cancer	
PRAD	cis	1	rs4150575	chr11:18356466	GTF2H1	chr11:18343816-18388590:+	0.71	15.15	1.74E-42	Pancreatic cancer	
PRAD	cis	1	rs4150579	chr11:18357180	GTF2H1	chr11:18343816-18388590:+	-0.65	-13.48	3.08E-35	Pancreatic cancer	
PRAD	cis	1	rs4150610	chr11:18364140	GTF2H1	chr11:18343816-18388590:+	0.74	15.65	9.96E-45	Pancreatic cancer	
PRAD	cis	1	rs4150612	chr11:18364358	GTF2H1	chr11:18343816-18388590:+	0.66	14.02	1.5E-37	Pancreatic cancer	
PRAD	cis	1	rs4150615	chr11:18365028	GTF2H1	chr11:18343816-18388590:+	-0.64	-13.33	1.26E-34	Pancreatic cancer	
PRAD	cis	1	rs4150622	chr11:18365710	GTF2H1	chr11:18343816-18388590:+	0.73	15.31	3.37E-43	Pancreatic cancer	
PRAD	cis	1	rs4150641	chr11:18370739	GTF2H1	chr11:18343816-18388590:+	0.7	14.98	9.32E-42	Pancreatic cancer	
PRAD	cis	1	rs4150650	chr11:18374279	GTF2H1	chr11:18343816-18388590:+	0.65	13.76	1.97E-36	Pancreatic cancer	
PRAD	cis	1	rs4150651	chr11:18374425	GTF2H1	chr11:18343816-18388590:+	0.65	13.59	9.99E-36	Pancreatic cancer	
PRAD	cis	1	rs4150655	chr11:18375164	GTF2H1	chr11:18343816-18388590:+	-0.71	-15.23	7.58E-43	Pancreatic cancer	
PRAD	cis	1	rs4150661	chr11:18379629	GTF2H1	chr11:18343816-18388590:+	0.67	14.25	1.45E-38	Pancreatic cancer	
PRAD	cis	1	rs4150673	chr11:18383449	GTF2H1	chr11:18343816-18388590:+	0.66	13.89	5.13E-37	Pancreatic cancer	
PRAD	cis	1	rs415842	chr6:167406681	RNASET2	chr6:167343008-167412795:-	-0.24	-5.8	1.21E-8	Crohn's disease	
PRAD	cis	1	rs415890	chr6:167406633	RNASET2	chr6:167343008-167412795:-	0.25	5.91	6.57E-9	Crohn's disease	
PRAD	cis	1	rs416131	chr6:167406544	RNASET2	chr6:167343008-167412795:-	0.22	5.34	1.43E-7	Crohn's disease	
PRAD	cis	1	rs416451	chr5:75922072	F2RL2	chr5:75911308-75919240:-	-0.2	-4.67	3.99E-6	Hearing impairment	
PRAD	cis	1	rs41748	chr7:116446573	MET	chr7:116312459-116438439:+	0.12	4.03	6.64E-5	Resting heart rate	
PRAD	cis	1	rs419603	chr7:65597341	CCT6P1	chr7:65216092-65228661:+	0.33	5.76	1.51E-8	Diabetic kidney disease	
PRAD	cis	1	rs419603	chr7:65597341	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000132	Diabetic kidney disease	
PRAD	cis	1	rs420259	chr16:23634026	COG7	chr16:23399816-23464503:-	-0.19	-3.68	0.000261	Bipolar disorder	
PRAD	cis	1	rs420259	chr16:23634026	DCTN5	chr16:23652807-23681182:+	-0.3	-5.25	2.32E-7	Bipolar disorder	
PRAD	cis	1	rs421214	chr6:167396629	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs422094	chr6:167397033	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs422164	chr7:65586605	CCT6P1	chr7:65216092-65228661:+	0.33	5.76	1.51E-8	Diabetic kidney disease	
PRAD	cis	1	rs422164	chr7:65586605	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000132	Diabetic kidney disease	
PRAD	cis	1	rs422421	chr5:176517326	RGS14	chr5:176784844-176799598:+	-0.21	-3.7	0.000239	Height	
PRAD	cis	1	rs422424	chr20:25445446	ENTPD6	chr20:25176339-25207360:+	-0.15	-3.83	0.000143	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs422424	chr20:25445446	FAM182B	chr20:25744102-25848786:-	0.39	7.18	2.71E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs422424	chr20:25445446	PYGB	chr20:25228706-25278647:+	-0.3	-6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs422562	chr6:167406318	RNASET2	chr6:167343008-167412795:-	-0.25	-6.05	2.93E-9	Crohn's disease	
PRAD	cis	1	rs422694	chr6:167406074	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.28E-8	Crohn's disease	
PRAD	cis	1	rs422780	chr6:167406209	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.28E-8	Crohn's disease	
PRAD	cis	1	rs422844	chr20:25445591	ENTPD6	chr20:25176339-25207360:+	-0.15	-3.83	0.000143	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs422844	chr20:25445591	FAM182B	chr20:25744102-25848786:-	0.39	7.18	2.71E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs422844	chr20:25445591	PYGB	chr20:25228706-25278647:+	-0.3	-6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs423258	chr5:137475787	REEP2	chr5:137774776-137782657:+	-0.09	-3.45	0.000606	Resting heart rate	
PRAD	cis	1	rs4233708	chr2:26291345	GPR113	chr2:26531041-26569685:-	-0.24	-3.52	0.000476	Gut microbiome composition (summer)	
PRAD	cis	1	rs4233710	chr2:26291565	GPR113	chr2:26531041-26569685:-	-0.27	-3.72	0.000224	Gut microbiome composition (summer)	
PRAD	cis	1	rs4234853	chr4:735150	MYL5	chr4:667369-675816:+	-0.14	-3.9	0.000109	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs4235388	chr4:17682030	MED28	chr4:17616273-17629791:+	0.17	4.13	4.35E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.59	12.07	2.06E-29	Forced vital capacity	
PRAD	cis	1	rs4238911	chr16:24977141	SLC5A11	chr16:24857316-24922943:+	0.42	3.61	0.000339	Blood metabolite levels	
PRAD	cis	1	rs4239227	chr17:28389103	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.11	4.74E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs4239612	chr19:15727442	CYP4F8	chr19:15726029-15740445:+	0.4	4.48	9.47E-6	Inflammatory biomarkers	
PRAD	cis	1	rs4239617	chr19:15741537	CYP4F8	chr19:15726029-15740445:+	0.31	3.63	0.000318	Inflammatory biomarkers	
PRAD	cis	1	rs4241407	chr3:49600319	AMIGO3	chr3:49754268-49757238:-	-0.44	-9.01	5.12E-18	Menarche (age at onset)	
PRAD	cis	1	rs4241407	chr3:49600319	CCDC36	chr3:49235861-49295537:+	0.23	4.13	4.27E-5	Menarche (age at onset)	
PRAD	cis	1	rs4241407	chr3:49600319	GMPPB	chr3:49758932-49761384:-	-0.49	-11.77	3.32E-28	Menarche (age at onset)	
PRAD	cis	1	rs4241407	chr3:49600319	NCKIPSD	chr3:48711280-48723334:-	0.32	6.31	6.55E-10	Menarche (age at onset)	
PRAD	cis	1	rs4241407	chr3:49600319	P4HTM	chr3:49027341-49044579:+	0.16	3.61	0.000341	Menarche (age at onset)	
PRAD	cis	1	rs4241407	chr3:49600319	WDR6	chr3:49044637-49053386:+	-0.2	-3.97	8.19E-5	Menarche (age at onset)	
PRAD	cis	1	rs4242434	chr8:22501830	BIN3	chr8:22477949-22526661:-	0.14	3.76	0.000191	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	
PRAD	cis	1	rs4242434	chr8:22501830	C8orf58	chr8:22457122-22461660:+	0.28	6.26	8.72E-10	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	
PRAD	cis	1	rs4243618	chr14:61067022	C14orf39	chr14:60902675-60952764:-	0.56	6.25	9.02E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs4244338	chr10:102272802	SEC31B	chr10:102246403-102289636:-	-0.3	-9.13	2.07E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs4245128	chr11:112791983	NCAM1	chr11:112831995-113149157:+	0.11	3.77	0.000186	Life satisfaction	
PRAD	cis	1	rs4245180	chr11:118144512	MPZL2	chr11:118124135-118135009:-	0.11	3.89	0.000115	Pain	
PRAD	cis	1	rs4245180	chr11:118144512	MPZL3	chr11:118100337-118123011:-	0.15	4.98	8.96E-7	Pain	
PRAD	cis	1	rs4245180	chr11:118144512	NLRX1	chr11:119039437-119054723:+	0.18	3.92	0.000103	Pain	
PRAD	cis	1	rs4245180	chr11:118144512	SCN2B	chr11:118033519-118047337:-	-0.11	-3.81	0.000158	Pain	
PRAD	cis	1	rs4245459	chr11:78065959	GAB2	chr11:77926343-78128766:-	-0.21	-6.66	7.71E-11	Testicular germ cell tumor	
PRAD	cis	1	rs4245459	chr11:78065959	NARS2	chr11:78147017-78285909:-	-0.18	-3.52	0.000476	Testicular germ cell tumor	
PRAD	cis	1	rs4245707	chr1:202391419	PPP1R12B	chr1:202317836-202557697:+	0.09	3.72	0.000227	Sex ratio	
PRAD	cis	1	rs4246215	chr11:61564299	FADS1	chr11:61567103-61584529:-	-0.28	-4.6	5.38E-6	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
PRAD	cis	1	rs4246892	chr9:115588649	C9orf80	chr9:115448793-115480387:-	0.31	4.09	5.14E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs4253766	chr22:46623905	PKDREJ	chr22:46651561-46659219:-	-0.55	-7.23	1.95E-12	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs4253772	chr22:46627603	PKDREJ	chr22:46651561-46659219:-	-0.58	-6.88	1.92E-11	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs4256922	chr10:52568616	ASAH2B	chr10:52499696-52514567:+	-0.35	-5.81	1.17E-8	Urate levels in lean individuals	
PRAD	cis	1	rs4260416	chr3:10125283	C3orf10	chr3:10157333-10168873:+	-0.2	-3.96	8.79E-5	Alzheimer's disease	
PRAD	cis	1	rs4260416	chr3:10125283	LOC401052	chr3:10048102-10052779:-	-0.3	-5.5	6.18E-8	Alzheimer's disease	
PRAD	cis	1	rs4261510	chr15:90890606	ZNF774	chr15:90895477-90904714:+	-0.26	-5.01	7.55E-7	Rheumatoid arthritis	
PRAD	cis	1	rs4261913	chr3:119546197	NR1I2	chr3:119499331-119537331:+	0.21	3.74	0.000206	HDL cholesterol	
PRAD	cis	1	rs4263408	chr4:39785276	RPL9	chr4:39455747-39460568:-	-0.42	-8.34	8.33E-16	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs42648	chr7:89977760	GTPBP10	chr7:89969690-90016650:+	0.2	4.91	1.27E-6	Homocysteine levels	
PRAD	cis	1	rs42648	chr7:89977760	STEAP2	chr7:89796904-89866991:+	0.14	3.75	0.000195	Homocysteine levels	
PRAD	cis	1	rs42649	chr7:89977789	GTPBP10	chr7:89969690-90016650:+	0.2	4.89	1.39E-6	Homocysteine levels	
PRAD	cis	1	rs42649	chr7:89977789	STEAP2	chr7:89796904-89866991:+	0.14	3.58	0.000382	Homocysteine levels	
PRAD	cis	1	rs42656	chr7:89981636	GTPBP10	chr7:89969690-90016650:+	0.2	4.94	1.07E-6	Homocysteine levels	
PRAD	cis	1	rs42656	chr7:89981636	STEAP2	chr7:89796904-89866991:+	0.14	3.67	0.000273	Homocysteine levels	
PRAD	cis	1	rs4265793	chr16:19028549	COQ7	chr16:19078927-19091350:+	-0.43	-4.2	3.21E-5	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs42658	chr7:89981915	GTPBP10	chr7:89969690-90016650:+	0.19	4.73	2.92E-6	Homocysteine levels	
PRAD	cis	1	rs4267943	chr6:49439805	CENPQ	chr6:49431096-49460820:+	0.39	8.01	9.31E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs4267943	chr6:49439805	MUT	chr6:49398994-49431031:-	-0.19	-5.2	3.01E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs4268415	chr10:4983590	AKR1C2	chr10:4964715-5060207:-	0.59	8.03	8.17E-15	Height	
PRAD	cis	1	rs4269070	chr3:10126083	C3orf10	chr3:10157333-10168873:+	-0.2	-3.9	0.00011	Alzheimer's disease	
PRAD	cis	1	rs4269070	chr3:10126083	LOC401052	chr3:10048102-10052779:-	-0.3	-5.46	7.59E-8	Alzheimer's disease	
PRAD	cis	1	rs4270120	chr15:45936234	DUOX1	chr15:45422192-45457774:+	-0.1	-3.44	0.00064	Obesity-related traits	
PRAD	cis	1	rs4270120	chr15:45936234	DUOX2	chr15:45384853-45406359:-	-0.15	-3.64	0.000306	Obesity-related traits	
PRAD	cis	1	rs4270120	chr15:45936234	SPATA5L1	chr15:45694519-45713614:+	0.23	3.45	0.000602	Obesity-related traits	
PRAD	cis	1	rs427044	chr7:65508545	CCT6P1	chr7:65216092-65228661:+	0.29	5.09	5.06E-7	Diabetic kidney disease	
PRAD	cis	1	rs427044	chr7:65508545	CRCP	chr7:65579805-65619551:+	-0.33	-4.15	3.94E-5	Diabetic kidney disease	
PRAD	cis	1	rs4271550	chr15:45936266	DUOX1	chr15:45422192-45457774:+	-0.1	-3.44	0.00064	Obesity-related traits	
PRAD	cis	1	rs4271550	chr15:45936266	DUOX2	chr15:45384853-45406359:-	-0.15	-3.64	0.000306	Obesity-related traits	
PRAD	cis	1	rs4271550	chr15:45936266	SPATA5L1	chr15:45694519-45713614:+	0.23	3.45	0.000602	Obesity-related traits	
PRAD	cis	1	rs4271626	chr17:65930133	LOC651250	chr17:66097696-66157623:+	-0.22	-3.98	7.89E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs4272382	chr8:8433488	ERI1	chr8:8860314-8890849:+	-0.34	-3.88	0.00012	Response to cytidine analogues (gemcitabine)	
PRAD	cis	1	rs4272382	chr8:8433488	PPP1R3B	chr8:8993774-9009084:-	-0.36	-4.79	2.28E-6	Response to cytidine analogues (gemcitabine)	
PRAD	cis	1	rs4272382	chr8:8433488	TNKS	chr8:9413445-9639855:+	-0.3	-4.45	1.09E-5	Response to cytidine analogues (gemcitabine)	
PRAD	cis	1	rs4273468	chr4:15737863	BST1	chr4:15704573-15739933:+	0.18	4.51	8.07E-6	Parkinson's disease	
PRAD	cis	1	rs4273468	chr4:15737863	FBXL5	chr4:15606154-15657013:-	0.19	3.45	0.000608	Parkinson's disease	
PRAD	cis	1	rs4276125	chr3:39285192	GORASP1	chr3:39138091-39149130:-	0.23	3.45	0.000606	Daytime sleep phenotypes	
PRAD	cis	1	rs4279493	chr7:66226620	CRCP	chr7:65579805-65619551:+	-0.21	-3.98	8.0E-5	Aortic root size	
PRAD	cis	1	rs4279493	chr7:66226620	LOC493754	chr7:65993446-66057363:-	-0.24	-5.5	6.24E-8	Aortic root size	
PRAD	cis	1	rs4279493	chr7:66226620	TPST1	chr7:65670259-65825437:+	0.15	3.56	0.000403	Aortic root size	
PRAD	cis	1	rs4280918	chr5:110162078	TMEM232	chr5:109624934-110062381:-	0.27	4.2	3.15E-5	Asthma and hay fever	
PRAD	cis	1	rs4283605	chr3:49678651	GMPPB	chr3:49758932-49761384:-	-0.21	-4.55	6.73E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs428445	chr20:55036547	C20orf43	chr20:55043647-55093942:+	-0.17	-4.15	3.97E-5	Refractive astigmatism	
PRAD	cis	1	rs4285028	chr3:121660664	IQCB1	chr3:121488610-121553926:-	-0.28	-5.09	5.3E-7	Multiple sclerosis	
PRAD	cis	1	rs429083	chr6:167383972	RNASET2	chr6:167343008-167412795:-	-0.24	-5.89	7.47E-9	Crohn's disease	
PRAD	cis	1	rs4293565	chr2:241834770	C2orf54	chr2:241825466-241835573:-	0.56	9.83	7.48E-21	Urinary metabolites	
PRAD	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.6	10.66	6.71E-24	Paget's disease	
PRAD	cis	1	rs4294134	chr7:135293128	SLC13A4	chr7:135365993-135412933:-	-0.7	-11.38	1.13E-26	Paget's disease	
PRAD	cis	1	rs4297570	chr13:36755179	SOHLH2	chr13:36742347-36871992:-	-0.2	-3.6	0.000347	Glucose homeostasis traits	
PRAD	cis	1	rs4298408	chr7:3358731	CARD11	chr7:2945769-3083579:-	0.08	3.65	0.000288	Motion sickness	
PRAD	cis	1	rs4300818	chr2:228713255	CCL20	chr2:228678558-228682280:+	0.28	5	8.19E-7	Blood pressure	
PRAD	cis	1	rs430097	chr6:167405073	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.28E-8	Crohn's disease	
PRAD	cis	1	rs430293	chr6:167404958	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.28E-8	Crohn's disease	
PRAD	cis	1	rs4304397	chr9:115598154	C9orf80	chr9:115448793-115480387:-	-0.28	-3.89	0.000115	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs430477	chr6:167389851	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs4304957	chr14:76647572	ESRRB	chr14:76837690-76968178:+	0.25	3.54	0.000447	Blood pressure	
PRAD	cis	1	rs4306571	chr17:40814207	EZH1	chr17:40852294-40897071:-	-0.33	-4.22	2.99E-5	Systolic blood pressure change trajectories	
PRAD	cis	1	rs4307563	chr1:16313788	CLCNKA	chr1:16345370-16360544:+	-0.44	-8.2	2.39E-15	Dilated cardiomyopathy	
PRAD	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.55	12.5	3.88E-31	Height	
PRAD	cis	1	rs4310508	chr10:65138573	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.52	0.000472	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4310508	chr10:65138573	NRBF2	chr10:64893007-64914785:+	-0.28	-6.19	1.32E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs431076	chr7:65600320	CCT6P1	chr7:65216092-65228661:+	0.33	5.78	1.37E-8	Diabetic kidney disease	
PRAD	cis	1	rs431076	chr7:65600320	CRCP	chr7:65579805-65619551:+	-0.31	-3.85	0.000135	Diabetic kidney disease	
PRAD	cis	1	rs4311055	chr2:241821017	C2orf54	chr2:241825466-241835573:-	0.56	10.34	1.05E-22	Urinary metabolites	
PRAD	cis	1	rs431318	chr7:65511597	CCT6P1	chr7:65216092-65228661:+	0.33	5.63	3.14E-8	Diabetic kidney disease	
PRAD	cis	1	rs431318	chr7:65511597	CRCP	chr7:65579805-65619551:+	-0.33	-4.06	5.81E-5	Diabetic kidney disease	
PRAD	cis	1	rs431328	chr19:22222236	ZNF208	chr19:22115760-22193745:-	0.27	5.29	1.92E-7	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs431328	chr19:22222236	ZNF257	chr19:22235266-22273901:+	0.5	8.35	7.62E-16	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4313418	chr1:28255308	RPA2	chr1:28218049-28241236:-	-0.26	-4.87	1.52E-6	Corneal astigmatism	
PRAD	cis	1	rs4313593	chr11:67438195	ALDH3B2	chr11:67429634-67448685:-	0.52	5.59	3.75E-8	Serum metabolite levels	
PRAD	cis	1	rs4314214	chr3:46328069	CCR5	chr3:46411633-46417690:+	-0.1	-4.08	5.31E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs4318247	chr17:65882172	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.98	17.05	4.12E-51	Type 2 diabetes	
PRAD	cis	1	rs4322591	chr14:75600697	EIF2B2	chr14:75469612-75476292:+	0.25	4.98	9.03E-7	Height	
PRAD	cis	1	rs4322591	chr14:75600697	MLH3	chr14:75480467-75518235:-	0.32	6.58	1.25E-10	Height	
PRAD	cis	1	rs4323442	chr8:96022986	C8orf38	chr8:95908040-96088396:+	-0.35	-6.21	1.14E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs4323442	chr8:96022986	TP53INP1	chr8:95938201-95961615:-	0.23	3.66	0.000278	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.38	-6.92	1.44E-11	Rheumatoid arthritis	
PRAD	cis	1	rs4323544	chr9:123647377	TRAF1	chr9:123664672-123691479:-	0.18	5.06	5.91E-7	Rheumatoid arthritis	
PRAD	cis	1	rs4325101	chr1:183644070	NCF2	chr1:183524698-183560046:-	0.23	3.51	0.000498	Systemic lupus erythematosus	
PRAD	cis	1	rs4328498	chr17:28344276	EFCAB5	chr17:28256874-28435469:+	-0.23	-3.9	0.000111	Coffee consumption (cups per day)	
PRAD	cis	1	rs4332037	chr7:1950809	MAD1L1	chr7:1855428-2272583:-	0.17	4.01	6.93E-5	Bipolar disorder	
PRAD	cis	1	rs4332428	chr10:4965434	AKR1C2	chr10:4964715-5060207:-	0.62	8.81	2.4E-17	Height	
PRAD	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.52	11.68	7.66E-28	Height	
PRAD	cis	1	rs4334685	chr3:134304335	CEP63	chr3:134204575-134293852:+	0.2	3.56	0.000415	Height	
PRAD	cis	1	rs433598	chr16:20680206	ACSM1	chr16:20634559-20709066:-	0.56	11.44	6.86E-27	Schizophrenia	
PRAD	cis	1	rs433598	chr16:20680206	TMEM159	chr16:21169912-21191935:+	0.27	4.63	4.69E-6	Schizophrenia	
PRAD	cis	1	rs4341440	chr10:4965293	AKR1C2	chr10:4964715-5060207:-	0.67	9.37	3.03E-19	Height	
PRAD	cis	1	rs4342423	chr6:33732679	LEMD2	chr6:33738991-33756906:-	-0.22	-6.79	3.34E-11	Crohn's disease	
PRAD	cis	1	rs434434	chr5:176516953	RGS14	chr5:176784844-176799598:+	-0.2	-3.78	0.000174	Height	
PRAD	cis	1	rs4344931	chr2:241818527	C2orf54	chr2:241825466-241835573:-	0.56	10.19	3.73E-22	Urinary metabolites	
PRAD	cis	1	rs4350617	chr17:28423088	EFCAB5	chr17:28256874-28435469:+	0.24	4.05	6.0E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs435066	chr1:68927513	DEPDC1	chr1:68939837-68962799:-	0.5	8.4	5.3E-16	IgG glycosylation	
PRAD	cis	1	rs4351285	chr6:159384673	RSPH3	chr6:159398268-159421198:-	0.29	4.58	6.04E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs4351999	chr15:65992380	IGDCC4	chr15:65673825-65715410:-	-0.15	-3.51	0.000496	Mean corpuscular hemoglobin	
PRAD	cis	1	rs4353250	chr11:18323517	GTF2H1	chr11:18343816-18388590:+	0.74	15.55	2.81E-44	Pancreatic cancer	
PRAD	cis	1	rs4356975	chr4:69972463	UGT2B28	chr4:70146217-70160767:+	0.2	3.69	0.00025	Obesity-related traits	
PRAD	cis	1	rs4358460	chr4:111382685	ENPEP	chr4:111397229-111484491:+	0.13	3.64	0.000298	Blood pressure	
PRAD	cis	1	rs4358532	chr5:42379957	GHR	chr5:42424026-42721925:+	-0.2	-4.6	5.55E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs436039	chr19:22214873	ZNF208	chr19:22115760-22193745:-	0.29	5.6	3.66E-8	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs436039	chr19:22214873	ZNF257	chr19:22235266-22273901:+	0.47	7.74	6.05E-14	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4362735	chr3:58429893	PXK	chr3:58318617-58410878:+	0.18	3.5	0.000517	Cholesterol, total	
PRAD	cis	1	rs4363822	chr15:67992583	IQCH	chr15:67547188-67794139:+	0.3	6.21	1.14E-9	Motion sickness	
PRAD	cis	1	rs436383	chr12:5768151	ANO2	chr12:5671817-6055398:-	-0.36	-6.87	1.98E-11	Plasma clusterin levels	
PRAD	cis	1	rs4366267	chr1:25023630	CLIC4	chr1:25071760-25170815:+	-0.09	-3.44	0.00063	Height	
PRAD	cis	1	rs436707	chr6:167388843	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.54	12.44	6.31E-31	Height	
PRAD	cis	1	rs4367688	chr9:135791103	C9orf98	chr9:135600965-135754198:-	0.18	3.46	0.000581	Psoriasis	
PRAD	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.65	9.63E-28	Height	
PRAD	cis	1	rs4371280	chr19:15715768	CYP4F8	chr19:15726029-15740445:+	0.41	4.3	2.11E-5	Inflammatory biomarkers	
PRAD	cis	1	rs4372836	chr2:28973883	PPP1CB	chr2:28974612-29025805:+	0.28	5.87	8.05E-9	Body mass index	
PRAD	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.41	-8.5	2.55E-16	Body mass index	
PRAD	cis	1	rs437298	chr1:76113770	ACADM	chr1:76190043-76229353:+	-0.18	-3.99	7.63E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs4373160	chr4:106648641	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs4374383	chr2:112770770	MERTK	chr2:112656191-112786945:+	0.2	3.83	0.000144	Hepatitis C induced liver fibrosis	
PRAD	cis	1	rs4375281	chr1:92987575	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs4375701	chr17:45712218	C17orf57	chr17:45401142-45518675:+	0.38	8.9	1.17E-17	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs4375701	chr17:45712218	TBKBP1	chr17:45772630-45789427:+	-0.16	-4.4	1.35E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs4376778	chr1:46288846	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	8.94E-30	Body mass index	
PRAD	cis	1	rs4376778	chr1:46288846	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000146	Body mass index	
PRAD	cis	1	rs4376778	chr1:46288846	MUTYH	chr1:45794915-45806142:-	0.21	5.96	4.88E-9	Body mass index	
PRAD	cis	1	rs437889	chr7:65509234	CCT6P1	chr7:65216092-65228661:+	0.33	5.58	4.11E-8	Diabetic kidney disease	
PRAD	cis	1	rs437889	chr7:65509234	CRCP	chr7:65579805-65619551:+	-0.33	-4.05	5.93E-5	Diabetic kidney disease	
PRAD	cis	1	rs4379723	chr10:64963449	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.57	0.000399	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4379723	chr10:64963449	NRBF2	chr10:64893007-64914785:+	-0.29	-6.48	2.31E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4383562	chr3:46320633	CCR5	chr3:46411633-46417690:+	-0.1	-4.06	5.64E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs439237	chr6:167391392	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs439295	chr3:156572455	LEKR1	chr3:156544076-156763918:+	-0.43	-6.3	6.77E-10	Bone mineral density	
PRAD	cis	1	rs4394010	chr4:129894649	C4orf33	chr4:130014829-130033842:+	0.48	8.05	6.62E-15	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs439553	chr6:167391212	RNASET2	chr6:167343008-167412795:-	-0.24	-5.94	5.56E-9	Crohn's disease	
PRAD	cis	1	rs4397735	chr10:4965543	AKR1C2	chr10:4964715-5060207:-	0.74	10.1	7.55E-22	Height	
PRAD	cis	1	rs4398671	chr5:115557842	COMMD10	chr5:115420727-115628978:+	0.29	3.76	0.000192	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs4399232	chr10:64999490	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.57	0.000399	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4399232	chr10:64999490	NRBF2	chr10:64893007-64914785:+	-0.29	-6.48	2.31E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4399394	chr12:5765928	ANO2	chr12:5671817-6055398:-	0.34	6.7	6.06E-11	Plasma clusterin levels	
PRAD	cis	1	rs4400684	chr10:65012687	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.59	0.000359	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4400684	chr10:65012687	NRBF2	chr10:64893007-64914785:+	-0.3	-6.58	1.25E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4402953	chr3:23193690	UBE2E2	chr3:23244653-23632296:+	-0.29	-4.33	1.82E-5	Type 2 diabetes	
PRAD	cis	1	rs440341	chr15:68210959	IQCH	chr15:67547188-67794139:+	-0.18	-3.46	0.000588	Cognitive performance	
PRAD	cis	1	rs440341	chr15:68210959	PIAS1	chr15:68346572-68480402:+	-0.14	-4.35	1.65E-5	Cognitive performance	
PRAD	cis	1	rs4405410	chr12:124435788	ZNF664	chr12:124457670-124499967:+	-0.15	-4.05	5.98E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs4407214	chr2:29118258	PPP1CB	chr2:28974612-29025805:+	-0.28	-5.55	4.69E-8	Breast cancer (estrogen-receptor negative);Breast cancer	
PRAD	cis	1	rs4407214	chr2:29118258	TRMT61B	chr2:29072690-29093175:-	0.33	6.21	1.17E-9	Breast cancer (estrogen-receptor negative);Breast cancer	
PRAD	cis	1	rs4408325	chr11:124821575	PATE1	chr11:125616188-125619742:+	-0.18	-3.57	0.000397	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4408325	chr11:124821575	ROBO3	chr11:124735282-124751361:+	-0.12	-3.43	0.000661	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4408846	chr3:41753679	ULK4	chr3:41288091-42003660:-	0.75	11.66	8.95E-28	Diastolic blood pressure	
PRAD	cis	1	rs4409675	chr1:28262409	RPA2	chr1:28218049-28241236:-	-0.27	-5.1	4.95E-7	Corneal astigmatism	
PRAD	cis	1	rs441109	chr1:76120430	ACADM	chr1:76190043-76229353:+	-0.19	-4.04	6.3E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs441109	chr1:76120430	RABGGTB	chr1:76251886-76260764:+	-0.16	-3.43	0.000647	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs4413107	chr2:127621402	POLR2D	chr2:128603841-128615729:-	-0.24	-3.48	0.000546	Pelvic organ prolapse (moderate/severe)	
PRAD	cis	1	rs4413108	chr2:127622047	POLR2D	chr2:128603841-128615729:-	-0.24	-3.48	0.000546	Pelvic organ prolapse (moderate/severe)	
PRAD	cis	1	rs4416166	chr2:127624454	POLR2D	chr2:128603841-128615729:-	-0.24	-3.57	0.000394	Pelvic organ prolapse (moderate/severe)	
PRAD	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.53	11.98	4.7E-29	Height	
PRAD	cis	1	rs441810	chr21:42698907	FAM3B	chr21:42676177-42729654:+	-0.19	-3.97	8.28E-5	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
PRAD	cis	1	rs4420500	chr15:78962964	CHRNA3	chr15:78885397-78913322:-	-0.22	-3.94	9.5E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.37	1.26E-26	Height	
PRAD	cis	1	rs442856	chr5:176517292	RGS14	chr5:176784844-176799598:+	-0.2	-3.84	0.000138	Height	
PRAD	cis	1	rs4431687	chr9:130111697	SLC2A8	chr9:130159465-130170161:+	-0.15	-3.63	0.000316	Metabolite levels (HVA)	
PRAD	cis	1	rs4442739	chr14:76647645	ESRRB	chr14:76837690-76968178:+	0.3	4.11	4.71E-5	Blood pressure	
PRAD	cis	1	rs444988	chr6:167389674	RNASET2	chr6:167343008-167412795:-	-0.24	-5.76	1.48E-8	Crohn's disease	
PRAD	cis	1	rs4450360	chr15:31682030	CHRFAM7A	chr15:30653443-30685864:-	-0.33	-3.58	0.000381	Survival in colorectal cancer (non-distant metastatic)	
PRAD	cis	1	rs4452748	chr7:50625056	DDC	chr7:50526136-50633154:-	-0.23	-3.93	9.92E-5	Malaria	
PRAD	cis	1	rs4452748	chr7:50625056	FIGNL1	chr7:50511834-50518088:-	0.23	6.22	1.08E-9	Malaria	
PRAD	cis	1	rs4453193	chr11:46787406	ARHGAP1	chr11:46698634-46722120:-	-0.21	-3.43	0.000651	HDL cholesterol	
PRAD	cis	1	rs4453791	chr3:38882519	XIRP1	chr3:39224707-39234077:-	0.25	3.78	0.000179	Social communication problems	
PRAD	cis	1	rs4455806	chr8:55457873	RP1	chr8:55528627-55682531:+	0.24	3.62	0.000325	Intracranial aneurysm	
PRAD	cis	1	rs4460230	chr6:159369990	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs4464069	chr16:69816284	CLEC18C	chr16:69984626-70220796:+	-0.21	-3.52	0.000476	IgE levels	
PRAD	cis	1	rs4465649	chr17:28394747	EFCAB5	chr17:28256874-28435469:+	-0.23	-3.93	9.8E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs4465650	chr17:28396721	EFCAB5	chr17:28256874-28435469:+	0.24	4.11	4.7E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs4469291	chr6:49440614	CENPQ	chr6:49431096-49460820:+	-0.39	-8.21	2.11E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs4469291	chr6:49440614	MUT	chr6:49398994-49431031:-	0.18	4.99	8.46E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs4473887	chr6:159369470	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs447722	chr20:25443510	ENTPD6	chr20:25176339-25207360:+	-0.15	-3.83	0.000143	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs447722	chr20:25443510	FAM182B	chr20:25744102-25848786:-	0.39	7.18	2.71E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs447722	chr20:25443510	PYGB	chr20:25228706-25278647:+	-0.3	-6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4478072	chr3:53106125	ITIH4	chr3:52847007-52866554:-	-0.18	-3.44	0.000638	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs4478072	chr3:53106125	RFT1	chr3:53122503-53164470:-	0.42	5.09	5.31E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs4478072	chr3:53106125	TMEM110	chr3:52867139-52931547:-	0.3	4.09	5.16E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs4479194	chr15:75422131	MPI	chr15:75182410-75190565:+	0.15	3.46	0.000588	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs4480156	chr8:65685148	BHLHE22	chr8:65492814-65496185:+	0.28	5.37	1.21E-7	HIV-1 susceptibility	
PRAD	cis	1	rs448060	chr6:167382622	RNASET2	chr6:167343008-167412795:-	-0.24	-5.74	1.74E-8	Crohn's disease	
PRAD	cis	1	rs448396	chr20:25440269	ENTPD6	chr20:25176339-25207360:+	-0.15	-3.83	0.000143	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs448396	chr20:25440269	FAM182B	chr20:25744102-25848786:-	0.39	7.18	2.71E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs448396	chr20:25440269	PYGB	chr20:25228706-25278647:+	-0.3	-6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4486588	chr11:92093534	CCDC67	chr11:93063156-93171634:+	-0.26	-3.65	0.000292	Homeostasis model assessment of beta-cell function (interaction)	
PRAD	cis	1	rs4487084	chr2:228713179	CCL20	chr2:228678558-228682280:+	0.28	4.88	1.48E-6	Blood pressure	
PRAD	cis	1	rs4490383	chr3:48484683	ATRIP	chr3:48488141-48507708:+	0.28	6.74	4.71E-11	Longevity	
PRAD	cis	1	rs4490383	chr3:48484683	CDC25A	chr3:48198668-48229801:-	0.22	4.13	4.36E-5	Longevity	
PRAD	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.17	-4.75	2.71E-6	Longevity	
PRAD	cis	1	rs449043	chr21:42700410	FAM3B	chr21:42676177-42729654:+	0.18	3.8	0.000163	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
PRAD	cis	1	rs4490669	chr6:56789465	BEND6	chr6:56819773-56892138:+	-0.59	-10.94	5.91E-25	Menarche (age at onset)	
PRAD	cis	1	rs4490669	chr6:56789465	KIAA1586	chr6:56911384-56920021:+	-0.21	-3.51	0.000499	Menarche (age at onset)	
PRAD	cis	1	rs4491945	chr3:119598725	NR1I2	chr3:119499331-119537331:+	0.22	3.97	8.17E-5	HDL cholesterol	
PRAD	cis	1	rs4492844	chr11:78026516	GAB2	chr11:77926343-78128766:-	-0.21	-6.57	1.38E-10	Testicular germ cell tumor	
PRAD	cis	1	rs4492844	chr11:78026516	NARS2	chr11:78147017-78285909:-	-0.2	-4.02	6.87E-5	Testicular germ cell tumor	
PRAD	cis	1	rs449303	chr14:60605788	DHRS7	chr14:60611502-60636561:-	-0.33	-6.09	2.34E-9	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs4493873	chr8:92075643	LRRC69	chr8:92114847-92231464:+	-0.34	-5.45	8.36E-8	Migraine - clinic-based	
PRAD	cis	1	rs449761	chr15:68210579	PIAS1	chr15:68346572-68480402:+	-0.14	-4.62	5.04E-6	Cognitive performance	
PRAD	cis	1	rs4497901	chr2:239969	SH3YL1	chr2:218138-264810:-	-0.76	-18.58	3.6E-58	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.51	11.53	2.94E-27	Height	
PRAD	cis	1	rs4502963	chr6:159369462	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs4506607	chr11:92093618	CCDC67	chr11:93063156-93171634:+	-0.26	-3.65	0.000292	Homeostasis model assessment of beta-cell function (interaction)	
PRAD	cis	1	rs4509958	chr15:50894175	SPPL2A	chr15:50999739-51057910:-	0.26	5.38	1.17E-7	QT interval	
PRAD	cis	1	rs4510208	chr2:203734866	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs4510228	chr2:17774685	GEN1	chr2:17935162-17966632:+	0.41	5.23	2.51E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs4510229	chr2:17774701	GEN1	chr2:17935162-17966632:+	0.41	5.23	2.51E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs451396	chr7:65484074	CCT6P1	chr7:65216092-65228661:+	0.3	5.24	2.43E-7	Diabetic kidney disease	
PRAD	cis	1	rs451396	chr7:65484074	CRCP	chr7:65579805-65619551:+	-0.31	-4.03	6.49E-5	Diabetic kidney disease	
PRAD	cis	1	rs4515105	chr3:190987891	UTS2D	chr3:190984945-191048325:-	-0.26	-5.42	9.62E-8	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs4520624	chr11:111172210	C11orf92	chr11:111164171-111175770:-	0.17	3.51	0.000499	Colorectal cancer	
PRAD	cis	1	rs4520624	chr11:111172210	C11orf93	chr11:111169976-111179353:+	0.17	3.7	0.000237	Colorectal cancer	
PRAD	cis	1	rs4525554	chr17:30312819	C17orf79	chr17:30178885-30186326:-	-0.27	-4.39	1.38E-5	Height	
PRAD	cis	1	rs452888	chr6:169816416	WDR27	chr6:169857307-170102159:-	-0.12	-3.47	0.000572	Corneal astigmatism	
PRAD	cis	1	rs453329	chr20:25440593	ENTPD6	chr20:25176339-25207360:+	-0.17	-4.31	1.95E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs453329	chr20:25440593	FAM182B	chr20:25744102-25848786:-	0.39	7.15	3.43E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs453329	chr20:25440593	PYGB	chr20:25228706-25278647:+	-0.32	-6.91	1.62E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4533340	chr17:28277951	EFCAB5	chr17:28256874-28435469:+	0.25	4.26	2.49E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.53	-11.86	1.42E-28	Height	
PRAD	cis	1	rs4538475	chr4:15737937	BST1	chr4:15704573-15739933:+	-0.19	-4.65	4.26E-6	Parkinson's disease	
PRAD	cis	1	rs45439091	chr11:119054208	CBL	chr11:119076990-119178858:+	-0.26	-4.37	1.53E-5	Platelet count	
PRAD	cis	1	rs454422	chr20:5943693	CRLS1	chr20:5986739-6020694:+	-0.27	-5.09	5.26E-7	HIV-1 viral setpoint	
PRAD	cis	1	rs454422	chr20:5943693	MCM8	chr20:5931298-5975829:+	-0.39	-8.58	1.42E-16	HIV-1 viral setpoint	
PRAD	cis	1	rs4545281	chr1:46360054	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.34	1.75E-30	Body mass index	
PRAD	cis	1	rs4545281	chr1:46360054	MMACHC	chr1:45965856-45976737:+	-0.16	-3.73	0.000211	Body mass index	
PRAD	cis	1	rs4545281	chr1:46360054	MUTYH	chr1:45794915-45806142:-	0.21	6.02	3.59E-9	Body mass index	
PRAD	cis	1	rs45463097	chr14:90744188	C14orf102	chr14:90744398-90798279:-	0.2	3.63	0.000316	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs45469101	chr20:61875007	BIRC7	chr20:61867276-61871853:+	0.37	4.09	4.99E-5	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs45472399	chr10:17209967	TRDMT1	chr10:17184983-17243681:-	-0.27	-5.39	1.09E-7	Homocysteine levels	
PRAD	cis	1	rs4548056	chr7:65298873	CCT6P1	chr7:65216092-65228661:+	0.29	5.15	3.92E-7	Diabetic kidney disease	
PRAD	cis	1	rs4549034	chr2:28972579	PPP1CB	chr2:28974612-29025805:+	0.28	5.87	8.05E-9	Body mass index	
PRAD	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.41	-8.5	2.55E-16	Body mass index	
PRAD	cis	1	rs4549329	chr4:239785	ZNF718	chr4:53272-156488:+	0.36	6.27	8.06E-10	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs4549852	chr9:115584223	C9orf80	chr9:115448793-115480387:-	0.31	4.09	5.14E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs4552585	chr5:137533159	REEP2	chr5:137774776-137782657:+	-0.1	-3.89	0.000117	Resting heart rate	
PRAD	cis	1	rs4552882	chr8:55462324	RP1	chr8:55528627-55682531:+	0.24	3.54	0.000439	Intracranial aneurysm	
PRAD	cis	1	rs4553557	chr14:103309743	RCOR1	chr14:103059233-103196912:+	-0.19	-3.74	0.000206	Body mass index	
PRAD	cis	1	rs4553560	chr14:75334199	RPS6KL1	chr14:75372347-75389958:-	-0.27	-4.86	1.61E-6	Caffeine consumption	
PRAD	cis	1	rs4553671	chr17:46848272	SNF8	chr17:47007461-47022154:-	-0.14	-4.07	5.55E-5	Schizophrenia or bipolar disorder	
PRAD	cis	1	rs45559033	chr14:74341124	LIN52	chr14:74551656-74667117:+	0.27	4.37	1.53E-5	Morning vs. evening chronotype	
PRAD	cis	1	rs4559448	chr1:76203456	ACADM	chr1:76190043-76229353:+	0.18	3.86	0.000129	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs4560537	chr5:150262586	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.29	6.73	4.81E-11	Hematology traits	
PRAD	cis	1	rs4560868	chr9:115985499	PRPF4	chr9:116037974-116055054:+	-0.21	-4.35	1.67E-5	Hematology traits	
PRAD	cis	1	rs45615636	chr10:17210591	TRDMT1	chr10:17184983-17243681:-	-0.26	-5.22	2.69E-7	Homocysteine levels	
PRAD	cis	1	rs4568579	chr8:92072144	LRRC69	chr8:92114847-92231464:+	-0.35	-5.63	3.02E-8	Migraine - clinic-based	
PRAD	cis	1	rs4569014	chr11:67438284	ALDH3B2	chr11:67429634-67448685:-	0.49	5.26	2.17E-7	Serum metabolite levels	
PRAD	cis	1	rs4569324	chr17:65872750	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs4572541	chr2:127618600	POLR2D	chr2:128603841-128615729:-	-0.24	-3.47	0.000563	Pelvic organ prolapse (moderate/severe)	
PRAD	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.72	5.46E-28	Height	
PRAD	cis	1	rs4575590	chr17:28361969	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.11	4.64E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs4578482	chr12:5766206	ANO2	chr12:5671817-6055398:-	0.34	6.7	6.06E-11	Plasma clusterin levels	
PRAD	cis	1	rs4579248	chr5:150268151	C5orf62	chr5:150157867-150176297:+	0.31	3.7	0.000237	Crohn's disease	
PRAD	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.71	10.07	1.01E-21	Crohn's disease	
PRAD	cis	1	rs4580915	chr6:111760764	KIAA1919	chr6:111580482-111590259:+	0.38	4.01	7.0E-5	Psoriasis	
PRAD	cis	1	rs4581755	chr17:28427898	EFCAB5	chr17:28256874-28435469:+	0.24	4.03	6.45E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs458196	chr22:29978026	SEC14L2	chr22:30792933-30824976:+	-0.28	-4.05	6.03E-5	Lipid traits	
PRAD	cis	1	rs4582105	chr4:246342	ZNF718	chr4:53272-156488:+	0.33	5.32	1.58E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs458291	chr7:65520479	CCT6P1	chr7:65216092-65228661:+	0.33	5.63	3.14E-8	Diabetic kidney disease	
PRAD	cis	1	rs458291	chr7:65520479	CRCP	chr7:65579805-65619551:+	-0.33	-4.06	5.81E-5	Diabetic kidney disease	
PRAD	cis	1	rs4586937	chr4:103556462	NHEDC1	chr4:103806209-103940876:-	-0.19	-3.54	0.000441	Primary biliary cirrhosis	
PRAD	cis	1	rs459048	chr6:111689632	KIAA1919	chr6:111580482-111590259:+	0.36	3.82	0.000154	Psoriasis	
PRAD	cis	1	rs4591517	chr3:23143047	UBE2E2	chr3:23244653-23632296:+	-0.18	-3.54	0.000444	Colorectal cancer	
PRAD	cis	1	rs4594164	chr14:35509571	PPP2R3C	chr14:35554679-35591679:-	0.31	4.7	3.44E-6	Atopic dermatitis	
PRAD	cis	1	rs4595427	chr10:65012944	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.59	0.000359	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4595427	chr10:65012944	NRBF2	chr10:64893007-64914785:+	-0.3	-6.58	1.25E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4595905	chr19:18547305	ELL	chr19:18553475-18632937:-	-0.17	-3.87	0.000125	Breast cancer	
PRAD	cis	1	rs4595905	chr19:18547305	SSBP4	chr19:18530221-18545371:+	-0.18	-5.85	9.1E-9	Breast cancer	
PRAD	cis	1	rs4597304	chr16:85055741	ZDHHC7	chr16:85008067-85045141:-	0.41	7.28	1.42E-12	Dysphagia	
PRAD	cis	1	rs459888	chr6:111651156	KIAA1919	chr6:111580482-111590259:+	-0.38	-4.06	5.85E-5	Psoriasis	
PRAD	cis	1	rs4601530	chr1:25044111	CLIC4	chr1:25071760-25170815:+	0.09	3.61	0.00034	Height	
PRAD	cis	1	rs4604732	chr1:247623872	LOC148824	chr1:247687982-247694106:-	0.23	4.2	3.25E-5	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
PRAD	cis	1	rs4604805	chr10:102261409	SEC31B	chr10:102246403-102289636:-	-0.32	-9.87	5.06E-21	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs4604928	chr11:117044203	PCSK7	chr11:117075789-117102811:-	-0.34	-4.48	9.47E-6	Protein quantitative trait loci	
PRAD	cis	1	rs4605213	chr17:49244747	NME1-NME2	chr17:49230920-49249104:+	0.38	8.14	3.63E-15	Height	
PRAD	cis	1	rs4605213	chr17:49244747	NME2	chr17:49242891-49249104:+	-0.12	-3.93	9.87E-5	Height	
PRAD	cis	1	rs4606360	chr1:173699007	ANKRD45	chr1:173577475-173639001:-	0.33	6.86	2.14E-11	Subjective well-being	
PRAD	cis	1	rs4619228	chr12:5766236	ANO2	chr12:5671817-6055398:-	0.34	6.7	6.06E-11	Plasma clusterin levels	
PRAD	cis	1	rs4624820	chr5:141681788	PCDHGA8	chr5:140771483-140892546:+	0.21	3.5	0.000501	Testicular germ cell cancer;Testicular germ cell tumor	
PRAD	cis	1	rs4625780	chr17:30249214	C17orf79	chr17:30178885-30186326:-	-0.26	-4.72	3.18E-6	Height	
PRAD	cis	1	rs4627050	chr11:18822037	PTPN5	chr11:18749478-18813389:-	-0.26	-4.85	1.69E-6	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
PRAD	cis	1	rs4627115	chr11:78007873	GAB2	chr11:77926343-78128766:-	-0.21	-6.31	6.46E-10	Testicular germ cell tumor	
PRAD	cis	1	rs4627115	chr11:78007873	NARS2	chr11:78147017-78285909:-	-0.19	-3.73	0.000211	Testicular germ cell tumor	
PRAD	cis	1	rs462853	chr7:65558167	CCT6P1	chr7:65216092-65228661:+	0.34	5.94	5.58E-9	Diabetic kidney disease	
PRAD	cis	1	rs462853	chr7:65558167	CRCP	chr7:65579805-65619551:+	-0.28	-3.51	0.000494	Diabetic kidney disease	
PRAD	cis	1	rs4628584	chr10:4972697	AKR1C2	chr10:4964715-5060207:-	0.7	9.59	5.17E-20	Height	
PRAD	cis	1	rs4631576	chr9:100705210	C9orf156	chr9:100666772-100684852:-	-0.19	-3.72	0.000224	Quantitative traits	
PRAD	cis	1	rs4631830	chr10:51543344	MSMB	chr10:51549553-51562590:+	0.25	5.92	6.16E-9	Prostate-specific antigen levels	
PRAD	cis	1	rs4631830	chr10:51543344	NCOA4	chr10:51565108-51590733:+	-0.17	-4.45	1.07E-5	Prostate-specific antigen levels	
PRAD	cis	1	rs463543	chr6:111667552	KIAA1919	chr6:111580482-111590259:+	0.37	3.96	8.59E-5	Psoriasis	
PRAD	cis	1	rs4637050	chr2:127619117	POLR2D	chr2:128603841-128615729:-	-0.24	-3.47	0.000563	Pelvic organ prolapse (moderate/severe)	
PRAD	cis	1	rs4640348	chr2:28965479	PPP1CB	chr2:28974612-29025805:+	0.27	5.78	1.39E-8	Body mass index	
PRAD	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.41	-8.45	3.61E-16	Body mass index	
PRAD	cis	1	rs4642241	chr4:17617111	MED28	chr4:17616273-17629791:+	0.2	4.9	1.33E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4643294	chr15:85250253	LOC388152	chr15:84867600-84898920:-	-0.32	-5.42	9.53E-8	Schizophrenia	
PRAD	cis	1	rs4643294	chr15:85250253	NMB	chr15:85198362-85201802:-	-0.52	-12.28	2.93E-30	Schizophrenia	
PRAD	cis	1	rs4643294	chr15:85250253	WDR73	chr15:85186012-85197524:-	-0.27	-5.62	3.27E-8	Schizophrenia	
PRAD	cis	1	rs4646530	chr19:15735238	CYP4F8	chr19:15726029-15740445:+	-0.31	-3.7	0.000237	Inflammatory biomarkers	
PRAD	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.37	8.09	5.17E-15	Multiple sclerosis	
PRAD	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.53	-13.34	1.2E-34	Multiple sclerosis	
PRAD	cis	1	rs4646536	chr12:58157988	XRCC6BP1	chr12:58335445-58351051:+	-0.25	-5.05	6.46E-7	Multiple sclerosis	
PRAD	cis	1	rs4646961	chr1:76217169	ACADM	chr1:76190043-76229353:+	0.17	3.75	0.000197	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs464895	chr7:65527106	CCT6P1	chr7:65216092-65228661:+	0.34	5.92	6.24E-9	Diabetic kidney disease	
PRAD	cis	1	rs464895	chr7:65527106	CRCP	chr7:65579805-65619551:+	-0.29	-3.55	0.000425	Diabetic kidney disease	
PRAD	cis	1	rs4649941	chr1:72031176	NEGR1	chr1:71868626-72748405:-	-0.1	-3.59	0.000363	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs465359	chr7:65558164	CCT6P1	chr7:65216092-65228661:+	0.34	5.94	5.58E-9	Diabetic kidney disease	
PRAD	cis	1	rs465359	chr7:65558164	CRCP	chr7:65579805-65619551:+	-0.28	-3.51	0.000494	Diabetic kidney disease	
PRAD	cis	1	rs4654863	chr1:20902244	CDA	chr1:20915444-20945398:+	-0.15	-3.76	0.000188	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs4654863	chr1:20902244	FAM43B	chr1:20878932-20881512:+	0.15	3.72	0.000225	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs465742	chr22:29959335	SEC14L2	chr22:30792933-30824976:+	0.29	3.83	0.000148	Lipid traits	
PRAD	cis	1	rs465969	chr6:111655530	KIAA1919	chr6:111580482-111590259:+	0.28	3.74	0.000208	Psoriasis	
PRAD	cis	1	rs4660303	chr1:40060473	BMP8A	chr1:39957318-39995537:+	0.22	3.44	0.000631	C-reactive protein levels or triglyceride levels (pleiotropy)	
PRAD	cis	1	rs4660303	chr1:40060473	OXCT2	chr1:40235197-40237020:-	0.23	3.78	0.000177	C-reactive protein levels or triglyceride levels (pleiotropy)	
PRAD	cis	1	rs4660303	chr1:40060473	PABPC4	chr1:40026485-40042521:-	-0.29	-5.5	6.16E-8	C-reactive protein levels or triglyceride levels (pleiotropy)	
PRAD	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.91	27.64	1.4E-100	Homocysteine levels	
PRAD	cis	1	rs4660306	chr1:45978675	MMACHC	chr1:45965856-45976737:+	0.23	4.91	1.25E-6	Homocysteine levels	
PRAD	cis	1	rs4660306	chr1:45978675	MUTYH	chr1:45794915-45806142:-	-0.2	-5.34	1.47E-7	Homocysteine levels	
PRAD	cis	1	rs4660317	chr1:46326226	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	9.04E-30	Body mass index	
PRAD	cis	1	rs4660317	chr1:46326226	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000145	Body mass index	
PRAD	cis	1	rs4660317	chr1:46326226	MUTYH	chr1:45794915-45806142:-	0.21	5.97	4.63E-9	Body mass index	
PRAD	cis	1	rs4660319	chr1:46341623	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	9.04E-30	Body mass index	
PRAD	cis	1	rs4660319	chr1:46341623	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000145	Body mass index	
PRAD	cis	1	rs4660319	chr1:46341623	MUTYH	chr1:45794915-45806142:-	0.21	5.97	4.63E-9	Body mass index	
PRAD	cis	1	rs4660321	chr1:46366760	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.13	1.15E-29	Body mass index	
PRAD	cis	1	rs4660321	chr1:46366760	MMACHC	chr1:45965856-45976737:+	-0.17	-3.82	0.000153	Body mass index	
PRAD	cis	1	rs4660321	chr1:46366760	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.23E-9	Body mass index	
PRAD	cis	1	rs4660456	chr1:41239511	NFYC	chr1:41157242-41237273:+	-0.27	-5.46	7.7E-8	Platelet count	
PRAD	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.85	-23.14	1.24E-79	Homocysteine levels	
PRAD	cis	1	rs4660870	chr1:45995231	MMACHC	chr1:45965856-45976737:+	-0.19	-4.06	5.71E-5	Homocysteine levels	
PRAD	cis	1	rs4660870	chr1:45995231	MUTYH	chr1:45794915-45806142:-	0.2	5.29	1.9E-7	Homocysteine levels	
PRAD	cis	1	rs4660898	chr1:46402171	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.13	1.15E-29	Body mass index	
PRAD	cis	1	rs4660898	chr1:46402171	MMACHC	chr1:45965856-45976737:+	-0.17	-3.82	0.000153	Body mass index	
PRAD	cis	1	rs4660898	chr1:46402171	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.23E-9	Body mass index	
PRAD	cis	1	rs4660910	chr1:46548402	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.25	3.85E-30	Body mass index	
PRAD	cis	1	rs4660910	chr1:46548402	MMACHC	chr1:45965856-45976737:+	-0.17	-3.9	0.000112	Body mass index	
PRAD	cis	1	rs4660910	chr1:46548402	MUTYH	chr1:45794915-45806142:-	0.2	5.78	1.39E-8	Body mass index	
PRAD	cis	1	rs4661151	chr1:155903408	RIT1	chr1:155867601-155881177:-	0.17	3.94	9.39E-5	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs4661175	chr1:155931368	RIT1	chr1:155867601-155881177:-	0.17	4.02	6.81E-5	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs4664308	chr2:160917497	LY75	chr2:160625141-160761262:-	0.14	4.66	4.22E-6	Idiopathic membranous nephropathy	
PRAD	cis	1	rs4664308	chr2:160917497	PLA2R1	chr2:160798012-160919121:-	0.24	5.47	7.51E-8	Idiopathic membranous nephropathy	
PRAD	cis	1	rs4665147	chr2:160917062	LY75	chr2:160625141-160761262:-	0.14	4.64	4.5E-6	Idiopathic membranous nephropathy	
PRAD	cis	1	rs4665147	chr2:160917062	PLA2R1	chr2:160798012-160919121:-	0.24	5.46	7.63E-8	Idiopathic membranous nephropathy	
PRAD	cis	1	rs4665238	chr2:23942446	C2orf84	chr2:24397531-24414566:+	-0.27	-5.26	2.24E-7	Obesity-related traits	
PRAD	cis	1	rs4665238	chr2:23942446	LOC375190	chr2:24299728-24397519:+	0.24	6.8	3.23E-11	Obesity-related traits	
PRAD	cis	1	rs4665299	chr2:26256840	GPR113	chr2:26531041-26569685:-	-0.25	-3.57	0.000393	Gut microbiome composition (summer)	
PRAD	cis	1	rs4665306	chr2:26319124	GPR113	chr2:26531041-26569685:-	-0.24	-3.5	0.000505	Gut microbiome composition (summer)	
PRAD	cis	1	rs4665308	chr2:26330514	GPR113	chr2:26531041-26569685:-	-0.25	-3.76	0.000189	Gut microbiome composition (summer)	
PRAD	cis	1	rs4665309	chr2:26335502	GPR113	chr2:26531041-26569685:-	-0.25	-3.76	0.000189	Gut microbiome composition (summer)	
PRAD	cis	1	rs4665768	chr2:25372229	POMC	chr2:25383722-25391559:-	0.22	4.64	4.42E-6	Body mass index	
PRAD	cis	1	rs4665811	chr2:26260017	GPR113	chr2:26531041-26569685:-	-0.23	-3.43	0.000658	Gut microbiome composition (summer)	
PRAD	cis	1	rs4665817	chr2:26305167	GPR113	chr2:26531041-26569685:-	-0.27	-3.76	0.00019	Gut microbiome composition (summer)	
PRAD	cis	1	rs4665819	chr2:26309073	GPR113	chr2:26531041-26569685:-	-0.24	-3.52	0.000476	Gut microbiome composition (summer)	
PRAD	cis	1	rs4665820	chr2:26309150	GPR113	chr2:26531041-26569685:-	-0.24	-3.52	0.000476	Gut microbiome composition (summer)	
PRAD	cis	1	rs4665958	chr2:27443196	C2orf28	chr2:27434899-27440044:+	0.26	7.09	4.86E-12	Blood metabolite levels	
PRAD	cis	1	rs4665958	chr2:27443196	KHK	chr2:27309611-27323619:+	0.21	4.6	5.47E-6	Blood metabolite levels	
PRAD	cis	1	rs4666118	chr2:28951698	PPP1CB	chr2:28974612-29025805:+	0.3	6.37	4.56E-10	Body mass index	
PRAD	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.39	-8.14	3.49E-15	Body mass index	
PRAD	cis	1	rs4666119	chr2:28975690	PPP1CB	chr2:28974612-29025805:+	0.29	6.29	7.33E-10	Body mass index	
PRAD	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.4	-8.52	2.13E-16	Body mass index	
PRAD	cis	1	rs466983	chr7:65520496	CCT6P1	chr7:65216092-65228661:+	0.34	5.64	2.89E-8	Diabetic kidney disease	
PRAD	cis	1	rs466983	chr7:65520496	CRCP	chr7:65579805-65619551:+	-0.34	-4.09	5.05E-5	Diabetic kidney disease	
PRAD	cis	1	rs4670885	chr2:38910402	GALM	chr2:38893052-38961908:+	0.43	5.03	7.16E-7	5-HTT brain serotonin transporter levels	
PRAD	cis	1	rs4671400	chr2:61472632	AHSA2	chr2:61404553-61414058:+	-0.17	-4.12	4.53E-5	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs4674284	chr2:219161241	CCDC108	chr2:219867576-219906245:-	0.14	3.69	0.000252	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs4674372	chr2:220141963	CDK5R2	chr2:219824398-219826876:+	0.29	4.41	1.26E-5	Educational attainment	
PRAD	cis	1	rs4674372	chr2:220141963	CRYBA2	chr2:219854912-219858127:-	0.24	4.03	6.53E-5	Educational attainment	
PRAD	cis	1	rs4674	chr19:41930396	ATP5SL	chr19:41937224-41945810:-	0.16	3.55	0.000426	Height	
PRAD	cis	1	rs4675860	chr2:241840417	C2orf54	chr2:241825466-241835573:-	0.58	10.31	1.27E-22	Urinary metabolites	
PRAD	cis	1	rs4675863	chr2:241830763	C2orf54	chr2:241825466-241835573:-	0.56	10.18	3.98E-22	Urinary metabolites	
PRAD	cis	1	rs4675868	chr2:241828542	C2orf54	chr2:241825466-241835573:-	0.57	10.4	6.16E-23	Urinary metabolites	
PRAD	cis	1	rs4675874	chr2:241819796	C2orf54	chr2:241825466-241835573:-	-0.56	-9.89	4.52E-21	Urinary metabolites	
PRAD	cis	1	rs4677834	chr3:195093631	C3orf21	chr3:194789015-194991895:-	-0.31	-6.59	1.2E-10	Body mass index	
PRAD	cis	1	rs4680356	chr3:151051100	P2RY12	chr3:151055238-151102544:-	-0.15	-3.79	0.000169	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)	
PRAD	cis	1	rs4682751	chr3:42528065	VIPR1	chr3:42544104-42579065:+	0.25	3.9	0.000108	Magnesium levels	
PRAD	cis	1	rs4683200	chr3:46333235	CCR5	chr3:46411633-46417690:+	-0.1	-4.04	6.29E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs4683208	chr3:46336899	CCR5	chr3:46411633-46417690:+	-0.1	-3.93	9.88E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs4684106	chr3:12550199	TSEN2	chr3:12525931-12581122:+	-0.39	-4.43	1.16E-5	Prostate cancer (gene x gene interaction)	
PRAD	cis	1	rs4686792	chr3:184552325	VPS8	chr3:184529931-184770402:+	-0.35	-4.35	1.64E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs4686865	chr3:184614436	VPS8	chr3:184529931-184770402:+	-0.35	-4.35	1.67E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs4687205	chr3:190983967	UTS2D	chr3:190984945-191048325:-	-0.22	-4.49	9.0E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs4687552	chr3:52838402	GNL3	chr3:52719936-52728508:+	-0.16	-3.9	0.000111	Bipolar disorder	
PRAD	cis	1	rs4687552	chr3:52838402	ITIH4	chr3:52847007-52866554:-	0.12	3.49	0.000531	Bipolar disorder	
PRAD	cis	1	rs4687552	chr3:52838402	NEK4	chr3:52744803-52804951:-	-0.17	-4.58	5.96E-6	Bipolar disorder	
PRAD	cis	1	rs4687552	chr3:52838402	NT5DC2	chr3:52558386-52569093:-	-0.17	-3.69	0.000248	Bipolar disorder	
PRAD	cis	1	rs4687552	chr3:52838402	RFT1	chr3:53122503-53164470:-	-0.2	-3.58	0.000385	Bipolar disorder	
PRAD	cis	1	rs4687701	chr3:53121276	ITIH4	chr3:52847007-52866554:-	-0.15	-4.59	5.57E-6	Height	
PRAD	cis	1	rs4687721	chr3:51598254	HEMK1	chr3:50606583-50622419:+	0.17	3.44	0.000631	Melanoma	
PRAD	cis	1	rs4687721	chr3:51598254	TEX264	chr3:51705222-51738338:+	-0.13	-3.51	0.000484	Melanoma	
PRAD	cis	1	rs468795	chr22:29955450	SEC14L2	chr22:30792933-30824976:+	0.28	3.99	7.74E-5	Lipid traits	
PRAD	cis	1	rs468852	chr22:29956156	SEC14L2	chr22:30792933-30824976:+	0.28	4.05	5.96E-5	Lipid traits	
PRAD	cis	1	rs4690192	chr4:743670	MYL5	chr4:667369-675816:+	-0.14	-3.89	0.000113	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs4690909	chr4:159629151	ETFDH	chr4:159593277-159629839:+	-0.25	-4.52	7.9E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
PRAD	cis	1	rs4691139	chr4:165908721	C4orf39	chr4:165878100-165880273:+	0.15	3.53	0.000457	Ovarian cancer in BRCA1 mutation carriers	
PRAD	cis	1	rs4693089	chr4:84373622	MRPS18C	chr4:84377118-84389352:+	-0.26	-6.12	1.95E-9	Menopause (age at onset)	
PRAD	cis	1	rs4693975	chr4:89821884	FAM13A	chr4:89647106-90032549:-	0.18	3.54	0.000437	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs4693976	chr4:89839840	FAM13A	chr4:89647106-90032549:-	0.18	3.48	0.000549	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs4694437	chr4:72747171	NPFFR2	chr4:72897521-73018748:+	0.42	3.48	0.00054	Metabolite levels	
PRAD	cis	1	rs4696572	chr4:155354916	DCHS2	chr4:155155527-155412930:-	0.14	3.82	0.000152	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs469727	chr5:112242968	SRP19	chr5:112196993-112228774:+	0.15	3.44	0.000629	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.37	-11.8	2.47E-28	Ankylosing spondylitis	
PRAD	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.56	10.83	1.43E-24	Ankylosing spondylitis	
PRAD	cis	1	rs4698198	chr4:17656536	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4698199	chr4:17656738	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4698200	chr4:17657051	MED28	chr4:17616273-17629791:+	0.2	4.96	9.63E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4698432	chr4:15964763	FGFBP2	chr4:15961864-15964859:-	0.25	4.48	9.56E-6	QT interval	
PRAD	cis	1	rs4698433	chr4:15964863	FGFBP2	chr4:15961864-15964859:-	-0.25	-4.47	9.86E-6	QT interval	
PRAD	cis	1	rs4698634	chr4:17630192	MED28	chr4:17616273-17629791:+	-0.19	-4.66	4.13E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4698635	chr4:17630242	MED28	chr4:17616273-17629791:+	0.23	5.68	2.33E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4698641	chr4:17642630	MED28	chr4:17616273-17629791:+	0.22	5.53	5.19E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4698648	chr4:17692715	MED28	chr4:17616273-17629791:+	0.18	4.44	1.13E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4698649	chr4:17692782	MED28	chr4:17616273-17629791:+	0.18	4.44	1.13E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4698651	chr4:17694223	MED28	chr4:17616273-17629791:+	0.18	4.51	8.18E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs4699052	chr4:104137790	BDH2	chr4:103998783-104021024:-	0.26	6.91	1.57E-11	Testicular germ cell tumor	
PRAD	cis	1	rs4699052	chr4:104137790	MANBA	chr4:103552644-103682151:-	0.22	4.26	2.52E-5	Testicular germ cell tumor	
PRAD	cis	1	rs4699055	chr4:104154500	BDH2	chr4:103998783-104021024:-	0.26	6.92	1.45E-11	Testicular germ cell tumor	
PRAD	cis	1	rs4699055	chr4:104154500	MANBA	chr4:103552644-103682151:-	0.22	4.17	3.64E-5	Testicular germ cell tumor	
PRAD	cis	1	rs470119	chr22:50966914	SCO2	chr22:50961999-50964034:-	0.2	6.08	2.43E-9	Mean corpuscular hemoglobin	
PRAD	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.49	-11.38	1.09E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.49	-11.44	6.46E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs4709159	chr6:167664918	UNC93A	chr6:167704803-167729501:+	-0.29	-5.32	1.62E-7	Parental extreme longevity (95 years and older)	
PRAD	cis	1	rs4709248	chr6:159355637	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs4709251	chr6:159380322	RSPH3	chr6:159398268-159421198:-	0.28	4.52	7.78E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs4709252	chr6:159380384	RSPH3	chr6:159398268-159421198:-	0.28	4.52	7.78E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs4709254	chr6:159408597	RSPH3	chr6:159398268-159421198:-	0.29	4.57	6.35E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs4709256	chr6:159409058	RSPH3	chr6:159398268-159421198:-	0.29	4.57	6.35E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs4709258	chr6:159412010	RSPH3	chr6:159398268-159421198:-	0.29	4.58	5.95E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs4709259	chr6:159419584	RSPH3	chr6:159398268-159421198:-	0.28	4.34	1.77E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs4710147	chr6:167374239	RNASET2	chr6:167343008-167412795:-	0.24	5.92	6.28E-9	Crohn's disease	
PRAD	cis	1	rs4711336	chr6:33659046	ITPR3	chr6:33589161-33664346:+	0.12	4.12	4.5E-5	Height	
PRAD	cis	1	rs4711337	chr6:33659987	ITPR3	chr6:33589161-33664346:+	-0.12	-3.92	9.97E-5	Height	
PRAD	cis	1	rs4711346	chr6:33730996	LEMD2	chr6:33738991-33756906:-	0.18	4.47	9.94E-6	Body mass index	
PRAD	cis	1	rs4711351	chr6:33754592	LEMD2	chr6:33738991-33756906:-	-0.23	-7.02	7.63E-12	Crohn's disease	
PRAD	cis	1	rs4711935	chr6:49647822	CRISP1	chr6:49801979-49834218:-	0.27	5.63	3.15E-8	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs4711935	chr6:49647822	CRISP2	chr6:49660072-49681299:-	0.4	7.56	2.17E-13	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs4711935	chr6:49647822	CRISP3	chr6:49695092-49712056:-	0.48	10.46	3.63E-23	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs4711935	chr6:49647822	RHAG	chr6:49572893-49604587:-	0.46	8.74	4.08E-17	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs4712120	chr6:56092916	COL21A1	chr6:55921389-56258892:-	0.24	7.12	4.05E-12	Pulse pressure	
PRAD	cis	1	rs4713006	chr6:26519872	BTN2A3	chr6:26422317-26431927:+	0.25	6.45	2.86E-10	Educational attainment	
PRAD	cis	1	rs4713006	chr6:26519872	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.46	0.000585	Educational attainment	
PRAD	cis	1	rs4713006	chr6:26519872	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000366	Educational attainment	
PRAD	cis	1	rs4713008	chr6:26538268	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs4713008	chr6:26538268	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs4713039	chr6:10906256	ELOVL2	chr6:10980995-11044624:-	0.26	3.56	0.000414	Allergic rhinitis	
PRAD	cis	1	rs4713039	chr6:10906256	MAK	chr6:10762957-10838760:-	0.33	4.77	2.51E-6	Allergic rhinitis	
PRAD	cis	1	rs4713682	chr6:33757047	LEMD2	chr6:33738991-33756906:-	-0.22	-6.78	3.54E-11	Crohn's disease	
PRAD	cis	1	rs4713684	chr6:33766488	LEMD2	chr6:33738991-33756906:-	-0.22	-6.91	1.58E-11	Crohn's disease	
PRAD	cis	1	rs4713882	chr6:35501370	TULP1	chr6:35465653-35480647:-	-0.32	-4.55	6.96E-6	Hepatitis C induced liver fibrosis	
PRAD	cis	1	rs4713	chr9:131910805	CRAT	chr9:131857075-131873070:-	-0.24	-4.53	7.57E-6	Blood metabolite ratios	
PRAD	cis	1	rs4714483	chr6:41528214	FOXP4	chr6:41514164-41570121:+	-0.22	-4.28	2.28E-5	Prostate cancer	
PRAD	cis	1	rs4714485	chr6:41536587	FOXP4	chr6:41514164-41570121:+	-0.22	-4.16	3.81E-5	Prostate cancer	
PRAD	cis	1	rs4714486	chr6:41542417	FOXP4	chr6:41514164-41570121:+	-0.21	-4.07	5.56E-5	Prostate cancer	
PRAD	cis	1	rs4715129	chr6:49415043	CENPQ	chr6:49431096-49460820:+	-0.4	-8.36	7.32E-16	Folate pathway vitamin levels	
PRAD	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.19	5.18	3.34E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs4715130	chr6:49416825	CENPQ	chr6:49431096-49460820:+	-0.4	-8.12	4.17E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.16	4.45	1.08E-5	Folate pathway vitamin levels	
PRAD	cis	1	rs4715134	chr6:49488287	CENPQ	chr6:49431096-49460820:+	0.21	4.2	3.19E-5	Brain structure	
PRAD	cis	1	rs4715590	chr6:56060017	COL21A1	chr6:55921389-56258892:-	0.25	7.36	8.27E-13	Pulse pressure	
PRAD	cis	1	rs4716375	chr6:170071218	WDR27	chr6:169857307-170102159:-	-0.13	-3.5	0.000503	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs4716380	chr6:170090399	WDR27	chr6:169857307-170102159:-	-0.13	-3.47	0.000577	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs4717292	chr7:65895598	TPST1	chr7:65670259-65825437:+	0.18	4.41	1.3E-5	Aortic root size	
PRAD	cis	1	rs4717300	chr7:65947380	TPST1	chr7:65670259-65825437:+	0.18	4.4	1.32E-5	Aortic root size	
PRAD	cis	1	rs4717310	chr7:66161007	CRCP	chr7:65579805-65619551:+	-0.21	-3.94	9.52E-5	Aortic root size	
PRAD	cis	1	rs4717310	chr7:66161007	LOC493754	chr7:65993446-66057363:-	-0.23	-5.28	1.97E-7	Aortic root size	
PRAD	cis	1	rs4717310	chr7:66161007	TPST1	chr7:65670259-65825437:+	0.15	3.61	0.000341	Aortic root size	
PRAD	cis	1	rs4717319	chr7:66242593	CRCP	chr7:65579805-65619551:+	-0.21	-3.98	7.97E-5	Aortic root size	
PRAD	cis	1	rs4717319	chr7:66242593	LOC493754	chr7:65993446-66057363:-	-0.24	-5.51	5.83E-8	Aortic root size	
PRAD	cis	1	rs4717319	chr7:66242593	TPST1	chr7:65670259-65825437:+	0.15	3.57	0.0004	Aortic root size	
PRAD	cis	1	rs4718269	chr7:65200778	CCT6P1	chr7:65216092-65228661:+	-0.33	-5.76	1.51E-8	Diabetic kidney disease	
PRAD	cis	1	rs4718269	chr7:65200778	CRCP	chr7:65579805-65619551:+	0.3	3.75	0.000197	Diabetic kidney disease	
PRAD	cis	1	rs4718269	chr7:65200778	ZNF117	chr7:64434830-64467121:-	0.3	3.65	0.000291	Diabetic kidney disease	
PRAD	cis	1	rs4718270	chr7:65202407	CCT6P1	chr7:65216092-65228661:+	0.32	5.7	2.13E-8	Diabetic kidney disease	
PRAD	cis	1	rs4718270	chr7:65202407	CRCP	chr7:65579805-65619551:+	-0.29	-3.66	0.000285	Diabetic kidney disease	
PRAD	cis	1	rs4718307	chr7:65610988	TPST1	chr7:65670259-65825437:+	-0.18	-4.48	9.52E-6	Aortic root size	
PRAD	cis	1	rs4718309	chr7:65627764	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.85	9.2E-9	Diabetic kidney disease	
PRAD	cis	1	rs4718309	chr7:65627764	CRCP	chr7:65579805-65619551:+	0.32	3.94	9.21E-5	Diabetic kidney disease	
PRAD	cis	1	rs4718315	chr7:65648541	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs4718315	chr7:65648541	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs4718316	chr7:65648731	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs4718316	chr7:65648731	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs4718317	chr7:65648901	CCT6P1	chr7:65216092-65228661:+	-0.32	-5.53	5.21E-8	Diabetic kidney disease	
PRAD	cis	1	rs4718317	chr7:65648901	CRCP	chr7:65579805-65619551:+	0.34	4.26	2.52E-5	Diabetic kidney disease	
PRAD	cis	1	rs4718333	chr7:65772758	CCT6P1	chr7:65216092-65228661:+	-0.33	-5.52	5.68E-8	Diabetic kidney disease	
PRAD	cis	1	rs4718333	chr7:65772758	CRCP	chr7:65579805-65619551:+	0.35	4.28	2.31E-5	Diabetic kidney disease	
PRAD	cis	1	rs4718334	chr7:65789454	CCT6P1	chr7:65216092-65228661:+	-0.31	-5.23	2.57E-7	Diabetic kidney disease	
PRAD	cis	1	rs4718334	chr7:65789454	CRCP	chr7:65579805-65619551:+	0.36	4.5	8.46E-6	Diabetic kidney disease	
PRAD	cis	1	rs4718343	chr7:65874288	TPST1	chr7:65670259-65825437:+	0.18	4.46	1.03E-5	Aortic root size	
PRAD	cis	1	rs4718344	chr7:65874381	TPST1	chr7:65670259-65825437:+	0.18	4.5	8.62E-6	Aortic root size	
PRAD	cis	1	rs4718357	chr7:65960878	TPST1	chr7:65670259-65825437:+	0.18	4.42	1.2E-5	Aortic root size	
PRAD	cis	1	rs4721546	chr7:16888614	AGR2	chr7:16832266-16844738:-	-0.22	-4.03	6.6E-5	Type 2 diabetes (dietary heme iron intake interaction)	
PRAD	cis	1	rs4722286	chr7:23913624	C7orf46	chr7:23719749-23742268:+	-0.23	-5.82	1.1E-8	Schizophrenia	
PRAD	cis	1	rs4722606	chr7:26558149	LOC441204	chr7:26438339-26538594:+	-0.28	-5.29	1.83E-7	Smoking behavior	
PRAD	cis	1	rs4722606	chr7:26558149	NFE2L3	chr7:26191847-26226754:+	-0.15	-3.75	0.000203	Smoking behavior	
PRAD	cis	1	rs472402	chr5:6635591	LOC255167	chr5:6582287-6588612:+	-0.25	-5.52	5.52E-8	Response to amphetamines	
PRAD	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.49	-9.18	1.4E-18	Obesity-related traits	
PRAD	cis	1	rs4726669	chr7:143758191	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.59	0.000359	Obesity-related traits	
PRAD	cis	1	rs4726669	chr7:143758191	OR2A9P	chr7:143991573-143997832:+;chr7	-0.31	-5.32	1.57E-7	Obesity-related traits	
PRAD	cis	1	rs4727443	chr7:99593346	TRIM4	chr7:99488037-99517154:-	-0.31	-6.27	8.24E-10	Interstitial lung disease	
PRAD	cis	1	rs4727750	chr7:78336855	MAGI2	chr7:77646375-79082890:-	-0.21	-4.65	4.3E-6	Schizophrenia	
PRAD	cis	1	rs4727751	chr7:78336934	MAGI2	chr7:77646375-79082890:-	-0.21	-4.65	4.3E-6	Schizophrenia	
PRAD	cis	1	rs4728142	chr7:128573967	IRF5	chr7:128577769-128590086:+	0.46	11.76	3.58E-28	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs473005	chr4:56288125	TMEM165	chr4:56262090-56292342:+	-0.16	-3.56	0.000416	Personality dimensions	
PRAD	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.35	9.4	2.36E-19	Response to temozolomide	
PRAD	cis	1	rs473188	chr11:116812029	PCSK7	chr11:117075789-117102811:-	-0.26	-3.68	0.000258	Protein quantitative trait loci	
PRAD	cis	1	rs4733724	chr8:130723728	GSDMC	chr8:130760443-130799134:-	0.19	3.86	0.000127	Infant length;Height	
PRAD	cis	1	rs4733732	chr8:130738457	GSDMC	chr8:130760443-130799134:-	0.19	3.64	0.000305	Infant length;Height	
PRAD	cis	1	rs473651	chr2:239335401	ASB1	chr2:239335626-239360890:+	-0.15	-3.44	0.000642	Multiple system atrophy	
PRAD	cis	1	rs4737199	chr8:65641907	BHLHE22	chr8:65492814-65496185:+	0.32	5.88	7.93E-9	HIV-1 susceptibility	
PRAD	cis	1	rs4737678	chr8:65646643	BHLHE22	chr8:65492814-65496185:+	0.3	5.74	1.7E-8	HIV-1 susceptibility	
PRAD	cis	1	rs4737680	chr8:65675055	BHLHE22	chr8:65492814-65496185:+	0.28	5.28	1.94E-7	HIV-1 susceptibility	
PRAD	cis	1	rs4737681	chr8:65684304	BHLHE22	chr8:65492814-65496185:+	-0.26	-4.96	9.76E-7	HIV-1 susceptibility	
PRAD	cis	1	rs473771	chr10:131408155	MGMT	chr10:131265454-131565783:+	0.35	9.63	3.79E-20	Response to temozolomide	
PRAD	cis	1	rs4743305	chr9:101760026	COL15A1	chr9:101706138-101833068:+	0.1	4.18	3.46E-5	Epithelial ovarian cancer	
PRAD	cis	1	rs474600	chr1:228585837	TRIM11	chr1:228581379-228594517:-	-0.23	-3.81	0.000155	Hip circumference (psychosocial stress interaction)	
PRAD	cis	1	rs4746112	chr10:74042995	ASCC1	chr10:73856278-73976892:-	0.2	4.04	6.36E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs4746112	chr10:74042995	DNAJB12	chr10:74092588-74114907:-	0.2	4.1	4.83E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs4746822	chr10:70982941	HKDC1	chr10:70980059-71027314:+	-0.3	-5.3	1.77E-7	Glycemic traits (pregnancy)	
PRAD	cis	1	rs4747241	chr10:74036429	ASCC1	chr10:73856278-73976892:-	0.17	3.49	0.000536	Heschl's gyrus morphology	
PRAD	cis	1	rs4747241	chr10:74036429	DNAJB12	chr10:74092588-74114907:-	0.2	4.13	4.28E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs4747242	chr10:74037193	ASCC1	chr10:73856278-73976892:-	0.2	3.91	0.000107	Heschl's gyrus morphology	
PRAD	cis	1	rs4747242	chr10:74037193	DNAJB12	chr10:74092588-74114907:-	0.2	4.06	5.75E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.33	-9.08	3.01E-18	Response to temozolomide	
PRAD	cis	1	rs4751185	chr10:132056415	GLRX3	chr10:131934663-131982784:+	-0.23	-3.47	0.000564	HIV-1 susceptibility	
PRAD	cis	1	rs4752797	chr11:47874364	C1QTNF4	chr11:47611216-47615961:-	-0.13	-3.44	0.000629	Subjective well-being	
PRAD	cis	1	rs4752856	chr11:47648042	C1QTNF4	chr11:47611216-47615961:-	-0.15	-3.73	0.000217	Subjective well-being	
PRAD	cis	1	rs4752857	chr11:47655752	C1QTNF4	chr11:47611216-47615961:-	-0.14	-3.64	0.000302	Subjective well-being	
PRAD	cis	1	rs4752933	chr11:46803785	ARHGAP1	chr11:46698634-46722120:-	-0.21	-3.43	0.000651	HDL cholesterol	
PRAD	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.58	-12	3.98E-29	Forced vital capacity	
PRAD	cis	1	rs4757676	chr11:18640477	SPTY2D1	chr11:18627949-18656020:-	-0.3	-10.86	1.12E-24	Cholesterol, total	
PRAD	cis	1	rs4758213	chr11:7705666	CYB5R2	chr11:7686327-7694994:-	0.19	4.32	1.94E-5	Waist circumference	
PRAD	cis	1	rs4758214	chr11:7705679	CYB5R2	chr11:7686327-7694994:-	0.19	4.32	1.94E-5	Waist circumference	
PRAD	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.78	-15.55	2.8E-44	Cognitive function	
PRAD	cis	1	rs4759318	chr12:54420098	FLJ12825	chr12:54452038-54516018:+	0.21	4.02	6.85E-5	Bone mineral density	
PRAD	cis	1	rs4759361	chr12:123178280	GPR109B	chr12:123199304-123201439:-	0.36	6.3	6.74E-10	Adiponectin levels	
PRAD	cis	1	rs4761074	chr12:85425369	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.09	5.14E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761074	chr12:85425369	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.92	1.18E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761074	chr12:85425369	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.51	5.93E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761075	chr12:85448372	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761075	chr12:85448372	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761075	chr12:85448372	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761077	chr12:85499132	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.26	2.47E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761077	chr12:85499132	SLC6A15	chr12:85253269-85306606:-	-0.31	-4.81	2.08E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761077	chr12:85499132	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.72	1.9E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761113	chr12:85485664	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761113	chr12:85485664	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761113	chr12:85485664	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761114	chr12:85485723	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761114	chr12:85485723	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761114	chr12:85485723	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761115	chr12:85486119	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761115	chr12:85486119	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4761115	chr12:85486119	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs4763555	chr12:10721456	KLRC2	chr12:10579193-10588592:-	-0.25	-4.13	4.26E-5	Cognitive function	
PRAD	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.32	-7.05	6.23E-12	Type 1 diabetes	
PRAD	cis	1	rs4765219	chr12:124440110	ZNF664	chr12:124457670-124499967:+	-0.15	-3.82	0.000149	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs4765305	chr12:124430612	ZNF664	chr12:124457670-124499967:+	-0.15	-4.01	7.03E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs476633	chr15:41392134	CHP	chr15:41523437-41574081:+	-0.17	-3.96	8.5E-5	Glomerular filtration rate (creatinine)	
PRAD	cis	1	rs4768236	chr12:40756472	LRRK2	chr12:40618813-40763084:+	0.09	3.5	0.000504	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs4768943	chr12:51355939	TFCP2	chr12:51488608-51566917:-	-0.21	-3.5	0.000515	Type 2 diabetes	
PRAD	cis	1	rs4768	chr3:49758764	AMIGO3	chr3:49754268-49757238:-	-0.22	-4.45	1.08E-5	Resting heart rate	
PRAD	cis	1	rs4768	chr3:49758764	CACNA2D2	chr3:50400233-50540892:-	-0.22	-4.56	6.62E-6	Resting heart rate	
PRAD	cis	1	rs4768	chr3:49758764	GMPPB	chr3:49758932-49761384:-	-0.23	-5.22	2.65E-7	Resting heart rate	
PRAD	cis	1	rs4768	chr3:49758764	RBM6	chr3:49977592-50137484:+	-0.15	-5.11	4.8E-7	Resting heart rate	
PRAD	cis	1	rs4768	chr3:49758764	WDR6	chr3:49044637-49053386:+	-0.21	-4.35	1.66E-5	Resting heart rate	
PRAD	cis	1	rs4774469	chr15:63311927	RPS27L	chr15:63445540-63449741:-	0.15	3.57	0.000396	Orofacial clefts	
PRAD	cis	1	rs4774470	chr15:63312119	RPS27L	chr15:63445540-63449741:-	0.15	3.71	0.000236	Orofacial clefts	
PRAD	cis	1	rs4775599	chr15:63311495	RPS27L	chr15:63445540-63449741:-	0.15	3.76	0.000188	Orofacial clefts	
PRAD	cis	1	rs4775600	chr15:63311940	RPS27L	chr15:63445540-63449741:-	0.15	3.56	0.000409	Orofacial clefts	
PRAD	cis	1	rs4775601	chr15:63311980	RPS27L	chr15:63445540-63449741:-	-0.15	-3.62	0.000333	Orofacial clefts	
PRAD	cis	1	rs4775893	chr15:50898695	SPPL2A	chr15:50999739-51057910:-	0.27	5.61	3.42E-8	QT interval	
PRAD	cis	1	rs4775897	chr15:50944066	SPPL2A	chr15:50999739-51057910:-	0.26	5.35	1.4E-7	QT interval	
PRAD	cis	1	rs4776059	chr15:52886962	ARPP19	chr15:52839432-52861364:-	0.14	3.64	0.000303	Schizophrenia	
PRAD	cis	1	rs4776065	chr15:52929716	ARPP19	chr15:52839432-52861364:-	-0.17	-4.57	6.29E-6	Schizophrenia	
PRAD	cis	1	rs4776066	chr15:52930499	ARPP19	chr15:52839432-52861364:-	0.16	4.27	2.35E-5	Schizophrenia	
PRAD	cis	1	rs4776068	chr15:52947401	ARPP19	chr15:52839432-52861364:-	0.17	4.63	4.72E-6	Schizophrenia	
PRAD	cis	1	rs4776471	chr15:69992458	C15orf50	chr15:70127573-70135305:+	0.2	3.61	0.000342	Chronic lymphocytic leukemia	
PRAD	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.35	9.87	5.45E-21	Response to temozolomide	
PRAD	cis	1	rs4777182	chr15:69998612	C15orf50	chr15:70127573-70135305:+	0.2	3.43	0.000664	Chronic lymphocytic leukemia	
PRAD	cis	1	rs477895	chr11:64048912	C11orf20	chr11:64067863-64072238:+	0.27	4.18	3.42E-5	Mean platelet volume	
PRAD	cis	1	rs477930	chr5:6635882	LOC255167	chr5:6582287-6588612:+	-0.25	-5.53	5.29E-8	Response to amphetamines	
PRAD	cis	1	rs4782193	chr16:19035682	COQ7	chr16:19078927-19091350:+	-0.38	-4.25	2.6E-5	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs4783896	chr16:55606360	CAPNS2	chr16:55600584-55601592:+	0.18	5.27	2.1E-7	Thyroid hormone levels	
PRAD	cis	1	rs4783896	chr16:55606360	LPCAT2	chr16:55542913-55620581:+	-0.14	-5.07	5.74E-7	Thyroid hormone levels	
PRAD	cis	1	rs4784054	chr16:58776314	C16orf80	chr16:58147497-58163296:-	-0.42	-4.68	3.78E-6	Blood metabolite levels	
PRAD	cis	1	rs4784054	chr16:58776314	ZNF319	chr16:58028573-58033762:-	-0.26	-3.52	0.000479	Blood metabolite levels	
PRAD	cis	1	rs4784549	chr16:55612918	CAPNS2	chr16:55600584-55601592:+	0.16	4.56	6.55E-6	Thyroid hormone levels	
PRAD	cis	1	rs4784549	chr16:55612918	LPCAT2	chr16:55542913-55620581:+	-0.13	-4.49	9.13E-6	Thyroid hormone levels	
PRAD	cis	1	rs4787491	chr16:30015337	FAM57B	chr16:30035749-30042186:-	-0.2	-3.83	0.000144	Body mass index	
PRAD	cis	1	rs4787491	chr16:30015337	MAPK3	chr16:30125427-30134630:-	-0.17	-3.68	0.00026	Body mass index	
PRAD	cis	1	rs4787491	chr16:30015337	PHKG2	chr16:30759737-30768682:+	-0.12	-3.78	0.000178	Body mass index	
PRAD	cis	1	rs4787491	chr16:30015337	PPP4C	chr16:30087341-30096688:+	-0.11	-3.91	0.000106	Body mass index	
PRAD	cis	1	rs4787491	chr16:30015337	TBX6	chr16:30097117-30103208:-	0.24	5.36	1.3E-7	Body mass index	
PRAD	cis	1	rs4787659	chr16:24987206	SLC5A11	chr16:24857316-24922943:+	-0.45	-3.51	0.000498	Blood metabolite levels	
PRAD	cis	1	rs4788196	chr16:29967434	LOC595101	chr16:30278914-30346695:-	-0.22	-3.67	0.000269	Pubertal anthropometrics	
PRAD	cis	1	rs4788196	chr16:29967434	MAPK3	chr16:30125427-30134630:-	-0.21	-4.71	3.26E-6	Pubertal anthropometrics	
PRAD	cis	1	rs4788196	chr16:29967434	PHKG2	chr16:30759737-30768682:+	-0.11	-3.49	0.000537	Pubertal anthropometrics	
PRAD	cis	1	rs4788196	chr16:29967434	TBX6	chr16:30097117-30103208:-	0.22	4.9	1.32E-6	Pubertal anthropometrics	
PRAD	cis	1	rs4789693	chr17:80421870	HEXDC	chr17:80376252-80400515:+	0.1	3.78	0.000179	Glucocorticoid-induced osteonecrosis	
PRAD	cis	1	rs4789693	chr17:80421870	NARF	chr17:80416060-80446141:+	-0.17	-3.63	0.00031	Glucocorticoid-induced osteonecrosis	
PRAD	cis	1	rs4790908	chr17:65852907	LOC651250	chr17:66097696-66157623:+	-0.24	-4.48	9.22E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs4791212	chr17:65975385	KPNA2	chr17:66031848-66042969:+	-0.15	-4.05	6.06E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs4791212	chr17:65975385	LOC651250	chr17:66097696-66157623:+	-0.27	-4.78	2.33E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs4791299	chr17:65930937	LOC651250	chr17:66097696-66157623:+	-0.24	-4.51	8.21E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs479343	chr6:111690904	KIAA1919	chr6:111580482-111590259:+	0.36	3.82	0.000154	Psoriasis	
PRAD	cis	1	rs4794016	chr17:45725931	C17orf57	chr17:45401142-45518675:+	-0.39	-9.12	2.28E-18	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs4794016	chr17:45725931	TBKBP1	chr17:45772630-45789427:+	0.14	3.94	9.34E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs4794048	chr17:45763073	C17orf57	chr17:45401142-45518675:+	0.37	8.51	2.29E-16	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs4794048	chr17:45763073	TBKBP1	chr17:45772630-45789427:+	-0.16	-4.41	1.3E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs4794202	chr17:45930539	SCRN2	chr17:45915049-45918699:-	-0.31	-7.18	2.68E-12	Alzheimer's disease (cognitive decline)	
PRAD	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.35	9.5	1.09E-19	Response to temozolomide	
PRAD	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.33	-5.84	9.56E-9	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.35	-6	3.97E-9	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.34	-5.84	1.0E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.33	-5.82	1.11E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.33	-5.82	1.11E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.33	-5.84	9.56E-9	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs4795525	chr17:28388487	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.11	4.74E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs4796034	chr17:26093792	LGALS9	chr17:25958174-25976585:+	-0.09	-4.28	2.22E-5	Fractional exhaled nitric oxide (childhood)	
PRAD	cis	1	rs479879	chr10:105945985	C10orf79	chr10:105889647-105992120:-	0.26	4.65	4.3E-6	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs4801872	chr19:52025017	ZNF175	chr19:52074531-52092990:+	-0.33	-5.11	4.67E-7	Carotid intima media thickness	
PRAD	cis	1	rs4802200	chr19:44289518	LYPD5	chr19:44300080-44324808:-	-0.25	-5.34	1.43E-7	Breast cancer	
PRAD	cis	1	rs4802200	chr19:44289518	ZNF155	chr19:44488355-44502477:+	-0.25	-4.86	1.59E-6	Breast cancer	
PRAD	cis	1	rs4802200	chr19:44289518	ZNF404	chr19:44376516-44384288:-	-0.2	-4.18	3.47E-5	Breast cancer	
PRAD	cis	1	rs4802803	chr19:52027587	ZNF175	chr19:52074531-52092990:+	-0.34	-4.52	7.77E-6	Carotid intima media thickness	
PRAD	cis	1	rs4802803	chr19:52027587	ZNF766	chr19:52772824-52795977:+	-0.39	-3.71	0.000229	Carotid intima media thickness	
PRAD	cis	1	rs4803463	chr19:41911040	ATP5SL	chr19:41937224-41945810:-	0.16	3.8	0.000165	Height	
PRAD	cis	1	rs4803468	chr19:41922352	ATP5SL	chr19:41937224-41945810:-	0.16	3.61	0.000337	Height	
PRAD	cis	1	rs4803469	chr19:41922775	ATP5SL	chr19:41937224-41945810:-	0.16	3.61	0.000337	Height	
PRAD	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.59	12.97	4.05E-33	Schizophrenia	
PRAD	cis	1	rs4803658	chr19:44290013	LYPD5	chr19:44300080-44324808:-	-0.24	-5.07	5.63E-7	Breast cancer	
PRAD	cis	1	rs4803658	chr19:44290013	ZNF155	chr19:44488355-44502477:+	-0.24	-4.64	4.59E-6	Breast cancer	
PRAD	cis	1	rs4803658	chr19:44290013	ZNF223	chr19:44556164-44572142:+	-0.15	-3.44	0.000634	Breast cancer	
PRAD	cis	1	rs4803658	chr19:44290013	ZNF404	chr19:44376516-44384288:-	-0.2	-4.27	2.34E-5	Breast cancer	
PRAD	cis	1	rs4803774	chr19:45450872	APOC2	chr19:45449243-45452817:+	-0.56	-12.61	1.34E-31	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs4803774	chr19:45450872	APOE	chr19:45409039-45412649:+	0.14	3.77	0.000184	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs4804411	chr19:7222377	ZNF358	chr19:7581004-7585911:+	-0.1	-3.93	9.68E-5	Triglycerides	
PRAD	cis	1	rs4805834	chr19:33453659	SLC7A9	chr19:33321421-33360683:-	-0.36	-5.14	4.06E-7	Creatinine levels	
PRAD	cis	1	rs480643	chr10:131400308	MGMT	chr10:131265454-131565783:+	0.36	9.76	1.35E-20	Response to temozolomide	
PRAD	cis	1	rs4808133	chr19:18608518	ELL	chr19:18553475-18632937:-	-0.17	-3.94	9.27E-5	Breast cancer	
PRAD	cis	1	rs4808133	chr19:18608518	SSBP4	chr19:18530221-18545371:+	-0.18	-6.06	2.77E-9	Breast cancer	
PRAD	cis	1	rs4808134	chr19:18608579	ELL	chr19:18553475-18632937:-	-0.17	-3.94	9.27E-5	Breast cancer	
PRAD	cis	1	rs4808134	chr19:18608579	SSBP4	chr19:18530221-18545371:+	-0.18	-6.06	2.77E-9	Breast cancer	
PRAD	cis	1	rs4808136	chr19:18618867	ELL	chr19:18553475-18632937:-	0.16	3.76	0.000189	Breast cancer	
PRAD	cis	1	rs4808136	chr19:18618867	SSBP4	chr19:18530221-18545371:+	0.18	5.9	6.98E-9	Breast cancer	
PRAD	cis	1	rs4808326	chr19:15726147	CYP4F8	chr19:15726029-15740445:+	0.4	4.45	1.07E-5	Inflammatory biomarkers	
PRAD	cis	1	rs4808801	chr19:18571141	SSBP4	chr19:18530221-18545371:+	-0.17	-5.63	3.19E-8	Breast cancer	
PRAD	cis	1	rs4808804	chr19:18585325	ELL	chr19:18553475-18632937:-	-0.15	-3.57	0.000401	Breast cancer	
PRAD	cis	1	rs4808804	chr19:18585325	SSBP4	chr19:18530221-18545371:+	-0.16	-5.42	9.63E-8	Breast cancer	
PRAD	cis	1	rs4809219	chr20:62303115	ZGPAT	chr20:62338794-62370459:+	0.13	4.2	3.19E-5	Atopic dermatitis	
PRAD	cis	1	rs4809758	chr20:48440853	SPATA2	chr20:48519931-48532080:-	-0.2	-4.4	1.36E-5	Gut microbiota (beta diversity)	
PRAD	cis	1	rs4809760	chr20:48454671	SPATA2	chr20:48519931-48532080:-	0.19	4.11	4.58E-5	Gut microbiota (beta diversity)	
PRAD	cis	1	rs4810909	chr20:47621372	CSE1L	chr20:47662838-47713484:+	-0.2	-4.74	2.8E-6	Anger	
PRAD	cis	1	rs4810988	chr20:48465969	SPATA2	chr20:48519931-48532080:-	-0.21	-4.54	7.09E-6	Gut microbiota (beta diversity)	
PRAD	cis	1	rs4811602	chr20:36849088	SRC	chr20:35973088-36033819:+	-0.18	-3.52	0.000481	Heart rate	
PRAD	cis	1	rs4811694	chr20:55029388	C20orf43	chr20:55043647-55093942:+	0.17	4.2	3.19E-5	Refractive astigmatism	
PRAD	cis	1	rs4812048	chr20:57587771	TH1L	chr20:57556311-57570186:+	-0.45	-7.43	5.01E-13	Mean platelet volume	
PRAD	cis	1	rs4812048	chr20:57587771	TUBB1	chr20:57594309-57601707:+	-0.27	-3.55	0.000418	Mean platelet volume	
PRAD	cis	1	rs4813452	chr20:22276813	PAX1	chr20:21686297-21696620:+	0.15	3.95	8.84E-5	Glucose homeostasis traits	
PRAD	cis	1	rs4813454	chr20:22284723	PAX1	chr20:21686297-21696620:+	0.16	4.03	6.63E-5	Glucose homeostasis traits	
PRAD	cis	1	rs4813562	chr20:25352588	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4813562	chr20:25352588	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4813562	chr20:25352588	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4813563	chr20:25365340	ENTPD6	chr20:25176339-25207360:+	0.18	4.68	3.68E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4813563	chr20:25365340	FAM182B	chr20:25744102-25848786:-	-0.36	-6.61	1.03E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4813563	chr20:25365340	PYGB	chr20:25228706-25278647:+	0.34	7.38	7.19E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4813566	chr20:25386465	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4813566	chr20:25386465	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4813566	chr20:25386465	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815103	chr20:22291219	PAX1	chr20:21686297-21696620:+	-0.14	-3.67	0.000266	Glucose homeostasis traits	
PRAD	cis	1	rs4815404	chr20:25301845	ENTPD6	chr20:25176339-25207360:+	0.18	4.67	3.92E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815404	chr20:25301845	FAM182B	chr20:25744102-25848786:-	-0.36	-6.67	7.33E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815404	chr20:25301845	PYGB	chr20:25228706-25278647:+	0.34	7.39	6.85E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815405	chr20:25317492	ENTPD6	chr20:25176339-25207360:+	0.16	4.17	3.64E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815405	chr20:25317492	FAM182B	chr20:25744102-25848786:-	-0.37	-6.73	4.91E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815405	chr20:25317492	PYGB	chr20:25228706-25278647:+	0.32	7.05	6.56E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815406	chr20:25341316	ENTPD6	chr20:25176339-25207360:+	0.16	4.27	2.35E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815406	chr20:25341316	FAM182B	chr20:25744102-25848786:-	-0.38	-7.1	4.53E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815406	chr20:25341316	PYGB	chr20:25228706-25278647:+	0.32	7	8.9E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815407	chr20:25341478	ENTPD6	chr20:25176339-25207360:+	0.18	4.67	3.92E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815407	chr20:25341478	FAM182B	chr20:25744102-25848786:-	-0.36	-6.67	7.33E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815407	chr20:25341478	PYGB	chr20:25228706-25278647:+	0.34	7.39	6.85E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815408	chr20:25346678	ENTPD6	chr20:25176339-25207360:+	0.18	4.67	3.85E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815408	chr20:25346678	FAM182B	chr20:25744102-25848786:-	-0.36	-6.68	6.97E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815408	chr20:25346678	PYGB	chr20:25228706-25278647:+	0.34	7.4	6.32E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815409	chr20:25346697	ENTPD6	chr20:25176339-25207360:+	0.16	4.27	2.35E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815409	chr20:25346697	FAM182B	chr20:25744102-25848786:-	-0.38	-7.1	4.53E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815409	chr20:25346697	PYGB	chr20:25228706-25278647:+	0.32	7	8.9E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815411	chr20:25350223	ENTPD6	chr20:25176339-25207360:+	0.16	4.26	2.45E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815411	chr20:25350223	FAM182B	chr20:25744102-25848786:-	-0.38	-7.07	5.76E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815411	chr20:25350223	PYGB	chr20:25228706-25278647:+	0.32	7	8.64E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815412	chr20:25350325	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.27	2.35E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815412	chr20:25350325	FAM182B	chr20:25744102-25848786:-	0.38	7.1	4.53E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815412	chr20:25350325	PYGB	chr20:25228706-25278647:+	-0.32	-7	8.9E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815417	chr20:25379526	ENTPD6	chr20:25176339-25207360:+	0.16	4.35	1.65E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815417	chr20:25379526	FAM182B	chr20:25744102-25848786:-	-0.38	-7.1	4.65E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815417	chr20:25379526	PYGB	chr20:25228706-25278647:+	0.32	7.03	7.13E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815418	chr20:25382211	ENTPD6	chr20:25176339-25207360:+	0.17	4.45	1.07E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815418	chr20:25382211	FAM182B	chr20:25744102-25848786:-	-0.37	-6.8	3.27E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815418	chr20:25382211	PYGB	chr20:25228706-25278647:+	0.32	7.04	7.07E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815420	chr20:25383979	ENTPD6	chr20:25176339-25207360:+	0.16	4.19	3.39E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815420	chr20:25383979	FAM182B	chr20:25744102-25848786:-	-0.39	-7.1	4.69E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815420	chr20:25383979	PYGB	chr20:25228706-25278647:+	0.32	6.92	1.52E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815421	chr20:25386509	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815421	chr20:25386509	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815421	chr20:25386509	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815424	chr20:25390284	ENTPD6	chr20:25176339-25207360:+	0.18	4.68	3.68E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815424	chr20:25390284	FAM182B	chr20:25744102-25848786:-	-0.36	-6.61	1.03E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815424	chr20:25390284	PYGB	chr20:25228706-25278647:+	0.34	7.38	7.19E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815426	chr20:25405186	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815426	chr20:25405186	FAM182B	chr20:25744102-25848786:-	-0.38	-7.09	5.05E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815426	chr20:25405186	PYGB	chr20:25228706-25278647:+	0.32	7.02	7.71E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs4815603	chr20:3772527	CDC25B	chr20:3767578-3786759:+	0.36	10.33	1.12E-22	Bipolar disorder	
PRAD	cis	1	rs4819388	chr21:45647421	ICOSLG	chr21:45646724-45660834:-	-0.4	-8.09	5.06E-15	Celiac disease	
PRAD	cis	1	rs4820294	chr22:38071043	GALR3	chr22:38219389-38221502:+	0.26	4.58	6.01E-6	Fat distribution (HIV)	
PRAD	cis	1	rs4820294	chr22:38071043	LGALS1	chr22:38071613-38075807:+	-0.09	-4.83	1.87E-6	Fat distribution (HIV)	
PRAD	cis	1	rs4820294	chr22:38071043	LGALS2	chr22:37966254-37976024:-	0.17	4.37	1.55E-5	Fat distribution (HIV)	
PRAD	cis	1	rs4820345	chr22:39091151	CBY1	chr22:39052658-39069853:+	0.16	4.61	5.29E-6	Resting heart rate	
PRAD	cis	1	rs4820345	chr22:39091151	LOC646851	chr22:38974125-39052634:-	0.18	4.16	3.81E-5	Resting heart rate	
PRAD	cis	1	rs4820834	chr22:30751627	GATSL3	chr22:30681108-30695540:-	-0.27	-4.23	2.8E-5	Coronary artery calcification	
PRAD	cis	1	rs4820834	chr22:30751627	SEC14L2	chr22:30792933-30824976:+	-0.38	-4.55	6.74E-6	Coronary artery calcification	
PRAD	cis	1	rs4821544	chr22:37258503	NCF4	chr22:37257030-37274058:+	0.11	5.16	3.63E-7	Atopic dermatitis	
PRAD	cis	1	rs4821798	chr22:39021165	CBY1	chr22:39052658-39069853:+	0.13	3.68	0.000259	Resting heart rate	
PRAD	cis	1	rs4821798	chr22:39021165	LOC646851	chr22:38974125-39052634:-	0.21	5.08	5.54E-7	Resting heart rate	
PRAD	cis	1	rs4821808	chr22:39065739	CBY1	chr22:39052658-39069853:+	0.17	4.7	3.42E-6	Resting heart rate	
PRAD	cis	1	rs4821808	chr22:39065739	LOC646851	chr22:38974125-39052634:-	0.18	4.3	2.1E-5	Resting heart rate	
PRAD	cis	1	rs4821809	chr22:39065743	CBY1	chr22:39052658-39069853:+	0.17	4.7	3.42E-6	Resting heart rate	
PRAD	cis	1	rs4821809	chr22:39065743	LOC646851	chr22:38974125-39052634:-	0.18	4.3	2.1E-5	Resting heart rate	
PRAD	cis	1	rs4821810	chr22:39072098	CBY1	chr22:39052658-39069853:+	0.14	4.07	5.53E-5	Resting heart rate	
PRAD	cis	1	rs4821810	chr22:39072098	LOC646851	chr22:38974125-39052634:-	0.19	4.72	3.16E-6	Resting heart rate	
PRAD	cis	1	rs4821811	chr22:39075145	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs4821811	chr22:39075145	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs4821812	chr22:39075235	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs4821812	chr22:39075235	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs4821816	chr22:39113134	CBY1	chr22:39052658-39069853:+	0.14	3.97	8.46E-5	Resting heart rate	
PRAD	cis	1	rs4821816	chr22:39113134	LOC646851	chr22:38974125-39052634:-	0.19	4.71	3.21E-6	Resting heart rate	
PRAD	cis	1	rs4823086	chr22:30688659	GATSL3	chr22:30681108-30695540:-	-0.28	-4.4	1.34E-5	Coronary artery calcification	
PRAD	cis	1	rs4823086	chr22:30688659	SEC14L2	chr22:30792933-30824976:+	-0.38	-4.62	5.05E-6	Coronary artery calcification	
PRAD	cis	1	rs4823087	chr22:30693581	GATSL3	chr22:30681108-30695540:-	-0.27	-4.34	1.77E-5	Coronary artery calcification	
PRAD	cis	1	rs4823087	chr22:30693581	SEC14L2	chr22:30792933-30824976:+	-0.38	-4.59	5.6E-6	Coronary artery calcification	
PRAD	cis	1	rs4824112	chr22:50284345	CRELD2	chr22:50312283-50321186:+	0.21	4.27	2.39E-5	Schizophrenia	
PRAD	cis	1	rs4835669	chr5:137473391	REEP2	chr5:137774776-137782657:+	-0.09	-3.69	0.000253	Resting heart rate	
PRAD	cis	1	rs4835671	chr5:137511801	REEP2	chr5:137774776-137782657:+	-0.1	-3.93	9.83E-5	Resting heart rate	
PRAD	cis	1	rs4835681	chr5:137783690	BRD8	chr5:137384973-137514358:-	-0.17	-3.79	0.000173	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	
PRAD	cis	1	rs4835682	chr5:137784254	BRD8	chr5:137384973-137514358:-	-0.17	-3.79	0.000171	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	
PRAD	cis	1	rs4835796	chr5:137782115	BRD8	chr5:137384973-137514358:-	-0.17	-3.75	0.000198	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	
PRAD	cis	1	rs4835796	chr5:137782115	EGR1	chr5:137801181-137805004:+	-0.18	-3.68	0.000265	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	
PRAD	cis	1	rs4836534	chr5:122729998	CEP120	chr5:122680580-122759252:-	-0.23	-5.07	5.8E-7	Waist circumference	
PRAD	cis	1	rs4838890	chr1:110616679	ALX3	chr1:110602998-110613322:-	-0.24	-4.49	8.92E-6	Blood metabolite levels	
PRAD	cis	1	rs4839103	chr1:110620701	ALX3	chr1:110602998-110613322:-	-0.22	-4.24	2.64E-5	Blood metabolite levels	
PRAD	cis	1	rs4842838	chr15:84582124	NMB	chr15:85198362-85201802:-	0.17	4.02	6.74E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs4842923	chr15:84581904	NMB	chr15:85198362-85201802:-	-0.16	-3.86	0.000127	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs4842924	chr15:84587607	FAM103A1	chr15:83654995-83659423:+	0.17	3.6	0.000356	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs4842924	chr15:84587607	NMB	chr15:85198362-85201802:-	0.17	4.11	4.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs4844588	chr1:207429668	CD55	chr1:207494817-207534309:+	0.47	8.8	2.61E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs4844590	chr1:207496129	CD55	chr1:207494817-207534309:+	0.55	10.38	6.99E-23	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs4844591	chr1:207500293	CD55	chr1:207494817-207534309:+	0.25	4.45	1.08E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs4844592	chr1:207501211	CD55	chr1:207494817-207534309:+	0.24	4.28	2.3E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs4845756	chr1:152254919	FLG	chr1:152274651-152297679:-	-0.32	-5.29	1.91E-7	Atopic dermatitis	
PRAD	cis	1	rs4847181	chr1:93028792	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs4850410	chr2:197920169	ANKRD44	chr2:197831743-198175495:-	-0.14	-3.98	7.85E-5	Interferon alpha levels in systemic lupus erythematosus	
PRAD	cis	1	rs4850996	chr2:102697052	MFSD9	chr2:103333666-103353337:-	0.16	3.69	0.000251	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs4850997	chr2:102702313	MFSD9	chr2:103333666-103353337:-	0.18	4.21	3.07E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs4851539	chr2:102696765	MFSD9	chr2:103333666-103353337:-	0.16	3.73	0.000213	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs4852715	chr2:71088070	CLEC4F	chr2:71035779-71047732:-	-0.21	-3.83	0.000143	IgG glycosylation	
PRAD	cis	1	rs4853461	chr2:192119298	GLS	chr2:191745547-191829776:+	-0.14	-3.76	0.00019	Obesity-related traits	
PRAD	cis	1	rs4853461	chr2:192119298	STAT4	chr2:191894306-192038902:-	0.11	3.62	0.000325	Obesity-related traits	
PRAD	cis	1	rs4853462	chr2:192123804	GLS	chr2:191745547-191829776:+	-0.14	-3.76	0.00019	Obesity-related traits	
PRAD	cis	1	rs4853462	chr2:192123804	STAT4	chr2:191894306-192038902:-	0.11	3.62	0.000325	Obesity-related traits	
PRAD	cis	1	rs4853515	chr2:191552575	OSGEPL1	chr2:190611386-190627953:-	0.2	3.71	0.000229	Primary biliary cirrhosis	
PRAD	cis	1	rs4853561	chr2:192107706	STAT4	chr2:191894306-192038902:-	0.13	3.98	8.09E-5	Obesity-related traits	
PRAD	cis	1	rs4853562	chr2:192118422	GLS	chr2:191745547-191829776:+	-0.14	-3.76	0.00019	Obesity-related traits	
PRAD	cis	1	rs4853562	chr2:192118422	STAT4	chr2:191894306-192038902:-	0.11	3.62	0.000325	Obesity-related traits	
PRAD	cis	1	rs4853563	chr2:192119534	GLS	chr2:191745547-191829776:+	-0.14	-3.76	0.00019	Obesity-related traits	
PRAD	cis	1	rs4853563	chr2:192119534	STAT4	chr2:191894306-192038902:-	0.11	3.62	0.000325	Obesity-related traits	
PRAD	cis	1	rs4853564	chr2:192123665	GLS	chr2:191745547-191829776:+	-0.14	-3.76	0.00019	Obesity-related traits	
PRAD	cis	1	rs4853564	chr2:192123665	STAT4	chr2:191894306-192038902:-	0.11	3.62	0.000325	Obesity-related traits	
PRAD	cis	1	rs4853565	chr2:192123746	GLS	chr2:191745547-191829776:+	-0.14	-3.76	0.00019	Obesity-related traits	
PRAD	cis	1	rs4853565	chr2:192123746	STAT4	chr2:191894306-192038902:-	0.11	3.62	0.000325	Obesity-related traits	
PRAD	cis	1	rs4853568	chr2:192126190	GLS	chr2:191745547-191829776:+	-0.13	-3.64	0.000308	Obesity-related traits	
PRAD	cis	1	rs4853568	chr2:192126190	STAT4	chr2:191894306-192038902:-	0.12	3.69	0.000249	Obesity-related traits	
PRAD	cis	1	rs4854058	chr2:240923677	NDUFA10	chr2:240900158-240964798:-	0.27	6	3.85E-9	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.35	9.87	5.45E-21	Response to temozolomide	
PRAD	cis	1	rs4858793	chr3:48415007	ATRIP	chr3:48488141-48507708:+	-0.26	-6.3	6.67E-10	Longevity	
PRAD	cis	1	rs4858793	chr3:48415007	TREX1	chr3:48501186-48509043:+	0.15	4.3	2.1E-5	Longevity	
PRAD	cis	1	rs4858817	chr3:48416756	ATRIP	chr3:48488141-48507708:+	-0.27	-6.61	1.02E-10	Longevity	
PRAD	cis	1	rs4858817	chr3:48416756	CDC25A	chr3:48198668-48229801:-	-0.2	-3.85	0.000135	Longevity	
PRAD	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.16	4.59	5.64E-6	Longevity	
PRAD	cis	1	rs4858888	chr3:47405305	C3orf75	chr3:47537131-47555199:-	0.17	5.09	5.19E-7	Colorectal cancer	
PRAD	cis	1	rs4858888	chr3:47405305	NBEAL2	chr3:47021173-47051193:+	0.16	4.93	1.16E-6	Colorectal cancer	
PRAD	cis	1	rs4862406	chr4:185629339	CASP3	chr4:185548852-185570629:-	-0.16	-3.65	0.00029	Kawasaki disease	
PRAD	cis	1	rs4862406	chr4:185629339	CCDC111	chr4:185570767-185616112:+	-0.18	-4.24	2.7E-5	Kawasaki disease	
PRAD	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.48	13.68	4.21E-36	Kawasaki disease	
PRAD	cis	1	rs4864759	chr4:54259408	FIP1L1	chr4:54243820-54326102:+	-0.18	-3.93	9.6E-5	DNA methylation (variation)	
PRAD	cis	1	rs4865008	chr4:56410855	TMEM165	chr4:56262090-56292342:+	0.16	3.43	0.000653	Personality dimensions	
PRAD	cis	1	rs4865463	chr4:1742400	FAM53A	chr4:1641609-1685854:-	-0.42	-7.68	9.31E-14	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs4865467	chr4:1745500	FAM53A	chr4:1641609-1685854:-	0.41	7.53	2.56E-13	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs4869313	chr5:96223880	ERAP1	chr5:96096515-96149837:-	0.13	3.88	0.000119	Pediatric autoimmune diseases	
PRAD	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-1.03	-35.31	2.64E-134	Pediatric autoimmune diseases	
PRAD	cis	1	rs4871	chr6:26545632	BTN2A3	chr6:26422317-26431927:+	0.25	6.31	6.29E-10	Educational attainment	
PRAD	cis	1	rs4871	chr6:26545632	ZNF184	chr6:27418522-27440897:-	-0.17	-3.62	0.000327	Educational attainment	
PRAD	cis	1	rs488079	chr1:155890581	RIT1	chr1:155867601-155881177:-	0.18	4.12	4.41E-5	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs4881994	chr11:48498139	FOLH1	chr11:49168188-49230222:-	-0.15	-3.45	0.000611	HDL cholesterol	
PRAD	cis	1	rs4882010	chr11:48559173	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000333	HDL cholesterol	
PRAD	cis	1	rs4882015	chr11:48565573	FOLH1	chr11:49168188-49230222:-	-0.15	-3.43	0.000655	HDL cholesterol	
PRAD	cis	1	rs4882016	chr11:48570125	FOLH1	chr11:49168188-49230222:-	-0.16	-3.63	0.000312	HDL cholesterol	
PRAD	cis	1	rs4882019	chr11:48598748	FOLH1	chr11:49168188-49230222:-	-0.15	-3.45	0.000602	HDL cholesterol	
PRAD	cis	1	rs4882021	chr11:48615966	FOLH1	chr11:49168188-49230222:-	-0.15	-3.48	0.000547	HDL cholesterol	
PRAD	cis	1	rs4882096	chr11:48534102	FOLH1	chr11:49168188-49230222:-	-0.16	-3.67	0.000271	HDL cholesterol	
PRAD	cis	1	rs4882111	chr11:48558447	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000333	HDL cholesterol	
PRAD	cis	1	rs4882117	chr11:48565468	FOLH1	chr11:49168188-49230222:-	-0.15	-3.43	0.000655	HDL cholesterol	
PRAD	cis	1	rs4882120	chr11:48573529	FOLH1	chr11:49168188-49230222:-	-0.16	-3.7	0.000244	HDL cholesterol	
PRAD	cis	1	rs4882123	chr11:48575739	FOLH1	chr11:49168188-49230222:-	-0.16	-3.7	0.000244	HDL cholesterol	
PRAD	cis	1	rs4882129	chr11:48588774	FOLH1	chr11:49168188-49230222:-	-0.16	-3.68	0.000261	HDL cholesterol	
PRAD	cis	1	rs4882130	chr11:48588954	FOLH1	chr11:49168188-49230222:-	-0.16	-3.68	0.000261	HDL cholesterol	
PRAD	cis	1	rs4882132	chr11:48593125	FOLH1	chr11:49168188-49230222:-	-0.16	-3.48	0.000539	HDL cholesterol	
PRAD	cis	1	rs4882134	chr11:48598795	FOLH1	chr11:49168188-49230222:-	-0.15	-3.45	0.000602	HDL cholesterol	
PRAD	cis	1	rs4882136	chr11:48615311	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000344	HDL cholesterol	
PRAD	cis	1	rs4886018	chr13:52990717	CKAP2	chr13:53029495-53050763:+	-0.48	-10	1.82E-21	Lewy body disease	
PRAD	cis	1	rs4886018	chr13:52990717	NEK3	chr13:52706780-52733996:-	0.3	5.76	1.5E-8	Lewy body disease	
PRAD	cis	1	rs4886422	chr15:75426723	MPI	chr15:75182410-75190565:+	0.15	3.61	0.000342	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs4886615	chr15:75131661	MPI	chr15:75182410-75190565:+	0.19	4.64	4.62E-6	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
PRAD	cis	1	rs4886615	chr15:75131661	ULK3	chr15:75128459-75135552:-	-0.14	-3.65	0.000287	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
PRAD	cis	1	rs4886818	chr15:76880939	SCAPER	chr15:76640529-77197744:-	-0.13	-3.85	0.000132	Blood metabolite levels	
PRAD	cis	1	rs4887067	chr15:78886947	CHRNA3	chr15:78885397-78913322:-	-0.28	-4.91	1.26E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs4887067	chr15:78886947	CHRNA5	chr15:78857906-78886458:+	-0.21	-4.28	2.25E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs4887783	chr16:74700743	RFWD3	chr16:74655298-74700779:-	-0.29	-7.23	1.93E-12	Testicular germ cell tumor	
PRAD	cis	1	rs4888262	chr16:74670458	RFWD3	chr16:74655298-74700779:-	-0.32	-8.08	5.68E-15	Testicular germ cell tumor	
PRAD	cis	1	rs4888264	chr16:74681632	RFWD3	chr16:74655298-74700779:-	-0.28	-7.1	4.67E-12	Testicular germ cell tumor	
PRAD	cis	1	rs4888265	chr16:74683737	RFWD3	chr16:74655298-74700779:-	-0.28	-6.93	1.43E-11	Testicular germ cell tumor	
PRAD	cis	1	rs4888668	chr16:77779481	NUDT7	chr16:77756411-77776153:+	0.24	3.62	0.000328	Obesity-related traits	
PRAD	cis	1	rs4888722	chr16:78063578	CLEC3A	chr16:78056443-78065997:+	-0.47	-5.96	5.0E-9	Colorectal or endometrial cancer	
PRAD	cis	1	rs4889609	chr16:31026427	HSD3B7	chr16:30996519-31000473:+	0.49	10.68	5.7E-24	Response to metformin (IC50)	
PRAD	cis	1	rs4889609	chr16:31026427	MYST1	chr16:31128985-31142713:+	0.21	6.42	3.24E-10	Response to metformin (IC50)	
PRAD	cis	1	rs4889609	chr16:31026427	PRSS36	chr16:31150251-31161415:-	0.19	4.93	1.12E-6	Response to metformin (IC50)	
PRAD	cis	1	rs4889609	chr16:31026427	PRSS53	chr16:31094747-31106276:-	-0.19	-3.75	0.000199	Response to metformin (IC50)	
PRAD	cis	1	rs4889609	chr16:31026427	STX1B	chr16:31000577-31021829:-	0.22	5.75	1.6E-8	Response to metformin (IC50)	
PRAD	cis	1	rs4894410	chr3:139043236	CLSTN2	chr3:139654027-140286917:+	-0.5	-4.69	3.6E-6	Kawasaki disease	
PRAD	cis	1	rs4897107	chr6:149601591	ULBP2	chr6:150263136-150270366:+	0.19	3.45	0.000601	Breast cancer	
PRAD	cis	1	rs4899015	chr14:61126036	C14orf39	chr14:60902675-60952764:-	0.44	3.93	9.84E-5	Immune reponse to smallpox (secreted IFN-alpha)	
PRAD	cis	1	rs4899148	chr14:65303778	CHURC1	chr14:65381140-65411309:+	0.49	6.41	3.59E-10	Daytime sleep phenotypes	
PRAD	cis	1	rs4899329	chr14:70620642	MAP3K9	chr14:71194856-71275888:-	-0.15	-3.93	9.89E-5	IgG glycosylation	
PRAD	cis	1	rs4899544	chr14:75546556	EIF2B2	chr14:75469612-75476292:+	0.24	4.85	1.67E-6	Height	
PRAD	cis	1	rs4899544	chr14:75546556	MLH3	chr14:75480467-75518235:-	0.33	6.65	8.16E-11	Height	
PRAD	cis	1	rs4899546	chr14:75594946	EIF2B2	chr14:75469612-75476292:+	0.25	4.98	9.01E-7	Height	
PRAD	cis	1	rs4899546	chr14:75594946	MLH3	chr14:75480467-75518235:-	0.32	6.58	1.25E-10	Height	
PRAD	cis	1	rs4899586	chr14:76660856	C14orf118	chr14:76618259-76669133:+	0.14	3.61	0.00034	Blood pressure	
PRAD	cis	1	rs4899586	chr14:76660856	ESRRB	chr14:76837690-76968178:+	0.26	3.66	0.000276	Blood pressure	
PRAD	cis	1	rs4901985	chr14:60948318	C14orf39	chr14:60902675-60952764:-	0.46	6.11	2.07E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs4901985	chr14:60948318	DHRS7	chr14:60611502-60636561:-	0.2	3.46	0.000583	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs4901994	chr14:61090202	C14orf39	chr14:60902675-60952764:-	0.55	6.28	7.68E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs4901995	chr14:61090629	C14orf39	chr14:60902675-60952764:-	0.56	6.41	3.48E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs490234	chr9:128303734	PBX3	chr9:128509617-128729653:+	0.2	4.42	1.23E-5	Mean arterial pressure	
PRAD	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.43	-11.55	2.36E-27	Common traits (Other)	
PRAD	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.43	-11.55	2.36E-27	Common traits (Other)	
PRAD	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.43	-11.55	2.36E-27	Common traits (Other)	
PRAD	cis	1	rs4903275	chr14:75512509	EIF2B2	chr14:75469612-75476292:+	0.25	5.08	5.43E-7	Height	
PRAD	cis	1	rs4903275	chr14:75512509	MLH3	chr14:75480467-75518235:-	0.33	6.63	9.05E-11	Height	
PRAD	cis	1	rs4903279	chr14:75546583	EIF2B2	chr14:75469612-75476292:+	0.24	4.85	1.67E-6	Height	
PRAD	cis	1	rs4903279	chr14:75546583	MLH3	chr14:75480467-75518235:-	0.33	6.65	8.16E-11	Height	
PRAD	cis	1	rs4903281	chr14:75554361	EIF2B2	chr14:75469612-75476292:+	0.25	4.91	1.25E-6	Height	
PRAD	cis	1	rs4903281	chr14:75554361	MLH3	chr14:75480467-75518235:-	0.33	6.64	8.48E-11	Height	
PRAD	cis	1	rs4903284	chr14:75592483	EIF2B2	chr14:75469612-75476292:+	0.25	4.97	9.32E-7	Height	
PRAD	cis	1	rs4903284	chr14:75592483	MLH3	chr14:75480467-75518235:-	0.32	6.6	1.09E-10	Height	
PRAD	cis	1	rs4903289	chr14:75623988	EIF2B2	chr14:75469612-75476292:+	-0.24	-4.79	2.2E-6	Height	
PRAD	cis	1	rs4903289	chr14:75623988	MLH3	chr14:75480467-75518235:-	-0.33	-6.74	4.63E-11	Height	
PRAD	cis	1	rs4903386	chr14:76669658	C14orf118	chr14:76618259-76669133:+	0.14	3.49	0.000523	Blood pressure	
PRAD	cis	1	rs4903386	chr14:76669658	ESRRB	chr14:76837690-76968178:+	0.26	3.54	0.000448	Blood pressure	
PRAD	cis	1	rs4905138	chr14:94466357	DDX24	chr14:94517269-94547558:-	-0.16	-3.57	0.000396	Coronary artery aneurysm in Kawasaki disease	
PRAD	cis	1	rs4906205	chr14:102932447	ANKRD9	chr14:102973198-102976128:-	0.18	4.33	1.79E-5	QT interval	
PRAD	cis	1	rs4907240	chr2:97228039	GPAT2	chr2:96687695-96701722:-	-0.23	-3.49	0.00052	Event-related brain oscillations	
PRAD	cis	1	rs4909017	chr3:32937596	CCR4	chr3:32993066-32996403:+	-0.1	-3.55	0.000421	Pulmonary function	
PRAD	cis	1	rs491098	chr13:113769346	F7	chr13:113760105-113774994:+	0.4	5.73	1.77E-8	End-stage coagulation	
PRAD	cis	1	rs4911178	chr20:33952620	CEP250	chr20:34042996-34099802:+	-0.24	-5.43	8.94E-8	Height	
PRAD	cis	1	rs4911178	chr20:33952620	CPNE1	chr20:34213968-34262539:-	0.2	4	7.32E-5	Height	
PRAD	cis	1	rs4911178	chr20:33952620	FAM83C	chr20:33873287-33880225:-	0.16	3.66	0.000283	Height	
PRAD	cis	1	rs4911178	chr20:33952620	GDF5	chr20:33897002-34042568:-	-0.2	-4.87	1.5E-6	Height	
PRAD	cis	1	rs4911178	chr20:33952620	MMP24	chr20:33814539-33864804:+	0.15	3.71	0.000231	Height	
PRAD	cis	1	rs4911178	chr20:33952620	UQCC	chr20:33890383-33999833:-	0.38	7.19	2.62E-12	Height	
PRAD	cis	1	rs4911180	chr20:33972948	CEP250	chr20:34042996-34099802:+	-0.25	-5.51	5.77E-8	Height	
PRAD	cis	1	rs4911180	chr20:33972948	CPNE1	chr20:34213968-34262539:-	0.2	3.95	9.07E-5	Height	
PRAD	cis	1	rs4911180	chr20:33972948	FAM83C	chr20:33873287-33880225:-	0.17	3.69	0.000252	Height	
PRAD	cis	1	rs4911180	chr20:33972948	GDF5	chr20:33897002-34042568:-	-0.2	-4.83	1.84E-6	Height	
PRAD	cis	1	rs4911180	chr20:33972948	UQCC	chr20:33890383-33999833:-	0.37	7	9.07E-12	Height	
PRAD	cis	1	rs4911491	chr20:33947285	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.2E-7	Height	
PRAD	cis	1	rs4911491	chr20:33947285	CPNE1	chr20:34213968-34262539:-	0.2	3.97	8.15E-5	Height	
PRAD	cis	1	rs4911491	chr20:33947285	FAM83C	chr20:33873287-33880225:-	0.17	3.7	0.000237	Height	
PRAD	cis	1	rs4911491	chr20:33947285	GDF5	chr20:33897002-34042568:-	-0.2	-4.91	1.29E-6	Height	
PRAD	cis	1	rs4911491	chr20:33947285	MMP24	chr20:33814539-33864804:+	0.14	3.62	0.000328	Height	
PRAD	cis	1	rs4911491	chr20:33947285	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.76E-12	Height	
PRAD	cis	1	rs4911492	chr20:33951799	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.2E-7	Height	
PRAD	cis	1	rs4911492	chr20:33951799	CPNE1	chr20:34213968-34262539:-	0.2	3.97	8.15E-5	Height	
PRAD	cis	1	rs4911492	chr20:33951799	FAM83C	chr20:33873287-33880225:-	0.17	3.7	0.000237	Height	
PRAD	cis	1	rs4911492	chr20:33951799	GDF5	chr20:33897002-34042568:-	-0.2	-4.91	1.29E-6	Height	
PRAD	cis	1	rs4911492	chr20:33951799	MMP24	chr20:33814539-33864804:+	0.14	3.62	0.000328	Height	
PRAD	cis	1	rs4911492	chr20:33951799	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.76E-12	Height	
PRAD	cis	1	rs4911494	chr20:33971914	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.2E-7	Height	
PRAD	cis	1	rs4911494	chr20:33971914	CPNE1	chr20:34213968-34262539:-	0.2	3.97	8.15E-5	Height	
PRAD	cis	1	rs4911494	chr20:33971914	FAM83C	chr20:33873287-33880225:-	0.17	3.7	0.000237	Height	
PRAD	cis	1	rs4911494	chr20:33971914	GDF5	chr20:33897002-34042568:-	-0.2	-4.91	1.29E-6	Height	
PRAD	cis	1	rs4911494	chr20:33971914	MMP24	chr20:33814539-33864804:+	0.14	3.62	0.000328	Height	
PRAD	cis	1	rs4911494	chr20:33971914	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.76E-12	Height	
PRAD	cis	1	rs4911496	chr20:33972053	CEP250	chr20:34042996-34099802:+	0.23	5.01	7.64E-7	Height	
PRAD	cis	1	rs4911496	chr20:33972053	CPNE1	chr20:34213968-34262539:-	-0.19	-3.83	0.000147	Height	
PRAD	cis	1	rs4911496	chr20:33972053	GDF5	chr20:33897002-34042568:-	0.19	4.61	5.19E-6	Height	
PRAD	cis	1	rs4911496	chr20:33972053	UQCC	chr20:33890383-33999833:-	-0.35	-6.47	2.46E-10	Height	
PRAD	cis	1	rs4917901	chr10:102201773	SEC31B	chr10:102246403-102289636:-	-0.31	-9.29	5.91E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs4919429	chr10:101938630	CWF19L1	chr10:101992055-102027437:-	-0.38	-4.33	1.82E-5	Schizophrenia	
PRAD	cis	1	rs4919431	chr10:101944325	CWF19L1	chr10:101992055-102027437:-	-0.38	-4.71	3.26E-6	Schizophrenia	
PRAD	cis	1	rs4919464	chr10:102221195	SEC31B	chr10:102246403-102289636:-	-0.32	-9.62	3.98E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs4919465	chr10:102221703	SEC31B	chr10:102246403-102289636:-	-0.32	-9.62	3.98E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs4919466	chr10:102241213	SEC31B	chr10:102246403-102289636:-	-0.31	-9.74	1.57E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs4919468	chr10:102288343	SEC31B	chr10:102246403-102289636:-	-0.33	-9.51	9.79E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs4919469	chr10:102298855	SEC31B	chr10:102246403-102289636:-	-0.28	-8.5	2.56E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs4919470	chr10:102298920	SEC31B	chr10:102246403-102289636:-	-0.31	-8.95	8.23E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs4919471	chr10:102299239	SEC31B	chr10:102246403-102289636:-	-0.28	-8.52	2.12E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs4919472	chr10:102315864	SEC31B	chr10:102246403-102289636:-	-0.27	-8.09	5.21E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs4919690	chr10:104616500	AS3MT	chr10:104613967-104661653:+	0.42	8.31	1.07E-15	Arsenic metabolism	
PRAD	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.4	7.43	5.05E-13	Arsenic metabolism	
PRAD	cis	1	rs4919690	chr10:104616500	NT5C2	chr10:104845940-104953056:-	0.23	3.85	0.000132	Arsenic metabolism	
PRAD	cis	1	rs4924935	chr17:18753870	FAM18B	chr17:18684582-18710026:+	-0.22	-4.4	1.35E-5	Pancreatic cancer	
PRAD	cis	1	rs4925166	chr17:18210810	EVPLL	chr17:18281079-18292958:+	-0.14	-4.02	6.73E-5	Multiple sclerosis	
PRAD	cis	1	rs4925166	chr17:18210810	FAM106A	chr17:18427880-18430160:-	-0.31	-5.38	1.2E-7	Multiple sclerosis	
PRAD	cis	1	rs4925166	chr17:18210810	LOC220594	chr17:18414577-18445234:-	-0.4	-6.11	2.13E-9	Multiple sclerosis	
PRAD	cis	1	rs4925166	chr17:18210810	MYO15A	chr17:18012020-18083115:+	0.28	5.79	1.31E-8	Multiple sclerosis	
PRAD	cis	1	rs4925540	chr1:247214878	ZNF670	chr1:247200087-247242069:-	-0.32	-7.14	3.47E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs4926400	chr1:149931541	MTMR11	chr1:149900544-149908791:-	0.16	3.89	0.000116	Height	
PRAD	cis	1	rs4929903	chr11:48913332	FOLH1	chr11:49168188-49230222:-	-0.16	-3.57	0.000394	HDL cholesterol	
PRAD	cis	1	rs4929983	chr11:2024579	LOC100133545	chr11:2004440-2011150:-	-0.15	-3.52	0.000472	DNA methylation (variation);DNA methylation (parent-of-origin)	
PRAD	cis	1	rs4930103	chr11:2024544	LOC100133545	chr11:2004440-2011150:-	-0.16	-3.64	0.000304	DNA methylation (variation);DNA methylation (parent-of-origin)	
PRAD	cis	1	rs4930723	chr12:124423600	ZNF664	chr12:124457670-124499967:+	-0.14	-3.62	0.000324	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs4930725	chr12:124428162	ZNF664	chr12:124457670-124499967:+	-0.15	-4.08	5.21E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs4930726	chr12:124428331	ZNF664	chr12:124457670-124499967:+	-0.15	-3.89	0.000114	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs4930743	chr12:5766807	ANO2	chr12:5671817-6055398:-	0.35	6.84	2.54E-11	Plasma clusterin levels	
PRAD	cis	1	rs4930776	chr12:5767385	ANO2	chr12:5671817-6055398:-	0.34	6.59	1.16E-10	Plasma clusterin levels	
PRAD	cis	1	rs4932143	chr15:90372067	AP3S2	chr15:90373832-90456222:-	-0.86	-17.96	2.75E-55	Type 2 diabetes	
PRAD	cis	1	rs4932143	chr15:90372067	C15orf38	chr15:90443832-90456222:-	0.2	3.77	0.000187	Type 2 diabetes	
PRAD	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.87	-18.79	3.49E-59	Type 2 diabetes	
PRAD	cis	1	rs4932148	chr15:90394356	C15orf38	chr15:90443832-90456222:-	0.2	3.87	0.000123	Type 2 diabetes	
PRAD	cis	1	rs4932236	chr15:90163339	GABARAPL3	chr15:90889765-90892679:-	-0.32	-3.43	0.000663	Obesity-related traits	
PRAD	cis	1	rs4932236	chr15:90163339	PEX11A	chr15:90226289-90233958:-	0.36	4.58	5.9E-6	Obesity-related traits	
PRAD	cis	1	rs4932237	chr15:90164185	GABARAPL3	chr15:90889765-90892679:-	-0.4	-3.48	0.000539	Obesity-related traits	
PRAD	cis	1	rs4932237	chr15:90164185	PEX11A	chr15:90226289-90233958:-	0.55	5.82	1.08E-8	Obesity-related traits	
PRAD	cis	1	rs4933206	chr10:93338600	PPP1R3C	chr10:93388201-93392858:-	-0.15	-3.49	0.000528	Smoking behavior	
PRAD	cis	1	rs4937126	chr11:126281897	ST3GAL4	chr11:126225579-126310752:+	-0.22	-3.67	0.000272	Coronary heart disease	
PRAD	cis	1	rs4938493	chr11:118144804	MPZL2	chr11:118124135-118135009:-	0.11	3.89	0.000115	Pain	
PRAD	cis	1	rs4938493	chr11:118144804	MPZL3	chr11:118100337-118123011:-	0.15	4.98	8.96E-7	Pain	
PRAD	cis	1	rs4938493	chr11:118144804	NLRX1	chr11:119039437-119054723:+	0.18	3.92	0.000103	Pain	
PRAD	cis	1	rs4938493	chr11:118144804	SCN2B	chr11:118033519-118047337:-	-0.11	-3.81	0.000158	Pain	
PRAD	cis	1	rs4938637	chr11:119075323	CBL	chr11:119076990-119178858:+	-0.29	-4.57	6.26E-6	Platelet count	
PRAD	cis	1	rs4938642	chr11:119099906	CBL	chr11:119076990-119178858:+	-0.33	-5.29	1.92E-7	Platelet count	
PRAD	cis	1	rs4938644	chr11:119153359	CBL	chr11:119076990-119178858:+	-0.31	-4.91	1.25E-6	Platelet count	
PRAD	cis	1	rs4939312	chr11:59900106	PATL1	chr11:59404194-59436511:-	0.11	3.63	0.000312	Alzheimer's disease (late onset)	
PRAD	cis	1	rs4939314	chr11:59900575	PATL1	chr11:59404194-59436511:-	-0.11	-3.55	0.000429	Alzheimer's disease (late onset)	
PRAD	cis	1	rs493954	chr1:228579613	TRIM11	chr1:228581379-228594517:-	-0.21	-3.46	0.000586	Hip circumference (psychosocial stress interaction)	
PRAD	cis	1	rs494003	chr11:65542298	CTSW	chr11:65647284-65651212:+	-0.26	-5.21	2.87E-7	Systemic lupus erythematosus	
PRAD	cis	1	rs494003	chr11:65542298	SNX32	chr11:65601410-65621170:+	0.31	4.44	1.14E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs4942487	chr13:46709389	ESD	chr13:47345392-47371367:-	-0.25	-3.77	0.000185	Non-alcoholic fatty liver disease histology (other)	
PRAD	cis	1	rs4943744	chr13:40808367	COG6	chr13:40229764-40365802:+	0.19	4.02	6.69E-5	Select biomarker traits	
PRAD	cis	1	rs4944195	chr11:78003499	GAB2	chr11:77926343-78128766:-	-0.21	-6.31	6.46E-10	Testicular germ cell tumor	
PRAD	cis	1	rs4944195	chr11:78003499	NARS2	chr11:78147017-78285909:-	-0.19	-3.73	0.000211	Testicular germ cell tumor	
PRAD	cis	1	rs4944198	chr11:78032605	GAB2	chr11:77926343-78128766:-	-0.19	-6.14	1.77E-9	Testicular germ cell tumor	
PRAD	cis	1	rs4944198	chr11:78032605	NARS2	chr11:78147017-78285909:-	-0.22	-4.55	6.82E-6	Testicular germ cell tumor	
PRAD	cis	1	rs4945261	chr11:77990260	GAB2	chr11:77926343-78128766:-	0.21	6.56	1.45E-10	Testicular germ cell tumor	
PRAD	cis	1	rs4945261	chr11:77990260	NARS2	chr11:78147017-78285909:-	0.19	3.71	0.000231	Testicular germ cell tumor	
PRAD	cis	1	rs4945267	chr11:78037933	GAB2	chr11:77926343-78128766:-	-0.21	-6.42	3.32E-10	Testicular germ cell tumor	
PRAD	cis	1	rs4945268	chr11:78037936	GAB2	chr11:77926343-78128766:-	-0.21	-6.42	3.32E-10	Testicular germ cell tumor	
PRAD	cis	1	rs4945270	chr11:78068216	GAB2	chr11:77926343-78128766:-	-0.2	-6.39	3.99E-10	Testicular germ cell tumor	
PRAD	cis	1	rs4945270	chr11:78068216	NARS2	chr11:78147017-78285909:-	-0.17	-3.47	0.000564	Testicular germ cell tumor	
PRAD	cis	1	rs4945274	chr11:78109260	GAB2	chr11:77926343-78128766:-	-0.17	-5.8	1.2E-8	Testicular germ cell tumor	
PRAD	cis	1	rs4945274	chr11:78109260	NARS2	chr11:78147017-78285909:-	-0.19	-4.14	4.17E-5	Testicular germ cell tumor	
PRAD	cis	1	rs4947534	chr7:56079094	GBAS	chr7:56032296-56067871:+	-0.44	-8.3	1.12E-15	Blood metabolite levels;Amino acid levels	
PRAD	cis	1	rs4947534	chr7:56079094	PSPH	chr7:56078746-56184090:-	-0.24	-4.29	2.18E-5	Blood metabolite levels;Amino acid levels	
PRAD	cis	1	rs494754	chr11:114402572	FAM55A	chr11:114392438-114430580:-	-0.2	-4.06	5.75E-5	Ulcerative colitis	
PRAD	cis	1	rs4948102	chr7:56097265	GBAS	chr7:56032296-56067871:+	-0.44	-8.19	2.55E-15	Plasma homocysteine levels (post-methionine load test)	
PRAD	cis	1	rs4948102	chr7:56097265	PSPH	chr7:56078746-56184090:-	-0.25	-4.46	1.03E-5	Plasma homocysteine levels (post-methionine load test)	
PRAD	cis	1	rs4948502	chr10:63839417	ARID5B	chr10:63661443-63856703:+	-0.16	-3.53	0.000464	Corneal structure	
PRAD	cis	1	rs4949674	chr1:76213715	ACADM	chr1:76190043-76229353:+	0.17	3.75	0.000197	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs4949872	chr1:76131392	ACADM	chr1:76190043-76229353:+	0.19	4.09	5.02E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs4949872	chr1:76131392	RABGGTB	chr1:76251886-76260764:+	0.17	3.47	0.000561	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs4949874	chr1:76161889	ACADM	chr1:76190043-76229353:+	0.18	3.83	0.000147	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs4949875	chr1:76173080	ACADM	chr1:76190043-76229353:+	0.2	4.26	2.51E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs4949875	chr1:76173080	RABGGTB	chr1:76251886-76260764:+	0.18	3.63	0.00032	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs4949876	chr1:76173377	ACADM	chr1:76190043-76229353:+	0.18	4.03	6.39E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs4949879	chr1:76237143	ACADM	chr1:76190043-76229353:+	0.18	3.92	0.000101	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs4950848	chr1:202356174	PPP1R12B	chr1:202317836-202557697:+	0.09	3.71	0.000233	Sex ratio	
PRAD	cis	1	rs4950849	chr1:202408518	PPP1R12B	chr1:202317836-202557697:+	0.09	3.83	0.000147	Sex ratio	
PRAD	cis	1	rs4951261	chr1:205717823	PM20D1	chr1:205797154-205819245:-	0.29	5.59	3.76E-8	Menarche (age at onset)	
PRAD	cis	1	rs4951261	chr1:205717823	RAB7L1	chr1:205737115-205744610:-	-0.34	-7.65	1.13E-13	Menarche (age at onset)	
PRAD	cis	1	rs4954218	chr2:135803425	DARS	chr2:136664254-136743222:-	-0.23	-3.8	0.000167	Corneal structure	
PRAD	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.52	11.88	1.2E-28	Height	
PRAD	cis	1	rs4955485	chr3:134295843	CEP63	chr3:134204575-134293852:+	0.22	3.82	0.00015	Height	
PRAD	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.55	12.74	3.85E-32	Height	
PRAD	cis	1	rs4958422	chr5:150186734	LOC134466	chr5:150310000-150326146:-	0.71	9.16	1.56E-18	Crohn's disease	
PRAD	cis	1	rs4958424	chr5:150225036	C5orf62	chr5:150157867-150176297:+	0.29	3.78	0.000177	Crohn's disease	
PRAD	cis	1	rs4958424	chr5:150225036	LOC134466	chr5:150310000-150326146:-	0.57	8.63	9.23E-17	Crohn's disease	
PRAD	cis	1	rs4958426	chr5:150278346	LOC134466	chr5:150310000-150326146:-	0.71	9.78	1.1E-20	Crohn's disease	
PRAD	cis	1	rs4958842	chr5:150224877	C5orf62	chr5:150157867-150176297:+	0.33	3.91	0.000107	Crohn's disease	
PRAD	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.7	10.08	8.89E-22	Crohn's disease	
PRAD	cis	1	rs4958843	chr5:150224924	C5orf62	chr5:150157867-150176297:+	0.29	3.78	0.000177	Crohn's disease	
PRAD	cis	1	rs4958843	chr5:150224924	LOC134466	chr5:150310000-150326146:-	0.57	8.63	9.23E-17	Crohn's disease	
PRAD	cis	1	rs4958848	chr5:150271122	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs4958852	chr5:150330631	LOC134466	chr5:150310000-150326146:-	0.65	8.36	7.06E-16	Crohn's disease	
PRAD	cis	1	rs4962416	chr10:126696872	CTBP2	chr10:126676419-126849624:-	0.45	7.39	6.62E-13	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs4962419	chr10:126697114	CTBP2	chr10:126676419-126849624:-	0.45	7.38	7.13E-13	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs4962720	chr10:126696840	CTBP2	chr10:126676419-126849624:-	0.45	7.39	6.78E-13	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs4962723	chr10:126705111	CTBP2	chr10:126676419-126849624:-	0.22	3.49	0.000533	Height	
PRAD	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.58	-7.34	9.35E-13	Tumor biomarkers	
PRAD	cis	1	rs496584	chr15:43831923	CKMT1A	chr15:43985084-43991419:+	-0.37	-4.12	4.39E-5	Tumor biomarkers	
PRAD	cis	1	rs496584	chr15:43831923	TUBGCP4	chr15:43663313-43698238:+	0.18	3.79	0.000171	Tumor biomarkers	
PRAD	cis	1	rs4970696	chr1:92968853	EVI5	chr1:92974255-93257961:-	-0.31	-6.25	9.1E-10	Cholesterol, total	
PRAD	cis	1	rs4970698	chr1:92972933	EVI5	chr1:92974255-93257961:-	-0.31	-6.2	1.23E-9	Cholesterol, total	
PRAD	cis	1	rs4970705	chr1:92971828	EVI5	chr1:92974255-93257961:-	0.31	6.26	8.52E-10	Cholesterol, total	
PRAD	cis	1	rs4970708	chr1:92986514	EVI5	chr1:92974255-93257961:-	-0.31	-6.2	1.23E-9	Cholesterol, total	
PRAD	cis	1	rs4970709	chr1:92988592	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs4970710	chr1:92988717	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs4970712	chr1:92993547	EVI5	chr1:92974255-93257961:-	0.28	5.75	1.57E-8	Cholesterol, total	
PRAD	cis	1	rs4971316	chr1:247210903	ZNF670	chr1:247200087-247242069:-	-0.32	-7.17	2.84E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs4971319	chr1:247211565	ZNF670	chr1:247200087-247242069:-	-0.32	-7.17	2.84E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs4973380	chr2:228725402	CCL20	chr2:228678558-228682280:+	0.27	4.76	2.64E-6	Blood pressure	
PRAD	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-0.88	-14.6	4.25E-40	Diastolic blood pressure	
PRAD	cis	1	rs4974105	chr3:51369574	HEMK1	chr3:50606583-50622419:+	0.21	3.92	0.000102	Melanoma	
PRAD	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.51	11.74	4.25E-28	Height	
PRAD	cis	1	rs4974483	chr3:134219001	CEP63	chr3:134204575-134293852:+	0.2	3.47	0.000573	Height	
PRAD	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.5	11.25	3.5E-26	Height	
PRAD	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.52	11.72	5.21E-28	Height	
PRAD	cis	1	rs4974559	chr4:1380848	CRIPAK	chr4:1385340-1389782:+	-0.34	-6.33	5.75E-10	Systolic blood pressure	
PRAD	cis	1	rs4974931	chr4:39110516	KLHL5	chr4:39046659-39123828:+	-0.13	-3.72	0.000219	Uric acid levels	
PRAD	cis	1	rs4974997	chr4:39110771	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000188	Uric acid levels	
PRAD	cis	1	rs4974998	chr4:39110749	KLHL5	chr4:39046659-39123828:+	-0.13	-3.74	0.000207	Uric acid levels	
PRAD	cis	1	rs4975193	chr4:129980630	C4orf33	chr4:130014829-130033842:+	-0.47	-8.02	8.76E-15	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs4975194	chr4:129982377	C4orf33	chr4:130014829-130033842:+	-0.47	-8.02	8.76E-15	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs4978966	chr9:113662374	PTGR1	chr9:114312003-114362135:-	-0.26	-4.07	5.46E-5	Corneal structure	
PRAD	cis	1	rs4979148	chr9:115553399	C9orf80	chr9:115448793-115480387:-	0.27	4.32	1.92E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs4979150	chr9:115553502	C9orf80	chr9:115448793-115480387:-	0.27	4.32	1.92E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs4979153	chr9:115554984	C9orf80	chr9:115448793-115480387:-	0.27	4.32	1.92E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs4979154	chr9:115555031	C9orf80	chr9:115448793-115480387:-	0.3	4	7.23E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs4979155	chr9:115560134	C9orf80	chr9:115448793-115480387:-	0.3	4.03	6.45E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs4979413	chr9:117259548	DFNB31	chr9:117164361-117267730:-	-0.23	-4.68	3.71E-6	Bipolar disorder	
PRAD	cis	1	rs4979414	chr9:117260185	DFNB31	chr9:117164361-117267730:-	-0.22	-4.59	5.66E-6	Bipolar disorder	
PRAD	cis	1	rs4988359	chr11:112025915	IL18	chr11:112013976-112034840:-	-0.21	-6.79	3.41E-11	Interleukin-18 levels	
PRAD	cis	1	rs4990365	chr6:159375553	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs5008830	chr3:122030462	CSTA	chr3:122044011-122060813:+	-0.25	-4.6	5.51E-6	Serum parathyroid hormone levels	
PRAD	cis	1	rs5011018	chr10:4967006	AKR1C2	chr10:4964715-5060207:-	0.67	9.36	3.29E-19	Height	
PRAD	cis	1	rs501220	chr6:25873025	BTN3A2	chr6:26365398-26378546:+	-0.45	-7.58	1.92E-13	Homocysteine levels	
PRAD	cis	1	rs5019163	chr11:67438476	ALDH3B2	chr11:67429634-67448685:-	0.49	5.24	2.43E-7	Serum metabolite levels	
PRAD	cis	1	rs5019496	chr9:96184414	ECM2	chr9:95255834-95298904:-	-0.1	-3.66	0.000284	Body mass index	
PRAD	cis	1	rs5019496	chr9:96184414	NINJ1	chr9:95883772-95896570:-	0.16	3.7	0.000244	Body mass index	
PRAD	cis	1	rs501999	chr5:6635601	LOC255167	chr5:6582287-6588612:+	-0.25	-5.52	5.52E-8	Response to amphetamines	
PRAD	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.35	9.68	2.45E-20	Response to temozolomide	
PRAD	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.35	9.66	2.9E-20	Response to temozolomide	
PRAD	cis	1	rs507080	chr11:118549582	TREH	chr11:118528942-118550381:-	0.21	4.34	1.77E-5	Serum metabolite levels	
PRAD	cis	1	rs507525	chr12:123181581	GPR109B	chr12:123199304-123201439:-	0.35	5.9	7.06E-9	Adiponectin levels	
PRAD	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.35	-9.49	1.13E-19	Response to temozolomide	
PRAD	cis	1	rs508970	chr11:60906450	CD5	chr11:60869930-60895321:+	-0.14	-5.07	5.85E-7	Rheumatoid arthritis	
PRAD	cis	1	rs509548	chr12:123181855	GPR109B	chr12:123199304-123201439:-	0.37	6.44	2.91E-10	Adiponectin levels	
PRAD	cis	1	rs513736	chr10:131406489	MGMT	chr10:131265454-131565783:+	0.35	9.45	1.56E-19	Response to temozolomide	
PRAD	cis	1	rs514257	chr1:170136342	C1orf156	chr1:169761675-169764031:-	0.18	3.77	0.000183	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
PRAD	cis	1	rs514257	chr1:170136342	KIFAP3	chr1:169890472-170043879:-	0.18	3.52	0.000479	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
PRAD	cis	1	rs514591	chr1:196640320	CFH	chr1:196621008-196716631:+	0.13	3.65	0.000287	Circulating myeloperoxidase levels (serum)	
PRAD	cis	1	rs515910	chr10:105966404	C10orf79	chr10:105889647-105992120:-	0.23	4.19	3.32E-5	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.35	9.62	3.94E-20	Response to temozolomide	
PRAD	cis	1	rs5219	chr11:17409572	NUCB2	chr11:17281887-17371521:+	-0.21	-3.44	0.000641	Type 2 diabetes	
PRAD	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.34	-9.17	1.5E-18	Response to temozolomide	
PRAD	cis	1	rs523340	chr9:111854246	C9orf5	chr9:111777416-111882225:-	-0.24	-4.84	1.79E-6	Information processing speed	
PRAD	cis	1	rs524911	chr11:114401577	FAM55A	chr11:114392438-114430580:-	-0.2	-4.04	6.27E-5	Ulcerative colitis	
PRAD	cis	1	rs525215	chr12:123179771	GPR109B	chr12:123199304-123201439:-	0.36	6.32	6.26E-10	Adiponectin levels	
PRAD	cis	1	rs525304	chr11:70506206	ANO1	chr11:69924408-70035649:+	0.12	3.91	0.000105	Response to fenofibrate (adiponectin levels)	
PRAD	cis	1	rs527154	chr10:105943683	C10orf79	chr10:105889647-105992120:-	0.26	4.6	5.5E-6	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.35	9.76	1.3E-20	Response to temozolomide	
PRAD	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.35	-9.86	5.93E-21	Response to temozolomide	
PRAD	cis	1	rs533928	chr1:150884271	CTSK	chr1:150768687-150780812:-	0.21	4.89	1.37E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs534417	chr1:23784965	ASAP3	chr1:23755056-23811057:-	0.41	6.21	1.18E-9	Cholesterol, total	
PRAD	cis	1	rs534417	chr1:23784965	TCEA3	chr1:23707555-23751261:-	0.22	3.67	0.000273	Cholesterol, total	
PRAD	cis	1	rs534417	chr1:23784965	ZNF436	chr1:23685942-23696357:-	-0.26	-3.85	0.000134	Cholesterol, total	
PRAD	cis	1	rs534912	chr11:114413446	FAM55A	chr11:114392438-114430580:-	-0.2	-4.06	5.75E-5	Ulcerative colitis	
PRAD	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.35	9.53	8.65E-20	Response to temozolomide	
PRAD	cis	1	rs539602	chr1:155899020	RIT1	chr1:155867601-155881177:-	0.17	3.91	0.000104	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs543725	chr11:57483039	MED19	chr11:57471182-57479673:-	-0.17	-3.68	0.000261	Schizophrenia	
PRAD	cis	1	rs543725	chr11:57483039	TIMM10	chr11:57295936-57298232:-	-0.17	-4.41	1.27E-5	Schizophrenia	
PRAD	cis	1	rs546131	chr11:34851760	APIP	chr11:34896714-34937939:-	0.22	3.84	0.000143	Lung disease severity in cystic fibrosis	
PRAD	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.35	9.61	4.49E-20	Response to temozolomide	
PRAD	cis	1	rs548756	chr11:114428866	FAM55A	chr11:114392438-114430580:-	-0.2	-3.95	9.13E-5	Ulcerative colitis	
PRAD	cis	1	rs550213	chr17:30317518	C17orf79	chr17:30178885-30186326:-	-0.21	-3.67	0.000267	Height	
PRAD	cis	1	rs551042	chr1:170132339	C1orf156	chr1:169761675-169764031:-	0.17	3.5	0.000503	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
PRAD	cis	1	rs551397	chr1:196642072	CFH	chr1:196621008-196716631:+	0.14	3.92	0.000101	Circulating myeloperoxidase levels (serum)	
PRAD	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.35	9.65	3.29E-20	Response to temozolomide	
PRAD	cis	1	rs553989	chr3:47400328	C3orf75	chr3:47537131-47555199:-	0.16	4.69	3.55E-6	Colorectal cancer	
PRAD	cis	1	rs553989	chr3:47400328	NBEAL2	chr3:47021173-47051193:+	0.14	4.53	7.49E-6	Colorectal cancer	
PRAD	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.35	9.61	4.45E-20	Response to temozolomide	
PRAD	cis	1	rs555	chr4:17625658	MED28	chr4:17616273-17629791:+	0.2	4.9	1.33E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs556292	chr10:105961957	C10orf79	chr10:105889647-105992120:-	0.24	4.33	1.79E-5	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs55638602	chr1:207428942	CD55	chr1:207494817-207534309:+	0.47	8.8	2.61E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs55642283	chr8:120384772	NOV	chr8:120428552-120436678:+	-0.24	-3.72	0.000221	Hypertension	
PRAD	cis	1	rs55645900	chr21:43515728	C21orf128	chr21:43522244-43528644:-	0.35	4.92	1.17E-6	IgG glycosylation	
PRAD	cis	1	rs55650602	chr8:65688677	BHLHE22	chr8:65492814-65496185:+	0.28	5.42	9.35E-8	HIV-1 susceptibility	
PRAD	cis	1	rs55657382	chr11:46634963	HARBI1	chr11:46624857-46638777:-	0.27	3.63	0.00031	Schizophrenia	
PRAD	cis	1	rs55662404	chr15:75432341	MPI	chr15:75182410-75190565:+	-0.15	-3.58	0.000384	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs55666439	chr1:44111212	SLC2A1	chr1:43391046-43424847:-	-0.18	-3.46	0.000593	Hypertension risk in short sleep duration	
PRAD	cis	1	rs55674647	chr17:61794195	DDX42	chr17:61851567-61896676:+	-0.29	-5.61	3.44E-8	Body mass index	
PRAD	cis	1	rs55674647	chr17:61794195	FTSJ3	chr17:61896795-61905031:-	0.36	6.76	4.02E-11	Body mass index	
PRAD	cis	1	rs55674647	chr17:61794195	TCAM1P	chr17:61934376-61941738:+	-0.23	-3.81	0.000157	Body mass index	
PRAD	cis	1	rs55675294	chr3:128043050	RUVBL1	chr3:127783627-127872757:-	0.23	4.2	3.19E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs55684215	chr3:127812792	RUVBL1	chr3:127783627-127872757:-	0.25	4.62	4.94E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs55685046	chr12:92992791	NUDT4	chr12:93771701-93797022:+	0.31	3.43	0.000662	Periodontitis (Mean PAL)	
PRAD	cis	1	rs55687017	chr6:149606817	ULBP2	chr6:150263136-150270366:+	0.2	3.5	0.000505	Breast cancer	
PRAD	cis	1	rs55696836	chr20:33549887	MMP24	chr20:33814539-33864804:+	-0.31	-4.59	5.62E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs55703214	chr2:118747026	INSIG2	chr2:118846050-118867596:+	0.36	4.38	1.48E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs55705257	chr9:113677427	PTGR1	chr9:114312003-114362135:-	-0.25	-3.81	0.000156	Corneal structure	
PRAD	cis	1	rs55708724	chr2:112666922	MERTK	chr2:112656191-112786945:+	-0.24	-4.07	5.43E-5	Multiple sclerosis	
PRAD	cis	1	rs55716899	chr3:71498561	EIF4E3	chr3:71728442-71803924:-	0.17	3.43	0.000653	Educational attainment (years of education)	
PRAD	cis	1	rs55722539	chr14:88878035	SPATA7	chr14:88852012-88904802:+	-0.21	-3.98	7.95E-5	Coronary artery calcification	
PRAD	cis	1	rs55728465	chr2:112666096	MERTK	chr2:112656191-112786945:+	-0.23	-3.95	9.1E-5	Multiple sclerosis	
PRAD	cis	1	rs55734215	chr20:33585437	MMP24	chr20:33814539-33864804:+	-0.32	-4.77	2.45E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs55737216	chr9:100695901	C9orf156	chr9:100666772-100684852:-	-0.19	-3.9	0.000109	Quantitative traits	
PRAD	cis	1	rs55749333	chr17:7371932	CHRNB1	chr17:7348406-7360931:+	-0.36	-7.34	9.37E-13	Height	
PRAD	cis	1	rs55753056	chr2:243929	SH3YL1	chr2:218138-264810:-	-0.75	-17.98	2.18E-55	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs55761949	chr11:77993860	GAB2	chr11:77926343-78128766:-	-0.19	-6.02	3.49E-9	Testicular germ cell tumor	
PRAD	cis	1	rs55761949	chr11:77993860	NARS2	chr11:78147017-78285909:-	-0.23	-4.73	2.96E-6	Testicular germ cell tumor	
PRAD	cis	1	rs55762931	chr3:127847675	RUVBL1	chr3:127783627-127872757:-	0.24	4.47	9.62E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs55773124	chr12:21397957	SLCO1A2	chr12:21417535-21548371:-	0.24	3.56	0.000406	Blood metabolite levels	
PRAD	cis	1	rs55775340	chr6:33751784	LEMD2	chr6:33738991-33756906:-	0.17	4.53	7.37E-6	Body mass index	
PRAD	cis	1	rs55781567	chr15:78857986	CHRNA3	chr15:78885397-78913322:-	-0.26	-4.63	4.8E-6	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs55781567	chr15:78857986	CHRNA5	chr15:78857906-78886458:+	-0.2	-4.16	3.79E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs55785997	chr2:112661447	MERTK	chr2:112656191-112786945:+	-0.24	-4.01	7.04E-5	Multiple sclerosis	
PRAD	cis	1	rs55786720	chr6:56783647	BEND6	chr6:56819773-56892138:+	-0.59	-10.88	9.24E-25	Menarche (age at onset)	
PRAD	cis	1	rs55791720	chr12:1066834	RAD52	chr12:1021255-1099219:-	0.23	5.17	3.49E-7	Lung cancer	
PRAD	cis	1	rs55795031	chr2:118661032	INSIG2	chr2:118846050-118867596:+	0.39	4.72	3.14E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs55805990	chr1:21827179	RAP1GAP	chr1:21922709-21995856:-	-0.26	-3.54	0.000446	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	
PRAD	cis	1	rs55822690	chr3:10128003	C3orf10	chr3:10157333-10168873:+	-0.21	-4.12	4.55E-5	Alzheimer's disease	
PRAD	cis	1	rs55822690	chr3:10128003	LOC401052	chr3:10048102-10052779:-	-0.29	-5.35	1.37E-7	Alzheimer's disease	
PRAD	cis	1	rs55825352	chr11:78034424	GAB2	chr11:77926343-78128766:-	-0.21	-6.53	1.76E-10	Testicular germ cell tumor	
PRAD	cis	1	rs55825352	chr11:78034424	NARS2	chr11:78147017-78285909:-	-0.2	-4.06	5.86E-5	Testicular germ cell tumor	
PRAD	cis	1	rs55834832	chr11:48562583	FOLH1	chr11:49168188-49230222:-	-0.16	-3.65	0.000294	HDL cholesterol	
PRAD	cis	1	rs55835850	chr2:28949296	PPP1CB	chr2:28974612-29025805:+	-0.28	-5.89	7.37E-9	Body mass index	
PRAD	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.41	8.38	6.02E-16	Body mass index	
PRAD	cis	1	rs55838400	chr3:122032293	CSTA	chr3:122044011-122060813:+	-0.29	-5.36	1.3E-7	Serum parathyroid hormone levels	
PRAD	cis	1	rs55840680	chr1:150097602	RPRD2	chr1:150336990-150449039:+	0.13	3.47	0.00056	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs55842567	chr5:437586	C5orf55	chr5:441645-443258:-	0.17	3.76	0.000192	Cystic fibrosis severity	
PRAD	cis	1	rs55842567	chr5:437586	LOC25845	chr5:470626-473080:-	0.28	4.88	1.46E-6	Cystic fibrosis severity	
PRAD	cis	1	rs55847558	chr11:59903793	PATL1	chr11:59404194-59436511:-	-0.11	-3.44	0.000642	Alzheimer's disease (late onset)	
PRAD	cis	1	rs55857306	chr1:11895795	CLCN6	chr1:11866207-11907674:+	0.27	4.99	8.62E-7	QRS complex (12-leadsum)	
PRAD	cis	1	rs55857306	chr1:11895795	TARDBP	chr1:11072679-11085548:+	0.22	3.72	0.000227	QRS complex (12-leadsum)	
PRAD	cis	1	rs55863909	chr8:65692999	BHLHE22	chr8:65492814-65496185:+	0.27	5.16	3.74E-7	HIV-1 susceptibility	
PRAD	cis	1	rs55868506	chr17:61851686	DDX42	chr17:61851567-61896676:+	-0.27	-5.59	3.89E-8	Body mass index	
PRAD	cis	1	rs55868506	chr17:61851686	FTSJ3	chr17:61896795-61905031:-	0.34	6.76	4.14E-11	Body mass index	
PRAD	cis	1	rs55868506	chr17:61851686	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.52	7.79E-6	Body mass index	
PRAD	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.35	-9.54	7.58E-20	Response to temozolomide	
PRAD	cis	1	rs55879323	chr1:152168740	FLG	chr1:152274651-152297679:-	-0.56	-12.01	3.69E-29	Inflammatory skin disease	
PRAD	cis	1	rs55882090	chr3:10139082	C3orf10	chr3:10157333-10168873:+	-0.19	-3.77	0.000181	Alzheimer's disease	
PRAD	cis	1	rs55882090	chr3:10139082	LOC401052	chr3:10048102-10052779:-	-0.3	-5.54	5.09E-8	Alzheimer's disease	
PRAD	cis	1	rs55885592	chr14:104126024	BAG5	chr14:104022889-104029151:-	0.17	3.63	0.000314	Body mass index	
PRAD	cis	1	rs55885592	chr14:104126024	C14orf153	chr14:104029299-104057227:+	0.14	4.18	3.52E-5	Body mass index	
PRAD	cis	1	rs55885592	chr14:104126024	CKB	chr14:103985996-103989170:-	0.23	5.23	2.55E-7	Body mass index	
PRAD	cis	1	rs55885592	chr14:104126024	KLC1	chr14:104029299-104167887:+	-0.18	-3.68	0.000262	Body mass index	
PRAD	cis	1	rs55885592	chr14:104126024	MARK3	chr14:103851701-103970164:+	0.24	4.93	1.15E-6	Body mass index	
PRAD	cis	1	rs55895244	chr7:65387678	CCT6P1	chr7:65216092-65228661:+	0.3	5.31	1.65E-7	Diabetic kidney disease	
PRAD	cis	1	rs55895244	chr7:65387678	CRCP	chr7:65579805-65619551:+	-0.27	-3.54	0.000439	Diabetic kidney disease	
PRAD	cis	1	rs55895244	chr7:65387678	ZNF117	chr7:64434830-64467121:-	-0.27	-3.43	0.000659	Diabetic kidney disease	
PRAD	cis	1	rs55896768	chr17:65913358	LOC651250	chr17:66097696-66157623:+	-0.24	-4.43	1.17E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs55905547	chr20:57589995	TH1L	chr20:57556311-57570186:+	-0.44	-7.27	1.47E-12	Mean platelet volume	
PRAD	cis	1	rs55905547	chr20:57589995	TUBB1	chr20:57594309-57601707:+	-0.28	-3.69	0.000253	Mean platelet volume	
PRAD	cis	1	rs55909363	chr20:33549407	MMP24	chr20:33814539-33864804:+	-0.32	-4.68	3.74E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs55912359	chr1:114167099	PHTF1	chr1:114239824-114302098:-	0.24	4.53	7.39E-6	Bacteremia	
PRAD	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.55	12.74	3.85E-32	Height	
PRAD	cis	1	rs55914901	chr19:50528346	SIGLEC16	chr19:50472912-50479075:+	0.39	3.93	9.68E-5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs55914901	chr19:50528346	TSKS	chr19:50243012-50266515:-	0.33	3.61	0.000344	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs55925538	chr3:128042877	RUVBL1	chr3:127783627-127872757:-	0.22	4.08	5.33E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs55931012	chr9:136949669	BRD3	chr9:136895454-136933655:-	-0.29	-6.02	3.48E-9	Platelet count	
PRAD	cis	1	rs55936726	chr2:258210	SH3YL1	chr2:218138-264810:-	-0.79	-18.83	2.42E-59	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs55938551	chr2:242033593	PASK	chr2:242045515-242088878:-	0.33	3.93	9.78E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs55939327	chr4:17642937	MED28	chr4:17616273-17629791:+	0.19	4.74	2.83E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs55939964	chr17:65869297	LOC651250	chr17:66097696-66157623:+	-0.24	-4.3	2.05E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs55946144	chr20:33629610	MMP24	chr20:33814539-33864804:+	-0.23	-3.81	0.000156	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs55946380	chr2:268293	SH3YL1	chr2:218138-264810:-	-0.79	-18.71	9.01E-59	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs559555	chr2:31810974	NLRC4	chr2:32449518-32490801:-	0.18	4.19	3.38E-5	Blood metabolite levels;Blood metabolite ratios	
PRAD	cis	1	rs55957623	chr1:152223196	FLG	chr1:152274651-152297679:-	0.35	5.08	5.55E-7	Atopic dermatitis	
PRAD	cis	1	rs55962648	chr7:65625751	TPST1	chr7:65670259-65825437:+	-0.18	-4.47	1.0E-5	Aortic root size	
PRAD	cis	1	rs55968743	chr16:24984772	SLC5A11	chr16:24857316-24922943:+	-0.45	-3.51	0.000498	Blood metabolite levels	
PRAD	cis	1	rs55971458	chr17:28427016	EFCAB5	chr17:28256874-28435469:+	0.24	4.05	6.0E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs55979739	chr16:31049155	HSD3B7	chr16:30996519-31000473:+	0.44	9.39	2.66E-19	Response to metformin (IC50)	
PRAD	cis	1	rs55979739	chr16:31049155	MYST1	chr16:31128985-31142713:+	0.19	5.95	5.37E-9	Response to metformin (IC50)	
PRAD	cis	1	rs55979739	chr16:31049155	PRSS36	chr16:31150251-31161415:-	0.19	4.75	2.7E-6	Response to metformin (IC50)	
PRAD	cis	1	rs55979739	chr16:31049155	PRSS53	chr16:31094747-31106276:-	-0.18	-3.66	0.000286	Response to metformin (IC50)	
PRAD	cis	1	rs55979739	chr16:31049155	STX1B	chr16:31000577-31021829:-	0.21	5.33	1.55E-7	Response to metformin (IC50)	
PRAD	cis	1	rs55989768	chr3:128043004	RUVBL1	chr3:127783627-127872757:-	0.23	4.2	3.19E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs55990776	chr12:124447466	ZNF664	chr12:124457670-124499967:+	-0.15	-4.08	5.39E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs55998153	chr1:179453824	C1orf125	chr1:179335107-179523868:+	0.31	3.57	0.000393	Multiple sclerosis (age of onset)	
PRAD	cis	1	rs56000731	chr3:128647141	ACAD9	chr3:128598333-128634910:+	-0.27	-3.44	0.000629	Dental caries	
PRAD	cis	1	rs56003071	chr3:128596048	ACAD9	chr3:128598333-128634910:+	-0.28	-3.63	0.000316	Dental caries	
PRAD	cis	1	rs56004802	chr10:1159187	IDI2	chr10:1064847-1071799:-	0.37	4.77	2.47E-6	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs56013339	chr3:12543198	TSEN2	chr3:12525931-12581122:+	0.38	4.16	3.76E-5	Prostate cancer (gene x gene interaction)	
PRAD	cis	1	rs56015036	chr10:17226767	TRDMT1	chr10:17184983-17243681:-	-0.27	-5.46	7.73E-8	Homocysteine levels	
PRAD	cis	1	rs56015123	chr15:50977228	SPPL2A	chr15:50999739-51057910:-	0.26	5.37	1.25E-7	QT interval	
PRAD	cis	1	rs56016656	chr7:65383481	CCT6P1	chr7:65216092-65228661:+	0.35	6.14	1.71E-9	Diabetic kidney disease	
PRAD	cis	1	rs56016656	chr7:65383481	CRCP	chr7:65579805-65619551:+	-0.27	-3.49	0.000526	Diabetic kidney disease	
PRAD	cis	1	rs56020497	chr20:33166470	NECAB3	chr20:32244894-32262264:-	-0.31	-4.36	1.58E-5	Melanoma	
PRAD	cis	1	rs56028644	chr19:17388790	ANKLE1	chr19:17392454-17398454:+	0.33	6.53	1.74E-10	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs56028644	chr19:17388790	MRPL34	chr19:17416477-17417652:+	-0.19	-3.86	0.000129	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs56028644	chr19:17388790	OCEL1	chr19:17337055-17340027:+	0.21	4.99	8.32E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs56030203	chr6:56783857	BEND6	chr6:56819773-56892138:+	-0.59	-10.88	9.24E-25	Menarche (age at onset)	
PRAD	cis	1	rs56031077	chr6:88354955	C6orf165	chr6:88117721-88205858:+	0.46	4.2	3.15E-5	Obesity-related traits	
PRAD	cis	1	rs56040780	chr16:28861881	ATP2A1	chr16:28889809-28915830:+	0.2	3.7	0.000239	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs56040780	chr16:28861881	CCDC101	chr16:28565249-28603110:+	-0.13	-3.72	0.000227	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs56040780	chr16:28861881	EIF3CL	chr16:28699879-28747052:+;chr16	0.41	8.18	2.7E-15	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs56040780	chr16:28861881	SBK1	chr16:28303840-28335162:+	-0.17	-3.61	0.000342	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs56040780	chr16:28861881	SULT1A1	chr16:28616918-28634866:-	-0.22	-4.52	7.94E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs56040780	chr16:28861881	SULT1A2	chr16:28603266-28608391:-	0.23	4.57	6.32E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs56040780	chr16:28861881	TUFM	chr16:28853732-28857729:-	0.2	5.81	1.16E-8	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs56042615	chr5:437667	C5orf55	chr5:441645-443258:-	0.17	3.76	0.000192	Cystic fibrosis severity	
PRAD	cis	1	rs56042615	chr5:437667	LOC25845	chr5:470626-473080:-	0.28	4.88	1.46E-6	Cystic fibrosis severity	
PRAD	cis	1	rs56043407	chr17:2166078	SRR	chr17:2207248-2228553:+	-0.76	-14.44	2.21E-39	Esophageal cancer (squamous cell)	
PRAD	cis	1	rs56057198	chr17:61733332	DDX42	chr17:61851567-61896676:+	-0.25	-4.77	2.43E-6	Body mass index	
PRAD	cis	1	rs56057198	chr17:61733332	FTSJ3	chr17:61896795-61905031:-	0.38	7.15	3.38E-12	Body mass index	
PRAD	cis	1	rs56057198	chr17:61733332	TCAM1P	chr17:61934376-61941738:+	-0.22	-3.76	0.00019	Body mass index	
PRAD	cis	1	rs56063711	chr3:128585715	ACAD9	chr3:128598333-128634910:+	-0.27	-3.51	0.000492	Dental caries	
PRAD	cis	1	rs56069856	chr20:3965709	MAVS	chr20:3827449-3856761:+	-0.25	-3.5	0.000509	Response to antidepressants in depression	
PRAD	cis	1	rs56069965	chr15:50966973	SPPL2A	chr15:50999739-51057910:-	0.26	5.3	1.78E-7	QT interval	
PRAD	cis	1	rs56071315	chr12:85497371	LRRIQ1	chr12:85430099-85638880:+	-0.24	-3.97	8.18E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs56071315	chr12:85497371	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.99	8.55E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs56071315	chr12:85497371	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.5	6.15E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs56077333	chr15:78899003	CHRNA3	chr15:78885397-78913322:-	-0.31	-5.42	9.55E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs56077333	chr15:78899003	CHRNA5	chr15:78857906-78886458:+	-0.21	-4.29	2.21E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs56080544	chr15:50950970	SPPL2A	chr15:50999739-51057910:-	0.26	5.31	1.68E-7	QT interval	
PRAD	cis	1	rs56098064	chr14:50105849	PPIL5	chr14:50065415-50081389:+	-0.23	-4.12	4.44E-5	Carotid intima media thickness	
PRAD	cis	1	rs56098064	chr14:50105849	RPL36AL	chr14:50085407-50087349:-	0.39	11.17	7.72E-26	Carotid intima media thickness	
PRAD	cis	1	rs56100812	chr1:202365422	PPP1R12B	chr1:202317836-202557697:+	0.09	3.63	0.000318	Sex ratio	
PRAD	cis	1	rs56101873	chr1:119474790	WARS2	chr1:119573841-119683295:-	0.36	4.91	1.25E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs56104584	chr5:437542	C5orf55	chr5:441645-443258:-	0.17	3.76	0.000192	Cystic fibrosis severity	
PRAD	cis	1	rs56104584	chr5:437542	LOC25845	chr5:470626-473080:-	0.28	4.88	1.46E-6	Cystic fibrosis severity	
PRAD	cis	1	rs56105592	chr2:17779641	GEN1	chr2:17935162-17966632:+	0.45	5.66	2.65E-8	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs56113315	chr19:39184166	LGALS7	chr19:39261608-39264157:-	-0.16	-3.71	0.000236	Heart rate	
PRAD	cis	1	rs56118429	chr15:50923849	SPPL2A	chr15:50999739-51057910:-	0.26	5.38	1.2E-7	QT interval	
PRAD	cis	1	rs56119980	chr4:39141010	KLHL5	chr4:39046659-39123828:+	-0.12	-3.48	0.000545	Uric acid levels	
PRAD	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.81	12.12	1.36E-29	Diastolic blood pressure	
PRAD	cis	1	rs56127630	chr3:49438036	AMIGO3	chr3:49754268-49757238:-	0.43	8.79	2.93E-17	Menarche (age at onset)	
PRAD	cis	1	rs56127630	chr3:49438036	CCDC36	chr3:49235861-49295537:+	-0.23	-4.18	3.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs56127630	chr3:49438036	GMPPB	chr3:49758932-49761384:-	0.48	11.64	1.05E-27	Menarche (age at onset)	
PRAD	cis	1	rs56127630	chr3:49438036	NCKIPSD	chr3:48711280-48723334:-	-0.31	-6.09	2.34E-9	Menarche (age at onset)	
PRAD	cis	1	rs56127630	chr3:49438036	P4HTM	chr3:49027341-49044579:+	-0.16	-3.67	0.000275	Menarche (age at onset)	
PRAD	cis	1	rs56127630	chr3:49438036	WDR6	chr3:49044637-49053386:+	0.19	3.83	0.000146	Menarche (age at onset)	
PRAD	cis	1	rs56131635	chr20:47774343	CSE1L	chr20:47662838-47713484:+	0.17	4.29	2.19E-5	Anger	
PRAD	cis	1	rs56131635	chr20:47774343	PREX1	chr20:47240793-47444420:-	-0.17	-3.61	0.000333	Anger	
PRAD	cis	1	rs56139710	chr1:27269788	PIGV	chr1:27114455-27124886:+	-0.31	-3.85	0.000134	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs56141565	chr20:3998603	MAVS	chr20:3827449-3856761:+	-0.27	-3.63	0.000318	Response to antidepressants in depression	
PRAD	cis	1	rs56145559	chr2:73623439	ALMS1P	chr2:73872046-73912692:+	0.46	7.77	4.9E-14	Schizophrenia	
PRAD	cis	1	rs56145559	chr2:73623439	NAT8	chr2:73867850-73869537:-	0.24	3.61	0.000338	Schizophrenia	
PRAD	cis	1	rs56148300	chr17:65892752	LOC651250	chr17:66097696-66157623:+	-0.23	-4.28	2.29E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs56149730	chr16:24946396	SLC5A11	chr16:24857316-24922943:+	-0.48	-3.76	0.000194	Blood metabolite levels	
PRAD	cis	1	rs56153133	chr1:11885647	CLCN6	chr1:11866207-11907674:+	0.24	4.54	7.11E-6	QRS complex (12-leadsum)	
PRAD	cis	1	rs56153133	chr1:11885647	TARDBP	chr1:11072679-11085548:+	0.2	3.5	0.000506	QRS complex (12-leadsum)	
PRAD	cis	1	rs56154726	chr2:73721767	ALMS1P	chr2:73872046-73912692:+	0.48	8.34	8.55E-16	Metabolite levels	
PRAD	cis	1	rs56154726	chr2:73721767	NAT8	chr2:73867850-73869537:-	0.26	3.96	8.72E-5	Metabolite levels	
PRAD	cis	1	rs56155961	chr1:21827094	RAP1GAP	chr1:21922709-21995856:-	-0.26	-3.54	0.000446	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	
PRAD	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.81	12.12	1.36E-29	Diastolic blood pressure	
PRAD	cis	1	rs56159542	chr19:19682971	YJEFN3	chr19:19639720-19648393:+	0.15	4.34	1.71E-5	Attention deficit hyperactivity disorder symptom score	
PRAD	cis	1	rs56167434	chr2:282137	SH3YL1	chr2:218138-264810:-	-0.79	-18.56	4.18E-58	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs561722	chr11:114386830	FAM55A	chr11:114392438-114430580:-	-0.19	-3.85	0.000132	Ulcerative colitis	
PRAD	cis	1	rs56175756	chr5:157391080	NIPAL4	chr5:156887027-156901729:+	0.23	3.85	0.000133	IgG glycosylation	
PRAD	cis	1	rs56184857	chr1:119468861	WARS2	chr1:119573841-119683295:-	0.36	4.91	1.25E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs56190030	chr1:11887382	CLCN6	chr1:11866207-11907674:+	0.23	4.55	6.8E-6	QRS complex (12-leadsum)	
PRAD	cis	1	rs56204645	chr8:55421769	RP1	chr8:55528627-55682531:+	0.23	3.57	0.0004	Intracranial aneurysm	
PRAD	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.87	12.39	1.07E-30	Diastolic blood pressure	
PRAD	cis	1	rs56207945	chr16:68589412	PDF	chr16:69362524-69364498:-	0.21	3.59	0.00036	Response to antipsychotic treatment in schizophrenia (reasoning);HIV-1 viral setpoint	
PRAD	cis	1	rs56221117	chr4:147498316	ZNF827	chr4:146681892-146859607:-	-0.17	-3.77	0.000181	Heart rate	
PRAD	cis	1	rs56224112	chr8:120658724	DSCC1	chr8:120846182-120868170:-	-0.27	-4.17	3.6E-5	Height	
PRAD	cis	1	rs56234712	chr16:67241754	FHOD1	chr16:67263294-67281425:-	0.6	7.65	1.17E-13	HDL cholesterol	
PRAD	cis	1	rs56234712	chr16:67241754	SLC9A5	chr16:67282855-67306093:+	0.38	5.47	7.46E-8	HDL cholesterol	
PRAD	cis	1	rs56259214	chr2:118719139	INSIG2	chr2:118846050-118867596:+	0.34	4.25	2.6E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs56270432	chr3:10087517	C3orf10	chr3:10157333-10168873:+	-0.19	-3.8	0.000164	Alzheimer's disease	
PRAD	cis	1	rs56270432	chr3:10087517	LOC401052	chr3:10048102-10052779:-	-0.27	-4.85	1.7E-6	Alzheimer's disease	
PRAD	cis	1	rs56280226	chr17:28429575	EFCAB5	chr17:28256874-28435469:+	0.24	3.96	8.68E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs56287882	chr3:128030343	RUVBL1	chr3:127783627-127872757:-	0.22	3.93	9.63E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs56291018	chr7:65390339	CCT6P1	chr7:65216092-65228661:+	0.35	6.14	1.71E-9	Diabetic kidney disease	
PRAD	cis	1	rs56291018	chr7:65390339	CRCP	chr7:65579805-65619551:+	-0.27	-3.49	0.000526	Diabetic kidney disease	
PRAD	cis	1	rs56297666	chr2:160902023	LY75	chr2:160625141-160761262:-	0.13	4.3	2.09E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs56297666	chr2:160902023	PLA2R1	chr2:160798012-160919121:-	0.24	5.29	1.88E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs56306402	chr20:33937704	CEP250	chr20:34042996-34099802:+	-0.23	-5.28	1.99E-7	Height	
PRAD	cis	1	rs56306402	chr20:33937704	CPNE1	chr20:34213968-34262539:-	0.2	3.96	8.68E-5	Height	
PRAD	cis	1	rs56306402	chr20:33937704	GDF5	chr20:33897002-34042568:-	-0.19	-4.71	3.33E-6	Height	
PRAD	cis	1	rs56306402	chr20:33937704	MMP24	chr20:33814539-33864804:+	0.14	3.5	0.000515	Height	
PRAD	cis	1	rs56306402	chr20:33937704	UQCC	chr20:33890383-33999833:-	0.37	7.05	6.6E-12	Height	
PRAD	cis	1	rs56308330	chr4:17643050	MED28	chr4:17616273-17629791:+	0.2	4.96	9.63E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs56314138	chr3:121356656	IQCB1	chr3:121488610-121553926:-	0.51	10.01	1.68E-21	Cognitive performance	
PRAD	cis	1	rs56317427	chr10:81861934	SFTPA1	chr10:81370712-81375201:+	-0.4	-3.69	0.00025	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs56317427	chr10:81861934	SFTPD	chr10:81697498-81708861:-	0.32	3.93	9.89E-5	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs56321614	chr2:268191	SH3YL1	chr2:218138-264810:-	-0.75	-17.98	2.11E-55	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs56322409	chr10:97395962	ENTPD1	chr10:97471536-97637022:+	0.13	3.95	8.86E-5	Blood metabolite levels	
PRAD	cis	1	rs56322409	chr10:97395962	TCTN3	chr10:97423154-97453900:-	0.23	4.43	1.18E-5	Blood metabolite levels	
PRAD	cis	1	rs56324992	chr20:3978153	MAVS	chr20:3827449-3856761:+	-0.25	-3.67	0.000275	Response to antidepressants in depression	
PRAD	cis	1	rs56328893	chr3:128041830	RUVBL1	chr3:127783627-127872757:-	0.21	3.79	0.000168	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs56331152	chr11:46885016	ARHGAP1	chr11:46698634-46722120:-	-0.26	-3.84	0.000138	Schizophrenia	
PRAD	cis	1	rs56346965	chr2:191541366	HIBCH	chr2:191069361-191184559:-	-0.18	-3.79	0.00017	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs56348638	chr17:53064550	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.91	0.000107	Breast cancer	
PRAD	cis	1	rs563538	chr13:37433721	ALG5	chr13:37523910-37573504:-	0.38	4.03	6.43E-5	Spontaneous preterm birth (preterm birth)	
PRAD	cis	1	rs563538	chr13:37433721	EXOSC8	chr13:37574678-37583749:+	0.36	4.77	2.48E-6	Spontaneous preterm birth (preterm birth)	
PRAD	cis	1	rs56363533	chr20:33626005	MMP24	chr20:33814539-33864804:+	-0.23	-3.82	0.000153	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs56364728	chr18:11988517	IMPA2	chr18:11981057-12030876:+	-0.3	-3.85	0.000134	Stroke	
PRAD	cis	1	rs56365761	chr19:39148103	LGALS7	chr19:39261608-39264157:-	-0.15	-3.44	0.000634	Heart rate	
PRAD	cis	1	rs56369603	chr1:150106834	RPRD2	chr1:150336990-150449039:+	0.13	3.54	0.000444	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs56383601	chr17:61929968	DDX42	chr17:61851567-61896676:+	-0.28	-5.66	2.69E-8	Body mass index	
PRAD	cis	1	rs56383601	chr17:61929968	FTSJ3	chr17:61896795-61905031:-	0.34	6.69	6.39E-11	Body mass index	
PRAD	cis	1	rs56383601	chr17:61929968	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.19	3.35E-5	Body mass index	
PRAD	cis	1	rs56390833	chr15:78877381	CHRNA3	chr15:78885397-78913322:-	-0.29	-4.99	8.48E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs56390833	chr15:78877381	CHRNA5	chr15:78857906-78886458:+	-0.22	-4.52	7.79E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs56392198	chr1:179451124	C1orf125	chr1:179335107-179523868:+	0.31	3.57	0.000393	Multiple sclerosis (age of onset)	
PRAD	cis	1	rs56393562	chr17:65933918	LOC651250	chr17:66097696-66157623:+	-0.22	-4.05	6.01E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs56394211	chr10:17186447	TRDMT1	chr10:17184983-17243681:-	-0.26	-5.17	3.41E-7	Homocysteine levels	
PRAD	cis	1	rs56394721	chr3:10150795	C3orf10	chr3:10157333-10168873:+	-0.23	-4.41	1.27E-5	Alzheimer's disease	
PRAD	cis	1	rs56394721	chr3:10150795	LOC401052	chr3:10048102-10052779:-	-0.31	-5.55	4.85E-8	Alzheimer's disease	
PRAD	cis	1	rs56402416	chr12:51357791	TFCP2	chr12:51488608-51566917:-	-0.22	-3.57	0.000393	Type 2 diabetes	
PRAD	cis	1	rs56404791	chr17:65893019	LOC651250	chr17:66097696-66157623:+	-0.23	-4.35	1.7E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs564343	chr11:65895166	C11orf80	chr11:66512207-66610987:+	-0.19	-4.44	1.12E-5	Obesity (early onset extreme)	
PRAD	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.35	9.61	4.45E-20	Response to temozolomide	
PRAD	cis	1	rs56660916	chr14:104126137	BAG5	chr14:104022889-104029151:-	0.17	3.63	0.000314	Body mass index	
PRAD	cis	1	rs56660916	chr14:104126137	C14orf153	chr14:104029299-104057227:+	0.14	4.18	3.52E-5	Body mass index	
PRAD	cis	1	rs56660916	chr14:104126137	CKB	chr14:103985996-103989170:-	0.23	5.23	2.55E-7	Body mass index	
PRAD	cis	1	rs56660916	chr14:104126137	KLC1	chr14:104029299-104167887:+	-0.18	-3.68	0.000262	Body mass index	
PRAD	cis	1	rs56660916	chr14:104126137	MARK3	chr14:103851701-103970164:+	0.24	4.93	1.15E-6	Body mass index	
PRAD	cis	1	rs56672945	chr2:73622663	ALMS1P	chr2:73872046-73912692:+	0.5	8.49	2.69E-16	Metabolite levels	
PRAD	cis	1	rs56672945	chr2:73622663	NAT8	chr2:73867850-73869537:-	0.25	3.83	0.000146	Metabolite levels	
PRAD	cis	1	rs56758429	chr1:183637537	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs56763150	chr6:24482999	GPLD1	chr6:24428405-24489850:-	0.41	8.18	2.74E-15	Hematological and biochemical traits	
PRAD	cis	1	rs56763150	chr6:24482999	MRS2	chr6:24403153-24425809:+	0.26	4.14	4.2E-5	Hematological and biochemical traits	
PRAD	cis	1	rs56765024	chr2:198876286	PLCL1	chr2:198669426-199014606:+	0.16	4.18	3.46E-5	Ulcerative colitis	
PRAD	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.35	9.61	4.45E-20	Response to temozolomide	
PRAD	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.83	13.08	1.41E-33	Diastolic blood pressure	
PRAD	cis	1	rs56818101	chr2:17776053	GEN1	chr2:17935162-17966632:+	0.42	5.33	1.54E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs56850662	chr3:128061922	RUVBL1	chr3:127783627-127872757:-	0.24	4.55	6.7E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.83	-26.34	1.37E-94	Crohn's disease	
PRAD	cis	1	rs568617	chr11:65653242	KCNK7	chr11:65360327-65363467:-	-0.16	-3.45	0.000611	Crohn's disease	
PRAD	cis	1	rs568617	chr11:65653242	SNX32	chr11:65601410-65621170:+	0.45	6.93	1.37E-11	Crohn's disease	
PRAD	cis	1	rs56864281	chr15:85357649	LOC388152	chr15:84867600-84898920:-	-0.31	-5.11	4.6E-7	Schizophrenia	
PRAD	cis	1	rs56864281	chr15:85357649	NMB	chr15:85198362-85201802:-	-0.54	-12.83	1.59E-32	Schizophrenia	
PRAD	cis	1	rs56864281	chr15:85357649	WDR73	chr15:85186012-85197524:-	-0.26	-5.4	1.05E-7	Schizophrenia	
PRAD	cis	1	rs56884994	chr1:247211057	ZNF670	chr1:247200087-247242069:-	-0.33	-7.31	1.15E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs56901035	chr8:96043188	C8orf38	chr8:95908040-96088396:+	-0.39	-6.76	4.09E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.33	-5.76	1.5E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs569235	chr10:131411620	MGMT	chr10:131265454-131565783:+	0.35	9.64	3.39E-20	Response to temozolomide	
PRAD	cis	1	rs56932185	chr1:27056643	PIGV	chr1:27114455-27124886:+	-0.35	-4.05	6.03E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs569557	chr13:113769917	F7	chr13:113760105-113774994:+	-0.41	-5.63	3.1E-8	End-stage coagulation	
PRAD	cis	1	rs56974987	chr4:17627856	MED28	chr4:17616273-17629791:+	0.19	4.84	1.73E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs569856	chr10:105942304	C10orf79	chr10:105889647-105992120:-	0.26	4.6	5.51E-6	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs56985706	chr7:65394562	CCT6P1	chr7:65216092-65228661:+	0.3	5.31	1.65E-7	Diabetic kidney disease	
PRAD	cis	1	rs56985706	chr7:65394562	CRCP	chr7:65579805-65619551:+	-0.27	-3.54	0.000439	Diabetic kidney disease	
PRAD	cis	1	rs56985706	chr7:65394562	ZNF117	chr7:64434830-64467121:-	-0.27	-3.43	0.000659	Diabetic kidney disease	
PRAD	cis	1	rs56987357	chr14:88824363	SPATA7	chr14:88852012-88904802:+	-0.2	-3.96	8.67E-5	Coronary artery calcification	
PRAD	cis	1	rs569967	chr10:105942337	C10orf79	chr10:105889647-105992120:-	0.26	4.6	5.51E-6	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs57001853	chr5:150272452	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs57002197	chr15:50873760	SPPL2A	chr15:50999739-51057910:-	0.27	5.64	3.02E-8	QT interval	
PRAD	cis	1	rs57012661	chr14:66172750	LOC645431	chr14:65877313-65879335:-	-0.44	-4.51	8.15E-6	Ischemic stroke	
PRAD	cis	1	rs57025426	chr10:102205868	SEC31B	chr10:102246403-102289636:-	-0.31	-9.15	1.67E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs57057549	chr7:65405738	CCT6P1	chr7:65216092-65228661:+	0.35	6.16	1.57E-9	Diabetic kidney disease	
PRAD	cis	1	rs57057549	chr7:65405738	CRCP	chr7:65579805-65619551:+	-0.28	-3.5	0.000502	Diabetic kidney disease	
PRAD	cis	1	rs57060498	chr2:54479230	C2orf73	chr2:54558071-54588714:+	0.28	3.79	0.000173	Telomere length	
PRAD	cis	1	rs57075379	chr14:35577801	PPP2R3C	chr14:35554679-35591679:-	0.37	5.85	9.23E-9	Atopic dermatitis	
PRAD	cis	1	rs57080353	chr2:203376547	NOP58	chr2:203130515-203168382:+	0.28	4.49	9.12E-6	Urate levels	
PRAD	cis	1	rs57104699	chr7:21928079	CDCA7L	chr7:21940518-21985542:-	-0.2	-3.75	0.000197	Multiple myeloma and monoclonal gammopathy;Multiple myeloma	
PRAD	cis	1	rs57117519	chr2:242033696	MTERFD2	chr2:242034545-242041747:-	0.36	3.98	8.12E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs57117519	chr2:242033696	PASK	chr2:242045515-242088878:-	0.31	3.96	8.73E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs57137641	chr12:56741228	MIP	chr12:56843885-56848429:-	0.77	5.72	1.93E-8	Psoriasis vulgaris	
PRAD	cis	1	rs57139546	chr6:44067745	MRPL14	chr6:44081374-44095191:-	-0.12	-3.55	0.000424	Major depressive disorder	
PRAD	cis	1	rs57157809	chr2:178676410	PDE11A	chr2:178487979-178973066:-	-0.34	-4.35	1.68E-5	Height	
PRAD	cis	1	rs57185954	chr17:46844961	SNF8	chr17:47007461-47022154:-	-0.14	-4.04	6.12E-5	Schizophrenia or bipolar disorder	
PRAD	cis	1	rs57201867	chr14:66093872	LOC645431	chr14:65877313-65879335:-	-0.4	-3.92	0.000102	Ischemic stroke	
PRAD	cis	1	rs57217461	chr1:27027916	PIGV	chr1:27114455-27124886:+	-0.32	-3.62	0.000324	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs57218990	chr14:104128007	BAG5	chr14:104022889-104029151:-	0.18	3.74	0.000203	Body mass index	
PRAD	cis	1	rs57218990	chr14:104128007	C14orf153	chr14:104029299-104057227:+	0.14	4.25	2.54E-5	Body mass index	
PRAD	cis	1	rs57218990	chr14:104128007	CKB	chr14:103985996-103989170:-	0.23	5.3	1.82E-7	Body mass index	
PRAD	cis	1	rs57218990	chr14:104128007	KLC1	chr14:104029299-104167887:+	-0.18	-3.71	0.000234	Body mass index	
PRAD	cis	1	rs57218990	chr14:104128007	MARK3	chr14:103851701-103970164:+	0.24	5.01	7.68E-7	Body mass index	
PRAD	cis	1	rs57279772	chr12:56698960	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs57279772	chr12:56698960	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs57307201	chr17:40572793	CNTNAP1	chr17:40834632-40852010:+	0.16	4.63	4.84E-6	Crohn's disease	
PRAD	cis	1	rs57307201	chr17:40572793	NAGLU	chr17:40687951-40696464:+	-0.18	-4.25	2.54E-5	Crohn's disease	
PRAD	cis	1	rs57311533	chr8:89582889	MMP16	chr8:89049462-89339717:-	0.15	3.63	0.000318	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs57368576	chr11:46922133	ARHGAP1	chr11:46698634-46722120:-	-0.25	-3.52	0.000479	Schizophrenia	
PRAD	cis	1	rs573890	chr11:108251363	ATM	chr11:108093559-108239826:+	0.16	5	8.09E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs57403433	chr1:183622951	NCF2	chr1:183524698-183560046:-	0.27	3.96	8.55E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs57406211	chr5:150170966	LOC134466	chr5:150310000-150326146:-	0.73	9.72	1.74E-20	Crohn's disease	
PRAD	cis	1	rs57411618	chr17:28273052	EFCAB5	chr17:28256874-28435469:+	0.24	4.09	5.16E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs57415683	chr13:36684221	C13orf38	chr13:36801182-36871992:-	0.25	4.38	1.49E-5	Optic cup area	
PRAD	cis	1	rs57415683	chr13:36684221	SOHLH2	chr13:36742347-36871992:-	0.39	6.01	3.66E-9	Optic cup area	
PRAD	cis	1	rs5743890	chr11:1325829	TOLLIP	chr11:1295602-1330839:-	-0.32	-4.75	2.66E-6	Idiopathic pulmonary fibrosis	
PRAD	cis	1	rs5744249	chr11:112025306	IL18	chr11:112013976-112034840:-	-0.21	-6.66	7.79E-11	Interleukin-18 levels	
PRAD	cis	1	rs5744256	chr11:112022848	IL18	chr11:112013976-112034840:-	-0.21	-6.78	3.54E-11	Interleukin-18 levels	
PRAD	cis	1	rs5744258	chr11:112021767	IL18	chr11:112013976-112034840:-	-0.21	-6.78	3.54E-11	Interleukin-18 levels	
PRAD	cis	1	rs5745568	chr6:33548394	ITPR3	chr6:33589161-33664346:+	-0.13	-3.55	0.000418	Platelet count	
PRAD	cis	1	rs57461652	chr11:118146197	MPZL2	chr11:118124135-118135009:-	0.11	3.89	0.000115	Pain	
PRAD	cis	1	rs57461652	chr11:118146197	MPZL3	chr11:118100337-118123011:-	0.15	4.98	8.96E-7	Pain	
PRAD	cis	1	rs57461652	chr11:118146197	NLRX1	chr11:119039437-119054723:+	0.18	3.92	0.000103	Pain	
PRAD	cis	1	rs57461652	chr11:118146197	SCN2B	chr11:118033519-118047337:-	-0.11	-3.81	0.000158	Pain	
PRAD	cis	1	rs57479675	chr3:41798038	ULK4	chr3:41288091-42003660:-	0.82	13.15	7.76E-34	Diastolic blood pressure	
PRAD	cis	1	rs5748871	chr22:17603477	CECR4	chr22:17640279-17646334:+	0.16	3.65	0.000289	Discordance in emotional problems in monozygotic twins	
PRAD	cis	1	rs57493332	chr11:96115556	CCDC82	chr11:96085930-96123083:-	-0.24	-3.72	0.000226	Parkinson's disease	
PRAD	cis	1	rs5749696	chr22:22063337	PPIL2	chr22:22020273-22052201:+	-0.14	-3.43	0.000664	Schizophrenia	
PRAD	cis	1	rs5750621	chr22:38956166	CBY1	chr22:39052658-39069853:+	0.14	3.95	8.89E-5	Resting heart rate	
PRAD	cis	1	rs5750621	chr22:38956166	LOC646851	chr22:38974125-39052634:-	0.16	3.75	0.0002	Resting heart rate	
PRAD	cis	1	rs5750622	chr22:38956464	CBY1	chr22:39052658-39069853:+	0.15	4.13	4.38E-5	Resting heart rate	
PRAD	cis	1	rs5750622	chr22:38956464	LOC646851	chr22:38974125-39052634:-	0.16	3.76	0.000188	Resting heart rate	
PRAD	cis	1	rs5750626	chr22:38977890	CBY1	chr22:39052658-39069853:+	0.16	4.58	5.91E-6	Resting heart rate	
PRAD	cis	1	rs5750626	chr22:38977890	LOC646851	chr22:38974125-39052634:-	0.18	4.16	3.79E-5	Resting heart rate	
PRAD	cis	1	rs5750627	chr22:38982321	CBY1	chr22:39052658-39069853:+	0.13	3.71	0.000229	Resting heart rate	
PRAD	cis	1	rs5750627	chr22:38982321	LOC646851	chr22:38974125-39052634:-	0.21	4.98	9.09E-7	Resting heart rate	
PRAD	cis	1	rs5750630	chr22:38985818	CBY1	chr22:39052658-39069853:+	0.16	4.56	6.57E-6	Resting heart rate	
PRAD	cis	1	rs5750630	chr22:38985818	LOC646851	chr22:38974125-39052634:-	0.17	4.02	6.65E-5	Resting heart rate	
PRAD	cis	1	rs5750633	chr22:38993467	CBY1	chr22:39052658-39069853:+	0.14	3.95	8.94E-5	Resting heart rate	
PRAD	cis	1	rs5750633	chr22:38993467	LOC646851	chr22:38974125-39052634:-	0.21	5.1	4.97E-7	Resting heart rate	
PRAD	cis	1	rs57506367	chr11:118141993	MPZL2	chr11:118124135-118135009:-	0.11	3.9	0.00011	Pain	
PRAD	cis	1	rs57506367	chr11:118141993	MPZL3	chr11:118100337-118123011:-	0.15	4.98	9.14E-7	Pain	
PRAD	cis	1	rs57506367	chr11:118141993	NLRX1	chr11:119039437-119054723:+	0.18	3.92	0.000103	Pain	
PRAD	cis	1	rs57506367	chr11:118141993	SCN2B	chr11:118033519-118047337:-	-0.11	-3.79	0.000168	Pain	
PRAD	cis	1	rs5750649	chr22:39036769	CBY1	chr22:39052658-39069853:+	0.13	3.66	0.000276	Resting heart rate	
PRAD	cis	1	rs5750649	chr22:39036769	LOC646851	chr22:38974125-39052634:-	0.21	5.08	5.49E-7	Resting heart rate	
PRAD	cis	1	rs5750652	chr22:39048316	CBY1	chr22:39052658-39069853:+	0.13	3.66	0.000276	Resting heart rate	
PRAD	cis	1	rs5750652	chr22:39048316	LOC646851	chr22:38974125-39052634:-	0.21	5.08	5.49E-7	Resting heart rate	
PRAD	cis	1	rs5750659	chr22:39068789	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs5750659	chr22:39068789	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs5750662	chr22:39072472	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs5750662	chr22:39072472	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs5750664	chr22:39072769	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs5750664	chr22:39072769	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs5750668	chr22:39079964	CBY1	chr22:39052658-39069853:+	0.18	5.07	5.84E-7	Resting heart rate	
PRAD	cis	1	rs5750668	chr22:39079964	LOC646851	chr22:38974125-39052634:-	0.2	4.66	4.2E-6	Resting heart rate	
PRAD	cis	1	rs5750669	chr22:39080638	CBY1	chr22:39052658-39069853:+	0.17	4.83	1.87E-6	Resting heart rate	
PRAD	cis	1	rs5750669	chr22:39080638	LOC646851	chr22:38974125-39052634:-	0.2	4.65	4.34E-6	Resting heart rate	
PRAD	cis	1	rs5750671	chr22:39094619	CBY1	chr22:39052658-39069853:+	0.14	4.1	4.79E-5	Resting heart rate	
PRAD	cis	1	rs5750671	chr22:39094619	LOC646851	chr22:38974125-39052634:-	0.19	4.74	2.78E-6	Resting heart rate	
PRAD	cis	1	rs5750672	chr22:39104168	CBY1	chr22:39052658-39069853:+	-0.17	-4.67	3.96E-6	Resting heart rate	
PRAD	cis	1	rs5750672	chr22:39104168	LOC646851	chr22:38974125-39052634:-	-0.19	-4.51	8.26E-6	Resting heart rate	
PRAD	cis	1	rs5750673	chr22:39110124	CBY1	chr22:39052658-39069853:+	0.17	4.82	1.91E-6	Resting heart rate	
PRAD	cis	1	rs5750673	chr22:39110124	LOC646851	chr22:38974125-39052634:-	0.2	4.65	4.23E-6	Resting heart rate	
PRAD	cis	1	rs5750677	chr22:39147715	CBY1	chr22:39052658-39069853:+	0.14	4.08	5.29E-5	Resting heart rate	
PRAD	cis	1	rs5750677	chr22:39147715	LOC646851	chr22:38974125-39052634:-	0.18	4.27	2.35E-5	Resting heart rate	
PRAD	cis	1	rs5751255	chr22:42648408	C22orf32	chr22:42475699-42480287:+	0.15	4.69	3.61E-6	Cognitive function	
PRAD	cis	1	rs5751255	chr22:42648408	CYP2D6	chr22:42522502-42526883:-	-0.32	-9.62	4.21E-20	Cognitive function	
PRAD	cis	1	rs5751255	chr22:42648408	NAGA	chr22:42454339-42466846:-	0.25	4.89	1.39E-6	Cognitive function	
PRAD	cis	1	rs57512806	chr2:17776078	GEN1	chr2:17935162-17966632:+	0.41	5.23	2.51E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs57514701	chr10:1146169	IDI2	chr10:1064847-1071799:-	0.39	5.07	5.72E-7	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs5751901	chr22:24992266	GSTT2	chr22:24322314-24326104:+;chr22	-0.25	-4.18	3.43E-5	Protein quantitative trait loci	
PRAD	cis	1	rs5751901	chr22:24992266	LOC644165	chr22:25028882-25049326:+	0.19	4.63	4.79E-6	Protein quantitative trait loci	
PRAD	cis	1	rs57526195	chr6:88364471	C6orf165	chr6:88117721-88205858:+	0.46	4.2	3.15E-5	Obesity-related traits	
PRAD	cis	1	rs57535407	chr11:46570286	HARBI1	chr11:46624857-46638777:-	0.27	3.66	0.000284	Schizophrenia	
PRAD	cis	1	rs57542536	chr9:97326311	FAM22F	chr9:97080478-97090926:-	0.43	3.77	0.000182	Height	
PRAD	cis	1	rs57542652	chr2:228088	SH3YL1	chr2:218138-264810:-	-0.81	-19.5	1.7E-62	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs5756813	chr22:38175477	GALR3	chr22:38219389-38221502:+	0.34	6.57	1.32E-10	Optic cup area;Vertical cup-disc ratio	
PRAD	cis	1	rs5756813	chr22:38175477	LGALS2	chr22:37966254-37976024:-	0.13	3.45	0.000605	Optic cup area;Vertical cup-disc ratio	
PRAD	cis	1	rs5756813	chr22:38175477	TRIOBP	chr22:38082344-38172562:+	-0.21	-5.83	1.04E-8	Optic cup area;Vertical cup-disc ratio	
PRAD	cis	1	rs5757141	chr22:38957483	CBY1	chr22:39052658-39069853:+	0.13	3.73	0.000216	Resting heart rate	
PRAD	cis	1	rs5757141	chr22:38957483	LOC646851	chr22:38974125-39052634:-	0.15	3.54	0.000436	Resting heart rate	
PRAD	cis	1	rs5757162	chr22:38993370	CBY1	chr22:39052658-39069853:+	0.16	4.58	5.91E-6	Resting heart rate	
PRAD	cis	1	rs5757162	chr22:38993370	LOC646851	chr22:38974125-39052634:-	0.18	4.16	3.79E-5	Resting heart rate	
PRAD	cis	1	rs5757166	chr22:38995385	CBY1	chr22:39052658-39069853:+	0.13	3.85	0.000137	Resting heart rate	
PRAD	cis	1	rs5757166	chr22:38995385	LOC646851	chr22:38974125-39052634:-	0.2	4.96	1.0E-6	Resting heart rate	
PRAD	cis	1	rs5757181	chr22:39013522	CBY1	chr22:39052658-39069853:+	0.15	4.28	2.3E-5	Resting heart rate	
PRAD	cis	1	rs5757181	chr22:39013522	LOC646851	chr22:38974125-39052634:-	0.17	3.93	9.94E-5	Resting heart rate	
PRAD	cis	1	rs5757187	chr22:39021522	CBY1	chr22:39052658-39069853:+	-0.16	-4.55	6.68E-6	Resting heart rate	
PRAD	cis	1	rs5757187	chr22:39021522	LOC646851	chr22:38974125-39052634:-	-0.18	-4.35	1.66E-5	Resting heart rate	
PRAD	cis	1	rs5757193	chr22:39034867	CBY1	chr22:39052658-39069853:+	-0.15	-4.29	2.15E-5	Resting heart rate	
PRAD	cis	1	rs5757193	chr22:39034867	LOC646851	chr22:38974125-39052634:-	-0.18	-4.23	2.81E-5	Resting heart rate	
PRAD	cis	1	rs5757196	chr22:39039855	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs5757196	chr22:39039855	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs5757200	chr22:39043491	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs5757200	chr22:39043491	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs5757203	chr22:39044152	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs5757203	chr22:39044152	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs5757204	chr22:39046700	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs5757204	chr22:39046700	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs5757208	chr22:39049230	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs5757208	chr22:39049230	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs5757211	chr22:39051705	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs5757211	chr22:39051705	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs5757213	chr22:39053888	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs5757213	chr22:39053888	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs5757226	chr22:39070550	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs5757226	chr22:39070550	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs5757231	chr22:39071658	CBY1	chr22:39052658-39069853:+	-0.17	-4.72	3.16E-6	Resting heart rate	
PRAD	cis	1	rs5757231	chr22:39071658	LOC646851	chr22:38974125-39052634:-	-0.2	-4.72	3.07E-6	Resting heart rate	
PRAD	cis	1	rs5757232	chr22:39071677	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs5757232	chr22:39071677	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs5757234	chr22:39072686	CBY1	chr22:39052658-39069853:+	0.14	4.07	5.53E-5	Resting heart rate	
PRAD	cis	1	rs5757234	chr22:39072686	LOC646851	chr22:38974125-39052634:-	0.19	4.72	3.16E-6	Resting heart rate	
PRAD	cis	1	rs5757253	chr22:39104320	CBY1	chr22:39052658-39069853:+	0.13	3.95	8.88E-5	Resting heart rate	
PRAD	cis	1	rs5757253	chr22:39104320	LOC646851	chr22:38974125-39052634:-	0.19	4.72	3.1E-6	Resting heart rate	
PRAD	cis	1	rs57576544	chr6:44072726	MRPL14	chr6:44081374-44095191:-	-0.12	-3.58	0.000376	Major depressive disorder	
PRAD	cis	1	rs57576577	chr16:31036367	HSD3B7	chr16:30996519-31000473:+	0.48	10.55	1.7E-23	Response to metformin (IC50)	
PRAD	cis	1	rs57576577	chr16:31036367	MYST1	chr16:31128985-31142713:+	0.2	6.13	1.82E-9	Response to metformin (IC50)	
PRAD	cis	1	rs57576577	chr16:31036367	PRSS36	chr16:31150251-31161415:-	0.19	4.74	2.78E-6	Response to metformin (IC50)	
PRAD	cis	1	rs57576577	chr16:31036367	PRSS53	chr16:31094747-31106276:-	-0.19	-3.83	0.000146	Response to metformin (IC50)	
PRAD	cis	1	rs57576577	chr16:31036367	STX1B	chr16:31000577-31021829:-	0.22	5.55	4.74E-8	Response to metformin (IC50)	
PRAD	cis	1	rs5758659	chr22:42622003	C22orf32	chr22:42475699-42480287:+	0.15	4.65	4.31E-6	Cognitive function	
PRAD	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.32	-9.72	1.83E-20	Cognitive function	
PRAD	cis	1	rs5758659	chr22:42622003	NAGA	chr22:42454339-42466846:-	0.25	4.87	1.5E-6	Cognitive function	
PRAD	cis	1	rs5758660	chr22:42623718	C22orf32	chr22:42475699-42480287:+	0.15	4.6	5.34E-6	Cognitive function	
PRAD	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.32	-9.62	4.12E-20	Cognitive function	
PRAD	cis	1	rs5758660	chr22:42623718	NAGA	chr22:42454339-42466846:-	0.26	4.92	1.18E-6	Cognitive function	
PRAD	cis	1	rs5758677	chr22:42643039	C22orf32	chr22:42475699-42480287:+	0.15	4.71	3.28E-6	Cognitive function	
PRAD	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.32	-9.69	2.27E-20	Cognitive function	
PRAD	cis	1	rs5758677	chr22:42643039	NAGA	chr22:42454339-42466846:-	0.26	4.97	9.48E-7	Cognitive function	
PRAD	cis	1	rs5759667	chr22:23603957	GNAZ	chr22:23412669-23467221:+	-0.1	-3.52	0.000479	Height	
PRAD	cis	1	rs5760216	chr22:24539734	SUSD2	chr22:24577444-24585074:+	0.66	8.78	2.94E-17	Amyotrophic lateral sclerosis	
PRAD	cis	1	rs5760220	chr22:24542480	SUSD2	chr22:24577444-24585074:+	0.7	9.39	2.58E-19	Amyotrophic lateral sclerosis	
PRAD	cis	1	rs5760229	chr22:24560254	SUSD2	chr22:24577444-24585074:+	0.69	9.3	5.19E-19	Amyotrophic lateral sclerosis	
PRAD	cis	1	rs5761618	chr22:26993706	CRYBA4	chr22:27017928-27026635:+	0.48	9.13	2.0E-18	Developmental language disorder (linguistic errors)	
PRAD	cis	1	rs5761618	chr22:26993706	TPST2	chr22:26921716-26986089:-	0.28	5.7	2.16E-8	Developmental language disorder (linguistic errors)	
PRAD	cis	1	rs5761672	chr22:27069439	CRYBA4	chr22:27017928-27026635:+	-0.26	-4.99	8.48E-7	Electroencephalogram traits	
PRAD	cis	1	rs5762311	chr22:28090207	PITPNB	chr22:28247658-28315255:-	-0.26	-3.62	0.000332	Sudden cardiac arrest	
PRAD	cis	1	rs57631744	chr3:10118962	C3orf10	chr3:10157333-10168873:+	-0.2	-3.84	0.00014	Alzheimer's disease	
PRAD	cis	1	rs57631744	chr3:10118962	LOC401052	chr3:10048102-10052779:-	-0.29	-5.22	2.75E-7	Alzheimer's disease	
PRAD	cis	1	rs5763305	chr22:29930195	SEC14L2	chr22:30792933-30824976:+	0.26	3.61	0.000344	Lipid traits	
PRAD	cis	1	rs576779	chr4:56274307	TMEM165	chr4:56262090-56292342:+	-0.16	-3.51	0.000487	Personality dimensions	
PRAD	cis	1	rs5768991	chr22:46983018	CERK	chr22:47080308-47134152:-	0.14	4.14	4.16E-5	Urate levels in obese individuals	
PRAD	cis	1	rs57690120	chr20:33731437	GDF5	chr20:33897002-34042568:-	0.24	3.81	0.000158	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs57690120	chr20:33731437	MMP24	chr20:33814539-33864804:+	-0.24	-3.99	7.62E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs57699322	chr3:128065313	RUVBL1	chr3:127783627-127872757:-	0.21	3.82	0.000154	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs5770911	chr22:51011241	CPT1B	chr22:51007291-51017096:-	-0.26	-4.96	1.0E-6	Narcolepsy	
PRAD	cis	1	rs5770911	chr22:51011241	LOC100144603	chr22:51021455-51022353:+	-0.41	-4.31	1.99E-5	Narcolepsy	
PRAD	cis	1	rs5770917	chr22:51017353	CPT1B	chr22:51007291-51017096:-	-0.2	-4.3	2.08E-5	Narcolepsy	
PRAD	cis	1	rs5770917	chr22:51017353	LOC100144603	chr22:51021455-51022353:+	-0.35	-4.02	6.78E-5	Narcolepsy	
PRAD	cis	1	rs5770924	chr22:51024542	CPT1B	chr22:51007291-51017096:-	-0.26	-4.96	1.01E-6	Narcolepsy	
PRAD	cis	1	rs5770924	chr22:51024542	LOC100144603	chr22:51021455-51022353:+	-0.42	-4.38	1.44E-5	Narcolepsy	
PRAD	cis	1	rs5771109	chr22:50678571	SELO	chr22:50639408-50656044:+	0.11	4.14	4.14E-5	Obesity-related traits	
PRAD	cis	1	rs577227	chr10:131404528	MGMT	chr10:131265454-131565783:+	0.35	9.51	9.68E-20	Response to temozolomide	
PRAD	cis	1	rs57735707	chr3:128065815	RUVBL1	chr3:127783627-127872757:-	0.22	3.96	8.54E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs57738705	chr11:77994489	GAB2	chr11:77926343-78128766:-	-0.2	-6.3	6.78E-10	Testicular germ cell tumor	
PRAD	cis	1	rs57738705	chr11:77994489	NARS2	chr11:78147017-78285909:-	-0.24	-4.82	1.9E-6	Testicular germ cell tumor	
PRAD	cis	1	rs57804141	chr3:129962512	COL6A4P2	chr3:129931663-129992648:+	0.23	4.12	4.39E-5	Response to amphetamines	
PRAD	cis	1	rs578056	chr11:65514874	CTSW	chr11:65647284-65651212:+	-0.26	-5.13	4.16E-7	Systemic lupus erythematosus	
PRAD	cis	1	rs578056	chr11:65514874	SNX32	chr11:65601410-65621170:+	0.31	4.45	1.06E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs57844481	chr14:76684493	ESRRB	chr14:76837690-76968178:+	-0.27	-3.46	0.00058	Blood pressure	
PRAD	cis	1	rs57866349	chr4:155349420	DCHS2	chr4:155155527-155412930:-	0.14	3.89	0.000116	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs5786757	chr10:88836152	FAM22A	chr10:88985205-88994731:+	0.18	3.46	0.000583	Nose morphology	
PRAD	cis	1	rs57912102	chr19:22136043	ZNF257	chr19:22235266-22273901:+	0.39	5.29	1.92E-7	Body mass index (change over time)	
PRAD	cis	1	rs57925408	chr8:96062930	C8orf38	chr8:95908040-96088396:+	-0.38	-6.69	6.2E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs57925408	chr8:96062930	TP53INP1	chr8:95938201-95961615:-	0.23	3.55	0.000417	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs57994353	chr9:139356987	SDCCAG3	chr9:139296375-139305054:-	-0.18	-5.06	6.07E-7	cutaneous squamous cell carcinoma	
PRAD	cis	1	rs57994353	chr9:139356987	SEC16A	chr9:139334549-139377507:-	-0.23	-5.64	2.93E-8	cutaneous squamous cell carcinoma	
PRAD	cis	1	rs58062456	chr7:65394852	CCT6P1	chr7:65216092-65228661:+	0.3	5.31	1.65E-7	Diabetic kidney disease	
PRAD	cis	1	rs58062456	chr7:65394852	CRCP	chr7:65579805-65619551:+	-0.27	-3.54	0.000439	Diabetic kidney disease	
PRAD	cis	1	rs58062456	chr7:65394852	ZNF117	chr7:64434830-64467121:-	-0.27	-3.43	0.000659	Diabetic kidney disease	
PRAD	cis	1	rs580705	chr11:114430047	FAM55A	chr11:114392438-114430580:-	-0.21	-4.29	2.16E-5	Ulcerative colitis	
PRAD	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.35	9.72	1.8E-20	Response to temozolomide	
PRAD	cis	1	rs58088385	chr20:33748229	MMP24	chr20:33814539-33864804:+	-0.28	-4.3	2.03E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs58115860	chr14:66057626	LOC645431	chr14:65877313-65879335:-	-0.41	-4.15	3.97E-5	Ischemic stroke	
PRAD	cis	1	rs58119858	chr15:79219423	CTSH	chr15:79214092-79237420:-	0.44	6.19	1.32E-9	Bipolar disorder	
PRAD	cis	1	rs58122682	chr17:65876915	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs58133129	chr14:104104759	BAG5	chr14:104022889-104029151:-	0.18	3.75	0.0002	Body mass index	
PRAD	cis	1	rs58133129	chr14:104104759	C14orf153	chr14:104029299-104057227:+	0.14	4.33	1.86E-5	Body mass index	
PRAD	cis	1	rs58133129	chr14:104104759	CKB	chr14:103985996-103989170:-	0.22	5.07	5.87E-7	Body mass index	
PRAD	cis	1	rs58133129	chr14:104104759	KLC1	chr14:104029299-104167887:+	-0.18	-3.76	0.000189	Body mass index	
PRAD	cis	1	rs58133129	chr14:104104759	MARK3	chr14:103851701-103970164:+	0.24	4.89	1.39E-6	Body mass index	
PRAD	cis	1	rs58162302	chr11:118146199	MPZL2	chr11:118124135-118135009:-	0.11	3.89	0.000115	Pain	
PRAD	cis	1	rs58162302	chr11:118146199	MPZL3	chr11:118100337-118123011:-	0.15	4.98	8.96E-7	Pain	
PRAD	cis	1	rs58162302	chr11:118146199	NLRX1	chr11:119039437-119054723:+	0.18	3.92	0.000103	Pain	
PRAD	cis	1	rs58162302	chr11:118146199	SCN2B	chr11:118033519-118047337:-	-0.11	-3.81	0.000158	Pain	
PRAD	cis	1	rs581686	chr10:105983356	C10orf79	chr10:105889647-105992120:-	0.26	4.61	5.22E-6	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs58189451	chr6:149921388	NUP43	chr6:150045453-150067688:-	-0.56	-10.96	4.7E-25	Lung cancer	
PRAD	cis	1	rs58189451	chr6:149921388	ULBP2	chr6:150263136-150270366:+	0.25	5.36	1.29E-7	Lung cancer	
PRAD	cis	1	rs58195923	chr8:65693017	BHLHE22	chr8:65492814-65496185:+	0.27	5.16	3.74E-7	HIV-1 susceptibility	
PRAD	cis	1	rs58204112	chr14:74359417	LIN52	chr14:74551656-74667117:+	0.27	4.51	8.14E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs58235466	chr11:78030886	GAB2	chr11:77926343-78128766:-	-0.18	-5.93	5.82E-9	Testicular germ cell tumor	
PRAD	cis	1	rs58235466	chr11:78030886	NARS2	chr11:78147017-78285909:-	-0.24	-5.09	5.16E-7	Testicular germ cell tumor	
PRAD	cis	1	rs58275763	chr3:10143274	C3orf10	chr3:10157333-10168873:+	-0.21	-4.11	4.58E-5	Alzheimer's disease	
PRAD	cis	1	rs58275763	chr3:10143274	LOC401052	chr3:10048102-10052779:-	-0.3	-5.52	5.65E-8	Alzheimer's disease	
PRAD	cis	1	rs58281712	chr4:89810956	FAM13A	chr4:89647106-90032549:-	0.18	3.44	0.000642	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs58288071	chr2:203214739	NOP58	chr2:203130515-203168382:+	0.28	4.39	1.38E-5	Urate levels	
PRAD	cis	1	rs58305064	chr4:23005484	PPARGC1A	chr4:23793645-23891700:-	0.2	3.46	0.000593	White matter lesion progression (adjusted for white matter lesion burden at baseline)	
PRAD	cis	1	rs58336952	chr19:12057916	ZNF763	chr19:12035900-12091196:+	-0.37	-4.01	7.1E-5	Multiple sclerosis	
PRAD	cis	1	rs58355920	chr2:178684897	PDE11A	chr2:178487979-178973066:-	-0.32	-4.24	2.65E-5	Height	
PRAD	cis	1	rs583583	chr1:147083114	ACP6	chr1:147119168-147142634:-	0.59	12.77	2.84E-32	Schizophrenia (negative symptoms)	
PRAD	cis	1	rs58365910	chr15:78849034	CHRNA3	chr15:78885397-78913322:-	-0.26	-4.54	7.22E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs58365910	chr15:78849034	CHRNA5	chr15:78857906-78886458:+	-0.22	-4.49	9.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs58389158	chr22:38128283	GALR3	chr22:38219389-38221502:+	-0.26	-4.63	4.81E-6	Age-related hearing impairment	
PRAD	cis	1	rs58389158	chr22:38128283	TRIOBP	chr22:38082344-38172562:+	0.19	5.03	6.87E-7	Age-related hearing impairment	
PRAD	cis	1	rs58415361	chr1:6592377	TNFRSF25	chr1:6521221-6526255:-	-0.14	-3.7	0.000237	Body mass index	
PRAD	cis	1	rs58416181	chr15:85264461	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.43	0.000655	Schizophrenia	
PRAD	cis	1	rs58416181	chr15:85264461	LOC388152	chr15:84867600-84898920:-	-0.33	-5.46	7.74E-8	Schizophrenia	
PRAD	cis	1	rs58416181	chr15:85264461	NMB	chr15:85198362-85201802:-	-0.54	-12.63	1.09E-31	Schizophrenia	
PRAD	cis	1	rs58416181	chr15:85264461	WDR73	chr15:85186012-85197524:-	-0.27	-5.77	1.46E-8	Schizophrenia	
PRAD	cis	1	rs58421016	chr1:27070529	PIGV	chr1:27114455-27124886:+	-0.35	-4.05	6.03E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs584309	chr10:105956776	C10orf79	chr10:105889647-105992120:-	0.24	4.39	1.38E-5	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs58436485	chr15:90900633	ZNF774	chr15:90895477-90904714:+	-0.24	-4.52	7.73E-6	Rheumatoid arthritis	
PRAD	cis	1	rs58442170	chr2:178676416	PDE11A	chr2:178487979-178973066:-	-0.34	-4.35	1.68E-5	Height	
PRAD	cis	1	rs58453750	chr2:17778329	GEN1	chr2:17935162-17966632:+	0.45	5.66	2.65E-8	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs58461606	chr2:267367	SH3YL1	chr2:218138-264810:-	-0.79	-19.02	2.98E-60	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs58479136	chr8:39417462	TACC1	chr8:38585704-38710545:+	0.16	3.63	0.000314	Visceral adipose tissue/subcutaneous adipose tissue ratio	
PRAD	cis	1	rs58479700	chr6:24483199	GPLD1	chr6:24428405-24489850:-	0.41	8.18	2.74E-15	Hematological and biochemical traits	
PRAD	cis	1	rs58479700	chr6:24483199	MRS2	chr6:24403153-24425809:+	0.26	4.14	4.2E-5	Hematological and biochemical traits	
PRAD	cis	1	rs58507982	chr11:118146510	MPZL2	chr11:118124135-118135009:-	0.11	3.89	0.000115	Pain	
PRAD	cis	1	rs58507982	chr11:118146510	MPZL3	chr11:118100337-118123011:-	0.15	4.98	8.96E-7	Pain	
PRAD	cis	1	rs58507982	chr11:118146510	NLRX1	chr11:119039437-119054723:+	0.18	3.92	0.000103	Pain	
PRAD	cis	1	rs58507982	chr11:118146510	SCN2B	chr11:118033519-118047337:-	-0.11	-3.81	0.000158	Pain	
PRAD	cis	1	rs585101	chr5:139058454	SLC23A1	chr5:138702891-138719039:-	0.19	3.53	0.000465	Schizophrenia	
PRAD	cis	1	rs58515922	chr2:86173037	REEP1	chr2:86441122-86564777:-	0.44	4.16	3.73E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs58551145	chr17:65837235	LOC651250	chr17:66097696-66157623:+	-0.23	-4.14	4.16E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs58556096	chr18:11987415	IMPA2	chr18:11981057-12030876:+	-0.37	-4.54	7.18E-6	Stroke	
PRAD	cis	1	rs58565853	chr11:78036707	GAB2	chr11:77926343-78128766:-	-0.2	-6.51	1.96E-10	Testicular germ cell tumor	
PRAD	cis	1	rs58565853	chr11:78036707	NARS2	chr11:78147017-78285909:-	-0.22	-4.49	8.97E-6	Testicular germ cell tumor	
PRAD	cis	1	rs58603761	chr2:73726605	ALMS1P	chr2:73872046-73912692:+	0.5	8.43	4.25E-16	Metabolite levels	
PRAD	cis	1	rs58603761	chr2:73726605	NAT8	chr2:73867850-73869537:-	0.27	4.14	4.1E-5	Metabolite levels	
PRAD	cis	1	rs58619315	chr10:59732920	LOC728640	chr10:60474775-60477291:+	-0.28	-3.5	0.000514	Blood pressure	
PRAD	cis	1	rs58620414	chr1:183621957	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs58641606	chr2:112670732	MERTK	chr2:112656191-112786945:+	-0.24	-4.12	4.57E-5	Multiple sclerosis	
PRAD	cis	1	rs58660500	chr3:53086573	RFT1	chr3:53122503-53164470:-	0.45	4.73	2.94E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs58660500	chr3:53086573	TMEM110	chr3:52867139-52931547:-	0.4	4.76	2.59E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs586608	chr19:15694168	EPHX3	chr19:15337731-15343858:-	0.19	3.44	0.000625	Inflammatory biomarkers	
PRAD	cis	1	rs58669269	chr7:65951953	CCT6P1	chr7:65216092-65228661:+	0.31	5.19	3.2E-7	Diabetic kidney disease	
PRAD	cis	1	rs58669269	chr7:65951953	CRCP	chr7:65579805-65619551:+	-0.34	-4.18	3.5E-5	Diabetic kidney disease	
PRAD	cis	1	rs58672934	chr2:86163236	REEP1	chr2:86441122-86564777:-	0.34	3.43	0.000654	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs58717741	chr5:150284936	C5orf62	chr5:150157867-150176297:+	0.29	3.57	0.000393	Crohn's disease	
PRAD	cis	1	rs58717741	chr5:150284936	LOC134466	chr5:150310000-150326146:-	0.68	10.29	1.54E-22	Crohn's disease	
PRAD	cis	1	rs58749629	chr20:44571317	WFDC3	chr20:44402847-44420547:-	-0.5	-6.96	1.17E-11	Abdominal aortic aneurysm	
PRAD	cis	1	rs58852079	chr12:56706922	MIP	chr12:56843885-56848429:-	0.77	5.69	2.28E-8	Psoriasis vulgaris	
PRAD	cis	1	rs58986862	chr3:128061689	RUVBL1	chr3:127783627-127872757:-	0.24	4.55	6.7E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs58994922	chr8:65641267	BHLHE22	chr8:65492814-65496185:+	0.32	5.88	7.93E-9	HIV-1 susceptibility	
PRAD	cis	1	rs58999537	chr12:51357104	TFCP2	chr12:51488608-51566917:-	-0.21	-3.5	0.000515	Type 2 diabetes	
PRAD	cis	1	rs59043558	chr5:150334662	LOC134466	chr5:150310000-150326146:-	0.5	6.99	9.59E-12	Crohn's disease	
PRAD	cis	1	rs59049611	chr11:118139403	MPZL2	chr11:118124135-118135009:-	0.11	3.67	0.000268	Pain	
PRAD	cis	1	rs59049611	chr11:118139403	MPZL3	chr11:118100337-118123011:-	0.15	5.02	7.49E-7	Pain	
PRAD	cis	1	rs59049611	chr11:118139403	NLRX1	chr11:119039437-119054723:+	0.18	3.85	0.000135	Pain	
PRAD	cis	1	rs59049611	chr11:118139403	SCN2B	chr11:118033519-118047337:-	-0.11	-3.77	0.000186	Pain	
PRAD	cis	1	rs59065735	chr3:128595566	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.000438	Dental caries	
PRAD	cis	1	rs59117465	chr14:66052472	LOC645431	chr14:65877313-65879335:-	-0.4	-3.92	0.000102	Ischemic stroke	
PRAD	cis	1	rs59123962	chr4:103512451	BDH2	chr4:103998783-104021024:-	0.15	3.8	0.000163	Ulcerative colitis	
PRAD	cis	1	rs59150578	chr11:18340862	GTF2H1	chr11:18343816-18388590:+	0.68	14.27	1.25E-38	Pancreatic cancer	
PRAD	cis	1	rs591519	chr15:48894200	DUT	chr15:48623621-48635568:+	-0.23	-3.72	0.000221	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs59162293	chr4:142158774	ZNF330	chr4:142142049-142155848:+	-0.27	-5	8.19E-7	Conduct disorder	
PRAD	cis	1	rs591784	chr10:105936290	C10orf79	chr10:105889647-105992120:-	0.26	4.73	2.92E-6	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs59204447	chr14:66106727	LOC645431	chr14:65877313-65879335:-	-0.41	-4.14	4.09E-5	Ischemic stroke	
PRAD	cis	1	rs59214302	chr19:10836062	LOC147727	chr19:10762539-10764548:-	0.29	3.7	0.000242	LDL cholesterol	
PRAD	cis	1	rs59226697	chr22:25870037	CRYBB2	chr22:25615612-25627836:+	0.87	10.66	6.79E-24	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs59227481	chr12:110007993	KCTD10	chr12:109886460-109915155:-	-0.33	-9.53	8.15E-20	Age-related nuclear cataracts	
PRAD	cis	1	rs59227481	chr12:110007993	MMAB	chr12:109991523-110011358:-	-0.2	-5.79	1.31E-8	Age-related nuclear cataracts	
PRAD	cis	1	rs59227481	chr12:110007993	MYO1H	chr12:109826524-109886176:+	-0.17	-3.59	0.000364	Age-related nuclear cataracts	
PRAD	cis	1	rs59227481	chr12:110007993	UBE3B	chr12:109915439-109974506:+	-0.2	-4.9	1.34E-6	Age-related nuclear cataracts	
PRAD	cis	1	rs59244547	chr3:156582997	LEKR1	chr3:156544076-156763918:+	-0.43	-5.62	3.27E-8	Bone mineral density	
PRAD	cis	1	rs59244622	chr2:97501632	CNNM3	chr2:97481991-97501120:+	-0.23	-3.5	0.000517	Erectile dysfunction and prostate cancer treatment	
PRAD	cis	1	rs59264451	chr3:184787463	AP2M1	chr3:183892634-183901878:+	-0.26	-3.46	0.000598	Heschl's gyrus morphology	
PRAD	cis	1	rs59264451	chr3:184787463	SENP2	chr3:185300507-185348883:+	-0.28	-4.15	4.0E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs59264451	chr3:184787463	VPS8	chr3:184529931-184770402:+	-0.39	-4.89	1.39E-6	Heschl's gyrus morphology	
PRAD	cis	1	rs59274738	chr17:28437635	EFCAB5	chr17:28256874-28435469:+	0.24	4.03	6.45E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs59295315	chr12:56708576	MIP	chr12:56843885-56848429:-	0.77	5.69	2.28E-8	Psoriasis vulgaris	
PRAD	cis	1	rs592955	chr11:108156473	ATM	chr11:108093559-108239826:+	-0.15	-4.63	4.65E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs593126	chr15:45935777	DUOX1	chr15:45422192-45457774:+	-0.1	-3.44	0.00064	Obesity-related traits	
PRAD	cis	1	rs593126	chr15:45935777	DUOX2	chr15:45384853-45406359:-	-0.15	-3.64	0.000306	Obesity-related traits	
PRAD	cis	1	rs593126	chr15:45935777	SPATA5L1	chr15:45694519-45713614:+	0.23	3.45	0.000602	Obesity-related traits	
PRAD	cis	1	rs593151	chr10:105935979	C10orf79	chr10:105889647-105992120:-	0.26	4.73	2.92E-6	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs59321715	chr5:150313480	LOC134466	chr5:150310000-150326146:-	0.72	9.31	4.93E-19	Crohn's disease	
PRAD	cis	1	rs59343240	chr16:67850529	C16orf86	chr16:67700717-67702659:+	-0.3	-4.75	2.69E-6	Crohn's disease	
PRAD	cis	1	rs59343240	chr16:67850529	FHOD1	chr16:67263294-67281425:-	0.29	3.47	0.000564	Crohn's disease	
PRAD	cis	1	rs59363432	chr14:74397545	LIN52	chr14:74551656-74667117:+	0.33	5.37	1.22E-7	Morning vs. evening chronotype	
PRAD	cis	1	rs59377495	chr10:1157019	IDI2	chr10:1064847-1071799:-	0.37	4.83	1.85E-6	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs59400168	chr11:126280544	ST3GAL4	chr11:126225579-126310752:+	-0.22	-3.62	0.000323	Coronary heart disease	
PRAD	cis	1	rs594074	chr6:6552994	LY86	chr6:6588934-6655216:+	0.14	4.31	1.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs59428599	chr10:4970849	AKR1C2	chr10:4964715-5060207:-	0.64	8.99	6.14E-18	Height	
PRAD	cis	1	rs59441945	chr2:198879645	PLCL1	chr2:198669426-199014606:+	0.15	4.01	6.96E-5	Ulcerative colitis	
PRAD	cis	1	rs59468948	chr1:156288058	BGLAP	chr1:156182784-156213112:+	0.22	5.59	3.8E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs59468948	chr1:156288058	CCT3	chr1:156278752-156308195:-	-0.15	-3.45	0.000616	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs59531858	chr5:150247063	C5orf62	chr5:150157867-150176297:+	0.33	3.95	9.03E-5	Crohn's disease	
PRAD	cis	1	rs59531858	chr5:150247063	LOC134466	chr5:150310000-150326146:-	0.7	9.91	3.89E-21	Crohn's disease	
PRAD	cis	1	rs595449	chr13:30896852	KATNAL1	chr13:30776768-30881584:-	0.19	4.12	4.39E-5	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs59561356	chr14:66020022	LOC645431	chr14:65877313-65879335:-	-0.45	-4.52	7.98E-6	Ischemic stroke	
PRAD	cis	1	rs59574684	chr6:149606514	ULBP2	chr6:150263136-150270366:+	0.2	3.63	0.000315	Breast cancer	
PRAD	cis	1	rs59583591	chr3:53119581	ITIH4	chr3:52847007-52866554:-	-0.19	-3.56	0.000402	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs59583591	chr3:53119581	RFT1	chr3:53122503-53164470:-	0.42	5.14	4.08E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs59583591	chr3:53119581	TMEM110	chr3:52867139-52931547:-	0.29	3.96	8.5E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs59606579	chr6:25608370	SCGN	chr6:25652429-25702006:+	0.43	7.33	1.01E-12	Uric acid levels	
PRAD	cis	1	rs59626664	chr12:56636975	COQ10A	chr12:56660642-56664748:+	-0.36	-3.53	0.000459	Psoriasis vulgaris	
PRAD	cis	1	rs59626664	chr12:56636975	MIP	chr12:56843885-56848429:-	0.69	5.1	5.05E-7	Psoriasis vulgaris	
PRAD	cis	1	rs59630213	chr16:77777030	NUDT7	chr16:77756411-77776153:+	0.25	3.67	0.00027	Obesity-related traits	
PRAD	cis	1	rs59676254	chr14:65942840	LOC645431	chr14:65877313-65879335:-	-0.44	-4.46	1.05E-5	Ischemic stroke	
PRAD	cis	1	rs59685862	chr14:66080130	LOC645431	chr14:65877313-65879335:-	-0.4	-4.11	4.63E-5	Ischemic stroke	
PRAD	cis	1	rs59715646	chr19:10839447	LOC147727	chr19:10762539-10764548:-	0.27	3.53	0.000459	LDL cholesterol	
PRAD	cis	1	rs59715748	chr5:150189287	LOC134466	chr5:150310000-150326146:-	0.71	9.16	1.56E-18	Crohn's disease	
PRAD	cis	1	rs59715866	chr1:27079176	PIGV	chr1:27114455-27124886:+	-0.36	-4.06	5.84E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs59770215	chr6:159371062	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs59784306	chr20:61859596	BIRC7	chr20:61867276-61871853:+	0.35	4.35	1.7E-5	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs59794892	chr7:65415873	CCT6P1	chr7:65216092-65228661:+	0.3	5.34	1.45E-7	Diabetic kidney disease	
PRAD	cis	1	rs59794892	chr7:65415873	CRCP	chr7:65579805-65619551:+	-0.28	-3.59	0.000362	Diabetic kidney disease	
PRAD	cis	1	rs59794892	chr7:65415873	ZNF117	chr7:64434830-64467121:-	-0.28	-3.44	0.000624	Diabetic kidney disease	
PRAD	cis	1	rs59804446	chr4:56429541	TMEM165	chr4:56262090-56292342:+	0.18	3.73	0.000215	Personality dimensions	
PRAD	cis	1	rs59808242	chr5:130754894	P4HA2	chr5:131528306-131563556:-	-0.21	-3.78	0.000178	Life satisfaction	
PRAD	cis	1	rs59811639	chr12:56695954	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs59811639	chr12:56695954	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs59822422	chr14:65889566	LOC645431	chr14:65877313-65879335:-	-0.44	-4.48	9.29E-6	Ischemic stroke	
PRAD	cis	1	rs59872949	chr1:183613649	NCF2	chr1:183524698-183560046:-	0.26	3.88	0.000117	Systemic lupus erythematosus	
PRAD	cis	1	rs59889312	chr18:11987355	IMPA2	chr18:11981057-12030876:+	-0.37	-4.54	7.18E-6	Stroke	
PRAD	cis	1	rs59905513	chr14:90749638	C14orf102	chr14:90744398-90798279:-	0.2	3.56	0.000404	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs59921977	chr14:66018659	LOC645431	chr14:65877313-65879335:-	-0.45	-4.52	7.98E-6	Ischemic stroke	
PRAD	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.34	-5.85	9.05E-9	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs59937473	chr2:271797	SH3YL1	chr2:218138-264810:-	-0.75	-17.98	2.23E-55	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs5994434	chr22:32229649	SFI1	chr22:31892261-32014533:+	-0.18	-3.59	0.000362	Intelligence	
PRAD	cis	1	rs59945106	chr16:77780154	NUDT7	chr16:77756411-77776153:+	0.24	3.51	0.00049	Obesity-related traits	
PRAD	cis	1	rs59947468	chr2:86289436	LOC90784	chr2:86247339-86250991:-	-0.54	-4.45	1.09E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs59950564	chr17:65860859	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs599558	chr11:108177538	ATM	chr11:108093559-108239826:+	-0.15	-4.46	1.01E-5	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs5995610	chr22:39064681	CBY1	chr22:39052658-39069853:+	0.17	4.7	3.42E-6	Resting heart rate	
PRAD	cis	1	rs5995610	chr22:39064681	LOC646851	chr22:38974125-39052634:-	0.18	4.3	2.1E-5	Resting heart rate	
PRAD	cis	1	rs59960858	chr1:24519437	IL28RA	chr1:24480648-24513751:-	0.27	3.76	0.000192	Psoriasis vulgaris	
PRAD	cis	1	rs5996946	chr22:25875988	CRYBB2	chr22:25615612-25627836:+	0.93	15.66	9.09E-45	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs59980321	chr5:150241813	C5orf62	chr5:150157867-150176297:+	0.29	3.7	0.000241	Crohn's disease	
PRAD	cis	1	rs59980321	chr5:150241813	LOC134466	chr5:150310000-150326146:-	0.59	8.93	9.5E-18	Crohn's disease	
PRAD	cis	1	rs59983196	chr1:183591797	NCF2	chr1:183524698-183560046:-	0.25	3.66	0.00028	Systemic lupus erythematosus	
PRAD	cis	1	rs599946	chr5:139057461	SLC23A1	chr5:138702891-138719039:-	0.19	3.49	0.000538	Schizophrenia	
PRAD	cis	1	rs6001173	chr22:39015302	CBY1	chr22:39052658-39069853:+	0.13	3.85	0.000137	Resting heart rate	
PRAD	cis	1	rs6001173	chr22:39015302	LOC646851	chr22:38974125-39052634:-	0.2	4.96	1.0E-6	Resting heart rate	
PRAD	cis	1	rs6001175	chr22:39018334	CBY1	chr22:39052658-39069853:+	0.13	3.68	0.000264	Resting heart rate	
PRAD	cis	1	rs6001175	chr22:39018334	LOC646851	chr22:38974125-39052634:-	0.21	5.06	6.03E-7	Resting heart rate	
PRAD	cis	1	rs6001182	chr22:39047443	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs6001182	chr22:39047443	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs6001184	chr22:39052116	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs6001184	chr22:39052116	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs6001185	chr22:39052155	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs6001185	chr22:39052155	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs6001188	chr22:39062194	CBY1	chr22:39052658-39069853:+	0.16	4.45	1.07E-5	Resting heart rate	
PRAD	cis	1	rs6001188	chr22:39062194	LOC646851	chr22:38974125-39052634:-	0.19	4.39	1.38E-5	Resting heart rate	
PRAD	cis	1	rs6001191	chr22:39074452	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs6001191	chr22:39074452	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs6001204	chr22:39100239	CBY1	chr22:39052658-39069853:+	0.14	4.1	4.79E-5	Resting heart rate	
PRAD	cis	1	rs6001204	chr22:39100239	LOC646851	chr22:38974125-39052634:-	0.19	4.74	2.78E-6	Resting heart rate	
PRAD	cis	1	rs6001214	chr22:39149155	CBY1	chr22:39052658-39069853:+	0.14	4.07	5.5E-5	Resting heart rate	
PRAD	cis	1	rs6001214	chr22:39149155	LOC646851	chr22:38974125-39052634:-	0.16	3.8	0.000164	Resting heart rate	
PRAD	cis	1	rs60025964	chr2:99880577	MRPL30	chr2:99758185-99939196:+	0.22	3.51	0.0005	IgG glycosylation	
PRAD	cis	1	rs60025964	chr2:99880577	TSGA10	chr2:99613725-99771187:-	0.31	4.59	5.63E-6	IgG glycosylation	
PRAD	cis	1	rs600329	chr11:108163733	ATM	chr11:108093559-108239826:+	-0.16	-4.73	3.04E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs60037734	chr1:35679187	C1orf216	chr1:36179477-36184790:-	-0.32	-3.91	0.000104	Endometrial cancer	
PRAD	cis	1	rs6003958	chr22:24264089	DDT	chr22:24237099-24322019:-	0.21	4.4	1.34E-5	S-phenylmercapturic acid levels in smokers	
PRAD	cis	1	rs6003958	chr22:24264089	DDTL	chr22:24309026-24314747:+	0.33	6.4	3.82E-10	S-phenylmercapturic acid levels in smokers	
PRAD	cis	1	rs6003958	chr22:24264089	GSTT1	chr22:24376141-24384284:-	-0.81	-13.86	7.55E-37	S-phenylmercapturic acid levels in smokers	
PRAD	cis	1	rs6003958	chr22:24264089	GSTT2	chr22:24322314-24326104:+;chr22	0.41	5.58	4.18E-8	S-phenylmercapturic acid levels in smokers	
PRAD	cis	1	rs6003958	chr22:24264089	LOC391322	chr22:24373117-24374043:+	-0.66	-10.79	2.05E-24	S-phenylmercapturic acid levels in smokers	
PRAD	cis	1	rs6003958	chr22:24264089	MIF	chr22:24236565-24237409:+	0.27	6.45	2.73E-10	S-phenylmercapturic acid levels in smokers	
PRAD	cis	1	rs60043652	chr2:17778944	GEN1	chr2:17935162-17966632:+	0.41	5.22	2.74E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs6004667	chr22:25874464	CRYBB2	chr22:25615612-25627836:+	-0.94	-15.61	1.51E-44	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs6004668	chr22:25874502	CRYBB2	chr22:25615612-25627836:+	-0.92	-15.24	6.45E-43	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs6004669	chr22:25875803	CRYBB2	chr22:25615612-25627836:+	0.93	15.63	1.15E-44	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs6004671	chr22:25879474	CRYBB2	chr22:25615612-25627836:+	0.93	15.48	5.89E-44	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs6004672	chr22:25881013	CRYBB2	chr22:25615612-25627836:+	0.93	15.48	5.89E-44	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs6004673	chr22:25885353	CRYBB2	chr22:25615612-25627836:+	0.94	15.56	2.46E-44	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs6004675	chr22:25889385	CRYBB2	chr22:25615612-25627836:+	0.93	15.26	5.18E-43	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs6005807	chr22:28934313	LOC284900	chr22:28315364-28404267:+	0.23	4.06	5.84E-5	Cerebrospinal fluid p-Tau181p:AB1-42 ratio;Cerebrospinal P-tau181p levels;Cerebrospinal T-tau levels	
PRAD	cis	1	rs6005881	chr22:29183133	ZNRF3	chr22:29279890-29453475:+	-0.14	-3.54	0.000444	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
PRAD	cis	1	rs600848	chr5:139057270	SLC23A1	chr5:138702891-138719039:-	0.19	3.49	0.000519	Schizophrenia	
PRAD	cis	1	rs600931	chr11:108117335	ATM	chr11:108093559-108239826:+	-0.16	-4.68	3.81E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs601019	chr10:105976452	C10orf79	chr10:105889647-105992120:-	-0.19	-3.56	0.000411	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs60115501	chr6:149607540	ULBP2	chr6:150263136-150270366:+	0.2	3.5	0.000505	Breast cancer	
PRAD	cis	1	rs6011674	chr20:61854452	BIRC7	chr20:61867276-61871853:+	-0.28	-3.78	0.00018	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs6011691	chr20:61867454	BIRC7	chr20:61867276-61871853:+	0.35	4.27	2.39E-5	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs6012564	chr20:47541600	CSE1L	chr20:47662838-47713484:+	0.2	4.9	1.33E-6	Anger	
PRAD	cis	1	rs601324	chr5:139057179	SLC23A1	chr5:138702891-138719039:-	0.19	3.49	0.000519	Schizophrenia	
PRAD	cis	1	rs601336	chr5:139057167	SLC23A1	chr5:138702891-138719039:-	0.19	3.47	0.000576	Schizophrenia	
PRAD	cis	1	rs601338	chr19:49206674	FUT2	chr19:49199228-49209190:+	-0.29	-7.61	1.49E-13	Blood metabolite levels;Blood metabolite ratios	
PRAD	cis	1	rs601339	chr12:123174743	GPR109B	chr12:123199304-123201439:-	0.36	6.29	7.19E-10	Adiponectin levels	
PRAD	cis	1	rs60134818	chr5:150261043	LOC134466	chr5:150310000-150326146:-	0.56	8.71	5.28E-17	Crohn's disease	
PRAD	cis	1	rs60146975	chr6:159358206	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs60149603	chr2:285421	SH3YL1	chr2:218138-264810:-	-0.79	-18.53	6.11E-58	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs60156786	chr1:183596905	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs601728	chr5:139057076	SLC23A1	chr5:138702891-138719039:-	0.19	3.49	0.000519	Schizophrenia	
PRAD	cis	1	rs6017495	chr20:43756955	SLPI	chr20:43880879-43883206:-	0.23	3.75	0.0002	Parental longevity (mother's age at death)	
PRAD	cis	1	rs60178264	chr4:17685308	MED28	chr4:17616273-17629791:+	0.17	4.3	2.05E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs60184524	chr19:44294215	LYPD5	chr19:44300080-44324808:-	-0.23	-5.06	6.13E-7	Breast cancer	
PRAD	cis	1	rs60184524	chr19:44294215	ZNF155	chr19:44488355-44502477:+	-0.23	-4.56	6.6E-6	Breast cancer	
PRAD	cis	1	rs60184524	chr19:44294215	ZNF404	chr19:44376516-44384288:-	-0.2	-4.22	2.91E-5	Breast cancer	
PRAD	cis	1	rs601923	chr5:176417386	FGFR4	chr5:176513921-176525124:+	0.17	3.53	0.000458	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs6020091	chr20:48482670	SPATA2	chr20:48519931-48532080:-	-0.21	-4.5	8.51E-6	Gut microbiota (beta diversity)	
PRAD	cis	1	rs6020092	chr20:48482934	SPATA2	chr20:48519931-48532080:-	-0.21	-4.55	6.99E-6	Gut microbiota (beta diversity)	
PRAD	cis	1	rs6020100	chr20:48494650	SPATA2	chr20:48519931-48532080:-	-0.2	-4.35	1.64E-5	Gut microbiota (beta diversity)	
PRAD	cis	1	rs6020101	chr20:48495761	SPATA2	chr20:48519931-48532080:-	-0.2	-4.35	1.64E-5	Gut microbiota (beta diversity)	
PRAD	cis	1	rs60228607	chr8:130735460	GSDMC	chr8:130760443-130799134:-	0.2	3.9	0.000108	Infant length;Height	
PRAD	cis	1	rs60251819	chr6:24468648	GPLD1	chr6:24428405-24489850:-	0.49	10.45	3.91E-23	Hematological and biochemical traits	
PRAD	cis	1	rs60251819	chr6:24468648	MRS2	chr6:24403153-24425809:+	0.27	4.46	1.05E-5	Hematological and biochemical traits	
PRAD	cis	1	rs60258676	chr11:46897787	ARHGAP1	chr11:46698634-46722120:-	-0.22	-3.76	0.00019	HDL cholesterol	
PRAD	cis	1	rs6028335	chr20:37845477	DHX35	chr20:37591000-37668363:+	-0.22	-4.51	8.23E-6	Alcohol and nictotine co-dependence	
PRAD	cis	1	rs6028	chr1:169551682	F5	chr1:169481192-169555769:-	-0.22	-4.5	8.45E-6	Activated partial thromboplastin time	
PRAD	cis	1	rs6029526	chr20:39672618	ZHX3	chr20:39807089-39946242:-	-0.27	-6	3.87E-9	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs6029549	chr20:39754695	ZHX3	chr20:39807089-39946242:-	-0.27	-5.93	6.02E-9	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs6029552	chr20:39760448	ZHX3	chr20:39807089-39946242:-	-0.27	-5.87	8.05E-9	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs60306160	chr10:126703761	CTBP2	chr10:126676419-126849624:-	0.22	3.52	0.000481	Height	
PRAD	cis	1	rs60310240	chr14:88822709	SPATA7	chr14:88852012-88904802:+	-0.2	-3.88	0.000119	Coronary artery calcification	
PRAD	cis	1	rs6032006	chr20:43755053	SLPI	chr20:43880879-43883206:-	0.2	3.44	0.000628	Parental longevity (mother's age at death)	
PRAD	cis	1	rs60326618	chr7:66166358	CCT6P1	chr7:65216092-65228661:+	0.32	5.47	7.45E-8	Gout	
PRAD	cis	1	rs60326618	chr7:66166358	CRCP	chr7:65579805-65619551:+	-0.34	-4.19	3.32E-5	Gout	
PRAD	cis	1	rs60340200	chr1:27287716	PIGV	chr1:27114455-27124886:+	-0.34	-3.95	9.07E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs60354841	chr7:38873461	FAM183B	chr7:38724947-38726689:-	0.38	3.69	0.000251	Cognitive performance	
PRAD	cis	1	rs6037086	chr20:25306338	ENTPD6	chr20:25176339-25207360:+	0.16	4.32	1.88E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037086	chr20:25306338	FAM182B	chr20:25744102-25848786:-	-0.37	-6.81	3.08E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037086	chr20:25306338	PYGB	chr20:25228706-25278647:+	0.33	7.21	2.22E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037095	chr20:25335687	ENTPD6	chr20:25176339-25207360:+	0.18	4.67	3.92E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037095	chr20:25335687	FAM182B	chr20:25744102-25848786:-	-0.36	-6.67	7.33E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037095	chr20:25335687	PYGB	chr20:25228706-25278647:+	0.34	7.39	6.85E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037099	chr20:25356876	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037099	chr20:25356876	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037099	chr20:25356876	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037105	chr20:25374199	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037105	chr20:25374199	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037105	chr20:25374199	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037121	chr20:25428311	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.28	2.26E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037121	chr20:25428311	FAM182B	chr20:25744102-25848786:-	0.38	7.09	4.94E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037121	chr20:25428311	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.59E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6037498	chr20:3185982	C20orf27	chr20:3734156-3748452:-	-0.22	-3.68	0.000263	Response to hepatitis C treatment	
PRAD	cis	1	rs6037526	chr20:3251248	ITPA	chr20:3190056-3204504:+	-0.3	-7.62	1.44E-13	IFN-related cytopenia	
PRAD	cis	1	rs6037532	chr20:3267911	ITPA	chr20:3190056-3204504:+	-0.3	-7.63	1.34E-13	IFN-related cytopenia	
PRAD	cis	1	rs6037533	chr20:3268817	ITPA	chr20:3190056-3204504:+	-0.3	-7.63	1.34E-13	IFN-related cytopenia	
PRAD	cis	1	rs6037535	chr20:3270621	ITPA	chr20:3190056-3204504:+	-0.31	-7.72	7.0E-14	IFN-related cytopenia	
PRAD	cis	1	rs6037538	chr20:3282978	ITPA	chr20:3190056-3204504:+	-0.31	-7.85	2.86E-14	IFN-related cytopenia	
PRAD	cis	1	rs6037547	chr20:3299228	ITPA	chr20:3190056-3204504:+	-0.31	-7.88	2.25E-14	IFN-related cytopenia	
PRAD	cis	1	rs6037551	chr20:3306690	ITPA	chr20:3190056-3204504:+	-0.31	-7.95	1.42E-14	IFN-related cytopenia	
PRAD	cis	1	rs6037553	chr20:3313884	ITPA	chr20:3190056-3204504:+	-0.31	-7.85	2.92E-14	IFN-related cytopenia	
PRAD	cis	1	rs6037554	chr20:3315613	ITPA	chr20:3190056-3204504:+	-0.3	-7.75	5.89E-14	IFN-related cytopenia	
PRAD	cis	1	rs6037556	chr20:3317890	ITPA	chr20:3190056-3204504:+	-0.3	-7.75	5.89E-14	IFN-related cytopenia	
PRAD	cis	1	rs6037560	chr20:3323055	ITPA	chr20:3190056-3204504:+	-0.3	-7.82	3.49E-14	IFN-related cytopenia	
PRAD	cis	1	rs6037562	chr20:3326141	ITPA	chr20:3190056-3204504:+	-0.3	-7.82	3.49E-14	IFN-related cytopenia	
PRAD	cis	1	rs6037567	chr20:3332160	ITPA	chr20:3190056-3204504:+	-0.3	-7.82	3.49E-14	IFN-related cytopenia	
PRAD	cis	1	rs6037579	chr20:3347980	ITPA	chr20:3190056-3204504:+	-0.31	-7.83	3.28E-14	IFN-related cytopenia	
PRAD	cis	1	rs6037583	chr20:3360632	ITPA	chr20:3190056-3204504:+	-0.3	-7.59	1.79E-13	IFN-related cytopenia	
PRAD	cis	1	rs6037590	chr20:3374085	ITPA	chr20:3190056-3204504:+	-0.31	-7.82	3.6E-14	IFN-related cytopenia	
PRAD	cis	1	rs60376560	chr11:18453742	LDHC	chr11:18433853-18472792:+	-0.3	-3.74	0.000205	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs6037708	chr20:3961253	MAVS	chr20:3827449-3856761:+	-0.24	-3.5	0.000504	Response to antidepressants in depression	
PRAD	cis	1	rs60399786	chr3:128062070	RUVBL1	chr3:127783627-127872757:-	0.24	4.55	6.7E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs60401377	chr1:27052247	PIGV	chr1:27114455-27124886:+	-0.35	-4.05	6.03E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs6041	chr13:113772707	F10	chr13:113777113-113803841:+	0.17	3.49	0.000533	End-stage coagulation	
PRAD	cis	1	rs6041	chr13:113772707	F7	chr13:113760105-113774994:+	-0.37	-4.77	2.43E-6	End-stage coagulation	
PRAD	cis	1	rs60425110	chr15:75333000	PPCDC	chr15:75315927-75343066:+	0.16	4.3	2.04E-5	Blood trace element (Zn levels)	
PRAD	cis	1	rs60425110	chr15:75333000	SCAMP5	chr15:75287901-75313836:+	0.42	7.55	2.26E-13	Blood trace element (Zn levels)	
PRAD	cis	1	rs6042	chr13:113770068	F7	chr13:113760105-113774994:+	-0.41	-5.6	3.65E-8	End-stage coagulation	
PRAD	cis	1	rs60432293	chr17:65860407	LOC651250	chr17:66097696-66157623:+	-0.24	-4.45	1.08E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs60449834	chr5:78957986	DMGDH	chr5:78293430-78365449:-	0.29	3.5	0.000512	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs60479377	chr2:86283948	LOC90784	chr2:86247339-86250991:-	-0.57	-4.99	8.54E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs6047999	chr20:22268484	PAX1	chr20:21686297-21696620:+	0.15	4.02	6.72E-5	Glucose homeostasis traits	
PRAD	cis	1	rs60484953	chr2:221560	SH3YL1	chr2:218138-264810:-	-0.79	-18.66	1.54E-58	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs60500975	chr4:102901822	BANK1	chr4:102341118-102995967:+	-0.23	-4.62	4.97E-6	Gut microbiota (beta diversity)	
PRAD	cis	1	rs6050542	chr20:25318879	ENTPD6	chr20:25176339-25207360:+	0.16	4.2	3.19E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050542	chr20:25318879	FAM182B	chr20:25744102-25848786:-	-0.37	-6.8	3.24E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050542	chr20:25318879	PYGB	chr20:25228706-25278647:+	0.33	7.14	3.6E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050544	chr20:25320228	ENTPD6	chr20:25176339-25207360:+	0.18	4.67	3.92E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050544	chr20:25320228	FAM182B	chr20:25744102-25848786:-	-0.36	-6.67	7.33E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050544	chr20:25320228	PYGB	chr20:25228706-25278647:+	0.34	7.39	6.85E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050547	chr20:25326012	ENTPD6	chr20:25176339-25207360:+	0.16	4.17	3.64E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050547	chr20:25326012	FAM182B	chr20:25744102-25848786:-	-0.37	-6.73	4.91E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050547	chr20:25326012	PYGB	chr20:25228706-25278647:+	0.32	7.05	6.56E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050555	chr20:25328543	ENTPD6	chr20:25176339-25207360:+	0.14	3.72	0.000221	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050555	chr20:25328543	FAM182B	chr20:25744102-25848786:-	-0.37	-6.54	1.63E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050555	chr20:25328543	PYGB	chr20:25228706-25278647:+	0.3	6.27	8.28E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050559	chr20:25329915	ENTPD6	chr20:25176339-25207360:+	-0.18	-4.67	3.92E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050559	chr20:25329915	FAM182B	chr20:25744102-25848786:-	0.36	6.67	7.33E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050559	chr20:25329915	PYGB	chr20:25228706-25278647:+	-0.34	-7.39	6.85E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050561	chr20:25334855	ENTPD6	chr20:25176339-25207360:+	0.16	4.27	2.35E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050561	chr20:25334855	FAM182B	chr20:25744102-25848786:-	-0.38	-7.1	4.53E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050561	chr20:25334855	PYGB	chr20:25228706-25278647:+	0.32	7	8.9E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050562	chr20:25336186	ENTPD6	chr20:25176339-25207360:+	0.18	4.67	3.92E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050562	chr20:25336186	FAM182B	chr20:25744102-25848786:-	-0.36	-6.67	7.33E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050562	chr20:25336186	PYGB	chr20:25228706-25278647:+	0.34	7.39	6.85E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050564	chr20:25344231	ENTPD6	chr20:25176339-25207360:+	0.16	4.27	2.35E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050564	chr20:25344231	FAM182B	chr20:25744102-25848786:-	-0.38	-7.1	4.53E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050564	chr20:25344231	PYGB	chr20:25228706-25278647:+	0.32	7	8.9E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050565	chr20:25347563	ENTPD6	chr20:25176339-25207360:+	0.16	4.25	2.59E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050565	chr20:25347563	FAM182B	chr20:25744102-25848786:-	-0.39	-7.14	3.52E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050565	chr20:25347563	PYGB	chr20:25228706-25278647:+	0.32	6.93	1.37E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050566	chr20:25351071	ENTPD6	chr20:25176339-25207360:+	0.18	4.68	3.68E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050566	chr20:25351071	FAM182B	chr20:25744102-25848786:-	-0.36	-6.61	1.03E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050566	chr20:25351071	PYGB	chr20:25228706-25278647:+	0.34	7.38	7.19E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050573	chr20:25366065	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.27	2.32E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050573	chr20:25366065	FAM182B	chr20:25744102-25848786:-	0.38	6.93	1.39E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050573	chr20:25366065	PYGB	chr20:25228706-25278647:+	-0.32	-6.92	1.46E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050590	chr20:25384994	ENTPD6	chr20:25176339-25207360:+	0.16	4.36	1.57E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050590	chr20:25384994	FAM182B	chr20:25744102-25848786:-	-0.38	-7.06	6.06E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050590	chr20:25384994	PYGB	chr20:25228706-25278647:+	0.32	6.95	1.2E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050598	chr20:25397257	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.27	2.35E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050598	chr20:25397257	FAM182B	chr20:25744102-25848786:-	0.38	7.1	4.53E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050598	chr20:25397257	PYGB	chr20:25228706-25278647:+	-0.32	-7	8.9E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050599	chr20:25400240	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050599	chr20:25400240	FAM182B	chr20:25744102-25848786:-	-0.38	-7.09	5.05E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050599	chr20:25400240	PYGB	chr20:25228706-25278647:+	0.32	7.02	7.71E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050602	chr20:25401203	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050602	chr20:25401203	FAM182B	chr20:25744102-25848786:-	-0.38	-7.09	5.05E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050602	chr20:25401203	PYGB	chr20:25228706-25278647:+	0.32	7.02	7.71E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050609	chr20:25411751	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050609	chr20:25411751	FAM182B	chr20:25744102-25848786:-	-0.38	-7.09	5.05E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050609	chr20:25411751	PYGB	chr20:25228706-25278647:+	0.32	7.02	7.71E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050617	chr20:25421648	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.28	2.26E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050617	chr20:25421648	FAM182B	chr20:25744102-25848786:-	0.38	7.09	4.94E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050617	chr20:25421648	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.59E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050626	chr20:25428261	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.28	2.26E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050626	chr20:25428261	FAM182B	chr20:25744102-25848786:-	0.38	7.09	4.79E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050626	chr20:25428261	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.98E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050629	chr20:25430680	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.28	2.26E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050629	chr20:25430680	FAM182B	chr20:25744102-25848786:-	0.38	7.09	4.94E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050629	chr20:25430680	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.59E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050630	chr20:25430745	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.28	2.26E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050630	chr20:25430745	FAM182B	chr20:25744102-25848786:-	0.38	7.09	4.94E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050630	chr20:25430745	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.59E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050631	chr20:25431749	ENTPD6	chr20:25176339-25207360:+	-0.18	-4.65	4.42E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050631	chr20:25431749	FAM182B	chr20:25744102-25848786:-	0.37	6.79	3.44E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050631	chr20:25431749	PYGB	chr20:25228706-25278647:+	-0.34	-7.34	9.45E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050632	chr20:25432601	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.28	2.26E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050632	chr20:25432601	FAM182B	chr20:25744102-25848786:-	0.38	7.09	4.94E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6050632	chr20:25432601	PYGB	chr20:25228706-25278647:+	-0.32	-7.02	7.59E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6051080	chr20:25975674	FAM182A	chr20:26035250-26067552:+	0.39	6.89	1.82E-11	Colorectal or endometrial cancer	
PRAD	cis	1	rs6051080	chr20:25975674	FAM182B	chr20:25744102-25848786:-	0.78	16.64	3.24E-49	Colorectal or endometrial cancer	
PRAD	cis	1	rs60512868	chr3:48483445	ATRIP	chr3:48488141-48507708:+	0.28	6.69	6.5E-11	Longevity	
PRAD	cis	1	rs60512868	chr3:48483445	CDC25A	chr3:48198668-48229801:-	0.22	4.16	3.82E-5	Longevity	
PRAD	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.17	-4.78	2.3E-6	Longevity	
PRAD	cis	1	rs6051672	chr20:3224819	ITPA	chr20:3190056-3204504:+	-0.3	-7.71	7.47E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051702	chr20:3251924	ITPA	chr20:3190056-3204504:+	-0.3	-7.62	1.44E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051703	chr20:3252347	ITPA	chr20:3190056-3204504:+	-0.3	-7.56	2.19E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051705	chr20:3253143	ITPA	chr20:3190056-3204504:+	-0.3	-7.56	2.19E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051708	chr20:3262493	ITPA	chr20:3190056-3204504:+	-0.3	-7.76	5.38E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051709	chr20:3263685	ITPA	chr20:3190056-3204504:+	-0.3	-7.58	1.85E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051712	chr20:3265029	ITPA	chr20:3190056-3204504:+	-0.3	-7.63	1.34E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051713	chr20:3265779	ITPA	chr20:3190056-3204504:+	0.3	7.53	2.56E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051715	chr20:3266548	ITPA	chr20:3190056-3204504:+	-0.3	-7.63	1.34E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051716	chr20:3267736	ITPA	chr20:3190056-3204504:+	-0.33	-7.96	1.33E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051718	chr20:3270370	ITPA	chr20:3190056-3204504:+	-0.31	-7.83	3.38E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051722	chr20:3274435	ITPA	chr20:3190056-3204504:+	-0.3	-7.76	5.24E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051723	chr20:3278512	ITPA	chr20:3190056-3204504:+	-0.31	-7.95	1.42E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051724	chr20:3279338	ITPA	chr20:3190056-3204504:+	-0.3	-7.75	5.89E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051732	chr20:3294182	ITPA	chr20:3190056-3204504:+	-0.31	-7.95	1.42E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051736	chr20:3296898	ITPA	chr20:3190056-3204504:+	-0.31	-7.88	2.25E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051737	chr20:3296992	ITPA	chr20:3190056-3204504:+	-0.3	-7.75	5.89E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051745	chr20:3307243	ITPA	chr20:3190056-3204504:+	-0.31	-7.88	2.25E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051747	chr20:3307945	ITPA	chr20:3190056-3204504:+	-0.3	-7.75	5.89E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051751	chr20:3310049	ITPA	chr20:3190056-3204504:+	-0.31	-7.88	2.25E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051753	chr20:3315513	ITPA	chr20:3190056-3204504:+	-0.31	-7.95	1.42E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051762	chr20:3321590	ITPA	chr20:3190056-3204504:+	-0.33	-8.09	5.03E-15	IFN-related cytopenia	
PRAD	cis	1	rs6051763	chr20:3321616	ITPA	chr20:3190056-3204504:+	-0.31	-7.89	2.13E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051764	chr20:3321807	ITPA	chr20:3190056-3204504:+	0.32	7.99	1.06E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051779	chr20:3333449	ITPA	chr20:3190056-3204504:+	-0.3	-7.69	8.99E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051790	chr20:3342994	ITPA	chr20:3190056-3204504:+	-0.3	-7.57	1.95E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051792	chr20:3343519	ITPA	chr20:3190056-3204504:+	-0.3	-7.57	1.95E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051806	chr20:3350319	ITPA	chr20:3190056-3204504:+	-0.3	-7.77	4.98E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051807	chr20:3350485	ITPA	chr20:3190056-3204504:+	-0.32	-7.9	2.02E-14	IFN-related cytopenia	
PRAD	cis	1	rs6051808	chr20:3350697	ITPA	chr20:3190056-3204504:+	-0.3	-7.55	2.23E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051809	chr20:3352551	ITPA	chr20:3190056-3204504:+	-0.3	-7.57	1.95E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051810	chr20:3355384	ITPA	chr20:3190056-3204504:+	-0.3	-7.59	1.72E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051827	chr20:3372007	ITPA	chr20:3190056-3204504:+	-0.3	-7.59	1.72E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051831	chr20:3373712	ITPA	chr20:3190056-3204504:+	0.3	7.53	2.58E-13	IFN-related cytopenia	
PRAD	cis	1	rs6051838	chr20:3389012	ITPA	chr20:3190056-3204504:+	-0.31	-8.12	4.28E-15	IFN-related cytopenia	
PRAD	cis	1	rs60518431	chr2:191541839	OSGEPL1	chr2:190611386-190627953:-	0.22	3.99	7.58E-5	Primary biliary cirrhosis	
PRAD	cis	1	rs6052196	chr20:3945824	MAVS	chr20:3827449-3856761:+	-0.25	-3.56	0.000406	Response to antidepressants in depression	
PRAD	cis	1	rs6052209	chr20:3961747	MAVS	chr20:3827449-3856761:+	-0.25	-3.56	0.000406	Response to antidepressants in depression	
PRAD	cis	1	rs6052217	chr20:3970211	MAVS	chr20:3827449-3856761:+	-0.25	-3.56	0.000406	Response to antidepressants in depression	
PRAD	cis	1	rs6052218	chr20:3970212	MAVS	chr20:3827449-3856761:+	-0.25	-3.56	0.000406	Response to antidepressants in depression	
PRAD	cis	1	rs6052220	chr20:3970594	MAVS	chr20:3827449-3856761:+	-0.25	-3.58	0.000381	Response to antidepressants in depression	
PRAD	cis	1	rs6053815	chr20:5970438	CRLS1	chr20:5986739-6020694:+	-0.27	-5.02	7.2E-7	HIV-1 viral setpoint	
PRAD	cis	1	rs6053815	chr20:5970438	MCM8	chr20:5931298-5975829:+	-0.38	-8.37	6.72E-16	HIV-1 viral setpoint	
PRAD	cis	1	rs6053816	chr20:5970750	CRLS1	chr20:5986739-6020694:+	-0.26	-4.91	1.24E-6	HIV-1 viral setpoint	
PRAD	cis	1	rs6053816	chr20:5970750	MCM8	chr20:5931298-5975829:+	-0.39	-8.54	1.81E-16	HIV-1 viral setpoint	
PRAD	cis	1	rs60554055	chr14:66068285	LOC645431	chr14:65877313-65879335:-	-0.35	-3.67	0.000265	Ischemic stroke	
PRAD	cis	1	rs60563713	chr5:78313516	BHMT2	chr5:78365583-78385273:+	0.09	3.68	0.000264	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs6058219	chr20:33859244	MMP24	chr20:33814539-33864804:+	-0.21	-3.44	0.000636	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs6058352	chr20:30269179	COX4I2	chr20:30225691-30232800:+	0.14	3.69	0.000249	Subcortical brain region volumes	
PRAD	cis	1	rs6058465	chr20:30397691	COX4I2	chr20:30225691-30232800:+	0.15	3.85	0.000133	Subcortical brain region volumes	
PRAD	cis	1	rs6058468	chr20:30406448	COX4I2	chr20:30225691-30232800:+	0.14	3.8	0.000163	Subcortical brain region volumes	
PRAD	cis	1	rs6060235	chr20:33691652	MMP24	chr20:33814539-33864804:+	-0.29	-4.45	1.07E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs6060236	chr20:33692618	MMP24	chr20:33814539-33864804:+	-0.29	-4.45	1.09E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs6060244	chr20:33699435	MMP24	chr20:33814539-33864804:+	0.27	4.49	9.15E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs6060245	chr20:33699625	MMP24	chr20:33814539-33864804:+	-0.28	-4.31	2.0E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs6060246	chr20:33701107	MMP24	chr20:33814539-33864804:+	-0.28	-4.4	1.32E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs6060401	chr20:34005214	CEP250	chr20:34042996-34099802:+	-0.24	-5.35	1.34E-7	Height	
PRAD	cis	1	rs6060401	chr20:34005214	CPNE1	chr20:34213968-34262539:-	0.19	3.86	0.00013	Height	
PRAD	cis	1	rs6060401	chr20:34005214	FAM83C	chr20:33873287-33880225:-	0.17	3.83	0.000146	Height	
PRAD	cis	1	rs6060401	chr20:34005214	GDF5	chr20:33897002-34042568:-	-0.2	-4.67	3.87E-6	Height	
PRAD	cis	1	rs6060401	chr20:34005214	MMP24	chr20:33814539-33864804:+	0.16	3.95	9.08E-5	Height	
PRAD	cis	1	rs6060401	chr20:34005214	UQCC	chr20:33890383-33999833:-	0.38	7.04	6.67E-12	Height	
PRAD	cis	1	rs6060402	chr20:34005240	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.18E-7	Height	
PRAD	cis	1	rs6060402	chr20:34005240	CPNE1	chr20:34213968-34262539:-	0.19	3.86	0.000132	Height	
PRAD	cis	1	rs6060402	chr20:34005240	FAM83C	chr20:33873287-33880225:-	0.17	3.65	0.000287	Height	
PRAD	cis	1	rs6060402	chr20:34005240	GDF5	chr20:33897002-34042568:-	-0.2	-4.76	2.61E-6	Height	
PRAD	cis	1	rs6060402	chr20:34005240	MMP24	chr20:33814539-33864804:+	0.16	3.9	0.000112	Height	
PRAD	cis	1	rs6060402	chr20:34005240	UQCC	chr20:33890383-33999833:-	0.38	7.16	3.14E-12	Height	
PRAD	cis	1	rs6060599	chr20:30257754	COX4I2	chr20:30225691-30232800:+	0.14	3.74	0.000204	Subcortical brain region volumes	
PRAD	cis	1	rs6060621	chr20:30261562	COX4I2	chr20:30225691-30232800:+	0.14	3.68	0.000264	Subcortical brain region volumes	
PRAD	cis	1	rs6060716	chr20:30274847	COX4I2	chr20:30225691-30232800:+	0.14	3.72	0.000221	Subcortical brain region volumes	
PRAD	cis	1	rs6060857	chr20:30300222	COX4I2	chr20:30225691-30232800:+	0.14	3.69	0.000249	Subcortical brain region volumes	
PRAD	cis	1	rs6060915	chr20:30330306	COX4I2	chr20:30225691-30232800:+	0.15	3.94	9.36E-5	Subcortical brain region volumes	
PRAD	cis	1	rs6060919	chr20:30331922	COX4I2	chr20:30225691-30232800:+	0.14	3.7	0.00024	Subcortical brain region volumes	
PRAD	cis	1	rs6060922	chr20:30333909	COX4I2	chr20:30225691-30232800:+	0.14	3.7	0.00024	Subcortical brain region volumes	
PRAD	cis	1	rs6060932	chr20:30350545	COX4I2	chr20:30225691-30232800:+	0.14	3.68	0.000264	Subcortical brain region volumes	
PRAD	cis	1	rs6060933	chr20:30351903	COX4I2	chr20:30225691-30232800:+	0.14	3.58	0.000382	Subcortical brain region volumes	
PRAD	cis	1	rs6060944	chr20:30372114	COX4I2	chr20:30225691-30232800:+	0.14	3.68	0.000264	Subcortical brain region volumes	
PRAD	cis	1	rs6060950	chr20:30378031	COX4I2	chr20:30225691-30232800:+	0.14	3.63	0.000318	Subcortical brain region volumes	
PRAD	cis	1	rs6060962	chr20:30397847	COX4I2	chr20:30225691-30232800:+	0.15	3.85	0.000133	Subcortical brain region volumes	
PRAD	cis	1	rs6061231	chr20:60956917	LAMA5	chr20:60884123-60942368:-	-0.16	-3.73	0.000215	Colorectal cancer	
PRAD	cis	1	rs60622165	chr8:89599455	MMP16	chr8:89049462-89339717:-	0.15	3.65	0.000295	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs606275	chr11:108184594	ATM	chr11:108093559-108239826:+	-0.14	-4.44	1.12E-5	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs6063312	chr20:47343059	PREX1	chr20:47240793-47444420:-	0.41	6.68	6.68E-11	Tonometry	
PRAD	cis	1	rs6063313	chr20:47343532	PREX1	chr20:47240793-47444420:-	0.42	6.83	2.66E-11	Tonometry	
PRAD	cis	1	rs6063349	chr20:47681882	CSE1L	chr20:47662838-47713484:+	-0.19	-4.29	2.16E-5	Non-response to citalopram or escitalopram and depression	
PRAD	cis	1	rs6063352	chr20:47718594	CSE1L	chr20:47662838-47713484:+	0.19	4.74	2.86E-6	Anger	
PRAD	cis	1	rs6063353	chr20:47719810	CSE1L	chr20:47662838-47713484:+	0.19	4.74	2.86E-6	Anger	
PRAD	cis	1	rs6063354	chr20:47719949	CSE1L	chr20:47662838-47713484:+	0.19	4.74	2.86E-6	Anger	
PRAD	cis	1	rs6063360	chr20:47748375	CSE1L	chr20:47662838-47713484:+	0.19	4.76	2.64E-6	Anger	
PRAD	cis	1	rs6063360	chr20:47748375	PREX1	chr20:47240793-47444420:-	-0.17	-3.5	0.000516	Anger	
PRAD	cis	1	rs6063361	chr20:47757963	CSE1L	chr20:47662838-47713484:+	0.18	4.51	8.17E-6	Anger	
PRAD	cis	1	rs6063361	chr20:47757963	PREX1	chr20:47240793-47444420:-	-0.17	-3.55	0.000429	Anger	
PRAD	cis	1	rs6064045	chr20:52701293	BCAS1	chr20:52560079-52687304:-	0.17	4.44	1.13E-5	IgG glycosylation	
PRAD	cis	1	rs6064401	chr20:55057904	C20orf43	chr20:55043647-55093942:+	0.16	3.89	0.000114	Refractive astigmatism	
PRAD	cis	1	rs6064405	chr20:55070946	C20orf43	chr20:55043647-55093942:+	0.16	3.87	0.000125	Refractive astigmatism	
PRAD	cis	1	rs6065311	chr20:39724338	ZHX3	chr20:39807089-39946242:-	-0.27	-5.93	5.75E-9	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs60654041	chr20:55077917	C20orf43	chr20:55043647-55093942:+	0.16	3.98	8.08E-5	Refractive astigmatism	
PRAD	cis	1	rs6065945	chr20:44921631	ZSWIM1	chr20:44509848-44513904:+	-0.18	-3.44	0.000642	IgG glycosylation	
PRAD	cis	1	rs60659886	chr1:26994245	PIGV	chr1:27114455-27124886:+	-0.3	-3.77	0.000181	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs6066825	chr20:47340117	PREX1	chr20:47240793-47444420:-	0.19	4.12	4.4E-5	Colorectal cancer	
PRAD	cis	1	rs6066968	chr20:47727341	CSE1L	chr20:47662838-47713484:+	0.19	4.72	3.18E-6	Anger	
PRAD	cis	1	rs6066968	chr20:47727341	PREX1	chr20:47240793-47444420:-	-0.17	-3.54	0.000444	Anger	
PRAD	cis	1	rs6066975	chr20:47750377	CSE1L	chr20:47662838-47713484:+	-0.2	-4.77	2.5E-6	Anger	
PRAD	cis	1	rs6066977	chr20:47755075	CSE1L	chr20:47662838-47713484:+	0.19	4.7	3.44E-6	Anger	
PRAD	cis	1	rs6066977	chr20:47755075	PREX1	chr20:47240793-47444420:-	-0.17	-3.51	0.000487	Anger	
PRAD	cis	1	rs6066978	chr20:47755742	CSE1L	chr20:47662838-47713484:+	0.18	4.51	8.17E-6	Anger	
PRAD	cis	1	rs6066978	chr20:47755742	PREX1	chr20:47240793-47444420:-	-0.17	-3.55	0.000429	Anger	
PRAD	cis	1	rs6066982	chr20:47763558	CSE1L	chr20:47662838-47713484:+	0.19	4.78	2.38E-6	Anger	
PRAD	cis	1	rs6066982	chr20:47763558	PREX1	chr20:47240793-47444420:-	-0.17	-3.49	0.000521	Anger	
PRAD	cis	1	rs60676431	chr2:20263863	TTC32	chr2:20096518-20101744:-	-0.2	-3.48	0.000549	Major depressive disorder	
PRAD	cis	1	rs60683927	chr7:65394768	CCT6P1	chr7:65216092-65228661:+	0.3	5.31	1.65E-7	Diabetic kidney disease	
PRAD	cis	1	rs60683927	chr7:65394768	CRCP	chr7:65579805-65619551:+	-0.27	-3.54	0.000439	Diabetic kidney disease	
PRAD	cis	1	rs60683927	chr7:65394768	ZNF117	chr7:64434830-64467121:-	-0.27	-3.43	0.000659	Diabetic kidney disease	
PRAD	cis	1	rs60693825	chr14:35514456	PPP2R3C	chr14:35554679-35591679:-	0.31	4.71	3.32E-6	Atopic dermatitis	
PRAD	cis	1	rs60697554	chr19:12057759	ZNF763	chr19:12035900-12091196:+	-0.37	-4.01	7.1E-5	Multiple sclerosis	
PRAD	cis	1	rs6069758	chr20:55046735	C20orf43	chr20:55043647-55093942:+	0.17	4.09	5.18E-5	Refractive astigmatism	
PRAD	cis	1	rs6069763	chr20:55071639	C20orf43	chr20:55043647-55093942:+	-0.16	-3.91	0.000107	Refractive astigmatism	
PRAD	cis	1	rs6069766	chr20:55079036	C20orf43	chr20:55043647-55093942:+	0.16	3.96	8.6E-5	Refractive astigmatism	
PRAD	cis	1	rs6070692	chr20:57586374	TH1L	chr20:57556311-57570186:+	-0.46	-7.66	1.1E-13	Mean platelet volume	
PRAD	cis	1	rs6070692	chr20:57586374	TUBB1	chr20:57594309-57601707:+	-0.27	-3.47	0.000562	Mean platelet volume	
PRAD	cis	1	rs6070696	chr20:57597645	TH1L	chr20:57556311-57570186:+	-0.4	-6.9	1.65E-11	Mean platelet volume	
PRAD	cis	1	rs6070696	chr20:57597645	TUBB1	chr20:57594309-57601707:+	-0.28	-3.88	0.00012	Mean platelet volume	
PRAD	cis	1	rs6070697	chr20:57599402	TH1L	chr20:57556311-57570186:+	-0.43	-7.2	2.38E-12	Mean platelet volume	
PRAD	cis	1	rs6070697	chr20:57599402	TUBB1	chr20:57594309-57601707:+	-0.31	-4.11	4.69E-5	Mean platelet volume	
PRAD	cis	1	rs6072249	chr20:39656342	ZHX3	chr20:39807089-39946242:-	-0.26	-5.75	1.62E-8	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs6072263	chr20:39705546	ZHX3	chr20:39807089-39946242:-	-0.27	-6	4.01E-9	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs60722866	chr11:46650438	HARBI1	chr11:46624857-46638777:-	0.28	3.86	0.000132	Schizophrenia	
PRAD	cis	1	rs6073534	chr20:43365504	KCNK15	chr20:43374488-43379666:+	0.26	4.83	1.83E-6	Obesity-related traits	
PRAD	cis	1	rs6074022	chr20:44740196	SEMG1	chr20:43835638-43838414:+	-0.25	-3.48	0.000549	Crohn's disease;Inflammatory bowel disease;Multiple sclerosis	
PRAD	cis	1	rs607541	chr15:45934869	DUOX2	chr15:45384853-45406359:-	-0.16	-3.68	0.00026	Obesity-related traits	
PRAD	cis	1	rs60755785	chr19:10839494	LOC147727	chr19:10762539-10764548:-	0.27	3.53	0.000459	LDL cholesterol	
PRAD	cis	1	rs607594	chr15:45934840	DUOX2	chr15:45384853-45406359:-	-0.16	-3.68	0.00026	Obesity-related traits	
PRAD	cis	1	rs6076336	chr20:25319212	ENTPD6	chr20:25176339-25207360:+	0.16	4.17	3.64E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6076336	chr20:25319212	FAM182B	chr20:25744102-25848786:-	-0.37	-6.73	4.91E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6076336	chr20:25319212	PYGB	chr20:25228706-25278647:+	0.32	7.05	6.56E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6076339	chr20:25348712	ENTPD6	chr20:25176339-25207360:+	0.14	3.84	0.000142	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6076339	chr20:25348712	FAM182B	chr20:25744102-25848786:-	-0.39	-7.29	1.35E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6076339	chr20:25348712	PYGB	chr20:25228706-25278647:+	0.29	6.49	2.25E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6076345	chr20:25381895	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6076345	chr20:25381895	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6076345	chr20:25381895	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs608086	chr11:108185023	ATM	chr11:108093559-108239826:+	-0.16	-5.02	7.52E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs6083804	chr20:25317060	ENTPD6	chr20:25176339-25207360:+	0.16	4.17	3.64E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083804	chr20:25317060	FAM182B	chr20:25744102-25848786:-	-0.37	-6.73	4.91E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083804	chr20:25317060	PYGB	chr20:25228706-25278647:+	0.32	7.05	6.56E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083805	chr20:25317356	ENTPD6	chr20:25176339-25207360:+	0.18	4.67	3.92E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083805	chr20:25317356	FAM182B	chr20:25744102-25848786:-	-0.36	-6.67	7.33E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083805	chr20:25317356	PYGB	chr20:25228706-25278647:+	0.34	7.39	6.85E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083809	chr20:25329309	ENTPD6	chr20:25176339-25207360:+	0.16	4.27	2.35E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083809	chr20:25329309	FAM182B	chr20:25744102-25848786:-	-0.38	-7.1	4.53E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083809	chr20:25329309	PYGB	chr20:25228706-25278647:+	0.32	7	8.9E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083813	chr20:25337671	ENTPD6	chr20:25176339-25207360:+	0.16	4.27	2.34E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083813	chr20:25337671	FAM182B	chr20:25744102-25848786:-	-0.38	-7.09	4.98E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083813	chr20:25337671	PYGB	chr20:25228706-25278647:+	0.32	7.01	8.27E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083825	chr20:25366424	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083825	chr20:25366424	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083825	chr20:25366424	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083828	chr20:25369918	ENTPD6	chr20:25176339-25207360:+	0.18	4.76	2.63E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083828	chr20:25369918	FAM182B	chr20:25744102-25848786:-	-0.38	-7.06	5.83E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083828	chr20:25369918	PYGB	chr20:25228706-25278647:+	0.33	7.28	1.37E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083844	chr20:25386832	ENTPD6	chr20:25176339-25207360:+	0.16	4.18	3.52E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083844	chr20:25386832	FAM182B	chr20:25744102-25848786:-	-0.38	-6.99	9.53E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083844	chr20:25386832	PYGB	chr20:25228706-25278647:+	0.31	6.85	2.35E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083856	chr20:25407585	ENTPD6	chr20:25176339-25207360:+	0.18	4.75	2.67E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083856	chr20:25407585	FAM182B	chr20:25744102-25848786:-	-0.36	-6.48	2.35E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083856	chr20:25407585	PYGB	chr20:25228706-25278647:+	0.35	7.69	8.68E-14	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083862	chr20:25411086	FAM182B	chr20:25744102-25848786:-	-0.36	-6.61	1.02E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6083862	chr20:25411086	PYGB	chr20:25228706-25278647:+	0.29	6.14	1.79E-9	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs60843830	chr2:286756	SH3YL1	chr2:218138-264810:-	-0.74	-16.83	4.49E-50	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs60844734	chr2:73623205	ALMS1P	chr2:73872046-73912692:+	0.5	8.49	2.69E-16	Metabolite levels	
PRAD	cis	1	rs60844734	chr2:73623205	NAT8	chr2:73867850-73869537:-	0.25	3.83	0.000146	Metabolite levels	
PRAD	cis	1	rs60866116	chr20:33726150	GDF5	chr20:33897002-34042568:-	0.25	3.91	0.000106	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs60866116	chr20:33726150	MMP24	chr20:33814539-33864804:+	-0.25	-4.08	5.36E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs60867652	chr3:184759421	VPS8	chr3:184529931-184770402:+	-0.33	-4.16	3.72E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs6087698	chr20:33948919	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.2E-7	Height	
PRAD	cis	1	rs6087698	chr20:33948919	CPNE1	chr20:34213968-34262539:-	0.2	3.97	8.15E-5	Height	
PRAD	cis	1	rs6087698	chr20:33948919	FAM83C	chr20:33873287-33880225:-	0.17	3.7	0.000237	Height	
PRAD	cis	1	rs6087698	chr20:33948919	GDF5	chr20:33897002-34042568:-	-0.2	-4.91	1.29E-6	Height	
PRAD	cis	1	rs6087698	chr20:33948919	MMP24	chr20:33814539-33864804:+	0.14	3.62	0.000328	Height	
PRAD	cis	1	rs6087698	chr20:33948919	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.76E-12	Height	
PRAD	cis	1	rs6087702	chr20:33995945	CEP250	chr20:34042996-34099802:+	-0.24	-5.37	1.25E-7	Height	
PRAD	cis	1	rs6087702	chr20:33995945	CPNE1	chr20:34213968-34262539:-	0.2	3.95	9.1E-5	Height	
PRAD	cis	1	rs6087702	chr20:33995945	FAM83C	chr20:33873287-33880225:-	0.16	3.67	0.000271	Height	
PRAD	cis	1	rs6087702	chr20:33995945	GDF5	chr20:33897002-34042568:-	-0.21	-5.02	7.29E-7	Height	
PRAD	cis	1	rs6087702	chr20:33995945	MMP24	chr20:33814539-33864804:+	0.14	3.63	0.00032	Height	
PRAD	cis	1	rs6087702	chr20:33995945	UQCC	chr20:33890383-33999833:-	0.39	7.43	5.31E-13	Height	
PRAD	cis	1	rs6087703	chr20:33996433	CEP250	chr20:34042996-34099802:+	-0.23	-5.3	1.8E-7	Height	
PRAD	cis	1	rs6087703	chr20:33996433	CPNE1	chr20:34213968-34262539:-	0.2	3.96	8.74E-5	Height	
PRAD	cis	1	rs6087703	chr20:33996433	GDF5	chr20:33897002-34042568:-	-0.19	-4.72	3.17E-6	Height	
PRAD	cis	1	rs6087703	chr20:33996433	MMP24	chr20:33814539-33864804:+	0.14	3.49	0.000522	Height	
PRAD	cis	1	rs6087703	chr20:33996433	UQCC	chr20:33890383-33999833:-	0.37	7.04	7.05E-12	Height	
PRAD	cis	1	rs6087704	chr20:34001058	CEP250	chr20:34042996-34099802:+	-0.23	-5.3	1.8E-7	Height	
PRAD	cis	1	rs6087704	chr20:34001058	CPNE1	chr20:34213968-34262539:-	0.2	4.03	6.58E-5	Height	
PRAD	cis	1	rs6087704	chr20:34001058	GDF5	chr20:33897002-34042568:-	-0.19	-4.68	3.73E-6	Height	
PRAD	cis	1	rs6087704	chr20:34001058	MMP24	chr20:33814539-33864804:+	0.14	3.47	0.000574	Height	
PRAD	cis	1	rs6087704	chr20:34001058	UQCC	chr20:33890383-33999833:-	0.37	6.98	1.03E-11	Height	
PRAD	cis	1	rs6087705	chr20:34001250	CEP250	chr20:34042996-34099802:+	-0.24	-5.37	1.26E-7	Height	
PRAD	cis	1	rs6087705	chr20:34001250	CPNE1	chr20:34213968-34262539:-	0.2	4.02	6.83E-5	Height	
PRAD	cis	1	rs6087705	chr20:34001250	FAM83C	chr20:33873287-33880225:-	0.16	3.63	0.000313	Height	
PRAD	cis	1	rs6087705	chr20:34001250	GDF5	chr20:33897002-34042568:-	-0.2	-4.99	8.72E-7	Height	
PRAD	cis	1	rs6087705	chr20:34001250	MMP24	chr20:33814539-33864804:+	0.14	3.6	0.000352	Height	
PRAD	cis	1	rs6087705	chr20:34001250	UQCC	chr20:33890383-33999833:-	0.39	7.37	7.79E-13	Height	
PRAD	cis	1	rs6087771	chr20:30306724	COX4I2	chr20:30225691-30232800:+	0.14	3.74	0.000205	Subcortical brain region volumes	
PRAD	cis	1	rs6087779	chr20:30370566	COX4I2	chr20:30225691-30232800:+	0.14	3.71	0.000233	Subcortical brain region volumes	
PRAD	cis	1	rs6087782	chr20:30391580	COX4I2	chr20:30225691-30232800:+	0.15	3.93	9.79E-5	Subcortical brain region volumes	
PRAD	cis	1	rs6087990	chr20:31349908	MAPRE1	chr20:31407699-31438210:+	0.18	4.26	2.51E-5	Ulcerative colitis	
PRAD	cis	1	rs6088799	chr20:33934301	CEP250	chr20:34042996-34099802:+	-0.24	-5.37	1.25E-7	Height	
PRAD	cis	1	rs6088799	chr20:33934301	CPNE1	chr20:34213968-34262539:-	0.2	3.98	8.06E-5	Height	
PRAD	cis	1	rs6088799	chr20:33934301	FAM83C	chr20:33873287-33880225:-	0.17	3.69	0.000247	Height	
PRAD	cis	1	rs6088799	chr20:33934301	GDF5	chr20:33897002-34042568:-	-0.2	-4.9	1.29E-6	Height	
PRAD	cis	1	rs6088799	chr20:33934301	MMP24	chr20:33814539-33864804:+	0.15	3.64	0.000308	Height	
PRAD	cis	1	rs6088799	chr20:33934301	UQCC	chr20:33890383-33999833:-	0.38	7.14	3.58E-12	Height	
PRAD	cis	1	rs6088812	chr20:33974163	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.2E-7	Height	
PRAD	cis	1	rs6088812	chr20:33974163	CPNE1	chr20:34213968-34262539:-	0.2	3.97	8.15E-5	Height	
PRAD	cis	1	rs6088812	chr20:33974163	FAM83C	chr20:33873287-33880225:-	0.17	3.7	0.000237	Height	
PRAD	cis	1	rs6088812	chr20:33974163	GDF5	chr20:33897002-34042568:-	-0.2	-4.91	1.29E-6	Height	
PRAD	cis	1	rs6088812	chr20:33974163	MMP24	chr20:33814539-33864804:+	0.14	3.62	0.000328	Height	
PRAD	cis	1	rs6088812	chr20:33974163	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.76E-12	Height	
PRAD	cis	1	rs6088813	chr20:33975181	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.2E-7	Height	
PRAD	cis	1	rs6088813	chr20:33975181	CPNE1	chr20:34213968-34262539:-	0.2	3.97	8.15E-5	Height	
PRAD	cis	1	rs6088813	chr20:33975181	FAM83C	chr20:33873287-33880225:-	0.17	3.7	0.000237	Height	
PRAD	cis	1	rs6088813	chr20:33975181	GDF5	chr20:33897002-34042568:-	-0.2	-4.91	1.29E-6	Height	
PRAD	cis	1	rs6088813	chr20:33975181	MMP24	chr20:33814539-33864804:+	0.14	3.62	0.000328	Height	
PRAD	cis	1	rs6088813	chr20:33975181	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.76E-12	Height	
PRAD	cis	1	rs6088815	chr20:33976474	CEP250	chr20:34042996-34099802:+	-0.24	-5.35	1.4E-7	Height	
PRAD	cis	1	rs6088815	chr20:33976474	CPNE1	chr20:34213968-34262539:-	0.2	3.95	9.03E-5	Height	
PRAD	cis	1	rs6088815	chr20:33976474	FAM83C	chr20:33873287-33880225:-	0.16	3.65	0.000286	Height	
PRAD	cis	1	rs6088815	chr20:33976474	GDF5	chr20:33897002-34042568:-	-0.2	-5.01	7.75E-7	Height	
PRAD	cis	1	rs6088815	chr20:33976474	MMP24	chr20:33814539-33864804:+	0.14	3.63	0.000315	Height	
PRAD	cis	1	rs6088815	chr20:33976474	UQCC	chr20:33890383-33999833:-	0.39	7.44	4.9E-13	Height	
PRAD	cis	1	rs6088816	chr20:33982435	CEP250	chr20:34042996-34099802:+	-0.23	-5.26	2.2E-7	Height	
PRAD	cis	1	rs6088816	chr20:33982435	CPNE1	chr20:34213968-34262539:-	0.19	3.92	0.000103	Height	
PRAD	cis	1	rs6088816	chr20:33982435	FAM83C	chr20:33873287-33880225:-	0.16	3.69	0.000255	Height	
PRAD	cis	1	rs6088816	chr20:33982435	GDF5	chr20:33897002-34042568:-	-0.2	-4.87	1.56E-6	Height	
PRAD	cis	1	rs6088816	chr20:33982435	MMP24	chr20:33814539-33864804:+	0.14	3.61	0.000333	Height	
PRAD	cis	1	rs6088816	chr20:33982435	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.88E-12	Height	
PRAD	cis	1	rs6088820	chr20:33987298	CEP250	chr20:34042996-34099802:+	-0.23	-5.16	3.67E-7	Height	
PRAD	cis	1	rs6088820	chr20:33987298	CPNE1	chr20:34213968-34262539:-	0.2	3.95	9.13E-5	Height	
PRAD	cis	1	rs6088820	chr20:33987298	FAM83C	chr20:33873287-33880225:-	0.17	3.72	0.000222	Height	
PRAD	cis	1	rs6088820	chr20:33987298	GDF5	chr20:33897002-34042568:-	-0.21	-5.01	7.81E-7	Height	
PRAD	cis	1	rs6088820	chr20:33987298	MMP24	chr20:33814539-33864804:+	0.14	3.54	0.000433	Height	
PRAD	cis	1	rs6088820	chr20:33987298	UQCC	chr20:33890383-33999833:-	0.4	7.55	2.24E-13	Height	
PRAD	cis	1	rs6088821	chr20:33987576	CEP250	chr20:34042996-34099802:+	-0.23	-5.3	1.8E-7	Height	
PRAD	cis	1	rs6088821	chr20:33987576	CPNE1	chr20:34213968-34262539:-	0.2	3.96	8.74E-5	Height	
PRAD	cis	1	rs6088821	chr20:33987576	GDF5	chr20:33897002-34042568:-	-0.19	-4.72	3.17E-6	Height	
PRAD	cis	1	rs6088821	chr20:33987576	MMP24	chr20:33814539-33864804:+	0.14	3.49	0.000522	Height	
PRAD	cis	1	rs6088821	chr20:33987576	UQCC	chr20:33890383-33999833:-	0.37	7.04	7.05E-12	Height	
PRAD	cis	1	rs6088823	chr20:33994265	CEP250	chr20:34042996-34099802:+	-0.23	-5.3	1.8E-7	Height	
PRAD	cis	1	rs6088823	chr20:33994265	CPNE1	chr20:34213968-34262539:-	0.2	3.96	8.74E-5	Height	
PRAD	cis	1	rs6088823	chr20:33994265	GDF5	chr20:33897002-34042568:-	-0.19	-4.72	3.17E-6	Height	
PRAD	cis	1	rs6088823	chr20:33994265	MMP24	chr20:33814539-33864804:+	0.14	3.49	0.000522	Height	
PRAD	cis	1	rs6088823	chr20:33994265	UQCC	chr20:33890383-33999833:-	0.37	7.04	7.05E-12	Height	
PRAD	cis	1	rs6088825	chr20:33995972	CEP250	chr20:34042996-34099802:+	-0.23	-5.26	2.2E-7	Height	
PRAD	cis	1	rs6088825	chr20:33995972	CPNE1	chr20:34213968-34262539:-	0.19	3.92	0.000103	Height	
PRAD	cis	1	rs6088825	chr20:33995972	FAM83C	chr20:33873287-33880225:-	0.16	3.69	0.000255	Height	
PRAD	cis	1	rs6088825	chr20:33995972	GDF5	chr20:33897002-34042568:-	-0.2	-4.87	1.56E-6	Height	
PRAD	cis	1	rs6088825	chr20:33995972	MMP24	chr20:33814539-33864804:+	0.14	3.61	0.000333	Height	
PRAD	cis	1	rs6088825	chr20:33995972	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.88E-12	Height	
PRAD	cis	1	rs60907095	chr6:42496096	PRPH2	chr6:42664334-42690358:-	-0.18	-3.52	0.000482	Obesity-related traits	
PRAD	cis	1	rs6091803	chr20:52617347	BCAS1	chr20:52560079-52687304:-	-0.19	-3.75	0.000195	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs609261	chr11:108158134	ATM	chr11:108093559-108239826:+	-0.15	-4.63	4.71E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs60927973	chr14:65897331	LOC645431	chr14:65877313-65879335:-	-0.45	-4.37	1.52E-5	Ischemic stroke	
PRAD	cis	1	rs609412	chr5:146225244	PPP2R2B	chr5:145969070-146461054:-	0.16	3.55	0.00043	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
PRAD	cis	1	rs60942590	chr3:53016421	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs60942590	chr3:53016421	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs60942639	chr14:66107636	LOC645431	chr14:65877313-65879335:-	-0.4	-3.92	0.000102	Ischemic stroke	
PRAD	cis	1	rs609429	chr11:108196509	ATM	chr11:108093559-108239826:+	-0.16	-5.11	4.59E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs6095261	chr20:47346494	PREX1	chr20:47240793-47444420:-	0.41	6.68	6.68E-11	Tonometry	
PRAD	cis	1	rs6095357	chr20:47523865	CSE1L	chr20:47662838-47713484:+	-0.17	-4.14	4.1E-5	Schizophrenia	
PRAD	cis	1	rs60957376	chr15:85280792	LOC388152	chr15:84867600-84898920:-	-0.33	-5.47	7.35E-8	Schizophrenia	
PRAD	cis	1	rs60957376	chr15:85280792	NMB	chr15:85198362-85201802:-	-0.53	-12.58	1.7E-31	Schizophrenia	
PRAD	cis	1	rs60957376	chr15:85280792	WDR73	chr15:85186012-85197524:-	-0.27	-5.74	1.67E-8	Schizophrenia	
PRAD	cis	1	rs60967688	chr17:28437052	EFCAB5	chr17:28256874-28435469:+	0.22	3.8	0.000163	Coffee consumption (cups per day)	
PRAD	cis	1	rs60981340	chr2:86177046	LOC90784	chr2:86247339-86250991:-	-0.44	-5.1	4.82E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs60982898	chr6:49385806	CENPQ	chr6:49431096-49460820:+	-0.39	-8.21	2.1E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.18	5.03	7.09E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs6099171	chr20:55071253	C20orf43	chr20:55043647-55093942:+	0.16	3.88	0.00012	Refractive astigmatism	
PRAD	cis	1	rs6099184	chr20:55097478	C20orf43	chr20:55043647-55093942:+	0.16	4	7.45E-5	Refractive astigmatism	
PRAD	cis	1	rs6102287	chr20:39744650	ZHX3	chr20:39807089-39946242:-	-0.25	-5.59	3.95E-8	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs61028733	chr10:59725426	LOC728640	chr10:60474775-60477291:+	-0.29	-3.54	0.000437	Blood pressure	
PRAD	cis	1	rs61028788	chr8:65665928	BHLHE22	chr8:65492814-65496185:+	0.31	5.72	1.92E-8	HIV-1 susceptibility	
PRAD	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.59	-11.96	5.96E-29	Forced vital capacity	
PRAD	cis	1	rs61040652	chr1:183642153	NCF2	chr1:183524698-183560046:-	0.25	3.74	0.000205	Systemic lupus erythematosus	
PRAD	cis	1	rs61044849	chr3:128065466	RUVBL1	chr3:127783627-127872757:-	0.22	3.96	8.54E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs61052895	chr3:10147516	C3orf10	chr3:10157333-10168873:+	-0.22	-4.26	2.45E-5	Alzheimer's disease	
PRAD	cis	1	rs61052895	chr3:10147516	LOC401052	chr3:10048102-10052779:-	-0.3	-5.46	7.6E-8	Alzheimer's disease	
PRAD	cis	1	rs61069599	chr8:39432023	TACC1	chr8:38585704-38710545:+	0.17	3.77	0.000184	Visceral adipose tissue/subcutaneous adipose tissue ratio	
PRAD	cis	1	rs6107033	chr20:25363591	ENTPD6	chr20:25176339-25207360:+	0.14	3.84	0.000142	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107033	chr20:25363591	FAM182B	chr20:25744102-25848786:-	-0.39	-7.29	1.35E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107033	chr20:25363591	PYGB	chr20:25228706-25278647:+	0.29	6.49	2.25E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107045	chr20:25441936	ENTPD6	chr20:25176339-25207360:+	-0.17	-4.42	1.21E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107045	chr20:25441936	FAM182B	chr20:25744102-25848786:-	0.38	6.89	1.83E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107045	chr20:25441936	PYGB	chr20:25228706-25278647:+	-0.34	-7.35	8.72E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107046	chr20:25442049	ENTPD6	chr20:25176339-25207360:+	-0.17	-4.44	1.13E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107046	chr20:25442049	FAM182B	chr20:25744102-25848786:-	0.38	6.87	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107046	chr20:25442049	PYGB	chr20:25228706-25278647:+	-0.33	-7.29	1.29E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107047	chr20:25442097	ENTPD6	chr20:25176339-25207360:+	-0.17	-4.44	1.13E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107047	chr20:25442097	FAM182B	chr20:25744102-25848786:-	0.38	6.87	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107047	chr20:25442097	PYGB	chr20:25228706-25278647:+	-0.33	-7.29	1.29E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6107386	chr20:3972756	MAVS	chr20:3827449-3856761:+	-0.26	-3.73	0.000213	Response to antidepressants in depression	
PRAD	cis	1	rs6107391	chr20:3983083	MAVS	chr20:3827449-3856761:+	-0.24	-3.46	0.000598	Response to antidepressants in depression	
PRAD	cis	1	rs6107393	chr20:3987738	MAVS	chr20:3827449-3856761:+	-0.24	-3.45	0.000618	Response to antidepressants in depression	
PRAD	cis	1	rs61077902	chr3:10126153	C3orf10	chr3:10157333-10168873:+	-0.21	-4.12	4.41E-5	Alzheimer's disease	
PRAD	cis	1	rs61077902	chr3:10126153	LOC401052	chr3:10048102-10052779:-	-0.3	-5.49	6.63E-8	Alzheimer's disease	
PRAD	cis	1	rs61102033	chr1:46382441	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.13	1.15E-29	Body mass index	
PRAD	cis	1	rs61102033	chr1:46382441	MMACHC	chr1:45965856-45976737:+	-0.17	-3.82	0.000153	Body mass index	
PRAD	cis	1	rs61102033	chr1:46382441	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.23E-9	Body mass index	
PRAD	cis	1	rs6113620	chr20:22280350	PAX1	chr20:21686297-21696620:+	0.15	3.92	9.99E-5	Glucose homeostasis traits	
PRAD	cis	1	rs6113622	chr20:22280603	PAX1	chr20:21686297-21696620:+	0.14	3.66	0.000276	Glucose homeostasis traits	
PRAD	cis	1	rs6113624	chr20:22286430	PAX1	chr20:21686297-21696620:+	0.15	3.87	0.000126	Glucose homeostasis traits	
PRAD	cis	1	rs6115140	chr20:25285507	ENTPD6	chr20:25176339-25207360:+	-0.18	-4.74	2.88E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115140	chr20:25285507	FAM182B	chr20:25744102-25848786:-	0.36	6.54	1.62E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115140	chr20:25285507	PYGB	chr20:25228706-25278647:+	-0.35	-7.7	8.07E-14	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115146	chr20:25304507	ENTPD6	chr20:25176339-25207360:+	0.16	4.17	3.64E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115146	chr20:25304507	FAM182B	chr20:25744102-25848786:-	-0.37	-6.73	4.91E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115146	chr20:25304507	PYGB	chr20:25228706-25278647:+	0.32	7.05	6.56E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115153	chr20:25325567	ENTPD6	chr20:25176339-25207360:+	0.16	4.27	2.35E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115153	chr20:25325567	FAM182B	chr20:25744102-25848786:-	-0.38	-7.1	4.53E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115153	chr20:25325567	PYGB	chr20:25228706-25278647:+	0.32	7	8.9E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115159	chr20:25350944	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115159	chr20:25350944	FAM182B	chr20:25744102-25848786:-	-0.38	-7.05	6.54E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115159	chr20:25350944	PYGB	chr20:25228706-25278647:+	0.32	6.99	9.46E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115168	chr20:25372891	ENTPD6	chr20:25176339-25207360:+	0.16	4.27	2.37E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115168	chr20:25372891	FAM182B	chr20:25744102-25848786:-	-0.38	-7.06	5.87E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115168	chr20:25372891	PYGB	chr20:25228706-25278647:+	0.32	6.97	1.11E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115182	chr20:25410259	ENTPD6	chr20:25176339-25207360:+	0.16	4.28	2.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115182	chr20:25410259	FAM182B	chr20:25744102-25848786:-	-0.38	-7.09	5.05E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115182	chr20:25410259	PYGB	chr20:25228706-25278647:+	0.32	7.02	7.71E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115191	chr20:25440478	ENTPD6	chr20:25176339-25207360:+	-0.17	-4.44	1.13E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115191	chr20:25440478	FAM182B	chr20:25744102-25848786:-	0.38	6.87	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6115191	chr20:25440478	PYGB	chr20:25228706-25278647:+	-0.33	-7.29	1.29E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6116130	chr20:3947026	MAVS	chr20:3827449-3856761:+	-0.25	-3.56	0.000406	Response to antidepressants in depression	
PRAD	cis	1	rs61172708	chr3:52996052	RFT1	chr3:53122503-53164470:-	0.38	4.28	2.3E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs61172708	chr3:52996052	TMEM110	chr3:52867139-52931547:-	0.41	5.37	1.26E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs611744	chr8:109228008	EIF3E	chr8:109213973-109260959:-	-0.15	-3.88	0.000121	Dupuytren's disease	
PRAD	cis	1	rs611744	chr8:109228008	TTC35	chr8:109455853-109499136:+	-0.19	-3.95	9.09E-5	Dupuytren's disease	
PRAD	cis	1	rs61190950	chr2:178683867	PDE11A	chr2:178487979-178973066:-	-0.3	-3.85	0.000133	Height	
PRAD	cis	1	rs6119650	chr20:30258480	COX4I2	chr20:30225691-30232800:+	0.14	3.84	0.000139	Subcortical brain region volumes	
PRAD	cis	1	rs6119652	chr20:30259445	COX4I2	chr20:30225691-30232800:+	0.14	3.68	0.000264	Subcortical brain region volumes	
PRAD	cis	1	rs6120974	chr20:34126827	CEP250	chr20:34042996-34099802:+	0.32	5.46	7.91E-8	Triglycerides	
PRAD	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.7	-11.94	7.27E-29	Triglycerides	
PRAD	cis	1	rs6121038	chr20:30254773	COX4I2	chr20:30225691-30232800:+	0.16	4.11	4.72E-5	Subcortical brain region volumes	
PRAD	cis	1	rs6121172	chr20:30296095	COX4I2	chr20:30225691-30232800:+	0.14	3.69	0.000249	Subcortical brain region volumes	
PRAD	cis	1	rs6121243	chr20:30415094	COX4I2	chr20:30225691-30232800:+	0.14	3.65	0.000297	Subcortical brain region volumes	
PRAD	cis	1	rs61212610	chr5:78961892	DMGDH	chr5:78293430-78365449:-	0.29	3.48	0.000548	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs6122763	chr20:47797653	CSE1L	chr20:47662838-47713484:+	-0.19	-4.83	1.85E-6	Anger	
PRAD	cis	1	rs6122763	chr20:47797653	PREX1	chr20:47240793-47444420:-	0.17	3.62	0.000323	Anger	
PRAD	cis	1	rs6123336	chr20:52617703	BCAS1	chr20:52560079-52687304:-	-0.19	-3.54	0.000442	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs6124323	chr20:39794489	ZHX3	chr20:39807089-39946242:-	-0.27	-5.95	5.16E-9	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs6125539	chr20:47703810	CSE1L	chr20:47662838-47713484:+	0.21	4.95	1.02E-6	Anger	
PRAD	cis	1	rs6125540	chr20:47704039	CSE1L	chr20:47662838-47713484:+	0.2	5.08	5.33E-7	Anger	
PRAD	cis	1	rs6125576	chr20:47776919	CSE1L	chr20:47662838-47713484:+	0.19	4.45	1.05E-5	Anger	
PRAD	cis	1	rs61265590	chr1:183591790	NCF2	chr1:183524698-183560046:-	0.25	3.66	0.00028	Systemic lupus erythematosus	
PRAD	cis	1	rs61270113	chr5:150226263	C5orf62	chr5:150157867-150176297:+	0.27	3.46	0.000599	Crohn's disease	
PRAD	cis	1	rs61270113	chr5:150226263	LOC134466	chr5:150310000-150326146:-	0.55	8.14	3.64E-15	Crohn's disease	
PRAD	cis	1	rs6127049	chr20:52616373	BCAS1	chr20:52560079-52687304:-	-0.19	-3.63	0.000311	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs6127054	chr20:52619331	BCAS1	chr20:52560079-52687304:-	-0.2	-3.83	0.000145	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs61280878	chr6:24468741	GPLD1	chr6:24428405-24489850:-	0.49	10.43	4.6E-23	Hematological and biochemical traits	
PRAD	cis	1	rs61280878	chr6:24468741	MRS2	chr6:24403153-24425809:+	0.26	4.42	1.22E-5	Hematological and biochemical traits	
PRAD	cis	1	rs613089	chr1:147081187	ACP6	chr1:147119168-147142634:-	-0.59	-12.02	3.43E-29	Schizophrenia (negative symptoms)	
PRAD	cis	1	rs61315421	chr14:66076603	LOC645431	chr14:65877313-65879335:-	-0.39	-3.82	0.000149	Ischemic stroke	
PRAD	cis	1	rs6132677	chr20:23840242	CST5	chr20:23856572-23860380:-	0.24	3.6	0.000356	Response to TNF antagonist treatment	
PRAD	cis	1	rs6132678	chr20:23842323	CST5	chr20:23856572-23860380:-	0.24	3.6	0.000356	Response to TNF antagonist treatment	
PRAD	cis	1	rs6132679	chr20:23842400	CST5	chr20:23856572-23860380:-	0.24	3.6	0.000356	Response to TNF antagonist treatment	
PRAD	cis	1	rs6132835	chr20:25434667	ENTPD6	chr20:25176339-25207360:+	-0.15	-3.82	0.000151	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6132835	chr20:25434667	FAM182B	chr20:25744102-25848786:-	0.4	7.26	1.62E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6132835	chr20:25434667	PYGB	chr20:25228706-25278647:+	-0.31	-6.63	9.3E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs613291	chr13:30894404	KATNAL1	chr13:30776768-30881584:-	0.19	4.04	6.22E-5	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs6133036	chr20:3349682	ITPA	chr20:3190056-3204504:+	-0.3	-7.57	1.95E-13	IFN-related cytopenia	
PRAD	cis	1	rs61360320	chr17:61800392	DDX42	chr17:61851567-61896676:+	-0.27	-5.45	8.07E-8	Body mass index	
PRAD	cis	1	rs61360320	chr17:61800392	FTSJ3	chr17:61896795-61905031:-	0.34	6.72	5.36E-11	Body mass index	
PRAD	cis	1	rs61360320	chr17:61800392	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.42	1.23E-5	Body mass index	
PRAD	cis	1	rs6137287	chr20:21180259	PLK1S1	chr20:21106624-21227256:+	0.26	4.57	6.21E-6	Height	
PRAD	cis	1	rs6137473	chr20:21884693	PAX1	chr20:21686297-21696620:+	-0.14	-3.44	0.000628	Adolescent idiopathic scoliosis	
PRAD	cis	1	rs61378129	chr13:36684353	C13orf38	chr13:36801182-36871992:-	0.25	4.38	1.49E-5	Optic cup area	
PRAD	cis	1	rs61378129	chr13:36684353	SOHLH2	chr13:36742347-36871992:-	0.39	6.01	3.66E-9	Optic cup area	
PRAD	cis	1	rs6138150	chr20:23847009	CST5	chr20:23856572-23860380:-	0.25	3.64	0.000297	Response to TNF antagonist treatment	
PRAD	cis	1	rs6138151	chr20:23847180	CST5	chr20:23856572-23860380:-	0.25	3.7	0.000239	Response to TNF antagonist treatment	
PRAD	cis	1	rs61382645	chr11:46923107	ARHGAP1	chr11:46698634-46722120:-	-0.26	-3.54	0.00044	Schizophrenia	
PRAD	cis	1	rs6138572	chr20:25435934	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.2	3.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6138572	chr20:25435934	FAM182B	chr20:25744102-25848786:-	0.39	7.14	3.51E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6138572	chr20:25435934	PYGB	chr20:25228706-25278647:+	-0.32	-6.97	1.07E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6138575	chr20:25438952	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.2	3.24E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6138575	chr20:25438952	FAM182B	chr20:25744102-25848786:-	0.39	7.14	3.51E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6138575	chr20:25438952	PYGB	chr20:25228706-25278647:+	-0.32	-6.97	1.07E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6139064	chr20:3277050	ITPA	chr20:3190056-3204504:+	-0.3	-7.75	5.89E-14	IFN-related cytopenia	
PRAD	cis	1	rs6139068	chr20:3284393	ITPA	chr20:3190056-3204504:+	-0.31	-7.95	1.42E-14	IFN-related cytopenia	
PRAD	cis	1	rs6139088	chr20:3329063	ITPA	chr20:3190056-3204504:+	-0.3	-7.82	3.49E-14	IFN-related cytopenia	
PRAD	cis	1	rs6139103	chr20:3361140	ITPA	chr20:3190056-3204504:+	-0.3	-7.75	5.71E-14	IFN-related cytopenia	
PRAD	cis	1	rs6139117	chr20:3387785	ITPA	chr20:3190056-3204504:+	-0.33	-8.75	3.98E-17	IFN-related cytopenia	
PRAD	cis	1	rs61394483	chr6:33751945	LEMD2	chr6:33738991-33756906:-	0.19	4.96	1.01E-6	Body mass index	
PRAD	cis	1	rs61402842	chr16:77780398	NUDT7	chr16:77756411-77776153:+	0.24	3.51	0.00049	Obesity-related traits	
PRAD	cis	1	rs6141546	chr20:33949282	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.2E-7	Height	
PRAD	cis	1	rs6141546	chr20:33949282	CPNE1	chr20:34213968-34262539:-	0.2	3.97	8.15E-5	Height	
PRAD	cis	1	rs6141546	chr20:33949282	FAM83C	chr20:33873287-33880225:-	0.17	3.7	0.000237	Height	
PRAD	cis	1	rs6141546	chr20:33949282	GDF5	chr20:33897002-34042568:-	-0.2	-4.91	1.29E-6	Height	
PRAD	cis	1	rs6141546	chr20:33949282	MMP24	chr20:33814539-33864804:+	0.14	3.62	0.000328	Height	
PRAD	cis	1	rs6141546	chr20:33949282	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.76E-12	Height	
PRAD	cis	1	rs6141548	chr20:33971085	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.2E-7	Height	
PRAD	cis	1	rs6141548	chr20:33971085	CPNE1	chr20:34213968-34262539:-	0.2	3.97	8.15E-5	Height	
PRAD	cis	1	rs6141548	chr20:33971085	FAM83C	chr20:33873287-33880225:-	0.17	3.7	0.000237	Height	
PRAD	cis	1	rs6141548	chr20:33971085	GDF5	chr20:33897002-34042568:-	-0.2	-4.91	1.29E-6	Height	
PRAD	cis	1	rs6141548	chr20:33971085	MMP24	chr20:33814539-33864804:+	0.14	3.62	0.000328	Height	
PRAD	cis	1	rs6141548	chr20:33971085	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.76E-12	Height	
PRAD	cis	1	rs6141549	chr20:33974051	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.2E-7	Height	
PRAD	cis	1	rs6141549	chr20:33974051	CPNE1	chr20:34213968-34262539:-	0.2	3.97	8.15E-5	Height	
PRAD	cis	1	rs6141549	chr20:33974051	FAM83C	chr20:33873287-33880225:-	0.17	3.7	0.000237	Height	
PRAD	cis	1	rs6141549	chr20:33974051	GDF5	chr20:33897002-34042568:-	-0.2	-4.91	1.29E-6	Height	
PRAD	cis	1	rs6141549	chr20:33974051	MMP24	chr20:33814539-33864804:+	0.14	3.62	0.000328	Height	
PRAD	cis	1	rs6141549	chr20:33974051	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.76E-12	Height	
PRAD	cis	1	rs6142358	chr20:33960308	CEP250	chr20:34042996-34099802:+	0.24	5.43	8.94E-8	Height	
PRAD	cis	1	rs6142358	chr20:33960308	CPNE1	chr20:34213968-34262539:-	-0.2	-4	7.32E-5	Height	
PRAD	cis	1	rs6142358	chr20:33960308	FAM83C	chr20:33873287-33880225:-	-0.16	-3.66	0.000283	Height	
PRAD	cis	1	rs6142358	chr20:33960308	GDF5	chr20:33897002-34042568:-	0.2	4.87	1.5E-6	Height	
PRAD	cis	1	rs6142358	chr20:33960308	MMP24	chr20:33814539-33864804:+	-0.15	-3.71	0.000231	Height	
PRAD	cis	1	rs6142358	chr20:33960308	UQCC	chr20:33890383-33999833:-	-0.38	-7.19	2.62E-12	Height	
PRAD	cis	1	rs6142359	chr20:33960450	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.2E-7	Height	
PRAD	cis	1	rs6142359	chr20:33960450	CPNE1	chr20:34213968-34262539:-	0.2	3.97	8.15E-5	Height	
PRAD	cis	1	rs6142359	chr20:33960450	FAM83C	chr20:33873287-33880225:-	0.17	3.7	0.000237	Height	
PRAD	cis	1	rs6142359	chr20:33960450	GDF5	chr20:33897002-34042568:-	-0.2	-4.91	1.29E-6	Height	
PRAD	cis	1	rs6142359	chr20:33960450	MMP24	chr20:33814539-33864804:+	0.14	3.62	0.000328	Height	
PRAD	cis	1	rs6142359	chr20:33960450	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.76E-12	Height	
PRAD	cis	1	rs6142360	chr20:33960486	CEP250	chr20:34042996-34099802:+	-0.25	-5.68	2.3E-8	Height	
PRAD	cis	1	rs6142360	chr20:33960486	CPNE1	chr20:34213968-34262539:-	0.19	3.86	0.000129	Height	
PRAD	cis	1	rs6142360	chr20:33960486	GDF5	chr20:33897002-34042568:-	-0.19	-4.62	5.07E-6	Height	
PRAD	cis	1	rs6142360	chr20:33960486	MMP24	chr20:33814539-33864804:+	0.14	3.47	0.000575	Height	
PRAD	cis	1	rs6142360	chr20:33960486	UQCC	chr20:33890383-33999833:-	0.36	6.75	4.29E-11	Height	
PRAD	cis	1	rs6142369	chr20:33973315	CEP250	chr20:34042996-34099802:+	-0.23	-5.28	1.99E-7	Height	
PRAD	cis	1	rs6142369	chr20:33973315	CPNE1	chr20:34213968-34262539:-	0.2	3.96	8.68E-5	Height	
PRAD	cis	1	rs6142369	chr20:33973315	GDF5	chr20:33897002-34042568:-	-0.19	-4.71	3.33E-6	Height	
PRAD	cis	1	rs6142369	chr20:33973315	MMP24	chr20:33814539-33864804:+	0.14	3.5	0.000515	Height	
PRAD	cis	1	rs6142369	chr20:33973315	UQCC	chr20:33890383-33999833:-	0.37	7.05	6.6E-12	Height	
PRAD	cis	1	rs6142370	chr20:33973378	CEP250	chr20:34042996-34099802:+	-0.24	-5.38	1.2E-7	Height	
PRAD	cis	1	rs6142370	chr20:33973378	CPNE1	chr20:34213968-34262539:-	0.2	3.97	8.15E-5	Height	
PRAD	cis	1	rs6142370	chr20:33973378	FAM83C	chr20:33873287-33880225:-	0.17	3.7	0.000237	Height	
PRAD	cis	1	rs6142370	chr20:33973378	GDF5	chr20:33897002-34042568:-	-0.2	-4.91	1.29E-6	Height	
PRAD	cis	1	rs6142370	chr20:33973378	MMP24	chr20:33814539-33864804:+	0.14	3.62	0.000328	Height	
PRAD	cis	1	rs6142370	chr20:33973378	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.76E-12	Height	
PRAD	cis	1	rs6142373	chr20:33983314	CEP250	chr20:34042996-34099802:+	-0.24	-5.37	1.25E-7	Height	
PRAD	cis	1	rs6142373	chr20:33983314	CPNE1	chr20:34213968-34262539:-	0.2	3.95	9.1E-5	Height	
PRAD	cis	1	rs6142373	chr20:33983314	FAM83C	chr20:33873287-33880225:-	0.16	3.67	0.000271	Height	
PRAD	cis	1	rs6142373	chr20:33983314	GDF5	chr20:33897002-34042568:-	-0.21	-5.02	7.29E-7	Height	
PRAD	cis	1	rs6142373	chr20:33983314	MMP24	chr20:33814539-33864804:+	0.14	3.63	0.00032	Height	
PRAD	cis	1	rs6142373	chr20:33983314	UQCC	chr20:33890383-33999833:-	0.39	7.43	5.31E-13	Height	
PRAD	cis	1	rs6142374	chr20:33985568	CEP250	chr20:34042996-34099802:+	-0.23	-5.3	1.8E-7	Height	
PRAD	cis	1	rs6142374	chr20:33985568	CPNE1	chr20:34213968-34262539:-	0.2	3.96	8.74E-5	Height	
PRAD	cis	1	rs6142374	chr20:33985568	GDF5	chr20:33897002-34042568:-	-0.19	-4.72	3.17E-6	Height	
PRAD	cis	1	rs6142374	chr20:33985568	MMP24	chr20:33814539-33864804:+	0.14	3.49	0.000522	Height	
PRAD	cis	1	rs6142374	chr20:33985568	UQCC	chr20:33890383-33999833:-	0.37	7.04	7.05E-12	Height	
PRAD	cis	1	rs6142376	chr20:33992761	CEP250	chr20:34042996-34099802:+	-0.23	-5.26	2.2E-7	Height	
PRAD	cis	1	rs6142376	chr20:33992761	CPNE1	chr20:34213968-34262539:-	0.19	3.92	0.000103	Height	
PRAD	cis	1	rs6142376	chr20:33992761	FAM83C	chr20:33873287-33880225:-	0.16	3.69	0.000255	Height	
PRAD	cis	1	rs6142376	chr20:33992761	GDF5	chr20:33897002-34042568:-	-0.2	-4.87	1.56E-6	Height	
PRAD	cis	1	rs6142376	chr20:33992761	MMP24	chr20:33814539-33864804:+	0.14	3.61	0.000333	Height	
PRAD	cis	1	rs6142376	chr20:33992761	UQCC	chr20:33890383-33999833:-	0.38	7.13	3.88E-12	Height	
PRAD	cis	1	rs6142379	chr20:33999267	CEP250	chr20:34042996-34099802:+	-0.23	-5.31	1.68E-7	Height	
PRAD	cis	1	rs6142379	chr20:33999267	CPNE1	chr20:34213968-34262539:-	0.2	4.01	7.05E-5	Height	
PRAD	cis	1	rs6142379	chr20:33999267	GDF5	chr20:33897002-34042568:-	-0.19	-4.7	3.5E-6	Height	
PRAD	cis	1	rs6142379	chr20:33999267	MMP24	chr20:33814539-33864804:+	0.14	3.47	0.000572	Height	
PRAD	cis	1	rs6142379	chr20:33999267	UQCC	chr20:33890383-33999833:-	0.37	6.98	1.02E-11	Height	
PRAD	cis	1	rs61457762	chr1:27284157	PIGV	chr1:27114455-27124886:+	-0.31	-3.84	0.000138	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs61477982	chr2:86160532	LOC90784	chr2:86247339-86250991:-	-0.37	-3.73	0.000217	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-0.94	-11.94	6.64E-29	Blood metabolite levels	
PRAD	cis	1	rs61517255	chr10:17208918	TRDMT1	chr10:17184983-17243681:-	-0.25	-5.13	4.19E-7	Homocysteine levels	
PRAD	cis	1	rs61524473	chr15:45646283	GATM	chr15:45653324-45670980:-	-0.16	-5.52	5.52E-8	Metabolite levels (small molecules and protein measures)	
PRAD	cis	1	rs61524473	chr15:45646283	SPATA5L1	chr15:45694519-45713614:+	0.57	11.8	2.55E-28	Metabolite levels (small molecules and protein measures)	
PRAD	cis	1	rs61530785	chr5:150261364	C5orf62	chr5:150157867-150176297:+	0.29	3.49	0.000524	Crohn's disease	
PRAD	cis	1	rs61530785	chr5:150261364	LOC134466	chr5:150310000-150326146:-	0.69	9.87	5.07E-21	Crohn's disease	
PRAD	cis	1	rs615581	chr8:102482839	UBR5	chr8:103265569-103424495:-	-0.14	-3.55	0.000427	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
PRAD	cis	1	rs61596977	chr8:95997165	C8orf38	chr8:95908040-96088396:+	-0.41	-6.87	2.04E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs61605589	chr2:198876532	PLCL1	chr2:198669426-199014606:+	0.15	3.9	0.000112	Ulcerative colitis	
PRAD	cis	1	rs616147	chr3:39534481	RPSA	chr3:39448204-39454030:+	0.15	4.58	5.88E-6	Corticobasal degeneration;Progressive supranuclear palsy	
PRAD	cis	1	rs61634114	chr19:17387254	ANKLE1	chr19:17392454-17398454:+	0.32	6.09	2.36E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs61634114	chr19:17387254	MRPL34	chr19:17416477-17417652:+	-0.21	-4.2	3.16E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs61634114	chr19:17387254	OCEL1	chr19:17337055-17340027:+	0.22	5.25	2.35E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs61650587	chr10:73398722	CHST3	chr10:73724120-73773321:+	-0.11	-3.53	0.000465	Selective IgA deficiency	
PRAD	cis	1	rs61662306	chr6:33746697	LEMD2	chr6:33738991-33756906:-	0.19	4.92	1.18E-6	Body mass index	
PRAD	cis	1	rs61697794	chr2:96902604	LOC729234	chr2:96676299-96688882:+	-0.18	-4.1	4.92E-5	Cardiac Troponin-T levels	
PRAD	cis	1	rs617219	chr5:78429594	DMGDH	chr5:78293430-78365449:-	-0.24	-5.1	5.05E-7	Betaine levels in individuals undergoing cardiac evaluation	
PRAD	cis	1	rs61744385	chr3:41756986	ULK4	chr3:41288091-42003660:-	0.75	11.73	4.69E-28	Diastolic blood pressure	
PRAD	cis	1	rs61744388	chr3:41756965	ULK4	chr3:41288091-42003660:-	0.75	11.73	4.69E-28	Diastolic blood pressure	
PRAD	cis	1	rs61783200	chr1:46297403	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	8.94E-30	Body mass index	
PRAD	cis	1	rs61783200	chr1:46297403	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000146	Body mass index	
PRAD	cis	1	rs61783200	chr1:46297403	MUTYH	chr1:45794915-45806142:-	0.21	5.96	4.88E-9	Body mass index	
PRAD	cis	1	rs61783220	chr1:46335312	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	9.04E-30	Body mass index	
PRAD	cis	1	rs61783220	chr1:46335312	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000145	Body mass index	
PRAD	cis	1	rs61783220	chr1:46335312	MUTYH	chr1:45794915-45806142:-	0.21	5.97	4.63E-9	Body mass index	
PRAD	cis	1	rs61789695	chr1:28255693	RPA2	chr1:28218049-28241236:-	0.36	6.25	9.4E-10	Corneal astigmatism	
PRAD	cis	1	rs61792114	chr4:289139	ZNF718	chr4:53272-156488:+	0.39	6.62	9.68E-11	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs61792116	chr4:301077	ZNF718	chr4:53272-156488:+	0.35	5.72	1.87E-8	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs61794996	chr4:209328	ZNF718	chr4:53272-156488:+	0.32	5.25	2.27E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs61794997	chr4:222103	ZNF718	chr4:53272-156488:+	0.32	5.2	3.02E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs61795001	chr4:242057	ZNF718	chr4:53272-156488:+	0.34	5.4	1.04E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs61795002	chr4:242797	ZNF718	chr4:53272-156488:+	0.33	5.37	1.27E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs61795006	chr4:253601	ZNF718	chr4:53272-156488:+	0.37	6.38	4.18E-10	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs61795007	chr4:255264	ZNF718	chr4:53272-156488:+	0.37	6.38	4.18E-10	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs61806199	chr1:119450102	WARS2	chr1:119573841-119683295:-	0.39	5.22	2.69E-7	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs61806202	chr1:119465457	WARS2	chr1:119573841-119683295:-	0.37	5.05	6.19E-7	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs61806205	chr1:119482315	WARS2	chr1:119573841-119683295:-	0.35	4.86	1.58E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs61806231	chr1:119496482	WARS2	chr1:119573841-119683295:-	0.36	4.9	1.29E-6	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs6180	chr5:42719239	CCDC152	chr5:42756920-42802539:+	0.15	4.21	3.11E-5	Height	
PRAD	cis	1	rs6180	chr5:42719239	SEPP1	chr5:42799983-42825998:-	0.14	3.99	7.77E-5	Height	
PRAD	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.65	9.73	1.65E-20	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs61820166	chr1:150556036	CTSK	chr1:150768687-150780812:-	-0.2	-4.62	4.95E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs61822669	chr1:207421214	CD55	chr1:207494817-207534309:+	0.51	9.55	7.25E-20	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs61822674	chr1:207436723	CD55	chr1:207494817-207534309:+	0.47	8.8	2.61E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs61822697	chr1:207485164	CD55	chr1:207494817-207534309:+	0.54	10.03	1.36E-21	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs61826828	chr1:174015261	SERPINC1	chr1:173872943-173886516:-	0.3	4.58	6.07E-6	Schizophrenia	
PRAD	cis	1	rs61852630	chr1:247210193	ZNF670	chr1:247200087-247242069:-	-0.32	-7.17	2.84E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs61852637	chr1:247219636	ZNF670	chr1:247200087-247242069:-	-0.32	-7.16	3.09E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs61856137	chr10:5087978	AKR1C2	chr10:4964715-5060207:-	0.22	3.71	0.000236	Longevity	
PRAD	cis	1	rs61871790	chr10:97391223	ENTPD1	chr10:97471536-97637022:+	0.13	3.81	0.000157	Blood metabolite levels	
PRAD	cis	1	rs61871790	chr10:97391223	TCTN3	chr10:97423154-97453900:-	0.21	4.17	3.66E-5	Blood metabolite levels	
PRAD	cis	1	rs61871792	chr10:97397586	ENTPD1	chr10:97471536-97637022:+	0.13	3.95	8.86E-5	Blood metabolite levels	
PRAD	cis	1	rs61871792	chr10:97397586	TCTN3	chr10:97423154-97453900:-	0.23	4.43	1.18E-5	Blood metabolite levels	
PRAD	cis	1	rs61871793	chr10:97407738	ENTPD1	chr10:97471536-97637022:+	0.14	4.07	5.56E-5	Blood metabolite levels	
PRAD	cis	1	rs61871793	chr10:97407738	TCTN3	chr10:97423154-97453900:-	0.23	4.48	9.48E-6	Blood metabolite levels	
PRAD	cis	1	rs61876323	chr11:462855	ANO9	chr11:417930-442011:-	0.25	4.14	4.04E-5	Body mass index	
PRAD	cis	1	rs61876323	chr11:462855	LRRC56	chr11:537522-554915:+	0.31	4.75	2.65E-6	Body mass index	
PRAD	cis	1	rs61876323	chr11:462855	RNH1	chr11:494512-507273:-	-0.2	-3.77	0.000184	Body mass index	
PRAD	cis	1	rs61876326	chr11:467368	ANO9	chr11:417930-442011:-	0.25	4.17	3.56E-5	Body mass index	
PRAD	cis	1	rs61876326	chr11:467368	LRRC56	chr11:537522-554915:+	0.29	4.45	1.1E-5	Body mass index	
PRAD	cis	1	rs61876326	chr11:467368	RNH1	chr11:494512-507273:-	-0.21	-3.84	0.000137	Body mass index	
PRAD	cis	1	rs61876332	chr11:487101	ANO9	chr11:417930-442011:-	0.25	4.03	6.59E-5	Body mass index	
PRAD	cis	1	rs61876332	chr11:487101	LRRC56	chr11:537522-554915:+	0.3	4.51	8.37E-6	Body mass index	
PRAD	cis	1	rs61876332	chr11:487101	RNH1	chr11:494512-507273:-	-0.21	-3.92	0.000104	Body mass index	
PRAD	cis	1	rs61876333	chr11:487136	LRRC56	chr11:537522-554915:+	0.29	4.32	1.91E-5	Body mass index	
PRAD	cis	1	rs61876333	chr11:487136	RNH1	chr11:494512-507273:-	-0.21	-3.82	0.000153	Body mass index	
PRAD	cis	1	rs61876334	chr11:487201	ANO9	chr11:417930-442011:-	0.25	4.03	6.59E-5	Body mass index	
PRAD	cis	1	rs61876334	chr11:487201	LRRC56	chr11:537522-554915:+	0.3	4.51	8.37E-6	Body mass index	
PRAD	cis	1	rs61876334	chr11:487201	RNH1	chr11:494512-507273:-	-0.21	-3.92	0.000104	Body mass index	
PRAD	cis	1	rs61876335	chr11:488878	ANO9	chr11:417930-442011:-	0.32	5.3	1.74E-7	Body mass index	
PRAD	cis	1	rs61876335	chr11:488878	LRRC56	chr11:537522-554915:+	0.28	4.38	1.48E-5	Body mass index	
PRAD	cis	1	rs61876335	chr11:488878	PSMD13	chr11:236808-252984:+	0.18	3.44	0.00064	Body mass index	
PRAD	cis	1	rs61876335	chr11:488878	RNH1	chr11:494512-507273:-	-0.21	-3.88	0.000121	Body mass index	
PRAD	cis	1	rs61876336	chr11:489537	ANO9	chr11:417930-442011:-	0.25	4.09	5.07E-5	Body mass index	
PRAD	cis	1	rs61876336	chr11:489537	LRRC56	chr11:537522-554915:+	0.3	4.52	7.93E-6	Body mass index	
PRAD	cis	1	rs61876336	chr11:489537	RNH1	chr11:494512-507273:-	-0.21	-3.91	0.000104	Body mass index	
PRAD	cis	1	rs61876339	chr11:495283	ANO9	chr11:417930-442011:-	0.23	3.76	0.000192	Body mass index	
PRAD	cis	1	rs61876339	chr11:495283	LRRC56	chr11:537522-554915:+	0.28	4.27	2.35E-5	Body mass index	
PRAD	cis	1	rs61876339	chr11:495283	RNH1	chr11:494512-507273:-	-0.2	-3.65	0.00029	Body mass index	
PRAD	cis	1	rs61876340	chr11:495699	ANO9	chr11:417930-442011:-	0.25	3.98	7.92E-5	Body mass index	
PRAD	cis	1	rs61876340	chr11:495699	LRRC56	chr11:537522-554915:+	0.27	4.1	4.89E-5	Body mass index	
PRAD	cis	1	rs61876340	chr11:495699	RNH1	chr11:494512-507273:-	-0.21	-3.74	0.00021	Body mass index	
PRAD	cis	1	rs61876341	chr11:495892	ANO9	chr11:417930-442011:-	0.25	3.98	7.92E-5	Body mass index	
PRAD	cis	1	rs61876341	chr11:495892	LRRC56	chr11:537522-554915:+	0.27	4.1	4.89E-5	Body mass index	
PRAD	cis	1	rs61876341	chr11:495892	RNH1	chr11:494512-507273:-	-0.21	-3.74	0.00021	Body mass index	
PRAD	cis	1	rs61876342	chr11:496193	ANO9	chr11:417930-442011:-	0.24	3.86	0.000131	Body mass index	
PRAD	cis	1	rs61876342	chr11:496193	LRRC56	chr11:537522-554915:+	0.27	4.15	3.89E-5	Body mass index	
PRAD	cis	1	rs61876342	chr11:496193	RNH1	chr11:494512-507273:-	-0.2	-3.7	0.000243	Body mass index	
PRAD	cis	1	rs61877760	chr11:506596	ANO9	chr11:417930-442011:-	0.24	3.93	9.93E-5	Body mass index	
PRAD	cis	1	rs61877760	chr11:506596	LRRC56	chr11:537522-554915:+	0.27	4.05	6.11E-5	Body mass index	
PRAD	cis	1	rs61877760	chr11:506596	RNH1	chr11:494512-507273:-	-0.2	-3.65	0.000296	Body mass index	
PRAD	cis	1	rs61877775	chr11:521462	LRRC56	chr11:537522-554915:+	0.28	3.99	7.79E-5	Body mass index	
PRAD	cis	1	rs61877775	chr11:521462	RNH1	chr11:494512-507273:-	-0.21	-3.6	0.000347	Body mass index	
PRAD	cis	1	rs61879300	chr11:22117880	ANO5	chr11:22214722-22304913:+	0.23	5.43	9.13E-8	Parkinson's disease	
PRAD	cis	1	rs61882678	chr11:46368241	HARBI1	chr11:46624857-46638777:-	0.27	3.5	0.000514	Schizophrenia	
PRAD	cis	1	rs61882701	chr11:46443275	HARBI1	chr11:46624857-46638777:-	0.27	3.58	0.000383	Schizophrenia	
PRAD	cis	1	rs61882743	chr11:46548754	ARHGAP1	chr11:46698634-46722120:-	-0.21	-3.87	0.000123	Schizophrenia	
PRAD	cis	1	rs61882743	chr11:46548754	HARBI1	chr11:46624857-46638777:-	0.25	3.59	0.000359	Schizophrenia	
PRAD	cis	1	rs61882746	chr11:46567475	HARBI1	chr11:46624857-46638777:-	0.29	3.89	0.000115	Schizophrenia	
PRAD	cis	1	rs61882750	chr11:46584227	HARBI1	chr11:46624857-46638777:-	0.28	3.8	0.000161	Schizophrenia	
PRAD	cis	1	rs61882758	chr11:46611805	HARBI1	chr11:46624857-46638777:-	0.28	3.86	0.000132	Schizophrenia	
PRAD	cis	1	rs61884262	chr11:46631299	HARBI1	chr11:46624857-46638777:-	0.27	3.62	0.000328	Schizophrenia	
PRAD	cis	1	rs61884264	chr11:46639582	HARBI1	chr11:46624857-46638777:-	0.28	3.86	0.000132	Schizophrenia	
PRAD	cis	1	rs61888887	chr11:57099051	TIMM10	chr11:57295936-57298232:-	-0.22	-3.58	0.000382	Low high density lipoprotein cholesterol levels	
PRAD	cis	1	rs61898463	chr11:46873406	ARHGAP1	chr11:46698634-46722120:-	-0.26	-3.84	0.000138	Schizophrenia	
PRAD	cis	1	rs61901691	chr11:59902799	PATL1	chr11:59404194-59436511:-	-0.11	-3.53	0.000457	Alzheimer's disease (late onset)	
PRAD	cis	1	rs61931739	chr12:34089973	ALG10	chr12:34175216-34181234:+	0.14	3.78	0.000178	Morning vs. evening chronotype	
PRAD	cis	1	rs61977049	chr14:88827000	SPATA7	chr14:88852012-88904802:+	-0.2	-4	7.32E-5	Coronary artery calcification	
PRAD	cis	1	rs61977058	chr14:88881915	SPATA7	chr14:88852012-88904802:+	-0.22	-4.21	3.08E-5	Coronary artery calcification	
PRAD	cis	1	rs61989986	chr14:90739180	C14orf102	chr14:90744398-90798279:-	0.2	3.52	0.000472	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs61995780	chr14:104120612	BAG5	chr14:104022889-104029151:-	0.18	3.76	0.000193	Body mass index	
PRAD	cis	1	rs61995780	chr14:104120612	C14orf153	chr14:104029299-104057227:+	0.14	4.26	2.43E-5	Body mass index	
PRAD	cis	1	rs61995780	chr14:104120612	CKB	chr14:103985996-103989170:-	0.23	5.24	2.41E-7	Body mass index	
PRAD	cis	1	rs61995780	chr14:104120612	KLC1	chr14:104029299-104167887:+	-0.18	-3.73	0.000215	Body mass index	
PRAD	cis	1	rs61995780	chr14:104120612	MARK3	chr14:103851701-103970164:+	0.24	4.97	9.53E-7	Body mass index	
PRAD	cis	1	rs619972	chr11:108169619	ATM	chr11:108093559-108239826:+	-0.16	-4.95	1.03E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs62008532	chr15:62365877	C2CD4A	chr15:62359176-62363109:+	0.18	3.54	0.000447	Height	
PRAD	cis	1	rs62017189	chr15:50922032	SPPL2A	chr15:50999739-51057910:-	0.26	5.38	1.2E-7	QT interval	
PRAD	cis	1	rs62017206	chr15:50955626	SPPL2A	chr15:50999739-51057910:-	0.27	5.52	5.76E-8	QT interval	
PRAD	cis	1	rs62017210	chr15:50960620	SPPL2A	chr15:50999739-51057910:-	0.27	5.45	8.27E-8	QT interval	
PRAD	cis	1	rs62019464	chr15:85294469	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.48	0.000539	Schizophrenia	
PRAD	cis	1	rs62019464	chr15:85294469	LOC388152	chr15:84867600-84898920:-	-0.32	-5.28	2.02E-7	Schizophrenia	
PRAD	cis	1	rs62019464	chr15:85294469	NMB	chr15:85198362-85201802:-	-0.53	-12.52	2.98E-31	Schizophrenia	
PRAD	cis	1	rs62019464	chr15:85294469	WDR73	chr15:85186012-85197524:-	-0.27	-5.63	3.12E-8	Schizophrenia	
PRAD	cis	1	rs62019469	chr15:85321220	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.46	0.000598	Schizophrenia	
PRAD	cis	1	rs62019469	chr15:85321220	LOC388152	chr15:84867600-84898920:-	-0.31	-5.27	2.05E-7	Schizophrenia	
PRAD	cis	1	rs62019469	chr15:85321220	NMB	chr15:85198362-85201802:-	-0.52	-12.31	2.13E-30	Schizophrenia	
PRAD	cis	1	rs62019469	chr15:85321220	WDR73	chr15:85186012-85197524:-	-0.27	-5.67	2.55E-8	Schizophrenia	
PRAD	cis	1	rs62021219	chr15:85256159	LOC388152	chr15:84867600-84898920:-	-0.32	-5.42	9.53E-8	Schizophrenia	
PRAD	cis	1	rs62021219	chr15:85256159	NMB	chr15:85198362-85201802:-	-0.52	-12.28	2.93E-30	Schizophrenia	
PRAD	cis	1	rs62021219	chr15:85256159	WDR73	chr15:85186012-85197524:-	-0.27	-5.62	3.27E-8	Schizophrenia	
PRAD	cis	1	rs62023352	chr15:52889448	ARPP19	chr15:52839432-52861364:-	0.14	3.57	0.0004	Schizophrenia	
PRAD	cis	1	rs62026530	chr15:84775840	GOLGA6L5	chr15:85047738-85060078:-	-0.19	-4.74	2.79E-6	Schizophrenia	
PRAD	cis	1	rs62026530	chr15:84775840	LOC388152	chr15:84867600-84898920:-	-0.36	-6.25	9.07E-10	Schizophrenia	
PRAD	cis	1	rs62026530	chr15:84775840	NMB	chr15:85198362-85201802:-	-0.37	-8.3	1.1E-15	Schizophrenia	
PRAD	cis	1	rs62026530	chr15:84775840	WDR73	chr15:85186012-85197524:-	-0.22	-4.6	5.48E-6	Schizophrenia	
PRAD	cis	1	rs62027286	chr15:75429720	MPI	chr15:75182410-75190565:+	0.16	3.64	0.000302	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs62067978	chr17:2013058	SRR	chr17:2207248-2228553:+	0.3	4.47	9.62E-6	Body mass index	
PRAD	cis	1	rs62070270	chr17:28263980	EFCAB5	chr17:28256874-28435469:+	0.25	4.26	2.49E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs62070312	chr17:28438877	EFCAB5	chr17:28256874-28435469:+	0.24	4.05	6.0E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs62073605	chr17:18066791	LOC220594	chr17:18414577-18445234:-	-0.3	-4.01	7.15E-5	Obesity-related traits	
PRAD	cis	1	rs62073605	chr17:18066791	MYO15A	chr17:18012020-18083115:+	0.25	4.66	4.03E-6	Obesity-related traits	
PRAD	cis	1	rs62073606	chr17:18069142	LOC220594	chr17:18414577-18445234:-	-0.3	-4.01	7.15E-5	Obesity-related traits	
PRAD	cis	1	rs62073606	chr17:18069142	MYO15A	chr17:18012020-18083115:+	0.25	4.66	4.03E-6	Obesity-related traits	
PRAD	cis	1	rs62081900	chr18:50279358	DCC	chr18:49866571-51057782:+	-0.24	-3.63	0.000317	Alcoholism (alcohol use disorder factor score)	
PRAD	cis	1	rs62084208	chr17:65827443	LOC651250	chr17:66097696-66157623:+	-0.21	-3.67	0.000272	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62084210	chr17:65828710	LOC651250	chr17:66097696-66157623:+	-0.21	-3.52	0.000479	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62084213	chr17:65842016	LOC651250	chr17:66097696-66157623:+	-0.24	-4.24	2.67E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62084214	chr17:65843325	LOC651250	chr17:66097696-66157623:+	-0.24	-4.24	2.67E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62084238	chr17:65856573	LOC651250	chr17:66097696-66157623:+	-0.24	-4.26	2.49E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62084240	chr17:65859233	LOC651250	chr17:66097696-66157623:+	-0.24	-4.16	3.83E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62084246	chr17:65867911	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62084248	chr17:65874541	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62084249	chr17:65874998	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62084251	chr17:65878736	LOC651250	chr17:66097696-66157623:+	-0.24	-4.31	1.97E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62085992	chr17:65923083	KPNA2	chr17:66031848-66042969:+	-0.13	-3.61	0.000336	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62085992	chr17:65923083	LOC651250	chr17:66097696-66157623:+	-0.24	-4.15	3.91E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62085993	chr17:65923152	LOC651250	chr17:66097696-66157623:+	-0.23	-4.1	4.83E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs62104262	chr19:9996578	PIN1	chr19:9945999-9960358:+	0.12	3.73	0.000214	Menarche (age at onset)	
PRAD	cis	1	rs62112907	chr19:22209569	ZNF257	chr19:22235266-22273901:+	0.37	5.1	4.83E-7	Body mass index (change over time)	
PRAD	cis	1	rs62112917	chr19:22226580	ZNF257	chr19:22235266-22273901:+	0.38	5.02	7.37E-7	Body mass index (change over time)	
PRAD	cis	1	rs62112917	chr19:22226580	ZNF676	chr19:22361903-22379753:-	0.25	3.48	0.000539	Body mass index (change over time)	
PRAD	cis	1	rs62113284	chr19:52031926	ZNF175	chr19:52074531-52092990:+	-0.32	-4.38	1.47E-5	Carotid intima media thickness	
PRAD	cis	1	rs62113284	chr19:52031926	ZNF766	chr19:52772824-52795977:+	-0.35	-3.44	0.000641	Carotid intima media thickness	
PRAD	cis	1	rs62114497	chr2:214837	SH3YL1	chr2:218138-264810:-	-0.78	-18.12	4.85E-56	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs62114501	chr2:231741	SH3YL1	chr2:218138-264810:-	-0.78	-18.4	2.49E-57	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs62114505	chr2:242426	SH3YL1	chr2:218138-264810:-	-0.78	-18.64	1.81E-58	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs62114544	chr2:269679	SH3YL1	chr2:218138-264810:-	-0.79	-18.71	9.01E-59	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs62114548	chr2:274672	SH3YL1	chr2:218138-264810:-	-0.78	-17.93	3.73E-55	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs62114762	chr19:24233868	LOC100101266	chr19:24344995-24346249:-	0.32	4.56	6.64E-6	Response to taxane treatment (placlitaxel)	
PRAD	cis	1	rs62116203	chr19:52023841	ZNF175	chr19:52074531-52092990:+	-0.34	-4.5	8.61E-6	Carotid intima media thickness	
PRAD	cis	1	rs62116203	chr19:52023841	ZNF766	chr19:52772824-52795977:+	-0.39	-3.7	0.00024	Carotid intima media thickness	
PRAD	cis	1	rs62116204	chr19:52024375	ZNF175	chr19:52074531-52092990:+	-0.32	-4.37	1.5E-5	Carotid intima media thickness	
PRAD	cis	1	rs62116205	chr19:52025634	ZNF175	chr19:52074531-52092990:+	-0.32	-4.37	1.5E-5	Carotid intima media thickness	
PRAD	cis	1	rs62117633	chr19:24219474	LOC100101266	chr19:24344995-24346249:-	0.37	5.15	3.83E-7	Response to taxane treatment (placlitaxel)	
PRAD	cis	1	rs62120832	chr19:23064264	ZNF492	chr19:22817126-22850472:+	-0.33	-4.24	2.71E-5	Bronchopulmonary dysplasia	
PRAD	cis	1	rs62132091	chr2:17770276	GEN1	chr2:17935162-17966632:+	0.4	5.16	3.71E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132092	chr2:17770893	GEN1	chr2:17935162-17966632:+	0.46	5.26	2.14E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132093	chr2:17771207	GEN1	chr2:17935162-17966632:+	0.46	5.26	2.14E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132125	chr2:17776997	GEN1	chr2:17935162-17966632:+	0.41	5.24	2.48E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132127	chr2:17778708	GEN1	chr2:17935162-17966632:+	0.45	5.66	2.65E-8	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132129	chr2:17778782	GEN1	chr2:17935162-17966632:+	0.45	5.21	2.87E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132133	chr2:17780483	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132135	chr2:17783190	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132137	chr2:17784194	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132138	chr2:17784781	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132139	chr2:17785987	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132140	chr2:17786559	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132141	chr2:17786758	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132142	chr2:17788469	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132143	chr2:17788743	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132144	chr2:17788790	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132145	chr2:17789253	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132146	chr2:17790133	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132147	chr2:17790876	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.09E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132148	chr2:17791048	GEN1	chr2:17935162-17966632:+	0.45	5.23	2.57E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132150	chr2:17792359	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132151	chr2:17792698	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62132152	chr2:17794404	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62133576	chr2:17795297	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62133577	chr2:17798777	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62133578	chr2:17799575	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62133579	chr2:17800196	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62133583	chr2:17805779	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62133584	chr2:17805944	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62133586	chr2:17806579	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62133587	chr2:17806654	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62133588	chr2:17807469	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62133589	chr2:17807626	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62133590	chr2:17811126	GEN1	chr2:17935162-17966632:+	0.47	5.46	7.78E-8	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs62136864	chr2:46829124	ATP6V1E2	chr2:46738988-46769696:-	-0.2	-3.72	0.000221	Height	
PRAD	cis	1	rs62136864	chr2:46829124	CRIPT	chr2:46844325-46852880:+	0.34	6.86	2.15E-11	Height	
PRAD	cis	1	rs62139200	chr2:54475507	C2orf73	chr2:54558071-54588714:+	0.3	3.93	9.87E-5	Telomere length	
PRAD	cis	1	rs62139251	chr2:54478605	C2orf73	chr2:54558071-54588714:+	0.3	3.94	9.54E-5	Telomere length	
PRAD	cis	1	rs62139254	chr2:54480336	C2orf73	chr2:54558071-54588714:+	0.3	3.91	0.000105	Telomere length	
PRAD	cis	1	rs62151652	chr2:73700131	ALMS1P	chr2:73872046-73912692:+	0.5	8.58	1.38E-16	Metabolite levels	
PRAD	cis	1	rs62151652	chr2:73700131	NAT8	chr2:73867850-73869537:-	0.25	3.88	0.000118	Metabolite levels	
PRAD	cis	1	rs62152793	chr2:97484948	CNNM4	chr2:97426639-97477626:+	0.23	3.49	0.000536	Erectile dysfunction and prostate cancer treatment	
PRAD	cis	1	rs62153845	chr2:99887162	MRPL30	chr2:99758185-99939196:+	0.22	3.51	0.0005	IgG glycosylation	
PRAD	cis	1	rs62153845	chr2:99887162	TSGA10	chr2:99613725-99771187:-	0.31	4.59	5.63E-6	IgG glycosylation	
PRAD	cis	1	rs62157778	chr2:88934090	RPIA	chr2:88991176-89050451:+	0.18	3.63	0.000316	Height	
PRAD	cis	1	rs62175515	chr2:160909524	LY75	chr2:160625141-160761262:-	0.12	4.15	3.94E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs62175515	chr2:160909524	PLA2R1	chr2:160798012-160919121:-	0.23	5.34	1.46E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs62175517	chr2:160911575	LY75	chr2:160625141-160761262:-	0.12	4.15	3.94E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs62175517	chr2:160911575	PLA2R1	chr2:160798012-160919121:-	0.23	5.34	1.46E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs62180307	chr2:63341015	C2orf86	chr2:63348537-63815851:-	0.24	4.41	1.27E-5	Prostate cancer	
PRAD	cis	1	rs62180307	chr2:63341015	EHBP1	chr2:62901013-63273619:+	0.22	3.81	0.000158	Prostate cancer	
PRAD	cis	1	rs62184315	chr2:190771945	ASNSD1	chr2:190526125-190535556:+	-0.41	-5.93	5.99E-9	Alcohol dependence (age at onset)	
PRAD	cis	1	rs62184315	chr2:190771945	ORMDL1	chr2:190634994-190649097:-	0.42	7.6	1.63E-13	Alcohol dependence (age at onset)	
PRAD	cis	1	rs62202817	chr20:22273720	PAX1	chr20:21686297-21696620:+	0.16	4.03	6.63E-5	Glucose homeostasis traits	
PRAD	cis	1	rs62202820	chr20:22283238	PAX1	chr20:21686297-21696620:+	0.15	3.92	9.99E-5	Glucose homeostasis traits	
PRAD	cis	1	rs62202846	chr20:22288388	PAX1	chr20:21686297-21696620:+	0.14	3.62	0.000323	Glucose homeostasis traits	
PRAD	cis	1	rs62206437	chr20:43759316	SLPI	chr20:43880879-43883206:-	0.24	3.84	0.000141	Parental longevity (mother's age at death)	
PRAD	cis	1	rs62207635	chr20:47951583	PREX1	chr20:47240793-47444420:-	0.29	3.76	0.000189	QT interval	
PRAD	cis	1	rs62211529	chr20:33959315	CEP250	chr20:34042996-34099802:+	-0.23	-5.28	1.99E-7	Height	
PRAD	cis	1	rs62211529	chr20:33959315	CPNE1	chr20:34213968-34262539:-	0.2	3.96	8.68E-5	Height	
PRAD	cis	1	rs62211529	chr20:33959315	GDF5	chr20:33897002-34042568:-	-0.19	-4.71	3.33E-6	Height	
PRAD	cis	1	rs62211529	chr20:33959315	MMP24	chr20:33814539-33864804:+	0.14	3.5	0.000515	Height	
PRAD	cis	1	rs62211529	chr20:33959315	UQCC	chr20:33890383-33999833:-	0.37	7.05	6.6E-12	Height	
PRAD	cis	1	rs62212343	chr20:33196937	NECAB3	chr20:32244894-32262264:-	-0.29	-3.91	0.000107	Melanoma	
PRAD	cis	1	rs62229266	chr21:37460271	SETD4	chr21:37406840-37451687:-	-0.29	-8.64	8.9E-17	Mitral valve prolapse	
PRAD	cis	1	rs62232223	chr22:45253764	PRR5-ARHGAP8	chr22:45098083-45258662:+	-0.33	-4.26	2.43E-5	Binge eating behaviour in bipolar disorder	
PRAD	cis	1	rs62236665	chr22:38059847	GALR3	chr22:38219389-38221502:+	0.26	4.58	5.99E-6	Fat distribution (HIV)	
PRAD	cis	1	rs62236665	chr22:38059847	LGALS1	chr22:38071613-38075807:+	-0.09	-4.87	1.55E-6	Fat distribution (HIV)	
PRAD	cis	1	rs62236665	chr22:38059847	LGALS2	chr22:37966254-37976024:-	0.18	4.65	4.4E-6	Fat distribution (HIV)	
PRAD	cis	1	rs62236667	chr22:38061520	GALR3	chr22:38219389-38221502:+	0.26	4.61	5.16E-6	Fat distribution (HIV)	
PRAD	cis	1	rs62236667	chr22:38061520	LGALS1	chr22:38071613-38075807:+	-0.09	-4.91	1.26E-6	Fat distribution (HIV)	
PRAD	cis	1	rs62236667	chr22:38061520	LGALS2	chr22:37966254-37976024:-	0.17	4.53	7.44E-6	Fat distribution (HIV)	
PRAD	cis	1	rs62236668	chr22:38063870	GALR3	chr22:38219389-38221502:+	0.26	4.61	5.16E-6	Fat distribution (HIV)	
PRAD	cis	1	rs62236668	chr22:38063870	LGALS1	chr22:38071613-38075807:+	-0.09	-4.91	1.26E-6	Fat distribution (HIV)	
PRAD	cis	1	rs62236668	chr22:38063870	LGALS2	chr22:37966254-37976024:-	0.17	4.53	7.44E-6	Fat distribution (HIV)	
PRAD	cis	1	rs62243926	chr3:46319920	CCR5	chr3:46411633-46417690:+	-0.1	-4.06	5.64E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs62253764	chr3:32935515	CCR4	chr3:32993066-32996403:+	-0.1	-3.58	0.000376	Pulmonary function	
PRAD	cis	1	rs62253765	chr3:32935819	CCR4	chr3:32993066-32996403:+	-0.1	-3.57	0.000396	Pulmonary function	
PRAD	cis	1	rs62259933	chr3:49469703	AMIGO3	chr3:49754268-49757238:-	0.44	8.99	6.12E-18	Menarche (age at onset)	
PRAD	cis	1	rs62259933	chr3:49469703	CCDC36	chr3:49235861-49295537:+	-0.23	-4.06	5.8E-5	Menarche (age at onset)	
PRAD	cis	1	rs62259933	chr3:49469703	GMPPB	chr3:49758932-49761384:-	0.5	12.08	1.95E-29	Menarche (age at onset)	
PRAD	cis	1	rs62259933	chr3:49469703	NCKIPSD	chr3:48711280-48723334:-	-0.3	-6.02	3.42E-9	Menarche (age at onset)	
PRAD	cis	1	rs62259933	chr3:49469703	WDR6	chr3:49044637-49053386:+	0.21	4.07	5.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs62259944	chr3:49430883	AMIGO3	chr3:49754268-49757238:-	0.48	9.51	1.0E-19	Menarche (age at onset)	
PRAD	cis	1	rs62259944	chr3:49430883	CCDC36	chr3:49235861-49295537:+	-0.24	-4.15	3.98E-5	Menarche (age at onset)	
PRAD	cis	1	rs62259944	chr3:49430883	GMPPB	chr3:49758932-49761384:-	0.52	12.34	1.62E-30	Menarche (age at onset)	
PRAD	cis	1	rs62259944	chr3:49430883	NCKIPSD	chr3:48711280-48723334:-	-0.29	-5.44	8.49E-8	Menarche (age at onset)	
PRAD	cis	1	rs62259944	chr3:49430883	WDR6	chr3:49044637-49053386:+	0.22	4.16	3.78E-5	Menarche (age at onset)	
PRAD	cis	1	rs62259947	chr3:49439924	AMIGO3	chr3:49754268-49757238:-	0.46	9.13	2.04E-18	Menarche (age at onset)	
PRAD	cis	1	rs62259947	chr3:49439924	CCDC36	chr3:49235861-49295537:+	-0.22	-3.86	0.000131	Menarche (age at onset)	
PRAD	cis	1	rs62259947	chr3:49439924	GMPPB	chr3:49758932-49761384:-	0.51	12.15	9.47E-30	Menarche (age at onset)	
PRAD	cis	1	rs62259947	chr3:49439924	NCKIPSD	chr3:48711280-48723334:-	-0.29	-5.6	3.73E-8	Menarche (age at onset)	
PRAD	cis	1	rs62259947	chr3:49439924	WDR6	chr3:49044637-49053386:+	0.2	3.93	9.84E-5	Menarche (age at onset)	
PRAD	cis	1	rs62261249	chr3:49594060	AMIGO3	chr3:49754268-49757238:-	0.48	9.45	1.64E-19	Menarche (age at onset)	
PRAD	cis	1	rs62261249	chr3:49594060	CCDC36	chr3:49235861-49295537:+	-0.23	-4	7.21E-5	Menarche (age at onset)	
PRAD	cis	1	rs62261249	chr3:49594060	GMPPB	chr3:49758932-49761384:-	0.52	12.33	1.91E-30	Menarche (age at onset)	
PRAD	cis	1	rs62261249	chr3:49594060	NCKIPSD	chr3:48711280-48723334:-	-0.29	-5.5	6.32E-8	Menarche (age at onset)	
PRAD	cis	1	rs62261249	chr3:49594060	WDR6	chr3:49044637-49053386:+	0.22	4.12	4.52E-5	Menarche (age at onset)	
PRAD	cis	1	rs62268732	chr3:121370455	IQCB1	chr3:121488610-121553926:-	0.5	9.72	1.73E-20	Cognitive performance	
PRAD	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.54	12.38	1.12E-30	Height	
PRAD	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.44	6.73E-27	Height	
PRAD	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.37	1.26E-26	Height	
PRAD	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.52	11.68	7.66E-28	Height	
PRAD	cis	1	rs62271515	chr3:134300507	CEP63	chr3:134204575-134293852:+	0.2	3.56	0.000415	Height	
PRAD	cis	1	rs62295634	chr4:17685346	MED28	chr4:17616273-17629791:+	0.17	4.31	1.99E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs62308746	chr4:89805969	FAM13A	chr4:89647106-90032549:-	0.18	3.47	0.00057	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs62310332	chr4:39114559	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	cis	1	rs62310476	chr4:89832328	FAM13A	chr4:89647106-90032549:-	0.18	3.57	0.000392	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs62321365	chr4:107013723	TBCK	chr4:106967233-107237861:-	0.19	4.03	6.43E-5	Airflow obstruction	
PRAD	cis	1	rs62322549	chr4:71319058	AMTN	chr4:71384298-71398459:+	0.4	7.66	1.08E-13	Alcoholism (heaviness of drinking)	
PRAD	cis	1	rs62327566	chr4:142150894	ZNF330	chr4:142142049-142155848:+	-0.25	-4.45	1.06E-5	Conduct disorder	
PRAD	cis	1	rs62327586	chr4:142159228	ZNF330	chr4:142142049-142155848:+	-0.26	-4.69	3.65E-6	Conduct disorder	
PRAD	cis	1	rs62331930	chr4:155349319	DCHS2	chr4:155155527-155412930:-	0.15	3.99	7.51E-5	Alzheimer's disease (age of onset)	
PRAD	cis	1	rs623675	chr19:15705115	CYP4F8	chr19:15726029-15740445:+	-0.4	-4.26	2.46E-5	Inflammatory biomarkers	
PRAD	cis	1	rs62381795	chr5:137577870	REEP2	chr5:137774776-137782657:+	-0.1	-4.12	4.39E-5	Resting heart rate	
PRAD	cis	1	rs62384471	chr5:115631273	COMMD10	chr5:115420727-115628978:+	0.25	3.43	0.000654	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs62384678	chr5:115422688	COMMD10	chr5:115420727-115628978:+	0.28	3.57	0.000387	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs62402013	chr6:26915000	BTN2A3	chr6:26422317-26431927:+	0.16	3.75	0.000197	Schizophrenia	
PRAD	cis	1	rs62402013	chr6:26915000	BTN3A2	chr6:26365398-26378546:+	0.24	5.29	1.83E-7	Schizophrenia	
PRAD	cis	1	rs62402013	chr6:26915000	LOC100270746	chr6:26987146-26988085:-	-0.19	-3.83	0.000143	Schizophrenia	
PRAD	cis	1	rs62402365	chr6:46318800	TNFRSF21	chr6:47199269-47277680:-	0.18	3.64	0.0003	Body mass index	
PRAD	cis	1	rs62404566	chr6:35118432	UHRF1BP1	chr6:34759794-34853117:+	-0.12	-4.04	6.27E-5	Airway responsiveness in chronic obstructive pulmonary disease	
PRAD	cis	1	rs624159	chr10:105939451	C10orf79	chr10:105889647-105992120:-	0.26	4.73	2.92E-6	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs62417699	chr6:88301786	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs62417701	chr6:88309327	C6orf165	chr6:88117721-88205858:+	0.37	3.57	0.000397	Obesity-related traits	
PRAD	cis	1	rs62417727	chr6:88364354	C6orf165	chr6:88117721-88205858:+	0.46	4.2	3.15E-5	Obesity-related traits	
PRAD	cis	1	rs62421536	chr6:118727972	C6orf204	chr6:118786239-119031238:-	-0.15	-3.5	0.00051	Renal cell carcinoma	
PRAD	cis	1	rs62421539	chr6:118730559	C6orf204	chr6:118786239-119031238:-	-0.15	-3.55	0.00043	Renal cell carcinoma	
PRAD	cis	1	rs62422228	chr6:118957276	C6orf204	chr6:118786239-119031238:-	-0.14	-3.43	0.000664	Renal cell carcinoma	
PRAD	cis	1	rs62424172	chr6:118777533	C6orf204	chr6:118786239-119031238:-	-0.14	-3.45	0.000621	Renal cell carcinoma	
PRAD	cis	1	rs62428484	chr6:149606568	ULBP2	chr6:150263136-150270366:+	0.2	3.5	0.000505	Breast cancer	
PRAD	cis	1	rs624366	chr11:108154097	ATM	chr11:108093559-108239826:+	0.14	4.18	3.42E-5	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs62442899	chr7:1948454	MAD1L1	chr7:1855428-2272583:-	0.15	3.51	0.000487	Bipolar disorder	
PRAD	cis	1	rs62465144	chr7:72883106	MLXIPL	chr7:73007524-73038870:-	0.25	3.84	0.00014	Triglycerides	
PRAD	cis	1	rs62466793	chr7:66191517	CRCP	chr7:65579805-65619551:+	-0.21	-3.96	8.56E-5	Aortic root size	
PRAD	cis	1	rs62466793	chr7:66191517	LOC493754	chr7:65993446-66057363:-	-0.24	-5.5	6.31E-8	Aortic root size	
PRAD	cis	1	rs62466793	chr7:66191517	TPST1	chr7:65670259-65825437:+	0.15	3.57	0.000394	Aortic root size	
PRAD	cis	1	rs62466794	chr7:66191579	CRCP	chr7:65579805-65619551:+	-0.21	-3.95	9.12E-5	Aortic root size	
PRAD	cis	1	rs62466794	chr7:66191579	LOC493754	chr7:65993446-66057363:-	-0.24	-5.4	1.08E-7	Aortic root size	
PRAD	cis	1	rs62466794	chr7:66191579	TPST1	chr7:65670259-65825437:+	0.15	3.52	0.000472	Aortic root size	
PRAD	cis	1	rs62521129	chr8:65680661	BHLHE22	chr8:65492814-65496185:+	0.3	5.67	2.56E-8	HIV-1 susceptibility	
PRAD	cis	1	rs625658	chr1:155891045	RIT1	chr1:155867601-155881177:-	0.18	4.09	5.03E-5	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs62574275	chr9:100985311	TBC1D2	chr9:100961281-101018003:-	0.25	4.4	1.36E-5	Post-traumatic stress disorder	
PRAD	cis	1	rs62578126	chr9:129375338	LMX1B	chr9:129376748-129463311:+	0.23	3.75	0.000202	Eyebrow thickness	
PRAD	cis	1	rs62578127	chr9:129386860	LMX1B	chr9:129376748-129463311:+	0.23	3.69	0.000255	Eyebrow thickness	
PRAD	cis	1	rs629286	chr17:40679159	EZH1	chr17:40852294-40897071:-	-0.33	-4.14	4.19E-5	Systolic blood pressure change trajectories	
PRAD	cis	1	rs629301	chr1:109818306	PSRC1	chr1:109822179-109825808:-	-0.23	-4.55	6.98E-6	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs630408	chr12:123172822	GPR109B	chr12:123199304-123201439:-	0.36	6.29	7.19E-10	Adiponectin levels	
PRAD	cis	1	rs634552	chr11:75282052	SERPINH1	chr11:75273170-75283844:+	-0.17	-3.53	0.000463	Height	
PRAD	cis	1	rs635400	chr12:123171089	GPR109B	chr12:123199304-123201439:-	0.34	6.11	2.12E-9	Adiponectin levels	
PRAD	cis	1	rs636291	chr1:10556097	APITD1	chr1:10490159-10512208:+	-0.25	-5.21	2.9E-7	Prostate cancer	
PRAD	cis	1	rs637064	chr11:108140909	ATM	chr11:108093559-108239826:+	-0.15	-4.55	6.76E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.83	-26.38	9.14E-95	Crohn's disease	
PRAD	cis	1	rs641018	chr11:65655393	KCNK7	chr11:65360327-65363467:-	-0.16	-3.51	0.000493	Crohn's disease	
PRAD	cis	1	rs641018	chr11:65655393	SNX32	chr11:65601410-65621170:+	0.46	7.03	7.31E-12	Crohn's disease	
PRAD	cis	1	rs6414438	chr3:10073824	C3orf10	chr3:10157333-10168873:+	-0.19	-3.81	0.000159	Alzheimer's disease	
PRAD	cis	1	rs6414438	chr3:10073824	LOC401052	chr3:10048102-10052779:-	-0.28	-5.04	6.51E-7	Alzheimer's disease	
PRAD	cis	1	rs6415085	chr6:161023460	LPA	chr6:160952516-161087407:-	0.17	3.79	0.000173	Lipoprotein (a) levels	
PRAD	cis	1	rs641605	chr11:108101919	ATM	chr11:108093559-108239826:+	-0.17	-5.18	3.38E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs641862	chr13:110790232	ANKRD10	chr13:111530888-111567416:-	0.3	4.74	2.83E-6	Obesity-related traits	
PRAD	cis	1	rs641862	chr13:110790232	ARHGEF7	chr13:111767624-111958080:+	0.34	4.05	6.1E-5	Obesity-related traits	
PRAD	cis	1	rs641862	chr13:110790232	CARKD	chr13:111267881-111292340:+	0.71	6.71	5.52E-11	Obesity-related traits	
PRAD	cis	1	rs641862	chr13:110790232	CARS2	chr13:111293757-111365950:-	0.48	5.41	1.03E-7	Obesity-related traits	
PRAD	cis	1	rs641862	chr13:110790232	ING1	chr13:111365083-111373420:+	0.48	4.16	3.86E-5	Obesity-related traits	
PRAD	cis	1	rs6422512	chr1:93024844	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs6424898	chr1:183596045	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs6425323	chr1:175125036	KIAA0040	chr1:175126123-175162229:-	0.15	3.52	0.000481	Alcohol dependence	
PRAD	cis	1	rs6427950	chr1:202472066	PPP1R12B	chr1:202317836-202557697:+	0.09	3.81	0.000156	Sex ratio	
PRAD	cis	1	rs6427952	chr1:202492418	PPP1R12B	chr1:202317836-202557697:+	0.09	3.79	0.000173	Sex ratio	
PRAD	cis	1	rs6428476	chr1:89126005	CCBL2	chr1:89401456-89458643:-	0.45	8.81	2.34E-17	Height	
PRAD	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.92	-28.5	1.63E-104	Homocysteine levels	
PRAD	cis	1	rs6429567	chr1:45956700	MMACHC	chr1:45965856-45976737:+	-0.24	-5.19	3.12E-7	Homocysteine levels	
PRAD	cis	1	rs6429567	chr1:45956700	MUTYH	chr1:45794915-45806142:-	0.19	5.15	3.92E-7	Homocysteine levels	
PRAD	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.85	-23.54	1.57E-81	Homocysteine levels	
PRAD	cis	1	rs6429569	chr1:46001330	MMACHC	chr1:45965856-45976737:+	-0.18	-3.84	0.00014	Homocysteine levels	
PRAD	cis	1	rs6429569	chr1:46001330	MUTYH	chr1:45794915-45806142:-	0.2	5.34	1.46E-7	Homocysteine levels	
PRAD	cis	1	rs6429582	chr1:46321843	CCDC163P	chr1:45960581-45965646:-	0.5	11.21	5.39E-26	Body mass index	
PRAD	cis	1	rs6429582	chr1:46321843	MUTYH	chr1:45794915-45806142:-	-0.2	-5.82	1.08E-8	Body mass index	
PRAD	cis	1	rs6431191	chr2:127630688	POLR2D	chr2:128603841-128615729:-	-0.24	-3.56	0.000414	Pelvic organ prolapse (moderate/severe)	
PRAD	cis	1	rs6434928	chr2:198304577	PLCL1	chr2:198669426-199014606:+	0.16	4.62	4.87E-6	Schizophrenia	
PRAD	cis	1	rs6434950	chr2:198869979	PLCL1	chr2:198669426-199014606:+	0.15	4.09	5.18E-5	Ulcerative colitis	
PRAD	cis	1	rs6435079	chr2:202200331	ALS2CR12	chr2:202153148-202222101:-	-0.3	-5.08	5.48E-7	Basal cell carcinoma	
PRAD	cis	1	rs6435081	chr2:202220623	ALS2CR12	chr2:202153148-202222101:-	-0.29	-5.04	6.69E-7	Basal cell carcinoma	
PRAD	cis	1	rs6435081	chr2:202220623	ORC2L	chr2:201774895-201828410:-	-0.1	-3.44	0.00063	Basal cell carcinoma	
PRAD	cis	1	rs6435169	chr2:203753016	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs643632	chr9:111839949	C9orf5	chr9:111777416-111882225:-	-0.25	-5.01	7.77E-7	Information processing speed	
PRAD	cis	1	rs6436741	chr2:228714598	CCL20	chr2:228678558-228682280:+	0.28	5	8.19E-7	Blood pressure	
PRAD	cis	1	rs6438552	chr3:119631814	NR1I2	chr3:119499331-119537331:+	-0.22	-4.03	6.59E-5	HDL cholesterol	
PRAD	cis	1	rs6438553	chr3:119640029	NR1I2	chr3:119499331-119537331:+	-0.22	-4	7.4E-5	HDL cholesterol	
PRAD	cis	1	rs6439116	chr3:127849067	RUVBL1	chr3:127783627-127872757:-	0.23	4.15	3.95E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6439124	chr3:128007466	RUVBL1	chr3:127783627-127872757:-	-0.25	-4.72	3.09E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6439135	chr3:128358633	RPN1	chr3:128338813-128399918:-	-0.15	-3.43	0.000646	Monocyte count	
PRAD	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.55	12.6	1.4E-31	Height	
PRAD	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.55	12.6	1.4E-31	Height	
PRAD	cis	1	rs6441104	chr3:156681441	LEKR1	chr3:156544076-156763918:+	-0.47	-6.51	1.98E-10	Bone mineral density	
PRAD	cis	1	rs644148	chr19:44970935	ZNF229	chr19:44930426-44952766:-	-0.18	-3.47	0.000567	Personality dimensions	
PRAD	cis	1	rs6442117	chr3:48419897	ATRIP	chr3:48488141-48507708:+	-0.27	-6.39	4.08E-10	Longevity	
PRAD	cis	1	rs6442117	chr3:48419897	CDC25A	chr3:48198668-48229801:-	-0.22	-4.11	4.61E-5	Longevity	
PRAD	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.18	4.88	1.43E-6	Longevity	
PRAD	cis	1	rs6442118	chr3:48440047	ATRIP	chr3:48488141-48507708:+	0.27	6.31	6.41E-10	Longevity	
PRAD	cis	1	rs6442118	chr3:48440047	CDC25A	chr3:48198668-48229801:-	0.22	4.03	6.42E-5	Longevity	
PRAD	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.18	-5.09	5.26E-7	Longevity	
PRAD	cis	1	rs6442119	chr3:48440178	ATRIP	chr3:48488141-48507708:+	0.24	5.79	1.3E-8	Longevity	
PRAD	cis	1	rs6442119	chr3:48440178	CDC25A	chr3:48198668-48229801:-	0.2	3.67	0.00027	Longevity	
PRAD	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.19	-5.21	2.79E-7	Longevity	
PRAD	cis	1	rs6442120	chr3:48464503	ATRIP	chr3:48488141-48507708:+	0.27	6.48	2.38E-10	Longevity	
PRAD	cis	1	rs6442120	chr3:48464503	CDC25A	chr3:48198668-48229801:-	0.22	4	7.39E-5	Longevity	
PRAD	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.19	-5.12	4.36E-7	Longevity	
PRAD	cis	1	rs6442123	chr3:48500286	ATRIP	chr3:48488141-48507708:+	0.27	6.48	2.32E-10	Longevity	
PRAD	cis	1	rs6442123	chr3:48500286	CDC25A	chr3:48198668-48229801:-	0.21	3.94	9.22E-5	Longevity	
PRAD	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.17	-4.74	2.82E-6	Longevity	
PRAD	cis	1	rs6442146	chr3:10073544	C3orf10	chr3:10157333-10168873:+	-0.2	-3.82	0.000151	Alzheimer's disease	
PRAD	cis	1	rs6442146	chr3:10073544	LOC401052	chr3:10048102-10052779:-	-0.29	-5.22	2.67E-7	Alzheimer's disease	
PRAD	cis	1	rs6442147	chr3:10078247	C3orf10	chr3:10157333-10168873:+	-0.19	-3.81	0.000159	Alzheimer's disease	
PRAD	cis	1	rs6442147	chr3:10078247	LOC401052	chr3:10048102-10052779:-	-0.28	-5.04	6.51E-7	Alzheimer's disease	
PRAD	cis	1	rs6442148	chr3:10078289	C3orf10	chr3:10157333-10168873:+	-0.2	-3.86	0.000128	Alzheimer's disease	
PRAD	cis	1	rs6442148	chr3:10078289	LOC401052	chr3:10048102-10052779:-	-0.29	-5.3	1.8E-7	Alzheimer's disease	
PRAD	cis	1	rs6442150	chr3:10122575	C3orf10	chr3:10157333-10168873:+	-0.22	-4.16	3.82E-5	Alzheimer's disease	
PRAD	cis	1	rs6442150	chr3:10122575	LOC401052	chr3:10048102-10052779:-	-0.29	-5.1	4.96E-7	Alzheimer's disease	
PRAD	cis	1	rs6442522	chr3:15440556	EAF1	chr3:15469064-15484119:+	0.12	3.73	0.000216	Uric acid levels	
PRAD	cis	1	rs6444530	chr3:190982425	UTS2D	chr3:190984945-191048325:-	-0.24	-4.9	1.35E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs6444531	chr3:190988002	UTS2D	chr3:190984945-191048325:-	-0.25	-5.05	6.23E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs644493	chr15:45935816	DUOX1	chr15:45422192-45457774:+	-0.1	-3.44	0.00064	Obesity-related traits	
PRAD	cis	1	rs644493	chr15:45935816	DUOX2	chr15:45384853-45406359:-	-0.15	-3.64	0.000306	Obesity-related traits	
PRAD	cis	1	rs644493	chr15:45935816	SPATA5L1	chr15:45694519-45713614:+	0.23	3.45	0.000602	Obesity-related traits	
PRAD	cis	1	rs6445358	chr3:52308845	GNL3	chr3:52719936-52728508:+	-0.14	-3.7	0.000241	Electroencephalogram traits	
PRAD	cis	1	rs6445358	chr3:52308845	LOC440957	chr3:52570621-52574586:+	-0.15	-4.68	3.7E-6	Electroencephalogram traits	
PRAD	cis	1	rs6445358	chr3:52308845	NEK4	chr3:52744803-52804951:-	-0.19	-5.4	1.08E-7	Electroencephalogram traits	
PRAD	cis	1	rs6445358	chr3:52308845	NT5DC2	chr3:52558386-52569093:-	-0.18	-4.34	1.78E-5	Electroencephalogram traits	
PRAD	cis	1	rs6445557	chr3:53083969	RFT1	chr3:53122503-53164470:-	-0.4	-4.94	1.07E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs6445557	chr3:53083969	TMEM110	chr3:52867139-52931547:-	-0.31	-4.37	1.53E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs6445622	chr3:51356823	HEMK1	chr3:50606583-50622419:+	0.21	3.92	0.000102	Melanoma	
PRAD	cis	1	rs6446262	chr3:49401153	AMIGO3	chr3:49754268-49757238:-	-0.46	-9.13	2.04E-18	Menarche (age at onset)	
PRAD	cis	1	rs6446262	chr3:49401153	CCDC36	chr3:49235861-49295537:+	0.22	3.86	0.000131	Menarche (age at onset)	
PRAD	cis	1	rs6446262	chr3:49401153	GMPPB	chr3:49758932-49761384:-	-0.51	-12.15	9.47E-30	Menarche (age at onset)	
PRAD	cis	1	rs6446262	chr3:49401153	NCKIPSD	chr3:48711280-48723334:-	0.29	5.6	3.73E-8	Menarche (age at onset)	
PRAD	cis	1	rs6446262	chr3:49401153	WDR6	chr3:49044637-49053386:+	-0.2	-3.93	9.84E-5	Menarche (age at onset)	
PRAD	cis	1	rs6446268	chr3:49445695	AMIGO3	chr3:49754268-49757238:-	0.42	8.52	2.17E-16	Menarche (age at onset)	
PRAD	cis	1	rs6446268	chr3:49445695	CCDC36	chr3:49235861-49295537:+	-0.23	-4	7.4E-5	Menarche (age at onset)	
PRAD	cis	1	rs6446268	chr3:49445695	GMPPB	chr3:49758932-49761384:-	0.47	11.29	2.65E-26	Menarche (age at onset)	
PRAD	cis	1	rs6446268	chr3:49445695	NCKIPSD	chr3:48711280-48723334:-	-0.31	-6.06	2.79E-9	Menarche (age at onset)	
PRAD	cis	1	rs6446268	chr3:49445695	P4HTM	chr3:49027341-49044579:+	-0.17	-3.7	0.000241	Menarche (age at onset)	
PRAD	cis	1	rs6446268	chr3:49445695	WDR6	chr3:49044637-49053386:+	0.18	3.58	0.000377	Menarche (age at onset)	
PRAD	cis	1	rs6446275	chr3:49466871	AMIGO3	chr3:49754268-49757238:-	0.44	8.99	6.12E-18	Menarche (age at onset)	
PRAD	cis	1	rs6446275	chr3:49466871	CCDC36	chr3:49235861-49295537:+	-0.23	-4.06	5.8E-5	Menarche (age at onset)	
PRAD	cis	1	rs6446275	chr3:49466871	GMPPB	chr3:49758932-49761384:-	0.5	12.08	1.95E-29	Menarche (age at onset)	
PRAD	cis	1	rs6446275	chr3:49466871	NCKIPSD	chr3:48711280-48723334:-	-0.3	-6.02	3.42E-9	Menarche (age at onset)	
PRAD	cis	1	rs6446275	chr3:49466871	WDR6	chr3:49044637-49053386:+	0.21	4.07	5.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs6447875	chr4:8503206	C4orf23	chr4:8440604-8495258:+	-0.31	-5	7.94E-7	Response to antineoplastic agents	
PRAD	cis	1	rs6449319	chr4:17640283	MED28	chr4:17616273-17629791:+	0.2	5.02	7.35E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs6449323	chr4:17683916	MED28	chr4:17616273-17629791:+	0.15	3.74	0.00021	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.96	16.74	1.1E-49	Type 2 diabetes	
PRAD	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.9	15.8	2.17E-45	Type 2 diabetes	
PRAD	cis	1	rs6453424	chr5:78315367	BHMT2	chr5:78365583-78385273:+	-0.09	-3.69	0.000249	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs6453429	chr5:78371861	BHMT2	chr5:78365583-78385273:+	0.15	4.92	1.18E-6	Urinary metabolites	
PRAD	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.49	11.69	7.09E-28	Response to antipsychotic treatment	
PRAD	cis	1	rs645485	chr11:108168863	ATM	chr11:108093559-108239826:+	-0.14	-4.34	1.73E-5	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs645491	chr12:123181661	GPR109B	chr12:123199304-123201439:-	0.36	6.3	6.69E-10	Adiponectin levels	
PRAD	cis	1	rs6456265	chr6:19786950	ID4	chr6:19837617-19840914:+	0.14	3.55	0.000427	Endometriosis	
PRAD	cis	1	rs6456617	chr6:24480769	GPLD1	chr6:24428405-24489850:-	0.47	9.34	3.95E-19	Hematological and biochemical traits	
PRAD	cis	1	rs6456617	chr6:24480769	MRS2	chr6:24403153-24425809:+	0.28	4.39	1.41E-5	Hematological and biochemical traits	
PRAD	cis	1	rs6456733	chr6:26566804	BTN2A3	chr6:26422317-26431927:+	0.26	6.44	3.0E-10	Educational attainment	
PRAD	cis	1	rs6456733	chr6:26566804	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.44	0.00064	Educational attainment	
PRAD	cis	1	rs6456733	chr6:26566804	ZNF184	chr6:27418522-27440897:-	-0.18	-3.74	0.000206	Educational attainment	
PRAD	cis	1	rs6456734	chr6:26566965	BTN2A3	chr6:26422317-26431927:+	0.26	6.44	3.0E-10	Educational attainment	
PRAD	cis	1	rs6456734	chr6:26566965	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.44	0.00064	Educational attainment	
PRAD	cis	1	rs6456734	chr6:26566965	ZNF184	chr6:27418522-27440897:-	-0.18	-3.74	0.000206	Educational attainment	
PRAD	cis	1	rs6456745	chr6:10894268	ELOVL2	chr6:10980995-11044624:-	-0.37	-6.81	3.07E-11	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs6456745	chr6:10894268	MAK	chr6:10762957-10838760:-	-0.32	-6	3.86E-9	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs6456745	chr6:10894268	SYCP2L	chr6:10747995-10974539:+	-0.24	-3.83	0.000147	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs6457805	chr6:35120443	UHRF1BP1	chr6:34759794-34853117:+	-0.12	-4.1	4.89E-5	Airway responsiveness in chronic obstructive pulmonary disease	
PRAD	cis	1	rs6458228	chr6:41543793	FOXP4	chr6:41514164-41570121:+	-0.21	-4.07	5.56E-5	Prostate cancer	
PRAD	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.43	-9.17	1.53E-18	Homocysteine levels	
PRAD	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.43	-9.11	2.39E-18	Homocysteine levels	
PRAD	cis	1	rs6458690	chr6:49411619	CENPQ	chr6:49431096-49460820:+	-0.4	-8.4	5.49E-16	Folate pathway vitamin levels	
PRAD	cis	1	rs6458690	chr6:49411619	MUT	chr6:49398994-49431031:-	0.18	5.15	3.84E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs6458694	chr6:49445306	CENPQ	chr6:49431096-49460820:+	-0.39	-8.21	2.11E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs6458694	chr6:49445306	MUT	chr6:49398994-49431031:-	0.18	4.99	8.46E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs6459561	chr6:17657651	NUP153	chr6:17615269-17706818:-	0.1	3.67	0.000267	Obesity-related traits	
PRAD	cis	1	rs6459657	chr6:170136454	WDR27	chr6:169857307-170102159:-	-0.13	-3.56	0.000402	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs6460260	chr7:65215455	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.8	1.21E-8	Diabetic kidney disease	
PRAD	cis	1	rs6460260	chr7:65215455	CRCP	chr7:65579805-65619551:+	0.3	3.77	0.00018	Diabetic kidney disease	
PRAD	cis	1	rs6460260	chr7:65215455	ZNF117	chr7:64434830-64467121:-	0.29	3.48	0.000558	Diabetic kidney disease	
PRAD	cis	1	rs6460261	chr7:65215580	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.8	1.21E-8	Diabetic kidney disease	
PRAD	cis	1	rs6460261	chr7:65215580	CRCP	chr7:65579805-65619551:+	0.3	3.77	0.00018	Diabetic kidney disease	
PRAD	cis	1	rs6460261	chr7:65215580	ZNF117	chr7:64434830-64467121:-	0.29	3.48	0.000558	Diabetic kidney disease	
PRAD	cis	1	rs6460274	chr7:65628484	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.85	9.2E-9	Diabetic kidney disease	
PRAD	cis	1	rs6460274	chr7:65628484	CRCP	chr7:65579805-65619551:+	0.32	3.94	9.21E-5	Diabetic kidney disease	
PRAD	cis	1	rs6460292	chr7:65810075	TPST1	chr7:65670259-65825437:+	-0.18	-4.49	8.8E-6	Aortic root size	
PRAD	cis	1	rs6460295	chr7:65882728	TPST1	chr7:65670259-65825437:+	0.18	4.46	1.03E-5	Aortic root size	
PRAD	cis	1	rs6460296	chr7:65895139	TPST1	chr7:65670259-65825437:+	0.18	4.45	1.09E-5	Aortic root size	
PRAD	cis	1	rs6461993	chr7:3356463	CARD11	chr7:2945769-3083579:-	0.07	3.44	0.000635	Motion sickness	
PRAD	cis	1	rs6461994	chr7:3356483	CARD11	chr7:2945769-3083579:-	0.08	3.6	0.000355	Motion sickness	
PRAD	cis	1	rs6464573	chr7:143748098	ARHGEF35	chr7:143883677-143892736:-	0.51	9.56	6.41E-20	Obesity-related traits	
PRAD	cis	1	rs6464573	chr7:143748098	OR2A1	chr7:144015236-144016148:+;chr7	0.25	4.08	5.22E-5	Obesity-related traits	
PRAD	cis	1	rs6464573	chr7:143748098	OR2A9P	chr7:143991573-143997832:+;chr7	0.33	5.6	3.66E-8	Obesity-related traits	
PRAD	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.54	-10.15	5.26E-22	Obesity-related traits	
PRAD	cis	1	rs6464574	chr7:143748257	OR2A1	chr7:144015236-144016148:+;chr7	-0.26	-4.12	4.45E-5	Obesity-related traits	
PRAD	cis	1	rs6464574	chr7:143748257	OR2A9P	chr7:143991573-143997832:+;chr7	-0.33	-5.59	3.81E-8	Obesity-related traits	
PRAD	cis	1	rs6465657	chr7:97816327	BHLHA15	chr7:97840778-97842271:+	-0.14	-3.6	0.000351	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs6465658	chr7:97816638	BHLHA15	chr7:97840778-97842271:+	-0.14	-3.56	0.000402	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs6467244	chr7:129049507	TMEM209	chr7:129804555-129845338:-	0.23	3.92	0.000102	Tuberculosis	
PRAD	cis	1	rs646776	chr1:109818530	PSRC1	chr1:109822179-109825808:-	-0.23	-4.46	1.01E-5	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs646867	chr1:25709258	RHCE	chr1:25688741-25756683:-	0.61	13.78	1.65E-36	Erythrocyte sedimentation rate	
PRAD	cis	1	rs646867	chr1:25709258	RHD	chr1:25598981-25656935:+	-0.57	-11.1	1.38E-25	Erythrocyte sedimentation rate	
PRAD	cis	1	rs6470763	chr8:130720646	GSDMC	chr8:130760443-130799134:-	-0.19	-3.65	0.000293	Infant length;Height	
PRAD	cis	1	rs6470764	chr8:130725665	GSDMC	chr8:130760443-130799134:-	0.21	4.13	4.25E-5	Infant length;Height	
PRAD	cis	1	rs6470765	chr8:130736697	GSDMC	chr8:130760443-130799134:-	0.2	3.9	0.000108	Infant length;Height	
PRAD	cis	1	rs6477692	chr9:111904758	C9orf5	chr9:111777416-111882225:-	0.23	4.53	7.51E-6	Information processing speed	
PRAD	cis	1	rs6477998	chr9:115997249	CDC26	chr9:116029290-116037869:-	0.25	5.9	7.03E-9	Hematology traits	
PRAD	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.39	-7.04	6.91E-12	Rheumatoid arthritis	
PRAD	cis	1	rs6478484	chr9:123652380	TRAF1	chr9:123664672-123691479:-	0.18	4.92	1.17E-6	Rheumatoid arthritis	
PRAD	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.38	-6.9	1.72E-11	Rheumatoid arthritis	
PRAD	cis	1	rs6478486	chr9:123655329	TRAF1	chr9:123664672-123691479:-	0.18	5.12	4.54E-7	Rheumatoid arthritis	
PRAD	cis	1	rs6478867	chr9:131903923	CRAT	chr9:131857075-131873070:-	-0.21	-4.05	6.04E-5	Blood metabolite ratios	
PRAD	cis	1	rs6483501	chr11:96108061	CCDC82	chr11:96085930-96123083:-	-0.23	-3.62	0.000329	Parkinson's disease	
PRAD	cis	1	rs6483880	chr11:22852740	SVIP	chr11:22843600-22851382:-	0.28	6.88	1.97E-11	Dialysis-related mortality	
PRAD	cis	1	rs648541	chr11:114429934	FAM55A	chr11:114392438-114430580:-	-0.21	-4.21	3.02E-5	Ulcerative colitis	
PRAD	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.56	-11.65	1.01E-27	Forced vital capacity	
PRAD	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.58	12.57	2.0E-31	Forced vital capacity	
PRAD	cis	1	rs6485682	chr11:46446264	HARBI1	chr11:46624857-46638777:-	-0.29	-4.1	4.91E-5	Schizophrenia	
PRAD	cis	1	rs6485700	chr11:46875933	ARHGAP1	chr11:46698634-46722120:-	0.26	3.72	0.00022	Schizophrenia	
PRAD	cis	1	rs6485788	chr11:47873883	AGBL2	chr11:47681145-47736302:-	-0.17	-3.51	0.000499	Intraocular pressure	
PRAD	cis	1	rs6485872	chr11:48579710	FOLH1	chr11:49168188-49230222:-	-0.15	-3.46	0.000581	HDL cholesterol	
PRAD	cis	1	rs6485875	chr11:48581034	FOLH1	chr11:49168188-49230222:-	-0.16	-3.68	0.000261	HDL cholesterol	
PRAD	cis	1	rs6485888	chr11:48605339	FOLH1	chr11:49168188-49230222:-	-0.15	-3.48	0.000547	HDL cholesterol	
PRAD	cis	1	rs6485903	chr11:48639004	FOLH1	chr11:49168188-49230222:-	-0.17	-3.84	0.00014	HDL cholesterol	
PRAD	cis	1	rs6485907	chr11:48651695	FOLH1	chr11:49168188-49230222:-	-0.17	-3.94	9.33E-5	HDL cholesterol	
PRAD	cis	1	rs6485911	chr11:48654784	FOLH1	chr11:49168188-49230222:-	-0.17	-4.03	6.56E-5	HDL cholesterol	
PRAD	cis	1	rs6486190	chr11:14401216	COPB1	chr11:14479049-14521441:-	0.12	3.89	0.000116	Mitochondrial DNA levels	
PRAD	cis	1	rs6487679	chr12:9371332	LOC642846	chr12:9436253-9466684:+	0.28	6.11	2.12E-9	Non-alcoholic fatty liver disease histology (AST)	
PRAD	cis	1	rs6489785	chr12:121363724	COQ5	chr12:120941083-120966964:-	-0.2	-4.24	2.65E-5	Longevity	
PRAD	cis	1	rs6489785	chr12:121363724	GATC	chr12:120884284-120897761:+	-0.15	-3.51	0.000488	Longevity	
PRAD	cis	1	rs6489785	chr12:121363724	P2RX4	chr12:121647664-121671907:+	-0.16	-3.5	0.000504	Longevity	
PRAD	cis	1	rs6490604	chr13:21284828	IFT88	chr13:21141208-21265574:+	0.25	4.1	4.81E-5	Dental caries	
PRAD	cis	1	rs6490605	chr13:21285009	IFT88	chr13:21141208-21265574:+	0.25	4.06	5.74E-5	Dental caries	
PRAD	cis	1	rs6490606	chr13:21285096	IFT88	chr13:21141208-21265574:+	-0.25	-4.16	3.73E-5	Dental caries	
PRAD	cis	1	rs6495206	chr15:76870963	SCAPER	chr15:76640529-77197744:-	-0.13	-3.83	0.000148	Blood metabolite levels	
PRAD	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.88	-18.65	1.71E-58	Type 2 diabetes	
PRAD	cis	1	rs6496609	chr15:90379632	C15orf38	chr15:90443832-90456222:-	0.2	3.8	0.000164	Type 2 diabetes	
PRAD	cis	1	rs6496665	chr15:90891615	CRTC3	chr15:91073198-91188576:+	-0.16	-3.66	0.000278	Rheumatoid arthritis	
PRAD	cis	1	rs6496665	chr15:90891615	ZNF774	chr15:90895477-90904714:+	-0.24	-4.87	1.56E-6	Rheumatoid arthritis	
PRAD	cis	1	rs6496666	chr15:90891662	CRTC3	chr15:91073198-91188576:+	-0.16	-3.54	0.000445	Rheumatoid arthritis	
PRAD	cis	1	rs6496666	chr15:90891662	ZNF774	chr15:90895477-90904714:+	-0.23	-4.63	4.7E-6	Rheumatoid arthritis	
PRAD	cis	1	rs6496667	chr15:90893668	CRTC3	chr15:91073198-91188576:+	-0.16	-3.61	0.000334	Rheumatoid arthritis	
PRAD	cis	1	rs6496667	chr15:90893668	ZNF774	chr15:90895477-90904714:+	-0.23	-4.59	5.74E-6	Rheumatoid arthritis	
PRAD	cis	1	rs6496668	chr15:90893704	ZNF774	chr15:90895477-90904714:+	-0.26	-5.05	6.18E-7	Rheumatoid arthritis	
PRAD	cis	1	rs6496669	chr15:90895265	CRTC3	chr15:91073198-91188576:+	0.16	3.57	0.000398	Rheumatoid arthritis	
PRAD	cis	1	rs6496669	chr15:90895265	ZNF774	chr15:90895477-90904714:+	0.22	4.33	1.86E-5	Rheumatoid arthritis	
PRAD	cis	1	rs6499255	chr16:69830328	CLEC18C	chr16:69984626-70220796:+	-0.2	-3.43	0.000649	IgE levels	
PRAD	cis	1	rs6499766	chr16:55604128	CAPNS2	chr16:55600584-55601592:+	-0.18	-5.11	4.72E-7	Thyroid hormone levels	
PRAD	cis	1	rs6499766	chr16:55604128	LPCAT2	chr16:55542913-55620581:+	0.13	4.69	3.59E-6	Thyroid hormone levels	
PRAD	cis	1	rs6499983	chr16:58843909	GOT2	chr16:58741035-58768246:-	-0.22	-4.73	2.92E-6	Blood metabolite ratios	
PRAD	cis	1	rs650128	chr11:108174191	ATM	chr11:108093559-108239826:+	-0.16	-4.98	8.87E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs650173	chr11:108174173	ATM	chr11:108093559-108239826:+	-0.15	-4.63	4.68E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs6502050	chr17:80058236	CCDC57	chr17:80059346-80170689:-	-0.18	-4.78	2.37E-6	Life satisfaction	
PRAD	cis	1	rs6502674	chr17:18776897	FAM18B	chr17:18684582-18710026:+	-0.24	-4.69	3.61E-6	Pancreatic cancer	
PRAD	cis	1	rs6502677	chr17:18803658	FAM18B	chr17:18684582-18710026:+	-0.28	-5.89	7.39E-9	Educational attainment (years of education)	
PRAD	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.33	-5.84	9.56E-9	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs6503703	chr17:40592207	CNTNAP1	chr17:40834632-40852010:+	0.16	4.69	3.55E-6	Crohn's disease	
PRAD	cis	1	rs6503703	chr17:40592207	NAGLU	chr17:40687951-40696464:+	-0.17	-3.97	8.38E-5	Crohn's disease	
PRAD	cis	1	rs6503704	chr17:40592253	CNTNAP1	chr17:40834632-40852010:+	0.16	4.68	3.71E-6	Crohn's disease	
PRAD	cis	1	rs6503704	chr17:40592253	NAGLU	chr17:40687951-40696464:+	-0.18	-4.03	6.52E-5	Crohn's disease	
PRAD	cis	1	rs6503716	chr17:40796211	EZH1	chr17:40852294-40897071:-	-0.31	-4	7.28E-5	Systolic blood pressure change trajectories	
PRAD	cis	1	rs6504167	chr17:61693194	DDX42	chr17:61851567-61896676:+	-0.26	-5.27	2.13E-7	Body mass index	
PRAD	cis	1	rs6504167	chr17:61693194	FTSJ3	chr17:61896795-61905031:-	0.33	6.39	4.05E-10	Body mass index	
PRAD	cis	1	rs6504167	chr17:61693194	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.31	1.99E-5	Body mass index	
PRAD	cis	1	rs6504168	chr17:61697469	DDX42	chr17:61851567-61896676:+	-0.26	-5.11	4.65E-7	Body mass index	
PRAD	cis	1	rs6504168	chr17:61697469	FTSJ3	chr17:61896795-61905031:-	0.34	6.6	1.1E-10	Body mass index	
PRAD	cis	1	rs6504168	chr17:61697469	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.23	2.78E-5	Body mass index	
PRAD	cis	1	rs6504169	chr17:61709145	CD79B	chr17:62006098-62009704:-	0.12	3.45	0.0006	Body mass index	
PRAD	cis	1	rs6504169	chr17:61709145	DDX42	chr17:61851567-61896676:+	-0.23	-4.71	3.25E-6	Body mass index	
PRAD	cis	1	rs6504169	chr17:61709145	FTSJ3	chr17:61896795-61905031:-	0.37	7.4	6.41E-13	Body mass index	
PRAD	cis	1	rs6504169	chr17:61709145	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.48	9.33E-6	Body mass index	
PRAD	cis	1	rs6504170	chr17:61709168	DDX42	chr17:61851567-61896676:+	-0.24	-5.02	7.42E-7	Body mass index	
PRAD	cis	1	rs6504170	chr17:61709168	FTSJ3	chr17:61896795-61905031:-	0.35	6.99	9.47E-12	Body mass index	
PRAD	cis	1	rs6504170	chr17:61709168	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.25	2.62E-5	Body mass index	
PRAD	cis	1	rs6504171	chr17:61710010	DDX42	chr17:61851567-61896676:+	-0.24	-4.89	1.37E-6	Body mass index	
PRAD	cis	1	rs6504171	chr17:61710010	FTSJ3	chr17:61896795-61905031:-	0.35	7.09	4.92E-12	Body mass index	
PRAD	cis	1	rs6504171	chr17:61710010	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.13	4.22E-5	Body mass index	
PRAD	cis	1	rs6504173	chr17:61735056	DDX42	chr17:61851567-61896676:+	-0.24	-4.89	1.41E-6	Body mass index	
PRAD	cis	1	rs6504173	chr17:61735056	FTSJ3	chr17:61896795-61905031:-	0.35	7.1	4.52E-12	Body mass index	
PRAD	cis	1	rs6504173	chr17:61735056	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.14	4.12E-5	Body mass index	
PRAD	cis	1	rs6504182	chr17:61823672	CD79B	chr17:62006098-62009704:-	0.12	3.44	0.000644	Body mass index	
PRAD	cis	1	rs6504182	chr17:61823672	DDX42	chr17:61851567-61896676:+	-0.26	-5.4	1.07E-7	Body mass index	
PRAD	cis	1	rs6504182	chr17:61823672	FTSJ3	chr17:61896795-61905031:-	0.32	6.44	2.98E-10	Body mass index	
PRAD	cis	1	rs6504182	chr17:61823672	TCAM1P	chr17:61934376-61941738:+	-0.22	-3.92	0.000101	Body mass index	
PRAD	cis	1	rs6504542	chr17:65836642	LOC651250	chr17:66097696-66157623:+	-0.24	-4.38	1.47E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs6504543	chr17:65837659	LOC651250	chr17:66097696-66157623:+	-0.25	-4.57	6.19E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs6504548	chr17:65886048	LOC651250	chr17:66097696-66157623:+	-0.25	-4.71	3.34E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs6504549	chr17:65888784	LOC651250	chr17:66097696-66157623:+	-0.25	-4.64	4.52E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs6504555	chr17:65940727	LOC651250	chr17:66097696-66157623:+	0.24	4.39	1.39E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs6504661	chr17:48580126	MYCBPAP	chr17:48585745-48608861:+	0.31	5.28	1.98E-7	Visceral fat	
PRAD	cis	1	rs6504948	chr17:53049987	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs6504949	chr17:53050133	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs6504950	chr17:53056471	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs6504951	chr17:53056975	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs6505152	chr17:28331466	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.11	4.65E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs6505158	chr17:28403348	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.04	6.27E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs6505700	chr18:11987988	IMPA2	chr18:11981057-12030876:+	-0.32	-3.92	0.000103	Stroke	
PRAD	cis	1	rs6508710	chr19:37749886	ZNF607	chr19:38187276-38210691:-	-0.22	-4.09	5.16E-5	Coronary artery calcification	
PRAD	cis	1	rs6508710	chr19:37749886	ZNF781	chr19:38158650-38183216:-	0.23	4	7.41E-5	Coronary artery calcification	
PRAD	cis	1	rs6508977	chr19:41909346	ATP5SL	chr19:41937224-41945810:-	0.16	3.8	0.000165	Height	
PRAD	cis	1	rs6510348	chr19:33601946	GPATCH1	chr19:33571786-33621318:+	0.53	9.61	4.52E-20	Bone properties (heel)	
PRAD	cis	1	rs6511313	chr19:22215905	ZNF257	chr19:22235266-22273901:+	0.36	5.06	5.94E-7	Body mass index (change over time)	
PRAD	cis	1	rs651164	chr6:160581374	SLC22A3	chr6:160769425-160876013:+	0.25	5.22	2.7E-7	Prostate cancer	
PRAD	cis	1	rs6515651	chr20:25414539	ENTPD6	chr20:25176339-25207360:+	0.18	4.68	3.71E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6515651	chr20:25414539	FAM182B	chr20:25744102-25848786:-	-0.36	-6.65	8.08E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6515651	chr20:25414539	PYGB	chr20:25228706-25278647:+	0.34	7.42	5.72E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs6515773	chr20:3174105	ITPA	chr20:3190056-3204504:+	0.17	4.72	3.05E-6	Night sleep phenotypes	
PRAD	cis	1	rs6515773	chr20:3174105	ProSAPiP1	chr20:3143273-3154192:-	0.23	4.18	3.45E-5	Night sleep phenotypes	
PRAD	cis	1	rs6519119	chr22:38989007	CBY1	chr22:39052658-39069853:+	0.17	4.74	2.85E-6	Resting heart rate	
PRAD	cis	1	rs6519119	chr22:38989007	LOC646851	chr22:38974125-39052634:-	0.18	4.2	3.14E-5	Resting heart rate	
PRAD	cis	1	rs6519120	chr22:38991393	CBY1	chr22:39052658-39069853:+	-0.17	-4.89	1.41E-6	Resting heart rate	
PRAD	cis	1	rs6519120	chr22:38991393	LOC646851	chr22:38974125-39052634:-	-0.19	-4.56	6.65E-6	Resting heart rate	
PRAD	cis	1	rs6519124	chr22:39045099	CBY1	chr22:39052658-39069853:+	0.13	3.66	0.000276	Resting heart rate	
PRAD	cis	1	rs6519124	chr22:39045099	LOC646851	chr22:38974125-39052634:-	0.21	5.08	5.49E-7	Resting heart rate	
PRAD	cis	1	rs652311	chr11:108240069	ATM	chr11:108093559-108239826:+	-0.18	-5.74	1.73E-8	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs6531775	chr4:85730914	C4orf12	chr4:85887971-85928168:+	0.16	3.96	8.83E-5	Oropharynx cancer	
PRAD	cis	1	rs6532022	chr4:88773734	SPP1	chr4:88896802-88904562:+	-0.2	-3.65	0.000288	Bone mineral density;Bone mineral density (paediatric, total body less head)	
PRAD	cis	1	rs6532023	chr4:88773849	SPP1	chr4:88896802-88904562:+	-0.2	-3.65	0.000288	Bone mineral density;Bone mineral density (paediatric, total body less head)	
PRAD	cis	1	rs653251	chr13:30894542	KATNAL1	chr13:30776768-30881584:-	0.18	3.77	0.000181	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs6533059	chr4:104133376	BDH2	chr4:103998783-104021024:-	0.26	7.04	6.88E-12	Testicular germ cell tumor	
PRAD	cis	1	rs6533059	chr4:104133376	MANBA	chr4:103552644-103682151:-	0.25	4.61	5.26E-6	Testicular germ cell tumor	
PRAD	cis	1	rs6533060	chr4:104139996	BDH2	chr4:103998783-104021024:-	0.26	6.91	1.55E-11	Testicular germ cell tumor	
PRAD	cis	1	rs6533060	chr4:104139996	MANBA	chr4:103552644-103682151:-	0.22	4.25	2.61E-5	Testicular germ cell tumor	
PRAD	cis	1	rs6536365	chr4:159632293	ETFDH	chr4:159593277-159629839:+	0.24	4.29	2.13E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
PRAD	cis	1	rs6539882	chr12:85530198	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.25	2.63E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs6539882	chr12:85530198	SLC6A15	chr12:85253269-85306606:-	-0.3	-4.65	4.32E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs6539882	chr12:85530198	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.71	1.97E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs654005	chr11:108155397	ATM	chr11:108093559-108239826:+	-0.15	-4.49	8.84E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs6540893	chr1:207435727	CD55	chr1:207494817-207534309:+	0.47	8.8	2.61E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs6540896	chr1:207440851	CD55	chr1:207494817-207534309:+	0.22	4.13	4.37E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs6542334	chr2:111907214	ACOXL	chr2:111490150-111875799:+	0.21	3.71	0.000229	Chronic lymphocytic leukemia	
PRAD	cis	1	rs6542334	chr2:111907214	BCL2L11	chr2:111878491-111926022:+	-0.15	-3.43	0.000647	Chronic lymphocytic leukemia	
PRAD	cis	1	rs6544065	chr2:37497417	CEBPZ	chr2:37428778-37458740:-	-0.2	-4.27	2.37E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs654585	chr1:23514714	C1orf213	chr1:23695464-23698278:+	-0.17	-4.22	2.98E-5	Height	
PRAD	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.23	-9.27	6.84E-19	Tuberculosis	
PRAD	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.52	9.9	4.16E-21	Tuberculosis	
PRAD	cis	1	rs6546535	chr2:69833382	C2orf42	chr2:70377019-70418151:-	0.2	3.44	0.000633	Serum thyroid-stimulating hormone levels	
PRAD	cis	1	rs6546726	chr2:26275116	GPR113	chr2:26531041-26569685:-	-0.23	-3.48	0.000545	Gut microbiome composition (summer)	
PRAD	cis	1	rs6546728	chr2:26276531	GPR113	chr2:26531041-26569685:-	-0.27	-3.73	0.000212	Gut microbiome composition (summer)	
PRAD	cis	1	rs6546736	chr2:26293878	GPR113	chr2:26531041-26569685:-	0.24	3.62	0.000327	Gut microbiome composition (summer)	
PRAD	cis	1	rs6546744	chr2:26302161	GPR113	chr2:26531041-26569685:-	-0.24	-3.5	0.000505	Gut microbiome composition (summer)	
PRAD	cis	1	rs6546766	chr2:26328680	GPR113	chr2:26531041-26569685:-	-0.25	-3.76	0.000189	Gut microbiome composition (summer)	
PRAD	cis	1	rs6546767	chr2:26328746	GPR113	chr2:26531041-26569685:-	-0.25	-3.75	0.000201	Gut microbiome composition (summer)	
PRAD	cis	1	rs6546768	chr2:26328800	GPR113	chr2:26531041-26569685:-	-0.25	-3.75	0.000201	Gut microbiome composition (summer)	
PRAD	cis	1	rs6546835	chr2:73664715	ALMS1P	chr2:73872046-73912692:+	0.48	8.36	7.37E-16	Metabolite levels	
PRAD	cis	1	rs6546835	chr2:73664715	NAT8	chr2:73867850-73869537:-	0.26	4.02	6.81E-5	Metabolite levels	
PRAD	cis	1	rs6546836	chr2:73677833	ALMS1P	chr2:73872046-73912692:+	0.48	8.37	6.64E-16	Metabolite levels	
PRAD	cis	1	rs6546836	chr2:73677833	NAT8	chr2:73867850-73869537:-	0.26	3.96	8.59E-5	Metabolite levels	
PRAD	cis	1	rs6546837	chr2:73677898	ALMS1P	chr2:73872046-73912692:+	0.49	8.47	3.13E-16	Metabolite levels	
PRAD	cis	1	rs6546837	chr2:73677898	NAT8	chr2:73867850-73869537:-	0.26	4.04	6.36E-5	Metabolite levels	
PRAD	cis	1	rs6546838	chr2:73679280	ALMS1P	chr2:73872046-73912692:+	0.49	8.42	4.44E-16	Metabolite levels	
PRAD	cis	1	rs6546838	chr2:73679280	NAT8	chr2:73867850-73869537:-	0.26	4.01	7.11E-5	Metabolite levels	
PRAD	cis	1	rs6546839	chr2:73680508	ALMS1P	chr2:73872046-73912692:+	0.49	8.47	3.13E-16	Metabolite levels	
PRAD	cis	1	rs6546839	chr2:73680508	NAT8	chr2:73867850-73869537:-	0.26	4.04	6.36E-5	Metabolite levels	
PRAD	cis	1	rs6547872	chr2:28978074	PPP1CB	chr2:28974612-29025805:+	0.28	6.15	1.63E-9	Body mass index	
PRAD	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.38	-8.28	1.3E-15	Body mass index	
PRAD	cis	1	rs655015	chr15:48891107	DUT	chr15:48623621-48635568:+	-0.24	-3.88	0.000117	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs6554100	chr4:54240108	FIP1L1	chr4:54243820-54326102:+	-0.18	-3.92	0.000101	DNA methylation (variation)	
PRAD	cis	1	rs6554106	chr4:54292791	FIP1L1	chr4:54243820-54326102:+	-0.18	-3.94	9.38E-5	DNA methylation (variation)	
PRAD	cis	1	rs6557265	chr6:153433402	RGS17	chr6:153332041-153452389:-	-0.56	-13.61	8.88E-36	Prostate cancer	
PRAD	cis	1	rs6557266	chr6:153433534	RGS17	chr6:153332041-153452389:-	-0.56	-13.61	8.88E-36	Prostate cancer	
PRAD	cis	1	rs6560517	chr9:79038170	RFK	chr9:79000433-79009444:-	-0.2	-3.64	0.000306	Dialysis-related mortality	
PRAD	cis	1	rs6563380	chr13:36770422	SOHLH2	chr13:36742347-36871992:-	0.21	3.7	0.000241	Glucose homeostasis traits	
PRAD	cis	1	rs6563389	chr13:36777536	C13orf38	chr13:36801182-36871992:-	0.22	3.72	0.000223	Economic and political preferences	
PRAD	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.83	-26.38	9.14E-95	Crohn's disease	
PRAD	cis	1	rs656980	chr11:65656282	KCNK7	chr11:65360327-65363467:-	-0.16	-3.51	0.000493	Crohn's disease	
PRAD	cis	1	rs656980	chr11:65656282	SNX32	chr11:65601410-65621170:+	0.46	7.03	7.31E-12	Crohn's disease	
PRAD	cis	1	rs6570043	chr6:136134098	C6orf217	chr6:135818939-136037192:+	-0.3	-5.1	4.82E-7	Phosphorus levels	
PRAD	cis	1	rs6572602	chr14:23093540	ABHD4	chr14:23067147-23081257:+	0.18	3.61	0.000337	Microalbuminuria	
PRAD	cis	1	rs6573312	chr14:60952536	C14orf39	chr14:60902675-60952764:-	0.44	5.85	9.4E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs6573313	chr14:60961299	C14orf39	chr14:60902675-60952764:-	0.46	5.82	1.12E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs6573316	chr14:61058029	C14orf39	chr14:60902675-60952764:-	0.56	6.41	3.48E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs6573318	chr14:61087985	C14orf39	chr14:60902675-60952764:-	0.55	6.28	7.68E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs6573320	chr14:61092022	C14orf39	chr14:60902675-60952764:-	0.6	7.01	8.31E-12	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs6573320	chr14:61092022	SIX6	chr14:60975938-60978523:+	0.31	3.6	0.000352	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs6573333	chr14:61308337	MNAT1	chr14:61201470-61435396:+	0.43	4.81	2.07E-6	Immune reponse to smallpox (secreted IFN-alpha)	
PRAD	cis	1	rs6573333	chr14:61308337	SNAPC1	chr14:62229075-62263145:+	0.48	3.86	0.000128	Immune reponse to smallpox (secreted IFN-alpha)	
PRAD	cis	1	rs6574278	chr14:76663838	C14orf118	chr14:76618259-76669133:+	0.14	3.56	0.000408	Blood pressure	
PRAD	cis	1	rs6574278	chr14:76663838	ESRRB	chr14:76837690-76968178:+	0.26	3.66	0.000279	Blood pressure	
PRAD	cis	1	rs6575793	chr14:101032217	BEGAIN	chr14:101003486-101036131:-	-0.17	-4.56	6.42E-6	Menarche (age at onset)	
PRAD	cis	1	rs6579208	chr20:33598612	MMP24	chr20:33814539-33864804:+	-0.23	-3.76	0.000194	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs6579210	chr20:33605802	MMP24	chr20:33814539-33864804:+	-0.23	-3.77	0.000182	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs6579211	chr20:33605857	MMP24	chr20:33814539-33864804:+	-0.31	-4.75	2.69E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs6579234	chr20:33983485	CEP250	chr20:34042996-34099802:+	-0.24	-5.37	1.25E-7	Height	
PRAD	cis	1	rs6579234	chr20:33983485	CPNE1	chr20:34213968-34262539:-	0.2	3.95	9.1E-5	Height	
PRAD	cis	1	rs6579234	chr20:33983485	FAM83C	chr20:33873287-33880225:-	0.16	3.67	0.000271	Height	
PRAD	cis	1	rs6579234	chr20:33983485	GDF5	chr20:33897002-34042568:-	-0.21	-5.02	7.29E-7	Height	
PRAD	cis	1	rs6579234	chr20:33983485	MMP24	chr20:33814539-33864804:+	0.14	3.63	0.00032	Height	
PRAD	cis	1	rs6579234	chr20:33983485	UQCC	chr20:33890383-33999833:-	0.39	7.43	5.31E-13	Height	
PRAD	cis	1	rs6579245	chr20:34125271	CEP250	chr20:34042996-34099802:+	0.33	5.44	8.69E-8	Cholesterol, total	
PRAD	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.73	-12.4	9.17E-31	Cholesterol, total	
PRAD	cis	1	rs6579803	chr5:150255559	LOC134466	chr5:150310000-150326146:-	0.58	9.01	5.3E-18	Crohn's disease	
PRAD	cis	1	rs6579804	chr5:150255931	LOC134466	chr5:150310000-150326146:-	0.58	9.01	5.3E-18	Crohn's disease	
PRAD	cis	1	rs6579806	chr5:150271084	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs6580200	chr5:139059562	SLC23A1	chr5:138702891-138719039:-	0.2	3.56	0.000402	Schizophrenia	
PRAD	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.37	7.96	1.33E-14	Multiple sclerosis	
PRAD	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.53	-13.04	2.08E-33	Multiple sclerosis	
PRAD	cis	1	rs6581155	chr12:58178162	XRCC6BP1	chr12:58335445-58351051:+	-0.24	-4.81	2.04E-6	Multiple sclerosis	
PRAD	cis	1	rs6584347	chr10:101906963	CWF19L1	chr10:101992055-102027437:-	-0.3	-3.9	0.000109	Schizophrenia	
PRAD	cis	1	rs6584349	chr10:101942556	CWF19L1	chr10:101992055-102027437:-	-0.38	-4.71	3.26E-6	Schizophrenia	
PRAD	cis	1	rs6584379	chr10:102224490	SEC31B	chr10:102246403-102289636:-	-0.32	-9.62	3.98E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs6584383	chr10:102303065	SEC31B	chr10:102246403-102289636:-	-0.28	-8.46	3.31E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs6587375	chr1:247861480	OR2W3	chr1:248031265-248060142:+	-0.32	-4.65	4.4E-6	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs6587375	chr1:247861480	TRIM58	chr1:248020501-248043436:+	-0.28	-4.12	4.43E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs6589575	chr11:116733310	PCSK7	chr11:117075789-117102811:-	-0.27	-3.53	0.000453	Protein quantitative trait loci	
PRAD	cis	1	rs6589576	chr11:116735788	PCSK7	chr11:117075789-117102811:-	0.27	3.61	0.00034	Protein quantitative trait loci	
PRAD	cis	1	rs6589589	chr11:116932428	PCSK7	chr11:117075789-117102811:-	-0.25	-3.5	0.000502	Protein quantitative trait loci	
PRAD	cis	1	rs6592284	chr11:86055901	C11orf73	chr11:86013253-86056984:+	0.21	4.32	1.87E-5	Cognitive performance	
PRAD	cis	1	rs6592772	chr11:78015563	GAB2	chr11:77926343-78128766:-	-0.21	-6.57	1.31E-10	Testicular germ cell tumor	
PRAD	cis	1	rs6592772	chr11:78015563	NARS2	chr11:78147017-78285909:-	-0.2	-3.83	0.000147	Testicular germ cell tumor	
PRAD	cis	1	rs6593585	chr1:76140273	ACADM	chr1:76190043-76229353:+	0.19	4.18	3.43E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs6593	chr14:104163282	BAG5	chr14:104022889-104029151:-	0.17	3.52	0.000471	Body mass index	
PRAD	cis	1	rs6593	chr14:104163282	C14orf153	chr14:104029299-104057227:+	0.14	4.02	6.69E-5	Body mass index	
PRAD	cis	1	rs6593	chr14:104163282	CKB	chr14:103985996-103989170:-	0.21	4.83	1.84E-6	Body mass index	
PRAD	cis	1	rs6593	chr14:104163282	KLC1	chr14:104029299-104167887:+	-0.18	-3.61	0.000333	Body mass index	
PRAD	cis	1	rs6593	chr14:104163282	MARK3	chr14:103851701-103970164:+	0.24	4.87	1.49E-6	Body mass index	
PRAD	cis	1	rs6594480	chr5:110173859	TMEM232	chr5:109624934-110062381:-	0.27	4.33	1.81E-5	Asthma and hay fever	
PRAD	cis	1	rs6594906	chr5:115171435	ATG12	chr5:115165818-115177520:-	0.29	4.82	1.97E-6	IgG glycosylation	
PRAD	cis	1	rs6594906	chr5:115171435	CDO1	chr5:115140432-115152405:-	0.24	3.84	0.000141	IgG glycosylation	
PRAD	cis	1	rs6598955	chr1:26619649	CCDC21	chr1:26560693-26605299:+	0.19	4.92	1.21E-6	Obesity-related traits	
PRAD	cis	1	rs6599069	chr3:40009196	MYRIP	chr3:39851303-40301804:+	0.25	3.6	0.000358	Information processing speed	
PRAD	cis	1	rs6599170	chr3:41772718	ULK4	chr3:41288091-42003660:-	0.82	13.11	1.13E-33	Diastolic blood pressure	
PRAD	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-0.8	-13.01	2.87E-33	Diastolic blood pressure	
PRAD	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-0.81	-13.24	3.28E-34	Diastolic blood pressure	
PRAD	cis	1	rs6599178	chr3:41842129	ULK4	chr3:41288091-42003660:-	0.84	13.74	2.46E-36	Diastolic blood pressure	
PRAD	cis	1	rs6599179	chr3:41855284	ULK4	chr3:41288091-42003660:-	0.87	14.13	4.98E-38	Diastolic blood pressure	
PRAD	cis	1	rs6599318	chr4:243968	ZNF718	chr4:53272-156488:+	0.32	5.24	2.38E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs659969	chr11:118549803	TREH	chr11:118528942-118550381:-	0.21	4.34	1.72E-5	Serum metabolite levels	
PRAD	cis	1	rs6600365	chr1:41556253	RLF	chr1:40627041-40706592:+	0.12	3.45	0.000613	Height	
PRAD	cis	1	rs6601327	chr8:9395532	TNKS	chr8:9413445-9639855:+	-0.16	-3.63	0.000312	Multiple myeloma (hyperdiploidy)	
PRAD	cis	1	rs6603003	chr15:84565602	FAM103A1	chr15:83654995-83659423:+	-0.18	-3.71	0.000235	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs6603003	chr15:84565602	NMB	chr15:85198362-85201802:-	-0.16	-3.89	0.000114	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs6603004	chr15:84568504	NMB	chr15:85198362-85201802:-	0.16	3.8	0.000164	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs6603033	chr15:83335875	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.11	3.5	0.000513	Schizophrenia	
PRAD	cis	1	rs6603033	chr15:83335875	LOC80154	chr15:82944795-82975797:+;chr15	-0.2	-4.11	4.7E-5	Schizophrenia	
PRAD	cis	1	rs6603975	chr1:92951239	EVI5	chr1:92974255-93257961:-	-0.3	-5.97	4.74E-9	Cholesterol, total	
PRAD	cis	1	rs6603979	chr1:92979354	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs6603981	chr1:92993807	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs6603982	chr1:92994033	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs6603984	chr1:93011572	EVI5	chr1:92974255-93257961:-	-0.31	-6.2	1.23E-9	Cholesterol, total	
PRAD	cis	1	rs6603985	chr1:93017159	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs6603987	chr1:93019313	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs6603990	chr1:93030735	EVI5	chr1:92974255-93257961:-	-0.31	-6.37	4.39E-10	Cholesterol, total	
PRAD	cis	1	rs660429	chr11:108181511	ATM	chr11:108093559-108239826:+	-0.17	-5.15	3.75E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs661054	chr11:114430410	FAM55A	chr11:114392438-114430580:-	-0.21	-4.26	2.47E-5	Ulcerative colitis	
PRAD	cis	1	rs6650153	chr10:5019320	AKR1C2	chr10:4964715-5060207:-	0.77	10.17	4.23E-22	Height	
PRAD	cis	1	rs6651255	chr8:130723792	GSDMC	chr8:130760443-130799134:-	-0.18	-3.86	0.000131	Infant length;Height	
PRAD	cis	1	rs6651271	chr8:96047621	C8orf38	chr8:95908040-96088396:+	-0.39	-6.57	1.37E-10	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs6651271	chr8:96047621	TP53INP1	chr8:95938201-95961615:-	0.26	3.85	0.000135	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs6651272	chr8:96047933	C8orf38	chr8:95908040-96088396:+	0.37	6.26	8.57E-10	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs6651272	chr8:96047933	TP53INP1	chr8:95938201-95961615:-	-0.25	-3.89	0.000116	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs66518563	chr12:51358252	TFCP2	chr12:51488608-51566917:-	-0.23	-3.63	0.000315	Type 2 diabetes	
PRAD	cis	1	rs66530629	chr1:25032168	CLIC4	chr1:25071760-25170815:+	-0.09	-3.53	0.000455	Height	
PRAD	cis	1	rs66534347	chr2:240899346	NDUFA10	chr2:240900158-240964798:-	0.25	5.76	1.5E-8	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs6656432	chr1:93029453	EVI5	chr1:92974255-93257961:-	-0.31	-6.37	4.39E-10	Cholesterol, total	
PRAD	cis	1	rs6656815	chr1:27292462	PIGV	chr1:27114455-27124886:+	-0.32	-3.88	0.000119	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs6656992	chr1:46333068	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	9.04E-30	Body mass index	
PRAD	cis	1	rs6656992	chr1:46333068	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000145	Body mass index	
PRAD	cis	1	rs6656992	chr1:46333068	MUTYH	chr1:45794915-45806142:-	0.21	5.97	4.63E-9	Body mass index	
PRAD	cis	1	rs6658064	chr1:183621175	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs6658393	chr1:183621477	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs6658718	chr1:207458906	CD55	chr1:207494817-207534309:+	0.42	8	9.91E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs6659176	chr1:27239920	PIGV	chr1:27114455-27124886:+	-0.37	-4.11	4.66E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs66598018	chr2:61878318	AHSA2	chr2:61404553-61414058:+	-0.11	-3.85	0.000134	Homeostasis model assessment of beta-cell function (interaction)	
PRAD	cis	1	rs66598018	chr2:61878318	C2orf74	chr2:61372243-61391964:+	0.32	5.48	6.98E-8	Homeostasis model assessment of beta-cell function (interaction)	
PRAD	cis	1	rs6659824	chr1:175125378	KIAA0040	chr1:175126123-175162229:-	0.15	3.52	0.000481	Alcohol dependence	
PRAD	cis	1	rs6660254	chr1:207446091	CD55	chr1:207494817-207534309:+	0.5	9.31	4.83E-19	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs6660557	chr1:207454596	CD55	chr1:207494817-207534309:+	0.43	8.24	1.79E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs6660565	chr1:171261193	FMO4	chr1:171283486-171311222:+	-0.23	-4.58	5.91E-6	Sudden cardiac arrest	
PRAD	cis	1	rs6661134	chr1:93010908	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs6661167	chr1:152312870	FLG	chr1:152274651-152297679:-	0.35	4.95	1.03E-6	Atopic dermatitis	
PRAD	cis	1	rs6661715	chr1:183622314	NCF2	chr1:183524698-183560046:-	0.26	4.15	3.89E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs66617212	chr12:85452631	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs66617212	chr12:85452631	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs66617212	chr12:85452631	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs6661910	chr1:46290632	CCDC163P	chr1:45960581-45965646:-	-0.53	-11.96	5.63E-29	Body mass index	
PRAD	cis	1	rs6661910	chr1:46290632	MMACHC	chr1:45965856-45976737:+	-0.17	-3.8	0.000165	Body mass index	
PRAD	cis	1	rs6661910	chr1:46290632	MUTYH	chr1:45794915-45806142:-	0.2	5.67	2.56E-8	Body mass index	
PRAD	cis	1	rs6661970	chr1:202520925	PPP1R12B	chr1:202317836-202557697:+	0.09	3.83	0.000145	Sex ratio	
PRAD	cis	1	rs6662070	chr1:207505709	CD55	chr1:207494817-207534309:+	0.25	4.45	1.06E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs66624122	chr10:4981039	AKR1C2	chr10:4964715-5060207:-	0.69	9.52	8.89E-20	Height	
PRAD	cis	1	rs6662641	chr1:46571509	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.9	1.02E-28	Body mass index	
PRAD	cis	1	rs6662641	chr1:46571509	MMACHC	chr1:45965856-45976737:+	-0.16	-3.7	0.000243	Body mass index	
PRAD	cis	1	rs6662641	chr1:46571509	MUTYH	chr1:45794915-45806142:-	0.2	5.91	6.68E-9	Body mass index	
PRAD	cis	1	rs6663499	chr1:183640764	NCF2	chr1:183524698-183560046:-	0.23	3.51	0.000498	Systemic lupus erythematosus	
PRAD	cis	1	rs6663565	chr1:41563688	RLF	chr1:40627041-40706592:+	0.12	3.5	0.000514	Height	
PRAD	cis	1	rs6664815	chr1:207415563	CD55	chr1:207494817-207534309:+	0.22	3.93	9.95E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs66651343	chr15:43558004	STRC	chr15:43891762-43924561:-	0.25	4.99	8.58E-7	Lung cancer	
PRAD	cis	1	rs66651343	chr15:43558004	TGM7	chr15:43568479-43594453:-	0.24	3.87	0.000124	Lung cancer	
PRAD	cis	1	rs66668401	chr3:46894675	PRSS45	chr3:46783582-46790130:-	0.26	3.53	0.000452	Microalbuminuria	
PRAD	cis	1	rs66670017	chr6:33763563	IP6K3	chr6:33689443-33714762:-	0.19	3.7	0.000244	Obesity (extreme)	
PRAD	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.93	-28.93	1.96E-106	Homocysteine levels	
PRAD	cis	1	rs6667191	chr1:45982844	MMACHC	chr1:45965856-45976737:+	-0.24	-5.15	3.76E-7	Homocysteine levels	
PRAD	cis	1	rs6667191	chr1:45982844	MUTYH	chr1:45794915-45806142:-	0.19	5.22	2.75E-7	Homocysteine levels	
PRAD	cis	1	rs6668284	chr1:46354510	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.1	1.61E-29	Body mass index	
PRAD	cis	1	rs6668284	chr1:46354510	MMACHC	chr1:45965856-45976737:+	-0.17	-3.88	0.000119	Body mass index	
PRAD	cis	1	rs6668284	chr1:46354510	MUTYH	chr1:45794915-45806142:-	0.2	5.79	1.31E-8	Body mass index	
PRAD	cis	1	rs6668683	chr1:207459191	CD55	chr1:207494817-207534309:+	0.43	8.24	1.79E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs6668853	chr1:183608040	NCF2	chr1:183524698-183560046:-	0.27	3.78	0.00018	Systemic lupus erythematosus	
PRAD	cis	1	rs6669008	chr1:114166561	PHTF1	chr1:114239824-114302098:-	0.25	4.55	6.72E-6	Bacteremia	
PRAD	cis	1	rs6669119	chr1:19108549	CAPZB	chr1:19665274-19811992:-	0.23	3.72	0.000227	Percentage gas trapping	
PRAD	cis	1	rs6669371	chr1:11882142	CLCN6	chr1:11866207-11907674:+	0.25	4.65	4.41E-6	QRS complex (12-leadsum)	
PRAD	cis	1	rs6669371	chr1:11882142	TARDBP	chr1:11072679-11085548:+	0.2	3.52	0.000481	QRS complex (12-leadsum)	
PRAD	cis	1	rs6669522	chr1:46397941	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.17	8.32E-30	Body mass index	
PRAD	cis	1	rs6669522	chr1:46397941	MMACHC	chr1:45965856-45976737:+	-0.17	-3.77	0.000181	Body mass index	
PRAD	cis	1	rs6669522	chr1:46397941	MUTYH	chr1:45794915-45806142:-	0.21	5.94	5.4E-9	Body mass index	
PRAD	cis	1	rs6669544	chr1:19109036	CAPZB	chr1:19665274-19811992:-	-0.23	-3.73	0.000215	Percentage gas trapping	
PRAD	cis	1	rs6671085	chr1:183602532	NCF2	chr1:183524698-183560046:-	0.25	3.73	0.000217	Systemic lupus erythematosus	
PRAD	cis	1	rs6672180	chr1:76123973	ACADM	chr1:76190043-76229353:+	0.18	4.03	6.39E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs6672180	chr1:76123973	RABGGTB	chr1:76251886-76260764:+	0.17	3.46	0.000599	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs6672898	chr1:46290588	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	8.94E-30	Body mass index	
PRAD	cis	1	rs6672898	chr1:46290588	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000146	Body mass index	
PRAD	cis	1	rs6672898	chr1:46290588	MUTYH	chr1:45794915-45806142:-	0.21	5.96	4.88E-9	Body mass index	
PRAD	cis	1	rs6673333	chr1:207459147	CD55	chr1:207494817-207534309:+	0.52	9.62	4.05E-20	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs6673809	chr1:183603060	NCF2	chr1:183524698-183560046:-	-0.27	-3.95	8.85E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs6674310	chr1:183603471	NCF2	chr1:183524698-183560046:-	0.24	3.7	0.000245	Systemic lupus erythematosus	
PRAD	cis	1	rs6674368	chr1:183603375	NCF2	chr1:183524698-183560046:-	0.24	3.69	0.000251	Systemic lupus erythematosus	
PRAD	cis	1	rs66753001	chr19:17394839	ANKLE1	chr19:17392454-17398454:+	0.33	6.2	1.25E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs66753001	chr19:17394839	MRPL34	chr19:17416477-17417652:+	-0.23	-4.43	1.17E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs66753001	chr19:17394839	OCEL1	chr19:17337055-17340027:+	0.22	5.17	3.46E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs66754062	chr20:23839051	CST5	chr20:23856572-23860380:-	0.25	3.68	0.000258	Response to TNF antagonist treatment	
PRAD	cis	1	rs6675726	chr1:46560643	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.25	3.85E-30	Body mass index	
PRAD	cis	1	rs6675726	chr1:46560643	MMACHC	chr1:45965856-45976737:+	-0.17	-3.9	0.000112	Body mass index	
PRAD	cis	1	rs6675726	chr1:46560643	MUTYH	chr1:45794915-45806142:-	0.2	5.78	1.39E-8	Body mass index	
PRAD	cis	1	rs6675828	chr1:147086967	ACP6	chr1:147119168-147142634:-	0.28	4.23	2.76E-5	Warfarin maintenance dose	
PRAD	cis	1	rs6675946	chr1:46371774	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.13	1.15E-29	Body mass index	
PRAD	cis	1	rs6675946	chr1:46371774	MMACHC	chr1:45965856-45976737:+	-0.17	-3.82	0.000153	Body mass index	
PRAD	cis	1	rs6675946	chr1:46371774	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.23E-9	Body mass index	
PRAD	cis	1	rs6676158	chr1:28257209	RPA2	chr1:28218049-28241236:-	-0.27	-5.07	5.6E-7	Corneal astigmatism	
PRAD	cis	1	rs6676348	chr1:183640787	NCF2	chr1:183524698-183560046:-	0.23	3.51	0.000498	Systemic lupus erythematosus	
PRAD	cis	1	rs6677007	chr1:46400590	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.13	1.15E-29	Body mass index	
PRAD	cis	1	rs6677007	chr1:46400590	MMACHC	chr1:45965856-45976737:+	-0.17	-3.82	0.000153	Body mass index	
PRAD	cis	1	rs6677007	chr1:46400590	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.23E-9	Body mass index	
PRAD	cis	1	rs6677194	chr1:183635587	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs6678622	chr1:78092479	USP33	chr1:78161676-78225537:-	-0.18	-3.96	8.71E-5	Obesity	
PRAD	cis	1	rs6679002	chr1:63199936	DOCK7	chr1:62920398-63153969:-	-0.14	-3.77	0.000182	Blood metabolite levels	
PRAD	cis	1	rs6679073	chr1:205756484	PM20D1	chr1:205797154-205819245:-	-0.33	-5.67	2.46E-8	Prostate-specific antigen levels	
PRAD	cis	1	rs6679145	chr1:156256000	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs6679145	chr1:156256000	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs6679552	chr1:202449586	PPP1R12B	chr1:202317836-202557697:+	0.09	3.72	0.000222	Sex ratio	
PRAD	cis	1	rs66797209	chr3:10078526	C3orf10	chr3:10157333-10168873:+	-0.22	-4.17	3.66E-5	Alzheimer's disease	
PRAD	cis	1	rs66797209	chr3:10078526	LOC401052	chr3:10048102-10052779:-	-0.3	-5.26	2.22E-7	Alzheimer's disease	
PRAD	cis	1	rs66797613	chr10:1090469	IDI2	chr10:1064847-1071799:-	-0.27	-5.14	3.97E-7	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs66797613	chr10:1090469	WDR37	chr10:1102344-1178237:+	0.33	5.53	5.46E-8	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.65	9.87	5.44E-21	Diastolic blood pressure;Blood pressure	
PRAD	cis	1	rs6680380	chr1:46300189	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	8.94E-30	Body mass index	
PRAD	cis	1	rs6680380	chr1:46300189	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000146	Body mass index	
PRAD	cis	1	rs6680380	chr1:46300189	MUTYH	chr1:45794915-45806142:-	0.21	5.96	4.88E-9	Body mass index	
PRAD	cis	1	rs668092	chr1:35687203	C1orf216	chr1:36179477-36184790:-	-0.25	-3.47	0.000563	Endometrial cancer	
PRAD	cis	1	rs6681020	chr1:175125264	KIAA0040	chr1:175126123-175162229:-	0.15	3.52	0.000481	Alcohol dependence	
PRAD	cis	1	rs6681661	chr1:183605801	NCF2	chr1:183524698-183560046:-	0.27	3.78	0.00018	Systemic lupus erythematosus	
PRAD	cis	1	rs6682784	chr1:202313978	PPP1R12B	chr1:202317836-202557697:+	0.09	3.53	0.000453	Sex ratio	
PRAD	cis	1	rs6683533	chr1:175125440	KIAA0040	chr1:175126123-175162229:-	0.15	3.52	0.000481	Alcohol dependence	
PRAD	cis	1	rs66838678	chr3:10150350	C3orf10	chr3:10157333-10168873:+	-0.23	-4.47	1.0E-5	Alzheimer's disease	
PRAD	cis	1	rs66838678	chr3:10150350	LOC401052	chr3:10048102-10052779:-	-0.31	-5.51	5.85E-8	Alzheimer's disease	
PRAD	cis	1	rs6684514	chr1:156255456	BGLAP	chr1:156182784-156213112:+	0.21	5.51	6.04E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs6684514	chr1:156255456	CCT3	chr1:156278752-156308195:-	-0.15	-3.52	0.000479	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs6684804	chr1:207439015	CD55	chr1:207494817-207534309:+	0.47	8.8	2.61E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs6685373	chr1:202314199	PPP1R12B	chr1:202317836-202557697:+	0.08	3.44	0.000625	Sex ratio	
PRAD	cis	1	rs6686494	chr1:183622598	NCF2	chr1:183524698-183560046:-	0.28	3.99	7.69E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs6686643	chr1:165616588	MGST3	chr1:165600450-165624853:+	0.29	6.33	5.78E-10	Total ventricular volume	
PRAD	cis	1	rs6686842	chr1:41530871	RLF	chr1:40627041-40706592:+	-0.13	-3.56	0.000413	Height	
PRAD	cis	1	rs6686912	chr1:183603126	NCF2	chr1:183524698-183560046:-	0.24	3.7	0.000245	Systemic lupus erythematosus	
PRAD	cis	1	rs6687454	chr1:149999764	PRPF3	chr1:150293928-150325703:+	-0.14	-3.47	0.000565	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs66885174	chr10:4975650	AKR1C2	chr10:4964715-5060207:-	0.77	10.36	8.52E-23	Height	
PRAD	cis	1	rs6688641	chr1:183635678	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs6690464	chr1:85466369	MCOLN2	chr1:85391267-85462796:-	0.31	5.57	4.34E-8	Serum sulfate level	
PRAD	cis	1	rs6690583	chr1:85466337	MCOLN2	chr1:85391267-85462796:-	0.29	5.14	3.94E-7	Serum sulfate level	
PRAD	cis	1	rs6690764	chr1:92976590	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs6692187	chr1:93035020	EVI5	chr1:92974255-93257961:-	-0.3	-6.21	1.16E-9	Cholesterol, total	
PRAD	cis	1	rs6692924	chr1:183624098	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs6693049	chr1:183624260	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs6693388	chr1:151930645	S100A10	chr1:151955387-151966714:-	-0.23	-4.22	2.88E-5	Blood metabolite ratios	
PRAD	cis	1	rs6695144	chr1:202489218	PPP1R12B	chr1:202317836-202557697:+	0.09	3.81	0.000159	Sex ratio	
PRAD	cis	1	rs6695809	chr1:46285461	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.19	7.12E-30	Body mass index	
PRAD	cis	1	rs6695809	chr1:46285461	MMACHC	chr1:45965856-45976737:+	-0.17	-3.76	0.000188	Body mass index	
PRAD	cis	1	rs6695809	chr1:46285461	MUTYH	chr1:45794915-45806142:-	0.21	5.97	4.73E-9	Body mass index	
PRAD	cis	1	rs66965793	chr1:156285814	BGLAP	chr1:156182784-156213112:+	0.22	5.54	5.01E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs6696611	chr1:202493689	PPP1R12B	chr1:202317836-202557697:+	0.09	3.65	0.000296	Sex ratio	
PRAD	cis	1	rs66968227	chr11:64070930	C11orf20	chr11:64067863-64072238:+	-0.43	-5.84	9.95E-9	Mean platelet volume	
PRAD	cis	1	rs6698036	chr1:183603017	NCF2	chr1:183524698-183560046:-	0.24	3.7	0.000245	Systemic lupus erythematosus	
PRAD	cis	1	rs66987356	chr3:127841098	RUVBL1	chr3:127783627-127872757:-	0.23	4.21	3.03E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6699011	chr1:183622379	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs6699033	chr1:183622450	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.01E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs66990486	chr9:100680919	C9orf156	chr9:100666772-100684852:-	-0.19	-3.75	0.000202	Quantitative traits	
PRAD	cis	1	rs6699417	chr1:89123443	CCBL2	chr1:89401456-89458643:-	-0.45	-9.04	4.2E-18	Height	
PRAD	cis	1	rs6700079	chr1:207501872	CD55	chr1:207494817-207534309:+	0.25	4.45	1.08E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs6700168	chr1:207502534	CD55	chr1:207494817-207534309:+	-0.25	-4.45	1.07E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs6700597	chr1:46284246	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.26	3.52E-30	Body mass index	
PRAD	cis	1	rs6700597	chr1:46284246	MMACHC	chr1:45965856-45976737:+	-0.17	-3.81	0.00016	Body mass index	
PRAD	cis	1	rs6700597	chr1:46284246	MUTYH	chr1:45794915-45806142:-	0.21	5.99	4.24E-9	Body mass index	
PRAD	cis	1	rs67006488	chr3:10152993	C3orf10	chr3:10157333-10168873:+	-0.23	-4.53	7.35E-6	Alzheimer's disease	
PRAD	cis	1	rs67006488	chr3:10152993	LOC401052	chr3:10048102-10052779:-	-0.31	-5.55	4.88E-8	Alzheimer's disease	
PRAD	cis	1	rs6701614	chr1:46309420	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.19	6.79E-30	Body mass index	
PRAD	cis	1	rs6701614	chr1:46309420	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000145	Body mass index	
PRAD	cis	1	rs6701614	chr1:46309420	MUTYH	chr1:45794915-45806142:-	0.21	5.96	4.95E-9	Body mass index	
PRAD	cis	1	rs6701713	chr1:207786289	CD55	chr1:207494817-207534309:+	-0.2	-3.45	0.000605	Alzheimer's disease (late onset)	
PRAD	cis	1	rs6702010	chr1:175123858	KIAA0040	chr1:175126123-175162229:-	0.15	3.46	0.000598	Alcohol dependence	
PRAD	cis	1	rs6702997	chr1:207502347	CD55	chr1:207494817-207534309:+	0.25	4.45	1.08E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs6703002	chr1:207502372	CD55	chr1:207494817-207534309:+	0.25	4.45	1.08E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs67034206	chr1:156270260	BGLAP	chr1:156182784-156213112:+	0.22	5.59	3.8E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs67034206	chr1:156270260	CCT3	chr1:156278752-156308195:-	-0.15	-3.45	0.000616	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs6703857	chr1:207443553	CD55	chr1:207494817-207534309:+	0.22	3.98	8.06E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs6704770	chr2:232109816	ARMC9	chr2:232063342-232238606:+	0.23	4.35	1.65E-5	Food antigen IgG levels	
PRAD	cis	1	rs6704784	chr2:192109558	STAT4	chr2:191894306-192038902:-	0.12	3.96	8.51E-5	Obesity-related traits	
PRAD	cis	1	rs6704930	chr2:26325705	GPR113	chr2:26531041-26569685:-	-0.25	-3.75	0.000201	Gut microbiome composition (summer)	
PRAD	cis	1	rs6705122	chr2:86176258	LOC90784	chr2:86247339-86250991:-	-0.44	-5.1	4.82E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs6705489	chr2:73648811	ALMS1P	chr2:73872046-73912692:+	0.5	8.59	1.3E-16	Metabolite levels	
PRAD	cis	1	rs6705489	chr2:73648811	NAT8	chr2:73867850-73869537:-	0.24	3.69	0.000247	Metabolite levels	
PRAD	cis	1	rs67073037	chr2:29119585	PPP1CB	chr2:28974612-29025805:+	-0.28	-5.55	4.83E-8	Breast cancer (estrogen-receptor negative);Breast cancer	
PRAD	cis	1	rs67073037	chr2:29119585	TRMT61B	chr2:29072690-29093175:-	0.32	6.17	1.48E-9	Breast cancer (estrogen-receptor negative);Breast cancer	
PRAD	cis	1	rs6707458	chr2:160914540	LY75	chr2:160625141-160761262:-	0.12	4.15	3.88E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs6707458	chr2:160914540	PLA2R1	chr2:160798012-160919121:-	0.25	5.65	2.78E-8	Idiopathic membranous nephropathy	
PRAD	cis	1	rs6707722	chr2:73654363	ALMS1P	chr2:73872046-73912692:+	0.48	8.26	1.53E-15	Metabolite levels	
PRAD	cis	1	rs6707722	chr2:73654363	NAT8	chr2:73867850-73869537:-	0.26	4	7.22E-5	Metabolite levels	
PRAD	cis	1	rs6707848	chr2:28988083	PPP1CB	chr2:28974612-29025805:+	0.28	6.33	5.87E-10	Body mass index	
PRAD	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.38	-8.26	1.48E-15	Body mass index	
PRAD	cis	1	rs6708328	chr2:24412413	C2orf84	chr2:24397531-24414566:+	0.4	6.94	1.27E-11	Venous thromboembolism (SNP x SNP interaction)	
PRAD	cis	1	rs6708328	chr2:24412413	LOC375190	chr2:24299728-24397519:+	-0.28	-7.16	3.05E-12	Venous thromboembolism (SNP x SNP interaction)	
PRAD	cis	1	rs6709534	chr2:217334	SH3YL1	chr2:218138-264810:-	-0.79	-18.76	5.18E-59	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs6710438	chr2:73820108	ALMS1P	chr2:73872046-73912692:+	-0.49	-8.69	6.29E-17	Metabolite levels	
PRAD	cis	1	rs6710438	chr2:73820108	NAT8	chr2:73867850-73869537:-	-0.26	-4.12	4.41E-5	Metabolite levels	
PRAD	cis	1	rs6710959	chr2:28958603	PPP1CB	chr2:28974612-29025805:+	0.28	5.94	5.46E-9	Body mass index	
PRAD	cis	1	rs6710959	chr2:28958603	TRMT61B	chr2:29072690-29093175:-	-0.4	-8.34	8.37E-16	Body mass index	
PRAD	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.48	8.32	9.59E-16	Metabolite levels	
PRAD	cis	1	rs6711033	chr2:73746643	NAT8	chr2:73867850-73869537:-	0.25	3.82	0.000152	Metabolite levels	
PRAD	cis	1	rs6711127	chr2:202213515	CFLAR	chr2:201980816-202029001:+	-0.2	-4.17	3.7E-5	Rheumatoid arthritis	
PRAD	cis	1	rs6711127	chr2:202213515	NIF3L1	chr2:201754050-201768655:+	-0.34	-4.59	5.58E-6	Rheumatoid arthritis	
PRAD	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.75	-9.36	3.26E-19	Rheumatoid arthritis	
PRAD	cis	1	rs6711312	chr2:232122348	ARMC9	chr2:232063342-232238606:+	0.21	4.04	6.31E-5	Food antigen IgG levels	
PRAD	cis	1	rs6711368	chr2:161574919	RBMS1	chr2:161128663-161350318:-	0.11	3.69	0.000249	Educational attainment	
PRAD	cis	1	rs6711941	chr2:202178130	CFLAR	chr2:201980816-202029001:+	-0.19	-4.42	1.24E-5	Rheumatoid arthritis	
PRAD	cis	1	rs6711941	chr2:202178130	NIF3L1	chr2:201754050-201768655:+	-0.35	-5.3	1.75E-7	Rheumatoid arthritis	
PRAD	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.76	-10.75	3.09E-24	Rheumatoid arthritis	
PRAD	cis	1	rs67134728	chr3:10151431	C3orf10	chr3:10157333-10168873:+	-0.23	-4.41	1.27E-5	Alzheimer's disease	
PRAD	cis	1	rs67134728	chr3:10151431	LOC401052	chr3:10048102-10052779:-	-0.31	-5.55	4.85E-8	Alzheimer's disease	
PRAD	cis	1	rs6714736	chr2:202214148	ALS2CR12	chr2:202153148-202222101:-	0.3	5.19	3.11E-7	Basal cell carcinoma	
PRAD	cis	1	rs6715284	chr2:202154397	CFLAR	chr2:201980816-202029001:+	-0.17	-4	7.42E-5	Rheumatoid arthritis	
PRAD	cis	1	rs6715284	chr2:202154397	NIF3L1	chr2:201754050-201768655:+	-0.3	-4.76	2.53E-6	Rheumatoid arthritis	
PRAD	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.71	-10.63	8.65E-24	Rheumatoid arthritis	
PRAD	cis	1	rs6715380	chr2:202214505	CFLAR	chr2:201980816-202029001:+	-0.21	-4.4	1.32E-5	Rheumatoid arthritis	
PRAD	cis	1	rs6715380	chr2:202214505	NIF3L1	chr2:201754050-201768655:+	-0.32	-4.38	1.49E-5	Rheumatoid arthritis	
PRAD	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.75	-9.61	4.33E-20	Rheumatoid arthritis	
PRAD	cis	1	rs6715819	chr2:73772309	ALMS1P	chr2:73872046-73912692:+	0.48	8.11	4.53E-15	Metabolite levels	
PRAD	cis	1	rs6715819	chr2:73772309	NAT8	chr2:73867850-73869537:-	0.24	3.67	0.00027	Metabolite levels	
PRAD	cis	1	rs6717980	chr2:27452784	C2orf28	chr2:27434899-27440044:+	0.26	7.2	2.39E-12	Blood metabolite levels	
PRAD	cis	1	rs6717980	chr2:27452784	KHK	chr2:27309611-27323619:+	0.21	4.59	5.79E-6	Blood metabolite levels	
PRAD	cis	1	rs6718083	chr2:25362194	POMC	chr2:25383722-25391559:-	0.22	4.44	1.1E-5	Body mass index	
PRAD	cis	1	rs67180937	chr1:222823743	AIDA	chr1:222841357-222886526:-	0.18	3.44	0.00063	Coronary artery disease	
PRAD	cis	1	rs6718632	chr2:86176084	LOC90784	chr2:86247339-86250991:-	-0.39	-4.21	3.13E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs6719686	chr2:160908292	LY75	chr2:160625141-160761262:-	0.12	4.04	6.22E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs6719686	chr2:160908292	PLA2R1	chr2:160798012-160919121:-	0.24	5.51	6.05E-8	Idiopathic membranous nephropathy	
PRAD	cis	1	rs6720314	chr2:26334852	GPR113	chr2:26531041-26569685:-	-0.27	-3.76	0.000188	Gut microbiome composition (summer)	
PRAD	cis	1	rs67205460	chr10:1090366	IDI2	chr10:1064847-1071799:-	-0.28	-5.16	3.57E-7	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs67205460	chr10:1090366	WDR37	chr10:1102344-1178237:+	0.33	5.49	6.45E-8	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs67205746	chr12:85487996	LRRIQ1	chr12:85430099-85638880:+	-0.24	-3.97	8.18E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs67205746	chr12:85487996	SLC6A15	chr12:85253269-85306606:-	-0.33	-4.99	8.55E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs67205746	chr12:85487996	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.5	6.15E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.71	-8.21	2.18E-15	Plasma clusterin levels	
PRAD	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.68	-7.9	1.96E-14	Plasma clusterin levels	
PRAD	cis	1	rs6722332	chr2:203745327	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs672233	chr13:30899601	KATNAL1	chr13:30776768-30881584:-	0.2	4.24	2.66E-5	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs6723704	chr2:203738664	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs67239267	chr7:143745116	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.3	5.52E-19	Obesity-related traits	
PRAD	cis	1	rs67239267	chr7:143745116	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.59	0.000359	Obesity-related traits	
PRAD	cis	1	rs67239267	chr7:143745116	OR2A9P	chr7:143991573-143997832:+;chr7	-0.32	-5.44	8.53E-8	Obesity-related traits	
PRAD	cis	1	rs6724025	chr2:86200835	LOC90784	chr2:86247339-86250991:-	-0.56	-5.21	2.86E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs6724253	chr2:232121998	ARMC9	chr2:232063342-232238606:+	0.21	4.19	3.39E-5	Food antigen IgG levels	
PRAD	cis	1	rs6724662	chr2:241831560	C2orf54	chr2:241825466-241835573:-	0.57	10	1.75E-21	Urinary metabolites	
PRAD	cis	1	rs6724782	chr2:73679990	ALMS1P	chr2:73872046-73912692:+	0.49	8.47	3.13E-16	Metabolite levels	
PRAD	cis	1	rs6724782	chr2:73679990	NAT8	chr2:73867850-73869537:-	0.26	4.04	6.36E-5	Metabolite levels	
PRAD	cis	1	rs67257959	chr19:17158145	HAUS8	chr19:17160573-17186343:-	-0.18	-5.12	4.38E-7	Selective IgA deficiency	
PRAD	cis	1	rs67261873	chr11:4619666	OR52I1	chr11:4615269-4616242:+	0.49	4.52	7.98E-6	Response to serotonin reuptake inhibitors in major depressive disorder	
PRAD	cis	1	rs672655	chr11:108129657	ATM	chr11:108093559-108239826:+	-0.16	-4.83	1.81E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs6729037	chr2:112656777	MERTK	chr2:112656191-112786945:+	-0.23	-3.91	0.000105	Multiple sclerosis	
PRAD	cis	1	rs6729080	chr2:26301282	GPR113	chr2:26531041-26569685:-	-0.24	-3.52	0.000476	Gut microbiome composition (summer)	
PRAD	cis	1	rs6729757	chr2:26285102	GPR113	chr2:26531041-26569685:-	-0.24	-3.51	0.000492	Gut microbiome composition (summer)	
PRAD	cis	1	rs6730503	chr2:37528478	CEBPZ	chr2:37428778-37458740:-	0.2	4.46	1.02E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs6731027	chr2:203202166	NOP58	chr2:203130515-203168382:+	0.28	4.41	1.26E-5	Urate levels	
PRAD	cis	1	rs6732189	chr2:161572781	RBMS1	chr2:161128663-161350318:-	-0.11	-3.69	0.000255	Educational attainment	
PRAD	cis	1	rs6732236	chr2:136501509	DARS	chr2:136664254-136743222:-	0.21	3.46	0.000598	Corneal structure	
PRAD	cis	1	rs67325097	chr2:69725982	LOC100133985	chr2:70351169-70352448:-	-0.28	-3.86	0.000129	Parkinson's disease (age of onset)	
PRAD	cis	1	rs6732666	chr2:242055918	PASK	chr2:242045515-242088878:-	0.34	4.22	2.94E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs673281	chr11:108182069	ATM	chr11:108093559-108239826:+	-0.16	-4.93	1.12E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs6736866	chr2:73661986	ALMS1P	chr2:73872046-73912692:+	0.51	8.51	2.39E-16	Metabolite levels	
PRAD	cis	1	rs6736866	chr2:73661986	NAT8	chr2:73867850-73869537:-	0.26	3.91	0.000106	Metabolite levels	
PRAD	cis	1	rs6737085	chr2:202221441	ALS2CR12	chr2:202153148-202222101:-	-0.29	-5.04	6.69E-7	Basal cell carcinoma	
PRAD	cis	1	rs6737085	chr2:202221441	ORC2L	chr2:201774895-201828410:-	-0.1	-3.44	0.00063	Basal cell carcinoma	
PRAD	cis	1	rs6738618	chr2:203749439	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs6738964	chr2:228739135	CCL20	chr2:228678558-228682280:+	0.27	4.85	1.71E-6	Blood pressure	
PRAD	cis	1	rs6739198	chr2:203356996	NOP58	chr2:203130515-203168382:+	0.24	4.15	4.0E-5	Urate levels	
PRAD	cis	1	rs6739772	chr2:241840711	C2orf54	chr2:241825466-241835573:-	0.57	10.09	8.38E-22	Urinary metabolites	
PRAD	cis	1	rs67401267	chr22:30750209	GATSL3	chr22:30681108-30695540:-	-0.27	-4.17	3.66E-5	Coronary artery calcification	
PRAD	cis	1	rs67401267	chr22:30750209	SEC14L2	chr22:30792933-30824976:+	-0.37	-4.42	1.21E-5	Coronary artery calcification	
PRAD	cis	1	rs6740223	chr2:73653332	ALMS1P	chr2:73872046-73912692:+	0.48	8.26	1.53E-15	Metabolite levels	
PRAD	cis	1	rs6740223	chr2:73653332	NAT8	chr2:73867850-73869537:-	0.26	4	7.22E-5	Metabolite levels	
PRAD	cis	1	rs6740641	chr2:54482989	C2orf73	chr2:54558071-54588714:+	0.27	3.68	0.000258	Telomere length	
PRAD	cis	1	rs67411574	chr17:18797337	FAM18B	chr17:18684582-18710026:+	-0.28	-5.96	4.95E-9	Educational attainment (years of education)	
PRAD	cis	1	rs67412075	chr19:17385502	ANKLE1	chr19:17392454-17398454:+	0.34	6.61	1.07E-10	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs67412075	chr19:17385502	MRPL34	chr19:17416477-17417652:+	-0.19	-3.84	0.000141	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs67412075	chr19:17385502	OCEL1	chr19:17337055-17340027:+	0.21	4.99	8.37E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs6741380	chr2:198165121	PLCL1	chr2:198669426-199014606:+	0.11	3.43	0.00066	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs6741892	chr2:38916970	GALM	chr2:38893052-38961908:+	0.45	5.43	8.96E-8	5-HTT brain serotonin transporter levels	
PRAD	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.24	-9.84	6.6E-21	Tuberculosis	
PRAD	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.53	10.47	3.29E-23	Tuberculosis	
PRAD	cis	1	rs6742276	chr2:61768745	PUS10	chr2:61167550-61245365:-	-0.18	-3.68	0.000258	Tuberculosis	
PRAD	cis	1	rs6744308	chr2:228711816	CCL20	chr2:228678558-228682280:+	0.28	5	8.19E-7	Blood pressure	
PRAD	cis	1	rs6745368	chr2:73809974	ALMS1P	chr2:73872046-73912692:+	0.49	8.45	3.61E-16	Metabolite levels	
PRAD	cis	1	rs6745368	chr2:73809974	NAT8	chr2:73867850-73869537:-	0.25	3.81	0.000155	Metabolite levels	
PRAD	cis	1	rs6745511	chr2:102704915	MFSD9	chr2:103333666-103353337:-	0.17	4.1	4.78E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs674568	chr15:45936587	DUOX2	chr15:45384853-45406359:-	-0.15	-3.5	0.000502	Obesity-related traits	
PRAD	cis	1	rs674568	chr15:45936587	SPATA5L1	chr15:45694519-45713614:+	0.23	3.45	0.000608	Obesity-related traits	
PRAD	cis	1	rs6746608	chr2:111892984	ACOXL	chr2:111490150-111875799:+	-0.21	-3.67	0.000267	Chronic lymphocytic leukemia	
PRAD	cis	1	rs6746608	chr2:111892984	BCL2L11	chr2:111878491-111926022:+	0.16	3.84	0.000141	Chronic lymphocytic leukemia	
PRAD	cis	1	rs67466576	chr10:4977394	AKR1C2	chr10:4964715-5060207:-	0.67	9.18	1.38E-18	Height	
PRAD	cis	1	rs67477288	chr10:103587858	KCNIP2	chr10:103585732-103603677:-	0.33	4.39	1.41E-5	Coronary artery calcification	
PRAD	cis	1	rs6748296	chr2:197925677	ANKRD44	chr2:197831743-198175495:-	-0.15	-4.21	3.07E-5	Interferon alpha levels in systemic lupus erythematosus	
PRAD	cis	1	rs6748734	chr2:241837452	C2orf54	chr2:241825466-241835573:-	0.57	10.3	1.47E-22	Urinary metabolites	
PRAD	cis	1	rs6749232	chr2:192115052	GLS	chr2:191745547-191829776:+	-0.13	-3.5	0.000511	Obesity-related traits	
PRAD	cis	1	rs6749232	chr2:192115052	STAT4	chr2:191894306-192038902:-	0.12	3.94	9.44E-5	Obesity-related traits	
PRAD	cis	1	rs6749509	chr2:69739714	LOC100133985	chr2:70351169-70352448:-	-0.28	-3.86	0.000131	Parkinson's disease (age of onset)	
PRAD	cis	1	rs6749855	chr2:26255263	GPR113	chr2:26531041-26569685:-	-0.28	-4.05	5.91E-5	Gut microbiome composition (summer)	
PRAD	cis	1	rs67505314	chr10:17240134	TRDMT1	chr10:17184983-17243681:-	-0.24	-4.81	2.05E-6	Homocysteine levels	
PRAD	cis	1	rs6750599	chr2:111893869	BCL2L11	chr2:111878491-111926022:+	0.18	4.24	2.71E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs6750681	chr2:26329677	GPR113	chr2:26531041-26569685:-	-0.23	-3.48	0.00055	Gut microbiome composition (summer)	
PRAD	cis	1	rs6751693	chr2:241837332	C2orf54	chr2:241825466-241835573:-	0.56	9.85	6.31E-21	Urinary metabolites	
PRAD	cis	1	rs6753304	chr2:160040094	WDSUB1	chr2:160092305-160143236:-	-0.31	-5.28	1.97E-7	Resting heart rate	
PRAD	cis	1	rs6753344	chr2:73653138	ALMS1P	chr2:73872046-73912692:+	-0.48	-8.38	6.05E-16	Metabolite levels	
PRAD	cis	1	rs6753344	chr2:73653138	NAT8	chr2:73867850-73869537:-	-0.25	-3.84	0.000138	Metabolite levels	
PRAD	cis	1	rs67536397	chr7:65947917	CCT6P1	chr7:65216092-65228661:+	0.31	5.19	3.2E-7	Diabetic kidney disease	
PRAD	cis	1	rs67536397	chr7:65947917	CRCP	chr7:65579805-65619551:+	-0.34	-4.18	3.5E-5	Diabetic kidney disease	
PRAD	cis	1	rs675413	chr15:45936745	DUOX2	chr15:45384853-45406359:-	-0.15	-3.52	0.000471	Obesity-related traits	
PRAD	cis	1	rs675413	chr15:45936745	SPATA5L1	chr15:45694519-45713614:+	0.23	3.58	0.000375	Obesity-related traits	
PRAD	cis	1	rs67544533	chr15:75361539	PPCDC	chr15:75315927-75343066:+	0.14	3.57	0.000396	Blood trace element (Zn levels)	
PRAD	cis	1	rs67544533	chr15:75361539	SCAMP5	chr15:75287901-75313836:+	0.41	7.25	1.76E-12	Blood trace element (Zn levels)	
PRAD	cis	1	rs6755217	chr2:73641285	ALMS1P	chr2:73872046-73912692:+	0.52	8.71	5.14E-17	Metabolite levels	
PRAD	cis	1	rs6755217	chr2:73641285	NAT8	chr2:73867850-73869537:-	0.25	3.76	0.000194	Metabolite levels	
PRAD	cis	1	rs6755241	chr2:73641364	ALMS1P	chr2:73872046-73912692:+	0.5	8.52	2.16E-16	Metabolite levels	
PRAD	cis	1	rs6755241	chr2:73641364	NAT8	chr2:73867850-73869537:-	0.24	3.59	0.000361	Metabolite levels	
PRAD	cis	1	rs6755622	chr2:197923801	ANKRD44	chr2:197831743-198175495:-	-0.14	-4.03	6.61E-5	Interferon alpha levels in systemic lupus erythematosus	
PRAD	cis	1	rs67569278	chr3:10149893	C3orf10	chr3:10157333-10168873:+	-0.22	-4.27	2.35E-5	Alzheimer's disease	
PRAD	cis	1	rs67569278	chr3:10149893	LOC401052	chr3:10048102-10052779:-	-0.26	-4.64	4.58E-6	Alzheimer's disease	
PRAD	cis	1	rs6756987	chr2:73687077	ALMS1P	chr2:73872046-73912692:+	0.49	8.47	3.13E-16	Metabolite levels	
PRAD	cis	1	rs6756987	chr2:73687077	NAT8	chr2:73867850-73869537:-	0.26	4.04	6.36E-5	Metabolite levels	
PRAD	cis	1	rs67575175	chr3:127880226	RUVBL1	chr3:127783627-127872757:-	0.22	4.11	4.72E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6757825	chr2:69741801	LOC100133985	chr2:70351169-70352448:-	-0.29	-3.96	8.65E-5	Parkinson's disease (age of onset)	
PRAD	cis	1	rs675876	chr15:45936856	DUOX2	chr15:45384853-45406359:-	-0.15	-3.52	0.00048	Obesity-related traits	
PRAD	cis	1	rs6759004	chr2:202004676	CFLAR	chr2:201980816-202029001:+	-0.25	-6.39	4.03E-10	Triptolide cytotoxicity	
PRAD	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.94	-15.94	4.6E-46	Triptolide cytotoxicity	
PRAD	cis	1	rs6759489	chr2:86176032	LOC90784	chr2:86247339-86250991:-	-0.39	-4.21	3.13E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs6759836	chr2:160912802	LY75	chr2:160625141-160761262:-	0.12	4.22	2.97E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs6759836	chr2:160912802	PLA2R1	chr2:160798012-160919121:-	0.23	5.24	2.4E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs6759924	chr2:160912747	LY75	chr2:160625141-160761262:-	0.12	4.06	5.79E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs6759924	chr2:160912747	PLA2R1	chr2:160798012-160919121:-	0.23	5.28	1.95E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs6761514	chr2:202227549	ALS2CR12	chr2:202153148-202222101:-	-0.28	-4.87	1.52E-6	Basal cell carcinoma	
PRAD	cis	1	rs6761514	chr2:202227549	ORC2L	chr2:201774895-201828410:-	-0.11	-3.79	0.000172	Basal cell carcinoma	
PRAD	cis	1	rs67617961	chr20:52618367	BCAS1	chr20:52560079-52687304:-	-0.19	-3.54	0.000442	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs6761919	chr2:198163328	PLCL1	chr2:198669426-199014606:+	-0.11	-3.43	0.00066	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs6762167	chr3:15445037	EAF1	chr3:15469064-15484119:+	-0.13	-3.91	0.000108	Uric acid levels	
PRAD	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.69	6.89E-28	Height	
PRAD	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.56	2.28E-27	Height	
PRAD	cis	1	rs6763829	chr3:41897046	ULK4	chr3:41288091-42003660:-	0.88	14.28	1.11E-38	Diastolic blood pressure	
PRAD	cis	1	rs6764068	chr3:10153842	C3orf10	chr3:10157333-10168873:+	-0.23	-4.48	9.35E-6	Alzheimer's disease	
PRAD	cis	1	rs6764068	chr3:10153842	LOC401052	chr3:10048102-10052779:-	-0.3	-5.46	7.81E-8	Alzheimer's disease	
PRAD	cis	1	rs6764168	chr3:10123805	C3orf10	chr3:10157333-10168873:+	-0.22	-4.12	4.47E-5	Alzheimer's disease	
PRAD	cis	1	rs6764168	chr3:10123805	LOC401052	chr3:10048102-10052779:-	-0.29	-5.12	4.56E-7	Alzheimer's disease	
PRAD	cis	1	rs6765233	chr3:128002850	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.14	4.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs67654320	chr12:51356459	TFCP2	chr12:51488608-51566917:-	-0.21	-3.5	0.000515	Type 2 diabetes	
PRAD	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.54	12.38	1.12E-30	Height	
PRAD	cis	1	rs6765904	chr3:46195881	CCR9	chr3:45928019-45944667:+	0.32	3.69	0.000253	Celiac disease	
PRAD	cis	1	rs6766510	chr3:12551807	TSEN2	chr3:12525931-12581122:+	0.4	4.56	6.64E-6	Prostate cancer (gene x gene interaction)	
PRAD	cis	1	rs6766554	chr3:184728846	VPS8	chr3:184529931-184770402:+	-0.33	-4.26	2.44E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.54	12.17	8.4E-30	Height	
PRAD	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.5	11.42	7.9E-27	Height	
PRAD	cis	1	rs676729	chr11:108184841	ATM	chr11:108093559-108239826:+	-0.17	-5.39	1.11E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs6767366	chr3:184753814	VPS8	chr3:184529931-184770402:+	-0.33	-4.15	4.0E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs67674204	chr3:127824778	RUVBL1	chr3:127783627-127872757:-	0.25	4.6	5.48E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6768014	chr3:128592457	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.000438	Dental caries	
PRAD	cis	1	rs6768102	chr3:10149380	C3orf10	chr3:10157333-10168873:+	-0.22	-4.25	2.6E-5	Alzheimer's disease	
PRAD	cis	1	rs6768102	chr3:10149380	LOC401052	chr3:10048102-10052779:-	-0.3	-5.4	1.06E-7	Alzheimer's disease	
PRAD	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.83	13.07	1.56E-33	Diastolic blood pressure	
PRAD	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.83	13.07	1.56E-33	Diastolic blood pressure	
PRAD	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.83	13.04	2.21E-33	Diastolic blood pressure	
PRAD	cis	1	rs67696450	chr10:1090684	IDI2	chr10:1064847-1071799:-	-0.27	-5.14	3.97E-7	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs67696450	chr10:1090684	WDR37	chr10:1102344-1178237:+	0.33	5.53	5.46E-8	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.54	12.44	6.31E-31	Height	
PRAD	cis	1	rs6770470	chr3:48435123	ATRIP	chr3:48488141-48507708:+	0.27	6.47	2.44E-10	Longevity	
PRAD	cis	1	rs6770470	chr3:48435123	CDC25A	chr3:48198668-48229801:-	0.21	4.05	6.1E-5	Longevity	
PRAD	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.16	-4.64	4.58E-6	Longevity	
PRAD	cis	1	rs6770670	chr3:49686682	GMPPB	chr3:49758932-49761384:-	-0.21	-4.6	5.51E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs6770670	chr3:49686682	UBA7	chr3:49842639-49851391:-	0.14	3.46	0.000584	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs6772046	chr3:38479660	XYLB	chr3:38388251-38456467:+	0.22	4.99	8.61E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs6772315	chr3:10113644	C3orf10	chr3:10157333-10168873:+	-0.22	-4.15	4.02E-5	Alzheimer's disease	
PRAD	cis	1	rs6772315	chr3:10113644	LOC401052	chr3:10048102-10052779:-	-0.29	-5.18	3.38E-7	Alzheimer's disease	
PRAD	cis	1	rs6772407	chr3:128044372	RUVBL1	chr3:127783627-127872757:-	0.23	4.2	3.19E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs67728539	chr7:65378124	CCT6P1	chr7:65216092-65228661:+	0.28	5.03	7.0E-7	Diabetic kidney disease	
PRAD	cis	1	rs67728756	chr8:27078358	CHRNA2	chr8:27317279-27336813:-	0.17	3.77	0.000183	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs67728756	chr8:27078358	ESCO2	chr8:27632058-27670141:+	0.19	3.83	0.000146	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.51	11.48	4.72E-27	Height	
PRAD	cis	1	rs6773375	chr3:190980432	UTS2D	chr3:190984945-191048325:-	-0.21	-4.31	2.03E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs6773528	chr3:190980379	UTS2D	chr3:190984945-191048325:-	0.21	4.4	1.32E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs6774724	chr3:49381911	AMIGO3	chr3:49754268-49757238:-	-0.45	-9.06	3.47E-18	Menarche (age at onset)	
PRAD	cis	1	rs6774724	chr3:49381911	CCDC36	chr3:49235861-49295537:+	0.22	3.9	0.000109	Menarche (age at onset)	
PRAD	cis	1	rs6774724	chr3:49381911	GMPPB	chr3:49758932-49761384:-	-0.51	-12.23	4.64E-30	Menarche (age at onset)	
PRAD	cis	1	rs6774724	chr3:49381911	NCKIPSD	chr3:48711280-48723334:-	0.3	5.75	1.63E-8	Menarche (age at onset)	
PRAD	cis	1	rs6774724	chr3:49381911	WDR6	chr3:49044637-49053386:+	-0.2	-3.84	0.000138	Menarche (age at onset)	
PRAD	cis	1	rs6775591	chr3:184743844	VPS8	chr3:184529931-184770402:+	-0.33	-4.15	4.0E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs6775899	chr3:121319824	GTF2E1	chr3:120461558-120501915:+	-0.23	-3.69	0.000247	Aging (facial)	
PRAD	cis	1	rs67766926	chr2:61163581	AHSA2	chr2:61404553-61414058:+	-0.17	-5.58	4.04E-8	Inflammatory skin disease	
PRAD	cis	1	rs67766926	chr2:61163581	C2orf74	chr2:61372243-61391964:+	0.39	6.33	5.57E-10	Inflammatory skin disease	
PRAD	cis	1	rs6776700	chr3:48496758	ATRIP	chr3:48488141-48507708:+	0.27	6.31	6.41E-10	Longevity	
PRAD	cis	1	rs6776700	chr3:48496758	CDC25A	chr3:48198668-48229801:-	0.21	3.85	0.000132	Longevity	
PRAD	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.18	-5.04	6.54E-7	Longevity	
PRAD	cis	1	rs67780231	chr7:37966496	EPDR1	chr7:37960163-37991539:+	-0.27	-4.4	1.33E-5	Bone mineral density	
PRAD	cis	1	rs6778057	chr3:128647823	ACAD9	chr3:128598333-128634910:+	-0.27	-3.44	0.000629	Dental caries	
PRAD	cis	1	rs6778562	chr3:15482775	EAF1	chr3:15469064-15484119:+	0.14	4.08	5.25E-5	Uric acid levels	
PRAD	cis	1	rs6778660	chr3:46895300	PRSS45	chr3:46783582-46790130:-	0.27	3.8	0.000163	Microalbuminuria	
PRAD	cis	1	rs677977	chr1:147083744	ACP6	chr1:147119168-147142634:-	-0.59	-12.53	2.72E-31	Schizophrenia (negative symptoms)	
PRAD	cis	1	rs6780538	chr3:190982512	UTS2D	chr3:190984945-191048325:-	-0.22	-4.44	1.12E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs678069	chr12:53102196	EIF4B	chr12:53400062-53435992:+	0.27	3.7	0.000241	Electrodermal activity	
PRAD	cis	1	rs6780776	chr3:71554185	EIF4E3	chr3:71728442-71803924:-	-0.17	-3.57	0.000391	Educational attainment (years of education)	
PRAD	cis	1	rs6781266	chr3:46895333	PRSS45	chr3:46783582-46790130:-	0.26	3.58	0.000379	Microalbuminuria	
PRAD	cis	1	rs6781326	chr3:41777028	ULK4	chr3:41288091-42003660:-	0.81	13.09	1.31E-33	Diastolic blood pressure	
PRAD	cis	1	rs678170	chr11:114431956	FAM55A	chr11:114392438-114430580:-	-0.2	-4.04	6.12E-5	Ulcerative colitis	
PRAD	cis	1	rs6781811	chr3:10121922	C3orf10	chr3:10157333-10168873:+	0.2	3.81	0.000158	Alzheimer's disease	
PRAD	cis	1	rs6781811	chr3:10121922	LOC401052	chr3:10048102-10052779:-	0.26	4.73	2.97E-6	Alzheimer's disease	
PRAD	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.82	2.1E-28	Height	
PRAD	cis	1	rs6782563	chr3:134295959	CEP63	chr3:134204575-134293852:+	-0.21	-3.75	0.0002	Height	
PRAD	cis	1	rs6782602	chr3:10116541	C3orf10	chr3:10157333-10168873:+	-0.2	-3.84	0.00014	Alzheimer's disease	
PRAD	cis	1	rs6782602	chr3:10116541	LOC401052	chr3:10048102-10052779:-	-0.29	-5.22	2.75E-7	Alzheimer's disease	
PRAD	cis	1	rs6782799	chr3:119610793	NR1I2	chr3:119499331-119537331:+	-0.22	-3.97	8.17E-5	HDL cholesterol	
PRAD	cis	1	rs678292	chr10:105957561	C10orf79	chr10:105889647-105992120:-	0.25	4.46	1.03E-5	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	0.87	14.06	9.61E-38	Diastolic blood pressure	
PRAD	cis	1	rs6783003	chr3:49524778	AMIGO3	chr3:49754268-49757238:-	0.46	9.21	1.07E-18	Menarche (age at onset)	
PRAD	cis	1	rs6783003	chr3:49524778	CCDC36	chr3:49235861-49295537:+	-0.22	-3.84	0.000139	Menarche (age at onset)	
PRAD	cis	1	rs6783003	chr3:49524778	GMPPB	chr3:49758932-49761384:-	0.52	12.53	2.89E-31	Menarche (age at onset)	
PRAD	cis	1	rs6783003	chr3:49524778	NCKIPSD	chr3:48711280-48723334:-	-0.28	-5.45	8.35E-8	Menarche (age at onset)	
PRAD	cis	1	rs6783003	chr3:49524778	WDR6	chr3:49044637-49053386:+	0.21	4.14	4.09E-5	Menarche (age at onset)	
PRAD	cis	1	rs6783253	chr3:127851561	RUVBL1	chr3:127783627-127872757:-	0.21	3.91	0.000106	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6783628	chr3:14478997	SH3BP5	chr3:15296357-15382901:-	-0.14	-3.99	7.68E-5	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs6784159	chr3:127843378	RUVBL1	chr3:127783627-127872757:-	0.23	4.25	2.54E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6784322	chr3:48422235	ATRIP	chr3:48488141-48507708:+	0.27	6.38	4.31E-10	Longevity	
PRAD	cis	1	rs6784322	chr3:48422235	CDC25A	chr3:48198668-48229801:-	0.21	3.92	0.000102	Longevity	
PRAD	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.17	-4.77	2.41E-6	Longevity	
PRAD	cis	1	rs6784421	chr3:156655494	LEKR1	chr3:156544076-156763918:+	0.29	5.73	1.78E-8	Multiple sclerosis (severity)	
PRAD	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.54	-12.5	3.82E-31	Height	
PRAD	cis	1	rs6785045	chr3:49435243	AMIGO3	chr3:49754268-49757238:-	0.43	8.79	2.93E-17	Menarche (age at onset)	
PRAD	cis	1	rs6785045	chr3:49435243	CCDC36	chr3:49235861-49295537:+	-0.23	-4.18	3.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs6785045	chr3:49435243	GMPPB	chr3:49758932-49761384:-	0.48	11.64	1.05E-27	Menarche (age at onset)	
PRAD	cis	1	rs6785045	chr3:49435243	NCKIPSD	chr3:48711280-48723334:-	-0.31	-6.09	2.34E-9	Menarche (age at onset)	
PRAD	cis	1	rs6785045	chr3:49435243	P4HTM	chr3:49027341-49044579:+	-0.16	-3.67	0.000275	Menarche (age at onset)	
PRAD	cis	1	rs6785045	chr3:49435243	WDR6	chr3:49044637-49053386:+	0.19	3.83	0.000146	Menarche (age at onset)	
PRAD	cis	1	rs67852463	chr3:10157205	C3orf10	chr3:10157333-10168873:+	-0.23	-4.43	1.15E-5	Alzheimer's disease	
PRAD	cis	1	rs67852463	chr3:10157205	LOC401052	chr3:10048102-10052779:-	-0.29	-5.25	2.31E-7	Alzheimer's disease	
PRAD	cis	1	rs6785535	chr3:127834695	RUVBL1	chr3:127783627-127872757:-	0.25	4.6	5.48E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6785869	chr3:128643144	ACAD9	chr3:128598333-128634910:+	-0.2	-3.77	0.000185	IgG glycosylation	
PRAD	cis	1	rs67865942	chr8:89596642	MMP16	chr8:89049462-89339717:-	0.15	3.65	0.000295	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs6786638	chr3:10118075	C3orf10	chr3:10157333-10168873:+	-0.22	-4.15	4.02E-5	Alzheimer's disease	
PRAD	cis	1	rs6786638	chr3:10118075	LOC401052	chr3:10048102-10052779:-	-0.29	-5.18	3.38E-7	Alzheimer's disease	
PRAD	cis	1	rs6787312	chr3:51650510	TEX264	chr3:51705222-51738338:+	-0.14	-3.49	0.000528	Melanoma	
PRAD	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.54	12.43	7.27E-31	Height	
PRAD	cis	1	rs6787559	chr3:128381086	RPN1	chr3:128338813-128399918:-	-0.15	-3.47	0.000579	Monocyte count	
PRAD	cis	1	rs6787614	chr3:127817478	RUVBL1	chr3:127783627-127872757:-	0.25	4.62	4.94E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6787952	chr3:156609375	LEKR1	chr3:156544076-156763918:+	-0.46	-6.27	8.08E-10	Bone mineral density	
PRAD	cis	1	rs6789094	chr3:128591267	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.000438	Dental caries	
PRAD	cis	1	rs6789156	chr3:10124120	C3orf10	chr3:10157333-10168873:+	-0.19	-3.75	0.000201	Alzheimer's disease	
PRAD	cis	1	rs6789156	chr3:10124120	LOC401052	chr3:10048102-10052779:-	-0.28	-5.05	6.47E-7	Alzheimer's disease	
PRAD	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.74	11.04	2.37E-25	Diastolic blood pressure	
PRAD	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.51	11.53	2.94E-27	Height	
PRAD	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	0.88	14.25	1.49E-38	Diastolic blood pressure	
PRAD	cis	1	rs67912009	chr11:495057	ANO9	chr11:417930-442011:-	0.31	5.21	2.8E-7	Body mass index	
PRAD	cis	1	rs67912009	chr11:495057	LRRC56	chr11:537522-554915:+	0.27	4.11	4.67E-5	Body mass index	
PRAD	cis	1	rs67912009	chr11:495057	RNH1	chr11:494512-507273:-	-0.2	-3.7	0.000238	Body mass index	
PRAD	cis	1	rs6791806	chr3:41889995	ULK4	chr3:41288091-42003660:-	0.88	14.28	1.11E-38	Diastolic blood pressure	
PRAD	cis	1	rs6791810	chr3:10124444	C3orf10	chr3:10157333-10168873:+	0.2	3.79	0.000172	Alzheimer's disease	
PRAD	cis	1	rs6791810	chr3:10124444	CIDEC	chr3:9908399-10067820:-	0.21	3.46	0.000584	Alzheimer's disease	
PRAD	cis	1	rs6791810	chr3:10124444	LOC401052	chr3:10048102-10052779:-	0.29	5.27	2.09E-7	Alzheimer's disease	
PRAD	cis	1	rs6792572	chr3:119636096	NR1I2	chr3:119499331-119537331:+	-0.22	-4.03	6.59E-5	HDL cholesterol	
PRAD	cis	1	rs67927699	chr2:61187415	AHSA2	chr2:61404553-61414058:+	-0.17	-6.89	1.79E-11	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs67927699	chr2:61187415	C2orf74	chr2:61372243-61391964:+	0.5	10.2	3.26E-22	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs6793396	chr3:10110927	C3orf10	chr3:10157333-10168873:+	-0.22	-4.15	4.02E-5	Alzheimer's disease	
PRAD	cis	1	rs6793396	chr3:10110927	LOC401052	chr3:10048102-10052779:-	-0.29	-5.18	3.38E-7	Alzheimer's disease	
PRAD	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.77	3.25E-28	Height	
PRAD	cis	1	rs6793487	chr3:134299426	CEP63	chr3:134204575-134293852:+	-0.22	-3.78	0.000176	Height	
PRAD	cis	1	rs67940364	chr3:127833353	RUVBL1	chr3:127783627-127872757:-	0.25	4.6	5.48E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs67941642	chr20:60958108	LAMA5	chr20:60884123-60942368:-	-0.16	-3.6	0.000355	Colorectal cancer	
PRAD	cis	1	rs6794591	chr3:128031219	RUVBL1	chr3:127783627-127872757:-	0.23	4.3	2.04E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6794875	chr3:48455626	ATRIP	chr3:48488141-48507708:+	0.27	6.62	9.77E-11	Longevity	
PRAD	cis	1	rs6794875	chr3:48455626	CDC25A	chr3:48198668-48229801:-	0.2	3.84	0.000138	Longevity	
PRAD	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.16	-4.59	5.81E-6	Longevity	
PRAD	cis	1	rs679515	chr1:207750568	CD55	chr1:207494817-207534309:+	-0.24	-3.71	0.000232	Alzheimer's disease in APOE e4+ carriers	
PRAD	cis	1	rs6795293	chr3:128592669	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.000438	Dental caries	
PRAD	cis	1	rs6795653	chr3:119610565	NR1I2	chr3:119499331-119537331:+	-0.22	-3.97	8.17E-5	HDL cholesterol	
PRAD	cis	1	rs6795976	chr3:190982545	UTS2D	chr3:190984945-191048325:-	-0.22	-4.44	1.12E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs6796031	chr3:128593259	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.000438	Dental caries	
PRAD	cis	1	rs6796210	chr3:41851718	ULK4	chr3:41288091-42003660:-	0.86	14.03	1.28E-37	Diastolic blood pressure	
PRAD	cis	1	rs6796491	chr3:48430465	ATRIP	chr3:48488141-48507708:+	0.27	6.28	7.73E-10	Longevity	
PRAD	cis	1	rs6796491	chr3:48430465	CDC25A	chr3:48198668-48229801:-	0.22	4.12	4.39E-5	Longevity	
PRAD	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.18	-5.01	7.64E-7	Longevity	
PRAD	cis	1	rs6797834	chr3:127856400	RUVBL1	chr3:127783627-127872757:-	0.21	3.91	0.000106	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs67981189	chr14:71472226	PCNX	chr14:71374122-71582099:+	-0.15	-5.07	5.75E-7	Schizophrenia	
PRAD	cis	1	rs6798749	chr3:128056897	RUVBL1	chr3:127783627-127872757:-	-0.23	-4.36	1.59E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6800225	chr3:127862178	RUVBL1	chr3:127783627-127872757:-	0.22	3.96	8.63E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs68005215	chr10:4977435	AKR1C2	chr10:4964715-5060207:-	0.68	9.46	1.44E-19	Height	
PRAD	cis	1	rs6800622	chr3:119580678	NR1I2	chr3:119499331-119537331:+	0.22	3.97	8.38E-5	HDL cholesterol	
PRAD	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.52	12.06	2.34E-29	Height	
PRAD	cis	1	rs6800862	chr3:134228628	CEP63	chr3:134204575-134293852:+	0.2	3.62	0.000332	Height	
PRAD	cis	1	rs6800	chr1:156262653	BGLAP	chr1:156182784-156213112:+	0.22	5.77	1.41E-8	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs6800	chr1:156262653	CCT3	chr1:156278752-156308195:-	-0.15	-3.68	0.000259	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs680113	chr11:108165406	ATM	chr11:108093559-108239826:+	-0.16	-4.73	3.04E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs6801142	chr3:184698444	VPS8	chr3:184529931-184770402:+	-0.33	-4.15	3.87E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs6801343	chr3:41767234	ULK4	chr3:41288091-42003660:-	0.8	12.86	1.28E-32	Diastolic blood pressure	
PRAD	cis	1	rs68014803	chr2:192106603	STAT4	chr2:191894306-192038902:-	-0.12	-3.74	0.000211	Obesity-related traits	
PRAD	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.52	11.87	1.35E-28	Height	
PRAD	cis	1	rs6801596	chr3:134252114	CEP63	chr3:134204575-134293852:+	0.21	3.64	0.000303	Height	
PRAD	cis	1	rs6802340	chr3:41894034	ULK4	chr3:41288091-42003660:-	0.88	14.28	1.11E-38	Diastolic blood pressure	
PRAD	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.54	12.38	1.12E-30	Height	
PRAD	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	0.82	13.33	1.34E-34	Diastolic blood pressure	
PRAD	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	0.82	13.33	1.34E-34	Diastolic blood pressure	
PRAD	cis	1	rs6803830	chr3:150510579	SIAH2	chr3:150458911-150481263:-	0.49	4.38	1.49E-5	Breast cancer	
PRAD	cis	1	rs6804441	chr3:119260944	ARHGAP31	chr3:119013220-119138322:+	-0.11	-3.45	0.00061	Systemic lupus erythematosus	
PRAD	cis	1	rs6804449	chr3:184667576	VPS8	chr3:184529931-184770402:+	-0.33	-4.03	6.59E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs6804473	chr3:10060425	C3orf10	chr3:10157333-10168873:+	-0.2	-3.9	0.000112	Alzheimer's disease	
PRAD	cis	1	rs6804473	chr3:10060425	LOC401052	chr3:10048102-10052779:-	-0.3	-5.4	1.09E-7	Alzheimer's disease	
PRAD	cis	1	rs68045038	chr3:10151828	C3orf10	chr3:10157333-10168873:+	-0.23	-4.44	1.13E-5	Alzheimer's disease	
PRAD	cis	1	rs68045038	chr3:10151828	LOC401052	chr3:10048102-10052779:-	-0.31	-5.56	4.53E-8	Alzheimer's disease	
PRAD	cis	1	rs6804655	chr3:49738945	AMIGO3	chr3:49754268-49757238:-	-0.22	-4.31	1.99E-5	Resting heart rate	
PRAD	cis	1	rs6804655	chr3:49738945	CACNA2D2	chr3:50400233-50540892:-	-0.22	-4.55	6.93E-6	Resting heart rate	
PRAD	cis	1	rs6804655	chr3:49738945	GMPPB	chr3:49758932-49761384:-	-0.23	-5.11	4.59E-7	Resting heart rate	
PRAD	cis	1	rs6804655	chr3:49738945	RBM6	chr3:49977592-50137484:+	-0.15	-5.13	4.17E-7	Resting heart rate	
PRAD	cis	1	rs6804655	chr3:49738945	WDR6	chr3:49044637-49053386:+	-0.21	-4.34	1.78E-5	Resting heart rate	
PRAD	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.55	12.75	3.51E-32	Height	
PRAD	cis	1	rs6804774	chr3:48430617	ATRIP	chr3:48488141-48507708:+	0.27	6.28	7.73E-10	Longevity	
PRAD	cis	1	rs6804774	chr3:48430617	CDC25A	chr3:48198668-48229801:-	0.22	4.12	4.39E-5	Longevity	
PRAD	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.18	-5.01	7.64E-7	Longevity	
PRAD	cis	1	rs6805251	chr3:119560606	NR1I2	chr3:119499331-119537331:+	-0.22	-4.05	5.91E-5	HDL cholesterol	
PRAD	cis	1	rs6805582	chr3:128029008	RUVBL1	chr3:127783627-127872757:-	0.23	4.3	2.04E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6805609	chr3:49471522	AMIGO3	chr3:49754268-49757238:-	0.48	9.49	1.12E-19	Menarche (age at onset)	
PRAD	cis	1	rs6805609	chr3:49471522	CCDC36	chr3:49235861-49295537:+	-0.21	-3.55	0.000428	Menarche (age at onset)	
PRAD	cis	1	rs6805609	chr3:49471522	GMPPB	chr3:49758932-49761384:-	0.51	12.18	7.3E-30	Menarche (age at onset)	
PRAD	cis	1	rs6805609	chr3:49471522	IP6K1	chr3:49761728-49823975:-	0.21	3.82	0.00015	Menarche (age at onset)	
PRAD	cis	1	rs6805609	chr3:49471522	NCKIPSD	chr3:48711280-48723334:-	-0.26	-4.92	1.2E-6	Menarche (age at onset)	
PRAD	cis	1	rs6805609	chr3:49471522	RHOA	chr3:49396581-49449526:-	0.17	3.66	0.000283	Menarche (age at onset)	
PRAD	cis	1	rs6805609	chr3:49471522	WDR6	chr3:49044637-49053386:+	0.24	4.54	7.02E-6	Menarche (age at onset)	
PRAD	cis	1	rs6805621	chr3:128029204	RUVBL1	chr3:127783627-127872757:-	0.23	4.3	2.04E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.83	13.07	1.56E-33	Diastolic blood pressure	
PRAD	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.53	-12.21	5.68E-30	Height	
PRAD	cis	1	rs68067759	chr3:10150535	C3orf10	chr3:10157333-10168873:+	-0.22	-4.21	3.08E-5	Alzheimer's disease	
PRAD	cis	1	rs68067759	chr3:10150535	LOC401052	chr3:10048102-10052779:-	-0.31	-5.5	6.37E-8	Alzheimer's disease	
PRAD	cis	1	rs6807015	chr3:41754514	ULK4	chr3:41288091-42003660:-	0.75	11.6	1.52E-27	Diastolic blood pressure	
PRAD	cis	1	rs6807846	chr3:10134491	C3orf10	chr3:10157333-10168873:+	-0.2	-3.87	0.000122	Alzheimer's disease	
PRAD	cis	1	rs6807846	chr3:10134491	LOC401052	chr3:10048102-10052779:-	-0.3	-5.46	7.72E-8	Alzheimer's disease	
PRAD	cis	1	rs6808835	chr3:46449864	CCR5	chr3:46411633-46417690:+	0.17	5.26	2.2E-7	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
PRAD	cis	1	rs6810006	chr3:127856058	RUVBL1	chr3:127783627-127872757:-	0.25	4.66	4.09E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6810060	chr3:48434748	ATRIP	chr3:48488141-48507708:+	0.27	6.47	2.44E-10	Longevity	
PRAD	cis	1	rs6810060	chr3:48434748	CDC25A	chr3:48198668-48229801:-	0.21	4.05	6.1E-5	Longevity	
PRAD	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.16	-4.64	4.58E-6	Longevity	
PRAD	cis	1	rs6811887	chr4:17640858	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs6812540	chr4:39116423	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	cis	1	rs68141011	chr6:28217797	ZKSCAN3	chr6:28317691-28334523:+	-0.18	-3.65	0.000288	Depression	
PRAD	cis	1	rs68141011	chr6:28217797	ZNF187	chr6:28234788-28245978:+	-0.3	-5.5	6.23E-8	Depression	
PRAD	cis	1	rs68141011	chr6:28217797	ZNF323	chr6:28292517-28324048:-	0.38	5.1	4.96E-7	Depression	
PRAD	cis	1	rs68141011	chr6:28217797	ZNF389	chr6:28129551-28137375:+	-0.53	-7.63	1.31E-13	Depression	
PRAD	cis	1	rs68141011	chr6:28217797	ZSCAN23	chr6:28393287-28411279:-	0.17	4.69	3.5E-6	Depression	
PRAD	cis	1	rs6815464	chr4:1309901	KIAA1530	chr4:1341104-1381836:+	-0.29	-3.7	0.000245	Type 2 diabetes	
PRAD	cis	1	rs6816687	chr4:95521397	BMPR1B	chr4:95679128-96079592:+	0.22	3.93	9.91E-5	Response to simvastatin treatment (PCSK9 protein level change)	
PRAD	cis	1	rs68168863	chr6:33758238	IP6K3	chr6:33689443-33714762:-	0.19	3.77	0.000182	Obesity (extreme)	
PRAD	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.5	-11.42	8.13E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs681753	chr1:23515216	C1orf213	chr1:23695464-23698278:+	-0.18	-4.52	7.76E-6	Height	
PRAD	cis	1	rs68175808	chr7:38832209	FAM183B	chr7:38724947-38726689:-	0.39	3.91	0.000107	Cognitive performance	
PRAD	cis	1	rs6818639	chr4:17633049	MED28	chr4:17616273-17629791:+	0.19	4.63	4.65E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs68189316	chr7:65409169	CCT6P1	chr7:65216092-65228661:+	0.31	5.59	3.91E-8	Diabetic kidney disease	
PRAD	cis	1	rs68189316	chr7:65409169	CRCP	chr7:65579805-65619551:+	-0.27	-3.53	0.00045	Diabetic kidney disease	
PRAD	cis	1	rs6819660	chr4:56374577	TMEM165	chr4:56262090-56292342:+	-0.17	-3.81	0.000155	Personality dimensions	
PRAD	cis	1	rs6821283	chr4:165901645	C4orf39	chr4:165878100-165880273:+	0.16	3.58	0.000377	Ovarian cancer in BRCA1 mutation carriers	
PRAD	cis	1	rs6823347	chr4:106962725	TBCK	chr4:106967233-107237861:-	0.17	3.57	0.000398	Airflow obstruction	
PRAD	cis	1	rs6827269	chr4:54320617	FIP1L1	chr4:54243820-54326102:+	-0.2	-4.4	1.31E-5	DNA methylation (variation)	
PRAD	cis	1	rs6828394	chr4:166338080	KLHL2	chr4:166128770-166244307:+	-0.17	-3.53	0.000464	Pelvic organ prolapse (moderate/severe)	
PRAD	cis	1	rs6829234	chr4:39116206	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	cis	1	rs6829450	chr4:39116341	KLHL5	chr4:39046659-39123828:+	-0.13	-3.67	0.000269	Uric acid levels	
PRAD	cis	1	rs6831256	chr4:3473139	LRPAP1	chr4:3514290-3534224:-	0.16	3.81	0.000156	Triglycerides;Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs6832503	chr4:48028442	CNGA1	chr4:47937996-48018610:-	-0.25	-4.38	1.48E-5	Renal underexcretion gout;Gout	
PRAD	cis	1	rs6832503	chr4:48028442	NIPAL1	chr4:48018791-48039078:+	-0.21	-6.78	3.53E-11	Renal underexcretion gout;Gout	
PRAD	cis	1	rs6832503	chr4:48028442	TXK	chr4:48068412-48136273:-	-0.16	-3.57	0.000401	Renal underexcretion gout;Gout	
PRAD	cis	1	rs683395	chr3:182869818	ATP11B	chr3:182511291-182639419:+	-0.18	-3.48	0.000549	Bipolar disorder	
PRAD	cis	1	rs6834934	chr4:54242085	FIP1L1	chr4:54243820-54326102:+	-0.18	-3.92	0.000101	DNA methylation (variation)	
PRAD	cis	1	rs6837429	chr4:8502374	C4orf23	chr4:8440604-8495258:+	-0.31	-5	7.94E-7	Response to antineoplastic agents	
PRAD	cis	1	rs684232	chr17:618965	FAM57A	chr17:635847-646074:+	-0.45	-9.82	7.97E-21	Prostate cancer	
PRAD	cis	1	rs684232	chr17:618965	GEMIN4	chr17:647661-655501:-	-0.23	-5.34	1.43E-7	Prostate cancer	
PRAD	cis	1	rs684232	chr17:618965	VPS53	chr17:414730-618096:-	-0.37	-7.71	7.44E-14	Prostate cancer	
PRAD	cis	1	rs6845763	chr4:75141725	RASSF6	chr4:74438862-74486340:-	-0.37	-4.24	2.66E-5	Immune reponse to smallpox (secreted IL-1beta)	
PRAD	cis	1	rs6845891	chr4:744233	MYL5	chr4:667369-675816:+	-0.14	-3.89	0.000113	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs6846238	chr4:17629939	MED28	chr4:17616273-17629791:+	0.23	5.66	2.66E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs6846579	chr4:107011756	TBCK	chr4:106967233-107237861:-	0.19	3.99	7.82E-5	Airflow obstruction	
PRAD	cis	1	rs6847067	chr4:85732169	C4orf12	chr4:85887971-85928168:+	0.15	3.69	0.000248	Oropharynx cancer	
PRAD	cis	1	rs6848360	chr4:17634442	MED28	chr4:17616273-17629791:+	0.2	5.02	7.35E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs6849704	chr4:17652031	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs6851838	chr4:56420747	TMEM165	chr4:56262090-56292342:+	0.18	4.08	5.26E-5	Personality dimensions	
PRAD	cis	1	rs6853192	chr4:56409254	TMEM165	chr4:56262090-56292342:+	0.18	4.05	6.03E-5	Personality dimensions	
PRAD	cis	1	rs6853522	chr4:154706220	RNF175	chr4:154631313-154681387:-	0.2	4.64	4.49E-6	Electrocardiographic conduction measures	
PRAD	cis	1	rs6854733	chr4:17640526	MED28	chr4:17616273-17629791:+	0.19	4.72	3.06E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs6856137	chr4:142160161	ZNF330	chr4:142142049-142155848:+	0.25	4.44	1.12E-5	Conduct disorder	
PRAD	cis	1	rs6857024	chr4:54242283	FIP1L1	chr4:54243820-54326102:+	-0.18	-3.92	0.000101	DNA methylation (variation)	
PRAD	cis	1	rs6858542	chr4:8511547	C4orf23	chr4:8440604-8495258:+	0.29	4.64	4.52E-6	Response to antineoplastic agents	
PRAD	cis	1	rs6858666	chr4:85729936	C4orf12	chr4:85887971-85928168:+	0.16	3.95	8.89E-5	Oropharynx cancer	
PRAD	cis	1	rs6860540	chr5:156938327	NIPAL4	chr5:156887027-156901729:+	-0.2	-5.52	5.59E-8	Inflammatory skin disease	
PRAD	cis	1	rs6862814	chr5:150245259	LOC134466	chr5:150310000-150326146:-	0.54	8.65	8.5E-17	Crohn's disease	
PRAD	cis	1	rs686441	chr10:105950233	C10orf79	chr10:105889647-105992120:-	0.23	4.09	5.05E-5	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs6864847	chr5:137784515	EGR1	chr5:137801181-137805004:+	-0.18	-3.65	0.000295	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	
PRAD	cis	1	rs6865893	chr5:78324767	BHMT2	chr5:78365583-78385273:+	0.1	3.88	0.000122	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs6866910	chr5:79446102	SERINC5	chr5:79407474-79551870:-	0.15	4.34	1.73E-5	Borderline personality disorder features	
PRAD	cis	1	rs6867242	chr5:137561186	REEP2	chr5:137774776-137782657:+	-0.1	-4.18	3.52E-5	Resting heart rate	
PRAD	cis	1	rs686861	chr15:48885005	DUT	chr15:48623621-48635568:+	-0.24	-3.88	0.000117	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs6869502	chr5:110166083	TMEM232	chr5:109624934-110062381:-	0.27	4.26	2.48E-5	Asthma and hay fever	
PRAD	cis	1	rs6869774	chr5:110467086	CAMK4	chr5:110559648-110820746:+	0.18	3.63	0.000314	Eosinophil counts	
PRAD	cis	1	rs6870356	chr5:110467237	CAMK4	chr5:110559648-110820746:+	0.17	3.65	0.000294	Eosinophil counts	
PRAD	cis	1	rs6874202	chr5:156391628	TIMD4	chr5:156346293-156390266:-	-0.2	-3.98	8.0E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs6874560	chr5:150182713	LOC134466	chr5:150310000-150326146:-	0.7	9.13	2.03E-18	Crohn's disease	
PRAD	cis	1	rs6875011	chr5:150182710	C5orf62	chr5:150157867-150176297:+	0.32	3.61	0.000334	Crohn's disease	
PRAD	cis	1	rs6875011	chr5:150182710	LOC134466	chr5:150310000-150326146:-	0.67	8.87	1.52E-17	Crohn's disease	
PRAD	cis	1	rs687557	chr10:105989509	C10orf79	chr10:105889647-105992120:-	0.25	4.5	8.61E-6	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs6875748	chr5:37041593	NIPBL	chr5:36876861-37065920:+	-0.11	-4.65	4.38E-6	Height	
PRAD	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.83	24.73	4.26E-87	Crohn's disease	
PRAD	cis	1	rs687672	chr11:65649984	SNX32	chr11:65601410-65621170:+	-0.45	-6.8	3.18E-11	Crohn's disease	
PRAD	cis	1	rs6876835	chr5:6599222	LOC255167	chr5:6582287-6588612:+	0.26	5.38	1.17E-7	Visceral fat	
PRAD	cis	1	rs6877621	chr5:78314379	BHMT2	chr5:78365583-78385273:+	0.09	3.68	0.000264	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs6880889	chr5:115167896	ATG12	chr5:115165818-115177520:-	-0.26	-4.38	1.43E-5	IgG glycosylation	
PRAD	cis	1	rs6880889	chr5:115167896	CDO1	chr5:115140432-115152405:-	-0.23	-3.65	0.000291	IgG glycosylation	
PRAD	cis	1	rs6882076	chr5:156390297	TIMD4	chr5:156346293-156390266:-	-0.2	-3.98	8.0E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs6882423	chr5:79444409	SERINC5	chr5:79407474-79551870:-	-0.15	-4.67	3.95E-6	Borderline personality disorder features	
PRAD	cis	1	rs6884993	chr5:122746528	CEP120	chr5:122680580-122759252:-	0.23	5.28	2.02E-7	Waist circumference	
PRAD	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.94	16.03	1.93E-46	Type 2 diabetes	
PRAD	cis	1	rs6885792	chr5:110165413	TMEM232	chr5:109624934-110062381:-	0.27	4.21	3.09E-5	Asthma and hay fever	
PRAD	cis	1	rs688967	chr15:45936127	DUOX1	chr15:45422192-45457774:+	-0.1	-3.49	0.000522	Obesity-related traits	
PRAD	cis	1	rs688967	chr15:45936127	DUOX2	chr15:45384853-45406359:-	-0.15	-3.66	0.000281	Obesity-related traits	
PRAD	cis	1	rs688967	chr15:45936127	SPATA5L1	chr15:45694519-45713614:+	0.23	3.49	0.000525	Obesity-related traits	
PRAD	cis	1	rs6890695	chr5:130888424	P4HA2	chr5:131528306-131563556:-	0.19	3.51	0.000483	Alzheimer's disease in APOE e4- carriers	
PRAD	cis	1	rs6900057	chr6:88273969	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs690037	chr3:16395668	DPH3	chr3:16298569-16306496:-	0.16	3.68	0.00026	Optic nerve measurement (cup-to-disc ratio);Optic nerve measurement (cup area)	
PRAD	cis	1	rs6900902	chr6:105235757	HACE1	chr6:105175968-105307794:-	-0.13	-3.51	0.00049	Thyroid stimulating hormone	
PRAD	cis	1	rs6901126	chr6:153440062	RGS17	chr6:153332041-153452389:-	0.54	12.82	1.73E-32	Prostate cancer	
PRAD	cis	1	rs6901178	chr6:46631886	TDRD6	chr6:46655866-46670149:+	-0.3	-5.32	1.6E-7	Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs6901575	chr6:28250984	ZKSCAN3	chr6:28317691-28334523:+	-0.17	-3.56	0.000408	Depression	
PRAD	cis	1	rs6901575	chr6:28250984	ZNF187	chr6:28234788-28245978:+	-0.31	-5.62	3.31E-8	Depression	
PRAD	cis	1	rs6901575	chr6:28250984	ZNF323	chr6:28292517-28324048:-	0.4	5.44	8.69E-8	Depression	
PRAD	cis	1	rs6901575	chr6:28250984	ZNF389	chr6:28129551-28137375:+	-0.53	-7.74	6.34E-14	Depression	
PRAD	cis	1	rs6901575	chr6:28250984	ZSCAN23	chr6:28393287-28411279:-	0.17	4.59	5.63E-6	Depression	
PRAD	cis	1	rs6901703	chr6:24475300	GPLD1	chr6:24428405-24489850:-	-0.48	-10.38	6.97E-23	Hematological and biochemical traits	
PRAD	cis	1	rs6901703	chr6:24475300	MRS2	chr6:24403153-24425809:+	-0.27	-4.52	7.95E-6	Hematological and biochemical traits	
PRAD	cis	1	rs6902069	chr6:88302447	C6orf165	chr6:88117721-88205858:+	0.37	3.57	0.000397	Obesity-related traits	
PRAD	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.43	-9.17	1.53E-18	Homocysteine levels	
PRAD	cis	1	rs6903973	chr6:26499942	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.21E-10	Educational attainment	
PRAD	cis	1	rs6903973	chr6:26499942	ZNF184	chr6:27418522-27440897:-	-0.18	-3.72	0.000225	Educational attainment	
PRAD	cis	1	rs6904343	chr6:24317666	GPLD1	chr6:24428405-24489850:-	0.18	3.46	0.000596	Uric acid levels	
PRAD	cis	1	rs6904373	chr6:46628067	TDRD6	chr6:46655866-46670149:+	0.27	4.65	4.37E-6	Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs6904601	chr6:170131905	WDR27	chr6:169857307-170102159:-	-0.13	-3.45	0.00061	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs6904991	chr6:33732262	LEMD2	chr6:33738991-33756906:-	-0.22	-6.79	3.34E-11	Crohn's disease	
PRAD	cis	1	rs6905047	chr6:76498109	MYO6	chr6:76458909-76629254:+	0.25	4.81	2.01E-6	Prostate cancer	
PRAD	cis	1	rs6905391	chr6:28262686	ZKSCAN3	chr6:28317691-28334523:+	-0.16	-3.43	0.000645	Depression	
PRAD	cis	1	rs6905391	chr6:28262686	ZNF187	chr6:28234788-28245978:+	-0.31	-5.71	1.96E-8	Depression	
PRAD	cis	1	rs6905391	chr6:28262686	ZNF323	chr6:28292517-28324048:-	0.47	6.46	2.67E-10	Depression	
PRAD	cis	1	rs6905391	chr6:28262686	ZNF389	chr6:28129551-28137375:+	-0.51	-7.4	6.31E-13	Depression	
PRAD	cis	1	rs6905391	chr6:28262686	ZSCAN23	chr6:28393287-28411279:-	0.16	4.52	7.85E-6	Depression	
PRAD	cis	1	rs6905422	chr6:161068064	LPA	chr6:160952516-161087407:-	0.15	3.49	0.000536	Lipoprotein (a) levels	
PRAD	cis	1	rs6906615	chr6:76489774	MYO6	chr6:76458909-76629254:+	0.24	4.9	1.32E-6	Prostate cancer	
PRAD	cis	1	rs6907823	chr6:153433542	RGS17	chr6:153332041-153452389:-	-0.56	-13.61	8.88E-36	Prostate cancer	
PRAD	cis	1	rs6908390	chr6:25609756	SCGN	chr6:25652429-25702006:+	-0.42	-7.21	2.2E-12	Uric acid levels	
PRAD	cis	1	rs6910233	chr6:33534726	BAK1	chr6:33540324-33548070:-	0.25	4.8	2.09E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs6910233	chr6:33534726	CUTA	chr6:33384319-33386065:-	0.1	3.57	0.000398	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs6910460	chr6:24471712	GPLD1	chr6:24428405-24489850:-	0.49	10.43	4.6E-23	Hematological and biochemical traits	
PRAD	cis	1	rs6910460	chr6:24471712	MRS2	chr6:24403153-24425809:+	0.26	4.42	1.22E-5	Hematological and biochemical traits	
PRAD	cis	1	rs6910899	chr6:26524339	BTN2A3	chr6:26422317-26431927:+	0.25	6.45	2.83E-10	Educational attainment	
PRAD	cis	1	rs6910899	chr6:26524339	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.46	0.00058	Educational attainment	
PRAD	cis	1	rs6910899	chr6:26524339	ZNF184	chr6:27418522-27440897:-	-0.17	-3.58	0.000374	Educational attainment	
PRAD	cis	1	rs6911965	chr6:24480295	GPLD1	chr6:24428405-24489850:-	-0.44	-8.69	6.08E-17	Hematological and biochemical traits	
PRAD	cis	1	rs6911965	chr6:24480295	MRS2	chr6:24403153-24425809:+	-0.25	-4	7.5E-5	Hematological and biochemical traits	
PRAD	cis	1	rs6912959	chr6:170126224	WDR27	chr6:169857307-170102159:-	-0.13	-3.46	0.000588	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.49	-11.51	3.41E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.43	-9.29	5.59E-19	Homocysteine levels	
PRAD	cis	1	rs6916802	chr6:24465722	GPLD1	chr6:24428405-24489850:-	0.48	10.38	7.47E-23	Hematological and biochemical traits	
PRAD	cis	1	rs6916802	chr6:24465722	MRS2	chr6:24403153-24425809:+	0.26	4.41	1.26E-5	Hematological and biochemical traits	
PRAD	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.43	-9.17	1.53E-18	Homocysteine levels	
PRAD	cis	1	rs6917538	chr6:153440197	RGS17	chr6:153332041-153452389:-	-0.55	-13.21	4.36E-34	Prostate cancer	
PRAD	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.43	-9.18	1.33E-18	Homocysteine levels	
PRAD	cis	1	rs6918586	chr6:26097384	BTN3A2	chr6:26365398-26378546:+	-0.18	-4.31	2.01E-5	Schizophrenia	
PRAD	cis	1	rs6918586	chr6:26097384	HIST1H1T	chr6:26107641-26108364:-	0.25	4.54	7.31E-6	Schizophrenia	
PRAD	cis	1	rs6920075	chr6:33731797	LEMD2	chr6:33738991-33756906:-	-0.21	-6.67	7.15E-11	Crohn's disease	
PRAD	cis	1	rs6921487	chr6:33749293	LEMD2	chr6:33738991-33756906:-	0.15	4.17	3.7E-5	Body mass index	
PRAD	cis	1	rs6922617	chr6:41336101	MDFI	chr6:41604930-41621981:+	0.38	3.87	0.000123	Alzheimer's disease biomarkers	
PRAD	cis	1	rs6922824	chr6:26553815	BTN2A3	chr6:26422317-26431927:+	-0.26	-6.61	1.06E-10	Educational attainment	
PRAD	cis	1	rs6922824	chr6:26553815	ZNF184	chr6:27418522-27440897:-	0.17	3.52	0.000478	Educational attainment	
PRAD	cis	1	rs6923124	chr6:49419864	CENPQ	chr6:49431096-49460820:+	-0.4	-8.39	5.63E-16	Folate pathway vitamin levels	
PRAD	cis	1	rs6923124	chr6:49419864	MUT	chr6:49398994-49431031:-	0.19	5.22	2.72E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.5	12.12	1.29E-29	Response to antipsychotic treatment	
PRAD	cis	1	rs6923339	chr6:170128033	WDR27	chr6:169857307-170102159:-	-0.13	-3.46	0.000588	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs6923917	chr6:161031718	LPA	chr6:160952516-161087407:-	0.15	3.52	0.00047	Lipoprotein (a) levels	
PRAD	cis	1	rs6924373	chr6:87804222	C6orf165	chr6:88117721-88205858:+	0.26	4.68	3.83E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
PRAD	cis	1	rs6924838	chr6:26571756	BTN2A3	chr6:26422317-26431927:+	0.26	6.44	2.99E-10	Educational attainment	
PRAD	cis	1	rs6924838	chr6:26571756	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.44	0.000633	Educational attainment	
PRAD	cis	1	rs6924838	chr6:26571756	ZNF184	chr6:27418522-27440897:-	-0.18	-3.74	0.000208	Educational attainment	
PRAD	cis	1	rs6925273	chr6:33732448	LEMD2	chr6:33738991-33756906:-	-0.21	-6.7	6.03E-11	Crohn's disease	
PRAD	cis	1	rs6925703	chr6:26521589	BTN2A3	chr6:26422317-26431927:+	0.25	6.45	2.86E-10	Educational attainment	
PRAD	cis	1	rs6925703	chr6:26521589	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.46	0.000585	Educational attainment	
PRAD	cis	1	rs6925703	chr6:26521589	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000366	Educational attainment	
PRAD	cis	1	rs6925895	chr6:26572165	BTN2A3	chr6:26422317-26431927:+	0.25	6.38	4.2E-10	Educational attainment	
PRAD	cis	1	rs6925895	chr6:26572165	HIST1H2AG	chr6:27100817-27101313:+	0.18	3.48	0.000555	Educational attainment	
PRAD	cis	1	rs6925895	chr6:26572165	ZNF184	chr6:27418522-27440897:-	-0.18	-3.67	0.000266	Educational attainment	
PRAD	cis	1	rs6926054	chr6:49643873	RHAG	chr6:49572893-49604587:-	0.28	4.4	1.34E-5	Prothrombin fragments F1+2 levels in ischemic stroke	
PRAD	cis	1	rs6926629	chr6:26499903	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.21E-10	Educational attainment	
PRAD	cis	1	rs6926629	chr6:26499903	ZNF184	chr6:27418522-27440897:-	-0.18	-3.72	0.000225	Educational attainment	
PRAD	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.53	-10.16	4.66E-22	Diabetic kidney disease	
PRAD	cis	1	rs6927188	chr6:42912589	RPL7L1	chr6:42847671-42857596:+	0.2	5.3	1.79E-7	Diabetic kidney disease	
PRAD	cis	1	rs6927516	chr6:153441831	RGS17	chr6:153332041-153452389:-	-0.55	-13.5	2.52E-35	Prostate cancer	
PRAD	cis	1	rs6927654	chr6:88294309	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs6927826	chr6:88294297	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs6928435	chr6:24467366	GPLD1	chr6:24428405-24489850:-	0.49	10.43	4.6E-23	Hematological and biochemical traits	
PRAD	cis	1	rs6928435	chr6:24467366	MRS2	chr6:24403153-24425809:+	0.26	4.42	1.22E-5	Hematological and biochemical traits	
PRAD	cis	1	rs6928546	chr6:46632006	TDRD6	chr6:46655866-46670149:+	0.28	4.86	1.62E-6	Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs6929542	chr6:88302906	C6orf165	chr6:88117721-88205858:+	0.37	3.57	0.000397	Obesity-related traits	
PRAD	cis	1	rs6930076	chr6:88088654	C6orf164	chr6:88032306-88109459:+	-0.19	-4.12	4.45E-5	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs6930076	chr6:88088654	C6orf165	chr6:88117721-88205858:+	-0.54	-10.09	8.77E-22	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs6930076	chr6:88088654	SLC35A1	chr6:88146444-88222051:+	-0.22	-4.26	2.52E-5	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs6930120	chr6:26555484	BTN2A3	chr6:26422317-26431927:+	0.26	6.58	1.29E-10	Educational attainment	
PRAD	cis	1	rs6930120	chr6:26555484	ZNF184	chr6:27418522-27440897:-	-0.17	-3.51	0.000488	Educational attainment	
PRAD	cis	1	rs6930201	chr6:33738749	LEMD2	chr6:33738991-33756906:-	0.17	4.49	8.9E-6	Body mass index	
PRAD	cis	1	rs6931160	chr6:153430451	RGS17	chr6:153332041-153452389:-	-0.56	-13.61	8.88E-36	Prostate cancer	
PRAD	cis	1	rs6932156	chr6:26571506	BTN2A3	chr6:26422317-26431927:+	0.26	6.44	2.99E-10	Educational attainment	
PRAD	cis	1	rs6932156	chr6:26571506	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.44	0.000633	Educational attainment	
PRAD	cis	1	rs6932156	chr6:26571506	ZNF184	chr6:27418522-27440897:-	-0.18	-3.74	0.000208	Educational attainment	
PRAD	cis	1	rs6932590	chr6:27248931	BTN3A2	chr6:26365398-26378546:+	-0.35	-7.44	4.67E-13	Schizophrenia	
PRAD	cis	1	rs6932590	chr6:27248931	ZNF389	chr6:28129551-28137375:+	-0.32	-4.97	9.58E-7	Schizophrenia	
PRAD	cis	1	rs6932936	chr6:14115090	CD83	chr6:14117865-14137146:+	-0.23	-3.94	9.32E-5	Rheumatoid arthritis	
PRAD	cis	1	rs6933174	chr6:33751003	LEMD2	chr6:33738991-33756906:-	0.19	4.96	1.01E-6	Body mass index	
PRAD	cis	1	rs6933176	chr6:26540178	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs6933176	chr6:26540178	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.4	9.91	3.92E-21	Response to antipsychotic treatment	
PRAD	cis	1	rs6933568	chr6:33751261	LEMD2	chr6:33738991-33756906:-	0.2	4.98	8.81E-7	Body mass index	
PRAD	cis	1	rs6933576	chr6:161068176	LPA	chr6:160952516-161087407:-	0.15	3.47	0.000576	Lipoprotein (a) levels	
PRAD	cis	1	rs6933607	chr6:33743997	LEMD2	chr6:33738991-33756906:-	0.19	4.92	1.18E-6	Body mass index	
PRAD	cis	1	rs6933660	chr6:151803754	RMND1	chr6:151725989-151773316:-	-0.18	-4	7.34E-5	Menarche (age at onset)	
PRAD	cis	1	rs6934171	chr6:46316742	TNFRSF21	chr6:47199269-47277680:-	0.18	3.74	0.000207	Body mass index	
PRAD	cis	1	rs6935976	chr6:35498098	TULP1	chr6:35465653-35480647:-	-0.32	-4.55	6.83E-6	Hepatitis C induced liver fibrosis	
PRAD	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.48	-10.89	8.76E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs6936177	chr6:34783717	UHRF1BP1	chr6:34759794-34853117:+	0.17	4.5	8.44E-6	Pubertal anthropometrics	
PRAD	cis	1	rs6937935	chr6:167670223	UNC93A	chr6:167704803-167729501:+	0.3	5.24	2.38E-7	Parental extreme longevity (95 years and older)	
PRAD	cis	1	rs6938239	chr6:34683635	UHRF1BP1	chr6:34759794-34853117:+	-0.18	-4.67	3.86E-6	Pubertal anthropometrics	
PRAD	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.83	-26.34	1.37E-94	Crohn's disease	
PRAD	cis	1	rs693824	chr11:65654783	KCNK7	chr11:65360327-65363467:-	-0.16	-3.45	0.000611	Crohn's disease	
PRAD	cis	1	rs693824	chr11:65654783	SNX32	chr11:65601410-65621170:+	0.45	6.93	1.37E-11	Crohn's disease	
PRAD	cis	1	rs6940053	chr6:26562122	BTN2A3	chr6:26422317-26431927:+	0.26	6.59	1.15E-10	Educational attainment	
PRAD	cis	1	rs6940053	chr6:26562122	ZNF184	chr6:27418522-27440897:-	-0.18	-3.64	0.0003	Educational attainment	
PRAD	cis	1	rs6940188	chr6:26562029	BTN2A3	chr6:26422317-26431927:+	0.25	6.43	3.19E-10	Educational attainment	
PRAD	cis	1	rs6940188	chr6:26562029	ZNF184	chr6:27418522-27440897:-	-0.17	-3.45	0.000606	Educational attainment	
PRAD	cis	1	rs6940353	chr6:33752550	LEMD2	chr6:33738991-33756906:-	0.19	4.96	1.01E-6	Body mass index	
PRAD	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.48	-10.83	1.45E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs6941766	chr6:170131653	WDR27	chr6:169857307-170102159:-	-0.13	-3.45	0.00061	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs6942332	chr6:170131934	WDR27	chr6:169857307-170102159:-	-0.13	-3.64	0.000308	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs6945843	chr7:65734783	TPST1	chr7:65670259-65825437:+	-0.18	-4.48	9.29E-6	Aortic root size	
PRAD	cis	1	rs694609	chr13:28194806	POLR1D	chr13:28194895-28241547:+	-0.15	-3.46	0.000586	Large B-cell lymphoma	
PRAD	cis	1	rs6946143	chr7:65579722	TPST1	chr7:65670259-65825437:+	0.17	4.23	2.82E-5	Aortic root size	
PRAD	cis	1	rs6946471	chr7:77062284	PION	chr7:76940070-77045717:-	-0.2	-4.08	5.28E-5	Cervical cancer	
PRAD	cis	1	rs6947019	chr7:1950337	MAD1L1	chr7:1855428-2272583:-	0.15	3.45	0.000605	Bipolar disorder	
PRAD	cis	1	rs6948775	chr7:98945480	CYP3A5	chr7:99245818-99332821:-	0.3	6.23	1.05E-9	Blood metabolite levels	
PRAD	cis	1	rs6949812	chr7:65387101	CCT6P1	chr7:65216092-65228661:+	0.31	5.59	3.91E-8	Diabetic kidney disease	
PRAD	cis	1	rs6949812	chr7:65387101	CRCP	chr7:65579805-65619551:+	-0.27	-3.53	0.00045	Diabetic kidney disease	
PRAD	cis	1	rs6949897	chr7:50621920	DDC	chr7:50526136-50633154:-	0.23	3.9	0.000111	Malaria	
PRAD	cis	1	rs6949897	chr7:50621920	FIGNL1	chr7:50511834-50518088:-	-0.22	-5.79	1.31E-8	Malaria	
PRAD	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.83	-26.34	1.37E-94	Crohn's disease	
PRAD	cis	1	rs694994	chr11:65653309	KCNK7	chr11:65360327-65363467:-	-0.16	-3.45	0.000611	Crohn's disease	
PRAD	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.45	6.93	1.37E-11	Crohn's disease	
PRAD	cis	1	rs6951245	chr7:1058193	GPR146	chr7:1084243-1098897:+	0.27	3.6	0.000355	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs6951245	chr7:1058193	ZFAND2A	chr7:1192544-1199855:-	-0.31	-4.57	6.24E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs6952407	chr7:66045512	CCT6P1	chr7:65216092-65228661:+	0.13	3.48	0.000547	Cotinine glucuronidation	
PRAD	cis	1	rs6952407	chr7:66045512	CRCP	chr7:65579805-65619551:+	0.21	4.04	6.21E-5	Cotinine glucuronidation	
PRAD	cis	1	rs6952407	chr7:66045512	LOC493754	chr7:65993446-66057363:-	0.23	5.36	1.31E-7	Cotinine glucuronidation	
PRAD	cis	1	rs6952407	chr7:66045512	TPST1	chr7:65670259-65825437:+	-0.15	-3.76	0.000194	Cotinine glucuronidation	
PRAD	cis	1	rs6956179	chr7:65806659	TPST1	chr7:65670259-65825437:+	-0.16	-4.04	6.2E-5	Aortic root size	
PRAD	cis	1	rs6957199	chr7:65978519	TPST1	chr7:65670259-65825437:+	0.18	4.37	1.52E-5	Aortic root size	
PRAD	cis	1	rs6958271	chr7:65979331	TPST1	chr7:65670259-65825437:+	0.18	4.45	1.06E-5	Aortic root size	
PRAD	cis	1	rs6958277	chr7:65979349	TPST1	chr7:65670259-65825437:+	0.18	4.45	1.06E-5	Aortic root size	
PRAD	cis	1	rs6958289	chr7:65657111	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs6958289	chr7:65657111	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs6958420	chr7:65751171	CCT6P1	chr7:65216092-65228661:+	-0.33	-5.52	5.68E-8	Diabetic kidney disease	
PRAD	cis	1	rs6958420	chr7:65751171	CRCP	chr7:65579805-65619551:+	0.35	4.28	2.31E-5	Diabetic kidney disease	
PRAD	cis	1	rs6958484	chr7:65599446	TPST1	chr7:65670259-65825437:+	-0.18	-4.48	9.58E-6	Aortic root size	
PRAD	cis	1	rs6958520	chr7:66151453	CRCP	chr7:65579805-65619551:+	-0.2	-3.74	0.000206	Aortic root size	
PRAD	cis	1	rs6958520	chr7:66151453	LOC493754	chr7:65993446-66057363:-	-0.22	-5.13	4.16E-7	Aortic root size	
PRAD	cis	1	rs6958520	chr7:66151453	TPST1	chr7:65670259-65825437:+	0.15	3.74	0.000203	Aortic root size	
PRAD	cis	1	rs6959002	chr7:65650496	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs6959002	chr7:65650496	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs6959702	chr7:3356286	CARD11	chr7:2945769-3083579:-	0.08	3.52	0.000477	Motion sickness	
PRAD	cis	1	rs6961155	chr7:65933295	TPST1	chr7:65670259-65825437:+	0.18	4.4	1.32E-5	Aortic root size	
PRAD	cis	1	rs6961717	chr7:65587537	TPST1	chr7:65670259-65825437:+	-0.18	-4.48	9.58E-6	Aortic root size	
PRAD	cis	1	rs6961990	chr7:65888570	TPST1	chr7:65670259-65825437:+	0.18	4.43	1.18E-5	Aortic root size	
PRAD	cis	1	rs6962120	chr7:38847594	FAM183B	chr7:38724947-38726689:-	0.39	3.72	0.000224	Cognitive performance	
PRAD	cis	1	rs6962965	chr7:26568001	HOXA4	chr7:27168127-27170399:-	-0.22	-3.69	0.000251	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs6963495	chr7:105166853	RINT1	chr7:105172532-105208124:+	-0.29	-4.62	4.94E-6	Bipolar disorder (body mass index interaction)	
PRAD	cis	1	rs6963646	chr7:65685767	TPST1	chr7:65670259-65825437:+	-0.18	-4.47	9.95E-6	Aortic root size	
PRAD	cis	1	rs6964245	chr7:65718717	CCT6P1	chr7:65216092-65228661:+	-0.33	-5.52	5.68E-8	Diabetic kidney disease	
PRAD	cis	1	rs6964245	chr7:65718717	CRCP	chr7:65579805-65619551:+	0.35	4.28	2.31E-5	Diabetic kidney disease	
PRAD	cis	1	rs6964530	chr7:65718851	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.76	1.49E-8	Diabetic kidney disease	
PRAD	cis	1	rs6964530	chr7:65718851	CRCP	chr7:65579805-65619551:+	0.33	4.15	3.97E-5	Diabetic kidney disease	
PRAD	cis	1	rs6965016	chr7:97807882	BHLHA15	chr7:97840778-97842271:+	-0.14	-3.6	0.000351	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs6965685	chr7:158726462	WDR60	chr7:158649269-158738882:+	-0.21	-4.67	3.88E-6	Height	
PRAD	cis	1	rs6966322	chr7:65646754	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs6966322	chr7:65646754	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs6966619	chr7:3359491	CARD11	chr7:2945769-3083579:-	-0.08	-3.6	0.000348	Motion sickness	
PRAD	cis	1	rs6967330	chr7:105658451	NAMPT	chr7:105888734-105925638:-	-0.17	-3.72	0.000226	Asthma (childhood onset)	
PRAD	cis	1	rs6967385	chr7:12391319	VWDE	chr7:12370509-12443852:-	-0.33	-5.84	9.51E-9	Response to taxane treatment (placlitaxel)	
PRAD	cis	1	rs6970030	chr7:65968679	TPST1	chr7:65670259-65825437:+	0.18	4.46	1.05E-5	Aortic root size	
PRAD	cis	1	rs6970243	chr7:65388490	CCT6P1	chr7:65216092-65228661:+	0.31	5.59	3.91E-8	Diabetic kidney disease	
PRAD	cis	1	rs6970243	chr7:65388490	CRCP	chr7:65579805-65619551:+	-0.27	-3.53	0.00045	Diabetic kidney disease	
PRAD	cis	1	rs6970597	chr7:21583519	DNAH11	chr7:21582833-21941455:+	-0.18	-4.33	1.85E-5	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
PRAD	cis	1	rs6970985	chr7:21583597	DNAH11	chr7:21582833-21941455:+	-0.18	-4.38	1.49E-5	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
PRAD	cis	1	rs6974373	chr7:99590893	TRIM4	chr7:99488037-99517154:-	-0.31	-6.35	5.19E-10	Interstitial lung disease	
PRAD	cis	1	rs6974723	chr7:65637939	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs6974723	chr7:65637939	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs6975195	chr7:66124774	CRCP	chr7:65579805-65619551:+	0.2	3.72	0.000225	Aortic root size	
PRAD	cis	1	rs6975195	chr7:66124774	LOC493754	chr7:65993446-66057363:-	0.22	5.04	6.68E-7	Aortic root size	
PRAD	cis	1	rs6975195	chr7:66124774	TPST1	chr7:65670259-65825437:+	-0.15	-3.64	0.000302	Aortic root size	
PRAD	cis	1	rs6975557	chr7:107973297	NRCAM	chr7:107788084-108096826:-	0.23	3.72	0.00022	Femoral neck bone geometry and menarche (age at onset)	
PRAD	cis	1	rs6976053	chr7:100512119	UFSP1	chr7:100486346-100487339:-	-0.14	-3.53	0.00045	Plasminogen activator inhibitor type 1 levels (PAI-1)	
PRAD	cis	1	rs6976930	chr7:72885810	MLXIPL	chr7:73007524-73038870:-	0.25	3.91	0.000106	Triglycerides	
PRAD	cis	1	rs6977321	chr7:97774859	BHLHA15	chr7:97840778-97842271:+	-0.14	-3.7	0.000242	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs6979382	chr7:65886375	TPST1	chr7:65670259-65825437:+	0.18	4.43	1.18E-5	Aortic root size	
PRAD	cis	1	rs697970	chr7:65560052	TPST1	chr7:65670259-65825437:+	-0.19	-4.61	5.31E-6	Aortic root size	
PRAD	cis	1	rs6980323	chr7:3356207	CARD11	chr7:2945769-3083579:-	0.08	3.65	0.000297	Motion sickness	
PRAD	cis	1	rs6984009	chr8:96289091	C8orf37	chr8:96258235-96281437:-	0.25	3.55	0.000423	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
PRAD	cis	1	rs698500	chr15:83237769	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.12	-3.81	0.000159	Schizophrenia	
PRAD	cis	1	rs698500	chr15:83237769	LOC80154	chr15:82944795-82975797:+;chr15	0.18	3.63	0.000312	Schizophrenia	
PRAD	cis	1	rs6985880	chr8:96027599	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs6985880	chr8:96027599	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs6986256	chr8:130728361	GSDMC	chr8:130760443-130799134:-	0.2	4.04	6.36E-5	Infant length;Height	
PRAD	cis	1	rs6989010	chr8:12772755	LONRF1	chr8:12579406-12612992:-	-0.34	-3.65	0.000293	Colorectal cancer (diet interaction)	
PRAD	cis	1	rs6989203	chr8:41523745	ANK1	chr8:41510745-41754280:-	0.24	4.51	8.33E-6	Type 2 diabetes	
PRAD	cis	1	rs6989862	chr8:96027568	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs6989862	chr8:96027568	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs6993464	chr8:120544948	NOV	chr8:120428552-120436678:+	0.19	3.57	0.00039	Smoking cessation	
PRAD	cis	1	rs6999	chr20:55093901	C20orf43	chr20:55043647-55093942:+	0.17	4.24	2.65E-5	Refractive astigmatism	
PRAD	cis	1	rs700122	chr9:115551847	C9orf80	chr9:115448793-115480387:-	0.31	4.09	4.98E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs7002168	chr8:120541754	NOV	chr8:120428552-120436678:+	0.18	3.49	0.000532	Smoking cessation	
PRAD	cis	1	rs7002940	chr8:96027392	C8orf38	chr8:95908040-96088396:+	-0.34	-5.98	4.4E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs7002940	chr8:96027392	TP53INP1	chr8:95938201-95961615:-	0.24	3.78	0.000179	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs7004520	chr8:31327049	GTF2E2	chr8:30436032-30515738:-	0.24	3.52	0.000473	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs7004520	chr8:31327049	WRN	chr8:30890778-31031276:+	0.17	3.53	0.000452	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs7005380	chr8:120953873	DSCC1	chr8:120846182-120868170:-	-0.32	-7.35	8.79E-13	Interstitial lung disease	
PRAD	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	1.03	30.21	3.47E-112	Bone mineral density	
PRAD	cis	1	rs7007970	chr8:120647929	DSCC1	chr8:120846182-120868170:-	-0.27	-4.12	4.49E-5	Height	
PRAD	cis	1	rs7008542	chr8:96027863	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs7008542	chr8:96027863	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs7010313	chr8:39430627	TACC1	chr8:38585704-38710545:+	0.17	3.77	0.000184	Visceral adipose tissue/subcutaneous adipose tissue ratio	
PRAD	cis	1	rs7014273	chr8:67358694	C8orf46	chr8:67405491-67430757:+	-0.29	-4.79	2.28E-6	Blood metabolite levels	
PRAD	cis	1	rs7014578	chr8:92077568	LRRC69	chr8:92114847-92231464:+	-0.33	-5.36	1.32E-7	Migraine - clinic-based	
PRAD	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	1.03	29.95	4.85E-111	Bone mineral density	
PRAD	cis	1	rs7018	chr20:25278261	ENTPD6	chr20:25176339-25207360:+	-0.18	-4.67	3.96E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7018	chr20:25278261	FAM182B	chr20:25744102-25848786:-	0.37	6.71	5.71E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7018	chr20:25278261	PYGB	chr20:25228706-25278647:+	-0.34	-7.42	5.45E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7019	chr20:25278278	ENTPD6	chr20:25176339-25207360:+	-0.18	-4.74	2.88E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7019	chr20:25278278	FAM182B	chr20:25744102-25848786:-	0.36	6.54	1.62E-10	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7019	chr20:25278278	PYGB	chr20:25228706-25278647:+	-0.35	-7.7	8.07E-14	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7020651	chr9:22972837	ELAVL2	chr9:23690105-23826063:-	-0.36	-3.82	0.000149	Cannabis use (initiation)	
PRAD	cis	1	rs7020689	chr9:22972985	ELAVL2	chr9:23690105-23826063:-	-0.31	-3.46	0.000586	Cannabis use (initiation)	
PRAD	cis	1	rs7020708	chr9:131885131	CRAT	chr9:131857075-131873070:-	0.22	4.12	4.55E-5	Blood metabolite ratios	
PRAD	cis	1	rs7020	chr20:25278600	ENTPD6	chr20:25176339-25207360:+	-0.17	-4.55	6.84E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7020	chr20:25278600	FAM182B	chr20:25744102-25848786:-	0.37	6.88	1.9E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7020	chr20:25278600	PYGB	chr20:25228706-25278647:+	-0.33	-7.32	1.11E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7021449	chr9:131899312	CRAT	chr9:131857075-131873070:-	0.23	4.29	2.13E-5	Blood metabolite ratios	
PRAD	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.29	-6.71	5.59E-11	Hematology traits	
PRAD	cis	1	rs7022397	chr9:116007677	PRPF4	chr9:116037974-116055054:+	0.22	4.43	1.16E-5	Hematology traits	
PRAD	cis	1	rs7023900	chr9:131891152	CRAT	chr9:131857075-131873070:-	0.23	4.24	2.7E-5	Blood metabolite ratios	
PRAD	cis	1	rs702485	chr7:6449272	RAC1	chr7:6414126-6443597:+	0.16	3.66	0.000278	HDL cholesterol	
PRAD	cis	1	rs7026073	chr9:38040672	DCAF10	chr9:37800551-37867663:+	-0.16	-4.88	1.46E-6	Brain structure	
PRAD	cis	1	rs7026073	chr9:38040672	MCART1	chr9:37877572-37904350:-	-0.17	-3.45	0.000613	Brain structure	
PRAD	cis	1	rs7029536	chr9:130110411	SLC2A8	chr9:130159465-130170161:+	-0.15	-3.49	0.000527	Metabolite levels (HVA)	
PRAD	cis	1	rs7030795	chr9:115558962	C9orf80	chr9:115448793-115480387:-	0.31	4.07	5.5E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs7030887	chr9:100688511	C9orf156	chr9:100666772-100684852:-	-0.19	-3.68	0.000264	Quantitative traits	
PRAD	cis	1	rs7030907	chr9:100688577	C9orf156	chr9:100666772-100684852:-	-0.19	-3.68	0.000264	Quantitative traits	
PRAD	cis	1	rs7031325	chr9:6655056	GLDC	chr9:6532466-6645692:-	0.39	8.07	5.82E-15	Systemic lupus erythematosus	
PRAD	cis	1	rs7031325	chr9:6655056	KIAA2026	chr9:5919010-6008003:-	0.12	3.72	0.000219	Systemic lupus erythematosus	
PRAD	cis	1	rs7036114	chr9:131893406	CRAT	chr9:131857075-131873070:-	0.23	4.3	2.1E-5	Blood metabolite ratios	
PRAD	cis	1	rs7036236	chr9:131899299	CRAT	chr9:131857075-131873070:-	0.22	4.15	3.95E-5	Blood metabolite ratios	
PRAD	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.38	-6.9	1.72E-11	Rheumatoid arthritis	
PRAD	cis	1	rs7037140	chr9:123656327	TRAF1	chr9:123664672-123691479:-	0.18	5.12	4.54E-7	Rheumatoid arthritis	
PRAD	cis	1	rs7037163	chr9:131894340	CRAT	chr9:131857075-131873070:-	0.22	4.02	6.87E-5	Blood metabolite ratios	
PRAD	cis	1	rs7037351	chr9:113652080	PTGR1	chr9:114312003-114362135:-	-0.24	-3.87	0.000125	Corneal structure	
PRAD	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.36	-7.82	3.58E-14	Multiple sclerosis	
PRAD	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.51	12.61	1.32E-31	Multiple sclerosis	
PRAD	cis	1	rs703842	chr12:58162739	XRCC6BP1	chr12:58335445-58351051:+	0.23	4.77	2.44E-6	Multiple sclerosis	
PRAD	cis	1	rs7038684	chr9:115601431	C9orf80	chr9:115448793-115480387:-	0.28	3.71	0.000234	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.29	-6.71	5.59E-11	Hematology traits	
PRAD	cis	1	rs7038769	chr9:116007583	PRPF4	chr9:116037974-116055054:+	0.22	4.43	1.16E-5	Hematology traits	
PRAD	cis	1	rs7040639	chr9:101121741	ANP32B	chr9:100745489-100778222:+	0.24	3.54	0.000446	Folate pathway vitamin levels	
PRAD	cis	1	rs7041965	chr9:115598341	C9orf80	chr9:115448793-115480387:-	0.31	4.09	5.14E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs7042681	chr9:38040828	DCAF10	chr9:37800551-37867663:+	-0.16	-4.88	1.46E-6	Brain structure	
PRAD	cis	1	rs7042681	chr9:38040828	MCART1	chr9:37877572-37904350:-	-0.17	-3.45	0.000613	Brain structure	
PRAD	cis	1	rs7045881	chr9:26935996	IFT74	chr9:26947037-27062923:+	0.33	4.09	5.04E-5	Schizophrenia	
PRAD	cis	1	rs7045881	chr9:26935996	LRRC19	chr9:26993143-27005691:-	-0.74	-8.76	3.59E-17	Schizophrenia	
PRAD	cis	1	rs704	chr17:26694861	TMEM97	chr17:26646121-26655710:+	0.18	3.6	0.000357	Osteoprotegerin levels	
PRAD	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.8	15.52	3.66E-44	Cognitive function	
PRAD	cis	1	rs705747	chr1:202505283	SYT2	chr1:202559727-202679551:-	-0.17	-3.56	0.000412	Sex ratio	
PRAD	cis	1	rs7070296	chr10:65070438	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.72	0.000226	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7070296	chr10:65070438	NRBF2	chr10:64893007-64914785:+	-0.3	-6.64	8.7E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7070776	chr10:102264672	SEC31B	chr10:102246403-102289636:-	-0.31	-9.3	5.33E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7071195	chr10:59724463	LOC728640	chr10:60474775-60477291:+	-0.29	-3.54	0.00044	Blood pressure	
PRAD	cis	1	rs7071271	chr10:102264824	SEC31B	chr10:102246403-102289636:-	-0.31	-9.27	6.5E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.68	14.78	7.38E-41	Metabolite levels	
PRAD	cis	1	rs7072554	chr10:1090988	IDI2	chr10:1064847-1071799:-	-0.24	-4.73	3.0E-6	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs7072554	chr10:1090988	WDR37	chr10:1102344-1178237:+	0.24	4.3	2.05E-5	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs7072634	chr10:17240918	TRDMT1	chr10:17184983-17243681:-	-0.26	-5.24	2.4E-7	Homocysteine levels	
PRAD	cis	1	rs7073586	chr10:102307671	SEC31B	chr10:102246403-102289636:-	-0.28	-8.4	5.14E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7073746	chr10:64904071	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.52	0.000474	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7073746	chr10:64904071	NRBF2	chr10:64893007-64914785:+	-0.29	-6.46	2.61E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7075188	chr10:1088746	IDI2	chr10:1064847-1071799:-	0.24	4.81	2.01E-6	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs7075188	chr10:1088746	WDR37	chr10:1102344-1178237:+	-0.23	-4.13	4.28E-5	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs7078012	chr10:81705433	SFTPD	chr10:81697498-81708861:-	-0.22	-3.73	0.000218	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs7078799	chr10:102301447	SEC31B	chr10:102246403-102289636:-	-0.29	-8.52	2.16E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7079136	chr10:102292709	SEC31B	chr10:102246403-102289636:-	-0.3	-8.98	6.57E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7079679	chr10:102055546	CWF19L1	chr10:101992055-102027437:-	-0.21	-4.02	6.68E-5	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	
PRAD	cis	1	rs7079756	chr10:102302105	SEC31B	chr10:102246403-102289636:-	-0.29	-8.72	4.95E-17	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7080356	chr10:102266735	SEC31B	chr10:102246403-102289636:-	-0.3	-9.17	1.54E-18	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs708152	chr11:2384348	C11orf21	chr11:2317507-2323143:-	-0.21	-4.2	3.18E-5	Bacteremia	
PRAD	cis	1	rs7082376	chr10:17232223	TRDMT1	chr10:17184983-17243681:-	-0.27	-5.26	2.2E-7	Homocysteine levels	
PRAD	cis	1	rs7084476	chr10:17211383	TRDMT1	chr10:17184983-17243681:-	-0.24	-4.86	1.64E-6	Homocysteine levels	
PRAD	cis	1	rs7084810	chr10:102297546	SEC31B	chr10:102246403-102289636:-	-0.28	-8.5	2.56E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7084921	chr10:101813802	CWF19L1	chr10:101992055-102027437:-	0.28	5.49	6.57E-8	Bone mineral density	
PRAD	cis	1	rs7085439	chr10:102210100	SEC31B	chr10:102246403-102289636:-	-0.31	-9.28	6.33E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7088512	chr10:102303498	SEC31B	chr10:102246403-102289636:-	-0.28	-8.62	1.07E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7088591	chr10:59724403	LOC728640	chr10:60474775-60477291:+	-0.29	-3.54	0.00044	Blood pressure	
PRAD	cis	1	rs7088827	chr10:102303865	SEC31B	chr10:102246403-102289636:-	-0.28	-8.56	1.61E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7090431	chr10:102261753	SEC31B	chr10:102246403-102289636:-	-0.31	-9.41	2.29E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7090871	chr10:63830286	ARID5B	chr10:63661443-63856703:+	-0.16	-3.61	0.000337	Corneal structure	
PRAD	cis	1	rs709400	chr14:104149475	BAG5	chr14:104022889-104029151:-	0.18	3.7	0.000239	Body mass index	
PRAD	cis	1	rs709400	chr14:104149475	C14orf153	chr14:104029299-104057227:+	0.14	4.15	3.95E-5	Body mass index	
PRAD	cis	1	rs709400	chr14:104149475	CKB	chr14:103985996-103989170:-	0.22	4.88	1.49E-6	Body mass index	
PRAD	cis	1	rs709400	chr14:104149475	KLC1	chr14:104029299-104167887:+	-0.17	-3.53	0.00045	Body mass index	
PRAD	cis	1	rs709400	chr14:104149475	MARK3	chr14:103851701-103970164:+	0.24	5.02	7.22E-7	Body mass index	
PRAD	cis	1	rs7094631	chr10:100593063	CUTC	chr10:101491958-101515893:+	-0.21	-3.94	9.41E-5	Obesity-related traits	
PRAD	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.33	-5.82	1.12E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs7095944	chr10:126302936	METTL10	chr10:126447406-126480439:-	-0.22	-4.51	8.22E-6	Asthma	
PRAD	cis	1	rs709595	chr7:65817333	TPST1	chr7:65670259-65825437:+	0.18	4.54	7.23E-6	Aortic root size	
PRAD	cis	1	rs709597	chr7:65825983	TPST1	chr7:65670259-65825437:+	-0.19	-4.67	3.98E-6	Aortic root size	
PRAD	cis	1	rs709607	chr7:65449541	CCT6P1	chr7:65216092-65228661:+	-0.26	-4.58	5.86E-6	Diabetic kidney disease	
PRAD	cis	1	rs709607	chr7:65449541	CRCP	chr7:65579805-65619551:+	0.29	3.77	0.000186	Diabetic kidney disease	
PRAD	cis	1	rs7096692	chr10:17180828	TRDMT1	chr10:17184983-17243681:-	-0.29	-5.61	3.39E-8	Homocysteine levels	
PRAD	cis	1	rs7097610	chr10:82304162	ANXA11	chr10:81914880-81965433:-	-0.23	-3.7	0.000239	Post bronchodilator FEV1	
PRAD	cis	1	rs7097	chr13:28197436	POLR1D	chr13:28194895-28241547:+	0.16	3.64	0.000299	Large B-cell lymphoma	
PRAD	cis	1	rs7098825	chr10:104628234	SFXN2	chr10:104474298-104498946:+	-0.31	-3.54	0.000442	Hypertension;Systolic blood pressure;Diastolic blood pressure	
PRAD	cis	1	rs7099913	chr10:102314777	SEC31B	chr10:102246403-102289636:-	-0.27	-8.33	8.75E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7099965	chr10:102301165	SEC31B	chr10:102246403-102289636:-	-0.29	-8.54	1.91E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7099	chr20:43997646	SYS1	chr20:43991701-44004724:+	-0.36	-6.64	8.54E-11	Psoriasis	
PRAD	cis	1	rs7100163	chr10:17181177	TRDMT1	chr10:17184983-17243681:-	-0.27	-5.34	1.44E-7	Homocysteine levels	
PRAD	cis	1	rs7100386	chr10:102301417	SEC31B	chr10:102246403-102289636:-	-0.29	-8.52	2.16E-16	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7101429	chr11:77992967	GAB2	chr11:77926343-78128766:-	-0.21	-6.28	7.53E-10	Testicular germ cell tumor	
PRAD	cis	1	rs7101429	chr11:77992967	NARS2	chr11:78147017-78285909:-	-0.19	-3.66	0.00028	Testicular germ cell tumor	
PRAD	cis	1	rs7101582	chr11:47714610	AGBL2	chr11:47681145-47736302:-	0.16	3.46	0.000595	Intraocular pressure	
PRAD	cis	1	rs7103969	chr11:3260150	MRGPRE	chr11:3249042-3253616:-	-0.17	-3.86	0.000129	Multiple sclerosis	
PRAD	cis	1	rs7104094	chr11:3260259	MRGPRE	chr11:3249042-3253616:-	-0.16	-3.65	0.000289	Multiple sclerosis	
PRAD	cis	1	rs7104222	chr11:78007169	GAB2	chr11:77926343-78128766:-	-0.19	-6.04	3.18E-9	Testicular germ cell tumor	
PRAD	cis	1	rs7104222	chr11:78007169	NARS2	chr11:78147017-78285909:-	-0.24	-4.9	1.33E-6	Testicular germ cell tumor	
PRAD	cis	1	rs7104488	chr11:3259830	MRGPRE	chr11:3249042-3253616:-	-0.17	-3.86	0.000129	Multiple sclerosis	
PRAD	cis	1	rs7107174	chr11:77997936	GAB2	chr11:77926343-78128766:-	-0.21	-6.57	1.31E-10	Testicular germ cell tumor	
PRAD	cis	1	rs7107174	chr11:77997936	NARS2	chr11:78147017-78285909:-	-0.2	-3.79	0.000169	Testicular germ cell tumor	
PRAD	cis	1	rs7107184	chr11:48577069	FOLH1	chr11:49168188-49230222:-	-0.15	-3.48	0.000547	HDL cholesterol	
PRAD	cis	1	rs7108522	chr11:108281004	ATM	chr11:108093559-108239826:+	-0.17	-5.32	1.65E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs710865	chr1:19568972	KIAA0090	chr1:19544585-19578046:-	-0.21	-6.56	1.42E-10	Brain structure	
PRAD	cis	1	rs710865	chr1:19568972	MRTO4	chr1:19578075-19586621:+	-0.16	-5.09	5.2E-7	Brain structure	
PRAD	cis	1	rs710866	chr1:19568722	KIAA0090	chr1:19544585-19578046:-	-0.2	-6.24	9.52E-10	Brain structure	
PRAD	cis	1	rs710866	chr1:19568722	MRTO4	chr1:19578075-19586621:+	-0.15	-4.74	2.79E-6	Brain structure	
PRAD	cis	1	rs7108770	chr11:46648432	ARHGAP1	chr11:46698634-46722120:-	-0.19	-3.56	0.00041	Schizophrenia	
PRAD	cis	1	rs7108770	chr11:46648432	HARBI1	chr11:46624857-46638777:-	0.26	3.82	0.000152	Schizophrenia	
PRAD	cis	1	rs7109698	chr11:46673344	HARBI1	chr11:46624857-46638777:-	-0.28	-4.15	3.93E-5	Schizophrenia	
PRAD	cis	1	rs7110070	chr11:7707768	CYB5R2	chr11:7686327-7694994:-	0.19	4.18	3.54E-5	Waist circumference	
PRAD	cis	1	rs7111239	chr11:123958449	SLC37A2	chr11:124933013-124960411:+	0.27	3.88	0.000119	Obesity-related traits	
PRAD	cis	1	rs7111986	chr11:78102266	GAB2	chr11:77926343-78128766:-	-0.21	-6.66	7.47E-11	Testicular germ cell tumor	
PRAD	cis	1	rs7111986	chr11:78102266	NARS2	chr11:78147017-78285909:-	-0.18	-3.49	0.000524	Testicular germ cell tumor	
PRAD	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.88	-18.78	4.22E-59	Type 2 diabetes	
PRAD	cis	1	rs7111	chr15:90373873	C15orf38	chr15:90443832-90456222:-	0.2	3.86	0.000132	Type 2 diabetes	
PRAD	cis	1	rs7111	chr15:90373873	GABARAPL3	chr15:90889765-90892679:-	0.22	3.43	0.00065	Type 2 diabetes	
PRAD	cis	1	rs7112060	chr11:46891901	ARHGAP1	chr11:46698634-46722120:-	-0.26	-3.84	0.000138	Schizophrenia	
PRAD	cis	1	rs7112136	chr11:108287131	ATM	chr11:108093559-108239826:+	-0.17	-5.25	2.27E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs7112229	chr11:46513249	HARBI1	chr11:46624857-46638777:-	0.26	3.43	0.000661	Schizophrenia	
PRAD	cis	1	rs7112234	chr11:78102470	GAB2	chr11:77926343-78128766:-	-0.18	-6.12	1.98E-9	Testicular germ cell tumor	
PRAD	cis	1	rs7112234	chr11:78102470	NARS2	chr11:78147017-78285909:-	-0.21	-4.61	5.31E-6	Testicular germ cell tumor	
PRAD	cis	1	rs7112397	chr11:22854616	SVIP	chr11:22843600-22851382:-	0.27	6.5	2.08E-10	Dialysis-related mortality	
PRAD	cis	1	rs7112513	chr11:117037361	PCSK7	chr11:117075789-117102811:-	-0.36	-4.86	1.57E-6	Protein quantitative trait loci	
PRAD	cis	1	rs7113042	chr11:78035832	GAB2	chr11:77926343-78128766:-	0.17	5.84	9.74E-9	Testicular germ cell tumor	
PRAD	cis	1	rs7113042	chr11:78035832	NARS2	chr11:78147017-78285909:-	0.24	5.33	1.56E-7	Testicular germ cell tumor	
PRAD	cis	1	rs7115038	chr11:46897792	ARHGAP1	chr11:46698634-46722120:-	0.29	4.26	2.44E-5	Schizophrenia	
PRAD	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.59	-11.96	5.96E-29	Forced vital capacity	
PRAD	cis	1	rs7116611	chr11:78030046	GAB2	chr11:77926343-78128766:-	-0.21	-6.33	5.58E-10	Testicular germ cell tumor	
PRAD	cis	1	rs7116611	chr11:78030046	NARS2	chr11:78147017-78285909:-	-0.19	-3.62	0.000325	Testicular germ cell tumor	
PRAD	cis	1	rs7116698	chr11:77995191	GAB2	chr11:77926343-78128766:-	-0.21	-6.48	2.33E-10	Testicular germ cell tumor	
PRAD	cis	1	rs7116698	chr11:77995191	NARS2	chr11:78147017-78285909:-	-0.23	-4.62	5.04E-6	Testicular germ cell tumor	
PRAD	cis	1	rs7117238	chr11:78040259	GAB2	chr11:77926343-78128766:-	-0.17	-5.92	6.19E-9	Testicular germ cell tumor	
PRAD	cis	1	rs7117238	chr11:78040259	NARS2	chr11:78147017-78285909:-	-0.24	-5.39	1.13E-7	Testicular germ cell tumor	
PRAD	cis	1	rs7117324	chr11:114387956	FAM55A	chr11:114392438-114430580:-	-0.19	-3.65	0.000287	Ulcerative colitis	
PRAD	cis	1	rs7118648	chr11:96108428	CCDC82	chr11:96085930-96123083:-	-0.22	-3.48	0.00054	Parkinson's disease	
PRAD	cis	1	rs7119933	chr11:78049750	GAB2	chr11:77926343-78128766:-	-0.18	-6.16	1.59E-9	Testicular germ cell tumor	
PRAD	cis	1	rs7119933	chr11:78049750	NARS2	chr11:78147017-78285909:-	-0.25	-5.54	5.12E-8	Testicular germ cell tumor	
PRAD	cis	1	rs712022	chr11:22843155	SVIP	chr11:22843600-22851382:-	-0.26	-6.54	1.66E-10	Dialysis-related mortality	
PRAD	cis	1	rs7121460	chr11:48545232	FOLH1	chr11:49168188-49230222:-	-0.15	-3.46	0.000584	HDL cholesterol	
PRAD	cis	1	rs7121554	chr11:112048051	IL18	chr11:112013976-112034840:-	-0.21	-6.95	1.2E-11	Interleukin-18 levels	
PRAD	cis	1	rs7121992	chr11:48592582	FOLH1	chr11:49168188-49230222:-	-0.16	-3.66	0.000285	HDL cholesterol	
PRAD	cis	1	rs7122375	chr11:111171071	C11orf92	chr11:111164171-111175770:-	0.18	3.69	0.000249	Colorectal cancer	
PRAD	cis	1	rs7122375	chr11:111171071	C11orf93	chr11:111169976-111179353:+	0.18	3.93	9.75E-5	Colorectal cancer	
PRAD	cis	1	rs7122539	chr11:66662731	ACTN3	chr11:66313866-66330797:+	0.22	3.75	0.000196	HIV-1 susceptibility	
PRAD	cis	1	rs7122944	chr11:117034619	PCSK7	chr11:117075789-117102811:-	-0.35	-4.59	5.71E-6	Protein quantitative trait loci	
PRAD	cis	1	rs7123517	chr11:117027755	PCSK7	chr11:117075789-117102811:-	-0.35	-4.6	5.36E-6	Protein quantitative trait loci	
PRAD	cis	1	rs7123908	chr11:3260189	MRGPRE	chr11:3249042-3253616:-	-0.17	-3.86	0.000129	Multiple sclerosis	
PRAD	cis	1	rs7124305	chr11:4606952	OR52I1	chr11:4615269-4616242:+	0.47	4.4	1.34E-5	Response to serotonin reuptake inhibitors in major depressive disorder	
PRAD	cis	1	rs7124676	chr11:64313291	DNAJC4	chr11:63997753-64001752:+	0.11	3.47	0.000559	Obesity-related traits	
PRAD	cis	1	rs7124974	chr11:59906972	PATL1	chr11:59404194-59436511:-	-0.11	-3.53	0.000457	Alzheimer's disease (late onset)	
PRAD	cis	1	rs7126396	chr11:22130513	ANO5	chr11:22214722-22304913:+	0.2	5.26	2.18E-7	Parkinson's disease	
PRAD	cis	1	rs7127187	chr11:77995188	GAB2	chr11:77926343-78128766:-	-0.2	-6.44	2.95E-10	Testicular germ cell tumor	
PRAD	cis	1	rs7127187	chr11:77995188	NARS2	chr11:78147017-78285909:-	-0.23	-4.66	4.15E-6	Testicular germ cell tumor	
PRAD	cis	1	rs7127529	chr11:46582072	HARBI1	chr11:46624857-46638777:-	0.28	3.77	0.000181	Schizophrenia	
PRAD	cis	1	rs7128102	chr11:46928455	ARHGAP1	chr11:46698634-46722120:-	-0.26	-3.7	0.000245	Schizophrenia	
PRAD	cis	1	rs7128666	chr11:78102363	GAB2	chr11:77926343-78128766:-	-0.2	-6.41	3.59E-10	Testicular germ cell tumor	
PRAD	cis	1	rs7129229	chr11:92100356	CCDC67	chr11:93063156-93171634:+	0.25	3.54	0.000446	Homeostasis model assessment of beta-cell function (interaction)	
PRAD	cis	1	rs7129386	chr11:48616694	FOLH1	chr11:49168188-49230222:-	-0.15	-3.48	0.000547	HDL cholesterol	
PRAD	cis	1	rs71299622	chr3:52917038	RFT1	chr3:53122503-53164470:-	0.43	4.52	7.77E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs71299622	chr3:52917038	TMEM110	chr3:52867139-52931547:-	0.42	5.11	4.66E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs71301804	chr3:53073314	RFT1	chr3:53122503-53164470:-	0.43	4.72	3.18E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs71301804	chr3:53073314	TMEM110	chr3:52867139-52931547:-	0.4	5.06	6.11E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs71301808	chr3:53085577	RFT1	chr3:53122503-53164470:-	0.47	4.92	1.22E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs71301808	chr3:53085577	TMEM110	chr3:52867139-52931547:-	0.41	4.95	1.02E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs71301809	chr3:53090312	RFT1	chr3:53122503-53164470:-	0.45	4.73	2.94E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs71301809	chr3:53090312	TMEM110	chr3:52867139-52931547:-	0.4	4.76	2.59E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs71301814	chr3:53117663	RFT1	chr3:53122503-53164470:-	0.45	4.76	2.63E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs71301814	chr3:53117663	TMEM110	chr3:52867139-52931547:-	0.37	4.42	1.22E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7131094	chr11:112044917	IL18	chr11:112013976-112034840:-	-0.21	-6.95	1.2E-11	Interleukin-18 levels	
PRAD	cis	1	rs71311855	chr3:58320507	PXK	chr3:58318617-58410878:+	0.18	3.57	0.000393	Cholesterol, total	
PRAD	cis	1	rs71311857	chr3:58323377	PXK	chr3:58318617-58410878:+	0.19	3.62	0.00033	Cholesterol, total	
PRAD	cis	1	rs71311858	chr3:58323793	PXK	chr3:58318617-58410878:+	0.18	3.61	0.000337	Cholesterol, total	
PRAD	cis	1	rs7131882	chr12:124426736	ZNF664	chr12:124457670-124499967:+	-0.15	-3.97	8.22E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs713219	chr9:131900920	CRAT	chr9:131857075-131873070:-	0.23	4.29	2.13E-5	Blood metabolite ratios	
PRAD	cis	1	rs713243	chr7:38871105	FAM183B	chr7:38724947-38726689:-	0.38	3.69	0.000251	Cognitive performance	
PRAD	cis	1	rs7132655	chr12:124438973	ZNF664	chr12:124457670-124499967:+	-0.15	-4.05	5.98E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs71327038	chr3:46225995	CCR9	chr3:45928019-45944667:+	0.34	3.64	0.0003	Celiac disease	
PRAD	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.8	9.89	4.58E-21	Metabolite levels (HVA/5-HIAA ratio)	
PRAD	cis	1	rs71327718	chr3:125592857	SLC41A3	chr3:125725201-125820400:-	0.37	4.69	3.64E-6	Metabolite levels (HVA/5-HIAA ratio)	
PRAD	cis	1	rs713336	chr14:60974958	C14orf39	chr14:60902675-60952764:-	0.43	5.73	1.8E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs7133493	chr12:85490863	LRRIQ1	chr12:85430099-85638880:+	-0.26	-4.41	1.27E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7133493	chr12:85490863	SLC6A15	chr12:85253269-85306606:-	-0.31	-4.68	3.69E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7133493	chr12:85490863	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.65	2.83E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7134594	chr12:110000193	KCTD10	chr12:109886460-109915155:-	-0.33	-10.22	2.93E-22	HDL cholesterol	
PRAD	cis	1	rs7134594	chr12:110000193	MMAB	chr12:109991523-110011358:-	-0.18	-5.43	8.82E-8	HDL cholesterol	
PRAD	cis	1	rs7134594	chr12:110000193	MYO1H	chr12:109826524-109886176:+	-0.24	-5.39	1.1E-7	HDL cholesterol	
PRAD	cis	1	rs7134594	chr12:110000193	UBE3B	chr12:109915439-109974506:+	-0.15	-3.73	0.000217	HDL cholesterol	
PRAD	cis	1	rs7135053	chr12:85509686	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.32	1.9E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7135053	chr12:85509686	SLC6A15	chr12:85253269-85306606:-	-0.31	-4.65	4.22E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7135053	chr12:85509686	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.64	2.97E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7136515	chr12:85527315	LRRIQ1	chr12:85430099-85638880:+	0.24	4.2	3.24E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7136515	chr12:85527315	SLC6A15	chr12:85253269-85306606:-	0.3	4.62	5.03E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7136515	chr12:85527315	TSPAN19	chr12:85408095-85430055:-	0.32	5.77	1.41E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs71367913	chr17:40589869	CNTNAP1	chr17:40834632-40852010:+	0.16	4.58	5.97E-6	Crohn's disease	
PRAD	cis	1	rs71367913	chr17:40589869	NAGLU	chr17:40687951-40696464:+	-0.18	-4.05	5.88E-5	Crohn's disease	
PRAD	cis	1	rs713835	chr22:38064650	GALR3	chr22:38219389-38221502:+	0.26	4.61	5.16E-6	Fat distribution (HIV)	
PRAD	cis	1	rs713835	chr22:38064650	LGALS1	chr22:38071613-38075807:+	-0.09	-4.91	1.26E-6	Fat distribution (HIV)	
PRAD	cis	1	rs713835	chr22:38064650	LGALS2	chr22:37966254-37976024:-	0.17	4.53	7.44E-6	Fat distribution (HIV)	
PRAD	cis	1	rs7139238	chr12:73014917	TMEM19	chr12:72079878-72097837:+	-0.25	-3.54	0.000433	Diastolic blood pressure	
PRAD	cis	1	rs7139978	chr13:38196963	POSTN	chr13:38136720-38183563:-	-0.24	-6.04	3.08E-9	Life satisfaction	
PRAD	cis	1	rs7140261	chr14:65973956	LOC645431	chr14:65877313-65879335:-	-0.45	-4.37	1.52E-5	Ischemic stroke	
PRAD	cis	1	rs7141087	chr14:101036052	BEGAIN	chr14:101003486-101036131:-	-0.17	-4.69	3.61E-6	Menarche (age at onset)	
PRAD	cis	1	rs7142235	chr14:75559963	EIF2B2	chr14:75469612-75476292:+	0.24	4.9	1.35E-6	Height	
PRAD	cis	1	rs7142235	chr14:75559963	MLH3	chr14:75480467-75518235:-	0.32	6.56	1.46E-10	Height	
PRAD	cis	1	rs7142457	chr14:50097862	PPIL5	chr14:50065415-50081389:+	-0.24	-4.36	1.59E-5	Carotid intima media thickness	
PRAD	cis	1	rs7142457	chr14:50097862	RPL36AL	chr14:50085407-50087349:-	0.39	11.4	9.79E-27	Carotid intima media thickness	
PRAD	cis	1	rs71436418	chr13:31455888	C13orf33	chr13:31480312-31499708:+	0.24	3.71	0.000235	3-hydroxypropylmercapturic acid levels in smokers	
PRAD	cis	1	rs7144423	chr14:35572547	BRMS1L	chr14:36295597-36341168:+	0.18	3.49	0.000522	Atopic dermatitis	
PRAD	cis	1	rs7144423	chr14:35572547	PPP2R3C	chr14:35554679-35591679:-	0.38	5.92	6.14E-9	Atopic dermatitis	
PRAD	cis	1	rs7145159	chr14:75583268	EIF2B2	chr14:75469612-75476292:+	0.25	5.11	4.67E-7	Height	
PRAD	cis	1	rs7145159	chr14:75583268	MLH3	chr14:75480467-75518235:-	0.33	6.7	6.12E-11	Height	
PRAD	cis	1	rs7145202	chr14:23092105	ABHD4	chr14:23067147-23081257:+	0.17	3.45	0.000613	Microalbuminuria	
PRAD	cis	1	rs7145574	chr14:65884402	LOC645431	chr14:65877313-65879335:-	-0.44	-4.44	1.11E-5	Ischemic stroke	
PRAD	cis	1	rs7145588	chr14:88826796	SPATA7	chr14:88852012-88904802:+	-0.2	-4	7.32E-5	Coronary artery calcification	
PRAD	cis	1	rs7147118	chr14:75610170	EIF2B2	chr14:75469612-75476292:+	0.25	4.97	9.59E-7	Height	
PRAD	cis	1	rs7147118	chr14:75610170	MLH3	chr14:75480467-75518235:-	0.32	6.57	1.31E-10	Height	
PRAD	cis	1	rs7148538	chr14:74392342	LIN52	chr14:74551656-74667117:+	0.29	4.71	3.29E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs71487292	chr11:486076	LRRC56	chr11:537522-554915:+	0.29	4.35	1.71E-5	Body mass index	
PRAD	cis	1	rs71487292	chr11:486076	RNH1	chr11:494512-507273:-	-0.21	-3.78	0.000174	Body mass index	
PRAD	cis	1	rs71487296	chr11:500282	ANO9	chr11:417930-442011:-	0.25	4.02	6.7E-5	Body mass index	
PRAD	cis	1	rs71487296	chr11:500282	LRRC56	chr11:537522-554915:+	0.27	4.08	5.38E-5	Body mass index	
PRAD	cis	1	rs71487296	chr11:500282	RNH1	chr11:494512-507273:-	-0.2	-3.66	0.000279	Body mass index	
PRAD	cis	1	rs71494785	chr10:45964553	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs71494786	chr10:45970117	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs71494787	chr10:45972247	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs71494789	chr10:45972481	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs71494790	chr10:45972611	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs71494792	chr10:45983049	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs71494793	chr10:45985092	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs71494797	chr10:45997458	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs71494798	chr10:45998980	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs71494799	chr10:46002856	MARCH8	chr10:45952817-46090354:-	0.25	5.05	6.31E-7	Red blood cell traits	
PRAD	cis	1	rs71494800	chr10:46002954	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs71494802	chr10:46005624	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs71496603	chr10:46005649	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs71496605	chr10:46009818	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs71496606	chr10:46010098	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs71496608	chr10:46017132	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs71496609	chr10:46021031	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs71496612	chr10:46032505	MARCH8	chr10:45952817-46090354:-	0.25	5.52	5.74E-8	Red blood cell traits	
PRAD	cis	1	rs71496613	chr10:46032573	MARCH8	chr10:45952817-46090354:-	0.25	5.52	5.74E-8	Red blood cell traits	
PRAD	cis	1	rs71499565	chr10:45977715	MARCH8	chr10:45952817-46090354:-	0.25	5.53	5.23E-8	Red blood cell traits	
PRAD	cis	1	rs7150141	chr14:104129352	BAG5	chr14:104022889-104029151:-	0.18	3.82	0.000152	Body mass index	
PRAD	cis	1	rs7150141	chr14:104129352	C14orf153	chr14:104029299-104057227:+	0.16	4.96	9.97E-7	Body mass index	
PRAD	cis	1	rs7150141	chr14:104129352	CKB	chr14:103985996-103989170:-	0.21	4.89	1.42E-6	Body mass index	
PRAD	cis	1	rs7150141	chr14:104129352	KLC1	chr14:104029299-104167887:+	-0.19	-3.88	0.000121	Body mass index	
PRAD	cis	1	rs7150141	chr14:104129352	MARK3	chr14:103851701-103970164:+	0.26	5.35	1.41E-7	Body mass index	
PRAD	cis	1	rs71514277	chr1:27034428	PIGV	chr1:27114455-27124886:+	-0.34	-3.8	0.000164	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs71526949	chr8:89582882	MMP16	chr8:89049462-89339717:-	0.17	3.97	8.46E-5	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs71526953	chr8:89595818	MMP16	chr8:89049462-89339717:-	0.17	4	7.42E-5	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs7153160	chr14:74509377	COQ6	chr14:74416643-74429811:+	0.19	3.44	0.000626	Common traits (Other)	
PRAD	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.4	10.13	5.97E-22	Common traits (Other)	
PRAD	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.44	11.64	1.13E-27	Common traits (Other)	
PRAD	cis	1	rs7153679	chr14:66012954	LOC645431	chr14:65877313-65879335:-	-0.42	-4.33	1.86E-5	Ischemic stroke	
PRAD	cis	1	rs715378	chr4:142161354	ZNF330	chr4:142142049-142155848:+	-0.27	-5.02	7.46E-7	Conduct disorder	
PRAD	cis	1	rs7154306	chr14:35540499	BRMS1L	chr14:36295597-36341168:+	0.18	3.56	0.000409	Atopic dermatitis	
PRAD	cis	1	rs7154306	chr14:35540499	PPP2R3C	chr14:35554679-35591679:-	0.33	5.16	3.72E-7	Atopic dermatitis	
PRAD	cis	1	rs71550519	chr6:56780272	BEND6	chr6:56819773-56892138:+	-0.63	-11.1	1.34E-25	Menarche (age at onset)	
PRAD	cis	1	rs7155275	chr14:65502271	CHURC1	chr14:65381140-65411309:+	0.17	3.84	0.00014	Red blood cell traits	
PRAD	cis	1	rs7155454	chr14:65502239	CHURC1	chr14:65381140-65411309:+	0.2	4.33	1.79E-5	Red blood cell traits	
PRAD	cis	1	rs7156105	chr14:75541954	EIF2B2	chr14:75469612-75476292:+	0.25	5.04	6.68E-7	Height	
PRAD	cis	1	rs7156105	chr14:75541954	MLH3	chr14:75480467-75518235:-	0.33	6.69	6.48E-11	Height	
PRAD	cis	1	rs7156191	chr14:103297847	RCOR1	chr14:103059233-103196912:+	0.17	3.45	0.000604	Body mass index	
PRAD	cis	1	rs7156322	chr14:35544330	BRMS1L	chr14:36295597-36341168:+	0.19	3.53	0.000459	Atopic dermatitis	
PRAD	cis	1	rs7156322	chr14:35544330	PPP2R3C	chr14:35554679-35591679:-	0.34	5.18	3.29E-7	Atopic dermatitis	
PRAD	cis	1	rs7156328	chr14:75532941	EIF2B2	chr14:75469612-75476292:+	0.25	5.09	5.09E-7	Height	
PRAD	cis	1	rs7156328	chr14:75532941	MLH3	chr14:75480467-75518235:-	0.33	6.7	5.96E-11	Height	
PRAD	cis	1	rs71564866	chr6:56771207	BEND6	chr6:56819773-56892138:+	-0.62	-11.05	2.08E-25	Menarche (age at onset)	
PRAD	cis	1	rs71564866	chr6:56771207	KIAA1586	chr6:56911384-56920021:+	-0.22	-3.45	0.000616	Menarche (age at onset)	
PRAD	cis	1	rs71564868	chr6:56798441	BEND6	chr6:56819773-56892138:+	-0.61	-10.87	1.04E-24	Menarche (age at onset)	
PRAD	cis	1	rs71572769	chr6:88337049	C6orf165	chr6:88117721-88205858:+	0.42	3.9	0.00011	Obesity-related traits	
PRAD	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.43	-11.41	8.54E-27	Common traits (Other)	
PRAD	cis	1	rs7157940	chr14:94563193	IFI27L2	chr14:94594119-94595957:-	-0.1	-4.16	3.75E-5	Anthropometric traits	
PRAD	cis	1	rs7159212	chr14:61068725	C14orf39	chr14:60902675-60952764:-	0.55	6.26	8.56E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs7160408	chr14:60977471	C14orf39	chr14:60902675-60952764:-	0.46	5.81	1.16E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs71614592	chr4:147506263	ZNF827	chr4:146681892-146859607:-	-0.17	-3.8	0.000162	Heart rate	
PRAD	cis	1	rs71617204	chr3:53042951	RFT1	chr3:53122503-53164470:-	0.43	4.55	6.83E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs71617204	chr3:53042951	TMEM110	chr3:52867139-52931547:-	0.41	4.97	9.5E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7161986	chr15:79217400	CTSH	chr15:79214092-79237420:-	0.44	6.06	2.79E-9	Bipolar disorder	
PRAD	cis	1	rs7162089	chr15:68206452	PIAS1	chr15:68346572-68480402:+	0.14	4.56	6.55E-6	Cognitive performance	
PRAD	cis	1	rs7162129	chr15:84566444	FAM103A1	chr15:83654995-83659423:+	-0.17	-3.52	0.000466	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs7162129	chr15:84566444	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.82E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs7162175	chr15:90897473	ZNF774	chr15:90895477-90904714:+	-0.25	-4.91	1.25E-6	Rheumatoid arthritis	
PRAD	cis	1	rs7162243	chr15:90892631	CRTC3	chr15:91073198-91188576:+	-0.16	-3.51	0.000499	Rheumatoid arthritis	
PRAD	cis	1	rs7162243	chr15:90892631	ZNF774	chr15:90895477-90904714:+	-0.23	-4.54	7.25E-6	Rheumatoid arthritis	
PRAD	cis	1	rs7162900	chr15:75368017	SCAMP5	chr15:75287901-75313836:+	0.39	6.96	1.14E-11	Blood trace element (Zn levels)	
PRAD	cis	1	rs71636769	chr1:27020591	PIGV	chr1:27114455-27124886:+	-0.35	-3.98	8.09E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs71636770	chr1:27021115	PIGV	chr1:27114455-27124886:+	-0.35	-3.98	8.09E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs71636773	chr1:27051319	PIGV	chr1:27114455-27124886:+	-0.35	-4.05	6.03E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs71636777	chr1:27088268	PIGV	chr1:27114455-27124886:+	-0.36	-4.06	5.84E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs71636783	chr1:27139861	PIGV	chr1:27114455-27124886:+	-0.35	-3.94	9.23E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs71636795	chr1:27241025	PIGV	chr1:27114455-27124886:+	-0.29	-4.64	4.47E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs7163828	chr15:79221356	CTSH	chr15:79214092-79237420:-	0.44	6.06	2.85E-9	Bipolar disorder	
PRAD	cis	1	rs71640337	chr1:27004388	PIGV	chr1:27114455-27124886:+	-0.31	-3.6	0.000347	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs71640338	chr1:27011449	PIGV	chr1:27114455-27124886:+	-0.31	-3.58	0.000379	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs7164132	chr15:40675155	C15orf23	chr15:40674922-40686488:+	0.93	13.42	5.35E-35	Heschl's gyrus morphology	
PRAD	cis	1	rs71642219	chr1:28259338	RPA2	chr1:28218049-28241236:-	0.29	5.29	1.88E-7	Corneal astigmatism	
PRAD	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	0.91	13.25	2.75E-34	Heschl's gyrus morphology	
PRAD	cis	1	rs7167138	chr15:50958998	SPPL2A	chr15:50999739-51057910:-	0.26	5.25	2.37E-7	QT interval	
PRAD	cis	1	rs7167285	chr15:75368769	SCAMP5	chr15:75287901-75313836:+	0.39	6.96	1.14E-11	Blood trace element (Zn levels)	
PRAD	cis	1	rs7168539	chr15:100295200	C15orf51	chr15:100330361-100347132:-	-0.24	-3.59	0.000361	Major depressive disorder	
PRAD	cis	1	rs7168680	chr15:75369212	SCAMP5	chr15:75287901-75313836:+	0.39	6.96	1.14E-11	Blood trace element (Zn levels)	
PRAD	cis	1	rs7169404	chr15:40675443	C15orf23	chr15:40674922-40686488:+	0.93	13.42	5.35E-35	Heschl's gyrus morphology	
PRAD	cis	1	rs7170668	chr15:96014143	LOC145820	chr15:95976322-96051074:+	0.24	4.42	1.21E-5	Motion sickness	
PRAD	cis	1	rs7170930	chr15:66580853	DIS3L	chr15:66585633-66626235:+	0.31	3.67	0.000268	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs7170930	chr15:66580853	TIPIN	chr15:66629008-66649054:-	-0.77	-7.67	9.83E-14	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs7172118	chr15:78862453	CHRNA3	chr15:78885397-78913322:-	-0.28	-4.94	1.11E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs7172118	chr15:78862453	CHRNA5	chr15:78857906-78886458:+	-0.22	-4.45	1.06E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs7172137	chr15:68204357	IQCH	chr15:67547188-67794139:+	-0.18	-3.51	0.000483	Cognitive performance	
PRAD	cis	1	rs7172137	chr15:68204357	PIAS1	chr15:68346572-68480402:+	-0.15	-5.01	7.61E-7	Cognitive performance	
PRAD	cis	1	rs7172335	chr15:65977204	IGDCC4	chr15:65673825-65715410:-	-0.14	-3.48	0.000548	Mean corpuscular hemoglobin	
PRAD	cis	1	rs7173833	chr15:75369618	SCAMP5	chr15:75287901-75313836:+	0.38	6.78	3.72E-11	Blood trace element (Zn levels)	
PRAD	cis	1	rs7175720	chr15:75348962	PPCDC	chr15:75315927-75343066:+	-0.15	-3.75	0.000201	Blood trace element (Zn levels)	
PRAD	cis	1	rs7175720	chr15:75348962	SCAMP5	chr15:75287901-75313836:+	-0.44	-7.62	1.36E-13	Blood trace element (Zn levels)	
PRAD	cis	1	rs717593	chr20:33652964	MMP24	chr20:33814539-33864804:+	-0.32	-4.78	2.38E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7176508	chr15:70018990	C15orf50	chr15:70127573-70135305:+	0.22	3.81	0.000156	Chronic lymphocytic leukemia	
PRAD	cis	1	rs717658	chr7:150503637	TMEM176A	chr7:150497854-150502208:+	0.16	4.79	2.26E-6	Forced expiratory volume in 1 second (environmental interaction)	
PRAD	cis	1	rs7177486	chr15:90897109	ZNF774	chr15:90895477-90904714:+	-0.25	-4.84	1.8E-6	Rheumatoid arthritis	
PRAD	cis	1	rs7178496	chr15:90896959	CRTC3	chr15:91073198-91188576:+	-0.16	-3.57	0.0004	Rheumatoid arthritis	
PRAD	cis	1	rs7178496	chr15:90896959	ZNF774	chr15:90895477-90904714:+	-0.22	-4.54	7.24E-6	Rheumatoid arthritis	
PRAD	cis	1	rs7178663	chr15:90897058	ZNF774	chr15:90895477-90904714:+	-0.24	-4.78	2.37E-6	Rheumatoid arthritis	
PRAD	cis	1	rs7178962	chr15:84573248	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs7182544	chr15:90897480	CRTC3	chr15:91073198-91188576:+	-0.16	-3.57	0.0004	Rheumatoid arthritis	
PRAD	cis	1	rs7182544	chr15:90897480	ZNF774	chr15:90895477-90904714:+	-0.22	-4.54	7.24E-6	Rheumatoid arthritis	
PRAD	cis	1	rs7183263	chr15:84573041	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.56E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs718553	chr12:85466118	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs718553	chr12:85466118	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs718553	chr12:85466118	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7186227	chr16:55609568	CAPNS2	chr16:55600584-55601592:+	0.18	5.09	5.28E-7	Thyroid hormone levels	
PRAD	cis	1	rs7186227	chr16:55609568	LPCAT2	chr16:55542913-55620581:+	-0.14	-4.81	2.0E-6	Thyroid hormone levels	
PRAD	cis	1	rs7186553	chr16:55604471	CAPNS2	chr16:55600584-55601592:+	0.19	5.36	1.3E-7	Thyroid hormone levels	
PRAD	cis	1	rs7186553	chr16:55604471	LPCAT2	chr16:55542913-55620581:+	-0.14	-5.12	4.45E-7	Thyroid hormone levels	
PRAD	cis	1	rs7186721	chr16:55609474	CAPNS2	chr16:55600584-55601592:+	0.18	5.13	4.32E-7	Thyroid hormone levels	
PRAD	cis	1	rs7186721	chr16:55609474	LPCAT2	chr16:55542913-55620581:+	-0.14	-4.86	1.57E-6	Thyroid hormone levels	
PRAD	cis	1	rs7186908	chr16:72220373	HP	chr16:72088508-72094957:+	-0.31	-4.78	2.3E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs718847	chr11:116734146	PCSK7	chr11:117075789-117102811:-	-0.27	-3.53	0.000453	Protein quantitative trait loci	
PRAD	cis	1	rs7189424	chr16:69782746	CLEC18C	chr16:69984626-70220796:+	-0.22	-3.54	0.000437	IgE levels	
PRAD	cis	1	rs7190066	chr16:19032780	COQ7	chr16:19078927-19091350:+	-0.39	-4.53	7.49E-6	Response to angiotensin II receptor blocker therapy	
PRAD	cis	1	rs7190694	chr16:23900245	PRKCB	chr16:23847300-24231930:+	0.16	5.76	1.56E-8	Rheumatoid arthritis	
PRAD	cis	1	rs7191665	chr16:74688948	RFWD3	chr16:74655298-74700779:-	-0.29	-7.19	2.53E-12	Testicular germ cell tumor	
PRAD	cis	1	rs7191700	chr16:11406803	C16orf75	chr16:11343506-11445617:+	0.57	13.66	4.95E-36	Multiple sclerosis	
PRAD	cis	1	rs7195398	chr16:68175289	C16orf86	chr16:67700717-67702659:+	-0.31	-4.07	5.41E-5	Crohn's disease	
PRAD	cis	1	rs7195763	chr16:4649300	NMRAL1	chr16:4511696-4526307:-	-0.31	-5.46	7.66E-8	Obesity-related traits	
PRAD	cis	1	rs719756	chr5:42725629	CCDC152	chr5:42756920-42802539:+	0.15	4.16	3.79E-5	Height	
PRAD	cis	1	rs719756	chr5:42725629	SEPP1	chr5:42799983-42825998:-	0.14	4.04	6.22E-5	Height	
PRAD	cis	1	rs7201320	chr16:74694058	RFWD3	chr16:74655298-74700779:-	-0.29	-7.24	1.87E-12	Testicular germ cell tumor	
PRAD	cis	1	rs7203193	chr16:11641180	LITAF	chr16:11641582-11681322:-	-0.19	-3.52	0.000471	LDL cholesterol	
PRAD	cis	1	rs720475	chr7:144074929	ARHGEF5	chr7:144052489-144077724:+	0.29	4.77	2.47E-6	Breast cancer	
PRAD	cis	1	rs720475	chr7:144074929	OR2A7	chr7:143955790-143974852:-	-0.25	-3.88	0.000118	Breast cancer	
PRAD	cis	1	rs7205409	chr16:642610	PIGQ	chr16:617032-634108:+	-0.13	-3.96	8.76E-5	Height	
PRAD	cis	1	rs7205409	chr16:642610	WFIKKN1	chr16:679239-684116:+	0.48	10.02	1.47E-21	Height	
PRAD	cis	1	rs7207021	chr17:28400516	EFCAB5	chr17:28256874-28435469:+	-0.23	-3.87	0.000123	Coffee consumption (cups per day)	
PRAD	cis	1	rs7207276	chr17:18065737	LOC220594	chr17:18414577-18445234:-	-0.29	-3.98	8.08E-5	Obesity-related traits	
PRAD	cis	1	rs7207276	chr17:18065737	MYO15A	chr17:18012020-18083115:+	0.22	4.2	3.24E-5	Obesity-related traits	
PRAD	cis	1	rs7208663	chr17:65885171	LOC651250	chr17:66097696-66157623:+	-0.24	-4.44	1.15E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs7209131	chr17:7376411	CHRNB1	chr17:7348406-7360931:+	-0.36	-7.45	4.51E-13	Height	
PRAD	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.76	18.34	4.56E-57	Eye color traits	
PRAD	cis	1	rs7209435	chr17:61712964	DDX42	chr17:61851567-61896676:+	-0.24	-4.89	1.37E-6	Body mass index	
PRAD	cis	1	rs7209435	chr17:61712964	FTSJ3	chr17:61896795-61905031:-	0.35	7.09	4.92E-12	Body mass index	
PRAD	cis	1	rs7209435	chr17:61712964	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.13	4.22E-5	Body mass index	
PRAD	cis	1	rs7209675	chr17:65831258	LOC651250	chr17:66097696-66157623:+	-0.22	-3.97	8.46E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs7209700	chr17:45351118	TBKBP1	chr17:45772630-45789427:+	0.13	3.57	0.000398	IgG glycosylation	
PRAD	cis	1	rs7209758	chr17:61913621	DDX42	chr17:61851567-61896676:+	-0.29	-5.86	8.74E-9	Body mass index	
PRAD	cis	1	rs7209758	chr17:61913621	FTSJ3	chr17:61896795-61905031:-	0.34	6.56	1.39E-10	Body mass index	
PRAD	cis	1	rs7209758	chr17:61913621	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.46	1.03E-5	Body mass index	
PRAD	cis	1	rs7210027	chr17:65977053	LOC651250	chr17:66097696-66157623:+	0.27	5.04	6.58E-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs721048	chr2:63131731	C2orf86	chr2:63348537-63815851:-	0.26	4.55	6.73E-6	Prostate cancer	
PRAD	cis	1	rs721048	chr2:63131731	EHBP1	chr2:62901013-63273619:+	0.23	3.72	0.000222	Prostate cancer	
PRAD	cis	1	rs7210738	chr17:45757598	C17orf57	chr17:45401142-45518675:+	-0.38	-8.87	1.53E-17	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs7210738	chr17:45757598	TBKBP1	chr17:45772630-45789427:+	0.14	3.96	8.54E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs7211213	chr17:61769456	DDX42	chr17:61851567-61896676:+	-0.27	-5.66	2.66E-8	Body mass index	
PRAD	cis	1	rs7211213	chr17:61769456	FTSJ3	chr17:61896795-61905031:-	0.31	6.2	1.23E-9	Body mass index	
PRAD	cis	1	rs7211213	chr17:61769456	TCAM1P	chr17:61934376-61941738:+	-0.22	-3.91	0.000105	Body mass index	
PRAD	cis	1	rs7212293	chr17:65847325	LOC651250	chr17:66097696-66157623:+	-0.24	-4.34	1.74E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs7212497	chr17:28335949	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.11	4.59E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.76	18.34	4.56E-57	Eye color traits	
PRAD	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.34	-5.85	9.05E-9	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs7214312	chr17:61870863	DDX42	chr17:61851567-61896676:+	-0.27	-5.59	3.94E-8	Body mass index	
PRAD	cis	1	rs7214312	chr17:61870863	FTSJ3	chr17:61896795-61905031:-	0.35	6.83	2.58E-11	Body mass index	
PRAD	cis	1	rs7214312	chr17:61870863	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.52	7.88E-6	Body mass index	
PRAD	cis	1	rs7214758	chr17:65880538	LOC651250	chr17:66097696-66157623:+	-0.24	-4.33	1.82E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs7214921	chr17:40294025	DHX58	chr17:40253422-40264751:-	-0.35	-7.56	2.13E-13	Fibrinogen levels	
PRAD	cis	1	rs7214921	chr17:40294025	HSPB9	chr17:40274756-40275371:+	0.28	4.87	1.54E-6	Fibrinogen levels	
PRAD	cis	1	rs7214988	chr17:17491836	RAI1	chr17:17584787-17714763:+	0.21	3.46	0.000586	Obsessive-compulsive symptoms	
PRAD	cis	1	rs7215147	chr17:30266711	C17orf79	chr17:30178885-30186326:-	-0.21	-3.9	0.000112	Height	
PRAD	cis	1	rs7216064	chr17:65898809	LOC651250	chr17:66097696-66157623:+	-0.21	-3.88	0.000117	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs7216798	chr17:61740963	DDX42	chr17:61851567-61896676:+	-0.25	-5.32	1.59E-7	Body mass index	
PRAD	cis	1	rs7216798	chr17:61740963	FTSJ3	chr17:61896795-61905031:-	0.33	6.64	8.78E-11	Body mass index	
PRAD	cis	1	rs7216798	chr17:61740963	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.21	3.09E-5	Body mass index	
PRAD	cis	1	rs7217982	chr17:61832150	DDX42	chr17:61851567-61896676:+	-0.27	-5.43	8.89E-8	Body mass index	
PRAD	cis	1	rs7217982	chr17:61832150	FTSJ3	chr17:61896795-61905031:-	0.34	6.74	4.64E-11	Body mass index	
PRAD	cis	1	rs7217982	chr17:61832150	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.46	1.04E-5	Body mass index	
PRAD	cis	1	rs7218686	chr17:40813865	EZH1	chr17:40852294-40897071:-	-0.33	-4.22	2.99E-5	Systolic blood pressure change trajectories	
PRAD	cis	1	rs721869	chr5:153608050	GALNT10	chr5:153570295-153799809:+	0.15	4.5	8.67E-6	Carotid artery intima media thickness (sex interaction)	
PRAD	cis	1	rs7219014	chr17:37624790	PGAP3	chr17:37827376-37844310:-	-0.44	-9.57	6.01E-20	Urinary metabolites	
PRAD	cis	1	rs7219021	chr17:46840541	SNF8	chr17:47007461-47022154:-	-0.13	-3.82	0.000151	Schizophrenia or bipolar disorder	
PRAD	cis	1	rs7219220	chr17:40294280	DHX58	chr17:40253422-40264751:-	-0.35	-7.56	2.13E-13	Fibrinogen levels	
PRAD	cis	1	rs7219220	chr17:40294280	HSPB9	chr17:40274756-40275371:+	0.28	4.87	1.54E-6	Fibrinogen levels	
PRAD	cis	1	rs7219874	chr17:53065807	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.92	0.000103	Breast cancer	
PRAD	cis	1	rs7220821	chr17:61704147	DDX42	chr17:61851567-61896676:+	-0.25	-5.24	2.43E-7	Body mass index	
PRAD	cis	1	rs7220821	chr17:61704147	FTSJ3	chr17:61896795-61905031:-	0.33	6.57	1.3E-10	Body mass index	
PRAD	cis	1	rs7220821	chr17:61704147	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.04	6.18E-5	Body mass index	
PRAD	cis	1	rs7220892	chr17:61908316	DDX42	chr17:61851567-61896676:+	-0.28	-5.76	1.53E-8	Body mass index	
PRAD	cis	1	rs7220892	chr17:61908316	FTSJ3	chr17:61896795-61905031:-	0.34	6.66	7.71E-11	Body mass index	
PRAD	cis	1	rs7220892	chr17:61908316	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.5	8.41E-6	Body mass index	
PRAD	cis	1	rs7221109	chr17:38770286	KRT222	chr17:38804829-38821416:-	0.24	4.58	5.97E-6	Type 1 diabetes	
PRAD	cis	1	rs7221109	chr17:38770286	SMARCE1	chr17:38783976-38804103:-	-0.2	-4.25	2.59E-5	Type 1 diabetes	
PRAD	cis	1	rs7221223	chr17:53059007	TOM1L1	chr17:52978052-53039328:+	-0.17	-4.29	2.14E-5	Breast cancer	
PRAD	cis	1	rs722133	chr3:150892493	P2RY12	chr3:151055238-151102544:-	0.31	5.39	1.09E-7	Heschl's gyrus morphology	
PRAD	cis	1	rs7221651	chr17:65832390	LOC651250	chr17:66097696-66157623:+	0.24	4.4	1.33E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs7221743	chr17:28407876	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.07	5.6E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs7222060	chr17:61868279	DDX42	chr17:61851567-61896676:+	-0.27	-5.59	3.94E-8	Body mass index	
PRAD	cis	1	rs7222060	chr17:61868279	FTSJ3	chr17:61896795-61905031:-	0.35	6.83	2.58E-11	Body mass index	
PRAD	cis	1	rs7222060	chr17:61868279	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.52	7.88E-6	Body mass index	
PRAD	cis	1	rs7222197	chr17:53047499	TOM1L1	chr17:52978052-53039328:+	0.16	4.16	3.74E-5	Breast cancer	
PRAD	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.76	18.38	3.16E-57	Eye color traits	
PRAD	cis	1	rs7222308	chr17:28277041	EFCAB5	chr17:28256874-28435469:+	0.24	4.09	5.16E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs7223231	chr17:18811846	FAM18B	chr17:18684582-18710026:+	-0.28	-6.1	2.2E-9	Educational attainment (years of education)	
PRAD	cis	1	rs7223257	chr17:61787684	CD79B	chr17:62006098-62009704:-	-0.12	-3.61	0.000337	Height	
PRAD	cis	1	rs7223257	chr17:61787684	FTSJ3	chr17:61896795-61905031:-	0.27	5.53	5.43E-8	Height	
PRAD	cis	1	rs7223257	chr17:61787684	PSMC5	chr17:61904810-61909386:+	0.13	4.14	4.09E-5	Height	
PRAD	cis	1	rs7223257	chr17:61787684	TCAM1P	chr17:61934376-61941738:+	-0.21	-3.85	0.000135	Height	
PRAD	cis	1	rs7223412	chr17:61808172	DDX42	chr17:61851567-61896676:+	-0.27	-5.45	8.07E-8	Body mass index	
PRAD	cis	1	rs7223412	chr17:61808172	FTSJ3	chr17:61896795-61905031:-	0.34	6.72	5.36E-11	Body mass index	
PRAD	cis	1	rs7223412	chr17:61808172	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.42	1.23E-5	Body mass index	
PRAD	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.76	-18.34	4.56E-57	Eye color traits	
PRAD	cis	1	rs7223672	chr17:61720565	CD79B	chr17:62006098-62009704:-	0.12	3.5	0.000512	Body mass index	
PRAD	cis	1	rs7223672	chr17:61720565	DDX42	chr17:61851567-61896676:+	-0.22	-4.54	7.32E-6	Body mass index	
PRAD	cis	1	rs7223672	chr17:61720565	FTSJ3	chr17:61896795-61905031:-	0.36	7.21	2.19E-12	Body mass index	
PRAD	cis	1	rs7223672	chr17:61720565	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.55	6.75E-6	Body mass index	
PRAD	cis	1	rs7223784	chr17:40577580	CNTNAP1	chr17:40834632-40852010:+	0.16	4.65	4.26E-6	Crohn's disease	
PRAD	cis	1	rs7223784	chr17:40577580	NAGLU	chr17:40687951-40696464:+	-0.18	-4.17	3.6E-5	Crohn's disease	
PRAD	cis	1	rs7223786	chr17:28332107	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.12	4.53E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs7223813	chr17:65945840	LOC651250	chr17:66097696-66157623:+	-0.22	-3.94	9.24E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs7223930	chr17:65842186	LOC651250	chr17:66097696-66157623:+	-0.24	-4.38	1.47E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs7223966	chr17:61893398	DDX42	chr17:61851567-61896676:+	-0.28	-5.76	1.53E-8	Body mass index	
PRAD	cis	1	rs7223966	chr17:61893398	FTSJ3	chr17:61896795-61905031:-	0.34	6.7	5.99E-11	Body mass index	
PRAD	cis	1	rs7223966	chr17:61893398	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.54	7.14E-6	Body mass index	
PRAD	cis	1	rs7224725	chr17:17484654	RAI1	chr17:17584787-17714763:+	0.25	4.09	5.15E-5	Obsessive-compulsive symptoms	
PRAD	cis	1	rs7224737	chr17:40289364	DHX58	chr17:40253422-40264751:-	0.36	7.63	1.33E-13	Fibrinogen levels	
PRAD	cis	1	rs7224737	chr17:40289364	HSPB9	chr17:40274756-40275371:+	-0.25	-4.44	1.1E-5	Fibrinogen levels	
PRAD	cis	1	rs7224923	chr17:65842265	LOC651250	chr17:66097696-66157623:+	-0.24	-4.24	2.67E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs722509	chr3:10102377	C3orf10	chr3:10157333-10168873:+	-0.22	-4.15	4.02E-5	Alzheimer's disease	
PRAD	cis	1	rs722509	chr3:10102377	LOC401052	chr3:10048102-10052779:-	-0.29	-5.18	3.38E-7	Alzheimer's disease	
PRAD	cis	1	rs7226599	chr18:74491132	ZNF236	chr18:74536116-74682680:+	-0.14	-3.57	0.000391	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
PRAD	cis	1	rs722677	chr5:42748289	CCDC152	chr5:42756920-42802539:+	0.14	3.75	0.000197	Height	
PRAD	cis	1	rs722677	chr5:42748289	SEPP1	chr5:42799983-42825998:-	0.14	3.9	0.000111	Height	
PRAD	cis	1	rs7228051	chr18:71788898	FBXO15	chr18:71740588-71815100:-	0.31	5.31	1.71E-7	Venous thromboembolism (SNP x SNP interaction)	
PRAD	cis	1	rs7230346	chr18:11989373	IMPA2	chr18:11981057-12030876:+	-0.3	-3.71	0.000229	Stroke	
PRAD	cis	1	rs7243357	chr18:56883319	GRP	chr18:56887400-56898000:+	0.26	3.84	0.000142	Body mass index	
PRAD	cis	1	rs7243921	chr18:77695237	HSBP1L1	chr18:77724582-77730820:+	-0.28	-5.69	2.27E-8	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
PRAD	cis	1	rs7246657	chr19:37747108	ZNF607	chr19:38187276-38210691:-	0.22	4.16	3.72E-5	Coronary artery calcification	
PRAD	cis	1	rs7246657	chr19:37747108	ZNF781	chr19:38158650-38183216:-	-0.23	-3.96	8.51E-5	Coronary artery calcification	
PRAD	cis	1	rs7246967	chr19:23056346	ZNF492	chr19:22817126-22850472:+	-0.32	-4.15	3.96E-5	Bronchopulmonary dysplasia	
PRAD	cis	1	rs7247672	chr19:37743928	SIPA1L3	chr19:38397868-38699006:+	0.17	3.53	0.000455	Coronary artery calcification	
PRAD	cis	1	rs7247672	chr19:37743928	ZNF607	chr19:38187276-38210691:-	-0.19	-3.5	0.000511	Coronary artery calcification	
PRAD	cis	1	rs7247672	chr19:37743928	ZNF781	chr19:38158650-38183216:-	0.24	4.14	4.16E-5	Coronary artery calcification	
PRAD	cis	1	rs7251653	chr19:18608283	ELL	chr19:18553475-18632937:-	-0.17	-3.97	8.38E-5	Breast cancer	
PRAD	cis	1	rs7251653	chr19:18608283	SSBP4	chr19:18530221-18545371:+	-0.18	-5.97	4.73E-9	Breast cancer	
PRAD	cis	1	rs7251903	chr19:39184811	LGALS7	chr19:39261608-39264157:-	-0.16	-3.68	0.000261	Heart rate	
PRAD	cis	1	rs7252589	chr19:39170908	LGALS7	chr19:39261608-39264157:-	-0.16	-3.56	0.000407	Heart rate	
PRAD	cis	1	rs7252707	chr19:18612257	ELL	chr19:18553475-18632937:-	-0.15	-3.55	0.000428	Breast cancer	
PRAD	cis	1	rs7252707	chr19:18612257	LRRC25	chr19:18501955-18508421:-	-0.11	-3.47	0.000574	Breast cancer	
PRAD	cis	1	rs7252707	chr19:18612257	SSBP4	chr19:18530221-18545371:+	-0.17	-5.75	1.63E-8	Breast cancer	
PRAD	cis	1	rs7252848	chr19:18612351	ELL	chr19:18553475-18632937:-	-0.16	-3.75	0.000196	Breast cancer	
PRAD	cis	1	rs7252848	chr19:18612351	SSBP4	chr19:18530221-18545371:+	-0.18	-5.97	4.59E-9	Breast cancer	
PRAD	cis	1	rs725309	chr3:48418708	ATRIP	chr3:48488141-48507708:+	-0.27	-6.32	5.97E-10	Longevity	
PRAD	cis	1	rs725309	chr3:48418708	CDC25A	chr3:48198668-48229801:-	-0.22	-4.14	4.2E-5	Longevity	
PRAD	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.18	4.97	9.48E-7	Longevity	
PRAD	cis	1	rs725310	chr3:48418571	ATRIP	chr3:48488141-48507708:+	-0.26	-6.09	2.36E-9	Longevity	
PRAD	cis	1	rs725310	chr3:48418571	CDC25A	chr3:48198668-48229801:-	-0.21	-3.99	7.72E-5	Longevity	
PRAD	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.19	5.18	3.35E-7	Longevity	
PRAD	cis	1	rs7254349	chr19:24230343	LOC100101266	chr19:24344995-24346249:-	0.31	4.51	8.05E-6	Response to taxane treatment (placlitaxel)	
PRAD	cis	1	rs7254758	chr19:33608047	GPATCH1	chr19:33571786-33621318:+	0.53	9.52	8.97E-20	Bone properties (heel)	
PRAD	cis	1	rs7255066	chr19:45146103	PVR	chr19:45147098-45169426:+	0.19	3.9	0.000109	Multiple sclerosis	
PRAD	cis	1	rs7255436	chr19:8433196	ANGPTL4	chr19:8429011-8439257:+	0.42	9.96	2.54E-21	HDL cholesterol	
PRAD	cis	1	rs7255436	chr19:8433196	RPS28	chr19:8386384-8387278:+	-0.3	-5.15	3.8E-7	HDL cholesterol	
PRAD	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.62	13.7	3.41E-36	Schizophrenia	
PRAD	cis	1	rs7255968	chr19:33601902	GPATCH1	chr19:33571786-33621318:+	0.53	9.21	1.12E-18	Bone properties (heel)	
PRAD	cis	1	rs7256759	chr19:12065010	ZNF763	chr19:12035900-12091196:+	-0.37	-4.02	6.72E-5	Multiple sclerosis	
PRAD	cis	1	rs7257127	chr19:23056699	ZNF492	chr19:22817126-22850472:+	-0.3	-3.88	0.000119	Bronchopulmonary dysplasia	
PRAD	cis	1	rs7258465	chr19:18533642	ELL	chr19:18553475-18632937:-	-0.16	-3.75	0.000199	Breast cancer	
PRAD	cis	1	rs7258465	chr19:18533642	SSBP4	chr19:18530221-18545371:+	-0.16	-5.46	7.79E-8	Breast cancer	
PRAD	cis	1	rs7258890	chr19:46159609	SYMPK	chr19:46318701-46366548:-	-0.18	-4.09	5.16E-5	Type 2 diabetes	
PRAD	cis	1	rs725908	chr20:33968067	CEP250	chr20:34042996-34099802:+	-0.25	-5.69	2.22E-8	Height	
PRAD	cis	1	rs725908	chr20:33968067	CPNE1	chr20:34213968-34262539:-	0.19	3.86	0.000127	Height	
PRAD	cis	1	rs725908	chr20:33968067	GDF5	chr20:33897002-34042568:-	-0.19	-4.62	4.92E-6	Height	
PRAD	cis	1	rs725908	chr20:33968067	MMP24	chr20:33814539-33864804:+	0.14	3.46	0.000597	Height	
PRAD	cis	1	rs725908	chr20:33968067	UQCC	chr20:33890383-33999833:-	0.36	6.76	4.22E-11	Height	
PRAD	cis	1	rs7259376	chr19:22507705	ZNF98	chr19:22573899-22605148:-	-0.17	-3.48	0.000539	Telomere length	
PRAD	cis	1	rs7260482	chr19:45143942	PVR	chr19:45147098-45169426:+	0.19	3.92	0.000101	Multiple sclerosis	
PRAD	cis	1	rs7260598	chr19:24222786	LOC100101266	chr19:24344995-24346249:-	-0.33	-4.71	3.34E-6	Response to taxane treatment (placlitaxel)	
PRAD	cis	1	rs7261167	chr20:33576205	MMP24	chr20:33814539-33864804:+	-0.24	-4.03	6.5E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs72622599	chr3:182093947	LAMP3	chr3:182840004-182880667:-	0.16	3.51	0.000497	Cognitive function	
PRAD	cis	1	rs72627113	chr14:74340141	HEATR4	chr14:73945193-74025651:-	-0.43	-4.05	5.87E-5	Morning vs. evening chronotype	
PRAD	cis	1	rs72627117	chr14:74355233	LIN52	chr14:74551656-74667117:+	0.27	4.41	1.29E-5	Morning vs. evening chronotype	
PRAD	cis	1	rs72627119	chr14:74356274	LIN52	chr14:74551656-74667117:+	0.27	4.41	1.29E-5	Morning vs. evening chronotype	
PRAD	cis	1	rs72627120	chr14:74363480	LIN52	chr14:74551656-74667117:+	0.27	4.49	9.05E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs72627122	chr14:74368236	LIN52	chr14:74551656-74667117:+	0.28	4.62	4.99E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs72627123	chr14:74368331	LIN52	chr14:74551656-74667117:+	0.28	4.57	6.22E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs72627124	chr14:74369128	LIN52	chr14:74551656-74667117:+	0.28	4.62	4.99E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs72627125	chr14:74369623	LIN52	chr14:74551656-74667117:+	0.28	4.62	4.99E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs72627126	chr14:74370024	LIN52	chr14:74551656-74667117:+	0.28	4.61	5.28E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs72627127	chr14:74370098	LIN52	chr14:74551656-74667117:+	0.28	4.62	4.99E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs72627129	chr14:74374805	LIN52	chr14:74551656-74667117:+	0.28	4.62	4.99E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs72627130	chr14:74374897	LIN52	chr14:74551656-74667117:+	0.28	4.62	4.99E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs72627138	chr14:74401900	LIN52	chr14:74551656-74667117:+	0.33	5.37	1.22E-7	Morning vs. evening chronotype	
PRAD	cis	1	rs7263203	chr20:33773375	MMP24	chr20:33814539-33864804:+	-0.27	-4.08	5.35E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7263253	chr20:33649376	MMP24	chr20:33814539-33864804:+	-0.31	-4.75	2.69E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs72634258	chr1:8150638	PARK7	chr1:8021714-8045341:+	0.19	4.96	9.95E-7	Inflammatory bowel disease	
PRAD	cis	1	rs72644213	chr10:81783660	LOC219347	chr10:81805991-81838949:-	0.74	9.18	1.39E-18	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs72649163	chr1:20900592	CDA	chr1:20915444-20945398:+	-0.15	-3.79	0.000172	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs72649163	chr1:20900592	FAM43B	chr1:20878932-20881512:+	0.15	3.74	0.000206	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs7265317	chr20:33768523	MMP24	chr20:33814539-33864804:+	-0.26	-3.97	8.39E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs72653721	chr6:10971886	MAK	chr6:10762957-10838760:-	0.29	4.41	1.29E-5	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	
PRAD	cis	1	rs7265697	chr20:55070664	C20orf43	chr20:55043647-55093942:+	0.16	3.89	0.000112	Refractive astigmatism	
PRAD	cis	1	rs72669974	chr4:106519627	INTS12	chr4:106603787-106629881:-	-0.78	-7.68	9.0E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72669978	chr4:106520852	INTS12	chr4:106603787-106629881:-	-0.8	-7.55	2.31E-13	Post bronchodilator FEV1	
PRAD	cis	1	rs72669980	chr4:106523563	INTS12	chr4:106603787-106629881:-	-0.82	-7.81	3.83E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72669982	chr4:106524954	INTS12	chr4:106603787-106629881:-	-0.74	-7.37	7.61E-13	Post bronchodilator FEV1	
PRAD	cis	1	rs72669993	chr4:106583144	INTS12	chr4:106603787-106629881:-	-0.85	-8.51	2.42E-16	Post bronchodilator FEV1	
PRAD	cis	1	rs72669995	chr4:106585256	INTS12	chr4:106603787-106629881:-	-0.85	-8.51	2.42E-16	Post bronchodilator FEV1	
PRAD	cis	1	rs72669997	chr4:106589782	INTS12	chr4:106603787-106629881:-	-0.85	-8.51	2.42E-16	Post bronchodilator FEV1	
PRAD	cis	1	rs72671805	chr4:106603014	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671808	chr4:106605720	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671809	chr4:106611537	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671811	chr4:106615603	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671815	chr4:106618219	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671820	chr4:106620983	INTS12	chr4:106603787-106629881:-	-0.79	-7.88	2.34E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671824	chr4:106623223	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671826	chr4:106624502	INTS12	chr4:106603787-106629881:-	-0.79	-7.88	2.34E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671828	chr4:106624800	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671835	chr4:106631356	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671836	chr4:106633045	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671837	chr4:106635902	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671840	chr4:106638697	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671849	chr4:106643818	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671852	chr4:106646349	INTS12	chr4:106603787-106629881:-	-0.77	-7.7	8.37E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671853	chr4:106646886	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671854	chr4:106647023	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671856	chr4:106647366	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671858	chr4:106647679	INTS12	chr4:106603787-106629881:-	-0.77	-7.7	8.23E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671866	chr4:106657658	INTS12	chr4:106603787-106629881:-	-0.77	-7.7	8.23E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671869	chr4:106658658	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671870	chr4:106659345	INTS12	chr4:106603787-106629881:-	-0.77	-7.7	8.23E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671871	chr4:106660324	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671873	chr4:106661194	INTS12	chr4:106603787-106629881:-	-0.77	-7.7	8.23E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72671874	chr4:106661970	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671878	chr4:106662692	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671880	chr4:106664424	INTS12	chr4:106603787-106629881:-	-0.8	-8.04	7.34E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671885	chr4:106668546	INTS12	chr4:106603787-106629881:-	-0.8	-8.03	7.71E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671886	chr4:106670589	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671889	chr4:106676301	INTS12	chr4:106603787-106629881:-	-0.81	-8.13	3.87E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671892	chr4:106680363	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671895	chr4:106685633	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72671896	chr4:106685825	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72673803	chr4:106696756	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72673811	chr4:106707297	INTS12	chr4:106603787-106629881:-	-0.81	-7.97	1.24E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72673812	chr4:106710454	INTS12	chr4:106603787-106629881:-	-0.81	-8.08	5.61E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72673813	chr4:106710653	INTS12	chr4:106603787-106629881:-	-0.8	-7.89	2.18E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72673817	chr4:106713490	INTS12	chr4:106603787-106629881:-	-0.81	-8.08	5.61E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72673823	chr4:106719973	INTS12	chr4:106603787-106629881:-	-0.8	-7.89	2.18E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72673824	chr4:106724464	INTS12	chr4:106603787-106629881:-	-0.81	-8.08	5.61E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72673828	chr4:106730342	INTS12	chr4:106603787-106629881:-	-0.82	-8.15	3.33E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs72673831	chr4:106733380	INTS12	chr4:106603787-106629881:-	-0.81	-7.98	1.12E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72673832	chr4:106738760	INTS12	chr4:106603787-106629881:-	-0.8	-7.79	4.41E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72673834	chr4:106739374	INTS12	chr4:106603787-106629881:-	-0.8	-7.79	4.41E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72673853	chr4:106756877	INTS12	chr4:106603787-106629881:-	-0.76	-7.82	3.47E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72673858	chr4:106758056	INTS12	chr4:106603787-106629881:-	-0.76	-7.82	3.47E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs72673860	chr4:106762900	INTS12	chr4:106603787-106629881:-	-0.75	-7.63	1.3E-13	Post bronchodilator FEV1	
PRAD	cis	1	rs72673866	chr4:106771155	INTS12	chr4:106603787-106629881:-	-0.73	-7.25	1.75E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs72673870	chr4:106779865	INTS12	chr4:106603787-106629881:-	-0.73	-7.25	1.75E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs72673872	chr4:106779925	INTS12	chr4:106603787-106629881:-	-0.73	-7.25	1.75E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs72673873	chr4:106780301	INTS12	chr4:106603787-106629881:-	-0.73	-7.25	1.72E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs72677306	chr4:106997678	TBCK	chr4:106967233-107237861:-	0.19	4.06	5.64E-5	Airflow obstruction	
PRAD	cis	1	rs7267979	chr20:25298087	ENTPD6	chr20:25176339-25207360:+	-0.18	-4.75	2.68E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7267979	chr20:25298087	FAM182B	chr20:25744102-25848786:-	0.37	6.75	4.39E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7267979	chr20:25298087	PYGB	chr20:25228706-25278647:+	-0.34	-7.49	3.47E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7268053	chr20:25328286	ENTPD6	chr20:25176339-25207360:+	0.16	4.27	2.35E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7268053	chr20:25328286	FAM182B	chr20:25744102-25848786:-	-0.38	-7.1	4.53E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7268053	chr20:25328286	PYGB	chr20:25228706-25278647:+	0.32	7	8.9E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7268447	chr20:33649593	MMP24	chr20:33814539-33864804:+	-0.31	-4.75	2.69E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs72686191	chr1:76218319	ACADM	chr1:76190043-76229353:+	0.18	3.97	8.36E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs7269138	chr20:33570007	MMP24	chr20:33814539-33864804:+	-0.24	-3.99	7.72E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs72692857	chr1:150001632	RPRD2	chr1:150336990-150449039:+	0.13	3.54	0.000436	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72692862	chr1:150009216	RPRD2	chr1:150336990-150449039:+	0.13	3.5	0.000518	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694914	chr1:150074945	RPRD2	chr1:150336990-150449039:+	0.13	3.46	0.000585	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694915	chr1:150074988	RPRD2	chr1:150336990-150449039:+	0.13	3.46	0.000585	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694923	chr1:150077266	RPRD2	chr1:150336990-150449039:+	0.13	3.47	0.00056	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694926	chr1:150080113	RPRD2	chr1:150336990-150449039:+	0.13	3.47	0.00056	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694928	chr1:150081568	RPRD2	chr1:150336990-150449039:+	0.13	3.47	0.00056	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694933	chr1:150094532	RPRD2	chr1:150336990-150449039:+	0.13	3.47	0.00056	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694936	chr1:150098110	RPRD2	chr1:150336990-150449039:+	0.13	3.47	0.00056	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694943	chr1:150111980	FAM63A	chr1:150969302-150980854:-	0.21	3.44	0.00064	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694943	chr1:150111980	RPRD2	chr1:150336990-150449039:+	0.14	3.73	0.000215	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694944	chr1:150112476	RPRD2	chr1:150336990-150449039:+	0.13	3.54	0.000444	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694945	chr1:150113490	RPRD2	chr1:150336990-150449039:+	0.13	3.54	0.000444	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694946	chr1:150115486	RPRD2	chr1:150336990-150449039:+	0.13	3.49	0.000531	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694953	chr1:150119729	RPRD2	chr1:150336990-150449039:+	0.13	3.54	0.000444	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72694957	chr1:150135291	RPRD2	chr1:150336990-150449039:+	0.14	3.55	0.000419	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PRAD	cis	1	rs72696952	chr1:152172694	FLG	chr1:152274651-152297679:-	0.34	4.92	1.18E-6	Atopic dermatitis	
PRAD	cis	1	rs72696963	chr1:152181189	FLG	chr1:152274651-152297679:-	0.34	4.95	1.04E-6	Atopic dermatitis	
PRAD	cis	1	rs72696969	chr1:152196339	FLG	chr1:152274651-152297679:-	0.34	4.97	9.45E-7	Atopic dermatitis	
PRAD	cis	1	rs72696989	chr1:152248674	FLG	chr1:152274651-152297679:-	0.35	4.95	1.02E-6	Atopic dermatitis	
PRAD	cis	1	rs72697000	chr1:152276772	FLG	chr1:152274651-152297679:-	0.37	5.28	1.99E-7	Atopic dermatitis	
PRAD	cis	1	rs72698906	chr1:152307184	FLG	chr1:152274651-152297679:-	0.34	4.96	9.74E-7	Atopic dermatitis	
PRAD	cis	1	rs727005	chr1:36281336	C1orf216	chr1:36179477-36184790:-	-0.34	-4.86	1.6E-6	Schizophrenia	
PRAD	cis	1	rs7270354	chr20:44607661	DNTTIP1	chr20:44420576-44440064:+	-0.16	-3.6	0.000347	Abdominal aortic aneurysm	
PRAD	cis	1	rs7270354	chr20:44607661	SEMG1	chr20:43835638-43838414:+	0.28	3.64	0.000301	Abdominal aortic aneurysm	
PRAD	cis	1	rs7270354	chr20:44607661	WFDC3	chr20:44402847-44420547:-	-0.51	-7.37	7.89E-13	Abdominal aortic aneurysm	
PRAD	cis	1	rs72704712	chr14:103312965	RCOR1	chr14:103059233-103196912:+	-0.22	-3.88	0.000122	Body mass index	
PRAD	cis	1	rs72704731	chr14:103358070	RCOR1	chr14:103059233-103196912:+	-0.19	-3.63	0.000311	Body mass index	
PRAD	cis	1	rs7271729	chr20:33610992	MMP24	chr20:33814539-33864804:+	-0.31	-4.75	2.69E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs72717411	chr5:429124	C5orf55	chr5:441645-443258:-	0.18	3.8	0.000162	Cystic fibrosis severity	
PRAD	cis	1	rs72717411	chr5:429124	LOC25845	chr5:470626-473080:-	0.29	4.93	1.14E-6	Cystic fibrosis severity	
PRAD	cis	1	rs72717414	chr5:429818	C5orf55	chr5:441645-443258:-	0.18	3.8	0.000162	Cystic fibrosis severity	
PRAD	cis	1	rs72717414	chr5:429818	LOC25845	chr5:470626-473080:-	0.29	4.93	1.14E-6	Cystic fibrosis severity	
PRAD	cis	1	rs7272164	chr20:47766197	CSE1L	chr20:47662838-47713484:+	0.19	4.78	2.38E-6	Anger	
PRAD	cis	1	rs7272164	chr20:47766197	PREX1	chr20:47240793-47444420:-	-0.17	-3.49	0.000521	Anger	
PRAD	cis	1	rs72722847	chr15:31682346	CHRFAM7A	chr15:30653443-30685864:-	-0.33	-3.58	0.000381	Survival in colorectal cancer (non-distant metastatic)	
PRAD	cis	1	rs7273734	chr20:33599403	MMP24	chr20:33814539-33864804:+	-0.22	-3.62	0.000332	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7274811	chr20:32333181	C20orf134	chr20:32254304-32256330:+	0.38	6.21	1.18E-9	Height	
PRAD	cis	1	rs72748146	chr9:113677069	PTGR1	chr9:114312003-114362135:-	-0.25	-3.91	0.000105	Corneal structure	
PRAD	cis	1	rs72748148	chr9:113677241	PTGR1	chr9:114312003-114362135:-	-0.25	-3.91	0.000105	Corneal structure	
PRAD	cis	1	rs72748150	chr9:113677408	PTGR1	chr9:114312003-114362135:-	-0.25	-3.81	0.000156	Corneal structure	
PRAD	cis	1	rs7274866	chr20:33608616	MMP24	chr20:33814539-33864804:+	-0.23	-3.81	0.000156	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs727563	chr22:41867377	POLR3H	chr22:41921803-41940479:-	0.18	3.71	0.000229	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs727563	chr22:41867377	XPNPEP3	chr22:41253094-41363888:+	-0.21	-3.58	0.000373	Crohn's disease;Inflammatory bowel disease	
PRAD	cis	1	rs72764214	chr9:113657962	PTGR1	chr9:114312003-114362135:-	-0.26	-4.07	5.46E-5	Corneal structure	
PRAD	cis	1	rs72764216	chr9:113658221	PTGR1	chr9:114312003-114362135:-	-0.26	-4.07	5.46E-5	Corneal structure	
PRAD	cis	1	rs72768397	chr1:247219411	ZNF670	chr1:247200087-247242069:-	-0.33	-7.36	8.46E-13	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs72768411	chr9:115502670	C9orf80	chr9:115448793-115480387:-	-0.25	-3.49	0.000529	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs72768817	chr5:78944371	DMGDH	chr5:78293430-78365449:-	0.29	3.5	0.000512	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs72768824	chr5:78954839	DMGDH	chr5:78293430-78365449:-	0.29	3.48	0.000548	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs72768826	chr5:78956072	DMGDH	chr5:78293430-78365449:-	0.29	3.48	0.000548	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs72770488	chr16:24950086	SLC5A11	chr16:24857316-24922943:+	-0.5	-3.9	0.000111	Blood metabolite levels	
PRAD	cis	1	rs72770489	chr16:24953527	SLC5A11	chr16:24857316-24922943:+	-0.46	-3.61	0.00034	Blood metabolite levels	
PRAD	cis	1	rs72770490	chr16:24954883	SLC5A11	chr16:24857316-24922943:+	-0.45	-3.51	0.000498	Blood metabolite levels	
PRAD	cis	1	rs72778460	chr10:5348352	TUBAL3	chr10:5435062-5446793:-	-0.26	-3.61	0.000343	Intelligence	
PRAD	cis	1	rs72782294	chr2:28953390	PPP1CB	chr2:28974612-29025805:+	-0.29	-6.04	3.14E-9	Body mass index	
PRAD	cis	1	rs72782294	chr2:28953390	TRMT61B	chr2:29072690-29093175:-	0.4	8.19	2.45E-15	Body mass index	
PRAD	cis	1	rs72800847	chr16:31022639	HSD3B7	chr16:30996519-31000473:+	0.42	8.3	1.13E-15	Response to metformin (IC50)	
PRAD	cis	1	rs72800847	chr16:31022639	MYST1	chr16:31128985-31142713:+	0.18	5.22	2.71E-7	Response to metformin (IC50)	
PRAD	cis	1	rs72800847	chr16:31022639	PRSS36	chr16:31150251-31161415:-	0.2	4.9	1.35E-6	Response to metformin (IC50)	
PRAD	cis	1	rs72800847	chr16:31022639	PRSS53	chr16:31094747-31106276:-	-0.19	-3.68	0.000257	Response to metformin (IC50)	
PRAD	cis	1	rs72800847	chr16:31022639	STX1B	chr16:31000577-31021829:-	0.2	4.81	2.02E-6	Response to metformin (IC50)	
PRAD	cis	1	rs72811623	chr2:97496473	CNNM4	chr2:97426639-97477626:+	0.24	3.55	0.000424	Erectile dysfunction and prostate cancer treatment	
PRAD	cis	1	rs72816523	chr5:157403168	NIPAL4	chr5:156887027-156901729:+	0.21	3.62	0.000332	IgG glycosylation	
PRAD	cis	1	rs72816527	chr5:157409633	NIPAL4	chr5:156887027-156901729:+	0.21	3.68	0.000257	IgG glycosylation	
PRAD	cis	1	rs72816528	chr5:157410949	NIPAL4	chr5:156887027-156901729:+	0.2	3.66	0.000281	IgG glycosylation	
PRAD	cis	1	rs72816531	chr5:157413079	NIPAL4	chr5:156887027-156901729:+	0.2	3.76	0.00019	IgG glycosylation	
PRAD	cis	1	rs72816532	chr5:157413130	NIPAL4	chr5:156887027-156901729:+	0.2	3.76	0.00019	IgG glycosylation	
PRAD	cis	1	rs72816538	chr5:157414303	NIPAL4	chr5:156887027-156901729:+	0.2	3.76	0.00019	IgG glycosylation	
PRAD	cis	1	rs72819593	chr17:2199489	SRR	chr17:2207248-2228553:+	-0.77	-14.44	2.23E-39	Esophageal cancer (squamous cell)	
PRAD	cis	1	rs72823064	chr17:40569974	CNTNAP1	chr17:40834632-40852010:+	0.15	4.31	2.0E-5	Crohn's disease	
PRAD	cis	1	rs72823064	chr17:40569974	NAGLU	chr17:40687951-40696464:+	-0.17	-3.92	0.000101	Crohn's disease	
PRAD	cis	1	rs72823592	chr17:46123004	SNX11	chr17:46184911-46200105:+	0.21	3.82	0.000149	Epilepsy (generalized)	
PRAD	cis	1	rs72823619	chr2:102924615	IL1R1	chr2:102686836-102796333:+	-0.34	-5.25	2.33E-7	Asthma	
PRAD	cis	1	rs72823621	chr2:102925435	IL1R1	chr2:102686836-102796333:+	-0.34	-5.27	2.03E-7	Asthma	
PRAD	cis	1	rs72823632	chr2:102931534	IL1R1	chr2:102686836-102796333:+	-0.33	-5.21	2.79E-7	Asthma	
PRAD	cis	1	rs72823635	chr2:102931612	IL1R1	chr2:102686836-102796333:+	-0.33	-5.21	2.79E-7	Asthma	
PRAD	cis	1	rs72823646	chr2:102954213	IL1R1	chr2:102686836-102796333:+	-0.33	-5.16	3.66E-7	Asthma	
PRAD	cis	1	rs72825746	chr17:30364610	C17orf79	chr17:30178885-30186326:-	-0.27	-4.44	1.12E-5	Height	
PRAD	cis	1	rs72831853	chr17:46842575	SNF8	chr17:47007461-47022154:-	-0.13	-3.83	0.000143	Schizophrenia or bipolar disorder	
PRAD	cis	1	rs72834369	chr2:118662395	INSIG2	chr2:118846050-118867596:+	0.42	4.94	1.08E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72834373	chr2:118672643	INSIG2	chr2:118846050-118867596:+	0.43	5.07	5.6E-7	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72834377	chr2:118676385	INSIG2	chr2:118846050-118867596:+	0.43	5.08	5.47E-7	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72834384	chr2:118693249	INSIG2	chr2:118846050-118867596:+	0.38	4.58	6.08E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72837952	chr2:69742989	LOC100133985	chr2:70351169-70352448:-	-0.29	-3.92	0.000102	Parkinson's disease (age of onset)	
PRAD	cis	1	rs72838003	chr2:118700137	INSIG2	chr2:118846050-118867596:+	0.37	4.56	6.48E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72838008	chr2:118712411	INSIG2	chr2:118846050-118867596:+	0.37	4.52	7.99E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72838009	chr2:118720271	INSIG2	chr2:118846050-118867596:+	0.34	4.25	2.6E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72838023	chr2:118739791	INSIG2	chr2:118846050-118867596:+	0.37	4.52	7.88E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72838028	chr2:118743276	INSIG2	chr2:118846050-118867596:+	0.37	4.52	7.88E-6	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72838030	chr2:118749282	INSIG2	chr2:118846050-118867596:+	0.34	4.23	2.81E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72838036	chr2:118761192	INSIG2	chr2:118846050-118867596:+	0.36	4.44	1.13E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72838052	chr2:118778486	INSIG2	chr2:118846050-118867596:+	0.37	4.45	1.09E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72838054	chr2:118779769	INSIG2	chr2:118846050-118867596:+	0.32	3.81	0.00016	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72838057	chr2:118781395	INSIG2	chr2:118846050-118867596:+	0.35	4.07	5.57E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72838060	chr2:118790049	INSIG2	chr2:118846050-118867596:+	0.34	4.05	5.92E-5	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs72840063	chr2:85550396	CAPG	chr2:85621871-85641170:-	-0.11	-3.74	0.000205	Ear protrusion	
PRAD	cis	1	rs72840063	chr2:85550396	TGOLN2	chr2:85545147-85555374:-	-0.23	-7.84	3.13E-14	Ear protrusion	
PRAD	cis	1	rs72843784	chr6:26498758	BTN3A2	chr6:26365398-26378546:+	-0.86	-12.5	3.79E-31	Schizophrenia	
PRAD	cis	1	rs72845397	chr11:6950903	ZNF215	chr11:6947654-7005861:+	-0.33	-6.11	2.1E-9	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs72848797	chr17:61934664	DDX42	chr17:61851567-61896676:+	-0.27	-5.5	6.38E-8	Body mass index	
PRAD	cis	1	rs72848797	chr17:61934664	FTSJ3	chr17:61896795-61905031:-	0.35	6.81	2.91E-11	Body mass index	
PRAD	cis	1	rs72848797	chr17:61934664	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.19	3.28E-5	Body mass index	
PRAD	cis	1	rs7285549	chr22:25874580	CRYBB2	chr22:25615612-25627836:+	0.93	15.66	9.09E-45	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs728615	chr10:81848089	SFTPD	chr10:81697498-81708861:-	0.32	3.9	0.000111	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs728616	chr10:81847914	SFTPA1	chr10:81370712-81375201:+	-0.38	-3.67	0.000266	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs728616	chr10:81847914	SFTPD	chr10:81697498-81708861:-	0.32	4	7.32E-5	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs72873509	chr18:11986706	IMPA2	chr18:11981057-12030876:+	-0.36	-4.44	1.11E-5	Stroke	
PRAD	cis	1	rs72873510	chr18:11986727	IMPA2	chr18:11981057-12030876:+	-0.37	-4.52	7.74E-6	Stroke	
PRAD	cis	1	rs7289577	chr22:39042214	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs7289577	chr22:39042214	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs7289855	chr22:39042221	CBY1	chr22:39052658-39069853:+	0.17	4.68	3.84E-6	Resting heart rate	
PRAD	cis	1	rs7289855	chr22:39042221	LOC646851	chr22:38974125-39052634:-	0.19	4.43	1.2E-5	Resting heart rate	
PRAD	cis	1	rs7290710	chr22:50677454	SELO	chr22:50639408-50656044:+	0.1	3.64	0.000298	Obesity-related traits	
PRAD	cis	1	rs7291867	chr22:38062112	GALR3	chr22:38219389-38221502:+	0.27	4.78	2.38E-6	Fat distribution (HIV)	
PRAD	cis	1	rs7291867	chr22:38062112	LGALS1	chr22:38071613-38075807:+	-0.09	-4.83	1.88E-6	Fat distribution (HIV)	
PRAD	cis	1	rs7291867	chr22:38062112	LGALS2	chr22:37966254-37976024:-	0.17	4.47	9.94E-6	Fat distribution (HIV)	
PRAD	cis	1	rs72921498	chr11:62113090	ASRGL1	chr11:62104774-62160885:+	0.36	4.51	8.38E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs72921498	chr11:62113090	FADS3	chr11:61640999-61659422:-	0.21	3.6	0.000359	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs72921501	chr11:62115622	ASRGL1	chr11:62104774-62160885:+	0.4	4.8	2.1E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs72922733	chr11:65520746	CTSW	chr11:65647284-65651212:+	-0.29	-5.65	2.84E-8	Systemic lupus erythematosus	
PRAD	cis	1	rs72922733	chr11:65520746	SNX32	chr11:65601410-65621170:+	0.29	3.98	7.9E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs72931639	chr11:78036703	GAB2	chr11:77926343-78128766:-	-0.21	-6.63	9.18E-11	Testicular germ cell tumor	
PRAD	cis	1	rs72931639	chr11:78036703	NARS2	chr11:78147017-78285909:-	-0.18	-3.67	0.000265	Testicular germ cell tumor	
PRAD	cis	1	rs72931642	chr11:78037862	GAB2	chr11:77926343-78128766:-	-0.2	-6.33	5.71E-10	Testicular germ cell tumor	
PRAD	cis	1	rs72931642	chr11:78037862	NARS2	chr11:78147017-78285909:-	-0.18	-3.47	0.000559	Testicular germ cell tumor	
PRAD	cis	1	rs72931690	chr11:78073192	GAB2	chr11:77926343-78128766:-	-0.2	-6.29	7.29E-10	Testicular germ cell tumor	
PRAD	cis	1	rs72931690	chr11:78073192	NARS2	chr11:78147017-78285909:-	-0.17	-3.47	0.000577	Testicular germ cell tumor	
PRAD	cis	1	rs72932727	chr2:203649501	CYP20A1	chr2:204103164-204170562:+	0.35	3.57	0.000394	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72932780	chr2:203695826	CYP20A1	chr2:204103164-204170562:+	0.33	3.49	0.000524	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72932781	chr2:203697278	CYP20A1	chr2:204103164-204170562:+	0.33	3.5	0.000507	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72932784	chr2:203698470	CYP20A1	chr2:204103164-204170562:+	0.33	3.5	0.000507	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72932786	chr2:203698737	CYP20A1	chr2:204103164-204170562:+	0.33	3.5	0.000507	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72932789	chr2:203699379	CYP20A1	chr2:204103164-204170562:+	0.33	3.5	0.000507	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72932791	chr2:203700870	CYP20A1	chr2:204103164-204170562:+	0.33	3.5	0.000507	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72932793	chr2:203701004	CYP20A1	chr2:204103164-204170562:+	0.33	3.5	0.000507	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934537	chr2:203969504	CYP20A1	chr2:204103164-204170562:+	0.34	3.7	0.000241	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934545	chr2:203975958	CYP20A1	chr2:204103164-204170562:+	0.34	3.7	0.000241	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934554	chr2:203987806	CYP20A1	chr2:204103164-204170562:+	0.34	3.7	0.000241	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934563	chr2:203995405	CYP20A1	chr2:204103164-204170562:+	0.34	3.62	0.000331	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934573	chr2:204005072	CYP20A1	chr2:204103164-204170562:+	0.35	3.81	0.000156	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934704	chr2:203706433	CYP20A1	chr2:204103164-204170562:+	0.33	3.56	0.000403	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934706	chr2:203707752	CYP20A1	chr2:204103164-204170562:+	0.33	3.57	0.000389	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934707	chr2:203707878	CYP20A1	chr2:204103164-204170562:+	0.33	3.56	0.000403	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934710	chr2:203709776	CYP20A1	chr2:204103164-204170562:+	0.33	3.56	0.000403	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934711	chr2:203709997	CYP20A1	chr2:204103164-204170562:+	0.33	3.56	0.000403	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934714	chr2:203711581	CYP20A1	chr2:204103164-204170562:+	0.33	3.59	0.000372	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934715	chr2:203713280	CYP20A1	chr2:204103164-204170562:+	0.33	3.59	0.000372	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934729	chr2:203737770	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934732	chr2:203739856	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934735	chr2:203740010	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934737	chr2:203740798	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934738	chr2:203740861	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934740	chr2:203741362	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934745	chr2:203744454	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934749	chr2:203746816	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934751	chr2:203747522	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934753	chr2:203750272	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934763	chr2:203758396	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934764	chr2:203758521	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934765	chr2:203758551	CYP20A1	chr2:204103164-204170562:+	0.33	3.57	0.000387	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934767	chr2:203766563	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72934944	chr2:202190610	CFLAR	chr2:201980816-202029001:+	-0.19	-4.4	1.33E-5	Rheumatoid arthritis	
PRAD	cis	1	rs72934944	chr2:202190610	NIF3L1	chr2:201754050-201768655:+	-0.35	-5.27	2.09E-7	Rheumatoid arthritis	
PRAD	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.75	-10.57	1.37E-23	Rheumatoid arthritis	
PRAD	cis	1	rs72934960	chr2:202204749	CFLAR	chr2:201980816-202029001:+	-0.2	-4.17	3.7E-5	Rheumatoid arthritis	
PRAD	cis	1	rs72934960	chr2:202204749	NIF3L1	chr2:201754050-201768655:+	-0.34	-4.59	5.58E-6	Rheumatoid arthritis	
PRAD	cis	1	rs72934960	chr2:202204749	PPIL3	chr2:201735680-201753999:-	-0.75	-9.36	3.26E-19	Rheumatoid arthritis	
PRAD	cis	1	rs72934973	chr2:202213934	CFLAR	chr2:201980816-202029001:+	-0.2	-4.17	3.7E-5	Rheumatoid arthritis	
PRAD	cis	1	rs72934973	chr2:202213934	NIF3L1	chr2:201754050-201768655:+	-0.34	-4.59	5.58E-6	Rheumatoid arthritis	
PRAD	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.75	-9.36	3.26E-19	Rheumatoid arthritis	
PRAD	cis	1	rs72934999	chr2:202223524	CFLAR	chr2:201980816-202029001:+	-0.21	-4.4	1.34E-5	Rheumatoid arthritis	
PRAD	cis	1	rs72934999	chr2:202223524	NIF3L1	chr2:201754050-201768655:+	-0.32	-4.36	1.63E-5	Rheumatoid arthritis	
PRAD	cis	1	rs72934999	chr2:202223524	PPIL3	chr2:201735680-201753999:-	-0.75	-9.6	4.83E-20	Rheumatoid arthritis	
PRAD	cis	1	rs729354	chr11:77962453	GAB2	chr11:77926343-78128766:-	-0.18	-5.93	5.91E-9	Testicular germ cell tumor	
PRAD	cis	1	rs729354	chr11:77962453	NARS2	chr11:78147017-78285909:-	-0.2	-4.16	3.8E-5	Testicular germ cell tumor	
PRAD	cis	1	rs72936304	chr2:204036357	CYP20A1	chr2:204103164-204170562:+	0.39	4.11	4.75E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936309	chr2:204040296	CYP20A1	chr2:204103164-204170562:+	0.39	4.11	4.75E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936323	chr2:204050474	CYP20A1	chr2:204103164-204170562:+	0.4	4.38	1.47E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936326	chr2:204054141	CYP20A1	chr2:204103164-204170562:+	0.4	4.28	2.28E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936332	chr2:204056678	CYP20A1	chr2:204103164-204170562:+	0.4	4.28	2.28E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936348	chr2:204064839	CYP20A1	chr2:204103164-204170562:+	0.4	4.28	2.28E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936353	chr2:204070956	CYP20A1	chr2:204103164-204170562:+	0.4	4.28	2.28E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936830	chr2:203769803	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936834	chr2:203771260	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936838	chr2:203772984	CYP20A1	chr2:204103164-204170562:+	0.33	3.58	0.000376	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936842	chr2:203773686	CYP20A1	chr2:204103164-204170562:+	0.33	3.58	0.000376	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936846	chr2:203774734	CYP20A1	chr2:204103164-204170562:+	0.35	3.7	0.000244	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936847	chr2:203774748	CYP20A1	chr2:204103164-204170562:+	0.35	3.7	0.000244	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936852	chr2:203775475	CYP20A1	chr2:204103164-204170562:+	0.35	3.7	0.000244	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72936856	chr2:203775712	CYP20A1	chr2:204103164-204170562:+	0.35	3.7	0.000244	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs72937106	chr2:202225520	CFLAR	chr2:201980816-202029001:+	-0.21	-4.4	1.34E-5	Rheumatoid arthritis	
PRAD	cis	1	rs72937106	chr2:202225520	NIF3L1	chr2:201754050-201768655:+	-0.32	-4.36	1.63E-5	Rheumatoid arthritis	
PRAD	cis	1	rs72937106	chr2:202225520	PPIL3	chr2:201735680-201753999:-	-0.75	-9.6	4.83E-20	Rheumatoid arthritis	
PRAD	cis	1	rs72937118	chr2:202229527	CFLAR	chr2:201980816-202029001:+	-0.21	-4.4	1.34E-5	Rheumatoid arthritis	
PRAD	cis	1	rs72937118	chr2:202229527	NIF3L1	chr2:201754050-201768655:+	-0.32	-4.36	1.63E-5	Rheumatoid arthritis	
PRAD	cis	1	rs72937118	chr2:202229527	PPIL3	chr2:201735680-201753999:-	-0.75	-9.6	4.83E-20	Rheumatoid arthritis	
PRAD	cis	1	rs72937120	chr2:202232611	CFLAR	chr2:201980816-202029001:+	-0.21	-4.4	1.34E-5	Rheumatoid arthritis	
PRAD	cis	1	rs72937120	chr2:202232611	NIF3L1	chr2:201754050-201768655:+	-0.32	-4.36	1.63E-5	Rheumatoid arthritis	
PRAD	cis	1	rs72937120	chr2:202232611	PPIL3	chr2:201735680-201753999:-	-0.75	-9.6	4.83E-20	Rheumatoid arthritis	
PRAD	cis	1	rs729376	chr6:33704823	IP6K3	chr6:33689443-33714762:-	0.2	3.95	8.89E-5	Obesity (extreme)	
PRAD	cis	1	rs7294478	chr12:7266805	PEX5	chr12:7341759-7371167:+	0.29	5.27	2.11E-7	Neuritic plaque	
PRAD	cis	1	rs72952793	chr6:118892979	C6orf204	chr6:118786239-119031238:-	-0.15	-3.43	0.000662	Renal cell carcinoma	
PRAD	cis	1	rs72954221	chr2:99899445	MRPL30	chr2:99758185-99939196:+	0.24	3.9	0.000111	IgG glycosylation	
PRAD	cis	1	rs72954221	chr2:99899445	TSGA10	chr2:99613725-99771187:-	0.27	4.24	2.72E-5	IgG glycosylation	
PRAD	cis	1	rs72961173	chr2:99886868	MRPL30	chr2:99758185-99939196:+	0.24	3.9	0.000111	IgG glycosylation	
PRAD	cis	1	rs72961173	chr2:99886868	TSGA10	chr2:99613725-99771187:-	0.27	4.24	2.72E-5	IgG glycosylation	
PRAD	cis	1	rs72963846	chr11:94307762	MRE11A	chr11:94150469-94227040:-	-0.14	-4.03	6.55E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
PRAD	cis	1	rs72963850	chr11:94310732	MRE11A	chr11:94150469-94227040:-	-0.14	-4.13	4.23E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
PRAD	cis	1	rs72963868	chr11:94317709	MRE11A	chr11:94150469-94227040:-	-0.14	-4.08	5.29E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
PRAD	cis	1	rs72969531	chr6:118729974	C6orf204	chr6:118786239-119031238:-	-0.15	-3.55	0.00043	Renal cell carcinoma	
PRAD	cis	1	rs72973797	chr6:128286386	THEMIS	chr6:128029346-128239742:-	-0.16	-3.88	0.000121	Crohn's disease	
PRAD	cis	1	rs7297610	chr12:69824024	YEATS4	chr12:69753532-69784575:+	0.34	4.93	1.15E-6	Response to diuretic therapy	
PRAD	cis	1	rs7298108	chr12:9376168	LOC642846	chr12:9436253-9466684:+	-0.28	-6.18	1.41E-9	Non-alcoholic fatty liver disease histology (AST)	
PRAD	cis	1	rs7299044	chr12:85496496	LRRIQ1	chr12:85430099-85638880:+	-0.26	-4.34	1.76E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7299044	chr12:85496496	SLC6A15	chr12:85253269-85306606:-	-0.3	-4.47	9.68E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7299044	chr12:85496496	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.5	6.08E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs729931	chr14:52988585	GPR137C	chr14:53019866-53104430:+	0.19	3.85	0.000132	Orofacial clefts	
PRAD	cis	1	rs73018016	chr19:9997361	PIN1	chr19:9945999-9960358:+	0.14	4.11	4.73E-5	Menarche (age at onset)	
PRAD	cis	1	rs7302315	chr12:85452065	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.86E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7302315	chr12:85452065	SLC6A15	chr12:85253269-85306606:-	-0.33	-5.01	7.7E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7302315	chr12:85452065	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.53	5.43E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs73034271	chr2:178671155	PDE11A	chr2:178487979-178973066:-	-0.34	-4.31	2.03E-5	Height	
PRAD	cis	1	rs73034272	chr2:178671583	PDE11A	chr2:178487979-178973066:-	-0.34	-4.31	2.03E-5	Height	
PRAD	cis	1	rs73034273	chr2:178673425	PDE11A	chr2:178487979-178973066:-	-0.32	-4.01	7.0E-5	Height	
PRAD	cis	1	rs73034288	chr2:178678891	PDE11A	chr2:178487979-178973066:-	-0.32	-3.95	9.08E-5	Height	
PRAD	cis	1	rs73034292	chr2:178679243	PDE11A	chr2:178487979-178973066:-	-0.32	-4.01	7.11E-5	Height	
PRAD	cis	1	rs73036023	chr19:32948320	DPY19L3	chr19:32896677-32975236:+	0.11	3.56	0.000402	Bipolar disorder	
PRAD	cis	1	rs73036062	chr11:133828187	IGSF9B	chr11:133785186-133826880:-	0.18	3.54	0.000438	Schizophrenia	
PRAD	cis	1	rs73036065	chr11:133830067	IGSF9B	chr11:133785186-133826880:-	0.17	3.45	0.000621	Schizophrenia	
PRAD	cis	1	rs73036067	chr2:178682901	PDE11A	chr2:178487979-178973066:-	-0.3	-3.85	0.000133	Height	
PRAD	cis	1	rs73036079	chr2:178686495	PDE11A	chr2:178487979-178973066:-	-0.3	-3.85	0.000133	Height	
PRAD	cis	1	rs73036088	chr2:178692588	PDE11A	chr2:178487979-178973066:-	-0.28	-3.61	0.000344	Height	
PRAD	cis	1	rs73036090	chr2:178692914	PDE11A	chr2:178487979-178973066:-	-0.27	-3.51	0.000496	Height	
PRAD	cis	1	rs73036091	chr2:178693198	PDE11A	chr2:178487979-178973066:-	-0.27	-3.51	0.000496	Height	
PRAD	cis	1	rs73038232	chr19:32987653	DPY19L3	chr19:32896677-32975236:+	0.12	3.64	0.000306	Bipolar disorder	
PRAD	cis	1	rs7303	chr14:75520065	EIF2B2	chr14:75469612-75476292:+	0.26	5.14	3.98E-7	Height	
PRAD	cis	1	rs7303	chr14:75520065	MLH3	chr14:75480467-75518235:-	0.33	6.63	9.47E-11	Height	
PRAD	cis	1	rs7304576	chr12:85447749	LRRIQ1	chr12:85430099-85638880:+	-0.24	-4.02	6.64E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7304576	chr12:85447749	SLC6A15	chr12:85253269-85306606:-	-0.33	-5	8.28E-7	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7304576	chr12:85447749	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.56	4.58E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs730543	chr20:47635715	CSE1L	chr20:47662838-47713484:+	-0.19	-4.63	4.75E-6	Anger	
PRAD	cis	1	rs730543	chr20:47635715	PREX1	chr20:47240793-47444420:-	0.17	3.44	0.000643	Anger	
PRAD	cis	1	rs73057994	chr19:50091273	FLT3LG	chr19:49977486-49990893:+	0.09	3.57	0.000393	Fibrinogen levels	
PRAD	cis	1	rs73058820	chr2:198864358	PLCL1	chr2:198669426-199014606:+	0.15	3.89	0.000115	Ulcerative colitis	
PRAD	cis	1	rs73058821	chr2:198864597	PLCL1	chr2:198669426-199014606:+	0.15	3.89	0.000115	Ulcerative colitis	
PRAD	cis	1	rs73058829	chr2:198871145	PLCL1	chr2:198669426-199014606:+	0.16	4.09	5.03E-5	Ulcerative colitis	
PRAD	cis	1	rs73058832	chr2:198873214	PLCL1	chr2:198669426-199014606:+	0.15	3.81	0.000157	Ulcerative colitis	
PRAD	cis	1	rs73058834	chr2:198873779	PLCL1	chr2:198669426-199014606:+	0.15	3.9	0.000112	Ulcerative colitis	
PRAD	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.77	11.72	5.2E-28	Diastolic blood pressure	
PRAD	cis	1	rs73069394	chr3:41787233	ULK4	chr3:41288091-42003660:-	0.81	13.14	8.28E-34	Diastolic blood pressure	
PRAD	cis	1	rs73069396	chr3:41787236	ULK4	chr3:41288091-42003660:-	0.81	13.14	8.28E-34	Diastolic blood pressure	
PRAD	cis	1	rs73069940	chr4:1236502	KIAA1530	chr4:1341104-1381836:+	-0.28	-3.76	0.000192	Type 2 diabetes	
PRAD	cis	1	rs73070048	chr2:207641394	MDH1B	chr2:207598943-207630050:-	0.41	4.42	1.21E-5	Episodic memory	
PRAD	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.83	13.7	3.47E-36	Diastolic blood pressure	
PRAD	cis	1	rs73072749	chr12:22515384	KIAA0528	chr12:22601526-22697452:-	0.3	3.89	0.000115	Coronary artery calcification	
PRAD	cis	1	rs73072753	chr12:22515464	KIAA0528	chr12:22601526-22697452:-	0.3	3.89	0.000115	Coronary artery calcification	
PRAD	cis	1	rs73074358	chr3:48427247	ATRIP	chr3:48488141-48507708:+	0.27	6.28	7.73E-10	Longevity	
PRAD	cis	1	rs73074358	chr3:48427247	CDC25A	chr3:48198668-48229801:-	0.22	4.12	4.39E-5	Longevity	
PRAD	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.18	-5.01	7.64E-7	Longevity	
PRAD	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	0.85	13.92	4.11E-37	Diastolic blood pressure	
PRAD	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.8	11.92	8.15E-29	Diastolic blood pressure	
PRAD	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.83	13.07	1.69E-33	Diastolic blood pressure	
PRAD	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.81	12.16	9.23E-30	Diastolic blood pressure	
PRAD	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.81	12.16	9.23E-30	Diastolic blood pressure	
PRAD	cis	1	rs73084594	chr20:3916380	MAVS	chr20:3827449-3856761:+	-0.27	-3.63	0.000311	Response to antidepressants in depression	
PRAD	cis	1	rs73086505	chr20:3921571	MAVS	chr20:3827449-3856761:+	-0.27	-3.67	0.000266	Response to antidepressants in depression	
PRAD	cis	1	rs73086508	chr20:3921715	MAVS	chr20:3827449-3856761:+	-0.27	-3.67	0.000266	Response to antidepressants in depression	
PRAD	cis	1	rs73086510	chr20:3922131	MAVS	chr20:3827449-3856761:+	-0.27	-3.67	0.000266	Response to antidepressants in depression	
PRAD	cis	1	rs73086512	chr20:3922772	MAVS	chr20:3827449-3856761:+	-0.26	-3.49	0.000519	Response to antidepressants in depression	
PRAD	cis	1	rs73086535	chr20:3944150	MAVS	chr20:3827449-3856761:+	-0.25	-3.5	0.000509	Response to antidepressants in depression	
PRAD	cis	1	rs73086540	chr20:3950850	MAVS	chr20:3827449-3856761:+	-0.27	-3.7	0.000238	Response to antidepressants in depression	
PRAD	cis	1	rs73086544	chr20:3950928	MAVS	chr20:3827449-3856761:+	-0.27	-3.7	0.000238	Response to antidepressants in depression	
PRAD	cis	1	rs73086549	chr20:3954662	MAVS	chr20:3827449-3856761:+	-0.27	-3.7	0.000238	Response to antidepressants in depression	
PRAD	cis	1	rs73086581	chr20:3977325	MAVS	chr20:3827449-3856761:+	-0.27	-3.7	0.000238	Response to antidepressants in depression	
PRAD	cis	1	rs73086588	chr20:3982224	MAVS	chr20:3827449-3856761:+	-0.26	-3.53	0.000462	Response to antidepressants in depression	
PRAD	cis	1	rs73086595	chr20:3983448	MAVS	chr20:3827449-3856761:+	-0.26	-3.53	0.000462	Response to antidepressants in depression	
PRAD	cis	1	rs73086597	chr20:3983571	MAVS	chr20:3827449-3856761:+	-0.25	-3.47	0.000563	Response to antidepressants in depression	
PRAD	cis	1	rs73088137	chr3:49448423	AMIGO3	chr3:49754268-49757238:-	0.46	9.13	2.04E-18	Menarche (age at onset)	
PRAD	cis	1	rs73088137	chr3:49448423	CCDC36	chr3:49235861-49295537:+	-0.22	-3.86	0.000131	Menarche (age at onset)	
PRAD	cis	1	rs73088137	chr3:49448423	GMPPB	chr3:49758932-49761384:-	0.51	12.15	9.47E-30	Menarche (age at onset)	
PRAD	cis	1	rs73088137	chr3:49448423	NCKIPSD	chr3:48711280-48723334:-	-0.29	-5.6	3.73E-8	Menarche (age at onset)	
PRAD	cis	1	rs73088137	chr3:49448423	WDR6	chr3:49044637-49053386:+	0.2	3.93	9.84E-5	Menarche (age at onset)	
PRAD	cis	1	rs73088416	chr20:3995276	MAVS	chr20:3827449-3856761:+	-0.27	-3.76	0.00019	Response to antidepressants in depression	
PRAD	cis	1	rs73088421	chr20:3997871	MAVS	chr20:3827449-3856761:+	-0.27	-3.6	0.00035	Response to antidepressants in depression	
PRAD	cis	1	rs73090666	chr12:51356502	TFCP2	chr12:51488608-51566917:-	-0.21	-3.5	0.000515	Type 2 diabetes	
PRAD	cis	1	rs7309927	chr12:1000185	RAD52	chr12:1021255-1099219:-	-0.4	-6.78	3.68E-11	Colorectal cancer	
PRAD	cis	1	rs73108440	chr12:53273208	KRT8	chr12:53290971-53343626:-	-0.24	-4.4	1.34E-5	Prostate cancer	
PRAD	cis	1	rs73108447	chr12:53275614	KRT8	chr12:53290971-53343626:-	-0.24	-4.45	1.06E-5	Prostate cancer	
PRAD	cis	1	rs73108453	chr12:53276900	KRT8	chr12:53290971-53343626:-	-0.24	-4.45	1.06E-5	Prostate cancer	
PRAD	cis	1	rs731123	chr5:78317728	BHMT2	chr5:78365583-78385273:+	0.1	3.77	0.000187	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs731124	chr5:78317413	BHMT2	chr5:78365583-78385273:+	0.1	3.86	0.000128	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs73113674	chr7:38830477	FAM183B	chr7:38724947-38726689:-	0.37	3.51	0.00049	Cognitive performance	
PRAD	cis	1	rs73113699	chr7:38843618	FAM183B	chr7:38724947-38726689:-	0.37	3.45	0.000605	Cognitive performance	
PRAD	cis	1	rs73115614	chr7:38851025	FAM183B	chr7:38724947-38726689:-	0.39	3.64	0.000304	Cognitive performance	
PRAD	cis	1	rs73115622	chr7:38856802	FAM183B	chr7:38724947-38726689:-	0.39	3.64	0.000304	Cognitive performance	
PRAD	cis	1	rs73115623	chr7:38856889	FAM183B	chr7:38724947-38726689:-	0.39	3.64	0.000304	Cognitive performance	
PRAD	cis	1	rs73115628	chr7:38858397	FAM183B	chr7:38724947-38726689:-	0.39	3.64	0.000304	Cognitive performance	
PRAD	cis	1	rs73116394	chr2:242367915	SEPT2	chr2:242254723-242293439:+	0.57	8.62	1.06E-16	Chronic lymphocytic leukemia	
PRAD	cis	1	rs73116396	chr2:242368693	SEPT2	chr2:242254723-242293439:+	0.57	8.62	1.06E-16	Chronic lymphocytic leukemia	
PRAD	cis	1	rs73121378	chr7:38860268	FAM183B	chr7:38724947-38726689:-	0.39	3.64	0.000304	Cognitive performance	
PRAD	cis	1	rs73121380	chr7:38864179	FAM183B	chr7:38724947-38726689:-	0.39	3.64	0.000305	Cognitive performance	
PRAD	cis	1	rs73121381	chr7:38864327	FAM183B	chr7:38724947-38726689:-	0.35	3.74	0.000206	Cognitive performance	
PRAD	cis	1	rs73121384	chr7:38865187	FAM183B	chr7:38724947-38726689:-	0.38	3.69	0.000251	Cognitive performance	
PRAD	cis	1	rs73121386	chr7:38865235	FAM183B	chr7:38724947-38726689:-	0.38	3.69	0.000251	Cognitive performance	
PRAD	cis	1	rs73121396	chr7:38870102	FAM183B	chr7:38724947-38726689:-	0.4	4.12	4.45E-5	Cognitive performance	
PRAD	cis	1	rs73121399	chr7:38870368	FAM183B	chr7:38724947-38726689:-	0.38	3.69	0.000251	Cognitive performance	
PRAD	cis	1	rs73123603	chr7:38872711	FAM183B	chr7:38724947-38726689:-	0.38	3.6	0.000346	Cognitive performance	
PRAD	cis	1	rs73123614	chr7:38879811	FAM183B	chr7:38724947-38726689:-	0.38	3.6	0.000346	Cognitive performance	
PRAD	cis	1	rs73123618	chr7:38882389	FAM183B	chr7:38724947-38726689:-	0.4	4.06	5.7E-5	Cognitive performance	
PRAD	cis	1	rs73123624	chr7:38884960	FAM183B	chr7:38724947-38726689:-	0.35	3.67	0.000274	Cognitive performance	
PRAD	cis	1	rs73123626	chr7:38885242	FAM183B	chr7:38724947-38726689:-	0.4	4.07	5.53E-5	Cognitive performance	
PRAD	cis	1	rs73123893	chr7:38780531	FAM183B	chr7:38724947-38726689:-	0.37	3.51	0.000484	Cognitive performance	
PRAD	cis	1	rs7312404	chr12:124446728	ZNF664	chr12:124457670-124499967:+	-0.15	-4.07	5.49E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs73128528	chr20:44582187	SEMG1	chr20:43835638-43838414:+	0.29	3.46	0.000596	Abdominal aortic aneurysm	
PRAD	cis	1	rs73128528	chr20:44582187	WFDC3	chr20:44402847-44420547:-	-0.49	-6.24	9.79E-10	Abdominal aortic aneurysm	
PRAD	cis	1	rs7312933	chr12:42503467	GXYLT1	chr12:42475650-42538673:-	0.14	3.79	0.00017	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
PRAD	cis	1	rs7313036	chr12:85502666	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.3	2.05E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7313036	chr12:85502666	SLC6A15	chr12:85253269-85306606:-	-0.3	-4.62	5.01E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7313036	chr12:85502666	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.61	3.55E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs73132934	chr1:247868744	OR2W3	chr1:248031265-248060142:+	-0.32	-4.8	2.13E-6	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs73132934	chr1:247868744	TRIM58	chr1:248020501-248043436:+	-0.28	-4.27	2.38E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs73140069	chr7:75986790	SRCRB4D	chr7:76018647-76039012:-	0.23	4.57	6.15E-6	Multiple sclerosis	
PRAD	cis	1	rs73140069	chr7:75986790	UPK3B	chr7:76139745-76157197:+	-0.28	-5.03	6.84E-7	Multiple sclerosis	
PRAD	cis	1	rs73142121	chr7:65311206	CCT6P1	chr7:65216092-65228661:+	0.3	5.3	1.76E-7	Diabetic kidney disease	
PRAD	cis	1	rs73142122	chr7:65311298	CCT6P1	chr7:65216092-65228661:+	0.34	5.86	8.9E-9	Diabetic kidney disease	
PRAD	cis	1	rs73142162	chr7:65374296	CCT6P1	chr7:65216092-65228661:+	0.34	5.9	6.92E-9	Diabetic kidney disease	
PRAD	cis	1	rs73142166	chr7:65375832	CCT6P1	chr7:65216092-65228661:+	0.34	5.9	6.92E-9	Diabetic kidney disease	
PRAD	cis	1	rs73150014	chr7:65450919	CCT6P1	chr7:65216092-65228661:+	0.32	5.62	3.28E-8	Diabetic kidney disease	
PRAD	cis	1	rs73150014	chr7:65450919	CRCP	chr7:65579805-65619551:+	-0.3	-3.82	0.000154	Diabetic kidney disease	
PRAD	cis	1	rs73154395	chr13:25081803	PARP4	chr13:24995075-25086948:-	-0.21	-3.98	8.14E-5	Sudden cardiac arrest	
PRAD	cis	1	rs73154401	chr13:25085667	PARP4	chr13:24995075-25086948:-	-0.21	-4	7.44E-5	Sudden cardiac arrest	
PRAD	cis	1	rs731600	chr11:77963133	GAB2	chr11:77926343-78128766:-	-0.17	-5.82	1.11E-8	Testicular germ cell tumor	
PRAD	cis	1	rs731600	chr11:77963133	NARS2	chr11:78147017-78285909:-	-0.24	-5.19	3.07E-7	Testicular germ cell tumor	
PRAD	cis	1	rs73186030	chr3:122013465	CSTA	chr3:122044011-122060813:+	-0.27	-4.96	9.72E-7	Serum parathyroid hormone levels	
PRAD	cis	1	rs73186044	chr3:122028476	CSTA	chr3:122044011-122060813:+	-0.28	-5.29	1.87E-7	Serum parathyroid hormone levels	
PRAD	cis	1	rs73192978	chr3:127868275	RUVBL1	chr3:127783627-127872757:-	0.22	4.02	6.7E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs73192979	chr3:127868321	RUVBL1	chr3:127783627-127872757:-	0.22	4.02	6.7E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs73194058	chr21:34764288	TMEM50B	chr21:34804793-34852281:-	-0.41	-4.41	1.28E-5	Rheumatoid arthritis	
PRAD	cis	1	rs73197383	chr3:128030474	RUVBL1	chr3:127783627-127872757:-	0.22	3.93	9.63E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs73197388	chr3:128043920	RUVBL1	chr3:127783627-127872757:-	0.22	4.08	5.33E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs73201462	chr3:128059293	RUVBL1	chr3:127783627-127872757:-	0.22	3.93	9.79E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs73206853	chr12:110708746	C12orf24	chr12:110906229-110928191:+	-0.33	-5.01	7.71E-7	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	
PRAD	cis	1	rs73210606	chr3:128617426	ACAD9	chr3:128598333-128634910:+	-0.37	-3.44	0.000633	Dental caries	
PRAD	cis	1	rs73213796	chr12:93011764	NUDT4	chr12:93771701-93797022:+	0.3	3.49	0.00053	Periodontitis (Mean PAL)	
PRAD	cis	1	rs73215706	chr12:93020948	NUDT4	chr12:93771701-93797022:+	0.33	3.67	0.000271	Periodontitis (Mean PAL)	
PRAD	cis	1	rs732172	chr16:31050033	HSD3B7	chr16:30996519-31000473:+	0.44	9.39	2.66E-19	Response to metformin (IC50)	
PRAD	cis	1	rs732172	chr16:31050033	MYST1	chr16:31128985-31142713:+	0.19	5.95	5.37E-9	Response to metformin (IC50)	
PRAD	cis	1	rs732172	chr16:31050033	PRSS36	chr16:31150251-31161415:-	0.19	4.75	2.7E-6	Response to metformin (IC50)	
PRAD	cis	1	rs732172	chr16:31050033	PRSS53	chr16:31094747-31106276:-	-0.18	-3.66	0.000286	Response to metformin (IC50)	
PRAD	cis	1	rs732172	chr16:31050033	STX1B	chr16:31000577-31021829:-	0.21	5.33	1.55E-7	Response to metformin (IC50)	
PRAD	cis	1	rs732173	chr16:31050023	HSD3B7	chr16:30996519-31000473:+	0.44	9.36	3.29E-19	Response to metformin (IC50)	
PRAD	cis	1	rs732173	chr16:31050023	MYST1	chr16:31128985-31142713:+	0.19	5.71	2.01E-8	Response to metformin (IC50)	
PRAD	cis	1	rs732173	chr16:31050023	PRSS36	chr16:31150251-31161415:-	0.18	4.6	5.38E-6	Response to metformin (IC50)	
PRAD	cis	1	rs732173	chr16:31050023	PRSS53	chr16:31094747-31106276:-	-0.19	-3.76	0.000194	Response to metformin (IC50)	
PRAD	cis	1	rs732173	chr16:31050023	STX1B	chr16:31000577-31021829:-	0.21	5.18	3.38E-7	Response to metformin (IC50)	
PRAD	cis	1	rs73221200	chr4:743826	MYL5	chr4:667369-675816:+	-0.14	-3.89	0.000113	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs73221358	chr12:120869358	GATC	chr12:120884284-120897761:+	0.31	3.46	0.000595	Insulin resistance/response	
PRAD	cis	1	rs73221372	chr12:120899189	GATC	chr12:120884284-120897761:+	0.31	3.48	0.000547	Insulin resistance/response	
PRAD	cis	1	rs73221373	chr12:120901045	GATC	chr12:120884284-120897761:+	0.31	3.48	0.000547	Insulin resistance/response	
PRAD	cis	1	rs73221378	chr12:120910521	GATC	chr12:120884284-120897761:+	0.31	3.47	0.000573	Insulin resistance/response	
PRAD	cis	1	rs73239429	chr8:27079082	CHRNA2	chr8:27317279-27336813:-	0.19	3.94	9.45E-5	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs73239429	chr8:27079082	ESCO2	chr8:27632058-27670141:+	0.2	3.8	0.000165	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs73242927	chr6:170129573	WDR27	chr6:169857307-170102159:-	-0.13	-3.45	0.00061	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs7324557	chr13:24296862	C1QTNF9B	chr13:24465238-24471641:-	0.26	5.42	9.32E-8	Visceral adipose tissue adjusted for BMI	
PRAD	cis	1	rs7324557	chr13:24296862	PCOTH	chr13:24463028-24466241:+	0.3	6.56	1.42E-10	Visceral adipose tissue adjusted for BMI	
PRAD	cis	1	rs732680	chr4:154725211	RNF175	chr4:154631313-154681387:-	-0.19	-4.54	7.23E-6	Electrocardiographic conduction measures	
PRAD	cis	1	rs73268512	chr14:66088905	LOC645431	chr14:65877313-65879335:-	-0.4	-4.2	3.16E-5	Ischemic stroke	
PRAD	cis	1	rs73268521	chr14:66093243	LOC645431	chr14:65877313-65879335:-	-0.42	-4.19	3.33E-5	Ischemic stroke	
PRAD	cis	1	rs7326932	chr13:25004493	C1QTNF9	chr13:24553839-24896665:+	-0.21	-4.23	2.78E-5	Obesity-related traits	
PRAD	cis	1	rs7326932	chr13:25004493	LOC374491	chr13:25141011-25171810:+	-0.2	-3.48	0.000539	Obesity-related traits	
PRAD	cis	1	rs7326932	chr13:25004493	PARP4	chr13:24995075-25086948:-	0.19	4.99	8.7E-7	Obesity-related traits	
PRAD	cis	1	rs7327064	chr13:36771017	C13orf38	chr13:36801182-36871992:-	-0.27	-4.42	1.22E-5	Economic and political preferences	
PRAD	cis	1	rs73276406	chr8:96021760	C8orf38	chr8:95908040-96088396:+	-0.34	-6.07	2.59E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs73276406	chr8:96021760	TP53INP1	chr8:95938201-95961615:-	0.23	3.64	0.000306	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs73276417	chr8:96026312	C8orf38	chr8:95908040-96088396:+	-0.34	-6.01	3.63E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs73276417	chr8:96026312	TP53INP1	chr8:95938201-95961615:-	0.24	3.74	0.000207	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs73276437	chr8:96035511	C8orf38	chr8:95908040-96088396:+	-0.38	-6.67	7.21E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs73276444	chr8:96039247	C8orf38	chr8:95908040-96088396:+	-0.39	-6.84	2.48E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs73282209	chr5:150174959	C5orf62	chr5:150157867-150176297:+	0.3	3.44	0.000635	Crohn's disease	
PRAD	cis	1	rs73282209	chr5:150174959	LOC134466	chr5:150310000-150326146:-	0.71	9.88	4.7E-21	Crohn's disease	
PRAD	cis	1	rs73282234	chr5:150195924	C5orf62	chr5:150157867-150176297:+	0.33	3.7	0.000237	Crohn's disease	
PRAD	cis	1	rs73282234	chr5:150195924	LOC134466	chr5:150310000-150326146:-	0.67	8.84	1.9E-17	Crohn's disease	
PRAD	cis	1	rs73282255	chr5:150223647	C5orf62	chr5:150157867-150176297:+	0.29	3.72	0.000222	Crohn's disease	
PRAD	cis	1	rs73282255	chr5:150223647	LOC134466	chr5:150310000-150326146:-	0.57	8.64	8.67E-17	Crohn's disease	
PRAD	cis	1	rs73284121	chr14:65936936	LOC645431	chr14:65877313-65879335:-	-0.44	-4.46	1.05E-5	Ischemic stroke	
PRAD	cis	1	rs73284126	chr5:150261307	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs73284133	chr14:65946612	LOC645431	chr14:65877313-65879335:-	-0.44	-4.45	1.07E-5	Ischemic stroke	
PRAD	cis	1	rs73284141	chr5:150266086	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs732856	chr22:38060691	GALR3	chr22:38219389-38221502:+	-0.26	-4.56	6.49E-6	Fat distribution (HIV)	
PRAD	cis	1	rs732856	chr22:38060691	LGALS1	chr22:38071613-38075807:+	0.09	4.91	1.25E-6	Fat distribution (HIV)	
PRAD	cis	1	rs732856	chr22:38060691	LGALS2	chr22:37966254-37976024:-	-0.18	-4.67	4.01E-6	Fat distribution (HIV)	
PRAD	cis	1	rs73286118	chr14:66034821	LOC645431	chr14:65877313-65879335:-	-0.41	-3.96	8.52E-5	Ischemic stroke	
PRAD	cis	1	rs73286169	chr14:66078448	LOC645431	chr14:65877313-65879335:-	-0.41	-4.16	3.77E-5	Ischemic stroke	
PRAD	cis	1	rs73286173	chr14:66079540	LOC645431	chr14:65877313-65879335:-	-0.4	-4.2	3.16E-5	Ischemic stroke	
PRAD	cis	1	rs733010	chr10:100597860	CUTC	chr10:101491958-101515893:+	-0.19	-3.53	0.000459	Obesity-related traits	
PRAD	cis	1	rs73301712	chr14:59898245	C14orf149	chr14:59939406-59951126:-	-0.36	-4.61	5.1E-6	Schizophrenia	
PRAD	cis	1	rs73301725	chr14:59902159	C14orf149	chr14:59939406-59951126:-	-0.36	-4.61	5.1E-6	Schizophrenia	
PRAD	cis	1	rs73301741	chr14:59908444	C14orf149	chr14:59939406-59951126:-	-0.35	-4.31	1.96E-5	Schizophrenia	
PRAD	cis	1	rs73301746	chr14:59908485	C14orf149	chr14:59939406-59951126:-	-0.35	-4.31	1.96E-5	Schizophrenia	
PRAD	cis	1	rs7331003	chr13:44230253	CCDC122	chr13:44410491-44453826:-	-0.18	-3.5	0.000503	Response to tocilizumab in rheumatoid arthritis	
PRAD	cis	1	rs7331697	chr13:36763345	C13orf38	chr13:36801182-36871992:-	0.27	4.41	1.27E-5	Economic and political preferences	
PRAD	cis	1	rs7332189	chr13:36755610	SOHLH2	chr13:36742347-36871992:-	-0.2	-3.54	0.000433	Glucose homeostasis traits	
PRAD	cis	1	rs7332932	chr13:36755636	SOHLH2	chr13:36742347-36871992:-	-0.2	-3.54	0.000433	Glucose homeostasis traits	
PRAD	cis	1	rs73337598	chr17:61732576	DDX42	chr17:61851567-61896676:+	-0.23	-4.76	2.54E-6	Body mass index	
PRAD	cis	1	rs73337598	chr17:61732576	FTSJ3	chr17:61896795-61905031:-	0.35	7.1	4.64E-12	Body mass index	
PRAD	cis	1	rs73337598	chr17:61732576	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.31	1.97E-5	Body mass index	
PRAD	cis	1	rs73352808	chr17:65875157	LOC651250	chr17:66097696-66157623:+	-0.24	-4.46	1.03E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs7336933	chr13:42559076	KBTBD6	chr13:41701709-41706936:-	0.26	4	7.5E-5	Calcium levels	
PRAD	cis	1	rs73388053	chr9:1566977	DMRT3	chr9:976964-991732:+	0.35	3.92	0.000101	Superior frontal gyrus grey matter volume	
PRAD	cis	1	rs73395547	chr7:98922746	CYP3A5	chr7:99245818-99332821:-	0.3	6.11	2.07E-9	Blood metabolite levels	
PRAD	cis	1	rs73395557	chr7:98934424	CYP3A5	chr7:99245818-99332821:-	0.3	6.13	1.9E-9	Blood metabolite levels	
PRAD	cis	1	rs73398718	chr11:7706002	CYB5R2	chr11:7686327-7694994:-	0.19	4.26	2.43E-5	Waist circumference	
PRAD	cis	1	rs73404115	chr22:32147296	SFI1	chr22:31892261-32014533:+	-0.19	-3.82	0.000153	Intelligence	
PRAD	cis	1	rs7340989	chr4:107148720	TBCK	chr4:106967233-107237861:-	0.16	3.47	0.000562	Airflow obstruction	
PRAD	cis	1	rs73412140	chr6:33757014	LEMD2	chr6:33738991-33756906:-	0.2	5	8.24E-7	Body mass index	
PRAD	cis	1	rs7342170	chr11:94314477	MRE11A	chr11:94150469-94227040:-	-0.15	-4.37	1.51E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
PRAD	cis	1	rs73429729	chr6:44086727	MRPL14	chr6:44081374-44095191:-	-0.13	-3.59	0.000365	Major depressive disorder	
PRAD	cis	1	rs7343481	chr20:25300113	ENTPD6	chr20:25176339-25207360:+	0.16	4.17	3.64E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7343481	chr20:25300113	FAM182B	chr20:25744102-25848786:-	-0.37	-6.73	4.91E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7343481	chr20:25300113	PYGB	chr20:25228706-25278647:+	0.32	7.05	6.56E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs73436668	chr11:18443093	LDHC	chr11:18433853-18472792:+	-0.3	-3.66	0.000283	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs73438686	chr11:18459785	LDHC	chr11:18433853-18472792:+	-0.31	-3.71	0.000237	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs73440614	chr11:18466700	LDHC	chr11:18433853-18472792:+	-0.31	-3.82	0.000151	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs73440625	chr11:18470800	LDHC	chr11:18433853-18472792:+	-0.31	-3.82	0.000151	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs73449983	chr11:46612332	HARBI1	chr11:46624857-46638777:-	0.26	3.52	0.000473	Schizophrenia	
PRAD	cis	1	rs73452567	chr7:142816043	TMEM139	chr7:142982044-142985140:+	-0.24	-3.74	0.000206	Dermatomyositis	
PRAD	cis	1	rs734559	chr18:72179579	CNDP2	chr18:72163597-72188356:+	0.46	7.12	4.02E-12	Refractive error	
PRAD	cis	1	rs7349039	chr22:22068139	PPIL2	chr22:22020273-22052201:+	0.15	3.45	0.000608	Schizophrenia	
PRAD	cis	1	rs734999	chr1:2513216	MMEL1	chr1:2522081-2564481:-	-0.42	-8.25	1.65E-15	Ulcerative colitis	
PRAD	cis	1	rs7350721	chr14:56333513	DLGAP5	chr14:55614836-55658396:-	-0.13	-3.68	0.00026	Body mass index (interaction)	
PRAD	cis	1	rs73509052	chr19:12071802	ZNF763	chr19:12035900-12091196:+	-0.38	-3.84	0.000141	Multiple sclerosis	
PRAD	cis	1	rs73509996	chr19:17393449	ANKLE1	chr19:17392454-17398454:+	0.33	6.26	8.91E-10	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs73509996	chr19:17393449	MRPL34	chr19:17416477-17417652:+	-0.23	-4.38	1.49E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs73509996	chr19:17393449	OCEL1	chr19:17337055-17340027:+	0.22	5.14	4.0E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs73510924	chr19:12090150	ZNF763	chr19:12035900-12091196:+	-0.38	-3.88	0.000121	Multiple sclerosis	
PRAD	cis	1	rs73510930	chr19:12091762	ZNF763	chr19:12035900-12091196:+	-0.4	-3.93	9.84E-5	Multiple sclerosis	
PRAD	cis	1	rs73512559	chr11:70062699	FADD	chr11:70049269-70053508:+	-0.22	-3.44	0.000642	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs735531	chr20:33947730	CEP250	chr20:34042996-34099802:+	-0.23	-5.28	1.99E-7	Height	
PRAD	cis	1	rs735531	chr20:33947730	CPNE1	chr20:34213968-34262539:-	0.2	3.96	8.68E-5	Height	
PRAD	cis	1	rs735531	chr20:33947730	GDF5	chr20:33897002-34042568:-	-0.19	-4.71	3.33E-6	Height	
PRAD	cis	1	rs735531	chr20:33947730	MMP24	chr20:33814539-33864804:+	0.14	3.5	0.000515	Height	
PRAD	cis	1	rs735531	chr20:33947730	UQCC	chr20:33890383-33999833:-	0.37	7.05	6.6E-12	Height	
PRAD	cis	1	rs735539	chr13:21280034	IFT88	chr13:21141208-21265574:+	-0.27	-4.42	1.25E-5	Dental caries	
PRAD	cis	1	rs73559130	chr19:52022169	ZNF175	chr19:52074531-52092990:+	-0.32	-4.37	1.5E-5	Carotid intima media thickness	
PRAD	cis	1	rs73559183	chr19:52032367	ZNF175	chr19:52074531-52092990:+	-0.3	-4.19	3.34E-5	Carotid intima media thickness	
PRAD	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.53	12.11	1.5E-29	Height	
PRAD	cis	1	rs7356947	chr6:118767920	C6orf204	chr6:118786239-119031238:-	-0.14	-3.49	0.000525	Renal cell carcinoma	
PRAD	cis	1	rs735737	chr2:86177101	LOC90784	chr2:86247339-86250991:-	-0.44	-5.1	4.82E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs735765	chr6:28170297	ZNF187	chr6:28234788-28245978:+	-0.27	-4.54	7.28E-6	Depression	
PRAD	cis	1	rs735765	chr6:28170297	ZNF323	chr6:28292517-28324048:-	0.29	3.67	0.000271	Depression	
PRAD	cis	1	rs735765	chr6:28170297	ZNF389	chr6:28129551-28137375:+	-0.53	-7.11	4.47E-12	Depression	
PRAD	cis	1	rs735765	chr6:28170297	ZSCAN23	chr6:28393287-28411279:-	0.16	4.07	5.41E-5	Depression	
PRAD	cis	1	rs73579339	chr8:49888184	C8orf22	chr8:49984903-49988641:+	-0.19	-3.94	9.43E-5	Blood metabolite levels	
PRAD	cis	1	rs73579360	chr8:49920586	C8orf22	chr8:49984903-49988641:+	-0.19	-3.96	8.7E-5	Blood metabolite levels	
PRAD	cis	1	rs73586989	chr16:67234741	FHOD1	chr16:67263294-67281425:-	0.49	5.62	3.24E-8	HDL cholesterol	
PRAD	cis	1	rs7359981	chr19:12091659	ZNF763	chr19:12035900-12091196:+	-0.4	-3.89	0.000114	Multiple sclerosis	
PRAD	cis	1	rs736344	chr12:110001195	KCTD10	chr12:109886460-109915155:-	-0.33	-10.22	2.93E-22	HDL cholesterol	
PRAD	cis	1	rs736344	chr12:110001195	MMAB	chr12:109991523-110011358:-	-0.18	-5.43	8.82E-8	HDL cholesterol	
PRAD	cis	1	rs736344	chr12:110001195	MYO1H	chr12:109826524-109886176:+	-0.24	-5.39	1.1E-7	HDL cholesterol	
PRAD	cis	1	rs736344	chr12:110001195	UBE3B	chr12:109915439-109974506:+	-0.15	-3.73	0.000217	HDL cholesterol	
PRAD	cis	1	rs736408	chr3:52835354	GNL3	chr3:52719936-52728508:+	-0.15	-3.65	0.000286	Bipolar disorder	
PRAD	cis	1	rs736408	chr3:52835354	ITIH4	chr3:52847007-52866554:-	0.12	3.54	0.000442	Bipolar disorder	
PRAD	cis	1	rs736408	chr3:52835354	NEK4	chr3:52744803-52804951:-	-0.17	-4.66	4.09E-6	Bipolar disorder	
PRAD	cis	1	rs7364173	chr22:50681029	SELO	chr22:50639408-50656044:+	-0.11	-4.19	3.35E-5	Obesity-related traits	
PRAD	cis	1	rs7364180	chr22:42218856	NDUFA6	chr22:42481531-42486888:-	0.17	4.37	1.53E-5	Alzheimer's disease biomarkers	
PRAD	cis	1	rs73653483	chr9:97321920	FAM22F	chr9:97080478-97090926:-	0.44	3.83	0.000148	Height	
PRAD	cis	1	rs73653484	chr9:97322464	FAM22F	chr9:97080478-97090926:-	0.44	3.83	0.000148	Height	
PRAD	cis	1	rs7365904	chr1:20904528	CDA	chr1:20915444-20945398:+	-0.15	-3.94	9.4E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs736678	chr17:30347423	C17orf79	chr17:30178885-30186326:-	-0.28	-4.71	3.32E-6	Height	
PRAD	cis	1	rs737008	chr16:11374866	C16orf75	chr16:11343506-11445617:+	-0.26	-5.64	2.93E-8	Obesity-related traits	
PRAD	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.53	12.13	1.2E-29	Height	
PRAD	cis	1	rs7372217	chr3:41990122	ULK4	chr3:41288091-42003660:-	-0.9	-15.09	2.91E-42	Diastolic blood pressure	
PRAD	cis	1	rs73725075	chr7:142823479	TMEM139	chr7:142982044-142985140:+	-0.22	-3.64	0.000301	Dermatomyositis	
PRAD	cis	1	rs7373805	chr3:38455439	XYLB	chr3:38388251-38456467:+	0.23	5.06	5.97E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs7373816	chr3:38490443	XYLB	chr3:38388251-38456467:+	0.23	5.13	4.24E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs7373998	chr3:128008223	RUVBL1	chr3:127783627-127872757:-	-0.25	-4.72	3.09E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.55	12.6	1.4E-31	Height	
PRAD	cis	1	rs7374227	chr3:128001515	RUVBL1	chr3:127783627-127872757:-	0.25	4.72	3.09E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.53	12.11	1.5E-29	Height	
PRAD	cis	1	rs7374752	chr3:184732819	VPS8	chr3:184529931-184770402:+	-0.33	-4.17	3.68E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs7374952	chr3:128001367	RUVBL1	chr3:127783627-127872757:-	0.26	4.83	1.89E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs73772260	chr5:79446904	SERINC5	chr5:79407474-79551870:-	0.17	4.62	5.07E-6	Borderline personality disorder features	
PRAD	cis	1	rs73801329	chr4:23006975	PPARGC1A	chr4:23793645-23891700:-	0.21	3.46	0.000579	White matter lesion progression (adjusted for white matter lesion burden at baseline)	
PRAD	cis	1	rs73801333	chr4:23007449	PPARGC1A	chr4:23793645-23891700:-	0.21	3.46	0.000579	White matter lesion progression (adjusted for white matter lesion burden at baseline)	
PRAD	cis	1	rs738093	chr19:32930507	DPY19L3	chr19:32896677-32975236:+	0.11	3.47	0.00056	Bipolar disorder	
PRAD	cis	1	rs7383628	chr6:25607876	SCGN	chr6:25652429-25702006:+	0.43	7.33	1.01E-12	Uric acid levels	
PRAD	cis	1	rs73903009	chr20:33678732	MMP24	chr20:33814539-33864804:+	-0.22	-3.73	0.000213	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs73903017	chr20:33724758	GDF5	chr20:33897002-34042568:-	0.25	3.91	0.000106	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs73903017	chr20:33724758	MMP24	chr20:33814539-33864804:+	-0.25	-4.08	5.36E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs73903019	chr20:33727779	GDF5	chr20:33897002-34042568:-	0.25	3.88	0.000118	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs73903019	chr20:33727779	MMP24	chr20:33814539-33864804:+	-0.25	-4.05	5.98E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs73905019	chr20:33560314	MMP24	chr20:33814539-33864804:+	-0.25	-4.02	6.86E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs73905041	chr20:33592148	MMP24	chr20:33814539-33864804:+	-0.23	-3.76	0.000193	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs739139	chr22:38067011	GALR3	chr22:38219389-38221502:+	0.26	4.61	5.16E-6	Fat distribution (HIV)	
PRAD	cis	1	rs739139	chr22:38067011	LGALS1	chr22:38071613-38075807:+	-0.09	-4.91	1.26E-6	Fat distribution (HIV)	
PRAD	cis	1	rs739139	chr22:38067011	LGALS2	chr22:37966254-37976024:-	0.17	4.53	7.44E-6	Fat distribution (HIV)	
PRAD	cis	1	rs73921003	chr2:17775205	GEN1	chr2:17935162-17966632:+	0.41	5.24	2.48E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs739310	chr22:27051299	CRYBA4	chr22:27017928-27026635:+	0.51	8.07	5.87E-15	Obesity-related traits	
PRAD	cis	1	rs739310	chr22:27051299	TPST2	chr22:26921716-26986089:-	0.36	6.39	4.08E-10	Obesity-related traits	
PRAD	cis	1	rs73943909	chr2:86143378	REEP1	chr2:86441122-86564777:-	0.38	3.47	0.000561	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs739496	chr12:111887659	TMEM116	chr12:112369103-112450989:-	0.2	4.22	2.89E-5	Platelet count	
PRAD	cis	1	rs7395213	chr11:87869579	RAB38	chr11:87846431-87908599:-	-0.18	-5.29	1.87E-7	Frontotemporal dementia	
PRAD	cis	1	rs7395662	chr11:48518893	FOLH1	chr11:49168188-49230222:-	0.15	3.6	0.000354	HDL cholesterol	
PRAD	cis	1	rs73985728	chr2:207668245	MDH1B	chr2:207598943-207630050:-	0.49	4.38	1.47E-5	Episodic memory	
PRAD	cis	1	rs739954	chr5:139701920	HBEGF	chr5:139712429-139726188:-	-0.14	-3.62	0.000324	Alzheimer's disease in APOE e4- carriers	
PRAD	cis	1	rs74000358	chr2:242020779	PASK	chr2:242045515-242088878:-	0.31	3.67	0.000275	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs74000379	chr2:242034103	PASK	chr2:242045515-242088878:-	0.3	3.53	0.000451	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs74019800	chr16:58159888	C16orf80	chr16:58147497-58163296:-	-0.38	-4.08	5.24E-5	Telomere length	
PRAD	cis	1	rs74019802	chr16:58162210	C16orf80	chr16:58147497-58163296:-	-0.35	-3.7	0.000239	Telomere length	
PRAD	cis	1	rs740393	chr2:242065498	PASK	chr2:242045515-242088878:-	0.27	3.65	0.000287	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs7404928	chr16:23888840	PRKCB	chr16:23847300-24231930:+	0.15	5.52	5.63E-8	Rheumatoid arthritis	
PRAD	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.74	17.43	7.87E-53	Eye color traits	
PRAD	cis	1	rs74071851	chr14:88882202	SPATA7	chr14:88852012-88904802:+	-0.21	-4.07	5.55E-5	Coronary artery calcification	
PRAD	cis	1	rs74117831	chr10:1145707	IDI2	chr10:1064847-1071799:-	0.39	5.07	5.86E-7	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs74117848	chr10:1160974	IDI2	chr10:1064847-1071799:-	0.34	4.26	2.46E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs74117849	chr10:1165425	IDI2	chr10:1064847-1071799:-	0.36	4.67	3.95E-6	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs74117850	chr10:1165777	IDI2	chr10:1064847-1071799:-	0.36	4.67	3.95E-6	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs74120451	chr10:1126866	IDI2	chr10:1064847-1071799:-	0.37	4.84	1.74E-6	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs74174932	chr20:43756133	SLPI	chr20:43880879-43883206:-	0.24	3.78	0.000175	Parental longevity (mother's age at death)	
PRAD	cis	1	rs74174934	chr20:43761331	SLPI	chr20:43880879-43883206:-	0.24	3.84	0.000141	Parental longevity (mother's age at death)	
PRAD	cis	1	rs74210981	chr10:102287520	SEC31B	chr10:102246403-102289636:-	-0.33	-9.59	5.28E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs742132	chr6:25607571	SCGN	chr6:25652429-25702006:+	0.43	7.32	1.05E-12	Uric acid levels	
PRAD	cis	1	rs742134	chr22:43518275	TTLL12	chr22:43562629-43583107:-	-0.27	-4.13	4.32E-5	Prostate cancer	
PRAD	cis	1	rs7422899	chr2:198163527	PLCL1	chr2:198669426-199014606:+	-0.13	-4	7.37E-5	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs74244824	chr14:56334877	DLGAP5	chr14:55614836-55658396:-	0.12	3.56	0.00041	Body mass index (interaction)	
PRAD	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.85	-9.74	1.52E-20	Plasma clusterin levels	
PRAD	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.69	6.89E-28	Height	
PRAD	cis	1	rs7427165	chr3:121364624	IQCB1	chr3:121488610-121553926:-	0.5	9.87	5.34E-21	Cognitive performance	
PRAD	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.53	12.11	1.5E-29	Height	
PRAD	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.55	12.6	1.4E-31	Height	
PRAD	cis	1	rs7428	chr2:85545490	CAPG	chr2:85621871-85641170:-	0.11	3.75	0.000201	Ear protrusion	
PRAD	cis	1	rs7428	chr2:85545490	TGOLN2	chr2:85545147-85555374:-	0.23	7.83	3.17E-14	Ear protrusion	
PRAD	cis	1	rs74293240	chr6:24483896	GPLD1	chr6:24428405-24489850:-	0.41	8.18	2.74E-15	Hematological and biochemical traits	
PRAD	cis	1	rs74293240	chr6:24483896	MRS2	chr6:24403153-24425809:+	0.26	4.14	4.2E-5	Hematological and biochemical traits	
PRAD	cis	1	rs74298052	chr6:159405298	RSPH3	chr6:159398268-159421198:-	0.29	4.58	6.04E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs74298057	chr6:159417303	RSPH3	chr6:159398268-159421198:-	0.29	4.57	6.35E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs74298058	chr6:159419953	RSPH3	chr6:159398268-159421198:-	0.28	4.34	1.77E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.69	6.89E-28	Height	
PRAD	cis	1	rs7429990	chr3:47901803	CCDC72	chr3:48481686-48485537:+	0.13	4.06	5.8E-5	Educational attainment (years of education)	
PRAD	cis	1	rs7429990	chr3:47901803	CDC25A	chr3:48198668-48229801:-	0.34	6.07	2.65E-9	Educational attainment (years of education)	
PRAD	cis	1	rs7429990	chr3:47901803	SPINK8	chr3:48348336-48369831:-	0.26	4.97	9.19E-7	Educational attainment (years of education)	
PRAD	cis	1	rs74321972	chr10:103643036	KCNIP2	chr10:103585732-103603677:-	0.29	4.06	5.81E-5	Coronary artery calcification	
PRAD	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.53	11.97	5.35E-29	Height	
PRAD	cis	1	rs74328550	chr2:48177343	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.37	-4.36	1.57E-5	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.55	12.6	1.4E-31	Height	
PRAD	cis	1	rs7433707	chr3:38443180	XYLB	chr3:38388251-38456467:+	0.22	5.06	6.12E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.51	11.62	1.26E-27	Height	
PRAD	cis	1	rs7433991	chr3:134312292	CEP63	chr3:134204575-134293852:+	0.2	3.57	0.000388	Height	
PRAD	cis	1	rs74347384	chr7:1072440	GPR146	chr7:1084243-1098897:+	0.27	3.57	0.000387	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs74347384	chr7:1072440	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.15	3.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs74363821	chr6:26189524	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.77	0.000185	Renal underexcretion gout;Gout	
PRAD	cis	1	rs74363821	chr6:26189524	HIST1H3E	chr6:26224427-26226589:+	0.36	5.69	2.28E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs7436403	chr4:17692685	MED28	chr4:17616273-17629791:+	-0.16	-3.94	9.32E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs74366004	chr7:1088630	GPR146	chr7:1084243-1098897:+	0.27	3.65	0.000296	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs74366004	chr7:1088630	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.26	2.24E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs74369356	chr7:1071711	GPR146	chr7:1084243-1098897:+	0.27	3.57	0.000387	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs74369356	chr7:1071711	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.15	3.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs743777	chr22:37551607	TXN2	chr22:36863093-36877687:-	-0.11	-3.43	0.000651	Rheumatoid arthritis;Type 1 diabetes autoantibodies	
PRAD	cis	1	rs74395504	chr1:183633411	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs74398423	chr4:106720966	INTS12	chr4:106603787-106629881:-	-0.79	-7.95	1.44E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs744051	chr12:56667298	COQ10A	chr12:56660642-56664748:+	0.38	3.75	0.000197	Psoriasis vulgaris	
PRAD	cis	1	rs744051	chr12:56667298	MIP	chr12:56843885-56848429:-	-0.74	-5.53	5.19E-8	Psoriasis vulgaris	
PRAD	cis	1	rs74410979	chr6:159361089	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs7444	chr22:21976934	CCDC116	chr22:21987086-21991615:+	-0.27	-5.46	7.7E-8	Systemic lupus erythematosus	
PRAD	cis	1	rs7444	chr22:21976934	RIMBP3C	chr22:21738040-21743446:+;chr22	0.34	5.46	7.74E-8	Systemic lupus erythematosus	
PRAD	cis	1	rs74460168	chr2:178678792	PDE11A	chr2:178487979-178973066:-	-0.34	-4.34	1.73E-5	Height	
PRAD	cis	1	rs74471041	chr3:49542543	AMIGO3	chr3:49754268-49757238:-	0.44	8.95	8.33E-18	Menarche (age at onset)	
PRAD	cis	1	rs74471041	chr3:49542543	CCDC36	chr3:49235861-49295537:+	-0.23	-4.1	4.78E-5	Menarche (age at onset)	
PRAD	cis	1	rs74471041	chr3:49542543	GMPPB	chr3:49758932-49761384:-	0.49	12.03	3.09E-29	Menarche (age at onset)	
PRAD	cis	1	rs74471041	chr3:49542543	NCKIPSD	chr3:48711280-48723334:-	-0.3	-6.03	3.31E-9	Menarche (age at onset)	
PRAD	cis	1	rs74471041	chr3:49542543	P4HTM	chr3:49027341-49044579:+	-0.16	-3.48	0.000539	Menarche (age at onset)	
PRAD	cis	1	rs74471041	chr3:49542543	WDR6	chr3:49044637-49053386:+	0.2	4.02	6.86E-5	Menarche (age at onset)	
PRAD	cis	1	rs74496027	chr12:56726340	MIP	chr12:56843885-56848429:-	0.77	5.72	1.93E-8	Psoriasis vulgaris	
PRAD	cis	1	rs74497593	chr4:106616214	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs745080	chr14:52989228	GPR137C	chr14:53019866-53104430:+	-0.19	-3.76	0.000192	Orofacial clefts	
PRAD	cis	1	rs74508472	chr2:203382013	NOP58	chr2:203130515-203168382:+	0.28	4.49	9.12E-6	Urate levels	
PRAD	cis	1	rs745109	chr2:86841069	REEP1	chr2:86441122-86564777:-	0.23	3.49	0.000538	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
PRAD	cis	1	rs74541532	chr8:13082124	LONRF1	chr8:12579406-12612992:-	0.28	3.61	0.000339	Emphysema imaging phenotypes	
PRAD	cis	1	rs74543591	chr20:33658658	MMP24	chr20:33814539-33864804:+	-0.32	-4.79	2.27E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs74544416	chr8:82657745	CHMP4C	chr8:82644688-82671746:+	-0.93	-12.97	4.26E-33	Epithelial ovarian cancer;Ovarian cancer	
PRAD	cis	1	rs74552954	chr6:71132617	FAM135A	chr6:71123107-71270875:+	-0.43	-6.87	2.03E-11	Type 2 diabetes	
PRAD	cis	1	rs7456042	chr7:65299778	CCT6P1	chr7:65216092-65228661:+	0.31	5.42	9.41E-8	Diabetic kidney disease	
PRAD	cis	1	rs74568699	chr4:106665995	INTS12	chr4:106603787-106629881:-	-0.79	-7.86	2.61E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs74589786	chr20:61860939	BIRC7	chr20:61867276-61871853:+	0.4	4.48	9.48E-6	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs74599371	chr20:33561495	MMP24	chr20:33814539-33864804:+	-0.31	-4.65	4.39E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs74607112	chr2:86305534	LOC90784	chr2:86247339-86250991:-	-0.61	-5.14	4.01E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs74609824	chr17:17481353	RAI1	chr17:17584787-17714763:+	0.24	3.92	0.0001	Obsessive-compulsive symptoms	
PRAD	cis	1	rs74611500	chr14:66009789	LOC645431	chr14:65877313-65879335:-	-0.44	-4.39	1.39E-5	Ischemic stroke	
PRAD	cis	1	rs74626382	chr20:33746668	MMP24	chr20:33814539-33864804:+	-0.31	-4.61	5.17E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs746489	chr9:131910093	CRAT	chr9:131857075-131873070:-	0.22	4.2	3.14E-5	Blood metabolite ratios	
PRAD	cis	1	rs74650218	chr10:102293830	SEC31B	chr10:102246403-102289636:-	-0.29	-8.68	6.44E-17	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs74652290	chr7:1090109	GPR146	chr7:1084243-1098897:+	0.28	3.83	0.000147	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs74652290	chr7:1090109	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.14	4.11E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7466269	chr9:133464084	NCS1	chr9:132934857-132999583:+	0.12	3.73	0.000218	Bone mineral density	
PRAD	cis	1	rs7466269	chr9:133464084	USP20	chr9:132597696-132644107:+	0.14	3.52	0.000476	Bone mineral density	
PRAD	cis	1	rs74673257	chr12:56638077	COQ10A	chr12:56660642-56664748:+	-0.36	-3.53	0.000459	Psoriasis vulgaris	
PRAD	cis	1	rs74673257	chr12:56638077	MIP	chr12:56843885-56848429:-	0.69	5.1	5.05E-7	Psoriasis vulgaris	
PRAD	cis	1	rs74680618	chr2:242026270	PASK	chr2:242045515-242088878:-	0.33	3.88	0.000121	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs74720994	chr1:183607214	NCF2	chr1:183524698-183560046:-	0.27	3.78	0.00018	Systemic lupus erythematosus	
PRAD	cis	1	rs74737585	chr11:96114921	CCDC82	chr11:96085930-96123083:-	-0.23	-3.62	0.000328	Parkinson's disease	
PRAD	cis	1	rs7475154	chr10:131440584	MGMT	chr10:131265454-131565783:+	-0.34	-9.23	9.42E-19	Response to temozolomide	
PRAD	cis	1	rs7475343	chr10:5349871	TUBAL3	chr10:5435062-5446793:-	-0.26	-3.69	0.00025	Intelligence	
PRAD	cis	1	rs74758321	chr8:82667320	CHMP4C	chr8:82644688-82671746:+	-0.98	-13.4	6.81E-35	Epithelial ovarian cancer;Ovarian cancer	
PRAD	cis	1	rs74758713	chr10:126424299	METTL10	chr10:126447406-126480439:-	0.4	3.58	0.000383	Obesity-related traits	
PRAD	cis	1	rs74764972	chr2:48164933	GTF2A1L	chr2:48844948-48960284:+	-0.37	-3.78	0.000174	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs74764972	chr2:48164933	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.32	-3.83	0.000146	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs74766638	chr2:203309891	NOP58	chr2:203130515-203168382:+	0.28	4.58	6.08E-6	Urate levels	
PRAD	cis	1	rs747692	chr6:33737436	LEMD2	chr6:33738991-33756906:-	0.2	5.03	6.82E-7	Body mass index	
PRAD	cis	1	rs747695	chr6:33736672	LEMD2	chr6:33738991-33756906:-	-0.22	-6.82	2.85E-11	Crohn's disease	
PRAD	cis	1	rs7477246	chr10:102261538	SEC31B	chr10:102246403-102289636:-	-0.31	-9.48	1.27E-19	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7477	chr17:16246016	ADORA2B	chr17:15848231-15879210:+	-0.22	-5.1	4.89E-7	Amyotrophic lateral sclerosis	
PRAD	cis	1	rs7477	chr17:16246016	TTC19	chr17:15902782-15932096:+	0.17	3.48	0.000556	Amyotrophic lateral sclerosis	
PRAD	cis	1	rs7477	chr17:16246016	ZSWIM7	chr17:15879877-15903006:-	-0.17	-4	7.32E-5	Amyotrophic lateral sclerosis	
PRAD	cis	1	rs74785791	chr7:1088494	GPR146	chr7:1084243-1098897:+	0.27	3.65	0.000296	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs74785791	chr7:1088494	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.26	2.24E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7478900	chr11:48544003	FOLH1	chr11:49168188-49230222:-	-0.16	-3.68	0.000262	HDL cholesterol	
PRAD	cis	1	rs7479134	chr11:48625409	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000344	HDL cholesterol	
PRAD	cis	1	rs7479498	chr11:48660499	FOLH1	chr11:49168188-49230222:-	-0.18	-4.08	5.34E-5	HDL cholesterol	
PRAD	cis	1	rs7481308	chr11:48600067	FOLH1	chr11:49168188-49230222:-	-0.16	-3.67	0.000269	HDL cholesterol	
PRAD	cis	1	rs7481312	chr11:46596674	HARBI1	chr11:46624857-46638777:-	0.27	3.6	0.000351	Schizophrenia	
PRAD	cis	1	rs74817508	chr16:68138349	C16orf86	chr16:67700717-67702659:+	-0.34	-4.44	1.1E-5	Crohn's disease	
PRAD	cis	1	rs7481880	chr11:48609347	FOLH1	chr11:49168188-49230222:-	-0.16	-3.61	0.000344	HDL cholesterol	
PRAD	cis	1	rs7481995	chr11:62129312	ASRGL1	chr11:62104774-62160885:+	-0.36	-4.56	6.44E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs7482176	chr11:48604620	FOLH1	chr11:49168188-49230222:-	-0.15	-3.52	0.000474	HDL cholesterol	
PRAD	cis	1	rs74825034	chr1:27095132	PIGV	chr1:27114455-27124886:+	-0.36	-4.06	5.84E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs74834816	chr3:58321828	PXK	chr3:58318617-58410878:+	0.19	3.47	0.000561	Cholesterol, total	
PRAD	cis	1	rs7483920	chr11:48599969	FOLH1	chr11:49168188-49230222:-	-0.15	-3.45	0.000602	HDL cholesterol	
PRAD	cis	1	rs7484002	chr11:46640503	HARBI1	chr11:46624857-46638777:-	0.27	3.65	0.000289	Schizophrenia	
PRAD	cis	1	rs748404	chr15:43559231	STRC	chr15:43891762-43924561:-	0.25	5.03	7.14E-7	Lung cancer	
PRAD	cis	1	rs748404	chr15:43559231	TGM7	chr15:43568479-43594453:-	0.24	3.87	0.000124	Lung cancer	
PRAD	cis	1	rs74851284	chr16:68172568	C16orf86	chr16:67700717-67702659:+	-0.32	-4.09	5.04E-5	Crohn's disease	
PRAD	cis	1	rs74863812	chr8:13055338	LONRF1	chr8:12579406-12612992:-	0.27	3.5	0.000505	Emphysema imaging phenotypes	
PRAD	cis	1	rs7486388	chr12:5766338	ANO2	chr12:5671817-6055398:-	0.33	6.38	4.2E-10	Plasma clusterin levels	
PRAD	cis	1	rs74869372	chr6:46314617	TNFRSF21	chr6:47199269-47277680:-	0.17	3.52	0.000478	Body mass index	
PRAD	cis	1	rs74887741	chr7:1110658	GPR146	chr7:1084243-1098897:+	0.28	3.73	0.000215	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs74887741	chr7:1110658	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.1E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs74890219	chr2:242051224	PASK	chr2:242045515-242088878:-	0.3	3.47	0.000575	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs749050	chr10:97376115	ENTPD1	chr10:97471536-97637022:+	0.13	3.88	0.00012	Blood metabolite levels	
PRAD	cis	1	rs749050	chr10:97376115	TCTN3	chr10:97423154-97453900:-	0.21	4.16	3.82E-5	Blood metabolite levels	
PRAD	cis	1	rs74917833	chr4:106643161	INTS12	chr4:106603787-106629881:-	-0.78	-7.89	2.17E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs74928970	chr10:59723566	LOC728640	chr10:60474775-60477291:+	-0.29	-3.54	0.000441	Blood pressure	
PRAD	cis	1	rs74935794	chr2:198871195	PLCL1	chr2:198669426-199014606:+	0.16	4.09	5.03E-5	Ulcerative colitis	
PRAD	cis	1	rs7494544	chr14:101032707	BEGAIN	chr14:101003486-101036131:-	-0.16	-4.4	1.33E-5	Menarche (age at onset)	
PRAD	cis	1	rs74950732	chr3:150482621	SIAH2	chr3:150458911-150481263:-	0.44	3.6	0.000349	Breast cancer	
PRAD	cis	1	rs74955473	chr5:150174558	LOC134466	chr5:150310000-150326146:-	0.74	10.17	4.38E-22	Crohn's disease	
PRAD	cis	1	rs7496814	chr15:84584959	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs7496954	chr15:83345536	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.12	3.9	0.000111	Schizophrenia	
PRAD	cis	1	rs7496954	chr15:83345536	LOC80154	chr15:82944795-82975797:+;chr15	-0.2	-4.1	4.8E-5	Schizophrenia	
PRAD	cis	1	rs74981998	chr1:183593829	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs74984113	chr4:250522	ZNF718	chr4:53272-156488:+	0.32	5.24	2.38E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs74984740	chr2:17796007	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs75012526	chr1:183596921	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs75016635	chr7:1094121	GPR146	chr7:1084243-1098897:+	0.29	3.85	0.000135	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs75016635	chr7:1094121	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.06E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.76	18.34	4.56E-57	Eye color traits	
PRAD	cis	1	rs75040639	chr2:203351696	NOP58	chr2:203130515-203168382:+	0.28	4.49	9.12E-6	Urate levels	
PRAD	cis	1	rs750450	chr2:26324631	GPR113	chr2:26531041-26569685:-	-0.24	-3.54	0.000435	Gut microbiome composition (summer)	
PRAD	cis	1	rs750451	chr2:26324241	GPR113	chr2:26531041-26569685:-	-0.24	-3.58	0.000378	Gut microbiome composition (summer)	
PRAD	cis	1	rs750452	chr2:26324995	GPR113	chr2:26531041-26569685:-	-0.25	-3.75	0.000201	Gut microbiome composition (summer)	
PRAD	cis	1	rs750472	chr8:145701453	KIFC2	chr8:145691738-145699498:+	-0.1	-3.5	0.000505	Age at first birth	
PRAD	cis	1	rs750474	chr3:53085280	RFT1	chr3:53122503-53164470:-	0.39	4.73	2.98E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs750474	chr3:53085280	TMEM110	chr3:52867139-52931547:-	0.32	4.42	1.21E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7506045	chr18:11987272	IMPA2	chr18:11981057-12030876:+	0.42	5.27	2.06E-7	Stroke	
PRAD	cis	1	rs750625	chr8:41525914	ANK1	chr8:41510745-41754280:-	-0.2	-3.53	0.000457	Type 2 diabetes	
PRAD	cis	1	rs75063298	chr10:102213600	SEC31B	chr10:102246403-102289636:-	-0.32	-9.55	7.18E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs75069292	chr2:112668204	MERTK	chr2:112656191-112786945:+	-0.25	-4.18	3.48E-5	Multiple sclerosis	
PRAD	cis	1	rs75071288	chr5:150224379	C5orf62	chr5:150157867-150176297:+	0.29	3.78	0.000177	Crohn's disease	
PRAD	cis	1	rs75071288	chr5:150224379	LOC134466	chr5:150310000-150326146:-	0.57	8.63	9.23E-17	Crohn's disease	
PRAD	cis	1	rs75083896	chr4:154719082	RNF175	chr4:154631313-154681387:-	-0.18	-4.43	1.15E-5	Electrocardiographic conduction measures	
PRAD	cis	1	rs7508679	chr19:7222832	ZNF358	chr19:7581004-7585911:+	-0.1	-3.97	8.32E-5	Triglycerides	
PRAD	cis	1	rs75092650	chr4:106523436	INTS12	chr4:106603787-106629881:-	-0.82	-7.81	3.83E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs751075	chr3:51377300	HEMK1	chr3:50606583-50622419:+	0.21	3.94	9.2E-5	Melanoma	
PRAD	cis	1	rs751095	chr6:33742718	IP6K3	chr6:33689443-33714762:-	0.18	3.65	0.000296	Obesity (extreme)	
PRAD	cis	1	rs751096	chr6:33742838	LEMD2	chr6:33738991-33756906:-	-0.16	-4.06	5.66E-5	Body mass index	
PRAD	cis	1	rs7511006	chr22:50676259	SELO	chr22:50639408-50656044:+	0.1	3.64	0.000298	Obesity-related traits	
PRAD	cis	1	rs75116816	chr18:47289049	ACAA2	chr18:47309875-47340283:-	0.22	3.55	0.000428	Heschl's gyrus morphology	
PRAD	cis	1	rs75117781	chr16:4654204	NMRAL1	chr16:4511696-4526307:-	-0.3	-5.03	6.99E-7	Obesity-related traits	
PRAD	cis	1	rs7511962	chr1:247212122	ZNF670	chr1:247200087-247242069:-	-0.32	-7.2	2.43E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs7512150	chr1:247212326	ZNF670	chr1:247200087-247242069:-	-0.33	-7.31	1.15E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs7512413	chr1:175124789	KIAA0040	chr1:175126123-175162229:-	0.15	3.52	0.000481	Alcohol dependence	
PRAD	cis	1	rs7512422	chr1:207508950	CD55	chr1:207494817-207534309:+	0.24	4.3	2.08E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs7512552	chr1:150265704	ADAMTSL4	chr1:150521898-150533410:+	-0.13	-4.34	1.77E-5	Atopic dermatitis	
PRAD	cis	1	rs7512552	chr1:150265704	C1orf54	chr1:150244773-150253325:+	0.1	3.91	0.000108	Atopic dermatitis	
PRAD	cis	1	rs75126935	chr16:68198999	C16orf86	chr16:67700717-67702659:+	-0.29	-3.72	0.000222	Crohn's disease	
PRAD	cis	1	rs75128809	chr21:43418210	C21orf121	chr21:43442113-43445060:+	0.29	4.88	1.43E-6	Hand grip strength	
PRAD	cis	1	rs7513559	chr1:76173744	ACADM	chr1:76190043-76229353:+	0.2	4.26	2.51E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs7513559	chr1:76173744	RABGGTB	chr1:76251886-76260764:+	0.18	3.63	0.00032	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs7515491	chr1:46355079	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.94	7.19E-29	Body mass index	
PRAD	cis	1	rs7515491	chr1:46355079	MMACHC	chr1:45965856-45976737:+	-0.17	-3.78	0.000175	Body mass index	
PRAD	cis	1	rs7515491	chr1:46355079	MUTYH	chr1:45794915-45806142:-	0.2	5.77	1.41E-8	Body mass index	
PRAD	cis	1	rs7515577	chr1:93009438	EVI5	chr1:92974255-93257961:-	-0.31	-6.28	7.93E-10	Cholesterol, total	
PRAD	cis	1	rs75156726	chr4:106677999	INTS12	chr4:106603787-106629881:-	-0.8	-8.05	6.73E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs7516226	chr1:76234257	ACADM	chr1:76190043-76229353:+	0.18	3.81	0.000156	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs75164680	chr10:81686133	LOC219347	chr10:81805991-81838949:-	0.38	3.56	0.000411	Rheumatoid arthritis	
PRAD	cis	1	rs75165171	chr20:33651453	MMP24	chr20:33814539-33864804:+	-0.32	-4.78	2.38E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs75166090	chr2:203692760	CYP20A1	chr2:204103164-204170562:+	0.33	3.49	0.000524	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs75167249	chr19:22128655	ZNF257	chr19:22235266-22273901:+	0.37	5.02	7.43E-7	Body mass index (change over time)	
PRAD	cis	1	rs7517010	chr1:183594728	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs7517163	chr1:183594872	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs751728	chr6:33764033	LEMD2	chr6:33738991-33756906:-	-0.22	-6.98	9.89E-12	Crohn's disease	
PRAD	cis	1	rs7517566	chr1:150850035	CTSK	chr1:150768687-150780812:-	0.21	4.71	3.29E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs7517	chr1:150596411	CTSK	chr1:150768687-150780812:-	0.2	4.72	3.06E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs7518038	chr1:76154430	ACADM	chr1:76190043-76229353:+	0.17	3.63	0.00031	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.84	-9.48	1.27E-19	Plasma clusterin levels	
PRAD	cis	1	rs75183624	chr3:184777207	C3orf70	chr3:184795840-184870802:-	-0.17	-3.67	0.000273	Heschl's gyrus morphology	
PRAD	cis	1	rs75183624	chr3:184777207	VPS8	chr3:184529931-184770402:+	-0.33	-4.05	6.01E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs7518362	chr1:183610578	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs7518565	chr1:207420343	CD55	chr1:207494817-207534309:+	0.48	8.88	1.47E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs75185853	chr11:46751401	ARHGAP1	chr11:46698634-46722120:-	-0.21	-3.43	0.000652	HDL cholesterol	
PRAD	cis	1	rs7518935	chr1:202503549	PPP1R12B	chr1:202317836-202557697:+	0.09	3.64	0.000303	Sex ratio	
PRAD	cis	1	rs75197893	chr3:184640870	VPS8	chr3:184529931-184770402:+	-0.33	-4.17	3.57E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs7519795	chr1:247212126	ZNF670	chr1:247200087-247242069:-	-0.32	-7.2	2.43E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs7520516	chr1:150659695	CTSK	chr1:150768687-150780812:-	0.18	4.24	2.71E-5	Congenital left-sided heart lesions	
PRAD	cis	1	rs7520844	chr1:25054223	CLIC4	chr1:25071760-25170815:+	0.09	3.82	0.000153	Height	
PRAD	cis	1	rs7521457	chr1:207457147	CD55	chr1:207494817-207534309:+	0.43	8.24	1.79E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs75217232	chr3:53132373	ITIH4	chr3:52847007-52866554:-	-0.21	-3.79	0.000173	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs75217232	chr3:53132373	RFT1	chr3:53122503-53164470:-	0.44	5.1	4.94E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs75217232	chr3:53132373	TMEM110	chr3:52867139-52931547:-	0.35	4.59	5.67E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7522601	chr1:46419021	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.96	5.78E-29	Body mass index	
PRAD	cis	1	rs7522601	chr1:46419021	MMACHC	chr1:45965856-45976737:+	-0.17	-3.86	0.000129	Body mass index	
PRAD	cis	1	rs7522601	chr1:46419021	MUTYH	chr1:45794915-45806142:-	0.2	5.83	1.02E-8	Body mass index	
PRAD	cis	1	rs7522618	chr1:207417426	CD55	chr1:207494817-207534309:+	0.47	8.65	8.03E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs7522701	chr1:207410965	CD55	chr1:207494817-207534309:+	0.22	4.07	5.59E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.84	22.61	3.97E-77	Homocysteine levels	
PRAD	cis	1	rs7522705	chr1:45992300	MMACHC	chr1:45965856-45976737:+	0.17	3.44	0.000624	Homocysteine levels	
PRAD	cis	1	rs7522705	chr1:45992300	MUTYH	chr1:45794915-45806142:-	-0.19	-5.18	3.37E-7	Homocysteine levels	
PRAD	cis	1	rs7522948	chr1:156275308	BGLAP	chr1:156182784-156213112:+	0.23	5.93	6.04E-9	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
PRAD	cis	1	rs7522991	chr1:202492151	PPP1R12B	chr1:202317836-202557697:+	0.09	3.65	0.000288	Sex ratio	
PRAD	cis	1	rs7523050	chr1:109417679	CLCC1	chr1:109472130-109506111:-	0.24	3.64	0.000308	Fat distribution (HIV)	
PRAD	cis	1	rs7523050	chr1:109417679	GPSM2	chr1:109419603-109476957:+	-0.21	-4.08	5.37E-5	Fat distribution (HIV)	
PRAD	cis	1	rs75236700	chr12:53276938	KRT8	chr12:53290971-53343626:-	-0.24	-4.45	1.06E-5	Prostate cancer	
PRAD	cis	1	rs7524467	chr1:76194054	ACADM	chr1:76190043-76229353:+	0.18	3.82	0.000149	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs7524495	chr1:46266932	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.26	3.52E-30	Body mass index	
PRAD	cis	1	rs7524495	chr1:46266932	MMACHC	chr1:45965856-45976737:+	-0.17	-3.81	0.00016	Body mass index	
PRAD	cis	1	rs7524495	chr1:46266932	MUTYH	chr1:45794915-45806142:-	0.21	5.99	4.24E-9	Body mass index	
PRAD	cis	1	rs752621	chr17:61901880	DDX42	chr17:61851567-61896676:+	-0.28	-5.61	3.5E-8	Body mass index	
PRAD	cis	1	rs752621	chr17:61901880	FTSJ3	chr17:61896795-61905031:-	0.35	6.75	4.46E-11	Body mass index	
PRAD	cis	1	rs752621	chr17:61901880	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.24	2.73E-5	Body mass index	
PRAD	cis	1	rs75265219	chr12:56640341	COQ10A	chr12:56660642-56664748:+	-0.36	-3.53	0.000459	Psoriasis vulgaris	
PRAD	cis	1	rs75265219	chr12:56640341	MIP	chr12:56843885-56848429:-	0.69	5.1	5.05E-7	Psoriasis vulgaris	
PRAD	cis	1	rs7526521	chr1:183590453	NCF2	chr1:183524698-183560046:-	0.25	3.66	0.00028	Systemic lupus erythematosus	
PRAD	cis	1	rs7526831	chr1:207438606	CD55	chr1:207494817-207534309:+	0.53	9.79	1.03E-20	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs7526880	chr1:247862621	OR2W3	chr1:248031265-248060142:+	-0.32	-4.67	3.96E-6	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs7526880	chr1:247862621	TRIM58	chr1:248020501-248043436:+	-0.28	-4.15	3.98E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs75278386	chr15:40678312	C15orf23	chr15:40674922-40686488:+	0.93	13.46	3.63E-35	Heschl's gyrus morphology	
PRAD	cis	1	rs7528419	chr1:109817192	PSRC1	chr1:109822179-109825808:-	0.24	4.44	1.14E-5	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs7528684	chr1:157670816	FCRL3	chr1:157646278-157670775:-	0.18	4.81	2.03E-6	Type 1 diabetes autoantibodies	
PRAD	cis	1	rs75287019	chr20:33721261	GDF5	chr20:33897002-34042568:-	0.26	3.77	0.000181	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs75287019	chr20:33721261	MMP24	chr20:33814539-33864804:+	-0.29	-4.48	9.52E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs75287019	chr20:33721261	UQCC	chr20:33890383-33999833:-	-0.31	-3.47	0.000577	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs75291028	chr1:183609985	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs7529204	chr1:150845380	CTSK	chr1:150768687-150780812:-	-0.23	-4.64	4.54E-6	Congenital left-sided heart lesions	
PRAD	cis	1	rs75294883	chr5:150196503	C5orf62	chr5:150157867-150176297:+	0.32	3.45	0.000614	Crohn's disease	
PRAD	cis	1	rs75294883	chr5:150196503	LOC134466	chr5:150310000-150326146:-	0.7	8.82	2.24E-17	Crohn's disease	
PRAD	cis	1	rs7530186	chr1:183610283	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs7530294	chr1:183610416	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs7530521	chr1:183610653	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.8	-9.08	3.03E-18	Plasma clusterin levels	
PRAD	cis	1	rs7531202	chr1:110616474	ALX3	chr1:110602998-110613322:-	-0.23	-4.39	1.37E-5	Blood metabolite levels	
PRAD	cis	1	rs7531786	chr1:183595234	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs75321546	chr12:124447465	ZNF664	chr12:124457670-124499967:+	-0.15	-4.08	5.39E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs75324925	chr2:203698300	CYP20A1	chr2:204103164-204170562:+	0.33	3.5	0.000507	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs7532664	chr1:207426943	CD55	chr1:207494817-207534309:+	0.48	8.86	1.69E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs7532835	chr1:202518291	PPP1R12B	chr1:202317836-202557697:+	0.09	3.83	0.000147	Sex ratio	
PRAD	cis	1	rs75329885	chr1:100395646	LRRC39	chr1:100614413-100643800:-	0.4	3.58	0.000374	Carotid intima media thickness	
PRAD	cis	1	rs75330230	chr1:183592353	NCF2	chr1:183524698-183560046:-	0.25	3.66	0.00028	Systemic lupus erythematosus	
PRAD	cis	1	rs7533623	chr1:110616475	ALX3	chr1:110602998-110613322:-	-0.25	-4.6	5.43E-6	Blood metabolite levels	
PRAD	cis	1	rs7533888	chr1:76160449	ACADM	chr1:76190043-76229353:+	0.18	3.9	0.000111	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs7534086	chr1:202453155	PPP1R12B	chr1:202317836-202557697:+	0.09	3.73	0.000215	Sex ratio	
PRAD	cis	1	rs75344054	chr1:183598479	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.92	-28.22	3.26E-103	Homocysteine levels	
PRAD	cis	1	rs7534467	chr1:45988691	MMACHC	chr1:45965856-45976737:+	-0.24	-5.12	4.48E-7	Homocysteine levels	
PRAD	cis	1	rs7534467	chr1:45988691	MUTYH	chr1:45794915-45806142:-	0.19	5.27	2.05E-7	Homocysteine levels	
PRAD	cis	1	rs7534624	chr1:22494627	HSPC157	chr1:22351707-22357713:+	0.19	4.05	6.04E-5	Obesity-related traits	
PRAD	cis	1	rs7534754	chr1:76185308	ACADM	chr1:76190043-76229353:+	0.18	3.87	0.000127	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs7535032	chr1:150947745	CTSK	chr1:150768687-150780812:-	-0.16	-4.04	6.15E-5	Congenital left-sided heart lesions	
PRAD	cis	1	rs7535532	chr1:207438336	CD55	chr1:207494817-207534309:+	0.47	8.8	2.61E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.86	-24.03	7.89E-84	Homocysteine levels	
PRAD	cis	1	rs7536557	chr1:45992114	MMACHC	chr1:45965856-45976737:+	-0.19	-3.99	7.58E-5	Homocysteine levels	
PRAD	cis	1	rs7536557	chr1:45992114	MUTYH	chr1:45794915-45806142:-	0.19	5.25	2.33E-7	Homocysteine levels	
PRAD	cis	1	rs7537765	chr1:11887303	CLCN6	chr1:11866207-11907674:+	-0.21	-4.18	3.55E-5	QRS complex (12-leadsum)	
PRAD	cis	1	rs7539932	chr1:46292354	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	8.94E-30	Body mass index	
PRAD	cis	1	rs7539932	chr1:46292354	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000146	Body mass index	
PRAD	cis	1	rs7539932	chr1:46292354	MUTYH	chr1:45794915-45806142:-	0.21	5.96	4.88E-9	Body mass index	
PRAD	cis	1	rs7540325	chr1:46338217	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.16	9.04E-30	Body mass index	
PRAD	cis	1	rs7540325	chr1:46338217	MMACHC	chr1:45965856-45976737:+	-0.17	-3.83	0.000145	Body mass index	
PRAD	cis	1	rs7540325	chr1:46338217	MUTYH	chr1:45794915-45806142:-	0.21	5.97	4.63E-9	Body mass index	
PRAD	cis	1	rs75408336	chr1:179459485	C1orf125	chr1:179335107-179523868:+	0.3	3.47	0.000561	Multiple sclerosis (age of onset)	
PRAD	cis	1	rs75418383	chr4:154719084	RNF175	chr4:154631313-154681387:-	-0.18	-4.43	1.15E-5	Electrocardiographic conduction measures	
PRAD	cis	1	rs7542136	chr1:183595057	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs7542304	chr1:183595180	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs7542316	chr1:183595222	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs7543117	chr1:207438696	CD55	chr1:207494817-207534309:+	0.47	8.8	2.61E-17	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs7543250	chr1:207425043	CD55	chr1:207494817-207534309:+	-0.21	-3.95	9.15E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs7543276	chr1:247872942	OR2W3	chr1:248031265-248060142:+	-0.3	-4.35	1.69E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs7543276	chr1:247872942	TRIM58	chr1:248020501-248043436:+	-0.26	-3.84	0.000141	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs75444304	chr15:90894246	CRTC3	chr15:91073198-91188576:+	-0.16	-3.57	0.000395	Rheumatoid arthritis	
PRAD	cis	1	rs75444304	chr15:90894246	ZNF774	chr15:90895477-90904714:+	-0.24	-4.77	2.43E-6	Rheumatoid arthritis	
PRAD	cis	1	rs7545125	chr1:207424727	CD55	chr1:207494817-207534309:+	0.26	4.66	4.12E-6	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs75462421	chr1:183623105	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs7546342	chr1:247213292	ZNF670	chr1:247200087-247242069:-	-0.33	-7.31	1.15E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs7547997	chr1:158341273	CD1A	chr1:158223927-158228056:+	-0.23	-3.97	8.18E-5	QRS duration	
PRAD	cis	1	rs7548463	chr1:207502891	CD55	chr1:207494817-207534309:+	0.25	4.42	1.24E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs75487138	chr11:18461878	LDHC	chr11:18433853-18472792:+	-0.31	-3.82	0.000151	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs75488469	chr7:1102122	GPR146	chr7:1084243-1098897:+	0.27	3.67	0.000275	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs75488469	chr7:1102122	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.09	5.3E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7548962	chr1:76139266	ACADM	chr1:76190043-76229353:+	0.19	4.18	3.43E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs7549410	chr1:247214167	ZNF670	chr1:247200087-247242069:-	-0.32	-7.14	3.47E-12	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs7550746	chr1:46351719	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.32	2.03E-30	Body mass index	
PRAD	cis	1	rs7550746	chr1:46351719	MMACHC	chr1:45965856-45976737:+	-0.17	-3.92	0.000101	Body mass index	
PRAD	cis	1	rs7550746	chr1:46351719	MUTYH	chr1:45794915-45806142:-	0.2	5.77	1.44E-8	Body mass index	
PRAD	cis	1	rs755109	chr9:100696203	C9orf156	chr9:100666772-100684852:-	0.19	3.7	0.000242	Quantitative traits	
PRAD	cis	1	rs7551124	chr1:23785760	ASAP3	chr1:23755056-23811057:-	0.44	6.96	1.15E-11	Cholesterol, total	
PRAD	cis	1	rs7551124	chr1:23785760	TCEA3	chr1:23707555-23751261:-	0.28	4.7	3.5E-6	Cholesterol, total	
PRAD	cis	1	rs7551124	chr1:23785760	ZNF436	chr1:23685942-23696357:-	-0.26	-3.96	8.72E-5	Cholesterol, total	
PRAD	cis	1	rs7551732	chr1:89139041	CCBL2	chr1:89401456-89458643:-	0.48	9.4	2.44E-19	Height	
PRAD	cis	1	rs75518097	chr19:52026510	ZNF175	chr19:52074531-52092990:+	-0.33	-5.08	5.44E-7	Carotid intima media thickness	
PRAD	cis	1	rs7552167	chr1:24518643	IL28RA	chr1:24480648-24513751:-	-0.27	-3.92	0.000101	Psoriasis vulgaris	
PRAD	cis	1	rs7552404	chr1:76135946	ACADM	chr1:76190043-76229353:+	0.18	3.95	9.02E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs7553157	chr1:207457267	CD55	chr1:207494817-207534309:+	0.43	8.24	1.79E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs7553339	chr1:207457420	CD55	chr1:207494817-207534309:+	0.43	8.24	1.79E-15	Posterior cortical atrophy and Alzheimer's disease	
PRAD	cis	1	rs75535620	chr20:33601498	MMP24	chr20:33814539-33864804:+	-0.31	-4.69	3.55E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs75537616	chr20:33592588	MMP24	chr20:33814539-33864804:+	-0.32	-4.76	2.57E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs755495	chr6:33734128	LEMD2	chr6:33738991-33756906:-	-0.2	-4.97	9.19E-7	Body mass index	
PRAD	cis	1	rs755496	chr6:33734376	LEMD2	chr6:33738991-33756906:-	-0.21	-6.59	1.2E-10	Crohn's disease	
PRAD	cis	1	rs7555030	chr1:207508730	CD55	chr1:207494817-207534309:+	0.24	4.3	2.08E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs755587	chr20:47720957	CSE1L	chr20:47662838-47713484:+	0.19	4.72	3.18E-6	Anger	
PRAD	cis	1	rs755587	chr20:47720957	PREX1	chr20:47240793-47444420:-	-0.17	-3.54	0.000444	Anger	
PRAD	cis	1	rs755589	chr20:47721385	CSE1L	chr20:47662838-47713484:+	0.19	4.68	3.77E-6	Anger	
PRAD	cis	1	rs7556436	chr1:46363880	CCDC163P	chr1:45960581-45965646:-	0.53	11.98	4.87E-29	Body mass index	
PRAD	cis	1	rs7556436	chr1:46363880	MMACHC	chr1:45965856-45976737:+	0.16	3.51	0.000495	Body mass index	
PRAD	cis	1	rs7556436	chr1:46363880	MUTYH	chr1:45794915-45806142:-	-0.21	-6.24	9.52E-10	Body mass index	
PRAD	cis	1	rs7556615	chr1:46461369	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.03	3.07E-29	Body mass index	
PRAD	cis	1	rs7556615	chr1:46461369	MMACHC	chr1:45965856-45976737:+	-0.18	-3.98	8.14E-5	Body mass index	
PRAD	cis	1	rs7556615	chr1:46461369	MUTYH	chr1:45794915-45806142:-	0.2	5.84	9.96E-9	Body mass index	
PRAD	cis	1	rs7556629	chr1:202483678	PPP1R12B	chr1:202317836-202557697:+	0.09	3.78	0.000176	Sex ratio	
PRAD	cis	1	rs7558944	chr2:73810909	ALMS1P	chr2:73872046-73912692:+	0.5	8.72	5.0E-17	Metabolite levels	
PRAD	cis	1	rs7558944	chr2:73810909	NAT8	chr2:73867850-73869537:-	0.26	4.02	6.65E-5	Metabolite levels	
PRAD	cis	1	rs75595592	chr10:46039930	MARCH8	chr10:45952817-46090354:-	0.25	5.52	5.59E-8	Red blood cell traits	
PRAD	cis	1	rs7560328	chr2:202164837	ALS2CR12	chr2:202153148-202222101:-	-0.26	-4.61	5.25E-6	Melanoma;Esophageal squamous cell carcinoma	
PRAD	cis	1	rs7560357	chr2:99247820	MGAT4A	chr2:99235571-99347589:-	0.26	3.74	0.000206	Bipolar disorder	
PRAD	cis	1	rs7560547	chr2:203757916	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs75607323	chr2:207635770	MDH1B	chr2:207598943-207630050:-	0.44	3.59	0.000369	Episodic memory	
PRAD	cis	1	rs75615599	chr11:96112059	CCDC82	chr11:96085930-96123083:-	-0.23	-3.62	0.000329	Parkinson's disease	
PRAD	cis	1	rs7562170	chr2:28943516	PPP1CB	chr2:28974612-29025805:+	-0.29	-6.06	2.86E-9	Body mass index	
PRAD	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.4	8.1	4.89E-15	Body mass index	
PRAD	cis	1	rs75635914	chr20:33555815	MMP24	chr20:33814539-33864804:+	-0.32	-4.73	3.01E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs75648520	chr20:33724221	GDF5	chr20:33897002-34042568:-	0.25	3.6	0.000351	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs75648520	chr20:33724221	MMP24	chr20:33814539-33864804:+	-0.31	-4.72	3.1E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7564890	chr2:73641853	ALMS1P	chr2:73872046-73912692:+	0.5	8.7	5.58E-17	Metabolite levels	
PRAD	cis	1	rs7564890	chr2:73641853	NAT8	chr2:73867850-73869537:-	0.24	3.75	0.000203	Metabolite levels	
PRAD	cis	1	rs7565124	chr2:20261685	TTC32	chr2:20096518-20101744:-	-0.2	-3.48	0.000549	Major depressive disorder	
PRAD	cis	1	rs7565792	chr2:48649705	KLRAQ1	chr2:48667908-48742524:+	0.17	3.64	0.000299	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
PRAD	cis	1	rs7565875	chr2:203381135	NOP58	chr2:203130515-203168382:+	0.24	4.15	4.0E-5	Urate levels	
PRAD	cis	1	rs7566277	chr2:99916242	MRPL30	chr2:99758185-99939196:+	0.23	3.63	0.000319	IgG glycosylation	
PRAD	cis	1	rs7566277	chr2:99916242	TSGA10	chr2:99613725-99771187:-	0.26	4.02	6.86E-5	IgG glycosylation	
PRAD	cis	1	rs7566279	chr2:281178	SH3YL1	chr2:218138-264810:-	-0.79	-18.77	4.5E-59	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs7567444	chr2:111863438	ACOXL	chr2:111490150-111875799:+	0.21	3.68	0.000259	Chronic lymphocytic leukemia	
PRAD	cis	1	rs7567444	chr2:111863438	BCL2L11	chr2:111878491-111926022:+	-0.16	-3.66	0.000284	Chronic lymphocytic leukemia	
PRAD	cis	1	rs756769	chr9:135774059	C9orf98	chr9:135600965-135754198:-	0.21	3.97	8.47E-5	Psoriasis	
PRAD	cis	1	rs7567851	chr2:178684720	PDE11A	chr2:178487979-178973066:-	0.31	4.27	2.41E-5	Height	
PRAD	cis	1	rs7568106	chr2:20261969	TTC32	chr2:20096518-20101744:-	-0.2	-3.48	0.000549	Major depressive disorder	
PRAD	cis	1	rs7568632	chr2:112669950	MERTK	chr2:112656191-112786945:+	-0.24	-4.02	6.77E-5	Multiple sclerosis	
PRAD	cis	1	rs756920	chr11:2310870	C11orf21	chr11:2317507-2323143:-	0.32	6.05	2.99E-9	Obesity-related traits	
PRAD	cis	1	rs756920	chr11:2310870	SYT8	chr11:1848709-1858750:+	0.2	3.69	0.000252	Obesity-related traits	
PRAD	cis	1	rs756920	chr11:2310870	TSPAN32	chr11:2323243-2339430:+	0.19	3.43	0.000647	Obesity-related traits	
PRAD	cis	1	rs75712637	chr10:45988192	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs7571716	chr2:233441420	EIF4E2	chr2:233415357-233448349:+	0.19	3.71	0.000234	Height	
PRAD	cis	1	rs7572722	chr2:73724675	ALMS1P	chr2:73872046-73912692:+	0.48	8.39	5.55E-16	Metabolite levels	
PRAD	cis	1	rs7572722	chr2:73724675	NAT8	chr2:73867850-73869537:-	0.26	3.96	8.76E-5	Metabolite levels	
PRAD	cis	1	rs7573118	chr2:26308086	GPR113	chr2:26531041-26569685:-	-0.24	-3.52	0.000476	Gut microbiome composition (summer)	
PRAD	cis	1	rs75733050	chr16:68101941	C16orf86	chr16:67700717-67702659:+	-0.34	-4.46	1.02E-5	Crohn's disease	
PRAD	cis	1	rs75739761	chr16:68122914	C16orf86	chr16:67700717-67702659:+	-0.34	-4.46	1.02E-5	Crohn's disease	
PRAD	cis	1	rs7574255	chr2:228699884	CCL20	chr2:228678558-228682280:+	-0.26	-4.61	5.26E-6	Blood pressure	
PRAD	cis	1	rs75754909	chr12:56726349	MIP	chr12:56843885-56848429:-	0.77	5.72	1.93E-8	Psoriasis vulgaris	
PRAD	cis	1	rs7575552	chr2:112673634	MERTK	chr2:112656191-112786945:+	-0.24	-4.09	4.97E-5	Multiple sclerosis	
PRAD	cis	1	rs7576245	chr2:73829678	ALMS1P	chr2:73872046-73912692:+	0.49	8.37	6.44E-16	Metabolite levels	
PRAD	cis	1	rs7576245	chr2:73829678	NAT8	chr2:73867850-73869537:-	0.24	3.72	0.000227	Metabolite levels	
PRAD	cis	1	rs75768495	chr10:59723902	LOC728640	chr10:60474775-60477291:+	-0.29	-3.54	0.00044	Blood pressure	
PRAD	cis	1	rs75774363	chr5:150223722	C5orf62	chr5:150157867-150176297:+	0.3	3.72	0.000221	Crohn's disease	
PRAD	cis	1	rs75774363	chr5:150223722	LOC134466	chr5:150310000-150326146:-	0.63	9.22	1.0E-18	Crohn's disease	
PRAD	cis	1	rs7577696	chr2:32278782	NLRC4	chr2:32449518-32490801:-	-0.23	-5.08	5.58E-7	Inflammatory biomarkers	
PRAD	cis	1	rs7577851	chr2:69723710	LOC100133985	chr2:70351169-70352448:-	-0.22	-3.44	0.00064	Parkinson's disease (age of onset)	
PRAD	cis	1	rs7578199	chr2:242192848	FARP2	chr2:242295711-242434255:+	-0.25	-4.36	1.61E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs7578199	chr2:242192848	SEPT2	chr2:242254723-242293439:+	0.25	5.59	3.83E-8	Chronic lymphocytic leukemia	
PRAD	cis	1	rs7578452	chr2:161572223	RBMS1	chr2:161128663-161350318:-	-0.11	-3.65	0.000288	Educational attainment	
PRAD	cis	1	rs7578456	chr2:202235348	ALS2CR12	chr2:202153148-202222101:-	-0.28	-4.87	1.56E-6	Basal cell carcinoma	
PRAD	cis	1	rs7578456	chr2:202235348	ORC2L	chr2:201774895-201828410:-	-0.1	-3.62	0.000324	Basal cell carcinoma	
PRAD	cis	1	rs75788262	chr16:68172490	C16orf86	chr16:67700717-67702659:+	-0.31	-4.07	5.41E-5	Crohn's disease	
PRAD	cis	1	rs7579277	chr2:28996295	PPP1CB	chr2:28974612-29025805:+	0.28	6.28	7.52E-10	Body mass index	
PRAD	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.38	-8.22	2.06E-15	Body mass index	
PRAD	cis	1	rs7579553	chr2:96875297	LOC729234	chr2:96676299-96688882:+	-0.18	-4.01	7.15E-5	Cardiac Troponin-T levels	
PRAD	cis	1	rs757978	chr2:242371101	SEPT2	chr2:242254723-242293439:+	0.55	8.5	2.47E-16	Chronic lymphocytic leukemia	
PRAD	cis	1	rs7579905	chr2:198868109	PLCL1	chr2:198669426-199014606:+	0.15	4.04	6.2E-5	Ulcerative colitis	
PRAD	cis	1	rs7580240	chr2:29114372	PPP1CB	chr2:28974612-29025805:+	-0.3	-6.04	3.1E-9	Breast cancer (estrogen-receptor negative);Breast cancer	
PRAD	cis	1	rs7580240	chr2:29114372	TRMT61B	chr2:29072690-29093175:-	0.31	5.91	6.7E-9	Breast cancer (estrogen-receptor negative);Breast cancer	
PRAD	cis	1	rs7580825	chr2:73635148	ALMS1P	chr2:73872046-73912692:+	0.5	8.65	8.36E-17	Metabolite levels	
PRAD	cis	1	rs7580825	chr2:73635148	NAT8	chr2:73867850-73869537:-	0.25	3.84	0.00014	Metabolite levels	
PRAD	cis	1	rs75811104	chr2:242052338	PASK	chr2:242045515-242088878:-	0.31	3.72	0.000223	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs7581224	chr2:84709215	DNAH6	chr2:84743579-85046711:+	0.28	4.68	3.81E-6	Coronary artery calcification	
PRAD	cis	1	rs75817507	chr4:106767623	INTS12	chr4:106603787-106629881:-	-0.76	-7.82	3.47E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs75823291	chr10:103567057	KCNIP2	chr10:103585732-103603677:-	0.33	4.44	1.1E-5	Coronary artery calcification	
PRAD	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.44	11.67	8.17E-28	Common traits (Other)	
PRAD	cis	1	rs75824619	chr20:61856471	BIRC7	chr20:61867276-61871853:+	0.4	4.48	9.27E-6	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs7582606	chr2:73813945	ALMS1P	chr2:73872046-73912692:+	0.5	8.72	5.0E-17	Metabolite levels	
PRAD	cis	1	rs7582606	chr2:73813945	NAT8	chr2:73867850-73869537:-	0.26	4.02	6.65E-5	Metabolite levels	
PRAD	cis	1	rs7582715	chr2:198874310	PLCL1	chr2:198669426-199014606:+	0.15	4.09	5.18E-5	Ulcerative colitis	
PRAD	cis	1	rs7582720	chr2:203753072	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs758324	chr5:131109545	P4HA2	chr5:131528306-131563556:-	0.2	3.64	0.000301	Alzheimer's disease in APOE e4- carriers	
PRAD	cis	1	rs7583255	chr2:73797996	ALMS1P	chr2:73872046-73912692:+	0.49	8.46	3.3E-16	Metabolite levels	
PRAD	cis	1	rs7583255	chr2:73797996	NAT8	chr2:73867850-73869537:-	0.25	3.93	9.8E-5	Metabolite levels	
PRAD	cis	1	rs7584330	chr2:238387228	MLPH	chr2:238395053-238463960:+	-0.22	-5.05	6.34E-7	Prostate cancer	
PRAD	cis	1	rs7584535	chr2:232106857	ARMC9	chr2:232063342-232238606:+	0.23	4.28	2.24E-5	Food antigen IgG levels	
PRAD	cis	1	rs7584575	chr2:73666402	ALMS1P	chr2:73872046-73912692:+	0.49	8.5	2.49E-16	Metabolite levels	
PRAD	cis	1	rs7584575	chr2:73666402	NAT8	chr2:73867850-73869537:-	0.26	4.06	5.8E-5	Metabolite levels	
PRAD	cis	1	rs7585004	chr2:73666645	ALMS1P	chr2:73872046-73912692:+	0.47	7.99	1.07E-14	Metabolite levels	
PRAD	cis	1	rs7585004	chr2:73666645	NAT8	chr2:73867850-73869537:-	0.23	3.55	0.000429	Metabolite levels	
PRAD	cis	1	rs75857982	chr2:48164539	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.35	-3.95	9.05E-5	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs758598	chr17:59492714	C17orf82	chr17:59489112-59490641:+	0.15	3.49	0.000535	Sitting height ratio	
PRAD	cis	1	rs7586463	chr2:73798476	ALMS1P	chr2:73872046-73912692:+	0.49	8.46	3.3E-16	Metabolite levels	
PRAD	cis	1	rs7586463	chr2:73798476	NAT8	chr2:73867850-73869537:-	0.25	3.93	9.8E-5	Metabolite levels	
PRAD	cis	1	rs75866240	chr20:33558839	MMP24	chr20:33814539-33864804:+	-0.32	-4.73	3.01E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7587220	chr2:219160864	CCDC108	chr2:219867576-219906245:-	0.14	3.69	0.000252	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs7587234	chr2:203216422	NOP58	chr2:203130515-203168382:+	0.29	4.49	8.83E-6	Urate levels	
PRAD	cis	1	rs7587476	chr2:215653887	BARD1	chr2:215593275-215674428:-	0.28	8.3	1.15E-15	Neuroblastoma	
PRAD	cis	1	rs7588802	chr2:26277789	GPR113	chr2:26531041-26569685:-	-0.25	-3.61	0.000339	Gut microbiome composition (summer)	
PRAD	cis	1	rs75888794	chr20:33702998	MMP24	chr20:33814539-33864804:+	-0.28	-4.29	2.15E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs75889859	chr14:35539054	BRMS1L	chr14:36295597-36341168:+	0.19	3.58	0.000373	Atopic dermatitis	
PRAD	cis	1	rs75889859	chr14:35539054	PPP2R3C	chr14:35554679-35591679:-	0.33	5.09	5.29E-7	Atopic dermatitis	
PRAD	cis	1	rs7589014	chr2:201580954	PPIL3	chr2:201735680-201753999:-	0.34	3.92	0.000102	Intelligence	
PRAD	cis	1	rs758944	chr7:75953297	SRCRB4D	chr7:76018647-76039012:-	0.22	4.51	8.06E-6	Multiple sclerosis	
PRAD	cis	1	rs758944	chr7:75953297	UPK3B	chr7:76139745-76157197:+	-0.28	-4.89	1.36E-6	Multiple sclerosis	
PRAD	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.82	-9.4	2.41E-19	Plasma clusterin levels	
PRAD	cis	1	rs7590071	chr2:240900947	NDUFA10	chr2:240900158-240964798:-	0.26	6	4.02E-9	Odorant perception (isobutyraldehyde)	
PRAD	cis	1	rs75904349	chr4:106526694	INTS12	chr4:106603787-106629881:-	-0.82	-7.81	3.83E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs75905271	chr10:103686236	KCNIP2	chr10:103585732-103603677:-	0.29	4.08	5.24E-5	Coronary artery calcification	
PRAD	cis	1	rs7591163	chr2:228715375	CCL20	chr2:228678558-228682280:+	0.27	4.73	2.93E-6	Blood pressure	
PRAD	cis	1	rs75913297	chr10:81789845	LOC219347	chr10:81805991-81838949:-	0.78	9.37	3.11E-19	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs7591472	chr2:201889751	CFLAR	chr2:201980816-202029001:+	-0.17	-4.21	3.03E-5	Triptolide cytotoxicity	
PRAD	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.93	-16.51	1.32E-48	Triptolide cytotoxicity	
PRAD	cis	1	rs75919582	chr7:139054919	LUC7L2	chr7:139025105-139108198:+	-0.22	-4.51	8.29E-6	Diisocyanate-induced asthma	
PRAD	cis	1	rs75921373	chr6:26191843	HIST1H2AE	chr6:26217148-26217711:+	-0.27	-3.88	0.000121	Renal underexcretion gout;Gout	
PRAD	cis	1	rs75921373	chr6:26191843	HIST1H3E	chr6:26224427-26226589:+	0.36	5.63	3.05E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs75927128	chr14:65895320	LOC645431	chr14:65877313-65879335:-	-0.45	-4.37	1.52E-5	Ischemic stroke	
PRAD	cis	1	rs7593448	chr2:27449293	C2orf28	chr2:27434899-27440044:+	0.26	6.94	1.31E-11	Blood metabolite levels	
PRAD	cis	1	rs7593448	chr2:27449293	KHK	chr2:27309611-27323619:+	0.21	4.48	9.29E-6	Blood metabolite levels	
PRAD	cis	1	rs75936657	chr1:41001689	DEM1	chr1:40974433-40982212:+	0.45	5.52	5.5E-8	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs7594511	chr2:73681639	ALMS1P	chr2:73872046-73912692:+	0.49	8.5	2.5E-16	Metabolite levels	
PRAD	cis	1	rs7594511	chr2:73681639	NAT8	chr2:73867850-73869537:-	0.25	3.91	0.000105	Metabolite levels	
PRAD	cis	1	rs7594645	chr2:207646674	MDH1B	chr2:207598943-207630050:-	0.45	4.19	3.39E-5	Episodic memory	
PRAD	cis	1	rs7595075	chr2:264019	SH3YL1	chr2:218138-264810:-	-0.79	-18.91	1.05E-59	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs75952023	chr19:49508369	BAX	chr19:49458117-49465054:+	0.25	3.59	0.000361	Follicule stimulating hormone	
PRAD	cis	1	rs7596362	chr2:61204688	AHSA2	chr2:61404553-61414058:+	-0.15	-6.31	6.38E-10	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs7596362	chr2:61204688	C2orf74	chr2:61372243-61391964:+	0.47	9.69	2.31E-20	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs7597156	chr2:203194062	NOP58	chr2:203130515-203168382:+	0.26	4.36	1.6E-5	Urate levels	
PRAD	cis	1	rs7597469	chr2:203194270	NOP58	chr2:203130515-203168382:+	0.28	4.34	1.71E-5	Urate levels	
PRAD	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.49	8.46	3.3E-16	Metabolite levels	
PRAD	cis	1	rs7598396	chr2:73652628	NAT8	chr2:73867850-73869537:-	0.25	3.93	9.8E-5	Metabolite levels	
PRAD	cis	1	rs7598419	chr2:73798223	ALMS1P	chr2:73872046-73912692:+	0.51	8.6	1.24E-16	Metabolite levels	
PRAD	cis	1	rs7598419	chr2:73798223	NAT8	chr2:73867850-73869537:-	0.26	3.88	0.000117	Metabolite levels	
PRAD	cis	1	rs7598759	chr2:232321956	C2orf52	chr2:232373137-232379050:-	-0.43	-7.76	5.32E-14	Noise-induced hearing loss	
PRAD	cis	1	rs7598876	chr2:28974466	PPP1CB	chr2:28974612-29025805:+	0.28	5.91	6.53E-9	Body mass index	
PRAD	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.41	-8.51	2.39E-16	Body mass index	
PRAD	cis	1	rs7599132	chr2:26279810	GPR113	chr2:26531041-26569685:-	0.25	3.59	0.000363	Gut microbiome composition (summer)	
PRAD	cis	1	rs7601738	chr2:242375813	SEPT2	chr2:242254723-242293439:+	-0.58	-8.68	6.64E-17	Chronic lymphocytic leukemia	
PRAD	cis	1	rs76021735	chr2:203376199	NOP58	chr2:203130515-203168382:+	0.28	4.49	9.12E-6	Urate levels	
PRAD	cis	1	rs76024966	chr7:75995021	SRCRB4D	chr7:76018647-76039012:-	0.24	4.71	3.24E-6	Multiple sclerosis	
PRAD	cis	1	rs76024966	chr7:75995021	UPK3B	chr7:76139745-76157197:+	-0.29	-5.15	3.78E-7	Multiple sclerosis	
PRAD	cis	1	rs76041173	chr3:10078695	C3orf10	chr3:10157333-10168873:+	-0.22	-4.17	3.66E-5	Alzheimer's disease	
PRAD	cis	1	rs76041173	chr3:10078695	LOC401052	chr3:10048102-10052779:-	-0.3	-5.26	2.22E-7	Alzheimer's disease	
PRAD	cis	1	rs7604393	chr2:241825034	C2orf54	chr2:241825466-241835573:-	0.57	10.48	3.21E-23	Urinary metabolites	
PRAD	cis	1	rs7604682	chr2:73788026	ALMS1P	chr2:73872046-73912692:+	0.5	8.61	1.07E-16	Metabolite levels	
PRAD	cis	1	rs7604682	chr2:73788026	NAT8	chr2:73867850-73869537:-	0.28	4.26	2.42E-5	Metabolite levels	
PRAD	cis	1	rs7605484	chr2:203724495	CYP20A1	chr2:204103164-204170562:+	0.33	3.58	0.000376	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs760555	chr22:25872837	CRYBB2	chr22:25615612-25627836:+	0.93	15.38	1.54E-43	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs7605824	chr2:280819	SH3YL1	chr2:218138-264810:-	0.78	18.63	2.06E-58	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs76063782	chr2:48166824	GTF2A1L	chr2:48844948-48960284:+	-0.4	-3.79	0.000169	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs76063782	chr2:48166824	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.37	-4.19	3.28E-5	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs76068439	chr10:1121018	IDI2	chr10:1064847-1071799:-	0.48	5.52	5.49E-8	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
PRAD	cis	1	rs760699	chr22:43523188	TTLL12	chr22:43562629-43583107:-	0.23	3.5	0.000517	Prostate cancer	
PRAD	cis	1	rs7607014	chr2:73730174	ALMS1P	chr2:73872046-73912692:+	-0.47	-8.18	2.61E-15	Metabolite levels	
PRAD	cis	1	rs7607014	chr2:73730174	NAT8	chr2:73867850-73869537:-	-0.24	-3.67	0.000272	Metabolite levels	
PRAD	cis	1	rs76070988	chr1:183633490	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs760762	chr20:39776046	ZHX3	chr20:39807089-39946242:-	-0.27	-5.97	4.6E-9	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs76081054	chr2:86285037	LOC90784	chr2:86247339-86250991:-	-0.54	-4.45	1.09E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs7608391	chr2:20261167	TTC32	chr2:20096518-20101744:-	-0.2	-3.48	0.000543	Major depressive disorder	
PRAD	cis	1	rs7608578	chr2:161573231	RBMS1	chr2:161128663-161350318:-	-0.11	-3.69	0.000255	Educational attainment	
PRAD	cis	1	rs7608623	chr2:23948953	C2orf84	chr2:24397531-24414566:+	-0.27	-5.13	4.16E-7	Obesity-related traits	
PRAD	cis	1	rs7608623	chr2:23948953	LOC375190	chr2:24299728-24397519:+	0.26	7.15	3.42E-12	Obesity-related traits	
PRAD	cis	1	rs7608697	chr2:61204641	AHSA2	chr2:61404553-61414058:+	-0.16	-6.58	1.24E-10	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs7608697	chr2:61204641	C2orf74	chr2:61372243-61391964:+	0.49	10.18	3.81E-22	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs7608910	chr2:61204856	AHSA2	chr2:61404553-61414058:+	0.17	7.03	7.12E-12	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.46	-9.61	4.58E-20	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs7609851	chr3:156638503	LEKR1	chr3:156544076-156763918:+	-0.46	-6.64	8.83E-11	Bone mineral density	
PRAD	cis	1	rs76100917	chr7:33674811	BBS9	chr7:33169152-33645680:+	-0.39	-3.54	0.000433	Cytomegalovirus antibody response	
PRAD	cis	1	rs761025	chr20:25426968	ENTPD6	chr20:25176339-25207360:+	-0.18	-4.68	3.71E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs761025	chr20:25426968	FAM182B	chr20:25744102-25848786:-	0.36	6.65	8.08E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs761025	chr20:25426968	PYGB	chr20:25228706-25278647:+	-0.34	-7.42	5.72E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7610821	chr3:10136150	C3orf10	chr3:10157333-10168873:+	-0.19	-3.76	0.000195	Alzheimer's disease	
PRAD	cis	1	rs7610821	chr3:10136150	LOC401052	chr3:10048102-10052779:-	-0.29	-5.5	6.38E-8	Alzheimer's disease	
PRAD	cis	1	rs7611218	chr3:10063960	C3orf10	chr3:10157333-10168873:+	-0.2	-3.83	0.000145	Alzheimer's disease	
PRAD	cis	1	rs7611218	chr3:10063960	LOC401052	chr3:10048102-10052779:-	-0.29	-5.35	1.4E-7	Alzheimer's disease	
PRAD	cis	1	rs7611238	chr3:195072918	C3orf21	chr3:194789015-194991895:-	0.31	6.51	1.89E-10	Body mass index	
PRAD	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.52	11.7	6.19E-28	Height	
PRAD	cis	1	rs7611611	chr3:134307877	CEP63	chr3:134204575-134293852:+	0.2	3.55	0.000428	Height	
PRAD	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.55	12.55	2.37E-31	Height	
PRAD	cis	1	rs76129108	chr7:1089159	GPR146	chr7:1084243-1098897:+	0.27	3.65	0.000296	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs76129108	chr7:1089159	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.26	2.24E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7613282	chr3:47389409	C3orf75	chr3:47537131-47555199:-	0.16	4.82	1.92E-6	Colorectal cancer	
PRAD	cis	1	rs7613282	chr3:47389409	NBEAL2	chr3:47021173-47051193:+	0.15	4.76	2.52E-6	Colorectal cancer	
PRAD	cis	1	rs7613491	chr3:49508976	AMIGO3	chr3:49754268-49757238:-	0.46	9.21	1.07E-18	Menarche (age at onset)	
PRAD	cis	1	rs7613491	chr3:49508976	CCDC36	chr3:49235861-49295537:+	-0.22	-3.84	0.000139	Menarche (age at onset)	
PRAD	cis	1	rs7613491	chr3:49508976	GMPPB	chr3:49758932-49761384:-	0.52	12.53	2.89E-31	Menarche (age at onset)	
PRAD	cis	1	rs7613491	chr3:49508976	NCKIPSD	chr3:48711280-48723334:-	-0.28	-5.45	8.35E-8	Menarche (age at onset)	
PRAD	cis	1	rs7613491	chr3:49508976	WDR6	chr3:49044637-49053386:+	0.21	4.14	4.09E-5	Menarche (age at onset)	
PRAD	cis	1	rs7614727	chr3:52295895	GNL3	chr3:52719936-52728508:+	-0.14	-3.73	0.000216	Electroencephalogram traits	
PRAD	cis	1	rs7614727	chr3:52295895	LOC440957	chr3:52570621-52574586:+	-0.14	-4.57	6.37E-6	Electroencephalogram traits	
PRAD	cis	1	rs7614727	chr3:52295895	NEK4	chr3:52744803-52804951:-	-0.2	-5.53	5.21E-8	Electroencephalogram traits	
PRAD	cis	1	rs7614727	chr3:52295895	NT5DC2	chr3:52558386-52569093:-	-0.19	-4.38	1.46E-5	Electroencephalogram traits	
PRAD	cis	1	rs761500	chr20:43772272	SLPI	chr20:43880879-43883206:-	-0.27	-4.23	2.81E-5	Parental longevity (mother's age at death)	
PRAD	cis	1	rs76151170	chr12:56659320	COQ10A	chr12:56660642-56664748:+	-0.34	-3.44	0.000627	Psoriasis vulgaris	
PRAD	cis	1	rs76151170	chr12:56659320	MIP	chr12:56843885-56848429:-	0.69	5.24	2.44E-7	Psoriasis vulgaris	
PRAD	cis	1	rs761555	chr14:61109543	C14orf39	chr14:60902675-60952764:-	0.58	6.59	1.18E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs761555	chr14:61109543	SIX6	chr14:60975938-60978523:+	0.31	3.5	0.000507	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs7615646	chr3:10089773	C3orf10	chr3:10157333-10168873:+	-0.22	-4.15	4.02E-5	Alzheimer's disease	
PRAD	cis	1	rs7615646	chr3:10089773	LOC401052	chr3:10048102-10052779:-	-0.29	-5.18	3.38E-7	Alzheimer's disease	
PRAD	cis	1	rs7615764	chr3:10082592	C3orf10	chr3:10157333-10168873:+	-0.22	-4.16	3.84E-5	Alzheimer's disease	
PRAD	cis	1	rs7615764	chr3:10082592	LOC401052	chr3:10048102-10052779:-	-0.29	-5.21	2.88E-7	Alzheimer's disease	
PRAD	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.61	-8.97	7.01E-18	Blood pressure (smoking interaction)	
PRAD	cis	1	rs7615952	chr3:125649403	SLC41A3	chr3:125725201-125820400:-	-0.33	-5.1	4.89E-7	Blood pressure (smoking interaction)	
PRAD	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.62	9.01	5.04E-18	Blood pressure (smoking interaction)	
PRAD	cis	1	rs7616044	chr3:125649354	SLC41A3	chr3:125725201-125820400:-	0.33	5.03	7.04E-7	Blood pressure (smoking interaction)	
PRAD	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	0.88	14.34	6.1E-39	Diastolic blood pressure	
PRAD	cis	1	rs76170957	chr11:96126851	CCDC82	chr11:96085930-96123083:-	-0.23	-3.65	0.000289	Parkinson's disease	
PRAD	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-0.89	-15.11	2.62E-42	Diastolic blood pressure	
PRAD	cis	1	rs7617912	chr3:156576412	LEKR1	chr3:156544076-156763918:+	-0.42	-5.65	2.72E-8	Bone mineral density	
PRAD	cis	1	rs761879	chr22:50241210	CRELD2	chr22:50312283-50321186:+	-0.19	-3.92	0.000102	Schizophrenia	
PRAD	cis	1	rs76191812	chr20:33563911	MMP24	chr20:33814539-33864804:+	-0.32	-4.77	2.45E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7619340	chr3:10108178	C3orf10	chr3:10157333-10168873:+	-0.21	-4.12	4.39E-5	Alzheimer's disease	
PRAD	cis	1	rs7619340	chr3:10108178	LOC401052	chr3:10048102-10052779:-	-0.29	-5.23	2.51E-7	Alzheimer's disease	
PRAD	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.44	9.21	1.05E-18	Height	
PRAD	cis	1	rs76194	chr19:18630580	ELL	chr19:18553475-18632937:-	-0.16	-3.74	0.000203	Breast cancer	
PRAD	cis	1	rs76194	chr19:18630580	SSBP4	chr19:18530221-18545371:+	-0.17	-5.65	2.74E-8	Breast cancer	
PRAD	cis	1	rs7619789	chr3:49476263	AMIGO3	chr3:49754268-49757238:-	-0.42	-8.69	5.96E-17	Menarche (age at onset)	
PRAD	cis	1	rs7619789	chr3:49476263	CCDC36	chr3:49235861-49295537:+	0.24	4.38	1.49E-5	Menarche (age at onset)	
PRAD	cis	1	rs7619789	chr3:49476263	GMPPB	chr3:49758932-49761384:-	-0.48	-11.69	7.05E-28	Menarche (age at onset)	
PRAD	cis	1	rs7619789	chr3:49476263	NCKIPSD	chr3:48711280-48723334:-	0.28	5.67	2.45E-8	Menarche (age at onset)	
PRAD	cis	1	rs7619789	chr3:49476263	WDR6	chr3:49044637-49053386:+	-0.21	-4.23	2.78E-5	Menarche (age at onset)	
PRAD	cis	1	rs7620458	chr3:156576850	LEKR1	chr3:156544076-156763918:+	-0.46	-6.26	8.81E-10	Bone mineral density	
PRAD	cis	1	rs76214082	chr7:1102097	GPR146	chr7:1084243-1098897:+	0.28	3.73	0.000215	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs76214082	chr7:1102097	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.1E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	0.88	14.34	6.1E-39	Diastolic blood pressure	
PRAD	cis	1	rs7622420	chr3:53111069	ITIH4	chr3:52847007-52866554:-	-0.19	-3.65	0.000296	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7622420	chr3:53111069	RFT1	chr3:53122503-53164470:-	0.39	4.71	3.29E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7622420	chr3:53111069	TMEM110	chr3:52867139-52931547:-	0.28	3.85	0.000134	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7622963	chr3:10139825	C3orf10	chr3:10157333-10168873:+	-0.19	-3.77	0.000181	Alzheimer's disease	
PRAD	cis	1	rs7622963	chr3:10139825	LOC401052	chr3:10048102-10052779:-	-0.3	-5.54	5.09E-8	Alzheimer's disease	
PRAD	cis	1	rs7622966	chr3:10139833	C3orf10	chr3:10157333-10168873:+	-0.19	-3.77	0.000181	Alzheimer's disease	
PRAD	cis	1	rs7622966	chr3:10139833	LOC401052	chr3:10048102-10052779:-	-0.3	-5.54	5.09E-8	Alzheimer's disease	
PRAD	cis	1	rs762317	chr3:38497659	XYLB	chr3:38388251-38456467:+	0.23	5.1	4.98E-7	Electrocardiographic conduction measures	
PRAD	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	0.88	14.34	6.1E-39	Diastolic blood pressure	
PRAD	cis	1	rs7624377	chr3:190988079	UTS2D	chr3:190984945-191048325:-	-0.25	-5.05	6.23E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs7624642	chr3:184561541	VPS8	chr3:184529931-184770402:+	-0.33	-4.24	2.72E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs7625448	chr3:53120766	ITIH4	chr3:52847007-52866554:-	-0.18	-3.5	0.000503	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7625448	chr3:53120766	RFT1	chr3:53122503-53164470:-	0.43	5.23	2.57E-7	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7625448	chr3:53120766	TMEM110	chr3:52867139-52931547:-	0.29	3.95	8.99E-5	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs762676	chr22:51017794	CPT1B	chr22:51007291-51017096:-	-0.22	-4.8	2.11E-6	Narcolepsy	
PRAD	cis	1	rs762676	chr22:51017794	LOC100144603	chr22:51021455-51022353:+	-0.3	-3.51	0.000486	Narcolepsy	
PRAD	cis	1	rs762677	chr22:51017713	CPT1B	chr22:51007291-51017096:-	-0.22	-4.68	3.69E-6	Narcolepsy	
PRAD	cis	1	rs762677	chr22:51017713	LOC100144603	chr22:51021455-51022353:+	-0.3	-3.52	0.000472	Narcolepsy	
PRAD	cis	1	rs76284304	chr2:203291839	NOP58	chr2:203130515-203168382:+	0.28	4.45	1.09E-5	Urate levels	
PRAD	cis	1	rs7628448	chr3:10146828	C3orf10	chr3:10157333-10168873:+	-0.22	-4.18	3.48E-5	Alzheimer's disease	
PRAD	cis	1	rs7628448	chr3:10146828	LOC401052	chr3:10048102-10052779:-	-0.34	-5.92	6.32E-9	Alzheimer's disease	
PRAD	cis	1	rs7629072	chr3:52305633	LOC440957	chr3:52570621-52574586:+	-0.13	-4.15	4.0E-5	Electroencephalogram traits	
PRAD	cis	1	rs7629072	chr3:52305633	NEK4	chr3:52744803-52804951:-	-0.18	-5.09	5.23E-7	Electroencephalogram traits	
PRAD	cis	1	rs7629072	chr3:52305633	NT5DC2	chr3:52558386-52569093:-	-0.18	-4.18	3.46E-5	Electroencephalogram traits	
PRAD	cis	1	rs76291634	chr19:10836545	LOC147727	chr19:10762539-10764548:-	0.28	3.54	0.000437	LDL cholesterol	
PRAD	cis	1	rs76292674	chr5:115625260	COMMD10	chr5:115420727-115628978:+	0.27	3.55	0.000418	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs763014	chr16:675680	PIGQ	chr16:617032-634108:+	-0.12	-3.63	0.00031	Height	
PRAD	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.49	10.17	4.33E-22	Height	
PRAD	cis	1	rs7630741	chr3:48419723	ATRIP	chr3:48488141-48507708:+	0.27	6.48	2.36E-10	Longevity	
PRAD	cis	1	rs7630741	chr3:48419723	CDC25A	chr3:48198668-48229801:-	0.22	4.07	5.42E-5	Longevity	
PRAD	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.18	-4.94	1.11E-6	Longevity	
PRAD	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.72	5.46E-28	Height	
PRAD	cis	1	rs7631026	chr3:190979823	UTS2D	chr3:190984945-191048325:-	-0.21	-4.3	2.04E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs7631057	chr3:41817951	ULK4	chr3:41288091-42003660:-	0.79	12.28	2.86E-30	Diastolic blood pressure	
PRAD	cis	1	rs76315659	chr16:77781650	NUDT7	chr16:77756411-77776153:+	0.24	3.51	0.00049	Obesity-related traits	
PRAD	cis	1	rs7631678	chr3:10078816	C3orf10	chr3:10157333-10168873:+	-0.22	-4.17	3.66E-5	Alzheimer's disease	
PRAD	cis	1	rs7631678	chr3:10078816	LOC401052	chr3:10048102-10052779:-	-0.3	-5.26	2.22E-7	Alzheimer's disease	
PRAD	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.8	12.53	2.76E-31	Diastolic blood pressure	
PRAD	cis	1	rs76329209	chr6:26196430	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.72	0.000223	Renal underexcretion gout;Gout	
PRAD	cis	1	rs76329209	chr6:26196430	HIST1H3E	chr6:26224427-26226589:+	0.36	5.75	1.57E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs7632921	chr3:71543758	EIF4E3	chr3:71728442-71803924:-	0.19	3.81	0.00016	Educational attainment (years of education)	
PRAD	cis	1	rs76329678	chr5:49830286	EMB	chr5:49692033-49737234:-	0.17	3.82	0.00015	Schizophrenia	
PRAD	cis	1	rs7633265	chr3:195048814	C3orf21	chr3:194789015-194991895:-	0.32	6.69	6.37E-11	Body mass index	
PRAD	cis	1	rs7634345	chr3:195073403	C3orf21	chr3:194789015-194991895:-	0.34	7.05	6.52E-12	Body mass index	
PRAD	cis	1	rs7634377	chr3:48421258	ATRIP	chr3:48488141-48507708:+	0.27	6.38	4.19E-10	Longevity	
PRAD	cis	1	rs7634377	chr3:48421258	CDC25A	chr3:48198668-48229801:-	0.22	4.13	4.32E-5	Longevity	
PRAD	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.18	-4.95	1.01E-6	Longevity	
PRAD	cis	1	rs7635522	chr3:48423656	ATRIP	chr3:48488141-48507708:+	0.27	6.68	6.75E-11	Longevity	
PRAD	cis	1	rs7635522	chr3:48423656	CDC25A	chr3:48198668-48229801:-	0.2	3.72	0.000226	Longevity	
PRAD	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.17	-4.77	2.44E-6	Longevity	
PRAD	cis	1	rs7636044	chr3:48484560	ATRIP	chr3:48488141-48507708:+	0.28	6.74	4.71E-11	Longevity	
PRAD	cis	1	rs7636044	chr3:48484560	CDC25A	chr3:48198668-48229801:-	0.22	4.13	4.36E-5	Longevity	
PRAD	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.17	-4.75	2.71E-6	Longevity	
PRAD	cis	1	rs76363448	chr20:33655535	MMP24	chr20:33814539-33864804:+	-0.32	-4.78	2.38E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7636782	chr3:48421387	ATRIP	chr3:48488141-48507708:+	0.28	6.8	3.23E-11	Longevity	
PRAD	cis	1	rs7636782	chr3:48421387	CDC25A	chr3:48198668-48229801:-	0.19	3.67	0.00027	Longevity	
PRAD	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.17	-4.81	2.01E-6	Longevity	
PRAD	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.55	12.58	1.8E-31	Height	
PRAD	cis	1	rs7637404	chr3:190981868	UTS2D	chr3:190984945-191048325:-	-0.22	-4.44	1.12E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs7637888	chr3:10080722	C3orf10	chr3:10157333-10168873:+	-0.22	-4.17	3.66E-5	Alzheimer's disease	
PRAD	cis	1	rs7637888	chr3:10080722	LOC401052	chr3:10048102-10052779:-	-0.3	-5.26	2.22E-7	Alzheimer's disease	
PRAD	cis	1	rs76388414	chr7:1100694	GPR146	chr7:1084243-1098897:+	0.28	3.73	0.000215	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs76388414	chr7:1100694	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.1E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7638995	chr3:69173375	ARL6IP5	chr3:69134090-69155237:+	0.25	4.88	1.43E-6	Alzheimer's disease (late onset)	
PRAD	cis	1	rs763919	chr20:44016052	SYS1	chr20:43991701-44004724:+	-0.33	-5.97	4.77E-9	Psoriasis	
PRAD	cis	1	rs7639514	chr3:156576067	LEKR1	chr3:156544076-156763918:+	-0.45	-6.47	2.39E-10	Bone mineral density	
PRAD	cis	1	rs7641370	chr3:182071287	LAMP3	chr3:182840004-182880667:-	0.17	3.61	0.000336	Cognitive function	
PRAD	cis	1	rs76414143	chr5:115625396	COMMD10	chr5:115420727-115628978:+	0.27	3.55	0.000418	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs76419734	chr4:106624285	INTS12	chr4:106603787-106629881:-	-0.79	-7.88	2.34E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs76430365	chr12:56699993	MIP	chr12:56843885-56848429:-	0.77	5.69	2.28E-8	Psoriasis vulgaris	
PRAD	cis	1	rs76433514	chr5:150306532	LOC134466	chr5:150310000-150326146:-	0.69	9.86	5.91E-21	Crohn's disease	
PRAD	cis	1	rs76434589	chr7:106717217	PRKAR2B	chr7:106685178-106802255:+	-0.3	-3.61	0.000344	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs76439498	chr1:183643395	NCF2	chr1:183524698-183560046:-	0.27	3.93	9.8E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs7644148	chr3:49545241	AMIGO3	chr3:49754268-49757238:-	0.44	8.95	8.33E-18	Menarche (age at onset)	
PRAD	cis	1	rs7644148	chr3:49545241	CCDC36	chr3:49235861-49295537:+	-0.23	-4.1	4.78E-5	Menarche (age at onset)	
PRAD	cis	1	rs7644148	chr3:49545241	GMPPB	chr3:49758932-49761384:-	0.49	12.03	3.09E-29	Menarche (age at onset)	
PRAD	cis	1	rs7644148	chr3:49545241	NCKIPSD	chr3:48711280-48723334:-	-0.3	-6.03	3.31E-9	Menarche (age at onset)	
PRAD	cis	1	rs7644148	chr3:49545241	P4HTM	chr3:49027341-49044579:+	-0.16	-3.48	0.000539	Menarche (age at onset)	
PRAD	cis	1	rs7644148	chr3:49545241	WDR6	chr3:49044637-49053386:+	0.2	4.02	6.86E-5	Menarche (age at onset)	
PRAD	cis	1	rs7644510	chr3:190980797	UTS2D	chr3:190984945-191048325:-	-0.22	-4.61	5.18E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs76448403	chr11:43578989	HSD17B12	chr11:43702143-43878160:+	0.38	3.95	8.9E-5	Birth length	
PRAD	cis	1	rs76449411	chr2:17799354	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.52	11.66	8.67E-28	Height	
PRAD	cis	1	rs7645295	chr3:134307734	CEP63	chr3:134204575-134293852:+	0.2	3.49	0.000522	Height	
PRAD	cis	1	rs7645611	chr3:53125297	ITIH4	chr3:52847007-52866554:-	-0.21	-3.86	0.000128	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7645611	chr3:53125297	RFT1	chr3:53122503-53164470:-	0.41	4.89	1.41E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7645611	chr3:53125297	TMEM110	chr3:52867139-52931547:-	0.27	3.59	0.00037	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs7645716	chr3:46336781	CCR5	chr3:46411633-46417690:+	-0.1	-3.93	9.88E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.8	12.53	2.76E-31	Diastolic blood pressure	
PRAD	cis	1	rs76466034	chr12:56719450	MIP	chr12:56843885-56848429:-	0.77	5.69	2.28E-8	Psoriasis vulgaris	
PRAD	cis	1	rs76467433	chr7:142824852	TMEM139	chr7:142982044-142985140:+	-0.24	-3.74	0.000206	Dermatomyositis	
PRAD	cis	1	rs76471037	chr3:41799414	ULK4	chr3:41288091-42003660:-	0.82	13.16	7.08E-34	Diastolic blood pressure	
PRAD	cis	1	rs764752	chr6:33658066	ITPR3	chr6:33589161-33664346:+	-0.12	-4.1	4.78E-5	Height	
PRAD	cis	1	rs764752	chr6:33658066	LEMD2	chr6:33738991-33756906:-	-0.12	-3.57	0.000389	Height	
PRAD	cis	1	rs764754	chr6:33658310	ITPR3	chr6:33589161-33664346:+	-0.12	-4.1	4.78E-5	Height	
PRAD	cis	1	rs764754	chr6:33658310	LEMD2	chr6:33738991-33756906:-	-0.12	-3.57	0.000389	Height	
PRAD	cis	1	rs7647973	chr3:49510931	AMIGO3	chr3:49754268-49757238:-	0.46	9.21	1.07E-18	Menarche (age at onset)	
PRAD	cis	1	rs7647973	chr3:49510931	CCDC36	chr3:49235861-49295537:+	-0.22	-3.84	0.000139	Menarche (age at onset)	
PRAD	cis	1	rs7647973	chr3:49510931	GMPPB	chr3:49758932-49761384:-	0.52	12.53	2.89E-31	Menarche (age at onset)	
PRAD	cis	1	rs7647973	chr3:49510931	NCKIPSD	chr3:48711280-48723334:-	-0.28	-5.45	8.35E-8	Menarche (age at onset)	
PRAD	cis	1	rs7647973	chr3:49510931	WDR6	chr3:49044637-49053386:+	0.21	4.14	4.09E-5	Menarche (age at onset)	
PRAD	cis	1	rs7648104	chr3:10073311	C3orf10	chr3:10157333-10168873:+	-0.22	-4.17	3.66E-5	Alzheimer's disease	
PRAD	cis	1	rs7648104	chr3:10073311	LOC401052	chr3:10048102-10052779:-	-0.3	-5.26	2.22E-7	Alzheimer's disease	
PRAD	cis	1	rs7648357	chr3:41849670	ULK4	chr3:41288091-42003660:-	0.84	13.71	3.33E-36	Diastolic blood pressure	
PRAD	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	0.88	14.44	2.3E-39	Diastolic blood pressure	
PRAD	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.55	12.6	1.4E-31	Height	
PRAD	cis	1	rs7648995	chr3:49438803	AMIGO3	chr3:49754268-49757238:-	0.43	8.79	2.93E-17	Menarche (age at onset)	
PRAD	cis	1	rs7648995	chr3:49438803	CCDC36	chr3:49235861-49295537:+	-0.23	-4.18	3.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs7648995	chr3:49438803	GMPPB	chr3:49758932-49761384:-	0.48	11.64	1.05E-27	Menarche (age at onset)	
PRAD	cis	1	rs7648995	chr3:49438803	NCKIPSD	chr3:48711280-48723334:-	-0.31	-6.09	2.34E-9	Menarche (age at onset)	
PRAD	cis	1	rs7648995	chr3:49438803	P4HTM	chr3:49027341-49044579:+	-0.16	-3.67	0.000275	Menarche (age at onset)	
PRAD	cis	1	rs7648995	chr3:49438803	WDR6	chr3:49044637-49053386:+	0.19	3.83	0.000146	Menarche (age at onset)	
PRAD	cis	1	rs7649764	chr3:46330862	CCR5	chr3:46411633-46417690:+	-0.1	-3.95	9.05E-5	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs7650156	chr3:128361555	CCDC48	chr3:128720472-128759583:+	-0.17	-3.51	0.000497	Monocyte count	
PRAD	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	0.82	13.29	1.98E-34	Diastolic blood pressure	
PRAD	cis	1	rs76507298	chr20:33623522	MMP24	chr20:33814539-33864804:+	-0.31	-4.75	2.69E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7651058	chr3:10066964	C3orf10	chr3:10157333-10168873:+	-0.2	-3.85	0.000134	Alzheimer's disease	
PRAD	cis	1	rs7651058	chr3:10066964	LOC401052	chr3:10048102-10052779:-	-0.29	-5.22	2.64E-7	Alzheimer's disease	
PRAD	cis	1	rs7651407	chr3:48443816	ATRIP	chr3:48488141-48507708:+	0.27	6.41	3.63E-10	Longevity	
PRAD	cis	1	rs7651407	chr3:48443816	CDC25A	chr3:48198668-48229801:-	0.21	3.98	8.08E-5	Longevity	
PRAD	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.18	-5.07	5.6E-7	Longevity	
PRAD	cis	1	rs7651757	chr3:195077305	C3orf21	chr3:194789015-194991895:-	0.3	6.31	6.53E-10	Body mass index	
PRAD	cis	1	rs76524920	chr2:48136092	GTF2A1L	chr2:48844948-48960284:+	-0.36	-3.65	0.000292	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs76524920	chr2:48136092	KLRAQ1	chr2:48667908-48742524:+	0.26	3.47	0.000578	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs76524920	chr2:48136092	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.31	-3.67	0.000271	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs76528043	chr2:203330839	NOP58	chr2:203130515-203168382:+	0.28	4.49	9.12E-6	Urate levels	
PRAD	cis	1	rs7652935	chr3:10151138	C3orf10	chr3:10157333-10168873:+	-0.23	-4.41	1.27E-5	Alzheimer's disease	
PRAD	cis	1	rs7652935	chr3:10151138	LOC401052	chr3:10048102-10052779:-	-0.31	-5.55	4.85E-8	Alzheimer's disease	
PRAD	cis	1	rs7653691	chr3:48419689	ATRIP	chr3:48488141-48507708:+	-0.27	-6.38	4.23E-10	Longevity	
PRAD	cis	1	rs7653691	chr3:48419689	CDC25A	chr3:48198668-48229801:-	-0.22	-4.12	4.55E-5	Longevity	
PRAD	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.18	4.89	1.36E-6	Longevity	
PRAD	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.55	-6.89	1.82E-11	Tumor biomarkers	
PRAD	cis	1	rs76542740	chr15:43891512	CATSPER2	chr15:43922774-43959900:-	-0.27	-4.82	1.97E-6	Tumor biomarkers	
PRAD	cis	1	rs76542740	chr15:43891512	CKMT1A	chr15:43985084-43991419:+	-0.49	-5.52	5.75E-8	Tumor biomarkers	
PRAD	cis	1	rs7654345	chr4:17691796	MED28	chr4:17616273-17629791:+	0.17	4.42	1.23E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs76548544	chr5:150223515	C5orf62	chr5:150157867-150176297:+	0.29	3.72	0.000222	Crohn's disease	
PRAD	cis	1	rs76548544	chr5:150223515	LOC134466	chr5:150310000-150326146:-	0.57	8.64	8.67E-17	Crohn's disease	
PRAD	cis	1	rs7655122	chr4:39122016	KLHL5	chr4:39046659-39123828:+	-0.13	-3.79	0.000168	Uric acid levels	
PRAD	cis	1	rs765527	chr19:22129555	ZNF208	chr19:22115760-22193745:-	-0.28	-5.5	6.19E-8	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs765527	chr19:22129555	ZNF257	chr19:22235266-22273901:+	-0.46	-7.58	1.83E-13	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs76553384	chr14:74383679	LIN52	chr14:74551656-74667117:+	0.28	4.64	4.56E-6	Morning vs. evening chronotype	
PRAD	cis	1	rs7655841	chr4:129890790	C4orf33	chr4:130014829-130033842:+	0.44	7.19	2.5E-12	Chronic obstructive pulmonary disease (moderate to severe)	
PRAD	cis	1	rs7656037	chr4:39717965	RFC1	chr4:39289076-39367995:-	0.15	3.51	0.000484	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs7656037	chr4:39717965	RPL9	chr4:39455747-39460568:-	-0.4	-7.89	2.13E-14	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs76561339	chr9:97319565	FAM22F	chr9:97080478-97090926:-	0.45	3.89	0.000115	Height	
PRAD	cis	1	rs7657926	chr4:39134063	KLHL5	chr4:39046659-39123828:+	-0.13	-3.74	0.000204	Uric acid levels	
PRAD	cis	1	rs7657962	chr4:106966715	TBCK	chr4:106967233-107237861:-	0.2	4.12	4.54E-5	Airflow obstruction	
PRAD	cis	1	rs76582181	chr1:183613508	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs7659718	chr4:17638020	MED28	chr4:17616273-17629791:+	0.2	5.02	7.35E-7	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs76599129	chr11:18471627	LDHC	chr11:18433853-18472792:+	-0.31	-3.82	0.000151	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs7661070	chr4:39724365	KLB	chr4:39408473-39453151:+	0.22	3.85	0.000134	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs7661070	chr4:39724365	RFC1	chr4:39289076-39367995:-	0.15	3.53	0.000463	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.41	-7.79	4.28E-14	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs7661631	chr4:17679751	MED28	chr4:17616273-17629791:+	-0.15	-3.85	0.000133	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs7661702	chr4:104140129	BDH2	chr4:103998783-104021024:-	0.26	6.91	1.57E-11	Testicular germ cell tumor	
PRAD	cis	1	rs7661702	chr4:104140129	MANBA	chr4:103552644-103682151:-	0.22	4.26	2.52E-5	Testicular germ cell tumor	
PRAD	cis	1	rs76617854	chr1:183608743	NCF2	chr1:183524698-183560046:-	0.27	3.81	0.000159	Systemic lupus erythematosus	
PRAD	cis	1	rs76628322	chr1:183625835	NCF2	chr1:183524698-183560046:-	0.27	3.98	7.86E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs7663811	chr4:142154614	ZNF330	chr4:142142049-142155848:+	-0.25	-4.45	1.06E-5	Conduct disorder	
PRAD	cis	1	rs7664078	chr4:39118203	KLHL5	chr4:39046659-39123828:+	-0.14	-4.12	4.41E-5	Uric acid levels	
PRAD	cis	1	rs76644767	chr14:56334823	DLGAP5	chr14:55614836-55658396:-	0.12	3.56	0.00041	Body mass index (interaction)	
PRAD	cis	1	rs76648234	chr20:33689941	MMP24	chr20:33814539-33864804:+	-0.31	-4.67	4.0E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7665590	chr4:99796784	EIF4E	chr4:99799607-99851786:-	-0.17	-3.57	0.000399	Primary biliary cirrhosis	
PRAD	cis	1	rs7665727	chr4:277057	ZNF718	chr4:53272-156488:+	0.35	5.65	2.8E-8	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs7667496	chr4:103509455	BDH2	chr4:103998783-104021024:-	0.15	3.78	0.00018	Ulcerative colitis	
PRAD	cis	1	rs7668147	chr4:56339384	TMEM165	chr4:56262090-56292342:+	-0.17	-3.64	0.000301	Personality dimensions	
PRAD	cis	1	rs76683040	chr11:119152684	CBL	chr11:119076990-119178858:+	-0.31	-4.96	1.01E-6	Platelet count	
PRAD	cis	1	rs76683169	chr10:102358397	SEC31B	chr10:102246403-102289636:-	-0.25	-6.61	1.04E-10	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs76693798	chr3:184711113	VPS8	chr3:184529931-184770402:+	-0.35	-4.32	1.9E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs76694233	chr4:106681036	INTS12	chr4:106603787-106629881:-	-0.79	-7.86	2.61E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs7669892	chr4:309253	ZNF718	chr4:53272-156488:+	-0.21	-4.49	9.08E-6	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs7670221	chr4:147497597	ZNF827	chr4:146681892-146859607:-	-0.17	-3.77	0.000181	Heart rate	
PRAD	cis	1	rs7671752	chr4:17661398	MED28	chr4:17616273-17629791:+	0.19	4.61	5.1E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs7671823	chr4:147497707	ZNF827	chr4:146681892-146859607:-	-0.17	-3.77	0.000181	Heart rate	
PRAD	cis	1	rs76722536	chr6:26192946	HIST1H2AE	chr6:26217148-26217711:+	-0.27	-3.83	0.000147	Renal underexcretion gout;Gout	
PRAD	cis	1	rs76722536	chr6:26192946	HIST1H3E	chr6:26224427-26226589:+	0.36	5.65	2.81E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs7673299	chr4:39110758	KLHL5	chr4:39046659-39123828:+	-0.13	-3.64	0.000305	Uric acid levels	
PRAD	cis	1	rs7673500	chr4:17621383	MED28	chr4:17616273-17629791:+	0.23	5.65	2.74E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs7673908	chr4:56394819	TMEM165	chr4:56262090-56292342:+	0.16	3.62	0.000323	Personality dimensions	
PRAD	cis	1	rs76745316	chr12:56627652	COQ10A	chr12:56660642-56664748:+	-0.36	-3.47	0.000562	Psoriasis vulgaris	
PRAD	cis	1	rs76745316	chr12:56627652	MIP	chr12:56843885-56848429:-	0.73	5.31	1.71E-7	Psoriasis vulgaris	
PRAD	cis	1	rs7674560	chr4:263319	ZNF718	chr4:53272-156488:+	0.36	6.3	6.91E-10	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs767463	chr2:182457803	CERKL	chr2:182401402-182545381:-	-0.15	-3.74	0.000208	Response to iloperidone treatment (QT prolongation)	
PRAD	cis	1	rs767471	chr6:26557854	BTN2A3	chr6:26422317-26431927:+	0.26	6.58	1.29E-10	Educational attainment	
PRAD	cis	1	rs767471	chr6:26557854	ZNF184	chr6:27418522-27440897:-	-0.17	-3.51	0.000488	Educational attainment	
PRAD	cis	1	rs76751500	chr16:77785771	NUDT7	chr16:77756411-77776153:+	0.24	3.46	0.000581	Obesity-related traits	
PRAD	cis	1	rs76753180	chr5:130763701	P4HA2	chr5:131528306-131563556:-	-0.21	-3.66	0.000278	Life satisfaction	
PRAD	cis	1	rs7675782	chr4:39121668	KLHL5	chr4:39046659-39123828:+	-0.13	-3.74	0.000203	Uric acid levels	
PRAD	cis	1	rs7675861	chr4:5849821	CRMP1	chr4:5749811-5894785:-	0.23	3.99	7.59E-5	Dysphagia	
PRAD	cis	1	rs7676008	chr4:39121774	KLHL5	chr4:39046659-39123828:+	-0.13	-3.79	0.000168	Uric acid levels	
PRAD	cis	1	rs7676975	chr4:106763811	INTS12	chr4:106603787-106629881:-	-0.62	-7.12	4.16E-12	Post bronchodilator FEV1	
PRAD	cis	1	rs7677248	chr4:106960497	TBCK	chr4:106967233-107237861:-	-0.18	-3.75	0.000201	Airflow obstruction	
PRAD	cis	1	rs7677526	chr4:56349908	TMEM165	chr4:56262090-56292342:+	-0.16	-3.59	0.000364	Personality dimensions	
PRAD	cis	1	rs7678847	chr4:106987426	TBCK	chr4:106967233-107237861:-	0.17	3.69	0.000248	Airflow obstruction	
PRAD	cis	1	rs7679975	chr4:142154551	ZNF330	chr4:142142049-142155848:+	-0.25	-4.44	1.11E-5	Conduct disorder	
PRAD	cis	1	rs76801042	chr3:150482720	SIAH2	chr3:150458911-150481263:-	0.44	3.6	0.000349	Breast cancer	
PRAD	cis	1	rs76804143	chr7:1082021	GPR146	chr7:1084243-1098897:+	0.26	3.55	0.000429	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs76804143	chr7:1082021	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.22	2.68E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs76805415	chr10:46026163	MARCH8	chr10:45952817-46090354:-	0.25	5.53	5.23E-8	Red blood cell traits	
PRAD	cis	1	rs7681116	chr4:39134635	KLHL5	chr4:39046659-39123828:+	-0.14	-3.97	8.19E-5	Uric acid levels	
PRAD	cis	1	rs76812330	chr19:50531860	SIGLEC16	chr19:50472912-50479075:+	0.39	3.93	9.68E-5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs76812330	chr19:50531860	TSKS	chr19:50243012-50266515:-	0.33	3.61	0.000344	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs7682402	chr4:1743343	FAM53A	chr4:1641609-1685854:-	-0.44	-7.89	2.14E-14	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs7683315	chr4:88773095	SPP1	chr4:88896802-88904562:+	0.2	3.59	0.000371	Bone mineral density;Bone mineral density (paediatric, total body less head)	
PRAD	cis	1	rs76833820	chr7:1070278	GPR146	chr7:1084243-1098897:+	0.27	3.57	0.000387	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs76833820	chr7:1070278	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.15	3.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs76841360	chr1:40060025	BMP8A	chr1:39957318-39995537:+	0.23	3.59	0.000365	C-reactive protein levels or triglyceride levels (pleiotropy)	
PRAD	cis	1	rs76841360	chr1:40060025	PABPC4	chr1:40026485-40042521:-	-0.26	-5.1	4.86E-7	C-reactive protein levels or triglyceride levels (pleiotropy)	
PRAD	cis	1	rs7684664	chr4:142150860	ZNF330	chr4:142142049-142155848:+	-0.27	-4.99	8.72E-7	Conduct disorder	
PRAD	cis	1	rs76850134	chr20:33671725	MMP24	chr20:33814539-33864804:+	-0.32	-4.78	2.38E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7685082	chr4:39118092	KLHL5	chr4:39046659-39123828:+	-0.14	-4.12	4.41E-5	Uric acid levels	
PRAD	cis	1	rs76852223	chr6:159370432	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs76854106	chr11:73027110	RELT	chr11:73087405-73108518:+	0.18	3.57	0.000397	Pulmonary function (interaction)	
PRAD	cis	1	rs7685468	chr4:39118269	KLHL5	chr4:39046659-39123828:+	-0.13	-3.81	0.000156	Uric acid levels	
PRAD	cis	1	rs7686546	chr4:240614	ZNF718	chr4:53272-156488:+	0.33	5.37	1.27E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs768673	chr10:45966749	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs76872831	chr5:150171559	LOC134466	chr5:150310000-150326146:-	0.73	9.72	1.74E-20	Crohn's disease	
PRAD	cis	1	rs76873509	chr8:38021982	DDHD2	chr8:38089009-38120286:+	0.34	5.86	8.6E-9	Schizophrenia	
PRAD	cis	1	rs7687539	chr4:89806784	FAM13A	chr4:89647106-90032549:-	0.18	3.44	0.000625	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs7687557	chr4:39769260	RFC1	chr4:39289076-39367995:-	0.15	3.52	0.000472	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs7687557	chr4:39769260	RPL9	chr4:39455747-39460568:-	-0.4	-7.98	1.13E-14	Plasma amyloid beta peptide concentrations (ABx-40)	
PRAD	cis	1	rs76878669	chr11:66092567	ACTN3	chr11:66313866-66330797:+	0.24	3.76	0.000192	Educational attainment (years of education)	
PRAD	cis	1	rs7688014	chr4:103975060	BDH2	chr4:103998783-104021024:-	0.23	5.45	7.96E-8	Schizophrenia	
PRAD	cis	1	rs7688014	chr4:103975060	MANBA	chr4:103552644-103682151:-	0.3	5.17	3.43E-7	Schizophrenia	
PRAD	cis	1	rs7688682	chr4:17693794	MED28	chr4:17616273-17629791:+	-0.17	-4.39	1.39E-5	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs768994	chr6:159399348	RSPH3	chr6:159398268-159421198:-	0.29	4.58	6.04E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs76901676	chr1:179452520	C1orf125	chr1:179335107-179523868:+	0.31	3.57	0.000393	Multiple sclerosis (age of onset)	
PRAD	cis	1	rs76904798	chr12:40614434	LRRK2	chr12:40618813-40763084:+	0.13	3.69	0.000247	Parkinson's disease	
PRAD	cis	1	rs7692069	chr4:106959289	TBCK	chr4:106967233-107237861:-	0.17	3.53	0.000453	Airflow obstruction	
PRAD	cis	1	rs7692606	chr4:103509681	BDH2	chr4:103998783-104021024:-	0.15	3.78	0.00018	Ulcerative colitis	
PRAD	cis	1	rs76935404	chr19:41419294	CYP2B7P1	chr19:41430170-41456563:+	-0.23	-4.08	5.2E-5	nicotine metabolite ratio in current smokers	
PRAD	cis	1	rs7694020	chr4:17682597	MED28	chr4:17616273-17629791:+	0.19	4.82	1.9E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs7694190	chr4:104168017	BDH2	chr4:103998783-104021024:-	0.25	6.73	4.87E-11	Testicular germ cell tumor	
PRAD	cis	1	rs7694190	chr4:104168017	MANBA	chr4:103552644-103682151:-	0.22	4.08	5.31E-5	Testicular germ cell tumor	
PRAD	cis	1	rs7694760	chr4:39128101	KLHL5	chr4:39046659-39123828:+	-0.14	-4.02	6.68E-5	Uric acid levels	
PRAD	cis	1	rs7695732	chr4:89832791	FAM13A	chr4:89647106-90032549:-	0.18	3.44	0.000638	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs7697889	chr4:17617961	MED28	chr4:17616273-17629791:+	0.23	5.68	2.3E-8	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs76987839	chr12:119822411	CCDC60	chr12:119772517-119978851:+	-0.34	-3.52	0.000466	Schizophrenia	
PRAD	cis	1	rs76994419	chr15:40714150	C15orf23	chr15:40674922-40686488:+	0.98	14.07	8.89E-38	Heschl's gyrus morphology	
PRAD	cis	1	rs7703051	chr5:74625487	POLK	chr5:74807657-74895644:+	-0.11	-3.47	0.000568	LDL cholesterol	
PRAD	cis	1	rs77032009	chr12:56679971	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs77032009	chr12:56679971	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs77047385	chr1:183643180	NCF2	chr1:183524698-183560046:-	0.25	3.74	0.000205	Systemic lupus erythematosus	
PRAD	cis	1	rs7705093	chr5:96290647	ERAP1	chr5:96096515-96149837:-	-0.14	-4.08	5.22E-5	Birdshot chorioretinopathy	
PRAD	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1.08	38.05	1.33E-145	Birdshot chorioretinopathy	
PRAD	cis	1	rs7705542	chr5:150228318	C5orf62	chr5:150157867-150176297:+	0.29	3.81	0.000158	Crohn's disease	
PRAD	cis	1	rs7705542	chr5:150228318	LOC134466	chr5:150310000-150326146:-	0.57	8.61	1.11E-16	Crohn's disease	
PRAD	cis	1	rs77055954	chr16:68246428	C16orf86	chr16:67700717-67702659:+	-0.3	-3.58	0.000373	Crohn's disease	
PRAD	cis	1	rs7705658	chr5:78315305	BHMT2	chr5:78365583-78385273:+	0.1	3.77	0.000185	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs77066891	chr3:184553376	VPS8	chr3:184529931-184770402:+	-0.35	-4.35	1.64E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs77078012	chr19:49511397	BAX	chr19:49458117-49465054:+	0.24	3.47	0.00056	Follicule stimulating hormone	
PRAD	cis	1	rs77078697	chr4:252048	ZNF718	chr4:53272-156488:+	0.37	6.38	4.18E-10	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs77083167	chr7:1071823	GPR146	chr7:1084243-1098897:+	0.27	3.57	0.000387	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs77083167	chr7:1071823	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.15	3.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7708474	chr5:122676525	CEP120	chr5:122680580-122759252:-	-0.21	-4.41	1.25E-5	Height	
PRAD	cis	1	rs77092773	chr11:96110320	CCDC82	chr11:96085930-96123083:-	-0.24	-3.71	0.00023	Parkinson's disease	
PRAD	cis	1	rs7709388	chr5:150246539	LOC134466	chr5:150310000-150326146:-	0.54	8.65	8.5E-17	Crohn's disease	
PRAD	cis	1	rs7709464	chr5:150269441	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs7709472	chr5:78315151	BHMT2	chr5:78365583-78385273:+	0.1	4.06	5.73E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs7709650	chr5:150246685	C5orf62	chr5:150157867-150176297:+	0.29	3.7	0.000241	Crohn's disease	
PRAD	cis	1	rs7709650	chr5:150246685	LOC134466	chr5:150310000-150326146:-	0.59	8.93	9.5E-18	Crohn's disease	
PRAD	cis	1	rs77097088	chr6:159354815	RSPH3	chr6:159398268-159421198:-	0.29	4.65	4.41E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs7709757	chr5:78315329	BHMT2	chr5:78365583-78385273:+	0.1	3.77	0.000185	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs7710963	chr5:110164629	TMEM232	chr5:109624934-110062381:-	0.27	4.21	3.09E-5	Asthma and hay fever	
PRAD	cis	1	rs77120931	chr12:56646213	MIP	chr12:56843885-56848429:-	0.67	5.03	6.88E-7	Psoriasis vulgaris	
PRAD	cis	1	rs77131854	chr12:56664231	COQ10A	chr12:56660642-56664748:+	-0.38	-3.72	0.000226	Psoriasis vulgaris	
PRAD	cis	1	rs77131854	chr12:56664231	MIP	chr12:56843885-56848429:-	0.71	5.3	1.77E-7	Psoriasis vulgaris	
PRAD	cis	1	rs7714415	chr5:150270292	LOC134466	chr5:150310000-150326146:-	0.56	8.71	5.28E-17	Crohn's disease	
PRAD	cis	1	rs7714584	chr5:150270420	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs7715981	chr5:150258107	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs7716903	chr5:150258574	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs77181006	chr2:48137033	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.32	-3.67	0.000267	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs77187281	chr19:50507667	SIGLEC16	chr19:50472912-50479075:+	0.52	4.94	1.08E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs77187281	chr19:50507667	TSKS	chr19:50243012-50266515:-	0.34	3.54	0.000437	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs7718874	chr5:176358065	FGFR4	chr5:176513921-176525124:+	0.18	3.67	0.00027	Menopause (age at onset);Menarche and menopause (age at onset)	
PRAD	cis	1	rs77204970	chr10:46034949	MARCH8	chr10:45952817-46090354:-	0.25	5.52	5.74E-8	Red blood cell traits	
PRAD	cis	1	rs77225875	chr6:159418145	RSPH3	chr6:159398268-159421198:-	0.29	4.49	8.82E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs77234191	chr4:258294	ZNF718	chr4:53272-156488:+	0.33	5.4	1.08E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs7724036	chr5:150284808	LOC134466	chr5:150310000-150326146:-	-0.56	-9.06	3.55E-18	Crohn's disease	
PRAD	cis	1	rs77245075	chr2:17810302	GEN1	chr2:17935162-17966632:+	0.47	5.46	7.78E-8	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs7724558	chr5:150328866	LOC134466	chr5:150310000-150326146:-	0.66	8.73	4.32E-17	Crohn's disease	
PRAD	cis	1	rs77257477	chr8:96045399	C8orf38	chr8:95908040-96088396:+	-0.39	-6.57	1.37E-10	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs77257477	chr8:96045399	TP53INP1	chr8:95938201-95961615:-	0.26	3.85	0.000135	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs77268589	chr2:203751981	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs7727038	chr5:131590257	PDLIM4	chr5:131593351-131609145:+	-0.36	-11.5	3.79E-27	Blood metabolite levels	
PRAD	cis	1	rs7727038	chr5:131590257	SLC22A4	chr5:131630145-131679897:+	-0.18	-3.72	0.000219	Blood metabolite levels	
PRAD	cis	1	rs7727544	chr5:131590534	PDLIM4	chr5:131593351-131609145:+	-0.36	-11.5	3.79E-27	Blood metabolite levels	
PRAD	cis	1	rs7727544	chr5:131590534	SLC22A4	chr5:131630145-131679897:+	-0.18	-3.72	0.000219	Blood metabolite levels	
PRAD	cis	1	rs7727882	chr5:115614507	COMMD10	chr5:115420727-115628978:+	0.29	3.93	9.95E-5	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs77279246	chr11:96109554	CCDC82	chr11:96085930-96123083:-	-0.22	-3.6	0.000358	Parkinson's disease	
PRAD	cis	1	rs7728612	chr5:110164674	TMEM232	chr5:109624934-110062381:-	0.27	4.21	3.09E-5	Asthma and hay fever	
PRAD	cis	1	rs7729356	chr5:107397215	FBXL17	chr5:107194740-107717799:-	0.2	4.16	3.86E-5	Educational attainment	
PRAD	cis	1	rs7729926	chr5:137514641	REEP2	chr5:137774776-137782657:+	-0.11	-4.26	2.45E-5	Resting heart rate	
PRAD	cis	1	rs77305932	chr7:1100861	GPR146	chr7:1084243-1098897:+	0.28	3.73	0.000215	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs77305932	chr7:1100861	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.1E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7731142	chr5:78325519	BHMT2	chr5:78365583-78385273:+	0.09	3.63	0.000313	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs7732643	chr5:150261436	LOC134466	chr5:150310000-150326146:-	0.57	8.83	2.13E-17	Crohn's disease	
PRAD	cis	1	rs7732945	chr5:150261601	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs77346188	chr7:1114023	GPR146	chr7:1084243-1098897:+	0.28	3.73	0.000215	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs77346188	chr7:1114023	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.1E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7734635	chr5:110158844	TMEM232	chr5:109624934-110062381:-	0.25	3.84	0.000141	Asthma and hay fever	
PRAD	cis	1	rs7734778	chr5:150256556	LOC134466	chr5:150310000-150326146:-	0.58	8.92	1.06E-17	Crohn's disease	
PRAD	cis	1	rs7734928	chr5:150256613	LOC134466	chr5:150310000-150326146:-	0.59	9.07	3.15E-18	Crohn's disease	
PRAD	cis	1	rs7735031	chr5:78325380	BHMT2	chr5:78365583-78385273:+	0.09	3.57	0.000391	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs7735519	chr5:110153341	TMEM232	chr5:109624934-110062381:-	0.26	3.92	0.000102	Asthma and hay fever	
PRAD	cis	1	rs7735635	chr5:137508336	REEP2	chr5:137774776-137782657:+	0.1	3.96	8.67E-5	Resting heart rate	
PRAD	cis	1	rs7736554	chr5:150258308	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs7736873	chr5:150258482	LOC134466	chr5:150310000-150326146:-	0.57	8.88	1.45E-17	Crohn's disease	
PRAD	cis	1	rs77374467	chr6:24475278	GPLD1	chr6:24428405-24489850:-	0.56	10.1	7.54E-22	Hematological and biochemical traits	
PRAD	cis	1	rs77374467	chr6:24475278	MRS2	chr6:24403153-24425809:+	0.31	4.45	1.09E-5	Hematological and biochemical traits	
PRAD	cis	1	rs77379383	chr10:70759169	STOX1	chr10:70587294-70655209:+	-0.21	-3.72	0.000221	Schizophrenia	
PRAD	cis	1	rs7738268	chr6:88284363	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs7739264	chr6:19785588	ID4	chr6:19837617-19840914:+	0.14	3.55	0.000427	Endometriosis	
PRAD	cis	1	rs7740380	chr6:153440711	RGS17	chr6:153332041-153452389:-	-0.55	-13.21	4.36E-34	Prostate cancer	
PRAD	cis	1	rs7740476	chr6:88274765	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs7740487	chr6:28216486	ZKSCAN3	chr6:28317691-28334523:+	-0.17	-3.58	0.000375	Depression	
PRAD	cis	1	rs7740487	chr6:28216486	ZNF187	chr6:28234788-28245978:+	-0.3	-5.53	5.35E-8	Depression	
PRAD	cis	1	rs7740487	chr6:28216486	ZNF323	chr6:28292517-28324048:-	0.38	5.07	5.78E-7	Depression	
PRAD	cis	1	rs7740487	chr6:28216486	ZNF389	chr6:28129551-28137375:+	-0.53	-7.63	1.3E-13	Depression	
PRAD	cis	1	rs7740487	chr6:28216486	ZSCAN23	chr6:28393287-28411279:-	0.17	4.7	3.44E-6	Depression	
PRAD	cis	1	rs7740682	chr6:49488745	CENPQ	chr6:49431096-49460820:+	0.21	4.24	2.72E-5	Brain structure	
PRAD	cis	1	rs7742030	chr6:44065062	MRPL14	chr6:44081374-44095191:-	-0.13	-3.59	0.000367	Major depressive disorder	
PRAD	cis	1	rs7742626	chr6:136132496	C6orf217	chr6:135818939-136037192:+	0.31	5.09	5.25E-7	Phosphorus levels	
PRAD	cis	1	rs7742824	chr6:44065311	MRPL14	chr6:44081374-44095191:-	-0.12	-3.57	0.000399	Major depressive disorder	
PRAD	cis	1	rs77435512	chr2:203198888	NOP58	chr2:203130515-203168382:+	0.22	3.92	0.000103	Urate levels	
PRAD	cis	1	rs7743683	chr6:153432985	RGS17	chr6:153332041-153452389:-	-0.56	-13.61	8.88E-36	Prostate cancer	
PRAD	cis	1	rs77437249	chr20:33564738	MMP24	chr20:33814539-33864804:+	-0.32	-4.77	2.45E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7744190	chr6:88274881	C6orf165	chr6:88117721-88205858:+	0.37	3.63	0.000313	Obesity-related traits	
PRAD	cis	1	rs77446828	chr6:159414034	RSPH3	chr6:159398268-159421198:-	0.29	4.57	6.35E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs77447765	chr12:56690662	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs77447765	chr12:56690662	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs7745098	chr6:135415004	ALDH8A1	chr6:135238529-135271244:-	-0.41	-8.27	1.35E-15	Hodgkin's lymphoma	
PRAD	cis	1	rs77452668	chr2:48135517	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.31	-3.67	0.000266	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs77464790	chr16:77777609	NUDT7	chr16:77756411-77776153:+	0.24	3.64	0.000298	Obesity-related traits	
PRAD	cis	1	rs7747003	chr6:153428982	RGS17	chr6:153332041-153452389:-	-0.56	-13.6	9.54E-36	Prostate cancer	
PRAD	cis	1	rs7747645	chr6:170070291	WDR27	chr6:169857307-170102159:-	-0.13	-3.5	0.000503	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs77477310	chr14:35615793	PPP2R3C	chr14:35554679-35591679:-	0.37	5.83	1.05E-8	Atopic dermatitis	
PRAD	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.48	-11.2	5.92E-26	Response to antipsychotic treatment	
PRAD	cis	1	rs7749032	chr6:88316186	C6orf165	chr6:88117721-88205858:+	0.44	4.06	5.79E-5	Obesity-related traits	
PRAD	cis	1	rs77495258	chr2:48141834	GTF2A1L	chr2:48844948-48960284:+	-0.35	-3.53	0.000454	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs77495258	chr2:48141834	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.33	-3.8	0.000164	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs77499285	chr6:88352017	C6orf165	chr6:88117721-88205858:+	0.42	3.9	0.00011	Obesity-related traits	
PRAD	cis	1	rs7750528	chr6:88334169	C6orf165	chr6:88117721-88205858:+	0.42	3.9	0.00011	Obesity-related traits	
PRAD	cis	1	rs7750803	chr6:111800113	KIAA1919	chr6:111580482-111590259:+	-0.38	-3.92	0.000104	Psoriasis	
PRAD	cis	1	rs7750918	chr6:49430082	CENPQ	chr6:49431096-49460820:+	-0.38	-7.78	4.49E-14	Folate pathway vitamin levels	
PRAD	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.16	4.31	1.97E-5	Folate pathway vitamin levels	
PRAD	cis	1	rs775227	chr3:112995074	KIAA1407	chr3:113682986-113775460:-	-0.19	-3.49	0.000531	Dental caries	
PRAD	cis	1	rs7752653	chr6:44093808	MRPL14	chr6:44081374-44095191:-	-0.12	-3.52	0.000474	Major depressive disorder	
PRAD	cis	1	rs77531164	chr15:40673466	C15orf23	chr15:40674922-40686488:+	0.81	12.16	9.15E-30	Heschl's gyrus morphology	
PRAD	cis	1	rs775322	chr12:57958313	FAM119B	chr12:58166383-58176323:+	0.22	4.9	1.34E-6	Rheumatoid arthritis	
PRAD	cis	1	rs775322	chr12:57958313	PIP4K2C	chr12:57984942-57997210:+	-0.12	-3.46	0.000582	Rheumatoid arthritis	
PRAD	cis	1	rs775322	chr12:57958313	TSFM	chr12:58176536-58191367:+	-0.27	-6.34	5.26E-10	Rheumatoid arthritis	
PRAD	cis	1	rs7753298	chr6:167664193	UNC93A	chr6:167704803-167729501:+	0.3	5.37	1.25E-7	Parental extreme longevity (95 years and older)	
PRAD	cis	1	rs7755323	chr6:33761159	LEMD2	chr6:33738991-33756906:-	0.16	4.21	3.05E-5	Body mass index	
PRAD	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.49	-11.05	2.17E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs77564939	chr5:115564294	COMMD10	chr5:115420727-115628978:+	0.29	3.73	0.000212	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs7756935	chr6:46675025	TDRD6	chr6:46655866-46670149:+	0.26	4.8	2.15E-6	Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs7757014	chr6:49491690	CENPQ	chr6:49431096-49460820:+	-0.22	-4.44	1.12E-5	Brain structure	
PRAD	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.43	-9.13	2.1E-18	Homocysteine levels	
PRAD	cis	1	rs7759422	chr6:88339096	C6orf165	chr6:88117721-88205858:+	0.42	3.9	0.00011	Obesity-related traits	
PRAD	cis	1	rs7759648	chr6:88310836	C6orf165	chr6:88117721-88205858:+	0.37	3.57	0.000397	Obesity-related traits	
PRAD	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.5	-11.47	5.0E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs77605770	chr6:159370528	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs7760585	chr6:161070870	LPA	chr6:160952516-161087407:-	0.15	3.44	0.000638	Lipoprotein (a) levels	
PRAD	cis	1	rs7761377	chr6:161032481	LPA	chr6:160952516-161087407:-	0.17	3.73	0.000219	Lipoprotein (a) levels	
PRAD	cis	1	rs7762018	chr6:170113244	WDR27	chr6:169857307-170102159:-	-0.13	-3.46	0.000582	Thiazide-induced adverse metabolic effects in hypertensive patients	
PRAD	cis	1	rs77649955	chr10:46050689	MARCH8	chr10:45952817-46090354:-	0.25	5.42	9.35E-8	Red blood cell traits	
PRAD	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.49	-11.48	4.54E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs77668447	chr3:182104956	LAMP3	chr3:182840004-182880667:-	0.17	3.56	0.00041	Cognitive function	
PRAD	cis	1	rs77698001	chr5:150250367	LOC134466	chr5:150310000-150326146:-	0.59	8.96	7.62E-18	Crohn's disease	
PRAD	cis	1	rs77702926	chr7:1088838	GPR146	chr7:1084243-1098897:+	0.27	3.65	0.000296	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs77702926	chr7:1088838	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.26	2.24E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs77708076	chr1:183625280	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs7771129	chr6:161018464	LPA	chr6:160952516-161087407:-	0.15	3.44	0.000638	Lipoprotein (a) levels	
PRAD	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.49	-11.05	2.17E-25	Response to antipsychotic treatment	
PRAD	cis	1	rs7771394	chr6:24324421	GPLD1	chr6:24428405-24489850:-	-0.19	-3.7	0.00024	Uric acid levels	
PRAD	cis	1	rs7773987	chr6:135707486	AHI1	chr6:135605112-135818903:-	0.18	3.63	0.000309	Selective IgA deficiency	
PRAD	cis	1	rs7773987	chr6:135707486	C6orf217	chr6:135818939-136037192:+	0.22	3.8	0.000165	Selective IgA deficiency	
PRAD	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.43	-9.17	1.53E-18	Homocysteine levels	
PRAD	cis	1	rs77755392	chr6:41340512	MDFI	chr6:41604930-41621981:+	0.4	4.04	6.16E-5	Alzheimer's disease biomarkers	
PRAD	cis	1	rs77760339	chr7:1083927	GPR146	chr7:1084243-1098897:+	0.27	3.62	0.000326	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs77760339	chr7:1083927	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.25	2.27E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs77763497	chr20:3250007	ITPA	chr20:3190056-3204504:+	-0.3	-7.56	2.19E-13	IFN-related cytopenia	
PRAD	cis	1	rs77768890	chr12:56725121	MIP	chr12:56843885-56848429:-	0.77	5.72	1.93E-8	Psoriasis vulgaris	
PRAD	cis	1	rs7777389	chr7:143744802	ARHGEF35	chr7:143883677-143892736:-	-0.5	-9.3	5.52E-19	Obesity-related traits	
PRAD	cis	1	rs7777389	chr7:143744802	OR2A1	chr7:144015236-144016148:+;chr7	-0.22	-3.59	0.000359	Obesity-related traits	
PRAD	cis	1	rs7777389	chr7:143744802	OR2A9P	chr7:143991573-143997832:+;chr7	-0.32	-5.44	8.53E-8	Obesity-related traits	
PRAD	cis	1	rs77784507	chr6:88361339	C6orf165	chr6:88117721-88205858:+	0.46	4.2	3.15E-5	Obesity-related traits	
PRAD	cis	1	rs7778911	chr7:65694506	CCT6P1	chr7:65216092-65228661:+	-0.31	-5.23	2.57E-7	Diabetic kidney disease	
PRAD	cis	1	rs7778911	chr7:65694506	CRCP	chr7:65579805-65619551:+	0.36	4.5	8.46E-6	Diabetic kidney disease	
PRAD	cis	1	rs77790737	chr8:96037156	C8orf38	chr8:95908040-96088396:+	-0.38	-6.75	4.49E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs7780883	chr7:77062712	PION	chr7:76940070-77045717:-	-0.19	-3.91	0.000107	Cervical cancer	
PRAD	cis	1	rs7781698	chr7:65896312	TPST1	chr7:65670259-65825437:+	0.18	4.32	1.87E-5	Aortic root size	
PRAD	cis	1	rs7782320	chr7:66177098	CRCP	chr7:65579805-65619551:+	-0.21	-4.02	6.81E-5	Aortic root size	
PRAD	cis	1	rs7782320	chr7:66177098	LOC493754	chr7:65993446-66057363:-	-0.23	-5.33	1.53E-7	Aortic root size	
PRAD	cis	1	rs7783613	chr7:65805261	TPST1	chr7:65670259-65825437:+	-0.18	-4.47	9.75E-6	Aortic root size	
PRAD	cis	1	rs7783924	chr7:66209057	CRCP	chr7:65579805-65619551:+	-0.21	-3.98	8.04E-5	Aortic root size	
PRAD	cis	1	rs7783924	chr7:66209057	LOC493754	chr7:65993446-66057363:-	-0.24	-5.5	6.19E-8	Aortic root size	
PRAD	cis	1	rs7783924	chr7:66209057	TPST1	chr7:65670259-65825437:+	0.15	3.56	0.000404	Aortic root size	
PRAD	cis	1	rs7785213	chr7:66138978	CRCP	chr7:65579805-65619551:+	0.2	3.72	0.000222	Aortic root size	
PRAD	cis	1	rs7785213	chr7:66138978	LOC493754	chr7:65993446-66057363:-	0.22	5.03	6.94E-7	Aortic root size	
PRAD	cis	1	rs7785213	chr7:66138978	TPST1	chr7:65670259-65825437:+	-0.15	-3.69	0.000248	Aortic root size	
PRAD	cis	1	rs77853814	chr12:56687572	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs77853814	chr12:56687572	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs77855373	chr1:183598435	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs77855592	chr9:97326741	FAM22F	chr9:97080478-97090926:-	0.43	3.79	0.000173	Height	
PRAD	cis	1	rs778679	chr7:65840911	CCT6P1	chr7:65216092-65228661:+	0.31	5.23	2.57E-7	Diabetic kidney disease	
PRAD	cis	1	rs778679	chr7:65840911	CRCP	chr7:65579805-65619551:+	-0.36	-4.5	8.46E-6	Diabetic kidney disease	
PRAD	cis	1	rs77868187	chr7:1093968	GPR146	chr7:1084243-1098897:+	0.29	3.85	0.000135	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs77868187	chr7:1093968	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.06E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs778685	chr7:65836176	TPST1	chr7:65670259-65825437:+	0.18	4.51	8.35E-6	Aortic root size	
PRAD	cis	1	rs778691	chr7:65873092	CCT6P1	chr7:65216092-65228661:+	0.31	5.22	2.7E-7	Diabetic kidney disease	
PRAD	cis	1	rs778691	chr7:65873092	CRCP	chr7:65579805-65619551:+	-0.36	-4.49	9.17E-6	Diabetic kidney disease	
PRAD	cis	1	rs778694	chr7:65871558	TPST1	chr7:65670259-65825437:+	0.18	4.5	8.62E-6	Aortic root size	
PRAD	cis	1	rs778696	chr7:65870813	TPST1	chr7:65670259-65825437:+	0.18	4.5	8.62E-6	Aortic root size	
PRAD	cis	1	rs778699	chr7:65868290	TPST1	chr7:65670259-65825437:+	0.18	4.46	1.03E-5	Aortic root size	
PRAD	cis	1	rs778704	chr7:65863467	CCT6P1	chr7:65216092-65228661:+	0.31	5.22	2.7E-7	Diabetic kidney disease	
PRAD	cis	1	rs778704	chr7:65863467	CRCP	chr7:65579805-65619551:+	-0.36	-4.49	9.17E-6	Diabetic kidney disease	
PRAD	cis	1	rs778706	chr7:65860424	TPST1	chr7:65670259-65825437:+	0.18	4.46	1.03E-5	Aortic root size	
PRAD	cis	1	rs778710	chr7:65854834	TPST1	chr7:65670259-65825437:+	0.18	4.5	8.62E-6	Aortic root size	
PRAD	cis	1	rs778722	chr7:65844828	TPST1	chr7:65670259-65825437:+	0.18	4.46	1.03E-5	Aortic root size	
PRAD	cis	1	rs7787230	chr7:65629099	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.85	9.2E-9	Diabetic kidney disease	
PRAD	cis	1	rs7787230	chr7:65629099	CRCP	chr7:65579805-65619551:+	0.32	3.94	9.21E-5	Diabetic kidney disease	
PRAD	cis	1	rs778726	chr7:65828731	TPST1	chr7:65670259-65825437:+	0.18	4.51	8.35E-6	Aortic root size	
PRAD	cis	1	rs7787274	chr7:2275993	FTSJ2	chr7:2273928-2281833:-	0.34	7.36	8.25E-13	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
PRAD	cis	1	rs778729	chr7:65824419	CCT6P1	chr7:65216092-65228661:+	0.31	5.23	2.57E-7	Diabetic kidney disease	
PRAD	cis	1	rs778729	chr7:65824419	CRCP	chr7:65579805-65619551:+	-0.36	-4.5	8.46E-6	Diabetic kidney disease	
PRAD	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.24	-9.72	1.73E-20	Tuberculosis	
PRAD	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.53	10.48	3.03E-23	Tuberculosis	
PRAD	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.24	-9.81	8.29E-21	Tuberculosis	
PRAD	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.53	10.55	1.76E-23	Tuberculosis	
PRAD	cis	1	rs778762	chr2:61782921	PUS10	chr2:61167550-61245365:-	-0.17	-3.5	0.000503	Tuberculosis	
PRAD	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.24	-9.83	7.48E-21	Tuberculosis	
PRAD	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.52	10.4	6.17E-23	Tuberculosis	
PRAD	cis	1	rs778763	chr2:61785639	PUS10	chr2:61167550-61245365:-	-0.17	-3.56	0.000409	Tuberculosis	
PRAD	cis	1	rs77876414	chr6:159414811	RSPH3	chr6:159398268-159421198:-	0.29	4.57	6.35E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs77882972	chr1:183609281	NCF2	chr1:183524698-183560046:-	0.27	3.81	0.000159	Systemic lupus erythematosus	
PRAD	cis	1	rs7788576	chr7:66148302	CRCP	chr7:65579805-65619551:+	0.2	3.74	0.000206	Aortic root size	
PRAD	cis	1	rs7788576	chr7:66148302	LOC493754	chr7:65993446-66057363:-	0.22	5.13	4.16E-7	Aortic root size	
PRAD	cis	1	rs7788576	chr7:66148302	TPST1	chr7:65670259-65825437:+	-0.15	-3.74	0.000203	Aortic root size	
PRAD	cis	1	rs7789184	chr7:66210195	CRCP	chr7:65579805-65619551:+	-0.21	-3.98	8.04E-5	Aortic root size	
PRAD	cis	1	rs7789184	chr7:66210195	LOC493754	chr7:65993446-66057363:-	-0.24	-5.5	6.19E-8	Aortic root size	
PRAD	cis	1	rs7789184	chr7:66210195	TPST1	chr7:65670259-65825437:+	0.15	3.56	0.000404	Aortic root size	
PRAD	cis	1	rs7789554	chr7:65946038	TPST1	chr7:65670259-65825437:+	0.18	4.4	1.32E-5	Aortic root size	
PRAD	cis	1	rs7789768	chr7:65938980	TPST1	chr7:65670259-65825437:+	0.18	4.4	1.32E-5	Aortic root size	
PRAD	cis	1	rs7789940	chr7:75951230	SRCRB4D	chr7:76018647-76039012:-	0.22	4.39	1.4E-5	Multiple sclerosis	
PRAD	cis	1	rs7789940	chr7:75951230	UPK3B	chr7:76139745-76157197:+	-0.28	-4.92	1.19E-6	Multiple sclerosis	
PRAD	cis	1	rs77902909	chr6:24478715	GPLD1	chr6:24428405-24489850:-	0.57	10.17	4.37E-22	Hematological and biochemical traits	
PRAD	cis	1	rs77902909	chr6:24478715	MRS2	chr6:24403153-24425809:+	0.3	4.19	3.37E-5	Hematological and biochemical traits	
PRAD	cis	1	rs7792262	chr7:23915743	C7orf46	chr7:23719749-23742268:+	-0.22	-5.66	2.61E-8	Schizophrenia	
PRAD	cis	1	rs7792391	chr7:65773429	CCT6P1	chr7:65216092-65228661:+	-0.33	-5.52	5.68E-8	Diabetic kidney disease	
PRAD	cis	1	rs7792391	chr7:65773429	CRCP	chr7:65579805-65619551:+	0.35	4.28	2.31E-5	Diabetic kidney disease	
PRAD	cis	1	rs7792762	chr7:66004138	TPST1	chr7:65670259-65825437:+	0.18	4.43	1.15E-5	Aortic root size	
PRAD	cis	1	rs7792939	chr7:99207876	ZNF655	chr7:99156045-99174074:+	-0.25	-3.53	0.000462	Anthropometric traits	
PRAD	cis	1	rs77931721	chr2:203763076	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs7794279	chr7:3341806	CARD11	chr7:2945769-3083579:-	-0.08	-3.54	0.000433	Motion sickness	
PRAD	cis	1	rs7794661	chr7:65389730	CCT6P1	chr7:65216092-65228661:+	0.32	5.66	2.69E-8	Diabetic kidney disease	
PRAD	cis	1	rs7794661	chr7:65389730	CRCP	chr7:65579805-65619551:+	-0.28	-3.62	0.000326	Diabetic kidney disease	
PRAD	cis	1	rs7795242	chr7:65390094	CCT6P1	chr7:65216092-65228661:+	0.3	5.31	1.65E-7	Diabetic kidney disease	
PRAD	cis	1	rs7795242	chr7:65390094	CRCP	chr7:65579805-65619551:+	-0.27	-3.54	0.000439	Diabetic kidney disease	
PRAD	cis	1	rs7795242	chr7:65390094	ZNF117	chr7:64434830-64467121:-	-0.27	-3.43	0.000659	Diabetic kidney disease	
PRAD	cis	1	rs77956314	chr12:117323367	FBXW8	chr12:117348761-117470180:+	-0.53	-5.77	1.45E-8	Subcortical brain region volumes	
PRAD	cis	1	rs77957229	chr6:26185226	HIST1H3E	chr6:26224427-26226589:+	0.33	4.95	1.03E-6	Renal underexcretion gout;Gout	
PRAD	cis	1	rs77961951	chr6:26186075	HIST1H2AE	chr6:26217148-26217711:+	-0.25	-3.45	0.00062	Renal underexcretion gout;Gout	
PRAD	cis	1	rs77961951	chr6:26186075	HIST1H3E	chr6:26224427-26226589:+	0.33	4.97	9.38E-7	Renal underexcretion gout;Gout	
PRAD	cis	1	rs77965541	chr14:52876841	TXNDC16	chr14:52897309-53019301:-	-0.3	-4.08	5.38E-5	Smooth-surface caries	
PRAD	cis	1	rs78012445	chr6:26195080	HIST1H2AE	chr6:26217148-26217711:+	-0.25	-3.62	0.000322	Renal underexcretion gout;Gout	
PRAD	cis	1	rs78012445	chr6:26195080	HIST1H3E	chr6:26224427-26226589:+	0.36	5.75	1.63E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs7801282	chr7:65613687	TPST1	chr7:65670259-65825437:+	-0.18	-4.47	1.0E-5	Aortic root size	
PRAD	cis	1	rs78012987	chr1:183598625	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs78032828	chr2:86309032	LOC90784	chr2:86247339-86250991:-	-0.51	-4.53	7.6E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs7804223	chr7:65664559	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs7804223	chr7:65664559	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs78055011	chr20:33618606	MMP24	chr20:33814539-33864804:+	-0.31	-4.75	2.69E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7810970	chr7:2276385	FTSJ2	chr7:2273928-2281833:-	0.34	7.32	1.07E-12	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
PRAD	cis	1	rs781142	chr7:65438778	CCT6P1	chr7:65216092-65228661:+	0.29	5.11	4.73E-7	Diabetic kidney disease	
PRAD	cis	1	rs781142	chr7:65438778	CRCP	chr7:65579805-65619551:+	-0.31	-3.99	7.51E-5	Diabetic kidney disease	
PRAD	cis	1	rs781149	chr7:65481284	CCT6P1	chr7:65216092-65228661:+	0.28	4.97	9.54E-7	Diabetic kidney disease	
PRAD	cis	1	rs781149	chr7:65481284	CRCP	chr7:65579805-65619551:+	-0.31	-4.04	6.36E-5	Diabetic kidney disease	
PRAD	cis	1	rs781150	chr7:65480973	CCT6P1	chr7:65216092-65228661:+	0.33	5.66	2.68E-8	Diabetic kidney disease	
PRAD	cis	1	rs781150	chr7:65480973	CRCP	chr7:65579805-65619551:+	-0.32	-4	7.44E-5	Diabetic kidney disease	
PRAD	cis	1	rs781156	chr7:65479141	CCT6P1	chr7:65216092-65228661:+	0.3	5.24	2.43E-7	Diabetic kidney disease	
PRAD	cis	1	rs781156	chr7:65479141	CRCP	chr7:65579805-65619551:+	-0.31	-4.03	6.49E-5	Diabetic kidney disease	
PRAD	cis	1	rs781157	chr7:65478311	CCT6P1	chr7:65216092-65228661:+	0.28	4.97	9.54E-7	Diabetic kidney disease	
PRAD	cis	1	rs781157	chr7:65478311	CRCP	chr7:65579805-65619551:+	-0.31	-4.04	6.36E-5	Diabetic kidney disease	
PRAD	cis	1	rs78121408	chr12:56684798	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs78121408	chr12:56684798	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs7812184	chr7:38831628	FAM183B	chr7:38724947-38726689:-	0.36	3.51	0.000486	Cognitive performance	
PRAD	cis	1	rs78124692	chr3:46202237	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs7812644	chr8:65681616	BHLHE22	chr8:65492814-65496185:+	0.27	5.19	3.06E-7	HIV-1 susceptibility	
PRAD	cis	1	rs78134907	chr10:103652875	KCNIP2	chr10:103585732-103603677:-	0.26	3.7	0.000238	Coronary artery calcification	
PRAD	cis	1	rs78142636	chr10:103601727	KCNIP2	chr10:103585732-103603677:-	0.27	3.96	8.53E-5	Coronary artery calcification	
PRAD	cis	1	rs78143408	chr7:1096846	GPR146	chr7:1084243-1098897:+	0.29	3.85	0.000135	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78143408	chr7:1096846	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.06E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7814941	chr8:130718859	GSDMC	chr8:130760443-130799134:-	0.2	3.9	0.000109	Infant length;Height	
PRAD	cis	1	rs78149779	chr12:56694817	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs78149779	chr12:56694817	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs7815298	chr8:130732739	GSDMC	chr8:130760443-130799134:-	0.2	3.9	0.000108	Infant length;Height	
PRAD	cis	1	rs78153629	chr15:40673465	C15orf23	chr15:40674922-40686488:+	0.81	12.16	9.15E-30	Heschl's gyrus morphology	
PRAD	cis	1	rs7815827	chr8:27077507	CHRNA2	chr8:27317279-27336813:-	0.17	3.7	0.000242	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs7815827	chr8:27077507	ESCO2	chr8:27632058-27670141:+	0.18	3.59	0.000372	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs7815827	chr8:27077507	SCARA3	chr8:27491577-27534286:+	-0.1	-3.47	0.000561	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs78158942	chr7:1090440	GPR146	chr7:1084243-1098897:+	0.3	4.16	3.85E-5	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78158942	chr7:1090440	INTS1	chr7:1509913-1544018:-	0.19	3.5	0.000519	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78158942	chr7:1090440	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.03	6.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7816131	chr8:130719718	GSDMC	chr8:130760443-130799134:-	0.2	3.9	0.000109	Infant length;Height	
PRAD	cis	1	rs78162577	chr19:10839195	LOC147727	chr19:10762539-10764548:-	0.27	3.53	0.000459	LDL cholesterol	
PRAD	cis	1	rs78172786	chr17:61847114	DDX42	chr17:61851567-61896676:+	-0.27	-5.42	9.39E-8	Body mass index	
PRAD	cis	1	rs78172786	chr17:61847114	FTSJ3	chr17:61896795-61905031:-	0.34	6.67	7.24E-11	Body mass index	
PRAD	cis	1	rs78172786	chr17:61847114	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.11	4.65E-5	Body mass index	
PRAD	cis	1	rs78185558	chr7:1090183	GPR146	chr7:1084243-1098897:+	0.26	3.56	0.000413	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78185558	chr7:1090183	ZFAND2A	chr7:1192544-1199855:-	-0.33	-4.94	1.11E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78185801	chr7:1096367	GPR146	chr7:1084243-1098897:+	0.29	3.85	0.000135	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78185801	chr7:1096367	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.06E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7818688	chr8:96024082	C8orf38	chr8:95908040-96088396:+	-0.35	-6.2	1.24E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs7818688	chr8:96024082	TP53INP1	chr8:95938201-95961615:-	0.23	3.66	0.000279	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs7819570	chr8:89588626	MMP16	chr8:89049462-89339717:-	0.15	3.55	0.000431	Schizophrenia	
PRAD	cis	1	rs78202808	chr20:33667424	MMP24	chr20:33814539-33864804:+	-0.23	-3.87	0.000124	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs78207779	chr14:35506387	PPP2R3C	chr14:35554679-35591679:-	0.31	4.7	3.35E-6	Atopic dermatitis	
PRAD	cis	1	rs78209243	chr1:183633664	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs78210154	chr11:96109480	CCDC82	chr11:96085930-96123083:-	-0.23	-3.62	0.000329	Parkinson's disease	
PRAD	cis	1	rs7821416	chr8:120657392	DSCC1	chr8:120846182-120868170:-	-0.28	-4.2	3.16E-5	Height	
PRAD	cis	1	rs78220003	chr10:45988348	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs7822232	chr8:145145687	EXOSC4	chr8:145133522-145135550:+	-0.18	-3.72	0.000227	Blood metabolite levels	
PRAD	cis	1	rs7822232	chr8:145145687	KIAA1875	chr8:145162629-145173218:+	-0.31	-6.13	1.91E-9	Blood metabolite levels	
PRAD	cis	1	rs7824557	chr8:11104111	AMAC1L2	chr8:11188495-11189695:+	0.2	3.43	0.000655	Retinal vascular caliber	
PRAD	cis	1	rs7824557	chr8:11104111	TDH	chr8:11197146-11225961:+	0.2	3.73	0.000211	Retinal vascular caliber	
PRAD	cis	1	rs78246812	chr3:184761338	C3orf70	chr3:184795840-184870802:-	-0.17	-3.82	0.000151	Heschl's gyrus morphology	
PRAD	cis	1	rs78246812	chr3:184761338	VPS8	chr3:184529931-184770402:+	-0.34	-4.23	2.83E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs78249279	chr4:154718783	RNF175	chr4:154631313-154681387:-	-0.18	-4.43	1.15E-5	Electrocardiographic conduction measures	
PRAD	cis	1	rs7826493	chr8:130738972	GSDMC	chr8:130760443-130799134:-	0.19	3.64	0.000305	Infant length;Height	
PRAD	cis	1	rs7826501	chr8:65676291	BHLHE22	chr8:65492814-65496185:+	0.28	5.33	1.57E-7	HIV-1 susceptibility	
PRAD	cis	1	rs78267272	chr2:17790782	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.09E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs78308415	chr7:1072634	GPR146	chr7:1084243-1098897:+	0.27	3.62	0.000328	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78308415	chr7:1072634	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.05	6.4E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78324977	chr1:183598882	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs7832570	chr8:96023795	C8orf38	chr8:95908040-96088396:+	-0.35	-6.12	1.94E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs7832570	chr8:96023795	TP53INP1	chr8:95938201-95961615:-	0.23	3.6	0.000351	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs78343340	chr4:267437	ZNF718	chr4:53272-156488:+	0.33	5.49	6.61E-8	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs78343928	chr1:183598832	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs783531	chr15:83249119	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.12	-4.01	6.94E-5	Schizophrenia	
PRAD	cis	1	rs783531	chr15:83249119	LOC80154	chr15:82944795-82975797:+;chr15	0.18	3.67	0.000275	Schizophrenia	
PRAD	cis	1	rs783540	chr15:83254708	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.13	4.51	8.1E-6	Schizophrenia	
PRAD	cis	1	rs783540	chr15:83254708	LOC80154	chr15:82944795-82975797:+;chr15	-0.17	-3.53	0.000451	Schizophrenia	
PRAD	cis	1	rs78362565	chr5:115564293	COMMD10	chr5:115420727-115628978:+	0.3	3.79	0.00017	Asthma or chronic obstructive pulmonary disease	
PRAD	cis	1	rs78363416	chr10:46046134	MARCH8	chr10:45952817-46090354:-	0.25	5.51	5.85E-8	Red blood cell traits	
PRAD	cis	1	rs78378661	chr6:41337948	MDFI	chr6:41604930-41621981:+	0.4	4.19	3.3E-5	Alzheimer's disease biomarkers	
PRAD	cis	1	rs7838490	chr8:89585048	MMP16	chr8:89049462-89339717:-	0.14	3.5	0.000513	Body mass index and cholesterol (psychopharmacological treatment)	
PRAD	cis	1	rs7841833	chr8:26886807	ESCO2	chr8:27632058-27670141:+	0.23	3.46	0.000584	Epilepsy and lamotrigine-induced maculopapular eruptions	
PRAD	cis	1	rs7841981	chr8:130735330	GSDMC	chr8:130760443-130799134:-	0.2	3.9	0.000108	Infant length;Height	
PRAD	cis	1	rs78420872	chr6:24464429	GPLD1	chr6:24428405-24489850:-	0.57	10.28	1.71E-22	Hematological and biochemical traits	
PRAD	cis	1	rs78420872	chr6:24464429	MRS2	chr6:24403153-24425809:+	0.31	4.41	1.28E-5	Hematological and biochemical traits	
PRAD	cis	1	rs78431982	chr11:96105659	CCDC82	chr11:96085930-96123083:-	-0.24	-3.89	0.000115	Parkinson's disease	
PRAD	cis	1	rs78472555	chr15:100267322	LYSMD4	chr15:100255906-100273626:-	0.17	4.48	9.4E-6	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs7849160	chr9:131874552	CRAT	chr9:131857075-131873070:-	0.22	4.2	3.16E-5	Blood metabolite ratios	
PRAD	cis	1	rs7849270	chr9:131874641	CRAT	chr9:131857075-131873070:-	0.22	4.07	5.63E-5	Blood metabolite ratios	
PRAD	cis	1	rs78495928	chr12:56635080	COQ10A	chr12:56660642-56664748:+	-0.36	-3.53	0.000459	Psoriasis vulgaris	
PRAD	cis	1	rs78495928	chr12:56635080	MIP	chr12:56843885-56848429:-	0.69	5.1	5.05E-7	Psoriasis vulgaris	
PRAD	cis	1	rs7850311	chr9:38060968	DCAF10	chr9:37800551-37867663:+	-0.16	-4.64	4.5E-6	Brain structure	
PRAD	cis	1	rs7850311	chr9:38060968	MCART1	chr9:37877572-37904350:-	-0.19	-3.92	0.0001	Brain structure	
PRAD	cis	1	rs78503512	chr1:183643289	NCF2	chr1:183524698-183560046:-	0.25	3.73	0.000218	Systemic lupus erythematosus	
PRAD	cis	1	rs78520676	chr11:517173	ANO9	chr11:417930-442011:-	0.25	3.96	8.82E-5	Body mass index	
PRAD	cis	1	rs78520676	chr11:517173	LRRC56	chr11:537522-554915:+	0.28	4.27	2.35E-5	Body mass index	
PRAD	cis	1	rs78520676	chr11:517173	RNH1	chr11:494512-507273:-	-0.21	-3.8	0.000167	Body mass index	
PRAD	cis	1	rs7852067	chr9:94815594	NFIL3	chr9:94171329-94186144:-	-0.22	-3.61	0.000345	Bipolar disorder and schizophrenia	
PRAD	cis	1	rs78523927	chr7:1089458	GPR146	chr7:1084243-1098897:+	0.27	3.68	0.000262	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78523927	chr7:1089458	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.16	3.66E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78535748	chr1:183620483	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs785464	chr1:46523089	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.33	1.87E-30	Body mass index	
PRAD	cis	1	rs785464	chr1:46523089	MMACHC	chr1:45965856-45976737:+	-0.17	-3.96	8.74E-5	Body mass index	
PRAD	cis	1	rs785464	chr1:46523089	MUTYH	chr1:45794915-45806142:-	0.19	5.64	2.98E-8	Body mass index	
PRAD	cis	1	rs785471	chr1:46518677	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.04	2.63E-29	Body mass index	
PRAD	cis	1	rs785471	chr1:46518677	MMACHC	chr1:45965856-45976737:+	-0.17	-3.76	0.000193	Body mass index	
PRAD	cis	1	rs785471	chr1:46518677	MUTYH	chr1:45794915-45806142:-	0.2	5.8	1.23E-8	Body mass index	
PRAD	cis	1	rs785479	chr1:46492144	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.09	1.66E-29	Body mass index	
PRAD	cis	1	rs785479	chr1:46492144	MMACHC	chr1:45965856-45976737:+	-0.17	-3.71	0.00023	Body mass index	
PRAD	cis	1	rs785479	chr1:46492144	MUTYH	chr1:45794915-45806142:-	0.21	6.05	2.89E-9	Body mass index	
PRAD	cis	1	rs785481	chr1:46554518	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.25	3.85E-30	Body mass index	
PRAD	cis	1	rs785481	chr1:46554518	MMACHC	chr1:45965856-45976737:+	-0.17	-3.9	0.000112	Body mass index	
PRAD	cis	1	rs785481	chr1:46554518	MUTYH	chr1:45794915-45806142:-	0.2	5.78	1.39E-8	Body mass index	
PRAD	cis	1	rs785485	chr1:46574424	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.26	3.55E-30	Body mass index	
PRAD	cis	1	rs785485	chr1:46574424	MMACHC	chr1:45965856-45976737:+	-0.17	-3.9	0.00011	Body mass index	
PRAD	cis	1	rs785485	chr1:46574424	MUTYH	chr1:45794915-45806142:-	0.2	5.77	1.43E-8	Body mass index	
PRAD	cis	1	rs785488	chr1:46576095	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.26	3.54E-30	Body mass index	
PRAD	cis	1	rs785488	chr1:46576095	MMACHC	chr1:45965856-45976737:+	-0.17	-3.9	0.00011	Body mass index	
PRAD	cis	1	rs785488	chr1:46576095	MUTYH	chr1:45794915-45806142:-	0.2	5.79	1.32E-8	Body mass index	
PRAD	cis	1	rs785489	chr1:46576390	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.26	3.54E-30	Body mass index	
PRAD	cis	1	rs785489	chr1:46576390	MMACHC	chr1:45965856-45976737:+	-0.17	-3.9	0.00011	Body mass index	
PRAD	cis	1	rs785489	chr1:46576390	MUTYH	chr1:45794915-45806142:-	0.2	5.79	1.32E-8	Body mass index	
PRAD	cis	1	rs785491	chr1:46583418	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.27	3.31E-30	Body mass index	
PRAD	cis	1	rs785491	chr1:46583418	MMACHC	chr1:45965856-45976737:+	-0.17	-3.91	0.000107	Body mass index	
PRAD	cis	1	rs785491	chr1:46583418	MUTYH	chr1:45794915-45806142:-	0.2	5.77	1.45E-8	Body mass index	
PRAD	cis	1	rs785492	chr1:46583607	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.91	9.5E-29	Body mass index	
PRAD	cis	1	rs785492	chr1:46583607	MMACHC	chr1:45965856-45976737:+	-0.16	-3.7	0.000237	Body mass index	
PRAD	cis	1	rs785492	chr1:46583607	MUTYH	chr1:45794915-45806142:-	0.2	5.89	7.45E-9	Body mass index	
PRAD	cis	1	rs785494	chr1:46586626	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.21	5.86E-30	Body mass index	
PRAD	cis	1	rs785494	chr1:46586626	MMACHC	chr1:45965856-45976737:+	-0.17	-3.9	0.00011	Body mass index	
PRAD	cis	1	rs785494	chr1:46586626	MUTYH	chr1:45794915-45806142:-	0.19	5.61	3.54E-8	Body mass index	
PRAD	cis	1	rs785495	chr1:46587887	CCDC163P	chr1:45960581-45965646:-	-0.52	-11.77	3.24E-28	Body mass index	
PRAD	cis	1	rs785495	chr1:46587887	MMACHC	chr1:45965856-45976737:+	-0.16	-3.51	0.00049	Body mass index	
PRAD	cis	1	rs785495	chr1:46587887	MUTYH	chr1:45794915-45806142:-	0.21	5.99	4.09E-9	Body mass index	
PRAD	cis	1	rs785503	chr1:46595868	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.27	3.31E-30	Body mass index	
PRAD	cis	1	rs785503	chr1:46595868	MMACHC	chr1:45965856-45976737:+	-0.17	-3.91	0.000107	Body mass index	
PRAD	cis	1	rs785503	chr1:46595868	MUTYH	chr1:45794915-45806142:-	0.2	5.77	1.45E-8	Body mass index	
PRAD	cis	1	rs785520	chr1:46568836	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.26	3.54E-30	Body mass index	
PRAD	cis	1	rs785520	chr1:46568836	MMACHC	chr1:45965856-45976737:+	-0.17	-3.9	0.00011	Body mass index	
PRAD	cis	1	rs785520	chr1:46568836	MUTYH	chr1:45794915-45806142:-	0.2	5.79	1.32E-8	Body mass index	
PRAD	cis	1	rs78552657	chr6:159417840	RSPH3	chr6:159398268-159421198:-	0.29	4.56	6.43E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs7855278	chr9:131921365	CRAT	chr9:131857075-131873070:-	-0.22	-4.14	4.19E-5	Blood metabolite ratios	
PRAD	cis	1	rs78581866	chr1:27247566	PIGV	chr1:27114455-27124886:+	-0.38	-4.18	3.51E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs78587942	chr16:68216739	C16orf86	chr16:67700717-67702659:+	-0.31	-4.07	5.41E-5	Crohn's disease	
PRAD	cis	1	rs7859175	chr9:115587160	C9orf80	chr9:115448793-115480387:-	0.31	4.09	5.14E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs7859381	chr9:115546649	C9orf80	chr9:115448793-115480387:-	0.3	4.48	9.19E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs78594996	chr17:40570109	CNTNAP1	chr17:40834632-40852010:+	0.15	4.31	2.0E-5	Crohn's disease	
PRAD	cis	1	rs78594996	chr17:40570109	NAGLU	chr17:40687951-40696464:+	-0.17	-3.92	0.000101	Crohn's disease	
PRAD	cis	1	rs78604110	chr15:40681854	C15orf23	chr15:40674922-40686488:+	0.93	13.37	8.79E-35	Heschl's gyrus morphology	
PRAD	cis	1	rs7861089	chr9:79041902	RFK	chr9:79000433-79009444:-	0.19	3.59	0.000362	Dialysis-related mortality	
PRAD	cis	1	rs7861658	chr9:100679954	C9orf156	chr9:100666772-100684852:-	-0.19	-3.65	0.000288	Quantitative traits	
PRAD	cis	1	rs78620881	chr11:96100517	CCDC82	chr11:96085930-96123083:-	-0.26	-4.03	6.57E-5	Parkinson's disease	
PRAD	cis	1	rs78628466	chr7:1068453	GPR146	chr7:1084243-1098897:+	0.27	3.57	0.000387	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78628466	chr7:1068453	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.15	3.87E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs786425	chr12:124085502	ATP6V0A2	chr12:124196865-124246299:+	-0.22	-4.23	2.83E-5	Pubertal anthropometrics	
PRAD	cis	1	rs786425	chr12:124085502	DDX55	chr12:124086672-124105483:+	0.17	4.26	2.42E-5	Pubertal anthropometrics	
PRAD	cis	1	rs78646493	chr2:86283195	LOC90784	chr2:86247339-86250991:-	-0.56	-4.81	2.08E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs7864754	chr9:139126120	QSOX2	chr9:139098182-139137687:-	0.21	5.39	1.09E-7	Height	
PRAD	cis	1	rs7866350	chr9:100983826	TBC1D2	chr9:100961281-101018003:-	0.2	3.98	7.82E-5	Post-traumatic stress disorder	
PRAD	cis	1	rs78679088	chr21:33910827	TCP10L	chr21:33947152-33957845:-	-0.34	-5.29	1.84E-7	Gastritis	
PRAD	cis	1	rs7867960	chr9:101761716	COL15A1	chr9:101706138-101833068:+	0.1	4.09	5.1E-5	Epithelial ovarian cancer	
PRAD	cis	1	rs7868408	chr9:131917864	CRAT	chr9:131857075-131873070:-	0.22	4.04	6.21E-5	Blood metabolite ratios	
PRAD	cis	1	rs7868830	chr9:115577125	C9orf80	chr9:115448793-115480387:-	0.3	4.53	7.44E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs786961	chr9:115471346	C9orf80	chr9:115448793-115480387:-	-0.3	-3.87	0.000123	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs7869804	chr9:131913144	CRAT	chr9:131857075-131873070:-	0.22	4.2	3.14E-5	Blood metabolite ratios	
PRAD	cis	1	rs7870657	chr9:71724126	TJP2	chr9:71736224-71870118:+	-0.21	-4.55	6.88E-6	Seasonality	
PRAD	cis	1	rs78714242	chr1:183609310	NCF2	chr1:183524698-183560046:-	0.27	3.81	0.000159	Systemic lupus erythematosus	
PRAD	cis	1	rs78724141	chr8:82659661	CHMP4C	chr8:82644688-82671746:+	-0.95	-13.21	4.08E-34	Epithelial ovarian cancer;Ovarian cancer	
PRAD	cis	1	rs787271	chr9:115549463	C9orf80	chr9:115448793-115480387:-	0.25	4.24	2.73E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787272	chr9:115549547	C9orf80	chr9:115448793-115480387:-	-0.25	-3.94	9.42E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787274	chr9:115550363	C9orf80	chr9:115448793-115480387:-	0.3	4.55	6.73E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787275	chr9:115550523	C9orf80	chr9:115448793-115480387:-	0.3	4.55	6.73E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787276	chr9:115551891	C9orf80	chr9:115448793-115480387:-	0.27	4.32	1.92E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787278	chr9:115473531	C9orf80	chr9:115448793-115480387:-	-0.3	-3.87	0.000123	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787280	chr9:115539085	C9orf80	chr9:115448793-115480387:-	0.25	3.9	0.000112	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787285	chr9:115536743	C9orf80	chr9:115448793-115480387:-	0.28	3.68	0.000263	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787286	chr9:115534336	C9orf80	chr9:115448793-115480387:-	0.28	3.68	0.000263	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787291	chr9:115507904	C9orf80	chr9:115448793-115480387:-	-0.29	-3.79	0.000171	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787292	chr9:115508529	C9orf80	chr9:115448793-115480387:-	-0.26	-3.54	0.000441	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787294	chr9:115540424	C9orf80	chr9:115448793-115480387:-	0.28	3.68	0.000263	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787295	chr9:115541606	C9orf80	chr9:115448793-115480387:-	-0.25	-3.96	8.76E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787297	chr9:115542133	C9orf80	chr9:115448793-115480387:-	0.28	4.44	1.13E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787298	chr9:115542206	C9orf80	chr9:115448793-115480387:-	0.27	4.34	1.74E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787301	chr9:115542737	C9orf80	chr9:115448793-115480387:-	-0.23	-3.82	0.000151	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787302	chr9:115543839	C9orf80	chr9:115448793-115480387:-	0.3	3.95	8.85E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs787303	chr9:115491795	C9orf80	chr9:115448793-115480387:-	-0.3	-3.87	0.000126	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs78730917	chr1:183609966	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs7873102	chr9:38041142	DCAF10	chr9:37800551-37867663:+	-0.17	-4.89	1.42E-6	Brain structure	
PRAD	cis	1	rs7873102	chr9:38041142	MCART1	chr9:37877572-37904350:-	-0.17	-3.48	0.000544	Brain structure	
PRAD	cis	1	rs78740005	chr8:82659306	CHMP4C	chr8:82644688-82671746:+	-0.95	-13.33	1.35E-34	Epithelial ovarian cancer;Ovarian cancer	
PRAD	cis	1	rs7877	chr1:171254890	FMO4	chr1:171283486-171311222:+	0.24	4.73	2.99E-6	Sudden cardiac arrest	
PRAD	cis	1	rs78797111	chr2:242056048	PASK	chr2:242045515-242088878:-	0.32	3.9	0.000111	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
PRAD	cis	1	rs78803505	chr7:65382572	CCT6P1	chr7:65216092-65228661:+	0.3	5.31	1.65E-7	Diabetic kidney disease	
PRAD	cis	1	rs78803505	chr7:65382572	CRCP	chr7:65579805-65619551:+	-0.27	-3.54	0.000439	Diabetic kidney disease	
PRAD	cis	1	rs78803505	chr7:65382572	ZNF117	chr7:64434830-64467121:-	-0.27	-3.43	0.000659	Diabetic kidney disease	
PRAD	cis	1	rs78808915	chr6:24481312	GPLD1	chr6:24428405-24489850:-	0.4	8.03	8.09E-15	Hematological and biochemical traits	
PRAD	cis	1	rs78808915	chr6:24481312	MRS2	chr6:24403153-24425809:+	0.25	4	7.39E-5	Hematological and biochemical traits	
PRAD	cis	1	rs78813423	chr15:79231005	CTSH	chr15:79214092-79237420:-	0.43	5.95	5.18E-9	Bipolar disorder	
PRAD	cis	1	rs78836001	chr10:4981992	AKR1C2	chr10:4964715-5060207:-	0.77	10.4	5.95E-23	Height	
PRAD	cis	1	rs78861357	chr7:1095418	GPR146	chr7:1084243-1098897:+	0.29	3.86	0.000128	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78861357	chr7:1095418	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.21	2.77E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78867692	chr17:42263873	DHX8	chr17:41561334-41604166:+	0.28	3.5	0.000508	Glycated hemoglobin levels	
PRAD	cis	1	rs78896566	chr7:1080182	GPR146	chr7:1084243-1098897:+	0.26	3.55	0.000429	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78896566	chr7:1080182	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.22	2.68E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs78913745	chr10:46019911	MARCH8	chr10:45952817-46090354:-	0.25	5.45	7.96E-8	Red blood cell traits	
PRAD	cis	1	rs789208	chr10:105935096	C10orf79	chr10:105889647-105992120:-	0.26	4.6	5.39E-6	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs789213	chr3:128616359	ACAD9	chr3:128598333-128634910:+	0.2	3.71	0.00023	IgG glycosylation	
PRAD	cis	1	rs789227	chr3:128600585	ACAD9	chr3:128598333-128634910:+	-0.2	-3.63	0.000309	IgG glycosylation	
PRAD	cis	1	rs789232	chr3:128603080	ACAD9	chr3:128598333-128634910:+	-0.2	-3.63	0.000309	IgG glycosylation	
PRAD	cis	1	rs789237	chr3:128636961	ACAD9	chr3:128598333-128634910:+	-0.2	-3.62	0.000326	IgG glycosylation	
PRAD	cis	1	rs7893456	chr10:5007862	AKR1C2	chr10:4964715-5060207:-	0.71	9.79	1.0E-20	Height	
PRAD	cis	1	rs7894268	chr10:17199830	TRDMT1	chr10:17184983-17243681:-	-0.26	-5.08	5.45E-7	Homocysteine levels	
PRAD	cis	1	rs78945802	chr6:111728346	KIAA1919	chr6:111580482-111590259:+	0.38	3.99	7.65E-5	Psoriasis	
PRAD	cis	1	rs78953187	chr1:93000574	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs78961715	chr16:68131407	C16orf86	chr16:67700717-67702659:+	-0.34	-4.44	1.1E-5	Crohn's disease	
PRAD	cis	1	rs78962927	chr2:48175452	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.36	-4.27	2.35E-5	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs78967641	chr20:33783053	MMP24	chr20:33814539-33864804:+	-0.29	-4.43	1.15E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs78967811	chr11:67417662	ALDH3B2	chr11:67429634-67448685:-	-0.39	-3.53	0.000458	Serum metabolite levels	
PRAD	cis	1	rs78974622	chr22:38059925	GALR3	chr22:38219389-38221502:+	0.26	4.6	5.53E-6	Fat distribution (HIV)	
PRAD	cis	1	rs78974622	chr22:38059925	LGALS1	chr22:38071613-38075807:+	-0.09	-4.8	2.13E-6	Fat distribution (HIV)	
PRAD	cis	1	rs78974622	chr22:38059925	LGALS2	chr22:37966254-37976024:-	0.17	4.57	6.29E-6	Fat distribution (HIV)	
PRAD	cis	1	rs7898235	chr10:74038181	ASCC1	chr10:73856278-73976892:-	0.2	3.91	0.000107	Heschl's gyrus morphology	
PRAD	cis	1	rs7898235	chr10:74038181	DNAJB12	chr10:74092588-74114907:-	0.2	4.06	5.75E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs78994203	chr11:96123360	CCDC82	chr11:96085930-96123083:-	-0.23	-3.65	0.000292	Parkinson's disease	
PRAD	cis	1	rs789970	chr10:105977721	C10orf79	chr10:105889647-105992120:-	0.24	4.26	2.49E-5	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs79021809	chr9:97322190	FAM22F	chr9:97080478-97090926:-	0.44	3.83	0.000148	Height	
PRAD	cis	1	rs7903456	chr10:88919319	FAM35A	chr10:88854953-88951220:+	-0.18	-3.93	9.67E-5	Renal underexcretion gout;Gout	
PRAD	cis	1	rs79044944	chr15:40676285	C15orf23	chr15:40674922-40686488:+	0.93	13.42	5.35E-35	Heschl's gyrus morphology	
PRAD	cis	1	rs79048371	chr20:33731484	GDF5	chr20:33897002-34042568:-	0.25	3.57	0.000396	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs79048371	chr20:33731484	MMP24	chr20:33814539-33864804:+	-0.31	-4.69	3.54E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7905961	chr10:102297391	SEC31B	chr10:102246403-102289636:-	-0.28	-8.67	6.83E-17	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs7907012	chr10:114468116	VTI1A	chr10:114206756-114578501:+	-0.21	-3.77	0.000181	QRS duration	
PRAD	cis	1	rs7907361	chr10:114468137	VTI1A	chr10:114206756-114578501:+	0.2	3.45	0.000617	QRS duration	
PRAD	cis	1	rs79082707	chr1:183620572	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs7908994	chr10:5008383	AKR1C2	chr10:4964715-5060207:-	0.69	9.5	1.06E-19	Height	
PRAD	cis	1	rs79094565	chr4:154718997	RNF175	chr4:154631313-154681387:-	-0.18	-4.43	1.15E-5	Electrocardiographic conduction measures	
PRAD	cis	1	rs79101914	chr12:56729739	MIP	chr12:56843885-56848429:-	0.77	5.72	1.93E-8	Psoriasis vulgaris	
PRAD	cis	1	rs7910927	chr10:65138910	JMJD1C	chr10:64926990-65225722:-	-0.09	-3.47	0.000572	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7910927	chr10:65138910	NRBF2	chr10:64893007-64914785:+	-0.28	-6.17	1.46E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7912093	chr10:17203934	TRDMT1	chr10:17184983-17243681:-	-0.27	-5.41	9.98E-8	Homocysteine levels	
PRAD	cis	1	rs79123103	chr15:79220567	CTSH	chr15:79214092-79237420:-	0.44	6.06	2.85E-9	Bipolar disorder	
PRAD	cis	1	rs7912631	chr10:101915265	CWF19L1	chr10:101992055-102027437:-	-0.32	-4.1	4.79E-5	Schizophrenia	
PRAD	cis	1	rs7915944	chr10:101942253	CWF19L1	chr10:101992055-102027437:-	-0.38	-4.71	3.26E-6	Schizophrenia	
PRAD	cis	1	rs7916868	chr10:64988931	JMJD1C	chr10:64926990-65225722:-	-0.1	-3.56	0.000405	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7916868	chr10:64988931	NRBF2	chr10:64893007-64914785:+	-0.29	-6.39	3.94E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7917792	chr10:97365627	ENTPD1	chr10:97471536-97637022:+	0.13	3.74	0.000203	Blood metabolite levels	
PRAD	cis	1	rs7917792	chr10:97365627	TCTN3	chr10:97423154-97453900:-	0.21	4.04	6.15E-5	Blood metabolite levels	
PRAD	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.49	11.61	1.46E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs7918678	chr10:90829879	IFIT2	chr10:91061706-91069032:+	0.14	3.44	0.000632	Obesity-related traits	
PRAD	cis	1	rs79197732	chr20:33562476	MMP24	chr20:33814539-33864804:+	-0.31	-4.65	4.39E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs79199019	chr14:35581125	PPP2R3C	chr14:35554679-35591679:-	0.37	5.85	9.23E-9	Atopic dermatitis	
PRAD	cis	1	rs79199586	chr11:18452146	GTF2H1	chr11:18343816-18388590:+	-0.28	-3.43	0.000653	Amyotrophic lateral sclerosis (sporadic)	
PRAD	cis	1	rs7921162	chr10:17229004	TRDMT1	chr10:17184983-17243681:-	-0.25	-5.04	6.64E-7	Homocysteine levels	
PRAD	cis	1	rs7921185	chr10:4976430	AKR1C2	chr10:4964715-5060207:-	0.63	8.9	1.21E-17	Height	
PRAD	cis	1	rs7923609	chr10:65133822	JMJD1C	chr10:64926990-65225722:-	-0.09	-3.46	0.00058	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7923609	chr10:65133822	NRBF2	chr10:64893007-64914785:+	-0.28	-6.16	1.6E-9	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs7925955	chr11:48647533	FOLH1	chr11:49168188-49230222:-	-0.17	-3.88	0.000121	HDL cholesterol	
PRAD	cis	1	rs79264785	chr6:26194121	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.72	0.000223	Renal underexcretion gout;Gout	
PRAD	cis	1	rs79264785	chr6:26194121	HIST1H3E	chr6:26224427-26226589:+	0.36	5.75	1.57E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs79270274	chr16:77777624	NUDT7	chr16:77756411-77776153:+	0.24	3.64	0.000298	Obesity-related traits	
PRAD	cis	1	rs7928083	chr11:48613148	FOLH1	chr11:49168188-49230222:-	-0.15	-3.48	0.000547	HDL cholesterol	
PRAD	cis	1	rs7928758	chr11:134265967	B3GAT1	chr11:134248400-134281812:-	0.37	5.3	1.77E-7	Alcohol consumption (maxi-drinks)	
PRAD	cis	1	rs7930103	chr11:46484254	HARBI1	chr11:46624857-46638777:-	0.26	3.44	0.000642	Schizophrenia	
PRAD	cis	1	rs79318564	chr15:84786150	GOLGA6L5	chr15:85047738-85060078:-	-0.18	-4.67	3.86E-6	Schizophrenia	
PRAD	cis	1	rs79318564	chr15:84786150	LOC388152	chr15:84867600-84898920:-	-0.36	-6.15	1.62E-9	Schizophrenia	
PRAD	cis	1	rs79318564	chr15:84786150	NMB	chr15:85198362-85201802:-	-0.37	-8.18	2.73E-15	Schizophrenia	
PRAD	cis	1	rs79318564	chr15:84786150	WDR73	chr15:85186012-85197524:-	-0.21	-4.44	1.1E-5	Schizophrenia	
PRAD	cis	1	rs7931930	chr11:108268286	ATM	chr11:108093559-108239826:+	-0.16	-4.81	2.07E-6	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs7931984	chr11:48580835	FOLH1	chr11:49168188-49230222:-	-0.16	-3.71	0.00023	HDL cholesterol	
PRAD	cis	1	rs79327308	chr7:1108141	GPR146	chr7:1084243-1098897:+	0.27	3.64	0.000298	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs79327308	chr7:1108141	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.32	1.63E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs79327462	chr16:67958058	C16orf86	chr16:67700717-67702659:+	-0.32	-4.18	3.47E-5	Crohn's disease	
PRAD	cis	1	rs7932813	chr11:7708281	CYB5R2	chr11:7686327-7694994:-	0.19	4.18	3.47E-5	Waist circumference	
PRAD	cis	1	rs79341738	chr20:33702104	MMP24	chr20:33814539-33864804:+	-0.28	-4.38	1.49E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs79357647	chr6:159402432	RSPH3	chr6:159398268-159421198:-	0.3	4.68	3.77E-6	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs7936413	chr11:46393958	HARBI1	chr11:46624857-46638777:-	0.28	3.86	0.000128	Schizophrenia	
PRAD	cis	1	rs79366248	chr4:266659	ZNF718	chr4:53272-156488:+	0.33	5.4	1.04E-7	Immune response to smallpox vaccine (IL-6)	
PRAD	cis	1	rs7937890	chr11:14396485	COPB1	chr11:14479049-14521441:-	0.11	3.64	0.000306	Mitochondrial DNA levels	
PRAD	cis	1	rs7937	chr19:41302706	RAB4B	chr19:41281657-41302847:+	-0.12	-4.04	6.15E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Chronic obstructive pulmonary disease;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs7938380	chr11:64034866	C11orf20	chr11:64067863-64072238:+	-0.38	-5.29	1.86E-7	Mean platelet volume	
PRAD	cis	1	rs7938880	chr11:48642154	FOLH1	chr11:49168188-49230222:-	-0.16	-3.77	0.000186	HDL cholesterol	
PRAD	cis	1	rs7938960	chr11:46877082	ARHGAP1	chr11:46698634-46722120:-	-0.26	-3.84	0.000138	Schizophrenia	
PRAD	cis	1	rs7939107	chr11:64034773	C11orf20	chr11:64067863-64072238:+	-0.38	-5.29	1.86E-7	Mean platelet volume	
PRAD	cis	1	rs7939352	chr11:78003151	GAB2	chr11:77926343-78128766:-	-0.18	-5.99	4.08E-9	Testicular germ cell tumor	
PRAD	cis	1	rs7939352	chr11:78003151	NARS2	chr11:78147017-78285909:-	-0.25	-5.38	1.16E-7	Testicular germ cell tumor	
PRAD	cis	1	rs79396265	chr8:96071272	C8orf38	chr8:95908040-96088396:+	-0.37	-6.16	1.6E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs79396265	chr8:96071272	TP53INP1	chr8:95938201-95961615:-	0.26	3.93	9.9E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs7939646	chr11:78111613	GAB2	chr11:77926343-78128766:-	0.18	6.17	1.46E-9	Testicular germ cell tumor	
PRAD	cis	1	rs7939646	chr11:78111613	NARS2	chr11:78147017-78285909:-	0.2	4.3	2.11E-5	Testicular germ cell tumor	
PRAD	cis	1	rs7940310	chr11:117024481	PCSK7	chr11:117075789-117102811:-	-0.37	-5.01	7.86E-7	Protein quantitative trait loci	
PRAD	cis	1	rs7940554	chr11:118142930	MPZL2	chr11:118124135-118135009:-	0.1	3.54	0.000435	Pain	
PRAD	cis	1	rs7940554	chr11:118142930	MPZL3	chr11:118100337-118123011:-	0.14	4.79	2.25E-6	Pain	
PRAD	cis	1	rs7940554	chr11:118142930	NLRX1	chr11:119039437-119054723:+	0.17	3.78	0.000174	Pain	
PRAD	cis	1	rs7940554	chr11:118142930	SCN2B	chr11:118033519-118047337:-	-0.11	-3.89	0.000117	Pain	
PRAD	cis	1	rs7941030	chr11:122522375	LOC399959	chr11:121959811-122238467:-	0.09	4.37	1.5E-5	HDL cholesterol;Cholesterol, total	
PRAD	cis	1	rs79412014	chr4:106755444	INTS12	chr4:106603787-106629881:-	-0.76	-7.73	6.44E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs7941617	chr11:78021146	GAB2	chr11:77926343-78128766:-	-0.18	-5.95	5.32E-9	Testicular germ cell tumor	
PRAD	cis	1	rs7941617	chr11:78021146	NARS2	chr11:78147017-78285909:-	-0.25	-5.41	1.01E-7	Testicular germ cell tumor	
PRAD	cis	1	rs7941964	chr11:46805575	ARHGAP1	chr11:46698634-46722120:-	0.22	3.86	0.000128	HDL cholesterol	
PRAD	cis	1	rs79422648	chr7:1080241	GPR146	chr7:1084243-1098897:+	0.26	3.55	0.000429	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs79422648	chr7:1080241	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.22	2.68E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7943121	chr11:18656062	SPTY2D1	chr11:18627949-18656020:-	-0.29	-10.65	6.97E-24	Cholesterol, total	
PRAD	cis	1	rs7943165	chr11:108274890	ATM	chr11:108093559-108239826:+	-0.17	-5.33	1.55E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs79433889	chr1:19111355	AKR7A2	chr1:19630459-19638640:-	0.23	3.53	0.000455	Percentage gas trapping	
PRAD	cis	1	rs79433889	chr1:19111355	CAPZB	chr1:19665274-19811992:-	0.26	4.02	6.9E-5	Percentage gas trapping	
PRAD	cis	1	rs79436302	chr14:35578797	PPP2R3C	chr14:35554679-35591679:-	0.37	5.85	9.23E-9	Atopic dermatitis	
PRAD	cis	1	rs79436528	chr12:56686997	COQ10A	chr12:56660642-56664748:+	-0.36	-3.57	0.000394	Psoriasis vulgaris	
PRAD	cis	1	rs79436528	chr12:56686997	MIP	chr12:56843885-56848429:-	0.72	5.37	1.27E-7	Psoriasis vulgaris	
PRAD	cis	1	rs79438986	chr20:33702280	MMP24	chr20:33814539-33864804:+	-0.3	-4.54	7.08E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs79439610	chr20:33654689	MMP24	chr20:33814539-33864804:+	-0.32	-4.78	2.38E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs7944004	chr11:2311152	C11orf21	chr11:2317507-2323143:-	0.15	4.21	3.08E-5	Chronic lymphocytic leukemia	
PRAD	cis	1	rs79440439	chr11:478147	LRRC56	chr11:537522-554915:+	0.29	4.32	1.89E-5	Body mass index	
PRAD	cis	1	rs79440439	chr11:478147	RNH1	chr11:494512-507273:-	-0.21	-3.82	0.000153	Body mass index	
PRAD	cis	1	rs7944109	chr11:5564919	UBQLNL	chr11:5535624-5537956:-	-0.18	-3.77	0.000183	QRS duration in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs79442859	chr5:150171210	LOC134466	chr5:150310000-150326146:-	0.73	9.72	1.74E-20	Crohn's disease	
PRAD	cis	1	rs7944356	chr11:48610154	FOLH1	chr11:49168188-49230222:-	-0.15	-3.48	0.000547	HDL cholesterol	
PRAD	cis	1	rs79443843	chr7:1075245	GPR146	chr7:1084243-1098897:+	0.26	3.52	0.000482	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs79443843	chr7:1075245	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.27	2.05E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7945192	chr11:48580737	FOLH1	chr11:49168188-49230222:-	-0.16	-3.71	0.00023	HDL cholesterol	
PRAD	cis	1	rs7945548	chr11:46900280	ARHGAP1	chr11:46698634-46722120:-	-0.26	-3.84	0.000138	Schizophrenia	
PRAD	cis	1	rs7946955	chr11:108284833	ATM	chr11:108093559-108239826:+	-0.17	-5.2	2.93E-7	Response to metformin in type 2 diabetes (glycemic);Response to metformin	
PRAD	cis	1	rs7947143	chr11:64090422	C11orf20	chr11:64067863-64072238:+	-0.42	-5.88	7.68E-9	Mean platelet volume	
PRAD	cis	1	rs7947378	chr11:18381327	GTF2H1	chr11:18343816-18388590:+	0.74	15.56	2.35E-44	Pancreatic cancer	
PRAD	cis	1	rs79477087	chr11:22116168	ANO5	chr11:22214722-22304913:+	0.24	5.59	3.89E-8	Parkinson's disease	
PRAD	cis	1	rs7948486	chr11:48912140	FOLH1	chr11:49168188-49230222:-	0.17	3.99	7.65E-5	HDL cholesterol	
PRAD	cis	1	rs7949348	chr11:48493801	FOLH1	chr11:49168188-49230222:-	-0.15	-3.45	0.000611	HDL cholesterol	
PRAD	cis	1	rs7949554	chr11:48581992	FOLH1	chr11:49168188-49230222:-	-0.16	-3.68	0.000261	HDL cholesterol	
PRAD	cis	1	rs79508374	chr2:198864568	PLCL1	chr2:198669426-199014606:+	0.15	4.04	6.2E-5	Ulcerative colitis	
PRAD	cis	1	rs79515366	chr10:103582573	KCNIP2	chr10:103585732-103603677:-	0.3	4.24	2.69E-5	Coronary artery calcification	
PRAD	cis	1	rs7951579	chr11:46469900	ARHGAP1	chr11:46698634-46722120:-	-0.2	-3.75	0.0002	Schizophrenia	
PRAD	cis	1	rs7951579	chr11:46469900	HARBI1	chr11:46624857-46638777:-	0.24	3.44	0.000632	Schizophrenia	
PRAD	cis	1	rs7951870	chr11:46373311	HARBI1	chr11:46624857-46638777:-	0.25	3.55	0.000423	Schizophrenia	
PRAD	cis	1	rs79519767	chr1:183598988	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs7953014	chr12:109998097	KCTD10	chr12:109886460-109915155:-	-0.33	-10.07	1.02E-21	HDL cholesterol	
PRAD	cis	1	rs7953014	chr12:109998097	MMAB	chr12:109991523-110011358:-	-0.18	-5.38	1.19E-7	HDL cholesterol	
PRAD	cis	1	rs7953014	chr12:109998097	MYO1H	chr12:109826524-109886176:+	-0.24	-5.4	1.08E-7	HDL cholesterol	
PRAD	cis	1	rs7953014	chr12:109998097	UBE3B	chr12:109915439-109974506:+	-0.14	-3.5	0.000507	HDL cholesterol	
PRAD	cis	1	rs79534455	chr1:183623626	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000226	Systemic lupus erythematosus	
PRAD	cis	1	rs79539678	chr2:203740938	CYP20A1	chr2:204103164-204170562:+	0.33	3.55	0.000426	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
PRAD	cis	1	rs7954144	chr12:110015893	KCTD10	chr12:109886460-109915155:-	-0.34	-10.33	1.12E-22	HDL cholesterol	
PRAD	cis	1	rs7954144	chr12:110015893	MMAB	chr12:109991523-110011358:-	-0.18	-5.6	3.71E-8	HDL cholesterol	
PRAD	cis	1	rs7954144	chr12:110015893	MYO1H	chr12:109826524-109886176:+	-0.24	-5.36	1.31E-7	HDL cholesterol	
PRAD	cis	1	rs7954144	chr12:110015893	UBE3B	chr12:109915439-109974506:+	-0.15	-3.75	0.000198	HDL cholesterol	
PRAD	cis	1	rs7954638	chr12:96314795	AMDHD1	chr12:96337071-96362369:+	0.26	4.67	3.9E-6	Metabolite levels (small molecules and protein measures)	
PRAD	cis	1	rs79546878	chr1:183609492	NCF2	chr1:183524698-183560046:-	0.27	3.81	0.000159	Systemic lupus erythematosus	
PRAD	cis	1	rs795484	chr12:118589862	VSIG10	chr12:118501400-118541810:-	0.18	3.48	0.000556	Morphine dose requirement in tonsillectomy and adenoidectomy surgery	
PRAD	cis	1	rs79548696	chr3:41803385	ULK4	chr3:41288091-42003660:-	0.82	13.21	4.34E-34	Diastolic blood pressure	
PRAD	cis	1	rs79559916	chr2:112665080	MERTK	chr2:112656191-112786945:+	-0.23	-3.95	9.1E-5	Multiple sclerosis	
PRAD	cis	1	rs7956568	chr12:85494454	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.29	2.19E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7956568	chr12:85494454	SLC6A15	chr12:85253269-85306606:-	-0.32	-4.85	1.66E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7956568	chr12:85494454	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.75	1.6E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs79568175	chr1:27038216	PIGV	chr1:27114455-27124886:+	-0.35	-3.98	8.09E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
PRAD	cis	1	rs79571438	chr4:106616198	INTS12	chr4:106603787-106629881:-	-0.79	-7.88	2.34E-14	Post bronchodilator FEV1	
PRAD	cis	1	rs7957213	chr12:42475438	GXYLT1	chr12:42475650-42538673:-	-0.15	-4.01	7.15E-5	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	
PRAD	cis	1	rs79579293	chr14:88822068	SPATA7	chr14:88852012-88904802:+	-0.2	-3.86	0.000131	Coronary artery calcification	
PRAD	cis	1	rs7958691	chr12:124440743	ZNF664	chr12:124457670-124499967:+	-0.14	-3.82	0.000152	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs7958864	chr12:58783716	TSFM	chr12:58176536-58191367:+	-0.19	-3.83	0.000148	Obesity-related traits	
PRAD	cis	1	rs79602855	chr19:50525725	SIGLEC16	chr19:50472912-50479075:+	0.5	4.81	2.03E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs79602855	chr19:50525725	TSKS	chr19:50243012-50266515:-	0.33	3.43	0.00065	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs7960384	chr12:21395908	SLCO1A2	chr12:21417535-21548371:-	0.24	3.56	0.000406	Blood metabolite levels	
PRAD	cis	1	rs7960688	chr12:21395869	SLCO1A2	chr12:21417535-21548371:-	0.24	3.56	0.000406	Blood metabolite levels	
PRAD	cis	1	rs7960884	chr12:31360640	DDX11	chr12:31226779-31257725:+	0.29	4.92	1.18E-6	Systolic blood pressure response to hydrochlorothiazide in hypertension	
PRAD	cis	1	rs7961449	chr12:124437215	ZNF664	chr12:124457670-124499967:+	0.15	3.91	0.000105	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs79617366	chr7:1111958	GPR146	chr7:1084243-1098897:+	0.28	3.73	0.000215	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs79617366	chr7:1111958	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.1E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs79631436	chr16:67728369	C16orf86	chr16:67700717-67702659:+	-0.3	-3.64	0.000304	Crohn's disease	
PRAD	cis	1	rs79633979	chr19:50488612	SIGLEC16	chr19:50472912-50479075:+	0.52	4.96	9.94E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs79633979	chr19:50488612	TSKS	chr19:50243012-50266515:-	0.35	3.53	0.000455	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs7964021	chr12:109997645	KCTD10	chr12:109886460-109915155:-	-0.32	-9.79	1.0E-20	HDL cholesterol	
PRAD	cis	1	rs7964021	chr12:109997645	MMAB	chr12:109991523-110011358:-	-0.17	-5.26	2.15E-7	HDL cholesterol	
PRAD	cis	1	rs7964021	chr12:109997645	MYO1H	chr12:109826524-109886176:+	-0.24	-5.33	1.55E-7	HDL cholesterol	
PRAD	cis	1	rs7964021	chr12:109997645	UBE3B	chr12:109915439-109974506:+	-0.14	-3.43	0.000657	HDL cholesterol	
PRAD	cis	1	rs79643038	chr7:38880129	FAM183B	chr7:38724947-38726689:-	0.4	4.12	4.45E-5	Cognitive performance	
PRAD	cis	1	rs7966221	chr12:93009698	NUDT4	chr12:93771701-93797022:+	0.33	3.6	0.000357	Periodontitis (Mean PAL)	
PRAD	cis	1	rs79674297	chr7:38775085	FAM183B	chr7:38724947-38726689:-	0.36	3.48	0.000554	Cognitive performance	
PRAD	cis	1	rs79683221	chr7:1096139	GPR146	chr7:1084243-1098897:+	0.29	3.86	0.000128	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs79683221	chr7:1096139	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.21	2.77E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs7969523	chr12:123168636	GPR109B	chr12:123199304-123201439:-	0.36	6.18	1.35E-9	Adiponectin levels	
PRAD	cis	1	rs7969761	chr12:355842	CCDC77	chr12:498516-551804:+	0.17	3.59	0.000369	Blood metabolite ratios	
PRAD	cis	1	rs79702597	chr14:35558856	BRMS1L	chr14:36295597-36341168:+	0.18	3.49	0.00053	Atopic dermatitis	
PRAD	cis	1	rs79702597	chr14:35558856	PPP2R3C	chr14:35554679-35591679:-	0.36	5.76	1.52E-8	Atopic dermatitis	
PRAD	cis	1	rs7971436	chr12:93005686	NUDT4	chr12:93771701-93797022:+	0.33	3.62	0.000324	Periodontitis (Mean PAL)	
PRAD	cis	1	rs79716074	chr2:277003	SH3YL1	chr2:218138-264810:-	-0.79	-18.53	5.77E-58	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs79718165	chr12:56644251	COQ10A	chr12:56660642-56664748:+	-0.36	-3.52	0.000468	Psoriasis vulgaris	
PRAD	cis	1	rs79718165	chr12:56644251	MIP	chr12:56843885-56848429:-	0.69	5.1	5.05E-7	Psoriasis vulgaris	
PRAD	cis	1	rs7972422	chr12:85535814	LRRIQ1	chr12:85430099-85638880:+	-0.25	-4.27	2.32E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7972422	chr12:85535814	SLC6A15	chr12:85253269-85306606:-	-0.3	-4.67	3.89E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7972422	chr12:85535814	TSPAN19	chr12:85408095-85430055:-	-0.32	-5.74	1.7E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7972439	chr12:85535851	LRRIQ1	chr12:85430099-85638880:+	-0.24	-3.98	8.02E-5	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7972439	chr12:85535851	SLC6A15	chr12:85253269-85306606:-	-0.32	-4.83	1.81E-6	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7972439	chr12:85535851	TSPAN19	chr12:85408095-85430055:-	-0.31	-5.54	5.14E-8	Bone mineral density (Ward's triangle area)	
PRAD	cis	1	rs7973683	chr12:124449223	ZNF664	chr12:124457670-124499967:+	-0.15	-4.08	5.35E-5	Waist-to-hip ratio adjusted for body mass index	
PRAD	cis	1	rs7973719	chr12:7334813	PEX5	chr12:7341759-7371167:+	0.49	10.1	7.92E-22	IgG glycosylation	
PRAD	cis	1	rs79738251	chr2:17786558	GEN1	chr2:17935162-17966632:+	0.46	5.37	1.23E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs79746696	chr1:183608776	NCF2	chr1:183524698-183560046:-	0.27	3.81	0.000159	Systemic lupus erythematosus	
PRAD	cis	1	rs79750959	chr12:56702012	MIP	chr12:56843885-56848429:-	0.77	5.69	2.28E-8	Psoriasis vulgaris	
PRAD	cis	1	rs79753938	chr1:183623422	NCF2	chr1:183524698-183560046:-	0.27	3.98	8.03E-5	Systemic lupus erythematosus	
PRAD	cis	1	rs79755798	chr2:178675373	PDE11A	chr2:178487979-178973066:-	-0.34	-4.35	1.68E-5	Height	
PRAD	cis	1	rs79765398	chr7:1073764	GPR146	chr7:1084243-1098897:+	0.27	3.62	0.000328	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs79765398	chr7:1073764	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.05	6.4E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs79770253	chr2:17784158	GEN1	chr2:17935162-17966632:+	0.46	5.27	2.04E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs79780973	chr5:150174810	LOC134466	chr5:150310000-150326146:-	0.74	10.17	4.38E-22	Crohn's disease	
PRAD	cis	1	rs7978141	chr12:58756924	TSFM	chr12:58176536-58191367:+	-0.17	-3.45	0.000613	Obesity-related traits	
PRAD	cis	1	rs7979058	chr12:5401450	VWF	chr12:6058040-6233836:-	-0.23	-3.65	0.000288	Neuropathic pain in type 2 diabetes	
PRAD	cis	1	rs7980501	chr12:3912972	C12orf5	chr12:4430359-4469188:+	-0.22	-3.63	0.00031	Cognitive performance	
PRAD	cis	1	rs7980687	chr12:123822711	ABCB9	chr12:123413540-123459752:-	0.26	4.19	3.35E-5	Educational attainment;Height;Head circumference (infant)	
PRAD	cis	1	rs7980687	chr12:123822711	CDK2AP1	chr12:123745542-123756687:-	-0.23	-4.72	3.19E-6	Educational attainment;Height;Head circumference (infant)	
PRAD	cis	1	rs79808876	chr11:465763	ANO9	chr11:417930-442011:-	0.24	3.99	7.58E-5	Body mass index	
PRAD	cis	1	rs79808876	chr11:465763	LRRC56	chr11:537522-554915:+	0.29	4.46	1.02E-5	Body mass index	
PRAD	cis	1	rs79808876	chr11:465763	RNH1	chr11:494512-507273:-	-0.21	-3.9	0.000109	Body mass index	
PRAD	cis	1	rs79818376	chr1:183598452	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs79824801	chr12:56728137	MIP	chr12:56843885-56848429:-	0.77	5.72	1.93E-8	Psoriasis vulgaris	
PRAD	cis	1	rs79825742	chr9:1566638	DMRT3	chr9:976964-991732:+	0.35	3.78	0.00018	Superior frontal gyrus grey matter volume	
PRAD	cis	1	rs79831012	chr10:102237059	SEC31B	chr10:102246403-102289636:-	-0.32	-9.77	1.24E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs79837090	chr4:147506402	ZNF827	chr4:146681892-146859607:-	-0.16	-3.65	0.00029	Heart rate	
PRAD	cis	1	rs79839205	chr10:103628939	KCNIP2	chr10:103585732-103603677:-	0.32	4.24	2.69E-5	Coronary artery calcification	
PRAD	cis	1	rs798412	chr5:130698474	P4HA2	chr5:131528306-131563556:-	-0.22	-3.97	8.47E-5	Life satisfaction	
PRAD	cis	1	rs798415	chr5:130693723	P4HA2	chr5:131528306-131563556:-	-0.22	-3.93	9.69E-5	Life satisfaction	
PRAD	cis	1	rs798416	chr5:130693100	P4HA2	chr5:131528306-131563556:-	-0.22	-3.95	8.93E-5	Life satisfaction	
PRAD	cis	1	rs79846980	chr19:22141343	ZNF257	chr19:22235266-22273901:+	0.39	5.31	1.69E-7	Body mass index (change over time)	
PRAD	cis	1	rs7985	chr22:27066535	CRYBA4	chr22:27017928-27026635:+	-0.27	-5.15	3.81E-7	Electroencephalogram traits	
PRAD	cis	1	rs79868973	chr6:26189312	HIST1H2AE	chr6:26217148-26217711:+	-0.26	-3.83	0.000148	Renal underexcretion gout;Gout	
PRAD	cis	1	rs79868973	chr6:26189312	HIST1H3E	chr6:26224427-26226589:+	0.36	5.77	1.45E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs798719	chr4:1698183	FAM53A	chr4:1641609-1685854:-	-0.48	-8.92	1.01E-17	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs798724	chr4:1704643	FAM53A	chr4:1641609-1685854:-	-0.45	-8.45	3.8E-16	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs798741	chr4:1712413	FAM53A	chr4:1641609-1685854:-	-0.43	-8.09	5.13E-15	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs798744	chr4:1714684	FAM53A	chr4:1641609-1685854:-	-0.48	-8.75	3.73E-17	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs798754	chr4:1720757	FAM53A	chr4:1641609-1685854:-	-0.43	-8.02	8.19E-15	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs798755	chr4:1720824	FAM53A	chr4:1641609-1685854:-	-0.43	-8.15	3.29E-15	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs798756	chr4:1707447	FAM53A	chr4:1641609-1685854:-	-0.45	-8.31	1.02E-15	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs798762	chr4:1731150	FAM53A	chr4:1641609-1685854:-	-0.42	-7.82	3.54E-14	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs798766	chr4:1734239	FAM53A	chr4:1641609-1685854:-	0.45	8.09	5.05E-15	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs798767	chr4:1734281	FAM53A	chr4:1641609-1685854:-	-0.44	-7.93	1.61E-14	Urinary bladder cancer;Bladder cancer	
PRAD	cis	1	rs7988810	chr13:25019096	C1QTNF9	chr13:24553839-24896665:+	-0.21	-4.17	3.57E-5	Obesity-related traits	
PRAD	cis	1	rs7988810	chr13:25019096	LOC374491	chr13:25141011-25171810:+	-0.21	-3.51	0.000492	Obesity-related traits	
PRAD	cis	1	rs7988810	chr13:25019096	PARP4	chr13:24995075-25086948:-	0.19	5.07	5.78E-7	Obesity-related traits	
PRAD	cis	1	rs79888893	chr14:35510676	PPP2R3C	chr14:35554679-35591679:-	0.31	4.7	3.44E-6	Atopic dermatitis	
PRAD	cis	1	rs79919139	chr2:203247509	NOP58	chr2:203130515-203168382:+	0.28	4.53	7.48E-6	Urate levels	
PRAD	cis	1	rs7992643	chr13:100555038	CLYBL	chr13:100258936-100544823:+	-0.28	-5.76	1.53E-8	Attention deficit hyperactivity disorder	
PRAD	cis	1	rs7992980	chr13:33181142	N4BP2L2	chr13:33006930-33112936:-	0.15	3.5	0.000506	Body mass index	
PRAD	cis	1	rs79944554	chr19:56463734	TMEM150B	chr19:55824227-55845416:-	0.31	3.44	0.000642	Immune reponse to smallpox (secreted IFN-alpha);Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
PRAD	cis	1	rs7995669	chr13:36762986	C13orf38	chr13:36801182-36871992:-	0.27	4.41	1.27E-5	Economic and political preferences	
PRAD	cis	1	rs79972507	chr16:68282777	C16orf86	chr16:67700717-67702659:+	-0.3	-3.53	0.000455	Crohn's disease	
PRAD	cis	1	rs79987695	chr3:184535604	VPS8	chr3:184529931-184770402:+	-0.35	-4.32	1.92E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs7999554	chr13:25009769	C1QTNF9	chr13:24553839-24896665:+	-0.21	-4.17	3.69E-5	Obesity-related traits	
PRAD	cis	1	rs7999554	chr13:25009769	LOC374491	chr13:25141011-25171810:+	-0.2	-3.47	0.000569	Obesity-related traits	
PRAD	cis	1	rs7999554	chr13:25009769	PARP4	chr13:24995075-25086948:-	0.19	5.07	5.62E-7	Obesity-related traits	
PRAD	cis	1	rs80007414	chr3:46202238	CCR9	chr3:45928019-45944667:+	0.36	3.83	0.000148	Celiac disease	
PRAD	cis	1	rs80013399	chr1:183598837	NCF2	chr1:183524698-183560046:-	0.25	3.69	0.000246	Systemic lupus erythematosus	
PRAD	cis	1	rs800142	chr11:2385071	C11orf21	chr11:2317507-2323143:-	-0.2	-4.13	4.31E-5	Bacteremia	
PRAD	cis	1	rs800153	chr11:2373515	C11orf21	chr11:2317507-2323143:-	-0.22	-4.48	9.22E-6	Bacteremia	
PRAD	cis	1	rs800156	chr11:2376436	C11orf21	chr11:2317507-2323143:-	-0.22	-4.53	7.65E-6	Bacteremia	
PRAD	cis	1	rs800157	chr11:2376602	C11orf21	chr11:2317507-2323143:-	-0.23	-4.79	2.25E-6	Bacteremia	
PRAD	cis	1	rs800158	chr11:2378447	C11orf21	chr11:2317507-2323143:-	0.22	4.52	7.7E-6	Bacteremia	
PRAD	cis	1	rs800160	chr11:2380134	C11orf21	chr11:2317507-2323143:-	0.2	4.07	5.56E-5	Bacteremia	
PRAD	cis	1	rs8002180	chr13:95922765	ABCC4	chr13:95672084-95953687:-	0.22	5.21	2.84E-7	Blood metabolite levels	
PRAD	cis	1	rs8002861	chr13:44474517	CCDC122	chr13:44410491-44453826:-	-0.3	-5.9	6.99E-9	Leprosy	
PRAD	cis	1	rs800292	chr1:196642233	CFH	chr1:196621008-196716631:+	0.15	3.98	7.83E-5	Circulating myeloperoxidase levels (serum)	
PRAD	cis	1	rs8003061	chr14:81451956	SEL1L	chr14:81939240-82000205:-	0.14	3.6	0.000358	Graves' disease	
PRAD	cis	1	rs80031817	chr7:1096793	GPR146	chr7:1084243-1098897:+	0.29	3.85	0.000135	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs80031817	chr7:1096793	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.06E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs8003506	chr14:75586288	EIF2B2	chr14:75469612-75476292:+	-0.28	-5.64	2.97E-8	Height	
PRAD	cis	1	rs8003506	chr14:75586288	MLH3	chr14:75480467-75518235:-	-0.36	-7.21	2.26E-12	Height	
PRAD	cis	1	rs8004736	chr14:61053061	C14orf39	chr14:60902675-60952764:-	0.57	6.51	1.98E-10	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs8005161	chr14:88472595	GPR65	chr14:88471496-88478414:+	0.15	3.45	0.000616	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	cis	1	rs8005309	chr14:66056508	LOC645431	chr14:65877313-65879335:-	-0.41	-4.17	3.68E-5	Ischemic stroke	
PRAD	cis	1	rs8005447	chr14:56336462	DLGAP5	chr14:55614836-55658396:-	0.13	3.65	0.000286	Body mass index (interaction)	
PRAD	cis	1	rs80056677	chr10:59742569	LOC728640	chr10:60474775-60477291:+	-0.29	-3.61	0.000334	Blood pressure	
PRAD	cis	1	rs8005686	chr14:76633967	ESRRB	chr14:76837690-76968178:+	0.25	3.54	0.000447	Blood pressure	
PRAD	cis	1	rs8006176	chr14:101033288	BEGAIN	chr14:101003486-101036131:-	-0.18	-4.85	1.66E-6	Menarche (age at onset)	
PRAD	cis	1	rs80063229	chr2:48169673	GTF2A1L	chr2:48844948-48960284:+	-0.37	-3.62	0.000328	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs80063229	chr2:48169673	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.37	-4.33	1.85E-5	QT interval in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs8006389	chr14:101033435	BEGAIN	chr14:101003486-101036131:-	-0.16	-4.4	1.33E-5	Menarche (age at onset)	
PRAD	cis	1	rs8006419	chr14:65500735	CHURC1	chr14:65381140-65411309:+	-0.21	-4.81	2.08E-6	Red blood cell traits	
PRAD	cis	1	rs8006543	chr14:101033420	BEGAIN	chr14:101003486-101036131:-	-0.16	-4.4	1.33E-5	Menarche (age at onset)	
PRAD	cis	1	rs80075680	chr5:150223737	C5orf62	chr5:150157867-150176297:+	0.29	3.82	0.00015	Crohn's disease	
PRAD	cis	1	rs80075680	chr5:150223737	LOC134466	chr5:150310000-150326146:-	0.56	8.54	1.86E-16	Crohn's disease	
PRAD	cis	1	rs80076579	chr4:106991115	TBCK	chr4:106967233-107237861:-	0.17	3.7	0.000245	Airflow obstruction	
PRAD	cis	1	rs8008024	chr14:81818492	STON2	chr14:81727000-81893748:-	-0.19	-3.56	0.000406	Night sleep phenotypes	
PRAD	cis	1	rs80080632	chr10:103710001	KCNIP2	chr10:103585732-103603677:-	0.29	4.13	4.37E-5	Coronary artery calcification	
PRAD	cis	1	rs80085676	chr2:242347907	SEPT2	chr2:242254723-242293439:+	0.55	8.38	5.96E-16	Chronic lymphocytic leukemia	
PRAD	cis	1	rs80088736	chr2:112674805	MERTK	chr2:112656191-112786945:+	-0.24	-4.09	4.97E-5	Multiple sclerosis	
PRAD	cis	1	rs80094748	chr7:1103958	GPR146	chr7:1084243-1098897:+	0.28	3.73	0.000215	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs80094748	chr7:1103958	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.1E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs80095925	chr6:26184942	HIST1H3E	chr6:26224427-26226589:+	0.33	4.97	9.6E-7	Renal underexcretion gout;Gout	
PRAD	cis	1	rs8010432	chr14:52881059	TXNDC16	chr14:52897309-53019301:-	-0.31	-4.03	6.4E-5	Smooth-surface caries	
PRAD	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.62	-21.36	3.12E-71	IgG glycosylation	
PRAD	cis	1	rs8010715	chr14:24609147	RNF31	chr14:24616096-24635772:+	0.22	4.57	6.15E-6	IgG glycosylation	
PRAD	cis	1	rs80109502	chr20:33587596	MMP24	chr20:33814539-33864804:+	-0.32	-4.76	2.57E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs80123796	chr3:184739700	VPS8	chr3:184529931-184770402:+	-0.35	-4.32	1.9E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs80133219	chr10:103584701	KCNIP2	chr10:103585732-103603677:-	0.34	4.6	5.5E-6	Coronary artery calcification	
PRAD	cis	1	rs8013540	chr14:35513760	PPP2R3C	chr14:35554679-35591679:-	0.31	4.71	3.32E-6	Atopic dermatitis	
PRAD	cis	1	rs8014170	chr14:50071694	PPIL5	chr14:50065415-50081389:+	-0.21	-3.62	0.000327	Carotid intima media thickness	
PRAD	cis	1	rs8014170	chr14:50071694	RPL36AL	chr14:50085407-50087349:-	0.42	11.77	3.23E-28	Carotid intima media thickness	
PRAD	cis	1	rs8014204	chr14:75322794	RPS6KL1	chr14:75372347-75389958:-	0.28	4.86	1.6E-6	Caffeine consumption	
PRAD	cis	1	rs8014374	chr14:75322914	RPS6KL1	chr14:75372347-75389958:-	-0.27	-4.8	2.14E-6	Caffeine consumption	
PRAD	cis	1	rs8015462	chr14:61046687	C14orf39	chr14:60902675-60952764:-	0.43	5.6	3.72E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs80161161	chr2:17812016	GEN1	chr2:17935162-17966632:+	0.48	5.48	6.95E-8	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs8016947	chr14:35832666	PPP2R3C	chr14:35554679-35591679:-	0.18	3.71	0.00023	Psoriasis	
PRAD	cis	1	rs80170004	chr20:33551462	MMP24	chr20:33814539-33864804:+	-0.3	-4.6	5.46E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs8017642	chr14:75590822	EIF2B2	chr14:75469612-75476292:+	0.25	5.03	6.93E-7	Height	
PRAD	cis	1	rs8017642	chr14:75590822	MLH3	chr14:75480467-75518235:-	0.33	6.62	9.83E-11	Height	
PRAD	cis	1	rs8017980	chr14:102961341	ANKRD9	chr14:102973198-102976128:-	0.17	4.07	5.41E-5	QT interval	
PRAD	cis	1	rs8018909	chr14:65960405	LOC645431	chr14:65877313-65879335:-	-0.44	-4.48	9.29E-6	Ischemic stroke	
PRAD	cis	1	rs8018967	chr14:73976934	HEATR4	chr14:73945193-74025651:-	-0.32	-5.95	5.37E-9	Blood metabolite ratios	
PRAD	cis	1	rs8018979	chr14:104109087	BAG5	chr14:104022889-104029151:-	0.18	3.63	0.000309	Body mass index	
PRAD	cis	1	rs8018979	chr14:104109087	C14orf153	chr14:104029299-104057227:+	0.14	4.25	2.6E-5	Body mass index	
PRAD	cis	1	rs8018979	chr14:104109087	CKB	chr14:103985996-103989170:-	0.22	5	8.07E-7	Body mass index	
PRAD	cis	1	rs8018979	chr14:104109087	KLC1	chr14:104029299-104167887:+	-0.18	-3.73	0.000212	Body mass index	
PRAD	cis	1	rs8018979	chr14:104109087	MARK3	chr14:103851701-103970164:+	0.23	4.81	2.06E-6	Body mass index	
PRAD	cis	1	rs8019491	chr14:66168110	LOC645431	chr14:65877313-65879335:-	-0.42	-4.37	1.55E-5	Ischemic stroke	
PRAD	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.52	4.93	1.12E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs80202648	chr19:50494386	TSKS	chr19:50243012-50266515:-	0.34	3.54	0.000435	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs802070	chr6:49656358	CRISP1	chr6:49801979-49834218:-	0.26	5.47	7.5E-8	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs802070	chr6:49656358	CRISP2	chr6:49660072-49681299:-	0.39	7.39	6.95E-13	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs802070	chr6:49656358	CRISP3	chr6:49695092-49712056:-	0.47	10.27	1.88E-22	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs802070	chr6:49656358	RHAG	chr6:49572893-49604587:-	0.47	8.87	1.57E-17	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs802072	chr6:49656000	CRISP1	chr6:49801979-49834218:-	0.26	5.37	1.21E-7	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs802072	chr6:49656000	CRISP2	chr6:49660072-49681299:-	0.39	7.34	9.19E-13	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs802072	chr6:49656000	CRISP3	chr6:49695092-49712056:-	0.47	10.21	3.17E-22	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs802072	chr6:49656000	RHAG	chr6:49572893-49604587:-	0.46	8.76	3.6E-17	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs802075	chr6:49654166	CRISP1	chr6:49801979-49834218:-	0.26	5.37	1.21E-7	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs802075	chr6:49654166	CRISP2	chr6:49660072-49681299:-	0.37	6.97	1.07E-11	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs802075	chr6:49654166	CRISP3	chr6:49695092-49712056:-	0.46	9.99	1.99E-21	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs802075	chr6:49654166	RHAG	chr6:49572893-49604587:-	0.47	8.81	2.36E-17	Bone mineral density (hip) and age at menarche	
PRAD	cis	1	rs80212261	chr7:1114012	GPR146	chr7:1084243-1098897:+	0.28	3.73	0.000215	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs80212261	chr7:1114012	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.19	3.1E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs8021347	chr14:60952773	C14orf39	chr14:60902675-60952764:-	0.41	5.31	1.67E-7	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs8021348	chr14:60952777	C14orf39	chr14:60902675-60952764:-	0.42	5.49	6.54E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs8021348	chr14:60952777	SIX6	chr14:60975938-60978523:+	0.27	3.49	0.000535	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs8023644	chr15:50937123	SPPL2A	chr15:50999739-51057910:-	0.26	5.35	1.4E-7	QT interval	
PRAD	cis	1	rs8023776	chr15:90897952	ZNF774	chr15:90895477-90904714:+	0.21	4.23	2.84E-5	Rheumatoid arthritis	
PRAD	cis	1	rs8024418	chr15:84586308	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs80245547	chr4:106628955	INTS12	chr4:106603787-106629881:-	-0.79	-8.07	6.06E-15	Post bronchodilator FEV1	
PRAD	cis	1	rs8024628	chr15:84586463	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs8025791	chr15:68210145	PIAS1	chr15:68346572-68480402:+	0.14	4.56	6.55E-6	Cognitive performance	
PRAD	cis	1	rs80259160	chr6:26190199	HIST1H2AE	chr6:26217148-26217711:+	-0.25	-3.62	0.000322	Renal underexcretion gout;Gout	
PRAD	cis	1	rs80259160	chr6:26190199	HIST1H3E	chr6:26224427-26226589:+	0.36	5.75	1.63E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs80260495	chr2:17803101	GEN1	chr2:17935162-17966632:+	0.43	5.07	5.85E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs8026533	chr15:90893228	CRTC3	chr15:91073198-91188576:+	-0.16	-3.65	0.000291	Rheumatoid arthritis	
PRAD	cis	1	rs8026533	chr15:90893228	ZNF774	chr15:90895477-90904714:+	-0.23	-4.62	5.06E-6	Rheumatoid arthritis	
PRAD	cis	1	rs8026800	chr15:52933548	ARPP19	chr15:52839432-52861364:-	0.15	4.01	6.92E-5	Schizophrenia	
PRAD	cis	1	rs80277764	chr20:33739456	MMP24	chr20:33814539-33864804:+	-0.31	-4.57	6.15E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs80280023	chr11:43583301	HSD17B12	chr11:43702143-43878160:+	0.36	3.78	0.000179	Birth length	
PRAD	cis	1	rs8028182	chr15:75718669	MAN2C1	chr15:75648135-75660941:-	0.14	3.5	0.000517	Sudden cardiac arrest	
PRAD	cis	1	rs8028182	chr15:75718669	NEIL1	chr15:75639331-75647586:+	0.13	3.91	0.000105	Sudden cardiac arrest	
PRAD	cis	1	rs80285556	chr19:50540170	SIGLEC16	chr19:50472912-50479075:+	0.38	3.83	0.000146	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs80285556	chr19:50540170	TSKS	chr19:50243012-50266515:-	0.32	3.53	0.000458	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs8029016	chr15:84586464	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs8030379	chr15:84590910	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs80304739	chr2:86142539	REEP1	chr2:86441122-86564777:-	0.4	3.57	0.000395	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
PRAD	cis	1	rs80313145	chr6:26194965	HIST1H2AE	chr6:26217148-26217711:+	-0.28	-3.82	0.000153	Renal underexcretion gout;Gout	
PRAD	cis	1	rs80313145	chr6:26194965	HIST1H3E	chr6:26224427-26226589:+	0.38	5.59	3.81E-8	Renal underexcretion gout;Gout	
PRAD	cis	1	rs80314222	chr19:50525514	SIGLEC16	chr19:50472912-50479075:+	0.5	4.8	2.18E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PRAD	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.87	-18.18	2.7E-56	Type 2 diabetes	
PRAD	cis	1	rs8031576	chr15:90380214	C15orf38	chr15:90443832-90456222:-	0.2	3.76	0.000194	Type 2 diabetes	
PRAD	cis	1	rs80317430	chr12:56727705	MIP	chr12:56843885-56848429:-	0.77	5.72	1.93E-8	Psoriasis vulgaris	
PRAD	cis	1	rs8031948	chr15:78816057	CHRNA3	chr15:78885397-78913322:-	-0.22	-3.82	0.000152	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs8031948	chr15:78816057	CHRNA5	chr15:78857906-78886458:+	-0.19	-3.77	0.000186	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs8032208	chr15:75431245	MPI	chr15:75182410-75190565:+	0.16	3.75	0.000198	Systemic lupus erythematosus and Systemic sclerosis	
PRAD	cis	1	rs8032416	chr15:62409070	C2CD4A	chr15:62359176-62363109:+	0.2	4.02	6.74E-5	Type 2 diabetes	
PRAD	cis	1	rs8032675	chr15:67959464	IQCH	chr15:67547188-67794139:+	0.32	6.49	2.23E-10	Motion sickness	
PRAD	cis	1	rs8033837	chr15:75353975	PPCDC	chr15:75315927-75343066:+	0.14	3.68	0.000256	Blood trace element (Zn levels)	
PRAD	cis	1	rs8033837	chr15:75353975	SCAMP5	chr15:75287901-75313836:+	0.43	7.43	5.2E-13	Blood trace element (Zn levels)	
PRAD	cis	1	rs8033938	chr15:40703114	C15orf23	chr15:40674922-40686488:+	0.96	13.78	1.57E-36	Heschl's gyrus morphology	
PRAD	cis	1	rs8034191	chr15:78806023	CHRNA3	chr15:78885397-78913322:-	-0.27	-4.73	2.95E-6	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs8034191	chr15:78806023	CHRNA5	chr15:78857906-78886458:+	-0.22	-4.54	7.21E-6	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs8034542	chr15:79228371	CTSH	chr15:79214092-79237420:-	0.4	5.69	2.18E-8	Bipolar disorder	
PRAD	cis	1	rs8035326	chr15:68208533	PIAS1	chr15:68346572-68480402:+	-0.14	-4.62	5.06E-6	Cognitive performance	
PRAD	cis	1	rs8035675	chr15:67965581	IQCH	chr15:67547188-67794139:+	0.31	6.3	7.04E-10	Motion sickness	
PRAD	cis	1	rs8036075	chr15:45934921	DUOX1	chr15:45422192-45457774:+	-0.1	-3.44	0.000642	Obesity-related traits	
PRAD	cis	1	rs8036075	chr15:45934921	DUOX2	chr15:45384853-45406359:-	-0.15	-3.67	0.000267	Obesity-related traits	
PRAD	cis	1	rs8036075	chr15:45934921	SPATA5L1	chr15:45694519-45713614:+	0.23	3.45	0.00062	Obesity-related traits	
PRAD	cis	1	rs8036197	chr15:75370232	SCAMP5	chr15:75287901-75313836:+	0.39	6.96	1.14E-11	Blood trace element (Zn levels)	
PRAD	cis	1	rs8036588	chr15:50956834	SPPL2A	chr15:50999739-51057910:-	0.27	5.52	5.76E-8	QT interval	
PRAD	cis	1	rs803688	chr15:83216793	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.13	-4.15	3.95E-5	Schizophrenia	
PRAD	cis	1	rs803688	chr15:83216793	LOC80154	chr15:82944795-82975797:+;chr15	0.18	3.55	0.000425	Schizophrenia	
PRAD	cis	1	rs8038465	chr15:73978337	CD276	chr15:73976622-74006859:+	0.16	3.84	0.000139	Liver enzyme levels (gamma-glutamyl transferase)	
PRAD	cis	1	rs8041056	chr15:84564817	FAM103A1	chr15:83654995-83659423:+	-0.17	-3.61	0.000345	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs8041056	chr15:84564817	NMB	chr15:85198362-85201802:-	-0.16	-3.87	0.000126	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs8041847	chr15:78529575	CIB2	chr15:78396991-78423878:-	0.18	3.55	0.000423	Personality dimensions	
PRAD	cis	1	rs8042366	chr15:66012443	IGDCC4	chr15:65673825-65715410:-	-0.14	-3.43	0.000653	Mean corpuscular hemoglobin	
PRAD	cis	1	rs8042807	chr15:66012444	IGDCC4	chr15:65673825-65715410:-	-0.14	-3.47	0.000578	Mean corpuscular hemoglobin	
PRAD	cis	1	rs804280	chr8:11612698	FAM66A	chr8:12219528-12279968:+	0.19	3.78	0.000179	Myopia (pathological)	
PRAD	cis	1	rs804281	chr8:11611865	FAM66A	chr8:12219528-12279968:+	0.2	3.76	0.000193	Myopia (pathological)	
PRAD	cis	1	rs8042825	chr15:90897885	ZNF774	chr15:90895477-90904714:+	0.23	4.71	3.24E-6	Rheumatoid arthritis	
PRAD	cis	1	rs8042849	chr15:78817929	CHRNA3	chr15:78885397-78913322:-	0.24	4.24	2.66E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs8042849	chr15:78817929	CHRNA5	chr15:78857906-78886458:+	0.21	4.39	1.38E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs8042970	chr15:84586368	NMB	chr15:85198362-85201802:-	-0.17	-4.02	6.71E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs8044653	chr16:55615757	CAPNS2	chr16:55600584-55601592:+	0.18	5.14	3.98E-7	Thyroid hormone levels	
PRAD	cis	1	rs8044653	chr16:55615757	LPCAT2	chr16:55542913-55620581:+	-0.15	-5.16	3.71E-7	Thyroid hormone levels	
PRAD	cis	1	rs8046998	chr16:58825013	GOT2	chr16:58741035-58768246:-	-0.18	-3.98	8.12E-5	Blood metabolite ratios	
PRAD	cis	1	rs8049439	chr16:28837515	ATP2A1	chr16:28889809-28915830:+	0.2	3.75	0.000202	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs8049439	chr16:28837515	CCDC101	chr16:28565249-28603110:+	-0.14	-4.17	3.63E-5	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs8049439	chr16:28837515	EIF3CL	chr16:28699879-28747052:+;chr16	0.39	7.96	1.32E-14	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs8049439	chr16:28837515	SBK1	chr16:28303840-28335162:+	-0.18	-3.96	8.64E-5	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs8049439	chr16:28837515	SULT1A1	chr16:28616918-28634866:-	-0.19	-4.08	5.34E-5	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs8049439	chr16:28837515	SULT1A2	chr16:28603266-28608391:-	0.23	4.72	3.07E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs8049439	chr16:28837515	TUFM	chr16:28853732-28857729:-	0.21	6.48	2.29E-10	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PRAD	cis	1	rs8049804	chr16:27436783	GTF3C1	chr16:27471935-27561251:-	-0.17	-3.7	0.000239	Bone mineral density	
PRAD	cis	1	rs8049804	chr16:27436783	SBK1	chr16:28303840-28335162:+	-0.19	-3.96	8.7E-5	Bone mineral density	
PRAD	cis	1	rs8050907	chr16:4646878	NMRAL1	chr16:4511696-4526307:-	-0.31	-5.2	3.05E-7	Obesity-related traits	
PRAD	cis	1	rs8051653	chr16:67848515	C16orf86	chr16:67700717-67702659:+	-0.3	-4.75	2.69E-6	Crohn's disease	
PRAD	cis	1	rs8051653	chr16:67848515	FHOD1	chr16:67263294-67281425:-	0.29	3.47	0.000564	Crohn's disease	
PRAD	cis	1	rs8052287	chr16:67865073	C16orf86	chr16:67700717-67702659:+	-0.3	-4.14	4.16E-5	Crohn's disease	
PRAD	cis	1	rs8055187	chr16:158324	NPRL3	chr16:134273-188672:-	0.18	4.74	2.84E-6	Red blood cell traits	
PRAD	cis	1	rs8056742	chr16:85092748	KLHL36	chr16:84682131-84695915:+	-0.22	-3.57	0.000393	Amyotrophic lateral sclerosis	
PRAD	cis	1	rs8057892	chr16:58832759	GOT2	chr16:58741035-58768246:-	-0.21	-4.56	6.54E-6	Blood metabolite ratios	
PRAD	cis	1	rs8058835	chr16:67814865	C16orf86	chr16:67700717-67702659:+	-0.28	-4.58	5.89E-6	Crohn's disease	
PRAD	cis	1	rs8060686	chr16:67911517	DPEP3	chr16:68009567-68014452:-	-0.24	-3.5	0.000514	HDL cholesterol;Metabolic syndrome	
PRAD	cis	1	rs8060686	chr16:67911517	FHOD1	chr16:67263294-67281425:-	0.3	5.13	4.15E-7	HDL cholesterol;Metabolic syndrome	
PRAD	cis	1	rs8060686	chr16:67911517	PRMT7	chr16:68344945-68391162:+	0.2	3.84	0.000139	HDL cholesterol;Metabolic syndrome	
PRAD	cis	1	rs8060686	chr16:67911517	SLC9A5	chr16:67282855-67306093:+	0.21	4.18	3.44E-5	HDL cholesterol;Metabolic syndrome	
PRAD	cis	1	rs8061992	chr16:27435038	GTF3C1	chr16:27471935-27561251:-	0.17	3.67	0.00027	Bone mineral density	
PRAD	cis	1	rs8061992	chr16:27435038	SBK1	chr16:28303840-28335162:+	0.18	3.82	0.000149	Bone mineral density	
PRAD	cis	1	rs8062670	chr16:27435206	GTF3C1	chr16:27471935-27561251:-	-0.17	-3.69	0.000254	Bone mineral density	
PRAD	cis	1	rs8062670	chr16:27435206	SBK1	chr16:28303840-28335162:+	-0.18	-3.78	0.000178	Bone mineral density	
PRAD	cis	1	rs8062783	chr16:74691264	RFWD3	chr16:74655298-74700779:-	0.26	6.38	4.34E-10	Testicular germ cell tumor	
PRAD	cis	1	rs8064261	chr17:61705212	CD79B	chr17:62006098-62009704:-	0.12	3.51	0.000497	Body mass index	
PRAD	cis	1	rs8064261	chr17:61705212	DDX42	chr17:61851567-61896676:+	-0.25	-5.14	4.13E-7	Body mass index	
PRAD	cis	1	rs8064261	chr17:61705212	FTSJ3	chr17:61896795-61905031:-	0.34	6.68	6.72E-11	Body mass index	
PRAD	cis	1	rs8064261	chr17:61705212	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.4	1.34E-5	Body mass index	
PRAD	cis	1	rs8065059	chr17:28417376	EFCAB5	chr17:28256874-28435469:+	-0.25	-4.13	4.38E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs8065261	chr17:28418041	EFCAB5	chr17:28256874-28435469:+	-0.25	-4.13	4.38E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs8065437	chr17:45721653	C17orf57	chr17:45401142-45518675:+	0.38	8.98	6.65E-18	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs8065437	chr17:45721653	TBKBP1	chr17:45772630-45789427:+	-0.16	-4.38	1.45E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs8065669	chr17:45724996	C17orf57	chr17:45401142-45518675:+	0.39	8.92	1.02E-17	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs8065669	chr17:45724996	TBKBP1	chr17:45772630-45789427:+	-0.16	-4.38	1.46E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs8066156	chr17:30361629	C17orf79	chr17:30178885-30186326:-	-0.23	-4.25	2.62E-5	Height	
PRAD	cis	1	rs8066385	chr17:18761133	FAM18B	chr17:18684582-18710026:+	-0.24	-5.01	7.56E-7	Educational attainment (years of education)	
PRAD	cis	1	rs8066719	chr17:61825764	DDX42	chr17:61851567-61896676:+	-0.27	-5.41	9.88E-8	Body mass index	
PRAD	cis	1	rs8066719	chr17:61825764	FTSJ3	chr17:61896795-61905031:-	0.34	6.79	3.49E-11	Body mass index	
PRAD	cis	1	rs8066719	chr17:61825764	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.44	1.14E-5	Body mass index	
PRAD	cis	1	rs8067064	chr17:61825984	DDX42	chr17:61851567-61896676:+	-0.27	-5.45	8.15E-8	Body mass index	
PRAD	cis	1	rs8067064	chr17:61825984	FTSJ3	chr17:61896795-61905031:-	0.34	6.78	3.66E-11	Body mass index	
PRAD	cis	1	rs8067064	chr17:61825984	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.42	1.25E-5	Body mass index	
PRAD	cis	1	rs8067431	chr17:61817048	DDX42	chr17:61851567-61896676:+	-0.27	-5.41	1.01E-7	Body mass index	
PRAD	cis	1	rs8067431	chr17:61817048	FTSJ3	chr17:61896795-61905031:-	0.34	6.62	9.63E-11	Body mass index	
PRAD	cis	1	rs8067431	chr17:61817048	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.15	3.88E-5	Body mass index	
PRAD	cis	1	rs8067892	chr17:65837983	LOC651250	chr17:66097696-66157623:+	-0.24	-4.38	1.47E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs8068603	chr17:61755211	DDX42	chr17:61851567-61896676:+	-0.25	-5.32	1.59E-7	Body mass index	
PRAD	cis	1	rs8068603	chr17:61755211	FTSJ3	chr17:61896795-61905031:-	0.33	6.64	8.78E-11	Body mass index	
PRAD	cis	1	rs8068603	chr17:61755211	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.21	3.09E-5	Body mass index	
PRAD	cis	1	rs8069687	chr17:61883023	DDX42	chr17:61851567-61896676:+	0.27	5.55	4.88E-8	Body mass index	
PRAD	cis	1	rs8069687	chr17:61883023	FTSJ3	chr17:61896795-61905031:-	-0.34	-6.6	1.14E-10	Body mass index	
PRAD	cis	1	rs8069687	chr17:61883023	TCAM1P	chr17:61934376-61941738:+	0.25	4.42	1.22E-5	Body mass index	
PRAD	cis	1	rs8070432	chr17:17480474	RAI1	chr17:17584787-17714763:+	0.23	3.44	0.000641	Obsessive-compulsive symptoms	
PRAD	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.33	-5.82	1.11E-8	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs8070650	chr17:61744040	CD79B	chr17:62006098-62009704:-	0.12	3.51	0.000496	Body mass index	
PRAD	cis	1	rs8070650	chr17:61744040	DDX42	chr17:61851567-61896676:+	-0.25	-5.18	3.28E-7	Body mass index	
PRAD	cis	1	rs8070650	chr17:61744040	FTSJ3	chr17:61896795-61905031:-	0.34	6.81	3.06E-11	Body mass index	
PRAD	cis	1	rs8070650	chr17:61744040	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.56E-6	Body mass index	
PRAD	cis	1	rs8071056	chr17:40822308	EZH1	chr17:40852294-40897071:-	-0.3	-3.8	0.000165	Systolic blood pressure change trajectories	
PRAD	cis	1	rs8071463	chr17:65938655	LOC651250	chr17:66097696-66157623:+	0.24	4.4	1.37E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs8071789	chr17:38006333	PGAP3	chr17:37827376-37844310:-	-0.31	-6.68	6.6E-11	Selective IgA deficiency	
PRAD	cis	1	rs8072100	chr17:45674687	C17orf57	chr17:45401142-45518675:+	-0.39	-9.12	2.12E-18	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs8072100	chr17:45674687	TBKBP1	chr17:45772630-45789427:+	0.15	4.14	4.12E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PRAD	cis	1	rs8072225	chr17:65912960	LOC651250	chr17:66097696-66157623:+	-0.25	-4.55	6.76E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs8073373	chr17:61703320	DDX42	chr17:61851567-61896676:+	-0.25	-5.24	2.43E-7	Body mass index	
PRAD	cis	1	rs8073373	chr17:61703320	FTSJ3	chr17:61896795-61905031:-	0.33	6.57	1.3E-10	Body mass index	
PRAD	cis	1	rs8073373	chr17:61703320	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.04	6.18E-5	Body mass index	
PRAD	cis	1	rs8074078	chr17:65838743	LOC651250	chr17:66097696-66157623:+	-0.23	-4.28	2.31E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs8074708	chr17:40286354	DHX58	chr17:40253422-40264751:-	0.35	7.6	1.65E-13	Fibrinogen levels	
PRAD	cis	1	rs8074708	chr17:40286354	HSPB9	chr17:40274756-40275371:+	-0.27	-4.74	2.8E-6	Fibrinogen levels	
PRAD	cis	1	rs8074742	chr17:17455196	RAI1	chr17:17584787-17714763:+	0.25	3.63	0.00032	Obsessive-compulsive symptoms	
PRAD	cis	1	rs8074771	chr17:61735865	CD79B	chr17:62006098-62009704:-	0.12	3.51	0.000496	Body mass index	
PRAD	cis	1	rs8074771	chr17:61735865	DDX42	chr17:61851567-61896676:+	-0.25	-5.18	3.28E-7	Body mass index	
PRAD	cis	1	rs8074771	chr17:61735865	FTSJ3	chr17:61896795-61905031:-	0.34	6.81	3.06E-11	Body mass index	
PRAD	cis	1	rs8074771	chr17:61735865	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.56E-6	Body mass index	
PRAD	cis	1	rs8075061	chr17:61804723	DDX42	chr17:61851567-61896676:+	-0.27	-5.45	8.07E-8	Body mass index	
PRAD	cis	1	rs8075061	chr17:61804723	FTSJ3	chr17:61896795-61905031:-	0.34	6.72	5.36E-11	Body mass index	
PRAD	cis	1	rs8075061	chr17:61804723	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.42	1.23E-5	Body mass index	
PRAD	cis	1	rs8075257	chr17:61728750	DDX42	chr17:61851567-61896676:+	-0.23	-4.75	2.76E-6	Body mass index	
PRAD	cis	1	rs8075257	chr17:61728750	FTSJ3	chr17:61896795-61905031:-	0.35	6.96	1.12E-11	Body mass index	
PRAD	cis	1	rs8075257	chr17:61728750	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.27	2.37E-5	Body mass index	
PRAD	cis	1	rs8075273	chr17:61728881	CD79B	chr17:62006098-62009704:-	0.16	4	7.45E-5	Body mass index	
PRAD	cis	1	rs8075273	chr17:61728881	FTSJ3	chr17:61896795-61905031:-	0.22	3.72	0.000221	Body mass index	
PRAD	cis	1	rs8075273	chr17:61728881	TCAM1P	chr17:61934376-61941738:+	-0.24	-3.66	0.000276	Body mass index	
PRAD	cis	1	rs8075422	chr17:61804686	DDX42	chr17:61851567-61896676:+	-0.26	-5.44	8.64E-8	Body mass index	
PRAD	cis	1	rs8075422	chr17:61804686	FTSJ3	chr17:61896795-61905031:-	0.33	6.6	1.12E-10	Body mass index	
PRAD	cis	1	rs8075422	chr17:61804686	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.12	4.46E-5	Body mass index	
PRAD	cis	1	rs8075521	chr17:61804954	DDX42	chr17:61851567-61896676:+	-0.27	-5.45	8.07E-8	Body mass index	
PRAD	cis	1	rs8075521	chr17:61804954	FTSJ3	chr17:61896795-61905031:-	0.34	6.72	5.36E-11	Body mass index	
PRAD	cis	1	rs8075521	chr17:61804954	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.42	1.23E-5	Body mass index	
PRAD	cis	1	rs807624	chr2:15782471	DDX1	chr2:15731770-15771224:+	0.29	5.98	4.46E-9	Wilms tumor	
PRAD	cis	1	rs807669	chr22:19154522	SLC25A1	chr22:19163095-19166301:-	-0.27	-8.81	2.39E-17	Metabolite levels	
PRAD	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.21	-7.09	4.95E-12	Metabolite levels	
PRAD	cis	1	rs8076717	chr17:61850301	DDX42	chr17:61851567-61896676:+	0.27	5.34	1.45E-7	Body mass index	
PRAD	cis	1	rs8076717	chr17:61850301	FTSJ3	chr17:61896795-61905031:-	-0.35	-6.87	2.02E-11	Body mass index	
PRAD	cis	1	rs8076717	chr17:61850301	TCAM1P	chr17:61934376-61941738:+	0.24	4.18	3.45E-5	Body mass index	
PRAD	cis	1	rs8077265	chr17:61732727	DDX42	chr17:61851567-61896676:+	-0.24	-4.87	1.52E-6	Body mass index	
PRAD	cis	1	rs8077265	chr17:61732727	FTSJ3	chr17:61896795-61905031:-	0.35	7.07	5.47E-12	Body mass index	
PRAD	cis	1	rs8077265	chr17:61732727	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.13	4.3E-5	Body mass index	
PRAD	cis	1	rs8077577	chr17:18064730	LOC220594	chr17:18414577-18445234:-	-0.29	-3.88	0.000118	Obesity-related traits	
PRAD	cis	1	rs8077577	chr17:18064730	MYO15A	chr17:18012020-18083115:+	0.23	4.28	2.25E-5	Obesity-related traits	
PRAD	cis	1	rs807810	chr3:47403892	C3orf75	chr3:47537131-47555199:-	0.17	5.27	2.06E-7	Colorectal cancer	
PRAD	cis	1	rs807810	chr3:47403892	NBEAL2	chr3:47021173-47051193:+	0.14	4.25	2.55E-5	Colorectal cancer	
PRAD	cis	1	rs8078462	chr17:61857937	DDX42	chr17:61851567-61896676:+	-0.27	-5.59	3.94E-8	Body mass index	
PRAD	cis	1	rs8078462	chr17:61857937	FTSJ3	chr17:61896795-61905031:-	0.35	6.83	2.58E-11	Body mass index	
PRAD	cis	1	rs8078462	chr17:61857937	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.52	7.88E-6	Body mass index	
PRAD	cis	1	rs8078550	chr17:53053379	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.62	0.000332	Breast cancer	
PRAD	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.34	-5.93	5.81E-9	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PRAD	cis	1	rs8078862	chr17:61854068	DDX42	chr17:61851567-61896676:+	-0.27	-5.57	4.36E-8	Body mass index	
PRAD	cis	1	rs8078862	chr17:61854068	FTSJ3	chr17:61896795-61905031:-	0.34	6.77	3.95E-11	Body mass index	
PRAD	cis	1	rs8078862	chr17:61854068	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.5	8.45E-6	Body mass index	
PRAD	cis	1	rs807931	chr3:47389317	C3orf75	chr3:47537131-47555199:-	-0.15	-4.67	3.89E-6	Colorectal cancer	
PRAD	cis	1	rs807931	chr3:47389317	NBEAL2	chr3:47021173-47051193:+	-0.15	-4.57	6.19E-6	Colorectal cancer	
PRAD	cis	1	rs807936	chr3:47322496	C3orf75	chr3:47537131-47555199:-	-0.17	-5.23	2.59E-7	Colorectal cancer	
PRAD	cis	1	rs807936	chr3:47322496	NBEAL2	chr3:47021173-47051193:+	-0.13	-4.12	4.39E-5	Colorectal cancer	
PRAD	cis	1	rs8079754	chr17:65887896	LOC651250	chr17:66097696-66157623:+	-0.23	-4.17	3.56E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs8080211	chr17:61729882	DDX42	chr17:61851567-61896676:+	-0.24	-4.77	2.48E-6	Body mass index	
PRAD	cis	1	rs8080211	chr17:61729882	FTSJ3	chr17:61896795-61905031:-	0.38	7.36	8.11E-13	Body mass index	
PRAD	cis	1	rs8080211	chr17:61729882	TCAM1P	chr17:61934376-61941738:+	-0.22	-3.85	0.000134	Body mass index	
PRAD	cis	1	rs8080491	chr17:53049869	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs8081517	chr17:65845697	LOC651250	chr17:66097696-66157623:+	-0.24	-4.38	1.47E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs8081541	chr17:61812483	DDX42	chr17:61851567-61896676:+	-0.27	-5.45	8.07E-8	Body mass index	
PRAD	cis	1	rs8081541	chr17:61812483	FTSJ3	chr17:61896795-61905031:-	0.34	6.72	5.36E-11	Body mass index	
PRAD	cis	1	rs8081541	chr17:61812483	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.42	1.23E-5	Body mass index	
PRAD	cis	1	rs8081612	chr17:61724695	DDX42	chr17:61851567-61896676:+	0.23	4.75	2.7E-6	Body mass index	
PRAD	cis	1	rs8081612	chr17:61724695	FTSJ3	chr17:61896795-61905031:-	-0.34	-6.77	3.88E-11	Body mass index	
PRAD	cis	1	rs8081612	chr17:61724695	TCAM1P	chr17:61934376-61941738:+	0.23	4.13	4.31E-5	Body mass index	
PRAD	cis	1	rs8082471	chr17:53067993	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.92	0.000103	Breast cancer	
PRAD	cis	1	rs8082512	chr17:65837059	LOC651250	chr17:66097696-66157623:+	-0.24	-4.24	2.67E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs8082647	chr17:2010597	SRR	chr17:2207248-2228553:+	-0.26	-4	7.39E-5	Body mass index	
PRAD	cis	1	rs8085433	chr18:40249522	SYT4	chr18:40847859-40857615:-	0.23	3.65	0.000297	Cognitive performance	
PRAD	cis	1	rs809367	chr10:89741806	ATAD1	chr10:89512875-89577917:-	0.23	3.66	0.000283	Parental extreme longevity (95 years and older)	
PRAD	cis	1	rs809367	chr10:89741806	KILLIN	chr10:89618919-89623194:-	0.26	3.94	9.24E-5	Parental extreme longevity (95 years and older)	
PRAD	cis	1	rs809367	chr10:89741806	MINPP1	chr10:89264223-89313168:+	0.26	3.81	0.000158	Parental extreme longevity (95 years and older)	
PRAD	cis	1	rs809367	chr10:89741806	PTEN	chr10:89623195-89728531:+	0.3	5.44	8.47E-8	Parental extreme longevity (95 years and older)	
PRAD	cis	1	rs809367	chr10:89741806	RNLS	chr10:89892057-90343082:-	0.33	4.87	1.5E-6	Parental extreme longevity (95 years and older)	
PRAD	cis	1	rs809775	chr1:46538040	CCDC163P	chr1:45960581-45965646:-	-0.54	-12.32	2.11E-30	Body mass index	
PRAD	cis	1	rs809775	chr1:46538040	MMACHC	chr1:45965856-45976737:+	-0.17	-3.93	9.96E-5	Body mass index	
PRAD	cis	1	rs809775	chr1:46538040	MUTYH	chr1:45794915-45806142:-	0.2	5.78	1.35E-8	Body mass index	
PRAD	cis	1	rs8098670	chr18:40208385	SYT4	chr18:40847859-40857615:-	0.21	3.43	0.000661	Cognitive performance	
PRAD	cis	1	rs8100042	chr19:22127841	ZNF257	chr19:22235266-22273901:+	0.39	5.28	2.03E-7	Body mass index (change over time)	
PRAD	cis	1	rs8100392	chr19:33605933	GPATCH1	chr19:33571786-33621318:+	0.53	9.57	6.28E-20	Bone properties (heel)	
PRAD	cis	1	rs8101881	chr19:33364628	SLC7A9	chr19:33321421-33360683:-	-0.34	-7.53	2.63E-13	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
PRAD	cis	1	rs8103622	chr19:18572834	SSBP4	chr19:18530221-18545371:+	-0.17	-5.62	3.3E-8	Breast cancer	
PRAD	cis	1	rs8104559	chr19:22205167	ZNF257	chr19:22235266-22273901:+	0.37	5.09	5.28E-7	Body mass index (change over time)	
PRAD	cis	1	rs8104845	chr19:46161326	SYMPK	chr19:46318701-46366548:-	-0.18	-4.09	5.16E-5	Type 2 diabetes	
PRAD	cis	1	rs8105895	chr19:22215457	ZNF257	chr19:22235266-22273901:+	0.37	5.1	4.83E-7	Body mass index (change over time)	
PRAD	cis	1	rs8105994	chr19:18593553	SSBP4	chr19:18530221-18545371:+	-0.16	-5.25	2.34E-7	Breast cancer	
PRAD	cis	1	rs8107236	chr19:46158436	SYMPK	chr19:46318701-46366548:-	-0.18	-3.98	7.85E-5	Type 2 diabetes	
PRAD	cis	1	rs8107240	chr19:15737392	CYP4F8	chr19:15726029-15740445:+	0.31	3.63	0.000318	Inflammatory biomarkers	
PRAD	cis	1	rs8107367	chr19:18564705	SSBP4	chr19:18530221-18545371:+	-0.17	-5.62	3.24E-8	Breast cancer	
PRAD	cis	1	rs8107416	chr19:39237950	CAPN12	chr19:39220832-39235114:-	0.13	3.56	0.000412	Heart rate	
PRAD	cis	1	rs8107416	chr19:39237950	LGALS7	chr19:39261608-39264157:-	-0.18	-4.04	6.2E-5	Heart rate	
PRAD	cis	1	rs8108269	chr19:46158513	SYMPK	chr19:46318701-46366548:-	0.18	4.12	4.57E-5	Type 2 diabetes	
PRAD	cis	1	rs8108840	chr19:33094452	PDCD5	chr19:33072104-33078322:+	-0.14	-3.45	0.000608	Eosinophilic esophagitis	
PRAD	cis	1	rs8109573	chr19:18617151	ELL	chr19:18553475-18632937:-	-0.16	-3.83	0.000143	Breast cancer	
PRAD	cis	1	rs8109573	chr19:18617151	SSBP4	chr19:18530221-18545371:+	-0.17	-5.81	1.16E-8	Breast cancer	
PRAD	cis	1	rs8110011	chr19:37745813	SIPA1L3	chr19:38397868-38699006:+	0.17	3.53	0.000455	Coronary artery calcification	
PRAD	cis	1	rs8110011	chr19:37745813	ZNF607	chr19:38187276-38210691:-	-0.19	-3.5	0.000511	Coronary artery calcification	
PRAD	cis	1	rs8110011	chr19:37745813	ZNF781	chr19:38158650-38183216:-	0.24	4.14	4.16E-5	Coronary artery calcification	
PRAD	cis	1	rs8110181	chr19:33605939	GPATCH1	chr19:33571786-33621318:+	0.53	9.57	6.28E-20	Bone properties (heel)	
PRAD	cis	1	rs8110727	chr19:24230916	LOC100101266	chr19:24344995-24346249:-	0.36	5.09	5.15E-7	Response to taxane treatment (placlitaxel)	
PRAD	cis	1	rs811115	chr3:47322133	C3orf75	chr3:47537131-47555199:-	-0.17	-5.23	2.59E-7	Colorectal cancer	
PRAD	cis	1	rs811115	chr3:47322133	NBEAL2	chr3:47021173-47051193:+	-0.13	-4.12	4.39E-5	Colorectal cancer	
PRAD	cis	1	rs8111708	chr19:18558876	ELL	chr19:18553475-18632937:-	-0.16	-3.7	0.000238	Breast cancer	
PRAD	cis	1	rs8111708	chr19:18558876	SSBP4	chr19:18530221-18545371:+	-0.17	-5.64	3.0E-8	Breast cancer	
PRAD	cis	1	rs8111746	chr19:39212859	LGALS7	chr19:39261608-39264157:-	-0.16	-3.74	0.000206	Heart rate	
PRAD	cis	1	rs8111946	chr19:45152394	PVR	chr19:45147098-45169426:+	0.19	3.88	0.000122	Multiple sclerosis	
PRAD	cis	1	rs8113312	chr19:23061182	ZNF492	chr19:22817126-22850472:+	-0.31	-3.97	8.37E-5	Bronchopulmonary dysplasia	
PRAD	cis	1	rs8114671	chr20:33789142	FAM83C	chr20:33873287-33880225:-	0.16	3.47	0.000559	Height	
PRAD	cis	1	rs8114671	chr20:33789142	MMP24	chr20:33814539-33864804:+	0.18	4.38	1.45E-5	Height	
PRAD	cis	1	rs8114671	chr20:33789142	UQCC	chr20:33890383-33999833:-	0.2	3.65	0.000294	Height	
PRAD	cis	1	rs8117100	chr20:33692261	MMP24	chr20:33814539-33864804:+	-0.28	-4.29	2.19E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs8117847	chr20:33642480	MMP24	chr20:33814539-33864804:+	-0.22	-3.74	0.00021	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs8118005	chr20:33636219	MMP24	chr20:33814539-33864804:+	-0.23	-3.81	0.000156	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs8118008	chr20:3168166	ITPA	chr20:3190056-3204504:+	0.18	5.21	2.78E-7	Parkinson's disease	
PRAD	cis	1	rs8118008	chr20:3168166	ProSAPiP1	chr20:3143273-3154192:-	0.23	4.43	1.16E-5	Parkinson's disease	
PRAD	cis	1	rs811880	chr7:65818646	TPST1	chr7:65670259-65825437:+	0.18	4.54	7.23E-6	Aortic root size	
PRAD	cis	1	rs8118978	chr20:33574458	MMP24	chr20:33814539-33864804:+	-0.23	-3.74	0.000205	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs8119827	chr20:33726873	GDF5	chr20:33897002-34042568:-	0.26	3.77	0.000184	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs8119827	chr20:33726873	MMP24	chr20:33814539-33864804:+	-0.3	-4.51	8.13E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs8119827	chr20:33726873	UQCC	chr20:33890383-33999833:-	-0.31	-3.46	0.000586	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs8121957	chr20:33676109	MMP24	chr20:33814539-33864804:+	-0.22	-3.72	0.000227	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs8123062	chr20:55069310	C20orf43	chr20:55043647-55093942:+	0.16	3.87	0.000124	Refractive astigmatism	
PRAD	cis	1	rs8123289	chr20:3253831	ITPA	chr20:3190056-3204504:+	-0.32	-7.83	3.29E-14	IFN-related cytopenia	
PRAD	cis	1	rs8123978	chr20:33598789	MMP24	chr20:33814539-33864804:+	-0.31	-4.69	3.55E-6	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs8124662	chr20:33639256	MMP24	chr20:33814539-33864804:+	-0.23	-3.81	0.000156	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs8124887	chr20:22290780	PAX1	chr20:21686297-21696620:+	0.15	4.01	7.1E-5	Glucose homeostasis traits	
PRAD	cis	1	rs8125868	chr20:25324410	ENTPD6	chr20:25176339-25207360:+	0.18	4.67	3.92E-6	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs8125868	chr20:25324410	FAM182B	chr20:25744102-25848786:-	-0.36	-6.67	7.33E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs8125868	chr20:25324410	PYGB	chr20:25228706-25278647:+	0.34	7.39	6.85E-13	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs8129913	chr21:27064339	JAM2	chr21:27011589-27087235:+	-0.1	-4.18	3.53E-5	Longitudinal change in brain amyloid plaque burden	
PRAD	cis	1	rs813101	chr9:115532907	C9orf80	chr9:115448793-115480387:-	0.25	3.8	0.000164	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs8133949	chr21:43421114	C21orf121	chr21:43442113-43445060:+	0.34	5.55	4.79E-8	Hand grip strength	
PRAD	cis	1	rs8137478	chr22:51017296	CPT1B	chr22:51007291-51017096:-	-0.23	-4.86	1.63E-6	Narcolepsy	
PRAD	cis	1	rs8137478	chr22:51017296	LOC100144603	chr22:51021455-51022353:+	-0.31	-3.6	0.000357	Narcolepsy	
PRAD	cis	1	rs8138799	chr22:24556902	SUSD2	chr22:24577444-24585074:+	0.66	9.42	2.03E-19	Amyotrophic lateral sclerosis	
PRAD	cis	1	rs8138996	chr22:39047435	CBY1	chr22:39052658-39069853:+	0.17	4.86	1.63E-6	Resting heart rate	
PRAD	cis	1	rs8138996	chr22:39047435	LOC646851	chr22:38974125-39052634:-	0.2	4.79	2.23E-6	Resting heart rate	
PRAD	cis	1	rs8141797	chr22:24582041	SUSD2	chr22:24577444-24585074:+	-0.57	-8.44	4.0E-16	Amyotrophic lateral sclerosis	
PRAD	cis	1	rs8142098	chr22:39058757	CBY1	chr22:39052658-39069853:+	0.17	4.88	1.48E-6	Resting heart rate	
PRAD	cis	1	rs8142098	chr22:39058757	LOC646851	chr22:38974125-39052634:-	0.19	4.41	1.3E-5	Resting heart rate	
PRAD	cis	1	rs815306	chr1:76168624	ACADM	chr1:76190043-76229353:+	0.17	4.06	5.75E-5	Daytime sleep phenotypes	
PRAD	cis	1	rs816535	chr20:26255996	FAM182B	chr20:25744102-25848786:-	0.24	3.47	0.00056	Parkinson disease and lewy body pathology	
PRAD	cis	1	rs8170	chr19:17389704	ANKLE1	chr19:17392454-17398454:+	0.32	6.16	1.58E-9	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs8170	chr19:17389704	MRPL34	chr19:17416477-17417652:+	-0.21	-4.21	3.11E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs8170	chr19:17389704	OCEL1	chr19:17337055-17340027:+	0.21	4.97	9.47E-7	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PRAD	cis	1	rs8180040	chr3:47388947	C3orf75	chr3:47537131-47555199:-	-0.16	-4.93	1.15E-6	Colorectal cancer	
PRAD	cis	1	rs8180040	chr3:47388947	NBEAL2	chr3:47021173-47051193:+	-0.15	-4.77	2.46E-6	Colorectal cancer	
PRAD	cis	1	rs8180991	chr8:126500350	TATDN1	chr8:125500735-125551329:-	-0.18	-3.66	0.000278	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	
PRAD	cis	1	rs8181295	chr10:124041678	BTBD16	chr10:124030821-124097676:+	-0.26	-4.5	8.61E-6	Gut microbiome composition (summer)	
PRAD	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.38	7.97	1.25E-14	Multiple sclerosis	
PRAD	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.54	-13.14	8.19E-34	Multiple sclerosis	
PRAD	cis	1	rs8181644	chr12:58173466	XRCC6BP1	chr12:58335445-58351051:+	-0.24	-4.78	2.4E-6	Multiple sclerosis	
PRAD	cis	1	rs8182198	chr16:23905225	PRKCB	chr16:23847300-24231930:+	0.17	6	3.95E-9	Rheumatoid arthritis	
PRAD	cis	1	rs8189391	chr11:48859789	FOLH1	chr11:49168188-49230222:-	0.2	4.55	6.95E-6	HDL cholesterol	
PRAD	cis	1	rs8192482	chr15:78886198	CHRNA3	chr15:78885397-78913322:-	-0.28	-4.91	1.26E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs8192482	chr15:78886198	CHRNA5	chr15:78857906-78886458:+	-0.21	-4.28	2.25E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs823144	chr1:205744546	RAB7L1	chr1:205737115-205744610:-	0.31	6.1	2.2E-9	Parkinson's disease	
PRAD	cis	1	rs823156	chr1:205764640	PM20D1	chr1:205797154-205819245:-	-0.27	-4.04	6.24E-5	Parkinson's disease	
PRAD	cis	1	rs823301	chr3:195123495	C3orf21	chr3:194789015-194991895:-	-0.31	-6.38	4.31E-10	Body mass index	
PRAD	cis	1	rs823302	chr3:195104741	C3orf21	chr3:194789015-194991895:-	-0.32	-6.81	2.95E-11	Body mass index	
PRAD	cis	1	rs823306	chr3:195108320	C3orf21	chr3:194789015-194991895:-	-0.32	-6.67	7.14E-11	Body mass index	
PRAD	cis	1	rs823310	chr3:195127093	C3orf21	chr3:194789015-194991895:-	-0.31	-6.55	1.55E-10	Body mass index	
PRAD	cis	1	rs823311	chr3:195141029	C3orf21	chr3:194789015-194991895:-	-0.31	-6.37	4.44E-10	Body mass index	
PRAD	cis	1	rs823314	chr3:195132402	C3orf21	chr3:194789015-194991895:-	-0.31	-6.54	1.65E-10	Body mass index	
PRAD	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.97	16.52	1.08E-48	Type 2 diabetes	
PRAD	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.92	15.61	1.5E-44	Type 2 diabetes	
PRAD	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.95	16.17	4.56E-47	Type 2 diabetes	
PRAD	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.98	16.98	8.95E-51	Type 2 diabetes	
PRAD	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.98	16.98	8.95E-51	Type 2 diabetes	
PRAD	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.98	16.98	8.95E-51	Type 2 diabetes	
PRAD	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.95	16.62	4.17E-49	Type 2 diabetes	
PRAD	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.97	16.52	1.08E-48	Type 2 diabetes	
PRAD	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.97	16.47	1.91E-48	Type 2 diabetes	
PRAD	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.96	-16.51	1.22E-48	Type 2 diabetes	
PRAD	cis	1	rs834811	chr7:135884571	CHRM2	chr7:136553399-136701771:+	-0.17	-3.52	0.000472	Post-traumatic stress disorder	
PRAD	cis	1	rs837721	chr10:100582488	CUTC	chr10:101491958-101515893:+	-0.21	-3.92	0.000102	Obesity-related traits	
PRAD	cis	1	rs837730	chr10:100552512	CUTC	chr10:101491958-101515893:+	-0.18	-3.45	0.000603	Obesity-related traits	
PRAD	cis	1	rs838705	chr2:234273242	USP40	chr2:234384166-234475428:-	-0.18	-3.44	0.000633	Calcium levels	
PRAD	cis	1	rs8396	chr4:159630817	ETFDH	chr4:159593277-159629839:+	-0.2	-3.62	0.000331	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
PRAD	cis	1	rs840163	chr12:57320711	RDH16	chr12:57345218-57396703:-	0.26	4.49	8.91E-6	Alzheimer's disease (survival time)	
PRAD	cis	1	rs842625	chr2:61080482	PUS10	chr2:61167550-61245365:-	0.17	3.43	0.000662	Psoriasis	
PRAD	cis	1	rs846495	chr13:30894250	KATNAL1	chr13:30776768-30881584:-	0.19	4.04	6.22E-5	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs846498	chr13:30900541	KATNAL1	chr13:30776768-30881584:-	0.2	4.17	3.61E-5	Antineutrophil cytoplasmic antibody-associated vasculitis	
PRAD	cis	1	rs853676	chr6:28299687	ZKSCAN3	chr6:28317691-28334523:+	-0.18	-3.7	0.00024	Depression	
PRAD	cis	1	rs853676	chr6:28299687	ZNF187	chr6:28234788-28245978:+	-0.3	-5.38	1.17E-7	Depression	
PRAD	cis	1	rs853676	chr6:28299687	ZNF323	chr6:28292517-28324048:-	0.46	6.19	1.27E-9	Depression	
PRAD	cis	1	rs853676	chr6:28299687	ZNF389	chr6:28129551-28137375:+	-0.47	-6.6	1.08E-10	Depression	
PRAD	cis	1	rs853676	chr6:28299687	ZSCAN23	chr6:28393287-28411279:-	0.18	4.77	2.51E-6	Depression	
PRAD	cis	1	rs853678	chr6:28297313	ZNF187	chr6:28234788-28245978:+	-0.3	-5.38	1.16E-7	Depression	
PRAD	cis	1	rs853678	chr6:28297313	ZNF323	chr6:28292517-28324048:-	0.46	6.33	5.67E-10	Depression	
PRAD	cis	1	rs853678	chr6:28297313	ZNF389	chr6:28129551-28137375:+	-0.49	-7.08	5.35E-12	Depression	
PRAD	cis	1	rs853678	chr6:28297313	ZSCAN23	chr6:28393287-28411279:-	0.17	4.76	2.56E-6	Depression	
PRAD	cis	1	rs853679	chr6:28296863	ZNF187	chr6:28234788-28245978:+	-0.3	-5.38	1.16E-7	Depression	
PRAD	cis	1	rs853679	chr6:28296863	ZNF323	chr6:28292517-28324048:-	0.46	6.33	5.67E-10	Depression	
PRAD	cis	1	rs853679	chr6:28296863	ZNF389	chr6:28129551-28137375:+	-0.49	-7.08	5.35E-12	Depression	
PRAD	cis	1	rs853679	chr6:28296863	ZSCAN23	chr6:28393287-28411279:-	0.17	4.76	2.56E-6	Depression	
PRAD	cis	1	rs853685	chr6:28288785	ZNF187	chr6:28234788-28245978:+	-0.3	-5.41	9.91E-8	Depression	
PRAD	cis	1	rs853685	chr6:28288785	ZNF323	chr6:28292517-28324048:-	0.47	6.38	4.37E-10	Depression	
PRAD	cis	1	rs853685	chr6:28288785	ZNF389	chr6:28129551-28137375:+	-0.5	-7.1	4.7E-12	Depression	
PRAD	cis	1	rs853685	chr6:28288785	ZSCAN23	chr6:28393287-28411279:-	0.18	4.79	2.25E-6	Depression	
PRAD	cis	1	rs853694	chr6:28279100	ZKSCAN3	chr6:28317691-28334523:+	-0.17	-3.59	0.000362	Depression	
PRAD	cis	1	rs853694	chr6:28279100	ZNF187	chr6:28234788-28245978:+	-0.31	-5.64	2.98E-8	Depression	
PRAD	cis	1	rs853694	chr6:28279100	ZNF323	chr6:28292517-28324048:-	0.46	6.4	3.84E-10	Depression	
PRAD	cis	1	rs853694	chr6:28279100	ZNF389	chr6:28129551-28137375:+	-0.5	-7.15	3.28E-12	Depression	
PRAD	cis	1	rs853694	chr6:28279100	ZSCAN23	chr6:28393287-28411279:-	0.17	4.58	5.92E-6	Depression	
PRAD	cis	1	rs854572	chr7:94954696	PON1	chr7:94927671-95025687:-	0.53	10.59	1.22E-23	Paraoxonase activity	
PRAD	cis	1	rs858239	chr7:23286315	GPNMB	chr7:23286316-23314728:+	-0.2	-5.47	7.37E-8	Parkinson's disease	
PRAD	cis	1	rs858240	chr7:23284237	GPNMB	chr7:23286316-23314728:+	-0.2	-5.41	1.02E-7	Parkinson's disease	
PRAD	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.43	-9.18	1.33E-18	Homocysteine levels	
PRAD	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.98	-17.41	9.83E-53	Type 2 diabetes	
PRAD	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.97	16.12	7.24E-47	Type 2 diabetes	
PRAD	cis	1	rs861536	chr14:104167564	BAG5	chr14:104022889-104029151:-	0.17	3.48	0.000542	Body mass index	
PRAD	cis	1	rs861536	chr14:104167564	C14orf153	chr14:104029299-104057227:+	0.15	4.27	2.37E-5	Body mass index	
PRAD	cis	1	rs861536	chr14:104167564	CKB	chr14:103985996-103989170:-	0.22	4.86	1.59E-6	Body mass index	
PRAD	cis	1	rs861536	chr14:104167564	MARK3	chr14:103851701-103970164:+	0.23	4.76	2.58E-6	Body mass index	
PRAD	cis	1	rs861538	chr14:104166733	BAG5	chr14:104022889-104029151:-	0.17	3.5	0.000513	Body mass index	
PRAD	cis	1	rs861538	chr14:104166733	C14orf153	chr14:104029299-104057227:+	0.14	4.18	3.53E-5	Body mass index	
PRAD	cis	1	rs861538	chr14:104166733	CKB	chr14:103985996-103989170:-	0.22	5.01	7.73E-7	Body mass index	
PRAD	cis	1	rs861538	chr14:104166733	MARK3	chr14:103851701-103970164:+	0.22	4.57	6.19E-6	Body mass index	
PRAD	cis	1	rs861539	chr14:104165753	BAG5	chr14:104022889-104029151:-	0.17	3.51	0.000489	Body mass index	
PRAD	cis	1	rs861539	chr14:104165753	C14orf153	chr14:104029299-104057227:+	0.14	4	7.38E-5	Body mass index	
PRAD	cis	1	rs861539	chr14:104165753	CKB	chr14:103985996-103989170:-	0.21	4.74	2.79E-6	Body mass index	
PRAD	cis	1	rs861539	chr14:104165753	KLC1	chr14:104029299-104167887:+	-0.18	-3.62	0.000328	Body mass index	
PRAD	cis	1	rs861539	chr14:104165753	MARK3	chr14:103851701-103970164:+	0.23	4.71	3.29E-6	Body mass index	
PRAD	cis	1	rs862393	chr12:5769587	ANO2	chr12:5671817-6055398:-	-0.36	-6.81	3.04E-11	Plasma clusterin levels	
PRAD	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.96	16.1	9.63E-47	Type 2 diabetes	
PRAD	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.97	16.13	6.98E-47	Type 2 diabetes	
PRAD	cis	1	rs867186	chr20:33764554	MMP24	chr20:33814539-33864804:+	0.26	4.21	3.12E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs867529	chr2:88913273	RPIA	chr2:88991176-89050451:+	0.17	3.46	0.000598	Height	
PRAD	cis	1	rs868105	chr4:8501030	C4orf23	chr4:8440604-8495258:+	0.31	5.06	5.97E-7	Response to antineoplastic agents	
PRAD	cis	1	rs868213	chr16:67220457	FHOD1	chr16:67263294-67281425:-	0.45	6.03	3.39E-9	HDL cholesterol	
PRAD	cis	1	rs868213	chr16:67220457	PLEKHG4	chr16:67311413-67323402:+	0.3	3.85	0.000135	HDL cholesterol	
PRAD	cis	1	rs868213	chr16:67220457	SLC9A5	chr16:67282855-67306093:+	0.28	4.25	2.53E-5	HDL cholesterol	
PRAD	cis	1	rs868475	chr15:51636454	FLJ10038	chr15:50641137-50647076:-	-0.33	-4.01	7.11E-5	Calcaneal bone ultrasound measurement (speed of sound)	
PRAD	cis	1	rs871130	chr12:56648777	COQ10A	chr12:56660642-56664748:+	0.35	3.52	0.000466	Psoriasis vulgaris	
PRAD	cis	1	rs871130	chr12:56648777	MIP	chr12:56843885-56848429:-	-0.69	-5.29	1.88E-7	Psoriasis vulgaris	
PRAD	cis	1	rs871546	chr21:43413553	C21orf121	chr21:43442113-43445060:+	0.31	5.16	3.62E-7	Hand grip strength	
PRAD	cis	1	rs872842	chr22:43530631	MCAT	chr22:43528212-43539403:-	0.18	3.49	0.000532	Prostate cancer	
PRAD	cis	1	rs873686	chr4:185638876	CCDC111	chr4:185570767-185616112:+	-0.16	-3.78	0.000176	Kawasaki disease	
PRAD	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.48	13.64	6.06E-36	Kawasaki disease	
PRAD	cis	1	rs8758	chr10:97366107	ENTPD1	chr10:97471536-97637022:+	0.13	3.76	0.000194	Blood metabolite levels	
PRAD	cis	1	rs8758	chr10:97366107	TCTN3	chr10:97423154-97453900:-	0.2	3.97	8.44E-5	Blood metabolite levels	
PRAD	cis	1	rs875971	chr7:65617595	TPST1	chr7:65670259-65825437:+	-0.17	-4.29	2.21E-5	Aortic root size	
PRAD	cis	1	rs876402	chr14:75601862	EIF2B2	chr14:75469612-75476292:+	-0.27	-5.44	8.66E-8	Height	
PRAD	cis	1	rs876402	chr14:75601862	MLH3	chr14:75480467-75518235:-	-0.34	-6.91	1.57E-11	Height	
PRAD	cis	1	rs876403	chr14:75602834	EIF2B2	chr14:75469612-75476292:+	0.25	4.98	9.04E-7	Height	
PRAD	cis	1	rs876403	chr14:75602834	MLH3	chr14:75480467-75518235:-	0.32	6.58	1.26E-10	Height	
PRAD	cis	1	rs876755	chr3:128627933	ACAD9	chr3:128598333-128634910:+	-0.2	-3.73	0.000213	IgG glycosylation	
PRAD	cis	1	rs876756	chr3:128627623	ACAD9	chr3:128598333-128634910:+	-0.2	-3.69	0.000254	IgG glycosylation	
PRAD	cis	1	rs877049	chr1:207422996	CD55	chr1:207494817-207534309:+	0.22	4.08	5.19E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs877187	chr6:33706211	IP6K3	chr6:33689443-33714762:-	-0.19	-3.77	0.000187	Obesity (extreme)	
PRAD	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.79	-16.43	2.84E-48	Cognitive function	
PRAD	cis	1	rs877710	chr12:109993976	KCTD10	chr12:109886460-109915155:-	-0.33	-10.12	6.59E-22	HDL cholesterol	
PRAD	cis	1	rs877710	chr12:109993976	MMAB	chr12:109991523-110011358:-	-0.18	-5.47	7.52E-8	HDL cholesterol	
PRAD	cis	1	rs877710	chr12:109993976	MYO1H	chr12:109826524-109886176:+	-0.24	-5.32	1.64E-7	HDL cholesterol	
PRAD	cis	1	rs877710	chr12:109993976	UBE3B	chr12:109915439-109974506:+	-0.15	-3.76	0.000189	HDL cholesterol	
PRAD	cis	1	rs878083	chr19:41897688	ATP5SL	chr19:41937224-41945810:-	0.18	4.14	4.09E-5	Height	
PRAD	cis	1	rs878361	chr7:26557868	HOXA4	chr7:27168127-27170399:-	-0.22	-3.63	0.000315	Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs879568	chr18:34311659	C18orf10	chr18:34366472-34409158:-	-0.24	-3.91	0.000105	QRS duration	
PRAD	cis	1	rs880143	chr1:247868113	OR2W3	chr1:248031265-248060142:+	-0.28	-4.11	4.68E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs880143	chr1:247868113	TRIM58	chr1:248020501-248043436:+	-0.27	-3.98	7.91E-5	Pre-treatment pain in head and neck squamous cell carcinoma	
PRAD	cis	1	rs881299	chr8:38332249	FGFR1	chr8:38268657-38326352:-	0.15	4.99	8.38E-7	Response to cognitive-behavioural therapy in anxiety disorder	
PRAD	cis	1	rs881301	chr8:38332318	FGFR1	chr8:38268657-38326352:-	0.15	4.88	1.49E-6	Response to cognitive-behavioural therapy in anxiety disorder	
PRAD	cis	1	rs881301	chr8:38332318	WHSC1L1	chr8:38132563-38239790:-	0.15	3.59	0.000367	Response to cognitive-behavioural therapy in anxiety disorder	
PRAD	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.38	-6.92	1.44E-11	Rheumatoid arthritis	
PRAD	cis	1	rs881375	chr9:123652898	TRAF1	chr9:123664672-123691479:-	0.18	5.06	5.91E-7	Rheumatoid arthritis	
PRAD	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.86	-23.98	1.4E-83	Homocysteine levels	
PRAD	cis	1	rs882803	chr1:45976147	MMACHC	chr1:45965856-45976737:+	-0.19	-4.02	6.72E-5	Homocysteine levels	
PRAD	cis	1	rs882803	chr1:45976147	MUTYH	chr1:45794915-45806142:-	0.19	5.27	2.11E-7	Homocysteine levels	
PRAD	cis	1	rs883180	chr16:55612277	CAPNS2	chr16:55600584-55601592:+	0.19	5.54	5.1E-8	Thyroid hormone levels	
PRAD	cis	1	rs883180	chr16:55612277	LPCAT2	chr16:55542913-55620581:+	-0.14	-5.01	7.62E-7	Thyroid hormone levels	
PRAD	cis	1	rs883394	chr19:39205613	LGALS7	chr19:39261608-39264157:-	-0.17	-3.75	0.000197	Heart rate	
PRAD	cis	1	rs883433	chr19:39206288	LGALS7	chr19:39261608-39264157:-	0.16	3.65	0.000292	Heart rate	
PRAD	cis	1	rs883565	chr3:39055317	TTC21A	chr3:39149152-39180394:+	0.19	4.43	1.15E-5	Handedness	
PRAD	cis	1	rs883838	chr9:135815474	C9orf98	chr9:135600965-135754198:-	0.19	3.65	0.000297	Psoriasis	
PRAD	cis	1	rs884247	chr14:65895706	LOC645431	chr14:65877313-65879335:-	-0.44	-4.48	9.29E-6	Ischemic stroke	
PRAD	cis	1	rs884613	chr20:25288505	ENTPD6	chr20:25176339-25207360:+	0.16	4.32	1.88E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs884613	chr20:25288505	FAM182B	chr20:25744102-25848786:-	-0.37	-6.81	3.08E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs884613	chr20:25288505	PYGB	chr20:25228706-25278647:+	0.33	7.21	2.22E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.48	-10.87	1.1E-24	Response to antipsychotic treatment	
PRAD	cis	1	rs884977	chr7:1066410	GPR146	chr7:1084243-1098897:+	0.23	3.46	0.000598	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs884977	chr7:1066410	ZFAND2A	chr7:1192544-1199855:-	-0.29	-4.64	4.49E-6	C-reactive protein levels or total cholesterol levels (pleiotropy)	
PRAD	cis	1	rs885387	chr9:115596390	C9orf80	chr9:115448793-115480387:-	0.28	3.85	0.000136	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs886716	chr7:26557618	LOC441204	chr7:26438339-26538594:+	-0.28	-5.29	1.83E-7	Smoking behavior	
PRAD	cis	1	rs886716	chr7:26557618	NFE2L3	chr7:26191847-26226754:+	-0.15	-3.75	0.000203	Smoking behavior	
PRAD	cis	1	rs886717	chr7:26558380	LOC441204	chr7:26438339-26538594:+	-0.28	-5.29	1.83E-7	Smoking behavior	
PRAD	cis	1	rs886717	chr7:26558380	NFE2L3	chr7:26191847-26226754:+	-0.15	-3.75	0.000203	Smoking behavior	
PRAD	cis	1	rs886719	chr7:26558545	LOC441204	chr7:26438339-26538594:+	-0.28	-5.29	1.87E-7	Smoking behavior	
PRAD	cis	1	rs886719	chr7:26558545	NFE2L3	chr7:26191847-26226754:+	-0.15	-3.73	0.000218	Smoking behavior	
PRAD	cis	1	rs887701	chr2:191562927	OSGEPL1	chr2:190611386-190627953:-	-0.22	-4.04	6.2E-5	Primary biliary cirrhosis	
PRAD	cis	1	rs888192	chr12:109995097	KCTD10	chr12:109886460-109915155:-	0.33	9.97	2.26E-21	HDL cholesterol	
PRAD	cis	1	rs888192	chr12:109995097	MMAB	chr12:109991523-110011358:-	0.18	5.36	1.29E-7	HDL cholesterol	
PRAD	cis	1	rs888192	chr12:109995097	MYO1H	chr12:109826524-109886176:+	0.25	5.48	7.03E-8	HDL cholesterol	
PRAD	cis	1	rs888192	chr12:109995097	UBE3B	chr12:109915439-109974506:+	0.14	3.51	0.000497	HDL cholesterol	
PRAD	cis	1	rs889122	chr19:9995867	PIN1	chr19:9945999-9960358:+	0.14	4.18	3.55E-5	Menarche (age at onset)	
PRAD	cis	1	rs889312	chr5:56031884	C5orf35	chr5:56205103-56213010:+	0.39	6.61	1.05E-10	Breast cancer (early onset);Breast cancer	
PRAD	cis	1	rs889648	chr16:11455816	C16orf75	chr16:11343506-11445617:+	0.26	4.22	2.98E-5	HDL cholesterol	
PRAD	cis	1	rs889704	chr16:71392062	ATXN1L	chr16:71879899-71919174:+	0.18	3.47	0.000573	Schizophrenia	
PRAD	cis	1	rs889704	chr16:71392062	DHX38	chr16:72127615-72146810:+	0.28	3.83	0.000144	Schizophrenia	
PRAD	cis	1	rs8897	chr3:49460407	AMIGO3	chr3:49754268-49757238:-	-0.43	-8.76	3.57E-17	Menarche (age at onset)	
PRAD	cis	1	rs8897	chr3:49460407	CCDC36	chr3:49235861-49295537:+	0.22	4.03	6.43E-5	Menarche (age at onset)	
PRAD	cis	1	rs8897	chr3:49460407	GMPPB	chr3:49758932-49761384:-	-0.48	-11.79	2.7E-28	Menarche (age at onset)	
PRAD	cis	1	rs8897	chr3:49460407	NCKIPSD	chr3:48711280-48723334:-	0.3	5.92	6.35E-9	Menarche (age at onset)	
PRAD	cis	1	rs8897	chr3:49460407	WDR6	chr3:49044637-49053386:+	-0.21	-4.11	4.59E-5	Menarche (age at onset)	
PRAD	cis	1	rs891368	chr3:53123273	ITIH4	chr3:52847007-52866554:-	0.15	4.56	6.6E-6	Height	
PRAD	cis	1	rs891376	chr1:207491489	CD55	chr1:207494817-207534309:+	0.23	4.06	5.72E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs891378	chr1:207490319	CD55	chr1:207494817-207534309:+	0.25	4.37	1.56E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs892055	chr19:38912764	PPP1R14A	chr19:38741879-38747172:-	0.09	3.47	0.000567	Asperger disorder	
PRAD	cis	1	rs892974	chr3:49398514	AMIGO3	chr3:49754268-49757238:-	-0.46	-9.13	2.04E-18	Menarche (age at onset)	
PRAD	cis	1	rs892974	chr3:49398514	CCDC36	chr3:49235861-49295537:+	0.22	3.86	0.000131	Menarche (age at onset)	
PRAD	cis	1	rs892974	chr3:49398514	GMPPB	chr3:49758932-49761384:-	-0.51	-12.15	9.47E-30	Menarche (age at onset)	
PRAD	cis	1	rs892974	chr3:49398514	NCKIPSD	chr3:48711280-48723334:-	0.29	5.6	3.73E-8	Menarche (age at onset)	
PRAD	cis	1	rs892974	chr3:49398514	WDR6	chr3:49044637-49053386:+	-0.2	-3.93	9.84E-5	Menarche (age at onset)	
PRAD	cis	1	rs893363	chr3:53847062	CHDH	chr3:53850388-53880419:-	0.16	3.76	0.00019	Axial length	
PRAD	cis	1	rs894157	chr15:90168108	GABARAPL3	chr15:90889765-90892679:-	0.41	3.91	0.000104	Obesity-related traits	
PRAD	cis	1	rs894157	chr15:90168108	PEX11A	chr15:90226289-90233958:-	-0.43	-5.01	7.54E-7	Obesity-related traits	
PRAD	cis	1	rs894737	chr12:54418143	FLJ12825	chr12:54452038-54516018:+	0.21	3.89	0.000114	Bone mineral density	
PRAD	cis	1	rs894738	chr12:54417525	FLJ12825	chr12:54452038-54516018:+	0.21	3.89	0.000114	Bone mineral density	
PRAD	cis	1	rs898225	chr3:48413179	ATRIP	chr3:48488141-48507708:+	-0.28	-6.57	1.31E-10	Longevity	
PRAD	cis	1	rs898225	chr3:48413179	CDC25A	chr3:48198668-48229801:-	-0.22	-4.15	3.89E-5	Longevity	
PRAD	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.18	4.86	1.6E-6	Longevity	
PRAD	cis	1	rs900012	chr11:116966435	PCSK7	chr11:117075789-117102811:-	-0.28	-3.63	0.000311	Protein quantitative trait loci	
PRAD	cis	1	rs901103	chr11:77931346	GAB2	chr11:77926343-78128766:-	-0.19	-5.8	1.25E-8	Testicular germ cell tumor	
PRAD	cis	1	rs901103	chr11:77931346	NARS2	chr11:78147017-78285909:-	-0.18	-3.49	0.00053	Testicular germ cell tumor	
PRAD	cis	1	rs901104	chr11:77930499	GAB2	chr11:77926343-78128766:-	-0.2	-5.83	1.06E-8	Testicular germ cell tumor	
PRAD	cis	1	rs901104	chr11:77930499	NARS2	chr11:78147017-78285909:-	-0.2	-3.71	0.000229	Testicular germ cell tumor	
PRAD	cis	1	rs901682	chr10:45965861	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs901683	chr10:45966422	MARCH8	chr10:45952817-46090354:-	0.25	5.68	2.38E-8	Red blood cell traits	
PRAD	cis	1	rs901684	chr10:45966628	MARCH8	chr10:45952817-46090354:-	0.25	5.41	1.01E-7	Red blood cell traits	
PRAD	cis	1	rs902774	chr12:53273904	KRT8	chr12:53290971-53343626:-	-0.2	-3.84	0.000138	Prostate cancer	
PRAD	cis	1	rs905872	chr11:4613366	OR52I1	chr11:4615269-4616242:+	-0.46	-5.05	6.37E-7	Response to serotonin reuptake inhibitors in major depressive disorder	
PRAD	cis	1	rs906134	chr7:65444288	CCT6P1	chr7:65216092-65228661:+	0.33	5.68	2.33E-8	Diabetic kidney disease	
PRAD	cis	1	rs906134	chr7:65444288	CRCP	chr7:65579805-65619551:+	-0.32	-3.98	7.9E-5	Diabetic kidney disease	
PRAD	cis	1	rs909341	chr20:62328742	ZGPAT	chr20:62338794-62370459:+	-0.16	-5.34	1.48E-7	Atopic dermatitis	
PRAD	cis	1	rs910316	chr14:75626042	EIF2B2	chr14:75469612-75476292:+	0.25	5.12	4.51E-7	Height	
PRAD	cis	1	rs910316	chr14:75626042	MLH3	chr14:75480467-75518235:-	0.33	6.62	9.97E-11	Height	
PRAD	cis	1	rs910391	chr6:116575344	FAM26F	chr6:116782556-116784933:+	-0.16	-4.69	3.53E-6	Fast beta electroencephalogram	
PRAD	cis	1	rs910873	chr20:33171772	NECAB3	chr20:32244894-32262264:-	-0.32	-4.43	1.19E-5	Melanoma	
PRAD	cis	1	rs910997	chr20:25267301	ENTPD6	chr20:25176339-25207360:+	-0.16	-4.16	3.81E-5	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs910997	chr20:25267301	FAM182B	chr20:25744102-25848786:-	0.37	6.74	4.76E-11	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs910997	chr20:25267301	PYGB	chr20:25228706-25278647:+	-0.33	-7.09	5.03E-12	Liver enzyme levels (alkaline phosphatase)	
PRAD	cis	1	rs911411	chr20:47718431	CSE1L	chr20:47662838-47713484:+	0.19	4.74	2.86E-6	Anger	
PRAD	cis	1	rs913074	chr6:41538545	FOXP4	chr6:41514164-41570121:+	-0.2	-3.78	0.000175	Prostate cancer	
PRAD	cis	1	rs913527	chr6:3372245	SLC22A23	chr6:3269207-3456793:-	-0.2	-4.13	4.38E-5	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	
PRAD	cis	1	rs914187	chr21:42619749	BACE2	chr21:42539728-42648523:+	-0.26	-5.4	1.08E-7	Body mass index	
PRAD	cis	1	rs914187	chr21:42619749	PLAC4	chr21:42547159-42557166:-	-0.24	-4.72	3.07E-6	Body mass index	
PRAD	cis	1	rs916134	chr12:54069803	TARBP2	chr12:53894705-53900213:+	-0.14	-3.88	0.000118	Height	
PRAD	cis	1	rs916926	chr17:39030283	TMEM99	chr17:38975374-38992526:+	0.33	7.27	1.52E-12	Height	
PRAD	cis	1	rs9174	chr4:25419283	ZCCHC4	chr4:25314396-25372003:+	-0.21	-4.44	1.1E-5	Rheumatoid arthritis	
PRAD	cis	1	rs917665	chr4:17668504	MED28	chr4:17616273-17629791:+	-0.23	-5.91	6.55E-9	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.35	7.62	1.42E-13	Type 1 diabetes	
PRAD	cis	1	rs918814	chr2:23948466	C2orf84	chr2:24397531-24414566:+	-0.27	-5.17	3.54E-7	Obesity-related traits	
PRAD	cis	1	rs918814	chr2:23948466	LOC375190	chr2:24299728-24397519:+	0.23	6.57	1.36E-10	Obesity-related traits	
PRAD	cis	1	rs919433	chr2:198166565	PLCL1	chr2:198669426-199014606:+	-0.12	-3.89	0.000116	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	
PRAD	cis	1	rs919586	chr8:13174671	LONRF1	chr8:12579406-12612992:-	0.27	4.35	1.67E-5	Obesity-related traits	
PRAD	cis	1	rs9213	chr2:218386	SH3YL1	chr2:218138-264810:-	-0.79	-18.75	5.72E-59	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs921450	chr7:50623260	DDC	chr7:50526136-50633154:-	-0.24	-3.97	8.28E-5	Malaria	
PRAD	cis	1	rs921450	chr7:50623260	FIGNL1	chr7:50511834-50518088:-	0.23	6.19	1.34E-9	Malaria	
PRAD	cis	1	rs921451	chr7:50623285	DDC	chr7:50526136-50633154:-	0.23	3.84	0.000142	Malaria	
PRAD	cis	1	rs921451	chr7:50623285	FIGNL1	chr7:50511834-50518088:-	-0.22	-5.84	9.67E-9	Malaria	
PRAD	cis	1	rs9217	chr17:7363088	CHRNB1	chr17:7348406-7360931:+	0.35	7.08	5.12E-12	Height	
PRAD	cis	1	rs921943	chr5:78316476	BHMT2	chr5:78365583-78385273:+	0.1	3.78	0.000177	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs922075	chr3:48489398	ATRIP	chr3:48488141-48507708:+	-0.28	-6.78	3.54E-11	Longevity	
PRAD	cis	1	rs922075	chr3:48489398	CDC25A	chr3:48198668-48229801:-	-0.19	-3.62	0.000322	Longevity	
PRAD	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.18	4.99	8.37E-7	Longevity	
PRAD	cis	1	rs922483	chr8:11351912	FAM66D	chr8:11973291-12424354:+	-0.22	-3.44	0.00064	Systemic lupus erythematosus	
PRAD	cis	1	rs922664	chr15:84569555	NMB	chr15:85198362-85201802:-	-0.17	-3.98	7.98E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs925130	chr1:207503432	CD55	chr1:207494817-207534309:+	0.25	4.42	1.24E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs925131	chr1:207503721	CD55	chr1:207494817-207534309:+	0.24	4.16	3.81E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs9253	chr1:37958813	MEAF6	chr1:37958176-37980364:-	-0.35	-5.07	5.67E-7	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs9253	chr1:37958813	SNIP1	chr1:38002145-38019903:-	-0.27	-4.62	4.96E-6	Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs925410	chr2:160912652	LY75	chr2:160625141-160761262:-	-0.12	-4.09	5.14E-5	Idiopathic membranous nephropathy	
PRAD	cis	1	rs925410	chr2:160912652	PLA2R1	chr2:160798012-160919121:-	-0.23	-5.35	1.4E-7	Idiopathic membranous nephropathy	
PRAD	cis	1	rs925532	chr1:202533880	PPP1R12B	chr1:202317836-202557697:+	0.09	3.75	0.000198	Sex ratio	
PRAD	cis	1	rs925533	chr1:202534108	PPP1R12B	chr1:202317836-202557697:+	0.09	3.75	0.000198	Sex ratio	
PRAD	cis	1	rs926299	chr22:39095698	CBY1	chr22:39052658-39069853:+	0.14	4.1	4.79E-5	Resting heart rate	
PRAD	cis	1	rs926299	chr22:39095698	LOC646851	chr22:38974125-39052634:-	0.19	4.74	2.78E-6	Resting heart rate	
PRAD	cis	1	rs926345	chr20:39771947	ZHX3	chr20:39807089-39946242:-	-0.27	-5.93	5.76E-9	Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs926391	chr20:37690485	FAM83D	chr20:37554955-37581701:+	-0.21	-4.85	1.7E-6	Dialysis-related mortality	
PRAD	cis	1	rs926392	chr20:37690464	FAM83D	chr20:37554955-37581701:+	-0.21	-4.89	1.36E-6	Dialysis-related mortality	
PRAD	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.94	16.23	2.27E-47	Type 2 diabetes	
PRAD	cis	1	rs9287719	chr2:10710730	ODC1	chr2:10580508-10588453:-	0.22	4.08	5.3E-5	Prostate cancer	
PRAD	cis	1	rs9288316	chr2:202163483	ALS2CR12	chr2:202153148-202222101:-	0.28	4.83	1.87E-6	Melanoma;Esophageal squamous cell carcinoma	
PRAD	cis	1	rs9288316	chr2:202163483	PPIL3	chr2:201735680-201753999:-	-0.19	-3.57	0.000398	Melanoma;Esophageal squamous cell carcinoma	
PRAD	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.63	9.06	3.52E-18	Blood pressure (smoking interaction)	
PRAD	cis	1	rs9289275	chr3:125648659	SLC41A3	chr3:125725201-125820400:-	0.33	4.99	8.68E-7	Blood pressure (smoking interaction)	
PRAD	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.55	12.75	3.51E-32	Height	
PRAD	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.55	12.6	1.4E-31	Height	
PRAD	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.52	11.85	1.58E-28	Height	
PRAD	cis	1	rs9289476	chr3:134237103	CEP63	chr3:134204575-134293852:+	0.2	3.61	0.000335	Height	
PRAD	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.52	11.87	1.35E-28	Height	
PRAD	cis	1	rs9289478	chr3:134268619	CEP63	chr3:134204575-134293852:+	0.21	3.64	0.000303	Height	
PRAD	cis	1	rs929039	chr22:38071511	GALR3	chr22:38219389-38221502:+	0.25	4.38	1.47E-5	Fat distribution (HIV)	
PRAD	cis	1	rs929039	chr22:38071511	LGALS1	chr22:38071613-38075807:+	-0.09	-4.73	2.98E-6	Fat distribution (HIV)	
PRAD	cis	1	rs929039	chr22:38071511	LGALS2	chr22:37966254-37976024:-	0.16	4.25	2.61E-5	Fat distribution (HIV)	
PRAD	cis	1	rs9291659	chr4:17662360	MED28	chr4:17616273-17629791:+	0.2	4.9	1.35E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs9291683	chr4:10324160	DRD5	chr4:9783258-9785632:+	0.18	3.66	0.000285	Bone mineral density	
PRAD	cis	1	rs9295130	chr6:161068891	LPA	chr6:160952516-161087407:-	0.15	3.49	0.000536	Lipoprotein (a) levels	
PRAD	cis	1	rs9295695	chr6:26528250	BTN2A3	chr6:26422317-26431927:+	-0.26	-6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs9295695	chr6:26528250	ZNF184	chr6:27418522-27440897:-	0.17	3.59	0.000369	Educational attainment	
PRAD	cis	1	rs929596	chr2:234674476	UGT1A4	chr2:234627438-234681945:+	0.2	4.32	1.93E-5	Total bilirubin levels in HIV-1 infection	
PRAD	cis	1	rs9296365	chr6:41535379	FOXP4	chr6:41514164-41570121:+	-0.22	-4.16	3.79E-5	Prostate cancer	
PRAD	cis	1	rs9296404	chr6:42925803	CNPY3	chr6:42896860-42907007:+	0.22	7.06	5.9E-12	Plasma homocysteine levels (post-methionine load test)	
PRAD	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.66	15.76	3.23E-45	Plasma homocysteine levels (post-methionine load test)	
PRAD	cis	1	rs9296404	chr6:42925803	VEGFA	chr6:43737953-43754221:+	-0.18	-3.79	0.000173	Plasma homocysteine levels (post-methionine load test)	
PRAD	cis	1	rs9296504	chr6:46629505	CYP39A1	chr6:46517445-46620523:-	0.17	3.69	0.00025	QRS complex (Sokolow-Lyon)	
PRAD	cis	1	rs9296504	chr6:46629505	SLC25A27	chr6:46620679-46645925:+	0.18	7.42	5.36E-13	QRS complex (Sokolow-Lyon)	
PRAD	cis	1	rs9296505	chr6:46629841	CYP39A1	chr6:46517445-46620523:-	0.16	3.59	0.000361	QRS complex (Sokolow-Lyon)	
PRAD	cis	1	rs9296505	chr6:46629841	SLC25A27	chr6:46620679-46645925:+	0.18	7.4	6.42E-13	QRS complex (Sokolow-Lyon)	
PRAD	cis	1	rs9296616	chr6:49414235	CENPQ	chr6:49431096-49460820:+	-0.4	-8.12	4.17E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.16	4.45	1.08E-5	Folate pathway vitamin levels	
PRAD	cis	1	rs9296617	chr6:49428360	CENPQ	chr6:49431096-49460820:+	-0.41	-8.51	2.34E-16	Folate pathway vitamin levels	
PRAD	cis	1	rs9296617	chr6:49428360	MUT	chr6:49398994-49431031:-	0.19	5.2	3.03E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs9296832	chr6:56100909	COL21A1	chr6:55921389-56258892:-	0.25	7.36	8.34E-13	Pulse pressure	
PRAD	cis	1	rs9297950	chr8:96025659	C8orf38	chr8:95908040-96088396:+	-0.34	-6.07	2.59E-9	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs9297950	chr8:96025659	TP53INP1	chr8:95938201-95961615:-	0.23	3.64	0.000306	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs9297951	chr8:96041437	C8orf38	chr8:95908040-96088396:+	-0.39	-6.76	4.09E-11	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
PRAD	cis	1	rs929843	chr16:70045748	CLEC18C	chr16:69984626-70220796:+	0.26	4.09	5.11E-5	Menarche (age at onset)	
PRAD	cis	1	rs929843	chr16:70045748	EXOSC6	chr16:70284134-70285833:-	-0.27	-3.92	0.000103	Menarche (age at onset)	
PRAD	cis	1	rs929843	chr16:70045748	PDXDC2	chr16:70010210-70099851:-	-0.23	-5.45	8.1E-8	Menarche (age at onset)	
PRAD	cis	1	rs9298506	chr8:55437524	RP1	chr8:55528627-55682531:+	0.22	3.53	0.000462	Intracranial aneurysm	
PRAD	cis	1	rs9304341	chr18:44670263	KATNAL2	chr18:44497557-44628613:+	0.23	4.21	3.06E-5	Educational attainment	
PRAD	cis	1	rs9304578	chr19:39250337	LGALS7	chr19:39261608-39264157:-	0.19	4.17	3.65E-5	Heart rate	
PRAD	cis	1	rs9304742	chr19:53451291	ZNF816A	chr19:53452632-53466114:-	-0.26	-5.83	1.03E-8	Psoriasis	
PRAD	cis	1	rs9304861	chr19:35271888	LOC643719	chr19:35067639-35068596:-	-0.19	-3.44	0.000627	Alzheimer disease and age of onset	
PRAD	cis	1	rs9304861	chr19:35271888	ZNF302	chr19:35168567-35177302:+	-0.29	-5.48	7.04E-8	Alzheimer disease and age of onset	
PRAD	cis	1	rs9306329	chr22:39072454	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs9306329	chr22:39072454	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs9308731	chr2:111908262	ACOXL	chr2:111490150-111875799:+	0.21	3.65	0.000293	Chronic lymphocytic leukemia	
PRAD	cis	1	rs9308731	chr2:111908262	BCL2L11	chr2:111878491-111926022:+	-0.15	-3.45	0.000605	Chronic lymphocytic leukemia	
PRAD	cis	1	rs9309331	chr2:61141615	AHSA2	chr2:61404553-61414058:+	-0.19	-6.68	6.92E-11	Inflammatory skin disease	
PRAD	cis	1	rs9309331	chr2:61141615	C2orf74	chr2:61372243-61391964:+	0.33	5.66	2.67E-8	Inflammatory skin disease	
PRAD	cis	1	rs9309331	chr2:61141615	PUS10	chr2:61167550-61245365:-	-0.19	-3.46	0.000587	Inflammatory skin disease	
PRAD	cis	1	rs9309473	chr2:73743982	ALMS1P	chr2:73872046-73912692:+	0.49	8.43	4.15E-16	Metabolite levels	
PRAD	cis	1	rs9309473	chr2:73743982	NAT8	chr2:73867850-73869537:-	0.26	3.96	8.59E-5	Metabolite levels	
PRAD	cis	1	rs931058	chr5:150333698	LOC134466	chr5:150310000-150326146:-	0.63	8.08	5.58E-15	Crohn's disease	
PRAD	cis	1	rs931127	chr11:65405300	CTSW	chr11:65647284-65651212:+	0.2	4.84	1.79E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs931127	chr11:65405300	EIF1AD	chr11:65764017-65769588:-	-0.17	-3.68	0.000259	Systemic lupus erythematosus	
PRAD	cis	1	rs9311288	chr3:41804581	ULK4	chr3:41288091-42003660:-	0.85	14.04	1.21E-37	Diastolic blood pressure	
PRAD	cis	1	rs9311423	chr3:48420308	ATRIP	chr3:48488141-48507708:+	0.27	6.38	4.19E-10	Longevity	
PRAD	cis	1	rs9311423	chr3:48420308	CDC25A	chr3:48198668-48229801:-	0.22	4.13	4.32E-5	Longevity	
PRAD	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.18	-4.95	1.01E-6	Longevity	
PRAD	cis	1	rs9311474	chr3:52338852	LOC440957	chr3:52570621-52574586:+	-0.14	-4.24	2.68E-5	Electroencephalogram traits	
PRAD	cis	1	rs9311474	chr3:52338852	NEK4	chr3:52744803-52804951:-	-0.18	-5.01	7.89E-7	Electroencephalogram traits	
PRAD	cis	1	rs9311474	chr3:52338852	NT5DC2	chr3:52558386-52569093:-	-0.18	-4.1	4.94E-5	Electroencephalogram traits	
PRAD	cis	1	rs9311676	chr3:58470351	ABHD6	chr3:58223259-58280459:+	0.19	3.65	0.00029	Systemic lupus erythematosus	
PRAD	cis	1	rs9311676	chr3:58470351	PDHB	chr3:58413355-58419565:-	-0.35	-7.13	3.86E-12	Systemic lupus erythematosus	
PRAD	cis	1	rs931182	chr4:54243230	FIP1L1	chr4:54243820-54326102:+	-0.18	-3.93	9.9E-5	DNA methylation (variation)	
PRAD	cis	1	rs9313669	chr5:173646730	CPEB4	chr5:173315331-173387312:+	0.13	3.79	0.000171	Information processing speed	
PRAD	cis	1	rs9315204	chr13:33693837	KL	chr13:33590201-33640281:+	0.23	3.77	0.000182	Intracranial aneurysm	
PRAD	cis	1	rs9315204	chr13:33693837	STARD13	chr13:33677273-34250932:-	0.27	4.46	1.04E-5	Intracranial aneurysm	
PRAD	cis	1	rs931794	chr15:78826180	CHRNA3	chr15:78885397-78913322:-	0.27	4.67	3.88E-6	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs931794	chr15:78826180	CHRNA5	chr15:78857906-78886458:+	0.22	4.45	1.05E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs9318086	chr13:24432467	C1QTNF9	chr13:24553839-24896665:+	-0.28	-5.7	2.12E-8	Myopia (pathological)	
PRAD	cis	1	rs9318086	chr13:24432467	PCOTH	chr13:24463028-24466241:+	0.19	4.48	9.39E-6	Myopia (pathological)	
PRAD	cis	1	rs9320287	chr6:109744690	SMPD2	chr6:109761931-109765121:+	0.27	5.88	7.86E-9	Height	
PRAD	cis	1	rs9322193	chr6:149919143	NUP43	chr6:150045453-150067688:-	-0.59	-11.61	1.36E-27	Lung cancer	
PRAD	cis	1	rs9322193	chr6:149919143	ULBP2	chr6:150263136-150270366:+	0.23	4.86	1.57E-6	Lung cancer	
PRAD	cis	1	rs9322817	chr6:105232233	HACE1	chr6:105175968-105307794:-	-0.13	-3.44	0.000632	Thyroid stimulating hormone	
PRAD	cis	1	rs9324660	chr5:150257054	LOC134466	chr5:150310000-150326146:-	0.58	8.95	8.38E-18	Crohn's disease	
PRAD	cis	1	rs932644	chr6:167404187	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.28E-8	Crohn's disease	
PRAD	cis	1	rs9327608	chr5:130650134	P4HA2	chr5:131528306-131563556:-	0.23	4.15	3.95E-5	Life satisfaction	
PRAD	cis	1	rs932833	chr9:131884041	CRAT	chr9:131857075-131873070:-	0.22	4.12	4.55E-5	Blood metabolite ratios	
PRAD	cis	1	rs932835	chr9:131887071	CRAT	chr9:131857075-131873070:-	0.23	4.26	2.42E-5	Blood metabolite ratios	
PRAD	cis	1	rs9328573	chr15:100511004	C15orf51	chr15:100330361-100347132:-	0.16	3.68	0.000259	Urate levels in lean individuals	
PRAD	cis	1	rs9333289	chr2:187498107	FAM171B	chr2:187558789-187630684:+	0.15	3.46	0.00058	Urinary albumin-to-creatinine ratio;Urinary albumin-to-creatinine ratio in non-diabetics	
PRAD	cis	1	rs933683	chr5:78324003	BHMT2	chr5:78365583-78385273:+	0.09	3.67	0.000274	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs933684	chr5:78324075	BHMT2	chr5:78365583-78385273:+	0.1	3.89	0.000115	Blood trace element (Se levels);Blood and toenail selenium levels	
PRAD	cis	1	rs933856	chr15:50483736	SLC27A2	chr15:50474393-50528588:+	-0.18	-3.58	0.000383	Blood metabolite ratios	
PRAD	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.52	11.96	6.01E-29	Height	
PRAD	cis	1	rs934624	chr15:50968906	SPPL2A	chr15:50999739-51057910:-	0.25	5.19	3.16E-7	QT interval	
PRAD	cis	1	rs934625	chr15:50968756	SPPL2A	chr15:50999739-51057910:-	0.27	5.52	5.76E-8	QT interval	
PRAD	cis	1	rs9348968	chr6:35117251	UHRF1BP1	chr6:34759794-34853117:+	-0.12	-4.23	2.87E-5	Airway responsiveness in chronic obstructive pulmonary disease	
PRAD	cis	1	rs9349804	chr6:56098876	COL21A1	chr6:55921389-56258892:-	0.25	7.35	8.74E-13	Pulse pressure	
PRAD	cis	1	rs935334	chr14:76613678	C14orf118	chr14:76618259-76669133:+	0.15	3.78	0.000179	Blood pressure	
PRAD	cis	1	rs935334	chr14:76613678	ESRRB	chr14:76837690-76968178:+	0.27	3.68	0.000263	Blood pressure	
PRAD	cis	1	rs9355256	chr6:159375477	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs9356933	chr6:24321213	GPLD1	chr6:24428405-24489850:-	0.17	3.51	0.000497	Uric acid levels	
PRAD	cis	1	rs9357010	chr6:26527945	BTN2A3	chr6:26422317-26431927:+	0.25	6.43	3.1E-10	Educational attainment	
PRAD	cis	1	rs9357010	chr6:26527945	HIST1H2AG	chr6:27100817-27101313:+	0.18	3.52	0.000469	Educational attainment	
PRAD	cis	1	rs9357010	chr6:26527945	ZNF184	chr6:27418522-27440897:-	-0.17	-3.63	0.000314	Educational attainment	
PRAD	cis	1	rs9357037	chr6:27327349	C6orf41	chr6:26924772-26991752:+	0.19	3.53	0.000456	Glomerular filtration rate (creatinine)	
PRAD	cis	1	rs9357512	chr6:46642875	TDRD6	chr6:46655866-46670149:+	-0.28	-4.85	1.68E-6	Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs9357619	chr6:49490094	CENPQ	chr6:49431096-49460820:+	0.22	4.39	1.38E-5	Brain structure	
PRAD	cis	1	rs9358270	chr6:19780584	ID4	chr6:19837617-19840914:+	0.14	3.52	0.00047	Endometriosis	
PRAD	cis	1	rs936228	chr15:75132164	MPI	chr15:75182410-75190565:+	0.18	4.49	8.87E-6	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
PRAD	cis	1	rs936228	chr15:75132164	ULK3	chr15:75128459-75135552:-	-0.14	-3.74	0.00021	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
PRAD	cis	1	rs936229	chr15:75132319	MPI	chr15:75182410-75190565:+	0.18	4.54	7.3E-6	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
PRAD	cis	1	rs936229	chr15:75132319	ULK3	chr15:75128459-75135552:-	-0.15	-3.82	0.000151	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
PRAD	cis	1	rs9362426	chr6:88089874	C6orf165	chr6:88117721-88205858:+	-0.53	-10.12	6.37E-22	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs9362426	chr6:88089874	SLC35A1	chr6:88146444-88222051:+	-0.2	-3.86	0.000129	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs9364505	chr6:159375426	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs9364554	chr6:160833664	SLC22A2	chr6:160592093-160679959:-	-0.2	-3.63	0.000316	Prostate cancer (gene x gene interaction);Prostate cancer	
PRAD	cis	1	rs9365012	chr6:159373408	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs9365013	chr6:159373446	RSPH3	chr6:159398268-159421198:-	0.28	4.42	1.21E-5	Bladder cancer (smoking interaction)	
PRAD	cis	1	rs936525	chr19:23056189	ZNF492	chr19:22817126-22850472:+	-0.29	-3.87	0.000126	Bronchopulmonary dysplasia	
PRAD	cis	1	rs936526	chr19:23055987	ZNF492	chr19:22817126-22850472:+	-0.32	-4.15	3.96E-5	Bronchopulmonary dysplasia	
PRAD	cis	1	rs9366567	chr6:24323858	GPLD1	chr6:24428405-24489850:-	-0.19	-3.68	0.000261	Uric acid levels	
PRAD	cis	1	rs9366664	chr6:10892499	ELOVL2	chr6:10980995-11044624:-	-0.39	-7.33	9.91E-13	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9366664	chr6:10892499	MAK	chr6:10762957-10838760:-	-0.32	-6.13	1.91E-9	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9366664	chr6:10892499	SYCP2L	chr6:10747995-10974539:+	-0.24	-3.83	0.000147	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9366716	chr6:11042418	ELOVL2	chr6:10980995-11044624:-	0.79	13.53	1.87E-35	Blood metabolite ratios	
PRAD	cis	1	rs9366716	chr6:11042418	MAK	chr6:10762957-10838760:-	0.34	5.36	1.34E-7	Blood metabolite ratios	
PRAD	cis	1	rs9367243	chr6:46316112	TNFRSF21	chr6:47199269-47277680:-	-0.18	-3.67	0.000267	Body mass index	
PRAD	cis	1	rs9368564	chr6:11060283	ELOVL2	chr6:10980995-11044624:-	0.79	13.52	1.97E-35	Blood metabolite ratios	
PRAD	cis	1	rs9368564	chr6:11060283	MAK	chr6:10762957-10838760:-	0.34	5.3	1.8E-7	Blood metabolite ratios	
PRAD	cis	1	rs9368849	chr6:35118236	UHRF1BP1	chr6:34759794-34853117:+	-0.12	-4.19	3.31E-5	Airway responsiveness in chronic obstructive pulmonary disease	
PRAD	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.43	-9.17	1.53E-18	Homocysteine levels	
PRAD	cis	1	rs9369911	chr6:49637781	RHAG	chr6:49572893-49604587:-	0.29	4.56	6.47E-6	Prothrombin fragments F1+2 levels in ischemic stroke	
PRAD	cis	1	rs937108	chr7:65428452	CCT6P1	chr7:65216092-65228661:+	0.32	5.71	2.06E-8	Diabetic kidney disease	
PRAD	cis	1	rs937108	chr7:65428452	CRCP	chr7:65579805-65619551:+	-0.27	-3.48	0.000543	Diabetic kidney disease	
PRAD	cis	1	rs9371884	chr6:155645607	TFB1M	chr6:155578791-155635626:-	-0.43	-5.94	5.69E-9	Life satisfaction	
PRAD	cis	1	rs937495	chr7:65779798	TPST1	chr7:65670259-65825437:+	-0.18	-4.49	9.12E-6	Aortic root size	
PRAD	cis	1	rs9377228	chr6:149921998	NUP43	chr6:150045453-150067688:-	-0.61	-12.18	7.81E-30	Lung cancer	
PRAD	cis	1	rs9377228	chr6:149921998	ULBP2	chr6:150263136-150270366:+	0.27	5.82	1.07E-8	Lung cancer	
PRAD	cis	1	rs9377229	chr6:149928791	NUP43	chr6:150045453-150067688:-	-0.59	-11.6	1.61E-27	Lung cancer	
PRAD	cis	1	rs9377229	chr6:149928791	ULBP2	chr6:150263136-150270366:+	0.23	4.87	1.5E-6	Lung cancer	
PRAD	cis	1	rs9380378	chr6:33765479	LEMD2	chr6:33738991-33756906:-	-0.22	-7.03	7.55E-12	Crohn's disease	
PRAD	cis	1	rs9380516	chr6:35502202	TULP1	chr6:35465653-35480647:-	-0.32	-4.55	6.96E-6	Hepatitis C induced liver fibrosis	
PRAD	cis	1	rs9381040	chr6:41154650	LOC221442	chr6:41068773-41108567:+	0.17	4.55	6.71E-6	Alzheimer's disease (late onset)	
PRAD	cis	1	rs9381040	chr6:41154650	TREM2	chr6:41126246-41130922:-	0.18	3.85	0.000133	Alzheimer's disease (late onset)	
PRAD	cis	1	rs9381080	chr6:41527698	FOXP4	chr6:41514164-41570121:+	-0.22	-4.17	3.63E-5	Prostate cancer	
PRAD	cis	1	rs9381082	chr6:41542214	FOXP4	chr6:41514164-41570121:+	-0.2	-3.88	0.000119	Prostate cancer	
PRAD	cis	1	rs9381469	chr6:46630068	CYP39A1	chr6:46517445-46620523:-	-0.16	-3.48	0.000539	QRS complex (Sokolow-Lyon)	
PRAD	cis	1	rs9381469	chr6:46630068	SLC25A27	chr6:46620679-46645925:+	-0.18	-7.22	2.18E-12	QRS complex (Sokolow-Lyon)	
PRAD	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.38	7.68	9.15E-14	Homocysteine levels	
PRAD	cis	1	rs9381813	chr6:49638243	RHAG	chr6:49572893-49604587:-	0.29	4.61	5.1E-6	Prothrombin fragments F1+2 levels in ischemic stroke	
PRAD	cis	1	rs938295	chr1:16087260	FBLIM1	chr1:16083154-16114431:+	0.18	3.71	0.00023	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs9383649	chr6:153428102	RGS17	chr6:153332041-153452389:-	-0.56	-13.6	9.54E-36	Prostate cancer	
PRAD	cis	1	rs9384082	chr6:153440515	RGS17	chr6:153332041-153452389:-	-0.55	-13.21	4.36E-34	Prostate cancer	
PRAD	cis	1	rs938875	chr15:67952922	IQCH	chr15:67547188-67794139:+	0.3	6.18	1.35E-9	Motion sickness	
PRAD	cis	1	rs938878	chr15:67993366	IQCH	chr15:67547188-67794139:+	0.3	6.21	1.14E-9	Motion sickness	
PRAD	cis	1	rs9392918	chr6:7708631	BMP6	chr6:7727011-7881960:+	-0.22	-4.26	2.42E-5	Height	
PRAD	cis	1	rs9393692	chr6:26276650	BTN3A2	chr6:26365398-26378546:+	0.18	4.03	6.4E-5	Educational attainment	
PRAD	cis	1	rs9393692	chr6:26276650	HIST1H3E	chr6:26224427-26226589:+	0.19	3.86	0.000128	Educational attainment	
PRAD	cis	1	rs9393728	chr6:26509330	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.21E-10	Educational attainment	
PRAD	cis	1	rs9393728	chr6:26509330	ZNF184	chr6:27418522-27440897:-	-0.18	-3.72	0.000225	Educational attainment	
PRAD	cis	1	rs9393729	chr6:26514166	BTN2A3	chr6:26422317-26431927:+	0.25	6.4	3.76E-10	Educational attainment	
PRAD	cis	1	rs9393729	chr6:26514166	ZNF184	chr6:27418522-27440897:-	-0.18	-3.71	0.000232	Educational attainment	
PRAD	cis	1	rs9393731	chr6:26529374	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs9393731	chr6:26529374	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs9393732	chr6:26530898	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs9393732	chr6:26530898	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs9393903	chr6:11042909	ELOVL2	chr6:10980995-11044624:-	-0.79	-13.58	1.12E-35	Blood metabolite ratios	
PRAD	cis	1	rs9393903	chr6:11042909	MAK	chr6:10762957-10838760:-	-0.34	-5.36	1.31E-7	Blood metabolite ratios	
PRAD	cis	1	rs9393915	chr6:11072322	ELOVL2	chr6:10980995-11044624:-	0.76	13.14	8.18E-34	Blood metabolite ratios	
PRAD	cis	1	rs9393915	chr6:11072322	MAK	chr6:10762957-10838760:-	0.31	4.94	1.1E-6	Blood metabolite ratios	
PRAD	cis	1	rs9394166	chr6:33751122	LEMD2	chr6:33738991-33756906:-	-0.21	-6.69	6.38E-11	Crohn's disease	
PRAD	cis	1	rs9394766	chr6:41159801	LOC221442	chr6:41068773-41108567:+	0.17	4.46	1.05E-5	Alzheimer's disease (late onset)	
PRAD	cis	1	rs9394767	chr6:41159905	LOC221442	chr6:41068773-41108567:+	0.18	4.55	6.74E-6	Alzheimer's disease (late onset)	
PRAD	cis	1	rs9394931	chr6:42873245	CNPY3	chr6:42896860-42907007:+	-0.15	-4.69	3.6E-6	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
PRAD	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.36	-7.43	5.02E-13	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
PRAD	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.43	-9.19	1.32E-18	Homocysteine levels	
PRAD	cis	1	rs9395521	chr6:49637947	RHAG	chr6:49572893-49604587:-	0.29	4.61	5.1E-6	Prothrombin fragments F1+2 levels in ischemic stroke	
PRAD	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-0.89	-15.01	6.71E-42	Diastolic blood pressure	
PRAD	cis	1	rs9397240	chr6:155648579	TFB1M	chr6:155578791-155635626:-	0.41	6.03	3.3E-9	Life satisfaction	
PRAD	cis	1	rs9398235	chr6:110732116	DDO	chr6:110713384-110736753:-	-0.21	-3.59	0.000366	Systemic lupus erythematosus	
PRAD	cis	1	rs9399693	chr6:149933854	NUP43	chr6:150045453-150067688:-	-0.61	-12.06	2.29E-29	Lung cancer	
PRAD	cis	1	rs9399693	chr6:149933854	ULBP2	chr6:150263136-150270366:+	0.26	5.64	2.95E-8	Lung cancer	
PRAD	cis	1	rs940045	chr3:49449638	AMIGO3	chr3:49754268-49757238:-	-0.41	-8.5	2.57E-16	Menarche (age at onset)	
PRAD	cis	1	rs940045	chr3:49449638	CCDC36	chr3:49235861-49295537:+	0.25	4.5	8.75E-6	Menarche (age at onset)	
PRAD	cis	1	rs940045	chr3:49449638	GMPPB	chr3:49758932-49761384:-	-0.46	-11.27	2.94E-26	Menarche (age at onset)	
PRAD	cis	1	rs940045	chr3:49449638	NCKIPSD	chr3:48711280-48723334:-	0.28	5.74	1.69E-8	Menarche (age at onset)	
PRAD	cis	1	rs940045	chr3:49449638	P4HTM	chr3:49027341-49044579:+	0.15	3.54	0.00044	Menarche (age at onset)	
PRAD	cis	1	rs940045	chr3:49449638	WDR6	chr3:49044637-49053386:+	-0.2	-3.99	7.54E-5	Menarche (age at onset)	
PRAD	cis	1	rs9400478	chr6:111799644	KIAA1919	chr6:111580482-111590259:+	-0.41	-4.08	5.31E-5	Psoriasis	
PRAD	cis	1	rs940341	chr2:228724726	CCL20	chr2:228678558-228682280:+	0.27	4.8	2.13E-6	Blood pressure	
PRAD	cis	1	rs9409123	chr9:115507165	C9orf80	chr9:115448793-115480387:-	-0.26	-3.61	0.000345	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs940934	chr15:84575528	NMB	chr15:85198362-85201802:-	-0.17	-3.96	8.6E-5	Waist circumference adjusted for body mass index;Waist circumference	
PRAD	cis	1	rs9410	chr4:159631991	ETFDH	chr4:159593277-159629839:+	0.23	4.17	3.6E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
PRAD	cis	1	rs941653	chr14:35592538	PPP2R3C	chr14:35554679-35591679:-	0.4	6.36	4.81E-10	Atopic dermatitis	
PRAD	cis	1	rs9419788	chr10:96013705	HELLS	chr10:96305543-96361855:+	-0.15	-3.47	0.000573	Personality traits in bipolar disorder	
PRAD	cis	1	rs9419897	chr10:102246125	SEC31B	chr10:102246403-102289636:-	-0.32	-9.78	1.14E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs942023	chr14:102972170	ANKRD9	chr14:102973198-102976128:-	0.18	4.35	1.65E-5	QT interval	
PRAD	cis	1	rs942023	chr14:102972170	TRAF3	chr14:103243816-103372628:+	0.15	3.48	0.000543	QT interval	
PRAD	cis	1	rs9420782	chr10:102235015	SEC31B	chr10:102246403-102289636:-	-0.31	-9.62	3.91E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs9420785	chr10:102240451	SEC31B	chr10:102246403-102289636:-	-0.31	-9.74	1.57E-20	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs9420797	chr10:102331147	SEC31B	chr10:102246403-102289636:-	-0.26	-8.3	1.13E-15	Palmitoleic acid (16:1n-7) plasma levels	
PRAD	cis	1	rs9420	chr11:57510294	MED19	chr11:57471182-57479673:-	0.18	3.89	0.000114	Schizophrenia	
PRAD	cis	1	rs9420	chr11:57510294	TIMM10	chr11:57295936-57298232:-	0.17	4.44	1.12E-5	Schizophrenia	
PRAD	cis	1	rs9422439	chr10:46040473	MARCH8	chr10:45952817-46090354:-	0.25	5.52	5.59E-8	Red blood cell traits	
PRAD	cis	1	rs9422440	chr10:46045125	MARCH8	chr10:45952817-46090354:-	0.25	5.51	5.85E-8	Red blood cell traits	
PRAD	cis	1	rs9422441	chr10:46048053	MARCH8	chr10:45952817-46090354:-	0.25	5.51	6.06E-8	Red blood cell traits	
PRAD	cis	1	rs9422442	chr10:46048078	MARCH8	chr10:45952817-46090354:-	0.25	5.51	6.06E-8	Red blood cell traits	
PRAD	cis	1	rs9422650	chr10:46045761	MARCH8	chr10:45952817-46090354:-	0.25	5.44	8.55E-8	Red blood cell traits	
PRAD	cis	1	rs9422651	chr10:46047456	MARCH8	chr10:45952817-46090354:-	0.25	5.51	5.85E-8	Red blood cell traits	
PRAD	cis	1	rs9422652	chr10:46047934	MARCH8	chr10:45952817-46090354:-	0.25	5.39	1.11E-7	Red blood cell traits	
PRAD	cis	1	rs9422653	chr10:46048918	MARCH8	chr10:45952817-46090354:-	-0.24	-5.26	2.16E-7	Red blood cell traits	
PRAD	cis	1	rs9422654	chr10:46051401	MARCH8	chr10:45952817-46090354:-	0.25	5.42	9.35E-8	Red blood cell traits	
PRAD	cis	1	rs9422655	chr10:46051408	MARCH8	chr10:45952817-46090354:-	0.25	5.45	8.22E-8	Red blood cell traits	
PRAD	cis	1	rs942270	chr1:76177332	ACADM	chr1:76190043-76229353:+	0.18	3.97	8.24E-5	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs9425766	chr1:173853127	ANKRD45	chr1:173577475-173639001:-	0.31	6.11	2.1E-9	Life satisfaction	
PRAD	cis	1	rs9426691	chr1:23484904	C1orf213	chr1:23695464-23698278:+	-0.17	-3.78	0.000175	Coenzyme Q10 levels	
PRAD	cis	1	rs9429183	chr1:46524582	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.33	1.82E-30	Body mass index	
PRAD	cis	1	rs9429183	chr1:46524582	MMACHC	chr1:45965856-45976737:+	-0.17	-3.96	8.66E-5	Body mass index	
PRAD	cis	1	rs9429183	chr1:46524582	MUTYH	chr1:45794915-45806142:-	0.19	5.64	3.01E-8	Body mass index	
PRAD	cis	1	rs9433030	chr1:86901465	CLCA2	chr1:86889769-86922238:+	0.29	5.19	3.09E-7	Crohn's disease-related phenotypes	
PRAD	cis	1	rs943461	chr6:33769409	LEMD2	chr6:33738991-33756906:-	0.2	5.25	2.35E-7	Body mass index	
PRAD	cis	1	rs943462	chr6:33769578	LEMD2	chr6:33738991-33756906:-	0.2	5.25	2.35E-7	Body mass index	
PRAD	cis	1	rs943466	chr6:33731787	LEMD2	chr6:33738991-33756906:-	-0.17	-4.32	1.87E-5	Body mass index	
PRAD	cis	1	rs943477	chr6:33750931	LEMD2	chr6:33738991-33756906:-	-0.23	-7.02	7.63E-12	Crohn's disease	
PRAD	cis	1	rs9436116	chr1:150454724	ADAMTSL4	chr1:150521898-150533410:+	0.12	4	7.43E-5	Morning vs. evening chronotype	
PRAD	cis	1	rs9439746	chr1:19111857	CAPZB	chr1:19665274-19811992:-	0.25	3.96	8.79E-5	Percentage gas trapping	
PRAD	cis	1	rs9439747	chr1:19111912	CAPZB	chr1:19665274-19811992:-	0.25	3.95	9.17E-5	Percentage gas trapping	
PRAD	cis	1	rs9443189	chr6:76495882	MYO6	chr6:76458909-76629254:+	0.24	4.8	2.12E-6	Prostate cancer	
PRAD	cis	1	rs944722	chr17:26092037	LGALS9	chr17:25958174-25976585:+	-0.09	-3.87	0.000123	Fractional exhaled nitric oxide (childhood)	
PRAD	cis	1	rs944990	chr9:96191004	ECM2	chr9:95255834-95298904:-	-0.1	-3.58	0.000384	Body mass index	
PRAD	cis	1	rs944990	chr9:96191004	NINJ1	chr9:95883772-95896570:-	0.16	3.71	0.000236	Body mass index	
PRAD	cis	1	rs9450662	chr6:88088593	C6orf164	chr6:88032306-88109459:+	-0.21	-4.38	1.49E-5	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs9450662	chr6:88088593	C6orf165	chr6:88117721-88205858:+	-0.54	-10.2	3.21E-22	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs9450662	chr6:88088593	SLC35A1	chr6:88146444-88222051:+	-0.23	-4.31	2.03E-5	Depressive episodes in bipolar disorder	
PRAD	cis	1	rs945635	chr1:157670290	FCRL3	chr1:157646278-157670775:-	0.18	4.99	8.44E-7	Type 1 diabetes autoantibodies	
PRAD	cis	1	rs9457247	chr6:167392174	RNASET2	chr6:167343008-167412795:-	-0.24	-5.79	1.32E-8	Crohn's disease	
PRAD	cis	1	rs945961	chr20:33769926	MMP24	chr20:33814539-33864804:+	-0.26	-3.97	8.39E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs9461259	chr6:26504835	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.21E-10	Educational attainment	
PRAD	cis	1	rs9461259	chr6:26504835	ZNF184	chr6:27418522-27440897:-	-0.18	-3.72	0.000225	Educational attainment	
PRAD	cis	1	rs9461271	chr6:26554968	BTN2A3	chr6:26422317-26431927:+	0.26	6.58	1.29E-10	Educational attainment	
PRAD	cis	1	rs9461271	chr6:26554968	ZNF184	chr6:27418522-27440897:-	-0.17	-3.51	0.000488	Educational attainment	
PRAD	cis	1	rs9462007	chr6:34715341	UHRF1BP1	chr6:34759794-34853117:+	0.17	4.63	4.7E-6	Pubertal anthropometrics	
PRAD	cis	1	rs9462016	chr6:34739790	UHRF1BP1	chr6:34759794-34853117:+	0.17	4.61	5.15E-6	Pubertal anthropometrics	
PRAD	cis	1	rs9463473	chr6:49380121	CENPQ	chr6:49431096-49460820:+	-0.39	-8.21	2.1E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.18	5.03	7.09E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs9463474	chr6:49380199	CENPQ	chr6:49431096-49460820:+	-0.39	-8.21	2.1E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.18	5.03	7.09E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs9463475	chr6:49380899	CENPQ	chr6:49431096-49460820:+	0.38	8.03	8.05E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.18	-5.02	7.18E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs9463477	chr6:49386446	CENPQ	chr6:49431096-49460820:+	-0.39	-8.21	2.1E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.18	5.03	7.09E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.43	-9.12	2.23E-18	Homocysteine levels	
PRAD	cis	1	rs9463479	chr6:49393275	CENPQ	chr6:49431096-49460820:+	-0.39	-8.21	2.1E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.18	5.03	7.09E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs9463480	chr6:49400795	CENPQ	chr6:49431096-49460820:+	-0.39	-8.12	4.28E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.18	5.06	6.01E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs946529	chr1:46485548	CCDC163P	chr1:45960581-45965646:-	-0.53	-12.11	1.39E-29	Body mass index	
PRAD	cis	1	rs946529	chr1:46485548	MMACHC	chr1:45965856-45976737:+	-0.17	-3.73	0.000212	Body mass index	
PRAD	cis	1	rs946529	chr1:46485548	MUTYH	chr1:45794915-45806142:-	0.21	6.12	1.97E-9	Body mass index	
PRAD	cis	1	rs9467176	chr6:24464907	GPLD1	chr6:24428405-24489850:-	-0.48	-10.21	3.19E-22	Hematological and biochemical traits	
PRAD	cis	1	rs9467176	chr6:24464907	MRS2	chr6:24403153-24425809:+	-0.27	-4.47	9.9E-6	Hematological and biochemical traits	
PRAD	cis	1	rs9467182	chr6:24468654	GPLD1	chr6:24428405-24489850:-	0.49	10.45	3.91E-23	Hematological and biochemical traits	
PRAD	cis	1	rs9467182	chr6:24468654	MRS2	chr6:24403153-24425809:+	0.27	4.46	1.05E-5	Hematological and biochemical traits	
PRAD	cis	1	rs9467190	chr6:24474771	GPLD1	chr6:24428405-24489850:-	0.48	10.38	7.37E-23	Hematological and biochemical traits	
PRAD	cis	1	rs9467190	chr6:24474771	MRS2	chr6:24403153-24425809:+	0.26	4.44	1.15E-5	Hematological and biochemical traits	
PRAD	cis	1	rs9467773	chr6:26498426	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.21E-10	Educational attainment	
PRAD	cis	1	rs9467773	chr6:26498426	ZNF184	chr6:27418522-27440897:-	-0.18	-3.72	0.000225	Educational attainment	
PRAD	cis	1	rs9467774	chr6:26505036	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.21E-10	Educational attainment	
PRAD	cis	1	rs9467774	chr6:26505036	ZNF184	chr6:27418522-27440897:-	-0.18	-3.72	0.000225	Educational attainment	
PRAD	cis	1	rs9467778	chr6:26534743	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs9467778	chr6:26534743	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs9467779	chr6:26536687	BTN2A3	chr6:26422317-26431927:+	-0.26	-6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs9467779	chr6:26536687	ZNF184	chr6:27418522-27440897:-	0.17	3.59	0.000369	Educational attainment	
PRAD	cis	1	rs9467782	chr6:26542773	BTN2A3	chr6:26422317-26431927:+	0.26	6.54	1.62E-10	Educational attainment	
PRAD	cis	1	rs9467782	chr6:26542773	ZNF184	chr6:27418522-27440897:-	-0.17	-3.59	0.000369	Educational attainment	
PRAD	cis	1	rs9467783	chr6:26542894	BTN2A3	chr6:26422317-26431927:+	0.25	6.35	5.15E-10	Educational attainment	
PRAD	cis	1	rs9467783	chr6:26542894	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.44	0.000638	Educational attainment	
PRAD	cis	1	rs9467783	chr6:26542894	ZNF184	chr6:27418522-27440897:-	-0.19	-3.95	9.08E-5	Educational attainment	
PRAD	cis	1	rs9467787	chr6:26556769	BTN2A3	chr6:26422317-26431927:+	0.26	6.58	1.29E-10	Educational attainment	
PRAD	cis	1	rs9467787	chr6:26556769	ZNF184	chr6:27418522-27440897:-	-0.17	-3.51	0.000488	Educational attainment	
PRAD	cis	1	rs9467791	chr6:26562486	BTN2A3	chr6:26422317-26431927:+	-0.26	-6.41	3.64E-10	Educational attainment	
PRAD	cis	1	rs9467791	chr6:26562486	HIST1H2AG	chr6:27100817-27101313:+	-0.18	-3.58	0.000386	Educational attainment	
PRAD	cis	1	rs9467791	chr6:26562486	ZNF184	chr6:27418522-27440897:-	0.18	3.78	0.000175	Educational attainment	
PRAD	cis	1	rs9467796	chr6:26568411	BTN2A3	chr6:26422317-26431927:+	0.26	6.44	3.0E-10	Educational attainment	
PRAD	cis	1	rs9467796	chr6:26568411	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.44	0.00064	Educational attainment	
PRAD	cis	1	rs9467796	chr6:26568411	ZNF184	chr6:27418522-27440897:-	-0.18	-3.74	0.000206	Educational attainment	
PRAD	cis	1	rs9467797	chr6:26568473	BTN2A3	chr6:26422317-26431927:+	0.26	6.44	3.0E-10	Educational attainment	
PRAD	cis	1	rs9467797	chr6:26568473	HIST1H2AG	chr6:27100817-27101313:+	0.17	3.44	0.00064	Educational attainment	
PRAD	cis	1	rs9467797	chr6:26568473	ZNF184	chr6:27418522-27440897:-	-0.18	-3.74	0.000206	Educational attainment	
PRAD	cis	1	rs9468186	chr6:27626631	ZNF184	chr6:27418522-27440897:-	0.2	3.71	0.000234	Neuroticism	
PRAD	cis	1	rs9468186	chr6:27626631	ZNF323	chr6:28292517-28324048:-	0.3	4.64	4.54E-6	Neuroticism	
PRAD	cis	1	rs9468186	chr6:27626631	ZSCAN23	chr6:28393287-28411279:-	0.11	3.51	0.000483	Neuroticism	
PRAD	cis	1	rs9469860	chr6:34724815	UHRF1BP1	chr6:34759794-34853117:+	0.17	4.5	8.49E-6	Pubertal anthropometrics	
PRAD	cis	1	rs9469890	chr6:34763982	UHRF1BP1	chr6:34759794-34853117:+	0.17	4.61	5.15E-6	Pubertal anthropometrics	
PRAD	cis	1	rs9471491	chr6:41153622	UNC5CL	chr6:40994772-41039015:-	0.3	3.68	0.000259	C-reactive protein	
PRAD	cis	1	rs947211	chr1:205752665	PM20D1	chr1:205797154-205819245:-	-0.2	-3.43	0.000655	Parkinson's disease	
PRAD	cis	1	rs947211	chr1:205752665	RAB7L1	chr1:205737115-205744610:-	0.31	6.28	7.93E-10	Parkinson's disease	
PRAD	cis	1	rs9472819	chr6:46653789	TDRD6	chr6:46655866-46670149:+	-0.29	-5.1	5.05E-7	Lipoprotein-associated phospholipase A2 activity and mass	
PRAD	cis	1	rs9473549	chr6:49380020	CENPQ	chr6:49431096-49460820:+	-0.39	-7.96	1.28E-14	Folate pathway vitamin levels	
PRAD	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.16	4.3	2.07E-5	Folate pathway vitamin levels	
PRAD	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.4	-8.52	2.15E-16	Homocysteine levels	
PRAD	cis	1	rs9473552	chr6:49387154	CENPQ	chr6:49431096-49460820:+	-0.39	-8.21	2.1E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.18	5.03	7.09E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs9473553	chr6:49395977	CENPQ	chr6:49431096-49460820:+	-0.39	-8.14	3.68E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.18	5.04	6.65E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs9473555	chr6:49409487	CENPQ	chr6:49431096-49460820:+	-0.39	-8.19	2.45E-15	Folate pathway vitamin levels	
PRAD	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.18	5.05	6.42E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs9473560	chr6:49427918	CENPQ	chr6:49431096-49460820:+	-0.41	-8.51	2.34E-16	Folate pathway vitamin levels	
PRAD	cis	1	rs9473560	chr6:49427918	MUT	chr6:49398994-49431031:-	0.19	5.2	3.03E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs9473561	chr6:49428755	CENPQ	chr6:49431096-49460820:+	-0.41	-8.73	4.39E-17	Folate pathway vitamin levels	
PRAD	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.19	5.23	2.55E-7	Folate pathway vitamin levels	
PRAD	cis	1	rs9473563	chr6:49453651	CENPQ	chr6:49431096-49460820:+	-0.38	-7.83	3.26E-14	Folate pathway vitamin levels	
PRAD	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.16	4.31	2.01E-5	Folate pathway vitamin levels	
PRAD	cis	1	rs9473582	chr6:49488908	CENPQ	chr6:49431096-49460820:+	0.21	4.24	2.72E-5	Brain structure	
PRAD	cis	1	rs9475752	chr6:56780741	BEND6	chr6:56819773-56892138:+	-0.59	-11.54	2.73E-27	Menarche (age at onset)	
PRAD	cis	1	rs947583	chr6:136133659	C6orf217	chr6:135818939-136037192:+	-0.29	-4.72	3.12E-6	Phosphorus levels	
PRAD	cis	1	rs947609	chr9:115516562	C9orf80	chr9:115448793-115480387:-	0.28	3.7	0.000245	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9479517	chr6:153442789	RGS17	chr6:153332041-153452389:-	-0.56	-13.53	1.82E-35	Prostate cancer	
PRAD	cis	1	rs9480933	chr6:109671391	SMPD2	chr6:109761931-109765121:+	0.25	5.25	2.27E-7	Height	
PRAD	cis	1	rs9480953	chr6:109739144	SMPD2	chr6:109761931-109765121:+	0.25	5.43	8.99E-8	Height	
PRAD	cis	1	rs9480955	chr6:109744533	SMPD2	chr6:109761931-109765121:+	0.27	5.88	7.86E-9	Height	
PRAD	cis	1	rs9481808	chr6:118784571	C6orf204	chr6:118786239-119031238:-	-0.14	-3.45	0.000621	Renal cell carcinoma	
PRAD	cis	1	rs9481825	chr6:118876092	C6orf204	chr6:118786239-119031238:-	-0.15	-3.65	0.000295	Renal cell carcinoma	
PRAD	cis	1	rs9482848	chr6:128280375	THEMIS	chr6:128029346-128239742:-	-0.15	-3.59	0.000365	Crohn's disease	
PRAD	cis	1	rs9483335	chr6:132059074	ENPP3	chr6:131949582-132068549:+	-0.39	-4	7.21E-5	Response to fenofibrate (adiponectin levels)	
PRAD	cis	1	rs9485369	chr6:149604833	ULBP2	chr6:150263136-150270366:+	0.2	3.63	0.000315	Breast cancer	
PRAD	cis	1	rs9485370	chr6:149606801	ULBP2	chr6:150263136-150270366:+	0.2	3.63	0.000315	Breast cancer	
PRAD	cis	1	rs9485371	chr6:149606888	ULBP2	chr6:150263136-150270366:+	0.2	3.63	0.000315	Breast cancer	
PRAD	cis	1	rs9485372	chr6:149608874	ULBP2	chr6:150263136-150270366:+	0.2	3.63	0.000315	Breast cancer	
PRAD	cis	1	rs9485373	chr6:149609417	ULBP2	chr6:150263136-150270366:+	0.2	3.62	0.000326	Breast cancer	
PRAD	cis	1	rs948662	chr11:77979829	GAB2	chr11:77926343-78128766:-	-0.2	-6.24	9.7E-10	Testicular germ cell tumor	
PRAD	cis	1	rs948662	chr11:77979829	NARS2	chr11:78147017-78285909:-	-0.24	-4.93	1.13E-6	Testicular germ cell tumor	
PRAD	cis	1	rs9487094	chr6:109742015	SMPD2	chr6:109761931-109765121:+	0.25	5.46	7.56E-8	Height	
PRAD	cis	1	rs9487605	chr6:111582885	KIAA1919	chr6:111580482-111590259:+	-0.39	-8.16	3.1E-15	Inflammatory skin disease	
PRAD	cis	1	rs9489394	chr6:118758234	C6orf204	chr6:118786239-119031238:-	-0.14	-3.49	0.000525	Renal cell carcinoma	
PRAD	cis	1	rs9489395	chr6:118758884	C6orf204	chr6:118786239-119031238:-	-0.14	-3.49	0.000525	Renal cell carcinoma	
PRAD	cis	1	rs9489399	chr6:118767147	C6orf204	chr6:118786239-119031238:-	-0.14	-3.49	0.000525	Renal cell carcinoma	
PRAD	cis	1	rs9491892	chr6:128280358	THEMIS	chr6:128029346-128239742:-	-0.15	-3.59	0.000365	Crohn's disease	
PRAD	cis	1	rs9491893	chr6:128280931	THEMIS	chr6:128029346-128239742:-	-0.16	-3.62	0.000326	Crohn's disease	
PRAD	cis	1	rs9494145	chr6:135432552	ALDH8A1	chr6:135238529-135271244:-	-0.25	-4.15	3.91E-5	Fetal hemoglobin levels in sickle cell anemia;Platelet count;Mean platelet volume;Red blood cell traits	
PRAD	cis	1	rs9496639	chr6:143768508	ADAT2	chr6:143743970-143771841:-	-0.14	-3.93	9.84E-5	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
PRAD	cis	1	rs9498283	chr6:149605182	ULBP2	chr6:150263136-150270366:+	-0.2	-3.56	0.000402	Breast cancer	
PRAD	cis	1	rs9498287	chr6:149607644	ULBP2	chr6:150263136-150270366:+	0.2	3.63	0.000315	Breast cancer	
PRAD	cis	1	rs9498290	chr6:149609420	ULBP2	chr6:150263136-150270366:+	0.2	3.62	0.000326	Breast cancer	
PRAD	cis	1	rs9500256	chr6:58308955	GUSBL2	chr6:58246159-58287724:-	-0.3	-5.58	4.13E-8	Eosinophilic esophagitis (pediatric)	
PRAD	cis	1	rs950027	chr15:45801035	SPATA5L1	chr15:45694519-45713614:+	-0.27	-5.2	3.04E-7	Response to fenofibrate (adiponectin levels)	
PRAD	cis	1	rs950169	chr15:84706461	GOLGA6L5	chr15:85047738-85060078:-	-0.19	-4.73	3.0E-6	Schizophrenia	
PRAD	cis	1	rs950169	chr15:84706461	LOC388152	chr15:84867600-84898920:-	-0.36	-6.16	1.61E-9	Schizophrenia	
PRAD	cis	1	rs950169	chr15:84706461	NMB	chr15:85198362-85201802:-	-0.37	-8.28	1.27E-15	Schizophrenia	
PRAD	cis	1	rs950169	chr15:84706461	WDR73	chr15:85186012-85197524:-	-0.21	-4.51	8.3E-6	Schizophrenia	
PRAD	cis	1	rs9506537	chr13:21280410	IFT88	chr13:21141208-21265574:+	-0.27	-4.44	1.12E-5	Dental caries	
PRAD	cis	1	rs9507341	chr13:25006578	C1QTNF9	chr13:24553839-24896665:+	0.21	4.16	3.75E-5	Obesity-related traits	
PRAD	cis	1	rs9507341	chr13:25006578	LOC374491	chr13:25141011-25171810:+	0.21	3.55	0.00042	Obesity-related traits	
PRAD	cis	1	rs9507341	chr13:25006578	PARP4	chr13:24995075-25086948:-	-0.19	-4.99	8.36E-7	Obesity-related traits	
PRAD	cis	1	rs9511265	chr13:25012359	C1QTNF9	chr13:24553839-24896665:+	-0.21	-4.16	3.86E-5	Obesity-related traits	
PRAD	cis	1	rs9511265	chr13:25012359	LOC374491	chr13:25141011-25171810:+	-0.2	-3.48	0.000539	Obesity-related traits	
PRAD	cis	1	rs9511265	chr13:25012359	PARP4	chr13:24995075-25086948:-	0.19	5	7.96E-7	Obesity-related traits	
PRAD	cis	1	rs9511272	chr13:25020633	C1QTNF9	chr13:24553839-24896665:+	-0.21	-4.09	5.02E-5	Obesity-related traits	
PRAD	cis	1	rs9511272	chr13:25020633	PARP4	chr13:24995075-25086948:-	0.2	5.1	4.93E-7	Obesity-related traits	
PRAD	cis	1	rs951366	chr1:205685352	PM20D1	chr1:205797154-205819245:-	-0.29	-5.62	3.32E-8	Menarche (age at onset)	
PRAD	cis	1	rs951366	chr1:205685352	RAB7L1	chr1:205737115-205744610:-	0.32	7.2	2.4E-12	Menarche (age at onset)	
PRAD	cis	1	rs951677	chr11:62107249	ASRGL1	chr11:62104774-62160885:+	-0.39	-4.81	2.01E-6	Chronic obstructive pulmonary disease-related biomarkers	
PRAD	cis	1	rs952211	chr4:154717816	RNF175	chr4:154631313-154681387:-	-0.18	-4.26	2.43E-5	Electrocardiographic conduction measures	
PRAD	cis	1	rs952439	chr16:56975277	SLC12A3	chr16:56899119-56949760:+	0.28	3.94	9.55E-5	Metabolic syndrome	
PRAD	cis	1	rs9527	chr10:104623578	AS3MT	chr10:104613967-104661653:+	-0.46	-9.5	1.1E-19	Arsenic metabolism	
PRAD	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.46	-9.05	3.73E-18	Arsenic metabolism	
PRAD	cis	1	rs9527	chr10:104623578	NT5C2	chr10:104845940-104953056:-	-0.31	-5.41	9.89E-8	Arsenic metabolism	
PRAD	cis	1	rs9531455	chr13:36685304	C13orf38	chr13:36801182-36871992:-	0.25	4.35	1.71E-5	Optic cup area	
PRAD	cis	1	rs9531455	chr13:36685304	SOHLH2	chr13:36742347-36871992:-	0.39	6.03	3.33E-9	Optic cup area	
PRAD	cis	1	rs9535307	chr13:50291842	EBPL	chr13:50234811-50265623:-	-0.27	-4.19	3.38E-5	Obesity-related traits	
PRAD	cis	1	rs9546421	chr13:36690750	C13orf38	chr13:36801182-36871992:-	0.25	4.34	1.78E-5	Optic cup area	
PRAD	cis	1	rs9546421	chr13:36690750	SOHLH2	chr13:36742347-36871992:-	0.39	6	3.85E-9	Optic cup area	
PRAD	cis	1	rs9546430	chr13:36692673	C13orf38	chr13:36801182-36871992:-	0.25	4.34	1.78E-5	Optic cup area	
PRAD	cis	1	rs9546430	chr13:36692673	SOHLH2	chr13:36742347-36871992:-	0.39	6	3.85E-9	Optic cup area	
PRAD	cis	1	rs9546434	chr13:36694391	C13orf38	chr13:36801182-36871992:-	0.26	4.38	1.43E-5	Optic cup area	
PRAD	cis	1	rs9546434	chr13:36694391	SOHLH2	chr13:36742347-36871992:-	0.39	6.02	3.5E-9	Optic cup area	
PRAD	cis	1	rs9546652	chr13:36773131	C13orf38	chr13:36801182-36871992:-	-0.21	-3.66	0.00028	Economic and political preferences	
PRAD	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.52	12	3.99E-29	Response to antipsychotic treatment	
PRAD	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.52	-11.77	3.36E-28	Response to antipsychotic treatment	
PRAD	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.52	-11.55	2.36E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs957529	chr6:116604549	FAM26F	chr6:116782556-116784933:+	-0.13	-4.05	5.91E-5	Fast beta electroencephalogram	
PRAD	cis	1	rs9576321	chr13:38205546	POSTN	chr13:38136720-38183563:-	0.21	5.4	1.07E-7	Life satisfaction	
PRAD	cis	1	rs9576322	chr13:38205561	POSTN	chr13:38136720-38183563:-	-0.21	-5.51	6.0E-8	Life satisfaction	
PRAD	cis	1	rs957644	chr1:165616157	MGST3	chr1:165600450-165624853:+	0.29	6.31	6.43E-10	Total ventricular volume	
PRAD	cis	1	rs9579929	chr13:21282724	IFT88	chr13:21141208-21265574:+	-0.27	-4.38	1.45E-5	Dental caries	
PRAD	cis	1	rs9581094	chr13:25082630	PARP4	chr13:24995075-25086948:-	-0.19	-3.55	0.000423	Sudden cardiac arrest	
PRAD	cis	1	rs958476	chr11:129321818	BARX2	chr11:129245881-129322173:+	-0.25	-4.1	4.77E-5	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	
PRAD	cis	1	rs958504	chr14:60949740	C14orf39	chr14:60902675-60952764:-	0.44	5.85	9.4E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs958550	chr7:65635679	CCT6P1	chr7:65216092-65228661:+	-0.3	-5.11	4.68E-7	Diabetic kidney disease	
PRAD	cis	1	rs958550	chr7:65635679	CRCP	chr7:65579805-65619551:+	0.34	4.26	2.45E-5	Diabetic kidney disease	
PRAD	cis	1	rs9591145	chr13:33161459	N4BP2L2	chr13:33006930-33112936:-	0.15	3.5	0.000506	Body mass index	
PRAD	cis	1	rs9591165	chr13:33185153	N4BP2L2	chr13:33006930-33112936:-	0.16	3.67	0.000271	Body mass index	
PRAD	cis	1	rs9593	chr12:109994870	KCTD10	chr12:109886460-109915155:-	-0.33	-9.95	2.65E-21	HDL cholesterol	
PRAD	cis	1	rs9593	chr12:109994870	MMAB	chr12:109991523-110011358:-	-0.18	-5.42	9.44E-8	HDL cholesterol	
PRAD	cis	1	rs9593	chr12:109994870	MYO1H	chr12:109826524-109886176:+	-0.24	-5.33	1.49E-7	HDL cholesterol	
PRAD	cis	1	rs9593	chr12:109994870	UBE3B	chr12:109915439-109974506:+	-0.14	-3.54	0.000435	HDL cholesterol	
PRAD	cis	1	rs9595905	chr13:33183403	N4BP2L2	chr13:33006930-33112936:-	0.16	3.75	0.000195	Body mass index	
PRAD	cis	1	rs9595908	chr13:33184288	N4BP2L2	chr13:33006930-33112936:-	0.15	3.47	0.000561	Body mass index	
PRAD	cis	1	rs959617	chr1:165616881	MGST3	chr1:165600450-165624853:+	0.29	6.22	1.09E-9	Total ventricular volume	
PRAD	cis	1	rs9596219	chr13:50563447	EBPL	chr13:50234811-50265623:-	-0.18	-3.64	0.000298	Height	
PRAD	cis	1	rs9596220	chr13:50570191	EBPL	chr13:50234811-50265623:-	-0.18	-3.62	0.000323	Height	
PRAD	cis	1	rs9607469	chr22:37919267	CARD10	chr22:37875383-37915378:-	-0.25	-3.65	0.000286	Optic disc area	
PRAD	cis	1	rs9607469	chr22:37919267	CSNK1E	chr22:38686698-38794527:-	-0.18	-3.57	0.000388	Optic disc area	
PRAD	cis	1	rs9607566	chr22:39075434	CBY1	chr22:39052658-39069853:+	0.18	5.03	6.99E-7	Resting heart rate	
PRAD	cis	1	rs9607566	chr22:39075434	LOC646851	chr22:38974125-39052634:-	0.2	4.67	3.94E-6	Resting heart rate	
PRAD	cis	1	rs9610986	chr22:39025277	CBY1	chr22:39052658-39069853:+	0.17	4.83	1.81E-6	Resting heart rate	
PRAD	cis	1	rs9610986	chr22:39025277	LOC646851	chr22:38974125-39052634:-	0.2	4.8	2.13E-6	Resting heart rate	
PRAD	cis	1	rs9610993	chr22:39042818	CBY1	chr22:39052658-39069853:+	0.17	4.84	1.76E-6	Resting heart rate	
PRAD	cis	1	rs9610993	chr22:39042818	LOC646851	chr22:38974125-39052634:-	0.2	4.78	2.38E-6	Resting heart rate	
PRAD	cis	1	rs9616064	chr22:46982293	CERK	chr22:47080308-47134152:-	0.14	4.12	4.42E-5	Urate levels in obese individuals	
PRAD	cis	1	rs9621346	chr22:32230185	SFI1	chr22:31892261-32014533:+	0.2	4.17	3.69E-5	Intelligence	
PRAD	cis	1	rs962221	chr1:92970770	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs962222	chr1:92970953	EVI5	chr1:92974255-93257961:-	-0.31	-6.27	8.31E-10	Cholesterol, total	
PRAD	cis	1	rs9622833	chr22:39000397	CBY1	chr22:39052658-39069853:+	0.17	4.74	2.85E-6	Resting heart rate	
PRAD	cis	1	rs9622833	chr22:39000397	LOC646851	chr22:38974125-39052634:-	0.18	4.2	3.14E-5	Resting heart rate	
PRAD	cis	1	rs962366	chr8:11684403	GATA4	chr8:11534468-11617509:+	-0.16	-3.52	0.000473	Non-alcoholic fatty liver disease histology (lobular);Non-alcoholic fatty liver disease histology (other)	
PRAD	cis	1	rs9624447	chr22:24681555	POM121L9P	chr22:24647589-24661490:+	-0.23	-4.88	1.46E-6	Gut microbiome composition (summer)	
PRAD	cis	1	rs9628987	chr1:8386730	RERE	chr1:8412466-8877699:-	-0.18	-3.46	0.000584	Breast cancer	
PRAD	cis	1	rs9633304	chr1:183636878	NCF2	chr1:183524698-183560046:-	0.25	3.72	0.000222	Systemic lupus erythematosus	
PRAD	cis	1	rs9633535	chr10:63836088	ARID5B	chr10:63661443-63856703:+	-0.16	-3.51	0.000485	Corneal structure	
PRAD	cis	1	rs9633555	chr10:63834048	ARID5B	chr10:63661443-63856703:+	-0.16	-3.45	0.000602	Corneal structure	
PRAD	cis	1	rs9633556	chr10:63834853	ARID5B	chr10:63661443-63856703:+	-0.16	-3.48	0.000558	Corneal structure	
PRAD	cis	1	rs9633557	chr10:63835015	ARID5B	chr10:63661443-63856703:+	-0.16	-3.48	0.00054	Corneal structure	
PRAD	cis	1	rs9635251	chr14:65928468	LOC645431	chr14:65877313-65879335:-	-0.44	-4.48	9.29E-6	Ischemic stroke	
PRAD	cis	1	rs9635324	chr15:40703211	DISP2	chr15:40650434-40663256:+	0.34	6	4.01E-9	Blood metabolite levels;Blood metabolite ratios	
PRAD	cis	1	rs9637599	chr4:89206230	PPM1K	chr4:89181534-89205888:-	0.21	4.3	2.04E-5	Metabolite levels (small molecules and protein measures)	
PRAD	cis	1	rs9637655	chr4:142159065	ZNF330	chr4:142142049-142155848:+	-0.27	-4.92	1.21E-6	Conduct disorder	
PRAD	cis	1	rs9638180	chr7:72998952	MLXIPL	chr7:73007524-73038870:-	0.23	3.62	0.000328	Triglycerides	
PRAD	cis	1	rs9645642	chr11:48705455	FOLH1	chr11:49168188-49230222:-	-0.18	-4.05	6.04E-5	HDL cholesterol	
PRAD	cis	1	rs9646303	chr16:87461969	MTHFSD	chr16:86563783-86588841:-	-0.2	-3.55	0.000422	Major depressive disorder	
PRAD	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.49	-11.48	4.54E-27	Response to antipsychotic treatment	
PRAD	cis	1	rs9651768	chr11:77996020	GAB2	chr11:77926343-78128766:-	-0.19	-6.3	6.71E-10	Testicular germ cell tumor	
PRAD	cis	1	rs9651768	chr11:77996020	NARS2	chr11:78147017-78285909:-	-0.25	-5.3	1.8E-7	Testicular germ cell tumor	
PRAD	cis	1	rs9651769	chr11:77996166	GAB2	chr11:77926343-78128766:-	-0.19	-6.13	1.88E-9	Testicular germ cell tumor	
PRAD	cis	1	rs9651769	chr11:77996166	NARS2	chr11:78147017-78285909:-	-0.23	-4.72	3.19E-6	Testicular germ cell tumor	
PRAD	cis	1	rs9653557	chr2:73795962	ALMS1P	chr2:73872046-73912692:+	0.49	8.41	4.9E-16	Metabolite levels	
PRAD	cis	1	rs9653557	chr2:73795962	NAT8	chr2:73867850-73869537:-	0.25	3.89	0.000116	Metabolite levels	
PRAD	cis	1	rs965469	chr20:3381549	ITPA	chr20:3190056-3204504:+	-0.3	-7.75	5.54E-14	IFN-related cytopenia	
PRAD	cis	1	rs9661504	chr1:205915667	PM20D1	chr1:205797154-205819245:-	0.19	3.55	0.000427	Cystic fibrosis-related diabetes	
PRAD	cis	1	rs9662166	chr1:76235906	ACADM	chr1:76190043-76229353:+	0.18	3.92	0.000101	Blood metabolite levels;Acylcarnitine levels	
PRAD	cis	1	rs9662221	chr1:205915745	PM20D1	chr1:205797154-205819245:-	0.2	3.62	0.000331	Cystic fibrosis-related diabetes	
PRAD	cis	1	rs9665626	chr10:104300638	SFXN2	chr10:104474298-104498946:+	0.32	4.08	5.19E-5	Schizophrenia	
PRAD	cis	1	rs9668015	chr12:62506495	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs9668369	chr12:62506842	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs9668676	chr12:62504199	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs9668865	chr12:62507589	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs9672214	chr15:31677775	CHRFAM7A	chr15:30653443-30685864:-	-0.31	-3.46	0.00059	Survival in colorectal cancer (non-distant metastatic)	
PRAD	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.76	18.34	4.56E-57	Eye color traits	
PRAD	cis	1	rs9677476	chr2:232126290	ARMC9	chr2:232063342-232238606:+	-0.2	-3.87	0.000124	Food antigen IgG levels	
PRAD	cis	1	rs9678841	chr2:191561760	OSGEPL1	chr2:190611386-190627953:-	-0.21	-3.85	0.000133	Primary biliary cirrhosis	
PRAD	cis	1	rs9679122	chr2:10751710	ODC1	chr2:10580508-10588453:-	0.21	3.88	0.000118	Prostate cancer	
PRAD	cis	1	rs9684708	chr4:56430381	TMEM165	chr4:56262090-56292342:+	0.17	3.54	0.000443	Personality dimensions	
PRAD	cis	1	rs9686690	chr5:157412103	NIPAL4	chr5:156887027-156901729:+	0.2	3.76	0.00019	IgG glycosylation	
PRAD	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.6	13.81	1.2E-36	Erythrocyte sedimentation rate	
PRAD	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.55	-11.04	2.42E-25	Erythrocyte sedimentation rate	
PRAD	cis	1	rs9697030	chr9:131920181	CRAT	chr9:131857075-131873070:-	0.24	4.4	1.34E-5	Blood metabolite ratios	
PRAD	cis	1	rs971317	chr1:207476040	CD55	chr1:207494817-207534309:+	0.25	4.36	1.59E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs971318	chr1:207475596	CD55	chr1:207494817-207534309:+	-0.25	-4.35	1.7E-5	Spherical equivalent (joint main effects and education interaction)	
PRAD	cis	1	rs9715911	chr5:156394441	TIMD4	chr5:156346293-156390266:-	-0.2	-3.95	8.91E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
PRAD	cis	1	rs973009	chr19:39174332	ACTN4	chr19:39138327-39221170:+	0.17	3.86	0.00013	Migraine with aura	
PRAD	cis	1	rs9738122	chr12:62514673	MON2	chr12:62860597-62991362:+	-0.14	-3.54	0.000433	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs9738294	chr12:62508489	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs9739546	chr12:62508437	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000476	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs9739682	chr12:62516649	MON2	chr12:62860597-62991362:+	-0.14	-3.52	0.000472	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	cis	1	rs974495	chr3:49400482	AMIGO3	chr3:49754268-49757238:-	-0.41	-8.5	2.57E-16	Menarche (age at onset)	
PRAD	cis	1	rs974495	chr3:49400482	CCDC36	chr3:49235861-49295537:+	0.25	4.5	8.75E-6	Menarche (age at onset)	
PRAD	cis	1	rs974495	chr3:49400482	GMPPB	chr3:49758932-49761384:-	-0.46	-11.27	2.94E-26	Menarche (age at onset)	
PRAD	cis	1	rs974495	chr3:49400482	NCKIPSD	chr3:48711280-48723334:-	0.28	5.74	1.69E-8	Menarche (age at onset)	
PRAD	cis	1	rs974495	chr3:49400482	P4HTM	chr3:49027341-49044579:+	0.15	3.54	0.00044	Menarche (age at onset)	
PRAD	cis	1	rs974495	chr3:49400482	WDR6	chr3:49044637-49053386:+	-0.2	-3.99	7.54E-5	Menarche (age at onset)	
PRAD	cis	1	rs9747164	chr17:61864787	DDX42	chr17:61851567-61896676:+	-0.27	-5.51	6.08E-8	Body mass index	
PRAD	cis	1	rs9747164	chr17:61864787	FTSJ3	chr17:61896795-61905031:-	0.35	6.85	2.34E-11	Body mass index	
PRAD	cis	1	rs9747164	chr17:61864787	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.19	3.35E-5	Body mass index	
PRAD	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.76	18.34	4.56E-57	Eye color traits	
PRAD	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.76	18.26	1.05E-56	Eye color traits	
PRAD	cis	1	rs975752	chr10:101906333	CWF19L1	chr10:101992055-102027437:-	-0.3	-3.86	0.00013	Schizophrenia	
PRAD	cis	1	rs9767077	chr6:150109615	NUP43	chr6:150045453-150067688:-	-0.59	-11.61	1.43E-27	Lung cancer	
PRAD	cis	1	rs9767077	chr6:150109615	ULBP2	chr6:150263136-150270366:+	0.23	4.85	1.67E-6	Lung cancer	
PRAD	cis	1	rs9769098	chr7:23916732	C7orf46	chr7:23719749-23742268:+	0.22	5.62	3.27E-8	Schizophrenia	
PRAD	cis	1	rs9769882	chr7:65642925	CCT6P1	chr7:65216092-65228661:+	-0.34	-5.83	1.02E-8	Diabetic kidney disease	
PRAD	cis	1	rs9769882	chr7:65642925	CRCP	chr7:65579805-65619551:+	0.32	3.95	8.98E-5	Diabetic kidney disease	
PRAD	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.58	11.8	2.54E-28	Forced vital capacity	
PRAD	cis	1	rs9783347	chr11:18384938	GTF2H1	chr11:18343816-18388590:+	0.66	13.95	2.98E-37	Pancreatic cancer	
PRAD	cis	1	rs9783386	chr11:18386625	GTF2H1	chr11:18343816-18388590:+	0.73	14.67	2.24E-40	Pancreatic cancer	
PRAD	cis	1	rs9783747	chr16:69458193	CLEC18C	chr16:69984626-70220796:+	0.23	3.5	0.000508	Blood pressure (smoking interaction)	
PRAD	cis	1	rs9783749	chr16:69458248	CLEC18C	chr16:69984626-70220796:+	0.23	3.51	0.000488	Blood pressure (smoking interaction)	
PRAD	cis	1	rs9788721	chr15:78802869	CHRNA3	chr15:78885397-78913322:-	0.25	4.5	8.66E-6	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs9788721	chr15:78802869	CHRNA5	chr15:78857906-78886458:+	0.2	4.19	3.39E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
PRAD	cis	1	rs9789738	chr2:182476981	CERKL	chr2:182401402-182545381:-	-0.16	-3.76	0.000189	Response to iloperidone treatment (QT prolongation)	
PRAD	cis	1	rs9789748	chr2:17801397	GEN1	chr2:17935162-17966632:+	0.44	5.17	3.44E-7	Psychosis and Alzheimer's disease	
PRAD	cis	1	rs979233	chr5:42375243	GHR	chr5:42424026-42721925:+	-0.2	-4.6	5.55E-6	Systemic lupus erythematosus	
PRAD	cis	1	rs9793138	chr1:202339956	PPP1R12B	chr1:202317836-202557697:+	0.09	3.68	0.000262	Sex ratio	
PRAD	cis	1	rs979972	chr19:39144167	LGALS7	chr19:39261608-39264157:-	-0.15	-3.48	0.000558	Heart rate	
PRAD	cis	1	rs9804992	chr12:988894	RAD52	chr12:1021255-1099219:-	0.41	6.78	3.56E-11	Colorectal cancer	
PRAD	cis	1	rs9805979	chr14:75566209	EIF2B2	chr14:75469612-75476292:+	0.24	4.85	1.67E-6	Height	
PRAD	cis	1	rs9805979	chr14:75566209	MLH3	chr14:75480467-75518235:-	0.33	6.65	8.14E-11	Height	
PRAD	cis	1	rs9806762	chr15:88661739	NTRK3	chr15:88419988-88799661:-	0.17	4.32	1.95E-5	Gaucher disease severity	
PRAD	cis	1	rs9807825	chr19:52019947	ZNF175	chr19:52074531-52092990:+	-0.32	-4.37	1.5E-5	Carotid intima media thickness	
PRAD	cis	1	rs9807989	chr2:102971200	IL1R1	chr2:102686836-102796333:+	-0.19	-3.96	8.65E-5	Asthma	
PRAD	cis	1	rs9808612	chr20:61868348	BIRC7	chr20:61867276-61871853:+	0.34	4.12	4.52E-5	Response to cytadine analogues (cytosine arabinoside)	
PRAD	cis	1	rs9809061	chr3:10085130	C3orf10	chr3:10157333-10168873:+	-0.2	-3.85	0.000134	Alzheimer's disease	
PRAD	cis	1	rs9809061	chr3:10085130	LOC401052	chr3:10048102-10052779:-	-0.29	-5.25	2.31E-7	Alzheimer's disease	
PRAD	cis	1	rs9809263	chr3:190989466	UTS2D	chr3:190984945-191048325:-	-0.26	-5.29	1.93E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.55	12.66	8.07E-32	Height	
PRAD	cis	1	rs980970	chr20:22274930	PAX1	chr20:21686297-21696620:+	0.16	4.03	6.63E-5	Glucose homeostasis traits	
PRAD	cis	1	rs9809843	chr3:48434398	ATRIP	chr3:48488141-48507708:+	0.27	6.28	7.73E-10	Longevity	
PRAD	cis	1	rs9809843	chr3:48434398	CDC25A	chr3:48198668-48229801:-	0.22	4.12	4.39E-5	Longevity	
PRAD	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.18	-5.01	7.64E-7	Longevity	
PRAD	cis	1	rs9810077	chr3:195005422	C3orf21	chr3:194789015-194991895:-	0.41	8.61	1.13E-16	Body mass index	
PRAD	cis	1	rs9810890	chr3:128652553	ACAD9	chr3:128598333-128634910:+	-0.32	-3.92	0.000102	Dental caries	
PRAD	cis	1	rs9811771	chr3:10133949	C3orf10	chr3:10157333-10168873:+	-0.19	-3.77	0.000184	Alzheimer's disease	
PRAD	cis	1	rs9811771	chr3:10133949	LOC401052	chr3:10048102-10052779:-	-0.28	-5.26	2.16E-7	Alzheimer's disease	
PRAD	cis	1	rs9812647	chr3:48448914	ATRIP	chr3:48488141-48507708:+	-0.24	-5.69	2.2E-8	Longevity	
PRAD	cis	1	rs9812647	chr3:48448914	CDC25A	chr3:48198668-48229801:-	-0.2	-3.72	0.00022	Longevity	
PRAD	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.18	5.14	4.12E-7	Longevity	
PRAD	cis	1	rs9812791	chr3:49682311	GMPPB	chr3:49758932-49761384:-	-0.21	-4.51	8.27E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs9812791	chr3:49682311	UBA7	chr3:49842639-49851391:-	0.14	3.49	0.000534	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs9813712	chr3:129971101	COL6A4P2	chr3:129931663-129992648:+	0.23	4.16	3.84E-5	Response to amphetamines	
PRAD	cis	1	rs9813762	chr3:184756624	VPS8	chr3:184529931-184770402:+	-0.33	-4.15	4.0E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.55	12.75	3.51E-32	Height	
PRAD	cis	1	rs9813864	chr3:119590974	NR1I2	chr3:119499331-119537331:+	0.22	3.97	8.38E-5	HDL cholesterol	
PRAD	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.5	-11.18	6.53E-26	Height	
PRAD	cis	1	rs9815043	chr3:42896639	CYP8B1	chr3:42897498-42917633:-	-0.22	-3.68	0.00026	Obesity-related traits	
PRAD	cis	1	rs9815103	chr3:48414215	ATRIP	chr3:48488141-48507708:+	0.28	6.54	1.66E-10	Longevity	
PRAD	cis	1	rs9815103	chr3:48414215	CDC25A	chr3:48198668-48229801:-	0.22	4.08	5.34E-5	Longevity	
PRAD	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.18	-4.94	1.07E-6	Longevity	
PRAD	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.82	12.18	7.78E-30	Diastolic blood pressure	
PRAD	cis	1	rs9815925	chr3:184717901	EPHB3	chr3:184279587-184300195:+	-0.29	-3.46	0.000586	Heschl's gyrus morphology	
PRAD	cis	1	rs9815925	chr3:184717901	VPS8	chr3:184529931-184770402:+	-0.31	-4.24	2.68E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs9817062	chr3:190978642	UTS2D	chr3:190984945-191048325:-	-0.23	-4.7	3.49E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9817615	chr3:48470756	ATRIP	chr3:48488141-48507708:+	0.27	6.64	8.79E-11	Longevity	
PRAD	cis	1	rs9817615	chr3:48470756	CDC25A	chr3:48198668-48229801:-	0.22	4.1	4.96E-5	Longevity	
PRAD	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.17	-4.81	2.04E-6	Longevity	
PRAD	cis	1	rs9818109	chr3:67528739	SUCLG2	chr3:67425145-67705038:-	0.19	3.61	0.00034	Corneal astigmatism	
PRAD	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.82	12.96	4.74E-33	Diastolic blood pressure	
PRAD	cis	1	rs981946	chr6:3371291	SLC22A23	chr6:3269207-3456793:-	-0.19	-3.9	0.000108	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	
PRAD	cis	1	rs9819511	chr3:49884261	AMIGO3	chr3:49754268-49757238:-	-0.24	-4.48	9.58E-6	Resting heart rate	
PRAD	cis	1	rs9819511	chr3:49884261	CACNA2D2	chr3:50400233-50540892:-	-0.21	-4.1	4.81E-5	Resting heart rate	
PRAD	cis	1	rs9819511	chr3:49884261	GMPPB	chr3:49758932-49761384:-	-0.24	-5.04	6.65E-7	Resting heart rate	
PRAD	cis	1	rs9819511	chr3:49884261	RBM6	chr3:49977592-50137484:+	-0.16	-4.96	9.7E-7	Resting heart rate	
PRAD	cis	1	rs9819511	chr3:49884261	WDR6	chr3:49044637-49053386:+	-0.2	-3.89	0.000114	Resting heart rate	
PRAD	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.55	12.74	3.85E-32	Height	
PRAD	cis	1	rs9820192	chr3:41889281	ULK4	chr3:41288091-42003660:-	0.88	14.28	1.11E-38	Diastolic blood pressure	
PRAD	cis	1	rs9820598	chr3:10117912	C3orf10	chr3:10157333-10168873:+	-0.2	-3.84	0.00014	Alzheimer's disease	
PRAD	cis	1	rs9820598	chr3:10117912	LOC401052	chr3:10048102-10052779:-	-0.29	-5.22	2.75E-7	Alzheimer's disease	
PRAD	cis	1	rs9821494	chr3:190979316	UTS2D	chr3:190984945-191048325:-	-0.21	-4.25	2.54E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9821570	chr3:58335919	PXK	chr3:58318617-58410878:+	0.18	3.52	0.000473	Cholesterol, total	
PRAD	cis	1	rs9822268	chr3:49719729	GMPPB	chr3:49758932-49761384:-	-0.21	-4.6	5.51E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs9822268	chr3:49719729	UBA7	chr3:49842639-49851391:-	0.14	3.46	0.000584	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs9822370	chr3:184661756	VPS8	chr3:184529931-184770402:+	-0.33	-4.14	4.06E-5	Heschl's gyrus morphology	
PRAD	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.81	12.09	1.69E-29	Diastolic blood pressure	
PRAD	cis	1	rs9823546	chr3:49705512	GMPPB	chr3:49758932-49761384:-	-0.21	-4.51	8.3E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs9823546	chr3:49705512	MST1	chr3:49721381-49726196:-	0.1	3.49	0.000533	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs9823546	chr3:49705512	RBM6	chr3:49977592-50137484:+	0.11	3.46	0.000587	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs982393	chr2:164490529	FIGN	chr2:164464118-164592513:-	-0.22	-3.57	0.000389	Folate pathway vitamin levels	
PRAD	cis	1	rs9824585	chr3:10114802	C3orf10	chr3:10157333-10168873:+	-0.19	-3.8	0.000166	Alzheimer's disease	
PRAD	cis	1	rs9824585	chr3:10114802	LOC401052	chr3:10048102-10052779:-	-0.27	-4.84	1.73E-6	Alzheimer's disease	
PRAD	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.81	12.17	8.22E-30	Diastolic blood pressure	
PRAD	cis	1	rs9825119	chr3:128595514	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.000438	Dental caries	
PRAD	cis	1	rs9825741	chr3:41761828	ULK4	chr3:41288091-42003660:-	-0.8	-12.92	6.88E-33	Diastolic blood pressure	
PRAD	cis	1	rs9826058	chr3:41762062	ULK4	chr3:41288091-42003660:-	0.8	12.92	6.7E-33	Diastolic blood pressure	
PRAD	cis	1	rs9826195	chr3:48433635	ATRIP	chr3:48488141-48507708:+	0.27	6.28	7.73E-10	Longevity	
PRAD	cis	1	rs9826195	chr3:48433635	CDC25A	chr3:48198668-48229801:-	0.22	4.12	4.39E-5	Longevity	
PRAD	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.18	-5.01	7.64E-7	Longevity	
PRAD	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.55	12.83	1.66E-32	Height	
PRAD	cis	1	rs9827740	chr3:10120531	C3orf10	chr3:10157333-10168873:+	-0.2	-3.84	0.00014	Alzheimer's disease	
PRAD	cis	1	rs9827740	chr3:10120531	LOC401052	chr3:10048102-10052779:-	-0.29	-5.22	2.75E-7	Alzheimer's disease	
PRAD	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.53	12.11	1.5E-29	Height	
PRAD	cis	1	rs9828398	chr3:41895893	ULK4	chr3:41288091-42003660:-	0.88	14.28	1.11E-38	Diastolic blood pressure	
PRAD	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.55	12.6	1.4E-31	Height	
PRAD	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.52	11.68	7.4E-28	Height	
PRAD	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	0.88	14.3	8.82E-39	Diastolic blood pressure	
PRAD	cis	1	rs9830469	chr3:41762535	ULK4	chr3:41288091-42003660:-	0.8	12.84	1.45E-32	Diastolic blood pressure	
PRAD	cis	1	rs9832488	chr3:190981512	UTS2D	chr3:190984945-191048325:-	-0.22	-4.44	1.12E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9832495	chr3:190981523	UTS2D	chr3:190984945-191048325:-	-0.22	-4.44	1.12E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.52	11.72	5.21E-28	Height	
PRAD	cis	1	rs9832873	chr3:190981552	UTS2D	chr3:190984945-191048325:-	-0.22	-4.44	1.12E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs983392	chr11:59923508	PATL1	chr11:59404194-59436511:-	-0.12	-3.7	0.000244	Alzheimer's disease (late onset)	
PRAD	cis	1	rs9834098	chr3:41833493	ULK4	chr3:41288091-42003660:-	0.84	13.59	1.01E-35	Diastolic blood pressure	
PRAD	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.52	11.91	9.03E-29	Height	
PRAD	cis	1	rs9834980	chr3:10065528	C3orf10	chr3:10157333-10168873:+	-0.2	-3.83	0.000145	Alzheimer's disease	
PRAD	cis	1	rs9834980	chr3:10065528	LOC401052	chr3:10048102-10052779:-	-0.29	-5.35	1.4E-7	Alzheimer's disease	
PRAD	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.55	12.6	1.4E-31	Height	
PRAD	cis	1	rs9835434	chr3:190986962	UTS2D	chr3:190984945-191048325:-	-0.25	-5.04	6.66E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9835883	chr3:190987251	UTS2D	chr3:190984945-191048325:-	-0.25	-5.04	6.66E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9836053	chr3:150885877	P2RY12	chr3:151055238-151102544:-	0.3	5.21	2.78E-7	Heschl's gyrus morphology	
PRAD	cis	1	rs9836291	chr3:49697459	GMPPB	chr3:49758932-49761384:-	-0.21	-4.51	8.22E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs9837038	chr3:156568469	LEKR1	chr3:156544076-156763918:+	-0.29	-5.73	1.78E-8	Multiple sclerosis (severity)	
PRAD	cis	1	rs9838618	chr3:48487353	ATRIP	chr3:48488141-48507708:+	0.26	6.21	1.14E-9	Longevity	
PRAD	cis	1	rs9838618	chr3:48487353	CDC25A	chr3:48198668-48229801:-	0.22	4	7.46E-5	Longevity	
PRAD	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.19	-5.31	1.65E-7	Longevity	
PRAD	cis	1	rs9838965	chr3:41927938	ULK4	chr3:41288091-42003660:-	-0.87	-14.57	5.94E-40	Diastolic blood pressure	
PRAD	cis	1	rs9839399	chr3:41928044	ULK4	chr3:41288091-42003660:-	-0.87	-14.57	5.94E-40	Diastolic blood pressure	
PRAD	cis	1	rs9840037	chr3:41827522	ULK4	chr3:41288091-42003660:-	0.81	13.08	1.43E-33	Diastolic blood pressure	
PRAD	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	0.88	14.26	1.4E-38	Diastolic blood pressure	
PRAD	cis	1	rs9841038	chr3:15453986	EAF1	chr3:15469064-15484119:+	0.13	3.81	0.000158	Uric acid levels	
PRAD	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.51	11.65	1.0E-27	Height	
PRAD	cis	1	rs9841212	chr3:134191938	CEP63	chr3:134204575-134293852:+	0.21	3.71	0.000233	Height	
PRAD	cis	1	rs9842132	chr3:49427933	AMIGO3	chr3:49754268-49757238:-	0.43	8.79	2.93E-17	Menarche (age at onset)	
PRAD	cis	1	rs9842132	chr3:49427933	CCDC36	chr3:49235861-49295537:+	-0.23	-4.18	3.51E-5	Menarche (age at onset)	
PRAD	cis	1	rs9842132	chr3:49427933	GMPPB	chr3:49758932-49761384:-	0.48	11.64	1.05E-27	Menarche (age at onset)	
PRAD	cis	1	rs9842132	chr3:49427933	NCKIPSD	chr3:48711280-48723334:-	-0.31	-6.09	2.34E-9	Menarche (age at onset)	
PRAD	cis	1	rs9842132	chr3:49427933	P4HTM	chr3:49027341-49044579:+	-0.16	-3.67	0.000275	Menarche (age at onset)	
PRAD	cis	1	rs9842132	chr3:49427933	WDR6	chr3:49044637-49053386:+	0.19	3.83	0.000146	Menarche (age at onset)	
PRAD	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.46	-9.32	4.7E-19	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
PRAD	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.81	-12.85	1.35E-32	Diastolic blood pressure	
PRAD	cis	1	rs9842305	chr3:41998412	ULK4	chr3:41288091-42003660:-	-0.9	-15.12	2.24E-42	Diastolic blood pressure	
PRAD	cis	1	rs9845475	chr3:32842101	CMTM7	chr3:32433163-32496333:+	-0.25	-3.67	0.000269	Attention deficit hyperactivity disorder (time to onset)	
PRAD	cis	1	rs9845756	chr3:10067548	C3orf10	chr3:10157333-10168873:+	-0.2	-3.83	0.000145	Alzheimer's disease	
PRAD	cis	1	rs9845756	chr3:10067548	LOC401052	chr3:10048102-10052779:-	-0.29	-5.35	1.4E-7	Alzheimer's disease	
PRAD	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.81	12.17	8.22E-30	Diastolic blood pressure	
PRAD	cis	1	rs9847006	chr3:41755359	ULK4	chr3:41288091-42003660:-	0.81	13.12	9.53E-34	Diastolic blood pressure	
PRAD	cis	1	rs9847242	chr3:190989523	UTS2D	chr3:190984945-191048325:-	-0.25	-5.16	3.71E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9847430	chr3:15449640	EAF1	chr3:15469064-15484119:+	0.13	3.96	8.68E-5	Uric acid levels	
PRAD	cis	1	rs9847759	chr3:128594373	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.000438	Dental caries	
PRAD	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.75	11.16	8.07E-26	Diastolic blood pressure	
PRAD	cis	1	rs9848754	chr3:41753647	ULK4	chr3:41288091-42003660:-	0.75	10.92	6.61E-25	Diastolic blood pressure	
PRAD	cis	1	rs9849248	chr3:88241274	C3orf38	chr3:88198893-88207113:+	0.22	3.76	0.000191	Menarche (age at onset)	
PRAD	cis	1	rs9849434	chr3:10133710	C3orf10	chr3:10157333-10168873:+	0.2	4.09	5.0E-5	Alzheimer's disease	
PRAD	cis	1	rs9849434	chr3:10133710	LOC401052	chr3:10048102-10052779:-	0.3	5.52	5.7E-8	Alzheimer's disease	
PRAD	cis	1	rs9849509	chr3:48483432	ATRIP	chr3:48488141-48507708:+	0.28	6.69	6.5E-11	Longevity	
PRAD	cis	1	rs9849509	chr3:48483432	CDC25A	chr3:48198668-48229801:-	0.22	4.16	3.82E-5	Longevity	
PRAD	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.17	-4.78	2.3E-6	Longevity	
PRAD	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.54	12.17	8.56E-30	Height	
PRAD	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.51	11.6	1.58E-27	Height	
PRAD	cis	1	rs9852303	chr3:41759525	ULK4	chr3:41288091-42003660:-	0.82	13.24	3.2E-34	Diastolic blood pressure	
PRAD	cis	1	rs9852327	chr3:190981404	UTS2D	chr3:190984945-191048325:-	-0.22	-4.55	6.94E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9854155	chr3:46294468	CCR5	chr3:46411633-46417690:+	-0.1	-3.76	0.000188	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs9854249	chr3:190978633	UTS2D	chr3:190984945-191048325:-	-0.23	-4.7	3.49E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.54	12.37	1.25E-30	Height	
PRAD	cis	1	rs9854776	chr3:46294851	CCR5	chr3:46411633-46417690:+	0.1	3.82	0.000154	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs9854776	chr3:46294851	FYCO1	chr3:45959396-46037307:-	0.12	3.55	0.000419	Obesity-related traits;Monocyte chemoattractant protein-1	
PRAD	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	0.74	11.04	2.26E-25	Diastolic blood pressure	
PRAD	cis	1	rs9854838	chr3:41805670	ULK4	chr3:41288091-42003660:-	0.86	14.08	8.24E-38	Diastolic blood pressure	
PRAD	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.82	12.96	4.74E-33	Diastolic blood pressure	
PRAD	cis	1	rs9856076	chr3:190987344	UTS2D	chr3:190984945-191048325:-	-0.25	-5.04	6.66E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.82	12.96	4.74E-33	Diastolic blood pressure	
PRAD	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	0.89	14.73	1.21E-40	Diastolic blood pressure	
PRAD	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.52	11.68	7.66E-28	Height	
PRAD	cis	1	rs9856693	chr3:134306913	CEP63	chr3:134204575-134293852:+	0.2	3.56	0.000415	Height	
PRAD	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.82	13.17	6.2E-34	Diastolic blood pressure	
PRAD	cis	1	rs9857697	chr3:190991384	UTS2D	chr3:190984945-191048325:-	-0.25	-5.05	6.18E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9858213	chr3:49731861	GMPPB	chr3:49758932-49761384:-	-0.21	-4.43	1.2E-5	Educational attainment	
PRAD	cis	1	rs9858213	chr3:49731861	MST1	chr3:49721381-49726196:-	0.1	3.61	0.000337	Educational attainment	
PRAD	cis	1	rs9858542	chr3:49701983	GMPPB	chr3:49758932-49761384:-	0.21	4.52	7.97E-6	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs9860055	chr3:49506900	AMIGO3	chr3:49754268-49757238:-	0.44	8.95	8.33E-18	Menarche (age at onset)	
PRAD	cis	1	rs9860055	chr3:49506900	CCDC36	chr3:49235861-49295537:+	-0.23	-4.1	4.78E-5	Menarche (age at onset)	
PRAD	cis	1	rs9860055	chr3:49506900	GMPPB	chr3:49758932-49761384:-	0.49	12.03	3.09E-29	Menarche (age at onset)	
PRAD	cis	1	rs9860055	chr3:49506900	NCKIPSD	chr3:48711280-48723334:-	-0.3	-6.03	3.31E-9	Menarche (age at onset)	
PRAD	cis	1	rs9860055	chr3:49506900	P4HTM	chr3:49027341-49044579:+	-0.16	-3.48	0.000539	Menarche (age at onset)	
PRAD	cis	1	rs9860055	chr3:49506900	WDR6	chr3:49044637-49053386:+	0.2	4.02	6.86E-5	Menarche (age at onset)	
PRAD	cis	1	rs9862012	chr3:128572219	ACAD9	chr3:128598333-128634910:+	-0.27	-3.54	0.00044	Dental caries	
PRAD	cis	1	rs9862461	chr3:128572314	ACAD9	chr3:128598333-128634910:+	-0.29	-3.72	0.000225	Dental caries	
PRAD	cis	1	rs9862534	chr3:49598064	AMIGO3	chr3:49754268-49757238:-	-0.42	-8.54	1.82E-16	Menarche (age at onset)	
PRAD	cis	1	rs9862534	chr3:49598064	CCDC36	chr3:49235861-49295537:+	0.26	4.69	3.64E-6	Menarche (age at onset)	
PRAD	cis	1	rs9862534	chr3:49598064	GMPPB	chr3:49758932-49761384:-	-0.46	-11.13	1.02E-25	Menarche (age at onset)	
PRAD	cis	1	rs9862534	chr3:49598064	NCKIPSD	chr3:48711280-48723334:-	0.29	5.76	1.49E-8	Menarche (age at onset)	
PRAD	cis	1	rs9862534	chr3:49598064	WDR6	chr3:49044637-49053386:+	-0.2	-4.08	5.25E-5	Menarche (age at onset)	
PRAD	cis	1	rs9862969	chr3:58341917	PXK	chr3:58318617-58410878:+	0.18	3.52	0.000473	Cholesterol, total	
PRAD	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.55	12.6	1.4E-31	Height	
PRAD	cis	1	rs9863915	chr3:41762002	ULK4	chr3:41288091-42003660:-	0.82	13.24	3.2E-34	Diastolic blood pressure	
PRAD	cis	1	rs986417	chr14:60858761	C14orf39	chr14:60902675-60952764:-	-0.49	-6.02	3.58E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.74	11.07	1.8E-25	Diastolic blood pressure	
PRAD	cis	1	rs9864325	chr3:58336846	PXK	chr3:58318617-58410878:+	0.18	3.52	0.000473	Cholesterol, total	
PRAD	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.51	11.53	3.07E-27	Height	
PRAD	cis	1	rs9864346	chr3:134312352	CEP63	chr3:134204575-134293852:+	0.2	3.54	0.000448	Height	
PRAD	cis	1	rs9864371	chr3:48426766	ATRIP	chr3:48488141-48507708:+	0.27	6.37	4.45E-10	Longevity	
PRAD	cis	1	rs9864371	chr3:48426766	CDC25A	chr3:48198668-48229801:-	0.22	4.07	5.45E-5	Longevity	
PRAD	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.18	-4.99	8.59E-7	Longevity	
PRAD	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.52	11.83	1.86E-28	Height	
PRAD	cis	1	rs9864439	chr3:134298671	CEP63	chr3:134204575-134293852:+	0.22	3.85	0.000132	Height	
PRAD	cis	1	rs9864582	chr3:129970462	COL6A4P2	chr3:129931663-129992648:+	0.23	4.07	5.49E-5	Response to amphetamines	
PRAD	cis	1	rs9865127	chr3:41807448	ULK4	chr3:41288091-42003660:-	0.85	14.01	1.68E-37	Diastolic blood pressure	
PRAD	cis	1	rs9865780	chr3:41895802	ULK4	chr3:41288091-42003660:-	0.88	14.28	1.11E-38	Diastolic blood pressure	
PRAD	cis	1	rs9865905	chr3:156649594	LEKR1	chr3:156544076-156763918:+	0.29	5.73	1.78E-8	Multiple sclerosis (severity)	
PRAD	cis	1	rs9866092	chr3:41895967	ULK4	chr3:41288091-42003660:-	0.88	14.28	1.11E-38	Diastolic blood pressure	
PRAD	cis	1	rs986666	chr6:160813408	SLC22A2	chr6:160592093-160679959:-	-0.22	-3.48	0.000548	Response to hepatitis C treatment	
PRAD	cis	1	rs9866759	chr3:41758418	ULK4	chr3:41288091-42003660:-	0.82	13.24	3.2E-34	Diastolic blood pressure	
PRAD	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.75	-11.63	1.22E-27	Diastolic blood pressure	
PRAD	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	0.88	14.34	6.1E-39	Diastolic blood pressure	
PRAD	cis	1	rs9869282	chr3:41756064	ULK4	chr3:41288091-42003660:-	0.81	13.12	9.53E-34	Diastolic blood pressure	
PRAD	cis	1	rs9869440	chr3:41763155	ULK4	chr3:41288091-42003660:-	0.8	12.86	1.28E-32	Diastolic blood pressure	
PRAD	cis	1	rs9869689	chr3:121326676	IQCB1	chr3:121488610-121553926:-	0.29	3.6	0.000349	Alzheimer's disease in APOE e4+ carriers	
PRAD	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.55	12.6	1.4E-31	Height	
PRAD	cis	1	rs9871024	chr3:49554241	AMIGO3	chr3:49754268-49757238:-	0.44	8.88	1.43E-17	Menarche (age at onset)	
PRAD	cis	1	rs9871024	chr3:49554241	CCDC36	chr3:49235861-49295537:+	-0.23	-4.12	4.57E-5	Menarche (age at onset)	
PRAD	cis	1	rs9871024	chr3:49554241	GMPPB	chr3:49758932-49761384:-	0.49	11.91	9.35E-29	Menarche (age at onset)	
PRAD	cis	1	rs9871024	chr3:49554241	NCKIPSD	chr3:48711280-48723334:-	-0.31	-6.2	1.21E-9	Menarche (age at onset)	
PRAD	cis	1	rs9871024	chr3:49554241	P4HTM	chr3:49027341-49044579:+	-0.16	-3.63	0.000313	Menarche (age at onset)	
PRAD	cis	1	rs9871024	chr3:49554241	WDR6	chr3:49044637-49053386:+	0.2	3.98	7.96E-5	Menarche (age at onset)	
PRAD	cis	1	rs9871159	chr3:14478593	SH3BP5	chr3:15296357-15382901:-	-0.12	-3.49	0.000525	Response to taxane treatment (docetaxel)	
PRAD	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.5	11.25	3.5E-26	Height	
PRAD	cis	1	rs9872999	chr3:133457514	TF	chr3:133419211-133497635:+	-0.32	-7.43	5.1E-13	Iron status biomarkers	
PRAD	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.81	12.12	1.36E-29	Diastolic blood pressure	
PRAD	cis	1	rs9873477	chr3:119645976	NR1I2	chr3:119499331-119537331:+	-0.22	-3.92	0.000103	HDL cholesterol	
PRAD	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.81	12.16	9.23E-30	Diastolic blood pressure	
PRAD	cis	1	rs9874517	chr3:53128371	ITIH4	chr3:52847007-52866554:-	-0.19	-3.6	0.000353	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs9874517	chr3:53128371	RFT1	chr3:53122503-53164470:-	0.4	4.88	1.44E-6	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs9874517	chr3:53128371	TMEM110	chr3:52867139-52931547:-	0.28	3.87	0.000126	Immune reponse to smallpox (secreted IL-2)	
PRAD	cis	1	rs9875081	chr3:10083935	C3orf10	chr3:10157333-10168873:+	-0.2	-3.85	0.000134	Alzheimer's disease	
PRAD	cis	1	rs9875081	chr3:10083935	LOC401052	chr3:10048102-10052779:-	-0.29	-5.25	2.31E-7	Alzheimer's disease	
PRAD	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.74	11.04	2.26E-25	Diastolic blood pressure	
PRAD	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.81	13.15	7.25E-34	Diastolic blood pressure	
PRAD	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.46	-10.56	1.53E-23	Height	
PRAD	cis	1	rs9876781	chr3:48487338	ATRIP	chr3:48488141-48507708:+	0.27	6.62	9.83E-11	Longevity	
PRAD	cis	1	rs9876781	chr3:48487338	CDC25A	chr3:48198668-48229801:-	0.21	4.03	6.53E-5	Longevity	
PRAD	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.17	-4.81	2.08E-6	Longevity	
PRAD	cis	1	rs9876960	chr3:41985812	ULK4	chr3:41288091-42003660:-	-0.9	-15.07	3.69E-42	Diastolic blood pressure	
PRAD	cis	1	rs9877400	chr3:190991439	UTS2D	chr3:190984945-191048325:-	0.25	5.12	4.48E-7	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9877891	chr3:119260866	ARHGAP31	chr3:119013220-119138322:+	-0.11	-3.45	0.00061	Systemic lupus erythematosus	
PRAD	cis	1	rs9878473	chr3:119650788	NR1I2	chr3:119499331-119537331:+	-0.22	-3.98	8.13E-5	HDL cholesterol	
PRAD	cis	1	rs9878833	chr3:190988302	UTS2D	chr3:190984945-191048325:-	-0.24	-4.9	1.34E-6	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9879080	chr3:10084224	C3orf10	chr3:10157333-10168873:+	-0.19	-3.81	0.00016	Alzheimer's disease	
PRAD	cis	1	rs9879080	chr3:10084224	LOC401052	chr3:10048102-10052779:-	-0.29	-5.26	2.19E-7	Alzheimer's disease	
PRAD	cis	1	rs9879311	chr3:10415343	GHRLOS	chr3:10322637-10335132:+	0.22	5.14	4.07E-7	Schizophrenia	
PRAD	cis	1	rs9881491	chr3:48487911	ATRIP	chr3:48488141-48507708:+	0.27	6.43	3.17E-10	Longevity	
PRAD	cis	1	rs9881491	chr3:48487911	CDC25A	chr3:48198668-48229801:-	0.21	3.94	9.38E-5	Longevity	
PRAD	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.19	-5.14	4.1E-7	Longevity	
PRAD	cis	1	rs9881859	chr3:10072814	C3orf10	chr3:10157333-10168873:+	-0.19	-3.79	0.000171	Alzheimer's disease	
PRAD	cis	1	rs9881859	chr3:10072814	LOC401052	chr3:10048102-10052779:-	-0.29	-5.3	1.78E-7	Alzheimer's disease	
PRAD	cis	1	rs9882740	chr3:49702484	GMPPB	chr3:49758932-49761384:-	-0.21	-4.44	1.14E-5	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs9882740	chr3:49702484	MST1	chr3:49721381-49726196:-	0.1	3.5	0.000509	Crohn's disease;Ulcerative colitis	
PRAD	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.52	11.87	1.35E-28	Height	
PRAD	cis	1	rs9883753	chr3:134247231	CEP63	chr3:134204575-134293852:+	0.21	3.64	0.000303	Height	
PRAD	cis	1	rs9883759	chr3:48463618	ATRIP	chr3:48488141-48507708:+	0.27	6.48	2.38E-10	Longevity	
PRAD	cis	1	rs9883759	chr3:48463618	CDC25A	chr3:48198668-48229801:-	0.22	4	7.39E-5	Longevity	
PRAD	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.19	-5.12	4.36E-7	Longevity	
PRAD	cis	1	rs9883927	chr3:48463711	ATRIP	chr3:48488141-48507708:+	0.27	6.64	8.79E-11	Longevity	
PRAD	cis	1	rs9883927	chr3:48463711	CDC25A	chr3:48198668-48229801:-	0.22	4.1	4.96E-5	Longevity	
PRAD	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.17	-4.81	2.04E-6	Longevity	
PRAD	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.55	12.55	2.37E-31	Height	
PRAD	cis	1	rs9885413	chr5:110176128	TMEM232	chr5:109624934-110062381:-	0.38	4.4	1.32E-5	Mortality in heart failure	
PRAD	cis	1	rs988712	chr11:27563382	BDNFOS	chr11:27528399-27719773:+	0.22	3.62	0.000326	Obesity	
PRAD	cis	1	rs9889618	chr17:40293467	DHX58	chr17:40253422-40264751:-	-0.35	-7.56	2.13E-13	Fibrinogen levels	
PRAD	cis	1	rs9889618	chr17:40293467	HSPB9	chr17:40274756-40275371:+	0.28	4.87	1.54E-6	Fibrinogen levels	
PRAD	cis	1	rs9889640	chr17:40293497	DHX58	chr17:40253422-40264751:-	-0.35	-7.56	2.13E-13	Fibrinogen levels	
PRAD	cis	1	rs9889640	chr17:40293497	HSPB9	chr17:40274756-40275371:+	0.28	4.87	1.54E-6	Fibrinogen levels	
PRAD	cis	1	rs9890032	chr17:29165934	SUZ12P	chr17:29035714-29097067:+	0.17	5.15	3.83E-7	Height	
PRAD	cis	1	rs9890205	chr17:28382704	EFCAB5	chr17:28256874-28435469:+	-0.23	-3.94	9.43E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs9890886	chr17:28391076	EFCAB5	chr17:28256874-28435469:+	-0.23	-3.93	9.61E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs9890971	chr17:53059776	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.71	0.000229	Breast cancer	
PRAD	cis	1	rs9891018	chr17:61827856	DDX42	chr17:61851567-61896676:+	-0.26	-5.36	1.3E-7	Body mass index	
PRAD	cis	1	rs9891018	chr17:61827856	FTSJ3	chr17:61896795-61905031:-	0.34	6.77	3.73E-11	Body mass index	
PRAD	cis	1	rs9891018	chr17:61827856	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.41	1.28E-5	Body mass index	
PRAD	cis	1	rs9891865	chr17:53060033	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9891871	chr17:28370191	EFCAB5	chr17:28256874-28435469:+	-0.23	-3.94	9.43E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs9892173	chr17:53060214	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9892848	chr17:53059775	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.69	0.000255	Breast cancer	
PRAD	cis	1	rs9892976	chr17:53060329	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.81	0.000159	Breast cancer	
PRAD	cis	1	rs9893306	chr17:53054749	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9893348	chr17:61676534	DDX42	chr17:61851567-61896676:+	-0.21	-4.06	5.73E-5	Body mass index	
PRAD	cis	1	rs9893348	chr17:61676534	FTSJ3	chr17:61896795-61905031:-	0.32	6.06	2.82E-9	Body mass index	
PRAD	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.74	17.43	7.87E-53	Eye color traits	
PRAD	cis	1	rs9894529	chr17:53055246	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.78	0.00018	Breast cancer	
PRAD	cis	1	rs9895808	chr17:53048442	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9895920	chr17:61852719	DDX42	chr17:61851567-61896676:+	-0.26	-5.43	8.84E-8	Body mass index	
PRAD	cis	1	rs9895920	chr17:61852719	FTSJ3	chr17:61896795-61905031:-	0.33	6.55	1.53E-10	Body mass index	
PRAD	cis	1	rs9895920	chr17:61852719	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.17	3.67E-5	Body mass index	
PRAD	cis	1	rs9896044	chr17:53048542	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.78	0.00018	Breast cancer	
PRAD	cis	1	rs9896062	chr17:28357047	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.11	4.64E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs9896933	chr17:80898088	FN3KRP	chr17:80674582-80685889:+	-0.43	-5.95	5.34E-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	
PRAD	cis	1	rs9897206	chr17:28406108	EFCAB5	chr17:28256874-28435469:+	-0.23	-3.84	0.000142	Coffee consumption (cups per day)	
PRAD	cis	1	rs989727	chr7:117003539	ASZ1	chr7:117003276-117067577:-	0.33	3.5	0.00051	Coronary heart disease	
PRAD	cis	1	rs9897362	chr17:17456746	RAI1	chr17:17584787-17714763:+	0.25	3.64	0.000302	Obsessive-compulsive symptoms	
PRAD	cis	1	rs9897447	chr17:53048469	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9897982	chr17:65879592	LOC651250	chr17:66097696-66157623:+	-0.25	-4.63	4.68E-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs9899491	chr17:61934384	DDX42	chr17:61851567-61896676:+	-0.28	-5.61	3.53E-8	Body mass index	
PRAD	cis	1	rs9899491	chr17:61934384	FTSJ3	chr17:61896795-61905031:-	0.35	6.82	2.87E-11	Body mass index	
PRAD	cis	1	rs9899491	chr17:61934384	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.47	9.87E-6	Body mass index	
PRAD	cis	1	rs9899788	chr17:61756384	DDX42	chr17:61851567-61896676:+	-0.25	-5.32	1.59E-7	Body mass index	
PRAD	cis	1	rs9899788	chr17:61756384	FTSJ3	chr17:61896795-61905031:-	0.33	6.64	8.78E-11	Body mass index	
PRAD	cis	1	rs9899788	chr17:61756384	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.21	3.09E-5	Body mass index	
PRAD	cis	1	rs9901112	chr17:61730617	CD79B	chr17:62006098-62009704:-	0.13	3.74	0.000209	Body mass index	
PRAD	cis	1	rs9901112	chr17:61730617	DDX42	chr17:61851567-61896676:+	-0.23	-4.57	6.34E-6	Body mass index	
PRAD	cis	1	rs9901112	chr17:61730617	FTSJ3	chr17:61896795-61905031:-	0.36	7.13	3.83E-12	Body mass index	
PRAD	cis	1	rs9901112	chr17:61730617	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.4	1.35E-5	Body mass index	
PRAD	cis	1	rs9901225	chr17:40755811	CNTNAP1	chr17:40834632-40852010:+	0.11	3.58	0.000377	Colorectal or endometrial cancer	
PRAD	cis	1	rs9901225	chr17:40755811	HSD17B1	chr17:40703984-40707224:+	-0.19	-5.02	7.51E-7	Colorectal or endometrial cancer	
PRAD	cis	1	rs9901507	chr17:61765524	DDX42	chr17:61851567-61896676:+	-0.27	-5.59	3.84E-8	Body mass index	
PRAD	cis	1	rs9901507	chr17:61765524	FTSJ3	chr17:61896795-61905031:-	0.32	6.42	3.36E-10	Body mass index	
PRAD	cis	1	rs9901507	chr17:61765524	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.2	3.25E-5	Body mass index	
PRAD	cis	1	rs9902453	chr17:28349095	EFCAB5	chr17:28256874-28435469:+	-0.24	-4.09	5.01E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs9902687	chr17:53048924	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9902718	chr17:53061622	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.75	0.0002	Breast cancer	
PRAD	cis	1	rs9903146	chr17:53057747	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9903220	chr17:53057865	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9903444	chr17:53057893	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9903503	chr17:17457227	RAI1	chr17:17584787-17714763:+	0.25	3.63	0.000317	Obsessive-compulsive symptoms	
PRAD	cis	1	rs9903825	chr17:53057914	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9903897	chr17:61716705	DDX42	chr17:61851567-61896676:+	-0.23	-4.72	3.07E-6	Body mass index	
PRAD	cis	1	rs9903897	chr17:61716705	FTSJ3	chr17:61896795-61905031:-	0.35	7.06	5.93E-12	Body mass index	
PRAD	cis	1	rs9903897	chr17:61716705	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.16	3.84E-5	Body mass index	
PRAD	cis	1	rs9903903	chr17:61762044	DDX42	chr17:61851567-61896676:+	-0.26	-5.5	6.1E-8	Body mass index	
PRAD	cis	1	rs9903903	chr17:61762044	FTSJ3	chr17:61896795-61905031:-	0.32	6.5	2.11E-10	Body mass index	
PRAD	cis	1	rs9903903	chr17:61762044	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.2	3.16E-5	Body mass index	
PRAD	cis	1	rs9904004	chr17:17476791	RAI1	chr17:17584787-17714763:+	0.23	3.62	0.00033	Obsessive-compulsive symptoms	
PRAD	cis	1	rs9905032	chr17:17457768	RAI1	chr17:17584787-17714763:+	0.25	3.68	0.000263	Obsessive-compulsive symptoms	
PRAD	cis	1	rs9905191	chr17:17469918	RAI1	chr17:17584787-17714763:+	0.27	3.57	0.0004	Obsessive-compulsive symptoms	
PRAD	cis	1	rs9905565	chr17:18758641	FAM18B	chr17:18684582-18710026:+	-0.23	-4.44	1.13E-5	Pancreatic cancer	
PRAD	cis	1	rs9905704	chr17:56632543	TEX14	chr17:56634039-56769416:-	-0.22	-3.98	8.13E-5	Testicular germ cell tumor	
PRAD	cis	1	rs9905704	chr17:56632543	TRIM37	chr17:57060002-57184266:-	-0.19	-4.18	3.44E-5	Testicular germ cell tumor	
PRAD	cis	1	rs9906340	chr17:28398977	EFCAB5	chr17:28256874-28435469:+	-0.23	-3.88	0.000118	Coffee consumption (cups per day)	
PRAD	cis	1	rs9908044	chr17:61747032	DDX42	chr17:61851567-61896676:+	-0.25	-5.32	1.59E-7	Body mass index	
PRAD	cis	1	rs9908044	chr17:61747032	FTSJ3	chr17:61896795-61905031:-	0.33	6.64	8.78E-11	Body mass index	
PRAD	cis	1	rs9908044	chr17:61747032	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.21	3.09E-5	Body mass index	
PRAD	cis	1	rs9908102	chr17:12896553	ELAC2	chr17:12895703-12921359:-	0.37	7.02	7.59E-12	Schizophrenia	
PRAD	cis	1	rs9908552	chr17:1297991	RTN4RL1	chr17:1837973-1928178:-	-0.25	-4.35	1.64E-5	Schizophrenia	
PRAD	cis	1	rs9909940	chr17:80689036	FN3K	chr17:80693452-80709073:+	-0.28	-6.21	1.15E-9	Glycated hemoglobin levels	
PRAD	cis	1	rs9909940	chr17:80689036	FN3KRP	chr17:80674582-80685889:+	-0.6	-11.36	1.37E-26	Glycated hemoglobin levels	
PRAD	cis	1	rs9909992	chr17:61731931	CD79B	chr17:62006098-62009704:-	0.12	3.63	0.000319	Body mass index	
PRAD	cis	1	rs9909992	chr17:61731931	DDX42	chr17:61851567-61896676:+	-0.23	-4.7	3.47E-6	Body mass index	
PRAD	cis	1	rs9909992	chr17:61731931	FTSJ3	chr17:61896795-61905031:-	0.36	7.25	1.77E-12	Body mass index	
PRAD	cis	1	rs9909992	chr17:61731931	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.54	7.07E-6	Body mass index	
PRAD	cis	1	rs9912084	chr17:65868035	LOC651250	chr17:66097696-66157623:+	-0.24	-4.45	1.08E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs9912201	chr17:61763208	DDX42	chr17:61851567-61896676:+	-0.27	-5.53	5.35E-8	Body mass index	
PRAD	cis	1	rs9912201	chr17:61763208	FTSJ3	chr17:61896795-61905031:-	0.33	6.48	2.27E-10	Body mass index	
PRAD	cis	1	rs9912201	chr17:61763208	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.19	3.35E-5	Body mass index	
PRAD	cis	1	rs9912741	chr17:28359511	EFCAB5	chr17:28256874-28435469:+	-0.23	-3.94	9.43E-5	Coffee consumption (cups per day)	
PRAD	cis	1	rs9912770	chr17:65868233	LOC651250	chr17:66097696-66157623:+	-0.24	-4.45	1.08E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs9912904	chr17:61763534	DDX42	chr17:61851567-61896676:+	-0.26	-5.45	8.17E-8	Body mass index	
PRAD	cis	1	rs9912904	chr17:61763534	FTSJ3	chr17:61896795-61905031:-	0.33	6.58	1.26E-10	Body mass index	
PRAD	cis	1	rs9912904	chr17:61763534	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.87E-6	Body mass index	
PRAD	cis	1	rs9913471	chr17:65874495	LOC651250	chr17:66097696-66157623:+	-0.24	-4.45	1.08E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs9914266	chr17:2133250	SRR	chr17:2207248-2228553:+	0.37	6.6	1.09E-10	Myocardial infarction	
PRAD	cis	1	rs9914544	chr17:18787828	FAM18B	chr17:18684582-18710026:+	-0.27	-5.61	3.38E-8	Educational attainment (years of education)	
PRAD	cis	1	rs9914577	chr17:2005130	SRR	chr17:2207248-2228553:+	0.29	4.49	8.88E-6	Body mass index	
PRAD	cis	1	rs9914578	chr17:2005136	SRR	chr17:2207248-2228553:+	0.29	4.49	8.88E-6	Body mass index	
PRAD	cis	1	rs9914732	chr17:53054367	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9915108	chr17:65874463	LOC651250	chr17:66097696-66157623:+	-0.24	-4.45	1.08E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
PRAD	cis	1	rs9915112	chr17:2007826	SRR	chr17:2207248-2228553:+	0.29	4.42	1.24E-5	Body mass index	
PRAD	cis	1	rs9915183	chr17:53047137	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9915832	chr17:53054697	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9916245	chr17:18766825	FAM18B	chr17:18684582-18710026:+	-0.25	-5.21	2.9E-7	Educational attainment (years of education)	
PRAD	cis	1	rs9916642	chr17:53054497	TOM1L1	chr17:52978052-53039328:+	-0.15	-3.86	0.00013	Breast cancer	
PRAD	cis	1	rs9917716	chr3:190979147	UTS2D	chr3:190984945-191048325:-	-0.22	-4.44	1.12E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9917717	chr3:190979176	UTS2D	chr3:190984945-191048325:-	-0.22	-4.44	1.12E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9917773	chr3:190979184	UTS2D	chr3:190984945-191048325:-	-0.22	-4.44	1.12E-5	Age-related hearing impairment (interaction)	
PRAD	cis	1	rs9917978	chr4:165885143	C4orf39	chr4:165878100-165880273:+	0.15	3.45	0.000604	Ovarian cancer in BRCA1 mutation carriers	
PRAD	cis	1	rs9918016	chr4:159621997	ETFDH	chr4:159593277-159629839:+	0.24	4.32	1.87E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
PRAD	cis	1	rs991964	chr2:59282591	FANCL	chr2:58386380-58468515:-	-0.14	-3.46	0.000594	Uterine fibroids	
PRAD	cis	1	rs9920482	chr15:100510477	C15orf51	chr15:100330361-100347132:-	0.16	3.7	0.000246	Urate levels in lean individuals	
PRAD	cis	1	rs9920711	chr15:100510478	C15orf51	chr15:100330361-100347132:-	0.17	3.77	0.000185	Urate levels in lean individuals	
PRAD	cis	1	rs9921638	chr16:27435937	GTF3C1	chr16:27471935-27561251:-	-0.17	-3.74	0.000205	Bone mineral density	
PRAD	cis	1	rs9921638	chr16:27435937	SBK1	chr16:28303840-28335162:+	-0.19	-3.93	9.91E-5	Bone mineral density	
PRAD	cis	1	rs9921668	chr16:27436172	GTF3C1	chr16:27471935-27561251:-	-0.17	-3.75	0.000196	Bone mineral density	
PRAD	cis	1	rs9921668	chr16:27436172	SBK1	chr16:28303840-28335162:+	-0.19	-3.95	9.09E-5	Bone mineral density	
PRAD	cis	1	rs9923145	chr16:74686166	RFWD3	chr16:74655298-74700779:-	-0.28	-7.09	5.03E-12	Testicular germ cell tumor	
PRAD	cis	1	rs9923856	chr16:11210415	DEXI	chr16:11022750-11036257:-	0.11	3.59	0.000371	Adult asthma;Atopic dermatitis	
PRAD	cis	1	rs992416	chr17:61745905	CD79B	chr17:62006098-62009704:-	0.12	3.51	0.000496	Body mass index	
PRAD	cis	1	rs992416	chr17:61745905	DDX42	chr17:61851567-61896676:+	-0.25	-5.18	3.28E-7	Body mass index	
PRAD	cis	1	rs992416	chr17:61745905	FTSJ3	chr17:61896795-61905031:-	0.34	6.81	3.06E-11	Body mass index	
PRAD	cis	1	rs992416	chr17:61745905	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.56E-6	Body mass index	
PRAD	cis	1	rs9925659	chr16:55609592	CAPNS2	chr16:55600584-55601592:+	-0.18	-4.84	1.74E-6	Thyroid hormone levels	
PRAD	cis	1	rs9925659	chr16:55609592	LPCAT2	chr16:55542913-55620581:+	0.12	3.98	7.95E-5	Thyroid hormone levels	
PRAD	cis	1	rs9925964	chr16:31129895	HSD3B7	chr16:30996519-31000473:+	-0.33	-6.74	4.7E-11	Body mass index	
PRAD	cis	1	rs9925964	chr16:31129895	MYST1	chr16:31128985-31142713:+	-0.21	-6.39	3.96E-10	Body mass index	
PRAD	cis	1	rs9925964	chr16:31129895	PRSS36	chr16:31150251-31161415:-	-0.22	-5.74	1.71E-8	Body mass index	
PRAD	cis	1	rs9928374	chr16:67811930	C16orf86	chr16:67700717-67702659:+	0.27	3.8	0.000166	Crohn's disease	
PRAD	cis	1	rs9929423	chr16:67733113	C16orf86	chr16:67700717-67702659:+	-0.25	-3.88	0.000119	Crohn's disease	
PRAD	cis	1	rs9929496	chr16:74668473	RFWD3	chr16:74655298-74700779:-	-0.32	-7.97	1.22E-14	Testicular germ cell tumor	
PRAD	cis	1	rs9930086	chr16:27435778	GTF3C1	chr16:27471935-27561251:-	-0.17	-3.74	0.000205	Bone mineral density	
PRAD	cis	1	rs9930086	chr16:27435778	SBK1	chr16:28303840-28335162:+	-0.19	-3.93	9.91E-5	Bone mineral density	
PRAD	cis	1	rs9930728	chr16:69466275	PDF	chr16:69362524-69364498:-	0.24	4.53	7.6E-6	Blood pressure (smoking interaction)	
PRAD	cis	1	rs9931225	chr16:74699293	RFWD3	chr16:74655298-74700779:-	-0.3	-7.38	7.33E-13	Testicular germ cell tumor	
PRAD	cis	1	rs993648	chr2:182455994	CERKL	chr2:182401402-182545381:-	0.15	3.65	0.000297	Response to iloperidone treatment (QT prolongation)	
PRAD	cis	1	rs993650	chr2:182455848	CERKL	chr2:182401402-182545381:-	0.18	4.32	1.88E-5	Response to iloperidone treatment (QT prolongation)	
PRAD	cis	1	rs9938862	chr16:67723801	C16orf86	chr16:67700717-67702659:+	-0.27	-4.11	4.72E-5	Crohn's disease	
PRAD	cis	1	rs9938862	chr16:67723801	LRRC36	chr16:67360747-67419108:+	0.35	3.55	0.000421	Crohn's disease	
PRAD	cis	1	rs9939085	chr16:67733237	C16orf86	chr16:67700717-67702659:+	-0.27	-4.11	4.72E-5	Crohn's disease	
PRAD	cis	1	rs9939085	chr16:67733237	LRRC36	chr16:67360747-67419108:+	0.35	3.55	0.000421	Crohn's disease	
PRAD	cis	1	rs9939768	chr16:67219107	FHOD1	chr16:67263294-67281425:-	0.56	7.17	2.88E-12	HDL cholesterol	
PRAD	cis	1	rs9939768	chr16:67219107	SLC9A5	chr16:67282855-67306093:+	0.33	4.8	2.13E-6	HDL cholesterol	
PRAD	cis	1	rs9940227	chr16:55614794	CAPNS2	chr16:55600584-55601592:+	0.18	4.94	1.11E-6	Thyroid hormone levels	
PRAD	cis	1	rs9940227	chr16:55614794	LPCAT2	chr16:55542913-55620581:+	-0.13	-4.42	1.23E-5	Thyroid hormone levels	
PRAD	cis	1	rs9940665	chr16:67289841	FHOD1	chr16:67263294-67281425:-	0.52	5.84	9.96E-9	HDL cholesterol	
PRAD	cis	1	rs9941751	chr20:33645709	MMP24	chr20:33814539-33864804:+	-0.23	-3.81	0.000156	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
PRAD	cis	1	rs9943661	chr11:32893777	CCDC73	chr11:32623627-32816187:-	0.19	3.69	0.000246	Parkinson's disease (age of onset)	
PRAD	cis	1	rs9944423	chr17:17484934	RAI1	chr17:17584787-17714763:+	0.23	3.47	0.000578	Obsessive-compulsive symptoms	
PRAD	cis	1	rs9944914	chr18:40266471	SYT4	chr18:40847859-40857615:-	0.22	3.43	0.000651	Cognitive performance	
PRAD	cis	1	rs9945428	chr18:71788676	FBXO15	chr18:71740588-71815100:-	0.32	5.32	1.57E-7	Venous thromboembolism (SNP x SNP interaction)	
PRAD	cis	1	rs994578	chr10:100593646	CUTC	chr10:101491958-101515893:+	-0.19	-3.43	0.000665	Obesity-related traits	
PRAD	cis	1	rs9953625	chr18:40260494	SYT4	chr18:40847859-40857615:-	0.22	3.54	0.000437	Cognitive performance	
PRAD	cis	1	rs996285	chr14:60869837	C14orf39	chr14:60902675-60952764:-	-0.47	-5.56	4.41E-8	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.52	-11.81	2.23E-28	Height	
PRAD	cis	1	rs9969804	chr9:95429120	CENPP	chr9:95087741-95377435:+	0.21	4.47	1.0E-5	Height	
PRAD	cis	1	rs9969804	chr9:95429120	OGN	chr9:95146251-95166937:-	0.1	3.53	0.000462	Height	
PRAD	cis	1	rs997295	chr15:68016343	IQCH	chr15:67547188-67794139:+	0.29	5.97	4.59E-9	Motion sickness	
PRAD	cis	1	rs9973177	chr18:11988855	IMPA2	chr18:11981057-12030876:+	-0.31	-3.84	0.000138	Stroke	
PRAD	cis	1	rs9977571	chr21:43624157	CBS	chr21:44473301-44496472:-	0.24	3.6	0.000354	Eating disorder in bipolar disorder	
PRAD	cis	1	rs9978280	chr21:34736946	KCNE2	chr21:35736323-35743440:+	0.24	3.46	0.000584	Cognitive decline (age-related)	
PRAD	cis	1	rs997872	chr22:25878614	CRYBB2	chr22:25615612-25627836:+	0.93	15.63	1.15E-44	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs997873	chr22:25878282	CRYBB2	chr22:25615612-25627836:+	0.93	15.66	9.09E-45	Bipolar disorder with mood-incongruent psychosis	
PRAD	cis	1	rs9978964	chr21:34736952	KCNE2	chr21:35736323-35743440:+	0.24	3.46	0.000584	Cognitive decline (age-related)	
PRAD	cis	1	rs9979395	chr21:41217492	IGSF5	chr21:41117334-41174021:+	0.17	3.51	0.000495	Systolic blood pressure (alcohol consumption interaction)	
PRAD	cis	1	rs9980618	chr21:35600505	KCNE2	chr21:35736323-35743440:+	0.3	3.64	0.000306	Myocardial infarction;Myocardial infarction (early onset);Coronary artery disease;Coronary heart disease	
PRAD	cis	1	rs9980954	chr21:41213953	IGSF5	chr21:41117334-41174021:+	0.19	3.78	0.000174	Systolic blood pressure (alcohol consumption interaction)	
PRAD	cis	1	rs9981595	chr21:40560678	WRB	chr21:40752213-40769814:+	0.26	3.51	0.000487	Venous thromboembolism (SNP x SNP interaction)	
PRAD	cis	1	rs9982214	chr21:41217968	IGSF5	chr21:41117334-41174021:+	0.17	3.51	0.000494	Systolic blood pressure (alcohol consumption interaction)	
PRAD	cis	1	rs9982601	chr21:35599128	KCNE2	chr21:35736323-35743440:+	0.31	3.63	0.00032	Myocardial infarction;Myocardial infarction (early onset);Coronary artery disease;Coronary heart disease	
PRAD	cis	1	rs9982859	chr21:41217916	IGSF5	chr21:41117334-41174021:+	0.19	3.76	0.000192	Systolic blood pressure (alcohol consumption interaction)	
PRAD	cis	1	rs9983229	chr21:30137674	N6AMT1	chr21:30244513-30257693:-	0.3	3.94	9.38E-5	Cognitive test performance	
PRAD	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.48	-10.64	7.81E-24	Height	
PRAD	cis	1	rs9986382	chr6:26550619	BTN2A3	chr6:26422317-26431927:+	0.26	6.58	1.29E-10	Educational attainment	
PRAD	cis	1	rs9986382	chr6:26550619	ZNF184	chr6:27418522-27440897:-	-0.17	-3.51	0.000488	Educational attainment	
PRAD	cis	1	rs9986596	chr6:28219661	ZKSCAN3	chr6:28317691-28334523:+	-0.18	-3.65	0.000292	Depression	
PRAD	cis	1	rs9986596	chr6:28219661	ZNF187	chr6:28234788-28245978:+	-0.3	-5.52	5.52E-8	Depression	
PRAD	cis	1	rs9986596	chr6:28219661	ZNF323	chr6:28292517-28324048:-	0.38	5.13	4.27E-7	Depression	
PRAD	cis	1	rs9986596	chr6:28219661	ZNF389	chr6:28129551-28137375:+	-0.53	-7.63	1.35E-13	Depression	
PRAD	cis	1	rs9986596	chr6:28219661	ZSCAN23	chr6:28393287-28411279:-	0.17	4.73	3.03E-6	Depression	
PRAD	cis	1	rs9986696	chr7:65704576	TPST1	chr7:65670259-65825437:+	-0.18	-4.4	1.34E-5	Aortic root size	
PRAD	cis	1	rs9988866	chr11:18392983	GTF2H1	chr11:18343816-18388590:+	0.66	13.89	5.13E-37	Pancreatic cancer	
PRAD	cis	1	rs9989167	chr14:60942374	C14orf39	chr14:60902675-60952764:-	0.44	5.9	6.95E-9	Gut microbiota (bacterial taxa)	
PRAD	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.52	11.87	1.35E-28	Height	
PRAD	cis	1	rs9989967	chr3:134238964	CEP63	chr3:134204575-134293852:+	0.21	3.64	0.000303	Height	
PRAD	cis	1	rs9990343	chr3:46339812	CCR2	chr3:46395235-46402412:+	0.1	4.03	6.4E-5	Brain structure	
PRAD	cis	1	rs9990343	chr3:46339812	CCR5	chr3:46411633-46417690:+	0.1	4.28	2.25E-5	Brain structure	
PRAD	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.51	-11.61	1.42E-27	Height	
PRAD	cis	1	rs9990702	chr4:88772316	SPP1	chr4:88896802-88904562:+	-0.2	-3.65	0.000288	Bone mineral density;Bone mineral density (paediatric, total body less head)	
PRAD	cis	1	rs9990742	chr4:39121414	KLHL5	chr4:39046659-39123828:+	-0.13	-3.94	9.43E-5	Uric acid levels	
PRAD	cis	1	rs9990755	chr4:39121439	KLHL5	chr4:39046659-39123828:+	-0.13	-3.79	0.000168	Uric acid levels	
PRAD	cis	1	rs9991307	chr4:17662408	MED28	chr4:17616273-17629791:+	0.2	4.9	1.35E-6	Parasitemia in Tripanosoma cruzi seropositivity	
PRAD	cis	1	rs9991678	chr4:165885039	C4orf39	chr4:165878100-165880273:+	0.17	3.92	0.000103	Ovarian cancer in BRCA1 mutation carriers	
PRAD	cis	1	rs9992101	chr4:77360431	CCDC158	chr4:77234193-77328458:-	0.21	4.17	3.58E-5	Creatinine levels	
PRAD	cis	1	rs9992101	chr4:77360431	FAM47E	chr4:77135193-77204923:+	0.23	4.16	3.76E-5	Creatinine levels	
PRAD	cis	1	rs9996285	chr4:39132176	KLHL5	chr4:39046659-39123828:+	-0.13	-3.75	0.000202	Uric acid levels	
PRAD	cis	1	rs9997089	chr4:39120883	KLHL5	chr4:39046659-39123828:+	-0.13	-3.79	0.000168	Uric acid levels	
PRAD	cis	1	rs9998481	chr4:39118835	KLHL5	chr4:39046659-39123828:+	-0.14	-4.12	4.41E-5	Uric acid levels	
PRAD	cis	1	rs9998867	chr4:39119162	KLHL5	chr4:39046659-39123828:+	-0.13	-3.89	0.000113	Uric acid levels	
PRAD	cis	1	rs9998898	chr4:88772189	SPP1	chr4:88896802-88904562:+	-0.2	-3.65	0.000288	Bone mineral density;Bone mineral density (paediatric, total body less head)	
PRAD	cis	1	rs9998975	chr4:88772233	SPP1	chr4:88896802-88904562:+	-0.2	-3.65	0.000288	Bone mineral density;Bone mineral density (paediatric, total body less head)	
PRAD	cis	1	rs9999327	chr4:39111731	KLHL5	chr4:39046659-39123828:+	-0.13	-3.76	0.000193	Uric acid levels	
PRAD	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.56	-15.45	7.77E-44	Migraine without aura	
PRAD	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.62	13.28	2.1E-34	Educational attainment	
PRAD	trans	1	rs10456362	chr6:28221816	BTN3A2	chr6:26365398-26378546:+	0.5	9.34	3.83E-19	Depression	
PRAD	trans	1	rs10456362	chr6:28221816	VARS2	chr6:30881982-30894233:+	0.39	6.78	3.64E-11	Depression	
PRAD	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.62	13.37	9.01E-35	Educational attainment	
PRAD	trans	1	rs10491581	chr9:117609723	C6orf203	chr6:107349407-107372544:+	-0.34	-5.94	5.45E-9	Ulcerative colitis;Inflammatory bowel disease	
PRAD	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.61	13.07	1.7E-33	Educational attainment	
PRAD	trans	1	rs10742862	chr11:48649316	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.13	3.88E-15	HDL cholesterol	
PRAD	trans	1	rs10769371	chr11:48531184	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.01	8.83E-15	HDL cholesterol	
PRAD	trans	1	rs10769390	chr11:48618222	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.88	2.23E-14	HDL cholesterol	
PRAD	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.63	13.51	2.3E-35	Educational attainment	
PRAD	trans	1	rs10794671	chr1:121168242	NBPF14	chr1:148003643-148346791:-	0.38	9.21	1.1E-18	Hip geometry	
PRAD	trans	1	rs10838801	chr11:48098280	FOLH1B	chr11:89392465-89431885:+	-0.33	-5.96	4.91E-9	Height	
PRAD	trans	1	rs10838912	chr11:48496477	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.28	1.27E-15	HDL cholesterol	
PRAD	trans	1	rs10838917	chr11:48503127	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.28	1.32E-15	HDL cholesterol	
PRAD	trans	1	rs10838931	chr11:48540973	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.19	2.41E-15	HDL cholesterol	
PRAD	trans	1	rs10838943	chr11:48557442	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.89	2.08E-14	HDL cholesterol	
PRAD	trans	1	rs10838944	chr11:48559571	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.89	2.08E-14	HDL cholesterol	
PRAD	trans	1	rs10838954	chr11:48579323	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.82	3.49E-14	HDL cholesterol	
PRAD	trans	1	rs10838966	chr11:48589723	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.9	2.0E-14	HDL cholesterol	
PRAD	trans	1	rs10838971	chr11:48606624	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.04	7.14E-15	HDL cholesterol	
PRAD	trans	1	rs10838975	chr11:48617615	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.04	7.14E-15	HDL cholesterol	
PRAD	trans	1	rs10839171	chr11:48923034	FOLH1B	chr11:89392465-89431885:+	0.45	8.63	9.71E-17	HDL cholesterol	
PRAD	trans	1	rs10842750	chr12:26690565	RPL13AP6	chr10:112696361-112697013:-	-0.44	-6.11	2.03E-9	Kashin-Beck disease	
PRAD	trans	1	rs10903159	chr1:121181997	NBPF14	chr1:148003643-148346791:-	0.38	9.15	1.73E-18	Hip geometry	
PRAD	trans	1	rs10903161	chr1:121178741	NBPF14	chr1:148003643-148346791:-	0.36	8.67	6.89E-17	Hip geometry	
PRAD	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs10982287	chr9:117314215	SCARA5	chr8:27727753-27850198:-	0.26	5.85	9.14E-9	Bone mineral density (spine) and age at menarche	
PRAD	trans	1	rs10982438	chr9:117625899	HOXB13	chr17:46802129-46806111:-	0.35	5.91	6.77E-9	Ulcerative colitis;Inflammatory bowel disease	
PRAD	trans	1	rs11039745	chr11:48463811	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.12	4.28E-15	HDL cholesterol	
PRAD	trans	1	rs11039777	chr11:48517049	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.18	2.67E-15	HDL cholesterol	
PRAD	trans	1	rs11039779	chr11:48517895	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.11	4.42E-15	HDL cholesterol	
PRAD	trans	1	rs11039800	chr11:48542579	FOLH1B	chr11:89392465-89431885:+	0.41	8.01	9.01E-15	HDL cholesterol	
PRAD	trans	1	rs11039817	chr11:48561480	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.89	2.08E-14	HDL cholesterol	
PRAD	trans	1	rs11039819	chr11:48562181	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.97	1.23E-14	HDL cholesterol	
PRAD	trans	1	rs11039820	chr11:48562252	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.79	4.24E-14	HDL cholesterol	
PRAD	trans	1	rs11039821	chr11:48562875	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.01	9.35E-15	HDL cholesterol	
PRAD	trans	1	rs11039851	chr11:48600839	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.88	2.23E-14	HDL cholesterol	
PRAD	trans	1	rs11039854	chr11:48607688	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.88	2.23E-14	HDL cholesterol	
PRAD	trans	1	rs11039857	chr11:48610853	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.04	7.14E-15	HDL cholesterol	
PRAD	trans	1	rs11039859	chr11:48611988	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.04	7.14E-15	HDL cholesterol	
PRAD	trans	1	rs11039862	chr11:48618306	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.87	2.44E-14	HDL cholesterol	
PRAD	trans	1	rs11039868	chr11:48622146	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.88	2.23E-14	HDL cholesterol	
PRAD	trans	1	rs11039871	chr11:48626620	FOLH1B	chr11:89392465-89431885:+	0.41	7.9	2.03E-14	HDL cholesterol	
PRAD	trans	1	rs11039890	chr11:48653468	FOLH1B	chr11:89392465-89431885:+	-0.43	-8.44	3.87E-16	HDL cholesterol	
PRAD	trans	1	rs11039904	chr11:48682597	FOLH1B	chr11:89392465-89431885:+	0.53	6.81	2.96E-11	Axial length	
PRAD	trans	1	rs11039978	chr11:48760237	FOLH1B	chr11:89392465-89431885:+	0.53	6.81	2.96E-11	Axial length	
PRAD	trans	1	rs11249350	chr1:121178446	NBPF14	chr1:148003643-148346791:-	0.38	9.15	1.73E-18	Hip geometry	
PRAD	trans	1	rs11249351	chr1:121171942	NBPF14	chr1:148003643-148346791:-	0.37	8.81	2.34E-17	Hip geometry	
PRAD	trans	1	rs115224187	chr11:48757499	FOLH1B	chr11:89392465-89431885:+	0.45	8.57	1.54E-16	HDL cholesterol	
PRAD	trans	1	rs11530232	chr11:48622376	FOLH1B	chr11:89392465-89431885:+	0.57	6.58	1.23E-10	Axial length	
PRAD	trans	1	rs115429994	chr11:48761183	FOLH1B	chr11:89392465-89431885:+	0.53	6.81	2.96E-11	Axial length	
PRAD	trans	1	rs1167827	chr7:75163169	TRIM74	chr7:75021265-75040277:+	-0.27	-6.21	1.14E-9	Body mass index	
PRAD	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs11965538	chr6:28239915	BTN3A2	chr6:26365398-26378546:+	-0.49	-9.82	7.96E-21	Depression	
PRAD	trans	1	rs11965538	chr6:28239915	VARS2	chr6:30881982-30894233:+	-0.34	-6.14	1.72E-9	Depression	
PRAD	trans	1	rs12047116	chr1:121185770	NBPF14	chr1:148003643-148346791:-	0.38	9.14	1.82E-18	Hip geometry	
PRAD	trans	1	rs12145080	chr1:121185531	NBPF14	chr1:148003643-148346791:-	-0.38	-9.13	2.06E-18	Hip geometry	
PRAD	trans	1	rs12225599	chr11:48755868	FOLH1B	chr11:89392465-89431885:+	0.53	6.81	2.96E-11	Axial length	
PRAD	trans	1	rs12280020	chr11:48618844	FOLH1B	chr11:89392465-89431885:+	0.52	6.75	4.25E-11	Axial length	
PRAD	trans	1	rs12281162	chr11:48650491	FOLH1B	chr11:89392465-89431885:+	0.51	6.52	1.77E-10	Axial length	
PRAD	trans	1	rs12293522	chr11:49558425	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.35	8.68E-13	Height	
PRAD	trans	1	rs12332430	chr5:147550297	NFATC4	chr14:24836145-24848808:+	0.34	5.96	4.85E-9	Post bronchodilator FEV1/FVC ratio in COPD	
PRAD	trans	1	rs12361812	chr11:48563104	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.01	8.87E-15	HDL cholesterol	
PRAD	trans	1	rs12365220	chr11:48555957	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.89	2.08E-14	HDL cholesterol	
PRAD	trans	1	rs12366208	chr11:48563128	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.18	2.58E-15	HDL cholesterol	
PRAD	trans	1	rs12419576	chr11:48581644	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.87	2.47E-14	HDL cholesterol	
PRAD	trans	1	rs12420372	chr11:48497603	FOLH1B	chr11:89392465-89431885:+	0.42	8.11	4.57E-15	HDL cholesterol	
PRAD	trans	1	rs12421159	chr11:48624841	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.88	2.23E-14	HDL cholesterol	
PRAD	trans	1	rs12421879	chr11:48689978	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.65	8.49E-17	HDL cholesterol	
PRAD	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.62	13.26	2.65E-34	Educational attainment	
PRAD	trans	1	rs12806328	chr11:48647971	FOLH1B	chr11:89392465-89431885:+	-0.43	-8.37	6.5E-16	HDL cholesterol	
PRAD	trans	1	rs13195401	chr6:26463574	CDSN	chr6:31082870-31088223:-	-0.54	-5.95	5.18E-9	Schizophrenia	
PRAD	trans	1	rs13195401	chr6:26463574	RNF5P1	chr8:38457695-38458775:-	0.62	6.4	3.84E-10	Schizophrenia	
PRAD	trans	1	rs13195401	chr6:26463574	ZFP57	chr6:29640171-29648887:-	0.82	8.44	3.9E-16	Schizophrenia	
PRAD	trans	1	rs13195401	chr6:26463574	ZNF389	chr6:28129551-28137375:+	-0.66	-6.66	7.79E-11	Schizophrenia	
PRAD	trans	1	rs13195402	chr6:26463575	CDSN	chr6:31082870-31088223:-	-0.54	-5.95	5.18E-9	Schizophrenia	
PRAD	trans	1	rs13195402	chr6:26463575	RNF5P1	chr8:38457695-38458775:-	0.62	6.4	3.84E-10	Schizophrenia	
PRAD	trans	1	rs13195402	chr6:26463575	ZFP57	chr6:29640171-29648887:-	0.82	8.44	3.9E-16	Schizophrenia	
PRAD	trans	1	rs13195402	chr6:26463575	ZNF389	chr6:28129551-28137375:+	-0.66	-6.66	7.79E-11	Schizophrenia	
PRAD	trans	1	rs13200462	chr6:28218199	BTN3A2	chr6:26365398-26378546:+	-0.51	-9.98	2.07E-21	Depression	
PRAD	trans	1	rs13200462	chr6:28218199	ZFP57	chr6:29640171-29648887:-	0.44	6.2	1.27E-9	Depression	
PRAD	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.59	-12.56	2.11E-31	Educational attainment	
PRAD	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs13220495	chr6:26441640	CDSN	chr6:31082870-31088223:-	-0.55	-5.99	4.26E-9	Schizophrenia	
PRAD	trans	1	rs13220495	chr6:26441640	RNF5P1	chr8:38457695-38458775:-	0.61	6.21	1.15E-9	Schizophrenia	
PRAD	trans	1	rs13220495	chr6:26441640	ZFP57	chr6:29640171-29648887:-	0.82	8.45	3.59E-16	Schizophrenia	
PRAD	trans	1	rs13220495	chr6:26441640	ZNF389	chr6:28129551-28137375:+	-0.68	-6.81	3.04E-11	Schizophrenia	
PRAD	trans	1	rs1351696	chr11:48382471	FOLH1B	chr11:89392465-89431885:+	-0.56	-7.29	1.3E-12	D-dimer levels	
PRAD	trans	1	rs1419183	chr6:28242794	BTN3A2	chr6:26365398-26378546:+	-0.49	-9.81	8.84E-21	Depression	
PRAD	trans	1	rs1419183	chr6:28242794	VARS2	chr6:30881982-30894233:+	-0.34	-6.13	1.9E-9	Depression	
PRAD	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.63	13.51	2.3E-35	Educational attainment	
PRAD	trans	1	rs1591882	chr1:121183313	NBPF14	chr1:148003643-148346791:-	0.38	9.03	4.3E-18	Hip geometry	
PRAD	trans	1	rs1605364	chr11:48684843	FOLH1B	chr11:89392465-89431885:+	-0.43	-8.36	7.33E-16	HDL cholesterol	
PRAD	trans	1	rs1637214	chr7:23236842	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	6	3.95E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs1637224	chr7:23228400	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	6	3.95E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs1679709	chr6:28228342	BTN3A2	chr6:26365398-26378546:+	0.51	10.1	7.84E-22	Depression	
PRAD	trans	1	rs1679709	chr6:28228342	VARS2	chr6:30881982-30894233:+	0.35	6.27	7.96E-10	Depression	
PRAD	trans	1	rs1679709	chr6:28228342	ZFP57	chr6:29640171-29648887:-	-0.42	-5.99	4.14E-9	Depression	
PRAD	trans	1	rs1679732	chr6:28221264	BTN3A2	chr6:26365398-26378546:+	0.51	10.1	7.84E-22	Depression	
PRAD	trans	1	rs1679732	chr6:28221264	VARS2	chr6:30881982-30894233:+	0.35	6.27	7.96E-10	Depression	
PRAD	trans	1	rs1679732	chr6:28221264	ZFP57	chr6:29640171-29648887:-	-0.42	-5.99	4.14E-9	Depression	
PRAD	trans	1	rs17045500	chr2:116833994	MEA1	chr6:42948082-42981660:-	-0.31	-5.86	8.73E-9	Urate levels (BMI interaction)	
PRAD	trans	1	rs1728327	chr7:23235483	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	6	3.95E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs1728344	chr7:23250044	GAGE2D	chrX:49197563-49223943:+;chrX	0.27	6.33	5.81E-10	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs1778508	chr6:28229881	BTN3A2	chr6:26365398-26378546:+	0.49	9.75	1.43E-20	Depression	
PRAD	trans	1	rs1778508	chr6:28229881	VARS2	chr6:30881982-30894233:+	0.35	6.3	7.0E-10	Depression	
PRAD	trans	1	rs1778511	chr6:28229411	BTN3A2	chr6:26365398-26378546:+	0.5	9.96	2.41E-21	Depression	
PRAD	trans	1	rs1778511	chr6:28229411	VARS2	chr6:30881982-30894233:+	0.35	6.23	1.01E-9	Depression	
PRAD	trans	1	rs1778511	chr6:28229411	ZFP57	chr6:29640171-29648887:-	-0.41	-5.85	9.15E-9	Depression	
PRAD	trans	1	rs1809986	chr11:48987539	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.79	2.94E-17	HDL cholesterol	
PRAD	trans	1	rs1814175	chr11:49559172	FOLH1B	chr11:89392465-89431885:+	-0.43	-8.17	2.88E-15	Height	
PRAD	trans	1	rs1832558	chr1:121177380	NBPF14	chr1:148003643-148346791:-	0.36	8.68	6.38E-17	Hip geometry	
PRAD	trans	1	rs1856572	chr1:121169579	NBPF14	chr1:148003643-148346791:-	0.38	9.21	1.1E-18	Hip geometry	
PRAD	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.62	13.34	1.15E-34	Educational attainment	
PRAD	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.63	13.51	2.3E-35	Educational attainment	
PRAD	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.63	13.51	2.3E-35	Educational attainment	
PRAD	trans	1	rs1936365	chr6:28268452	BTN3A2	chr6:26365398-26378546:+	0.46	9	5.82E-18	Depression	
PRAD	trans	1	rs1936365	chr6:28268452	VARS2	chr6:30881982-30894233:+	0.34	6.07	2.61E-9	Depression	
PRAD	trans	1	rs1979	chr6:26377591	ZFP57	chr6:29640171-29648887:-	0.52	6.09	2.31E-9	Schizophrenia	
PRAD	trans	1	rs1979	chr6:26377591	ZNF389	chr6:28129551-28137375:+	-0.6	-7.08	5.34E-12	Schizophrenia	
PRAD	trans	1	rs1986111	chr1:121204788	NBPF14	chr1:148003643-148346791:-	0.38	8.85	1.8E-17	Hip geometry	
PRAD	trans	1	rs2185281	chr1:121179991	NBPF14	chr1:148003643-148346791:-	0.38	9.15	1.68E-18	Hip geometry	
PRAD	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.61	13.07	1.7E-33	Educational attainment	
PRAD	trans	1	rs2221559	chr11:48707973	FOLH1B	chr11:89392465-89431885:+	0.44	8.43	4.12E-16	HDL cholesterol	
PRAD	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.62	13.43	4.77E-35	Educational attainment	
PRAD	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.61	13.07	1.7E-33	Educational attainment	
PRAD	trans	1	rs2292239	chr12:56482180	RPS26P11	chrX:71264259-71264809:+	0.52	9.04	3.97E-18	Cognitive function	
PRAD	trans	1	rs2319969	chr1:121207335	NBPF14	chr1:148003643-148346791:-	0.35	8.26	1.5E-15	Hip geometry	
PRAD	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs2524005	chr6:29899677	BTN3A2	chr6:26365398-26378546:+	-0.36	-7.03	7.52E-12	Bipolar disorder and schizophrenia	
PRAD	trans	1	rs2744301	chr6:25323143	BTN3A2	chr6:26365398-26378546:+	-0.67	-6.98	1.01E-11	Schizophrenia	
PRAD	trans	1	rs2799077	chr6:28234597	BTN3A2	chr6:26365398-26378546:+	-0.5	-9.92	3.48E-21	Depression	
PRAD	trans	1	rs2799077	chr6:28234597	VARS2	chr6:30881982-30894233:+	-0.35	-6.21	1.15E-9	Depression	
PRAD	trans	1	rs2799079	chr6:28235176	BTN3A2	chr6:26365398-26378546:+	-0.48	-9.57	6.32E-20	Depression	
PRAD	trans	1	rs2799079	chr6:28235176	VARS2	chr6:30881982-30894233:+	-0.33	-5.93	6.0E-9	Depression	
PRAD	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs34636547	chr11:48590103	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.9	2.0E-14	HDL cholesterol	
PRAD	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.61	13.07	1.7E-33	Educational attainment	
PRAD	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.61	13.07	1.7E-33	Educational attainment	
PRAD	trans	1	rs41266839	chr6:26409890	CDSN	chr6:31082870-31088223:-	-0.55	-5.97	4.65E-9	Schizophrenia	
PRAD	trans	1	rs41266839	chr6:26409890	RNF5P1	chr8:38457695-38458775:-	0.6	6.08	2.44E-9	Schizophrenia	
PRAD	trans	1	rs41266839	chr6:26409890	ZFP57	chr6:29640171-29648887:-	0.84	8.61	1.12E-16	Schizophrenia	
PRAD	trans	1	rs41266839	chr6:26409890	ZNF389	chr6:28129551-28137375:+	-0.68	-6.75	4.3E-11	Schizophrenia	
PRAD	trans	1	rs4703855	chr5:71693899	INPP4B	chr4:142949184-143767604:-	0.23	5.97	4.69E-9	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
PRAD	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.62	13.3	1.84E-34	Educational attainment	
PRAD	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs4759229	chr12:56474480	RPS26P11	chrX:71264259-71264809:+	-0.55	-9.23	9.05E-19	Cognitive function	
PRAD	trans	1	rs4844380	chr1:121193620	NBPF14	chr1:148003643-148346791:-	0.38	8.97	6.89E-18	Hip geometry	
PRAD	trans	1	rs4844381	chr1:121184898	NBPF14	chr1:148003643-148346791:-	0.39	9.32	4.67E-19	Hip geometry	
PRAD	trans	1	rs4844607	chr1:121184059	NBPF14	chr1:148003643-148346791:-	-0.38	-9.19	1.26E-18	Hip geometry	
PRAD	trans	1	rs4844616	chr1:121171208	NBPF14	chr1:148003643-148346791:-	0.39	9.29	5.94E-19	Hip geometry	
PRAD	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.62	13.25	2.8E-34	Educational attainment	
PRAD	trans	1	rs4881994	chr11:48498139	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.28	1.27E-15	HDL cholesterol	
PRAD	trans	1	rs4882010	chr11:48559173	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.89	2.08E-14	HDL cholesterol	
PRAD	trans	1	rs4882015	chr11:48565573	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.16	3.03E-15	HDL cholesterol	
PRAD	trans	1	rs4882016	chr11:48570125	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.96	1.27E-14	HDL cholesterol	
PRAD	trans	1	rs4882017	chr11:48570182	FOLH1B	chr11:89392465-89431885:+	0.41	7.9	1.95E-14	HDL cholesterol	
PRAD	trans	1	rs4882019	chr11:48598748	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.06	6.26E-15	HDL cholesterol	
PRAD	trans	1	rs4882021	chr11:48615966	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.04	7.14E-15	HDL cholesterol	
PRAD	trans	1	rs4882096	chr11:48534102	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.01	8.83E-15	HDL cholesterol	
PRAD	trans	1	rs4882111	chr11:48558447	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.89	2.08E-14	HDL cholesterol	
PRAD	trans	1	rs4882117	chr11:48565468	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.16	3.03E-15	HDL cholesterol	
PRAD	trans	1	rs4882120	chr11:48573529	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.97	1.23E-14	HDL cholesterol	
PRAD	trans	1	rs4882123	chr11:48575739	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.97	1.23E-14	HDL cholesterol	
PRAD	trans	1	rs4882129	chr11:48588774	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.9	2.0E-14	HDL cholesterol	
PRAD	trans	1	rs4882130	chr11:48588954	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.9	2.0E-14	HDL cholesterol	
PRAD	trans	1	rs4882132	chr11:48593125	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.65	1.16E-13	HDL cholesterol	
PRAD	trans	1	rs4882134	chr11:48598795	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.06	6.26E-15	HDL cholesterol	
PRAD	trans	1	rs4882136	chr11:48615311	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.88	2.23E-14	HDL cholesterol	
PRAD	trans	1	rs4925166	chr17:18210810	LOC162632	chr17:16614993-16707819:+	0.48	7.96	1.26E-14	Multiple sclerosis	
PRAD	trans	1	rs4929903	chr11:48913332	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.91	1.92E-14	HDL cholesterol	
PRAD	trans	1	rs55834832	chr11:48562583	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.99	1.03E-14	HDL cholesterol	
PRAD	trans	1	rs6016142	chr20:38300807	KCNJ6	chr21:38996786-39288696:-	0.45	6.04	3.16E-9	Estradiol levels	
PRAD	trans	1	rs641862	chr13:110790232	ABHD13	chr13:108870763-108886602:+	0.52	6.29	7.47E-10	Obesity-related traits	
PRAD	trans	1	rs641862	chr13:110790232	CDC16	chr13:115000362-115038150:+	0.7	6.64	8.72E-11	Obesity-related traits	
PRAD	trans	1	rs641862	chr13:110790232	CUL4A	chr13:113863086-113919391:+	0.61	6.13	1.87E-9	Obesity-related traits	
PRAD	trans	1	rs641862	chr13:110790232	MCF2L	chr13:113622757-113752863:+	0.55	5.86	8.64E-9	Obesity-related traits	
PRAD	trans	1	rs641862	chr13:110790232	PCID2	chr13:113831925-113863029:-	0.7	6.33	5.58E-10	Obesity-related traits	
PRAD	trans	1	rs641862	chr13:110790232	TFDP1	chr13:114239003-114295786:+	0.59	6.75	4.43E-11	Obesity-related traits	
PRAD	trans	1	rs641862	chr13:110790232	TUBGCP3	chr13:113139328-113242481:-	0.56	6.81	3.06E-11	Obesity-related traits	
PRAD	trans	1	rs6455128	chr6:62697746	GUSBL2	chr6:58246159-58287724:-	-0.37	-5.91	6.41E-9	Protein quantitative trait loci	
PRAD	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.63	13.51	2.3E-35	Educational attainment	
PRAD	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.63	13.51	2.3E-35	Educational attainment	
PRAD	trans	1	rs6485872	chr11:48579710	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.17	2.85E-15	HDL cholesterol	
PRAD	trans	1	rs6485875	chr11:48581034	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.9	2.0E-14	HDL cholesterol	
PRAD	trans	1	rs6485882	chr11:48592435	FOLH1B	chr11:89392465-89431885:+	0.39	7.51	3.05E-13	HDL cholesterol	
PRAD	trans	1	rs6485888	chr11:48605339	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.04	7.14E-15	HDL cholesterol	
PRAD	trans	1	rs6485903	chr11:48639004	FOLH1B	chr11:89392465-89431885:+	-0.43	-8.29	1.23E-15	HDL cholesterol	
PRAD	trans	1	rs6485907	chr11:48651695	FOLH1B	chr11:89392465-89431885:+	-0.43	-8.44	4.04E-16	HDL cholesterol	
PRAD	trans	1	rs6485908	chr11:48652198	FOLH1B	chr11:89392465-89431885:+	-0.51	-6.61	1.04E-10	Axial length	
PRAD	trans	1	rs6485911	chr11:48654784	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.14	3.62E-15	HDL cholesterol	
PRAD	trans	1	rs6600669	chr1:121213639	NBPF14	chr1:148003643-148346791:-	0.38	8.93	9.42E-18	Hip geometry	
PRAD	trans	1	rs6600671	chr1:121200490	NBPF14	chr1:148003643-148346791:-	-0.36	-8.57	1.5E-16	Hip geometry	
PRAD	trans	1	rs68141011	chr6:28217797	BTN3A2	chr6:26365398-26378546:+	-0.51	-9.98	2.07E-21	Depression	
PRAD	trans	1	rs68141011	chr6:28217797	ZFP57	chr6:29640171-29648887:-	0.44	6.2	1.27E-9	Depression	
PRAD	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.58	16.09	1.05E-46	Migraine without aura	
PRAD	trans	1	rs6901575	chr6:28250984	BTN3A2	chr6:26365398-26378546:+	-0.49	-9.77	1.23E-20	Depression	
PRAD	trans	1	rs6901575	chr6:28250984	VARS2	chr6:30881982-30894233:+	-0.35	-6.16	1.58E-9	Depression	
PRAD	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.61	13.07	1.7E-33	Educational attainment	
PRAD	trans	1	rs6905391	chr6:28262686	BTN3A2	chr6:26365398-26378546:+	-0.46	-9.07	3.22E-18	Depression	
PRAD	trans	1	rs6905391	chr6:28262686	VARS2	chr6:30881982-30894233:+	-0.33	-5.96	4.91E-9	Depression	
PRAD	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.62	13.29	1.84E-34	Educational attainment	
PRAD	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.62	-13.36	1.0E-34	Educational attainment	
PRAD	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.63	13.5	2.43E-35	Educational attainment	
PRAD	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.62	13.3	1.84E-34	Educational attainment	
PRAD	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.63	13.53	1.91E-35	Educational attainment	
PRAD	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.61	13.07	1.7E-33	Educational attainment	
PRAD	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.62	13.43	4.77E-35	Educational attainment	
PRAD	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.63	13.5	2.43E-35	Educational attainment	
PRAD	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.62	13.33	1.36E-34	Educational attainment	
PRAD	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.62	13.37	9.15E-35	Educational attainment	
PRAD	trans	1	rs6955934	chr7:23251499	GAGE2D	chrX:49197563-49223943:+;chrX	0.27	6.33	5.81E-10	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs705696	chr12:56480648	RPS26P11	chrX:71264259-71264809:+	0.55	8.98	6.38E-18	Cognitive function	
PRAD	trans	1	rs7107184	chr11:48577069	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.14	3.55E-15	HDL cholesterol	
PRAD	trans	1	rs7121460	chr11:48545232	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.19	2.41E-15	HDL cholesterol	
PRAD	trans	1	rs7121992	chr11:48592582	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.88	2.32E-14	HDL cholesterol	
PRAD	trans	1	rs7125559	chr11:48984207	FOLH1B	chr11:89392465-89431885:+	0.53	6.84	2.54E-11	Axial length	
PRAD	trans	1	rs7125913	chr11:48984318	FOLH1B	chr11:89392465-89431885:+	0.53	6.84	2.54E-11	Axial length	
PRAD	trans	1	rs7129386	chr11:48616694	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.04	7.14E-15	HDL cholesterol	
PRAD	trans	1	rs7129556	chr11:77300048	INTS4L1	chr7:64601603-64694599:+	-0.42	-6.99	9.67E-12	Weight loss (gastric bypass surgery)	
PRAD	trans	1	rs7131020	chr11:48642132	FOLH1B	chr11:89392465-89431885:+	0.52	6.69	6.38E-11	Axial length	
PRAD	trans	1	rs72832650	chr2:116853156	MEA1	chr6:42948082-42981660:-	-0.34	-6.06	2.75E-9	Urate levels (BMI interaction)	
PRAD	trans	1	rs72843784	chr6:26498758	CDSN	chr6:31082870-31088223:-	-0.56	-6.1	2.26E-9	Schizophrenia	
PRAD	trans	1	rs72843784	chr6:26498758	RNF5P1	chr8:38457695-38458775:-	0.59	6	3.85E-9	Schizophrenia	
PRAD	trans	1	rs72843784	chr6:26498758	VARS2	chr6:30881982-30894233:+	-0.47	-5.86	8.62E-9	Schizophrenia	
PRAD	trans	1	rs72843784	chr6:26498758	ZFP57	chr6:29640171-29648887:-	0.82	8.35	7.64E-16	Schizophrenia	
PRAD	trans	1	rs72843784	chr6:26498758	ZNF389	chr6:28129551-28137375:+	-0.65	-6.47	2.51E-10	Schizophrenia	
PRAD	trans	1	rs735765	chr6:28170297	BTN3A2	chr6:26365398-26378546:+	-0.59	-11.11	1.3E-25	Depression	
PRAD	trans	1	rs735765	chr6:28170297	VARS2	chr6:30881982-30894233:+	-0.41	-6.94	1.28E-11	Depression	
PRAD	trans	1	rs7395662	chr11:48518893	FOLH1B	chr11:89392465-89431885:+	0.41	7.98	1.13E-14	HDL cholesterol	
PRAD	trans	1	rs7478900	chr11:48544003	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.02	8.45E-15	HDL cholesterol	
PRAD	trans	1	rs7479134	chr11:48625409	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.88	2.23E-14	HDL cholesterol	
PRAD	trans	1	rs7479498	chr11:48660499	FOLH1B	chr11:89392465-89431885:+	-0.43	-8.27	1.37E-15	HDL cholesterol	
PRAD	trans	1	rs7481308	chr11:48600067	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.89	2.15E-14	HDL cholesterol	
PRAD	trans	1	rs7481880	chr11:48609347	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.88	2.23E-14	HDL cholesterol	
PRAD	trans	1	rs7482176	chr11:48604620	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.53	2.69E-13	HDL cholesterol	
PRAD	trans	1	rs7482528	chr11:48640052	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.93	1.6E-14	HDL cholesterol	
PRAD	trans	1	rs7483920	chr11:48599969	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.06	6.26E-15	HDL cholesterol	
PRAD	trans	1	rs7532615	chr1:121172840	NBPF14	chr1:148003643-148346791:-	-0.38	-9.09	2.69E-18	Hip geometry	
PRAD	trans	1	rs76329678	chr5:49830286	LOC647121	chr1:121260910-121313686:+	-0.44	-9.25	7.98E-19	Schizophrenia	
PRAD	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.62	13.43	4.77E-35	Educational attainment	
PRAD	trans	1	rs7740487	chr6:28216486	BTN3A2	chr6:26365398-26378546:+	-0.51	-10.04	1.3E-21	Depression	
PRAD	trans	1	rs7740487	chr6:28216486	ZFP57	chr6:29640171-29648887:-	0.43	6.14	1.76E-9	Depression	
PRAD	trans	1	rs7925955	chr11:48647533	FOLH1B	chr11:89392465-89431885:+	-0.43	-8.37	6.5E-16	HDL cholesterol	
PRAD	trans	1	rs7928083	chr11:48613148	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.04	7.14E-15	HDL cholesterol	
PRAD	trans	1	rs7931984	chr11:48580835	FOLH1B	chr11:89392465-89431885:+	-0.41	-8	9.95E-15	HDL cholesterol	
PRAD	trans	1	rs7938880	chr11:48642154	FOLH1B	chr11:89392465-89431885:+	-0.43	-8.31	1.06E-15	HDL cholesterol	
PRAD	trans	1	rs7944356	chr11:48610154	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.04	7.14E-15	HDL cholesterol	
PRAD	trans	1	rs7945192	chr11:48580737	FOLH1B	chr11:89392465-89431885:+	-0.41	-8	9.95E-15	HDL cholesterol	
PRAD	trans	1	rs7948486	chr11:48912140	FOLH1B	chr11:89392465-89431885:+	0.44	8.53	2.02E-16	HDL cholesterol	
PRAD	trans	1	rs7949348	chr11:48493801	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.28	1.27E-15	HDL cholesterol	
PRAD	trans	1	rs7949554	chr11:48581992	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.9	2.0E-14	HDL cholesterol	
PRAD	trans	1	rs809367	chr10:89741806	PTENP1	chr9:33673507-33677418:-	0.35	6.23	1.01E-9	Parental extreme longevity (95 years and older)	
PRAD	trans	1	rs8188963	chr11:48685693	FOLH1B	chr11:89392465-89431885:+	0.53	6.81	2.96E-11	Axial length	
PRAD	trans	1	rs8189391	chr11:48859789	FOLH1B	chr11:89392465-89431885:+	0.43	8.15	3.33E-15	HDL cholesterol	
PRAD	trans	1	rs853676	chr6:28299687	BTN3A2	chr6:26365398-26378546:+	-0.49	-9.54	8.02E-20	Depression	
PRAD	trans	1	rs853676	chr6:28299687	VARS2	chr6:30881982-30894233:+	-0.37	-6.41	3.63E-10	Depression	
PRAD	trans	1	rs853678	chr6:28297313	BTN3A2	chr6:26365398-26378546:+	-0.48	-9.45	1.61E-19	Depression	
PRAD	trans	1	rs853678	chr6:28297313	VARS2	chr6:30881982-30894233:+	-0.34	-6.12	1.96E-9	Depression	
PRAD	trans	1	rs853679	chr6:28296863	BTN3A2	chr6:26365398-26378546:+	-0.48	-9.45	1.61E-19	Depression	
PRAD	trans	1	rs853679	chr6:28296863	VARS2	chr6:30881982-30894233:+	-0.34	-6.12	1.96E-9	Depression	
PRAD	trans	1	rs853685	chr6:28288785	BTN3A2	chr6:26365398-26378546:+	-0.48	-9.42	2.0E-19	Depression	
PRAD	trans	1	rs853685	chr6:28288785	VARS2	chr6:30881982-30894233:+	-0.35	-6.15	1.67E-9	Depression	
PRAD	trans	1	rs853694	chr6:28279100	BTN3A2	chr6:26365398-26378546:+	-0.47	-9.26	7.56E-19	Depression	
PRAD	trans	1	rs853694	chr6:28279100	VARS2	chr6:30881982-30894233:+	-0.34	-6.06	2.75E-9	Depression	
PRAD	trans	1	rs858232	chr7:23241719	GAGE2D	chrX:49197563-49223943:+;chrX	0.27	6.34	5.54E-10	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858237	chr7:23239223	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	6	3.95E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858245	chr7:23222727	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	6	3.95E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858247	chr7:23221283	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	6	3.95E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858277	chr7:23252261	GAGE2D	chrX:49197563-49223943:+;chrX	-0.27	-6.2	1.24E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858278	chr7:23252202	GAGE2D	chrX:49197563-49223943:+;chrX	0.26	6.1	2.21E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858280	chr7:23250874	GAGE2D	chrX:49197563-49223943:+;chrX	0.27	6.33	5.81E-10	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858281	chr7:23250567	GAGE2D	chrX:49197563-49223943:+;chrX	0.27	6.33	5.81E-10	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858282	chr7:23250035	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	5.91	6.59E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858285	chr7:23249518	GAGE2D	chrX:49197563-49223943:+;chrX	0.27	6.34	5.54E-10	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858291	chr7:23247361	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	5.92	6.28E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858292	chr7:23246733	GAGE2D	chrX:49197563-49223943:+;chrX	0.27	6.34	5.54E-10	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858293	chr7:23246324	GAGE2D	chrX:49197563-49223943:+;chrX	0.27	6.24	9.7E-10	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858296	chr7:23245548	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	5.92	6.39E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858297	chr7:23244961	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	5.92	6.39E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858298	chr7:23244920	GAGE2D	chrX:49197563-49223943:+;chrX	0.27	6.34	5.54E-10	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858301	chr7:23244323	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	5.92	6.39E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858302	chr7:23244243	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	5.92	6.39E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs858304	chr7:23243153	GAGE2D	chrX:49197563-49223943:+;chrX	-0.25	-5.92	6.39E-9	Chronic obstructive pulmonary disease	
PRAD	trans	1	rs877636	chr12:56480583	RPS26P11	chrX:71264259-71264809:+	-0.6	-10.47	3.31E-23	Cognitive function	
PRAD	trans	1	rs919586	chr8:13174671	AGPAT5	chr8:6565878-6619019:+	0.42	6.15	1.62E-9	Obesity-related traits	
PRAD	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.62	-13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.62	13.33	1.29E-34	Educational attainment	
PRAD	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.61	13.07	1.7E-33	Educational attainment	
PRAD	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.62	13.27	2.3E-34	Educational attainment	
PRAD	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.61	13.07	1.7E-33	Educational attainment	
PRAD	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.62	13.43	4.77E-35	Educational attainment	
PRAD	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.61	13.07	1.7E-33	Educational attainment	
PRAD	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.61	13.07	1.7E-33	Educational attainment	
PRAD	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.62	-13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.62	13.35	1.09E-34	Educational attainment	
PRAD	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.61	13.16	7.02E-34	Educational attainment	
PRAD	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.62	13.43	4.77E-35	Educational attainment	
PRAD	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.63	-13.38	7.79E-35	Educational attainment	
PRAD	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.63	13.51	2.3E-35	Educational attainment	
PRAD	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.63	13.51	2.3E-35	Educational attainment	
PRAD	trans	1	rs9645642	chr11:48705455	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.75	3.88E-17	HDL cholesterol	
PRAD	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.62	13.43	4.77E-35	Educational attainment	
PRAD	trans	1	rs9986596	chr6:28219661	BTN3A2	chr6:26365398-26378546:+	-0.51	-10.02	1.56E-21	Depression	
PRAD	trans	1	rs9986596	chr6:28219661	ZFP57	chr6:29640171-29648887:-	0.44	6.16	1.54E-9	Depression	
